PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sessa, M; Lorioli, L; Fumagalli, F; Acquati, S; Redaelli, D; Baldoli, C; Canale, S; Lopez, ID; Morena, F; Calabria, A; Fiori, R; Silvani, P; Rancoita, PMV; Gabaldo, M; Benedicenti, F; Antonioli, G; Assanelli, A; Cicalese, MP; del Carro, U; Sora, MGN; Martino, S; Quattrini, A; Montini, E; Di Serio, C; Ciceri, F; Roncarolo, MG; Aiuti, A; Naldini, L; Biffi, A				Sessa, Mario; Lorioli, Laura; Fumagalli, Francesca; Acquati, Serena; Redaelli, Daniela; Baldoli, Cristina; Canale, Sabrina; Lopez, Ignazio D.; Morena, Francesco; Calabria, Andrea; Fiori, Rossano; Silvani, Paolo; Rancoita, Paolo M. V.; Gabaldo, Michela; Benedicenti, Fabrizio; Antonioli, Gigliola; Assanelli, Andrea; Cicalese, Maria Pia; del Carro, Ubaldo; Sora, Maria Grazia Natali; Martino, Sabato; Quattrini, Angelo; Montini, Eugenio; Di Serio, Cielia; Ciceri, Fabio; Roncarolo, Maria Grazia; Aiuti, Alessandro; Naldini, Luigi; Biffi, Alessandra			Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial	LANCET			English	Article							NATURAL COURSE; NERVE-CONDUCTION; MOUSE MODEL; TRANSPLANTATION; CHILDREN; OUTCOMES; COHORT; MOTOR; INTEGRATION; PHENOTYPE	Background Metachromatic leukodystrophy (a deficiency of arylsulfatase A [ ARSA]) is a fatal demyelinating lysosomal disease with no approved treatment. We aimed to assess the long-term outcomes in a cohort of patients with early-onset metachromatic leukodystrophy who underwent haemopoietic stem-cell gene therapy (HSC-GT). Methods This is an ad-hoc analysis of data from an ongoing, non-randomised, open-label, single-arm phase 1/2 trial, in which we enrolled patients with a molecular and biochemical diagnosis of metachromatic leukodystrophy (presymptomatic late-infantile or early-juvenile disease or early-symptomatic early-juvenile disease) at the Paediatric Clinical Research Unit, Ospedale San Raffaele, in Milan. Trial participants received HSC-GT, which consisted of the infusion of autologous HSCs transduced with a lentiviral vector encoding ARSA cDNA, after exposure-targeted busulfan conditioning. The primary endpoints of the trial are safety (toxicity, absence of engraftment failure or delayed haematological reconstitution, and safety of lentiviral vector-tranduced cell infusion) and efficacy (improvement in Gross Motor Function Measure [GMFM] score relative to untreated historical controls, and ARSA activity, 24 months post-treatment) of HSC-GT. For this ad-hoc analysis, we assessed safety and efficacy outcomes in all patients who had received treatment and been followed up for at least 18 months post-treatment on June 1, 2015. This trial is registered with ClinicalTrials.gov, number NCT01560182. Findings Between April, 2010, and February, 2013, we had enrolled nine children with a diagnosis of early-onset disease (six had late-infantile disease, two had early-juvenile disease, and one had early-onset disease that could not be definitively classified). At the time of analysis all children had survived, with a median follow-up of 36 months (range 18-54). The most commonly reported adverse events were cytopenia (reported in all patients) and mucositis of different grades of severity (in five of nine patients [ grade 3 in four of five patients]). No serious adverse events related to the medicinal product were reported. Stable, sustained engraftment of gene-corrected HSCs was observed (a median of 60.4% [range 14.0-95.6] lentiviral vector-positive colony-forming cells across follow-up) and the engraftment level was stable during follow-up; engraftment determinants included the duration of absolute neutropenia and the vector copy number of the medicinal product. A progressive reconstitution of ARSA activity in circulating haemopoietic cells and in the cerebrospinal fluid was documented in all patients in association with a reduction of the storage material in peripheral nerve samples in six of seven patients. Eight patients, seven of whom received treatment when presymptomatic, had prevention of disease onset or halted disease progression as per clinical and instrumental assessment, compared with historical untreated control patients with early-onset disease. GMFM scores for six patients up to the last follow-up showed that gross motor performance was similar to that of normally developing children. The extent of benefit appeared to be influenced by the interval between HSC-GT and the expected time of disease onset. Treatment resulted in protection from CNS demyelination in eight patients and, in at least three patients, amelioration of peripheral nervous system abnormalities, with signs of remyelination at both sites. Interpretation Our ad-hoc findings provide preliminary evidence of safety and therapeutic benefit of HSC-GT in patients with early-onset metachromatic leukodystrophy who received treatment in the presymptomatic or very early-symptomatic stage. The results of this trial will be reported when all 20 patients have achieved 3 years of follow-up.	[Sessa, Mario; Lorioli, Laura; Fumagalli, Francesca; Acquati, Serena; Redaelli, Daniela; Canale, Sabrina; Calabria, Andrea; Gabaldo, Michela; Benedicenti, Fabrizio; Montini, Eugenio; Roncarolo, Maria Grazia; Aiuti, Alessandro; Naldini, Luigi; Biffi, Alessandra] SR TIGET, Div Regenerat Med Stem Cells & Gene Therapy, San Rafael, CA USA; [Sessa, Mario; Fumagalli, Francesca; Lopez, Ignazio D.; del Carro, Ubaldo; Sora, Maria Grazia Natali; Quattrini, Angelo] Neurol Unit, Milan, Italy; [Lorioli, Laura; Antonioli, Gigliola; Assanelli, Andrea; Cicalese, Maria Pia; Aiuti, Alessandro; Biffi, Alessandra] Pediat Immunohematol Unit, Milan, Italy; [Lorioli, Laura; Antonioli, Gigliola; Assanelli, Andrea; Cicalese, Maria Pia; Ciceri, Fabio; Aiuti, Alessandro; Biffi, Alessandra] Bone Marrow Transplantat Program, Milan, Italy; [Baldoli, Cristina] Neuroradiol Unit, Milan, Italy; [Fiori, Rossano; Silvani, Paolo] Dept Anesthesia & Crit Care, Milan, Italy; [Lorioli, Laura; Rancoita, Paolo M. V.; Di Serio, Cielia; Roncarolo, Maria Grazia; Naldini, Luigi; Biffi, Alessandra] IRCCS San Raffaele Sci Inst, Milan, Italy; [Lorioli, Laura; Rancoita, Paolo M. V.; Di Serio, Cielia; Roncarolo, Maria Grazia; Aiuti, Alessandro; Naldini, Luigi; Biffi, Alessandra] Univ Vita Salute San Raffaele, Milan, Italy; [Morena, Francesco; Martino, Sabato] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Perugia	Sessa, M (corresponding author), SR TIGET, Div Regenerat Med Stem Cells & Gene Therapy, San Rafael, CA USA.	alessandra.biffi@childrens.harvard.edu	Rancoita, Paola/AAN-2384-2020; Di Serio, Clelia/AAO-5494-2020; Morena, Francesco/AAB-2091-2019; Biffi, Alessandra/AAA-8890-2019; AIUTI, ALESSANDRO/K-3918-2016; Montini, Eugenio/L-1152-2016; Martino, Sabata/F-2309-2014; Baldoli, Cristina/AAF-2005-2020; Sessa, Maria/AAC-1943-2022; Fumagalli, Francesca/J-8697-2018; Del Carro, Ubaldo/AAO-3457-2020; Calabria, Andrea/AAA-3349-2019; Quattrini, Angelo/J-8373-2018	Morena, Francesco/0000-0001-9407-0576; AIUTI, ALESSANDRO/0000-0002-5398-1717; Montini, Eugenio/0000-0003-1771-6067; Martino, Sabata/0000-0002-3942-237X; Sessa, Maria/0000-0002-9589-0290; Fumagalli, Francesca/0000-0001-7476-4087; Del Carro, Ubaldo/0000-0003-3301-5412; Calabria, Andrea/0000-0003-3515-3384; Baldoli, Cristina/0000-0003-2697-5132; NALDINI, Luigi/0000-0002-7835-527X; Quattrini, Angelo/0000-0002-8226-8320; Rancoita, Paola M.V./0000-0001-9345-691X; Della Rosa, Pasquale Anthony/0000-0002-3137-1731; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	Italian Telethon Foundation; GlaxoSmithKline	Italian Telethon Foundation(Fondazione Telethon); GlaxoSmithKline(GlaxoSmithKline)	Italian Telethon Foundation and GlaxoSmithKline.	Biffi A, 2008, CLIN GENET, V74, P349, DOI 10.1111/j.1399-0004.2008.01058.x; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chen XQ, 2016, J CHILD NEUROL, V31, P338, DOI 10.1177/0883073815595078; Dacci P, 2010, GLIA, V58, P2005, DOI 10.1002/glia.21069; Garcia A, 2000, CLIN NEUROPHYSIOL, V111, P513, DOI 10.1016/S1388-2457(99)00279-5; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gieselmann V, 2010, NEUROPEDIATRICS, V41, P1, DOI 10.1055/s-0030-1253412; Groeschel S, 2011, J INHERIT METAB DIS, V34, P1095, DOI 10.1007/s10545-011-9361-1; Kehrer C, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-18; Kehrer C, 2011, DEV MED CHILD NEUROL, V53, P850, DOI 10.1111/j.1469-8749.2011.04028.x; Krageloh-Mann I, 2013, BONE MARROW TRANSPL, V48, P369, DOI 10.1038/bmt.2012.155; Lorioli L, 2015, EXPERT OPIN ORPHAN D, V3, P911, DOI 10.1517/21678707.2015.1062754; Martin HR, 2013, BIOL BLOOD MARROW TR, V19, P616, DOI 10.1016/j.bbmt.2013.01.010; Martinenghi S, 1997, DIABETOLOGIA, V40, P1110, DOI 10.1007/s001250050795; Musolino PL, 2014, NEUROPEDIATRICS, V45, P169, DOI 10.1055/s-0033-1364179; Orchard PJ, 2010, SEMIN HEMATOL, V47, P70, DOI 10.1053/j.seminhematol.2009.10.006; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PARANO E, 1993, J CHILD NEUROL, V8, P336, DOI 10.1177/088307389300800408; Pinheiro J, 2001, MIXED EFFECTS MODELS; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; van Egmond ME, 2013, JAMA NEUROL, V70, P779, DOI 10.1001/jamaneurol.2013.629; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234	29	288	296	1	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					476	487		10.1016/S0140-6736(16)30374-9	http://dx.doi.org/10.1016/S0140-6736(16)30374-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27289174				2022-12-28	WOS:000380559400027
J	Tap, WD; Jones, RL; Van Tine, BA				Tap, W. D.; Jones, R. L.; Van Tine, A. B.			Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial (vol 388, pg 488, 2016)	LANCET			English	Correction													van+Tine, Brain/AAI-1919-2019; Jones, Robin L/AAO-3738-2020	Jones, Robin L/0000-0003-4173-3844	NATIONAL CANCER INSTITUTE [P50CA140146, P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6	1	401	421	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					464	464						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27291997	Green Accepted			2022-12-28	WOS:000380559400025
J	Williams, EK; Chang, RB; Strochlic, DE; Umans, BD; Lowell, BB; Liberles, SD				Williams, Erika K.; Chang, Rui B.; Strochlic, David E.; Umans, Benjamin D.; Lowell, Bradford B.; Liberles, Stephen D.			Sensory Neurons that Detect Stretch and Nutrients in the Digestive System	CELL			English	Article							GLUCAGON-LIKE PEPTIDE-1; VAGAL AFFERENT RESPONSES; C-FOS EXPRESSION; FOOD-INTAKE; GASTRIC SATIATION; SMALL-INTESTINE; BRAIN-STEM; RAT; RECEPTORS; CHOLECYSTOKININ	Neural inputs from internal organs are essential for normal autonomic function. The vagus nerve is a key body-brain connection that monitors the digestive, cardiovascular, and respiratory systems. Within the gastrointestinal tract, vagal sensory neurons detect gut hormones and organ distension. Here, we investigate the molecular diversity of vagal sensory neurons and their roles in sensing gastrointestinal inputs. Genetic approaches allowed targeted investigation of gut-to-brain afferents involved in homeostatic responses to ingested nutrients (GPR65 neurons) and mechanical distension of the stomach and intestine (GLP1R neurons). Optogenetics, in vivo ganglion imaging, and genetically guided anatomical mapping provide direct links between neuron identity, peripheral anatomy, central anatomy, conduction velocity, response properties in vitro and in vivo, and physiological function. These studies clarify the roles of vagal afferents in mediating particular gut hormone responses. Moreover, genetic control over gut-to-brain neurons provides a molecular framework for understanding neural control of gastrointestinal physiology.	[Williams, Erika K.; Chang, Rui B.; Strochlic, David E.; Umans, Benjamin D.; Liberles, Stephen D.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Lowell, Bradford B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Liberles, SD (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	stephen_liberles@hms.harvard.edu		Liberles, Stephen/0000-0002-2177-9741; Umans, Benjamin/0000-0002-8209-9731	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK103703]; National Science Foundation (NSF) pre-doctoral fellowship; F30 NIH training grant [F30CA177170]; T32 training grant for the Harvard MSTP program [T32GM007753]; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL CANCER INSTITUTE [F30CA177170] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL132645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, P30DK057521, R01DK075632, R01DK103703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation (NSF) pre-doctoral fellowship(National Science Foundation (NSF)); F30 NIH training grant; T32 training grant for the Harvard MSTP program; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Ginty, Ardem Patapoutian, and John Flanagan for manuscript comments, the Nikon Imaging Center at Harvard Medical Center for microscopy assistance, and the Boston Area Diabetes Research Center Transgenic Core (P30 DK046200) and Boston Area Nutrition Research Center Transgenic Core (P30 DK057521) for generating knockin mice. Funding was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (RO1 DK103703 to S.D.L.), a National Science Foundation (NSF) pre-doctoral fellowship (to D.E.S.), an F30 NIH training grant (F30CA177170 to E.K.W.), a T32 training grant for the Harvard MSTP program (T32GM007753 to E.K.W.), and the Harvard-MIT Joint Research Grants Program in Basic Neuroscience (to S.D.L. and B.B.L.).	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Berthoud HR, 2004, NEUROGASTROENT MOTIL, V16, P28, DOI 10.1111/j.1743-3150.2004.00471.x; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; BLACKSHAW LA, 1990, J AUTONOM NERV SYST, V31, P191, DOI 10.1016/0165-1838(90)90185-L; Brookes SJH, 2013, NAT REV GASTRO HEPAT, V10, P286, DOI 10.1038/nrgastro.2013.29; Bucinskaite V, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01317.x; Chambers AP, 2013, CURR BIOL, V23, pR379, DOI 10.1016/j.cub.2013.03.020; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Fox EA, 2000, J COMP NEUROL, V428, P558, DOI 10.1002/1096-9861(20001218)428:3<558::AID-CNE11>3.0.CO;2-M; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hayes MR, 2010, PHYSIOL BEHAV, V100, P503, DOI 10.1016/j.physbeh.2010.02.029; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Hillsley K, 1998, NEUROSCI LETT, V255, P63, DOI 10.1016/S0304-3940(98)00690-9; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; JEANNINGROS R, 1982, PHYSIOL BEHAV, V28, P9, DOI 10.1016/0031-9384(82)90094-4; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; Mazda T, 2004, AM J PHYSIOL-GASTR L, V287, pG228, DOI 10.1152/ajpgi.00373.2003; MEI N, 1978, J PHYSIOL-LONDON, V282, P485, DOI 10.1113/jphysiol.1978.sp012477; MEI N, 1986, J AUTONOM NERV SYST, V16, P159, DOI 10.1016/0165-1838(86)90022-6; Page AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1376, DOI 10.1152/ajpgi.00536.2006; Phifer CB, 1998, AM J PHYSIOL-REG I, V274, pR1725, DOI 10.1152/ajpregu.1998.274.6.R1725; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; Richards W, 1996, J PHYSIOL-LONDON, V497, P473, DOI 10.1113/jphysiol.1996.sp021781; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; SCHWARTZ GJ, 1991, AM J PHYSIOL, V261, pR64, DOI 10.1152/ajpregu.1991.261.1.R64; Sisley S, 2014, J CLIN INVEST, V124, P2456, DOI 10.1172/JCI72434; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Willing AE, 1997, AM J PHYSIOL-REG I, V272, pR59, DOI 10.1152/ajpregu.1997.272.1.R59; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zagorodnyuk VP, 2001, J PHYSIOL-LONDON, V534, P255, DOI 10.1111/j.1469-7793.2001.00255.x; Zhang JC, 2012, AM J PHYSIOL-REG I, V302, pR264, DOI 10.1152/ajpregu.00114.2011; Zhu JX, 2001, J PHYSIOL-LONDON, V530, P431, DOI 10.1111/j.1469-7793.2001.0431k.x	43	279	284	5	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					209	221		10.1016/j.cell.2016.05.011	http://dx.doi.org/10.1016/j.cell.2016.05.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27238020	Green Accepted, Bronze			2022-12-28	WOS:000380254400022
J	Eumann, CNN; Hooker, JM; Ritter, T				Eumann, Constanze N. N.; Hooker, Jacob M.; Ritter, Tobias			Concerted nucleophilic aromatic substitution with F-19(-) and F-18(-)	NATURE			English	Article							OXIDATIVE FLUORINATION; DEOXYFLUORINATION; MECHANISMS; IONS; PET	Nucleophilic aromatic substitution (SNAr) is widely used by organic chemists to functionalize aromatic molecules, and it is the most commonly used method to generate arenes that contain F-18 for use in positron-emission tomography (PET) imaging(1). A wide range of nucleophiles exhibit SNAr reactivity, and the operational simplicity of the reaction means that the transformation can be conducted reliably and on large scales(2). During SNAr, attack of a nucleophile at a carbon atom bearing a 'leaving group' leads to a negatively charged intermediate called a Meisenheimer complex. Only arenes with electron-withdrawing substituents can sufficiently stabilize the resulting build-up of negative charge during Meisenheimer complex formation, limiting the scope of SNAr reactions: the most common SNAr substrates contain strong p-acceptors in the ortho and/or para position(s)(3.) Here we present an unusual concerted nucleophilic aromatic substitution reaction (CSNAr) that is not limited to electron-poor arenes, because it does not proceed via a Meisenheimer intermediate. We show a phenol deoxyfluorination reaction for which CSNAr is favoured over a stepwise displacement. Mechanistic insights enabled us to develop a functional-group-tolerant F-18-deoxyfluorination reaction of phenols, which can be used to synthesize F-18-PET probes. Selective F-18 introduction, without the need for the common, but cumbersome, azeotropic drying of F-18, can now be accomplished from phenols as starting materials, and provides access to F-18-labelled compounds not accessible through conventional chemistry.	[Eumann, Constanze N. N.; Ritter, Tobias] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hooker, Jacob M.; Ritter, Tobias] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA; [Hooker, Jacob M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Hooker, Jacob M.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ritter, Tobias] Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Max Planck Society	Ritter, T (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Ritter, T (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA.; Ritter, T (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	ritter@mpi-muelheim.mpg.de	Hooker, Jacob M/P-5716-2018; Ritter, Tobias/AAJ-8703-2021; Neumann, Constanze/AAL-3918-2020	Hooker, Jacob M/0000-0002-9394-7708; Neumann, Constanze/0000-0003-1004-1140	Patty and Michael Phelps Foundation; National Institutes of Health (NIH) National Institute of General Medical Sciences [GM088237]; NIH [1S10RR017208]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088237] Funding Source: NIH RePORTER	Patty and Michael Phelps Foundation; National Institutes of Health (NIH) National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Patty and Michael Phelps Foundation and the National Institutes of Health (NIH) National Institute of General Medical Sciences (GM088237) for funding. Radioisotope production and use were enabled by a shared instrument grant from the NIH (1S10RR017208). We thank S. Arlow and C. Kleinlein for preliminary mechanistic work and H. Lee for assistance with X-ray crystallography. We thank N. A. Stephenson for a synthetic precursor for S6 as well as the <SUP>19</SUP>F-standard for this substrate.	Bronner SM, 2011, J AM CHEM SOC, V133, P3832, DOI 10.1021/ja200437g; Cheron N, 2011, CHEM-EUR J, V17, P14929, DOI 10.1002/chem.201102463; Crampton M. R., 2012, ORGANIC REACTION MEC, P175; Dub PA, 2013, B CHEM SOC JPN, V86, P557, DOI 10.1246/bcsj.20120359; Fernandez I, 2010, J ORG CHEM, V75, P2971, DOI 10.1021/jo100195w; FRY SE, 1985, J AM CHEM SOC, V107, P6399, DOI 10.1021/ja00308a045; Fujimoto T, 2014, ORG PROCESS RES DEV, V18, P1041, DOI 10.1021/op500121w; Gao ZH, 2012, ANGEW CHEM INT EDIT, V51, P6733, DOI 10.1002/anie.201201502; Glukhovtsev MN, 1997, J ORG CHEM, V62, P4036, DOI 10.1021/jo962096e; Goryunov LI, 2010, EUR J ORG CHEM, V2010, P1111, DOI 10.1002/ejoc.200900880; HUNTER A, 1993, J CHEM SOC PERK T 2, P1703; HUNTER A, 1995, J AM CHEM SOC, V117, P5484, DOI 10.1021/ja00125a008; Ichiishi N, 2014, ORG LETT, V16, P3224, DOI 10.1021/ol501243g; Lasne MC, 2002, TOP CURR CHEM, V222, P201; Lee E, 2012, J AM CHEM SOC, V134, P17456, DOI 10.1021/ja3084797; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lloyd-Jones GC, 2008, SYNTHESIS-STUTTGART, P661, DOI 10.1055/s-2008-1032179; Matsson O, 2007, J LABELLED COMPD RAD, V50, P982, DOI 10.1002/jlcr.1443; Mu L, 2012, EUR J ORG CHEM, V2012, P889, DOI 10.1002/ejoc.201101730; Nawaz F, 2013, CHEM-EUR J, V19, P17578, DOI 10.1002/chem.201303359; Neumann CN, 2015, ANGEW CHEM INT EDIT, V54, P3216, DOI 10.1002/anie.201410288; Picazo E, 2015, TETRAHEDRON LETT, V56, P3511, DOI 10.1016/j.tetlet.2015.01.022; RENFREW AHM, 1994, J CHEM SOC PERK T 2, P2383, DOI 10.1039/p29940002383; SAWYER CB, 1973, J AM CHEM SOC, V95, P7375, DOI 10.1021/ja00803a027; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; Tang PP, 2011, J AM CHEM SOC, V133, P11482, DOI 10.1021/ja2048072; TERRIER F, 2013, MODERN NUCLEOPHILIC, P1; Tredwell M, 2014, ANGEW CHEM INT EDIT, V53, P7751, DOI 10.1002/anie.201404436; WILLIAMS A, 1994, CHEM SOC REV, V23, P93, DOI 10.1039/cs9942300093; YAMABE S, 1984, CAN J CHEM, V62, P235, DOI 10.1139/v84-038	30	167	166	3	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					369	373		10.1038/nature17667	http://dx.doi.org/10.1038/nature17667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281221	Green Accepted, Green Submitted			2022-12-28	WOS:000377856800032
J	Srivastava, R				Srivastava, Ranjana			The Sharing of Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Srivastava, Ranjana] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2309	2311		10.1056/NEJMp1603934	http://dx.doi.org/10.1056/NEJMp1603934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305191				2022-12-28	WOS:000377854600004
J	Bunge, RG				Bunge, Raymond G.			Satire Corporations Sans Humor (Reprinted from JAMA, vol 196, pg 282, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2474	2474		10.1001/jama.2015.17089	http://dx.doi.org/10.1001/jama.2015.17089			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299636				2022-12-28	WOS:000377656900038
J	Albert, S; Bauer, T; Michl, M; Biroli, G; Bouchaud, JP; Loidl, A; Lunkenheimer, P; Tourbot, R; Wiertel-Gasquet, C; Ladieu, F				Albert, S.; Bauer, Th.; Michl, M.; Biroli, G.; Bouchaud, J. -P.; Loidl, A.; Lunkenheimer, P.; Tourbot, R.; Wiertel-Gasquet, C.; Ladieu, F.			Fifth-order susceptibility unveils growth of thermodynamic amorphous order in glass-formers	SCIENCE			English	Article							SUPERCOOLED LIQUIDS; FORMING LIQUIDS; RELAXATION; TRANSITION; DYNAMICS	Glasses are ubiquitous in daily life and technology. However, the microscopic mechanisms generating this state of matter remain subject to debate: Glasses are considered either as merely hyperviscous liquids or as resulting from a genuine thermodynamic phase transition toward a rigid state. We showthat third-and fifth-order susceptibilities provide a definite answer to this long-standing controversy. Performing the corresponding high-precision nonlinear dielectric experiments for supercooled glycerol and propylene carbonate, we find strong support for theories based on thermodynamic amorphous order. Moreover, when lowering temperature, we find that the growing transient domains are compact-that is, their fractal dimension d(f) = 3. The glass transitionmay thus represent a class of critical phenomena different from canonical second-order phase transitions for which d(f) < 3.	[Albert, S.; Tourbot, R.; Wiertel-Gasquet, C.; Ladieu, F.] Univ Paris Saclay, CEA Saclay, CNRS, SPEC,CEA, Bat 772, F-91191 Gif Sur Yvette, France; [Bauer, Th.; Michl, M.; Loidl, A.; Lunkenheimer, P.] Univ Augsburg, Ctr Elect Correlat & Magnetism, Expt Phys 5, D-86159 Augsburg, Germany; [Biroli, G.] Univ Paris Saclay, CEA Saclay, CNRS, IPhT,CEA, Bat 774, F-91191 Gif Sur Yvette, France; [Biroli, G.] Ecole Normale Super, LPS, 24 Rue Lhomond, F-75231 Paris 05, France; [Bouchaud, J. -P.] Capital Fund Management, 23 Rue Univ, F-75007 Paris, France; [Bauer, Th.] Tech Univ Munich, Inst Machine Tools & Ind Management, D-85748 Garching, Germany	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Augsburg; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Technical University of Munich	Ladieu, F (corresponding author), Univ Paris Saclay, CEA Saclay, CNRS, SPEC,CEA, Bat 772, F-91191 Gif Sur Yvette, France.	francois.ladieu@cea.fr	Albert, Samuel/D-4635-2018; Bauer, Thomas/N-2549-2016; Lunkenheimer, Peter/C-6196-2008; Bauer, Thomas/ABC-9001-2020; Loidl, Alois/L-8199-2015	Albert, Samuel/0000-0001-9543-3981; Bauer, Thomas/0000-0002-2629-5682; Lunkenheimer, Peter/0000-0002-4525-1394; Bauer, Thomas/0000-0002-2629-5682; Loidl, Alois/0000-0002-5579-0746	ERC grant NPRGLASS; Labex RTRA grant Aricover; Institut des Systemes Complexes ISC-PIF; Deutsche Forschungsgemeinschaft via Research Unit [FOR1394]	ERC grant NPRGLASS; Labex RTRA grant Aricover; Institut des Systemes Complexes ISC-PIF; Deutsche Forschungsgemeinschaft via Research Unit(German Research Foundation (DFG))	We thank C. Alba-Simionesco, A. Coniglio, P.-M. Dejardin, G. Tarjus, and M. Tarzia for interesting discussions. The work in Saclay was supported by ERC grant NPRGLASS, by the Labex RTRA grant Aricover, and by the Institut des Systemes Complexes ISC-PIF. The work in Augsburg was supported by the Deutsche Forschungsgemeinschaft via Research Unit FOR1394. S.A., R.T., C. W.-G., and F.L. developed the experimental setup at Saclay; Th.B. and P.L. developed the experimental setup at Augsburg; Th.B. and M. M. performed the measurements and analysis of the Augsburg data; A.L. and P.L. conceived and supervised the project in Augsburg; G.B. and J.-P.B. derived the theoretical scaling analysis; and all authors were involved in the interpretation of the results and creation of this manuscript. Data are available as supplementary material. All authors have no competing financial interests.	Bauer T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225702; Berthier L, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4939640; Berthier L, 2011, REV MOD PHYS, V83, P587, DOI 10.1103/RevModPhys.83.587; Biroli G, 2008, NAT PHYS, V4, P771, DOI 10.1038/nphys1050; Biroli G., 2012, STRUCTURAL GLASSES S, P31, DOI DOI 10.1002/9781118202470.CH2; Blochowicz T, 2003, J CHEM PHYS, V118, P7544, DOI 10.1063/1.1563247; BOHMER R, 1993, J CHEM PHYS, V99, P4201, DOI 10.1063/1.466117; Bouchaud JP, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064204; Bouchaud JP, 2004, J CHEM PHYS, V121, P7347, DOI 10.1063/1.1796231; Brun C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.175702; Buchenau U, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042312; Casalini R, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4907371; Chandler D, 2010, ANNU REV PHYS CHEM, V61, P191, DOI 10.1146/annurev.physchem.040808.090405; COFFEY WT, 1978, P ROY IRISH ACAD A, V78, P17; Coniglio A., 2009, ENCY COMPLEXITY SY 3, P1596; Crauste-Thibierge C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.165703; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Dzero M, 2012, STRUCTURAL GLASSES S, P193; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; Kimura Y, 2000, PHYS REV E, V62, pR5907, DOI 10.1103/PhysRevE.62.R5907; Ladieu F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184207; LEVY LP, 1988, PHYS REV B, V38, P4963, DOI 10.1103/PhysRevB.38.4963; Mossa S, 2003, J CHEM PHYS, V119, P8069, DOI 10.1063/1.1604380; Pinney R, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4938424; Richert R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.095703; Stevenson JD, 2006, NAT PHYS, V2, P268, DOI 10.1038/nphys261; Tarjus G, 2005, J PHYS-CONDENS MAT, V17, pR1143, DOI 10.1088/0953-8984/17/50/R01	27	130	131	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1308	1311		10.1126/science.aaf3182	http://dx.doi.org/10.1126/science.aaf3182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284191	Green Submitted			2022-12-28	WOS:000377972000038
J	Oakeshott, P; Chappell, LC				Oakeshott, Pippa; Chappell, Lucy C.			10-MINUTE CONSULTATION Management of a new pregnancy in a woman with chronic hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oakeshott, Pippa] Univ London, Populat Hlth Res Inst, Gen Practice, London SW17 0RE, England; [Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, Obstet, London WC2R 2LS, England	University of London; University of London; King's College London	Oakeshott, P (corresponding author), Univ London, Populat Hlth Res Inst, Gen Practice, London SW17 0RE, England.	oakeshot@sgul.ac.uk		Oakeshott, Pippa/0000-0003-2568-8211	National Institute for Health Research [RP-2014-05-019] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bramham Kate, 2013, BMJ, V346, pf894, DOI 10.1136/bmj.f894; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Hodgkinson JA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6616; Li DK, 2011, BMJ-BRIT MED J, V343, pd5931, DOI [DOI 10.1136/BMJ.D5931, 10.1136/bmj.d5931pmid:22010128]; Magee LA, 2015, NEW ENGL J MED, V372, P407, DOI 10.1056/NEJMoa1404595; National Institute for Health and Care Excellence, 2010, HYP PREGN DIAGN MAN; National Institute for Health and Care Excellence, 2011, HYP AD DIAGN MAN PRI	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i1497	10.1136/bmj.i1497	http://dx.doi.org/10.1136/bmj.i1497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27270508				2022-12-28	WOS:000377857800001
J	Jain, P; Ruchin, P; Suttie, J				Jain, Pankaj; Ruchin, Peter; Suttie, Joseph			Proximal pulmonary artery stenosis: a rare manifestation of granulomatosis with polyangiitis	LANCET			English	Editorial Material							WEGENERS-GRANULOMATOSIS		[Jain, Pankaj; Ruchin, Peter; Suttie, Joseph] Wagga Wagga Base Hosp, Dept Cardiol, Wagga Wagga, NSW, Australia		Jain, P (corresponding author), Wagga Wagga Base Hosp, Wagga Wagga, NSW 2650, Australia.	pankaj185@gmail.com						Clark T, 2003, CLIN EXP RHEUMATOL, V21, pS124; Colin GC, 2014, EUR HEART J, V35, P3141, DOI 10.1093/eurheartj/ehu360; Doyle DJ, 2003, CLIN RADIOL, V58, P329, DOI 10.1016/S0009-9260(02)00517-2; Ozaki T, 2015, MOD RHEUMATOL, V2, P1	4	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2349	2350		10.1016/S0140-6736(16)00584-5	http://dx.doi.org/10.1016/S0140-6736(16)00584-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302274				2022-12-28	WOS:000376969100038
J	Pociot, F; Lernmark, A				Pociot, Flemming; Lernmark, Ake			Genetic risk factors for type 1 diabetes	LANCET			English	Article							GENERATION SEQUENCING REVEALS; AUTOANTIBODY APPEARANCE; ISLET AUTOANTIBODIES; DEPENDENT ONSET; YOUNG DAISY; AUTOIMMUNITY; DISEASE; SUSCEPTIBILITY; ASSOCIATION; CHILDREN	Type 1 diabetes is diagnosed at the end of a prodrome of beta-cell autoimmunity. The disease is most likely triggered at an early age by autoantibodies primarily directed against insulin or glutamic acid decarboxylase, or both, but rarely against islet antigen-2. After the initial appearance of one of these autoantibody biomarkers, a second, third, or fourth autoantibody against either islet antigen-2 or the ZnT8 transporter might also appear. The larger the number of beta-cell autoantibody types, the greater the risk of rapid progression to clinical onset of diabetes. This association does not necessarily mean that the beta-cell autoantibodies are pathogenic, but rather that they represent reproducible biomarkers of the pathogenesis. The primary risk factor for beta-cell autoimmunity is genetic, mainly occurring in individuals with either HLA-DR3-DQ2 or HLA-DR4-DQ8 haplotypes, or both, but a trigger from the environment is generally needed. The pathogenesis can be divided into three stages: 1, appearance of beta-cell autoimmunity, normoglycaemia, and no symptoms; 2, beta-cell autoimmunity, dysglycaemia, and no symptoms; and 3, beta-cell autoimmunity, dysglycaemia, and symptoms of diabetes. The genetic association with each one of the three stages can differ. Type 1 diabetes could serve as a disease model for organ-specific autoimmune disorders such as coeliac disease, thyroiditis, and Addison's disease, which show similar early markers of a prolonged disease process before clinical diagnosis.	[Pociot, Flemming] Herlev & Gentofte Hosp, Dept Pediat, DK-2730 Herlev, Denmark; [Lernmark, Ake] Lund Univ, Skane Univ Hosp, Dept Clin Sci, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Lernmark, A (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, SE-20502 Malmo, Sweden.	ake.lernmark@med.lu.se	Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499; Pociot, Flemming/0000-0003-3274-5448				Ahlqvist E, 2015, NAT REV NEPHROL, V11, P277, DOI 10.1038/nrneph.2015.37; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bunyavanich S, 2015, J ALLERGY CLIN IMMUN, V135, P31, DOI 10.1016/j.jaci.2014.10.015; Carmichael SK, 2003, GENET MED, V5, P77, DOI 10.1097/01.GIM.0000055196.67008.1B; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Couper JJ, 2001, J PAEDIATR CHILD H, V37, P218, DOI 10.1046/j.1440-1754.2001.00658.x; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; Doerflinger M, 2015, FEBS J, V282, P1006, DOI 10.1111/febs.13190; Erlich HA, 2013, DIABETES, V62, P2618, DOI 10.2337/db12-1387; Floyel T, 2014, P NATL ACAD SCI USA, V111, P10305, DOI 10.1073/pnas.1402571111; Fujimoto H, 2011, AM J PATHOL, V179, P2327, DOI 10.1016/j.ajpath.2011.08.001; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Ilonen J, 1996, DIABETOLOGIA, V39, P123; Ilonen J, 1998, DIABETES METAB REV, V14, P188, DOI 10.1002/(SICI)1099-0895(199806)14:2<188::AID-DMR1210>3.0.CO;2-0; Ilonen J, 2013, DIABETES, V62, P3636, DOI 10.2337/db13-0300; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; IRVINE WJ, 1979, J CLIN LAB IMMUNOL, V2, P23; Kaur S, 2016, MOL CELL ENDOCRINOL, V419, P83, DOI 10.1016/j.mce.2015.10.002; Knip M, 2002, AM J MED GENET, V115, P48, DOI 10.1002/ajmg.10343; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; Larsson HE, 2008, DIABETOLOGIA, V51, P1623, DOI 10.1007/s00125-008-1074-0; Leslie RD, 2016, DIABETOLOGIA, V59, P13, DOI 10.1007/s00125-015-3789-z; Mattila TK, 2010, DRUGS, V70, P2229, DOI 10.2165/11585220-000000000-00000; Meka RR, 2015, AUTOIMMUN REV, V14, P1131, DOI 10.1016/j.autrev.2015.08.001; Mirza AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105723; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Palmer JP, 2005, DIABETES, V54, pS62, DOI 10.2337/diabetes.54.suppl_2.S62; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pociot F, 2015, DIABETES CARE S3, V38, pS8; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; SANJEEVI CB, 1995, DIABETES, V44, P125, DOI 10.2337/diabetes.44.1.125; Sherwin R, 2012, J CLIN ENDOCR METAB, V97, P4293, DOI 10.1210/jc.2012-3487; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Torn C, 2015, DIABETES, V64, P1818, DOI 10.2337/db14-1497; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Wang HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011789; Wang R, 2008, CELL MOL LIFE SCI, V65, P3851, DOI 10.1007/s00018-008-8540-1; Wei P, 2009, DIABETOLOGIA, V52, P2142, DOI 10.1007/s00125-009-1446-0; Wion E, 2003, ANN NY ACAD SCI, V1005, P400, DOI 10.1196/annals.1288.067; Zhao LP, 2016, DIABETES, V65, P710, DOI 10.2337/db15-1115; ZIEGLER AG, 1993, DIABETOLOGIA, V36, P402, DOI 10.1007/BF00402275; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; ZIEGLER R, 1991, DIABETES, V40, P709, DOI 10.2337/diabetes.40.6.709; Zouk H, 2014, CLIN EXP IMMUNOL, V175, P485, DOI 10.1111/cei.12240	55	270	283	3	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2331	2339		10.1016/S0140-6736(16)30582-7	http://dx.doi.org/10.1016/S0140-6736(16)30582-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302272				2022-12-28	WOS:000376969100036
J	Goodarzi, H; Nguyen, HCB; Zhang, S; Dill, BD; Molina, H; Tavazoie, SF				Goodarzi, Hani; Nguyen, Hoang C. B.; Zhang, Steven; Dill, Brian D.; Molina, Henrik; Tavazoie, Sohail F.			Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression	CELL			English	Article							MESSENGER-RNA; CODON USAGE; BREAST-CANCER; TRANSLATION; BIAS; NEURODEGENERATION; PERTURBATIONS; CONSEQUENCES; METASTASIS; EFFICIENCY	Transfer RNAs (tRNAs) are primarily viewed as static contributors to gene expression. By developing a high-throughput tRNA profiling method, we find that specific tRNAs are upregulated in human breast cancer cells as they gain metastatic activity. Through loss-of-function, gain-of-function, and clinical-association studies, we implicate tRNAGluUUC and tRNAArgCCG as promoters of breast cancer metastasis. Upregulation of these tRNAs enhances stability and ribosome occupancy of transcripts enriched for their cognate codons. Specifically, tRNAGluUUC promotes metastatic progression by directly enhancing EXOSC2 expression and enhancing GRIPAP1-constituting an "inducible" pathway driven by a tRNA. The cellular proteomic shift toward a prometastatic state mirrors global tRNA shifts, allowing for cell-state and cell-type transgene expression optimization through codon content quantification. TRNA modulation represents a mechanism by which cells achieve altered expression of specific transcripts and proteins. TRNAs are thus dynamic regulators of gene expression and the tRNA codon landscape can causally and specifically impact disease progression.	[Goodarzi, Hani; Nguyen, Hoang C. B.; Zhang, Steven; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA; [Dill, Brian D.; Molina, Henrik] Rockefeller Univ, Proteome Resource Ctr, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Goodarzi, H; Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	hgoodarzi@mail.rockefeller.edu; stavazoie@mail.rockefeller.edu		Dill, Brian/0000-0002-4532-3044; Goodarzi, Hani/0000-0002-9648-8949; Bui Nguyen, Hoang/0000-0001-6975-3084	Ruth L. Kirschstein National Research Service Award [T32CA009673]; NIH Pathway to Independence Award [K99CA194077]; Department of Defense Era of Hope Scholar; Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; NATIONAL CANCER INSTITUTE [K99CA194077, T32CA009673, R00CA194077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Scholar(United States Department of Defense); Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Alarcon for technical help in performing Northern blot experiments. We also thank P. Freddolino, C. Alarcon, H. Najafabadi, and A. Nguyen for comments on previous versions of this manuscript. We are grateful to C. Zhao, C. Lai, and N. Nnatubeugo of the Rockefeller Genomics Resource Center for assistance with next-generation RNA sequencing and microarray profiling. H.G. was previously supported by a Ruth L. Kirschstein National Research Service Award (T32CA009673) and is currently supported by an NIH Pathway to Independence Award (K99CA194077). S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient.	Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Han K, 2014, NAT METHODS, V11, P86, DOI [10.1038/NMETH.2729, 10.1038/nmeth.2729]; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nilsson M, 2000, NAT BIOTECHNOL, V18, P791, DOI 10.1038/77367; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128	37	229	235	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1416	1427		10.1016/j.cell.2016.05.046	http://dx.doi.org/10.1016/j.cell.2016.05.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259150	Bronze, Green Accepted			2022-12-28	WOS:000377045400015
J	Konopkova, Z; McWilliams, RS; Gomez-Perez, N; Goncharov, AF				Konopkova, Zuzana; McWilliams, R. Stewart; Gomez-Perez, Natalia; Goncharov, Alexander F.			Direct measurement of thermal conductivity in solid iron at planetary core conditions	NATURE			English	Article							SITU X-RAY; ELECTRICAL-RESISTIVITY; HIGH-PRESSURE; REFRACTIVE-INDEX; EARTHS CORE; LIQUID FE; EVOLUTION; ALLOY; TRANSITION; BOUNDARY	The conduction of heat through minerals and melts at extreme pressures and temperatures is of central importance to the evolution and dynamics of planets. In the cooling Earth's core, the thermal conductivity of iron alloys defines the adiabatic heat flux and therefore the thermal and compositional energy available to support the production of Earth's magnetic field via dynamo action(1-3). Attempts to describe thermal transport in Earth's core have been problematic, with predictions of high thermal conductivity(4-7) at odds with traditional geophysical models and direct evidence for a primordial magnetic field in the rock record(8-10). Measurements of core heat transport are needed to resolve this difference. Here we present direct measurements of the thermal conductivity of solid iron at pressure and temperature conditions relevant to the cores of Mercury-sized to Earth-sized planets, using a dynamically laser-heated diamond-anvil cell(11,12). Our measurements place the thermal conductivity of Earth's core near the low end of previous estimates, at 18-44 watts per metre per kelvin. The result is in agreement with palaeomagnetic measurements(10) indicating that Earth's geodynamo has persisted since the beginning of Earth's history, and allows for a solid inner core as old as the dynamo.	[Konopkova, Zuzana] DESY Photon Sci, Notkestr 85, DE-22607 Hamburg, Germany; [McWilliams, R. Stewart; Gomez-Perez, Natalia] Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [McWilliams, R. Stewart; Gomez-Perez, Natalia] Univ Edinburgh, Ctr Sci Extreme Condit, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [Gomez-Perez, Natalia] Univ Los Andes, Dept Geociencias, Bogota, Colombia; [Goncharov, Alexander F.] Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, 350 Shushanghu Rd, Hefei 230031, Anhui, Peoples R China; [Goncharov, Alexander F.] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Konopkova, Zuzana] European XFEL GmbH, Notkestr 85, DE-22607 Hamburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Edinburgh; University of Edinburgh; Universidad de los Andes (Colombia); Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Carnegie Institution for Science; European XFEL	Konopkova, Z (corresponding author), DESY Photon Sci, Notkestr 85, DE-22607 Hamburg, Germany.; McWilliams, RS; Gomez-Perez, N (corresponding author), Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.; McWilliams, RS; Gomez-Perez, N (corresponding author), Univ Edinburgh, Ctr Sci Extreme Condit, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.; Gomez-Perez, N (corresponding author), Univ Los Andes, Dept Geociencias, Bogota, Colombia.; Goncharov, AF (corresponding author), Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, 350 Shushanghu Rd, Hefei 230031, Anhui, Peoples R China.; Goncharov, AF (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.; Konopkova, Z (corresponding author), European XFEL GmbH, Notkestr 85, DE-22607 Hamburg, Germany.	zuzana.konopkova@xfel.eu; r.s.mcwilliams@ed.ac.uk; ngomez@uniandes.edu.co; alex@issp.ac.cn	Gomez Perez, Natalia/E-3453-2012; Goncharov, Alexander F./AAX-9943-2020; McWilliams, R./J-4358-2016	Gomez Perez, Natalia/0000-0001-7751-2686; Goncharov, Alexander F./0000-0002-6422-8819; McWilliams, Stewart/0000-0002-3730-8661	NSF [DMR-1039807, EAR-1015239, EAR-1520648, EAR/IF-1128867]; Army Research Office [56122-CH-H]; Carnegie Institution of Washington; National Natural Science Foundation of China [21473211]; Chinese Academy of Science [YZ201524]; University of Edinburgh; British Council Researcher Links Programme; Division Of Earth Sciences [1520648] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Army Research Office; Carnegie Institution of Washington; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); University of Edinburgh; British Council Researcher Links Programme; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge experimental assistance from H. Marquardt. This work was supported by the NSF (grant numbers DMR-1039807, EAR-1015239, EAR-1520648 and EAR/IF-1128867), the Army Research Office (grant 56122-CH-H), the Carnegie Institution of Washington, the National Natural Science Foundation of China (grant number 21473211), the Chinese Academy of Science (grant number YZ201524), the University of Edinburgh, and the British Council Researcher Links Programme. Portions of this research were carried out at the light source Petra III at DESY, a member of the Helmholtz Association (HGF).	Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Beck P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799243; Bi Y, 2002, J PHYS-CONDENS MAT, V14, P10849, DOI 10.1088/0953-8984/14/44/389; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; BOHLIN L, 1976, SOLID STATE COMMUN, V19, P389, DOI 10.1016/0038-1098(76)91359-4; Chen B, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144110; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Deng LW, 2013, GEOPHYS RES LETT, V40, P33, DOI 10.1029/2012GL054347; Dewaele A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215504; Dubrovinsky LS, 2000, PHYS REV LETT, V84, P1720, DOI 10.1103/PhysRevLett.84.1720; Dubrovinsky LS, 2000, AM MINERAL, V85, P386, DOI 10.2138/am-2000-2-318; Franz R., 1853, ANN PHYS-NEW YORK, V165, P497, DOI 10.1002/andp.18531650802; French M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165113; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; Goncharov AF, 2012, J APPL PHYS, V111, DOI 10.1063/1.4726207; Goncharov AF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3499358; GRIMSDITCH M, 1986, J APPL PHYS, V60, P3479, DOI 10.1063/1.337597; Hauck SA, 2004, EARTH PLANET SC LETT, V222, P713, DOI 10.1016/j.epsl.2004.03.037; Ho C. Y., 1972, J PHYS CHEM REF DATA, V1, P279, DOI DOI 10.1063/1.3253100; Jackson JM, 2013, EARTH PLANET SC LETT, V362, P143, DOI 10.1016/j.epsl.2012.11.048; Johannsen PG, 1997, PHYS REV B, V55, P6856, DOI 10.1103/PhysRevB.55.6856; Keeler R. N., 1971, PHYS HIGH ENERGY DEN, V48, P106; Kiefer B, 2005, J APPL PHYS, V97, DOI 10.1063/1.1906292; Kittel C, 2021, INTRO SOLID STATE PH; Komabayashi T, 2009, EARTH PLANET SC LETT, V282, P252, DOI 10.1016/j.epsl.2009.03.025; Konopkova Z, 2011, HIGH PRESSURE RES, V31, P228, DOI 10.1080/08957959.2010.545059; Labrosse S, 2003, PHYS EARTH PLANET IN, V140, P127, DOI 10.1016/j.pepi.2003.07.006; McWilliams RS, 2015, PHYS EARTH PLANET IN, V247, P17, DOI 10.1016/j.pepi.2015.06.002; McWilliams RS, 2015, P NATL ACAD SCI USA, V112, P7925, DOI 10.1073/pnas.1421801112; Montoya JA, 2012, J APPL PHYS, V111, DOI 10.1063/1.4726231; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Nimmo F., 2015, TREATISE GEOPHYS, V8, DOI DOI 10.1016/B978-0-444-53802-4.00139-1; Nimmo F., 2015, TREATISE GEOPHYS, P27, DOI DOI 10.1016/B978-044452748-6.00128-0; Olson P, 2013, SCIENCE, V342, P431, DOI 10.1126/science.1243477; Panero WR, 2001, J GEOPHYS RES-SOL EA, V106, P6493, DOI 10.1029/2000JB900423; PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Rivoldini A, 2009, ICARUS, V201, P12, DOI 10.1016/j.icarus.2008.12.020; ROSS RG, 1984, REP PROG PHYS, V47, P1347, DOI 10.1088/0034-4885/47/10/002; Seagle CT, 2013, GEOPHYS RES LETT, V40, P5377, DOI 10.1002/2013GL057930; SECCO RA, 1989, J GEOPHYS RES-SOLID, V94, P5887, DOI 10.1029/JB094iB05p05887; Sha XW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/7/075401; Sharma SK, 2009, SOLID STATE COMMUN, V149, P2207, DOI 10.1016/j.ssc.2009.09.012; Shen GY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.185701; Sommerfeld A, 1928, Z PHYS, V47, P1, DOI 10.1007/BF01391052; Stacey FD, 2007, PHYS EARTH PLANET IN, V161, P13, DOI 10.1016/j.pepi.2006.12.001; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8; Tarduno JA, 2015, SCIENCE, V349, P521, DOI 10.1126/science.aaa9114; Tateno S, 2010, SCIENCE, V330, P359, DOI 10.1126/science.1194662; Yamazaki D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053540; Zytveld JBV, 1980, J PHYS COLLOQUES, DOI [10.1051/jphyscol:19808126, DOI 10.1051/JPHYSCOL:19808126]	52	175	179	7	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					99	+		10.1038/nature18009	http://dx.doi.org/10.1038/nature18009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251283	Green Accepted			2022-12-28	WOS:000376962300041
J	Garzon-Coral, C; Fantana, HA; Howard, J				Garzon-Coral, Carlos; Fantana, Horatiu A.; Howard, Jonathon			A force-generating machinery maintains the spindle at the cell center during mitosis	SCIENCE			English	Article							C. ELEGANS EMBRYOS; MITOTIC SPINDLE; PULLING FORCES; POSITION; MICROTUBULES; LENGTH	The position and orientation of the mitotic spindle is precisely regulated to ensure the accurate partition of the cytoplasm between daughter cells and the correct localization of the daughters within growing tissue. Using magnetic tweezers to perturb the position of the spindle in intact cells, we discovered a force-generating machinery that maintains the spindle at the cell center during metaphase and anaphase in one-and two-cell Caenorhabditis elegans embryos. The forces increase with the number of microtubules and are larger in smaller cells. The machinery is rigid enough to suppress thermal fluctuations to ensure precise localization of the mitotic spindle, yet compliant enough to allow molecular force generators to fine-tune the position of the mitotic spindle to facilitate asymmetric division.	[Garzon-Coral, Carlos; Fantana, Horatiu A.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Max Planck Society; Yale University	Howard, J (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA.	jonathon.howard@yale.edu	Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196	European network MitoSys project; Max Planck Society; Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110386] Funding Source: NIH RePORTER	European network MitoSys project; Max Planck Society(Max Planck Society); Yale University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Alper, A. Hyman, S. Grill, H. Bowne-Anderson, and F. Carrillo-Oesterreich for comments on the manuscript and R. Ma, C. Bruchatz, V. Thacker, J. Mucksch, and V. Duran for discussion and assistance. C.G.-C. was funded by the European network MitoSys project. H. A. F., C.G.-C., and J. H. designed the experiments. H. A. F. and C.G.-C. performed experiments and analyzed data. C.G.-C. and J. H. wrote the paper. All the authors discussed the results and commented on the manuscript. H. A. F., C.G.-C., and J. H. declare no competing financial interest. We thank the Max Planck Society and Yale University for support.	Campbell EKM, 2009, PLOS BIOL, V7, P904, DOI 10.1371/journal.pbio.1000088; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Hara Y, 2013, MOL BIOL CELL, V24, P1411, DOI 10.1091/mbc.E12-07-0528; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Ma R, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013018; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; Muller-Reichert T, 2008, J MICROSC-OXFORD, V230, P297, DOI 10.1111/j.1365-2818.2008.01985.x; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Shimamoto Y, 2011, CELL, V145, P1062, DOI 10.1016/j.cell.2011.05.038; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003	22	82	82	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1124	1127		10.1126/science.aad9745	http://dx.doi.org/10.1126/science.aad9745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230381	Green Accepted			2022-12-28	WOS:000376480800045
J	Li, T; Duca, L; Reitter, M; Grusdt, F; Demler, E; Endres, M; Schleier-Smith, M; Bloch, I; Schneider, U				Li, Tracy; Duca, Lucia; Reitter, Martin; Grusdt, Fabian; Demler, Eugene; Endres, Manuel; Schleier-Smith, Monika; Bloch, Immanuel; Schneider, Ulrich			Bloch state tomography using Wilson lines	SCIENCE			English	Article							ATOMS; PHASE	Topology and geometry are essential to our understanding of modern physics, underlying many foundational concepts from high-energy theories, quantum information, and condensed-matter physics. In condensed-matter systems, a wide range of phenomena stem from the geometry of the band eigenstates, which is encoded in the matrix-valued-Wilson line for general multiband systems. Using an ultracold gas of rubidium atoms loaded in a honeycomb optical lattice, we realize strong-force dynamics in Bloch bands that are described by Wilson lines and observe an evolution in the band populations that directly reveals the band geometry. Our technique enables a full determination of band eigenstates, Berry curvature, and topological invariants, including single-and multiband Chern and Z(2) numbers.	[Li, Tracy; Duca, Lucia; Reitter, Martin; Bloch, Immanuel; Schneider, Ulrich] Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany; [Li, Tracy; Duca, Lucia; Reitter, Martin; Bloch, Immanuel; Schneider, Ulrich] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Grusdt, Fabian] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; [Grusdt, Fabian] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany; [Grusdt, Fabian] Grad Sch Mat Sci Mainz, Gottlieb Daimler Str 47, D-67663 Kaiserslautern, Germany; [Grusdt, Fabian; Demler, Eugene; Endres, Manuel] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Endres, Manuel] CALTECH, Dept Phys, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Schleier-Smith, Monika] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Schneider, Ulrich] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England	University of Munich; Max Planck Society; University of Kaiserslautern; University of Kaiserslautern; Harvard University; California Institute of Technology; Stanford University; University of Cambridge	Schneider, U (corresponding author), Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.; Schneider, U (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.; Schneider, U (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	uws20@cam.ac.uk	Schneider, Ulrich/N-4820-2015; Demler, Eugene/ABG-1933-2021; Duca, Lucia/AFO-6835-2022; Bloch, Immanuel/G-3174-2010; Bloch, Immanuel/N-9169-2019; Duca, Lucia/N-2465-2016	Schneider, Ulrich/0000-0003-4345-9498; Demler, Eugene/0000-0002-2499-632X; Duca, Lucia/0000-0002-4598-4918; Bloch, Immanuel/0000-0002-0679-4759; Duca, Lucia/0000-0002-4598-4918; Schleier-Smith, Monika/0000-0002-4686-3528; Grusdt, Fabian/0000-0003-3531-8089	Alfred P. Sloan Foundation; European Commision (UQUAM, AQuS); Nanosystems Initiative Munich; Harvard Quantum Optics Center; Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms; NSF [DMR-1308435]; Defense Advanced Research Projects Agency Optical Lattice Emulator program; Air Force Office of Scientific Research, Quantum Simulation Multidisciplinary University Research Initiative (MURI); Army Research Office (ARO)-MURI on Atomtronics; ARO-MURI Qubit Enabled Imaging, Sensing, and Metrology program; Division Of Materials Research [1308435] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); European Commision (UQUAM, AQuS); Nanosystems Initiative Munich; Harvard Quantum Optics Center; Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms; NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Optical Lattice Emulator program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research, Quantum Simulation Multidisciplinary University Research Initiative (MURI); Army Research Office (ARO)-MURI on Atomtronics; ARO-MURI Qubit Enabled Imaging, Sensing, and Metrology program; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge illuminating discussions with A. Alexandradinata, J.-N. Fuchs, N. Goldman, D. Greif, L.-K. Lim, G. Montambaux, A. Polkovnikov, and G. Refael. This work was supported by the Alfred P. Sloan Foundation, the European Commision (UQUAM, AQuS), Nanosystems Initiative Munich, the Harvard Quantum Optics Center, the Harvard-Massachusetts Institute of Technology Center for Ultracold Atoms, NSF grant DMR-1308435, the Defense Advanced Research Projects Agency Optical Lattice Emulator program, the Air Force Office of Scientific Research, Quantum Simulation Multidisciplinary University Research Initiative (MURI), the Army Research Office (ARO)-MURI on Atomtronics, and the ARO-MURI Qubit Enabled Imaging, Sensing, and Metrology program.	Abanin DA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.165304; Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Alba E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235301; Alexandradinata A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155114; Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; Baur SK, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.051605; BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; Beri B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145301; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cooper NR, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.175301; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Goldman N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255302; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Grusdt F, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.043621; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hasan MZ., 2015, TOPOLOGICAL INSULATO, V1, P55; Hauke P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045303; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kennedy CJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225301; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Kling S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.215301; Lim LK, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.042119; Lim LK, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155302; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Liu GC, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053605; Mei F, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.013638; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Shevchenko SN, 2010, PHYS REP, V492, P1, DOI 10.1016/j.physrep.2010.03.002; Soluyanov AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035108; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yu R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075119; Zenesini A, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.065601; ZWANZIGER JW, 1990, ANNU REV PHYS CHEM, V41, P601	44	117	117	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1094	1097		10.1126/science.aad5812	http://dx.doi.org/10.1126/science.aad5812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230376	Green Submitted, Green Accepted			2022-12-28	WOS:000376480800037
J	Zhou, ZN; Tang, AT; Wong, WY; Bamezai, S; Goddard, LM; Shenkar, R; Zhou, S; Yang, JS; Wright, AC; Foley, M; Arthur, JSC; Whitehead, KJ; Awad, IA; Li, DY; Zheng, XJ; Kahn, ML				Zhou, Zinan; Tang, Alan T.; Wong, Weng-Yew; Bamezai, Sharika; Goddard, Lauren M.; Shenkar, Robert; Zhou, Su; Yang, Jisheng; Wright, Alexander C.; Foley, Matthew; Arthur, J. Simon C.; Whitehead, Kevin J.; Awad, Issam A.; Li, Dean Y.; Zheng, Xiangjian; Kahn, Mark L.			Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling (vol 532, pg 122, 2016)	NATURE			English	Correction													Shenkar, Robert/AAC-7065-2020	Foley, Matthew/0000-0003-4077-445X	NHLBI NIH HHS [K08 HL079095] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079095] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	2	7	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					488	488		10.1038/nature18311	http://dx.doi.org/10.1038/nature18311			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27281211	Bronze			2022-12-28	WOS:000382646600048
J	Dorr, J				Doerr, Jan			Haemopoietic stem-cell transplantation for multiple sclerosis: what next?	LANCET			English	Editorial Material							THERAPY; TRIAL		[Doerr, Jan] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Doerr, Jan] Klin Hennigsdorf, Multiple Sclerosis Ctr, Hennigsdorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dorr, J (corresponding author), Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany.; Dorr, J (corresponding author), Klin Hennigsdorf, Multiple Sclerosis Ctr, Hennigsdorf, Germany.	jan-markus.doerr@charite.de						Atkins H, 2016, LANCET; Burman J, 2014, J NEUROL NEUROSUR PS, V85, P1116, DOI 10.1136/jnnp-2013-307207; Burt RK, 2015, JAMA-J AM MED ASSOC, V313, P275, DOI 10.1001/jama.2014.17986; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Mancardi G, 2008, LANCET NEUROL, V7, P626, DOI 10.1016/S1474-4422(08)70138-8; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Rush CA, 2015, NAT REV NEUROL, V11, P379, DOI 10.1038/nrneurol.2015.85; Saccardi R, 2012, MULT SCLER J, V18, P825, DOI 10.1177/1352458512438454	9	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					536	538		10.1016/S0140-6736(16)30377-4	http://dx.doi.org/10.1016/S0140-6736(16)30377-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27291993				2022-12-28	WOS:000380756600005
J	Robinson, BM; Akizawa, T; Jager, KJ; Kerr, PG; Saran, R; Pisoni, RL				Robinson, Bruce M.; Akizawa, Tadao; Jager, Kitty J.; Kerr, Peter G.; Saran, Rajiv; Pisoni, Ronald L.			Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices	LANCET			English	Article							QUALITY-OF-LIFE; FREQUENT NOCTURNAL HEMODIALYSIS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; VASCULAR ACCESS; MAINTENANCE HEMODIALYSIS; MORTALITY RISK; UNITED-STATES; CONVENTIONAL HEMODIALYSIS; INTERNATIONAL COMPARISONS	More than 2 million people worldwide are being treated for end-stage kidney disease (ESKD). This Series paper provides an overview of incidence, modality use (in-centre haemodialysis, home dialysis, or transplantation), and mortality for patients with ESKD based on national registry data. We also present data from an international cohort study to highlight differences in haemodialysis practices that affect survival and the experience of patients who rely on this therapy, which is both life-sustaining and profoundly disruptive to their quality of life. Data illustrate disparities in access to renal replacement therapy of any kind and in the use of transplantation or home dialysis, both of which are widely considered preferable to in-centre haemodialysis for many patients with ESKD in settings where infrastructure permits. For most patients with ESKD worldwide who are treated with in-centre haemodialysis, overall survival is poor, but longer in some Asian countries than elsewhere in the world, and longer in Europe than in the USA, although this gap has reduced. Commendable haemodialysis practice includes exceptionally high use of surgical vascular access in Japan and in some European countries, and the use of longer or more frequent dialysis sessions in some countries, allowing for more effective volume management. Mortality is especially high soon after ESKD onset, and improved preparation for ESKD is needed including alignment of decision making with the wishes of patients and families.	[Robinson, Bruce M.; Pisoni, Ronald L.] Arbor Res Collaborat Hlth, Ann Arbor, MI 48104 USA; [Robinson, Bruce M.; Saran, Rajiv] Univ Michigan, Dept Internal Med & Nephrol, Ann Arbor, MI 48109 USA; [Akizawa, Tadao] Showa Univ, Sch Med, Shinagawa Ku, Tokyo, Japan; [Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, Amsterdam, Netherlands; [Kerr, Peter G.] Monash Med Ctr, Clayton, Vic, Australia; [Kerr, Peter G.] Monash Univ Clayton, Clayton, Vic, Australia	Arbor Research Collaborative for Health; University of Michigan System; University of Michigan; Showa University; University of Amsterdam; Academic Medical Center Amsterdam; Monash University; Monash University	Robinson, BM (corresponding author), Arbor Res Collaborat Hlth, Ann Arbor, MI 48104 USA.	Bruce.Robinson@ArborResearch.org	Kerr, Peter G/I-1461-2013	Robinson, Bruce/0000-0003-0749-1714; Jager, Kitty/0000-0003-0444-8569	US National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health, Department of Health and Human Services [HHSN276201400001C]; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA Registry); Amgen; Kyowa Hakko Kirin; AbbVie; Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme; Proteon Therapeutics; Relypsa; F Hoffmann-LaRoche; BHC Medical; Janssen; Takeda; Kidney Foundation of Canada; Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis	US National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health, Department of Health and Human Services; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA Registry); Amgen(Amgen); Kyowa Hakko Kirin(Kyowa Kirin Ltd); AbbVie(AbbVie); Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme(Merck & Company); Proteon Therapeutics; Relypsa; F Hoffmann-LaRoche(Hoffmann-La Roche); BHC Medical; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd); Kidney Foundation of Canada; Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis	Information regarding registry data in this Series paper are supported in whole or partly by funds from the US National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health, Department of Health and Human Services (Contract number HHSN276201400001C; US Renal Data System), and from the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA Registry). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The DOPPS programme is supported by Amgen, Kyowa Hakko Kirin, AbbVie, Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma. Additional support for specific projects and countries is also provided by Keryx Biopharmaceuticals, Merck Sharp & Dohme, Proteon Therapeutics, Relypsa, and F Hoffmann-LaRoche; in Canada by Amgen, BHC Medical, Janssen, Takeda, and Kidney Foundation of Canada (for logistics support); in Germany by Hexal, DGfN, Shire, and WiNe Institute; for PDOPPS in Japan by the Japanese Society for Peritoneal Dialysis. All support is provided without restrictions on publications. Grants are made to Arbor Research Collaborative for Health and not to individual investigators. We thank Brian Bieber, Alan Leichtman, Keith McCullough, Friedrich Port, Sarah White, and Lindsay Zepel for their supportive contributions to this Series paper, and Shauna Leighton for editorial assistance.	Abma I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004249; Allon M, 2006, AM J KIDNEY DIS, V47, P469, DOI 10.1053/j.ajkd.2005.11.023; Allon M, 2011, J AM SOC NEPHROL, V22, P426, DOI 10.1681/ASN.2010121219; ANZDATA Registry, 2014, 37 ANN REP ANZDATA R; Asano M, 2013, NEPHRON CLIN PRACT, V124, P23, DOI 10.1159/000353733; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bieber B, 2014, NEPHROL DIAL TRANSPL, V29, P1770, DOI 10.1093/ndt/gft472; Bikbov BT, NEPHROL DIA IN PRESS; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Bradbury BD, 2009, AM J KIDNEY DIS, V53, P804, DOI 10.1053/j.ajkd.2008.11.031; Brunelli SM, 2010, KIDNEY INT, V77, P630, DOI 10.1038/ki.2009.523; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Combe C, 2009, AM J KIDNEY DIS, V54, P680, DOI 10.1053/j.ajkd.2009.04.035; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Crews DC, 2014, AM J KIDNEY DIS, V63, P806, DOI 10.1053/j.ajkd.2013.12.010; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; Daugirdas JT, 2013, KIDNEY INT, V83, P9, DOI 10.1038/ki.2012.365; Depner T, 2004, KIDNEY INT, V65, P1386, DOI 10.1111/j.1523-1755.2004.00519.x; Engemann JJ, 2005, INFECT CONT HOSP EP, V26, P534, DOI 10.1086/502580; *ERA EDTA REG, 2007, ERA EDTA REG 2005 AN; ERA EDTA Registry, 2015, ERA EDTA REG ANN REP; Fissell RB, 2013, J VASC ACCESS, V14, P264, DOI 10.5301/jva.5000140; Flythe JE, 2013, KIDNEY INT, V83, P104, DOI 10.1038/ki.2012.346; Foley RN, 2014, KIDNEY INT, V86, P392, DOI 10.1038/ki.2014.15; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Fuller DS, 2016, J AM SOC NEPHROL, V27, P2205, DOI 10.1681/ASN.2015060673; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gillespie BW, 2015, CLIN KIDNEY J, V8, P772, DOI 10.1093/ckj/sfv103; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Hasegawa T, 2011, KIDNEY INT, V79, P340, DOI 10.1038/ki.2010.382; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; Hecking M, 2012, CLIN J AM SOC NEPHRO, V7, P92, DOI 10.2215/CJN.05440611; Hecking M, 2012, AM J KIDNEY DIS, V59, P238, DOI 10.1053/j.ajkd.2011.07.013; Herrington W, 2015, SEMIN DIALYSIS, V28, P35, DOI 10.1111/sdi.12281; Inrig JK, 2014, AM J KIDNEY DIS, V63, P771, DOI 10.1053/j.ajkd.2013.10.043; Jadoul M, 2012, CLIN J AM SOC NEPHRO, V7, P765, DOI 10.2215/CJN.08850811; Jha V, 2015, NEPHROLOGY, V20, P329, DOI 10.1111/nep.12404; Kalantar-Zadeh K, 2014, AM J KIDNEY DIS, V64, P181, DOI 10.1053/j.ajkd.2014.04.019; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; Kleophas W, 2013, KIDNEY INT, V84, P578, DOI 10.1038/ki.2013.143; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kruzel-Davila E, 2016, NEPHROL DIAL TRANSPL, V31, P349, DOI 10.1093/ndt/gfu391; Kumwenda M, 2015, CLIN PRACTICE GUIDEL, V6th; Lacson E, 2011, AM J KIDNEY DIS, V58, P235, DOI 10.1053/j.ajkd.2011.04.015; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lok CE, 2012, J AM SOC NEPHROL, V23, p268A; Lopes AA, 2012, AM J KIDNEY DIS, V60, P90, DOI 10.1053/j.ajkd.2011.12.025; Lopes AA, 2009, NEPHROL DIAL TRANSPL, V24, P2809, DOI 10.1093/ndt/gfp212; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Marshall MR, 2011, AM J KIDNEY DIS, V58, P782, DOI 10.1053/j.ajkd.2011.04.027; Masakane I, 2015, THER APHER DIAL, V19, P540, DOI 10.1111/1744-9987.12378; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; Mehrotra R, 2013, SEMIN DIALYSIS, V26, P644, DOI 10.1111/sdi.12127; Mendelssohn DC, 2008, NEPHROL DIAL TRANSPL, V23, P3227, DOI 10.1093/ndt/gfn195; National Kidney Foundation, 1997, AM J KIDNEY DIS, V30, pS67; National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI), 2006, GUID COMM; Nesrallah GE, 2012, J AM SOC NEPHROL, V23, P696, DOI 10.1681/ASN.2011070676; Ok E, 2016, LANCET, V388, P285, DOI 10.1016/S0140-6736(16)30389-0; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Pippias M, 2016, NEPHROL DIAL TRANSPL, V31, P831, DOI 10.1093/ndt/gfv327; Pisoni R, 2015, J AM SOC NEPHROL, V26, p285A; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Pisoni RL, 2015, AM J KIDNEY DIS, V65, P905, DOI 10.1053/j.ajkd.2014.12.014; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Port FK, 2004, AM J KIDNEY DIS, V43, P1014, DOI 10.1053/j.ajkd.2004.02.014; Port FK, 2003, BLOOD PURIFICAT, V21, P85, DOI 10.1159/000067859; Port FK, 2014, AM J KIDNEY DIS, V64, P969, DOI 10.1053/j.ajkd.2014.05.025; Ramirez SPB, 2009, J AM SOC NEPHROL, V20, P1094, DOI 10.1681/ASN.2008060579; Rayner HC, 2010, SEMIN DIALYSIS, V23, P6, DOI 10.1111/j.1525-139X.2009.00675.x; Remuzzi G, 2013, LANCET, V382, P353, DOI 10.1016/S0140-6736(13)60438-9; Renal Physicians Association, 2010, SHAR DEC MAK APPR IN; Robinson BM, 2006, J AM SOC NEPHROL, V17, P2910, DOI 10.1681/ASN.2005101078; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Robinson BM, 2012, CLIN J AM SOC NEPHRO, V7, P1897, DOI 10.2215/CJN.04940512; Robinson BM, 2012, KIDNEY INT, V82, P570, DOI 10.1038/ki.2012.136; Rocco MV, 2015, AM J KIDNEY DIS, V66, P459, DOI 10.1053/j.ajkd.2015.02.331; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Roderick P, 2009, NEPHROL DIAL TRANSPL, V24, P3774, DOI 10.1093/ndt/gfp348; Rosset S, 2011, NAT REV NEPHROL, V7, P313, DOI 10.1038/nrneph.2011.52; Saran R, 2008, ANN SURG, V247, P885, DOI 10.1097/SLA.0b013e31816c4044; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Seng WH, 2014, 21 REPORT MALAYSIAN; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tentori F, 2015, CLIN J AM SOC NEPHRO, V10, P98, DOI 10.2215/CJN.12941213; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; The Japanese Society for Dialysis Therapy, 2011, J JPN SOC DIAL THER, V44, P855; Thodis ED, 2011, J NEPHROL, V24, P398, DOI 10.5301/JN.2011.8374; Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; UK NHS, END LIF CAR ADV KIDN; UK NHS Department of Health, PAYM RES GUID 2011 1; United States Renal Data System U, 2015, 2015 USRDS ANN DAT R, V2; US Centers for Medicare & Medicaid Services, TECHN SPEC ESRD QIP; US Renal Data System, 2010, USRDS 2010 ANN DAT R; van de Luijtgaarden MWM, 2013, NEPHROL DIAL TRANSPL, V28, P2604, DOI 10.1093/ndt/gft287; van den Beukel TO, 2008, NEPHROL DIAL TRANSPL, V23, P3571, DOI 10.1093/ndt/gfn336; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008; van Manen JG, 2007, NEPHROL DIAL TRANSPL, V22, P187, DOI 10.1093/ndt/gfl502; Vassalotti JA, 2012, SEMIN DIALYSIS, V25, P303, DOI 10.1111/j.1525-139X.2012.01069.x; Watanabe Y, 2015, THER APHER DIAL, V19, P108, DOI 10.1111/1744-9987.12295; Watanabe Y, 2015, THER APHER DIAL, V19, P67, DOI 10.1111/1744-9987.12294; Watanabe Y, 2015, THER APHER DIAL, V19, P93, DOI 10.1111/1744-9987.12293; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104; Xue JL, 2003, AM J KIDNEY DIS, V42, P1013, DOI 10.1016/j.ajkd.2003.07.004; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x; Zhang H, 2012, KIDNEY INT, V81, P1108, DOI 10.1038/ki.2011.481	115	212	223	10	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					294	306		10.1016/S0140-6736(16)30448-2	http://dx.doi.org/10.1016/S0140-6736(16)30448-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27226132	Green Accepted			2022-12-28	WOS:000379736100034
J	Li, X; Bi, DQ; Yi, CY; Decoppet, JD; Luo, JS; Zakeeruddin, SM; Hagfeldt, A; Gratzel, M				Li, Xiong; Bi, Dongqin; Yi, Chenyi; Decoppet, Jean-David; Luo, Jingshan; Zakeeruddin, Shaik Mohammed; Hagfeldt, Anders; Gratzel, Michael			A vacuum flash-assisted solution process for high-efficiency large-area perovskite solar cells	SCIENCE			English	Article							HALIDE PEROVSKITES; BASE ADDUCT; CH3NH3PBI3; IODIDE; LIGHT; DEPOSITION	Metal halide perovskite solar cells (PSCs) currently attract enormous research interest because of their high solar-to-electric power conversion efficiency (PCE) and low fabrication costs, but their practical development is hampered by difficulties in achieving high performance with large-size devices. We devised a simple vacuum flash-assisted solution processing method to obtain shiny, smooth, crystalline perovskite films of high electronic quality over large areas. This enabled us to fabricate solar cells with an aperture area exceeding 1 square centimeter, a maximum efficiency of 20.5%, and a certified PCE of 19.6%. By contrast, the best certified PCE to date is 15.6% for PSCs of similar size. We demonstrate that the reproducibility of the method is excellent and that the cells show virtually no hysteresis. Our approach enables the realization of highly efficient large-area PSCs for practical deployment.	[Li, Xiong; Yi, Chenyi; Decoppet, Jean-David; Luo, Jingshan; Zakeeruddin, Shaik Mohammed; Gratzel, Michael] Ecole Polytech Fed Lausanne, Dept Chem & Chem Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland; [Bi, Dongqin; Hagfeldt, Anders] Ecole Polytech Fed Lausanne, Dept Chem & Chem Engn, Lab Photomol Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gratzel, M (corresponding author), Ecole Polytech Fed Lausanne, Dept Chem & Chem Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland.	michael.graetzel@epfl.ch	Luo, Jingshan/Q-1293-2016; Hagfeldt, Anders/B-8123-2014; Nazeeruddin, Mohammad K/B-1323-2008; Yi, Chenyi/Q-2947-2016; Zakeeruddin, Mohammed/D-3244-2014; Yi, Chenyi/A-3476-2019	Luo, Jingshan/0000-0002-1770-7681; Hagfeldt, Anders/0000-0001-6725-8856; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Yi, Chenyi/0000-0001-6383-7383; Yi, Chenyi/0000-0001-6383-7383; Li, Xiong/0000-0002-8932-6968	King Abdulaziz City for Science and Technology; EPFL Fellowship - European Union [291771]; Swiss National Science Foundation; NRP 70 "Energy Turnaround"; SNF-NanoTera (SYNERGY); Swiss Federal Office of Energy	King Abdulaziz City for Science and Technology; EPFL Fellowship - European Union; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NRP 70 "Energy Turnaround"; SNF-NanoTera (SYNERGY); Swiss Federal Office of Energy	Supported by King Abdulaziz City for Science and Technology (M.G. and S.M.Z.), an EPFL Fellowship co-funded by a Marie Curie stipend from the European Union's Seventh Framework Programme (no. 291771) (J.L.), the Swiss National Science Foundation, NRP 70 "Energy Turnaround," SNF-NanoTera (SYNERGY), and the Swiss Federal Office of Energy. We thank F. Zhang for experimental aid with the preparation of some perovskite solutions and TiO<INF>2</INF> films, I. Dar and G. J. Jacopin for assistance with the photoluminescence experiments, and W. Tress for help with the curve fitting. X.L., D.B., C.Y., S.M.Z., A.H., and M.G. have applied for a European patent for the VASP process.	Ahn N, 2015, J AM CHEM SOC, V137, P8696, DOI 10.1021/jacs.5b04930; Auer S, 2001, NATURE, V413, P711, DOI 10.1038/35099513; Bi DQ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501170; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen CW, 2014, ADV MATER, V26, P6647, DOI 10.1002/adma.201402461; Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015; Cho HC, 2015, SCIENCE, V350, P1222, DOI 10.1126/science.aad1818; Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Green MA, 2016, PROG PHOTOVOLTAICS, V24, P3, DOI 10.1002/pip.2728; Guo YL, 2015, J AM CHEM SOC, V137, P15907, DOI 10.1021/jacs.5b10599; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Lee JW, 2016, ACCOUNTS CHEM RES, V49, P311, DOI 10.1021/acs.accounts.5b00440; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Malinkiewicz O, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400345; McGehee MD, 2014, NAT MATER, V13, P845, DOI 10.1038/nmat4050; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Meloni S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10334; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Ono LK, 2014, ENERG ENVIRON SCI, V7, P3989, DOI 10.1039/c4ee02539c; Pang SP, 2014, CHEM MATER, V26, P1485, DOI 10.1021/cm404006p; Razza S, 2015, J POWER SOURCES, V277, P286, DOI 10.1016/j.jpowsour.2014.12.008; REITER G, 1992, PHYS REV LETT, V68, P75, DOI 10.1103/PhysRevLett.68.75; Seo J, 2014, ENERG ENVIRON SCI, V7, P2642, DOI 10.1039/c4ee01216j; Wengeler L., 2014, COATING DRYING PROCE, P78; Xie FX, 2015, ACS NANO, V9, P639, DOI 10.1021/nn505978r; Yang MJ, 2015, ADV MATER, V27, P6363, DOI 10.1002/adma.201502586; Yang Z, 2015, NANO ENERGY, V15, P670, DOI 10.1016/j.nanoen.2015.05.027; Yi CY, 2016, ENERG ENVIRON SCI, V9, P656, DOI 10.1039/c5ee03255e	32	1447	1470	47	1272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					58	62		10.1126/science.aaf8060	http://dx.doi.org/10.1126/science.aaf8060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27284168				2022-12-28	WOS:000378816200034
J	Fox, RG; Lytle, NK; Jaquish, DV; Park, FD; Ito, T; Bajaj, J; Koechlein, CS; Zimdahl, B; Yano, M; Kopp, JL; Kritzik, M; Sicklick, JK; Sander, M; Grandgenett, PM; Hollingsworth, MA; Shibata, S; Pizzo, D; Valasek, MA; Sasik, R; Scadeng, M; Okano, H; Kim, Y; MacLeod, AR; Lowy, AM; Reya, T				Fox, Raymond G.; Lytle, Nikki K.; Jaquish, Dawn V.; Park, Frederick D.; Ito, Takahiro; Bajaj, Jeevisha; Koechlein, Claire S.; Zimdahl, Bryan; Yano, Masato; Kopp, Janel L.; Kritzik, Marcie; Sicklick, Jason K.; Sander, Maike; Grandgenett, Paul M.; Hollingsworth, Michael A.; Shibata, Shinsuke; Pizzo, Donald; Valasek, Mark A.; Sasik, Roman; Scadeng, Miriam; Okano, Hideyuki; Kim, Youngsoo; MacLeod, A. Robert; Lowy, Andrew M.; Reya, Tannishtha			Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma	NATURE			English	Article							CANCER STEM-CELLS; ANTISENSE OLIGONUCLEOTIDES; MYELOID-LEUKEMIA; RNA; MUSASHI; MICROARRAY; REGULATOR; ANIMALS; MARKER; SCREEN	Pancreatic intraepithelial neoplasia is a pre-malignant lesion that can progress to pancreatic ductal adenocarcinoma, a highly lethal malignancy marked by its late stage at clinical presentation and profound drug resistance1. The genomic alterations that commonly occur in pancreatic cancer include activation of KRAS2 and inactivation of p53 and SMAD4 (refs 2-4). So far, however, it has been challenging to target these pathways therapeutically; thus the search for other key mediators of pancreatic cancer growth remains an important endeavour. Here we show that the stem cell determinant Musashi (Msi) is a critical element of pancreatic cancer progression both in genetic models and in patient-derived xenografts. Specifically, we developed Msi reporter mice that allowed image-based tracking of stem cell signals within cancers, revealing that Msi expression rises as pancreatic intraepithelial neoplasia progresses to adenocarcinoma, and that Msi-expressing cells are key drivers of pancreatic cancer: they preferentially harbour the capacity to propagate adenocarcinoma, are enriched in circulating tumour cells, and are markedly drug resistant. This population could be effectively targeted by deletion of either Msi1 or Msi2, which led to a striking defect in the progression of pancreatic intraepithelial neoplasia to adenocarcinoma and an improvement in overall survival. Msi inhibition also blocked the growth of primary patient-derived tumours, suggesting that this signal is required for human disease. To define the translational potential of this work we developed antisense oligonucleotides against Msi; these showed reliable tumour penetration, uptake and target inhibition, and effectively blocked pancreatic cancer growth. Collectively, these studies highlight Msi reporters as a unique tool to identify therapy resistance, and define Msi signalling as a central regulator of pancreatic cancer.	[Fox, Raymond G.; Lytle, Nikki K.; Park, Frederick D.; Ito, Takahiro; Bajaj, Jeevisha; Koechlein, Claire S.; Zimdahl, Bryan; Kritzik, Marcie; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Fox, Raymond G.; Lytle, Nikki K.; Park, Frederick D.; Ito, Takahiro; Bajaj, Jeevisha; Koechlein, Claire S.; Zimdahl, Bryan; Kritzik, Marcie; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Fox, Raymond G.; Lytle, Nikki K.; Park, Frederick D.; Ito, Takahiro; Bajaj, Jeevisha; Koechlein, Claire S.; Zimdahl, Bryan; Kritzik, Marcie; Sander, Maike; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Fox, Raymond G.; Lytle, Nikki K.; Jaquish, Dawn V.; Park, Frederick D.; Ito, Takahiro; Bajaj, Jeevisha; Koechlein, Claire S.; Zimdahl, Bryan; Kritzik, Marcie; Sicklick, Jason K.; Lowy, Andrew M.; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Jaquish, Dawn V.; Sicklick, Jason K.; Lowy, Andrew M.] Univ Calif San Diego, Sch Med, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA; [Park, Frederick D.] Univ Calif San Diego, Sch Med, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Yano, Masato; Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Tokyo 1608582, Japan; [Kopp, Janel L.; Sander, Maike] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Grandgenett, Paul M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol, Omaha, NE 68198 USA; [Pizzo, Donald; Valasek, Mark A.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Sasik, Roman] Univ Calif San Diego, Sch Med, Ctr Computat Biol & Bioinformat, La Jolla, CA 92093 USA; [Scadeng, Miriam] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA; [Kim, Youngsoo; MacLeod, A. Robert] Ionis Pharmaceut, Dept Oncol Drug Discovery, Carlsbad, CA 92010 USA; [Yano, Masato] Niigata Univ, Div Neurobiol & Anat, Grad Sch Med & Dent Sci, Chuo Ku, Niigata 9518510, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Keio University; University of California System; University of California San Diego; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ionis Pharmaceuticals, Inc.; Niigata University	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.; Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Reya, T (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Lowy, AM; Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA.; Lowy, AM (corresponding author), Univ Calif San Diego, Sch Med, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA.	alowy@ucsd.edu; treya@ucsd.edu	Okano, Hideyuki/I-7584-2019; Sander, Maike/N-6615-2016; Shibata, Shinsuke/AAM-6620-2020; Okano, Hideyuki/X-9131-2019; Ito, Takahiro/F-5006-2011	Sander, Maike/0000-0001-5308-7785; Okano, Hideyuki/0000-0001-7482-5935; Ito, Takahiro/0000-0001-7165-0412; Scadeng, Miriam/0000-0002-9593-2956; Valasek, Mark/0000-0003-1721-3451; Shibata, Shinsuke/0000-0002-1185-9043; Yano, Masato/0000-0003-0589-478X	California Institute for Regenerative Medicine; National Research Service Award [F31 CA206416]; National Institutes of Health (NIH) [F32CA136124]; Advanced Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation; University of California San Diego Clinical and Translational Research Institute KL2 Award; National Cancer Center; Leukemia and Lymphoma Society Scholar Award; Specialized Program of Research Excellence (SPORE) in Pancreatic Cancer [CA127297]; TMEN Tumor Microenvironment Network [U54]; National Cancer Institute Cancer Center Support Grant [P30 CA36727]; Early Detection Research Network (EDRN) [U01 CA111294]; NIH [DK078803, CA194839, K08CA168999]; Clinical and Translational Research Institute (CTRI) grant [UL1TR001442];  [T32 HL086344];  [T32 CA009523];  [T32 GM007752];  [T32 GM007184-33];  [CA155620];  [DK63031];  [HL097767];  [DP1 CA174422];  [R35 CA197699];  [CA186043]; NATIONAL CANCER INSTITUTE [F31CA206416, F32CA136124, U01CA111294, R01CA186043, R21CA192072, R50CA211462, R35CA197699, K08CA168999, P30CA036727, DP1CA174422, R21CA194839, R01CA155620, T32CA009523, P50CA127297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001442] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344, R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031, R01DK078803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, T32GM007184] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation; University of California San Diego Clinical and Translational Research Institute KL2 Award; National Cancer Center; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Specialized Program of Research Excellence (SPORE) in Pancreatic Cancer; TMEN Tumor Microenvironment Network; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network (EDRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Research Institute (CTRI) grant; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to I. Verma, M. Karin, and D. Cheresh for advice and comments on the manuscript, A. Luo and T. Wang for technical support, G. Yeo for advice on Msi targeting, K. Jenne for advice on MRI imaging, N. Patel and P. Mischel for reagents and experimental advice, and E. O'Conner and K. Marquez for cell sorting. R.F. is a recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship and received support from T32 HL086344 and T32 CA009523, C.K. received support from T32 GM007752, N.K.L. received support from T32 GM007752 and a National Research Service Award F31 CA206416, J.L.K. received support from National Institutes of Health (NIH)-F32CA136124 and an Advanced Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation, and B.Z. received support from T32 GM007184-33 (Duke University). F.P. is a recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship and the University of California San Diego Clinical and Translational Research Institute KL2 Award. T. I. is the recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship, J.B. is supported by a postdoctoral fellowship from National Cancer Center, and T.R. was supported in part by a Leukemia and Lymphoma Society Scholar Award. P. M. G. and M.A.H. are supported by a Specialized Program of Research Excellence (SPORE) in Pancreatic Cancer, CA127297, a TMEN Tumor Microenvironment Network U54, a National Cancer Institute Cancer Center Support Grant P30 CA36727, and an Early Detection Research Network (EDRN) U01 CA111294, M. Sa. is supported by NIH DK078803 and NIH CA194839, J.K.S. is supported by NIH K08CA168999, R.S. is supported by the Clinical and Translational Research Institute (CTRI) grant UL1TR001442, and A.M.L. is supported by donations from Ride the Point. This work was also supported by CA155620 to A.M.L., DK63031, HL097767, DP1 CA174422, and R35 CA197699 to T.R., and CA186043 to A.M.L. and T.R.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cleynen I, 2008, INT J ONCOL, V32, P289; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Dosch JS, 2015, CANCER RES, V75, P4582, DOI 10.1158/0008-5472.CAN-14-2793; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Hung GN, 2013, NUCLEIC ACID THER, V23, P369, DOI 10.1089/nat.2013.0443; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Koechlein C. S., NATURE COMM IN PRESS; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; Lee RG, 2013, J CARDIOVASC TRANSL, V6, P969, DOI 10.1007/s12265-013-9495-7; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li N, 2014, AM J CARDIOVASC DRUG, V14, P367, DOI 10.1007/s40256-014-0077-0; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okano H, 2002, J CELL SCI, V115, P1355; R Development Core Team, 2012, R LANG ENV STAT COMP; REDSTON MS, 1994, CANCER RES, V54, P3025; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wu J., GCRMA BACKGROUND ABJ; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	48	87	93	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					407	+		10.1038/nature17988	http://dx.doi.org/10.1038/nature17988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281208	Green Submitted, Green Accepted			2022-12-28	WOS:000377856800040
J	Golden, C; Allison, EH; Cheung, WWL; Dey, MM; Halpern, BS; McCauley, DJ; Smith, M; Vaitla, B; Zeller, D; Myers, SS				Golden, Christopher; Allison, Edward H.; Cheung, William W. L.; Dey, Madan M.; Halpern, Benjamin S.; McCauley, Douglas J.; Smith, Matthew; Vaitla, Bapu; Zeller, Dirk; Myers, Samuel S.			Fall in fish catch threatens human health	NATURE			English	Editorial Material							FISHERIES CATCHES; FOOD SECURITY; SEAFOOD		[Golden, Christopher] Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Golden, Christopher] Harvard Univ, Ctr Environm, Planetary Hlth Alliance, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Golden, C (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.; Golden, C (corresponding author), Harvard Univ, Ctr Environm, Planetary Hlth Alliance, Cambridge, MA 02138 USA.	golden@hsph.harvard.edu	Allison, Edward Hugh/B-8615-2009	Allison, Edward/0000-0003-4663-1396; Dey, Madan/0000-0001-5273-2789; Golden, Christopher/0000-0002-2258-7493; Zeller, Dirk/0000-0001-7304-4125; Smith, Matthew/0000-0001-5207-2370	Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Dey MM, 2013, FOOD POLICY, V43, P108, DOI [10.1016/j.foodpol.2013.08.0, 10.1016/j.foodpol.2013.08.011]; FAO (Food and Agriculture Organization of the United Nations), 2011, STAT WORLD FISH AQ S; Hall SJ, 2013, P NATL ACAD SCI USA, V110, P8393, DOI 10.1073/pnas.1208067110; OECD/Food and Agriculture Organization of the United Nations, 2015, OECD FAO AGR OUTL 20; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; World Bank, 2014, FISH 2030 PROSP FISH; Youn SJ, 2014, GLOB FOOD SECUR-AGR, V3, P142, DOI 10.1016/j.gfs.2014.09.005	15	316	320	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					317	320		10.1038/534317a	http://dx.doi.org/10.1038/534317a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306172	Green Submitted, Bronze			2022-12-28	WOS:000377856800011
J	Jiang, JL; Lapusta, N				Jiang, Junle; Lapusta, Nadia			Deeper penetration of large earthquakes on seismically quiescent faults	SCIENCE			English	Article							SAN-ANDREAS FAULT; FLUID PRESSURE; SLIP; ZONE; PROPAGATION; CALIFORNIA; MECHANISM; BEHAVIOR; SYSTEM; MODEL	Why many major strike-slip faults known to have had large earthquakes are silent in the interseismic period is a long-standing enigma. One would expect small earthquakes to occur at least at the bottom of the seismogenic zone, where deeper aseismic deformation concentrates loading. We suggest that the absence of such concentrated microseismicity indicates deep rupture past the seismogenic zone in previous large earthquakes. We support this conclusion with numerical simulations of fault behavior and observations of recent major events. Our modeling implies that the 1857 Fort Tejon earthquake on the San Andreas Fault in Southern California penetrated below the seismogenic zone by at least 3 to 5 kilometers. Our findings suggest that such deeper ruptures may occur on other major fault segments, potentially increasing the associated seismic hazard.	[Jiang, Junle; Lapusta, Nadia] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lapusta, Nadia] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Jiang, Junle] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography	Lapusta, N (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.; Lapusta, N (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	lapusta@caltech.edu	Jiang, Junle/B-3974-2008	Jiang, Junle/0000-0002-8796-5846	U.S. Geological Survey (USGS) [G14AP00033]; National Science Foundation (NSF) [EAR 1142183, 1520907]; Southern California Earthquake Center (SCEC NSF) [EAR-0529922]; Southern California Earthquake Center (USGS) [07HQAG0008]	U.S. Geological Survey (USGS)(United States Geological Survey); National Science Foundation (NSF)(National Science Foundation (NSF)); Southern California Earthquake Center (SCEC NSF); Southern California Earthquake Center (USGS)	This study was supported by the U.S. Geological Survey (USGS) (grant G14AP00033), the National Science Foundation (NSF) (grants EAR 1142183 and 1520907), and the Southern California Earthquake Center (SCEC, funded by NSF cooperative agreement EAR-0529922 and USGS Cooperative agreement 07HQAG0008). This is SCEC contribution no. 6139. Numerical simulations for this study were carried out on the CITerra Dell cluster at the Division of Geological and Planetary Sciences of the California Institute of Technology. We thank J.-P. Ampuero, J.-P. Avouac, E. Hauksson, and M. Simons for helpful discussions and comments on the manuscript. Earthquake catalogs and fault-slip models are compiled from published literature and publicly available sources. Numerical data are available from the authors upon request.	[Anonymous], TREATISE GEOPHYS; Barbot S, 2012, SCIENCE, V336, P707, DOI 10.1126/science.1218796; BEROZA GC, 1991, B SEISMOL SOC AM, V81, P1603; Bouchon M, 2008, SCIENCE, V320, P1323, DOI 10.1126/science.1155030; Chester FM, 1998, TECTONOPHYSICS, V295, P199, DOI 10.1016/S0040-1951(98)00121-8; Cole J, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004975; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Elliott JL, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004428; Fialko Y, 2006, NATURE, V441, P968, DOI 10.1038/nature04797; GRANT LB, 1994, B SEISMOL SOC AM, V84, P241; Hauksson E, 2012, B SEISMOL SOC AM, V102, P2239, DOI 10.1785/0120120010; Hirth G, 2015, GEOLOGY, V43, P223, DOI 10.1130/G36361.1; Kelemen PB, 2007, NATURE, V446, P787, DOI 10.1038/nature05717; Lapusta N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000793; Lin AM, 2005, TECTONOPHYSICS, V402, P21, DOI 10.1016/j.tecto.2004.10.016; Mai PM, 2014, SEISMOL RES LETT, V85, P1348, DOI 10.1785/0220140077; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Platt JD, 2014, J GEOPHYS RES-SOL EA, V119, P4334, DOI 10.1002/2013JB010711; Reilinger RE, 2000, SCIENCE, V289, P1519, DOI 10.1126/science.289.5484.1519; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Runnerstrom EE, 2002, B SEISMOL SOC AM, V92, P2659, DOI 10.1785/0120000603; Savage JC, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004021; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Segall P, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005896; Shaw BE, 2008, B SEISMOL SOC AM, V98, P1633, DOI 10.1785/0120070191; Shelly DR, 2010, NATURE, V463, P648, DOI 10.1038/nature08755; SHIMAMOTO T, 1989, J STRUCT GEOL, V11, P51, DOI 10.1016/0191-8141(89)90035-7; SIBSON RH, 1973, NATURE-PHYS SCI, V243, P66, DOI 10.1038/physci243066a0; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1421; Smith-Konter BR, 2011, J GEOPHYS RES-SOL EA, V116, DOI [10.1029/2010JB00S117, 10.1029/2010JB008117]; Waldhauser F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020649; Zielke O, 2010, SCIENCE, V327, P1119, DOI 10.1126/science.1182781	32	78	78	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1293	1297		10.1126/science.aaf1496	http://dx.doi.org/10.1126/science.aaf1496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284188				2022-12-28	WOS:000377972000034
J	Barends, R; Shabani, A; Lamata, L; Kelly, J; Mezzacapo, A; Heras, UL; Babbush, R; Fowler, AG; Campbell, B; Chen, Y; Chen, Z; Chiaro, B; Dunsworth, A; Jeffrey, E; Lucero, E; Megrant, A; Mutus, JY; Neeley, M; Neill, C; O'Malley, PJJ; Quintana, C; Roushan, P; Sank, D; Vainsencher, A; Wenner, J; White, TC; Solano, E; Neven, H; Martinis, JM				Barends, R.; Shabani, A.; Lamata, L.; Kelly, J.; Mezzacapo, A.; Heras, U. Las; Babbush, R.; Fowler, A. G.; Campbell, B.; Chen, Yu; Chen, Z.; Chiaro, B.; Dunsworth, A.; Jeffrey, E.; Lucero, E.; Megrant, A.; Mutus, J. Y.; Neeley, M.; Neill, C.; O'Malley, P. J. J.; Quintana, C.; Roushan, P.; Sank, D.; Vainsencher, A.; Wenner, J.; White, T. C.; Solano, E.; Neven, H.; Martinis, John M.			Digitized adiabatic quantum computing with a superconducting circuit	NATURE			English	Article							COMPUTATION; SIMULATION	Quantum mechanics can help to solve complex problems in physics(1) and chemistry(2), provided they can be programmed in a physical device. In adiabatic quantum computing(3-5), a system is slowly evolved from the ground state of a simple initial Hamiltonian to a final Hamiltonian that encodes a computational problem. The appeal of this approach lies in the combination of simplicity and generality; in principle, any problem can be encoded. In practice, applications are restricted by limited connectivity, available interactions and noise. A complementary approach is digital quantum computing(6), which enables the construction of arbitrary interactions and is compatible with error correction(7,8), but uses quantum circuit algorithms that are problem-specific. Here we combine the advantages of both approaches by implementing digitized adiabatic quantum computing in a superconducting system. We tomographically probe the system during the digitized evolution and explore the scaling of errors with system size. We then let the full system find the solution to random instances of the one-dimensional Ising problem as well as problem Hamiltonians that involve more complex interactions. This digital quantum simulation(9-12) of the adiabatic algorithm consists of up to nine qubits and up to 1,000 quantum logic gates. The demonstration of digitized adiabatic quantum computing in the solid state opens a path to synthesizing long-range correlations and solving complex computational problems. When combined with fault-tolerance, our approach becomes a general-purpose algorithm that is scalable.	[Barends, R.; Kelly, J.; Fowler, A. G.; Chen, Yu; Jeffrey, E.; Lucero, E.; Mutus, J. Y.; Neeley, M.; Roushan, P.; Sank, D.; Martinis, John M.] Google Inc, Santa Barbara, CA 93117 USA; [Shabani, A.; Babbush, R.; Neven, H.] Google Inc, Venice, CA 90291 USA; [Lamata, L.; Mezzacapo, A.; Heras, U. Las; Solano, E.] Univ Basque Country UPV EHU, Dept Phys Chem, Apartado 644, E-48080 Bilbao, Spain; [Campbell, B.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Megrant, A.; Neill, C.; O'Malley, P. J. J.; Quintana, C.; Vainsencher, A.; Wenner, J.; White, T. C.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Solano, E.] Basque Fdn Sci, Ikerbasque, Maria Diaz Haro 3, Bilbao 48013, Spain; [Mezzacapo, A.] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	Google Incorporated; Google Incorporated; University of Basque Country; University of California System; University of California Santa Barbara; Basque Foundation for Science; International Business Machines (IBM)	Barends, R (corresponding author), Google Inc, Santa Barbara, CA 93117 USA.; Shabani, A (corresponding author), Google Inc, Venice, CA 90291 USA.	barends@google.com; shabani@google.com	Wenner, James/G-3777-2014; Lamata, Lucas/CAG-6488-2022; Lamata, Lucas/B-2439-2009	Wenner, James/0000-0001-7107-4734; Lamata, Lucas/0000-0002-9504-8685; Lamata, Lucas/0000-0002-9504-8685; SOLANO VILLANUEVA, ENRIQUE LEONIDAS/0000-0002-8602-1181	Spanish MINECO [FIS2012-36673-C03-02]; Ramon y Cajal [RYC-2012-11391]; Basque Government [IT472-10]; UPV/EHU PhD grant; PROMISCE EU project; SCALEQIT EU project; NSF;  [UPV/EHU UFI 11/55];  [EHUA14/04]	Spanish MINECO(Spanish Government); Ramon y Cajal(Spanish Government); Basque Government(Basque Government); UPV/EHU PhD grant; PROMISCE EU project; SCALEQIT EU project; NSF(National Science Foundation (NSF)); ; 	We acknowledge support from Spanish MINECO FIS2012-36673-C03-02; Ramon y Cajal grant RYC-2012-11391; UPV/EHU UFI 11/55 and EHUA14/04; Basque Government IT472-10; a UPV/EHU PhD grant; and PROMISCE and SCALEQIT EU projects. Devices were made at the UC Santa Barbara Nanofabrication Facility, a part of the NSF-funded National Nanotechnology Infrastructure Network, and at the NanoStructures Cleanroom Facility.	Aspuru-Guzik A, 2005, SCIENCE, V309, P1704, DOI 10.1126/science.1113479; Babbush R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06603; Barends R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8654; Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Berry DW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.090502; Boixo S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10327; Bravyi S. B., 1998, PREPRINT; Bravyi SB, 2002, ANN PHYS-NEW YORK, V298, P210, DOI 10.1006/aphy.2002.6254; Bravyi S, 2008, QUANTUM INF COMPUT, V8, P361; Crosson E., 2014, PREPRINT; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; Farhi E., 2000, PREPRINT; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Kelly J, 2015, NATURE, V519, P66, DOI 10.1038/nature14270; KIBBLE TWB, 1980, PHYS REP, V67, P183, DOI 10.1016/0370-1573(80)90091-5; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Nishimori H., 2001, STAT PHYS SPIN GLASS; Salathe Y, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021027; Seeley JT, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4768229; Steffen M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.067903; SUZUKI M, 1990, PHYS LETT A, V146, P319, DOI 10.1016/0375-9601(90)90962-N; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Wiebe N, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/6/065203; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	29	274	279	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					222	226		10.1038/nature17658	http://dx.doi.org/10.1038/nature17658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279216	Green Submitted			2022-12-28	WOS:000377475100035
J	Hosker, CMG; Bennett, MI				Hosker, Christian M. G.; Bennett, Michael I.			Delirium and agitation at the end of life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFUSION ASSESSMENT METHOD; HOSPITALIZED-PATIENTS; ADVANCED CANCER; CARE; HALOPERIDOL; ANTIPSYCHOTICS; RECOGNITION; PREVALENCE; MANAGEMENT; SETTINGS		[Hosker, Christian M. G.] Leeds & York Partnership Fdn Trust, Leeds Liaison Psychiat Serv, Leeds LS9 7BE, W Yorkshire, England; [Bennett, Michael I.] Univ Leeds, Sch Med, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds LS2 9LJ, W Yorkshire, England	University of Leeds	Hosker, CMG (corresponding author), Leeds & York Partnership Fdn Trust, Leeds Liaison Psychiat Serv, Leeds LS9 7BE, W Yorkshire, England.	christian.hosker@nhs.net	Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349				Agar M, 2015, J AM GERIATR SOC, V63, pS99; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Bush SH, 2014, J PAIN SYMPTOM MANAG, V48, P215, DOI 10.1016/j.jpainsymman.2014.05.009; Bush SH, 2014, J PAIN SYMPTOM MANAG, V48, P231, DOI 10.1016/j.jpainsymman.2013.07.018; Canadian Coalition for Seniors Mental Health, 2010, GUID ASS TREATM DEL; Candy B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004770.pub2; Cobb JL, 2000, CANCER PRACT, V8, P172, DOI 10.1046/j.1523-5394.2000.84006.x; Cohen MZ, 2009, J PALLIAT CARE, V25, P164, DOI 10.1177/082585970902500303; Crawford GB, 2013, J PALLIAT MED, V16, P1335, DOI 10.1089/jpm.2013.0230; DESTOUTZ ND, 1995, J PAIN SYMPTOM MANAG, V10, P378, DOI 10.1016/0885-3924(95)90924-C; Dev R, 2012, CURR OPIN SUPPORT PA, V6, P365, DOI 10.1097/SPC.0b013e328356ab4a; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Fang CK, 2008, JPN J CLIN ONCOL, V38, P56, DOI 10.1093/jjco/hym155; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; Hosie A, 2014, INT J NURS STUD, V51, P1353, DOI 10.1016/j.ijnurstu.2014.02.005; Hosie A, 2013, PALLIATIVE MED, V27, P486, DOI 10.1177/0269216312457214; Inouye SK, 2014, LANCET PSYCHIAT, V1, P312, DOI 10.1016/S2215-0366(14)70263-9; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kurita GP, 2011, J CLIN ONCOL, V29, P1297, DOI 10.1200/JCO.2010.32.6884; Lawlor PG, 2014, J PAIN SYMPTOM MANAG, V48, P159, DOI 10.1016/j.jpainsymman.2013.12.245; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; LeGrand SB, 2012, J PAIN SYMPTOM MANAG, V44, P583, DOI 10.1016/j.jpainsymman.2011.10.013; Leonard M, 2008, PALLIATIVE MED, V22, P848, DOI 10.1177/0269216308094520; Leonard MM, 2014, J PAIN SYMPTOM MANAG, V48, P176, DOI 10.1016/j.jpainsymman.2013.10.024; Maltoni M, 2012, J CLIN ONCOL, V30, P1378, DOI 10.1200/JCO.2011.37.3795; Mercadante S, 2006, CANCER TREAT REV, V32, P304, DOI 10.1016/j.ctrv.2006.03.001; Morita T, 2001, J PAIN SYMPTOM MANAG, V22, P997, DOI 10.1016/S0885-3924(01)00360-8; National Cancer Institute, 2015, DEL PDQ HLTH PROF VE; National Institute for Health and Care Excellence, 2010, DEL PREV DIAGN MAN; Sands MB, 2010, PALLIATIVE MED, V24, P561, DOI 10.1177/0269216310371556; Scotland NHS, 2014, PALL CAR GUID DEL; Seitz DP, 2007, J CLIN PSYCHIAT, V68, P11, DOI 10.4088/JCP.v68n0102; Siddiqi N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub3; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229	38	28	29	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2016	353								i3085	10.1136/bmj.i3085	http://dx.doi.org/10.1136/bmj.i3085			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5YQ	27283962	Green Submitted			2022-12-28	WOS:000377859500003
J	Klass, P				Klass, Perri			Saving Tiny Tim - Pediatrics and Childhood Poverty in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klass, Perri] NYU, New York, NY USA	New York University	Klass, P (corresponding author), NYU, New York, NY USA.							American Academy of Pediatrics (AAP) Council on Community Pediatrics, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0339; Dreyer B, 2016, ACAD PEDIATR, V16, pS1, DOI 10.1016/j.acap.2016.02.010; Pascoe JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0340; Sherman A., 2015, EITC CHILD TAX CREDI; Weisleder A, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3239	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2201	2205		10.1056/NEJMp1603516	http://dx.doi.org/10.1056/NEJMp1603516			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO6VB	27276559				2022-12-28	WOS:000377920500003
J	Nolan, EM				Nolan, Elizabeth M.			BIOCHEMISTRY A metal shuttle keeps pathogens well fed	SCIENCE			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; NICKEL		[Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nolan, EM (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lnolan@mit.edu						Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Hiron A, 2007, J BACTERIOL, V189, P5119, DOI 10.1128/JB.00274-07; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Lebrette H, 2015, METALLOMICS, V7, P613, DOI 10.1039/c4mt00295d; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300	9	6	6	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1055	1056		10.1126/science.aaf8755	http://dx.doi.org/10.1126/science.aaf8755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230365				2022-12-28	WOS:000376480800020
J	Aronson, JK				Aronson, J. K.			"Collaborative care" is preferable to "patient centred care"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATTITUDES		[Aronson, J. K.] Radcliffe Infirm, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	Radcliffe Infirmary; University of Oxford	Aronson, JK (corresponding author), Radcliffe Infirm, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England.	jeffrey.aronson@phc.ox.ac.uk						BRAHMS D, 1985, LANCET, V2, P959; Garside R, 2000, J ROY SOC MED, V93, P563, DOI 10.1177/014107680009301103; General Medical Council, 2013, GOOD MED PRACTICE; Institute of Medicine, 2001, CROSSING QUALITY CHA; Inthorn J, 2015, MED HEALTH CARE PHIL, V18, P329, DOI 10.1007/s11019-014-9606-5; Memmel LM, 2006, CONTRACEPTION, V73, P372, DOI 10.1016/j.contraception.2005.10.001; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Royal College of General Practitioners, 2014, INQ PAT CTR CAR 21 C; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444	9	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2016	353								i2926	10.1136/bmj.i2926	http://dx.doi.org/10.1136/bmj.i2926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CL	27230429				2022-12-28	WOS:000376939900003
J	Alonso-Blanco, C; Andrade, J; Becker, C; Bemm, F; Bergelson, J; Borgwardt, KM; Cao, J; Chae, E; Dezwaan, TM; Ding, W; Ecker, JR; Exposito-Alonso, M; Farlow, A; Fitz, J; Gan, XC; Grimm, DG; Hancock, AM; Henz, SR; Holm, S; Horton, M; Jarsulic, M; Kerstetter, RA; Korte, A; Korte, P; Lanz, C; Lee, CR; Meng, DZ; Michael, TP; Mott, R; Muliyati, NW; Nagele, T; Nagler, M; Nizhynska, V; Nordborg, M; Novikova, PY; Pico, FX; Platzer, A; Rabanal, FA; Rodriguez, A; Rowan, BA; Salome, PA; Schmid, KJ; Schmitz, RJ; Seren, U; Sperone, FG; Sudkamp, M; Svardal, H; Tanzer, MM; Todd, D; Volchenboum, SL; Wang, CM; Wang, G; Wang, X; Weckwerth, W; Weigel, D; Zhou, XF				Alonso-Blanco, Carlos; Andrade, Jorge; Becker, Claude; Bemm, Felix; Bergelson, Joy; Borgwardt, Karsten M.; Cao, Jun; Chae, Eunyoung; Dezwaan, Todd M.; Ding, Wei; Ecker, Joseph R.; Exposito-Alonso, Moises; Farlow, Ashley; Fitz, Joffrey; Gan, Xiangchao; Grimm, Dominik G.; Hancock, Angela M.; Henz, Stefan R.; Holm, Svante; Horton, Matthew; Jarsulic, Mike; Kerstetter, Randall A.; Korte, Arthur; Korte, Pamela; Lanz, Christa; Lee, Cheng-Ruei; Meng, Dazhe; Michael, Todd P.; Mott, Richard; Muliyati, Ni Wayan; Nagele, Thomas; Nagler, Matthias; Nizhynska, Viktoria; Nordborg, Magnus; Novikova, Polina Yu.; Pico, F. Xavier; Platzer, Alexander; Rabanal, Fernando A.; Rodriguez, Alex; Rowan, Beth A.; Salome, Patrice A.; Schmid, Karl J.; Schmitz, Robert J.; Seren, Umit; Sperone, Felice Gianluca; Sudkamp, Mitchell; Svardal, Hannes; Tanzer, Matt M.; Todd, Donald; Volchenboum, Samuel L.; Wang, Congmao; Wang, George; Wang, Xi; Weckwerth, Wolfram; Weigel, Detlef; Zhou, Xuefeng		1001 Genomes Consortium	1,135 Genomes Reveal the Global Pattern of Polymorphism in Arabidopsis thaliana	CELL			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-VARIATION; FLOWERING TIME; LINKAGE DISEQUILIBRIUM; TARGET GENES; HISTORY; MODEL; ADAPTATION; DIVERSITY; ACCESSIONS	Arabidopsis thaliana serves as a model organism for the study of fundamental physiological, cellular, and molecular processes. It has also greatly advanced our understanding of intraspecific genome variation. We present a detailed map of variation in 1,135 high-quality re-sequenced natural inbred lines representing the native Eurasian and North African range and recently colonized North America. We identify relict populations that continue to inhabit ancestral habitats, primarily in the Iberian Peninsula. They have mixed with a lineage that has spread to northern latitudes from an unknown glacial refugium and is now found in a much broader spectrum of habitats. Insights into the history of the species and the fine-scale distribution of genetic diversity provide the basis for full exploitation of A. thaliana natural variation through integration of genomes and epigenomes with molecular and non-molecular phenotypes.	[Alonso-Blanco, Carlos; Andrade, Jorge; Becker, Claude; Bemm, Felix; Bergelson, Joy; Borgwardt, Karsten M.; Cao, Jun; Chae, Eunyoung; Dezwaan, Todd M.; Ding, Wei; Ecker, Joseph R.; Exposito-Alonso, Moises; Farlow, Ashley; Fitz, Joffrey; Gan, Xiangchao; Grimm, Dominik G.; Hancock, Angela M.; Henz, Stefan R.; Holm, Svante; Horton, Matthew; Jarsulic, Mike; Kerstetter, Randall A.; Korte, Arthur; Korte, Pamela; Lanz, Christa; Lee, Cheng-Ruei; Meng, Dazhe; Michael, Todd P.; Mott, Richard; Muliyati, Ni Wayan; Nagele, Thomas; Nagler, Matthias; Nizhynska, Viktoria; Nordborg, Magnus; Novikova, Polina Yu.; Pico, F. Xavier; Platzer, Alexander; Rabanal, Fernando A.; Rodriguez, Alex; Rowan, Beth A.; Salome, Patrice A.; Schmid, Karl J.; Schmitz, Robert J.; Seren, Umit; Sperone, Felice Gianluca; Sudkamp, Mitchell; Svardal, Hannes; Tanzer, Matt M.; Todd, Donald; Volchenboum, Samuel L.; Wang, Congmao; Wang, George; Wang, Xi; Weckwerth, Wolfram; Weigel, Detlef; Zhou, Xuefeng; 1001 Genomes Consortium] Max Planck Inst Dev Biol, Spemannstr 35, D-72076 Tubingen, Germany	Max Planck Society	Nordborg, M; Weigel, D (corresponding author), Max Planck Inst Dev Biol, Spemannstr 35, D-72076 Tubingen, Germany.	magnus.nordborg@gmi.oeaw.ac.at; weigel@weigelworld.org	Novikova, Polina Yu./AAZ-9233-2020; Weckwerth, Wolfram/G-5811-2010; Weigel, Detlef/AAR-3312-2021; Chae, Eunyoung/AAA-6997-2021; Korte, Arthur/H-3190-2019; Weigel, Detlef/GSJ-0799-2022; Pico, Xavier/E-5697-2016; Andrade, Jorge/H-3104-2019; Exposito-Alonso, Moises/AAG-9673-2019; Ecker, Joseph R/B-9144-2008; Schmitz, Robert/AAY-7659-2020; Weigel, Detlef/C-1418-2008; Grimm, Dominik/L-9088-2019; Svardal, Hannes/AAE-9989-2019; Alonso-Blanco, Carlos/F-8864-2016; Becker, Claude/H-9011-2019	Novikova, Polina Yu./0000-0002-4552-4575; Chae, Eunyoung/0000-0002-0889-9837; Korte, Arthur/0000-0003-0831-1463; Weigel, Detlef/0000-0002-2114-7963; Pico, Xavier/0000-0003-2849-4922; Andrade, Jorge/0000-0003-3210-2186; Exposito-Alonso, Moises/0000-0001-5711-0700; Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663; Weigel, Detlef/0000-0002-2114-7963; Grimm, Dominik/0000-0003-2085-4591; Svardal, Hannes/0000-0001-7866-7313; Alonso-Blanco, Carlos/0000-0002-4738-5556; Becker, Claude/0000-0003-3406-4670; Bemm, Felix/0000-0001-6557-4898; Lee, Cheng-Ruei/0000-0002-1913-9964; Bergelson, Joy/0000-0001-7893-7387; Horton, Matthew/0000-0002-7537-0730; Farlow, Ashley/0000-0003-3789-6456; Nagele, Thomas/0000-0002-5896-238X; Rabanal, Fernando/0000-0003-1538-9752; Platzer, Alexander/0000-0002-2318-8806; Nordborg, Magnus/0000-0001-7178-9748; Korte, Pamela/0000-0002-7835-4998; Borgwardt, Karsten/0000-0001-7221-2393; Seren, Umit/0000-0003-4031-0428; Weckwerth, Wolfram/0000-0002-9719-6358; Mott, Richard/0000-0002-1022-9330; Rowan, Beth/0000-0001-7240-4889; Hancock, Angela/0000-0002-4768-3377; Ding, Wei/0000-0001-5401-879X	EU Marie Curie program; Alexander von Humboldt Foundation [BIO2013-45407-P, CGL2012-33220/BOS]; Ministerio de Economia y Competitividad from Spain; BBSRC [BB/F022697/1]; Wellcome Trust [WT090532/Z/09/Z]; DFG [SCHM1354-7-1]; NIH; NSF; Austrian Science Fund [P 26342, I 1022]; ERC (MAXMAP); Austrian Science Fund; DFG (SPP ADAPTOMICS); Austrian Academy of Sciences; Max Planck Society; Biotechnology and Biological Sciences Research Council [BB/F022697/1] Funding Source: researchfish	EU Marie Curie program(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Ministerio de Economia y Competitividad from Spain(Spanish Government); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); ERC (MAXMAP); Austrian Science Fund(Austrian Science Fund (FWF)); DFG (SPP ADAPTOMICS)(German Research Foundation (DFG)); Austrian Academy of Sciences; Max Planck Society(Max Planck SocietyFoundation CELLEX); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Vijayaraghavan, G. Hightower, and E. Thomas for help with plant growth and data handling and generation and T. Karasov for critical reading of the manuscript. Funded in part by fellowships from EU Marie Curie program (A.M.H.) and Alexander von Humboldt Foundation (B.A.R.), grants BIO2013-45407-P (C.A.-B.) and CGL2012-33220/BOS (F.X.P.) from Ministerio de Economia y Competitividad from Spain, BBSRC BB/F022697/1 and Wellcome Trust WT090532/Z/09/Z (R.M.), DFG SCHM1354-7-1 (K.J.S.), NIH and NSF (J.B., J.R.E.), Austrian Science Fund P 26342 and I 1022 (M.No., T.N., W.W.), the ERC (MAXMAP, M.No.; IMMUNEMESIS, D.W.), a collaborative grant from Austrian Science Fund and DFG (SPP ADAPTOMICS; M.No., D.W.), Austrian Academy of Sciences (M.No.), and Max Planck Society (D.W.). K.M.B. and D.W. are shareholders of Computomics GmbH. J.C. is an employee of Dow AgroSciences LLC. T.M.D., R.A.K., T.P.M., M.S., M.M.T., D.T., X.Z. are current or former employees of Monsanto Company. J.F. is an employee of Tropic IT Ltd. X.W. is an employee of Bayer CropScience AG.	Abney M, 2015, GENET EPIDEMIOL, V39, P249, DOI 10.1002/gepi.21893; Acevedo-Garcia J, 2014, NEW PHYTOL, V204, P273, DOI 10.1111/nph.12889; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Birney E, 2015, NATURE, V526, P52, DOI 10.1038/526052a; Brennan AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-17; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hagmann J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004920; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; HANFSTINGL U, 1994, GENETICS, V138, P811; He BZ, 2014, GENETICS, V196, P557, DOI 10.1534/genetics.113.157800; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XQ, 2013, NEW PHYTOL, V199, P843, DOI 10.1111/nph.12306; Huber CD, 2014, MOL BIOL EVOL, V31, P3026, DOI 10.1093/molbev/msu247; Huo HQ, 2016, P NATL ACAD SCI USA, V113, pE2199, DOI 10.1073/pnas.1600558113; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Li PJ, 2014, GENE DEV, V28, P1635, DOI 10.1101/gad.245993.114; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Wang B, 2012, NEW PHYTOL, V194, P666, DOI 10.1111/j.1469-8137.2012.04107.x; Weigel D, 2015, ANNU REV GENET, V49, P315, DOI 10.1146/annurev-genet-120213-092110; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	60	543	547	13	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					481	491		10.1016/j.cell.2016.05.063	http://dx.doi.org/10.1016/j.cell.2016.05.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27293186	Green Published, hybrid			2022-12-28	WOS:000380255400023
J	Buck, MD; O'Sullivan, D; Geltink, RIK; Curtis, JD; Chang, CH; Sanin, DE; Qiu, J; Kretz, O; Braas, D; van der Windt, GJW; Chen, QY; Huang, SCC; O'Neill, CM; Edelson, BT; Pearce, EJ; Sesaki, H; Huber, TB; Rambold, AS; Pearce, EL				Buck, Michael D.; O'Sullivan, David; Geltink, Ramon I. Klein; Curtis, Jonathan D.; Chang, Chih-Hao; Sanin, David E.; Qiu, Jing; Kretz, Oliver; Braas, Daniel; van der Windt, Gerritje J. W.; Chen, Qiongyu; Huang, Stanley Ching-Cheng; O'Neill, Christina M.; Edelson, Brian T.; Pearce, Edward J.; Sesaki, Hiromi; Huber, Tobias B.; Rambold, Angelika S.; Pearce, Erika L.			Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming	CELL			English	Article							ADOPTIVE IMMUNOTHERAPY; ENDOPLASMIC-RETICULUM; RESPIRATORY CAPACITY; OXIDATIVE STRESS; FISSION; MEMORY; FUSION; OPA1; PROTEIN; LIPOLYSIS	Activated effector T (T-E) cells augment anabolic pathways of metabolism, such as aerobic glycolysis, while memory T (T-M) cells engage catabolic pathways, like fatty acid oxidation (FAO). However, signals that drive these differences remain unclear. Mitochondria are metabolic organelles that actively transform their ultrastructure. Therefore, we questioned whether mitochondrial dynamics controls T cell metabolism. We show that T-E cells have punctate mitochondria, while T-M cells maintain fused networks. The fusion protein Opa1 is required for TM, but not T-E cells after infection, and enforcing fusion in TE cells imposes T-M cell characteristics and enhances antitumor function. Our data suggest that, by altering cristae morphology, fusion in T-M cells configures electron transport chain (ETC) complex associations favoring oxidative phosphorylation (OXPHOS) and FAO, while fission in T-E cells leads to cristae expansion, reducing ETC efficiency and promoting aerobic glycolysis. Thus, mitochondrial remodeling is a signaling mechanism that instructs T cell metabolic programming.	[Buck, Michael D.; O'Sullivan, David; Geltink, Ramon I. Klein; Curtis, Jonathan D.; Sanin, David E.; Qiu, Jing; Pearce, Edward J.; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany; [Buck, Michael D.; Chang, Chih-Hao; Qiu, Jing; Chen, Qiongyu; Huang, Stanley Ching-Cheng; O'Neill, Christina M.; Edelson, Brian T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kretz, Oliver; Huber, Tobias B.] Univ Med Ctr Freiburg, Renal Div, D-79106 Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, Dept Neuroanat, D-79104 Freiburg, Germany; [Braas, Daniel] Univ Calif Los Angeles, Metabol Ctr, Los Angeles, CA 90095 USA; [van der Windt, Gerritje J. W.] Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pearce, Edward J.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Huber, Tobias B.] BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Rambold, Angelika S.] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Rambold, Angelika S.] Univ Freiburg, D-79106 Freiburg, Germany; [Rambold, Angelika S.] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society; Washington University (WUSTL); University of Freiburg; University of Freiburg; University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam; University of Freiburg; Johns Hopkins University; University of Freiburg; University of Freiburg; Max Planck Society	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.	pearce@ie-freiburg.mpg.de	Sanin, David E/CAA-0373-2022; Sanin, David E/CAA-0391-2022; Huang, Stanley Ching-Cheng/AAE-7866-2019	Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Edelson, Brian/0000-0003-2856-7650; Kretz, Oliver/0000-0003-1152-5956; CHANG, CHIH-HAO/0000-0002-0139-7439; Buck, Michael/0000-0002-9611-1199; Klein Geltink, Ramon/0000-0003-4610-3059; Huber, Tobias B./0000-0001-7175-5062	NIH [CA181125, AI091965, AI110481]; Burroughs Wellcome Fund; BMBF; Max Planck Society; NSF Graduate Research Fellowship [DGE-1143954]; NATIONAL CANCER INSTITUTE [R01CA181125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965, R01AI110481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); BMBF(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank David Chan (Caltech) for Mfn1/2 floxed mice, Tom Graeber (DMMP, David Geffen School of Medicine, UCLA Metabolomics Center), Wandy Beatty (Molecular Microbiology Imaging Facility, Washington University School of Medicine), Erica Lantelme, Dorjan Brinja, Barbara Joch, Hani Suleiman, Elena Tonc, Tara Bradstreet, and Elizabeth Schwarzkopf for technical assistance. This work was funded by the NIH (CA181125 and AI091965 to E.L.P. and AI110481 to E.J.P.), the Burroughs Wellcome Fund (Investigator in the Pathogenesis of Infectious Disease Award to E.L.P. and Career Award for Medical Scientists to B.T.E.), the BMBF (to A.S.R.), the Max Planck Society, and the NSF Graduate Research Fellowship DGE-1143954 (to M.D.B.).	Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; DAWSON AG, 1979, TRENDS BIOCHEM SCI, V4, P171, DOI 10.1016/0968-0004(79)90417-1; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Roth D, 2014, FEBS LETT, V588, P1749, DOI 10.1016/j.febslet.2014.03.029; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Sanchis-Gomar F, 2014, NEW ENGL J MED, V370, P1073, DOI 10.1056/NEJMc1316254; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933	61	716	736	17	172	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					63	76		10.1016/j.cell.2016.05.035	http://dx.doi.org/10.1016/j.cell.2016.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27293185	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000380254400011
J	Osteen, JD; Herzig, V; Gilchrist, J; Emrick, JJ; Zhang, CC; Wang, XD; Castro, J; Garcia-Caraballo, S; Grundy, L; Rychkov, GY; Weyer, AD; Dekan, Z; Undheim, EAB; Alewood, P; Stucky, CL; Brierley, SM; Basbaum, AI; Bosmans, F; King, GF; Julius, D				Osteen, Jeremiah D.; Herzig, Volker; Gilchrist, John; Emrick, Joshua J.; Zhang, Chuchu; Wang, Xidao; Castro, Joel; Garcia-Caraballo, Sonia; Grundy, Luke; Rychkov, Grigori Y.; Weyer, Andy D.; Dekan, Zoltan; Undheim, Eivind A. B.; Alewood, Paul; Stucky, Cheryl L.; Brierley, Stuart M.; Basbaum, Allan I.; Bosmans, Frank; King, Glenn F.; Julius, David			Selective spider toxins reveal a role for the Na(v)1.1 channel in mechanical pain	NATURE			English	Article							RAT DORSAL-ROOT; SENSITIVE SODIUM-CHANNELS; ANTIEPILEPTIC DRUGS; NEUROPATHIC PAIN; RECEPTOR; EXPRESSION; NEURONS; MUTATIONS; MIGRAINE; MOUSE	Voltage-gated sodium (Na-v) channels initiate action potentials in most neurons, including primary afferent nerve fibres of the pain pathway. Local anaesthetics block pain through non-specific actions at all Na-v channels, but the discovery of selective modulators would facilitate the analysis of individual subtypes of these channels and their contributions to chemical, mechanical, or thermal pain. Here we identify and characterize spider (Heteroscodra maculata) toxins that selectively activate the Na(v)1.1 subtype, the role of which in nociception and pain has not been elucidated. We use these probes to show that Na(v)1.1-expressing fibres are modality-specific nociceptors: their activation elicits robust pain behaviours without neurogenic inflammation and produces profound hypersensitivity to mechanical, but not thermal, stimuli. In the gut, high-threshold mechanosensitive fibres also express Na(v)1.1 and show enhanced toxin sensitivity in a mouse model of irritable bowel syndrome. Together, these findings establish an unexpected role for Na(v)1.1 channels in regulating the excitability of sensory nerve fibres that mediate mechanical pain.	[Osteen, Jeremiah D.; Emrick, Joshua J.; Zhang, Chuchu; Julius, David] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Herzig, Volker; Dekan, Zoltan; Undheim, Eivind A. B.; Alewood, Paul; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Gilchrist, John; Bosmans, Frank] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Gilchrist, John; Bosmans, Frank] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Castro, Joel; Garcia-Caraballo, Sonia; Grundy, Luke; Brierley, Stuart M.] Flinders Univ S Australia, Visceral Pain Grp, Bedford Pk, SA 5042, Australia; [Castro, Joel; Garcia-Caraballo, Sonia; Grundy, Luke; Rychkov, Grigori Y.; Brierley, Stuart M.] Univ Adelaide, SAHMRI, Ctr Nutr & Gastrointestinal Dis, Discipline Med, N Terrace, Adelaide, SA 5000, Australia; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	University of California System; University of California San Francisco; University of Queensland; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Medical College of Wisconsin	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.; King, GF (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.; Bosmans, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.; Bosmans, F (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	frankbosmans@jhmi.edu; glenn.king@imb.uq.edu.au; david.julius@ucsf.edu	Herzig, Volker/A-7177-2008; Grundy, Luke/Z-6126-2019; Undheim, Eivind/J-1557-2014; Emrick, Joshua/AAD-6816-2019; Bosmans, Frank/T-5589-2017; King, Glenn F/J-5059-2012	Herzig, Volker/0000-0003-2514-3983; Grundy, Luke/0000-0002-3900-7141; Emrick, Joshua/0000-0001-5619-1078; Bosmans, Frank/0000-0002-6476-235X; King, Glenn F/0000-0002-2308-2200; Gilchrist, John/0000-0002-9993-1387; Alewood, Paul/0000-0001-7454-6522; Weyer, Andy/0000-0003-4485-9530; Dekan, Zoltan/0000-0002-6841-4176; Bosmans, Frank/0000-0002-0451-6050; Garcia Caraballo, Sonia Carmen/0000-0001-5038-0820; Brierley, Stuart/0000-0002-2527-2905; Zhang, Chuchu/0000-0001-9234-6073; Undheim, Eivind/0000-0002-8667-3999; Castro, Joel/0000-0002-5781-2224; Rychkov, Grigori/0000-0002-2788-2977	UCSF CVRI; Ruth Kirschstein NIH [F32NS081907, F31NS084646, F30DE023476]; National Institutes of Health [R37NS065071, R01NS081115, R01NS091352, R01NS040538, R01NS070711, R37NS014627, R01DA29204]; National Health and Medical Research Council of Australia [APP1083480, APP1072113, APP1044414]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081115, R01NS091352, R37NS014627, R37NS065071, R01NS040538, F31NS084646, R01NS070711, F32NS081907, R01NS014627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029204] Funding Source: NIH RePORTER	UCSF CVRI; Ruth Kirschstein NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Deutsche Arachnologische Gesellschaft and particularly I. Wendt, J. Broghammer, A. Schlosser, B. Rast, M. Luescher, C. and F. Schneider and H. Auer for providing arthropods for milking; W. Catterall for providing floxed Na<INF>v</INF>1.1 mice; and J. Poblete, J. Maddern, T. O'Donnell and A. Harrington for technical assistance. This work was supported by a T32 Postdoctoral Training Grant from the UCSF CVRI (J.D.O.), Ruth Kirschstein NIH postdoctoral (F32NS081907 to J.D.O.) and predoctoral (F31NS084646 to J.G. and F30DE023476 to J.J.E.) fellowships, the National Institutes of Health (R37NS065071 and R01NS081115 to D.J., R01NS091352 to F.B., R01NS040538 and R01NS070711 to C.L.S., and R37NS014627 and R01DA29204 to A.I.B.), the National Health and Medical Research Council of Australia (Project Grant APP1083480 to S.M.B., Program Grant APP1072113 and Principal Research Fellowship APP1044414 to G.F.K.), and a grant from the Wellcome Trust to A. I. B. S.M.B. is a NHMRC R.D Wright Biomedical Research Fellow.	Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bende NS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5350; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2011, J GEN PHYSIOL, V138, P59, DOI 10.1085/jgp.201110614; Brierley SM, 2004, GASTROENTEROLOGY, V127, P166, DOI 10.1053/j.gastro.2004.04.008; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Cestele S, 2013, P NATL ACAD SCI USA, V110, P17546, DOI 10.1073/pnas.1309827110; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; de Araujo AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4165; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Fukuoka T, 2015, NEUROSCIENCE, V284, P693, DOI 10.1016/j.neuroscience.2014.10.027; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Gargus JJ, 2007, PEDIATR NEUROL, V37, P407, DOI 10.1016/j.pediatrneurol.2007.06.016; Gilchrist J, 2014, ACS CHEM BIOL, V9, P1204, DOI 10.1021/cb500108p; Gongora-Benitez M, 2012, ORG LETT, V14, P5472, DOI 10.1021/ol302550p; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Hoeijmakers JGJ, 2015, NEUROSCI LETT, V596, P51, DOI 10.1016/j.neulet.2014.12.056; Hughes PA, 2009, GUT, V58, P1333, DOI 10.1136/gut.2008.170811; Hughes PA, 2014, GUT, V63, P1199, DOI 10.1136/gutjnl-2013-306240; Jensen HS, 2014, TRENDS PHARMACOL SCI, V35, P113, DOI 10.1016/j.tips.2013.12.007; KAMBER B, 1980, HELV CHIM ACTA, V63, P899, DOI 10.1002/hlca.19800630418; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Kissin I, 1998, ANESTHESIOLOGY, V88, P224, DOI 10.1097/00000542-199801000-00031; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Lewallen KA, 2011, J NEUROSCI, V31, P3032, DOI 10.1523/JNEUROSCI.4345-10.2011; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; Pappagallo M, 2003, CLIN THER, V25, P2506, DOI 10.1016/S0149-2918(03)80314-4; Priest BT, 2009, CURR OPIN DRUG DISC, V12, P682; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Smith JAM, 2000, EUR J NEUROSCI, V12, P3250, DOI 10.1046/j.1460-9568.2000.00218.x; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; Suter MR, 2013, ANESTHESIOLOGY, V118, P160, DOI 10.1097/ALN.0b013e318278cade; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Tsunozaki M, 2013, J PHYSIOL-LONDON, V591, P3325, DOI 10.1113/jphysiol.2013.252106; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vetter I, 2012, BIOCHEM PHARMACOL, V84, P540, DOI 10.1016/j.bcp.2012.05.008; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Wang W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-16; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zhang XY, 2013, AM J HUM GENET, V93, P957, DOI 10.1016/j.ajhg.2013.09.016	65	192	201	13	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					494	+		10.1038/nature17976	http://dx.doi.org/10.1038/nature17976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27281198	Green Accepted, Green Submitted			2022-12-28	WOS:000378270300042
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Gillman, MW; Harper, DM; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Owens, DK; Phillips, WR; Phipps, MG; Pignone, MP; Siu, AL				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Gillman, Matthew W.; Harper, Diane M.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Owens, Douglas K.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Siu, Albert L.		US Preventive Serv Task Force	Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							AMERICAN-COLLEGE; COLONOSCOPY; GUIDELINES; MORTALITY; PATTERNS; OUTCOMES; TRIAL	IMPORTANCE Colorectal cancer is the second leading cause of cancer death in the United States. In 2016, an estimated 134 000 persons will be diagnosed with the disease, and about 49 000 will die from it. Colorectal cancer is most frequently diagnosed among adults aged 65 to 74 years; the median age at death from colorectal cancer is 68 years. OBJECTIVE To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for colorectal cancer. EVIDENCE REVIEW The USPSTF reviewed the evidence on the effectiveness of screening with colonoscopy, flexible sigmoidoscopy, computed tomography colonography, the guaiac-based fecal occult blood test, the fecal immunochemical test, the multitargeted stool DNA test, and the methylated SEPT9 DNA test in reducing the incidence of and mortality from colorectal cancer or all-cause mortality; the harms of these screening tests; and the test performance characteristics of these tests for detecting adenomatous polyps, advanced adenomas based on size, or both, as well as colorectal cancer. The USPSTF also commissioned a comparative modeling study to provide information on optimal starting and stopping ages and screening intervals across the different available screeningmethods. FINDINGS The USPSTF concludes with high certainty that screening for colorectal cancer in average-risk, asymptomatic adults aged 50 to 75 years is of substantial net benefit. Multiple screening strategies are available to choose from, with different levels of evidence to support their effectiveness, as well as unique advantages and limitations, although there are no empirical data to demonstrate that any of the reviewed strategies provide a greater net benefit. Screening for colorectal cancer is a substantially underused preventive health strategy in the United States. CONCLUSIONS AND RECOMMENDATIONS The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years (A recommendation). The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient's overall health and prior screening history (C recommendation).	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Harper, Diane M.] Univ Louisville, Louisville, KY 40292 USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; Univ Washington, Seattle, WA 98195 USA; Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA; [Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Louisville; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022; Phillips, William R./V-1065-2017; Harper, Diane M./I-2180-2014	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Harper, Diane M./0000-0001-7648-883X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Abdelsattar ZM, 2016, CANCER-AM CANCER SOC, V122, P929, DOI 10.1002/cncr.29716; American Academy of Family Physicians, CLIN PREV SERV REC C; [Anonymous], PREM APPR PMA EP PRO; [Anonymous], PREM APPR APPL PMA A; Brawley OW, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju075; Burt RW, 2013, J NATL COMPR CANC NE, V11, P1538, DOI 10.6004/jnccn.2013.0180; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Canadian Task Force Preventive Hlt, 2016, CAN MED ASSOC J, V188, P340, DOI 10.1503/cmaj.151125; Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P881; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Cooper GS, 2004, CANCER-AM CANCER SOC, V100, P418, DOI 10.1002/cncr.20014; Dignam JJ, 1999, JNCI-J NATL CANCER I, V91, P1933, DOI 10.1093/jnci/91.22.1933; Henrikson NB, 2015, GENET MED, V17, P702, DOI 10.1038/gim.2014.188; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Howlader N, 2011, SEER CANC STAT REV 1; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin JS., 2016, AHRQ PUBLICATION, V14-05203-EF-1; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Redwood DG, 2016, MAYO CLIN PROC, V91, P61, DOI 10.1016/j.mayocp.2015.10.008; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Wilt TJ, 2015, ANN INTERN MED, V162, P718, DOI 10.7326/M14-2326; Zauber A, 2015, AHRQ PUBLICATION	30	1131	1164	11	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2564	2575		10.1001/jama.2016.5989	http://dx.doi.org/10.1001/jama.2016.5989			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27304597	Bronze			2022-12-28	WOS:000378306700020
J	Knudsen, AB; Zauber, AG; Rutter, CM; Naber, SK; Doria-Rose, VP; Pabiniak, C; Johanson, C; Fischer, SE; Lansdorp-Vogelaar, I; Kuntz, KM				Knudsen, Amy B.; Zauber, Ann G.; Rutter, Carolyn M.; Naber, Steffie K.; Doria-Rose, V. Paul; Pabiniak, Chester; Johanson, Colden; Fischer, Sara E.; Lansdorp-Vogelaar, Iris; Kuntz, Karen M.			Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS ANALYSIS; FLEXIBLE SIGMOIDOSCOPY; CT COLONOGRAPHY; LARGE-INTESTINE; LARGE-BOWEL; NEGATIVE COLONOSCOPY; POPULATION; MORTALITY	IMPORTANCE The US Preventive Services Task Force (USPSTF) is updating its 2008 colorectal cancer (CRC) screening recommendations. OBJECTIVE To inform the USPSTF by modeling the benefits, burden, and harms of CRC screening strategies; estimating the optimal ages to begin and end screening; and identifying a set of model-recommendable strategies that provide similar life-years gained (LYG) and a comparable balance between LYG and screening burden. DESIGN, SETTING, AND PARTICIPANTS Comparative modeling with 3 microsimulation models of a hypothetical cohort of previously unscreened US 40-year-olds with no prior CRC diagnosis. EXPOSURES Screening with sensitive guaiac-based fecal occult blood testing, fecal immunochemical testing (FIT), multitarget stool DNA testing, flexible sigmoidoscopy with or without stool testing, computed tomographic colonography (CTC), or colonoscopy starting at age 45, 50, or 55 years and ending at age 75, 80, or 85 years. Screening intervals varied by modality. Full adherence for all strategies was assumed. MAIN OUTCOMES AND MEASURES Life-years gained compared with no screening (benefit), lifetime number of colonoscopies required (burden), lifetime number of colonoscopy complications (harms), and ratios of incremental burden and benefit (efficiency ratios) per 1000 40-year-olds. RESULTS The screening strategies provided LYG in the range of 152 to 313 per 1000 40-year-olds. Lifetime colonoscopy burden per 1000 persons ranged from fewer than 900 (FIT every 3 years from ages 55-75 years) to more than 7500 (colonoscopy screening every 5 years from ages 45-85 years). Harm from screening was at most 23 complications per 1000 persons screened. Strategies with screening beginning at age 50 years generally provided more LYG as well as more additional LYG per additional colonoscopy than strategies with screening beginning at age 55 years. There were limited empirical data to support a start age of 45 years. For persons adequately screened up to age 75 years, additional screening yielded small increases in LYG relative to the increase in colonoscopy burden. With screening from ages 50 to 75 years, 4 strategies yielded a comparable balance of screening burden and similar LYG (median LYG per 1000 across the models): colonoscopy every 10 years (270 LYG); sigmoidoscopy every 10 years with annual FIT (256 LYG); CTC every 5 years (248 LYG); and annual FIT (244 LYG). CONCLUSIONS AND RELEVANCE In this microsimulation modeling study of a previously unscreened population undergoing CRC screening that assumed 100% adherence, the strategies of colonoscopy every 10 years, annual FIT, sigmoidoscopy every 10 years with annual FIT, and CTC every 5 years performed from ages 50 through 75 years provided similar LYG and a comparable balance of benefit and screening burden.	[Zauber, Ann G.; Fischer, Sara E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave,Second Floor, New York, NY 10017 USA; [Knudsen, Amy B.; Johanson, Colden] Massachusetts Gen Hosp, Dept Radiol, Inst Technol Assessment, Boston, MA USA; [Rutter, Carolyn M.] RAND Corp, Santa Monica, CA USA; [Naber, Steffie K.; Lansdorp-Vogelaar, Iris] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Doria-Rose, V. Paul] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Pabiniak, Chester] Grp Hlth Res Inst, Seattle, WA USA; [Kuntz, Karen M.] Univ Minnesota, Sch Publ Hlth, Dept Hlth Policy & Management, Minneapolis, MN USA; [Johanson, Colden] Optum, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; RAND Corporation; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; Optum	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	zaubera@mskcc.org	Fischer, Sara/ABC-5123-2020; Rutter, Carolyn/AAZ-3677-2021; Naber, Steffie/A-9758-2015	Fischer, Sara/0000-0001-5960-1896; Naber, Steffie/0000-0001-8357-1738; Doria-Rose, Vincent/0000-0002-8802-5143	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [U01CA152959]; NCI Cancer Center Support Grant [P30CA008748]; NATIONAL CANCER INSTITUTE [U01CA152959, P30CA008748, U01CA199335] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This analysis was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) (through a supplement from the Agency for Healthcare Research and Quality [AHRQ]) under award U01CA152959. Dr Zauber was also supported in part by a NCI Cancer Center Support Grant under award P30CA008748.	Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Medicare & Medicaid Services, DEC MEM SCREEN COL C; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; Jensen CD, 2016, ANN INTERN MED, V164, P456, DOI 10.7326/M15-0983; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Jones RM, 2010, AM J PREV MED, V38, P499, DOI 10.1016/j.amepre.2010.01.020; Klabunde CN, 2011, CANCER EPIDEM BIOMAR, V20, P1611, DOI 10.1158/1055-9965.EPI-11-0220; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Kulasingam SL, 2013, J LOW GENIT TRACT DI, V17, P193, DOI 10.1097/LGT.0b013e3182616241; Kulasingam SL, 2011, 1105157EF1 AHRQ; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Lin JS., 2016, AHRQ PUBLICATION, V14-05203-EF-1; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; National Cancer Institute, CANC INT SURV MOD NE; National Center for Health Statistics, LIF TABL; Ness RM, 1999, AM J GASTROENTEROL, V94, P1650; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Painter J, 1999, ENDOSCOPY, V31, P227, DOI 10.1055/s-1999-13673; Pickhardt PJ, 2006, RADIOLOGY, V241, P417, DOI 10.1148/radiol.2412052007; Pickhardt PJ, 2015, DIGEST DIS SCI, V60, P647, DOI 10.1007/s10620-014-3454-2; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Rutter CM, 2007, STAT MED, V26, P98, DOI 10.1002/sim.2460; Rutter CM, 2016, MED DECIS MAKING, V36, P604, DOI 10.1177/0272989X15622642; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schroy PC, 2013, ANN INTERN MED, V159, P13, DOI 10.7326/0003-4819-159-1-201307020-00004; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; van Hees F, 2014, JAMA INTERN MED, V174, P1568, DOI 10.1001/jamainternmed.2014.3889; van Hees F, 2014, ANN INTERN MED, V160, P750, DOI 10.7326/M13-2263; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Wilschut JA, 2011, CANCER-AM CANCER SOC, V117, P4166, DOI 10.1002/cncr.26009; Zauber A, 2015, AHRQ PUBLICATION; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	69	298	303	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2595	2609		10.1001/jama.2016.6828	http://dx.doi.org/10.1001/jama.2016.6828			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27305518	Green Accepted, Bronze			2022-12-28	WOS:000378306700022
J	Ye, L; Allen, WE; Thompson, KR; Tian, QY; Hsueh, B; Ramakrishnan, C; Wang, AC; Jennings, JH; Adhikari, A; Halpern, CH; Witten, IB; Barth, AL; Luo, LQ; McNab, JA; Deisseroth, K				Ye, Li; Allen, William E.; Thompson, Kimberly R.; Tian, Qiyuan; Hsueh, Brian; Ramakrishnan, Charu; Wang, Ai-Chi; Jennings, Joshua H.; Adhikari, Avishek; Halpern, Casey H.; Witten, Ilana B.; Barth, Alison L.; Luo, Liqun; McNab, Jennifer A.; Deisseroth, Karl			Wiring and Molecular Features of Prefrontal Ensembles Representing Distinct Experiences	CELL			English	Article							ELEVATED-PLUS-MAZE; PROJECTION NEURONS; PLACE PREFERENCE; CINGULATE CORTEX; MESSENGER-RNA; NPAS4; BRAIN; EXPRESSION; RESPONSES; PROTEIN	A major challenge in understanding the cellular diversity of the brain has been linking activity during behavior with standard cellular typology. For example, it has not been possible to determine whether principal neurons in prefrontal cortex active during distinct experiences represent separable cell types, and it is not known whether these differentially active cells exert distinct causal influences on behavior. Here, we develop quantitative hydrogel-based technologies to connect activity in cells reporting on behavioral experience with measures for both brain-wide wiring and molecular phenotype. We find that positive and negative-valence experiences in prefrontal cortex are represented by cell populations that differ in their causal impact on behavior, long-range wiring, and gene expression profiles, with the major discriminant being expression of the adaptation-linked gene NPAS4. These findings illuminate cellular logic of prefrontal cortex information processing and natural adaptive behavior and may point the way to cell-type-specific understanding and treatment of disease-associated states.	[Ye, Li; Allen, William E.; Thompson, Kimberly R.; Hsueh, Brian; Ramakrishnan, Charu; Wang, Ai-Chi; Jennings, Joshua H.; Adhikari, Avishek; Witten, Ilana B.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ye, Li; Hsueh, Brian; Ramakrishnan, Charu; Wang, Ai-Chi; Jennings, Joshua H.; Adhikari, Avishek; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Allen, William E.; Hsueh, Brian] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Allen, William E.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Tian, Qiyuan; McNab, Jennifer A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Halpern, Casey H.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Ye, Li; Luo, Liqun; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Barth, Alison L.] Carnegie Mellon Univ, Biol Sci, Pittsburgh, PA 15213 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Carnegie Mellon University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	deissero@stanford.edu	Adhikari, Avishek/AAF-4444-2021; McNab, Jennifer/ABG-2746-2021	Adhikari, Avishek/0000-0002-9187-9211; McNab, Jennifer/0000-0002-1763-0792; Luo, Liqun/0000-0001-5467-9264	Fannie & John Hertz Foundation; NIMH; NIDA; Wiegers Family Fund; HHMI; U.S. Army Research Laboratory and Defense Advanced Research Projects Agency [W911NF-14-2-0013]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R37MH075957, K99MH106649, R01MH075957, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027749, R37DA035377] Funding Source: NIH RePORTER	Fannie & John Hertz Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wiegers Family Fund; HHMI(Howard Hughes Medical Institute); U.S. Army Research Laboratory and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Greenberg (Harvard) for the NPAS4 antibody, E. Rosen (Harvard) for ribosome tag mice, N. Renier and M. Tessier-Lavigne (Rockefeller) for valuable discussions during lab visits, Christina Kim for discussions, and S. Pak, M. Lo, and C. Perry for technical assistance. W.E.A. is supported by a Fannie & John Hertz Foundation Fellowship. K.D. is supported by NIMH, NIDA, the Wiegers Family Fund, HHMI (HCIA support to L.L. and K.D.), and the U.S. Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement Number W911NF-14-2-0013); nothing in this material represents the official views or policies of these funders. The authors have disclosed these findings to the Stanford Office of Technology Licensing. K.D. is a founder and scientific advisor of ClearLight Diagnostics, a startup exploring improvement of cancer diagnostics using CLARITY-related methods; all software, clones, sequences, protocols, and computational resources are freely distributed and supported (http://capture-clarity.org,http://clarityresourcecenter.org, and http://www.stanford.edu/group/dlab/optogenetics).	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Ekstrand MI, 2014, CELL, V157, P1230, DOI 10.1016/j.cell.2014.03.059; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Henderson JM, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00015; Hof PR, 1996, J COMP NEUROL, V376, P112; Hsiang HL, 2014, J NEUROSCI, V34, P14115, DOI 10.1523/JNEUROSCI.3327-14.2014; Insel N, 2015, CEREB CORTEX, V25, P2631, DOI 10.1093/cercor/bhu062; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johnson ZV, 2010, PHYSIOL BEHAV, V99, P412, DOI 10.1016/j.physbeh.2009.12.013; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Maya-Vetencourt JF, 2012, J PHYSIOL-LONDON, V590, P4777, DOI 10.1113/jphysiol.2012.234237; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pinto L, 2015, NEURON, V87, P437, DOI 10.1016/j.neuron.2015.06.021; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SCHILLING K, 1991, P NATL ACAD SCI USA, V88, P5665, DOI 10.1073/pnas.88.13.5665; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shepherd G. M., 1988, NEUROBIOLOGY; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Soloway AS, 2002, NEUROSCIENCE, V109, P461, DOI 10.1016/S0306-4522(01)00507-3; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tzschentke TM, 1998, BEHAV BRAIN RES, V97, P115, DOI 10.1016/S0166-4328(98)00034-5; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Xiu JB, 2014, NAT NEUROSCI, V17, P1552, DOI 10.1038/nn.3813	56	189	194	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1776	1788		10.1016/j.cell.2016.05.010	http://dx.doi.org/10.1016/j.cell.2016.05.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27238022	Green Accepted, Bronze			2022-12-28	WOS:000378062000026
J	Fruit, C				Fruit, Corinne			Three catalysts for activating carbon-hydrogen bonds	SCIENCE			English	Editorial Material							VISIBLE-LIGHT PHOTOREDOX; ARYLATION; FUNCTIONALIZATION; DERIVATIVES; ADJACENT		[Fruit, Corinne] Normandie Univ, INSA Rouen, UNIROUEN, CNRS,COBRA, F-76000 Rouen, France	Centre National de la Recherche Scientifique (CNRS)	Fruit, C (corresponding author), Normandie Univ, INSA Rouen, UNIROUEN, CNRS,COBRA, F-76000 Rouen, France.	corinne.fruit@univ-rouen.fr						Baudoin O, 2011, CHEM SOC REV, V40, P4902, DOI 10.1039/c1cs15058h; Bellina F, 2006, TETRAHEDRON, V62, P7213, DOI 10.1016/j.tet.2006.05.024; Campos KR, 2007, CHEM SOC REV, V36, P1069, DOI 10.1039/b607547a; Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; Kainz QM, 2016, SCIENCE, V351, P681, DOI 10.1126/science.aad8313; Pastine SJ, 2006, J AM CHEM SOC, V128, P14220, DOI 10.1021/ja064481j; Petersen IN, 2015, ACS MED CHEM LETT, V6, P472, DOI 10.1021/acsmedchemlett.5b00028; Pitts AK, 2015, ANGEW CHEM INT EDIT, V54, P5451, DOI 10.1002/anie.201500067; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Shaw MH, 2016, SCIENCE, V352, P1304, DOI 10.1126/science.aaf6635; Zhu SQ, 2012, CHEM COMMUN, V48, P11960, DOI 10.1039/c2cc36995h; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	12	4	4	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1277	1278		10.1126/science.aaf8923	http://dx.doi.org/10.1126/science.aaf8923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284182				2022-12-28	WOS:000377972000021
J	Cugola, FR; Fernandes, IR; Russo, FB; Freitas, BC; Dias, JLM; Guimaraes, KP; Benazzato, C; Almeida, N; Pignatari, GC; Romero, S; Polonio, CM; Cunha, I; Freitas, CL; Brandao, WN; Rossato, C; Andrade, DG; Faria, DD; Garcez, AT; Buchpigel, CA; Braconi, CT; Mendes, E; Sall, AA; Zanotto, PMD; Peron, JPS; Muotri, AR; Beltrao-Braga, PCB				Cugola, Fernanda R.; Fernandes, Isabella R.; Russo, Fabiele B.; Freitas, Beatriz C.; Dias, Joao L. M.; Guimaraes, Katia P.; Benazzato, Cecilia; Almeida, Nathalia; Pignatari, Graciela C.; Romero, Sarah; Polonio, Carolina M.; Cunha, Isabela; Freitas, Carla L.; Brandao, Wesley N.; Rossato, Cristiano; Andrade, David G.; Faria, Daniele de P.; Garcez, Alexandre T.; Buchpigel, Carlos A.; Braconi, Carla T.; Mendes, Erica; Sall, Amadou A.; Zanotto, Paolo M. de A.; Peron, Jean Pierre S.; Muotri, Alysson R.; Beltrao-Braga, Patricia C. B.			The Brazilian Zika virus strain causes birth defects in experimental models	NATURE			English	Article							INFECTION; BRAIN; GROWTH	Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel rhesus monkeys(1). Until the twentieth century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on Yap Island in Micronesia(2). Patients experienced fever, skin rash, arthralgia and conjunctivitis(2). From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America3. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barre syndrome(4,5). Despite clinical evidence, direct experimental evidence showing that the Brazilian ZIKV (ZIKVBR) strain causes birth defects remains absent(6). Here we demonstrate that ZIKVBR infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice. Moreover, the virus infects human cortical progenitor cells in vitro, leading to an increase in cell death. We also report that the infection of human brain organoids results in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKVBR crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKVBR outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKVBR in human neurodevelopment.	[Cugola, Fernanda R.; Fernandes, Isabella R.; Russo, Fabiele B.; Dias, Joao L. M.; Guimaraes, Katia P.; Benazzato, Cecilia; Almeida, Nathalia; Pignatari, Graciela C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil; [Fernandes, Isabella R.; Freitas, Beatriz C.; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA; [Russo, Fabiele B.; Pignatari, Graciela C.] Tismoo, BR-01401000 Sao Paulo, Brazil; [Polonio, Carolina M.; Cunha, Isabela; Freitas, Carla L.; Brandao, Wesley N.; Rossato, Cristiano; Andrade, David G.; Peron, Jean Pierre S.] Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil; [Faria, Daniele de P.; Garcez, Alexandre T.; Buchpigel, Carlos A.] Univ Sao Paulo, USP Sch Med, Dept Radiol & Oncol, BR-05403010 Sao Paulo, Brazil; [Braconi, Carla T.; Mendes, Erica; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, Brazil; [Sall, Amadou A.] Inst Pasteur, Dakar 220, Senegal; [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil	Universidade de Sao Paulo; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Universidade de Sao Paulo	Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.; Muotri, AR (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.; Peron, JPS (corresponding author), Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.	jeanpierre@usp.br; muotri@ucsd.edu; patriciacbbbraga@usp.br	de Paula Faria, Daniele/U-1731-2019; Brandão, Wesley N/K-5919-2017; Mendes, Erica/L-7333-2018; Russo, Fabiele/N-4340-2017; Braconi, Carla/B-3320-2014; Benazzato, Cecilia/AAB-8869-2019; Beltrão-Braga, Patricia C B/D-6450-2013; Buchpiguel, Carlos A/C-3774-2012; Benazzato, Cecília/U-5873-2017; Buchpiguel, Carlos/AAC-6237-2020; Peron, Jean Pierre S/F-9248-2012; de A. Zanotto, Paolo M./B-9286-2019; Cugola, Fernanda/I-9556-2016	de Paula Faria, Daniele/0000-0002-1766-2786; Brandão, Wesley N/0000-0001-9306-3251; Mendes, Erica/0000-0001-9007-1053; Russo, Fabiele/0000-0002-4076-1846; Braconi, Carla/0000-0002-5370-8980; Beltrão-Braga, Patricia C B/0000-0003-0004-1091; Buchpiguel, Carlos A/0000-0003-0956-2790; Benazzato, Cecília/0000-0002-8656-0871; Buchpiguel, Carlos/0000-0003-0956-2790; de A. Zanotto, Paolo M./0000-0002-8167-0625; Peron, Jean Pierre/0000-0003-1638-8866; Rossato, Cristiano/0000-0003-1124-0520; Almeida dos Santos, Nathalia/0000-0003-3145-186X; Cugola, Fernanda/0000-0002-6677-2404; Freitas, Carla Longo/0000-0002-7218-8597	Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO 'The Tooth Fairy Project'; National Institutes of Health [U19MH107367, R01MH094753]; NARSAD Independent Investigator Grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094753, U19MH107367] Funding Source: NIH RePORTER	Zika Network FAPESP; NGO 'The Tooth Fairy Project'; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Grant(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Zika Network FAPESP projects 2011/18703-2 and 2014/17766-9, the NGO 'The Tooth Fairy Project', the National Institutes of Health through the U19MH107367, R01MH094753 and an NARSAD Independent Investigator Grant to A.R.M. We would like to thank M. Goncalves and M. A. Miglino for scientific discussions, G. Amarante-Mendes for the FITC-Annexin V reagent, M. Zatz for the SJL mice, E. Durigon and his group for the ZIKV<SUP>BR</SUP> aliquots, P. Vasconcelos for providing a lyophilized ZIKV<SUP>BR</SUP> seed, N. Olsen for reagent and equipment support, D. Candido for analysis support, F. Mastrantonio for drawings and R. E. Grassi for electron and confocal microscopy support.	[Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Freire CCDM., 2015, BIORXIV, P32839, DOI [10.1101/032839, DOI 10.1101/032839]; Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Jang EA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00176; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, DOI [10.4269/ajtmh.16-0111, DOI 10.4269/AJTMH.16-0111, 10.4269/ajtmh.16-0111.]; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Stock NK, 2013, J VIROL, V87, P2895, DOI 10.1128/JVI.01116-12; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4	36	827	859	2	307	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					267	+		10.1038/nature18296	http://dx.doi.org/10.1038/nature18296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279226	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000377475100045
J	Dombard, AJ; O'Hara, S				Dombard, Andrew J.; O'Hara, Sean			PLANETARY SCIENCE Pluto's polygons explained	NATURE			English	Editorial Material									[Dombard, Andrew J.; O'Hara, Sean] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dombard, AJ (corresponding author), Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA.							McKinnon WB, 2016, NATURE, V534, P82, DOI 10.1038/nature18289; Schubert G, 2001, MANTLE CONVECTION EA; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Trowbridge AJ, 2016, NATURE, V534, P79, DOI 10.1038/nature18016; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032	5	1	1	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					40	41		10.1038/534040a	http://dx.doi.org/10.1038/534040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251270				2022-12-28	WOS:000376962300026
J	Hsu, J				Hsu, John			The ACA and Risk Pools - Insurer Losses in the Setting of Noncompliant Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hsu, John] Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA; [Hsu, John] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hsu, J (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA.; Hsu, J (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.							Jost Timothy, 2015, HLTH AFFAIRS BLOG; Kaiser Family Foundation, 2015, AN 2016 PREM CHANG A; Koskinen John A., 2015, COMMUNICATION; Norris L, 2016, 35 STATES TRANSITION; Sommers BD, 2015, NEW ENGL J MED, V373, P2395, DOI 10.1056/NEJMp1509462	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2105	2107		10.1056/NEJMp1602981	http://dx.doi.org/10.1056/NEJMp1602981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248617				2022-12-28	WOS:000387209900002
J	Jaubert, J; Verheyden, S; Genty, D; Soulier, M; Cheng, H; Blamart, D; Burlet, C; Camus, H; Delaby, S; Deldicque, D; Dwards, RLE; Ferrier, C; Lacrampe-Cuyaubere, F; Leveque, F; Maksud, F; Mora, P; Muth, X; Regnier, E; Rouzaud, JN; Santos, F				Jaubert, Jacques; Verheyden, Sophie; Genty, Dominique; Soulier, Michel; Cheng, Hai; Blamart, Dominique; Burlet, Christian; Camus, Hubert; Delaby, Serge; Deldicque, Damien; Dwards, R. Lawrence E.; Ferrier, Catherine; Lacrampe-Cuyaubere, Francois; Leveque, Francois; Maksud, Frederic; Mora, Pascal; Muth, Xavier; Regnier, Edouard; Rouzaud, Jean-Noel; Santos, Frederic			Early Neanderthal constructions deep in Bruniquel Cave in southwestern France	NATURE			English	Article							ORIGIN; PAINTINGS; HEARTHS; FIRE	Very little is known about Neanderthal cultures(1), particularly early ones. Other than lithic implements and exceptional bone tools(2), very few artefacts have been preserved. While those that do remain include red and black pigments(3) and burial sites(4), these indications of modernity are extremely sparse and few have been precisely dated, thus greatly limiting our knowledge of these predecessors of modern humans(5). Here we report the dating of annular constructions made of broken stalagmites found deep in Bruniquel Cave in southwest France. The regular geometry of the stalagmite circles, the arrangement of broken stalagmites and several traces of fire demonstrate the anthropogenic origin of these constructions. Uranium-series dating of stalagmite regrowths on the structures and on burnt bone, combined with the dating of stalagmite tips in the structures, give a reliable and replicated age of 176.5 thousand years (+/-2.1 thousand years), making these edifices among the oldest known well-dated constructions made by humans. Their presence at 336 metres from the entrance of the cave indicates that humans from this period had already mastered the underground environment, which can be considered a major step in human modernity.	[Jaubert, Jacques; Ferrier, Catherine; Santos, Frederic] Univ Bordeaux, PACEA, UMR 5199, CNRS,MCC, F-33615 Pessac, France; [Verheyden, Sophie; Burlet, Christian] Royal Belgian Inst Nat Sci, Earth & Hist Life, B-1000 Brussels, Belgium; [Verheyden, Sophie] Vrije Univ Brussel, AMGC, B-1050 Brussels, Belgium; [Genty, Dominique; Blamart, Dominique; Regnier, Edouard] UVSQ, CEA, CNRS, LSCE,UMR 8212, F-91400 Gif Sur Yvette, France; [Soulier, Michel] Soc Speleol & Archeol Caussade, 5 Rue Bourdelle, F-82300 Caussade, France; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai; Dwards, R. Lawrence E.] Univ Minnesota, Earth Sci, Minneapolis, MN 55455 USA; [Camus, Hubert] Protee Expert Sas, F-30250 Sommieres, France; [Delaby, Serge] Univ Mons, Fac Polytech, B-7000 Mons, Belgium; [Deldicque, Damien; Rouzaud, Jean-Noel] Ecole Normale Super, Lab Geol, UMR 8538, CNRS, F-75000 Paris, France; [Lacrampe-Cuyaubere, Francois] Archeosphere, F-11500 Quirbajou, France; [Lacrampe-Cuyaubere, Francois; Muth, Xavier] Get Situ, CH-1091 Bourg En Lavaux, Switzerland; [Leveque, Francois] Univ La Rochelle, CNRS, UMR 7266, LIENSs, F-17000 La Rochelle, France; [Maksud, Frederic] Minist Culture, Reg Archaeol Serv Midi Pyrenees, F-31080 Toulouse, France; [Mora, Pascal] SHS 3D, Archeostransfert, Archeovis, UMS 3657, F-33007 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Royal Belgian Institute of Natural Sciences; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; University of Mons; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Jaubert, J (corresponding author), Univ Bordeaux, PACEA, UMR 5199, CNRS,MCC, F-33615 Pessac, France.; Verheyden, S (corresponding author), Royal Belgian Inst Nat Sci, Earth & Hist Life, B-1000 Brussels, Belgium.; Verheyden, S (corresponding author), Vrije Univ Brussel, AMGC, B-1050 Brussels, Belgium.; Genty, D (corresponding author), UVSQ, CEA, CNRS, LSCE,UMR 8212, F-91400 Gif Sur Yvette, France.	jacques.jaubert@u-bordeaux.fr; sophie.verheyden@naturalsciences.be; dominique.genty@lsce.ipsl.fr	Leveque, François/N-7604-2014; CHENG, HAI/H-3413-2017; Santos, Frédéric/I-3565-2019	Leveque, François/0000-0003-0090-9110; CHENG, HAI/0000-0002-5305-9458; Santos, Frédéric/0000-0003-1445-3871; Burlet, Christian/0000-0002-2134-1969; Muth, Xavier/0000-0002-9412-9176; Jaubert, Jacques/0000-0001-5101-6254; ROUZAUD, Jean-Noel/0000-0002-1933-2617; Verheyden, Sophie/0000-0002-1755-0389	French MCC (DRAC-SRA Midi-Pyrenees, Toulouse); Belgian Science Policy Office	French MCC (DRAC-SRA Midi-Pyrenees, Toulouse); Belgian Science Policy Office(Belgian Federal Science Policy Office)	We thank the owners of the cave (Nidauzel association), the French Ministry of Culture & Communication, MCC (DRAC-SRA Midi-Pyrenees, Toulouse), M. Vaginay, P. Chalard, E. Mauduit, the Speleological & Archaeological Society of Caussade (SSAC), CNRS (InEE & InSU), the University of Bordeaux-PACEA, LSCE Gif-s/-Yvette, M. O'Farrell and C. Garrec for editing, V. Feruglio for a drawing. We thank F. Dewilde and F. Mansouri (LSCE) for their assistance with the isotopic measurements, Y. Vanbrabant (Belgian Geological Survey) for his assistance with the cave monitoring and B. Martinez for his help with the topography. We thank S. Mariot and R. Weil (LPS, Paris-XI University, Orsay) for their help in the infrared spectrometry measurements. This work is mainly supported by French MCC (DRAC-SRA Midi-Pyrenees, Toulouse) and in part by the Belgian Science Policy Office. The U-Th dating was supported in part by the U.S. NSF.	Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; BEDNARIK R.G., 1990, AUST ABORIG STUD, V1990, P64; Begouen R., 2013, CAVERNE TROIS FRERES; Berna F, 2012, P NATL ACAD SCI USA, V109, pE1215, DOI 10.1073/pnas.1117620109; Bertran P, 1997, SEDIMENTOLOGY, V44, P1, DOI 10.1111/j.1365-3091.1997.tb00421.x; Brodard A., 2014, ACT C MADAPCA MICR D, P233; Brodard A, 2012, QUAT GEOCHRONOL, V10, P353, DOI 10.1016/j.quageo.2012.04.013; Burens A., 2014, INT J HERITAGE DIGIT, V3, P179; Cantalejo P., 2014, INTERVENCIONES ARQUE, P119; Carrancho A, 2011, EARTH PLANET SC LETT, V312, P176, DOI 10.1016/j.epsl.2011.10.006; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; CLOTTES J, 1995, CR ACAD SCI II, V320, P1133; Clottes J., 1984, ART CAVERNES ATLAS G, P540; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; de Lumley Henry, 1969, CABANE ACHEULEENNE G, V7; Delannoy JJ, 2013, ANTIQUITY, V87, P12, DOI 10.1017/S0003598X00048596; Deldicque D., 2016, CARBON; Ellingham STD, 2015, SCI JUSTICE, V55, P181, DOI 10.1016/j.scijus.2014.12.002; Faivre J.-Ph., 2013, PALEO, V4, P231; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Hayden B, 2012, OXFORD J ARCHAEOL, V31, P1, DOI 10.1111/j.1468-0092.2011.00376.x; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Jrad A., 2013, ARCHAEOL PROSPECT; Lafon L., 1996, THESIS U TOULOUSE P; LEBON M, 2011, REV ARCHEOMETRIE, V35, P179; LEBORGNE E., 1960, Annales de Geographie, V16, P159; Lenoble A, 2004, J ARCHAEOL SCI, V31, P457, DOI 10.1016/j.jas.2003.09.013; LORBLANCHET M, 1999, NAISSANCE ART GENESE; Maki D, 2006, ARCHAEOL PROSPECT, V13, P207, DOI 10.1002/arp.277; Mania D. H., 1983, BILZINGSLEBEN; Maureille B., 2007, NEANDERTALIENS BIOL, P311; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Onac BP, 2005, QUATERNARY SCI REV, V24, P1151, DOI 10.1016/j.quascirev.2004.12.001; Otte M, 2012, QUATERN INT, V247, P212, DOI 10.1016/j.quaint.2010.11.031; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Plagnes V, 2003, QUATERNARY RES, V60, P172, DOI 10.1016/S0033-5894(03)00064-4; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rouzaud F., 1996, SPELUNCA, V60, P27; Rouzaud F., 1990, PALEO, V2, P89; Rouzaud JN, 2015, CR GEOSCI, V347, P124, DOI 10.1016/j.crte.2015.04.004; Scollar I., 1990, ARCHAEOL PROSPECT; Soressi M., 2007, NEANDERTALIENS BIOL, V23, P297, DOI DOI 10.1183/09031936.00022909; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Tchernych A. P., 1982, MOLODOVA, P6; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Wainer K, 2011, QUATERNARY SCI REV, V30, P130, DOI 10.1016/j.quascirev.2010.07.004; Wainer K, 2013, PALAEOGEOGR PALAEOCL, V376, P122, DOI 10.1016/j.palaeo.2013.02.026	49	99	102	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					111	+		10.1038/nature18291	http://dx.doi.org/10.1038/nature18291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27251286				2022-12-28	WOS:000376962300044
J	Bianchi, F; Trostl, J; Junninen, H; Frege, C; Henne, S; Hoyle, CR; Molteni, U; Herrmann, E; Adamov, A; Bukowiecki, N; Chen, X; Duplissy, J; Gysel, M; Hutterli, M; Kangasluoma, J; Kontkanen, J; Kurten, A; Manninen, HE; Munch, S; Perakyla, O; Petaja, T; Rondo, L; Williamson, C; Weingartner, E; Curtius, J; Worsnop, DR; Kulmala, M; Dommen, J; Baltensperger, U				Bianchi, F.; Trostl, J.; Junninen, H.; Frege, C.; Henne, S.; Hoyle, C. R.; Molteni, U.; Herrmann, E.; Adamov, A.; Bukowiecki, N.; Chen, X.; Duplissy, J.; Gysel, M.; Hutterli, M.; Kangasluoma, J.; Kontkanen, J.; Kuerten, A.; Manninen, H. E.; Muench, S.; Perakyla, O.; Petaja, T.; Rondo, L.; Williamson, C.; Weingartner, E.; Curtius, J.; Worsnop, D. R.; Kulmala, M.; Dommen, J.; Baltensperger, U.			New particle formation in the free troposphere: A question of chemistry and timing	SCIENCE			English	Article							SULFURIC-ACID; M A.S.L.; NUCLEATION; GROWTH; JUNGFRAUJOCH; OZONOLYSIS; PRODUCTS; SIZE	New particle formation (NPF) is the source of over half of the atmosphere's cloud condensation nuclei, thus influencing cloud properties and Earth's energy balance. Unlike in the planetary boundary layer, few observations of NPF in the free troposphere exist. We provide observational evidence that at high altitudes, NPF occurs mainly through condensation of highly oxygenated molecules (HOMs), in addition to taking place through sulfuric acid-ammonia nucleation. Neutral nucleation is more than 10 times faster than ion-induced nucleation, and growth rates are size-dependent. NPF is restricted to a time window of 1 to 2 days after contact of the air masses with the planetary boundary layer; this is related to the time needed for oxidation of organic compounds to form HOMs. These findings require improved NPF parameterization in atmospheric models.	[Bianchi, F.; Trostl, J.; Frege, C.; Hoyle, C. R.; Molteni, U.; Herrmann, E.; Bukowiecki, N.; Gysel, M.; Weingartner, E.; Dommen, J.; Baltensperger, U.] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Bianchi, F.] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Bianchi, F.; Junninen, H.; Adamov, A.; Chen, X.; Duplissy, J.; Kangasluoma, J.; Kontkanen, J.; Manninen, H. E.; Perakyla, O.; Petaja, T.; Worsnop, D. R.; Kulmala, M.] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Henne, S.] Empa, Swiss Fed Labs Mat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Hoyle, C. R.] Inst Snow & Avalanche Res SLF, WSL Swiss Fed Inst Forest Snow & Landscape Res, CH-7260 Davos, Switzerland; [Duplissy, J.] Univ Helsinki, Helsinki Inst Phys, FIN-00014 Helsinki, Finland; [Hutterli, M.] Tofwerk, CH-3600 Thun, Switzerland; [Kuerten, A.; Muench, S.; Rondo, L.; Williamson, C.; Curtius, J.] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Worsnop, D. R.] Aerodyne Res, Billerica, MA 01821 USA; [Williamson, C.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Weingartner, E.] Univ Appl Sci FHNW, Inst Aerosol & Sensor Technol, CH-5210 Windisch, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Helsinki; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Helsinki Institute of Physics; University of Helsinki; TOFWERK AG; Goethe University Frankfurt; Aerodyne Research; University of Colorado System; University of Colorado Boulder; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Bianchi, F; Baltensperger, U (corresponding author), Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland.; Bianchi, F (corresponding author), ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.; Bianchi, F (corresponding author), Univ Helsinki, Dept Phys, Helsinki 00014, Finland.	federico.bianchi@psi.ch; urs.baltensperger@psi.ch	Kürten, Andreas/O-3851-2019; Henne, Stephan/A-3467-2009; Williamson, Christina J/D-1484-2016; Worsnop, Douglas R/D-2817-2009; kangasluoma, juha/W-7450-2019; Bianchi, Federico/G-8428-2012; Chen, Xuemeng/F-6072-2019; Hoyle, Christopher R./B-7786-2008; Kangasluoma, Juha/AAY-7941-2021; Kontkanen, Jenni/AAL-1368-2020; Adamov, Alexey/V-2477-2018; Kulmala, Markku T/I-7671-2016; Petäjä, Tuukka/A-8009-2008; Weingartner, Ernest/B-6793-2009; Gysel-Beer, Martin/C-3843-2008; Duplissy, Jonathan/A-1723-2010; Curtius, Joachim/A-2681-2011; Herrmann, Erik/M-7054-2015; Junninen, Heikki/C-2157-2014	Kürten, Andreas/0000-0002-8955-4450; Williamson, Christina J/0000-0002-5188-9378; Worsnop, Douglas R/0000-0002-8928-8017; Bianchi, Federico/0000-0003-2996-3604; Chen, Xuemeng/0000-0002-7731-6842; Hoyle, Christopher R./0000-0002-1369-9143; Kangasluoma, Juha/0000-0002-1639-1187; Kontkanen, Jenni/0000-0002-5373-3537; Kulmala, Markku T/0000-0003-3464-7825; Petäjä, Tuukka/0000-0002-1881-9044; Weingartner, Ernest/0000-0002-2427-4634; Gysel-Beer, Martin/0000-0002-7453-1264; Duplissy, Jonathan/0000-0001-8819-0264; Curtius, Joachim/0000-0003-3153-4630; Trostl, Jasmin/0000-0002-2807-0348; Muench, Steffen/0000-0002-3551-1922; Herrmann, Erik/0000-0002-6474-6560; Junninen, Heikki/0000-0001-7178-9430; Perakyla, Otso/0000-0002-2089-0106; Molteni, Ugo/0000-0002-1623-1933	Swiss National Science Foundation [200020_135307, 20020_152907, 206021_144947, 200021_140663]; MeteoSwiss; EC FP7 (European Commission Seventh Framework Programme for Research and Technological Development) project ACTRIS (Aerosols, Clouds, and Trace Gases Research Infrastructure Network) [262254]; Academy of Finland Centre of Excellence [272041, 1118615]; EC FP7 Marie Curie Initial Training Network (CLOUD-TRAIN) [316662]; German Federal Ministry of Education and Research [01LK1222A]; EC FP7 project BACCHUS (Impact of Biogenic Versus Anthropogenic Emissions on Clouds and Climate: Towards a Holistic Understanding) [603445]; European Research Council [615922-BLACARAT]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MeteoSwiss; EC FP7 (European Commission Seventh Framework Programme for Research and Technological Development) project ACTRIS (Aerosols, Clouds, and Trace Gases Research Infrastructure Network); Academy of Finland Centre of Excellence(Academy of Finland); EC FP7 Marie Curie Initial Training Network (CLOUD-TRAIN); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EC FP7 project BACCHUS (Impact of Biogenic Versus Anthropogenic Emissions on Clouds and Climate: Towards a Holistic Understanding); European Research Council(European Research Council (ERC)European Commission)	We thank the International Foundation High Altitude Research Stations Jungfraujoch and Gornergrat for the opportunity to perform experiments at the Jungfraujoch and especially the research station's custodians J. and M. Fischer and M. and U. Otz for their support and hospitality. This work was supported by the Swiss National Science Foundation (grant nos. 200020_135307, 20020_152907, 206021_144947, and 200021_140663), MeteoSwiss in the framework of the Global Atmosphere Watch program, and the EC FP7 (European Commission Seventh Framework Programme for Research and Technological Development) project ACTRIS (Aerosols, Clouds, and Trace Gases Research Infrastructure Network) (grant agreement no. 262254). Funding was also received from the Academy of Finland Centre of Excellence (grant nos. 272041 and 1118615), the EC FP7 Marie Curie Initial Training Network (CLOUD-TRAIN, grant no. 316662), the German Federal Ministry of Education and Research (project no. 01LK1222A), the EC FP7 project BACCHUS (Impact of Biogenic Versus Anthropogenic Emissions on Clouds and Climate: Towards a Holistic Understanding; grant agreement no. 603445), and the European Research Council (grant no. 615922-BLACARAT). We thank the tofTools team for providing tools for mass spectrometry analysis. The authors declare no competing financial interests.	Anderson TL, 2005, B AM METEOROL SOC, V86, P1795, DOI 10.1175/BAMS-86-12-1795; Bianchi F, 2014, ENVIRON SCI TECHNOL, V48, P13675, DOI 10.1021/es502380b; Boulon J, 2010, ATMOS CHEM PHYS, V10, P9333, DOI 10.5194/acp-10-9333-2010; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; Duplissy J, 2016, J GEOPHYS RES-ATMOS, V121, P1752, DOI 10.1002/2015JD023539; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Eisele FL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006568; Herrmann E, 2015, J GEOPHYS RES-ATMOS, V120, P9459, DOI 10.1002/2015JD023660; Jokinen T, 2015, P NATL ACAD SCI USA, V112, P7123, DOI 10.1073/pnas.1423977112; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kulmala M, 1998, J GEOPHYS RES-ATMOS, V103, P8301, DOI 10.1029/97JD03718; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; Mentel TF, 2015, ATMOS CHEM PHYS, V15, P6745, DOI 10.5194/acp-15-6745-2015; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Mirme S, 2010, ATMOS CHEM PHYS, V10, P437, DOI 10.5194/acp-10-437-2010; Nieminen T, 2010, ATMOS CHEM PHYS, V10, P9773, DOI 10.5194/acp-10-9773-2010; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; Rissanen MP, 2014, J AM CHEM SOC, V136, P15596, DOI 10.1021/ja507146s; Rodriguez S, 2009, ATMOS CHEM PHYS, V9, P6319, DOI 10.5194/acp-9-6319-2009; Rose C, 2015, ATMOS CHEM PHYS, V15, P3413, DOI 10.5194/acp-15-3413-2015; Rose C, 2015, ATMOS ENVIRON, V102, P18, DOI 10.1016/j.atmosenv.2014.11.015; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Trostl J, 2016, NATURE, V533, P527, DOI 10.1038/nature18271; Venzac H, 2008, P NATL ACAD SCI USA, V105, P15666, DOI 10.1073/pnas.0801355105; Yu FQ, 2014, J GEOPHYS RES-ATMOS, V119, P12246, DOI 10.1002/2014JD022136; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756	29	281	285	20	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1109	1112		10.1126/science.aad5456	http://dx.doi.org/10.1126/science.aad5456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27226488	Green Accepted			2022-12-28	WOS:000376480800041
J	Cookson, T				Cookson, Toby			Gregory Anthony Hugh Cookson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2963	10.1136/bmj.i2963	http://dx.doi.org/10.1136/bmj.i2963			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27234942				2022-12-28	WOS:000376940700004
J	[Anonymous]				[Anonymous]			Refugee migration and risk of schizophrenia and other non-affective psychoses: cohort study of 1.3 million people in Sweden (vol 352, 1030, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		HOLLANDER AC, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I1030)	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2865	10.1136/bmj.i2865	http://dx.doi.org/10.1136/bmj.i2865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27233674	Bronze, Green Published			2022-12-28	WOS:000376940700001
J	Pacheco, O; Beltran, M; Nelson, CA; Valencia, D; Tolosa, N; Farr, SL; Padilla, AV; Tong, VT; Cuevas, EL; Espinosa-Bode, A; Pardo, L; Rico, A; Reefhuis, J; Gonzalez, M; Mercado, M; Chaparro, P; Duran, MM; Rao, CY; Munoz, MM; Powers, AM; Cuellar, C; Helfand, R; Huguett, C; Jamieson, DJ; Honein, MA; Martinez, MLO				Pacheco, Oscar; Beltran, Mauricio; Nelson, Christina A.; Valencia, Diana; Tolosa, Natalia; Farr, Sherry L.; Padilla, Ana V.; Tong, Van T.; Cuevas, Esther L.; Espinosa-Bode, Andres; Pardo, Lissethe; Rico, Angelica; Reefhuis, Jennita; Gonzalez, Maritza; Mercado, Marcela; Chaparro, Pablo; Martinez Duran, Mancel; Rao, Carol Y.; Munoz, Maria M.; Powers, Ann M.; Cuellar, Claudia; Helfand, Rita; Huguett, Claudia; Jamieson, Denise J.; Honein, Margaret A.; Ospina Martinez, Martha L.			Zika Virus Disease in Colombia - Preliminary Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; TRANSMISSION	BACKGROUND Colombia began official surveillance for Zika virus disease (ZVD) in August 2015. In October 2015, an outbreak of ZVD was declared after laboratory-confirmed disease was identified in nine patients. METHODS Using the national population-based surveillance system, we assessed patients with clinical symptoms of ZVD from August 9, 2015, to April 2, 2016. Laboratory test results and pregnancy outcomes were evaluated for a subgroup of pregnant women. Concurrently, we investigated reports of microcephaly for evidence of congenital ZVD. RESULTS By April 2, 2016, there were 65,726 cases of ZVD reported in Colombia, of which 2485 (4%) were confirmed by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay. The overall reported incidence of ZVD among female patients was twice that in male patients. A total of 11,944 pregnant women with ZVD were reported in Colombia, with 1484 (12%) of these cases confirmed on RT-PCR assay. In a subgroup of 1850 pregnant women, more than 90% of women who were reportedly infected during the third trimester had given birth, and no infants with apparent abnormalities, including microcephaly, have been identified. A majority of the women who contracted ZVD in the first or second trimester were still pregnant at the time of this report. Among the cases of microcephaly investigated from January 2016 through April 2016, four patients had laboratory evidence of congenital ZVD; all were born to asymptomatic mothers who were not included in the ZVD surveillance system. CONCLUSIONS Preliminary surveillance data in Colombia suggest that maternal infection with the Zika virus during the third trimester of pregnancy is not linked to structural abnormalities in the fetus. However, the monitoring of the effect of ZVD on pregnant women in Colombia is ongoing.	[Pacheco, Oscar; Beltran, Mauricio; Tolosa, Natalia; Padilla, Ana V.; Cuevas, Esther L.; Pardo, Lissethe; Rico, Angelica; Gonzalez, Maritza; Mercado, Marcela; Chaparro, Pablo; Martinez Duran, Mancel; Huguett, Claudia; Ospina Martinez, Martha L.] Inst Nacl Salud, Bogota, Colombia; [Munoz, Maria M.; Cuellar, Claudia] Minist Salud & Protecc Social, Bogota, Colombia; [Nelson, Christina A.; Valencia, Diana; Farr, Sherry L.; Tong, Van T.; Espinosa-Bode, Andres; Reefhuis, Jennita; Rao, Carol Y.; Powers, Ann M.; Helfand, Rita; Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA	Instituto Nacional de Salud (Colombia); Centers for Disease Control & Prevention - USA	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	mhonein@cdc.gov		Rao, Carol/0000-0001-7187-2189; Tong, Van/0000-0002-3970-1440; Helfand, Rita/0000-0001-5734-0258	Colombian Instituto Nacional de Salud; CDC	Colombian Instituto Nacional de Salud; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Colombian Instituto Nacional de Salud and the CDC.	[Anonymous], 2016, EPIDEMIOLOGICAL WEEK; [Anonymous], 2016, NACIMIENTOS AREA OCU; [Anonymous], 2016, CIRCULAR EXTERNA 004; [Anonymous], 2015, POPULATION PROJECTIO; Brasil P., 2016, N ENGL J MED; Calvet G, 2016, LANCET INFECT DIS; Cauchemez S, 2016, LANCET; Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ojeda G, 2011, NATL DEMOGRAPHIC HLT; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1; Pan American Health Organization, 2016, CUM ZIK SUSP CONF CA; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290	18	114	115	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2020	383	6							e44	10.1056/NEJMoa1604037	http://dx.doi.org/10.1056/NEJMoa1604037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB3TI	27305043	Bronze			2022-12-28	WOS:000560438400009
J	Cabanillas, ME; McFadden, DG; Durante, C				Cabanillas, Maria E.; McFadden, David G.; Durante, Cosimo			Thyroid cancer	LANCET			English	Review							TERT PROMOTER MUTATIONS; BRAF V600E MUTATION; RADIOIODINE REMNANT ABLATION; FOLLOW-UP; ASSOCIATION GUIDELINES; SERUM THYROGLOBULIN; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; BRAF(V600E) MUTATION; DOUBLE-BLIND; PHASE-II	Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment ( surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.	[Cabanillas, Maria E.] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77230 USA; [McFadden, David G.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Durante, Cosimo] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome	Cabanillas, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77230 USA.	mcabani@mdanderson.org	Cabanillas, Maria E./AAN-9055-2020; Durante, Cosimo/E-4926-2014	Durante, Cosimo/0000-0002-1791-5915	Roche Genentech; Eisai; Exelixis; AstraZeneca; Bayer	Roche Genentech(Roche HoldingGenentech); Eisai(Eisai Co Ltd); Exelixis; AstraZeneca(AstraZeneca); Bayer(Bayer AG)	MEC has received research funding from Roche Genentech, Eisai, and Exelixis, and consultant fees from AstraZeneca, Exelixis, Eisai, and Bayer. DGM and CD declare no competing interests.	Adam MA, 2014, ANN SURG, V260, P601, DOI 10.1097/SLA.0000000000000925; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alexander EK, 2014, J CLIN ENDOCR METAB, V99, P119, DOI 10.1210/jc.2013-2482; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; American Cancer Society, 2015, CANC FACTS FIG 2015; [Anonymous], 2012, PACK INS CAB COM; Barney BM, 2011, HEAD NECK-J SCI SPEC, V33, P645, DOI 10.1002/hed.21504; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Biondi B, 2005, NAT CLIN PRACT ENDOC, V1, P32, DOI 10.1038/ncpendmet0020; Brierley JD, 1997, CANCER, V79, P2414; Brito JP, 2014, J CLIN ENDOCR METAB, V99, P1253, DOI 10.1210/jc.2013-2928; Brose M, 2013, EUR CANC C 2013, V2013, P28; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Brose MS, 2015, ASCO M ABSTR S, V33, P6048; Cabanillas ME, 2015, HEMATOL ONCOL CLIN N, V29, P1123, DOI 10.1016/j.hoc.2015.07.011; Cabanillas ME, 2014, THYROID, V24, P1508, DOI 10.1089/thy.2014.0125; Carhill AA, 2015, J CLIN ENDOCR METAB, V100, P3270, DOI 10.1210/JC.2015-1346; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Chen YF, 2016, THYROID, V26, P248, DOI 10.1089/thy.2015.0391; Ciampi R, 2013, THYROID, V23, P50, DOI 10.1089/thy.2012.0207; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Crippa S, 2010, AM J CLIN PATHOL, V134, P343, DOI 10.1309/AJCPXM9WIRQ8JZBJ; Dadu R, 2015, THYROID S1, V25, P491; Dadu R, 2015, J CLIN ENDOCR METAB, V100, pE77, DOI 10.1210/jc.2014-2246; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Durante C, 2015, JAMA-J AM MED ASSOC, V313, P926, DOI 10.1001/jama.2015.0956; Durante C, 2013, J CLIN ENDOCR METAB, V98, P636, DOI 10.1210/jc.2012-3401; Durante C, 2012, J CLIN ENDOCR METAB, V97, P2748, DOI 10.1210/jc.2012-1123; Durante C, 2011, J CLIN ENDOCR METAB, V96, P3059, DOI 10.1210/jc.2011-1379; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Fabian P, 2014, ENDOCRINE, V46, P532, DOI 10.1007/s12020-013-0097-6; Falchook GS, 2015, THYROID, V25, P71, DOI 10.1089/thy.2014.0123; Filetti S, 2006, NAT CLIN PRACT ENDOC, V2, P384, DOI 10.1038/ncpendmet0215; Fukunari N, 2004, WORLD J SURG, V28, P1261, DOI 10.1007/s00268-004-7597-8; Godbert Y, 2015, J CLIN ONCOL, V33, pE84, DOI 10.1200/JCO.2013.49.6596; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Haigh PI, 2005, ANN SURG ONCOL, V12, P81, DOI 10.1007/s10434-004-1165-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell RM, 2014, ENDOCR PRACT, V20, P364, DOI 10.4158/EP13330.OR; Hauch A, 2014, ANN SURG ONCOL, V21, P3844, DOI 10.1245/s10434-014-3846-8; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Hong DS, 2016, 97 ANN M AM ASS CANC; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Howlader N., 2016, SEER CANC STAT REV 1; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Kelly LM, 2014, P NATL ACAD SCI USA, V111, P4233, DOI 10.1073/pnas.1321937111; Kim DS, 2009, J ULTRAS MED, V28, P1685, DOI 10.7863/jum.2009.28.12.1685; Kouvaraki MA, 2003, SURGERY, V134, P946, DOI 10.1016/S0039-6060(03)00424-0; Kowalska A, 2016, THYROID, V26, P543, DOI 10.1089/thy.2015.0352; Landa I, 2013, J CLIN ENDOCR METAB, V98, pE1562, DOI 10.1210/jc.2013-2383; Lee SH, 2013, ENDOCR PATHOL, V24, P177, DOI 10.1007/s12022-013-9263-x; Lim SM, 2013, ANN ONCOL, V24, P3089, DOI 10.1093/annonc/mdt379; Liu XL, 2014, J CLIN ENDOCR METAB, V99, pE1130, DOI 10.1210/jc.2013-4048; Lorch JH, 2013, P AM SOC CLIN ONCO S, V31, P6023; Lubitz CC, 2010, THYROID, V20, P25, DOI 10.1089/thy.2009.0208; Marti JL, 2015, ANN SURG ONCOL, V22, P3996, DOI 10.1245/s10434-015-4486-3; Matsuzu K, 2014, WORLD J SURG, V38, P68, DOI 10.1007/s00268-013-2224-1; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; McIver B, 2014, J CLIN ENDOCR METAB, V99, P4069, DOI 10.1210/jc.2013-3584; Meijer JAA, 2010, CLIN ENDOCRINOL, V72, P534, DOI 10.1111/j.1365-2265.2009.03666.x; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Mendelsohn AH, 2010, ARCH OTOLARYNGOL, V136, P1055, DOI 10.1001/archoto.2010.181; Miyakawa M, 2005, ENDOCR J, V52, P207, DOI 10.1507/endocrj.52.207; Moley JF, 2010, J NATL COMPR CANC NE, V8, P549, DOI 10.6004/jnccn.2010.0042; Nikiforov YE, 2015, THYROID, V25, P1217, DOI 10.1089/thy.2015.0305; Nikiforov YE, 2014, CANCER-AM CANCER SOC, V120, P3627, DOI 10.1002/cncr.29038; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Nixon IJ, 2012, SURGERY, V151, P571, DOI 10.1016/j.surg.2011.08.016; O'Connell K, 2013, SURGERY, V154, P697, DOI 10.1016/j.surg.2013.06.040; Orlov S, 2009, HEAD NECK-J SCI SPEC, V31, P782, DOI 10.1002/hed.21020; Pacini F, 2003, J CLIN ENDOCR METAB, V88, P3668, DOI 10.1210/jc.2002-021925; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Raman P, 2014, NAT REV ENDOCRINOL, V10, P616, DOI 10.1038/nrendo.2014.115; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Romei C, 2011, CLIN ENDOCRINOL, V74, P241, DOI 10.1111/j.1365-2265.2010.03900.x; Romei C, 2015, CLIN ENDOCRINOL, V82, P892, DOI 10.1111/cen.12686; Ross DS, 2009, THYROID, V19, P1043, DOI 10.1089/thy.2008.0407; Rothenberg SM, 2013, J CLIN ONCOL, V31; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Schlumberger M, 2015, ASCO M ABSTR S, V33, P6012, DOI DOI 10.1200/JC0.2015.33.15_; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Shah MH, 2015, THYROID S1, V25, P73; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Smith-Bindman R, 2013, JAMA INTERN MED, V173, P1788, DOI 10.1001/jamainternmed.2013.9245; Sosa JA, 2013, SURGERY, V154, P1420, DOI 10.1016/j.surg.2013.07.006; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Takahashi S, 2013, ANN ONCOL         S4, V24, piv340; Torlontano M, 2003, EUR J ENDOCRINOL, V148, P19, DOI 10.1530/eje.0.1480019; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Vaisman F, 2011, CLIN ENDOCRINOL, V75, P112, DOI 10.1111/j.1365-2265.2011.04002.x; Van Nostrand D, 2009, THYROID, V19, P1381, DOI 10.1089/thy.2009.1611; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190	105	693	725	19	184	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2783	2795		10.1016/S0140-6736(16)30172-6	http://dx.doi.org/10.1016/S0140-6736(16)30172-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	27240885	Green Published			2022-12-28	WOS:000389629800030
J	Ndabashimiye, G; Ghimire, S; Wu, MX; Browne, DA; Schafer, KJ; Gaarde, MB; Reis, DA				Ndabashimiye, Georges; Ghimire, Shambhu; Wu, Mengxi; Browne, Dana A.; Schafer, Kenneth J.; Gaarde, Mette B.; Reis, David A.			Solid-state harmonics beyond the atomic limit	NATURE			English	Article							GENERATION; POLARIZATION; ELLIPTICITY; NEON	Strong-field laser excitation of solids can produce extremely nonlinear electronic and optical behaviour. As recently demonstrated, this includes the generation of high harmonics extending into the vacuum-ultraviolet and extreme-ultraviolet regions of the electromagnetic spectrum(1-8). High harmonic generation is shown to occur fundamentally differently in solids and in dilute atomic gases(1-6,9-13). How the microscopic mechanisms in the solid and the gas differ remains a topic of intense debate(1-11,14-18). Here we report a direct comparison of high harmonic generation in the solid and gas phases of argon and krypton. Owing to the weak van der Waals interaction, rare (noble)-gas solids are a near-ideal medium in which to study the role of high density and periodicity in the generation process. We find that the high harmonic generation spectra from the rare-gas solids exhibit multiple plateaus extending well beyond the atomic limit of the corresponding gas-phase harmonics measured under similar conditions. The appearance of multiple plateaus indicates strong interband couplings involving multiple single-particle bands. We also compare the dependence of the solid and gas harmonic yield on laser ellipticity and find that they are similar, suggesting the importance of electron-hole recollision in these solids. This implies that gas-phase methods such as polarization gating for attosecond pulse generation and orbital tomography could be realized in solids.	[Ndabashimiye, Georges; Reis, David A.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Ndabashimiye, Georges; Ghimire, Shambhu; Reis, David A.] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Wu, Mengxi; Browne, Dana A.; Schafer, Kenneth J.; Gaarde, Mette B.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Louisiana State University System; Louisiana State University	Ndabashimiye, G; Reis, DA (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Ndabashimiye, G; Reis, DA (corresponding author), SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA.	ndabashi@stanford.edu; dreis@stanford.edu	Schafer, Kenneth/R-3729-2019; Young, Michelle A/N-7228-2017; Wu, Mengxi/L-8590-2017		US Department of Energy, Office of Science, Office of Basic Energy Sciences through the AMOS programme within the Chemical Sciences Division; Office of Science Early Career Research Program; National Science Foundation [PHY-1403236]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE AC02-76SF00515]	US Department of Energy, Office of Science, Office of Basic Energy Sciences through the AMOS programme within the Chemical Sciences Division(United States Department of Energy (DOE)); Office of Science Early Career Research Program; National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	At Stanford/SLAC, this work was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, through the AMOS programme within the Chemical Sciences Division (G.N., D.A.R.) and the Office of Science Early Career Research Program (S.G.). At Louisiana State University this work is supported by the National Science Foundation under grant number PHY-1403236. Solid Ar samples were characterized at Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, the use of which is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE AC02-76SF00515.	BACALIS NC, 1988, PHYS REV B, V38, P6218, DOI 10.1103/PhysRevB.38.6218; Blaha P., 2001, WIEN2K; BUDIL KS, 1993, PHYS REV A, V48, pR3437, DOI 10.1103/PhysRevA.48.R3437; BURNETT NH, 1995, PHYS REV A, V51, pR3418, DOI 10.1103/PhysRevA.51.R3418; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Gauthey FI, 1997, PHYS REV A, V56, P3093, DOI 10.1103/PhysRevA.56.3093; Ghimire S, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/20/204030; Ghimire S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043836; Ghimire S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.167407; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Golde D, 2009, PHYS STATUS SOLIDI C, V6, P420, DOI 10.1002/pssc.200880309; Higuchi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.213901; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Klein M. L., 1976, RARE GAS SOLIDS, V123; Korbman M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013006; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; McDonald CR, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033845; Ndabashimiye G., 2013, OPT SOC AM TECH DIG; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Shan B, 2005, J MOD OPTIC, V52, P277, DOI 10.1080/09500340410001729573; Tran F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226401; Vampa G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.193603; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Vampa G, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.064302; Vampa G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.073901; Wu MX, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043839	29	302	304	5	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					520	+		10.1038/nature17660	http://dx.doi.org/10.1038/nature17660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27281195				2022-12-28	WOS:000378270300047
J	Dukes, JW; Dewland, TA; Vittinghoff, E; Olgin, JE; Pletcher, MJ; Hahn, JA; Gladstone, RA; Marcus, GM				Dukes, Jonathan W.; Dewland, Thomas A.; Vittinghoff, Eric; Olgin, Jeffrey E.; Pletcher, Mark J.; Hahn, Judith A.; Gladstone, Rachel A.; Marcus, Gregory M.			Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; RISK-FACTORS; MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; DRINKING PATTERN; CONSUMPTION; FAILURE; MORTALITY; ASSOCIATION; STATES	OBJECTIVE To investigate the relation between alcohol consumption and heart disease by using differences in county level alcohol sales laws as a natural experiment. DESIGN Observational cohort study using differences in alcohol sales laws. SETTING Hospital based healthcare encounters in Texas, USA. Population 1 106 968 patients aged 21 or older who were residents of "wet" (no alcohol restrictions) and "dry" (complete prohibition of alcohol sales) counties and admitted to hospital between 2005 and 2010, identified using the Texas Inpatient Research Data File. OUTCOME MEASURES Prevalent and incident alcohol misuse and alcoholic liver disease were used for validation analyses. The main cardiovascular outcomes were atrial fibrillation, acute myocardial infarction, and congestive heart failure. RESULTS Residents of wet counties had a greater prevalence and incidence of alcohol misuse and alcoholic liver disease. After multivariable adjustment, wet county residents had a greater prevalence (odds ratio 1.05, 95% confidence interval 1.01 to 1.09; P=0.007) and incidence (hazard ratio 1.07, 1.01 to 1.13; P=0.014) of atrial fibrillation, a lower prevalence (odds ratio 0.83, 0.79 to 0.87; P<0.001) and incidence (hazard ratio 0.91, 0.87 to 0.99; P=0.019) of myocardial infarction, and a lower prevalence (odds ratio 0.87, 0.84 to 0.90; P<0.001) of congestive heart failure. Conversion of counties from dry to wet resulted in statistically significantly higher rates of alcohol misuse, alcoholic liver disease, atrial fibrillation, and congestive heart failure, with no detectable difference in myocardial infarction. CONCLUSIONS Greater access to alcohol was associated with more atrial fibrillation and less myocardial infarction and congestive heart failure, although an increased risk of congestive heart failure was seen shortly after alcohol sales were liberalized.	[Dukes, Jonathan W.; Olgin, Jeffrey E.; Gladstone, Rachel A.; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, 505 Parnassus Ave,M-1180B,Box 0124, San Francisco, CA 94143 USA; [Dewland, Thomas A.; Pletcher, Mark J.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hahn, Judith A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, 505 Parnassus Ave,M-1180B,Box 0124, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021; Hahn, Judith/J-5813-2014	Marcus, Gregory/0000-0001-5197-7696; Hahn, Judith/0000-0002-2697-8264	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R01AA022222]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA022586] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R01AA022222 (GMM). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the article for publication.	BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bryson CL, 2006, J AM COLL CARDIOL, V48, P305, DOI 10.1016/j.jacc.2006.02.066; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; GROGAN M, 1992, AM J CARDIOL, V69, P1570, DOI 10.1016/0002-9149(92)90705-4; Hammar N, 1997, J INTERN MED, V241, P125, DOI 10.1046/j.1365-2796.1997.92106000.x; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Heeb JL, 2005, ADDICT BEHAV, V30, P403, DOI 10.1016/j.addbeh.2004.04.022; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hemstrom O, 2001, ADDICTION, V96, pS93, DOI 10.1080/09652140020021206; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; KELBAEK H, 1985, AM J CARDIOL, V55, P164, DOI 10.1016/0002-9149(85)90320-0; Kerr WC, 2011, ADDICTION, V106, P313, DOI 10.1111/j.1360-0443.2010.03195.x; Kodama S, 2011, J AM COLL CARDIOL, V57, P427, DOI 10.1016/j.jacc.2010.08.641; KOMAJDA M, 1986, EUR HEART J, V7, P512, DOI 10.1093/oxfordjournals.eurheartj.a062099; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; Maxwell JC, 2003, DRUG ALCOHOL REV, V22, P347, DOI 10.1080/0959523031000154490; McKenna CJ, 1998, AM HEART J, V135, P833, DOI 10.1016/S0002-8703(98)70042-0; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Psaty BM, 1997, CIRCULATION, V96, P2455; Ramstedt M, 2006, DRUG ALCOHOL REV, V25, P315, DOI 10.1080/09595230600741057; Ramstedt M, 2009, DRUG ALCOHOL REV, V28, P390, DOI 10.1111/j.1465-3362.2009.00059.x; Regan R J, 1966, J Clin Invest, V45, P270, DOI 10.1172/JCI105340; Sauer BC, 2013, PHARMACOEPIDEM DR S, V22, P1139, DOI 10.1002/pds.3506; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E	39	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i2714	10.1136/bmj.i2714	http://dx.doi.org/10.1136/bmj.i2714			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP1GZ	27301557	hybrid, Green Published			2022-12-28	WOS:000378239800001
J	Kleinman, A; Estrin, GL; Usmani, S; Chisholm, D; Marquez, PV; Evans, TG; Saxena, S				Kleinman, Arthur; Estrin, Georgia Lockwood; Usmani, Shamaila; Chisholm, Dan; Marquez, Patricio V.; Evans, Tim G.; Saxena, Shekhar			Time for mental health to come out of the shadows	LANCET			English	Editorial Material							DISORDERS		[Kleinman, Arthur] Harvard Univ, Asia Ctr, Cambridge, MA 02138 USA; [Estrin, Georgia Lockwood; Usmani, Shamaila] Univ London London Sch Hyg & Trop Med, Ctr Global Mental Hlth, Keppel St, London WC1E 7HT, England; [Chisholm, Dan; Saxena, Shekhar] World Hlth Org, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland; [Marquez, Patricio V.; Evans, Tim G.] World Bank Grp, Hlth Nutr & Populat Global Practice, Washington, DC USA	Harvard University; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; The World Bank	Estrin, GL (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Global Mental Hlth, Keppel St, London WC1E 7HT, England.	georgia.lockwood-estrin@lshtm.ac.uk		Lockwood Estrin, Georgia/0000-0002-2069-2660; Lockwood Estrin, Georgia/0000-0001-9865-1415	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[APEC Health Working Group APEC Life Sciences Innovation Forum], 2014, 26 APEC MIN M BEIJ; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; Collins PY, 2016, NATURE, V532, P25, DOI 10.1038/532025a; Global Alliance for Chronic Diseases, 2016, GACD FUND MENT HLTH; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Marquez PV, 2016, WORLD BANK BLOG 0208; Mnookin S., 2016, OUT SHADOWS MAKING M; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2015, MENT HLTH AT 2014; World Bank Group WHO, 2016, P EV OUT SHAD MAK ME; World Bank Live, 2016, OUT SHAD MAK MENT HL; World Economic Forums Global Agenda Council on Mental Health, 7 ACT MENT HLTH ORG; World Health Organization, 2010, MHGAP MENT HLTH GAP	15	28	29	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2274	2275		10.1016/S0140-6736(16)30655-9	http://dx.doi.org/10.1016/S0140-6736(16)30655-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN3NN	27302252				2022-12-28	WOS:000376969100009
J	Brown, NG; VanderLinden, R; Watson, ER; Weissmann, F; Ordureau, A; Wu, KP; Zhang, W; Yu, SS; Mercredi, PY; Harrison, JS; Davidson, IF; Qiao, RP; Lu, Y; Dube, P; Brunner, MR; Grace, CRR; Miller, DJ; Haselbach, D; Jarvis, MA; Yamaguchi, M; Yanishevski, D; Petzold, G; Sidhu, SS; Kuhlman, B; Kirschner, MW; Harper, JW; Peters, JM; Stark, H; Schulman, BA				Brown, Nicholas G.; VanderLinden, Ryan; Watson, Edmond R.; Weissmann, Florian; Ordureau, Alban; Wu, Kuen-Phon; Zhang, Wei; Yu, Shanshan; Mercredi, Peter Y.; Harrison, Joseph S.; Davidson, Iain F.; Qiao, Renping; Lu, Ying; Dube, Prakash; Brunner, Michael R.; Grace, Christy R. R.; Miller, Darcie J.; Haselbach, David; Jarvis, Marc A.; Yamaguchi, Masaya; Yanishevski, David; Petzold, Georg; Sidhu, Sachdev S.; Kuhlman, Brian; Kirschner, Marc W.; Harper, J. Wade; Peters, Jan-Michael; Stark, Holger; Schulman, Brenda A.			Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/C	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT COMPLEX; SUBSTRATE DEGRADATION; LIGASE ACTIVITY; CYCLIN B1; MECHANISM; REVEALS; MITOSIS; INSIGHTS; E2	Protein ubiquitination involves E1, E2, and E3 trienzyme cascades. E2 and RING E3 enzymes often collaborate to first prime a substrate with a single ubiquitin (UB) and then achieve different forms of polyubiquitination: multiubiquitination of several sites and elongation of linkage-specific UB chains. Here, cryo-EM and biochemistry show that the human E3 anaphase-promoting complex/cyclosome (APC/C) and its two partner E2s, UBE2C (aka UBCH10) and UBE2S, adopt specialized catalytic architectures for these two distinct forms of polyubiquitination. The APC/C RING constrains UBE2C proximal to a substrate and simultaneously binds a substrate-linked UB to drive processive multiubiquitination. Alternatively, during UB chain elongation, the RING does not bind UBE2S but rather lures an evolving substrate-linked UB to UBE2S positioned through a cullin interaction to generate a Lys11-linked chain. Our findings define mechanisms of APC/C regulation, and establish principles by which specialized E3-E2-substrate-UB architectures control different forms of polyubiquitination.	[Brown, Nicholas G.; VanderLinden, Ryan; Watson, Edmond R.; Wu, Kuen-Phon; Yu, Shanshan; Mercredi, Peter Y.; Brunner, Michael R.; Grace, Christy R. R.; Miller, Darcie J.; Yamaguchi, Masaya; Yanishevski, David; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [VanderLinden, Ryan; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Weissmann, Florian; Davidson, Iain F.; Qiao, Renping; Jarvis, Marc A.; Petzold, Georg; Peters, Jan-Michael] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Ordureau, Alban; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Wei; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Harrison, Joseph S.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Harrison, Joseph S.; Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lu, Ying; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Dube, Prakash; Haselbach, David; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Harvard University; Harvard Medical School; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Max Planck Society	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.; Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.; Peters, JM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.; Stark, H (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	jan-michael.peters@imp.ac.at; hstark1@gwdg.de; brenda.schulman@stjude.org	Wu, Kuen-Phon/I-1789-2019; Ordureau, Alban/C-7558-2012	Wu, Kuen-Phon/0000-0002-1525-6004; Ordureau, Alban/0000-0002-4924-8520; Yamaguchi, Masaya/0000-0001-6886-8058; Petzold, Georg/0000-0001-5649-1716; Harper, Jeffrey/0000-0002-6944-7236; Schulman, Brenda/0000-0002-3083-1126; Holger, Stark/0000-0002-6161-1118; Qiao Coudevylle, Renping/0000-0002-6495-5004; Zhang, Wei/0000-0001-5813-240X; Haselbach, David/0000-0002-5276-5633; Brown, Nicholas/0000-0002-6141-0164; Weissmann, Florian/0000-0002-5174-6561; Harrison, Joseph/0000-0002-2118-6524	Jane Coffin Childs, Leukemia & Lymphoma Society; Edward R. & Anne G. Lefler Center; CIHR; Mitacs Elevate; FWF-Hertha Firnberg Program; Damon Runyon, Lallage Feazel Wall Fund; Japan Society for the Promotion of Science; CIHR MOP [111149, 136956]; NIH [R01GM073960, R01GM026875, R01AG011085, R37GM065930, P30CA021765, P41GM103403]; Boehringer Ingelheim; Austrian Science Fund [SFB-F34]; Austrian Research Promotion Agency (Headquarter grants) [FFG-832936, FFG-852936]; European Community (FP7) [241548]; DFG [Sonderforschungsbereich 860]; ALSAC; NECAT; APS - NIH [P41GM103403]; DOE [DE-AC02-06CH11357]; Austrian Research Promotion Agency (Laura Bassi Centre for Optimized Structural Studies grant) [FFG-840283]; HHMI; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, R01GM069530, R37GM069530, R01GM026875, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Jane Coffin Childs, Leukemia & Lymphoma Society; Edward R. & Anne G. Lefler Center; CIHR(Canadian Institutes of Health Research (CIHR)); Mitacs Elevate; FWF-Hertha Firnberg Program; Damon Runyon, Lallage Feazel Wall Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CIHR MOP(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (Headquarter grants); European Community (FP7); DFG(German Research Foundation (DFG)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NECAT; APS - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Austrian Research Promotion Agency (Laura Bassi Centre for Optimized Structural Studies grant); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Bollinger, J. Rogers, J.R. Michael, D.W. Miller, K. Kavdia, J. Peng, S. Frase. Funding: Jane Coffin Childs, Leukemia & Lymphoma Society (N.G.B.); Edward R. & Anne G. Lefler Center (A.O.); CIHR and Mitacs Elevate (W.Z.); FWF-Hertha Firnberg Program (R.Q.); Damon Runyon, Lallage Feazel Wall Fund (Y.L.); Japan Society for the Promotion of Science (M.Y.); CIHR MOP#111149 and 136956 (S.S.S.); NIH R01GM073960 (B.K.), R01GM026875 (M.W.K.), R01AG011085 (J.W.H.), R37GM065930 and P30CA021765 (B.A.S.), P41GM103403 (NECAT); Boehringer Ingelheim, the Austrian Science Fund (SFB-F34 and Wittgenstein award), the Austrian Research Promotion Agency (Headquarter grants FFG-832936 and FFG-852936, Laura Bassi Centre for Optimized Structural Studies grant FFG-840283), and the European Community (FP7/2007-2013, grant 241548, MitoSys) (J.-M.P.); DFG Sonderforschungsbereich 860 (H.S.); ALSAC, HHMI (B.A.S.). NECAT and APS - NIH P41GM103403, DOE DE-AC02-06CH11357. J.W.H. consults for Millennium: the Takeda Oncology Company and Biogen.	Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Craney A, 2016, P NATL ACAD SCI USA, V113, P1540, DOI 10.1073/pnas.1522423113; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grice GL, 2015, CELL REP, V12, P545, DOI 10.1016/j.celrep.2015.06.061; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Kamenz J, 2015, MOL CELL, V60, P446, DOI 10.1016/j.molcel.2015.09.022; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Lu D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0205-6; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wieser S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015776; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	50	95	96	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1440	1453		10.1016/j.cell.2016.05.037	http://dx.doi.org/10.1016/j.cell.2016.05.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259151	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000377045400017
J	Tucker, JL; Faul, MM				Tucker, John L.; Faul, Margaret M.			Drug companies must adopt green chemistry	NATURE			English	Editorial Material							SUSTAINABILITY		[Tucker, John L.; Faul, Margaret M.] Amgen Inc, Proc Dev, Thousand Oaks, CA 91320 USA	Amgen	Tucker, JL; Faul, MM (corresponding author), Amgen Inc, Proc Dev, Thousand Oaks, CA 91320 USA.	tuckerj@amgen.com; mfaul@amgen.com						Anastas P. T., 1998, GREEN CHEM THEORY PR; Elkington J., 1998, ENV QUAL MANAG, DOI DOI 10.1002/TQEM.3310080106; Fraser EDG, 2006, J ENVIRON MANAGE, V78, P114, DOI 10.1016/j.jenvman.2005.04.009; Leahy DK, 2013, ORG PROCESS RES DEV, V17, P1099, DOI 10.1021/op400192h; Morhardt J. E., 2012, 2012 SUSTAINABILITY; Ritter SK, 2014, CHEM ENG NEWS, V92, P32; Tucker JL, 2015, ALDRICHIM ACTA, V48, P16; Tucker JL, 2010, ORG PROCESS RES DEV, V14, P328, DOI 10.1021/op9000548	8	53	54	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					27	29		10.1038/534027a	http://dx.doi.org/10.1038/534027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27251259	Bronze			2022-12-28	WOS:000376962300016
J	Wei, XP; Su, XD; Cao, P; Liu, XY; Chang, WR; Li, M; Zhang, XZ; Liu, ZF				Wei, Xuepeng; Su, Xiaodong; Cao, Peng; Liu, Xiuying; Chang, Wenrui; Li, Mei; Zhang, Xinzheng; Liu, Zhenfeng			Structure of spinach photosystem II-LHCII supercomplex at 3.2 angstrom resolution	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; EXCITATION-ENERGY TRANSFER; HIGHER-PLANTS; CRYSTAL-STRUCTURE; SPECTROSCOPIC CHARACTERIZATION; SUPRAMOLECULAR ORGANIZATION; FUNCTIONAL ARCHITECTURE; 3-DIMENSIONAL STRUCTURE; BINDING-PROTEIN; CROSS-LINKING	During photosynthesis, the plant photosystem II core complex receives excitation energy from the peripheral light-harvesting complex II (LHCII). The pathways along which excitation energy is transferred between them, and their assembly mechanisms, remain to be deciphered through high-resolution structural studies. Here we report the structure of a 1.1-megadalton spinach photosystem II-LHCII supercomplex solved at 3.2 angstrom resolution through single-particle cryo-electron microscopy. The structure reveals a homodimeric supramolecular system in which each monomer contains 25 protein subunits, 105 chlorophylls, 28 carotenoids and other cofactors. Three extrinsic subunits (PsbO, PsbP and PsbQ), which are essential for optimal oxygen-evolving activity of photosystem II, form a triangular crown that shields the Mn4CaO5-binding domains of CP43 and D1. One major trimeric and two minor monomeric LHCIIs associate with each core-complex monomer, and the antenna-core interactions are reinforced by three small intrinsic subunits (PsbW, PsbH and PsbZ). By analysing the closely connected interfacial chlorophylls, we have obtained detailed insights into the energy-transfer pathways between the antenna and core complexes.	[Wei, Xuepeng; Su, Xiaodong; Cao, Peng; Liu, Xiuying; Chang, Wenrui; Li, Mei; Zhang, Xinzheng; Liu, Zhenfeng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wei, Xuepeng; Liu, Xiuying] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, M; Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	meili@moon.ibp.ac.cn; xzzhang@ibp.ac.cn	zhang, xinzheng/L-6254-2019	Li, Mei/0000-0002-1742-2360; Wei, Xuepeng/0000-0002-6514-7076; , Peng/0000-0002-2044-3074; Su, Xiaodong/0000-0001-6650-2327; liu, zhen feng/0000-0001-5502-9474	National 973 project [2011CBA00900]; Strategic Priority Research Program of CAS [XDB08020302]; National Natural Science Foundation of China [31570724, 31270793, 31170703]; 'National Thousand (Young) Talents Program' from the Office of Global Experts Recruitment in China	National 973 project(National Basic Research Program of China); Strategic Priority Research Program of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'National Thousand (Young) Talents Program' from the Office of Global Experts Recruitment in China	We thank J. P. Zhang and X. L. Zhao for their assistance in preparing thylakoid samples. Cryo-EM data collection was carried out at the Center for Biological Imaging, Core Facilities for Protein Science at the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS), and at the National Center for Protein Science Shanghai (NCPSS), Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences/Shanghai Science Research Center, Chinese Academy of Sciences, Shanghai, China. We thank X. J. Huang, G. Ji, W. Ding, F. Sun, and other staff members at the Center for Biological Imaging (IBP, CAS); L. L. Kong, X. Y. Shi, Y. N. He, J. P. Ding, and M. Lei for their support during data collection; X. B. Liang and X. M. An for support in organizing data collection trips; F. L. Zhang, J. Zhou, and Y. Li for support in measuring the oxygen evolution activity; L. L. Niu and X. Ding for mass spectrometry; J. H. Li for assistance in fluorescence measurement; R. Bassi, A. Pinnola and R. Croce for sharing experiences in purifying plant PSII-LHCII supercomplexes; and Y. Xiang for advice on cryo-EM sample preparation and structure refinement. The project was funded by National 973 project grant 2011CBA00900, the Strategic Priority Research Program of CAS (XDB08020302) and National Natural Science Foundation of China (31570724, 31270793 and 31170703). Z.L. and X.Z. received scholarships from the 'National Thousand (Young) Talents Program' from the Office of Global Experts Recruitment in China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 2016, J BIOL CHEM, V291, P5676, DOI 10.1074/jbc.M115.711689; Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Allahverdiyeva Y, 2007, BBA-BIOENERGETICS, V1767, P677, DOI 10.1016/j.bbabio.2007.01.011; Baena-Gonzalez E, 2001, J BIOL CHEM, V276, P20795, DOI 10.1074/jbc.M101255200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Bennett DIG, 2013, J AM CHEM SOC, V135, P9164, DOI 10.1021/ja403685a; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Caffarri S, 2011, BIOPHYS J, V100, P2094, DOI 10.1016/j.bpj.2011.03.049; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Das SK, 2002, BIOCHEMISTRY-US, V41, P13087, DOI 10.1021/bi0204802; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hankamer B, 1999, NAT STRUCT BIOL, V6, P560, DOI 10.1038/9341; Hankamer B, 2001, J STRUCT BIOL, V135, P262, DOI 10.1006/jsbi.2001.4405; Ido K, 2014, J BIOL CHEM, V289, P20150, DOI 10.1074/jbc.M114.574822; KAPAZOGLOU A, 1995, J BIOL CHEM, V270, P12197, DOI 10.1074/jbc.270.20.12197; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mummadisetti MP, 2014, P NATL ACAD SCI USA, V111, P16178, DOI 10.1073/pnas.1415165111; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson N, 2015, ANNU REV BIOCHEM, V84, P659, DOI 10.1146/annurev-biochem-092914-041942; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Novoderezhkin V, 2011, PHYS CHEM CHEM PHYS, V13, P17093, DOI 10.1039/c1cp21079c; Osto L, 2014, BBA-BIOENERGETICS, V1837, P1981, DOI 10.1016/j.bbabio.2014.09.011; Pan XW, 2013, CURR OPIN STRUC BIOL, V23, P515, DOI 10.1016/j.sbi.2013.04.004; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Pascal A, 1999, EUR J BIOCHEM, V262, P817, DOI 10.1046/j.1432-1327.1999.00457.x; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Rogl H, 1999, BIOCHEMISTRY-US, V38, P16214, DOI 10.1021/bi990739p; Ruf S, 2000, J CELL BIOL, V149, P369, DOI 10.1083/jcb.149.2.369; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shabestari MH, 2014, BIOPHYS J, V106, P1349, DOI 10.1016/j.bpj.2013.11.4506; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sun RX, 2015, BBA-BIOENERGETICS, V1847, P248, DOI 10.1016/j.bbabio.2014.11.005; Swiatek M, 2001, PLANT CELL, V13, P1347, DOI 10.1105/tpc.13.6.1347; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANAMERONGEN H, 1994, BBA-BIOENERGETICS, V1188, P227, DOI 10.1016/0005-2728(94)90040-X; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	66	350	364	21	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					69	+		10.1038/nature18020	http://dx.doi.org/10.1038/nature18020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251276				2022-12-28	WOS:000376962300034
J	Fui, MNT; Grossmann, M				Fui, Mark Ng Tang; Grossmann, Mathis			Hypogonadism from androgen deprivation therapy in identical twins	LANCET			English	Editorial Material									[Fui, Mark Ng Tang; Grossmann, Mathis] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Fui, MNT (corresponding author), Austin Hlth, Dept Endocrinol, Level 2 Centaur Wing,300 Waterdale Rd, Melbourne, Vic 3081, Australia.	mark.ng@unimelb.edu.au		Ng Tang Fui, Mark/0000-0002-5101-8572					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2653	2653		10.1016/S0140-6736(16)00583-3	http://dx.doi.org/10.1016/S0140-6736(16)00583-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27291998				2022-12-28	WOS:000388516800033
J	Lachs, MS; Teresi, JA; Ramirez, M; van Haitsma, K; Silver, S; Eimicke, JP; Boratgis, G; Sukha, G; Kong, J; Besas, AM; Luna, MR; Pillemer, KA				Lachs, Mark S.; Teresi, Jeanne A.; Ramirez, Mildred; van Haitsma, Kimberly; Silver, Stephanie; Eimicke, Joseph P.; Boratgis, Gabriel; Sukha, Gail; Kong, Jian; Besas, Alexandra M.; Luna, Maria Reyes; Pillemer, Karl A.			The Prevalence of Resident-to-Resident Elder Mistreatment in Nursing Homes	ANNALS OF INTERNAL MEDICINE			English	Article							ITEM RESPONSE THEORY; AGGRESSION	Background: Resident-to-resident elder mistreatment (R-REM) in nursing homes can cause physical and psychological injury and death, yet its prevalence remains unknown. Objective: To estimate the prevalence of physical, verbal, and sexual R-REM in nursing home residents and subgroups. Design: 1-month observational prevalence study. Setting: 5 urban and 5 suburban New York state nursing homes. Participants: 2011 residents in 10 facilities randomly selected on the basis of size and location; 83% of facilities and 84% of eligible residents participated. Measurements: R-REM was identified through resident interviews, staff interviews, shift coupons, observation, chart review, and accident or incident reports. Results: 407 of 2011 residents experienced at least 1 R-REM event; the total 1-month prevalence was 20.2% (95% CI, 18.1% to 22.5%). The most common forms were verbal (9.1% [CI, 7.7% to 10.8%]), other (such as invasion of privacy or menacing gestures) (5.3% [CI, 4.4% to 6.4%]), physical (5.2% [CI, 4.1% to 6.5%]), and sexual (0.6% [CI, 0.3% to 1.1%]). Several clinical and contextual factors (for example, lower vs. severe levels of cognitive impairment, residing on a dementia unit, and higher nurse aide caseload) were associated with higher estimated rates of R-REM. Limitations: Most facilities were relatively large. All R-REM cases may not have been detected; resident and staff reporting may be subject to recall bias. Conclusion: R-REM in nursing homes is highly prevalent. Verbal R-REM is most common, but physical mistreatment also occurs frequently. Because R-REM can cause injury or death, strategies are urgently needed to better understand its causes so that prevention strategies can be developed.	Weill Cornell Med Coll, New York, NY USA; Columbia Univ, Stroud Ctr, New York State Psychiat Inst, New York, NY USA; Cornell Univ, Coll Human Ecol, Ithaca, NY USA; [Teresi, Jeanne A.; Ramirez, Mildred; Silver, Stephanie; Eimicke, Joseph P.; Boratgis, Gabriel; Sukha, Gail; Kong, Jian; Besas, Alexandra M.; Luna, Maria Reyes] Hebrew Home Riverdale, Div Res, 5901 Palisade Ave, Riverdale, NY 10471 USA; Penn State Univ, Coll Nursing, University Pk, PA 16802 USA; Madlyn & Leonard Abramson Ctr Jewish Life, Polisher Res Inst, N Wales, PA USA; [Lachs, Mark S.] Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, 1300 York Ave, New York, NY 10065 USA; [van Haitsma, Kimberly] Penn State Univ, Coll Nursing, Hlth & Human Dev East 203, State Coll, PA 16801 USA; [Pillemer, Karl A.] Cornell Univ, Dept Human Dev, MVR Hall, Ithaca, NY 14853 USA	Cornell University; Columbia University; New York State Psychiatry Institute; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Cornell University	Lachs, MS (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, 1300 York Ave, New York, NY 10065 USA.	mslachs@med.cornell.edu		Pillemer, Karl/0000-0002-7700-3563; VanHaitsma, Kimberly/0000-0002-3727-1336	National Institute on Aging; NATIONAL INSTITUTE ON AGING [K24AG022399, R03AG049266, R01AG014299, P30AG022845] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging.	Ferrah N, 2015, AGE AGEING, V44, P356, DOI 10.1093/ageing/afv004; Floyd A., 2014, VALDOSTA DAILY  1115; Hutchinson Bill, 2014, NEW YORK DAILY NEWS; Kellogg VA, 2006, J NURS CARE QUAL, V21, P49, DOI 10.1097/00001786-200601000-00011; Pillemer K, 2012, GERONTOLOGIST, V52, P24, DOI 10.1093/geront/gnr107; Ramirez M, 2013, INT PSYCHOGERIATR, V25, P1245, DOI 10.1017/S1041610213000264; Shinoda-Tagawa T, 2004, JAMA-J AM MED ASSOC, V291, P591, DOI 10.1001/jama.291.5.591; Swanson K, 2014, KOAT ALBUQUERQU 1103; Teresi J.A., 2000, RES PRACT ALZHEIMERS, V4, P117; Teresi JA, 2000, RES AGING, V22, P738, DOI 10.1177/0164027500226007; Teresi JA, 2014, GERONTOLOGIST, V54, P460, DOI 10.1093/geront/gnt001	11	55	55	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					229	+		10.7326/M15-1209	http://dx.doi.org/10.7326/M15-1209			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27295575	Green Accepted			2022-12-28	WOS:000381267200011
J	Labuhn, H; Barredo, D; Ravets, S; de Leseleuc, S; Macri, T; Lahaye, T; Browaeys, A				Labuhn, Henning; Barredo, Daniel; Ravets, Sylvain; de Leseleuc, Sylvain; Macri, Tommaso; Lahaye, Thierry; Browaeys, Antoine			Tunable two-dimensional arrays of single Rydberg atoms for realizing quantum Ising models	NATURE			English	Article							SIMULATIONS	Spin models are the prime example of simplified many-body Hamiltonians used to model complex, strongly correlated real-world materials(1). However, despite the simplified character of such models, their dynamics often cannot be simulated exactly on classical computers when the number of particles exceeds a few tens. For this reason, quantum simulation(2) of spin Hamiltonians using the tools of atomic and molecular physics has become a very active field over the past years, using ultracold atoms(3) or molecules(4) in optical lattices, or trapped ions(5). All of these approaches have their own strengths and limitations. Here we report an alternative platform for the study of spin systems, using individual atoms trapped in tunable two-dimensional arrays of optical microtraps with arbitrary geometries, where filling fractions range from 60 to 100 per cent. When excited to high-energy Rydberg D states, the atoms undergo strong interactions whose anisotropic character opens the way to simulating exotic matter(6). We illustrate the versatility of our system by studying the dynamics of a quantum Ising-like spin-1/2 system in a transverse field with up to 30 spins, for a variety of geometries in one and two dimensions, and for a wide range of interaction strengths. For geometries where the anisotropy is expected to have small effects on the dynamics, we find excellent agreement with ab initio simulations of the spin-1/2 system, while for strongly anisotropic situations the multilevel structure of the D states has a measurable influence(7,8). Our findings establish arrays of single Rydberg atoms as a versatile platform for the study of quantum magnetism.	[Labuhn, Henning; Barredo, Daniel; Ravets, Sylvain; de Leseleuc, Sylvain; Lahaye, Thierry; Browaeys, Antoine] Univ Paris Sud, Univ Paris 11, Lab Charles Fabry, Inst Opt, 2 Ave Augustin Fresnel, F-91127 Palaiseau, France; [Macri, Tommaso] Univ Fed Rio Grande do Norte, Dept Fis Teor & Expt, Natal, RN, Brazil; [Macri, Tommaso] Int Inst Phys, Natal, RN, Brazil	UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio Grande do Norte	Lahaye, T (corresponding author), Univ Paris Sud, Univ Paris 11, Lab Charles Fabry, Inst Opt, 2 Ave Augustin Fresnel, F-91127 Palaiseau, France.	thierry.lahaye@institutoptique.fr	Browaeys, Antoine/E-1547-2017; Lahaye, Thierry/E-1551-2017; Macrì, Tommaso/S-9634-2017; Barredo, Daniel/D-3561-2015; Ravets, Sylvain/GRJ-9252-2022	Browaeys, Antoine/0000-0001-9941-8869; Lahaye, Thierry/0000-0002-2260-9859; Macrì, Tommaso/0000-0002-7778-8014; Barredo, Daniel/0000-0001-5307-1927; Ravets, Sylvain/0000-0003-1746-5245; de Leseleuc, Sylvain/0000-0002-4761-5753	EU (FET-Open Xtrack Project HAIRS); EU (FET-PROACT Project RySQ); EU (EU Marie-Curie Program ITN COHERENCE) [FP7-PEOPLE-2010-ITN-265031]; 'PALM' Labex (project QUANTICA); Region Ile-de-France	EU (FET-Open Xtrack Project HAIRS); EU (FET-PROACT Project RySQ); EU (EU Marie-Curie Program ITN COHERENCE); 'PALM' Labex (project QUANTICA); Region Ile-de-France(Region Ile-de-France)	We thank H. Busche for contributions in the early stages of the experiment I. Lesanovsky, H. P Buchler and T Pohl for discussions, and Y. Sortais for a reading of the manuscript. This work benefited from financial support by the EU (FET-Open Xtrack Project HAIRS, H2020 FET-PROACT Project RySQ, and EU Marie-Curie Program ITN COHERENCE FP7-PEOPLE-2010-ITN-265031 (H.L.)), by the 'PALM' Labex (project QUANTICA) and by the Region Ile-de-France in the framework of DIM Nano-K.	Ates C, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013408; Ates C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110603; Auerbach A., 1994, INTERACTING ELECT QU; Barredo D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.183002; Barredo D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.113002; Beguin L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263201; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Derevianko A, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063419; Dudin YO, 2012, NAT PHYS, V8, P790, DOI [10.1038/NPHYS2413, 10.1038/nphys2413]; Ebert M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.093601; Ebert M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043602; Fung YH, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/7/073011; Gaj A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5546; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Glaetzle AW, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041037; Hauke P, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113037; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Low R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033422; Nogrette F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021034; Peter D, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.053617; Petrosyan D, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053414; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schauss P, 2015, SCIENCE, V347, P1455, DOI 10.1126/science.1258351; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Senko C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021026; Shen C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053053; Tresp C, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.083602; Vermersch B, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.023411; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Zeiher J., 2016, MANY BODY INTERFEROM; Zeiher J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031015	34	423	424	12	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					667	+		10.1038/nature18274	http://dx.doi.org/10.1038/nature18274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27281203	Green Submitted			2022-12-28	WOS:000378676000032
J	Liu, S; Grinberg, I; Rappe, AM				Liu, Shi; Grinberg, Ilya; Rappe, Andrew M.			Intrinsic ferroelectric switching from first principles	NATURE			English	Article							DOMAIN-WALL MOTION; OXIDES; MECHANISM; DYNAMICS; TITANATE; FIELD	The existence of domain walls, which separate regions of different polarization, can influence the dielectric(1), piezoelectric(2), pyroelectric(3) and electronic properties(4,5) of ferroelectric materials. In particular, domain-wall motion is crucial for polarization switching, which is characterized by the hysteresis loop that is a signature feature of ferroelectric materials(6). Experimentally, the observed dynamics of polarization switching and domain-wall motion are usually explained as the behaviour of an elastic interface pinned by a random potential that is generated by defects(7,8), which appear to be strongly sample-dependent and affected by various elastic, microstructural and other extrinsic effects(9-12). Theoretically, connecting the zero-kelvin, first-principles-based, microscopic quantities of a sample with finite-temperature, macroscopic properties such as the coercive field is critical for material design and device performance; and the lack of such a connection has prevented the use of techniques based on ab initio calculations for high-throughput computational materials discovery. Here we use molecular dynamics simulations(13) of 90 degrees domain walls (separating domains with orthogonal polarization directions) in the ferroelectric material PbTiO3 to provide microscopic insights that enable the construction of a simple, universal, nucleation-and-growth-based analytical model that quantifies the dynamics of many types of domain walls in various ferroelectrics. We then predict the temperature and frequency dependence of hysteresis loops and coercive fields at finite temperatures from first principles. We find that, even in the absence of defects, the intrinsic temperature and field dependence of the domain-wall velocity can be described with a nonlinear creep-like region and a depinning-like region. Our model enables quantitative estimation of coercive fields, which agree well with experimental results for ceramics and thin films. This agreement between model and experiment suggests that, despite the complexity of ferroelectric materials, typical ferroelectric switching is largely governed by a simple, universal mechanism of intrinsic domain-wall motion, providing an efficient framework for predicting and optimizing the properties of ferroelectric materials.	[Liu, Shi] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Grinberg, Ilya; Rappe, Andrew M.] Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA; [Grinberg, Ilya] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel	Carnegie Institution for Science; University of Pennsylvania; Bar Ilan University	Liu, S (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.; Rappe, AM (corresponding author), Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA.	sliu@carnegiescience.edu; rappe@sas.upenn.edu	Rappe, Andrew Marshall/HFZ-8855-2022; LIU, SHI/I-5494-2013	LIU, SHI/0000-0002-8488-4848	NSF [DMR-1124696, CBET-1159736]; Carnegie Institution for Science; US ONR [N00014-12-1-1033]; US DOE [DE-FG02-07ER46431]; HPCMO; Direct For Mathematical & Physical Scien [1124696] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Carnegie Institution for Science; US ONR(Office of Naval Research); US DOE(United States Department of Energy (DOE)); HPCMO; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	S.L. was supported by the NSF through Grant DMR-1124696, Grant CBET-1159736, and the Carnegie Institution for Science. I.G. was supported by the US ONR under Grant N00014-12-1-1033. A.M.R. was supported by the US DOE under Grant DE-FG02-07ER46431. Computational support was provided by the US DOD through a Challenge Grant from the HPCMO, and by the US DOE through computer time at NERSC.	Chaplya PM, 2001, J APPL PHYS, V90, P5278, DOI 10.1063/1.1410330; Chauve P, 2000, PHYS REV B, V62, P6241, DOI 10.1103/PhysRevB.62.6241; Dieguez O, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024102; Gao P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3791; Guo EJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772006; Hooker M. W., 1998, NASACR1998208708; IOFFE LB, 1987, J PHYS C SOLID STATE, V20, P6149, DOI 10.1088/0022-3719/20/36/016; Jablonski ML, 2016, ACS APPL MATER INTER, V8, P2935, DOI 10.1021/acsami.5b08312; Jin L, 2014, J AM CERAM SOC, V97, P1, DOI 10.1111/jace.12773; Jo JY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.045701; Karthik J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.024102; Kong LB, 2001, MATER LETT, V51, P95, DOI 10.1016/S0167-577X(01)00272-5; Lente MH, 2004, J APPL PHYS, V95, P2646, DOI 10.1063/1.1645980; Lente MH, 2001, J APPL PHYS, V89, P5093, DOI 10.1063/1.1333742; Liu S, 2015, J PHYS CHEM LETT, V6, P693, DOI 10.1021/jz502666j; Liu S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4832421; Liu S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104102; MERZ WJ, 1954, PHYS REV, V95, P690, DOI 10.1103/PhysRev.95.690; Meyer B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104111; MILLER RC, 1960, PHYS REV, V117, P1460, DOI 10.1103/PhysRev.117.1460; Paruch P, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337356; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Pertsev NA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/37/375703; Pramanick A, 2012, CRIT REV SOLID STATE, V37, P243, DOI 10.1080/10408436.2012.686891; Ren W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187601; Rossetti GA, 1998, J MATER RES, V13, P3197, DOI 10.1557/JMR.1998.0434; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/NMAT2373, 10.1038/nmat2373]; Shelke V, 2011, ADV MATER, V23, P669, DOI 10.1002/adma.201000807; Shin YH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054104; Shin YH, 2007, NATURE, V449, P881, DOI 10.1038/nature06165; Suchomel M. R., 2005, THESIS; Tybell T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097601; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Wang Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267601; Wojdel JC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.247603; WU KW, 1992, J AM CERAM SOC, V75, P3385, DOI 10.1111/j.1151-2916.1992.tb04438.x; Xu RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4120; Yang SM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174125; Zhao Y, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2912068	39	114	115	12	382	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					360	+		10.1038/nature18286	http://dx.doi.org/10.1038/nature18286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306186				2022-12-28	WOS:000377856800030
J	Tsuchiya, H; Doki, S; Takemoto, M; Ikuta, T; Higuchi, T; Fukui, K; Usuda, Y; Tabuchi, E; Nagatoishi, S; Tsumoto, K; Nishizawa, T; Ito, K; Dohmae, N; Ishitani, R; Nureki, O				Tsuchiya, Hirotoshi; Doki, Shintaro; Takemoto, Mizuki; Ikuta, Tatsuya; Higuchi, Takashi; Fukui, Keita; Usuda, Yoshihiro; Tabuchi, Eri; Nagatoishi, Satoru; Tsumoto, Kouhei; Nishizawa, Tomohiro; Ito, Koichi; Dohmae, Naoshi; Ishitani, Ryuichiro; Nureki, Osamu			Structural basis for amino acid export by DMT superfamily transporter YddG	NATURE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; EFFLUX; EVOLUTION; FAMILY; MECHANISM; SYSTEMS; SIMULATION	The drug/metabolite transporter (DMT) superfamily is a large group of membrane transporters ubiquitously found in eukaryotes, bacteria and archaea, and includes exporters for a remarkably wide range of substrates, such as toxic compounds and metabolites(1). YddG is a bacterial DMT protein that expels aromatic amino acids and exogenous toxic compounds, thereby contributing to cellular homeostasis(2,3). Here we present structural and functional analyses of YddG. Using liposome-based analyses, we show that Escherichia coli and Starkeya novella YddG export various amino acids. The crystal structure of S. novella YddG at 2.4 resolution reveals a new membrane transporter topology, with ten transmembrane segments in an outward-facing state. The overall structure is basket-shaped, with a large substrate-binding cavity at the centre of the molecule, and is composed of inverted structural repeats related by two-fold pseudosymmetry. On the basis of this intramolecular symmetry, we propose a structural model for the inward-facing state and a mechanism of the conformational change for substrate transport, which we confirmed by biochemical analyses. These findings provide a structural basis for the mechanism of transport of DMT superfamily proteins.	[Tsuchiya, Hirotoshi; Doki, Shintaro; Takemoto, Mizuki; Ikuta, Tatsuya; Higuchi, Takashi; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Fukui, Keita] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan; [Usuda, Yoshihiro; Tabuchi, Eri] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Ito, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Dohmae, Naoshi] RIKEN, Ctr Sustainable Resource Sci, Biomol Characterizat Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Ishitani, Ryuichiro] RIKEN, Theoret Mol Sci Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	University of Tokyo; Ajinomoto Co Inc; Ajinomoto Co Inc; University of Tokyo; University of Tokyo; RIKEN; RIKEN	Ishitani, R; Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Ishitani, R (corresponding author), RIKEN, Theoret Mol Sci Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ishitani@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; NUREKI, OSAMU/G-4960-2014; Satoru, NAGATOISHI/AAY-8198-2021	Dohmae, Naoshi/0000-0002-5242-9410; Satoru, NAGATOISHI/0000-0002-0794-3963; Takemoto, Mizuki/0000-0002-6339-6431; Ikuta, Tatsuya/0000-0002-8597-0609; Ito, Koichi/0000-0002-2042-405X	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [24227004, 25291011, 26711003]; FIRST program; Grants-in-Aid for Scientific Research [16H04710, 16H06294, 16H02420] Funding Source: KAKEN	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FIRST program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Nishimasu and M. Hattori for comments on the manuscript; T. Tsukazaki and D. Drew for discussion; Y. Lee and A. Kurabayashi for technical assistance; the RIKEN BioResource Center for providing Starkeya novella genomic DNA; and the beam-line scientists at BL41XU and BL32XU of SPring-8 for assistance with data collection. The diffraction experiments were performed at SPring-8 BL41XU and BL32XU (proposals 2014A1091, 2014A1061, 2014A1093, 2014A1116 and 2014B1194). This work was supported by grants from the Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), JSPS KAKENHI (grants 24227004, 25291011 and 26711003), the FIRST program, and a Grant-in-Aid for JSPS Fellows. Partial calculations were performed on the HOKUSAI GreatWave supercomputer system at RIKEN and the NIG supercomputer at ROIS National Institute of Genetics.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Airich LG, 2010, J MOL MICROB BIOTECH, V19, P189, DOI 10.1159/000320699; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bay DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-140; Bellmann A, 2001, MICROBIOL-SGM, V147, P1765, DOI 10.1099/00221287-147-7-1765; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doroshenko V, 2007, FEMS MICROBIOL LETT, V275, P312, DOI 10.1111/j.1574-6968.2007.00894.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KRAMER R, 1994, ARCH MICROBIOL, V162, P1; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Livshits VA, 2003, RES MICROBIOL, V154, P123, DOI 10.1016/S0923-2508(03)00036-6; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Masuda A, 2013, ANAL BIOANAL CHEM, V405, P8073, DOI 10.1007/s00216-013-7056-1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Vastermark A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-123; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	43	41	44	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					417	+		10.1038/nature17991	http://dx.doi.org/10.1038/nature17991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281193				2022-12-28	WOS:000377856800042
J	Matter, JM; Stute, M; Snaebjornsdottir, SO; Oelkers, EH; Gislason, SR; Aradottir, ES; Sigfusson, B; Gunnarsson, I; Sigurdardottir, H; Gunnlaugsson, E; Axelsson, G; Alfredsson, HA; Wolff-Boenisch, D; Mesfin, K; Taya, DFD; Hall, J; Dideriksen, K; Broecker, WS				Matter, Juerg M.; Stute, Martin; Snaebjornsdottir, Sandra O.; Oelkers, Eric H.; Gislason, Sigurdur R.; Aradottir, Edda S.; Sigfusson, Bergur; Gunnarsson, Ingvi; Sigurdardottir, Holmfridur; Gunnlaugsson, Einar; Axelsson, Gudni; Alfredsson, Helgi A.; Wolff-Boenisch, Domenik; Mesfin, Kiflom; Taya, Diana Fernandez De la Reguera; Hall, Jennifer; Dideriksen, Knud; Broecker, Wallace S.			Rapid carbon mineralization for permanent disposal of anthropogenic carbon dioxide emissions	SCIENCE			English	Article							GEOLOGICAL RESERVOIRS; STORAGE; SEQUESTRATION; LEAKAGE; HELLISHEIDI; CAPTURE; WATER; FIELD	Carbon capture and storage (CCS) provides a solution toward decarbonization of the global economy. The success of this solution depends on the ability to safely and permanently store CO2. This study demonstrates for the first time the permanent disposal of CO2 as environmentally benign carbonate minerals in basaltic rocks. We find that over 95% of the CO2 injected into the CarbFix site in Iceland was mineralized to carbonate minerals in less than 2 years. This result contrastswith the common view that the immobilization of CO2 as carbonate minerals within geologic reservoirs takes several hundreds to thousands of years. Our results, therefore, demonstrate that the safe long-term storage of anthropogenic CO2 emissions through mineralization can be far faster than previously postulated.	[Matter, Juerg M.] Univ Southampton, Dept Ocean & Earth Sci, Southampton, Hants, England; [Matter, Juerg M.; Stute, Martin; Taya, Diana Fernandez De la Reguera; Hall, Jennifer; Broecker, Wallace S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Snaebjornsdottir, Sandra O.; Oelkers, Eric H.; Gislason, Sigurdur R.; Alfredsson, Helgi A.; Wolff-Boenisch, Domenik; Mesfin, Kiflom] Univ Iceland, Inst Earth Sci, IS-101 Reykjavik, Iceland; [Oelkers, Eric H.] Univ Toulouse 3, CNRS, UMR 5563, F-31062 Toulouse, France; [Oelkers, Eric H.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Aradottir, Edda S.; Sigfusson, Bergur; Gunnarsson, Ingvi; Sigurdardottir, Holmfridur; Gunnlaugsson, Einar] Reykjavik Energy, Reykjavik, Iceland; [Sigfusson, Bergur] European Commiss, Joint Res Ctr, Inst Energy & Transport, Petten, Netherlands; [Axelsson, Gudni] Iceland GeoSurvey, Reykjavik, Iceland; [Wolff-Boenisch, Domenik] Curtin Univ, Dept Appl Geol, Perth, WA 6845, Australia; [Dideriksen, Knud] Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen, Denmark	NERC National Oceanography Centre; University of Southampton; Columbia University; University of Iceland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); University of London; University College London; European Commission Joint Research Centre; EC JRC Institute for Energy & Transport (IET); Curtin University; University of Copenhagen	Matter, JM (corresponding author), Univ Southampton, Dept Ocean & Earth Sci, Southampton, Hants, England.; Matter, JM (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA.	j.matter@southampton.ac.uk	Dideriksen, Knud/O-9154-2019; Alfredsson, Helgi A./AAJ-4711-2020; Wolff-Boenisch, Domenik/AAB-7442-2020; Oelkers, Eric/ABI-6279-2020; Dideriksen, Knud/D-1010-2016	Dideriksen, Knud/0000-0003-3067-4834; Wolff-Boenisch, Domenik/0000-0002-2993-4259; Dideriksen, Knud/0000-0003-3067-4834; Oelkers, Eric/0000-0002-5759-524X	Reykjavik Energy; U.S. Department of Energy [DE-FE0004847]; European Commission through CarbFix (EC) [283148]; European Commission through Min-GRO [MC-RTN-35488]; European Commission through Delta-Min [PITN-GA-2008-215360]; European Commission through CO2-REACT (EC) [317235]; Nordic fund [11029-NORDICCS]; Icelandic GEORG Geothermal Research fund [09-02-001]	Reykjavik Energy(European Commission); U.S. Department of Energy(United States Department of Energy (DOE)); European Commission through CarbFix (EC); European Commission through Min-GRO; European Commission through Delta-Min; European Commission through CO2-REACT (EC); Nordic fund; Icelandic GEORG Geothermal Research fund	We acknowledge funding from Reykjavik Energy; the U.S. Department of Energy under award number DE-FE0004847 to J.M.M and M.S.; the European Commission through the projects CarbFix (EC coordinated action 283148), Min-GRO (MC-RTN-35488), Delta-Min (PITN-GA-2008-215360), and CO<INF>2</INF>-REACT (EC Project 317235) to S.R.G., E.H.O., and Reykjavik Energy; Nordic fund 11029-NORDICCS; and the Icelandic GEORG Geothermal Research fund (09-02-001) to S.R.G. and Reykjavik Energy. We thank T. Kristinsson and E. O. Prastarsonfor for helping with sample collection in the field. All data used in this study are included in the supplementary materials.	Alfredsson HA, 2016, GREENH GASES, V6, P167, DOI 10.1002/ghg.1543; Alfredsson HA, 2013, INT J GREENH GAS CON, V12, P399, DOI 10.1016/j.ijggc.2012.11.019; Aradottir ESP, 2012, INT J GREENH GAS CON, V9, P24, DOI 10.1016/j.ijggc.2012.02.006; Bachelor PP, 2008, J RADIOANAL NUCL CH, V277, P85, DOI 10.1007/s10967-008-0713-8; Bielicki JM, 2014, INT J GREENH GAS CON, V20, P272, DOI 10.1016/j.ijggc.2013.10.024; Clark I.D., 1997, ENV ISOTOPES HYDROGE, P328; Eggleston H.S., 2008, IPCC GUIDELINES NATL; Ellis B., 2011, SCI TECHNOL, V1, P248; Esposito A., 2010, P SOC PETR ENG 2010; Gilfillan SMV, 2009, NATURE, V458, P614, DOI 10.1038/nature07852; Gislason SR, 2014, SCIENCE, V344, P373, DOI 10.1126/science.1250828; Gislason SR, 2010, INT J GREENH GAS CON, V4, P537, DOI 10.1016/j.ijggc.2009.11.013; Goldberg DS, 2008, P NATL ACAD SCI USA, V105, P9920, DOI 10.1073/pnas.0804397105; Haugan PM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020295; Khalilabad MR, 2008, MINERAL MAG, V72, P121, DOI 10.1180/minmag.2008.072.1.121; Lackner KS, 2009, CLIMATIC CHANGE, V96, P357, DOI 10.1007/s10584-009-9632-0; Matter JM, 2009, NAT GEOSCI, V2, P837, DOI 10.1038/ngeo683; McGrail BP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004169; Metz B., 2005, IPCC SPECIAL REPORT; Sigfusson B, 2015, INT J GREENH GAS CON, V37, P213, DOI 10.1016/j.ijggc.2015.02.022; van der Zwaan B, 2009, ENVIRON MODEL ASSESS, V14, P135, DOI 10.1007/s10666-007-9125-3; Zoback MD, 2012, P NATL ACAD SCI USA, V109, P10164, DOI 10.1073/pnas.1202473109	22	389	402	46	435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1312	1314		10.1126/science.aad8132	http://dx.doi.org/10.1126/science.aad8132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284192	Green Submitted, Green Accepted			2022-12-28	WOS:000377972000039
J	Laine, AL				Laine, Anna-Liisa			Ilkka Hanski (1953-2016) OBITUARY	NATURE			English	Biographical-Item									[Laine, Anna-Liisa] Univ Helsinki, Plant Ecol, FIN-00014 Helsinki, Finland	University of Helsinki	Laine, AL (corresponding author), Univ Helsinki, Plant Ecol, FIN-00014 Helsinki, Finland.	anna-liisa.laine@helsinki.fi	Laine, Anna-Liisa/B-1398-2016	Laine, Anna-Liisa/0000-0002-0703-5850				HANSKI I, PUBLICATION LIST	1	1	1	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					180	180		10.1038/534180a	http://dx.doi.org/10.1038/534180a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279205	Bronze			2022-12-28	WOS:000377475100023
J	Tovote, P; Esposito, MS; Botta, P; Haudun, FC; Fadok, JP; Markovic, M; Wolff, SBE; Ramakrishnan, C; Fenno, L; Deisseroth, K; Herry, C; Arber, S; Luthi, A				Tovote, Philip; Esposito, Maria Soledad; Botta, Paolo; Haudun, Fabrice C.; Fadok, Jonathan P.; Markovic, Milica; Wolff, Steffen B. E.; Ramakrishnan, Charu; Fenno, Lief; Deisseroth, Karl; Herry, Cyril; Arber, Silvia; Luthi, Andreas			Midbrain circuits for defensive behaviour	NATURE			English	Article							VENTROLATERAL PERIAQUEDUCTAL GRAY; CONTEXTUAL CONDITIONED FEAR; AMINO-ACID MICROINJECTION; NEURONAL ORGANIZATION; IN-VIVO; ANXIETY; RAT; AMYGDALA; NUCLEUS; PROJECTIONS	Survival in threatening situations depends on the selection and rapid execution of an appropriate active or passive defensive response, yet the underlying brain circuitry is not understood. Here we use circuit-based optogenetic, in vivo and in vitro electrophysiological, and neuroanatomical tracing methods to define midbrain periaqueductal grey circuits for specific defensive behaviours. We identify an inhibitory pathway from the central nucleus of the amygdala to the ventrolateral periaqueductal grey that produces freezing by disinhibition of ventrolateral periaqueductal grey excitatory outputs to pre-motor targets in the magnocellular nucleus of the medulla. In addition, we provide evidence for anatomical and functional interaction of this freezing pathway with long-range and local circuits mediating flight. Our data define the neuronal circuitry underlying the execution of freezing, an evolutionarily conserved defensive behaviour, which is expressed by many species including fish, rodents and primates. In humans, dysregulation of this 'survival circuit' has been implicated in anxiety-related disorders.	[Tovote, Philip; Esposito, Maria Soledad; Botta, Paolo; Fadok, Jonathan P.; Markovic, Milica; Wolff, Steffen B. E.; Arber, Silvia; Luthi, Andreas] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Esposito, Maria Soledad; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Haudun, Fabrice C.; Herry, Cyril] INSERM, Neuroctr Magendie, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France; [Ramakrishnan, Charu; Fenno, Lief; Deisseroth, Karl] Stanford Univ, 318 Campus Dr West,Clark Ctr W080, Stanford, CA 94305 USA; [Botta, Paolo] Champalimaud Ctr Unknown, Ave Brasilia, P-1400038 Lisbon, Portugal; [Wolff, Steffen B. E.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Stanford University; Fundacao Champalimaud; Harvard University	Tovote, P; Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	philip.tovote@fmi.ch; andreas.luthi@fmi.ch	Tovote, Philip/AAC-5668-2019; Fadok, Jonathan/AAX-2999-2020; Fenno, Lief/AAF-9638-2019; Core, Vector/CAF-4832-2022; Herry, Cyril/AAP-9902-2020; Fenno, Lief/AAK-2924-2020	Herry, Cyril/0000-0003-2973-0843; Esposito, Maria Soledad/0000-0003-0673-4219; Arber, Silvia/0000-0002-6261-250X; Tovote, Philip/0000-0002-4598-722X; Botta, Paolo/0000-0003-0570-5774; Fadok, Jonathan/0000-0002-0608-5151; Markovic, Milica/0000-0002-6973-6679	Novartis Research Foundation; National Center of Competences in Research; Swiss National Science Foundation; European Research Council; Kanton Basel-Stadt; NARSAD Young Investigator Grants by the Brain and Behavior Foundation; Human Frontier Science Program; Synapsis Foundation; European Research Council (ERC) under the European Union [281168]; Fondation pour la Recherche Medicale	Novartis Research Foundation; National Center of Competences in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Kanton Basel-Stadt; NARSAD Young Investigator Grants by the Brain and Behavior Foundation(NARSAD); Human Frontier Science Program(Human Frontier Science Program); Synapsis Foundation; European Research Council (ERC) under the European Union(European Research Council (ERC)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank C. Muller, J. Ludke, K. Bylund, J. Alonso, T. Lu, P. Argast and P. Buchmann for technical assistance, J. J. Letzkus for input on the manuscript, and all members of the Luthi and Arber laboratories for discussions and other help with the project. We thank L. Gelman and S. Bourke for help with microscopy, and M. Stadler for statistical advice. We are grateful to G. Keller for providing viruses for optogenetics, Z. J. Huang for initially providing the Gad2-ires-Cre mouse line and L. Xiao and P. Scheiffele for the anti-rabiesG antibody. This work was supported by the Novartis Research Foundation, by the National Center of Competences in Research: 'SYNAPSY - The Synaptic Bases of Mental Diseases' (financed by the Swiss National Science Foundation) as well as by a Swiss National Science Foundation Core Grant, and a European Research Council Advanced Grant to A. L. Support for S. A. and M.S.E. was provided by a European Research Council Advanced Grant, the Swiss National Science Foundation and the Kanton Basel-Stadt. P. T. and J.P.F. were supported by NARSAD Young Investigator Grants by the Brain and Behavior Foundation. M.S.E. was also supported by a long-term post-doctoral fellowship of the Human Frontier Science Program and a Synapsis Foundation Grant. F.C. and C.H. were supported by grants from the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement number 281168 and the Fondation pour la Recherche Medicale.	An X, 1998, J COMP NEUROL, V401, P455; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; BANDLER R, 1985, BEHAV BRAIN RES, V15, P107, DOI 10.1016/0166-4328(85)90058-0; BANDLER R, 1988, BRAIN RES, V439, P95, DOI 10.1016/0006-8993(88)91465-5; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Blanchard DC, 2008, HBK BEHAV NEUROSCI, V17, P63, DOI 10.1016/S1569-7339(07)00005-7; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; CANTERAS NS, 1992, J COMP NEUROL, V324, P195, DOI 10.1002/cne.903240205; CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; DEPAULIS A, 1987, BRAIN RES, V436, P223, DOI 10.1016/0006-8993(87)91665-9; DEPAULIS A, 1992, EXP BRAIN RES, V90, P307; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; FANSELOW MS, 1991, NATO ADV SCI I A-LIF, V213, P151; FANSELOW MS, 1979, J COMP PHYSIOL PSYCH, V93, P736, DOI 10.1037/h0077609; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Halladay LR, 2015, J NEUROPHYSIOL, V114, P793, DOI 10.1152/jn.00656.2014; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Keay KA, 2001, NEUROSCI BIOBEHAV R, V25, P669, DOI 10.1016/S0149-7634(01)00049-5; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Leman S, 2003, BEHAV BRAIN RES, V143, P169, DOI 10.1016/S0166-4328(03)00033-0; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Morgan MM, 2005, BEHAV BRAIN RES, V164, P61, DOI 10.1016/j.bbr.2005.05.009; Oka T, 2008, NEUROSCI RES, V62, P286, DOI 10.1016/j.neures.2008.10.004; Orlovsky G., 1999, NEURONAL CONTROL LOC; Perusini JN, 2015, LEARN MEMORY, V22, P417, DOI 10.1101/lm.039180.115; RIZVI TA, 1991, J COMP NEUROL, V303, P121, DOI 10.1002/cne.903030111; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Silva BA, 2013, NAT NEUROSCI, V16, P1731, DOI 10.1038/nn.3573; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; TOMAZ C, 1988, PHARMACOL BIOCHEM BE, V30, P337, DOI 10.1016/0091-3057(88)90464-9; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tovote P, 2010, PSYCHONEUROENDOCRINO, V35, P887, DOI 10.1016/j.psyneuen.2009.12.001; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Vianna DML, 2001, NEUROSCI BIOBEHAV R, V25, P711, DOI 10.1016/S0149-7634(01)00052-5; Walker P, 2003, NEUROSCIENCE, V116, P897, DOI 10.1016/S0306-4522(02)00744-3; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang L, 2015, NEURON, V85, P1344, DOI 10.1016/j.neuron.2014.12.025; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; ZHANG SP, 1990, BRAIN RES, V520, P73, DOI 10.1016/0006-8993(90)91692-A	50	344	349	6	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					206	+		10.1038/nature17996	http://dx.doi.org/10.1038/nature17996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279213				2022-12-28	WOS:000377475100032
J	Ayres, JS				Ayres, Janelle S.			Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism	CELL			English	Review							INTESTINAL INFLAMMATION; DISEASE TOLERANCE; RESISTANCE; COLITIS; SYMBIOSIS; INNATE; GROWTH; IL-18; NLRP6; MICE	Animal defense strategies against microbes are most often thought of as a function of the immune system, the primary function of which is to sense and kill microbes through the execution of resistance mechanisms. However, this antagonistic view creates complications for our understanding of beneficial host-microbe interactions. Pathogenic microbes are described as employing a few common behaviors that promote their fitness at the expense of host health and fitness. Here, a complementary framework is proposed to suggest that, in addition to pathogens, beneficial microbes have evolved behaviors to manipulate host processes in order to promote their own fitness and do so through the promotion of host health and fitness. In this Perspective, I explore the idea that patterns or behaviors traditionally ascribed to pathogenic microbes are also employed by beneficial microbes to promote host tolerance defense strategies. Such strategies would promote host health without having a negative impact on microbial fitness and would thereby yield cooperative evolutionary dynamics that are likely required to drive mutualistic co-evolution of hosts and microbes.	[Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Ayres, JS (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jayres@salk.edu			NIH grant [R01AI114929, CA014195]; NOMIS Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; DARPA [D15AP00097]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114929] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOMIS Foundation; Searle Scholar Foundation; Ray Thomas Edward Foundation; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.S.A. is supported by NIH grant R01AI114929 and CA014195, the NOMIS Foundation, the Searle Scholar Foundation, the Ray Thomas Edward Foundation, and DARPA Young Faculty Award D15AP00097.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Ayres JS, 2013, CELL HOST MICROBE, V14, P491, DOI 10.1016/j.chom.2013.10.013; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; BENT AF, 1993, J NEMATOL, V25, P519; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; CALDWELL RM, 1958, SCIENCE, V128, P714, DOI 10.1126/science.128.3326.714; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LEVENSON SM, 1983, ARCH SURG-CHICAGO, V118, P310; Longman RS, 2013, COLD SH Q B, V78, P193, DOI 10.1101/sqb.2013.78.020081; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; OKADA M, 1994, SURG TODAY, V24, P347, DOI 10.1007/BF02348566; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; de Medina FS, 2014, INFLAMM BOWEL DIS, V20, P2394, DOI 10.1097/MIB.0000000000000204; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Svensson EI, 2010, TRENDS ECOL EVOL, V25, P267, DOI 10.1016/j.tree.2009.12.005; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	52	63	63	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1323	1331		10.1016/j.cell.2016.05.049	http://dx.doi.org/10.1016/j.cell.2016.05.049			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259146	Green Accepted, Bronze			2022-12-28	WOS:000377045400008
J	Evans, J; Evans, M; Evans, S; Evans, E				Evans, James; Evans, Matthew; Evans, Stephen; Evans, Eric			Richard Nesbit Evans Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		EVANS RN, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3110	10.1136/bmj.i3110	http://dx.doi.org/10.1136/bmj.i3110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255206				2022-12-28	WOS:000377479000015
J	McKenzie, KC				McKenzie, Katherine C.			A Modern Ars Moriendi	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McKenzie, Katherine C.] Yale Sch Med, New Haven, CT 06510 USA	Yale University	McKenzie, KC (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.			McKenzie, Katherine/0000-0002-7621-9741				Dugdale LS, 2015, DYING 21 CENTURY NEW	1	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2107	2109		10.1056/NEJMp1601820	http://dx.doi.org/10.1056/NEJMp1601820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248618				2022-12-28	WOS:000387209900003
J	Miller, R				Miller, Rachel			Barbara Williams Obituray	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		WILLIAMS B, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3104	10.1136/bmj.i3104	http://dx.doi.org/10.1136/bmj.i3104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255202				2022-12-28	WOS:000377479000009
J	Popp, MW; Maquat, LE				Popp, Maximilian W.; Maquat, Lynne E.			Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine	CELL			English	Review							IDENTIFICATION; MUTATIONS; UPF1	Nonsense-mediated mRNA decay (NMD) is a eukaryotic mRNA quality control and regulatory process that plays direct roles in human health and disease. In this Minireview, we discuss how understanding the molecular events that trigger NMD can facilitate strategic targeting of genes via CRISPR/Cas9 technologies and also inform disease diagnostics and treatments.	[Popp, Maximilian W.; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Popp, Maximilian W.; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, 601 Elmwood Ave, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.; Maquat, LE (corresponding author), Univ Rochester, Ctr RNA Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075	NIH [R01 GM59614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on NMD in the Maquat laboratory is supported by NIH R01 GM59614. M.W.P. was an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2119-12). We thank R.A. Elbarbary for comments on the manuscript and apologize to those colleagues whose work could not be cited due to word and reference limitations.	Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Ge ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.11155; Harter B, 2016, J PEDIATR GASTR NUTR, V62, P577, DOI 10.1097/MPG.0000000000001018; Jia J, 2015, CELL DEATH DIFFER, V22, P1754, DOI 10.1038/cdd.2015.18; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pereira FJC, 2015, NUCLEIC ACIDS RES, V43, P6528, DOI 10.1093/nar/gkv588; Popp MW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7632; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shum EY, 2016, CELL, V165, P382, DOI 10.1016/j.cell.2016.02.046; Smith JE, 2015, BIOESSAYS, V37, P612, DOI 10.1002/bies.201500007; Toma KG, 2015, RNA, V21, P887, DOI 10.1261/rna.048637.114; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Yamashita A, 2013, GENES CELLS, V18, P161, DOI 10.1111/gtc.12033; Zhao Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03032	21	156	157	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1319	1322		10.1016/j.cell.2016.05.053	http://dx.doi.org/10.1016/j.cell.2016.05.053			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259145	Bronze, Green Accepted			2022-12-28	WOS:000377045400007
J	Brill, ZG; Grover, HK; Maimone, TJ				Brill, Zachary G.; Grover, Huck K.; Maimone, Thomas J.			Enantioselective synthesis of an ophiobolin sesterterpene via a programmed radical cascade	SCIENCE			English	Article							CELL-CYCLE ARREST; CONSTRUCTION; CYCLIZATION; APOPTOSIS; ALCOHOLS; BIOLOGY	Cyclase enzymes weave simple polyprenyl chains into the elaborate polycyclic ring systems of terpenes, a sequence that is often difficult to emulate under abiotic conditions. Here we report a disparate synthetic approach to complex terpenes whereby simple prenyl-derived chains are cyclized using radical, rather than cationic, reaction pathways. This strategy allowed us to efficiently forge the intricate 5-8-5 fused ring systems found in numerous complex natural product classes and also enabled a nine-step total synthesis of (-)-6-epi-ophiobolin N, a member of the large family of cytotoxic ophiobolin sesterterpenes. A small-molecule thiol catalyst was found to override the inherent diastereoselectivity observed during a reductive radical cascade cyclization process. This work lays the foundation for efficient synthesis of terpenoid ring systems of interest in medicinal research, particularly those that have been historically challenging to access.	[Brill, Zachary G.; Grover, Huck K.; Maimone, Thomas J.] Univ Calif Berkeley, Dept Chem, 826 Latimer Hall, Berkeley, CA 94702 USA	University of California System; University of California Berkeley	Maimone, TJ (corresponding author), Univ Calif Berkeley, Dept Chem, 826 Latimer Hall, Berkeley, CA 94702 USA.	maimone@berkeley.edu			University of California, Berkeley (UC Berkeley); UC Berkeley Hellman Fellows Fund; Alfred P. Sloan Foundation; NIH National Institute of General Medical Sciences [R01GM116952]; NSF [DGE-1106400]; NIH [S10-RR027172]; UC Berkeley; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116952] Funding Source: NIH RePORTER	University of California, Berkeley (UC Berkeley)(University of California System); UC Berkeley Hellman Fellows Fund; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the University of California, Berkeley (UC Berkeley); the UC Berkeley Hellman Fellows Fund; the Alfred P. Sloan Foundation; and the NIH National Institute of General Medical Sciences (grant R01GM116952). Z.G.B. acknowledges UC Berkeley and the NSF for a Berkeley Fellowship and an NSF Graduate Research Fellowship (award DGE-1106400), respectively. We thank N. Shin for technical assistance, A. DiPasquale for x-ray crystallographic analysis and support from an NIH Shared Instrument grant (S10-RR027172), and N. Burns and F. Seidl (Stanford University) for various TADDOL diols used in early stages of this work. Metrical parameters for the structures of compounds 15 and SI-6 are available free of charge from the Cambridge Crystallographic Data Centre under accession numbers CCDC-1474968 and CCDC-1474969, respectively.	Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Breitmaier E., 2006, TERPENES FLAVORS FRA; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Cai Y., 2002, J CHEM SOC P1, V2002, P1376; Charette AB, 1998, J AM CHEM SOC, V120, P11943, DOI 10.1021/ja982055v; Charette AB, 1998, TETRAHEDRON LETT, V39, P7259, DOI 10.1016/S0040-4039(98)01582-2; Chiba R, 2013, ORG LETT, V15, P594, DOI 10.1021/ol303408a; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; CONCELLON JM, 1995, TETRAHEDRON, V51, P5573, DOI 10.1016/0040-4020(95)90943-Q; COREY EJ, 1965, J AM CHEM SOC, V87, P1353, DOI 10.1021/ja01084a034; DAUBEN WG, 1977, J ORG CHEM, V42, P922, DOI 10.1021/jo00425a042; Fujimoto H, 2000, CHEM PHARM BULL, V48, P1436, DOI 10.1248/cpb.48.1436; Hog DT, 2012, NAT PROD REP, V29, P752, DOI 10.1039/c2np20005h; Kasukabe T, 2008, CANCER SCI, V99, P1693, DOI 10.1111/j.1349-7006.2008.00867.x; Kim S, 2004, J NAT PROD, V67, P448, DOI 10.1021/np030384h; Lewis CA, 2006, ANGEW CHEM INT EDIT, V45, P5616, DOI 10.1002/anie.200601490; Li K, 2013, ORG BIOMOL CHEM, V11, P7550, DOI 10.1039/c3ob41693c; Liu L, 2005, J ORG CHEM, V70, P1539, DOI 10.1021/jo0481349; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; McCarroll AJ, 2001, ANGEW CHEM INT EDIT, V40, P2225; Mehta G, 1999, CHEM REV, V99, P881, DOI 10.1021/cr9800356; Meylemans HA, 2011, CHEMSUSCHEM, V4, P465, DOI 10.1002/cssc.201100017; Michalak M, 2011, J ORG CHEM, V76, P7497, DOI 10.1021/jo201357p; Miller RA, 1996, TETRAHEDRON LETT, V37, P3429, DOI 10.1016/0040-4039(96)00586-2; PAQUETTE LA, 1985, J ORG CHEM, V50, P201, DOI 10.1021/jo00202a012; Poupon E., 2011, BIOMIMETIC ORGANIC S, V1; Poupon E., 2011, BIOMIMETIC ORGANIC S, V2; RAJANBABU TV, 1991, ACCOUNTS CHEM RES, V24, P139, DOI 10.1021/ar00005a003; Razzak M, 2011, NAT CHEM BIOL, V7, P865, DOI [10.1038/NCHEMBIO.709, 10.1038/nchembio.709]; RIGBY JH, 1987, J ORG CHEM, V52, P4634, DOI 10.1021/jo00229a046; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; ROWLEY M, 1989, J AM CHEM SOC, V111, P2735, DOI 10.1021/ja00189a069; Sato T., 1991, J CHEM SOC P1, V1991, P353; Stockdale TP, 2015, CHEM SOC REV, V44, P7737, DOI 10.1039/c4cs00477a; Sun WX, 2013, MAR DRUGS, V11, P4570, DOI 10.3390/md11114570; Tsuna K, 2011, ANGEW CHEM INT EDIT, V50, P9452, DOI 10.1002/anie.201104447; Tucker JW, 2010, CHEM COMMUN, V46, P4985, DOI 10.1039/c0cc00981d; Wei H, 2004, TETRAHEDRON, V60, P6015, DOI 10.1016/j.tet.2004.05.021; Wender PA, 1997, J ORG CHEM, V62, P4908, DOI 10.1021/jo970841x; Yang TT, 2012, BIOORG MED CHEM LETT, V22, P579, DOI 10.1016/j.bmcl.2011.10.079; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhao YM, 2015, ANGEW CHEM INT EDIT, V54, P1223, DOI 10.1002/anie.201410443	42	92	92	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1078	1082		10.1126/science.aaf6742	http://dx.doi.org/10.1126/science.aaf6742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230373	Green Accepted			2022-12-28	WOS:000376480800033
J	Malkin, D; Garber, JE; Strong, LC; Friend, SH				Malkin, David; Garber, Judy E.; Strong, Louise C.; Friend, Stephen H.			CANCER The cancer predisposition revolution	SCIENCE			English	Editorial Material							LI-FRAUMENI-SYNDROME; SV40-TRANSFORMED CELLS; FAMILIAL SYNDROME; BREAST-CANCER; P53 GENE; MUTATIONS; NEOPLASMS; SARCOMAS; ANTIGEN		[Malkin, David] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Malkin, David] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Garber, Judy E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02215 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	Malkin, D (corresponding author), Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada.; Malkin, D (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada.	david.malkin@sickkids.ca	Malkin, David/AAW-8715-2021		NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Villani A, 2011, LANCET ONCOL, V12, P559, DOI 10.1016/S1470-2045(11)70119-X	13	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1052	1053		10.1126/science.aag0832	http://dx.doi.org/10.1126/science.aag0832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230363				2022-12-28	WOS:000376480800018
J	[Anonymous]				[Anonymous]			Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau (vol 333, 1245, 2006)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Garly ML, 2006, BMJ-BRIT MED J, V333, P1245, DOI 10.1136/bmj.38989.684178.AE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i3040	10.1136/bmj.i3040	http://dx.doi.org/10.1136/bmj.i3040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27234709	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000376940700013
J	Cresswell, K; Bates, DW; Sheikh, A				Cresswell, Kathrin; Bates, David W.; Sheikh, Aziz			Six ways for governments to get value from health IT	LANCET			English	Editorial Material							INFORMATION-TECHNOLOGY; IMPLEMENTATION		[Cresswell, Kathrin; Sheikh, Aziz] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Med Informat Ctr, Edinburgh EH8 9DX, Midlothian, Scotland; [Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Brigham & Women's Hospital	Sheikh, A (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Med Informat Ctr, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Bates, David/AAE-7283-2019	Sheikh, Aziz/0000-0001-7022-3056				Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Comments of CMS Acting Administrator Andy Slavitt at the J. P. Morgan Annual Health Care Conference, 2016, COMM CMS ACT ADM A S; Cresswell K, 2013, INT J MED INFORM, V82, pE73, DOI 10.1016/j.ijmedinf.2012.10.007; Cresswell K, 2012, JAMA-J AM MED ASSOC, V307, P2255, DOI 10.1001/jama.2012.3520; Department of Health and National Information Board, 2016, REV INF TECHN NHS; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Goroll AH, 2009, J AM MED INFORM ASSN, V16, P132, DOI 10.1197/jamia.M2899; Kellermann AL, 2013, HEALTH AFFAIR, V32, P63, DOI 10.1377/hlthaff.2012.0693; Middleton B, 2013, J AM MED INFORM ASSN, V20, pE2, DOI 10.1136/amiajnl-2012-001458; Richesson RL, 2015, J AM MED INFORM ASSN, V22, P492, DOI 10.1093/jamia/ocv039; Royal Statistical Society, 2016, OPP ETH BIG DAT; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Wright A, 2013, NEW ENGL J MED, V368, P779, DOI 10.1056/NEJMc1213481	13	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2074	2075		10.1016/S0140-6736(16)30519-0	http://dx.doi.org/10.1016/S0140-6736(16)30519-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM6HC	27301809	Green Submitted			2022-12-28	WOS:000376450800010
J	Gordon, KB; Blauvelt, A; Papp, KA; Langley, RG; Luger, T; Ohtsuki, M; Reich, K; Amato, D; Ball, SG; Braun, DK; Cameron, GS; Erickson, J; Konrad, RJ; Muram, TM; Nickoloff, BJ; Osuntokun, OO; Secrest, RJ; Zhao, F; Mallbris, L; Leonardi, CL				Gordon, K. B.; Blauvelt, A.; Papp, K. A.; Langley, R. G.; Luger, T.; Ohtsuki, M.; Reich, K.; Amato, D.; Ball, S. G.; Braun, D. K.; Cameron, G. S.; Erickson, J.; Konrad, R. J.; Muram, T. M.; Nickoloff, B. J.; Osuntokun, O. O.; Secrest, R. J.; Zhao, F.; Mallbris, L.; Leonardi, C. L.			Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELLS; INTERLEUKIN-17; MECHANISMS; ANTIBODY; OUTCOMES; SKIN	BACKGROUND Two phase 3 trials (UNCOVER-2 and UNCOVER-3) showed that at 12 weeks of treatment, ixekizumab, a monoclonal antibody against interleukin-17A, was superior to placebo and etanercept in the treatment of moderate-to-severe psoriasis. We report the 60-week data from the UNCOVER-2 and UNCOVER-3 trials, as well as 12-week and 60-week data from a third phase 3 trial, UNCOVER-1. METHODS We randomly assigned 1296 patients in the UNCOVER-1 trial, 1224 patients in the UNCOVER-2 trial, and 1346 patients in the UNCOVER-3 trial to receive subcutaneous injections of placebo (placebo group), 80 mg of ixekizumab every 2 weeks after a starting dose of 160 mg (2-wk dosing group), or 80 mg of ixekizumab every 4 weeks after a starting dose of 160 mg (4-wk dosing group). Additional cohorts in the UNCOVER-2 and UNCOVER-3 trials were randomly assigned to receive 50 mg of etanercept twice weekly. At week 12 in the UNCOVER-3 trial, the patients entered a long-term extension period during which they received 80 mg of ixekizumab every 4 weeks through week 60; at week 12 in the UNCOVER-1 and UNCOVER-2 trials, the patients who had a response to ixekizumab (defined as a static Physicians Global Assessment [sPGA] score of 0 [clear] or 1 [minimal psoriasis]) were randomly reassigned to receive placebo, 80 mg of ixekizumab every 4 weeks, or 80 mg of ixekizumab every 12 weeks through week 60. Coprimary end points were the percentage of patients who had a score on the sPGA of 0 or 1 and a 75% or greater reduction from baseline in Psoriasis Area and Severity Index (PASI 75) at week 12. RESULTS In the UNCOVER-1 trial, at week 12, the patients had better responses to ixekizumab than to placebo; in the 2-wk dosing group, 81.8% had an sPGA score of 0 or 1 and 89.1% had a PASI 75 response; in the 4-wk dosing group, the respective rates were 76.4% and 82.6%; and in the placebo group, the rates were 3.2% and 3.9% (P<0.001 for all comparisons of ixekizumab with placebo). In the UNCOVER-1 and UNCOVER-2 trials, among the patients who were randomly reassigned at week 12 to receive 80 mg of ixekizumab every 4 weeks, 80 mg of ixekizumab every 12 weeks, or placebo, an sPGA score of 0 or 1 was maintained by 73.8%, 39.0%, and 7.0% of the patients, respectively. Patients in the UNCOVER-3 trial received continuous treatment of ixekizumab from weeks 0 through 60, and at week 60, at least 73% had an sPGA score of 0 or 1 and at least 80% had a PASI 75 response. Adverse events reported during ixekizumab use included neutropenia, candidal infections, and inflammatory bowel disease. CONCLUSIONS In three phase 3 trials involving patients with psoriasis, ixekizumab was effective through 60 weeks of treatment. As with any treatment, the benefits need to be weighed against the risks of adverse events. The efficacy and safety of ixekizumab beyond 60 weeks of treatment are not yet known. (Funded by Eli Lilly; UNCOVER-1, UNCOVER-2, and UNCOVER-3 ClinicalTrials.gov numbers NCT01474512, NCT01597245, and NCT01646177, respectively.)	[Gordon, K. B.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Blauvelt, A.] Oregon Med Res Ctr, Portland, OR USA; [Papp, K. A.] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada; [Langley, R. G.] Dalhousie Univ, Div Dermatol, Dept Med, Halifax, NS, Canada; [Luger, T.] Univ Munster, Dept Dermatol, Munster, Germany; [Reich, K.] SCIderm Res Inst, Hamburg, Germany; [Reich, K.] Dermatologikum Hamburg, Hamburg, Germany; [Ohtsuki, M.] Jichi Med Univ, Dept Dermatol, Shimotsuke, Japan; [Amato, D.; Ball, S. G.; Braun, D. K.; Cameron, G. S.; Erickson, J.; Konrad, R. J.; Muram, T. M.; Nickoloff, B. J.; Osuntokun, O. O.; Secrest, R. J.; Zhao, F.; Mallbris, L.] Eli Lilly, Lilly Res Labs, Indianapolis, IN USA; [Leonardi, C. L.] St Louis Univ, Sch Med, Dept Dermatol, St Louis, MO 63103 USA	Northwestern University; Feinberg School of Medicine; Dalhousie University; University of Munster; Dermatologikum Hamburg; Jichi Medical University; Eli Lilly; Saint Louis University	Gordon, KB (corresponding author), Northwestern Univ, Feinberg Sch Med, 676 N St Clair St, Chicago, IL 60611 USA.	kenneth-gordon@northwestern.edu	Muram, Talia/AAC-1208-2022; Mallbris, Lotus/L-8607-2019; Kemeny, Lajos/ABF-1339-2021; Zbranca-Toporas, Anca/U-7166-2017	Kemeny, Lajos/0000-0002-2119-9501; Zbranca-Toporas, Anca/0000-0002-5474-4182; romanelli, marco/0000-0002-4127-0141; Ball, Susan/0000-0001-9866-6721; Papp, Kim A./0000-0001-9557-3642	Eli Lilly [UNCOVER-1, UNCOVER-2, UNCOVER-3]	Eli Lilly(Eli Lilly)	Funded by Eli Lilly; UNCOVER-1, UNCOVER-2, and UNCOVER-3 ClinicalTrials.gov numbers NCT01474512, NCT01597245, and NCT01646177, respectively.)	Cai YH, 2013, INT IMMUNOPHARMACOL, V16, P388, DOI 10.1016/j.intimp.2013.02.018; European Medicines Agency, 2004, GUID CLIN INV MED PR; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Simon T, 2013, EUR HEART J, V34, P570, DOI 10.1093/eurheartj/ehs263; Takeshita J, 2014, J AM ACAD DERMATOL, V71, P633, DOI 10.1016/j.jaad.2014.05.001; Taleb S, 2015, ARTERIOSCL THROM VAS, V35, P258, DOI 10.1161/ATVBAHA.114.303567; Torii H, 2012, J DERMATOL, V39, P253, DOI 10.1111/j.1346-8138.2011.01459.x; Viswanathan HN, 2015, J DERMATOL TREAT, V26, P235, DOI 10.3109/09546634.2014.943687	17	509	527	4	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					345	356		10.1056/NEJMoa1512711	http://dx.doi.org/10.1056/NEJMoa1512711			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0UV	27299809	Green Published, Bronze			2022-12-28	WOS:000380313200008
J	Park, GE; Ko, JH; Peck, KR; Lee, JY; Lee, JY; Cho, SY; Ha, YE; Kang, CI; Kang, JM; Kim, YJ; Huh, HJ; Ki, CS; Lee, NY; Lee, JH; Jo, IJ; Jeong, BH; Suh, GY; Park, J; Chung, CR; Song, JH; Chung, DR				Park, Ga Eun; Ko, Jae-Hoon; Peck, Kyong Ran; Lee, Ji Yeon; Lee, Ji Yong; Cho, Sun Young; Ha, Young Eun; Kang, Cheol-In; Kang, Ji-Man; Kim, Yae-Jean; Huh, Hee Jae; Ki, Chang-Seok; Lee, Nam Yong; Lee, Jun Haeng; Jo, Ik Joon; Jeong, Byeong-Ho; Suh, Gee Young; Park, Jinkyeong; Chung, Chi Ryang; Song, Jae-Hoon; Chung, Doo Ryeon			Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea	ANNALS OF INTERNAL MEDICINE			English	Article							SYNDROME CORONAVIRUS; SAUDI-ARABIA	Background: In 2015, a large outbreak of Middle East respiratory syndrome (MERS) occurred in the Republic of Korea. Half of the cases were associated with a tertiary care university hospital. Objective: To document the outbreak and successful control measures. Design: Descriptive study. Setting: A 1950-bed tertiary care university hospital. Patients: 92 patients with laboratory-confirmed MERS and 9793 exposed persons. Measurements: Description of the outbreak, including a timeline, and evaluation of the effectiveness of the control measures. Results: During the outbreak, 92 laboratory-confirmed MERS cases were associated with a large tertiary care hospital, 82 of which originated from unprotected exposure to 1 secondary patient. Contact tracing and monitoring exposed patients and assigned health care workers were at the core of the control measures in the outbreak. Nontargeted screening measures, including body temperature screening among employees and visitors at hospital gates, monitoring patients for MERS-related symptoms, chest radiographic screening, and employee symptom monitoring, did not detect additional patients with MERS without existing transmission links. All in-hospital transmissions originated from 3 patients with MERS who also had pneumonia and productive cough. Limitations: This was a retrospective single-center study. Statistical analysis could not be done. Because this MERS outbreak originated from a superspreader, effective control measures could differ in endemic areas or in other settings. Conclusion: Control strategies for MERS outbreaks should focus on tracing contacts of persons with epidemiologic links. Adjusting levels of quarantine and personal protective equipment according to the assumed infectivity of each patient with MERS may be appropriate.	[Park, Ga Eun; Ko, Jae-Hoon; Peck, Kyong Ran; Lee, Ji Yeon; Lee, Ji Yong; Cho, Sun Young; Ha, Young Eun; Kang, Cheol-In; Kang, Ji-Man; Kim, Yae-Jean; Huh, Hee Jae; Ki, Chang-Seok; Lee, Nam Yong; Lee, Jun Haeng; Jo, Ik Joon; Jeong, Byeong-Ho; Suh, Gee Young; Park, Jinkyeong; Chung, Chi Ryang; Song, Jae-Hoon; Chung, Doo Ryeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Park, Ga Eun; Ko, Jae-Hoon; Peck, Kyong Ran; Lee, Ji Yeon; Lee, Ji Yong; Cho, Sun Young; Ha, Young Eun; Kang, Cheol-In; Song, Jae-Hoon; Chung, Doo Ryeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea; [Kang, Ji-Man; Kim, Yae-Jean] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwon Ro, Seoul 06351, South Korea; [Huh, Hee Jae; Ki, Chang-Seok; Lee, Nam Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, 81 Irwon Ro, Seoul 06351, South Korea; [Lee, Jun Haeng] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Gastroenterol,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea; [Jo, Ik Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, 81 Irwon Ro, Seoul 06351, South Korea; [Jeong, Byeong-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pulm & Crit Care Med, 81 Irwon Ro, Seoul 06351, South Korea; [Suh, Gee Young; Park, Jinkyeong; Chung, Chi Ryang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, 81 Irwon Ro, Seoul 06351, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Peck, KR (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.	kaeun84@gmail.com; jaehoon.ko@gmail.com; krpeck@skku.edu	Suh, Gee Young/O-3676-2019; Peck, Kyong Ran/AGV-5205-2022; Park, Jinkyeong/GLV-1649-2022; Park, Jinkyeong/AGB-3445-2022; Ki, Chang-Seok/G-7559-2014; ki, cs/O-5931-2014	Suh, Gee Young/0000-0001-5473-1712; Park, Jinkyeong/0000-0002-8833-9062; Ki, Chang-Seok/0000-0001-7679-8731; Lee, Nam Yong/0000-0003-3688-0145; Huh, Hee Jae/0000-0001-8999-7561; Jeong, Byeong-Ho/0000-0002-3124-1718; Ko, Jae-Hoon/0000-0002-9490-6609; Lee, Ji Yong/0000-0002-8286-7913; Peck, Kyong Ran/0000-0002-7464-9780	Samsung Biomedical Research Institute	Samsung Biomedical Research Institute(Samsung)	Samsung Biomedical Research Institute.	Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Centers for Disease Control and Prevention, 2015, INT GUID HEALTHC PRO; Centers for Disease Control Prevention, 2015, INT INF PREV CONTR R; Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Madani TA, 2014, LANCET INFECT DIS, V14, P911, DOI 10.1016/S1473-3099(14)70918-1; Maltezou HC, 2014, AM J INFECT CONTROL, V42, P1261, DOI 10.1016/j.ajic.2014.06.019; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Ooi PL, 2005, AM J INFECT CONTROL, V33, P252, DOI 10.1016/j.ajic.2004.08.007; World Health Organization, 2015, SURV HUM INF MIDDL E; World Health Organization, 2015, DIS OUTBREAK NE 0208; World Health Organization, 2015, INV CAS HUM INF MIDD; World Health Organization, 2015, CLIN MAN SEV AC RESP; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	15	40	41	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					87	+		10.7326/M15-2495	http://dx.doi.org/10.7326/M15-2495			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27272273				2022-12-28	WOS:000380583100015
J	Di Stefano, B; Hochedlinger, K				Di Stefano, Bruno; Hochedlinger, Konrad			CELL REPROGRAMMING Brain versus brawn	NATURE			English	Editorial Material							FIBROBLASTS; CONVERSION		[Di Stefano, Bruno; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Di Stefano, Bruno; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Di Stefano, Bruno; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Di Stefano, Bruno; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Hochedlinger, K (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.; Hochedlinger, K (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	khochedlinger@mgh.harvard.edu	Di Stefano, Bruno/K-5020-2017	Di Stefano, Bruno/0000-0003-2532-3087				Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Treutlein B, 2016, NATURE, V534, P391, DOI 10.1038/nature18323; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang BX, 2015, CELL, V163, P230, DOI 10.1016/j.cell.2015.08.037	13	4	4	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					332	333						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281201				2022-12-28	WOS:000377856800024
J	Jones, DS; Grady, C; Lederer, SE				Jones, David S.; Grady, Christine; Lederer, Susan E.			"Ethics and Clinical Research" - The 50th Anniversary of Beecher's Bombshell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-EXPERIMENTATION; INFORMED-CONSENT		[Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Grady, Christine] NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Lederer, Susan E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Hist & Bioeth, Madison, WI 53706 USA	Harvard University; Harvard Medical School; Harvard University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Wisconsin System; University of Wisconsin Madison	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA.; Jones, DS (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.							Advisory Committee on Human Radiation Experiments, 1996, HUM RAD EXP, P236; American Academy of Arts and Sciences, 1969, DAEDALUS, V98, P219; Annas George J., 1992, NAZI DOCTORS NUREMBE; [Anonymous], 1966, NEW ENGL J MED, V274, P1382; [Anonymous], 2011, ETHICALLY IMPOSSIBLE; [Anonymous], 1916, JAMA-J AM MED ASSOC, V19, P1372; Beecher H. K., 1966, NEW ENGL J MED, V275, P791; BEECHER HK, 1963, JAMA-J AM MED ASSOC, V186, P858; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; BEECHER HK, 1959, JAMA-J AM MED ASSOC, V169, P461, DOI 10.1001/jama.1959.73000220003010; Beecher HK, 1970, RES INDIVIDUAL HUMAN, P231; Bernard C., 1957, INTRO LIT CORRES TON; Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; BURNETT CH, 1949, J PHARMACOL EXP THER, V96, P380; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Edelson Paul J., 2004, 20 CENTURY ETHICS HU, P219; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Faden R., 1986, HIST THEORY INFORM C; Fost N, 2007, JAMA-J AM MED ASSOC, V298, P2196, DOI 10.1001/jama.298.18.2196; Freidenfelds L, 2007, INT ANESTHESIOL CLIN, V45, P79, DOI 10.1097/AIA.0b013e31812e56de; Gericke CA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2105; Gold JA, 1991, NEW ENGL J MED, V325, P1387; Grady C, 2015, NEW ENGL J MED, V372, P855, DOI 10.1056/NEJMra1411250; Harkness J, 2001, B WORLD HEALTH ORGAN, V79, P365; Harris SH, 2002, THEIRISHTIMES; Henry K., BEECHER PAPERS 1848; Ingelfinger F J, 1973, N Engl J Med, V289, P641, DOI 10.1056/NEJM197309202891217; Koski G, 2014, BASIC BIOETH, P341; Lederer SE, 2004, 20 CENTURY ETHICS HU, P199; Lederer Susan, 1995, SUBJECTED SCI HUMAN; Lee TH, 2013, EUGENE BRAUNWALD RIS; Lerner BH, 2004, NEW ENGL J MED, V351, P628, DOI 10.1056/NEJMp048108; McCarthy C. R., 2008, OXFORD TXB CLIN RES, P541; Mccoy AW, 2007, J HIST BEHAV SCI, V43, P401, DOI 10.1002/jhbs.20271; Osler W., 1907, T C AM PHYSICIANS SU, V7, P7; Osmundsen J. A., 1965, NY TIMES; Podolsky SH, 2014, ANTIBIOTIC ERA REFOR, P92; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; Robinson W., 2008, OXFORD TXB CLIN RES, P80; Rothman D., 1991, STRANGERS BEDSIDE HI, DOI DOI 10.4324/9781315130286; ROTHMAN DJ, 1987, NEW ENGL J MED, V317, P1195, DOI 10.1056/NEJM198711053171906; SILVERMA.WA, 1966, NEW ENGL J MED, V275, P790; Smith SL, TOXIC EXPOS IN PRESS; Smith SL, 2008, J LAW MED ETHICS, V36, P517, DOI 10.1111/j.1748-720X.2008.299.x; Stark L., 2012, CLOSED DOORS IRBS MA; Truog RD, 2012, NEW ENGL J MED, V366, P581, DOI 10.1056/NEJMp1110848; Truop SB, 1991, JAMA-J AM MED ASSOC, V266, P851; Weindling P., 2004, 20 CENTURY ETHICS HU, P167; Weindling PJ, 2004, NAZI MEDICINE AND THE NUREMBERG TRIALS, P1, DOI 10.1057/9780230506053	49	27	27	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2393	2398		10.1056/NEJMms1603756	http://dx.doi.org/10.1056/NEJMms1603756			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5WW	27305197				2022-12-28	WOS:000377854600016
J	Buttgereit, F; Dejaco, C; Matteson, EL; Dasgupta, B				Buttgereit, Frank; Dejaco, Christian; Matteson, Eric L.; Dasgupta, Bhaskar			Polymyalgia Rheumatica and Giant Cell Arteritis A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSITRON-EMISSION-TOMOGRAPHY; COLOR DUPLEX ULTRASONOGRAPHY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; TEMPORAL ARTERITIS; DIAGNOSTIC-VALUE; FOLLOW-UP; RHEUMATISM/AMERICAN COLLEGE; DOPPLER ULTRASONOGRAPHY; INITIAL TREATMENT	IMPORTANCE Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and therapeutic approaches are heterogeneous in clinical practice. OBJECTIVE To summarize current evidence regarding optimal methods for diagnosing and treating PMR and GCA. EVIDENCE REVIEW MEDLINE, EMBASE, and Cochrane databases were searched from their inception dates to March 30, 2016. Screening by 2 authors resulted in 6626 abstracts, of which 50 articles met the inclusion criteria. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool or American College of Cardiology Foundation/American Heart Association methodology. FINDINGS Twenty randomized clinical trials for therapy (n = 1016 participants) and 30 imaging studies for diagnosis and/or assessing response to therapy (n = 2080 participants) were included. The diagnosis of PMR is based on clinical features such as new-onset bilateral shoulder pain, including subdeltoid bursitis, muscle or joint stiffness, and functional impairment. Headache and visual disturbances including loss of vision are characteristic of GCA. Constitutional symptoms and elevated inflammatory markers (>90%) are common in both diseases. Ultrasound imaging enables detection of bilateral subdeltoid bursitis in 69% of PMR patients. In GCA, temporal artery biopsy remains the standard for definitive diagnosis. Ultrasound and magnetic resonance imaging (MRI) of large vessels revealing inflammation-induced wall thickening support the diagnosis of GCA (specificity 78%-100% for ultrasound and 73%-97% for MRI). Glucocorticoids remain the primary treatment, but the optimal initial dose and tapering treatment regimens are unknown. According to consensus-based recommendations, initial therapy for PMR is prednisone, 12.5 to 25 mg/day or equivalent, and 40 to 60 mg/day for GCA, followed by individualized tapering regimens in both diseases. Adjunctive methotrexate may reduce cumulative glucocorticoid dosage by 20% to 44% and relapses by 36% to 54% in both PMR and GCA. Use of tocilizumab as additional treatment with prednisone showed a 2-to 4-fold increase in remission rates of GCA in a randomized clinical trial (N = 30). CONCLUSIONS AND RELEVANCE Diagnosis of PMR/GCA is made by clinical features and elevated inflammatory markers. In PMR, ultrasound imaging may improve diagnostic accuracy. In GCA, temporal artery biopsy may not be required in patients with typical disease features accompanied by characteristic ultrasound or MRI findings. Consensus-based recommendations suggest glucocorticoids as the most effective therapy for PMR/GCA. Methotrexate may be added to glucocorticoids in patients at risk for relapse and in those with glucocorticoid-related adverse effects or need for prolonged glucocorticoid therapy.	[Buttgereit, Frank] Charite, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany; [Dejaco, Christian] Med Univ Graz, Dept Rheumatol & Immunol, Graz, Austria; [Matteson, Eric L.] Mayo Clin, Div Rheumatol, Coll Med, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Div Epidemiol, Coll Med, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Dept Internal Med, Coll Med, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Dasgupta, Bhaskar] Southend Univ Hosp, Dept Rheumatol, Southend On Sea, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Buttgereit, F (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany.	frank.buttgereit@charite.de		Buttgereit, Frank/0000-0003-2534-550X; Dejaco, Christian/0000-0002-0173-0668	Horizon Pharma; Mundipharma International; Roche; Mundipharma; MSD; Pfizer; UCB; AbbVie; Novartis; Lilly; Celgene; Merck; Signatis Pharma; Napp	Horizon Pharma; Mundipharma International; Roche(Roche Holding); Mundipharma; MSD; Pfizer(Pfizer); UCB(UCB Pharma SA); AbbVie(AbbVie); Novartis(Novartis); Lilly(Eli Lilly); Celgene(Bristol-Myers SquibbCelgene Corporation); Merck(Merck & Company); Signatis Pharma; Napp	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Buttgereit reports receipt of consultancy fees, honoraria, and travel expenses from Horizon Pharma (formerly Nitec Pharma), Mundipharma International, and Roche; grant support from Horizon Pharma; and serving as coprincipal investigator and site investigator in a Mundipharma-sponsored trial in polymyalgia rheumatica investigating the effects of modified-release prednisone. Dr Dejaco reports receipt of consultancy fees and honoraria from MSD, Pfizer, UCB, AbbVie, Roche, Novartis, Lilly, Celgene, Merck, and Signatis Pharma; clinical trials design advisory board consultancies with GlaxoSmithKline; and unrestricted grant support from Pfizer and MSD. Dr Matteson reports serving as coordinating investigator with Novartis and consultant with GlaxoSmithKline in PMR trials; consultant with GlaxoSmithKline and Endocyte and site investigator in GCA trials with Bristol Meyer Squibb, Hoffman-LaRoche, Genentech, GlaxoSmithKline; and editor and contributor for polymyalgia rheumatica and giant cell arteritis with UpToDate and Paradigm. Dr Dasgupta reported clinical trials design advisory board consultancies with Roche, Servier, GlaxoSmithKline, Mundipharma, Pfizer, Merck, Sobi; unrestricted grant support from Napp and Roche; and speakers honoraria from UCB and Merck.	Artal NM, 2002, OPHTHALMOLOGY, V109, P1757, DOI 10.1016/S0161-6420(02)01195-8; Aschwanden M, 2015, CLIN EXP RHEUMATOL, V33, pS113; Aschwanden M, 2013, ULTRASCHALL MED, V34, P47, DOI 10.1055/s-0032-1312821; Aschwanden M, 2010, ANN RHEUM DIS, V69, P1356, DOI 10.1136/ard.2009.122135; BENGTSSON BA, 1981, ARTHRITIS RHEUM, V24, P899, DOI 10.1002/art.1780240706; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Bley TA, 2007, AM J NEURORADIOL, V28, P1722, DOI 10.3174/ajnr.A0638; Bley TA, 2005, ARTHRITIS RHEUM, V52, P2470, DOI 10.1002/art.21226; Blockmans D, 2008, RHEUMATOLOGY, V47, P1179, DOI 10.1093/rheumatology/ken119; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Blockmans D, 2006, ARTHRIT RHEUM-ARTHR, V55, P131, DOI 10.1002/art.21699; Blockmans D, 2000, AM J MED, V108, P246, DOI 10.1016/S0002-9343(99)00424-6; Bosley TM, 1998, INT OPHTHALMOL, V22, P59, DOI 10.1023/A:1006167213695; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Chevalet P, 2000, J RHEUMATOL, V27, P1484; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Dasgupta B, 1998, BRIT J RHEUMATOL, V37, P189; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Dasgupta B, 2010, RHEUMATOLOGY, V49, P1594, DOI 10.1093/rheumatology/keq039a; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; De Miguel E, 2012, CLIN EXP RHEUMATOL, V30, pS34; Dejaco C, 2015, ARTHRITIS RHEUMATOL, V67, P2569, DOI 10.1002/art.39333; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; Diamantopoulos AP, 2014, ARTHRIT CARE RES, V66, P113, DOI 10.1002/acr.22178; Dolan AL, 1997, ARTHRITIS RHEUM, V40, P2022, DOI 10.1002/art.1780401115; Doran MF, 2002, J RHEUMATOL, V29, P1694; Falsetti P, 2011, SCAND J RHEUMATOL, V40, P57, DOI 10.3109/03009742.2010.486766; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Franke P, 2014, EUR J RADIOL, V83, P1875, DOI 10.1016/j.ejrad.2014.06.022; FRANZEN P, 1992, J RHEUMATOL, V19, P273; Geiger J, 2010, J MAGN RESON IMAGING, V31, P470, DOI 10.1002/jmri.22047; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gran JT, 1997, J RHEUMATOL, V24, P1739; Habib HM, 2012, CLIN RHEUMATOL, V31, P231, DOI 10.1007/s10067-011-1808-0; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f; Jimenez-Palop M, 2010, ANN RHEUM DIS, V69, P879, DOI 10.1136/ard.2009.113555; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Karahaliou M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2003; Kermani TA, 2013, LANCET, V381, P63, DOI 10.1016/S0140-6736(12)60680-1; KLEIN RG, 1976, MAYO CLIN PROC, V51, P504; Klink T, 2014, RADIOLOGY, V273, P844, DOI 10.1148/radiol.14140056; Kreiner F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3140; KYLE V, 1989, ANN RHEUM DIS, V48, P658, DOI 10.1136/ard.48.8.658; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LeSar CJ, 2002, J VASC SURG, V36, P1154, DOI 10.1067/mva.2002.129648; Liozon F, 1993, EUR J INTERN MED, V4, P207; Macchioni P, 2009, RHEUMATOLOGY, V48, P1566, DOI 10.1093/rheumatology/kep286; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Martinez-Taboada VM, 2008, ANN RHEUM DIS, V67, P625, DOI 10.1136/ard.2007.082115; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Muratore F, 2015, RHEUMATOLOGY, V54, P463, DOI 10.1093/rheumatology/keu329; Murgatroyd H, 2003, EYE, V17, P415, DOI 10.1038/sj.eye.6700350; Myklebust G, 1996, BRIT J RHEUMATOL, V35, P1161; Nesher G, 2002, J RHEUMATOL, V29, P1224; OSTBERG G, 1971, ANN RHEUM DIS, V30, P224, DOI 10.1136/ard.30.3.224; Palard-Novello X, 2016, EUR J NUCL MED MOL I, V43, P773, DOI 10.1007/s00259-015-3287-z; Patil P, 2015, CLIN EXP RHEUMATOL, V33, pS103; Pfadenhauer K, 2003, J RHEUMATOL, V30, P2177; Ramstead CL, 2007, CAN J OPHTHALMOL, V42, P295, DOI 10.3129/canjophthalmol.i07-005; Reinhard M, 2004, RHEUMATOL INT, V24, P340, DOI 10.1007/s00296-003-0372-6; Romera-Villegas A, 2004, J ULTRAS MED, V23, P1493, DOI 10.7863/jum.2004.23.11.1493; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P293, DOI 10.1002/art.21075; Salvarani C, 2002, ANN INTERN MED, V137, P232, DOI 10.7326/0003-4819-137-4-200208200-00006; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; Samson M, 2013, CLIN EXP RHEUMATOL, V31, pS65; Schaufelberger C, 2006, SCAND J RHEUMATOL, V35, P327, DOI 10.1080/03009740500474537; Schaufelberger C, 1998, BRIT J RHEUMATOL, V37, P464; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; Seror R, 2014, ANN RHEUM DIS, V73, P2074, DOI 10.1136/annrheumdis-2013-203586; Siemonsen S, 2015, AM J NEURORADIOL, V36, P91, DOI 10.3174/ajnr.A4086; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Spiera RF, 2001, CLIN EXP RHEUMATOL, V19, P495; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; Veldhoen S, 2014, EUR RADIOL, V24, P2971, DOI 10.1007/s00330-014-3255-1; Villiger PM, 2016, LANCET, V387, P1921, DOI 10.1016/S0140-6736(16)00560-2; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	87	239	250	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2442	2458		10.1001/jama.2016.5444	http://dx.doi.org/10.1001/jama.2016.5444			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299619				2022-12-28	WOS:000377656900022
J	Godlee, F; Abbasi, K; Gulland, A; Coombes, R				Godlee, Fiona; Abbasi, Kamran; Gulland, Anne; Coombes, Rebecca			Why doctors should vote to remain in the EU on 23 June	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NHS		[Godlee, Fiona; Abbasi, Kamran; Gulland, Anne; Coombes, Rebecca] BMJ, London, England		Godlee, F (corresponding author), BMJ, London, England.	fgodlee@bmj.com						[Anonymous], 2016, GUARDIAN; [Anonymous], 2016, RESPONSE RCPS CALL V; Centre for Economic Performance, 2016, BREX IMP IMM UK; Dearden L., 2016, INDEPENDENT; Dilnot A., 2016, COMMUNICATION; Economist Intelligence Unit, 2016, THE GUARDIAN 0427; House of Commons Treasury Select Committee, 2016, EC FIN COSTS BEN UKS; Institute for Fiscal Studies, 2016, BREX UKS PUBL FIN; Mason R., 2016, GUARDIAN; National Institute for Economic and Social Research, 2011, IMP MIGR CONS ED CHI; Torjesen I, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2953; Wessely S., 2016, YORKSHIRE POST  0408; Wollaston S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3295	13	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3302	10.1136/bmj.i3302	http://dx.doi.org/10.1136/bmj.i3302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27302192				2022-12-28	WOS:000378239800013
J	Kamerow, D; Graham, R				Kamerow, Douglas; Graham, Robert			How to react to the Orlando massacre?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Ctr Policy Studies Primary Care, Washington, DC 20057 USA; Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Chivers CJ, 2016, NY TIMES	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3322	10.1136/bmj.i3322	http://dx.doi.org/10.1136/bmj.i3322			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27301346				2022-12-28	WOS:000378239800018
J	Waqar, S; Mughal, F; Rashid, A; Mant, J				Waqar, Salman; Mughal, Faraz; Rashid, Ahmed; Mant, Jonathan			CASE REVIEW Assessment of cardiovascular risk in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHARED DECISION-MAKING; MEDITERRANEAN DIET; MYOCARDIAL-INFARCTION; TASK-FORCE; DISEASE; PREVENTION; GUIDELINES; AIDS; METAANALYSIS; MODEL		[Waqar, Salman] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London W6 8RP, England; [Mughal, Faraz] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Primary Care, Coventry CV4 7AL, W Midlands, England; [Rashid, Ahmed; Mant, Jonathan] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	Imperial College London; University of Warwick; University of Cambridge	Waqar, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London W6 8RP, England.	s.waqar@imperial.ac.uk	Mughal, Faraz/AAF-6073-2019	Mughal, Faraz/0000-0002-5437-5962; Waqar, Salman/0000-0001-7886-873X	National Institute for Health Research [NF-SI-0514-10121] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Agoritsas T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7624; [Anonymous], BMJ; Bonner C, 2014, J MED INTERNET RES, V16, P118, DOI 10.2196/jmir.3190; Choices NHS, PHYSICAL ACTIVITY GU; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Coylewright M, 2014, CIRC-CARDIOVASC QUAL, V7, P360, DOI 10.1161/HCQ.0000000000000006; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; GOLDACRE B, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G4745; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mann DM, 2010, PATIENT EDUC COUNS, V80, P138, DOI 10.1016/j.pec.2009.10.008; Martin SC, 2008, INT J CLIN PRACT, V62, P961, DOI 10.1111/j.1742-1241.2007.01667.x; National Institute for Health and Care Excellence, 2006, CLINICAL GUIDANCE 43; National Institute for Health and Care Excellence, 2014, TAKING A STATIN TO R; National Institute for Health and Care Excellence, 2014, CLINICAL GUIDELINE 1; National Institute for Health and Care Excellence, 2011, CLINICAL GUIDELINE 1; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sheppard JP, 2014, BRIT J GEN PRACT, V64, pE641, DOI 10.3399/bjgp14X681817; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; van den Brink-Muinen A, 2006, HEALTH EXPECT, V9, P333, DOI 10.1111/j.1369-7625.2006.00413.x; van Staa TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106455; Volk Robert J, 2013, BMC Med Inform Decis Mak, V13 Suppl 2, pS1, DOI 10.1186/1472-6947-13-S2-S1; Wyatt KD, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-26	34	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2016	353								i3022	10.1136/bmj.i3022	http://dx.doi.org/10.1136/bmj.i3022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1FW	27296236	Green Submitted, Green Accepted			2022-12-28	WOS:000378236900001
J	Hamann, E; Gruber-Vodicka, H; Kleiner, M; Tegetmeyer, HE; Riedel, D; Littmann, S; Chen, JW; Milucka, J; Viehweger, B; Becker, KW; Dong, XL; Stairs, CW; Hinrichs, KU; Brown, MW; Roger, AJ; Strous, M				Hamann, Emmo; Gruber-Vodicka, Harald; Kleiner, Manuel; Tegetmeyer, Halina E.; Riedel, Dietmar; Littmann, Sten; Chen, Jianwei; Milucka, Jana; Viehweger, Bernhard; Becker, Kevin W.; Dong, Xiaoli; Stairs, Courtney W.; Hinrichs, Kai-Uwe; Brown, Matthew W.; Roger, Andrew J.; Strous, Marc			Environmental Breviatea harbour mutualistic Arcobacter epibionts	NATURE			English	Article							SHOTGUN PROTEOMICS; READ ALIGNMENT; GENOME REVEALS; PROTEIN; IDENTIFICATION; IMPROVEMENTS; PHYSIOLOGY; ALGORITHM; ABUNDANCE; INVASION	Breviatea form a lineage of free living, unicellular protists, distantly related to animals and fungi(1,2). This lineage emerged almost one billion years ago, when the oceanic oxygen content was low, and extant Breviatea have evolved or retained an anaerobic lifestyle(3,4). Here we report the cultivation of Lenisia limosa, gen. et sp. nov., a newly discovered breviate colonized by relatives of animal-associated Arcobacter. Physiological experiments show that the association of L. limosa with Arcobacter is driven by the transfer of hydrogen and is mutualistic, providing benefits to both partners. With whole-genome sequencing and differential proteomics, we show that an experimentally observed fitness gain of L. limosa could be explained by the activity of a so far unknown type of NAD(P) H-accepting hydrogenase, which is expressed in the presence, but not in the absence, of Arcobacter. Differential proteomics further reveal that the presence of Lenisia stimulates expression of known 'virulence' factors by Arcobacter. These proteins typically enable colonization of animal cells during infection(5), but may in the present case act for mutual benefit. Finally, re-investigation of two currently available transcriptomic data sets of other Breviatea(4) reveals the presence and activity of related hydrogen-consuming Arcobacter, indicating that mutualistic interaction between these two groups of microbes might be pervasive. Our results support the notion that molecular mechanisms involved in virulence can also support mutualism(6), as shown here for Arcobacter and Breviatea.	[Hamann, Emmo; Tegetmeyer, Halina E.; Chen, Jianwei; Strous, Marc] Max Planck Inst Marine Microbiol, Microbial Fitness Grp, Celsiusstr 1, D-28359 Bremen, Germany; [Hamann, Emmo; Kleiner, Manuel; Chen, Jianwei; Dong, Xiaoli; Strous, Marc] Univ Calgary, Dept Geosci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Gruber-Vodicka, Harald] Max Planck Inst Marine Microbiol, Symbiosis Dept, Celsiusstr 1, D-28359 Bremen, Germany; [Tegetmeyer, Halina E.; Strous, Marc] Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol, Univ Str 25, D-3615 Bielefeld, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany; [Littmann, Sten; Milucka, Jana] Max Planck Inst Marine Microbiol, Biogeochem Dept, Celsiusstr 1, D-28359 Bremen, Germany; [Viehweger, Bernhard; Becker, Kevin W.; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, Bibliothekstr 1, D-28359 Bremen, Germany; [Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, 6299 South St, Halifax, NS B3H 4R2, Canada; [Brown, Matthew W.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Max Planck Society; University of Calgary; Max Planck Society; University of Bielefeld; Max Planck Society; Max Planck Society; University of Bremen; Dalhousie University; Mississippi State University	Hamann, E; Strous, M (corresponding author), Max Planck Inst Marine Microbiol, Microbial Fitness Grp, Celsiusstr 1, D-28359 Bremen, Germany.; Hamann, E; Strous, M (corresponding author), Univ Calgary, Dept Geosci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Strous, M (corresponding author), Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol, Univ Str 25, D-3615 Bielefeld, Germany.	emmohamann@gmail.com; mstrous@ucalgary.ca	Kleiner, Manuel/D-2148-2011; Gruber-Vodicka, Harald/AAD-2445-2020; stairs, courtney w/AAJ-1459-2021; Strous, Marc/B-4064-2017; Becker, Kevin W./AAF-9506-2021; Hinrichs, Kai-Uwe/C-7675-2009	Kleiner, Manuel/0000-0001-6904-0287; Gruber-Vodicka, Harald/0000-0001-5819-1549; stairs, courtney w/0000-0001-6650-0970; Strous, Marc/0000-0001-9600-3828; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Becker, Kevin W./0000-0001-6317-1884; Brown, Matthew/0000-0002-1254-0608; Littmann, Sten/0000-0001-8685-5357; Tegetmeyer, Halina E./0000-0003-1970-4457	European Research Council [MASEM 242635]; Campus Alberta Innovation Chair Program; Canadian Foundation for Innovation; Alberta Small Equipment Grant Program; German Federal State Nordrhein-Westfalen; Max Planck Society; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Campus Alberta Innovation Chair Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Small Equipment Grant Program; German Federal State Nordrhein-Westfalen; Max Planck Society(Max Planck SocietyFoundation CELLEX); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Hargesheimer, D. Liu, G. Klockgether, P. Hach, R. Appel and I. Kattelmann for technical assistance, A. Simpson, G. Strous and Fulvio Reggiori for comments on electron micrographs, and C. Hubert, E. Ruff, S. Ahmerkamp and N. Dubilier for discussions. This study was supported by European Research Council starting grant MASEM 242635 (M.S., E.H., J.C.), the Campus Alberta Innovation Chair Program (M.S., E.H., X.D.), the Canadian Foundation for Innovation (M.S), the Alberta Small Equipment Grant Program (M.S.), the German Federal State Nordrhein-Westfalen (M.S.), the Max Planck Society, and the Natural Sciences and Engineering Research Council of Canada for a Banting fellowship to M.K. and a Discovery Grant to M.S.	Brown MW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1755; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chen N., 2004, CURR PROTOC BIOINFOR, V25; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferreira S, 2016, CRIT REV MICROBIOL, V42, P364, DOI 10.3109/1040841X.2014.954523; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Glass E. M., 2010, COLD SPRING HARB PRO, V5; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Mueller RS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.30; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Oberg AL, 2009, J PROTEOME RES, V8, P2144, DOI 10.1021/pr8010099; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Parks D. H., 2014, PEERJ, V3, P1; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sayavedra L, 2015, ELIFE, V4, DOI 10.7554/eLife.07966; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Smith CJ, 2007, APPL ENVIRON MICROB, V73, P3612, DOI 10.1128/AEM.02894-06; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Stairs CW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0326; Stairs CW, 2014, CURR BIOL, V24, P1176, DOI 10.1016/j.cub.2014.04.033; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu YL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-19	50	42	42	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					254	+		10.1038/nature18297	http://dx.doi.org/10.1038/nature18297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279223	Green Submitted, Green Accepted			2022-12-28	WOS:000377475100042
J	Zhou, Y; Guan, XF; Zhou, H; Ramadoss, K; Adam, S; Liu, HJ; Lee, S; Shi, J; Tsuchiya, M; Fong, DD; Ramanathan, S				Zhou, You; Guan, Xiaofei; Zhou, Hua; Ramadoss, Koushik; Adam, Suhare; Liu, Huajun; Lee, Sungsik; Shi, Jian; Tsuchiya, Masaru; Fong, Dillon D.; Ramanathan, Shriram			Strongly correlated perovskite fuel cells	NATURE			English	Article							QUANTUM MOLECULAR-DYNAMICS; PROTON CONDUCTION; TRANSPORT-PROPERTIES; TEMPERATURE; DIFFUSION; DESIGN; NICKEL; SRTIO3	Fuel cells convert chemical energy directly into electrical energy with high efficiencies and environmental benefits, as compared with traditional heat engines(1-4). Yttria-stabilized zirconia is perhaps the material with the most potential as an electrolyte in solid oxide fuel cells (SOFCs), owing to its stability and near-unity ionic transference number(5). Although there exist materials with superior ionic conductivity, they are often limited by their ability to suppress electronic leakage when exposed to the reducing environment at the fuel interface. Such electronic leakage reduces fuel cell power output and the associated chemo-mechanical stresses can also lead to catastrophic fracture of electrolyte membranes(6). Here we depart from traditional electrolyte design that relies on cation substitution to sustain ionic conduction. Instead, we use a perovskite nickelate as an electrolyte with high initial ionic and electronic conductivity. Since many such oxides are also correlated electron systems, we can suppress the electronic conduction through a filling-controlled Mott transition induced by spontaneous hydrogen incorporation. Using such a nickelate as the electrolyte in free-standing membrane geometry, we demonstrate a low-temperature micro-fabricated SOFC with high performance. The ionic conductivity of the nickelate perovskite is comparable to the best-performing solid electrolytes in the same temperature range, with a very low activation energy. The results present a design strategy for high-performance materials exhibiting emergent properties arising from strong electron correlations.	[Zhou, You; Guan, Xiaofei; Ramadoss, Koushik; Adam, Suhare; Shi, Jian; Ramanathan, Shriram] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Zhou, Hua; Lee, Sungsik] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Liu, Huajun; Fong, Dillon D.] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA; [Shi, Jian] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; [Tsuchiya, Masaru] SiEnergy Syst, Cambridge, MA 02140 USA; [Ramanathan, Shriram] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA	Harvard University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Rensselaer Polytechnic Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, Y; Ramanathan, S (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Ramanathan, S (corresponding author), Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.	youzhou@fas.harvard.edu; shriram@purdue.edu	Guan, Xiaofei/ABH-6224-2020; Zhou, You/C-9796-2011; Liu, Huajun/F-6347-2013; Zhou, You/X-9844-2019; Zhou, Hua/V-1827-2017	Zhou, You/0000-0002-9854-545X; Liu, Huajun/0000-0002-0540-6486; Zhou, You/0000-0002-9854-545X; Zhou, Hua/0000-0001-9642-8674; Lee, Sungsik/0000-0002-1425-9852; Ramadoss, Koushik/0000-0002-3974-7561	Army Research Office [W911NF-14-1-0348, W911NF-14-1-0669]; Air Force Office of Scientific Research [FA9550-12-1-0189]; Advanced Research Projects Agency-Energy (ARPA-E); IBM PhD Fellowship; National Academy of Sciences; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division	Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Advanced Research Projects Agency-Energy (ARPA-E)(United States Department of Energy (DOE)); IBM PhD Fellowship(International Business Machines (IBM)); National Academy of Sciences; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	Financial support was provided by the Army Research Office (grants W911NF-14-1-0348 and W911NF-14-1-0669), the Air Force Office of Scientific Research (grant FA9550-12-1-0189), the Advanced Research Projects Agency-Energy (ARPA-E), an IBM PhD Fellowship and the National Academy of Sciences. Part of the work was performed at the Center for Nanoscale Systems at Harvard University. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357. D.D.F. was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division.	Catalan G, 2008, PHASE TRANSIT, V81, P729, DOI 10.1080/01411590801992463; Duan CC, 2015, SCIENCE, V349, P1321, DOI 10.1126/science.aab3987; Esposito V, 2008, J AM CERAM SOC, V91, P1037, DOI 10.1111/j.1551-2916.2008.02347.x; Fabbri E, 2008, SOLID STATE IONICS, V179, P558, DOI 10.1016/j.ssi.2008.04.002; Garcia J, 1995, PHYS REV B, V52, P15823, DOI 10.1103/PhysRevB.52.15823; Goodenough JB, 2004, REP PROG PHYS, V67, P1915, DOI 10.1088/0034-4885/67/11/R01; Haile SM, 2003, ACTA MATER, V51, P5981, DOI 10.1016/j.actamat.2003.08.004; Haile SM, 2001, NATURE, V410, P910, DOI 10.1038/35073536; Ishihara T, 2000, J ELECTROCHEM SOC, V147, P1332, DOI 10.1149/1.1393358; Jaramillo R, 2014, NAT PHYS, V10, P304, DOI [10.1038/NPHYS2907, 10.1038/nphys2907]; Kerman K, 2012, J POWER SOURCES, V202, P120, DOI 10.1016/j.jpowsour.2011.11.062; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; Kreuer KD, 2000, SOLID STATE IONICS, V136, P149, DOI 10.1016/S0167-2738(00)00301-5; Liu ML, 1996, J ELECTROCHEM SOC, V143, pL109, DOI 10.1149/1.1836892; Medarde M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245105; Medarde ML, 1997, J PHYS-CONDENS MAT, V9, P1679, DOI 10.1088/0953-8984/9/8/003; Munch W, 1999, SOLID STATE IONICS, V125, P39, DOI 10.1016/S0167-2738(99)00156-3; Munch W, 1996, SOLID STATE IONICS, V86-8, P647, DOI 10.1016/0167-2738(96)00229-9; Munch W, 2000, SOLID STATE IONICS, V136, P183, DOI 10.1016/S0167-2738(00)00304-0; Natoli C. R., 1984, SPRINGER P PHYSICS, V2, P38; OGrady WE, 1996, J ELECTROCHEM SOC, V143, P1613, DOI 10.1149/1.1836687; Pergolesi D, 2010, NAT MATER, V9, P846, DOI [10.1038/nmat2837, 10.1038/NMAT2837]; Prinz FB., 2006, FUEL CELLS; Shao ZP, 2005, NATURE, V435, P795, DOI 10.1038/nature03673; Shi J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5860; Shim JH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2947584; Shklovskii B. I., 1984, ELECT PROPERTIES DOP, P202; Singhal SC, 2000, SOLID STATE IONICS, V135, P305, DOI 10.1016/S0167-2738(00)00452-5; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; TAN ZQ, 1993, PHYS REV B, V47, P12365, DOI 10.1103/PhysRevB.47.12365; Tuller HL, 2003, ELECTROCHIM ACTA, V48, P2879, DOI 10.1016/S0013-4686(03)00352-9; Wachsman ED, 2011, SCIENCE, V334, P935, DOI 10.1126/science.1204090; Wang SZ, 2008, J POWER SOURCES, V185, P917, DOI 10.1016/j.jpowsour.2008.08.039	33	276	280	45	798	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					231	+		10.1038/nature17653	http://dx.doi.org/10.1038/nature17653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279218	Green Submitted			2022-12-28	WOS:000377475100037
J	Feary, J; Pinnock, H; Cullinan, P				Feary, Johanna; Pinnock, Hilary; Cullinan, Paul			Occupational asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Feary, Johanna; Cullinan, Paul] Royal Brompton & Harefield NHS Fdn Trust, Dept Occupat & Environm Med, London SW3 6LR, England; [Pinnock, Hilary] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Asthma UK Ctr Appl Res, Edinburgh, Midlothian, Scotland; [Pinnock, Hilary] Whitstable Med Practice, Whitstable, Kent, England	Royal Brompton & Harefield NHS Foundation Trust; University of Edinburgh	Feary, J (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Dept Occupat & Environm Med, London SW3 6LR, England.	j.feary@imperial.ac.uk		Feary, Johanna/0000-0003-2903-6907; Cullinan, Paul/0000-0002-9314-6468	Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Asthma UK		[Anonymous], 2014, THORAX, V69, P1; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Boyd R, 2006, TRUE COST OCC ASTHM; CANNON J, 1995, BRIT MED J, V311, P602, DOI 10.1136/bmj.311.7005.602; Cullinan P, 2000, LANCET, V356, P1899, DOI 10.1016/S0140-6736(00)03264-5; Department for Work and Pensions, IND INJ DIS BEN; Descatha A, 2007, ALLERGY, V62, P795, DOI 10.1111/j.1398-9995.2007.01424.x; Fishwick David, 2007, Prim Care Respir J, V16, P304; Fishwick D, 2012, THORAX, V67, P278, DOI 10.1136/thoraxjnl-2011-200755; Nicholson PJ, 2010, OCCUPATIONAL ASTHMA; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; Walters GI, 2012, OCCUP MED-OXFORD, V62, P570, DOI 10.1093/occmed/kqs114	12	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i2658	10.1136/bmj.i2658	http://dx.doi.org/10.1136/bmj.i2658			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260766	Green Submitted, Green Published			2022-12-28	WOS:000377480200002
J	Thomas, MJ; Menz, HB; Mallen, CD				Thomas, Martin J.; Menz, Hylton B.; Mallen, Christian D.			Plantar heel pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FASCIITIS		[Thomas, Martin J.; Menz, Hylton B.; Mallen, Christian D.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Menz, Hylton B.] La Trobe Univ, Discipline Podiatry, Bundoora, Vic 3086, Australia; [Menz, Hylton B.] La Trobe Univ, Sch Allied Hlth, La Trobe Sport & Exercise Med Res Ctr, Bundoora, Vic 3086, Australia	Keele University; La Trobe University; La Trobe University	Thomas, MJ (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	m.thomas@keele.ac.uk	Thomas, Martin/AAQ-1365-2021; Thomas, Martin/AAU-2084-2021; Menz, Hylton/B-4508-2013	Thomas, Martin/0000-0002-4951-9925; Menz, Hylton/0000-0002-2045-3846				Argerakis NG, 2015, J AM PODIAT MED ASSN, V105, P135, DOI 10.7547/0003-0538-105.2.135; Buchbinder R, 2004, NEW ENGL J MED, V350, P2159, DOI 10.1056/NEJMcp032745; Martin RL, 2013, J ORTHOP SPORT PHYS, V43, pA1, DOI 10.2519/jospt.2013.0305; McMillan AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3260; Menz HB, 2015, GERONTOLOGY, V61, P381, DOI 10.1159/000368357; National Institute for Health and Care Excellence, PLANTAR FASCIITIS; Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872, DOI 10.2106/00004623-200305000-00015; Roddy E, 2015, RHEUMATOLOGY, V54, P39; Rogers J, 2015, BRIT J SPORT MED, DOI [10.1136/bjsports-2015-094695, DOI 10.1136/BJSP0RTS-2015-094695]; Sweeting D, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-19; WOLGIN M, 1994, FOOT ANKLE INT, V15, P97, DOI 10.1177/107110079401500303	11	5	5	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i2175	10.1136/bmj.i2175	http://dx.doi.org/10.1136/bmj.i2175			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260678	Green Accepted			2022-12-28	WOS:000377480200001
J	van't Hof, AE; Campagne, P; Rigden, DJ; Yung, CJ; Lingley, J; Quail, MA; Hall, N; Darby, AC; Saccheri, IJ				van't Hof, Arjen E.; Campagne, Pascal; Rigden, Daniel J.; Yung, Carl J.; Lingley, Jessica; Quail, Michael A.; Hall, Neil; Darby, Alistair C.; Saccheri, Ilik J.			The industrial melanism mutation in British peppered moths is a transposable element	NATURE			English	Article							EVOLUTION; GENETICS; ADAPTATION; SELECTION; APC/C	Discovering the mutational events that fuel adaptation to environmental change remains an important challenge for evolutionary biology. The classroom example of a visible evolutionary response is industrial melanism in the peppered moth (Biston betularia): the replacement, during the Industrial Revolution, of the common pale typica form by a previously unknown black (carbonaria) form, driven by the interaction between bird predation and coal pollution(1). The carbonaria locus has been coarsely localized to a 200-kilobase region, but the specific identity and nature of the sequence difference controlling the carbonaria-typica polymorphism, and the gene it influences, are unknown(2). Here we show that the mutation event giving rise to industrial melanism in Britain was the insertion of a large, tandemly repeated, transposable element into the first intron of the gene cortex. Statistical inference based on the distribution of recombined carbonaria haplotypes indicates that this transposition event occurred around 1819, consistent with the historical record. We have begun to dissect the mode of action of the carbonaria transposable element by showing that it increases the abundance of a cortex transcript, the protein product of which plays an important role in cell-cycle regulation, during early wing disc development. Our findings fill a substantial knowledge gap in the iconic example of microevolutionary change, adding a further layer of insight into the mechanism of adaptation in response to natural selection. The discovery that the mutation itself is a transposable element will stimulate further debate about the importance of 'jumping genes' as a source of major phenotypic novelty(3).	[van't Hof, Arjen E.; Campagne, Pascal; Rigden, Daniel J.; Yung, Carl J.; Lingley, Jessica; Hall, Neil; Darby, Alistair C.; Saccheri, Ilik J.] Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Quail, Michael A.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England	University of Liverpool; Wellcome Trust Sanger Institute	Saccheri, IJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	saccheri@liverpool.ac.uk	Darby, Alistair/I-6485-2012; Quail, michael/ABE-6131-2020; Van 't Hof, Arjen/AAE-8044-2022	Darby, Alistair/0000-0002-3786-6209; Hall, Neil/0000-0003-2808-0009; Rigden, Daniel/0000-0002-7565-8937	Natural Environment Research Council [NE/H024352/1, NE/J022993/1]; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; NERC [NE/J022993/1, NBAF010002, NE/H024352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish; Natural Environment Research Council [NBAF010002] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The University of Liverpool Centre for Genomic Research (M. Hughes, C. Bourne, R. Eccles, C. Hertz-Fowler and J. Kenny) performed next-generation sequencing and Fragment Analyzer measurements. L. Cook directed us to historical data sources. C. Bergman advised on transposon detection. Population genetics simulations were performed on the University of Liverpool Advanced Research Computing Condor service. This work was supported by Natural Environment Research Council grants NE/H024352/1 and NE/J022993/1.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; Brookfield JFY, 2004, CURR BIOL, V14, pR344, DOI 10.1016/j.cub.2004.04.021; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; CLARKE C A, 1979, Journal of the Lepidopterists' Society, V33, P60; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Cook LM, 2005, J HERED, V96, P522, DOI 10.1093/jhered/esi082; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Gonzalez J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000905; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Ito K, 2016, HEREDITY, V116, P52, DOI 10.1038/hdy.2015.69; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Koga A, 2006, MOL BIOL EVOL, V23, P1414, DOI 10.1093/molbev/msl003; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; LEES DR, 1977, HEREDITY, V39, P67, DOI 10.1038/hdy.1977.42; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Reed RD, 2008, P R SOC B, V275, P37, DOI 10.1098/rspb.2007.1115; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Whitfield ZJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001648	39	213	216	20	390	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					102	+		10.1038/nature17951	http://dx.doi.org/10.1038/nature17951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251284				2022-12-28	WOS:000376962300042
J	Zarate, C; Flint, J; Ehlers, MD; Sklar, P; Borenstein, J; Hyman, SE; Feng, GP				Zarate, Carlos; Flint, Jonathan; Ehlers, Michael D.; Sklar, Pamela; Borenstein, Jeffrey; Hyman, Steven E.; Feng, Guoping			Developing Effective Treatments for Psychiatric Diseases	CELL			English	Editorial Material									[Zarate, Carlos] NIMH, Hyderabad, Secunderabad, India; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Ehlers, Michael D.] Biogen, Cambridge, MA USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Borenstein, Jeffrey] Brain & Behav Res Fdn, London, England; [Hyman, Steven E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Feng, Guoping] MIT, McGovern Inst, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; Biogen; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Zarate, C (corresponding author), NIMH, Hyderabad, Secunderabad, India.		Feng, Guoping/Y-2827-2019; Zarate, Carlos/ABD-6843-2021; Borenstein, Jeffrey/K-5459-2019	Borenstein, Jeffrey/0000-0002-4482-3274					0	0	0	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1307	1309						3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259140	Bronze			2022-12-28	WOS:000377045400002
J	Li, ZF; Alyamani, M; Li, JN; Rogacki, K; Abazeed, M; Upadhyay, SK; Balk, SP; Taplin, ME; Auchus, RJ; Sharifi, N				Li, Zhenfei; Alyamani, Mohammad; Li, Jianneng; Rogacki, Kevin; Abazeed, Mohamed; Upadhyay, Sunil K.; Balk, Steven P.; Taplin, Mary-Ellen; Auchus, Richard J.; Sharifi, Nima			Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy	NATURE			English	Article							ANDROGEN-RECEPTOR; STEROID 5-ALPHA-REDUCTASE; CYP17A1 INHIBITION; DIHYDROTESTOSTERONE; DEHYDROGENASE; ACTIVATION; RESISTANCE; BIOLOGY; RAT; MEN	Abiraterone blocks androgen synthesis and prolongs survival in patients with castration-resistant prostate cancer, which is otherwise driven by intratumoral androgen synthesis(1,2). Abiraterone is metabolized in patients to Delta(4)-abiraterone (D4A), which has even greater anti-tumour activity and is structurally similar to endogenous steroidal 5 alpha-reductase substrates, such as testosterone(3). Here, we show that D4A is converted to at least three 5 alpha-reduced and three 5 beta-reduced metabolites in human serum. The initial 5 alpha-reduced metabolite, 3-keto-5 alpha-abiraterone, is present at higher concentrations than D4A in patients with prostate cancer taking abiraterone, and is an androgen receptor agonist, which promotes prostate cancer progression. In a clinical trial of abiraterone alone, followed by abiraterone plus dutasteride (a 5 alpha-reductase inhibitor), 3-keto-5 alpha-abiraterone and downstream metabolites were depleted by the addition of dutasteride, while D4A concentrations rose, showing that dutasteride effectively blocks production of a tumour-promoting metabolite and permits D4A accumulation. Furthermore, dutasteride did not deplete the three 5 beta-reduced metabolites, which were also clinically detectable, demonstrating the specific biochemical effects of pharmacological 5 alpha-reductase inhibition on abiraterone metabolism. Our findings suggest a previously unappreciated and biochemically specific method of clinically fine-tuning abiraterone metabolism to optimize therapy.	[Li, Zhenfei; Alyamani, Mohammad; Li, Jianneng; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Rogacki, Kevin; Abazeed, Mohamed] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44195 USA; [Upadhyay, Sunil K.; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Pharmacol, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA; [Upadhyay, Sunil K.; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA; [Balk, Steven P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Taplin, Mary-Ellen] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Sharifi, Nima] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44195 USA; [Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sharifi, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA.	sharifn@ccf.org	Li, Zhenfei/AAU-1097-2020; Abazeed, Mohamed/AAN-2376-2020; Alyamani, Mohammad/S-5905-2017	Li, Zhenfei/0000-0001-6520-431X; Abazeed, Mohamed/0000-0002-6614-4440; Alyamani, Mohammad/0000-0002-7127-0820	Howard Hughes Medical Institute; Prostate Cancer Foundation; American Cancer Society [12-038-01-CCE]; National Cancer Institute [R01CA168899, R01CA172382, R01CA190289, P01 CA163227, P50 CA090381]; US Army Medical Research and Materiel Command [PC121382]; NATIONAL CANCER INSTITUTE [P50CA090381, R01CA190289, R01CA168899, P01CA163227, R01CA172382] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Prostate Cancer Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Penning for use of the AKR1C2 construct and D. Russell for LY191704. This work was supported in part by funding from a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to N.S.), a Prostate Cancer Foundation Challenge Award (to N.S.), an American Cancer Society Research Scholar Award (12-038-01-CCE; to N.S.), grants from the National Cancer Institute (R01CA168899, R01CA172382, and R01CA190289; to N.S.), a grant from the US Army Medical Research and Materiel Command (PC121382 to Z.L.), a Prostate Cancer Foundation Young Investigator Award (to Z.L.), grants from the National Cancer Institute (P01 CA163227 and P50 CA090381), and a Prostate Cancer Foundation Challenge Award (to S.P.B.). Janssen provided clinical trial support (to M.-E.T.).	Alyamani, 2016, J STEROID BIOCH MOL; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BYRNE GC, 1986, J CLIN ENDOCR METAB, V62, P413, DOI 10.1210/jcem-62-2-413; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; HIRSCH KS, 1993, P NATL ACAD SCI USA, V90, P5277, DOI 10.1073/pnas.90.11.5277; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Li ZF, 2015, NATURE, V523, P347, DOI 10.1038/nature14406; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Papari-Zareei M, 2006, ENDOCRINOLOGY, V147, P1591, DOI 10.1210/en.2005-1141; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sharifi N, 2013, ENDOCRINOLOGY, V154, P4010, DOI 10.1210/en.2013-1466; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taplin ME, 2014, J CLIN ONCOL, V32, P3705, DOI 10.1200/JCO.2013.53.4578	31	109	112	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					547	+		10.1038/nature17954	http://dx.doi.org/10.1038/nature17954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225130	Green Submitted, Green Accepted			2022-12-28	WOS:000376443100044
J	Wang, T; Liang, L; Xue, Y; Jia, PF; Chen, W; Zhang, MX; Wang, YC; Li, HJ; Yang, WC				Wang, Tong; Liang, Liang; Xue, Yong; Jia, Peng-Fei; Chen, Wei; Zhang, Meng-Xia; Wang, Ying-Chun; Li, Hong-Ju; Yang, Wei-Cai			A receptor heteromer mediates the male perception of female attractants in plants (vol 531, pg 241, 2016)	NATURE			English	Correction													Yang, Wei-Cai/AAX-7879-2021	Yang, Wei-Cai/0000-0003-0252-7079				TONG W, 2016, NATURE, V531, P241, DOI DOI 10.1038/NATURE16975	1	4	5	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					360	360		10.1038/nature17985	http://dx.doi.org/10.1038/nature17985			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27281212	Bronze			2022-12-28	WOS:000381804900042
J	Lin, JS; Piper, MA; Perdue, LA; Rutter, CM; Webber, EM; O'Connor, E; Smith, N; Whitlock, EP				Lin, Jennifer S.; Piper, Margaret A.; Perdue, Leslie A.; Rutter, Carolyn M.; Webber, Elizabeth M.; O'Connor, Elizabeth; Smith, Ning; Whitlock, Evelyn P.			Screening for Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; COMPUTED-TOMOGRAPHY COLONOGRAPHY; AVERAGE-RISK POPULATION; ONCE-ONLY SIGMOIDOSCOPY; BASE-LINE FINDINGS; CT COLONOGRAPHY; FLEXIBLE SIGMOIDOSCOPY; EXTRACOLONIC FINDINGS; ASYMPTOMATIC ADULTS	IMPORTANCE Colorectal cancer (CRC) remains a significant cause of morbidity and mortality in the United States. OBJECTIVE To systematically review the effectiveness, diagnostic accuracy, and harms of screening for CRC. DATA SOURCES Searches of MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant studies published from January 1, 2008, through December 31, 2014, with surveillance through February 23, 2016. STUDY SELECTION English-language studies conducted in asymptomatic populations at general risk of CRC. DATA EXTRACTION AND SYNTHESIS Two reviewers independently appraised the articles and extracted relevant study data from fair-or good-quality studies. Random-effects meta-analyses were conducted. MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting CRC or adenomas, and serious adverse events. RESULTS Four pragmatic randomized clinical trials (RCTs) evaluating 1-time or 2-time flexible sigmoidoscopy (n = 458002) were associated with decreased CRC-specific mortality compared with no screening (incidence rate ratio, 0.73; 95% CI, 0.66-0.82). Five RCTs with multiple rounds of biennial screening with guaiac-based fecal occult blood testing (n = 419 966) showed reduced CRC-specific mortality (relative risk [RR], 0.91; 95% CI, 0.84-0.98, at 19.5 years to RR, 0.78; 95% CI, 0.65-0.93, at 30 years). Seven studies of computed tomographic colonography (CTC) with bowel preparation demonstrated per-person sensitivity and specificity to detect adenomas 6mm and larger comparable with colonoscopy (sensitivity from 73%[95% CI, 58%-84%] to 98%[95% CI, 91%-100%]; specificity from 89%[95% CI, 84%-93%] to 91%[95% CI, 88%-93%]); variability and imprecision may be due to differences in study designs or CTC protocols. Sensitivity of colonoscopy to detect adenomas 6mmor larger ranged from 75%(95% CI, 63%-84%) to 93%(95% CI, 88%-96%). On the basis of a single stool specimen, the most commonly evaluated families of fecal immunochemical tests (FITs) demonstrated good sensitivity (range, 73%-88%) and specificity (range, 90%-96%). One study (n = 9989) found that FIT plus stool DNA test had better sensitivity in detecting CRC than FIT alone (92%) but lower specificity (84%). Serious adverse events from colonoscopy in asymptomatic persons included perforations (4/10000 procedures, 95% CI, 2-5 in 10000) and major bleeds (8/10000 procedures, 95% CI, 5-14 in 10 000). Computed tomographic colonographymay have harms resulting from low-dose ionizing radiation exposure or identification of extracolonic findings. CONCLUSIONS AND RELEVANCE Colonoscopy, flexible sigmoidoscopy, CTC, and stool tests have differing levels of evidence to support their use, ability to detect cancer and precursor lesions, and risk of serious adverse events in average-risk adults. Although CRC screening has a large body of supporting evidence, additional research is still needed.	[Lin, Jennifer S.; Piper, Margaret A.; Perdue, Leslie A.; Webber, Elizabeth M.; O'Connor, Elizabeth; Smith, Ning; Whitlock, Evelyn P.] Kaiser Permanente, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA; [Rutter, Carolyn M.] Grp Hlth Res Inst, Seattle, WA USA; [Rutter, Carolyn M.] RAND Corp, Santa Monica, CA USA	Kaiser Permanente; RAND Corporation	Lin, JS (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org	Rutter, Carolyn/AAZ-3677-2021		Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	Adeyemo A, 2014, DIS COLON RECTUM, V57, P110, DOI 10.1097/DCR.0000000000000002; Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Alvarez C, 2013, GASTROINTEST ENDOSC, V78, P333, DOI 10.1016/j.gie.2013.03.003; American Cancer Society, CANC FACTS FIG 2013; An S, 2008, AM J ROENTGENOL, V191, pW100, DOI 10.2214/AJR.07.3367; [Anonymous], COL SUMM SAF EFF DAT; [Anonymous], COL VERS FEC IMM TES; Arora G, 2009, GASTROINTEST ENDOSC, V69, P654, DOI 10.1016/j.gie.2008.09.008; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Bair D, 2009, CAN J GASTROENTEROL, V23, P41, DOI 10.1155/2009/831029; Berhane C, 2009, AM SURGEON, V75, P699; Berry DP, 1997, BRIT J SURG, V84, P1274; Bielawska B, 2014, CLIN GASTROENTEROL H, V12, P85, DOI 10.1016/j.cgh.2013.06.030; Blotiere PO, 2014, CLIN RES HEPATOL GAS, V38, P112, DOI 10.1016/j.clinre.2013.10.005; Bokemeyer B, 2009, EUR J GASTROEN HEPAT, V21, P650, DOI 10.1097/MEG.0b013e32830b8acf; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Brenner H, 2010, AM J GASTROENTEROL, V105, P2457, DOI 10.1038/ajg.2010.301; Brenner H, 2010, INT J CANCER, V127, P1643, DOI 10.1002/ijc.25154; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; Brevinge H, 1997, INT J COLORECTAL DIS, V12, P291, DOI 10.1007/s003840050108; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Cash BD, 2012, AM J ROENTGENOL, V199, pW27, DOI 10.2214/AJR.11.7729; Castells A, 2015, DIGEST DIS SCI, V60, P672, DOI 10.1007/s10620-014-3446-2; Castiglione G, 2007, BRIT J CANCER, V96, P1750, DOI 10.1038/sj.bjc.6603759; Castro G, 2013, CANCER-AM CANCER SOC, V119, P2849, DOI 10.1002/cncr.28159; Chen LS, 2011, LANCET ONCOL, V12, P551, DOI 10.1016/S1470-2045(11)70101-2; Cheng TI, 2002, J FORMOS MED ASSOC, V101, P685; Chiang TH, 2014, GASTROENTEROLOGY, V147, P1317, DOI 10.1053/j.gastro.2014.08.043; Chin M, 2005, AM J GASTROENTEROL, V100, P2771, DOI 10.1111/j.1572-0241.2005.00337.x; Chiu HM, 2013, CLIN GASTROENTEROL H, V11, P832, DOI 10.1016/j.cgh.2013.01.013; Chukmaitov A, 2013, GASTROINTEST ENDOSC, V77, P436, DOI 10.1016/j.gie.2012.11.012; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Cooper GS, 2013, JAMA INTERN MED, V173, P551, DOI 10.1001/jamainternmed.2013.2908; Cotterill M, 2005, CAN FAM PHYSICIAN, V51, P1224; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; Dancourt V, 2008, EUR J CANCER, V44, P2254, DOI 10.1016/j.ejca.2008.06.041; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; de Wijkerslooth TR, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-47; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; Denters MJ, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-28; Dominitz JA, 2013, GASTROENTEROLOGY, V144, P298, DOI 10.1053/j.gastro.2012.10.038; Durbin JM, 2012, CLIN NEPHROL, V77, P204, DOI 10.5414/CN107242; Edwards JT, 2004, RADIOLOGY, V230, P459, DOI 10.1148/radiol.2302021422; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Faivre J, 2012, EUR J CANCER, V48, P2969, DOI 10.1016/j.ejca.2012.04.007; Faivre J, 2012, DIGEST LIVER DIS, V44, P700, DOI 10.1016/j.dld.2012.03.015; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Fletcher JG, 2013, AM J ROENTGENOL, V201, P787, DOI 10.2214/AJR.12.9225; Flicker MS, 2008, J COMPUT ASSIST TOMO, V32, P497, DOI 10.1097/RCT.0b013e3181692091; Forbes GM, 2006, MED J AUSTRALIA, V184, P546, DOI 10.5694/j.1326-5377.2006.tb00377.x; Gluecker TM, 2003, GASTROENTEROLOGY, V124, P911, DOI 10.1053/gast.2003.50158; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Grazzini G, 2004, EUR J CANCER PREV, V13, P19, DOI 10.1097/00008469-200402000-00004; Guittet L, 2009, BRIT J CANCER, V100, P1230, DOI 10.1038/sj.bjc.6604996; Guittet L, 2012, DIGEST LIVER DIS, V44, P694, DOI 10.1016/j.dld.2012.03.005; Guittet L, 2009, INT J CANCER, V125, P1127, DOI 10.1002/ijc.24407; Guolo A, PACKAGE METALIK; Hamdani U, 2013, WORLD J GASTROENTERO, V19, P3596, DOI 10.3748/wjg.v19.i23.3596; Hamza S, 2013, EUR J CANCER, V49, P2727, DOI 10.1016/j.ejca.2013.03.023; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Haug U, 2007, CLIN CHEM, V53, P787, DOI 10.1373/clinchem.2006.078188; Hernandez V, 2014, WORLD J GASTROENTERO, V20, P1038, DOI 10.3748/wjg.v20.i4.1038; Ho JM, 2012, CAN J GASTROENTEROL, V26, P436, DOI 10.1155/2012/238387; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; Hoff G, 2001, EUR J CANCER PREV, V10, P131, DOI 10.1097/00008469-200104000-00003; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Hsieh Teng-Kuei, 2009, Acta Anaesthesiol Taiwan, V47, P162, DOI 10.1016/S1875-4597(09)60049-7; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Iafrate F, 2013, DIGEST LIVER DIS, V45, P645, DOI 10.1016/j.dld.2013.02.020; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Itoh M, 1996, J Med Screen, V3, P66; Jain Ankur, 2002, Hawaii Med J, V61, P118; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Johnson CD, 2007, AM J ROENTGENOL, V189, P672, DOI 10.2214/AJR.07.2354; Johnson CD, 2012, RADIOLOGY, V263, P401, DOI 10.1148/radiol.12102177; Kamath AS, 2009, J GASTROINTEST SURG, V13, P2136, DOI 10.1007/s11605-009-1064-7; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Kang HY, 2008, DIGESTION, V78, P218, DOI 10.1159/000190811; Kao KT, 2009, ENDOSCOPY, V41, pE100, DOI 10.1055/s-0028-1119622; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Kim DH, 2010, RADIOLOGY, V254, P493, DOI 10.1148/radiol.09091478; Kim JS, 2013, SURG ENDOSC, V27, P501, DOI 10.1007/s00464-012-2465-3; Kim YS, 2008, J CLIN GASTROENTEROL, V42, P791, DOI 10.1097/MCG.0b013e31811edcb7; Kim YS, 2008, J GASTROEN HEPATOL, V23, pE49, DOI 10.1111/j.1440-1746.2007.05060.x; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Ko CW, 2007, GASTROINTEST ENDOSC, V65, P648, DOI 10.1016/j.gie.2006.06.020; Ko CW, 2010, CLIN GASTROENTEROL H, V8, P166, DOI 10.1016/j.cgh.2009.10.007; Korman LY, 2003, GASTROINTEST ENDOSC, V58, P554, DOI 10.1067/S0016-5107(03)01890-X; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Layton JB, 2014, CLIN GASTROENTEROL H, V12, P1514, DOI 10.1016/j.cgh.2014.01.034; Lee YH, 2015, CLIN CHEM LAB MED, V53, pE69, DOI 10.1515/cclm-2014-0442; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Lefere P, 2013, EUR J RADIOL, V82, pE262, DOI 10.1016/j.ejrad.2013.02.010; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Levy BT, 2014, J MED SCREEN, V21, P133, DOI 10.1177/0969141314541109; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lin JS., 2016, AHRQ PUBLICATION, V14-05203-EF-1; Lin JS, 2012, AHRQ PUBLICATION, V12-EHC022-EF; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Loffeld RJLF, 2011, ENDOSCOPY, V43, P240, DOI 10.1055/s-0030-1255939; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Lorenzo-Zuniga V, 2010, COLORECTAL DIS, V12, pE273, DOI 10.1111/j.1463-1318.2009.02146.x; Macari M, 2004, RADIOLOGY, V230, P629, DOI 10.1148/radiol.2303021624; Macari M, 2011, RADIOLOGY, V259, P767, DOI 10.1148/radiol.11102144; Malila N, 2011, J MED SCREEN, V18, P18, DOI 10.1258/jms.2010.010036; Malila N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2261; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansmann U, 2008, DTSCH ARZTEBL INT, V105, P434, DOI 10.3238/arztebl.2008.0434; Miles A, 2003, CANCER EPIDEM BIOMAR, V12, P651; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morikawa T, 2007, AM J GASTROENTEROL, V102, P2259, DOI 10.1111/j.1572-0241.2007.01404.x; Nakama H, 1996, J Med Screen, V3, P63; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; National Institute for Health and Clinical Excellence, 2006, GUID MAN; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; O'Connor SD, 2011, AM J ROENTGENOL, V197, P139, DOI 10.2214/AJR.10.5920; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Parra-Blanco A, 2006, WORLD J GASTROENTERO, V12, P6161, DOI 10.3748/wjg.v12.i38.6161; Pedersen BG, 2003, GUT, V52, P1744; Pickhardt PJ, 2008, RADIOLOGY, V249, P151, DOI 10.1148/radiol.2491072148; Pickhardt PJ, 2007, DIS COLON RECTUM, V50, P56, DOI 10.1007/s10350-006-0806-9; Pickhardt PJ, 2011, AM J ROENTGENOL, V196, pW400, DOI 10.2214/AJR.10.5392; Pickhardt PJ, 2010, ACAD RADIOL, V17, P784, DOI 10.1016/j.acra.2010.01.010; Pickhardt PJ, 2010, RADIOLOGY, V255, P83, DOI 10.1148/radiol.09090939; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pooler BD, 2016, AM J ROENTGENOL, V206, P313, DOI 10.2214/AJR.15.15193; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Quallick MR, 2009, GASTROINTEST ENDOSC, V69, P960, DOI 10.1016/j.gie.2008.11.011; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rasmussen M, 1999, SCAND J GASTROENTERO, V34, P73; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Redwood DG, 2016, MAYO CLIN PROC, V91, P61, DOI 10.1016/j.mayocp.2015.10.008; Regula J, 2008, NEW ENGL J MED, V358, P88; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2012, CANCER CAUSE CONTROL, V23, P289, DOI 10.1007/s10552-011-9878-5; Sagawa T, 2012, WORLD J GASTROENTERO, V18, P4898, DOI 10.3748/wjg.v18.i35.4898; Sali L, 2015, JNCI-J NATL CANCER I, V108, P108; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; Segnan N, 2002, J NATL CANCER I, V94, P1763; Segnan N, 2005, JNCI-J NATL CANCER I, V97, P347, DOI 10.1093/jnci/dji050; Segnan N, 2007, GASTROENTEROLOGY, V132, P2304, DOI 10.1053/j.gastro.2007.03.030; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Senore C, 2011, J MED SCREEN, V18, P128, DOI 10.1258/jms.2011.010135; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sieg A, 2001, GASTROINTEST ENDOSC, V53, P620, DOI 10.1067/mge.2001.114422; Singh H, 2009, GASTROINTEST ENDOSC, V69, P665, DOI 10.1016/j.gie.2008.09.046; Sohn Dae Kyung, 2005, Cancer Res Treat, V37, P20, DOI 10.4143/crt.2005.37.1.20; Sosna J, 2006, RADIOLOGY, V239, P457, DOI 10.1148/radiol.2392050287; Stock C, 2013, GASTROINTEST ENDOSC, V77, P419, DOI 10.1016/j.gie.2012.10.028; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Suissa A, 2012, DIAGN THER ENDOSC, V2012; Tam Michael S, 2013, Perm J, V17, P17, DOI 10.7812/TPP/12-095; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; THOMAS W, 1995, AM J EPIDEMIOL, V142, P176, DOI 10.1093/oxfordjournals.aje.a117616; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; van Dam L, 2013, ENDOSCOPY, V45, P182, DOI 10.1055/s-0032-1326080; van Roon AHC, 2013, GUT, V62, P409, DOI 10.1136/gutjnl-2011-301583; van Roon AHC, 2011, CLIN GASTROENTEROL H, V9, P333, DOI 10.1016/j.cgh.2010.12.012; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Veerappan GR, 2010, AM J ROENTGENOL, V195, P677, DOI 10.2214/AJR.09.3779; Verne JECW, 1998, BRIT MED J, V317, P182, DOI 10.1136/bmj.317.7152.182; Viiala CH, 2007, MED J AUSTRALIA, V187, P274, DOI 10.5694/j.1326-5377.2007.tb01241.x; Wallace MB, 1999, AM J MED, V107, P214, DOI 10.1016/S0002-9343(99)00225-9; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; Wells G., NEWCASTLE OTTAWA SCA; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Whitlock EP, 2008, SCREENING COLORECTAL; Xirasagar S, 2010, MED CARE, V48, P703, DOI 10.1097/MLR.0b013e3181e358a3; Zafar Hanna M, 2014, Prev Med Rep, V1, P3; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926; Zalis ME, 2012, ANN INTERN MED, V156, P692, DOI 10.7326/0003-4819-156-10-201205150-00005; Zubero MB, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00175	208	445	452	2	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2576	2594		10.1001/jama.2016.3332	http://dx.doi.org/10.1001/jama.2016.3332			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27305422	Bronze			2022-12-28	WOS:000378306700021
J	Yokota, Y; Ishikawa, T; Watanabe, S; Tashiro, T; Asada, A				Yokota, Yusuke; Ishikawa, Tadashi; Watanabe, Shun-ichi; Tashiro, Toshiharu; Asada, Akira			Seafloor geodetic constraints on interplate coupling of the Nankai Trough megathrust zone	NATURE			English	Article							TOHOKU-OKI EARTHQUAKE; SUBDUCTION ZONE; CRUSTAL DEFORMATION; SOUTHWEST JAPAN; SLIP; GPS; GEOMETRY; RUPTURE; LOCKING; KYUSHU	Interplate megathrust earthquakes have inflicted catastrophic damage on human society. Such an earthquake is predicted to occur in the near future along the Nankai Trough off southwestern Japan-an economically active and densely populated area in which megathrust earthquakes have already occurred(1-5). Megathrust earthquakes are the result of a plate-subduction mechanism and occur at slip-deficit regions (also known as 'coupling' regions)(6,7), where friction prevents plates from slipping against each other and the accumulated energy is eventually released forcefully. Many studies have attempted to capture distributions of slip-deficit rates (SDRs) in order to predict earthquakes(8-10). However, these studies could not obtain a complete view of the earthquake source region, because they had no seafloor geodetic data. The Hydrographic and Oceanographic Department of the Japan Coast Guard (JHOD) has been developing a precise and sustainable seafloor geodetic observation network(11) in this subduction zone to obtain information related to offshore SDRs. Here, we present seafloor geodetic observation data and an offshore interplate SDR-distribution model. Our data suggest that most offshore regions in this subduction zone have positive SDRs. Specifically, our observations indicate previously unknown regions of high SDR that will be important for tsunami disaster mitigation, and regions of low SDR that are consistent with distributions of shallow slow earthquakes and subducting seamounts. This is the first direct evidence that coupling conditions might be related to these seismological and geological phenomena. Our findings provide information for inferring megathrust earthquake scenarios and interpreting research on the Nankai Trough subduction zone.	[Yokota, Yusuke; Ishikawa, Tadashi; Watanabe, Shun-ichi; Tashiro, Toshiharu] Japan Coast Guard, Hydrog & Oceanog Dept, Chiyoda Ku, 3-1-1 Kasumigaseki, Tokyo 1008932, Japan; [Asada, Akira] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan	University of Tokyo	Yokota, Y (corresponding author), Japan Coast Guard, Hydrog & Oceanog Dept, Chiyoda Ku, 3-1-1 Kasumigaseki, Tokyo 1008932, Japan.	eisei@jodc.go.jp	Ishikawa, Tadashi/AAX-4085-2021; Yokota, Yusuke/AAT-6422-2021	Ishikawa, Tadashi/0000-0001-6385-7915; Yokota, Yusuke/0000-0003-2969-9110; Watanabe, Shun-ichi/0000-0002-9276-6112				Akaike H, 1980, BAYESIAN STAT, P143, DOI DOI 10.1007/BF02888350; Altamimi Z., 2007, GEOPHYS J INT, V112; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Asada A, 2001, P JPN ACAD B-PHYS, V77, P7, DOI 10.2183/pjab.77.7; Asano Y, 2008, EARTH PLANETS SPACE, V60, P871, DOI 10.1186/BF03352839; Baba T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022320; Chlieh M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004981; Colombo O.L., 1998, GPS GEODESY, V2nd Edn, P537; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Fujita M, 2006, EARTH PLANETS SPACE, V58, P265, DOI 10.1186/BF03351923; Gagnon K, 2005, NATURE, V434, P205, DOI 10.1038/nature03412; Hashimoto C, 2004, PURE APPL GEOPHYS, V161, P2053, DOI 10.1007/s00024-004-2548-8; Hirose H, 2010, SCIENCE, V330, P1502, DOI 10.1126/science.1197102; Hok S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008492; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Ito T, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2002JB002358; Kanamori H., 1972, Physics of the Earth and Planetary Interiors, V5, P129, DOI 10.1016/0031-9201(72)90082-9; Kido M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050057; Kodaira S, 2000, SCIENCE, V289, P104, DOI 10.1126/science.289.5476.104; Loveless JP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006248; Matsumoto Y., 2008, REP HYDROGR OCEANOGR, V26, P16; Moore GF, 2007, SCIENCE, V318, P1128, DOI 10.1126/science.1147195; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; National Research Institute for Earth Science and Disaster Prevention, 2015, REPORT COORDINATING, V94, P5; Ozawa S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009120; Park JO, 2004, EARTH PLANET SC LETT, V217, P77, DOI 10.1016/S0012-821X(03)00553-3; Park JO, 2002, SCIENCE, V297, P1157, DOI 10.1126/science.1074111; Perfettini H, 2010, NATURE, V465, P78, DOI 10.1038/nature09062; Sagiya T, 1999, J GEOPHYS RES-SOL EA, V104, P1111, DOI 10.1029/98JB02644; Sagiya T, 2000, PURE APPL GEOPHYS, V157, P2303; Sato M, 2013, J GEODESY, V87, P825, DOI 10.1007/s00190-013-0649-9; Sato M, 2013, J GEOPHYS RES-SOL EA, V118, P3860, DOI 10.1002/jgrb.50275; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Spiess FN, 1998, PHYS EARTH PLANET IN, V108, P101, DOI 10.1016/S0031-9201(98)00089-2; SPIESS FN, 1985, IEEE T GEOSCI REMOTE, V23, P502, DOI 10.1109/TGRS.1985.289441; Sun THZ, 2015, J GEOPHYS RES-SOL EA, V120, P1329, DOI 10.1002/2014JB011707; Sun T, 2014, NATURE, V514, P84, DOI 10.1038/nature13778; Tadokoro K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051696; Wang KL, 2012, NATURE, V484, P327, DOI 10.1038/nature11032; Watanabe S, 2014, GEOPHYS RES LETT, V41, P5789, DOI 10.1002/2014GL061134; YABUKI T, 1992, GEOPHYS J INT, V109, P363, DOI 10.1111/j.1365-246X.1992.tb00102.x; Yamamoto Y, 2013, TECTONOPHYSICS, V589, P90, DOI 10.1016/j.tecto.2012.12.028; Yamashita Y, 2015, SCIENCE, V348, P676, DOI 10.1126/science.aaa4242; Yokota Y, 2015, PROG EARTH PLANET SC, V2, DOI 10.1186/s40645-015-0040-y; Yoshioka S, 2013, TECTONOPHYSICS, V600, P165, DOI 10.1016/j.tecto.2013.01.023	45	158	162	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					374	+		10.1038/nature17632	http://dx.doi.org/10.1038/nature17632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281197	Green Submitted			2022-12-28	WOS:000377856800033
J	Attar, S				Attar, Samer			The Hell of Syria's Field Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Attar, Samer] Syrian Amer Med Soc, Canfield, OH 44406 USA; [Attar, Samer] Aleppo City Med Council, Aleppo, Syria; [Attar, Samer] Northwestern Univ, Dept Orthoped Surg, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Attar, S (corresponding author), Syrian Amer Med Soc, Canfield, OH 44406 USA.; Attar, S (corresponding author), Aleppo City Med Council, Aleppo, Syria.; Attar, S (corresponding author), Northwestern Univ, Dept Orthoped Surg, Feinberg Sch Med, Chicago, IL 60611 USA.								0	7	7	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2205	2207		10.1056/NEJMp1603673	http://dx.doi.org/10.1056/NEJMp1603673			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276560				2022-12-28	WOS:000377920500004
J	Hu, QY; Kim, DY; Yang, WG; Yang, LX; Meng, Y; Zhang, L; Mao, HK				Hu, Qingyang; Kim, Duck Young; Yang, Wenge; Yang, Liuxiang; Meng, Yue; Zhang, Li; Mao, Ho-Kwang			FeO2 and FeOOH under deep lower-mantle conditions and Earth's oxygen-hydrogen cycles	NATURE			English	Article							GENERALIZED GRADIENT APPROXIMATION; RAMAN-SPECTROSCOPY; HIGH-PRESSURES; (MG,FE)SIO3 PEROVSKITE; STABILITY; FE2O3; COMPLEXITY; STATE; CRUST; H-2	The distribution, accumulation and circulation of oxygen and hydrogen in Earth's interior dictate the geochemical evolution of the hydrosphere, atmosphere and biosphere(1). The oxygen-rich atmosphere and iron-rich core represent two end-members of the oxygen-iron (O-Fe) system, overlapping with the entire pressure-temperature-composition range of the planet. The extreme pressure and temperature conditions of the deep interior alter the oxidation states(1), spin states(2) and phase stabilities(3,4) of iron oxides, creating new stoichiometries, such as Fe4O5 (ref. 5) and Fe5O6 (ref. 6). Such interactions between O and Fe dictate Earth's formation, the separation of the core and mantle, and the evolution of the atmosphere. Iron, in its multiple oxidation states, controls the oxygen fugacity and oxygen budget, with hydrogen having a key role in the reaction of Fe and O (causing iron to rust in humid air). Here we use first-principles calculations and experiments to identify a highly stable, pyrite-structured iron oxide (FeO2) at 76 gigapascals and 1,800 kelvin that holds an excessive amount of oxygen. We show that the mineral goethite, FeOOH, which exists ubiquitously as 'rust' and is concentrated in bog iron ore, decomposes under the deep lower-mantle conditions to form FeO2 and release H-2. The reaction could cause accumulation of the heavy FeO2-bearing patches in the deep lower mantle, upward migration of hydrogen, and separation of the oxygen and hydrogen cycles. This process provides an alternative interpretation for the origin of seismic and geochemical anomalies in the deep lower mantle, as well as a sporadic O-2 source for the Great Oxidation Event over two billion years ago that created the present oxygen-rich atmosphere.	[Hu, Qingyang; Kim, Duck Young; Yang, Wenge; Yang, Liuxiang; Zhang, Li; Mao, Ho-Kwang] Ctr High Pressure Sci & Technol Adv Res HPSTAR, Shanghai 201203, Peoples R China; [Hu, Qingyang; Kim, Duck Young; Zhang, Li; Mao, Ho-Kwang] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Yang, Wenge; Yang, Liuxiang] Carnegie Inst, Geophys Lab, High Pressure Synerget Consortium HPSynC, Argonne, IL 60439 USA; [Meng, Yue] Carnegie Inst, Geophys Lab, High Pressure Collaborat Access Team HPCAT, Argonne, IL 60439 USA	Carnegie Institution for Science; Carnegie Institution for Science; Carnegie Institution for Science	Mao, HK (corresponding author), Ctr High Pressure Sci & Technol Adv Res HPSTAR, Shanghai 201203, Peoples R China.; Mao, HK (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	hmao@gl.ciw.edu	Zhang, Li/K-1633-2017; Zhang, Li/I-4658-2013; Kim, Duck Young/K-8387-2013; Hu, Qingyang/AAD-3320-2020	Kim, Duck Young/0000-0002-0765-6374; Hu, Qingyang/0000-0002-2742-3017	DOE-NNSA [DE-NA0001974]; DOE-BES [DE-FG02-99ER45775, DE-AC02-06CH11357]; NSF; COMPRES through the Partnership for Extreme Crystallography (PX2) project under NSF [EAR 11-57758]; NSF [EAR-1345112, EAR-1447438]; Foundation of President of China Academy of Engineering Physics [201402032]; National Natural Science Foundation of China [41574080, U1530402]	DOE-NNSA(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); DOE-BES(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); COMPRES through the Partnership for Extreme Crystallography (PX2) project under NSF; NSF(National Science Foundation (NSF)); Foundation of President of China Academy of Engineering Physics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Y. Fei for providing haematite powder samples; A. Goncharov for conducting the laser-heating treatment; and D. Z. Zhang, J.-F. Shu, J. Smith, Y. Kono, K. Yang, S. Yan, Z. H. Yu, Y. Yuan, M.Q. Hou and L. Xu for beamline technical support. XRD measurements were performed at the High Pressure Collaborative Access Team (HPCAT 16-IDB and 16-BMD) Advanced Photon Source (APS), Argonne National Laboratory, and the BL15U1 beamline, Shanghai Synchrotron Radiation Facility in China. Part of the experiments was performed at the 13BM-C experimental station of the GeoSoilEnviroCARS facility at the APS. HPCAT operations are supported by the DOE-NNSA under award number DE-NA0001974 and by the DOE-BES under award number DE-FG02-99ER45775, with partial instrumentation funding by the NSF. 13BM-C operation is supported by COMPRES through the Partnership for Extreme Crystallography (PX<SUP>2</SUP>) project, under NSF Cooperative Agreement EAR 11-57758. APS is supported by the DOE-BES, under contract number DE-AC02-06CH11357. Q.H. and H.-K.M. were supported by NSF grants EAR-1345112 and EAR-1447438. L. Z. was supported by the Foundation of President of China Academy of Engineering Physics (grant no. 201402032) and the National Natural Science Foundation of China (grant no. 41574080). This work was also supported in part by the National Natural Science Foundation of China (grant number U1530402).	Akahama Y, 1996, PHYS REV B, V54, P15602, DOI 10.1103/PhysRevB.54.R15602; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Bykova E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10661; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fei YW, 2007, P NATL ACAD SCI USA, V104, P9182, DOI 10.1073/pnas.0609013104; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Fujihisa H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.085503; Gleason AE, 2008, AM MINERAL, V93, P1882, DOI 10.2138/am.2008.2942; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Holzapfel C, 2005, SCIENCE, V309, P1707, DOI 10.1126/science.1111895; Howie RT, 2015, NAT MATER, V14, P495, DOI [10.1038/NMAT4213, 10.1038/nmat4213]; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; Jacobsen SD, 2006, GEOPHYS MONOGR SER, V168, P1, DOI 10.1029/GM168; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Lavina B, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400260; Lavina B, 2011, P NATL ACAD SCI USA, V108, P17281, DOI 10.1073/pnas.1107573108; Li MM, 2014, NAT GEOSCI, V7, P366, DOI [10.1038/ngeo2120, 10.1038/NGEO2120]; LOUBEYRE P, 1991, PHYS REV LETT, V67, P3271, DOI 10.1103/PhysRevLett.67.3271; LOUBEYRE P, 1992, PHYS REV B, V45, P12844, DOI 10.1103/PhysRevB.45.12844; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Meng Y, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4926895; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/NGEO2074, 10.1038/ngeo2074]; Oganov AR, 2011, ACCOUNTS CHEM RES, V44, P227, DOI 10.1021/ar1001318; Ono S, 2005, J PHYS CHEM SOLIDS, V66, P1714, DOI 10.1016/j.jpcs.2005.06.010; Pamato MG, 2015, NAT GEOSCI, V8, P75, DOI [10.1038/ngeo2306, 10.1038/NGEO2306]; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ren ZY, 2005, NATURE, V436, P837, DOI 10.1038/nature03907; Schmandt B, 2014, SCIENCE, V344, P1265, DOI [10.1126/science.1253358, 10.1126/science.1253258]; Shim SH, 2002, AM MINERAL, V87, P318; Sorensen HO, 2012, Z KRIST-CRYST MATER, V227, P63, DOI 10.1524/zkri.2012.1438; Stagno V, 2013, NATURE, V493, P84, DOI 10.1038/nature11679; Togo A, 2015, SCRIPTA MATER, V108, P1, DOI 10.1016/j.scriptamat.2015.07.021; Weerasinghe GL, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/45/455501; Yang JS, 2015, GONDWANA RES, V27, P459, DOI 10.1016/j.gr.2014.07.004; Zhang L, 2014, SCIENCE, V344, P877, DOI [10.1126/science.1254417, 10.1126/science.1250274]; Zhang L, 2013, P NATL ACAD SCI USA, V110, P6292, DOI 10.1073/pnas.1304402110	42	186	208	26	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					241	+		10.1038/nature18018	http://dx.doi.org/10.1038/nature18018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279220				2022-12-28	WOS:000377475100039
J	Cantor, AG; Pappas, M; Daeges, M; Nelson, HD				Cantor, Amy G.; Pappas, Miranda; Daeges, Monica; Nelson, Heidi D.			Screening for Syphilis Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ASYMPTOMATIC SYPHILIS; LABORATORY DIAGNOSIS; PENICILLIN TREATMENT; TESTS; IMMUNOASSAY; PREVALENCE; INCREASES; MEN; SEX	IMPORTANCE Screening for syphilis infection is currently recommended for high-risk individuals, including those with previous syphilis infection, an infected sexual partner, HIV infection, or more than 4 sex partners in the preceding year. OBJECTIVE To update a 2004 systematic review of studies of syphilis screening effectiveness, test accuracy, and screening harms in nonpregnant adults and adolescents. DATA SOURCES Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews through October 2015 and Ovid MEDLINE (January 2004 to October 2015), with updated search through March 2016. STUDY SELECTION English-language trials and observational studies of screening effectiveness, test accuracy, and screening harms in nonpregnant adults and adolescents. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data, a second checked data for accuracy, and 2 investigators independently assessed study quality using predefined criteria. MAIN OUTCOMES AND MEASURES Transmission of disease, including HIV; complications of syphilis; diagnostic accuracy; and harms of screening. RESULTS No evidence was identified regarding the effectiveness of screening on clinical outcomes or the effectiveness of risk assessment instruments; the harms of screening; or the effectiveness of screening in average-risk, nonpregnant adolescents or adults or high-risk individuals other than men who have sex with men (MSM) or men who are HIV positive. Four non-US studies indicated higher rates of syphilis detection with screening every 3 months vs 6 or 12 months for early syphilis in HIV-positive men or MSM. For example, there was an increased proportion of asymptomatic, higher-risk MSM in Australia (n = 6789 consultations) receiving a diagnosis of early syphilis when tested every 3 months vs annually (53% vs 16%, P =.001), but no difference among low-risk MSM. Treponemal and nontreponemal tests were accurate in asymptomatic individuals (sensitivity > 85%, specificity > 91%) in 3 studies but required confirmatory testing. Reverse sequence testing with an initial automated treponemal test yielded more false reactive test results than with rapid plasma reagin in 2 studies, one with a low-prevalence US population (0.6% vs 0.0%, P =.03) and another in a higher-prevalence Canadian population (0.26% vs 0.13%). CONCLUSIONS AND RELEVANCE Screening HIV-positive men or MSM for syphilis every 3 months is associated with improved syphilis detection. Treponemal or nontreponemal tests are accurate screening tests but require confirmation. Research is needed on the effect of screening on clinical outcomes; effective screening strategies, including reverse sequence screening, in various patient populations; and harms of screening.	[Cantor, Amy G.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Cantor, Amy G.] Oregon Hlth & Sci Univ, Dept Family Med, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Cantor, Amy G.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Pappas, Miranda; Daeges, Monica] Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Nelson, Heidi D.] Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Cantor, AG (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	cantor@ohsu.edu		Cantor, Amy/0000-0002-4467-8484	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	[Anonymous], FIN RES PLAN SYPH IN; [Anonymous], 2014 SEX TRANSM DIS; Berg AO, 2004, ANN FAM MED, V2, P362, DOI 10.1370/afm.215; Binnicker MJ, 2011, J CLIN MICROBIOL, V49, P1313, DOI 10.1128/JCM.02555-10; Binnicker MJ, 2012, J CLIN MICROBIOL, V50, P148, DOI 10.1128/JCM.05636-11; Bissessor M, 2011, CLIN INFECT DIS, V53, P57, DOI 10.1093/cid/cir271; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Brodsky JL, 2013, J CORRECT HEALTH CAR, V19, P54, DOI 10.1177/1078345812458088; Cantor A, 2016, AHRQ PUBLICATION, V14-05213-EF-1; Centers for Disease Control and Prevention, STD SURV CAS DEF; Cohen CE, 2005, SEX TRANSM INFECT, V81, P217, DOI 10.1136/sti.2004.012187; Douglas JM, 2009, JAMA-J AM MED ASSOC, V301, P769, DOI 10.1001/jama.2009.143; Juarez-Figueroa L, 2007, DIAGN MICR INFEC DIS, V59, P123, DOI 10.1016/j.diagmicrobio.2007.04.008; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Mahoney JF, 1943, AM J PUBLIC HEALTH N, V33, P1387, DOI 10.2105/AJPH.33.12.1387; Marangoni A, 2005, CLIN DIAGN LAB IMMUN, V12, P1231, DOI 10.1128/CDLI.12.10.1231-1234.2005; MARX R, 1991, SEX TRANSM DIS, V18, P92, DOI 10.1097/00007435-199118020-00008; Mayer KH, 2012, SEX TRANSM DIS, V39, P1, DOI 10.1097/OLQ.0b013e31823b1922; Mishra S, 2011, SEX TRANSM DIS, V38, P190, DOI 10.1097/OLQ.0b013e3181f07e91; Nelson HD, 2004, SCREENING SYPHILIS B; Radolf J. D., 2011, Morbidity and Mortality Weekly Report, V60, P133; Ratnam Sam, 2005, Can J Infect Dis Med Microbiol, V16, P45; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Tsang RSW, 2007, FEMS IMMUNOL MED MIC, V51, P118, DOI 10.1111/j.1574-695X.2007.00289.x; US Food & Drug Administration, 510 K SUBST EQ DET D; US Preventive Services Task Force, PROC MAN; Van Wagoner NJ, 2011, SEX TRANSM DIS, V38, P210, DOI 10.1097/OLQ.0b013e3181f6fe42; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wong EH, 2011, SEX TRANSM DIS, V38, P528, DOI 10.1097/OLQ.0b013e318205491a; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061972	30	59	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2328	2337		10.1001/jama.2016.4114	http://dx.doi.org/10.1001/jama.2016.4114			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272584	Bronze			2022-12-28	WOS:000377183100022
J	Gold, D				Gold, Deborah			Stop stalling and make PrEP for HIV available now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gold, Deborah] NAT, London EC1V 9FR, England		Gold, D (corresponding author), NAT, London EC1V 9FR, England.	Deborah.gold@nat.org.uk						Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Public Health England, HIV NEW DIAGN TREATM	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3160	10.1136/bmj.i3160	http://dx.doi.org/10.1136/bmj.i3160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27269364				2022-12-28	WOS:000377857800012
J	Wright, RHG; Lioutas, A; Le Dily, F; Soronellas, D; Pohl, A; Bonet, J; Nacht, AS; Samino, S; Font-Mateu, J; Vicent, GP; Wierer, M; Trabado, MA; Schelhorn, C; Carolis, C; Macias, MJ; Yanes, O; Oliva, B; Beato, M				Wright, Roni H. G.; Lioutas, Antonios; Le Dily, Francois; Soronellas, Daniel; Pohl, Andy; Bonet, Jaume; Nacht, A. S.; Samino, Sara; Font-Mateu, Jofre; Vicent, Guillermo P.; Wierer, Michael; Trabado, Miriam A.; Schelhorn, Constanze; Carolis, Carlo; Macias, Maria J.; Yanes, Oscar; Oliva, Baldo; Beato, Miguel			ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling	SCIENCE			English	Article							GENE-REGULATION; BREAST-CANCER; DNA-REPAIR; POLY(ADP-RIBOSE); (ADP-RIBOSE)(N); TRANSCRIPTION; ACTIVATION; SUBSTRATE; BINDING; CELLS	Key nuclear processes in eukaryotes, including DNA replication, repair, and gene regulation, require extensive chromatin remodeling catalyzed by energy-consuming enzymes. It remains unclear how the ATP demands of such processes are met in response to rapid stimuli. We analyzed this question in the context of the massive gene regulation changes induced by progestins in breast cancer cells and found that ATP is generated in the cell nucleus via the hydrolysis of poly(ADP-ribose) to ADP-ribose. In the presence of pyrophosphate, ADP-ribose is used by the pyrophosphatase NUDIX5 to generate nuclear ATP. The nuclear source of ATP is essential for hormone-induced chromatin remodeling, transcriptional regulation, and cell proliferation.	[Wright, Roni H. G.; Lioutas, Antonios; Le Dily, Francois; Soronellas, Daniel; Pohl, Andy; Nacht, A. S.; Font-Mateu, Jofre; Vicent, Guillermo P.; Wierer, Michael; Beato, Miguel] Barcelona Inst Sci & Technol, CRG, E-09003 Barcelona, Spain; [Wright, Roni H. G.; Lioutas, Antonios; Le Dily, Francois; Soronellas, Daniel; Pohl, Andy; Bonet, Jaume; Nacht, A. S.; Font-Mateu, Jofre; Vicent, Guillermo P.; Wierer, Michael; Oliva, Baldo; Beato, Miguel] Univ Pompeu Fabra, E-08003 Barcelona, Spain; [Bonet, Jaume; Oliva, Baldo] Univ Pompeu Fabra, Struct Bioinformat Lab, E-08003 Barcelona, Spain; [Samino, Sara; Yanes, Oscar] Spanish Biomed Res Ctr Diabet & Associated Metab, Metab Platform, Madrid 28029, Spain; [Samino, Sara; Yanes, Oscar] Univ Rovira & Virgili, Ctr Om Sci, E-43007 Tarragona, Spain; [Samino, Sara; Yanes, Oscar] Univ Rovira & Virgili, Dept Elect Engn, E-43007 Tarragona, Spain; [Trabado, Miriam A.; Carolis, Carlo] Ctr Regulacio Genom, Biomol Screening & Prot Technol Unit, E-08003 Barcelona, Spain; [Schelhorn, Constanze; Macias, Maria J.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Macias, Maria J.] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Wierer, Michael] Max Planck Inst Biochem, Munich, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Pompeu Fabra University; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Max Planck Society	Beato, M (corresponding author), Barcelona Inst Sci & Technol, CRG, E-09003 Barcelona, Spain.; Beato, M (corresponding author), Univ Pompeu Fabra, E-08003 Barcelona, Spain.	miguel.beato@crg.eu	Le Dily, François/GNH-3646-2022; Le Dily, François/J-9448-2015; Alloza-Trabado, Miriam/P-5550-2015; Gasull, Martina/J-4076-2019; Bonet, Jaume/C-5551-2011; Wright, Roni/AAG-5190-2019; Font-Mateu, Jofre/AAE-9801-2019; Lioutas, Antonios/AAH-4336-2020; Oliva, Baldomero/A-2690-2009; Vicent, Guillermo P./K-5432-2015; Yanes, Oscar/N-3630-2016; Macias, Maria J/K-3898-2014; Font-Mateu, Jofre/K-5492-2015; Carolis, Carlo/H-5978-2015	Le Dily, François/0000-0002-8324-7927; Le Dily, François/0000-0002-8324-7927; Alloza-Trabado, Miriam/0000-0002-4304-9790; Bonet, Jaume/0000-0001-5210-4387; Wright, Roni/0000-0002-8194-4614; Lioutas, Antonios/0000-0002-1075-7918; Oliva, Baldomero/0000-0003-0702-0250; Vicent, Guillermo P./0000-0002-0554-2226; Yanes, Oscar/0000-0003-3695-7157; Macias, Maria J/0000-0002-6915-963X; Samino, Sara/0000-0001-8371-679X; Font-Mateu, Jofre/0000-0001-9983-9647; Carolis, Carlo/0000-0003-4240-1139	Spanish MEC [CSD2006-00049, BMC 2003-02902, 2010-15313]; Catalan government (AGAUR) [BIO2014-57518-R, SAF2011-30578, BFU2014-53787-P]; MINECO (Spain); ICREA Funding Source: Custom	Spanish MEC(Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); MINECO (Spain); ICREA(ICREA)	We thank H. Kampinga for the luciferase plasmids, H. Imamura for the Ateam plasmids, M. Jacobson for the PARG-GST plasmid, V. Schreiber for the PARP1-GST plasmid, S. Capdevila and J. M. Caballero for support with IVIS, and J. Valcarcel for advice with the manuscript and CRG core facilities. Supported by the Spanish MEC (CSD2006-00049; BMC 2003-02902 and 2010-15313), and Catalan government (AGAUR) grants BIO2014-57518-R (B.O.), SAF2011-30578 (O.Y.), and BFU2014-53787-P (M. J. M.). CRG and IRB Barcelona are recipients of the Severo Ochoa Award of Excellence from MINECO (Spain). Global data sets have been deposited in GEO with accession numbers GSE53855, GSE64136, GSE64161, and GSE64163.	ALLFREY VG, 1957, P NATL ACAD SCI USA, V43, P589, DOI 10.1073/pnas.43.7.589; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; BETEL I, 1969, ARCH BIOCHEM BIOPHYS, V134, P271, DOI 10.1016/0003-9861(69)90283-5; Frizzell KM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2451; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Maruta H, 1997, BIOCHEM BIOPH RES CO, V236, P265, DOI 10.1006/bbrc.1997.6910; Maruta H, 2007, BIOL PHARM BULL, V30, P447, DOI 10.1248/bpb.30.447; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Wright RHG, 2012, GENE DEV, V26, P1972, DOI 10.1101/gad.193193.112; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078; Zhang T, 2012, J BIOL CHEM, V287, P12405, DOI 10.1074/jbc.M111.304469	20	97	103	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1221	1225		10.1126/science.aad9335	http://dx.doi.org/10.1126/science.aad9335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257257				2022-12-28	WOS:000377045700043
J	Cai, DJ; Aharoni, D; Shuman, T; Shobe, J; Biane, J; Song, WL; Wei, B; Veshkini, M; La-Vu, M; Lou, J; Flores, SE; Kim, I; Sano, Y; Zhou, M; Baumgaertel, K; Lavi, A; Kamata, M; Tuszynski, M; Mayford, M; Golshani, P; Silva, AJ				Cai, Denise J.; Aharoni, Daniel; Shuman, Tristan; Shobe, Justin; Biane, Jeremy; Song, Weilin; Wei, Brandon; Veshkini, Michael; La-Vu, Mimi; Lou, Jerry; Flores, Sergio E.; Kim, Isaac; Sano, Yoshitake; Zhou, Miou; Baumgaertel, Karsten; Lavi, Ayal; Kamata, Masakazu; Tuszynski, Mark; Mayford, Mark; Golshani, Peyman; Silva, Alcino J.			A shared neural ensemble links distinct contextual memories encoded close in time	NATURE			English	Article							INTRINSIC NEURONAL EXCITABILITY; FEAR MEMORY; ALLOCATION; MICE; PLACE; TRACE; HIPPOCAMPUS; ENVIRONMENT; SYSTEM; RECALL	Recent studies suggest that a shared neural ensemble may link distinct memories encoded close in time(1-12). According to the memory allocation hypothesis(1,2), learning triggers a temporary increase in neuronal excitability(13-15) that biases the representation of a subsequent memory to the neuronal ensemble encoding the first memory, such that recall of one memory increases the likelihood of recalling the other memory. Here we show in mice that the overlap between the hippocampal CA1 ensembles activated by two distinct contexts acquired within a day is higher than when they are separated by a week. Several findings indicate that this overlap of neuronal ensembles links two contextual memories. First, fear paired with one context is transferred to a neutral context when the two contexts are acquired within a day but not across a week. Second, the first memory strengthens the second memory within a day but not across a week. Older mice, known to have lower CA1 excitability(15,16), do not show the overlap between ensembles, the transfer of fear between contexts, or the strengthening of the second memory. Finally, in aged mice, increasing cellular excitability and activating a common ensemble of CA1 neurons during two distinct context exposures rescued the deficit in linking memories. Taken together, these findings demonstrate that contextual memories encoded close in time are linked by directing storage into overlapping ensembles. Alteration of these processes by ageing could affect the temporal structure of memories, thus impairing efficient recall of related information.	[Cai, Denise J.; Aharoni, Daniel; Shobe, Justin; Song, Weilin; Wei, Brandon; Veshkini, Michael; La-Vu, Mimi; Kim, Isaac; Sano, Yoshitake; Zhou, Miou; Lavi, Ayal; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90025 USA; [Cai, Denise J.; Aharoni, Daniel; Shuman, Tristan; Shobe, Justin; Song, Weilin; Wei, Brandon; Veshkini, Michael; La-Vu, Mimi; Lou, Jerry; Flores, Sergio E.; Kim, Isaac; Sano, Yoshitake; Zhou, Miou; Lavi, Ayal; Golshani, Peyman; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90025 USA; [Cai, Denise J.; Aharoni, Daniel; Shobe, Justin; Song, Weilin; Wei, Brandon; Veshkini, Michael; La-Vu, Mimi; Kim, Isaac; Sano, Yoshitake; Zhou, Miou; Lavi, Ayal; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA 90025 USA; [Aharoni, Daniel; Shuman, Tristan; Lou, Jerry; Flores, Sergio E.; Golshani, Peyman] Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Neurol, Los Angeles, CA 90025 USA; [Aharoni, Daniel; Shuman, Tristan; Lou, Jerry; Flores, Sergio E.; Golshani, Peyman] West Los Angeles VA Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA; [Biane, Jeremy; Tuszynski, Mark] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Biane, Jeremy; Tuszynski, Mark] Vet Affairs Med Ctr, San Diego, CA 92161 USA; [Baumgaertel, Karsten; Mayford, Mark] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Baumgaertel, Karsten; Mayford, Mark] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Neurosci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA 90025 USA.; Golshani, P; Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90025 USA.; Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA 90025 USA.; Golshani, P (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Integrat Ctr Learning & Memory, Dept Neurol, Los Angeles, CA 90025 USA.; Golshani, P (corresponding author), West Los Angeles VA Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	pgolshani@mednet.ucla.edu; silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021; Cai, Denise J/N-7229-2017; KAMATA, MASAKAZU/E-7550-2017; Zhou, Miou/AAK-1515-2021; Lavi, Ayal/Q-6395-2018	Silva, Alcino/0000-0002-1587-4558; Cai, Denise J/0000-0002-7729-0523; Zhou, Miou/0000-0001-8188-7392; Shuman, Tristan/0000-0003-2310-6142; Kamata, Masakazu/0000-0003-0323-3742; Flores, Sergio/0000-0003-4125-5862; Sano, Yoshitake/0000-0001-5188-3104; Mayford, Mark/0000-0002-9001-5024; Aharoni, Daniel/0000-0003-4931-8514	National Institute on Aging [R37 AG013622]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health [RO1 MH101198, 1U54 HD087101, U01 NS094286-01]; VA Merit Award [BX00152401A1]; National Research Service Award [F32 MH97413]; Behavioral Neuroscience Training Grant [T32 MH15795]; Neurobehavioral Genetics Training Grant [T32 NS048004]; Neural Microcircuits Training Grant [T32 NS058280]; Cellular Neurobiology Training Grant [T32 NS710133]; Epilepsy Foundation; David Geffen School of Medicine Dean's Fund for development of open-source miniaturized microscopes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315, R01MH101198, R01MH057368, T32MH015795, F32MH097413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS058280, T32NS048004, U01NS094286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622, R37AG013622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035657] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Behavioral Neuroscience Training Grant; Neurobehavioral Genetics Training Grant; Neural Microcircuits Training Grant; Cellular Neurobiology Training Grant; Epilepsy Foundation; David Geffen School of Medicine Dean's Fund for development of open-source miniaturized microscopes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Khakh for support in the development of the miniaturized microscopes. We thank E. Thai, D. Tarzi, A. Ahuja, K. Lew, E. Lu, E. Stuart, S. Zhang, S. Ghiaee, C. Yang, A. Fariborzi, K. Cheng, N. Rao, A. Chang, C. Grimmick and M. Einstein for help with experiments; N. Rao for assistance with graphical design; and all members of the Silva laboratory for their support. This work was supported by National Institute on Aging R37 AG013622 and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to A. J. S.; National Institutes of Health RO1 MH101198, 1U54 HD087101 and VA Merit Award BX00152401A1 to P. G.; National Research Service Award F32 MH97413 and Behavioral Neuroscience Training Grant T32 MH15795 to D. J. C.; Neurobehavioral Genetics Training Grant T32 NS048004 and Neural Microcircuits Training Grant T32 NS058280 to D. A.; Cellular Neurobiology Training Grant T32 NS710133 and Epilepsy Foundation Postdoctoral Research Training Fellowship to T. S.; National Institutes of Health U01 NS094286-01 and David Geffen School of Medicine Dean's Fund for development of open-source miniaturized microscopes to A. J. S. and P.G.	Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Deng W, 2013, ELIFE, V2, DOI 10.7554/eLife.00312; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Ezzyat Y, 2011, PSYCHOL SCI, V22, P243, DOI 10.1177/0956797610393742; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Kaczorowski CC, 2009, LEARN MEMORY, V16, P362, DOI 10.1101/lm.1365609; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Mckay BM, 2009, J NEUROPHYSIOL, V102, P2763, DOI 10.1152/jn.00347.2009; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; Moyer JR, 1996, J NEUROSCI, V16, P5536; Murphy GG, 2006, AM J GERIAT PSYCHIAT, V14, P1012, DOI 10.1097/01.JGP.0000209404.54310.b3; Oh MM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.002.2010; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Sano Y, 2014, CURR BIOL, V24, P2833, DOI 10.1016/j.cub.2014.10.018; Sederberg PB, 2008, PSYCHOL REV, V115, P893, DOI 10.1037/a0013396; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Tayler KK, 2013, CURR BIOL, V23, P99, DOI 10.1016/j.cub.2012.11.019; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	33	412	416	6	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					115	+		10.1038/nature17955	http://dx.doi.org/10.1038/nature17955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251287	Green Submitted, Green Accepted			2022-12-28	WOS:000376962300045
J	Wang, C; Gao, YY; Reinhold, P; Heeres, RW; Ofek, N; Chou, K; Axline, C; Reagor, M; Blumoff, J; Sliwa, KM; Frunzio, L; Girvin, SM; Jiang, L; Mirrahimi, M; Devoret, MH; Schoelkopf, RJ				Wang, Chen; Gao, Yvonne Y.; Reinhold, Philip; Heeres, R. W.; Ofek, Nissim; Chou, Kevin; Axline, Christopher; Reagor, Matthew; Blumoff, Jacob; Sliwa, K. M.; Frunzio, L.; Girvin, S. M.; Jiang, Liang; Mirrahimi, M.; Devoret, M. H.; Schoelkopf, R. J.			A Schrodinger cat living in two boxes	SCIENCE			English	Article							CLASSICAL LIGHT; QUANTUM; STATES; DECOHERENCE; MICROWAVE	Quantum superpositions of distinct coherent states in a single-mode harmonic oscillator, known as "cat states," have been an elegant demonstration of Schrodinger's famous cat paradox. Here, we realize a two-mode cat state of electromagnetic fields in two microwave cavities bridged by a superconducting artificial atom, which can also be viewed as an entangled pair of single-cavity cat states. We present full quantum state tomography of this complex cat state over a Hilbert space exceeding 100 dimensions via quantum nondemolition measurements of the joint photon number parity. The ability to manipulate such multicavity quantum states paves the way for logical operations between redundantly encoded qubits for fault-tolerant quantum computation and communication.	[Wang, Chen; Gao, Yvonne Y.; Reinhold, Philip; Heeres, R. W.; Ofek, Nissim; Chou, Kevin; Axline, Christopher; Reagor, Matthew; Blumoff, Jacob; Sliwa, K. M.; Frunzio, L.; Girvin, S. M.; Jiang, Liang; Mirrahimi, M.; Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys & Phys, New Haven, CT 06511 USA; [Mirrahimi, M.] INRIA Paris Rocquencourt, Domaine Voluceau, BP 105, F-78153 Le Chesnay, France	Yale University	Wang, C; Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys & Phys, New Haven, CT 06511 USA.	chen.wang@yale.edu; robert.schoelkopf@yale.edu	Gao, Yvonne/O-9328-2018; Jiang, Liang/A-9847-2008; Frunzio, Luigi/O-1573-2019; Gao, Yvonne/AAY-5024-2021; Jiang, Liang/GVU-8654-2022; Schoelkopf, Robert J/J-8178-2012	Gao, Yvonne/0000-0002-6360-9679; Jiang, Liang/0000-0002-0000-9342; Frunzio, Luigi/0000-0002-0272-5481; Gao, Yvonne/0000-0002-6360-9679; Jiang, Liang/0000-0002-0000-9342; Axline, Christopher/0000-0002-1708-3688; Mirrahimi, Mazyar/0000-0001-9471-6031	U.S. Army Research Office [W911NF-14-1-0011]; NSF [DMR-1301798]; Multidisciplinary University Research Initiatives program (MURI) through the Air Force Office of Scientific Research [FA9550-14-1-0052]; National Science Scholarship from Agency for Science, Technology, and Research (A*STAR) of Singapore	U.S. Army Research Office; NSF(National Science Foundation (NSF)); Multidisciplinary University Research Initiatives program (MURI) through the Air Force Office of Scientific Research; National Science Scholarship from Agency for Science, Technology, and Research (A*STAR) of Singapore	We thank A. Petrenko, Z. Leghtas, B. Vlastakis, W. Pfaff, M. Silveri, R. T. Brierley, and A. Roy for helpful discussions, and M. J. Hatridge and A. Narla for assistance on the parametric amplifier. This research was supported by the U.S. Army Research Office (W911NF-14-1-0011), NSF DMR-1301798, and the Multidisciplinary University Research Initiatives program (MURI) through the Air Force Office of Scientific Research (FA9550-14-1-0052). Facilities use was supported by the Yale Institute for Nanoscience and Quantum Engineering (YINQE), the Yale SEAS cleanroom, and the NSF (MRSECDMR 1119826). Y.Y.G. acknowledges support from a National Science Scholarship from Agency for Science, Technology, and Research (A*STAR) of Singapore.	Afek I, 2010, SCIENCE, V328, P879, DOI 10.1126/science.1188172; Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; CAHILL KE, 1969, PHYS REV, V177, P1882, DOI 10.1103/PhysRev.177.1882; Chuang IL, 1997, PHYS REV A, V56, P1114, DOI 10.1103/PhysRevA.56.1114; DAVIDOVICH L, 1993, PHYS REV LETT, V71, P2360, DOI 10.1103/PhysRevLett.71.2360; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Flammia ST, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230501; Haroche S, 2013, REV MOD PHYS, V85, P1083, DOI 10.1103/RevModPhys.85.1083; Joo J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.083601; Kelly J, 2015, NATURE, V519, P66, DOI 10.1038/nature14270; Leghtas Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042315; Michael M. H., 2016, NEW CLASS QUANTUM ER; Milman P, 2005, EUR PHYS J D, V32, P233, DOI 10.1140/epjd/e2004-00171-6; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Ofek N., 2016, QUANTUM ERROR CORREC; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Ourjoumtsev A, 2009, NAT PHYS, V5, P189, DOI 10.1038/NPHYS1199; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Reagor M, 2015, QUANTUM MEMORY NEAR; Roy A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.150503; Sanders BC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/24/244002; van Enk SJ, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022313; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wang H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060401; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103	29	181	185	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1087	1091		10.1126/science.aaf2941	http://dx.doi.org/10.1126/science.aaf2941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230374	Green Submitted			2022-12-28	WOS:000376480800035
J	Woolston, C				Woolston, Chris			EDUCATION Degrees of success	NATURE			English	Editorial Material																			0	0	0	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					569	+		10.1038/nj7604-569a	http://dx.doi.org/10.1038/nj7604-569a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM6EJ	27243044				2022-12-28	WOS:000376443100049
J	Pettitt, DA; Pai, A; Bradbury, E; Anandan, S; Kulkarni, M				Pettitt, David A.; Pai, Ashwin; Bradbury, Emma; Anandan, Suresh; Kulkarni, Mahendra			CASE REVIEW An unusual finger injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORF ECTHYMA CONTAGIOSUM; DIAGNOSIS		[Pettitt, David A.; Pai, Ashwin; Bradbury, Emma; Anandan, Suresh; Kulkarni, Mahendra] Wexham Pk Hosp, Dept Plast & Reconstruct Surg, Slough SL2 4L, Berks, England; [Pettitt, David A.] Univ Oxford, Dept Paediat, Oxford, England	University of Oxford	Pettitt, DA (corresponding author), Wexham Pk Hosp, Dept Plast & Reconstruct Surg, Slough SL2 4L, Berks, England.; Pettitt, DA (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	dapettitt@doctors.org.uk						Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P65; Bodilsen Jacob, 2013, Ugeskr Laeger, V175, P1121; Buchan J, 1996, BRIT MED J, V313, P203, DOI 10.1136/bmj.313.7051.203; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; Centers for Disease Control and Prevention, 1973, MMWR-MORBID MORTAL W, V22, P108; Degraeve C, 1999, DERMATOLOGY, V198, P162, DOI 10.1159/000018095; Erbagci Z, 2005, J DERMATOL TREAT, V16, P353, DOI 10.1080/09546630500375734; Gallina L, 2006, J VIROL METHODS, V134, P140, DOI 10.1016/j.jviromet.2005.12.014; GROVES RW, 1991, J AM ACAD DERMATOL, V25, P706, DOI 10.1016/0190-9622(91)70257-3; Inceoglu F, 2000, PLAST RECONSTR SURG, V106, P733, DOI 10.1097/00006534-200009030-00038; Mourtada I, 2000, ANN DERMATOL VENER, V127, P397; Paiba GA, 1999, VET REC, V145, P7, DOI 10.1136/vr.145.1.7; SANCHEZ RL, 1985, ARCH PATHOL LAB MED, V109, P166; SHELLEY WB, 1983, CUTIS, V31, P191; Torfason EG, 2002, J CLIN VIROL, V24, P79, DOI 10.1016/S1386-6532(01)00232-3	15	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2016	353								i2680	10.1136/bmj.i2680	http://dx.doi.org/10.1136/bmj.i2680			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CG	27225195				2022-12-28	WOS:000376939400002
J	Maruthappu, M; Watkins, J; Noor, AM; Williams, C; Ali, R; Sullivan, R; Zeltner, T; Atun, R				Maruthappu, Mahiben; Watkins, Johnathan; Noor, Aisyah Mohd; Williams, Callum; Ali, Raghib; Sullivan, Richard; Zeltner, Thomas; Atun, Rifat			Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis	LANCET			English	Article							EUROPEAN-UNION 1990-2009; BREAST-CANCER; GREAT RECESSION; PUBLIC-HEALTH; UNITED-STATES; UNEMPLOYMENT; CARE; EXPENDITURE; DIAGNOSIS; CRISES	Background The global economic crisis has been associated with increased unemployment and reduced public-sector expenditure on health care (PEH). We estimated the effects of changes in unemployment and PEH on cancer mortality, and identified how universal health coverage (UHC) affected these relationships. Methods For this longitudinal analysis, we obtained data from the World Bank and WHO (1990-2010). We aggregated mortality data for breast cancer in women, prostate cancer in men, and colorectal cancers in men and women, which are associated with survival rates that exceed 50%, into a treatable cancer class. We likewise aggregated data for lung and pancreatic cancers, which have 5 year survival rates of less than 10%, into an untreatable cancer class. We used multivariable regression analysis, controlling for country-specific demographics and infrastructure, with time-lag analyses and robustness checks to investigate the relationship between unemployment, PEH, and cancer mortality, with and without UHC. We used trend analysis to project mortality rates, on the basis of trends before the sharp unemployment rise that occurred in many countries from 2008 to 2010, and compared them with observed rates. Results Data were available for 75 countries, representing 2.106 billion people, for the unemployment analysis and for 79 countries, representing 2.156 billion people, for the PEH analysis. Unemployment rises were significantly associated with an increase in all-cancer mortality and all specific cancers except lung cancer in women. By contrast, untreatable cancer mortality was not significantly linked with changes in unemployment. Lag analyses showed significant associations remained 5 years after unemployment increases for the treatable cancer class. Rerunning analyses, while accounting for UHC status, removed the significant associations. All-cancer, treatable cancer, and specific cancer mortalities significantly decreased as PEH increased. Time-series analysis provided an estimate of more than 40 000 excess deaths due to a subset of treatable cancers from 2008 to 2010, on the basis of 2000-07 trends. Most of these deaths were in non-UHC countries. Interpretation Unemployment increases are associated with rises in cancer mortality; UHC seems to protect against this effect. PEH increases are associated with reduced cancer mortality. Access to health care could underlie these associations. We estimate that the 2008-10 economic crisis was associated with about 260 000 excess cancer-related deaths in the Organisation for Economic Co-operation and Development alone.	[Maruthappu, Mahiben] Imperial Coll London, Fac Med, London SW7 2AZ, England; [Watkins, Johnathan] Kings Coll London, Inst Math & Mol Biomed, London, England; [Watkins, Johnathan; Noor, Aisyah Mohd] Kings Coll London, Dept Res Oncol, London, England; [Sullivan, Richard] Kings Coll London, Kings Hlth Partners, Integrated Canc Ctr, Guys Hosp Campus, London, England; [Watkins, Johnathan] PILAR Res & Educ, Cambridge, England; [Williams, Callum] The Economist, London, England; [Ali, Raghib] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Ali, Raghib] United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Zeltner, Thomas] WHO, Geneva, Switzerland; [Zeltner, Thomas] Univ Bern, Bern, Switzerland; [Atun, Rifat] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Imperial College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Oxford; United Arab Emirates University; World Health Organization; University of Bern; Harvard University; Harvard T.H. Chan School of Public Health	Maruthappu, M (corresponding author), Imperial Coll London, Fac Med, London SW7 2AZ, England.	maruthappu@post.harvard.edu	Atun, Rifat/AAH-5537-2021; Watkins, Johnathan/ABI-8343-2020	Watkins, Johnathan/0000-0001-8370-6022; Sullivan, Richard/0000-0002-6435-1825; Atun, Rifat/0000-0002-1531-5983	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; Ades F, 2013, ANN ONCOL, V24, P2897, DOI 10.1093/annonc/mdt352; Akinyemiju TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061879; Alesina Alberto, 2012, CUT DEFICITS CUTTING; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Budhdeo S, 2015, J ROY SOC MED, V108, P490, DOI 10.1177/0141076815600907; Chang CH, 2011, JAMA-J AM MED ASSOC, V305, P2096, DOI 10.1001/jama.2011.665; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; De Vogli R, 2014, EUR J PUBLIC HEALTH, V24, P419, DOI 10.1093/eurpub/ckt173; Dickens C, 2014, INT J CANCER, V135, P2173, DOI 10.1002/ijc.28861; Ferlay J, 2013, GLOBOCAN 2012 V1 0; FORBES JF, 1987, INT J HEALTH SERV, V17, P233, DOI 10.2190/HQR1-U6XJ-GP7G-309H; Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Kaplan GA, 1996, BRIT MED J, V312, P999; KLEINHESSELINK DJ, 1992, INT J EPIDEMIOL, V21, P329, DOI 10.1093/ije/21.2.329; Maruthappu M, 2016, INT J PUBLIC HEALTH, V61, P119, DOI 10.1007/s00038-015-0727-2; Maruthappu M, 2015, EUR J PUBLIC HEALTH, V25, P330, DOI 10.1093/eurpub/cku167; Maruthappu M, 2014, EUR J GASTROEN HEPAT, V26, P1222, DOI 10.1097/MEG.0000000000000201; MORRIS JK, 1994, BMJ-BRIT MED J, V308, P1135, DOI 10.1136/bmj.308.6937.1135; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; Shafique K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056184; Singh GK, 2013, J COMMUN HEALTH, V38, P926, DOI 10.1007/s10900-013-9703-z; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Toffolutti V, 2014, PREV MED, V64, P54, DOI 10.1016/j.ypmed.2014.03.028; Williams C, 2013, AM J PUBLIC HEALTH, V103, P7, DOI 10.2105/AJPH.2012.300956	34	104	106	2	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					684	695		10.1016/S0140-6736(16)00577-8	http://dx.doi.org/10.1016/S0140-6736(16)00577-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27236345	Green Submitted			2022-12-28	WOS:000381268700028
J	Malik, VS; Willett, WC; Hu, FB				Malik, Vasanti S.; Willett, Walter C.; Hu, Frank B.			The Revised Nutrition Facts Label A Step Forward and More Room for Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US ADULTS		[Malik, Vasanti S.; Willett, Walter C.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Willett, Walter C.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Willett, Walter C.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Willett, Walter C.; Hu, Frank B.] Harvard Med Sch, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), 665 Huntington Ave, Boston, MA 02115 USA.	nhbfh@channing.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102896, P30DK046200] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60712, R01 HL060712] Funding Source: Medline; NIDDK NIH HHS [P30 DK046200, P30DK46200, DK102896, R01 DK102896] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2004, DIETARY REF INTAKES; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; DeSalvo KB, 2016, JAMA-J AM MED ASSOC, V315, P457, DOI 10.1001/jama.2015.18396; Doell D, 2012, FOOD ADDIT CONTAM A, V29, P861, DOI 10.1080/19440049.2012.664570; FDA, 2016, DIN RUL; Malik VS, 2015, J AM COLL CARDIOL, V66, P1615, DOI 10.1016/j.jacc.2015.08.025; Ollberding NJ, 2010, J AM DIET ASSOC, V110, P1233, DOI 10.1016/j.jada.2010.05.007; Roberto CA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3185; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640	10	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					583	584		10.1001/jama.2016.8005	http://dx.doi.org/10.1001/jama.2016.8005			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27272093	Green Accepted			2022-12-28	WOS:000380985600008
J	Shipman, SL; Nivala, J; Macklis, JD; Church, GM				Shipman, Seth L.; Nivala, Jeff; Macklis, Jeffrey D.; Church, George M.			Molecular recordings by directed CRISPR spacer acquisition	SCIENCE			English	Article							CAS ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; TOGGLE SWITCH; MECHANISTIC BASIS; GENETIC MEMORY; FOREIGN DNA; CELL FATE; ADAPTATION; SYSTEMS; GENERATION	The ability to write a stable record of identified molecular events into a specific genomic locus would enable the examination of long cellular histories and have many applications, ranging from developmental biology to synthetic devices. We show that the type I-E CRISPR ( clustered regularly interspaced short palindromic repeats)-Cas system of Escherichia coli can mediate acquisition of defined pieces of synthetic DNA. We harnessed this feature to generate records of specific DNA sequences into a population of bacterial genomes. We then applied directed evolution so as to alter the recognition of a protospacer adjacent motif by the Cas1-Cas2 complex, which enabled recording in two modes simultaneously. We used this system to reveal aspects of spacer acquisition, fundamental to the CRISPR-Cas adaptation process. These results lay the foundations of a multimodal intracellular recording device.	[Shipman, Seth L.; Nivala, Jeff; Church, George M.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Shipman, Seth L.; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Ctr Brain Sci, Bauer Lab 103, Cambridge, MA 02138 USA; [Shipman, Seth L.; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Bauer Lab 103, Cambridge, MA 02138 USA; [Shipman, Seth L.; Nivala, Jeff; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Church, GM (corresponding author), Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Church, GM (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Nivala, Jeff/0000-0002-8210-5417	National Institute on Aging [5T32AG000222]; National Institute of Mental Health [5R01MH103910]; National Human Genome Research Institute [5P50HG005550]; National Institute of Neurological Disorders and Stroke [5R01NS045523]; Allen Distinguished Investigator Award from the Paul G. Allen Family Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008525, P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Allen Distinguished Investigator Award from the Paul G. Allen Family Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.L.S., J.N., J.D.M, and G.M.C. are inventors on a provisional patent (62/296,812) filed by the President and Fellows of Harvard College that covers the work in this manuscript. S.L.S is a Shurl and Kay Curci Foundation Fellow of the Life Sciences Research Foundation and received additional support from the National Institute on Aging (grant 5T32AG000222). The project was supported by grants from the National Institute of Mental Health (grant 5R01MH103910) and National Human Genome Research Institute (grant 5P50HG005550) to G.M.C., the National Institute of Neurological Disorders and Stroke (grant 5R01NS045523) to J.D.M., and an Allen Distinguished Investigator Award from the Paul G. Allen Family Foundation to J.D.M. Sequence data will be deposited into the National Center for Biotechnology Information Sequence Read Archive database as appropriate, and plasmids will be available under a materials transfer agreement with Addgene.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Burrill DR, 2011, GENE DEV, V25, P434, DOI 10.1101/gad.1994911; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Delaney NF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002511; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Marblestone AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00137; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moon TS, 2011, J MOL BIOL, V406, P215, DOI 10.1016/j.jmb.2010.12.019; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vilaboa N, 2005, MOL THER, V12, P290, DOI 10.1016/j.ymthe.2005.03.029; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wu M, 2013, P NATL ACAD SCI USA, V110, P10610, DOI 10.1073/pnas.1305423110; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	46	119	131	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298							aaf1175	10.1126/science.aaf1175	http://dx.doi.org/10.1126/science.aaf1175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27284167	Green Accepted, Green Submitted			2022-12-28	WOS:000380583600033
J	Scott, DL				Scott, David L.			Beyond methotrexate monotherapy for early rheumatoid arthritis	LANCET			English	Editorial Material							THERAPY		[Scott, David L.] Kings Coll London, Dept Clin Rheumatol, London SE5 9RJ, England	University of London; King's College London	Scott, DL (corresponding author), Kings Coll London, Dept Clin Rheumatol, London SE5 9RJ, England.	d.scott1@nhs.net						Bijlsma JWJ, 2016, LANCET; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Hazlewood GS, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1777; Joensuu JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119683; Jurgens MS, 2012, CLIN EXP RHEUMATOL, V30, pS56; Kiely P, 2009, RHEUMATOLOGY, V48, P57, DOI 10.1093/rheumatology/ken406; Kuriya B, 2010, ANN RHEUM DIS, V69, P1298, DOI 10.1136/ard.2009.118307; National Institute for Health and Care Excellence, RHEUM ARTHR MAN RHEU; Scott DL, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18660; SHORT CL, 1948, NEW ENGL J MED, V238, P142, DOI 10.1056/NEJM194801292380502; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; WILSKE KR, 1993, SEMIN ARTHRITIS RHEU, V23, P11, DOI 10.1016/S0049-0172(10)80003-4	13	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					309	310		10.1016/S0140-6736(16)30678-X	http://dx.doi.org/10.1016/S0140-6736(16)30678-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27287831				2022-12-28	WOS:000380016900004
J	Huang, SF; Tao, X; Yuan, SC; Zhang, YH; Li, PY; Beilinson, HA; Zhang, Y; Yu, WJ; Pontarotti, P; Escriva, H; Le Petillon, Y; Liu, XL; Chen, SW; Schatz, DG; Xu, AL				Huang, Shengfeng; Tao, Xin; Yuan, Shaochun; Zhang, Yuhang; Li, Peiyi; Beilinson, Helen A.; Zhang, Ya; Yu, Wenjuan; Pontarotti, Pierre; Escriva, Hector; Le Petillon, Yann; Liu, Xiaolong; Chen, Shangwu; Schatz, David G.; Xu, Anlong			Discovery of an Active RAG Transposon Illuminates the Origins of V(D)J Recombination	CELL			English	Article							JOINING SIGNALS; IMMUNE-SYSTEM; IN-VITRO; GENE; VERTEBRATE; EVOLUTION; PROTEINS; DOMAIN; REARRANGEMENT; INITIATION	Co-option of RAG1 and RAG2 for antigen receptor gene assembly by V(D)J recombination was a crucial event in the evolution of jawed vertebrate adaptive immunity. RAG1/2 are proposed to have arisen from a transposable element, but definitive evidence for this is lacking. Here, we report the discovery of ProtoRAG, a DNA transposon family from lancelets, the most basal extant chordates. A typical ProtoRAG is flanked by 5-bp target site duplications and a pair of terminal inverted repeats (TIRs) resembling V(D) J recombination signal sequences. Between the TIRs reside tail-to-tail-oriented, intron-containing RAG1-like and RAG2-like genes. We demonstrate that ProtoRAG was recently active in the lancelet germ-line and that the lancelet RAG1/2-like proteins can mediate TIR-dependent transposon excision, host DNA recombination, transposition, and low-efficiency TIR rejoining using reaction mechanisms similar to those used by vertebrate RAGs. We propose that ProtoRAG represents a molecular "living fossil" of the long-sought RAG transposon.	[Huang, Shengfeng; Tao, Xin; Yuan, Shaochun; Li, Peiyi; Zhang, Ya; Yu, Wenjuan; Chen, Shangwu; Xu, Anlong] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Dong San Huan Rd, Beijing 100029, Peoples R China; [Zhang, Yuhang; Beilinson, Helen A.; Schatz, David G.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Schatz, David G.] Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06511 USA; [Pontarotti, Pierre] Aix Marseille Univ, CNRS, Equipe Evolut Biol & Modelisat, I2M UMR 7373,Centrale Marseille, F-13284 Marseille, France; [Escriva, Hector; Le Petillon, Yann] Univ Paris 06, CNRS, BIOM, Observ Oceanol Banyuls Sur Mer,UMR 7232, F-75005 Paris, France; [Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Sun Yat Sen University; Beijing University of Chinese Medicine; Yale University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xu, AL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Xu, AL (corresponding author), Beijing Univ Chinese Med, Dong San Huan Rd, Beijing 100029, Peoples R China.	lssxal@mail.sysu.edu.cn	Yuan, Shaochun/GQB-5134-2022; Escriva, Hector/K-8325-2013; Tao, Xin/ABG-1723-2020; , pontarotti/ABB-1753-2021	Escriva, Hector/0000-0001-7577-5028; Tao, Xin/0000-0001-9259-8326; Huang, Shengfeng/0000-0002-0968-1370; Pierre, Pontarotti/0000-0001-7202-3648; Beilinson, Helen/0000-0002-2888-5256; Schatz, David/0000-0002-5669-1176; Xu, Anlong/0000-0002-1419-3494	BAC 973 [2013CB835305, 2011CB946101]; NNSF [91231206, 31171193, 31470846]; New Star of Pearl River [2014J2200017]; NIH [R37AI32524]; National Supercomputer Center in Guangzhou and Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER	BAC 973; NNSF(National Natural Science Foundation of China (NSFC)); New Star of Pearl River; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Supercomputer Center in Guangzhou and Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Yiquan Wang and Dr. Guan Li for providing BAC libraries and Marius Surleac and Dr. Andrei Petrescu for sequence and structural analyses of RAG2-like genes. This work was supported by Project 2013CB835305 (973), 91231206 (NNSF), 2011CB946101 (973), 31171193 (NNSF), 31470846 (NNSF), 2014J2200017 (New Star of Pearl River), NIH R37AI32524 (to D.G.S., an investigator of the Howard Hughes Medical Institute), and by National Supercomputer Center in Guangzhou and Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Corneo B, 2002, EUR J IMMUNOL, V32, P2068, DOI 10.1002/1521-4141(200207)32:7<2068::AID-IMMU2068>3.0.CO;2-6; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Craig NL., 2002, MOBILE DNA-UK; DAVIS MM, 1984, IMMUNOL REV, V81, P235, DOI 10.1111/j.1600-065X.1984.tb01113.x; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dreyfus DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005778; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Elkin SK, 2003, EMBO J, V22, P1931, DOI 10.1093/emboj/cdg184; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Huang SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6896; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Little AJ, 2015, MOL BIOL B CELLS, P13; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Panchin Y, 2008, BIOCHEM BIOPH RES CO, V369, P818, DOI 10.1016/j.bbrc.2008.02.097; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsai CL, 2003, NUCLEIC ACIDS RES, V31, P6180, DOI 10.1093/nar/gkg819; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhang YN, 2014, P NATL ACAD SCI USA, V111, P397, DOI 10.1073/pnas.1318843111	42	106	111	7	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					102	114		10.1016/j.cell.2016.05.032	http://dx.doi.org/10.1016/j.cell.2016.05.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27293192	Green Accepted, Bronze			2022-12-28	WOS:000380254400014
J	Ray, A; Masch, WR; Saukkonen, K; Harrison, BT				Ray, Alaka; Masch, William R.; Saukkonen, Kai; Harrison, Beth T.			Case 18-2016: A 52-Year-Old Woman with a Pleural Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN-CANCER; ASCITES; FIBROMA; MASS		[Ray, Alaka; Saukkonen, Kai] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Masch, William R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Harrison, Beth T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ray, Alaka; Saukkonen, Kai] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Masch, William R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Harrison, Beth T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ray, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Ray, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.							Brun JL, 2007, GYNECOL ONCOL, V105, P796, DOI 10.1016/j.ygyno.2007.01.050; Chechia A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.053; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Guerriero S, 2001, GYNECOL ONCOL, V83, P299, DOI 10.1006/gyno.2001.6377; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Jung SE, 2002, RADIOGRAPHICS, V22, P1305, DOI 10.1148/rg.226025033; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; MEIGS JV, 1954, OBSTET GYNECOL, V3, P471; Meigs JV, 1939, ANN SURG, V110, P731, DOI 10.1097/00000658-193910000-00019; Nemeth AJ, 2003, J THORAC IMAG, V18, P100, DOI 10.1097/00005382-200304000-00009; Porcel JM, 2006, AM FAM PHYSICIAN, V73, P1211; Quinn T, 2013, THORAC SURG CLIN, V23, P11, DOI 10.1016/j.thorsurg.2012.10.009; Rauh-Hain JA, 2015, CLIN OBSTET GYNECOL, V58, P53, DOI 10.1097/GRF.0000000000000085; Riker D, 2013, J BRONCHOL INTERN PU, V20, P48, DOI 10.1097/LBR.0b013e31827ccb35; STOREY DD, 1976, JAMA-J AM MED ASSOC, V236, P2183, DOI 10.1001/jama.236.19.2183; Troiano RN, 1997, RADIOLOGY, V204, P795, DOI 10.1148/radiology.204.3.9280262; Tsuji T, 2005, HUM PATHOL, V36, P792, DOI 10.1016/j.humpath.2005.05.009; Yalcin NG, 2013, THORAC SURG CLIN, V23, P1, DOI 10.1016/j.thorsurg.2012.10.008	18	0	0	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2378	2387		10.1056/NEJMcpc1600612	http://dx.doi.org/10.1056/NEJMcpc1600612			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305196				2022-12-28	WOS:000377854600013
J	Nelson, WG; Rosen, A; Pronovost, PJ				Nelson, William G.; Rosen, Antony; Pronovost, Peter J.			Reengineering the Physical Examination for the New Millennium?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nelson, William G.; Rosen, Antony; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, 401 N Broadway St,Ste 1100, Baltimore, MD 21218 USA; [Nelson, William G.; Rosen, Antony; Pronovost, Peter J.] Johns Hopkins Univ, Kimmel Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Nelson, WG (corresponding author), Johns Hopkins Univ, Sch Med, 401 N Broadway St,Ste 1100, Baltimore, MD 21218 USA.	bnelson@jhmi.edu						Feddock CA, 2007, AM J MED, V120, P374, DOI 10.1016/j.amjmed.2007.01.023; Kim ESH, 2007, DIABETES CARE, V30, P1959, DOI 10.2337/dc07-0020; Krogsboll LT, 2013, JAMA-J AM MED ASSOC, V309, P2489, DOI 10.1001/jama.2013.5039; Loeb S, 2005, J UROLOGY, V173, P63, DOI 10.1097/01.ju.0000145883.01068.5f; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; U.S. Food & Drug Administration, COMP DIAGN; Verghese A, 2015, AM J MED, V128, P1322, DOI 10.1016/j.amjmed.2015.06.004	8	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2391	2392		10.1001/jama.2016.4470	http://dx.doi.org/10.1001/jama.2016.4470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299614				2022-12-28	WOS:000377656900010
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The department of spin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, GUARDIAN; Appleby J, 2016, DOES THIS YEARS NHS; Committee of Public Accounts, 2016, DET PLANS MUST ADDR; Eleftheriou-Smith LM, 2013, PR WEEK         0426; Hughes D, 2016, BBC NEWS; McCartney M., 2016, RESPONSE OVERWHELMIN; Wise J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2781	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2016	353								i3237	10.1136/bmj.i3237	http://dx.doi.org/10.1136/bmj.i3237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YY	27287258	Bronze, Green Published			2022-12-28	WOS:000377860300002
J	Clayden, J				Clayden, Jonathan			CHEMISTRY No turning back for motorized molecules	NATURE			English	Editorial Material									[Clayden, Jonathan] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England	University of Bristol	Clayden, J (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	j.clayden@bristol.ac.uk		Clayden, Jonathan/0000-0001-5080-9535				Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Collins B. S. L., 2016, NATURE CHEM; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P909, DOI 10.1002/(SICI)1521-3773(19980420)37:7<909::AID-ANIE909>3.0.CO;2-X; Kelly TR, 1998, J ORG CHEM, V63, P3655, DOI 10.1021/jo9723218; Klok M, 2008, J AM CHEM SOC, V130, P10484, DOI 10.1021/ja8037245; Wilson MR, 2016, NATURE, V534, P235, DOI 10.1038/nature18013	6	6	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					187	188		10.1038/534187a	http://dx.doi.org/10.1038/534187a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279210	Green Submitted			2022-12-28	WOS:000377475100028
J	Gomez-Robles, A				Gomez-Robles, Aida			PALAEOANTHROPOLOGY The dawn of Homo floresiensis	NATURE			English	Editorial Material							HOMININ; INDONESIA; EVOLUTION; SIZE		[Gomez-Robles, Aida] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA	George Washington University	Gomez-Robles, A (corresponding author), George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC 20052 USA.	agomezrobles@gwu.edu		Gomez-Robles, Aida/0000-0002-8719-2660				Baab K. L., 2016, J ANTHR SCI, V94; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brumm A, 2016, NATURE, V534, P249, DOI 10.1038/nature17663; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Evans AR, 2012, P NATL ACAD SCI USA, V109, P4187, DOI 10.1073/pnas.1120774109; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Grabowski M, 2015, J HUM EVOL, V85, P75, DOI 10.1016/j.jhevol.2015.05.005; Henneberg M, 2014, P NATL ACAD SCI USA, V111, P11967, DOI 10.1073/pnas.1407382111; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; van den Bergh GD, 2016, NATURE, V534, P245, DOI 10.1038/nature17999; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922	14	6	6	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					188	189		10.1038/534188a	http://dx.doi.org/10.1038/534188a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO0NH	27279211				2022-12-28	WOS:000377475100029
J	Hingorani, S				Hingorani, Sangeeta			Renal Complications of Hematopoietic-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE KIDNEY INJURY; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; LONG-TERM SURVIVORS; THROMBOTIC MICROANGIOPATHY; HEMORRHAGIC CYSTITIS; ADULT PATIENTS; RISK-FACTORS; MEMBRANOUS NEPHROPATHY; CHILDREN		[Hingorani, Sangeeta] Univ Washington, Sch Med, Dept Pediat, Div Nephrol, Seattle, WA 98195 USA; [Hingorani, Sangeeta] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Hingorani, S (corresponding author), Seattle Childrens Hosp, Div Nephrol, Mailstop 0C-9-820,4800 Sand Point Way NE, Seattle, WA 98105 USA.	sangeeta.hingorani@seattlechildrens.org						Abboud I, 2009, BIOL BLOOD MARROW TR, V15, P1251, DOI 10.1016/j.bbmt.2009.05.016; Aksenova M, 2015, PEDIATR TRANSPLANT, V19, pE29, DOI 10.1111/petr.12411; Ando M, 2010, BONE MARROW TRANSPL, V45, P1427, DOI 10.1038/bmt.2009.377; Ando M, 2010, NEPHROL DIAL TRANSPL, V25, P278, DOI 10.1093/ndt/gfp485; Ansari M, 2011, AM J TRANSPLANT, V11, P1748, DOI 10.1111/j.1600-6143.2011.03617.x; Bao YS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13225; Beitinjaneh A, 2010, CLIN TRANSPLANT, V24, pE94, DOI 10.1111/j.1399-0012.2009.01155.x; Bruno B, 2004, TRANSPLANTATION, V77, P1049, DOI 10.1097/01.TP.0000122421.71556.71; Bunin N, 2010, PEDIATR TRANSPLANT, V14, P1030, DOI 10.1111/j.1399-3046.2010.01401.x; Byrne-Dugan CJ, 2014, AM J KIDNEY DIS, V64, P987, DOI 10.1053/j.ajkd.2014.09.001; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; Cesaro S, 2013, BONE MARROW TRANSPL, V48, P809, DOI 10.1038/bmt.2012.247; Changsirikulchai S, 2009, CLIN J AM SOC NEPHRO, V4, P345, DOI 10.2215/CJN.02070508; Cho BS, 2010, TRANSPLANTATION, V90, P918, DOI 10.1097/TP.0b013e3181f24e8d; Chow EJ, 2014, J CLIN ONCOL, V32, P191, DOI 10.1200/JCO.2013.52.6582; Cohen EP, 2012, INT J RADIAT ONCOL, V83, P292, DOI 10.1016/j.ijrobp.2011.05.081; Coppell JA, 2010, BIOL BLOOD MARROW TR, V16, P157, DOI 10.1016/j.bbmt.2009.08.024; Currie G, 2014, INT J NEPHROL RENOV, V7, P13, DOI 10.2147/IJNRD.S40522; de Fontbrune FS, 2015, TRANSPLANTATION, V99, P1953, DOI 10.1097/TP.0000000000000601; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; DiCarlo JV, 2003, J PEDIAT HEMATOL ONC, V25, P801, DOI 10.1097/00043426-200310000-00012; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Erbey F, 2010, EXP CLIN TRANSPLANT, V8, P237; Fangmann J, 2011, AM J TRANSPLANT, V11, P156, DOI 10.1111/j.1600-6143.2010.03352.x; Fink JC, 1995, J AM SOC NEPHROL, V6, P1655; Flores FX, 2008, PEDIATR NEPHROL, V23, P625, DOI 10.1007/s00467-007-0672-2; Frisk P, 2010, PEDIATR NEPHROL, V25, P1337, DOI 10.1007/s00467-010-1501-6; Gaziev J, 2010, BIOL BLOOD MARROW TR, V16, P662, DOI 10.1016/j.bbmt.2009.12.009; Gilis L, 2014, BONE MARROW TRANSPL, V49, P664, DOI 10.1038/bmt.2013.235; Glezerman IG, 2010, BIOL BLOOD MARROW TR, V16, P976, DOI 10.1016/j.bbmt.2010.02.006; Haines HL, 2011, BIOL BLOOD MARROW TR, V17, P1512, DOI 10.1016/j.bbmt.2011.02.012; Heher EC, 2010, SEMIN NEPHROL, V30, P602, DOI 10.1016/j.semnephrol.2010.09.008; Higo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115399; Hingorani S, 2014, BONE MARROW TRANSPL, V49, P403, DOI 10.1038/bmt.2013.197; Hingorani SR, 2015, BONE MARROW TRANSPL, V50, P715, DOI 10.1038/bmt.2015.2; Hingorani S, 2015, CLIN J AM SOC NEPHRO, V10, P601, DOI 10.2215/CJN.06470614; Hingorani S, 2015, CLIN J AM SOC NEPHRO, V10, P12, DOI 10.2215/CJN.01840214; Hingorani SR, 2008, BIOL BLOOD MARROW TR, V14, P1365, DOI 10.1016/j.bbmt.2008.09.015; Hoffmeister PA, 2010, BIOL BLOOD MARROW TR, V16, P515, DOI 10.1016/j.bbmt.2009.11.018; Hosing C, 2011, BIOL BLOOD MARROW TR, V17, P674, DOI 10.1016/j.bbmt.2010.08.003; Hu SL, 2010, NEPHROL DIAL TRANSPL, V25, P1708, DOI 10.1093/ndt/gfp693; Huang XH, 2013, AM J MED SCI, V346, P32, DOI 10.1097/MAJ.0b013e318267b5cd; Ileri T, 2010, PEDIATR TRANSPLANT, V14, P138, DOI 10.1111/j.1399-3046.2009.01182.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jodele S, 2014, BLOOD, V124, P645, DOI 10.1182/blood-2014-03-564997; Jodele S, 2014, BIOL BLOOD MARROW TR, V20, P518, DOI 10.1016/j.bbmt.2013.12.565; Jodele S, 2013, BLOOD, V122, P2003, DOI 10.1182/blood-2013-05-501445; Jodele S, 2013, TRANSFUSION, V53, P661, DOI 10.1111/j.1537-2995.2012.03776.x; Jodele S, 2012, PEDIATR TRANSPLANT, V16, pE39, DOI 10.1111/j.1399-3046.2010.01408.x; Kagoya Y, 2011, BIOL BLOOD MARROW TR, V17, P394, DOI 10.1016/j.bbmt.2010.07.010; Kim JY, 2010, CLIN EXP NEPHROL, V14, P630, DOI 10.1007/s10157-010-0337-5; Koskenvuo M, 2013, J CLIN VIROL, V56, P77, DOI 10.1016/j.jcv.2012.09.003; Kwon HJ, 2013, TRANSPL INFECT DIS, V15, P569, DOI 10.1111/tid.12136; Labrador J, 2014, BONE MARROW TRANSPL, V49, P684, DOI 10.1038/bmt.2014.17; Laskin BL, 2011, BONE MARROW TRANSPL, V46, P682, DOI 10.1038/bmt.2010.182; Laskin BL, 2013, TRANSPLANTATION, V96, P217, DOI 10.1097/TP.0b013e31829807aa; Laskin BL, 2013, BIOL BLOOD MARROW TR, V19, P1175, DOI 10.1016/j.bbmt.2013.05.002; Li JM, 2009, IMMUNOTHERAPY-UK, V1, P599, DOI 10.2217/IMT.09.32; Liu H, 2010, BONE MARROW TRANSPL, V45, P153, DOI 10.1038/bmt.2009.99; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Luft T, 2011, BLOOD, V118, P1685, DOI 10.1182/blood-2011-02-334821; Luo XD, 2011, BLOOD CELL MOL DIS, V46, P182, DOI 10.1016/j.bcmd.2010.12.003; Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P1100, DOI 10.1016/j.bbmt.2009.05.010; Mattei D, 2010, BONE MARROW TRANSPL, V45, P1111, DOI 10.1038/bmt.2009.276; Michael M, 2004, PEDIATR NEPHROL, V19, P91, DOI 10.1007/s00467-003-1313-z; Mii A, 2011, PATHOL INT, V61, P518, DOI 10.1111/j.1440-1827.2011.02704.x; Miura K, 2012, CLIN EXP NEPHROL, V16, P180, DOI 10.1007/s10157-011-0538-6; Mori J, 2012, INTERNAL MED, V51, P2105, DOI 10.2169/internalmedicine.51.7418; Motoyoshi Y, 2014, CEN CASE REP, V3, P202, DOI 10.1007/s13730-014-0118-1; Munakata W, 2011, INT J HEMATOL, V93, P517, DOI 10.1007/s12185-011-0811-1; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Numata A, 2013, EXP CLIN TRANSPLANT, V11, P75, DOI 10.6002/ect.2012.0078; O'Donnell PH, 2009, BIOL BLOOD MARROW TR, V15, P1038, DOI 10.1016/j.bbmt.2009.04.016; Oshrine B, 2013, BIOL BLOOD MARROW TR, V19, P1702, DOI 10.1016/j.bbmt.2013.09.007; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Papanicolaou GA, 2015, AM J KIDNEY DIS, V65, P780, DOI 10.1053/j.ajkd.2014.11.020; Parikh CR, 2004, J AM SOC NEPHROL, V15, P1868, DOI 10.1097/01.asn.0000129981.50357.1c; Petri CR, 2014, LEUKEMIA LYMPHOMA, V55, P2866, DOI 10.3109/10428194.2014.897701; Petropoulou AD, 2010, TRANSPLANTATION, V90, P801, DOI 10.1097/TP.0b013e3181ee4431; Pilar F, 2013, EUR J HAEMATOL, V91, P129, DOI 10.1111/ejh.12149; Pinana JL, 2009, BIOL BLOOD MARROW TR, V15, P21, DOI 10.1016/j.bbmt.2008.10.011; Pinomaki A, 2010, BONE MARROW TRANSPL, V45, P730, DOI 10.1038/bmt.2009.227; Pulsipher MA, 2012, BIOL BLOOD MARROW TR, V18, P334, DOI 10.1016/j.bbmt.2012.01.003; Rosenthal J, 2011, PEDIATR BLOOD CANCER, V57, P142, DOI 10.1002/pbc.22861; Sadeghi B, 2013, BONE MARROW TRANSPL, V48, P284, DOI 10.1038/bmt.2012.120; Sakellari I, 2013, BONE MARROW TRANSPL, V48, P1329, DOI 10.1038/bmt.2013.55; Satwani P, 2011, BIOL BLOOD MARROW TR, V17, P1472, DOI 10.1016/j.bbmt.2011.02.006; Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450; Shayani S, 2013, BIOL BLOOD MARROW TR, V19, P298, DOI 10.1016/j.bbmt.2012.10.006; Shimoi T, 2013, BONE MARROW TRANSPL, V48, P80, DOI 10.1038/bmt.2012.85; Shingai N, 2015, BONE MARROW TRANSPL, V50, P1557, DOI 10.1038/bmt.2015.188; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tokgoz B, 2010, RENAL FAILURE, V32, P547, DOI 10.3109/08860221003728721; Touzot M, 2010, NEPHROL DIAL TRANSPL, V25, P624, DOI 10.1093/ndt/gfp529; Troxell ML, 2008, MODERN PATHOL, V21, P396, DOI 10.1038/modpathol.3801011; Vaughn JE, 2015, BIOL BLOOD MARROW TR, V21, P1418, DOI 10.1016/j.bbmt.2015.04.002; Wang HH, 2011, J CHIN MED ASSOC, V74, P419, DOI 10.1016/j.jcma.2011.08.008; Yang WC, 2013, AM J MED SCI, V345, P33, DOI 10.1097/MAJ.0b013e31824c6f29; Yu Zheng-Ping, 2010, Chin J Cancer, V29, P946	100	96	101	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2256	2267		10.1056/NEJMra1404711	http://dx.doi.org/10.1056/NEJMra1404711			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276563				2022-12-28	WOS:000377920500009
J	Sedrakyan, A; Campbell, B; Merino, JG; Kuntz, R; Hirst, A; McCulloch, P				Sedrakyan, Art; Campbell, Bruce; Merino, Jose G.; Kuntz, Richard; Hirst, Allison; McCulloch, Peter			IDEAL-D: a rational framework for evaluating and regulating the use of medical devices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; METAL; FAILURE		[Sedrakyan, Art] Cornell Univ, Weill Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Sedrakyan, Art] Cornell Univ, Weill Med Coll, Med Device Epidemiol Network MDEpiNet, Sci & Infrastruct Ctr, New York, NY 10021 USA; [Campbell, Bruce] Natl Inst Hlth & Care Excellence, Intervent Procedures Programme, London, England; [Merino, Jose G.] Johns Hopkins Community Phys, Bethesda, MD USA; [Kuntz, Richard] Medtronic, Minneapolis, MN USA; [Hirst, Allison; McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	Cornell University; Cornell University; National Institute for Health & Care Excellence; Johns Hopkins University; Johns Hopkins Medicine; Medtronic; University of Oxford	McCulloch, P (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	peter.mcculloch@nds.ox.ac.uk	Merino, Jose G./J-8474-2019	Merino, Jose G./0000-0002-6676-0008; McCulloch, Peter/0000-0002-3210-8273; Hirst, Allison/0000-0002-5864-4840				Ardaugh BM, 2013, NEW ENGL J MED, V368, P97, DOI 10.1056/NEJMp1211581; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Campion TR, 2014, MED CARE, V52, P26, DOI 10.1097/MLR.0000000000000012; Chatterjee S, 2015, JAMA INTERN MED, V175, P1104, DOI 10.1001/jamainternmed.2015.1513; Chick S, 2015, BAYESIAN DECISION TH; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Hart AJ, 2013, J BONE JOINT SURG AM, V95A, P678, DOI 10.2106/JBJS.J.01447; Horton R, 2012, LANCET, V379, P106, DOI 10.1016/S0140-6736(12)60032-4; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Krucoff MW, 2015, JAMA-J AM MED ASSOC, V314, P1691, DOI 10.1001/jama.2015.11036; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; Nappi F, 2015, J THORAC CARDIOV SUR, V149, P1134, DOI 10.1016/j.jtcvs.2014.12.056; National Institutes of Health, 2015, PRINC GUID REP PRECL; Pehrsson SK, 2003, SCAND CARDIOVASC J, V37, P235, DOI 10.1080/14017430310001681; PELTZMAN S, 1973, J POLIT ECON, V81, P1049, DOI 10.1086/260107; Pennell CP, 2016, INT J SURG, V28, P141, DOI 10.1016/j.ijsu.2016.01.082; Relton C, 2010, BMJ-BRIT MED J, V340, pc1066, DOI DOI 10.1136/BMJ.C1066; Sedrakyan A, 2014, J BONE JOINT SURG AM, V96A, P1, DOI 10.2106/JBJS.N.00739; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; U.S. Food and Drug Administration, 2013, INV DEV EX IDES EARL; US Food and Drug Administration, 2014, TOT PROD LIF CYCL TP; US Food and Drug Administration, 2011, TRANSCR PUBL WORKSH; WINSTONE NE, 1965, LANCET, V1, P843	28	116	120	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2016	353								i2372	10.1136/bmj.i2372	http://dx.doi.org/10.1136/bmj.i2372			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YQ	27283585	Green Submitted			2022-12-28	WOS:000377859500001
J	Zoma, AA				Zoma, Asad A.			Clinical overlap in proximal artery stenosis: two disorders or one?	LANCET			English	Editorial Material									[Zoma, Asad A.] Hairmyres Hosp, Lanarkshire Ctr Rheumatol, E Kilbride G75 8RG, Lanark, Scotland	University Hospital Hairmyres	Zoma, AA (corresponding author), Hairmyres Hosp, Lanarkshire Ctr Rheumatol, E Kilbride G75 8RG, Lanark, Scotland.	asad.zoma@lanarkshire.scot.nhs.uk						Clark T, 2003, CLIN EXP RHEUMATOL, V21, pS124; Jain P, 2016, LANCET, V387, P2349, DOI 10.1016/S0140-6736(16)00584-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2350	2350		10.1016/S0140-6736(16)30524-4	http://dx.doi.org/10.1016/S0140-6736(16)30524-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302275				2022-12-28	WOS:000376969100039
J	Khorasaninejad, M; Chen, WT; Devlin, RC; Oh, J; Zhu, AY; Capasso, F				Khorasaninejad, Mohammadreza; Chen, Wei Ting; Devlin, Robert C.; Oh, Jaewon; Zhu, Alexander Y.; Capasso, Federico			Metalenses at visible wavelengths: Diffraction-limited focusing and subwavelength resolution imaging	SCIENCE			English	Article							FLAT LENSES; PHASE; REFLECTION	Subwavelength resolution imaging requires high numerical aperture (NA) lenses, which are bulky and expensive. Metasurfaces allow the miniaturization of conventional refractive optics into planar structures. We show that high-aspect-ratio titanium dioxide metasurfaces can be fabricated and designed as metalenses with NA = 0.8. Diffraction-limited focusing is demonstrated at wavelengths of 405, 532, and 660 nm with corresponding efficiencies of 86, 73, and 66%. The metalenses can resolve nanoscale features separated by subwavelength distances and provide magnification as high as 170x, with image qualities comparable to a state-of-the-art commercial objective. Our results firmly establish that metalenses can have widespread applications in laser-based microscopy, imaging, and spectroscopy.	[Khorasaninejad, Mohammadreza; Chen, Wei Ting; Devlin, Robert C.; Oh, Jaewon; Zhu, Alexander Y.; Capasso, Federico] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Oh, Jaewon] Univ Waterloo, Waterloo, ON N2L 3G1, Canada	Harvard University; University of Waterloo	Capasso, F (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu	Chen, Wei Ting/J-7691-2012; Zhu, Alexander/Q-2473-2016	Chen, Wei Ting/0000-0001-8665-9241; Oh, Jaewon/0000-0002-9525-7380	Air Force Office of Scientific Research (MURI) [FA9550-14-1-0389]; Charles Stark Draper Laboratory, Inc. [SC001-0000000959]; Thorlabs Inc.; Ministry of Science and Technology, Taiwan [104-2917-I-564-058]; Charles Stark Draper Fellowship; Harvard John A. Paulson School of Engineering and Applied Sciences; A*STAR Singapore; NSF	Air Force Office of Scientific Research (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Charles Stark Draper Laboratory, Inc.; Thorlabs Inc.; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Charles Stark Draper Fellowship; Harvard John A. Paulson School of Engineering and Applied Sciences; A*STAR Singapore(Agency for Science Technology & Research (A*STAR)); NSF(National Science Foundation (NSF))	This work was supported in part by the Air Force Office of Scientific Research (MURI, grant FA9550-14-1-0389), Charles Stark Draper Laboratory, Inc. (SC001-0000000959), and Thorlabs Inc. W.T.C. acknowledges postdoctoral fellowship support from the Ministry of Science and Technology, Taiwan (104-2917-I-564-058). R.C.D. is supported by a Charles Stark Draper Fellowship. A.Y.Z. thanks Harvard John A. Paulson School of Engineering and Applied Sciences and A*STAR Singapore under the National Science Scholarship scheme. Fabrication work was carried out in the Harvard Center for Nanoscale Systems, which is supported by the NSF. We thank E. Hu for the supercontinuum laser (NKT "SuperK").	Aieta F, 2015, SCIENCE, V347, P1342, DOI 10.1126/science.aaa2494; Aieta F, 2013, OPT EXPRESS, V21, P31530, DOI 10.1364/OE.21.031530; Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Arbabi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8069; BERRY MV, 1987, J MOD OPTIC, V34, P1401, DOI 10.1080/09500348714551321; Bomzon Z, 2002, OPT LETT, V27, P285, DOI 10.1364/OL.27.000285; Chang-Hasnain CJ, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/1/014043; Chen WT, 2014, NANO LETT, V14, P225, DOI 10.1021/nl403811d; Chong KE, 2015, NANO LETT, V15, P5369, DOI 10.1021/acs.nanolett.5b01752; Devlin R C., 2016, ARXIV160302735; Fattal D, 2010, NAT PHOTONICS, V4, P466, DOI [10.1038/nphoton.2010.116, 10.1038/NPHOTON.2010.116]; Grbic A, 2008, SCIENCE, V320, P511, DOI 10.1126/science.1154753; High AA, 2015, NATURE, V522, P192, DOI 10.1038/nature14477; Jahani S, 2016, NAT NANOTECHNOL, V11, P23, DOI [10.1038/nnano.2015.304, 10.1038/NNANO.2015.304]; Khorasaninejad M, 2015, OPTICA, V2, P376, DOI 10.1364/OPTICA.2.000376; Khorasaninejad M, 2015, NANO LETT, V15, P6709, DOI 10.1021/acs.nanolett.5b02524; Khorasaninejad M, 2015, NANO LETT, V15, P5358, DOI 10.1021/acs.nanolett.5b01727; Khorasaninejad M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6386; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Larouche S, 2012, NAT MATER, V11, P450, DOI [10.1038/NMAT3278, 10.1038/nmat3278]; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Liu S, 2014, OPTICA, V1, P250, DOI 10.1364/OPTICA.1.000250; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; Monticone F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203903; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; PANCHARATNAM S., 1956, P INDIAN ACAD SCI A, V44, P398, DOI DOI 10.1007/BF03046095; Rogers ETF, 2012, NAT MATER, V11, P432, DOI [10.1038/NMAT3280, 10.1038/nmat3280]; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]; Spinelli P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1691; Sun SL, 2012, NANO LETT, V12, P6223, DOI 10.1021/nl3032668; Yang YM, 2014, NANO LETT, V14, P1394, DOI 10.1021/nl4044482; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yoshida M., 2013, U.S. Patent App., Patent No. [13/760,681, 13760681]; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zheng GX, 2015, NAT NANOTECHNOL, V10, P308, DOI [10.1038/nnano.2015.2, 10.1038/NNANO.2015.2]	36	1881	1981	178	1194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1190	1194		10.1126/science.aaf6644	http://dx.doi.org/10.1126/science.aaf6644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257251	Green Published			2022-12-28	WOS:000377045700035
J	Peters, JM; Colavin, A; Shi, HD; Czarny, TL; Larson, MH; Wong, S; Hawkins, JS; Lu, CHS; Koo, BM; Marta, E; Shiver, AL; Whitehead, EH; Weissman, JS; Brown, ED; Qi, LS; Huang, KC; Gross, CA				Peters, Jason M.; Colavin, Alexandre; Shi, Handuo; Czarny, Tomasz L.; Larson, Matthew H.; Wong, Spencer; Hawkins, John S.; Lu, Candy H. S.; Koo, Byoung-Mo; Marta, Elizabeth; Shiver, Anthony L.; Whitehead, Evan H.; Weissman, Jonathan S.; Brown, Eric D.; Qi, Lei S.; Huang, Kerwyn Casey; Gross, Carol A.			A Comprehensive, CRISPR-based Functional Analysis of Essential Genes in Bacteria	CELL			English	Article							PENICILLIN-BINDING PROTEINS; SEQUENCE-SPECIFIC CONTROL; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ROD SHAPE; GENOME; GROWTH; EXPRESSION; IDENTIFICATION; BIOSYNTHESIS	Essential gene functions underpin the core reactions required for cell viability, but their contributions and relationships are poorly studied in vivo. Using CRISPR interference, we created knockdowns of every essential gene in Bacillus subtilis and probed their phenotypes. Our high-confidence essential gene network, established using chemical genomics, showed extensive interconnections among distantly related processes and identified modes of action for uncharacterized antibiotics. Importantly, mild knockdown of essential gene functions significantly reduced stationary-phase survival without affecting maximal growth rate, suggesting that essential protein levels are set to maximize outgrowth from stationary phase. Finally, high-throughput microscopy indicated that cell morphology is relatively insensitive to mild knockdown but profoundly affected by depletion of gene function, revealing intimate connections between cell growth and shape. Our results provide a framework for systematic investigation of essential gene functions in vivo broadly applicable to diverse microorganisms and amenable to comparative analysis.	[Peters, Jason M.; Hawkins, John S.; Lu, Candy H. S.; Koo, Byoung-Mo; Marta, Elizabeth; Shiver, Anthony L.; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Colavin, Alexandre; Huang, Kerwyn Casey] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Shi, Handuo; Qi, Lei S.; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Czarny, Tomasz L.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 3Z5, Canada; [Larson, Matthew H.; Wong, Spencer; Whitehead, Evan H.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Larson, Matthew H.; Whitehead, Evan H.; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Hawkins, John S.; Shiver, Anthony L.] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94158 USA; [Whitehead, Evan H.; Weissman, Jonathan S.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Czarny, Tomasz L.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Qi, Lei S.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Qi, Lei S.] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Huang, Kerwyn Casey] Stanford Univ, Dept Microbiol & Immunol, Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; Stanford University; McMaster University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McMaster University; Stanford University; Stanford University; Stanford University	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.; Huang, KC (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Qi, LS; Huang, KC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Qi, LS (corresponding author), Stanford Univ, ChEM H, Stanford, CA 94305 USA.; Huang, KC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Med, Stanford, CA 94305 USA.	stanley.qi@stanford.edu; kchuang@stanford.edu; cgrossucsf@gmail.com	Qi, Lei S/AAC-5088-2019; Larson, Matthew/C-8289-2014	Shi, Handuo/0000-0002-1688-6905; Whitehead, Evan/0000-0002-4132-2140; /0000-0003-4306-7662; Weissman, Jonathan/0000-0003-2445-670X; Larson, Matthew/0000-0002-6778-2604; Qi, Lei S/0000-0002-3965-3223; Czarny, Tomasz/0000-0002-0972-8116; Koo, Byoung-Mo/0000-0003-1001-6367	UCSF Center for Systems and Synthetic Biology; Stanford Graduate Fellowship; Stanford Agilent Fellowship; Foundation Grant (from Canadian Institutes of Health Research); Canada Research Chair; NIH [F32 GM108222, DA036858, OD017887, R01 DA036858, DP2-OD006466, NIH R01 GM102790]; HHMI; NSF [MCB-1149328]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108222, T32GM008294, P50GM107615, R01GM102790, R35GM118061, T32GM008284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466, DP5OD017887] Funding Source: NIH RePORTER	UCSF Center for Systems and Synthetic Biology; Stanford Graduate Fellowship(Stanford University); Stanford Agilent Fellowship; Foundation Grant (from Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Rudner for strains/plasmids, O. Rosenberg for S. aureus DNA, G. Kritikos and N. Typas for colony-sizing software, and A. Grossman, G. W. Li, N. Typas, and anonymous reviewers for helpful comments. This work was supported by the UCSF Center for Systems and Synthetic Biology (to L.S.Q.), a Stanford Graduate Fellowship (to A.C.), a Stanford Agilent Fellowship (to H.S.), a Foundation Grant (from the Canadian Institutes of Health Research) and a Canada Research Chair to (E.D.B.), the NIH (F32 GM108222 to J.M.P.; DA036858 to J.S.W.; OD017887, R01 DA036858 to L.S.Q.; DP2-OD006466 to K.C.H.; NIH R01 GM102790 to C.A.G.), HHMI funding (to J.S.W.), and NSF funding (MCB-1149328) (to K.C.H.).	Arjes HA, 2014, CURR BIOL, V24, P2149, DOI 10.1016/j.cub.2014.07.055; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Busiek KK, 2015, CURR BIOL, V25, pR243, DOI 10.1016/j.cub.2015.01.030; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Czarny TL, 2014, ANTIMICROB AGENTS CH, V58, P3261, DOI 10.1128/AAC.02352-14; Elbaz M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001119; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Moche M, 1999, J BIOL CHEM, V274, P6031, DOI 10.1074/jbc.274.10.6031; MYODA TT, 1984, GENE, V29, P135, DOI 10.1016/0378-1119(84)90174-4; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Overkamp W, 2015, ENVIRON MICROBIOL, V17, P346, DOI 10.1111/1462-2920.12676; Peters JM, 2015, CURR OPIN MICROBIOL, V27, P121, DOI 10.1016/j.mib.2015.08.007; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Schujman GE, 2001, J BACTERIOL, V183, P3032, DOI 10.1128/JB.183.10.3032-3040.2001; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thomaides HB, 2007, J BACTERIOL, V189, P591, DOI 10.1128/JB.01381-06; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Xu L, 2007, PROTEINS, V68, P438, DOI 10.1002/prot.21377; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	45	342	352	9	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1493	1506		10.1016/j.cell.2016.05.003	http://dx.doi.org/10.1016/j.cell.2016.05.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27238023	Green Accepted, Bronze			2022-12-28	WOS:000377045400021
J	Sallam, T; Jones, MC; Gilliland, T; Zhang, L; Wu, XH; Eskin, A; Sandhu, J; Casero, D; Vallim, TQD; Hong, C; Katz, M; Lee, R; Whitelegge, J; Tontonoz, P				Sallam, Tamer; Jones, Marius C.; Gilliland, Thomas; Zhang, Li; Wu, Xiaohui; Eskin, Ascia; Sandhu, Jaspreet; Casero, David; Vallim, Thomas Q. de Aguiar; Hong, Cynthia; Katz, Melanie; Lee, Richard; Whitelegge, Julian; Tontonoz, Peter			Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis	NATURE			English	Article							LXR-ALPHA; MICE; PROTEIN; LIVER; GENE; RECEPTOR; ATHEROSCLEROSIS; TRANSCRIPTS; ACTIVATION; EXPRESSION	Liver X receptors (LXRs) are transcriptional regulators of cellular and systemic cholesterol homeostasis. Under conditions of excess cholesterol, LXR activation induces the expression of several genes involved in cholesterol efflux(1), facilitates cholesterol esterification by promoting fatty acid synthesis(2), and inhibits cholesterol uptake by the low-density lipoprotein receptor(3). The fact that sterol content is maintained in a narrow range in most cell types and in the organism as a whole suggests that extensive crosstalk between regulatory pathways must exist. However, the molecular mechanisms that integrate LXRs with other lipid metabolic pathways are incompletely understood. Here we show that ligand activation of LXRs in mouse liver not only promotes cholesterol efflux, but also simultaneously inhibits cholesterol biosynthesis. We further identify the long non-coding RNA LeXis as a mediator of this effect. Hepatic LeXis expression is robustly induced in response to a Western diet (high in fat and cholesterol) or to pharmacological LXR activation. Raising or lowering LeXis levels in the liver affects the expression of genes involved in cholesterol biosynthesis and alters the cholesterol levels in the liver and plasma. LeXis interacts with and affects the DNA interactions of RALY, a heterogeneous ribonucleoprotein that acts as a transcriptional cofactor for cholesterol biosynthetic genes in the mouse liver. These findings outline a regulatory role for a non-coding RNA in lipid metabolism and advance our understanding of the mechanisms that coordinate sterol homeostasis.	[Sallam, Tamer; Jones, Marius C.; Gilliland, Thomas; Zhang, Li; Wu, Xiaohui; Sandhu, Jaspreet; Casero, David; Hong, Cynthia; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sallam, Tamer; Wu, Xiaohui; Vallim, Thomas Q. de Aguiar] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Eskin, Ascia] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Katz, Melanie; Lee, Richard] Ionis Pharmaceut, Carlsbad, CA 92008 USA; [Whitelegge, Julian] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ionis Pharmaceuticals, Inc.; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Sallam, Tamer/0000-0001-7144-7393	NIH [HL030568, HL066088, DK063491, HL128822, DK102559, HL69766]; American Heart Association [13POST17080115]; American College of Cardiology Presidential CDA; UCLA Cardiovascular Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL090553, T32HL069766, T32HL007895, P01HL030568, K08HL128822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK102559] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American College of Cardiology Presidential CDA; UCLA Cardiovascular Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Tontonoz, Nagy, Smale and Black laboratories and the UCLA Atherosclerosis Research Unit for technical assistance and useful discussions. This work was support by NIH grants HL030568, HL066088, DK063491, HL128822, DK102559 and HL69766; American Heart Association grant 13POST17080115; American College of Cardiology Presidential CDA; and the UCLA Cardiovascular Discovery Fund (Lauren B. Leichtman and Arthur E. Levine Investigator Award).	Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carey M. F., 2009, COLD SPRING HARB PRO, V2009; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Hong C, 2014, CELL METAB, V20, P910, DOI 10.1016/j.cmet.2014.10.001; Hong C, 2012, J LIPID RES, V53, P1126, DOI 10.1194/jlr.M022061; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang WP, 1998, BBA-GENE STRUCT EXPR, V1399, P229, DOI 10.1016/S0167-4781(98)00114-6; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sallam T, 2014, J LIPID RES, V55, P1120, DOI 10.1194/jlr.M047548; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Tarling EJ, 2015, ARTERIOSCL THROM VAS, V35, P787, DOI 10.1161/ATVBAHA.114.304179; Tontonoz P, 2011, COLD SH Q B, V76, P129, DOI 10.1101/sqb.2011.76.010702; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	38	137	145	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					124	+		10.1038/nature17674	http://dx.doi.org/10.1038/nature17674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251289	Green Accepted, Green Submitted			2022-12-28	WOS:000376962300047
J	Saleh, A				Saleh, Ahmed			Bhasker Kamath OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2969	10.1136/bmj.i2969	http://dx.doi.org/10.1136/bmj.i2969			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27233807				2022-12-28	WOS:000376940700006
J	Blazer, DG				Blazer, Dan G.			Hearing Health Care: Review of a Report From the National Academies of Sciences, Engineering, and Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NUTRITION EXAMINATION SURVEY; UNITED-STATES; OLDER-ADULTS; LOSS PREVALENCE; AID USE		[Blazer, Dan G.] Duke Univ, Med Ctr, Durham, NC USA	Duke University	Blazer, DG (corresponding author), Duke Univ, Med Ctr, Psychiat & Behav Sci, Box 3003, Durham, NC 27710 USA.	dan.g.blazer@dm.duke.edu						Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Bainbridge KE, 2014, EAR HEARING, V35, P289, DOI 10.1097/01.aud.0000441036.40169.29; Blazer D G, 2016, HEARING HLTH CARE AD; Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2012, ARCH INTERN MED, V172, P369, DOI 10.1001/archinternmed.2011.728; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002	8	0	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					441	+		10.7326/M16-1209	http://dx.doi.org/10.7326/M16-1209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27273136				2022-12-28	WOS:000383962000020
J	Marso, SP; Daniels, GH; Brown-Frandsen, K; Kristensen, P; Mann, JFE; Nauck, MA; Nissen, SE; Pocock, S; Poulter, NR; Ravn, LS; Steinberg, WM; Stockner, M; Zinman, B; Bergenstal, RM; Buse, JB				Marso, Steven P.; Daniels, Gilbert H.; Brown-Frandsen, Kirstine; Kristensen, Peter; Mann, Johannes F. E.; Nauck, Michael A.; Nissen, Steven E.; Pocock, Stuart; Poulter, Neil R.; Ravn, Lasse S.; Steinberg, William M.; Stockner, Mette; Zinman, Bernard; Bergenstal, Richard M.; Buse, John B.		LEADER Steering Comm; LEADER Trial Investigators	Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANCREATITIS; TRIALS	BACKGROUND The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. METHODS In this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk to receive liraglutide or placebo. The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The primary hypothesis was that liraglutide would be noninferior to placebo with regard to the primary outcome, with a margin of 1.30 for the upper boundary of the 95% confidence interval of the hazard ratio. No adjustments for multiplicity were performed for the prespecified exploratory outcomes. RESULTS A total of 9340 patients underwent randomization. The median follow-up was 3.8 years. The primary outcome occurred in significantly fewer patients in the liraglutide group (608 of 4668 patients [13.0%]) than in the placebo group (694 of 4672 [14.9%]) (hazard ratio, 0.87; 95% confidence interval [CI], 0.78 to 0.97; P<0.001 for noninferiority; P = 0.01 for superiority). Fewer patients died from cardiovascular causes in the liraglutide group (219 patients [4.7%]) than in the placebo group (278 [6.0%]) (hazard ratio, 0.78; 95% CI, 0.66 to 0.93; P = 0.007). The rate of death from any cause was lower in the liraglutide group (381 patients [8.2%]) than in the placebo group (447 [9.6%]) (hazard ratio, 0.85; 95% CI, 0.74 to 0.97; P = 0.02). The rates of nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure were nonsignificantly lower in the liraglutide group than in the placebo group. The most common adverse events leading to the discontinuation of liraglutide were gastrointestinal events. The incidence of pancreatitis was nonsignificantly lower in the liraglutide group than in the placebo group. CONCLUSIONS In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients with type 2 diabetes mellitus was lower with liraglutide than with placebo. (Funded by Novo Nordisk and the National Institutes of Health; LEADER ClinicalTrials.gov number, NCT01179048.)	[Marso, Steven P.] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Daniels, Gilbert H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Brown-Frandsen, Kirstine; Kristensen, Peter; Ravn, Lasse S.; Stockner, Mette] Novo Nordisk, Bagsvaerd, Denmark; [Mann, Johannes F. E.] Univ Erlangen Nurnberg, Erlangen, Germany; [Nauck, Michael A.] Ruhr Univ, St Josef Hosp, Bochum, Germany; [Nissen, Steven E.] Cleveland Clin, Cleveland, OH 44106 USA; [Pocock, Stuart] London Sch Hyg & Trop Med Med, Stat Unit, London, England; [Poulter, Neil R.] Imperial Coll London, London, England; [Steinberg, William M.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Zinman, Bernard] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Bergenstal, Richard M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA; [Buse, John B.] Univ N Carolina, Sch Med, CB7172, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; University of Erlangen Nuremberg; Ruhr University Bochum; Cleveland Clinic Foundation; Imperial College London; George Washington University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; International Diabetes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Buse, JB (corresponding author), Univ N Carolina, Sch Med, CB7172, Chapel Hill, NC 27599 USA.	john_buse@med.unc.edu	Ozdem, Sadi S/C-1140-2016; Iyidir, Ozlem/K-7904-2019; Mann, Johannes/AAI-8803-2020; Gerchman, Fernando/K-1936-2017; BALCI, Mustafa Kemal/C-2979-2016; Hramiak, Irene/G-3305-2011; Gogas Yavuz, Dilek/AAC-3697-2020; Vladu, Mihaela Ionela/AAA-6254-2021; Strelkova, Alexandra/AAE-2917-2019; Saravanan, P/M-6142-2016; Uygur, Meliha Melin/AAJ-5766-2021; Lyudmila, Suplotova A/J-3596-2014; Gunasekaran, Prasad/AAW-4107-2021; Mattina, Alessandro/F-6020-2019; Tack, Cees J/A-2368-2014; Gogas Yavuz, Dilek/GPX-2330-2022; Prozesky, Hans Walter/ABE-6956-2020; Tamer, Ismet/AAR-6115-2020; Camafort-Babkowski, Miguel/H-6310-2014; Trachta, Pavel/B-2602-2017; Harbers, Veroniek/G-5470-2017; Haluzik, Martin/I-8190-2017; cavdar, umit/GSI-8283-2022; Gogas Yavuz, Dilek/GRR-7277-2022; Mehr, Ali Poyan/P-9665-2019; Buscemi, Silvio/K-9662-2016; Dagdelen, Selcuk/A-9432-2017; Popović, Ljiljana/ABC-1897-2021; Bogdański, Paweł/ABB-2938-2020; Ataoğlu, Hayriye Esra/AAD-5627-2019; Buse, John Bernard/J-9742-2019; Geloneze, Bruno/F-4231-2010; Anderlova, Katerina/D-9334-2017; Gilfillan, Christopher/O-4310-2019; Křížová, Jarmila/B-2601-2017; Hukkanen, Janne/C-7292-2013; Canani, Luis H/G-9686-2012; Zinman, Bernard/E-7266-2013; Nauck, Michael Albrecht/ABA-9752-2021; Correia-Deur, Joya/M-1037-2017; Eliasson, Bjorn/H-5783-2016; Alvarez-Villalobos, Neri/D-4055-2018	Ozdem, Sadi S/0000-0003-4325-5209; Iyidir, Ozlem/0000-0001-5305-6807; Gerchman, Fernando/0000-0001-5873-9498; BALCI, Mustafa Kemal/0000-0002-6494-3249; Gogas Yavuz, Dilek/0000-0002-0075-6313; Vladu, Mihaela Ionela/0000-0002-6133-4341; Strelkova, Alexandra/0000-0002-9077-889X; Saravanan, P/0000-0002-9566-2626; Uygur, Meliha Melin/0000-0002-6569-8142; Lyudmila, Suplotova A/0000-0001-9253-8075; Gunasekaran, Prasad/0000-0002-6852-528X; Mattina, Alessandro/0000-0003-3458-0894; Gogas Yavuz, Dilek/0000-0002-0075-6313; Prozesky, Hans Walter/0000-0001-9715-3449; Tamer, Ismet/0000-0001-9596-7203; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Trachta, Pavel/0000-0002-2218-3157; Haluzik, Martin/0000-0002-0201-6888; Gogas Yavuz, Dilek/0000-0002-0075-6313; Mehr, Ali Poyan/0000-0001-5610-2979; Buscemi, Silvio/0000-0003-0730-7649; Dagdelen, Selcuk/0000-0002-0513-1750; Bogdański, Paweł/0000-0002-0563-1624; Ataoğlu, Hayriye Esra/0000-0002-6559-2575; Buse, John Bernard/0000-0002-9723-3876; Geloneze, Bruno/0000-0002-0557-4578; Anderlova, Katerina/0000-0001-8794-6496; Křížová, Jarmila/0000-0001-7287-5672; Hukkanen, Janne/0000-0003-4981-0525; Canani, Luis H/0000-0002-1813-4491; Nauck, Michael Albrecht/0000-0002-5749-6954; Correia-Deur, Joya/0000-0002-5347-9321; Milicic, Tanja/0000-0001-7300-916X; Montenegro Junior, Renan/0000-0001-7287-8726; Reyes-Garcia, Rebeca/0000-0003-1729-4431; Huang, Chung-Huei/0000-0001-6736-1423; Kunecki, Marcin/0000-0003-4077-7378; Jaap, Alan/0000-0001-8289-704X; consoli, agostino/0000-0002-1885-451X; DINCER, IREM/0000-0002-3650-7060; Harbers, Veroniek/0000-0002-0428-3242; MARANGHI, MARIANNA/0000-0002-3117-7488; Madsbad, Sten/0000-0002-5017-1815; Valeeva, Farida/0000-0001-6000-8002; Hernandez Salazar, Eduardo/0000-0002-2087-6849; Eliasson, Bjorn/0000-0003-2569-4160; Sgarbi, Jose/0000-0001-7187-984X; Tarnow, Lise/0000-0002-8735-966X; Gilfillan, Christopher/0000-0002-8193-8994; Pieber, Thomas/0000-0003-3554-0405; KARAKILIC, ERSEN/0000-0003-3590-2656; Cederberg, Henna/0000-0003-2901-9373; Alvarez-Villalobos, Neri/0000-0001-5208-1429; O'Connell, Jean/0000-0001-7241-8025; Lindsay, Robert/0000-0002-9868-5217; Zurawska-Klis, Monika/0000-0002-2962-762X; Lin, Shu-Fu/0000-0001-8877-9685; Huang, Yu-Yao/0000-0002-4501-6140; English, Patrick/0000-0001-6268-8400; MOTA, JOSE ITALO/0000-0002-9763-0580; Kiseleva, Tatiana/0000-0001-8959-093X; Asik, mehmet/0000-0002-0716-0221; Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; ENGIN, ISMAIL/0000-0002-6493-9194; Holst, Anders Gaarsdal/0000-0002-5343-7367; S, Paramesh/0000-0002-0693-4483; Piya, Milan/0000-0002-2783-1168	Novo Nordisk; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111, UL1TR002489] Funding Source: NIH RePORTER	Novo Nordisk(Novo Nordisk); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Novo Nordisk and the National Institutes of Health; LEADER ClinicalTrials.gov number, NCT01179048.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 2016, DIABETES CARE S1, V39, pS1; [Anonymous], 2008, GUID IND DIAB MELL E; [Anonymous], 2012, GUID CLIN INV MED PR; Atlas D., 2015, IDF DIABETES ATLAS, V7th; Chalmer T, 2015, EXPERT OPIN DRUG SAF, V14, P171, DOI 10.1517/14740338.2015.975205; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Du Q, 2014, ADV THER, V31, P1182, DOI 10.1007/s12325-014-0164-2; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jensen TM, 2015, DIABETES CARE, V38, P1058, DOI 10.2337/dc13-1210; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Marso SP, 2013, AM HEART J, V166, P823, DOI 10.1016/j.ahj.2013.07.012; McGuire DK, 2016, JAMA CARDIOL, V1, P126, DOI 10.1001/jamacardio.2016.0103; Muskiet MHA, 2014, NAT REV NEPHROL, V10, P88, DOI 10.1038/nrneph.2013.272; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Robinson LE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001986; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Tanaka T, 2014, KIDNEY INT, V86, P701, DOI 10.1038/ki.2014.236; Tseng CH, 2015, J ENVIRON SCI HEAL C, V33, P67, DOI 10.1080/10590501.2015.1003496; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	27	4174	4337	23	400	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					311	322		10.1056/NEJMoa1603827	http://dx.doi.org/10.1056/NEJMoa1603827			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0UV	27295427	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000380313200005
J	Zhao, X; Hirota, T; Han, X; Cho, H; Chong, LW; Lamia, K; Liu, S; Atkins, AR; Banayo, E; Liddle, C; Yu, RT; Yates, JR; Kay, SA; Downes, M; Evans, RM				Zhao, Xuan; Hirota, Tsuyoshi; Han, Xuemei; Cho, Han; Chong, Ling-Wa; Lamia, Katja; Liu, Sihao; Atkins, Annette R.; Banayo, Ester; Liddle, Christopher; Yu, Ruth T.; Yates, John R., III; Kay, Steve A.; Downes, Michael; Evans, Ronald M.			Circadian Amplitude Regulation via FBXW7-Targeted REV-ERB alpha Degradation	CELL			English	Article							UBIQUITIN LIGASE; F-BOX; CELL-DIVISION; DNA-DAMAGE; IN-VIVO; CLOCK; METABOLISM; RHYTHMS; PROTEIN; RECEPTOR	Defects in circadian rhythm influence physiology and behavior with implications for the treatment of sleep disorders, metabolic disease, and cancer. Although core regulatory components of clock rhythmicity have been defined, insight into the mechanisms underpinning amplitude is limited. Here, we show that REV-ERB alpha, a core inhibitory component of clock transcription, is targeted for ubiquitination and subsequent degradation by the F-box protein FBXW7. By relieving REV-ERB alpha-dependent repression, FBXW7 provides an unrecognized mechanism for enhancing the amplitude of clock gene transcription. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of REV-ERB alpha is necessary for FBXW7 recognition. Moreover, targeted hepatic disruption of FBXW7 alters circadian expression of core clock genes and perturbs whole-body lipid and glucose levels. This CDK1-FBXW7 pathway controlling REV-ERB alpha repression defines an unexpected molecular mechanism for re-engaging the positive transcriptional arm of the clock, as well as a potential route to manipulate clock amplitude via small molecule CDK1 inhibition.	[Zhao, Xuan; Cho, Han; Chong, Ling-Wa; Lamia, Katja; Liu, Sihao; Atkins, Annette R.; Banayo, Ester; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hirota, Tsuyoshi; Kay, Steve A.] Nagoya Univ, Inst Transformat Biomol, Nagoya, Aichi 4648601, Japan; [Hirota, Tsuyoshi] Japan Sci & Technol Agcy, PRESTO, Nagoya, Aichi 4648601, Japan; [Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Liddle, Christopher] Univ Sydney, Sydney Med Sch, Storr Liver Ctr, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Kay, Steve A.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Lamia, Katja] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Nagoya University; Japan Science & Technology Agency (JST); Scripps Research Institute; University of Sydney; Westmead Institute for Medical Research; Scripps Research Institute; Scripps Research Institute	Downes, M; Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Hirota, Tsuyoshi/D-8158-2015; Kay, Steve A/F-6025-2011	Evans, Ronald/0000-0002-9986-5965; Hirota, Tsuyoshi/0000-0003-4876-3608; Kay, Steve A/0000-0002-0402-2878; Atkins, Annette/0000-0003-2558-7058; Yu, Ruth/0000-0002-9527-9627; Chong, Ling Wa/0000-0002-8571-5413	NIH [DK057978, DK090962, HL088093, HL105278, DK097164, R01GM074868, P41 GM103533, R01 MH067880]; Glenn Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED-002]; Ipsen/Biomeasure; Ellison Medical Foundation; Samuel Waxman Cancer Research Foundation; Susan G. Komen Breast Cancer Research Foundation [PDF0601100]; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097164, R24DK090962, R37DK057978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868, P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05590] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; Ellison Medical Foundation(Lawrence Ellison Foundation); Samuel Waxman Cancer Research Foundation; Susan G. Komen Breast Cancer Research Foundation(Susan G. Komen Breast Cancer Foundation); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs. S. Reed, G. Wahl, and B. Vogelstein for valuable reagents. We thank Y. Dai, L. Ong, and C. Brondos for technical and administrative assistance. R.M.E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology and was supported by NIH grants (DK057978, DK090962, HL088093, and HL105278), the Glenn Foundation, the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED-002), Ipsen/Biomeasure, the Ellison Medical Foundation, and the Samuel Waxman Cancer Research Foundation. X.Z. was supported by grants from the Susan G. Komen Breast Cancer Research Foundation (PDF0601100) and the Glenn Foundation for Medical Research. K.L. was supported by an NIH grant (DK097164). S.A.K was supported by an NIH grant (R01GM074868). J.R.Y was supported by NIH grants (P41 GM103533 and R01 MH067880).	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cai AH, 1997, AM J PHYSIOL-REG I, V272, pR422, DOI 10.1152/ajpregu.1997.272.1.R422; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; DeBruyne JP, 2015, P NATL ACAD SCI USA, V112, P12420, DOI 10.1073/pnas.1501204112; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gamsby JJ, 2009, J BIOL RHYTHM, V24, P193, DOI 10.1177/0748730409334748; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046; Goumidi L, 2013, INT J OBESITY, V37, P666, DOI 10.1038/ijo.2012.117; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; HURD MW, 1995, AM J PHYSIOL-REG I, V269, pR958, DOI 10.1152/ajpregu.1995.269.5.R958; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iurisci I, 2009, CHRONOBIOL INT, V26, P1169, DOI 10.1080/07420520903209942; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramkisoensing A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00128; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sancar G, 2014, CELL MOL LIFE SCI, V71, P2667, DOI 10.1007/s00018-014-1574-7; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Tong X, 2013, COMPR PHYSIOL, V3, P917, DOI 10.1002/cphy.c120017; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	57	97	98	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1644	1657		10.1016/j.cell.2016.05.012	http://dx.doi.org/10.1016/j.cell.2016.05.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27238018	Green Accepted, Bronze			2022-12-28	WOS:000378062000016
J	Coltart, T				Coltart, Tim			Richard Humphry Thomas Ward OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Coltart, Tim] Univ Coll London Hosp, Obstet & Gynaecol, London, England; [Coltart, Tim] Bartholomews Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London								WARD RHT, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i3335	10.1136/bmj.i3335	http://dx.doi.org/10.1136/bmj.i3335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27305915				2022-12-28	WOS:000378240400009
J	Ray, WA; Chung, CP; Murray, KT; Hall, K; Stein, CM				Ray, Wayne A.; Chung, Cecilia P.; Murray, Katherine T.; Hall, Kathi; Stein, C. Michael			Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE RISK SCORES; PRESCRIBING PATTERNS; PROPENSITY SCORES; SLEEP; OVERDOSE; ANALGESICS; PERFORMANCE; MEDICATION; THERAPY	IMPORTANCE Long-acting opioids increase the risk of unintentional overdose deaths but also may increase mortality from cardiorespiratory and other causes. OBJECTIVE To compare all-cause mortality for patients with chronic noncancer pain who were prescribed either long-acting opioids or alternative medications for moderate to severe chronic pain. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study between 1999 and 2012 of Tennessee Medicaid patients with chronic noncancer pain and no evidence of palliative or end-of-life care. EXPOSURES Propensity score-matched new episodes of prescribed therapy for long-acting opioids or either analgesic anticonvulsants or low-dose cyclic antidepressants (control medications). MAIN OUTCOMES AND MEASURES Total and cause-specific mortality as determined from death certificates. Adjusted hazard ratios (HRs) and risk differences (difference in incidence of death) were calculated for long-acting opioid therapy vs control medication. RESULTS There were 22 912 new episodes of prescribed therapy for both long-acting opioids and control medications (mean [SD] age, 48 [11] years; 60% women). The long-acting opioid group was followed up for a mean 176 days and had 185 deaths and the control treatment group was followed up for a mean 128 days and had 87 deaths. The HR for total mortality was 1.64 (95% CI, 1.26-2.12) with a risk difference of 68.5 excess deaths (95% CI, 28.2-120.7) per 10 000 person-years. Increased risk was due to out-of-hospital deaths (154 long-acting opioid, 60 control deaths; HR, 1.90; 95% CI, 1.40-2.58; risk difference, 67.1; 95% CI, 30.1-117.3) excess deaths per 10 000 person-years. For out-of-hospital deaths other than unintentional overdose (120 long-acting opioid, 53 control deaths), the HR was 1.72 (95% CI, 1.24-2.39) with a risk difference of 47.4 excess deaths (95% CI, 15.7-91.4) per 10 000 person-years. The HR for cardiovascular deaths (79 long-acting opioid, 36 control deaths) was 1.65 (95% CI, 1.10-2.46) with a risk difference of 28.9 excess deaths (95% CI, 4.6-65.3) per 10 000 person-years. The HR during the first 30 days of therapy (53 long-acting opioid, 13 control deaths) was 4.16 (95% CI, 2.27-7.63) with a risk difference of 200 excess deaths (95% CI, 80-420) per 10 000 person-years. CONCLUSIONS AND RELEVANCE Prescription of long-acting opioids for chronic noncancer pain, compared with anticonvulsants or cyclic antidepressants, was associated with a significantly increased risk of all-cause mortality, including deaths from causes other than overdose, with a modest absolute risk difference. These findings should be considered when evaluating harms and benefits of treatment.	[Ray, Wayne A.; Hall, Kathi] Vanderbilt Univ, Dept Hlth Policy, Sch Med, Nashville, TN 37212 USA; [Chung, Cecilia P.; Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, Village Vanderbilt, 1501 21st Ave S,Ste 2600, Nashville, TN 37212 USA.	wayne.ray@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	National Heart, Lung, and Blood Institute [5R01HL081707]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23AR064768]; Rheumatology Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR064768] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant 5R01HL081707 from the National Heart, Lung, and Blood Institute (Dr Ray), by grant K23AR064768 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr Chung), and by a grant from the Rheumatology Research Foundation (Dr Chung).	Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Arbogast PG, 2008, EPIDEMIOLOGY, V19, P30, DOI 10.1097/EDE.0b013e31815be000; Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brack A, 2011, J NEUROIMMUNE PHARM, V6, P490, DOI 10.1007/s11481-011-9290-7; Carragee EJ, 2005, NEW ENGL J MED, V352, P1891, DOI 10.1056/NEJMcp042054; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Coolen P., 2009, Morbidity and Mortality Weekly Report, V58, P1171; Correa D, 2015, ANESTH ANALG, V120, P1273, DOI 10.1213/ANE.0000000000000672; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Ghinea N, 2015, J EVAL CLIN PRACT, V21, P28, DOI 10.1111/jep.12223; Lee-Iannotti J, 2014, J CLIN SLEEP MED, V10, P645, DOI 10.5664/jcsm.3790; Mansukhani MP, 2015, AM J PHYSIOL-HEART C, V309, pH739, DOI 10.1152/ajpheart.00285.2015; McCarberg B H, 2001, Am J Ther, V8, P181, DOI 10.1097/00045391-200105000-00006; Menendez ME, 2015, CLIN ORTHOP RELAT R, V473, P2402, DOI 10.1007/s11999-015-4173-5; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub2; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pedersen Line, 2012, Tidsskr Nor Laegeforen, V132, P2489, DOI 10.4045/tidsskr.11.1214; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2015, JAMA INTERN MED, V175, P420, DOI 10.1001/jamainternmed.2014.6294; Ray WA, 2015, PHARMACOEPIDEM DR S, V24, P98, DOI 10.1002/pds.3727; Shadish WR, 2010, NEWBORN INFANT NURS, V10, P19, DOI 10.1053/j.nainr.2009.12.010; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Yue HJ, 2010, MED CLIN N AM, V94, P435, DOI 10.1016/j.mcna.2010.02.007; Zutler M, 2011, CURR PHARM DESIGN, V17, P1443, DOI 10.2174/138161211796197070	39	229	232	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2415	2423		10.1001/jama.2016.7789	http://dx.doi.org/10.1001/jama.2016.7789			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299617	Green Accepted, Bronze			2022-12-28	WOS:000377656900019
J	Brondizio, ES; Le Tourneau, FM				Brondizio, Eduardo S.; Le Tourneau, Francois-Michel			Environmental governance for all	SCIENCE			English	Editorial Material									[Brondizio, Eduardo S.] Indiana Univ, Dept Anthropol, Ctr Anal Social Ecol Landscapes, Bloomington, IN 47405 USA; [Brondizio, Eduardo S.] Indiana Univ, Ostrom Workshop Polit Theory & Policy Anal, Bloomington, IN 47405 USA; [Le Tourneau, Francois-Michel] Univ Paris 03, Ctr Res & Documentat Amer, F-75007 Paris, France; [Le Tourneau, Francois-Michel] CNRS, F-75007 Paris, France; [Brondizio, Eduardo S.; Le Tourneau, Francois-Michel] Inst Amer, F-92170 Vanves, France	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universite Sorbonne Nouvelle - Paris 3; Centre National de la Recherche Scientifique (CNRS)	Brondizio, ES (corresponding author), Indiana Univ, Dept Anthropol, Ctr Anal Social Ecol Landscapes, Bloomington, IN 47405 USA.; Brondizio, ES (corresponding author), Indiana Univ, Ostrom Workshop Polit Theory & Policy Anal, Bloomington, IN 47405 USA.; Brondizio, ES (corresponding author), Inst Amer, F-92170 Vanves, France.	ebrondiz@indiana.edu	Brondizio, Eduardo/R-7643-2019	Le Tourneau, Francois-Michel/0000-0003-1184-8624				Brockington D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0271; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; Calvet-Mir L, 2015, CURR OPIN ENV SUST, V14, P150, DOI 10.1016/j.cosust.2015.06.001; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; Duraiappah AK, 2014, CURR OPIN ENV SUST, V7, P94, DOI 10.1016/j.cosust.2013.11.031; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Fairhead J, 2012, J PEASANT STUD, V39, P237, DOI 10.1080/03066150.2012.671770; Le Tourneau FM, 2015, CURR OPIN ENV SUST, V14, P213, DOI 10.1016/j.cosust.2015.07.017; Mistry J, 2016, SCIENCE, V352, P1274, DOI 10.1126/science.aaf1160; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Qiu J, 2016, NATURE, V529, P142, DOI 10.1038/529142a; Reid RS, 2016, P NATL ACAD SCI USA, V113, P4579, DOI 10.1073/pnas.0900313106; Sikor T., 2013, JUSTICES INJUSTICES, P15	13	118	122	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1272	1273		10.1126/science.aaf5122	http://dx.doi.org/10.1126/science.aaf5122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7ON	27284179	Green Published			2022-12-28	WOS:000377972000018
J	Gulland, A				Gulland, Anne			EU REFERENDUM AND HEALTH Would Brexit stop the flow of doctors and patients between EU countries?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Royal Society, 2015, WHICH COUNTR CAN ACC; Scientists for EU, 2016, WOULD BREX CHANG OUR	2	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3138	10.1136/bmj.i3138	http://dx.doi.org/10.1136/bmj.i3138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27270168				2022-12-28	WOS:000377857800008
J	Rubin, R				Rubin, Rita			Kevan Herold: untangling type 1 diabetes in the clinic and the lab	LANCET			English	Biographical-Item													Rubin, Rita/AAD-1259-2020					HEROLD K, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2283	2283		10.1016/S0140-6736(16)30695-X	http://dx.doi.org/10.1016/S0140-6736(16)30695-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302258				2022-12-28	WOS:000376969100016
J	Ashworth, S				Ashworth, Sarah			Autism is underdiagnosed in prisoners	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULTS		[Ashworth, Sarah] Univ Nottingham, Ctr Forens & Family Psychol, Nottingham NG7 2RD, England; [Ashworth, Sarah] Derbyshire Autism Serv, Ripley, England	University of Nottingham	Ashworth, S (corresponding author), Univ Nottingham, Ctr Forens & Family Psychol, Nottingham NG7 2RD, England.; Ashworth, S (corresponding author), Derbyshire Autism Serv, Ripley, England.	lwxseash@nottingham.ac.uk						Allen D, 2008, J AUTISM DEV DISORD, V38, P748, DOI 10.1007/s10803-007-0442-9; Archer N., 2007, POLICE REV      1128, P28; Birmingham L, 2005, PSYCHIATR BULL, V29, P334, DOI 10.1192/pb.29.9.334; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Department of Health, 2010, FULF REW LIV STRAT A; Department of Health, 2014, THINK AUT FULF REW L; Jones L, 2014, J AUTISM DEV DISORD, V44, P3033, DOI 10.1007/s10803-014-2161-3; SCRAGG P, 1994, BRIT J PSYCHIAT, V165, P679, DOI 10.1192/bjp.165.5.679	8	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3028	10.1136/bmj.i3028	http://dx.doi.org/10.1136/bmj.i3028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO0OU	27255544				2022-12-28	WOS:000377479000004
J	Douvere, F				Douvere, Fanny			The seas cannot be saved on a budget of breadcrumbs	NATURE			English	Editorial Material							CLIMATE-CHANGE		[Douvere, Fanny] UNESCO, World Heritage Marine Programme, Paris, France		Douvere, F (corresponding author), UNESCO, World Heritage Marine Programme, Paris, France.	f.douvere@unesco.org						Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; [No title captured]	3	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					30	32		10.1038/534030a	http://dx.doi.org/10.1038/534030a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27251260	Bronze			2022-12-28	WOS:000376962300017
J	Gorbunova, V; Rezazadeh, S; Seluanov, A				Gorbunova, Vera; Rezazadeh, Sarallah; Seluanov, Andrei			Dangerous Entrapment for NRF2	CELL			English	Editorial Material							DNA-REPAIR; SIRT6; STRESS	Progerin, a mutated lamin A, causes the severe premature-aging syndrome Hutchinson-Gilford progeria (HGPS). Kubben et al. present a driving mechanism for HGPS involving trapping of NRF2 at the nuclear periphery by progerin. This local restriction results in impaired NRF2 signaling and chronic oxidative stress.	[Gorbunova, Vera; Rezazadeh, Sarallah; Seluanov, Andrei] Univ Rochester, Dept Biol, 434 Hutchison Hall,River Campus, Rochester, NY 14627 USA	University of Rochester	Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, 434 Hutchison Hall,River Campus, Rochester, NY 14627 USA.	vera.gorbunova@rochester.edu		rezazadeh, sarallah/0000-0002-7433-0067; Seluanov, Andrei/0000-0003-3400-538X; Gorbunova, Vera/0000-0001-8979-0333	NATIONAL INSTITUTE ON AGING [R01AG027237, P01AG047200, R01AG046320] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG027237, P01 AG047200, R01 AG046320] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ghosh S, 2015, CELL REP, V13, P1396, DOI 10.1016/j.celrep.2015.10.006; Gorbunova V., 2016, MUTAT RES; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Tsurumi A, 2012, EPIGENETICS-US, V7, P680, DOI 10.4161/epi.20540; Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	10	10	10	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1312	1313		10.1016/j.cell.2016.05.061	http://dx.doi.org/10.1016/j.cell.2016.05.061			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259142	Bronze			2022-12-28	WOS:000377045400004
J	Michaletz, ST; Cheng, DL; Kerkhoff, AJ; Enquist, BJ				Michaletz, Sean T.; Cheng, Dongliang; Kerkhoff, Andrew J.; Enquist, Brian J.			Convergence of terrestrial plant production across global climate gradients (vol 512, pg 39, 2014)	NATURE			English	Correction							BIOMASS						Enquist, Brian J/B-6436-2008; Michaletz, Sean/AAO-8175-2021	Enquist, Brian J/0000-0002-6124-7096; Michaletz, Sean/0000-0003-2158-6525				Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Hui DF, 2012, FOREST ECOL MANAG, V264, P72, DOI 10.1016/j.foreco.2011.10.012; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Luo T., 1996, THESIS; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.1890/1051-0761(2002)012[0980:EBAPON]2.0.CO;2; Michaletz ST, 2014, NATURE, V512, P39, DOI 10.1038/nature13470; Ni J, 2001, ANN FOR SCI, V58, P351, DOI 10.1051/forest:2001131	7	2	2	16	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					432	432		10.1038/nature18269	http://dx.doi.org/10.1038/nature18269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27281210	Bronze			2022-12-28	WOS:000383098000060
J	Skinner, SR; Marino, JL				Skinner, S. Rachel; Marino, Jennifer L.			England's Teenage Pregnancy Strategy: a hard-won success	LANCET			English	Editorial Material									[Skinner, S. Rachel] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW 2054, Australia; [Skinner, S. Rachel] Childrens Hosp Westmead, Sydney, NSW 2054, Australia; [Marino, Jennifer L.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Marino, Jennifer L.] Royal Womens Hosp, Melbourne, Vic, Australia	University of Sydney; University of Sydney; University of Melbourne	Skinner, SR (corresponding author), Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW 2054, Australia.; Skinner, SR (corresponding author), Childrens Hosp Westmead, Sydney, NSW 2054, Australia.	rachel.skinner@sydney.edu.au	Skinner, Rachel S/J-8455-2017; Marino, Jennifer L/O-2909-2017	Skinner, Rachel S/0000-0003-1970-9792; Marino, Jennifer L/0000-0001-6742-1940				Department for Education and Skills, 2006, TEEN PREGN NEXT STEP; European Centre for Disease Prevention and Control, 2012, INTR HPV VACC EU COU; Hindin MJ, 2016, B WORLD HEALTH ORGAN, V94, P159, DOI 10.2471/BLT.16.170688; Oringanje C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005215.PUB3; Parliament Scottish, 2013, INQ TEEN PREGN; Patton GC, 2016, LANCET; Smith MA, 2014, CANCER FORUM, V38, P207; *SOC EXCL UN, 1999, TEEN PREGN; Teenage Pregnancy Strategy Evaluation Team, 2005, TEEN PREGN STRAT EV; Wagner K, 2015, HUMAN PAPILLOMAVIRUS; Wellings K, 2016, LANCET; Williams R, 2011, GUARDIAN	12	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					538	540		10.1016/S0140-6736(16)30589-X	http://dx.doi.org/10.1016/S0140-6736(16)30589-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27229191	hybrid			2022-12-28	WOS:000380756600006
J	Dahlen, T; Edgren, G; Lambe, M; Hoglund, M; Bjorkholm, M; Sandin, F; Sjalander, A; Richter, J; Olsson-Stromberg, U; Ohm, L; Back, M; Stenke, L				Dahlen, Torsten; Edgren, Gustaf; Lambe, Mats; Hoglund, Martin; Bjorkholm, Magnus; Sandin, Fredrik; Sjalander, Anders; Richter, Johan; Olsson-Stromberg, Ulla; Ohm, Lotta; Back, Magnus; Stenke, Leif		Swedish CML Grp; Swedish CML Register Grp	Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ARTERIAL OCCLUSIVE DISEASE; NILOTINIB THERAPY; VASCULAR EVENTS; IMATINIB; TRIAL	Background: Tyrosine kinase inhibitors (TKIs) have increased survival dramatically for patients with chronic myeloid leukemia (CML), but continuous administration of these drugs may elicit long-term toxicity. Objective: To investigate the incidence of vascular events in patients with CML treated with first-and second-generation TKIs. Design: Retrospective cohort study using nationwide population-based registries. Setting: Sweden. Patients: All patients diagnosed with chronic-phase CML in Sweden from 2002 to 2012 and treated with a TKI, and 5 age- and sex-matched control individuals per patient. Measurements: Relative risks, expressed as incidence rate ratios comparing patients with control individuals, were calculated. Events per 1000 person-years were assessed in interdrug comparisons. Results: 896 patients, 94.4% with documented TKI treatment, were followed for a median of 4.2 years. There were 54 arterial and 20 venous events in the CML cohort, corresponding to relative risks of 1.5 (95% CI, 1.1 to 2.1) and 2.0 (CI, 1.2 to 3.3), respectively. The event rate for myocardial infarction was higher in patients treated with nilotinib or dasatinib (29 and 19 per 1000 person-years, respectively) than in those receiving imatinib (8 per 1000 person-years), although data are limited and the CIs were wide and overlapped. Among 31 patients treated with a TKI who had myocardial infarction, 26 (84%) had at least 1 major cardiac risk factor diagnosed before the event occurred. Limitations: Patients may have been exposed to multiple TKIs. Data on second-and third-generation TKIs were limited. Conclusion: An increased risk for arterial and venous vascular events was seen in patients with CML treated with a TKI. Further study is needed to determine whether the risk for myocardial infarction increases with second-generation drugs.	Karolinska Univ Hosp, Stockholm, Sweden; Karolinska Inst, Stockholm, Sweden; Reg Canc Ctr, Uppsala, Sweden; Univ Uppsala Hosp, Uppsala, Sweden; Umea Univ, Umea, Sweden; Skane Univ Hosp, Lund, Sweden; [Dahlen, Torsten; Bjorkholm, Magnus; Ohm, Lotta; Stenke, Leif] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, SE-17176 Stockholm, Sweden; [Edgren, Gustaf; Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Hoglund, Martin; Olsson-Stromberg, Ulla] Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Hoglund, Martin; Olsson-Stromberg, Ulla] Univ Hosp, Div Hematol, SE-75185 Uppsala, Sweden; [Sandin, Fredrik] Uppsala Univ Hosp, Reg Canc Ctr, SE-75185 Uppsala, Sweden; [Sjalander, Anders] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden; [Richter, Johan] Skane Univ Hosp, Dept Hematol & Vasc Disorders, SE-22241 Lund, Sweden; [Back, Magnus] Karolinska Univ Hosp, Dept Cardiol, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Umea University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Umea University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital	Dahlen, T (corresponding author), Karolinska Univ Hosp Solna, Div Hematol, Dept Med, SE-17176 Stockholm, Sweden.	torsten.dahlen@karolinska.se	Edgren, Gustaf/F-4013-2014	Edgren, Gustaf/0000-0002-2198-4745; Hoglund, Martin/0000-0003-2468-0226; Lambe, Mats/0000-0002-4624-3767				Aichberger KJ, 2011, AM J HEMATOL, V86, P533, DOI 10.1002/ajh.22037; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Bjorkholm M, 2011, J CLIN ONCOL, V29, P2514, DOI 10.1200/JCO.2011.34.7146; Breccia M, 2007, LEUKEMIA RES, V31, P1770, DOI 10.1016/j.leukres.2007.01.024; Breccia M, 2015, ANN HEMATOL, V94, P393, DOI 10.1007/s00277-014-2231-9; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Falanga A, 2014, SEMIN THROMB HEMOST, V40, P348, DOI 10.1055/s-0034-1370794; Giles FJ, 2013, LEUKEMIA, V27, P1310, DOI 10.1038/leu.2013.69; Hehlmann R, 2007, BLOOD, V109, P4686, DOI 10.1182/blood-2006-11-055186; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoglund M, 2010, HAEMATOL-HEMATOL J, V95, P337; Hoglund M, 2013, BLOOD, V122, P1284, DOI 10.1182/blood-2013-04-495598; Kim TD, 2013, LEUKEMIA, V27, P1316, DOI 10.1038/leu.2013.70; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Le Coutre P, 2011, J NATL CANCER I, V103, P1347, DOI 10.1093/jnci/djr292; Levato L, 2013, EUR J HAEMATOL, V90, P531, DOI 10.1111/ejh.12096; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; O'Brien S, 2014, J NATL COMPR CANC NE, V12, P1590, DOI 10.6004/jnccn.2014.0159; Quintas-Cardama A, 2012, CL LYMPH MYELOM LEUK, V12, P337, DOI 10.1016/j.clml.2012.04.005; Radich JP, 2012, BLOOD, V120, P3898, DOI 10.1182/blood-2012-02-410688; Rea D, 2014, HAEMATOLOGICA, V99, P1197, DOI 10.3324/haematol.2014.104075; Tefferi A, 2014, BLOOD, V124, P2507, DOI 10.1182/blood-2014-05-579136; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	24	69	69	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					161	+		10.7326/M15-2306	http://dx.doi.org/10.7326/M15-2306			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27295519				2022-12-28	WOS:000380583300004
J	Chikkaraddy, R; de Nijs, B; Benz, F; Barrow, SJ; Scherman, OA; Rosta, E; Demetriadou, A; Fox, P; Hess, O; Baumberg, JJ				Chikkaraddy, Rohit; de Nijs, Bart; Benz, Felix; Barrow, Steven J.; Scherman, Oren A.; Rosta, Edina; Demetriadou, Angela; Fox, Peter; Hess, Ortwin; Baumberg, Jeremy J.			Single-molecule strong coupling at room temperature in plasmonic nanocavities	NATURE			English	Article							LIGHT; ENHANCEMENT	Photon emitters placed in an optical cavity experience an environment that changes how they are coupled to the surrounding light field. In the weak-coupling regime, the extraction of light from the emitter is enhanced. But more profound effects emerge when single-emitter strong coupling occurs: mixed states are produced that are part light, part matter(1,2), forming building blocks for quantum information systems and for ultralow-power switches and lasers(3-6). Such cavity quantum electrodynamics has until now been the preserve of low temperatures and complicated fabrication methods, compromising its use(5,7,8). Here, by scaling the cavity volume to less than 40 cubic nanometres and using host-guest chemistry to align one to ten protectively isolated methylene-blue molecules, we reach the strong-coupling regime at room temperature and in ambient conditions. Dispersion curves from more than 50 such plasmonic nanocavities display characteristic light-matter mixing, with Rabi frequencies of 300 millielectronvolts for ten methylene-blue molecules, decreasing to 90 millielectronvolts for single molecules-matching quantitative models. Statistical analysis of vibrational spectroscopy time series and dark-field scattering spectra provides evidence of single-molecule strong coupling. This dressing of molecules with light can modify photochemistry, opening up the exploration of complex natural processes such as photosynthesis(9) and the possibility of manipulating chemical bonds(10).	[Chikkaraddy, Rohit; de Nijs, Bart; Benz, Felix; Baumberg, Jeremy J.] Univ Cambridge, Cavendish Lab, NanoPhoton Ctr, Cambridge CB3 0HE, England; [Barrow, Steven J.; Scherman, Oren A.] Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Lensfield Rd, Cambridge CB2 1EW, England; [Rosta, Edina] Kings Coll London, Dept Chem, London SE1 1DB, England; [Demetriadou, Angela; Fox, Peter; Hess, Ortwin] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England	University of Cambridge; University of Cambridge; University of London; King's College London; Imperial College London	Baumberg, JJ (corresponding author), Univ Cambridge, Cavendish Lab, NanoPhoton Ctr, Cambridge CB3 0HE, England.	jjb12@cam.ac.uk	de Nijs, Bart/AAT-7025-2020; Baumberg, Jeremy J/C-1409-2009; Chikkaraddy, Rohit/P-7111-2016; Hess, Ortwin/O-1345-2019; Demetriadou, Angela/L-4593-2013	Baumberg, Jeremy J/0000-0002-9606-9488; Chikkaraddy, Rohit/0000-0002-3840-4188; Hess, Ortwin/0000-0002-6024-0677; Demetriadou, Angela/0000-0001-7240-597X; Barrow, Steven/0000-0001-6417-1800; Rosta, Edina/0000-0002-9823-4766	UK's Engineering and Physical Sciences Research Council [EP/G060649/1, EP/N020669/1, EP/L027151/1, EP/I012060/1]; European Research Council [LINASS 320503]; Air Force Office of Scientific Research (AFOSR); European Office of Aerospace Research and Development (EOARD); Dr. Manmohan Singh scholarship from St John's College, University of Cambridge; Winton Programme for the Physics of Sustainability; European Commission (NANOSPHERE) [658360]; Engineering and Physical Sciences Research Council [1352498, 1366370, EP/H007024/1, EP/G060649/1, EP/L000253/1, EP/K028510/1, EP/N020669/1, EP/L027151/1, EP/M022609/1] Funding Source: researchfish; EPSRC [EP/H007024/1, EP/M022609/1, EP/N020669/1, EP/L027151/1, EP/K028510/1, EP/G060649/1, EP/L000253/1] Funding Source: UKRI	UK's Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); European Office of Aerospace Research and Development (EOARD); Dr. Manmohan Singh scholarship from St John's College, University of Cambridge; Winton Programme for the Physics of Sustainability; European Commission (NANOSPHERE)(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the UK's Engineering and Physical Sciences Research Council (grants EP/G060649/1, EP/N020669/1, EP/L027151/1 and EP/I012060/1) and the European Research Council (grant LINASS 320503). This study was partially supported by the Air Force Office of Scientific Research (AFOSR); the European Office of Aerospace Research and Development (EOARD) is also acknowledged. R.C. acknowledges support from the Dr. Manmohan Singh scholarship from St John's College, University of Cambridge. F.B. acknowledges support from the Winton Programme for the Physics of Sustainability. S.J.B. acknowledges support from the European Commission for a Marie Curie Fellowship (NANOSPHERE, 658360).	Akselrod GM, 2014, NAT PHOTONICS, V8, P835, DOI [10.1038/nphoton.2014.228, 10.1038/NPHOTON.2014.228]; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Benz F, 2015, NANO LETT, V15, P669, DOI 10.1021/nl5041786; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Coles DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6561; de Nijs B, 2015, FARADAY DISCUSS, V178, P185, DOI 10.1039/c4fd00195h; Faraon A, 2008, NAT PHYS, V4, P859, DOI 10.1038/nphys1078; Feist J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.196402; Galego J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041022; Groblacher S, 2007, NATURE, V446, P871, DOI 10.1038/nature05677; Hutchison JA, 2012, ANGEW CHEM INT EDIT, V51, P1592, DOI 10.1002/anie.201107033; Kasera S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06785; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Koenderink AF, 2015, SCIENCE, V348, P516, DOI 10.1126/science.1261243; Kravtsov V, 2014, NANO LETT, V14, P5270, DOI 10.1021/nl502297t; Liu XZ, 2015, NAT PHOTONICS, V9, P30, DOI [10.1038/nphoton.2014.304, 10.1038/NPHOTON.2014.304]; NETZER FP, 1992, CRIT REV SOLID STATE, V17, P397, DOI 10.1080/10408439208243753; Novotny L., 2012, PRINCIPLES NANOOPTIC; Patil K, 2000, PHYS CHEM CHEM PHYS, V2, P4313, DOI 10.1039/b005370h; Sato Y, 2012, NAT PHOTONICS, V6, P56, DOI [10.1038/NPHOTON.2011.286, 10.1038/nphoton.2011.286]; Schlather AE, 2013, NANO LETT, V13, P3281, DOI 10.1021/nl4014887; Shalabney A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6981; Tame MS, 2013, NAT PHYS, V9, P329, DOI [10.1038/NPHYS2615, 10.1038/nphys2615]; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Torma P, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/1/013901; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zengin G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.157401; Zengin G, 2013, SCI REP-UK, V3, DOI 10.1038/srep03074	30	1107	1122	55	1253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					127	130		10.1038/nature17974	http://dx.doi.org/10.1038/nature17974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27296227	Green Submitted, Green Accepted			2022-12-28	WOS:000379015600037
J	Lauria, MW; Saad, MJ				Lauria, Marcio W.; Saad, Mario J.			Acanthosis Nigricans and Insulin Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lauria, Marcio W.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Saad, Mario J.] Univ Estadual Campinas, Campinas, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual de Campinas	Lauria, MW (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	marciowlauria@gmail.com	Saad, Mario/ABD-8262-2020						0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					E31	E31		10.1056/NEJMicm1508730	http://dx.doi.org/10.1056/NEJMicm1508730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305209				2022-12-28	WOS:000377854600012
J	Yadav, M; Delamarre, L				Yadav, Mahesh; Delamarre, Lelia			Outsourcing the immune response to cancer	SCIENCE			English	Editorial Material							IMMUNOTHERAPY; MELANOMA; CELLS		[Yadav, Mahesh; Delamarre, Lelia] Genentech Inc, Dept Canc Immunol, MS 231B,1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech	Delamarre, L (corresponding author), Genentech Inc, Dept Canc Immunol, MS 231B,1 DNA Way, San Francisco, CA 94080 USA.	delamarre.lelia@gene.com						Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	10	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1275	1276		10.1126/science.aag1547	http://dx.doi.org/10.1126/science.aag1547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284181				2022-12-28	WOS:000377972000020
J	Pfenning, DW				Pfenning, David W.			EVOLUTIONARY BIOLOGY To mimicry and back again	NATURE			English	Editorial Material							CORAL SNAKE MIMICRY; BATESIAN MIMICRY; FREQUENCY; PREDATORS		[Pfenning, David W.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Pfenning, DW (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	dpfennig@unc.edu						Bates H.W., 1862, T LINN SOC LOND, V23, P495; BRODIE ED, 1995, FUNCT ECOL, V9, P186; Fisher R.A., 1930, GENETICAL THEORY NAT; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Rabosky ARD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11484; Stevens M., 2016, CHEATS DECEITS ANIMA; Wallace A. R, 1867, WESTMINSTER FOREIGN, V32, P1	9	5	5	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					184	185		10.1038/nature18441	http://dx.doi.org/10.1038/nature18441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279208				2022-12-28	WOS:000377475100026
J	Tarailo-Graovac, M; Shyr, C; Ross, CJ; Horvath, GA; Salvarinova, R; Ye, XC; Zhang, LH; Bhavsar, AP; Lee, JJY; Drogemoller, BI; Abdelsayed, M; Alfadhel, M; Armstrong, L; Baumgartner, MR; Burda, P; Connolly, MB; Cameron, J; Demos, M; Dewan, T; Dionne, J; Evans, AM; Friedman, JM; Garber, I; Lewis, S; Ling, J; Mandal, R; Mattman, A; McKinnon, M; Michoulas, A; Metzger, D; Ogunbayo, OA; Rakic, B; Rozmus, J; Ruben, P; Sayson, B; Santra, S; Schultz, KR; Selby, K; Shekel, P; Sirrs, S; Skrypnyk, C; Superti-Furga, A; Turvey, SE; Van Allen, MI; Wishart, D; Wu, J; Wu, J; Zafeiriou, D; Kluijtmans, L; Wevers, RA; Eydoux, P; Lehman, AM; Vallance, H; Stockler-Ipsiroglu, S; Sinclair, G; Wasserman, WW; van Karnebeek, CD				Tarailo-Graovac, M.; Shyr, C.; Ross, C. J.; Horvath, G. A.; Salvarinova, R.; Ye, X. C.; Zhang, L-H; Bhavsar, A. P.; Lee, J. J. Y.; Droegemoeller, B. I.; Abdelsayed, M.; Alfadhel, M.; Armstrong, L.; Baumgartner, M. R.; Burda, P.; Connolly, M. B.; Cameron, J.; Demos, M.; Dewan, T.; Dionne, J.; Evans, A. M.; Friedman, J. M.; Garber, I.; Lewis, S.; Ling, J.; Mandal, R.; Mattman, A.; McKinnon, M.; Michoulas, A.; Metzger, D.; Ogunbayo, O. A.; Rakic, B.; Rozmus, J.; Ruben, P.; Sayson, B.; Santra, S.; Schultz, K. R.; Selby, K.; Shekel, P.; Sirrs, S.; Skrypnyk, C.; Superti-Furga, A.; Turvey, S. E.; Van Allen, M. I.; Wishart, D.; Wu, J.; Wu, J.; Zafeiriou, D.; Kluijtmans, L.; Wevers, R. A.; Eydoux, P.; Lehman, A. M.; Vallance, H.; Stockler-Ipsiroglu, S.; Sinclair, G.; Wasserman, W. W.; van Karnebeek, C. D.			Exome Sequencing and the Management of Neurometabolic Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTELLECTUAL DISABILITY; INFANTILE ONSET; GENE-DISCOVERY; RARE-DISEASE; DEFICIENCY; MUTATIONS; PRESENTS; SPECTRUM	BACKGROUND Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception is inborn errors of metabolism, since many of these disorders are responsive to therapy that targets pathophysiological features at the molecular or cellular level. METHODS To uncover the genetic basis of potentially treatable inborn errors of metabolism, we combined deep clinical phenotyping (the comprehensive characterization of the discrete components of a patient's clinical and biochemical phenotype) with whole-exome sequencing analysis through a semiautomated bioinformatics pipeline in consecutively enrolled patients with intellectual developmental disorder and unexplained metabolic phenotypes. RESULTS We performed whole-exome sequencing on samples obtained from 47 probands. Of these patients, 6 were excluded, including 1 who withdrew from the study. The remaining 41 probands had been born to predominantly nonconsanguineous parents of European descent. In 37 probands, we identified variants in 2 genes newly implicated in disease, 9 candidate genes, 22 known genes with newly identified phenotypes, and 9 genes with expected phenotypes; in most of the genes, the variants were classified as either pathogenic or probably pathogenic. Complex phenotypes of patients in five families were explained by coexisting monogenic conditions. We obtained a diagnosis in 28 of 41 probands (68%) who were evaluated. A test of a targeted intervention was performed in 18 patients (44%). CONCLUSIONS Deep phenotyping and whole-exome sequencing in 41 probands with intellectual developmental disorder and unexplained metabolic abnormalities led to a diagnosis in 68%, the identification of 11 candidate genes newly implicated in neurometabolic disease, and a change in treatment beyond genetic counseling in 44%. (Funded by BC Children's Hospital Foundation and others.)	[Tarailo-Graovac, M.; Shyr, C.; Ye, X. C.; Zhang, L-H; Lee, J. J. Y.; Droegemoeller, B. I.; Garber, I.; Wasserman, W. W.; van Karnebeek, C. D.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6H 3V4, Canada; [Tarailo-Graovac, M.; Shyr, C.; Ross, C. J.; Ye, X. C.; Lee, J. J. Y.; Armstrong, L.; Friedman, J. M.; Lewis, S.; McKinnon, M.; Van Allen, M. I.; Lehman, A. M.; Wasserman, W. W.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3V4, Canada; [Ross, C. J.; Horvath, G. A.; Salvarinova, R.; Zhang, L-H; Bhavsar, A. P.; Droegemoeller, B. I.; Connolly, M. B.; Demos, M.; Dewan, T.; Dionne, J.; Michoulas, A.; Metzger, D.; Rozmus, J.; Schultz, K. R.; Selby, K.; Turvey, S. E.; Wu, J.; Stockler-Ipsiroglu, S.; van Karnebeek, C. D.] Univ British Columbia, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [Rakic, B.; Eydoux, P.; Vallance, H.; Sinclair, G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada; [Tarailo-Graovac, M.; Shyr, C.; Ross, C. J.; Horvath, G. A.; Ye, X. C.; Bhavsar, A. P.; Lee, J. J. Y.; Droegemoeller, B. I.; Armstrong, L.; Connolly, M. B.; Demos, M.; Dionne, J.; Friedman, J. M.; Garber, I.; Lewis, S.; McKinnon, M.; Metzger, D.; Rozmus, J.; Schultz, K. R.; Selby, K.; Turvey, S. E.; Van Allen, M. I.; Wu, J.; Eydoux, P.; Lehman, A. M.; Vallance, H.; Stockler-Ipsiroglu, S.; Sinclair, G.; Wasserman, W. W.; van Karnebeek, C. D.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Mattman, A.; Sirrs, S.] Univ British Columbia, Div Endocrinol, Adult Metab Dis Clin, Vancouver, BC V6H 3V4, Canada; [Horvath, G. A.; Salvarinova, R.; Sayson, B.; Stockler-Ipsiroglu, S.; van Karnebeek, C. D.] BC Childrens Hosp, Div Biochem Dis, Vancouver, BC, Canada; [Connolly, M. B.; Demos, M.; Michoulas, A.; Selby, K.] BC Childrens Hosp, Div Pediat Neurol, Vancouver, BC, Canada; [Dionne, J.] BC Childrens Hosp, Div Pediat Nephrol, Vancouver, BC, Canada; [Metzger, D.] BC Childrens Hosp, Div Pediat Endocrinol, Vancouver, BC, Canada; [Turvey, S. E.] BC Childrens Hosp, Div Immunol, Vancouver, BC, Canada; [Rozmus, J.; Schultz, K. R.; Wu, J.] BC Childrens Hosp, Michael Cuccione Childhood Canc Res Program, Div Hematol Oncol & Transplantat, Vancouver, BC, Canada; [Cameron, J.] Univ Toronto, Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Mandal, R.; Wishart, D.] Univ Alberta, Dept Biol & Comp Sci, Edmonton, AB, Canada; [Wishart, D.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Abdelsayed, M.; Ruben, P.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Alfadhel, M.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Div Genet, Dept Pediat, Riyadh, Saudi Arabia; [Baumgartner, M. R.; Burda, P.] Univ Childrens Hosp Zurich, Div Metab, Zurich, Switzerland; [Baumgartner, M. R.; Burda, P.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Superti-Furga, A.] Univ Lausanne, Dept Pediat, Lausanne, Switzerland; [Evans, A. M.; Ogunbayo, O. A.; Shekel, P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Santra, S.] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Ling, J.; Wu, J.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Skrypnyk, C.] Arabian Gulf Univ, Al Jawahra Ctr Mol Med & Inherited Disorders, Manama, Bahrain; [Zafeiriou, D.] Aristotle Univ Thessaloniki, Dept Pediat, GR-54006 Thessaloniki, Greece; [Kluijtmans, L.; Wevers, R. A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; National Research Council Canada; Simon Fraser University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Lausanne; University of Edinburgh; University of Birmingham; University of Texas System; University of Texas Health Science Center Houston; Arabian Gulf University; Aristotle University of Thessaloniki; Radboud University Nijmegen	van Karnebeek, CD (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, BC Childrens Hosp, Div Biochem Dis,Dept Pediat, Rm K3-201,4480 Oak St, Vancouver, BC V6H 3V4, Canada.		superti-furga, andrea/E-9162-2015; Kluijtmans, Leo A/L-4437-2015; Schultz, Kirk R/AAA-3440-2022; SKRYPNYK, CRISTINA/GLS-0546-2022; Turvey, Stuart/HGV-1191-2022; Baumgartner, Matthias/Q-2855-2017; Wevers, Ron A./H-8116-2014; Lehman, Anna/R-6706-2017; Ling, Jiqiang/AAU-1097-2021; Zafeiriou, Dimitrios/N-2641-2013	superti-furga, andrea/0000-0002-3543-7531; SKRYPNYK, CRISTINA/0000-0003-3469-1973; Baumgartner, Matthias/0000-0002-9270-0826; Wevers, Ron A./0000-0003-2278-9746; Lehman, Anna/0000-0003-0636-123X; Ling, Jiqiang/0000-0003-4466-8304; Lewis, Suzanne/0000-0002-6300-5381; Salvarinova Zivkovic, Ramona/0000-0002-8132-9136; Selby, Kathryn/0000-0001-9239-1704; Bhavsar, Amit/0000-0003-3336-9288; Rakic, Bojana/0000-0002-3460-6081; Dionne, Janis/0000-0003-4926-3218; Friedman, Jan/0000-0002-7482-9570; Wasserman, Wyeth/0000-0001-6098-6412; Tarailo-Graovac, Maja/0000-0002-4472-8584; Zafeiriou, Dimitrios/0000-0003-2187-9299; McKinnon, Margaret/0000-0002-3161-414X; Sinclair, Graham/0000-0002-3815-2005; Schultz, Kirk/0000-0002-0001-6438; Metzger, Daniel/0000-0002-1715-4319; , Jacob/0000-0003-4036-2105; Santra, Saikat/0000-0002-7497-3556; Vallance, Hilary/0000-0003-1734-1445; Armstrong, Linlea/0000-0002-8191-6429; Drogemoller, Britt/0000-0002-3348-5855; Connolly, Mary/0000-0002-7784-942X; Ross, Colin/0000-0003-1476-7037; Lee, Jessica/0000-0002-6050-0731; Turvey, Stuart/0000-0003-1599-1065	BC Children's Hospital Foundation; British Heart Foundation [RG/12/14/29885] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115431] Funding Source: NIH RePORTER	BC Children's Hospital Foundation; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by BC Children's Hospital Foundation and others.	Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Armstrong L, 2014, NEUROGENETICS, V15, P157, DOI 10.1007/s10048-014-0411-3; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Coughlin CR, 2015, MOL GENET METAB, V116, P35, DOI 10.1016/j.ymgme.2015.05.011; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Ellison JW, 2013, ANNU REV MED, V64, P441, DOI 10.1146/annurev-med-042711-140053; Foley KE, 2015, NAT MED, V21, P1242, DOI 10.1038/nm1115-1242; Horvath GA, 2016, MOL GENET METAB, V117, P42, DOI 10.1016/j.ymgme.2015.11.008; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Janer A, 2015, EUR J HUM GENET, V23, P1301, DOI 10.1038/ejhg.2014.293; Kevelam SH, 2015, ANN CLIN TRANSL NEUR, V2, P648, DOI 10.1002/acn3.203; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Meerding WJ, 1998, BRIT MED J, V317, P111, DOI 10.1136/bmj.317.7151.111; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Niemela JE, 2011, BLOOD, V117, P2883, DOI 10.1182/blood-2010-07-295501; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Perez B, 2010, J MED GENET, V47, P686, DOI 10.1136/jmg.2010.076836; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rilstone JJ, 2013, NEW ENGL J MED, V368, P543, DOI 10.1056/NEJMoa1207281; Rossi A, 2009, DERMATOLOGY, V218, P376, DOI 10.1159/000203646; Salvador-Carulla L, 2011, WORLD PSYCHIATRY, V10, P175; Salvarinova R, 2015, NEUROGENETICS, V16, P145, DOI 10.1007/s10048-014-0432-y; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van der Crabben SN, 2013, J INHERIT METAB DIS, V36, P613, DOI 10.1007/s10545-013-9592-4; van Karnebeek CD, 2014, AM J HUM GENET, V94, P453, DOI 10.1016/j.ajhg.2014.01.006; van Karnebeek CDM, 2014, MOL GENET METAB, V111, P428, DOI 10.1016/j.ymgme.2014.01.011; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zaharieva IT, 2015, BRAIN J NEUROL, V139, P674; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	34	186	193	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2246	2255		10.1056/NEJMoa1515792	http://dx.doi.org/10.1056/NEJMoa1515792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276562	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000377920500008
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Gillman, MW; Harper, DM; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phillips, WR; Phipps, MG; Pignone, MP				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Gillman, Matthew W.; Harper, Diane M.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.		USPSTF	Screening for Syphilis Infection in Nonpregnant Adults and Adolescents US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CD4 CELL COUNTS; HIV VIRAL LOAD; POPULATION; GUIDELINES	IMPORTANCE In 2014, 19 999 cases of syphilis were reported in the United States. Left untreated, syphilis can progress to late-stage disease in about 15% of persons who are infected. Late-stage syphilis can lead to development of inflammatory lesions throughout the body, which can lead to cardiovascular or organ dysfunction. Syphilis infection also increases the risk for acquiring or transmitting HIV infection. OBJECTIVE To update the 2004 US Preventive Services Task Force (USPSTF) recommendation on screening for syphilis infection in nonpregnant adults. Screening for syphilis in pregnant women was updated in a separate recommendation statement in 2009 (A recommendation). EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for syphilis infection in asymptomatic, nonpregnant adults and adolescents, including patients coinfected with other sexually transmitted infections (such as HIV). FINDINGS The USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. Accurate screening tests are available to identify syphilis infection in populations at increased risk. Effective treatment with antibiotics can prevent progression to late-stage disease, with small associated harms, providing an overall substantial health benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection. (A recommendation)populations	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Harper, Diane M.] Univ Louisville, Louisville, KY 40292 USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Louisville; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Harper, Diane M./I-2180-2014; Phillips, William R./V-1065-2017; Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Harper, Diane M./0000-0001-7648-883X; Phillips, William R./0000-0003-2802-4349; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; American Academy of Family Physicians, CLIN PREV SERV REC S; [Anonymous], 2014 SEX TRANSM DIS; [Anonymous], CLIN ADV OC SYPH US; Binnicker MJ, 2012, J CLIN MICROBIOL, V50, P148, DOI 10.1128/JCM.05636-11; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Calonge N, 2009, ANN INTERN MED, V150, P705; Cantor A, 2016, AHRQ PUBLICATION, V14-05213-EF-1; Cantor AG, 2016, JAMA-J AM MED ASSOC, V315, P2328, DOI 10.1001/jama.2016.4114; Centers for Disease Control and Prevention, SEX TRANSM DIS STDS; Centers for Disease Control and Prevention, SYPH CDC FACT SHEET; Horberg MA, 2010, SEX TRANSM DIS, V37, P53, DOI 10.1097/OLQ.0b013e3181b6f0cc; Kofoed K, 2006, SEX TRANSM DIS, V33, P143, DOI 10.1097/01.olq.0000187262.56820.c0; Mishra S, 2011, SEX TRANSM DIS, V38, P190, DOI 10.1097/OLQ.0b013e3181f07e91; MOORE MB, 1963, PUBLIC HEALTH REP, V78, P966, DOI 10.2307/4591989; Nelson HD, 2004, SCREENING SYPHILIS B; Palacios R, 2007, JAIDS-J ACQ IMM DEF, V44, P356, DOI 10.1097/QAI.0b013e31802ea4c6; Radolf J. D., 2011, Morbidity and Mortality Weekly Report, V60, P133; SCHROETER AL, 1971, J AMER MED ASSOC, V218, P711, DOI 10.1001/jama.218.5.711; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Yang BR, 2013, SEX TRANSM DIS, V40, P957, DOI 10.1097/OLQ.0000000000000056	21	86	87	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2321	2327		10.1001/jama.2016.5824	http://dx.doi.org/10.1001/jama.2016.5824			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272583	Bronze			2022-12-28	WOS:000377183100021
J	Nattinger, AB; Mitchell, JL				Nattinger, Ann B.; Mitchell, Julie L.			Breast Cancer Screening and Prevention	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BRCA-RELATED CANCER; RISK-ASSESSMENT; DIGITAL MAMMOGRAPHY; COST-EFFECTIVENESS; POOLED ANALYSIS; WOMEN; BENEFITS; DENSITY; HARMS; RECOMMENDATION							Nattinger, Ann/0000-0002-8189-3300	American College of Physicians	American College of Physicians	American College of Physicians.	American Cancer Society, CANC FACTS FIG 2015, P2105; Anderson K, 2006, ANN INTERN MED, V144, P397, DOI 10.7326/0003-4819-144-6-200603210-00006; [Anonymous], 2003, AM J HUM GENET, V72, P1117; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Brennan SF, 2010, AM J CLIN NUTR, V91, P1294, DOI 10.3945/ajcn.2009.28796; Centers for Medicare & Medicaid Services, 2016, 2016 PHYS QUAL REP S; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cuzick Jack, 2014, Lancet, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Grann VR, 2011, BREAST CANCER RES TR, V125, P837, DOI 10.1007/s10549-010-1043-4; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Iowa Cancer Consortium, INCR CANC SCREEN RAT; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lee CI, 2015, RADIOLOGY, V274, P772, DOI 10.1148/radiol.14141237; Lehman CD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv349; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Melnikow J, 2016, ANN INTERN MED, V164, P268, DOI 10.7326/M15-1789; Miglioretti DL, 2016, ANN INTERN MED, V164, P205, DOI 10.7326/M15-1241; Miglioretti DL, 2015, JAMA ONCOL, V1, P1069, DOI 10.1001/jamaoncol.2015.3084; Moskowitz CS, 2014, J CLIN ONCOL, V32, P2217, DOI 10.1200/JCO.2013.54.4601; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; National Cancer Institute, NCI CANC GEN SERV DI; National Cancer Institute, INT TOOL MEAS RISK I; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Pizot C, 2016, EUR J CANCER, V52, P138, DOI 10.1016/j.ejca.2015.10.063; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Slanetz PJ, 2015, NEW ENGL J MED, V372, P593, DOI 10.1056/NEJMp1413728; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Sprague BL, 2008, AM J EPIDEMIOL, V168, P404, DOI 10.1093/aje/kwn143; Sprague BL, 2015, ANN INTERN MED, V162, P157, DOI 10.7326/M14-0692; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Walter LC, 2014, JAMA-J AM MED ASSOC, V311, P1336, DOI 10.1001/jama.2014.2834; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072	51	16	17	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					ITC81	ITC94		10.7326/AITC201606070	http://dx.doi.org/10.7326/AITC201606070			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27270661				2022-12-28	WOS:000377510100001
J	Ogden, CL; Carroll, MD; Lawman, HG; Fryar, CD; Kruszon-Moran, D; Kit, BK; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Lawman, Hannah G.; Fryar, Cheryl D.; Kruszon-Moran, Deanna; Kit, Brian K.; Flegal, Katherine M.			Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; US CHILDREN; OVERWEIGHT PREVALENCE; CHILDHOOD OVERWEIGHT; WEIGHT; HEALTH; PREVENTION; HEIGHT; RISKS	IMPORTANCE Previous analyses of obesity trends among children and adolescents showed an increase between 1988-1994 and 1999-2000, but no change between 2003-2004 and 2011-2012, except for a significant decline among children aged 2 to 5 years. OBJECTIVES To provide estimates of obesity and extreme obesity prevalence for children and adolescents for 2011-2014 and investigate trends by age between 1988-1994 and 2013-2014. DESIGN, SETTING, AND PARTICIPANTS Children and adolescents aged 2 to 19 years with measured weight and height in the 1988-1994 through 2013-2014 National Health and Nutrition Examination Surveys. EXPOSURES Survey period. MAIN OUTCOMES AND MEASURES Obesity was defined as a body mass index (BMI) at or above the sex-specific 95th percentile on the US Centers for Disease Control and Prevention (CDC) BMI-for-age growth charts. Extreme obesity was defined as a BMI at or above 120% of the sex-specific 95th percentile on the CDC BMI-for-age growth charts. Detailed estimates are presented for 2011-2014. The analyses of linear and quadratic trends in prevalence were conducted using 9 survey periods. Trend analyses between 2005-2006 and 2013-2014 also were conducted. RESULTS Measurements from 40 780 children and adolescents (mean age, 11.0 years; 48.8% female) between 1988-1994 and 2013-2014 were analyzed. Among children and adolescents aged 2 to 19 years, the prevalence of obesity in 2011-2014 was 17.0% (95% CI, 15.5%-18.6%) and extreme obesity was 5.8% (95% CI, 4.9%-6.8%). Among children aged 2 to 5 years, obesity increased from 7.2%(95% CI, 5.8%-8.8%) in 1988-1994 to 13.9%(95% CI, 10.7%-17.7%) (P <.001) in 2003-2004 and then decreased to 9.4%(95% CI, 6.8%-12.6%) (P =.03) in 2013-2014. Among children aged 6 to 11 years, obesity increased from 11.3%(95% CI, 9.4%-13.4%) in 1988-1994 to 19.6%(95% CI, 17.1%-22.4%) (P <.001) in 2007-2008, and then did not change (2013-2014: 17.4%[95% CI, 13.8%-21.4%]; P =.44). Obesity increased among adolescents aged 12 to 19 years between 1988-1994 (10.5%[95% CI, 8.8%-12.5%]) and 2013-2014 (20.6%[95% CI, 16.2%-25.6%]; P <.001) as did extreme obesity among children aged 6 to 11 years (3.6%[95% CI, 2.5%-5.0%] in 1988-1994 to 4.3%[95% CI, 3.0%-6.1%] in 2013-2014; P =.02) and adolescents aged 12 to 19 years (2.6%[95% CI, 1.7%-3.9%] in 1988-1994 to 9.1% [95% CI, 7.0%-11.5%] in 2013-2014; P <.001). No significant trends were observed between 2005-2006 and 2013-2014 (P value range,.09-.87). CONCLUSIONS AND RELEVANCE In this nationally representative study of US children and adolescents aged 2 to 19 years, the prevalence of obesity in 2011-2014 was 17.0% and extreme obesity was 5.8%. Between 1988-1994 and 2013-2014, the prevalence of obesity increased until 2003-2004 and then decreased in children aged 2 to 5 years, increased until 2007-2008 and then leveled off in children aged 6 to 11 years, and increased among adolescents aged 12 to 19 years.	[Ogden, Cynthia L.; Carroll, Margaret D.; Lawman, Hannah G.; Fryar, Cheryl D.; Kruszon-Moran, Deanna; Kit, Brian K.; Flegal, Katherine M.] US Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service	Ogden, CL (corresponding author), US Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Flegal, Katherine M/A-4608-2013		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Akinbami LJ, 2009, OBESITY, V17, P1574, DOI 10.1038/oby.2009.1; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; CDC/National Center for Health Statistics, NAT HLTH NUTR EX SUR; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Johnson Clifford L, 2014, Vital Health Stat 2, P1; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Koebnick C, 2015, J PEDIATR-US, V167, P1264, DOI 10.1016/j.jpeds.2015.08.039; Korn E, 1998, SURV METHODOL, V24, P193; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ, 2000, HEALTH, V11, P1; May AL, 2013, MMWR-MORBID MORTAL W, V62, P629; Modi AC, 2008, OBESITY, V16, P2266, DOI 10.1038/oby.2008.347; Neter J, 1985, APPL LINEAR REGRESSI; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden Cynthia L, 2015, NCHS Data Brief, P1; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Puhl RM, 2013, PEDIATRICS, V131, pE1, DOI 10.1542/peds.2012-1106; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Wen XZ, 2012, PEDIATRICS, V129, P823, DOI 10.1542/peds.2011-1833; Wolters KM, 1982, INTRO VARIANCE ESTIM	38	1550	1584	10	153	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2292	2299		10.1001/jama.2016.6361	http://dx.doi.org/10.1001/jama.2016.6361			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272581	Green Accepted, Bronze			2022-12-28	WOS:000377183100018
J	Banchereau, R; Hong, S; Cantarel, B; Baldwin, N; Baisch, J; Edens, M; Cepika, AM; Acs, P; Turner, J; Anguiano, E; Vinod, P; Khan, S; Obermoser, G; Blankenship, D; Wakeland, E; Nassi, L; Gotte, A; Punaro, M; Liu, YJ; Banchereau, J; Rossello-Urgell, J; Wright, T; Pascual, V				Banchereau, Romain; Hong, Seunghee; Cantarel, Brandi; Baldwin, Nicole; Baisch, Jeanine; Edens, Michelle; Cepika, Alma-Martina; Acs, Peter; Turner, Jacob; Anguiano, Esperanza; Vinod, Parvathi; Khan, Shaheen; Obermoser, Gerlinde; Blankenship, Derek; Wakeland, Edward; Nassi, Lorien; Gotte, Alisa; Punaro, Marilynn; Liu, Yong-Jun; Banchereau, Jacques; Rossello-Urgell, Jose; Wright, Tracey; Pascual, Virginia			Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients (vol 165, pg 551, 2016)	CELL			English	Correction												virginia.pascual@bswhealth.org	Cantarel, Brandi/ABF-5756-2020; Pascual, Virginia/ABD-3099-2020	Cantarel, Brandi/0000-0003-4126-4478; Khan, Shaheen/0000-0002-1472-8129	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR070594] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008	1	68	70	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1548	1550		10.1016/j.cell.2016.05.057	http://dx.doi.org/10.1016/j.cell.2016.05.057			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259156	Bronze			2022-12-28	WOS:000377045400026
J	Bothwell, LE; Greene, JA; Podolsky, SH; Jones, DS				Bothwell, Laura E.; Greene, Jeremy A.; Podolsky, Scott H.; Jones, David S.			Assessing the Gold Standard - Lessons from the History of RCTs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ARTHROSCOPIC SURGERY; CLINICAL-RESEARCH; TRIALS; PSYCHOTHERAPY; VALIDITY; ISSUES; VIRUS		[Bothwell, Laura E.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Bothwell, Laura E.] Harvard Med Sch, Boston, MA 02115 USA; [Podolsky, Scott H.; Jones, David S.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Johns Hopkins University; Johns Hopkins University	Bothwell, LE (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Bothwell, LE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Ablon JS, 2002, AM J PSYCHIAT, V159, P775, DOI 10.1176/appi.ajp.159.5.775; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; [Anonymous], 1956, NEW ENGL J MED, V255, P1057; [Anonymous], 1977, N Engl J Med, V297, P1464; [Anonymous], 2004, LANCET, V364, P731; Avorn J, 2004, POWERFUL MED BENEFIT; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; BONCHEK LI, 1979, NEW ENGL J MED, V301, P44, DOI 10.1056/NEJM197907053010110; Bothwell L., 2014, THESIS; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Boyd EA, 2003, ACAD MED, V78, P769, DOI 10.1097/00001888-200308000-00002; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; BRAUNWALD E, 1977, NEW ENGL J MED, V297, P661, DOI 10.1056/NEJM197709222971209; Burdett S, 2003, INT J TECHNOL ASSESS, V19, P129, DOI 10.1017/S0266462303000126; Carpenter D, 2010, PRINC STUD AM POLIT, P1; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; Daly J., 2005, EVIDENCE BASED MED S; Deacon BJ, 2013, CLIN PSYCHOL REV, V33, P846, DOI 10.1016/j.cpr.2012.09.007; Deaton A, 2010, J ECON LIT, V48, P424, DOI 10.1257/jel.48.2.424; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; Epstein S, 1996, Med Soc (Berkeley), P1; Epstein S, 1997, SOC STUD SCI, V27, P691, DOI 10.1177/030631297027005001; Favaloro RG, 1998, J AM COLL CARDIOL, V31, p1B, DOI 10.1016/S0735-1097(97)00559-7; Fisher JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001271; Goodman J, 2000, CIVIL SOC DEMOCRACY, P150; Greene JA, 2012, NEW ENGL J MED, V367, P1481, DOI 10.1056/NEJMp1210007; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; HILL AB, 1963, BMJ-BRIT MED J, P1043, DOI 10.1136/bmj.1.5337.1043; Jones DS, 2015, LANCET, V385, P1502, DOI 10.1016/S0140-6736(15)60742-5; Jones DS, 2000, ISIS, V91, P504, DOI 10.1086/384853; Jones DS, 2016, THERAPEUTIC REVOLUTI; Kereiakes DJ, 2007, J AM COLL CARDIOL, V50, P1598, DOI 10.1016/j.jacc.2007.07.063; Kuo W-H, 2005, THESIS; LOVE JW, 1975, JAMA-J AM MED ASSOC, V232, P37, DOI 10.1001/jama.232.1.37; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Marks H., 1997, PROGR EXPT SCI THERA; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; MURPHY ML, 1977, NEW ENGL J MED, V297, P621, DOI 10.1056/NEJM197709222971201; Opinel A, 2013, INT J EPIDEMIOL, V42, P662, DOI 10.1093/ije/dyr162; Petryna A., 2009, EXPT TRAVEL CLIN TRI; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1; Podolsky SH, 2016, BLINDING SOLUTION BI, P45; Pollack A., 2008, NY TIMES        1127, pB1; Rothman DJ, 2000, NEW YORK REV BOOKS, V47, P60; Scannell J., 2015, FORBES          1013; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Sertkaya A., 2014, EXAMINATION CLIN TRI; Thorlund JB, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-h2747rep; Timmermans S, 2003, GOLD STANDARD CHALLE; ULLYOT DJ, 1976, J THORAC CARDIOV SUR, V72, P945; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	59	302	304	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2175	2181		10.1056/NEJMms1604593	http://dx.doi.org/10.1056/NEJMms1604593			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248626				2022-12-28	WOS:000387209900016
J	Soressi, M				Soressi, Marie			ARCHAEOLOGY Neanderthals built underground	NATURE			English	Editorial Material									[Soressi, Marie] Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Soressi, M (corresponding author), Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands.	m.a.soressi@arch.leidenuniv.nl	SORESSI, Marie/N-7728-2015	SORESSI, Marie/0000-0003-1733-7745				Clottes J., 1996, CHAMANES PREHISTOIRE; Guthrie R. D., 2005, NATURE PALEOLITHIC A; Jaubert J, 2016, NATURE, V534, P111, DOI 10.1038/nature18291; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd	4	1	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					43	44		10.1038/nature18440	http://dx.doi.org/10.1038/nature18440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27251273	Green Submitted			2022-12-28	WOS:000376962300029
J	Salisbury, C; O'Cathain, A; Thomas, C; Edwards, L; Gaunt, D; Dixon, P; Hollinghurst, S; Nicholl, J; Large, S; Yardley, L; Fahey, T; Foster, A; Garner, K; Horspool, K; Man, MS; Rogers, A; Pope, C; Montgomery, AA				Salisbury, Chris; O'Cathain, Alicia; Thomas, Clare; Edwards, Louisa; Gaunt, Daisy; Dixon, Padraig; Hollinghurst, Sandra; Nicholl, Jon; Large, Shirley; Yardley, Lucy; Fahey, Tom; Foster, Alexis; Garner, Katy; Horspool, Kimberley; Man, Mei-See; Rogers, Anne; Pope, Catherine; Montgomery, Alan A.			Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SELF-MANAGEMENT INTERVENTIONS; BLOOD-PRESSURE CONTROL; HYPERTENSION CONTROL; COST-EFFECTIVENESS; CARE; SUPPORT; TELEMEDICINE; VALIDATION; OUTCOMES; DIETARY	OBJECTIVE To assess whether non-clinical staff can effectively manage people at high risk of cardiovascular disease using digital health technologies. DESIGN Pragmatic, multicentre, randomised controlled trial. SETTING 42 general practices in three areas of England. PARTICIPANTS Between 3 December 2012 and 23 July 2013 we recruited 641 adults aged 40 to 74 years with a 10 year cardiovascular disease risk of 20% or more, no previous cardiovascular event, at least one modifiable risk factor (systolic blood pressure >= 140 mm Hg, body mass index >= 30, current smoker), and access to a telephone, the internet, and email. Participants were individually allocated to intervention (n=325) or control (n=316) groups using automated randomisation stratified by site, minimised by practice and baseline risk score. INTERVENTIONS Intervention was the Healthlines service (alongside usual care), comprising regular telephone calls from trained lay health advisors following scripts generated by interactive software. Advisors facilitated self management by supporting participants to use online resources to reduce risk factors, and sought to optimise drug use, improve treatment adherence, and encourage healthier lifestyles. The control group comprised usual care alone. MAIN OUTCOME MEASURES The primary outcome was the proportion of participants responding to treatment, defined as maintaining or reducing their cardiovascular risk after 12 months. Outcomes were collected six and 12 months after randomisation and analysed masked. Participants were not masked. RESULTS 50% (148/295) of participants in the intervention group responded to treatment compared with 43% (124/291) in the control group (adjusted odds ratio 1.3, 95% confidence interval 1.0 to 1.9; number needed to treat=13); a difference possibly due to chance (P=0.08). The intervention was associated with reductions in blood pressure (difference in mean systolic -2.7 mm Hg (95% confidence interval -4.7 to -0.6 mm Hg), mean diastolic -2.8 (-4.0 to -1.6 mm Hg); weight -1.0 kg (-1.8 to -0.3 kg), and body mass index -0.4 (-0.6 to -0.1) but not cholesterol -0.1 (-0.2 to 0.0), smoking status (adjusted odds ratio 0.4, 0.2 to 1.0), or overall cardiovascular risk as a continuous measure (-0.4, -1.2 to 0.3)). The intervention was associated with improvements in diet, physical activity, drug adherence, and satisfaction with access to care, treatment received, and care coordination. One serious related adverse event occurred, when a participant was admitted to hospital with low blood pressure. CONCLUSIONS This evidence based telehealth approach was associated with small clinical benefits for a minority of people with high cardiovascular risk, and there was no overall improvement in average risk. The Healthlines service was, however, associated with improvements in some risk behaviours, and in perceptions of support and access to care.	[Salisbury, Chris; Thomas, Clare; Edwards, Louisa; Dixon, Padraig; Hollinghurst, Sandra; Garner, Katy; Man, Mei-See] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England; [O'Cathain, Alicia; Nicholl, Jon; Foster, Alexis; Horspool, Kimberley] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Gaunt, Daisy] Univ Bristol, Bristol Randomised Trials Collaborat, Sch Social & Community Med, Bristol, Avon, England; [Large, Shirley] NHS England South Wessex, Southampton, Hants, England; [Yardley, Lucy] Univ Southampton, Dept Psychol, Southampton SO9 5NH, Hants, England; [Fahey, Tom] Royal Coll Surgeons Ireland, Dept Gen Practice, Dublin 2, Ireland; [Rogers, Anne; Pope, Catherine] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Montgomery, Alan A.] Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham Hlth Sci Partners, Nottingham NG7 2UH, England	University of Bristol; University of Sheffield; University of Bristol; University of Southampton; Royal College of Surgeons - Ireland; University of Southampton; University of Nottingham	Salisbury, C (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England.	c.salisbury@bristol.ac.uk	Gaunt, Daisy/AAP-1355-2021; Salisbury, Chris/C-6724-2008; Fahey, Tom/C-9367-2012	Gaunt, Daisy/0000-0002-1253-307X; Salisbury, Chris/0000-0002-4378-3960; Fahey, Tom/0000-0002-5896-5783; Pope, Catherine/0000-0002-8935-6702; Dixon, Padraig/0000-0001-5285-409X; Man, Mei-See/0000-0003-4948-5670; Foster, Alexis/0000-0002-7978-2791; Montgomery, Alan/0000-0003-0450-1606; Yardley, Lucy/0000-0002-3853-883X	National Institute for Health Research (NIHR) [RP-PG-0108-10011]; National Institute for Health Research [RP-PG-0108-10011, NF-SI-0513-10103, NF-SI-0515-10043] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This report summarises independent research funded by the National Institute for Health Research (NIHR) under its programme grant for applied research (grant reference No RP-PG-0108-10011). CS's time is supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. The views and opinions expressed in this report are those of the authors and do not necessarily reflect those of the NIHR the NHS, or the Department of Health. The funder had no role in the conduct of the study, the writing of the manuscript, or the decision to submit it for publication. The corresponding author (CS) had full access to all the data in the study and had final responsibility for the decision to submit for publication. CS, AOC, and JN act as members of boards for NIHR but were not on the board which commissioned this project.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; [Anonymous], 2015, COCHRANE DATABASE SY; [Anonymous], 2014, REAL WORLD TESTING O; Bosworth HB, 2011, ARCH INTERN MED, V171, P1173, DOI 10.1001/archinternmed.2011.276; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; CIVLJAK M, 2013, COCHRANE DB SYST REV, V7, P68431, DOI DOI 10.1016/J.PEC.2006.12.002; Civljak M, 2013, BMJ-BRIT MED J, V7; Coulter A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010523.pub2; Cruickshank J., 2012, TELEHEALTH WHAT CAN; Darkins A, 2008, TELEMED J E-HEALTH, V14, P1118, DOI 10.1089/tmj.2008.0021; *DEP HLTH, 2008, PUTTING PREVENTION F, P68431; Edwards L, 2014, J MED INTERNET RES, V16, P154, DOI 10.2196/jmir.3257; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; European Commission, 2013, RENEWING HEALTH REGI; Foster A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0773-3; Frangakis CE, 2002, BIOMETRICS, V58, P21, DOI 10.1111/j.0006-341X.2002.00021.x; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Haggerty JL, 2012, ANN FAM MED, V10, P443, DOI 10.1370/afm.1378; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Inkster M, 2005, BRIT J GEN PRACT, V55, P931; Man MS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0820-0; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Merriel SWD, 2014, PREV MED, V64, P88, DOI 10.1016/j.ypmed.2014.04.001; Mistry H, 2012, J TELEMED TELECARE, V18, P1, DOI 10.1258/jtt.2011.110505; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; *NATL I HLTH CAR E, 2011, HYPERTENSION CLINICA, pG127; Norman C, 2006, J MED INTERNET RES, V8, pe27; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Panagioti M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-356; Paxton AE, 2011, AM J PREV MED, V40, P67, DOI 10.1016/j.amepre.2010.10.009; Salisbury C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006448; Segar J, 2013, HEALTH SOC CARE COMM, V21, P606, DOI 10.1111/hsc.12047; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Thomas CL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-36; VANREENEN M, 2015, EQ 5D 5L USER GUIDE, V5, P5, DOI DOI 10.1001/JAMA.2013.6549; Vassilev I, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0238-9; Vegting IL, 2014, EUR J INTERN MED, V25, P73, DOI 10.1016/j.ejim.2013.08.008; Whittaker R, 2012, CARDIOVASCULAR DISEA, V11; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]; WIELAND LS, 2012, COCHRANE DB SYST REV, V8, P68431, DOI DOI 10.1186/S13063-015-0820-0; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Wootton R, 2012, J TELEMED TELECARE, V18, P211, DOI 10.1258/jtt.2012.120219; 2014, FIVE YEAR FORWARD VI, V10, P5, DOI DOI 10.1016/J.YPMED.2014.04.001	46	34	35	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2016	353								i2647	10.1136/bmj.i2647	http://dx.doi.org/10.1136/bmj.i2647			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OM	27252245	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000377478200001
J	Mol, GC; van de Ree, MA; Klok, FA; Tegelberg, MJAM; Sanders, FBM; Koppen, S; de Weerdt, O; Koster, T; Hovens, MMC; Kaasjager, HAH; Brouwer, RE; Kragten, E; Schaar, CG; Spiering, W; Arnold, WP; Biesma, DH; Huisman, MV				Mol, G. C.; van de Ree, M. A.; Klok, F. A.; Tegelberg, M. J. A. M.; Sanders, F. B. M.; Koppen, S.; de Weerdt, O.; Koster, T.; Hovens, M. M. C.; Kaasjager, H. A. H.; Brouwer, R. E.; Kragten, E.; Schaar, C. G.; Spiering, W.; Arnold, W. P.; Biesma, D. H.; Huisman, M. V.			One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; DEEP VENOUS THROMBOSIS; INTERVENTIONALLY TREATED PATIENTS; TERM-FOLLOW-UP; VEIN THROMBOSIS; DETERMINANTS; DIAGNOSIS; LEG	OBJECTIVE To study whether stopping elastic compression stockings (ECS) after 12 months is non-inferior to continuing them for 24 months after proximal deep venous thrombosis. DESIGN Multicentre single blind non-inferiority randomised controlled trial. SETTING Outpatient clinics in eight teaching hospitals in the Netherlands, including one university medical centre. PARTICIPANTS Patients compliant with compression therapy for 12 months after symptomatic, ultrasound proven proximal deep venous thrombosis of the leg. INTERVENTIONS Continuation or cessation of ECS 12 months after deep venous thrombosis. MAIN OUTCOME MEASURES The primary outcome was the incidence of postthrombotic syndrome 24 months after diagnosis of deep venous thrombosis, as assessed by the standardised Villalta scale in an intention to treat analysis. The predefined non-inferiority margin was 10%. The main secondary outcome was quality of life (VEINES-QOL/Sym). RESULTS 518 patients compliant with ECS and free of postthrombotic syndrome were randomised one year after diagnosis of deep venous thrombosis to stop or continue ECS therapy for another year. In the stop-ECS group, 51 of 256 patients developed post-thrombotic syndrome, with an incidence of 19.9% (95% confidence interval 16% to 24%). In the continue-ECS group, 34 of 262 patients developed post-thrombotic syndrome (incidence 13.0%, 9.9% to 17%), of whom 85% used ECS six or seven days a week during the study period, for an absolute difference of 6.9% (95% confidence interval upper limit 12.3%). Because the upper limit of the 95% confidence interval exceeds the predefined margin of 10%, non-inferiority was not reached. The number needed to treat to prevent one case of post-thrombotic syndrome by continuing ECS was 14 (95% confidence interval lower limit 8). Quality of life did not differ between the two groups. CONCLUSION Stopping ECS after one year in compliant patients with proximal deep venous thrombosis seemed not to be non-inferior to continuing ECS therapy for two years in this non-inferiority trial.	[Mol, G. C.; van de Ree, M. A.] Diakonessenhuis Hosp, Dept Internal Med, Utrecht, Netherlands; [Mol, G. C.; Kaasjager, H. A. H.] Univ Med Ctr, Dept Internal Med, Utrecht, Netherlands; [Mol, G. C.; Spiering, W.] Univ Med Ctr, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands; [Klok, F. A.; Huisman, M. V.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Tegelberg, M. J. A. M.] Diakonessenhuis Hosp, Dept Dermatol, Utrecht, Netherlands; [Sanders, F. B. M.] Diakonessenhuis Hosp, Dept Radiol, Utrecht, Netherlands; [Koppen, S.] St Antonius Hosp, Dept Dermatol, Nieuwegein, Netherlands; [de Weerdt, O.; Biesma, D. H.] St Antonius Hosp, Dept Hematol, Nieuwegein, Netherlands; [Koster, T.] Groene Hart Hosp, Dept Internal Med, Gouda, Netherlands; [Hovens, M. M. C.] Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands; [Brouwer, R. E.; Kragten, E.] Reinier de Graaf Grp, Dept Hematol, Delft, Netherlands; [Schaar, C. G.] Gelre Hosp, Dept Internal Med, Apeldoorn, Netherlands; [Arnold, W. P.] Gelderse Vallei Hosp, Dept Dermatol, Ede, Netherlands	Diakonessenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Diakonessenhuis; Diakonessenhuis; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Rijnstate Hospital; Reinier de Graaf Hospital; Gelre Hospitals; Gelderse Vallei Hospital	Huisman, MV (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.	m.v.huisman@lumc.nl	Klok, Erik/U-4870-2019; Biesma, Douwe H./AAV-6343-2020	Klok, Erik/0000-0001-9961-0754; Biesma, Douwe H./0000-0001-8334-3057	Fonds NutsOhra; Stichting Voorzorg; Cornelis Visser Stichting; Sanofi; Stichting Medicina et Scientia in the Netherlands	Fonds NutsOhra; Stichting Voorzorg; Cornelis Visser Stichting; Sanofi; Stichting Medicina et Scientia in the Netherlands(Netherlands Government)	Fonds NutsOhra, Stichting Voorzorg, the Cornelis Visser Stichting, Sanofi (unrestricted grant), and the Stichting Medicina et Scientia in the Netherlands provided research grants. All analyses were performed independently from the funding source.	Aschwanden M, 2008, J VASC SURG, V47, P1015, DOI 10.1016/j.jvs.2008.01.008; Baldwin MJ, 2013, J THROMB HAEMOST, V11, P795, DOI 10.1111/jth.12180; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Catarinella FS, 2015, PHLEBOLOGY, V30, P89, DOI 10.1177/0268355515569431; Catarinella FS, 2014, PHLEBOLOGY, V29, P104, DOI 10.1177/0268355514529505; Guanella R, 2011, J THROMB HAEMOST, V9, P2397, DOI 10.1111/j.1538-7836.2011.04516.x; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn SR, 2006, J CLIN EPIDEMIOL, V59, P1049, DOI 10.1016/j.jclinepi.2005.10.016; Kahn SR, 2014, CIRCULATION, V130, P1636, DOI 10.1161/CIR.0000000000000130; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Lamping DL, 2003, J VASC SURG, V37, P410, DOI 10.1067/mva.2003.152; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1997, HAEMATOLOGICA, V82, P423; Saarinen J, 2000, J CARDIOVASC SURG, V41, P441; Tan M, 2012, SEMIN RESP CRIT CARE, V33, P151, DOI 10.1055/s-0032-1311798; ten Cate-Hoek AJ, 2010, J VASC SURG, V52, P132, DOI 10.1016/j.jvs.2010.01.089; ten Cate-Hoek AJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005265; Villalta S, 1994, HAEMOSTASIS S1, V24, p158a	24	48	50	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i2691	10.1136/bmj.i2691	http://dx.doi.org/10.1136/bmj.i2691			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27245485	Green Published, hybrid			2022-12-28	WOS:000377477500003
J	Sadhu, MJ; Bloom, JS; Day, L; Kruglyak, L				Sadhu, Meru J.; Bloom, Joshua S.; Day, Laura; Kruglyak, Leonid			CRISPR-directed mitotic recombination enables genetic mapping without crosses	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING; DOMAIN; DRIVE	Linkage and association studies have mapped thousands of genomic regions that contribute to phenotypic variation, but narrowing these regions to the underlying causal genes and variants has proven much more challenging. Resolution of genetic mapping is limited by the recombination rate. We developed a method that uses CRISPR (clustered, regularly interspaced, short palindromic repeats) to build mapping panels with targeted recombination events. We tested the method by generating a panel with recombination events spaced along a yeast chromosome arm, mapping trait variation, and then targeting a high density of recombination events to the region of interest. Using this approach, we fine-mapped manganese sensitivity to a single polymorphism in the transporter Pmr1. Targeting recombination events to regions of interest allows us to rapidly and systematically identify causal variants underlying trait differences.	[Sadhu, Meru J.; Bloom, Joshua S.; Kruglyak, Leonid] Univ Calif Los Angeles, Dept Human Genet, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sadhu, MJ; Bloom, JS; Kruglyak, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Dept Biol Chem, Los Angeles, CA 90095 USA.	msadhu@mednet.ucla.edu; jbloom@mednet.ucla.edu; lkruglyak@mednet.ucla.edu	Sadhu, Meru/I-3929-2019	Sadhu, Meru/0000-0002-8636-9102	Howard Hughes Medical Institute; NIH [R01 GM102308, F32 GM116318]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102308, F32GM116318] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kruglyak laboratory members for helpful discussion, S. Clarke for strain BY4742, G. Church for plasmids, and S. Kosuri for his flow cytometer. Funding was provided by the Howard Hughes Medical Institute and NIH grants R01 GM102308 (L.K.) and F32 GM116318 (M.J.S). Sequencing data was deposited at the Sequence Read Archive under accession no. SRP072527, and other data and code was deposited at https://github.com/joshsbloom/crispr_loh.	Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Charles J., 2013, PLOS GENET, V9; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; HENSON V, 1991, P NATL ACAD SCI USA, V88, P6486, DOI 10.1073/pnas.88.15.6486; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Laureau R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005781; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MORTIMER RK, 1986, GENETICS, V113, P35; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Song G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120671; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Woodruff GC, 2010, GENETICS, V186, P997, DOI 10.1534/genetics.110.120550; Yin Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003894	21	60	63	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1113	1116		10.1126/science.aaf5124	http://dx.doi.org/10.1126/science.aaf5124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230379	Green Accepted, Green Submitted			2022-12-28	WOS:000376480800042
J	Schwartz, LM; Woloshin, S; Zheng, E; Tse, T; Zarin, DA				Schwartz, Lisa M.; Woloshin, Steven; Zheng, Eugene; Tse, Tony; Zarin, Deborah A.			ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials	ANNALS OF INTERNAL MEDICINE			English	Article							RESULTS DATABASE; ANTIINFLAMMATORY DRUGS; PUBLICATION	Background: Pharmaceutical companies and other trial sponsors must submit certain trial results to ClinicalTrials.gov. The validity of these results is unclear. Purpose: To validate results posted on ClinicalTrials.gov against publicly available U.S. Food and Drug Administration (FDA) reviews on Drugs@FDA. Data Sources: ClinicalTrials.gov (registry and results database) and Drugs@FDA (medical and statistical reviews). Study Selection: 100 parallel-group, randomized trials for new drug approvals (January 2013 to July 2014) with results posted on ClinicalTrials.gov (15 March 2015). Data Extraction: 2 assessors extracted, and another verified, the trial design, primary and secondary outcomes, adverse events, and deaths. Results: Most trials were phase 3 (90%), double-blind (92%), and placebo-controlled (73%) and involved 32 drugs from 24 companies. Of 137 primary outcomes identified from ClinicalTrials.gov, 134 (98%) had corresponding data at Drugs@FDA, 130 (95%) had concordant definitions, and 107 (78%) had concordant results. Most differences were nominal (that is, relative difference <10%). Primary outcome results in 14 trials could not be validated. Of 1927 secondary outcomes from ClinicalTrials.gov, Drugs@FDA mentioned 1061 (55%) and included results data for 367 (19%). Of 96 trials with 1 or more serious adverse events in either source, 14 could be compared and 7 had discordant numbers of persons experiencing the adverse events. Of 62 trials with 1 or more deaths in either source, 25 could be compared and 17 were discordant. Limitation: Unknown generalizability to uncontrolled or crossover trial results. Conclusion: Primary outcome definitions and results were largely concordant between ClinicalTrials. gov and Drugs@FDA. Half the secondary outcomes, as well as serious events and deaths, could not be validated because Drugs@FDA includes only "key outcomes" for regulatory decision making and frequently includes only adverse event results aggregated across multiple trials.	Dartmouth Inst Hlth Policy & Clin Practice, Dartmouth Hitchcock, NS, Canada; Informularly, Lebanon, NH USA; [Tse, Tony; Zarin, Deborah A.] Natl Lib Med, 8600 Rockville Pike, Bethesda, MD 20894 USA; [Woloshin, Steven] Dartmouth Inst, WTRB, Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA; [Zheng, Eugene] 2900 Univ Ave Southeast,Apartment 306, Minneapolis, MN 55414 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Dartmouth College	Woloshin, S (corresponding author), Dartmouth Inst, WTRB, Level 5,1 Med Ctr Dr, Lebanon, NH 03756 USA.	steven.woloshin@dartmouth.edu		Tse, Tony/0000-0002-9906-6864	National Library of Medicine; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: National Library of Medicine.	Becker JE, 2014, JAMA-J AM MED ASSOC, V311, P1063, DOI 10.1001/jama.2013.285634; Bouder F, 2015, RISK ANAL, V35, P1210, DOI 10.1111/risa.12386; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Earley A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001963; FDA, 2016, TETR; Gopal AD, 2015, JAMA-J AM MED ASSOC, V313, P1163, DOI 10.1001/jama.2015.1697; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Juni P, 2002, BRIT MED J, V324, P1287, DOI 10.1136/bmj.324.7349.1287; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5992; U.S. Food and Drug Administration, 2012, 60104 USDA MAPP CTR; US, 2016, DRUG SNAPSH 2016; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Woloshin S, 2016, JAMA INTERN MED, V176, P439, DOI 10.1001/jamainternmed.2016.0073; Woloshin S, 2014, JAMA-J AM MED ASSOC, V312, P2163, DOI 10.1001/jama.2014.13329; Zarin DA, 2015, NEW ENGL J MED, V372, P174, DOI 10.1056/NEJMsr1414226; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	23	29	29	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					421	+		10.7326/M15-2658	http://dx.doi.org/10.7326/M15-2658			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27294570	Green Accepted			2022-12-28	WOS:000383962000017
J	Bradley, CJ; Grossman, DC; Hubbard, RA; Ortega, AN; Curry, SJ				Bradley, Cathy J.; Grossman, David C.; Hubbard, Rebecca A.; Ortega, Alexander N.; Curry, Susan J.			Integrated Interventions for Improving Total Worker Health: A Panel Report From the National Institutes of Health Pathways to Prevention Workshop: Total Worker Health-What's Work Got to Do With It?	ANNALS OF INTERNAL MEDICINE			English	Review								This National Institutes of Health (NIH) Pathways to Prevention workshop was cosponsored by the NIH Office of Disease Prevention; National Heart, Lung, and Blood Institute; and National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention. A multidisciplinary working group developed the agenda, and an evidence-based practice center prepared an evidence report through a contract with the Agency for Healthcare Research and Quality. During the 1.5-day workshop, experts discussed the body of evidence and participants commented during open discussions. After weighing the data from the evidence report, expert presentations, and public comments, an unbiased, independent panel prepared a draft report that identified research gaps and future research priorities. The report was posted on the NIH Office of Disease Prevention Web site for 5 weeks for public comment. This article highlights 8 recommendations critical for advancing the science of integrated interventions to improve the total health of workers.	Univ Colorado, Ctr Canc, Denver, CO 80262 USA; [Grossman, David C.] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Hubbard, Rebecca A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, 604 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA; [Ortega, Alexander N.] Drexel Univ, Dornsife Sch Publ Hlth, Nesbitt Hall,3215 Market St,Room 335, Philadelphia, PA 19104 USA; [Curry, Susan J.] Univ Iowa, Dept Hlth Management & Policy, Coll Publ Hlth, 145 Riverside Dr,100 CPHB S153A, Iowa City, IA 52242 USA; [Bradley, Cathy J.] Univ Colorado, Ctr Canc, 13001 East 17th Pl,Campus Box F434, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Denver; University of Pennsylvania; Pennsylvania Medicine; Drexel University; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus	Curry, SJ (corresponding author), Univ Iowa, Dept Hlth Management & Policy, Coll Publ Hlth, 145 Riverside Dr,100 CPHB S153A, Iowa City, IA 52242 USA.	sue-curry@uiowa.edu	Ortega, Alexander/AAF-4175-2019; Hubbard, Rebecca/Y-6500-2019	Ortega, Alexander/0000-0001-6861-6993; Hubbard, Rebecca/0000-0003-0879-0994	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, 2016, TOT WORK HLTH; Feltner C, 2016, ANN INTERN MED, V165, P262, DOI 10.7326/M16-0626	2	37	37	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					279	+		10.7326/M16-0740	http://dx.doi.org/10.7326/M16-0740			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27240228				2022-12-28	WOS:000381267200017
J	Greer, PL; Bear, DM; Lassance, JM; Bloom, ML; Tsukahara, T; Pashkovski, SL; Masuda, FK; Nowlan, AC; Kirchner, R; Hoekstra, HE; Datta, SR				Greer, Paul L.; Bear, Daniel M.; Lassance, Jean-Marc; Bloom, Maria Lissitsyna; Tsukahara, Tatsuya; Pashkovski, Stan L.; Masuda, Francis Kei; Nowlan, Alexandra C.; Kirchner, Rory; Hoekstra, Hopi E.; Datta, Sandeep Robert			A Family of non-GPCR Chemosensors Defines an Alternative Logic for Mammalian Olfaction	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; GUANYLYL CYCLASE-D; ODORANT RECEPTORS; MULTIGENE FAMILY; MOLECULAR-BASIS; ION CHANNELS; GC-D; NEURONS; GENE; BETA	Odor perception in mammals is mediated by parallel sensory pathways that convey distinct information about the olfactory world. Multiple olfactory subsystems express characteristic seven-transmembrane G-protein-coupled receptors (GPCRs) in a one-receptor-per-neuron pattern that facilitates odor discrimination. Sensory neurons of the "necklace'' subsystem are nestled within the recesses of the olfactory epithelium and detect diverse odorants; however, they do not express known GPCR odor receptors. Here, we report that members of the four-pass transmembrane MS4A protein family are chemosensors expressed within necklace sensory neurons. These receptors localize to sensory endings and confer responses to ethologically relevant ligands, including pheromones and fatty acids, in vitro and in vivo. Individual necklace neurons co-express many MS4A proteins and are activated by multiple MS4A ligands; this pooling of information suggests that the necklace is organized more like subsystems for taste than for smell. The MS4As therefore define a distinct mechanism and functional logic for mammalian olfaction.	[Greer, Paul L.; Bear, Daniel M.; Bloom, Maria Lissitsyna; Tsukahara, Tatsuya; Pashkovski, Stan L.; Masuda, Francis Kei; Nowlan, Alexandra C.; Datta, Sandeep Robert] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lassance, Jean-Marc; Hoekstra, Hopi E.] Harvard Univ, Howard Hughes Med Inst, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lassance, Jean-Marc; Hoekstra, Hopi E.] Harvard Univ, Howard Hughes Med Inst, Ctr Brain Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kirchner, Rory] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard T.H. Chan School of Public Health	Datta, SR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	srdatta@hms.harvard.edu	Lassance, Jean-Marc/AAF-3933-2020; Tsukahara, Tatsuya/AAO-1707-2021; Hoekstra, Hopi E/I-6690-2012	Lassance, Jean-Marc/0000-0002-3675-6956; Tsukahara, Tatsuya/0000-0002-6928-8562; Hoekstra, Hopi E/0000-0003-1431-1769; Kirchner, Rory/0000-0003-4814-5885; Datta, Sandeep/0000-0002-8068-3862; Nowlan, Alexandra/0000-0001-8543-119X	Nancy Lurie Marks Foundation; William Randolph Hearst Fund; Leonard and Isabelle Goldenson Fund; Edward and Anne Lefler Foundation; NSF; Sackler Scholarship in Psychobiology; European Molecular Biology Organization [ALTF 379-2011]; Human Frontiers Science Program [LT001086/2012]; Belgian American Educational Foundation; Alice and Joseph E. Brooks Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Society for the Promotion of Science; NIDA F31 [DA036922-01]; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Searle Foundation; Sloan Foundation; Vallee Foundation; McKnight Foundation; Khodadad Program; National Institutes of Health [DP2OD007109, RO11DC011558]; Global Brain Initiative from the Simons Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA036922] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007109] Funding Source: NIH RePORTER	Nancy Lurie Marks Foundation; William Randolph Hearst Fund; Leonard and Isabelle Goldenson Fund; Edward and Anne Lefler Foundation; NSF(National Science Foundation (NSF)); Sackler Scholarship in Psychobiology; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Belgian American Educational Foundation; Alice and Joseph E. Brooks Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIDA F31; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Vallee Foundation; McKnight Foundation; Khodadad Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Brain Initiative from the Simons Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Vanessa Ruta, Michael Greenberg, Richard Axel, Steve Liberles, Bernardo Sabatini, Rachel Wilson, Elizabeth Hong, Steve Flavell, Eric Griffith, and members of the Datta Lab for helpful discussions and comments on the manuscript and Allison Petrosino, Neha Bhagat, and Lauren Coritt for laboratory assistance. We thank Andrew Giessel, Alexander Wiltschko, and Jeffrey Markowitz for coding assistance and Hannah Somhegyi for generation of the graphical abstract. P.L.G. was supported by the Nancy Lurie Marks Foundation, the William Randolph Hearst Fund, the Leonard and Isabelle Goldenson Fund, and the Edward and Anne Lefler Foundation. D.M.B. is supported by a NSF predoctoral fellowship and a Sackler Scholarship in Psychobiology. J.-M.L. is supported by the European Molecular Biology Organization (ALTF 379-2011), the Human Frontiers Science Program (LT001086/2012), and the Belgian American Educational Foundation. M.L.B. is supported by a NSF predoctoral fellowship. T.T. is supported by a postdoctoral fellowship from the Alice and Joseph E. Brooks Foundation, the Astellas Foundation for Research on Metabolic Disorders, and the Japan Society for the Promotion of Science postdoctoral fellowship for Research Abroad. S.L.P. was supported by a NIDA F31 (DA036922-01) and is a Stuart H.Q. & Victoria Quan Fellow at Harvard Medical School. H.H. is supported by the Howard Hughes Medical Institute. S.R.D. is supported by fellowships from the Burroughs Wellcome Fund, the Searle Foundation, the Sloan Foundation, the Vallee Foundation, the McKnight Foundation, the Khodadad Program, by grants DP2OD007109 and RO11DC011558 from the National Institutes of Health, and by the Global Brain Initiative from the Simons Foundation.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Arakawa H, 2013, CHEM SENSES, V38, P391, DOI 10.1093/chemse/bjt015; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Cockerham RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004657; Cruse G, 2013, IMMUNITY, V38, P906, DOI 10.1016/j.immuni.2013.04.007; Dalton RP, 2015, ANNU REV NEUROSCI, V38, P331, DOI 10.1146/annurev-neuro-071714-034145; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Duda T, 2008, BIOCHEM BIOPH RES CO, V367, P440, DOI 10.1016/j.bbrc.2007.12.153; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Gao L, 2010, NEUROSCIENCE, V170, P881, DOI 10.1016/j.neuroscience.2010.08.006; Grus WE, 2009, MOL BIOL EVOL, V26, P407, DOI 10.1093/molbev/msn262; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Hayakawa T, 2014, MOL BIOL EVOL, V31, P2018, DOI 10.1093/molbev/msu144; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Ihara S, 2013, NEUROSCIENCE, V254, P45, DOI 10.1016/j.neuroscience.2013.08.063; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Jiang Y, 2015, NAT NEUROSCI, V18, P1446, DOI 10.1038/nn.4104; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kim ST, 2015, CLIN TRANSL ONCOL, V17, P462, DOI 10.1007/s12094-014-1258-7; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Kuek LE, 2016, IMMUNOL CELL BIOL, V94, P11, DOI 10.1038/icb.2015.48; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Mamasuew K, 2011, CHEM SENSES, V36, P271, DOI 10.1093/chemse/bjq124; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Oberland S, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2075.00366, 10.3389/fncel.2015.00366]; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sabir A, 2012, J SCI FOOD AGR, V92, P1982, DOI 10.1002/jsfa.5571; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Secundo L, 2014, CURR OPIN NEUROBIOL, V25, P107, DOI 10.1016/j.conb.2013.12.010; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; Singer MS, 2000, CHEM SENSES, V25, P155, DOI 10.1093/chemse/25.2.155; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsai L, 2014, SCIENCE, V344, P197, DOI 10.1126/science.1248806; van Giesen L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10687; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wooding S, 2011, J MOL EVOL, V73, P257, DOI 10.1007/s00239-011-9481-0; Young JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000884; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zuccolo J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009369	69	72	74	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1734	1748		10.1016/j.cell.2016.05.001	http://dx.doi.org/10.1016/j.cell.2016.05.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27238024	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000378062000023
J	Kranz, LM; Diken, M; Haas, H; Kreiter, S; Loquai, C; Reuter, KC; Meng, M; Fritz, D; Vascotto, F; Hefesha, H; Grunwitz, C; Vormehr, M; Husemann, Y; Selmi, A; Kuhn, AN; Buck, J; Derhovanessian, E; Rae, R; Attig, S; Diekmann, J; Jabulowsky, RA; Heesch, S; Hassel, J; Langguth, P; Grabbe, S; Huber, C; Tureci, O; Sahin, U				Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen; Reuter, Kerstin C.; Meng, Martin; Fritz, Daniel; Vascotto, Fulvia; Hefesha, Hossam; Grunwitz, Christian; Vormehr, Mathias; Huesemann, Yves; Selmi, Abderraouf; Kuhn, Andreas N.; Buck, Janina; Derhovanessian, Evelyna; Rae, Richard; Attig, Sebastian; Diekmann, Jan; Jabulowsky, Robert A.; Heesch, Sandra; Hassel, Jessica; Langguth, Peter; Grabbe, Stephan; Huber, Christoph; Tuereci, Oezlem; Sahin, Ugur			Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy	NATURE			English	Article							CYTOLYTIC T-LYMPHOCYTES; IN-VIVO; IMMUNE-RESPONSES; ANTITUMOR IMMUNITY; ANTIGEN; INTERFERONS; MACROPINOCYTOSIS; VACCINATION; EFFICIENCY; INDUCTION	Lymphoid organs, in which antigen presenting cells (APCs) are in close proximity to T cells, are the ideal microenvironment for efficient priming and amplification of T-cell responses(1). However, the systemic delivery of vaccine antigens into dendritic cells (DCs) is hampered by various technical challenges. Here we show that DCs can be targeted precisely and effectively in vivo using intravenously administered RNA-lipoplexes (RNA-LPX) based on well-known lipid carriers by optimally adjusting net charge, without the need for functionalization of particles with molecular ligands. The LPX protects RNA from extracellular ribonucleases and mediates its efficient uptake and expression of the encoded antigen by DC populations and macrophages in various lymphoid compartments. RNA-LPX triggers interferon-alpha (IFN alpha) release by plasmacytoid DCs and macrophages. Consequently, DC maturation in situ and inflammatory immune mechanisms reminiscent of those in the early systemic phase of viral infection are activated(2). We show that RNA-LPX encoding viral or mutant neo-antigens or endogenous self-antigens induce strong effector and memory T-cell responses, and mediate potent IFN alpha-dependent rejection of progressive tumours. A phase I dose-escalation trial testing RNA-LPX that encode shared tumour antigens is ongoing. In the first three melanoma patients treated at a low-dose level, IFN alpha and strong antigen-specific T-cell responses were induced, supporting the identified mode of action and potency. As any polypeptide-based antigen can be encoded as RNA3,4, RNA-LPX represent a universally applicable vaccine class for systemic DC targeting and synchronized induction of both highly potent adaptive as well as type-I-IFN-mediated innate immune mechanisms for cancer immunotherapy.	[Kranz, Lena M.; Diken, Mustafa; Kreiter, Sebastian; Vascotto, Fulvia; Rae, Richard; Attig, Sebastian; Huber, Christoph; Sahin, Ugur] Johannes Gutenberg Univ gGmbH, TRON Translat Oncol, Univ Med Ctr, Freiligrathstr 12, D-55131 Mainz, Germany; [Kranz, Lena M.; Grunwitz, Christian; Vormehr, Mathias; Selmi, Abderraouf; Attig, Sebastian; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany; [Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Reuter, Kerstin C.; Meng, Martin; Fritz, Daniel; Hefesha, Hossam; Grunwitz, Christian; Vormehr, Mathias; Huesemann, Yves; Kuhn, Andreas N.; Buck, Janina; Derhovanessian, Evelyna; Diekmann, Jan; Jabulowsky, Robert A.; Heesch, Sandra; Huber, Christoph; Sahin, Ugur] Biopharmaceut New Technol BioNTech Corp, Goldgrube 12, D-55131 Mainz, Germany; [Loquai, Carmen; Grabbe, Stephan] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany; [Hassel, Jessica] Univ Heidelberg Hosp, Dept Dermatol, Neuenheimer Feld 440, D-69120 Heidelberg, Germany; [Langguth, Peter] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Langenbeckstr 1, D-55131 Mainz, Germany; [Tuereci, Oezlem] Cluster Individualized Immune Intervent, Kupferbergterasse 19, D-55116 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; BioNTech SE; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), Johannes Gutenberg Univ gGmbH, TRON Translat Oncol, Univ Med Ctr, Freiligrathstr 12, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Biopharmaceut New Technol BioNTech Corp, Goldgrube 12, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Grabe, Stephan/AAJ-4578-2021; Vormehr, Mathias/AAJ-7808-2021; Sahin, Ugur/L-4818-2017; Loquai, Carmen/AAW-9241-2020	Grabe, Stephan/0000-0002-6863-8719; Vormehr, Mathias/0000-0001-7788-3380; Sahin, Ugur/0000-0003-0363-1564; Roth, Rene/0000-0002-4333-695X; Vascotto, Fulvia/0000-0002-9839-3484; Kranz, Lena/0000-0003-1943-3431	Rhineland Palatinate government; InnoTop program; CI3 Cutting Edge Cluster Funding of the German Ministry of Technology (BMBF); Collaborative Research Group 1066 of Deutsche Forschungsgemeinschaft (DFG); Graduate School of Immunotherapy 1043 of DFG	Rhineland Palatinate government; InnoTop program; CI3 Cutting Edge Cluster Funding of the German Ministry of Technology (BMBF); Collaborative Research Group 1066 of Deutsche Forschungsgemeinschaft (DFG); Graduate School of Immunotherapy 1043 of DFG	The authors thank M. Holzmann, R. Roth, U. Schmitt, M. Brkic, A. Konig, C. Worm, N. Krimmel, A.-K. Thiel, C. Bender, M. Suchan, A.-L. Popa, P. Bezerra Gomes, S. Herbert, M. Lux, D. Wintergerst, V. Bischoff, R. Krishna, Y. Hajime, J. Gross, A. Spruss, M. Erdeljan, S. Woll, T. Bukur, H. Muramatsu and M. Baiersdorfer for technical support, NIH Tetramer Core Facility for providing gp70 MHC class I tetramer, A. Kong for critical reading, A. Kemmer-Bruck, D. Schwarck, S. Bolte for clinical operations support and K. Kariko for advice. This work was supported by the technology innovation program of the Rhineland Palatinate government, the InnoTop program, the CI3 Cutting Edge Cluster Funding of the German Ministry of Technology (BMBF) and the Collaborative Research Group 1066 of Deutsche Forschungsgemeinschaft (DFG). L.M.K. was funded by the Graduate School of Immunotherapy 1043 of DFG.	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Bacher N, 2013, CANCER RES, V73, P5647, DOI 10.1158/0008-5472.CAN-12-3788; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bangham A.D., 1974, METHODS MEMBRANE BIO, P1, DOI [DOI 10.1007/978-1-4615-7422-4_1, 10.1007/978-1-4615-7422-4_1]; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Barichello JM, 2010, METHODS MOL BIOL, V605, P461, DOI 10.1007/978-1-60327-360-2_32; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chuang CM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-49; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Diken M, 2011, GENE THER, V18, P702, DOI 10.1038/gt.2011.17; Duzgunes N., 2009, METHODS ENZYMOLOGY; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Hess PR, 2006, CANCER IMMUNOL IMMUN, V55, P672, DOI 10.1007/s00262-005-0064-z; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2007, CANCER IMMUNOL IMMUN, V56, P1577, DOI 10.1007/s00262-007-0302-7; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee ER, 1996, HUM GENE THER, V7, P1701, DOI 10.1089/hum.1996.7.14-1701; Lin K.-Y., 1996, CANCER RES, P21; Liu Y, 1997, NAT BIOTECHNOL, V15, P167, DOI 10.1038/nbt0297-167; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Perche F, 2011, NANOMED-NANOTECHNOL, V7, P445, DOI 10.1016/j.nano.2010.12.010; Phua KKL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/680620; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Pollard C, 2013, MOL THER, V21, P251, DOI 10.1038/mt.2012.202; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Simon P, 2014, CANCER IMMUNOL RES, V2, P1230, DOI 10.1158/2326-6066.CIR-14-0108; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; WEXLER H, 1966, JNCI-J NATL CANCER I, V36, P641, DOI 10.1093/jnci/36.4.641; Zhou WZ, 1999, HUM GENE THER, V10, P2719, DOI 10.1089/10430349950016762; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	52	840	900	54	618	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					396	+		10.1038/nature18300	http://dx.doi.org/10.1038/nature18300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281205				2022-12-28	WOS:000377856800038
J	Parisien, MA				Parisien, Marc-Andre			Science can map a solution to a fast-burning problem	NATURE			English	Editorial Material									[Parisien, Marc-Andre] Canadian Forest Serv, Edmonton, AB, Canada	Natural Resources Canada; Canadian Forest Service	Parisien, MA (corresponding author), Canadian Forest Serv, Edmonton, AB, Canada.	marc-andre.parisien@canada.ca							0	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					297	297		10.1038/534297a	http://dx.doi.org/10.1038/534297a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306154	Bronze			2022-12-28	WOS:000377856800004
J	Christie, B				Christie, Bryan			Sixty seconds on ... minimum alcohol price	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							ENGLAND											Alcohol Focus Scotland, PRIC CHECK REV CHEAP; Brennan A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5452; Christie B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6990; Christie B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4756; Christie B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3425; Hawkes N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8140; O'Dowd A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4622	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3300	10.1136/bmj.i3300	http://dx.doi.org/10.1136/bmj.i3300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27301437				2022-12-28	WOS:000378239800012
J	Lim, YW; Chia, A				Lim, Yee Wei; Chia, Audrey			Social Entrepreneurship Improving Global Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lim, Yee Wei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr,2 09-01W, Singapore 117549, Singapore; [Chia, Audrey] Natl Univ Singapore, NUS Business Sch, Singapore 117549, Singapore	National University of Singapore; National University of Singapore	Lim, YW (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr,2 09-01W, Singapore 117549, Singapore.	yee_wei_lim@nuhs.edu.sg		Chia, Audrey/0000-0001-6098-2526				Hutton DW, 2014, INVEST OPHTH VIS SCI, V55; Krishnan A, ARAVIND EYE CARE SYS; United Nations, MILL DEV GOALS REP 2; United Nations, SUST DEV GOALS	4	8	8	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2393	2394		10.1001/jama.2016.4400	http://dx.doi.org/10.1001/jama.2016.4400			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299615				2022-12-28	WOS:000377656900011
J	Planer, JD; Peng, YQ; Kau, AL; Blanton, LV; Ndao, IM; Tarr, PI; Warner, BB; Gordon, JI				Planer, Joseph D.; Peng, Yangqing; Kau, Andrew L.; Blanton, Laura V.; Ndao, I. Malick; Tarr, Phillip I.; Warner, Barbara B.; Gordon, Jeffrey I.			Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice	NATURE			English	Article							BACTERIA; PATTERNS	Immunoglobulin A (IgA), the major class of antibody secreted by the gut mucosa, is an important contributor to gut barrier function(1-3). The repertoire of IgA bound to gut bacteria reflects both T-cell-dependent and -independent pathways(4,5), plus glycans present on the antibody's secretory component(6). Human gut bacterial taxa targeted by IgA in the setting of barrier dysfunction are capable of producing intestinal pathology when isolated and transferred to gnotobiotic mice(7,8). A complex reorientation of gut immunity occurs as infants transition from passively acquired IgA present in breast milk to host-derived IgA(9-11). How IgA responses co-develop with assembly of the microbiota during this period remains poorly understood. Here, we (1) identify a set of age-discriminatory bacterial taxa whose representations define a program of microbiota assembly and maturation during the first 2 postnatal years that is shared across 40 healthy twin pairs in the USA; (2) describe a pattern of progression of gut mucosal IgA responses to bacterial members of the microbiota that is highly distinctive for family members (twin pairs) during the first several postnatal months then generalizes across pairs in the second year; and (3) assess the effects of zygosity, birth mode, and breast feeding. Age-associated differences in these IgA responses can be recapitulated in young germ-free mice, colonized with faecal microbiota obtained from two twin pairs at 6 and 18 months of age, and fed a sequence of human diets that simulate the transition from milk feeding to complementary foods. Most of these responses were robust to diet, suggesting that 'intrinsic' properties of community members play a dominant role in dictating IgA responses. The approach described can be used to define gut mucosal immune development in health and disease states and to help discover ways of repairing or preventing perturbations in this facet of host immunity.	[Planer, Joseph D.; Peng, Yangqing; Kau, Andrew L.; Blanton, Laura V.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Planer, Joseph D.; Peng, Yangqing; Kau, Andrew L.; Blanton, Laura V.; Gordon, Jeffrey I.] Washington Univ, Ctr Gut Microbiome & Nutr Res, Sch Med, St Louis, MO 63110 USA; [Ndao, I. Malick; Tarr, Phillip I.; Warner, Barbara B.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Ctr Gut Microbiome & Nutr Res, Sch Med, St Louis, MO 63110 USA.	jgordon@wustl.edu	Kau, Andrew/AGX-9881-2022	Kau, Andrew/0000-0002-9386-3766	National Institutes of Health [DK30292, DK052574]; Children's Discovery Institute; Bill & Melinda Gates Foundation; Crohn's and Colitis Foundation of America; Washington University Medical Scientist Training Program (National Institutes of Health) [GM007200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI113184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, P30DK052574, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200, T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohn's and Colitis Foundation of America; Washington University Medical Scientist Training Program (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. O'Donnell, M. Karlsson, J. Serugo, and S. Wagoner for help with gnotobiotic husbandry; S. Deng, J. Guruge, J. Hoisington-Lopez and M. Meier for technical assistance; G. Dantas for help with maintaining our archive of de-identified human samples; and N. Griffin for comments about facets of the data analysis. This work was supported by grants from the National Institutes of Health (DK30292, DK052574), the Children's Discovery Institute, the Bill & Melinda Gates Foundation, and the Crohn's and Colitis Foundation of America. J.D.P. is a member of the Washington University Medical Scientist Training Program (National Institutes of Health GM007200).	Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gustafson CE, 2014, MUCOSAL IMMUNOL, V7, P467, DOI 10.1038/mi.2013.64; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kau A. L., 2015, SCI TRANSL MED, V7; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mathias A, 2011, GUT MICROBES, V2, P287, DOI 10.4161/gmic.2.5.18269; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; Rogosch T, 2012, J IMMUNOL, V189, P5449, DOI 10.4049/jimmunol.1103347; Sela DA, 2014, AM J CLIN NUTR, V99, p697S, DOI 10.3945/ajcn.113.071795; Siega-Riz AM, 2010, J AM DIET ASSOC, V110, pS38, DOI 10.1016/j.jada.2010.09.001; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101	30	178	189	7	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					263	+		10.1038/nature17940	http://dx.doi.org/10.1038/nature17940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279225	Green Accepted			2022-12-28	WOS:000377475100044
J	Wilson, MR; Sola, J; Carlone, A; Goldup, SM; Lebrasseur, N; Leigh, DA				Wilson, Miriam R.; Sola, Jordi; Carlone, Armando; Goldup, Stephen M.; Lebrasseur, Nathalie; Leigh, David A.			An autonomous chemically fuelled small-molecule motor	NATURE			English	Article							ROTARY MOTOR; DRIVEN; MOTION; CONTRACTION; ROTATION	Molecular machines are among the most complex of all functional molecules and lie at the heart of nearly every biological process(1). A number of synthetic small-molecule machines have been developed(2), including molecular muscles(3,4), synthesizers(5,6), pumps(7-9), walkers(10), transporters(11) and light-driven(12-16) and electrically(17,18) driven rotary motors. However, although biological molecular motors are powered by chemical gradients or the hydrolysis of adenosine triphosphate (ATP)(1), so far there are no synthetic small-molecule motors that can operate autonomously using chemical energy (that is, the components move with net directionality as long as a chemical fuel is present)(19). Here we describe a system in which a small molecular ring (macrocycle) is continuously transported directionally around a cyclic molecular track when powered by irreversible reactions of a chemical fuel, 9-fluorenylmethoxycarbonyl chloride. Key to the design is that the rate of reaction of this fuel with reactive sites on the cyclic track is faster when the macrocycle is far from the reactive site than when it is near to it. We find that a bulky pyridine-based catalyst promotes carbonate-forming reactions that ratchet the displacement of the macrocycle away from the reactive sites on the track. Under reaction conditions where both attachment and cleavage of the 9-fluorenylmethoxycarbonyl groups occur through different processes, and the cleavage reaction occurs at a rate independent of macrocycle location, net directional rotation of the molecular motor continues for as long as unreacted fuel remains. We anticipate that autonomous chemically fuelled molecular motors will find application as engines in molecular nanotechnology(2,19,20).	[Wilson, Miriam R.; Sola, Jordi; Carlone, Armando; Goldup, Stephen M.; Lebrasseur, Nathalie; Leigh, David A.] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England; [Sola, Jordi] Inst Adv Chem Catalonia IQAC CSIC, Jordi Girona 18-26, Barcelona 08034, Spain; [Carlone, Armando] Dr Reddys, Chirotech Technol Ctr, Cambridge CB4 0PE, England; [Goldup, Stephen M.] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England; [Lebrasseur, Nathalie] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Southampton; University of London; Queen Mary University London	Leigh, DA (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	david.leigh@manchester.ac.uk	Goldup, Stephen M/M-3136-2014; Leigh, David/K-5965-2015; Sola, Jordi/D-3479-2014; Carlone, Armando/AFU-2696-2022	Goldup, Stephen M/0000-0003-3781-0464; Leigh, David/0000-0002-1202-4507; Sola, Jordi/0000-0002-3389-3429; Carlone, Armando/0000-0003-2983-6445	European Research Council (ERC)	European Research Council (ERC)(European Research Council (ERC))	We thank D. R. Astumian for the analysis of the catenane motor reaction kinetics, the European Research Council (ERC) for funding and the EPSRC National Mass Spectrometry Service Centre (Swansea, UK) for high-resolution mass spectrometry.	Alvarez-Perez M, 2008, J AM CHEM SOC, V130, P1836, DOI 10.1021/ja7102394; Astumian RD, 2012, NAT NANOTECHNOL, V7, P684, DOI 10.1038/nnano.2012.188; Bruns CJ, 2014, ACCOUNTS CHEM RES, V47, P2186, DOI 10.1021/ar500138u; Carlone A, 2012, J AM CHEM SOC, V134, P8321, DOI 10.1021/ja302711z; Cheng CY, 2015, ACS NANO, V9, P8672, DOI 10.1021/acsnano.5b03809; Cheng CY, 2015, NAT NANOTECHNOL, V10, P547, DOI [10.1038/nnano.2015.96, 10.1038/NNANO.2015.96]; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P909, DOI 10.1002/(SICI)1521-3773(19980420)37:7<909::AID-ANIE909>3.0.CO;2-X; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Erbas-Cakmak S, 2015, CHEM REV, V115, P10081, DOI 10.1021/acs.chemrev.5b00146; Feynman R.P., 1963, FEYNMAN LECT PHYS; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; Greb L, 2015, ANGEW CHEM INT EDIT, V54, P14345, DOI 10.1002/anie.201506691; Greb L, 2014, J AM CHEM SOC, V136, P13114, DOI 10.1021/ja506034n; Haberhauer G, 2011, ANGEW CHEM INT EDIT, V50, P6415, DOI 10.1002/anie.201101501; Hernandez JV, 2004, SCIENCE, V306, P1532, DOI 10.1126/science.1103949; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Kassem S, 2016, NAT CHEM, V8, P138, DOI [10.1038/nchem.2410, 10.1038/NCHEM.2410]; Kay ER, 2015, ANGEW CHEM INT EDIT, V54, P10080, DOI 10.1002/anie.201503375; Kelly TR, 2007, J AM CHEM SOC, V129, P376, DOI 10.1021/ja066044a; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kelly TR, 1997, ANGEW CHEM INT EDIT, V36, P1866, DOI 10.1002/anie.199718661; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Lewandowski B, 2013, SCIENCE, V339, P189, DOI 10.1126/science.1229753; Li Q, 2015, NAT NANOTECHNOL, V10, P161, DOI [10.1038/nnano.2014.315, 10.1038/NNANO.2014.315]; Lu CH, 2013, NANO LETT, V13, P2303, DOI 10.1021/nl401010e; Perera UGE, 2013, NAT NANOTECHNOL, V8, P46, DOI [10.1038/nnano.2012.218, 10.1038/NNANO.2012.218]; Ragazzon G, 2015, NAT NANOTECHNOL, V10, P70, DOI [10.1038/nnano.2014.260, 10.1038/NNANO.2014.260]; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Serreli V, 2007, NATURE, V445, P523, DOI 10.1038/nature05452; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Tierney HL, 2011, NAT NANOTECHNOL, V6, P625, DOI [10.1038/nnano.2011.142, 10.1038/NNANO.2011.142]; von Delius M, 2010, NAT CHEM, V2, P96, DOI [10.1038/NCHEM.481, 10.1038/nchem.481]	33	253	254	18	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					235	+		10.1038/nature18013	http://dx.doi.org/10.1038/nature18013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279219	Green Accepted, Green Submitted			2022-12-28	WOS:000377475100038
J	Croce, R; Xu, PQ				Croce, Roberta; Xu, Pengqi			STRUCTURAL BIOLOGY A photo shoot of plant photosystem II	NATURE			English	Editorial Material							CRYSTAL-STRUCTURE; RESOLUTION; ANGSTROM; PROTEINS; ANTENNA		[Croce, Roberta; Xu, Pengqi] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Photosynth Grp, NL-1081 Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Croce, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Photosynth Grp, NL-1081 Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X				Caffarri S, 2011, BIOPHYS J, V100, P2094, DOI 10.1016/j.bpj.2011.03.049; Chmeliov J, 2014, J AM CHEM SOC, V136, P8963, DOI 10.1021/ja5027858; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Ifuku K, 2015, BIOSCI BIOTECH BIOCH, V79, P1223, DOI 10.1080/09168451.2015.1031078; Jarvi S, 2015, BBA-BIOENERGETICS, V1847, P900, DOI 10.1016/j.bbabio.2015.01.006; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020	10	1	1	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					42	43		10.1038/nature18438	http://dx.doi.org/10.1038/nature18438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251272				2022-12-28	WOS:000376962300028
J	Gerdes, K; Semsey, S				Gerdes, Kenn; Semsey, Szabolcs			MICROBIOLOGY Pumping persisters	NATURE			English	Editorial Material							BACTERIAL PERSISTENCE		[Gerdes, Kenn; Semsey, Szabolcs] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	University of Copenhagen	Gerdes, K (corresponding author), Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.	kgerdes@bio.ku.dk	Gerdes, Kenn/AAS-5548-2021	Gerdes, Kenn/0000-0002-7462-4612	Novo Nordisk Fonden [NNF12OC0000638] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Pu YY, 2016, MOL CELL, V62, P284, DOI 10.1016/j.molcel.2016.03.035; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011	8	27	28	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					41	42		10.1038/nature18442	http://dx.doi.org/10.1038/nature18442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251271				2022-12-28	WOS:000376962300027
J	Liggio, J; Li, SM; Hayden, K; Taha, YM; Stroud, C; Darlington, A; Drollette, BD; Gordon, M; Lee, P; Liu, P; Leithead, A; Moussa, SG; Wang, D; O'Brien, J; Mittermeier, RL; Brook, JR; Lu, G; Staebler, RM; Han, YM; Tokarek, TW; Osthoff, HD; Makar, PA; Zhang, JH; Plata, DL; Gentner, DR				Liggio, John; Li, Shao-Meng; Hayden, Katherine; Taha, Youssef M.; Stroud, Craig; Darlington, Andrea; Drollette, Brian D.; Gordon, Mark; Lee, Patrick; Liu, Peter; Leithead, Amy; Moussa, Samar G.; Wang, Danny; O'Brien, Jason; Mittermeier, Richard L.; Brook, Jeffrey R.; Lu, Gang; Staebler, Ralf M.; Han, Yuemei; Tokarek, Travis W.; Osthoff, Hans D.; Makar, Paul A.; Zhang, Junhua; Plata, Desiree L.; Gentner, Drew R.			Oil sands operations as a large source of secondary organic aerosols	NATURE			English	Article							EMISSION RATES; PARTICULATE MATTER; BLACK CARBON; ISOPRENE; ALBERTA; SIMULATION; DEPOSITION; IMPACT	Worldwide heavy oil and bitumen deposits amount to 9 trillion barrels of oil distributed in over 280 basins around the world(1), with Canada home to oil sands deposits of 1.7 trillion barrels(2). The global development of this resource and the increase in oil production from oil sands has caused environmental concerns over the presence of toxic compounds in nearby ecosystems(3,4) and acid deposition(5,6). The contribution of oil sands exploration to secondary organic aerosol formation, an important component of atmospheric particulate matter that affects air quality and climate(7), remains poorly understood. Here we use data from airborne measurements over the Canadian oil sands, laboratory experiments and a box-model study to provide a quantitative assessment of the magnitude of secondary organic aerosol production from oil sands emissions. We find that the evaporation and atmospheric oxidation of low-volatility organic vapours from the mined oil sands material is directly responsible for the majority of the observed secondary organic aerosol mass. The resultant production rates of 45-84 tonnes per day make the oil sands one of the largest sources of anthropogenic secondary organic aerosols in North America. Heavy oil and bitumen account for over ten per cent of global oil production today(8), and this figure continues to grow(9). Our findings suggest that the production of the more viscous crude oils could be a large source of secondary organic aerosols in many production and refining regions worldwide, and that such production should be considered when assessing the environmental impacts of current and planned bitumen and heavy oil extraction projects globally.	[Liggio, John; Li, Shao-Meng; Hayden, Katherine; Stroud, Craig; Darlington, Andrea; Gordon, Mark; Lee, Patrick; Liu, Peter; Leithead, Amy; Moussa, Samar G.; Wang, Danny; O'Brien, Jason; Mittermeier, Richard L.; Brook, Jeffrey R.; Lu, Gang; Staebler, Ralf M.; Han, Yuemei; Makar, Paul A.; Zhang, Junhua] Environm & Climate Change Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada; [Taha, Youssef M.; Tokarek, Travis W.; Osthoff, Hans D.] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Drollette, Brian D.; Plata, Desiree L.; Gentner, Drew R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Environment & Climate Change Canada; University of Calgary; Yale University	Liggio, J; Li, SM (corresponding author), Environm & Climate Change Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada.	John.Liggio@canada.ca; Shao-Meng.Li@canada.ca		Leithead, Amy/0000-0002-2860-0468; Li, Shao-Meng/0000-0002-7628-6581; O'Brien, Jason/0000-0001-8431-5824; Osthoff, Hans/0000-0001-7155-6493; Staebler, Ralf/0000-0002-6372-0414; Taha, Youssef/0000-0002-6199-3195; Darlington, Andrea/0000-0002-7469-5541; Gordon, Mark/0000-0003-4896-4661	Clean Air Regulatory Agenda; Joint Oil Sands Monitoring program	Clean Air Regulatory Agenda; Joint Oil Sands Monitoring program	We thank the National Research Council of Canada flight crew of the Convair-580, the technical support staff of the Air Quality Research Division, S. Cober for the management of the study, and the community of Fort McKay for the support of the Oski otin ground site at Fort McKay. The project was supported by the Clean Air Regulatory Agenda and the Joint Oil Sands Monitoring program.	Alberta Energy Regulator, 2013, ALB MIN OIL SANDS PL; BP, 2011, HEAV OIL VS LIGHT OI; Carter WPL, 2010, ATMOS ENVIRON, V44, P5336, DOI 10.1016/j.atmosenv.2010.01.024; Chen YZ, 2015, ATMOS ENVIRON, V105, P109, DOI 10.1016/j.atmosenv.2015.01.042; de Gouw J, 2003, INT J MASS SPECTROM, V223, P365, DOI 10.1016/S1387-3806(02)00926-0; de Gouw JA, 2011, SCIENCE, V331, P1295, DOI 10.1126/science.1200320; de Gouw J, 2007, MASS SPECTROM REV, V26, P223, DOI 10.1002/mas.20119; De Gouw J, 2009, ENVIRON SCI TECHNOL, V43, P7614, DOI 10.1021/es9006004; DeCarlo PF, 2006, ANAL CHEM, V78, P8281, DOI 10.1021/ac061249n; Donahue NM, 2009, ATMOS ENVIRON, V43, P94, DOI 10.1016/j.atmosenv.2008.09.055; Dusseault M., 2002, COLD HEAVY OIL PRODU; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Emil D.A., 2007, HEAVY OIL NATURAL BI HEAVY OIL NATURAL BI; Freney EJ, 2014, ATMOS CHEM PHYS, V14, P1397, DOI 10.5194/acp-14-1397-2014; Fuzzi S, 2015, ATMOS CHEM PHYS, V15, P8217, DOI 10.5194/acp-15-8217-2015; Garratt JR, 1994, ATMOSPHERIC BOUNDARY; Gentner DR, 2014, ATMOS CHEM PHYS, V14, P4955, DOI 10.5194/acp-14-4955-2014; Gentner DR, 2012, P NATL ACAD SCI USA, V109, P18318, DOI 10.1073/pnas.1212272109; Gilman JB, 2013, ENVIRON SCI TECHNOL, V47, P1297, DOI 10.1021/es304119a; Gordon M, 2015, ATMOS MEAS TECH, V8, P3745, DOI 10.5194/amt-8-3745-2015; Government of Alberta, 2009, ENV MAN ALB OIL SAND; Grieshop AP, 2009, ATMOS CHEM PHYS, V9, P1263, DOI 10.5194/acp-9-1263-2009; Hakola H, 2006, BIOGEOSCIENCES, V3, P93, DOI 10.5194/bg-3-93-2006; Hayes PL, 2015, ATMOS CHEM PHYS, V15, P5773, DOI 10.5194/acp-15-5773-2015; Helmig D, 2007, ENVIRON SCI TECHNOL, V41, P1545, DOI 10.1021/es0618907; Jathar SH, 2014, P NATL ACAD SCI USA, V111, P10473, DOI 10.1073/pnas.1323740111; Jung KH, 2013, ATMOS ENVIRON, V69, P56, DOI 10.1016/j.atmosenv.2012.12.010; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kirk JL, 2014, ENVIRON SCI TECHNOL, V48, P7374, DOI 10.1021/es500986r; Kleinman LI, 2008, ATMOS CHEM PHYS, V8, P1559, DOI 10.5194/acp-8-1559-2008; Kleinman LI, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007786; Li R, 2013, ENVIRON SCI TECHNOL, V47, P12566, DOI 10.1021/es402265y; Liu Y, 2015, ATMOS CHEM PHYS, V15, P13569, DOI 10.5194/acp-15-13569-2015; Miyakawa T, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009493; Moteki N, 2010, AEROSOL SCI TECH, V44, P663, DOI 10.1080/02786826.2010.484450; Murphy BN, 2011, ATMOS CHEM PHYS, V11, P7859, DOI 10.5194/acp-11-7859-2011; Ng NL, 2011, ENVIRON SCI TECHNOL, V45, P910, DOI 10.1021/es102951k; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Robinson NH, 2011, ATMOS CHEM PHYS, V11, P1039, DOI 10.5194/acp-11-1039-2011; Schwarz JP, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007076; Shrivastava MK, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009735; Simpson IJ, 2010, ATMOS CHEM PHYS, V10, P11931, DOI 10.5194/acp-10-11931-2010; Tsimpidi AP, 2010, ATMOS CHEM PHYS, V10, P525, DOI 10.5194/acp-10-525-2010; Vinuesa JF, 2009, BOUND-LAY METEOROL, V133, P1, DOI 10.1007/s10546-009-9416-0; Watmough SA, 2014, SCI TOTAL ENVIRON, V493, P1, DOI 10.1016/j.scitotenv.2014.05.110; Xie Y, 2013, ATMOS CHEM PHYS, V13, P8439, DOI 10.5194/acp-13-8439-2013; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979; Zhao J, 2004, ATMOS ENVIRON, V38, P2177, DOI 10.1016/j.atmosenv.2004.01.019; Zhao YL, 2014, ENVIRON SCI TECHNOL, V48, P13743, DOI 10.1021/es5035188	49	103	104	4	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					91	+		10.1038/nature17646	http://dx.doi.org/10.1038/nature17646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251281				2022-12-28	WOS:000376962300039
J	Rochmyaningsih, D				Rochmyaningsih, Dyna			The developing world needs basic research too	NATURE			English	Editorial Material												drochmya87@gmail.com							0	3	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					7	7		10.1038/534007a	http://dx.doi.org/10.1038/534007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27251238	Bronze			2022-12-28	WOS:000376962300005
J	[Anonymous]				[Anonymous]			10-MINUTE CONSULTATION Tooth avulsion (vol 353, i1394, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Moran I, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1394; Public Health England, 2013, IMM INF DIS GREEN BO	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i3076	10.1136/bmj.i3076	http://dx.doi.org/10.1136/bmj.i3076			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27245175	Bronze, Green Published			2022-12-28	WOS:000377477500013
J	Yang, Y; Perry, IB; Lu, G; Liu, P; Buchwald, SL				Yang, Yang; Perry, Ian B.; Lu, Gang; Liu, Peng; Buchwald, Stephen L.			Copper-catalyzed asymmetric addition of olefin-derived nucleophiles to ketones	SCIENCE			English	Article							C BOND FORMATION; CARBONYL; HYDROGENATION; 1,3-ENYNES; ALCOHOLS; HYDROAMINATION; PROPARGYLATION; ALDEHYDES; REAGENTS; AMINES	Enantioenriched alcohols found in an array of bioactive natural products and pharmaceutical agents are often synthesized by asymmetric nucleophilic addition to carbonyls. However, this approach generally shows limited functional-group compatibility, requiring the use of preformed organometallic reagents in conjunction with a stoichiometric or substoichiometric amount of chiral controller to deliver optically active alcohols. Herein we report a copper-catalyzed strategy for the stereoselective nucleophilic addition of propargylic and other alkyl groups to ketones, using easily accessible (poly) unsaturated hydrocarbons as latent carbanion equivalents. Our method features the catalytic generation of highly enantioenriched organocopper intermediates and their subsequent diastereoselective addition to ketones, allowing for the effective construction of highly substituted stereochemical dyads with excellent stereocontrol. Moreover, this process is general, scalable, and occurs at ambient temperature.	[Yang, Yang; Perry, Ian B.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Lu, Gang; Liu, Peng] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Liu, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pengliu@pitt.edu; sbuchwal@mit.edu	Liu, Peng/A-9043-2008; Lu, Gang/M-5729-2017	Liu, Peng/0000-0002-8188-632X; Lu, Gang/0000-0002-7319-4315; Perry, Ian/0000-0001-8287-9976; Yang, Yang/0000-0002-4956-2034	NIH [GM 46059]; Undergraduate Research Opportunities Program at MIT; University of Pittsburgh; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046059, R37GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Research Opportunities Program at MIT; University of Pittsburgh(University of Pittsburgh); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the NIH (grant GM 46059 to S.L.B.), the Undergraduate Research Opportunities Program at MIT (I.B.P.), and the University of Pittsburgh (P.L.) for financial support. The content in this paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank Y.-M. Wang and M. T. Pirnot (MIT) for advice on the preparation of this manuscript and P. Muller (MIT) for x-ray crystallographic analysis of 5f. Cambridge Crystallographic Data Centre accession number 1470340 contains the supplementary crystallographic data for 5f. Calculations were performed at the Center for Simulation and Modeling at the University of Pittsburgh and the Extreme Science and Engineering Discovery Environment (XSEDE) supported by the NSF.	Ascic E, 2015, J AM CHEM SOC, V137, P4666, DOI 10.1021/jacs.5b02316; Berman AM, 2004, J AM CHEM SOC, V126, P5680, DOI 10.1021/ja049474e; Bower JF, 2009, ANGEW CHEM INT EDIT, V48, P34, DOI 10.1002/anie.200802938; Chaulagain MR, 2007, J AM CHEM SOC, V129, P9568, DOI 10.1021/ja072992f; Clayden J, 2011, BEILSTEIN J ORG CHEM, V7, P582, DOI 10.3762/bjoc.7.68; Corey E. J., 2010, ENANTIOSELECTIVE CHE; Deschamp J, 2006, ANGEW CHEM INT EDIT, V45, P1292, DOI 10.1002/anie.200503791; Ding CH, 2011, CHEM REV, V111, P1914, DOI 10.1021/cr100284m; Fandrick KR, 2011, J AM CHEM SOC, V133, P10332, DOI 10.1021/ja2028958; Geary LM, 2012, ANGEW CHEM INT EDIT, V51, P2972, DOI 10.1002/anie.201200239; Jackson EP, 2015, ACCOUNTS CHEM RES, V48, P1736, DOI 10.1021/acs.accounts.5b00096; Jang HY, 2004, ACCOUNTS CHEM RES, V37, P653, DOI 10.1021/ar020108e; Knochel P, 2003, ANGEW CHEM INT EDIT, V42, P4302, DOI 10.1002/anie.200300579; Komanduri V, 2006, J AM CHEM SOC, V128, P16448, DOI 10.1021/ja0673027; Lipshutz BH, 2003, J AM CHEM SOC, V125, P8779, DOI 10.1021/ja021391f; Lipshutz BH, 2008, J AM CHEM SOC, V130, P14378, DOI 10.1021/ja8045475; Meng FK, 2014, J AM CHEM SOC, V136, P11304, DOI 10.1021/ja5071202; Meng FK, 2013, ANGEW CHEM INT EDIT, V52, P5046, DOI 10.1002/anie.201301018; Miki Y, 2014, ORG LETT, V16, P1498, DOI 10.1021/ol5003219; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; Miller KM, 2004, J AM CHEM SOC, V126, P15342, DOI 10.1021/ja0446799; Moslin RM, 2007, CHEM COMMUN, P4441, DOI 10.1039/b707737h; Nishikawa D, 2015, J AM CHEM SOC, V137, P15620, DOI 10.1021/jacs.5b09773; NOYORI R, 1991, ANGEW CHEM INT EDIT, V30, P49, DOI 10.1002/anie.199100491; Pirnot MT, 2016, ANGEW CHEM INT EDIT, V55, P48, DOI 10.1002/anie.201507594; Pu L, 2001, CHEM REV, V101, P757, DOI 10.1021/cr000411y; Riant O, 2007, ORG BIOMOL CHEM, V5, P873, DOI 10.1039/b617746h; Sasaki Y, 2011, ANGEW CHEM INT EDIT, V50, P2778, DOI 10.1002/anie.201007182; Saxena A, 2012, J AM CHEM SOC, V134, P8428, DOI 10.1021/ja3036916; Shi SL, 2010, J AM CHEM SOC, V132, P6638, DOI 10.1021/ja101948s; Shibasaki M, 2008, CHEM REV, V108, P2853, DOI 10.1021/cr078340r; Skucas E, 2007, ACCOUNTS CHEM RES, V40, P1394, DOI 10.1021/ar7001123; Stymiest JL, 2008, NATURE, V456, P778, DOI 10.1038/nature07592; Whittaker AM, 2013, ORG LETT, V15, P1112, DOI 10.1021/ol4001679; Xi YM, 2016, ANGEW CHEM INT EDIT, V55, P776, DOI 10.1002/anie.201509235; Zhao DB, 2006, J AM CHEM SOC, V128, P14440, DOI 10.1021/ja0652565	36	150	151	4	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					144	150		10.1126/science.aaf7720	http://dx.doi.org/10.1126/science.aaf7720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27284169	Green Accepted, Green Published			2022-12-28	WOS:000379208400033
J	Gibson, BA; Zhang, YJ; Jiang, H; Hussey, KM; Shrimp, JH; Lin, HN; Schwede, F; Yu, YH; Kraus, WL				Gibson, Bryan A.; Zhang, Yajie; Jiang, Hong; Hussey, Kristine M.; Shrimp, Jonathan H.; Lin, Hening; Schwede, Frank; Yu, Yonghao; Kraus, W. Lee			Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation	SCIENCE			English	Article							ADP-RIBOSYLATION; POLYMERASE; POLY(ADP-RIBOSE); BINDING	Poly[adenosine diphosphate (ADP)-ribose] polymerases (PARPs) are a family of enzymes that modulate diverse biological processes through covalent transfer of ADP-ribose from the oxidized form of nicotinamide adenine dinucleotide (NAD(+)) onto substrate proteins. Here we report a robust NAD(+) analog-sensitive approach for PARPs, which allows PARP-specific ADP-ribosylation of substrates that is suitable for subsequent copper-catalyzed azide-alkyne cycloaddition reactions. Using this approach, we mapped hundreds of sites of ADP-ribosylation for PARPs 1, 2, and 3 across the proteome, as well as thousands of PARP-1-mediated ADP-ribosylation sites across the genome. We found that PARP-1 ADP-ribosylates and inhibits negative elongation factor (NELF), a protein complex that regulates promoter-proximal pausing by RNA polymerase II (Pol II). Depletion or inhibition of PARP-1 or mutation of the ADP-ribosylation sites on NELF-E promotes Pol II pausing, providing a clear functional link between PARP-1, ADP-ribosylation, and NELF. This analog-sensitive approach should be broadly applicable across the PARP family and has the potential to illuminate the ADP-ribosylated proteome and the molecular mechanisms used by individual PARPs to mediate their responses to cellular signals.	[Gibson, Bryan A.; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Lab Signaling & Gene Express, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Gibson, Bryan A.; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Zhang, Yajie; Yu, Yonghao] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Jiang, Hong; Shrimp, Jonathan H.; Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14850 USA; [Jiang, Hong; Shrimp, Jonathan H.; Lin, Hening] Cornell Univ, Dept Chem, Ithaca, NY 14850 USA; [Hussey, Kristine M.] Sarepta Therapeut, Cambridge, MA 02142 USA; [Schwede, Frank] Biolog Life Sci Inst, D-28199 Bremen, Germany; [Jiang, Hong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201203, Peoples R China; [Shrimp, Jonathan H.] NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; Howard Hughes Medical Institute; Cornell University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kraus, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Lab Signaling & Gene Express, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.; Kraus, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	lee.kraus@utsouthwestern.edu		Shrimp, Jonathan/0000-0001-9872-942X	American Heart Association; Cancer Prevention and Research Institute of Texas [CPRIT R1103]; Welch Foundation [I-1800]; UT Southwestern Endowed Scholars Program; NIH National Institute of General Medical Sciences [GM086703]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK069710]; Cecil H. and Ida Green Center for Reproductive Biology Sciences Endowments; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086703] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); UT Southwestern Endowed Scholars Program; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cecil H. and Ida Green Center for Reproductive Biology Sciences Endowments; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Chae, Q. Liang, J. DeBrabander, U. Havemann, and D. Imren for technical assistance and members of the Kraus laboratory for helpful discussions about this project. The asPARP expression constructs and the NAD<SUP>+</SUP> analogs can be obtained from University of Texas (UT) Southwestern Medical Center and Biolog Life Science Institute, respectively, under a material transfer agreement. W.L.K., B.A.G., F.S., and H.L. are inventors on U.S. patent application no. 62/144,711, filed by UT Southwestern Medical Center, related to the asPARP technology. W.L.K. and B.A.G. are inventors on U.S. patent application nos. 62/009,955 and PCT/US2015/034852, filed by UT Southwestern Medical Center, related to the ADP-ribose detection reagents. Y.Y. is an inventor on U.S. patent no. 8828672 B2, filed by UT Southwestern Medical Center, related to technology for the determination of D/E-ADP-ribosylation sites. This work was supported by a predoctoral fellowship from the American Heart Association to B.A.G.; grants from the Cancer Prevention and Research Institute of Texas (CPRIT R1103), the Welch Foundation (I-1800), and the UT Southwestern Endowed Scholars Program to Y.Y., who is the Virginia Murchison Linthicum Scholar in Medical Research and a CPRIT Scholar in Cancer Research; a grant from the NIH National Institute of General Medical Sciences (GM086703) to H.L.; and a grant from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (DK069710) and support from the Cecil H. and Ida Green Center for Reproductive Biology Sciences Endowments to W.L.K. W.L.K. is a founder and consultant for Ribon Therapeutics. The genomic data sets from this study are available from the National Center for Biotechnology Information Gene Expression Omnibus database under accession numbers GSE74141 (ChIP-seq) and GSE74142 (GRO-seq and RNA-seq). The proteomic data sets generated for these studies are available in table S1. Author contributions: On the basis of (7), B.A.G. conceived the asPARP concept, with input from W.L.K. W.L.K. conceived the Click-ChIP-seq method, which was further developed by B.A.G. B.A.G. performed all experiments and computational analyses, except as follows: H. J., J. H. S., H.L., and F.S. synthesized all precursors and NAD+ analogs used in this study. B.A.G. and H. J. performed the enzyme kinetics assays. B.A.G., Y.Z., and Y.Y. prepared the samples and ran the LC-MS/MS analysis. K.M.H. made the PARP-1 knockdown MCF-7 cells and prepared the GRO-seq samples. W.L.K. secured funding to support this project and provided intellectual support for all aspects of the work. B.A.G. and W.L.K. prepared the figures and wrote the paper.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Bartolomei G, 2016, MOL CELL, V61, P474, DOI 10.1016/j.molcel.2015.12.025; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Carter-O'Connell I, 2016, CELL REP, V14, P621, DOI 10.1016/j.celrep.2015.12.045; Carter-O'Connell I, 2014, J AM CHEM SOC, V136, P5201, DOI 10.1021/ja412897a; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	19	214	219	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					45	50		10.1126/science.aaf7865	http://dx.doi.org/10.1126/science.aaf7865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27256882	Green Accepted			2022-12-28	WOS:000378816200031
J	Kaiko, GE; Ryu, SH; Koues, OI; Collins, PL; Solnica-Krezel, L; Pearce, EJ; Pearce, EL; Oltz, EM; Stappenbeck, TS				Kaiko, Gerard E.; Ryu, Stacy H.; Koues, Olivia I.; Collins, Patrick L.; Solnica-Krezel, Lilianna; Pearce, Edward J.; Pearce, Erika L.; Oltz, Eugene M.; Stappenbeck, Thaddeus S.			The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites	CELL			English	Article							CHAIN FATTY-ACIDS; SMALL-INTESTINE; IN-VITRO; DIFFERENTIATION; RECEPTOR; RENEWAL; MATURATION; DISEASE; ORIGIN; FOXOS	In the mammalian intestine, crypts of Leiberkuhn house intestinal epithelial stem/progenitor cells at their base. The mammalian intestine also harbors a diverse array of microbial metabolite compounds that potentially modulate stem/progenitor cell activity. Unbiased screening identified butyrate, a prominent bacterial metabolite, as a potent inhibitor of intestinal stem/progenitor proliferation at physiologic concentrations. During homeostasis, differentiated colonocytes metabolized butyrate likely preventing it from reaching proliferating epithelial stem/progenitor cells within the crypt. Exposure of stem/progenitor cells in vivo to butyrate through either mucosal injury or application to a naturally crypt-less host organism led to inhibition of proliferation and delayed wound repair. The mechanism of butyrate action depended on the transcription factor Foxo3. Our findings indicate that mammalian crypt architecture protects stem/progenitor cell proliferation in part through a metabolic barrier formed by differentiated colonocytes that consume butyrate and stimulate future studies on the interplay of host anatomy and microbiome metabolism.	[Kaiko, Gerard E.; Ryu, Stacy H.; Koues, Olivia I.; Collins, Patrick L.; Pearce, Edward J.; Pearce, Erika L.; Oltz, Eugene M.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Solnica-Krezel, Lilianna; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenent, Dept Immunometab, D-79108 Freiburg, Germany	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	stappenb@wustl.edu	Collins, Patrick/AAN-7599-2020; Kaiko, Gerard/ABC-2169-2021	Collins, Patrick/0000-0003-4550-4272; Kaiko, Gerard/0000-0002-3167-3174; Ryu, Stacy Hyunji/0000-0002-5448-339X	Crohn's & Colitis Foundation of America (CCFA); NIH [DK071619, AI115734]; WashU DDRCC [P30DK052574]; NATIONAL CANCER INSTITUTE [R01CA181125, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK071619] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WashU DDRCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Crohn's & Colitis Foundation of America (CCFA), NIH (DK071619, AI115734), and WashU DDRCC (P30DK052574) supported this work. We thank Wandy Beatty (EM), Maxene Ilagan (screening, P30CA91842), Brad Evans (Danforth, mass spectrometry), Dallas Donohoe (U. Tenn. scientific discussion), William Sly (SLU, Car4 antibody), and Stephen Canter (zebrafish).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kelly CL, 1996, MAMM GENOME, V7, P262, DOI 10.1007/s003359900078; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Lickert H, 2000, DEVELOPMENT, V127, P3805; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mohammad S, 2015, CURR DRUG TARGETS, V16, P771, DOI 10.2174/1389450116666150408103557; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wang LC, 2002, GASTROENTEROLOGY, V122, P469, DOI 10.1053/gast.2002.31102; WEIDEMAN.MJ, 1970, BIOCHEM J, V117, P177, DOI 10.1042/bj1170177; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	54	311	319	6	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1708	1720		10.1016/j.cell.2016.05.018	http://dx.doi.org/10.1016/j.cell.2016.05.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27264604	Bronze, Green Accepted			2022-12-28	WOS:000378062000021
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			State Initiatives to Control Medication Costs - Can Transparency Legislation Help?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Anderson Richard, 2014, BBC NEWS; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Barlas Stephen, 2015, P T, V40, P260; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; IMS Institute for Healthcare Informatics, 2016, MED US SPEND US REV	5	19	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2301	2304		10.1056/NEJMp1605100	http://dx.doi.org/10.1056/NEJMp1605100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305189				2022-12-28	WOS:000377854600001
J	Aune, D; Keum, N; Giovannucci, E; Fadnes, LT; Boffetta, P; Greenwood, DC; Tonstad, S; Vatten, LJ; Riboli, E; Norat, T				Aune, Dagfinn; Keum, NaNa; Giovannucci, Edward; Fadnes, Lars T.; Boffetta, Paolo; Greenwood, Darren C.; Tonstad, Serena; Vatten, Lars J.; Riboli, Elio; Norat, Teresa			Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; DIETARY FIBER INTAKE; LIFE-STYLE FACTORS; GAMMA-GLUTAMYL-TRANSFERASE; MEDITERRANEAN DIET; REFINED-GRAIN; MYOCARDIAL-INFARCTION; RICE CONSUMPTION; ISCHEMIC-STROKE; FOLLOW-UP	OBJECTIVE To quantify the dose-response relation between consumption of whole grain and specific types of grains and the risk of cardiovascular disease, total cancer, and all cause and cause specific mortality. DATA SOURCES PubMed and Embase searched up to 3 April 2016. STUDY SELECTION Prospective studies reporting adjusted relative risk estimates for the association between intake of whole grains or specific types of grains and cardiovascular disease, total cancer, all cause or cause specific mortality. DATA SYNTHESIS Summary relative risks and 95% confidence intervals calculated with a random effects model. RESULTS 45 studies (64 publications) were included. The summary relative risks per 90 g/day increase in whole grain intake (90 g is equivalent to three servings-for example, two slices of bread and one bowl of cereal or one and a half pieces of pita bread made from whole grains) was 0.81 (95% confidence interval 0.75 to 0.87; I-2=9%, n=7 studies) for coronary heart disease, 0.88 (0.75 to 1.03; I-2=56%, n=6) for stroke, and 0.78 (0.73 to 0.85; I-2=40%, n=10) for cardiovascular disease, with similar results when studies were stratified by whether the outcome was incidence or mortality. The relative risks for morality were 0.85 (0.80 to 0.91; I-2=37%, n=6) for total cancer, 0.83 (0.77 to 0.90; I-2=83%, n=11) for all causes, 0.78 (0.70 to 0.87; I-2=0%, n=4) for respiratory disease, 0.49 (0.23 to 1.05; I-2=85%, n=4) for diabetes, 0.74 (0.56 to 0.96; I-2=0%, n=3) for infectious diseases, 1.15 (0.66 to 2.02; I-2=79%, n=2) for diseases of the nervous system disease, and 0.78 (0.75 to 0.82; I-2=0%, n=5) for all non-cardiovascular, non-cancer causes. Reductions in risk were observed up to an intake of 210-225 g/day (seven to seven and a half servings per day) for most of the outcomes. Intakes of specific types of whole grains including whole grain bread, whole grain breakfast cereals, and added bran, as well as total bread and total breakfast cereals were also associated with reduced risks of cardiovascular disease and/or all cause mortality, but there was little evidence of an association with refined grains, white rice, total rice, or total grains. CONCLUSIONS This meta-analysis provides further evidence that whole grain intake is associated with a reduced risk of coronary heart disease, cardiovascular disease, and total cancer, and mortality from all causes, respiratory diseases, infectious diseases, diabetes, and all non-cardiovascular, non-cancer causes. These findings support dietary guidelines that recommend increased intake of whole grain to reduce the risk of chronic diseases and premature mortality.	[Aune, Dagfinn; Riboli, Elio; Norat, Teresa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Aune, Dagfinn; Vatten, Lars J.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Keum, NaNa; Giovannucci, Edward] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA USA; [Giovannucci, Edward] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA USA; [Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Fadnes, Lars T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Fadnes, Lars T.] Univ Bergen, Dept Clin Dent, Bergen, Norway; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Greenwood, Darren C.] Univ Leeds, Ctr Epidemiol & Biostat, Biostat Unit, Leeds, W Yorkshire, England; [Tonstad, Serena] Oslo Univ Hosp Ulleval, Dept Endocrinol Morbid Obes & Prevent Med, Sect Prevent Cardiol, Oslo, Norway	Imperial College London; Norwegian University of Science & Technology (NTNU); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Icahn School of Medicine at Mount Sinai; University of Leeds; University of Oslo	Aune, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England.	d.aune@imperial.ac.uk	Vatten, Lars/AAF-9380-2022; Fadnes, Lars T/AAA-8691-2021; Vatten, Lars/AFK-2073-2022; Boffetta, Paolo/AAI-7767-2021; Fadnes, Lars T/E-9086-2016	Boffetta, Paolo/0000-0002-3811-2791; Fadnes, Lars T/0000-0001-8757-2092; Riboli, Elio/0000-0001-6795-6080; Aune, Dagfinn/0000-0002-4533-1722	Olav og Gerd Meidel Raagholt's Stiftelse for Medisinsk Forskning; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)	Olav og Gerd Meidel Raagholt's Stiftelse for Medisinsk Forskning; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)	This project was funded by Olav og Gerd Meidel Raagholt's Stiftelse for Medisinsk Forskning, the liaison committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), and the Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Appleby P N, 2002, IARC Sci Publ, V156, P131; Atkins JL, 2014, J NUTR, V144, P673, DOI 10.3945/jn.113.186486; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Aune Dagfinn, 2011, BMJ, V343, pd6617, DOI 10.1136/bmj.d6617; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Boggs DA, 2015, J NUTR, V145, P547, DOI 10.3945/jn.114.195735; Bongard V, 2016, EUR J CLIN NUTR, V70, P715, DOI 10.1038/ejcn.2016.19; Buckland G, 2011, BRIT J NUTR, V106, P1581, DOI 10.1017/S0007114511002078; Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282; Buil-Cosiales P, 2014, AM J CLIN NUTR, V100, P1498, DOI 10.3945/ajcn.114.093757; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; Cohen LA, 1996, J NATL CANCER I, V88, P899, DOI 10.1093/jnci/88.13.899; Coleman HG, 2013, NUTR REV, V71, P474, DOI 10.1111/nure.12032; Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du GL, 2013, PREV MED, V57, P31, DOI 10.1016/j.ypmed.2013.03.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eshak ES, 2014, AM J CLIN NUTR, V100, P199, DOI 10.3945/ajcn.113.079038; Eshak ES, 2011, J NUTR, V141, P595, DOI 10.3945/jn.110.132167; Esmaillzadeh A, 2005, EUR J CLIN NUTR, V59, P353, DOI 10.1038/sj.ejcn.1602080; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Fitzgerald KC, 2012, J THROMB HAEMOST, V10, P189, DOI 10.1111/j.1538-7836.2011.04588.x; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Flint AJ, 2009, AM J CLIN NUTR, V90, P493, DOI 10.3945/ajcn.2009.27460; Foerster J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109606; Fortes C, 2000, EPIDEMIOLOGY, V11, P440, DOI 10.1097/00001648-200007000-00013; Gardener H, 2011, AM J CLIN NUTR, V94, P1458, DOI 10.3945/ajcn.111.012799; Gartside PS, 1998, J AM COLL NUTR, V17, P263, DOI 10.1080/07315724.1998.10718757; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hays Judith C., 2005, Journal of Nutrition for the Elderly, V25, P41, DOI 10.1300/J052v25n02_04; Helns A, 2016, AM J CLIN NUTR, V103, P999, DOI 10.3945/ajcn.115.124271; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holloender PLB, 2015, AM J CLIN NUTR, V102, P556, DOI 10.3945/ajcn.115.109165; Huang T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0294-7; Iso H, 2007, ASIAN PAC J CANCER P, V8, P35; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jacobs DR, 2007, AM J CLIN NUTR, V85, P1606, DOI 10.1093/ajcn/85.6.1606; Jacobs DR, 1999, AM J PUBLIC HEALTH, V89, P322, DOI 10.2105/AJPH.89.3.322; Jacobs DR, 1998, NUTR CANCER, V30, P85, DOI 10.1080/01635589809514647; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Jacobs DR, 2001, EUR J CLIN NUTR, V55, P137, DOI 10.1038/sj.ejcn.1601133; Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258; Jensen MK, 2004, AM J CLIN NUTR, V80, P1492, DOI 10.1093/ajcn/80.6.1492; Johnsen NF, 2015, BRIT J NUTR, V114, P608, DOI 10.1017/S0007114515001701; KAHN HA, 1984, AM J EPIDEMIOL, V119, P775, DOI 10.1093/oxfordjournals.aje.a113798; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Katcher HI, 2008, AM J CLIN NUTR, V87, P79, DOI 10.1093/ajcn/87.1.79; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Kim Y, 2014, AM J EPIDEMIOL, V180, P565, DOI 10.1093/aje/kwu174; Knoops KTB, 2006, EUR J CLIN NUTR, V60, P746, DOI 10.1038/sj.ejcn.1602378; Kyro C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt352; Kyro C, 2012, SCAND J PUBLIC HEALT, V40, P76, DOI 10.1177/1403494811421057; Kyro C, 2011, PUBLIC HEALTH NUTR, V14, P1787, DOI 10.1017/S1368980011000206; Larsson SC, 2009, EUR J CLIN NUTR, V63, P1016, DOI 10.1038/ejcn.2009.16; Li KR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-59; Liu SM, 2000, JAMA-J AM MED ASSOC, V284, P1534, DOI 10.1001/jama.284.12.1534; Liu SM, 1999, AM J CLIN NUTR, V70, P412; Liu SM, 2003, AM J CLIN NUTR, V77, P594, DOI 10.1093/ajcn/77.3.594; Mann KD, 2015, BRIT J NUTR, V113, P1643, DOI 10.1017/S0007114515000422; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez-Gonzalez MA, 2012, J NUTR, V142, P1672, DOI 10.3945/jn.112.162891; Masters RC, 2010, J NUTR, V140, P587, DOI 10.3945/jn.109.116640; McKeown NM, 2010, AM J CLIN NUTR, V92, P1165, DOI 10.3945/ajcn.2009.29106; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Mizrahi A, 2009, BRIT J NUTR, V102, P1075, DOI 10.1017/S0007114509359097; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mok Y, 2016, INT J CANCER, V138, P311, DOI 10.1002/ijc.29659; Montonen J, 2003, AM J CLIN NUTR, V77, P622, DOI 10.1093/ajcn/77.3.622; Montonen J, 2013, EUR J NUTR, V52, P337, DOI 10.1007/s00394-012-0340-6; Muhihi A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-26; Muraki I, 2015, AM J CLIN NUTR, V101, P164, DOI 10.3945/ajcn.114.087551; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nanri A, 2010, AM J CLIN NUTR, V92, P1468, DOI 10.3945/ajcn.2010.29512; Oba S, 2010, METABOLISM, V59, P1574, DOI 10.1016/j.metabol.2010.02.004; Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Orsini N, 2011, STATA J, V11, P1; Osler M, 1997, INT J EPIDEMIOL, V26, P155, DOI 10.1093/ije/26.1.155; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Pietinen P, 1996, CIRCULATION, V94, P2720, DOI 10.1161/01.CIR.94.11.2720; Prinelli F, 2015, BRIT J NUTR, V113, P1003, DOI 10.1017/S0007114515000318; Qi L, 2006, DIABETES CARE, V29, P207, DOI 10.2337/diacare.29.02.06.dc05-1903; Rautiainen S, 2012, AM J MED, V125, P974, DOI 10.1016/j.amjmed.2012.03.008; Rebello SA, 2014, AM J CLIN NUTR, V100, P53, DOI 10.3945/ajcn.113.076273; Ross AB, 2015, AM J CLIN NUTR, V101, P903, DOI 10.3945/ajcn.114.098046; Roswall N, 2015, EUR J EPIDEMIOL, V30, P509, DOI 10.1007/s10654-015-0021-x; ROTEVATN S, 1989, PREV MED, V18, P433, DOI 10.1016/0091-7435(89)90003-0; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Sahyoun NR, 2006, AM J CLIN NUTR, V83, P124; Sharma S, 2013, CANCER CAUSE CONTROL, V24, P685, DOI 10.1007/s10552-013-0148-6; Shi ZM, 2015, NUTRIENTS, V7, P7562, DOI 10.3390/nu7095353; Simila ME, 2013, BRIT J NUTR, V110, P1704, DOI 10.1017/S0007114513000858; Slavin JL, 2001, J AM DIET ASSOC, V101, P780, DOI 10.1016/S0002-8223(01)00194-8; Sluik D, 2014, DIABETOLOGIA, V57, P63, DOI 10.1007/s00125-013-3074-y; Sonestedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126104; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879; Threapleton DE, 2013, STROKE, V44, P1360, DOI 10.1161/STROKEAHA.111.000151; Tognon G, 2014, BRIT J NUTR, V111, P151, DOI 10.1017/S0007114513001931; Tognon G, 2011, AGE, V33, P439, DOI 10.1007/s11357-010-9193-1; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou Antonia, 2009, BMJ, V338, pb2337, DOI 10.1136/bmj.b2337; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7; Wang JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22619; Wells GA, THE NEWCASTLE OTTAWA; World Cancer Research Fund American Institute for Cancer R, 2007, FOOD NUTRITION PHYSI; Wu HY, 2015, JAMA INTERN MED, V175, P373, DOI 10.1001/jamainternmed.2014.6283; Xu M, 2016, J AM COLL NUTR, V35, P217, DOI 10.1080/07315724.2014.971193; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Yu DX, 2013, AM J EPIDEMIOL, V178, P1542, DOI 10.1093/aje/kwt178; Zhang G, 2011, J NUTR, V141, P1685, DOI 10.3945/jn.111.142224; Zhang R, 2016, INT J CANCER, V138, P555, DOI 10.1002/ijc.29704	122	556	572	13	129	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i2716	10.1136/bmj.i2716	http://dx.doi.org/10.1136/bmj.i2716			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27301975	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000378239800002
J	van den Bergh, GD; Kaifu, Y; Kurniawan, I; Kono, RT; Brumm, A; Setiyabudi, E; Aziz, F; Morwood, MJ				van den Bergh, Gerrit D.; Kaifu, Yousuke; Kurniawan, Iwan; Kono, Reiko T.; Brumm, Adam; Setiyabudi, Erick; Aziz, Fachroel; Morwood, Michael J.			Homo floresiensis-like fossils from the early Middle Pleistocene of Flores	NATURE			English	Article							TAXONOMIC AFFINITIES; LIANG-BUA; DENTAL REMAINS; HOMININ; SHAPE; MORPHOLOGY; SANGIRAN; DMANISI; DIVERSITY; GEORGIA	The evolutionary origin of Homo floresiensis, a diminutive hominin species previously known only by skeletal remains from Liang Bua in western Flores, Indonesia, has been intensively debated. It is a matter of controversy whether this primitive form, dated to the Late Pleistocene, evolved from early Asian Homo erectus and represents a unique and striking case of evolutionary reversal in hominin body and brain size within an insular environment(1-4). The alternative hypothesis is that H. floresiensis derived from an older, smaller-brained member of our genus, such as Homo habilis, or perhaps even late Australopithecus, signalling a hitherto undocumented dispersal of hominins from Africa into eastern Asia by two million years ago (2 Ma)(5,6). Here we describe hominin fossils excavated in 2014 from an early Middle Pleistocene site (Mata Menge) in the So'a Basin of central Flores. These specimens comprise a mandible fragment and six isolated teeth belonging to at least three small-jawed and small-toothed individuals. Dating to similar to 0.7 Ma, these fossils now constitute the oldest hominin remains from Flores(7). The Mata Menge mandible and teeth are similar in dimensions and morphological characteristics to those of H. floresiensis from Liang Bua. The exception is the mandibular first molar, which retains a more primitive condition. Notably, the Mata Menge mandible and molar are even smaller in size than those of the two existing H. floresiensis individuals from Liang Bua. The Mata Menge fossils are derived compared with Australopithecus and H. habilis, and so tend to support the view that H. floresiensis is a dwarfed descendent of early Asian H. erectus. Our findings suggest that hominins on Flores had acquired extremely small body size and other morphological traits specific to H. floresiensis at an unexpectedly early time.	[van den Bergh, Gerrit D.; Morwood, Michael J.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Kaifu, Yousuke; Kono, Reiko T.] Natl Museum Nat & Sci, Dept Anthropol, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan; [Kurniawan, Iwan; Setiyabudi, Erick; Aziz, Fachroel] Geol Museum Bandung, Geol Agcy, Jalan Diponegoro 57, Bandung 40122, Indonesia; [Brumm, Adam] Griffith Univ, Environm Futures Res Inst, Res Ctr Human Evolut, Nathan, Qld 4111, Australia; [Brumm, Adam] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia	University of Wollongong; National Museum of Nature and Science; Griffith University; University of Wollongong	Kaifu, Y (corresponding author), Natl Museum Nat & Sci, Dept Anthropol, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	kaifu@kahaku.go.jp	van den Bergh, Gerrit D/I-7670-2016	Kaifu, Yousuke/0000-0003-0483-104X; Setiabudi, Erick/0000-0002-8417-4133; van den Bergh, Gerrit Dirk/0000-0003-1507-3336	Australian Research Council (ARC) [DP1093342]; Japan Society for the Promotion of Science [24247044]; Geological Survey Centre of Indonesia	Australian Research Council (ARC)(Australian Research Council); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Geological Survey Centre of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Funding for the So'a Basin project was provided by an Australian Research Council (ARC) Discovery grant (DP1093342) awarded to M.J.M. and A.B., and the project was directed by M.J.M. (2010-2013) and G.D.v.d.B. (2013-2015). The Japan Society for the Promotion of Science provided a grant (No. 24247044) to Y.K. Financial and technical support was provided by the Geological Survey Centre of Indonesia. The Indonesian State Ministry of Research and Technology granted permission to undertake this research, and we thank the successive directors of the Geological Survey Centre, Y. Kusumahbrata, A. Wibowo and A. Pribadi, the Heads of the Geological Agency (R. Sukyiar and Surono), and the successive directors of the Geology Museum in Bandung (S. Baskoro and O. Abdurahman) for facilitating and supporting this research. In addition, we acknowledge support and advice provided by I. Setiadi, D. Pribadi and Suyono. We also thank M. R. Puspaningrum, H. Insani, I. Sutisna, S. Sonjaya, U. P. Wibowo, A. Gunawan, A. M. Saiful, S. Hayes, B. Burhan, E. Sukandar, A. Rahman, A. Rahmadi and E. E. Laksmana for their assistance in the field (2014-2015), and G. Suwa, T. Djubiantono, F. Aziz, T. Jacob, E. Mbua, F. Schrenk, I. Tattersall, K. Mowbray, J. de Vos, P. Mennecier, F. Demeter, Nguyen Kim Thuy, and Nguyen Lan Cuong for access to the specimens in their care.	Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Bailey SE, 2005, AM J PHYS ANTHROPOL, V126, P268, DOI 10.1002/ajpa.20037; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Brumm A., 2016, NATURE; Brumm A, 2006, NATURE, V441, P624, DOI 10.1038/nature04618; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; Dennell RW, 2014, QUATERNARY SCI REV, V96, P98, DOI 10.1016/j.quascirev.2013.06.031; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Kaifu Y, 2015, ANTHROPOL SCI, V123, P161, DOI 10.1537/ase.150702; Kaifu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141614; Kaifu Y, 2015, ANTHROPOL SCI, V123, P129, DOI 10.1537/ase.150501; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lestrel PE, 2013, HOMO, V64, P247, DOI 10.1016/j.jchb.2013.05.001; LISTER AM, 1989, NATURE, V342, P539, DOI 10.1038/342539a0; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Morwood M., 2007, DISCOVERY HOBBIT; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Rosas A, 1998, AM J PHYS ANTHROPOL, V107, P145, DOI 10.1002/(SICI)1096-8644(199810)107:2<145::AID-AJPA2>3.3.CO;2-8; Ruff CB, 2015, J HUM EVOL, V80, P147, DOI 10.1016/j.jhevol.2014.12.004; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Suwa G., 1996, Human Evolution, V11, P269, DOI 10.1007/BF02436630; Suwa G., 1990, THESIS U CALIFORNIA; Tobias P.V., 1991, OLDUVAI GORGE, V4; van den Bergh GD, 2009, J HUM EVOL, V57, P527, DOI 10.1016/j.jhevol.2008.08.015; Van den Bergh GD, 2016, NATURE, V529, P208, DOI 10.1038/nature16448; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Weidenreich F., 1937, Palaeontologia Sinica, Vno. 101, P1; WHITE TD, 1981, S AFR J SCI, V77, P445; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1983, J ANAT, V136, P197; Wood B, 2014, NATURE, V508, P31, DOI 10.1038/508031a; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Zanolli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067233	53	80	81	4	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					245	+		10.1038/nature17999	http://dx.doi.org/10.1038/nature17999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO0NH	27279221				2022-12-28	WOS:000377475100040
J	Yagi, T				Yagi, Takehiko			GEOCHEMISTRY Hydrogen and oxygen in the deep Earth	NATURE			English	Editorial Material									[Yagi, Takehiko] Univ Tokyo, Geochem Res Ctr, Tokyo 1130033, Japan	University of Tokyo	Yagi, T (corresponding author), Univ Tokyo, Geochem Res Ctr, Tokyo 1130033, Japan.	yagi@eqchem.s.u-tokyo.ac.jp						Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Hattori T, 2015, NUCL INSTRUM METH A, V780, P55, DOI 10.1016/j.nima.2015.01.059; Hu QY, 2016, NATURE, V534, P241, DOI 10.1038/nature18018; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; LIU LG, 1976, PHYS EARTH PLANET IN, V11, P289, DOI 10.1016/0031-9201(76)90016-9; Machida A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6063; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Sano-Furukawa A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4901095; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Sorensen HO, 2012, Z KRIST-CRYST MATER, V227, P63, DOI 10.1524/zkri.2012.1438	10	5	7	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					183	184		10.1038/534183a	http://dx.doi.org/10.1038/534183a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279207				2022-12-28	WOS:000377475100025
J	Oliver, D				Oliver, David			David Oliver: Values statements aren't worth the paper	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bell JS, 2013, AGE AGEING, V42, P555, DOI 10.1093/ageing/aft079; Cornwell J, 2012, CONTINUITY CARE HOSP; Ham C., 2016, GUARDIAN; Imison C, 2012, OLDER PEOPLE EMERGEN; McNamara C., BASICS DEV MISSION V; NHS Benchmarking Network, 2016, OLD PEOPL CAR AC SET; O'Donnell M., 1997, BMJ; Oliver D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2684; Stephenson J., 2014, NURS TIMES; Tadd W., 2011, DIGNITY PRACTICE EXP; Thompson J., 2015, DELAYED TRANSFERS CA	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i3103	10.1136/bmj.i3103	http://dx.doi.org/10.1136/bmj.i3103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260797	Bronze, Green Published			2022-12-28	WOS:000377480200006
J	Chan, H				Chan, Heather			Colin Deas Campbell Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		CAMPBELL CD, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3109	10.1136/bmj.i3109	http://dx.doi.org/10.1136/bmj.i3109			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255425				2022-12-28	WOS:000377479000014
J	Kinney, MO; Morrow, J				Kinney, Michael Owen; Morrow, James			Epilepsy in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IN-UTERO EXPOSURE; SUDDEN UNEXPECTED DEATH; ANTIEPILEPTIC DRUGS; CONGENITAL-MALFORMATIONS; MANAGEMENT ISSUES; UK-EPILEPSY; FOLIC-ACID; SPECTRUM DISORDERS; SEIZURE FREQUENCY; INFORMATION NEEDS		[Kinney, Michael Owen] Royal Grp Hosp, Dept Neurosci, Belfast, Antrim, North Ireland; [Morrow, James] Royal Grp Hosp, Off UK & Ireland Epilepsy & Pregnancy Register, Belfast BT12 6BA, Antrim, North Ireland		Morrow, J (corresponding author), Royal Grp Hosp, Off UK & Ireland Epilepsy & Pregnancy Register, Belfast BT12 6BA, Antrim, North Ireland.	jjimorrow@btinternet.com						Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; [Anonymous], 2008, JAMA-J AM MED ASSOC, V299, P756, DOI DOI 10.1001/JAMA.299.7.756; Asadi-Pooya AA, 2015, SEIZURE-EUR J EPILEP, V27, P51, DOI 10.1016/j.seizure.2015.02.030; Aurlien D, 2012, EPILEPSIA, V53, P258, DOI 10.1111/j.1528-1167.2011.03334.x; Battino D, 2013, EPILEPSIA, V54, P1621, DOI 10.1111/epi.12302; Betts T, 1999, SEIZURE-EUR J EPILEP, V8, P322, DOI 10.1053/seiz.1999.0325; Bjork MH, 2015, EPILEPSIA, V56, P28, DOI 10.1111/epi.12884; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010236.pub2; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Campbell E, 2013, EPILEPSY BEHAV, V28, P354, DOI 10.1016/j.yebeh.2013.05.019; Campbell E, 2013, EPILEPSIA, V54, P165, DOI 10.1111/epi.12001; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Crawford P, 2003, SEIZURE-EUR J EPILEP, V12, P502, DOI 10.1016/S1059-1311(03)00085-2; Crawford P, 1999, SEIZURE-EUR J EPILEP, V8, P201, DOI 10.1053/seiz.1999.0295; Cummings C, 2011, ARCH DIS CHILD, V96, P643, DOI 10.1136/adc.2009.176990; Cunnington MC, 2011, NEUROLOGY, V76, P1817, DOI 10.1212/WNL.0b013e31821ccd18; Dean JCS, 2002, J MED GENET, V39, P251, DOI 10.1136/jmg.39.4.251; Devinsky O, 1994, ADV NEUROLOGY, V64; Dlouhy BJ, 2016, J NEUROL NEUROSUR PS, V87, P402, DOI 10.1136/jnnp-2013-307442; Edey S, 2014, EPILEPSIA, V55, pE72, DOI 10.1111/epi.12621; Floyd RL, 2008, AM J OBSTET GYNECOL, V199, pS333, DOI 10.1016/j.ajog.2008.09.018; Fried S, 2004, DRUG SAFETY, V27, P197, DOI 10.2165/00002018-200427030-00004; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; Harden CL, 2009, EPILEPSIA, V50, P1247, DOI 10.1111/j.1528-1167.2009.02130.x; Harden CL, 2009, EPILEPSIA, V50, P1229, DOI 10.1111/j.1528-1167.2009.02128.x; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Holmes LB, 2011, ARCH NEUROL-CHICAGO, V68, P1275, DOI 10.1001/archneurol.2011.133; Hunt S, 2008, NEUROLOGY, V71, P272, DOI 10.1212/01.wnl.0000318293.28278.33; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Katz O, 2006, J MATERN-FETAL NEO M, V19, P21, DOI 10.1080/14767050500434096; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Maternal Newborn and Infant Clinical Outcome Review Programme. MBRRACE, SAV LIV IMPR MOTH CA; Mawhinney E, 2012, SEIZURE-EUR J EPILEP, V21, P215, DOI 10.1016/j.seizure.2012.01.005; Mawhinney E, 2013, NEUROLOGY, V80, P400, DOI 10.1212/WNL.0b013e31827f0874; McGrath A, 2014, EPILEPSY BEHAV, V31, P246, DOI 10.1016/j.yebeh.2013.09.044; Meador KJ, 2008, NEUROLOGY, V71, P1109, DOI 10.1212/01.wnl.0000316199.92256.af; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; National Institute for Health and Clinical Excellence, 2012, EP DIAGN MAN; National Institute for Health Research, 2013, EMP ANT DRUG MON PRE; Olafsson E, 1998, EPILEPSIA, V39, P887, DOI 10.1111/j.1528-1157.1998.tb01186.x; Pashley S, 2009, J FAM PLAN REPROD H, V35, P153, DOI 10.1783/147118909788708002; Pennell PB, 2008, NEUROLOGY, V70, P2130, DOI 10.1212/01.wnl.0000289511.20864.2a; Pennell PB, 2008, EPILEPSIA, V49, P43, DOI 10.1111/j.1528-1167.2008.01926.x; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Pittschieler S, 2008, J NEUROL, V255, P1926, DOI 10.1007/s00415-008-0029-1; Reisinger TL, 2013, EPILEPSY BEHAV, V29, P13, DOI 10.1016/j.yebeh.2013.06.026; Sabers A, 2012, ACTA NEUROL SCAND, V126, pe1, DOI 10.1111/j.1600-0404.2011.01627.x; Sabers A, 2009, EPILEPSIA, V50, P2163, DOI 10.1111/j.1528-1167.2009.02166.x; Sahoo S, 2005, ARCH NEUROL-CHICAGO, V62, P1304, DOI 10.1001/archneur.62.8.1304; Scottish Intercollegiate Guidelines Network, 2015, DIAGN MAN EP AD; Shallcross R, 2014, NEUROLOGY, V82, P213, DOI 10.1212/WNL.0000000000000030; Shallcross R, 2011, NEUROLOGY, V76, P383, DOI 10.1212/WNL.0b013e3182088297; Tinker SC, 2010, J WOMENS HEALTH, V19, P2211, DOI 10.1089/jwh.2010.2160; Tomson T, 2006, NEUROLOGY, V66, P354; Tomson T, 2007, BRIT MED J, V335, P769, DOI 10.1136/bmj.39266.473113.BE; Tomson T, 2007, EPILEPSIA, V48, P1111, DOI 10.1111/j.1528-1167.2007.01032.x; Tomson T, 2016, LANCET NEUROL, V15, P210, DOI [10.1016/S1474-4422(15)00398-1, 10.1016/S1474-4422(15)00314-2]; Tomson T, 2015, NEUROLOGY, V85, P866, DOI 10.1212/WNL.0000000000001772; Tomson T, 2015, EPILEPSIA, V56, P1006, DOI 10.1111/epi.13021; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Tomson T, 2010, EPILEPSIA, V51, P909, DOI 10.1111/j.1528-1167.2010.02525.x; Turner K, 2008, BIRTH-ISS PERINAT C, V35, P147, DOI 10.1111/j.1523-536X.2008.00228.x; Vajda FJE, 2012, J CLIN NEUROSCI, V19, P57, DOI 10.1016/j.jocn.2011.08.003; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Vajda FJE, 2013, EPILEPSIA, V54, P181, DOI 10.1111/j.1528-1167.2012.03625.x; Weckesser A, 2013, SEIZURE-EUR J EPILEP, V22, P91, DOI 10.1016/j.seizure.2012.11.001; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Westin AA, 2008, SEIZURE-EUR J EPILEP, V17, P192, DOI 10.1016/j.seizure.2007.11.027; Winterbottom J, 2009, EPILEPSY BEHAV, V14, P273, DOI 10.1016/j.yebeh.2008.11.008; Winterbottom JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006645.pub2	78	15	15	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i2880	10.1136/bmj.i2880	http://dx.doi.org/10.1136/bmj.i2880			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255543				2022-12-28	WOS:000377479000001
J	Nadeau, NJ; Pardo-Diaz, C; Whibley, A; Supple, MA; Saenko, SV; Wallbank, RWR; Wu, GC; Maroja, L; Ferguson, L; Hanly, JJ; Hines, H; Salazar, C; Merrill, RM; Dowling, AJ; Ffrench-Constant, RH; Llaurens, V; Joron, M; McMillan, WO; Jiggins, CD				Nadeau, Nicola J.; Pardo-Diaz, Carolina; Whibley, Annabel; Supple, Megan A.; Saenko, Suzanne V.; Wallbank, Richard W. R.; Wu, Grace C.; Maroja, Luana; Ferguson, Laura; Hanly, Joseph J.; Hines, Heather; Salazar, Camilo; Merrill, Richard M.; Dowling, Andrea J.; Ffrench-Constant, Richard H.; Llaurens, Violaine; Joron, Mathieu; McMillan, W. Owen; Jiggins, Chris D.			The gene cortex controls mimicry and crypsis in butterflies and moths	NATURE			English	Article							GENOMIC SEQUENCE; WARNING-COLOR; HYBRID ZONES; HELICONIUS; EVOLUTION; QUANTIFICATION; DIVERGENCE; EXPRESSION; GENERATION; SPECIATION	The wing patterns of butterflies and moths (Lepidoptera) are diverse and striking examples of evolutionary diversification by natural selection(1,2). Lepidopteran wing colour patterns are a key innovation, consisting of arrays of coloured scales. We still lack a general understanding of how these patterns are controlled and whether this control shows any commonality across the 160,000 moth and 17,000 butterfly species. Here, we use fine-scale mapping with population genomics and gene expression analyses to identify a gene, cortex, that regulates pattern switches in multiple species across the mimetic radiation in Heliconius butterflies. cortex belongs to a fast-evolving subfamily of the otherwise highly conserved fizzy family of cell-cycle regulators(3), suggesting that it probably regulates pigmentation patterning by regulating scale cell development. In parallel with findings in the peppered moth (Biston betularia)(4), our results suggest that this mechanism is common within Lepidoptera and that cortex has become a major target for natural selection acting on colour and pattern variation in this group of insects.	[Nadeau, Nicola J.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Nadeau, Nicola J.; Supple, Megan A.; Wallbank, Richard W. R.; Hanly, Joseph J.; Merrill, Richard M.; McMillan, W. Owen; Jiggins, Chris D.] Smithsonian Trop Res Inst, Apartado Postal 0843-00153, Panama City, Panama; [Pardo-Diaz, Carolina; Salazar, Camilo] Univ Rosario, Fac Nat Sci & Math, Biol Program, Cra 24 63C-69, Bogota 111221, Colombia; [Whibley, Annabel; Saenko, Suzanne V.; Llaurens, Violaine; Joron, Mathieu] Univ Paris 06, Sorbonne Univ, Inst Systemat Evolut & Biodivers,UMR 7205, CNRS,MNHN,EPHE, CP50,57 Rue Cuvier, F-75005 Paris, France; [Whibley, Annabel] John Innes Ctr, Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Supple, Megan A.] Australian Natl Univ, Res Sch Biol, 134 Linnaeus Way, Acton0, ACT 2601, Australia; [Wallbank, Richard W. R.; Hanly, Joseph J.; Merrill, Richard M.; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Wu, Grace C.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Maroja, Luana] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Ferguson, Laura] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England; [Hines, Heather] Penn State Univ, 517 Mueller, University Pk, PA 16802 USA; [Dowling, Andrea J.; Ffrench-Constant, Richard H.] Univ Exeter Cornwall, Sch Biosci, Penryn TR10 9FE, Cornwall, England; [Joron, Mathieu] Univ Montpellier, Univ Paul Valery Montpellier, Ctr Ecol Fonctionnelle & Evolut, CEFE,UMR 5175,CNRS,EPHE, 1919 Route de Mende, F-34293 Montpellier, France	University of Sheffield; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad del Rosario; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Australian National University; University of Cambridge; University of California System; University of California Berkeley; Williams College; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Exeter; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Nadeau, NJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.; Nadeau, NJ; Jiggins, CD (corresponding author), Smithsonian Trop Res Inst, Apartado Postal 0843-00153, Panama City, Panama.; Jiggins, CD (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	n.nadeau@sheffield.ac.uk; c.jiggins@zoo.cam.ac.uk	Nadeau, Nicola J./E-1149-2011; Whibley, Annabel/P-2509-2017; Merrill, Richard/T-9978-2019; Jiggins, Chris/T-4296-2019; Jiggins, Chris D/B-9960-2008; C, Salazar/A-1647-2010; Pardo-Diaz, Carolina/C-7936-2016	Nadeau, Nicola J./0000-0002-9319-921X; Whibley, Annabel/0000-0003-1878-7705; Jiggins, Chris/0000-0002-7809-062X; Jiggins, Chris D/0000-0002-7809-062X; C, Salazar/0000-0001-9217-6588; Dowling, Andrea/0000-0003-0818-6092; Saenko, Suzanne/0000-0002-9019-6590; Pardo-Diaz, Carolina/0000-0002-7259-1183; Llaurens, Violaine/0000-0003-1962-7391; Merrill, Richard/0000-0003-4527-9298; Wu, Grace C./0000-0002-8290-119X; McMillan, W. Owen/0000-0003-2805-2745	Leverhulme Trust [RPG-2014-167]; BBSRC [H01439X/1]; ERC (SpeciationGenetics) [339873]; NERC [MGF 280, NE/K008498/1]; NSF [DEB 1257689, IOS 1052541]; ERC [StG-243179]; French National Agency for Research (ANR) [ANR-12-JSV7-0005, ANR-13-JSV7-0003-01]; Biotechnology and Biological Sciences Research Council [BB/H01439X/1, BB/H014268/1, BB/E006191/1] Funding Source: researchfish; Natural Environment Research Council [NE/K008498/1, NE/D000114/2] Funding Source: researchfish; BBSRC [BB/H01439X/1, BB/H014268/1, BB/E006191/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC (SpeciationGenetics); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); French National Agency for Research (ANR)(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Saski for assembly of the H. erato BACs; M. Abanto and A. Tapia for assistance with raising butterflies; M. Chouteau, J. Morris and K. Dasmahapatra for providing larvae for in situ hybridizations; A. Morrison, R. Tetley, S. Carl and H. Wegener for assistance with laboratory work; S. Baxter for the H. melpomene fosmid libraries; and the governments of Colombia, Ecuador, Panama and Peru for permission to collect butterflies. This work was funded by a Leverhulme Trust award (RPG-2014-167), BBSRC (H01439X/1), ERC (SpeciationGenetics 339873), and NERC small project (MGF 280) grants to C. D. J., NSF grants (DEB 1257689, IOS 1052541) to W. O. M., an ERC starting grant (StG-243179) to M. J. and French National Agency for Research (ANR) grants to M. J. (ANR-12-JSV7-0005) and V. L. (ANR-13-JSV7-0003-01). N. J. N. is funded by a NERC fellowship (NE/K008498/1).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., FASTQC; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; de la Bastide M., 2007, CURR PROTOC BIOINFOR, V11, P114; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Ferguson L, 2010, MOL ECOL, V19, P240, DOI 10.1111/j.1365-294X.2009.04475.x; Gilbert L.E., 1988, Journal of Research on the Lepidoptera, V26, P141; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Ito K, 2016, HEREDITY, V116, P52, DOI 10.1038/hdy.2015.69; Jiggins CD, 2008, BIOSCIENCE, V58, P541, DOI 10.1641/B580610; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Koch PB, 2000, DEV GENES EVOL, V210, P536, DOI 10.1007/s004270000101; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavoie CA, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-21; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MALLET J, 1989, PROC R SOC SER B-BIO, V236, P163, DOI 10.1098/rspb.1989.0019; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Maroja LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048627; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Nadeau NJ, 2014, GENOME RES, V24, P1316, DOI 10.1101/gr.169292.113; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Pardo-Diaz C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002752; Pesin JA, 2007, PLOS GENET, V3, P2208, DOI 10.1371/journal.pgen.0030202; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Supple MA, 2013, GENOME RES, V23, P1248, DOI 10.1101/gr.150615.112; Surridge AK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-62; Swan A, 2007, DEVELOPMENT, V134, P891, DOI 10.1242/dev.02784; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353	58	125	126	10	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					106	+		10.1038/nature17961	http://dx.doi.org/10.1038/nature17961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251285	Green Accepted, Green Published			2022-12-28	WOS:000376962300043
J	Pope, SD; Medzhitov, R				Pope, Scott D.; Medzhitov, Ruslan			GENE EXPRESSION Unwinding inducible gene expression	SCIENCE			English	Editorial Material							REMODELING COMPLEXES; CHROMATIN; INHIBITORS		[Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327	12	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1058	1059		10.1126/science.aag0365	http://dx.doi.org/10.1126/science.aag0365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230367				2022-12-28	WOS:000376480800022
J	Trostl, J; Chuang, WK; Gordon, H; Heinritzi, M; Yan, C; Molteni, U; Ahlm, L; Frege, C; Bianchi, F; Wagner, R; Simon, M; Lehtipalo, K; Williamson, C; Craven, JS; Duplissy, J; Adamov, A; Almeida, J; Bernhammer, AK; Breitenlechner, M; Brilke, S; Dias, A; Ehrhart, S; Flagan, RC; Franchin, A; Fuchs, C; Guida, R; Gysel, M; Hansel, A; Hoyle, CR; Jokinen, T; Junninen, H; Kangasluoma, J; Keskinen, H; Kim, J; Krapf, M; Kurten, A; Laaksonen, A; Lawler, M; Leiminger, M; Mathot, S; Mohler, O; Nieminen, T; Onnela, A; Petaja, T; Piel, FM; Miettinen, P; Rissanen, MP; Rondo, L; Sarnela, N; Schobesberger, S; Sengupta, K; Sipila, M; Smith, JN; Steiner, G; Tome, A; Virtanen, A; Wagner, AC; Weingartner, E; Wimmer, D; Winkler, PM; Ye, PL; Carslaw, KS; Curtius, J; Dommen, J; Kirkby, J; Kulmala, M; Riipinen, I; Worsnop, DR; Donahue, NM; Baltensperger, U				Troestl, Jasmin; Chuang, Wayne K.; Gordon, Hamish; Heinritzi, Martin; Yan, Chao; Molteni, Ugo; Ahlm, Lars; Frege, Carla; Bianchi, Federico; Wagner, Robert; Simon, Mario; Lehtipalo, Katrianne; Williamson, Christina; Craven, Jill S.; Duplissy, Jonathan; Adamov, Alexey; Almeida, Joao; Bernhammer, Anne-Kathrin; Breitenlechner, Martin; Brilke, Sophia; Dias, Antonio; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Fuchs, Claudia; Guida, Roberto; Gysel, Martin; Hansel, Armin; Hoyle, Christopher R.; Jokinen, Tuija; Junninen, Heikki; Kangasluoma, Juha; Keskinen, Helmi; Kim, Jaeseok; Krapf, Manuel; Kuerten, Andreas; Laaksonen, Ari; Lawler, Michael; Leiminger, Markus; Mathot, Serge; Moehler, Ottmar; Nieminen, Tuomo; Onnela, Antti; Petaejae, Tuukka; Piel, Felix M.; Miettinen, Pasi; Rissanen, Matti P.; Rondo, Linda; Sarnela, Nina; Schobesberger, Siegfried; Sengupta, Kamalika; Sipila, Mikko; Smith, James N.; Steiner, Gerhard; Tome, Antonio; Virtanen, Annele; Wagner, Andrea C.; Weingartner, Ernest; Wimmer, Daniela; Winkler, Paul M.; Ye, Penglin; Carslaw, Kenneth S.; Curtius, Joachim; Dommen, Josef; Kirkby, Jasper; Kulmala, Markku; Riipinen, Ilona; Worsnop, Douglas R.; Donahue, Neil M.; Baltensperger, Urs			The role of low-volatility organic compounds in initial particle growth in the atmosphere	NATURE			English	Article							DIFFERENTIAL MOBILITY ANALYZER; OXIDIZED RO2 RADICALS; SULFURIC-ACID; AEROSOL FORMATION; ALPHA-PINENE; OXIDATION-PRODUCTS; MASS-SPECTROMETER; SIZE; NUCLEATION; OZONOLYSIS	About half of present-day cloud condensation nuclei originate from atmospheric nucleation, frequently appearing as a burst of new particles near midday(1). Atmospheric observations show that the growth rate of new particles often accelerates when the diameter of the particles is between one and ten nanometres(2,3). In this critical size range, new particles are most likely to be lost by coagulation with pre-existing particles(4), thereby failing to form new cloud condensation nuclei that are typically 50 to 100 nanometres across. Sulfuric acid vapour is often involved in nucleation but is too scarce to explain most subsequent growth(5,6), leaving organic vapours as the most plausible alternative, at least in the planetary boundary layer(7-10). Although recent studies(11-13) predict that low-volatility organic vapours contribute during initial growth, direct evidence has been lacking. The accelerating growth may result from increased photolytic production of condensable organic species in the afternoon(2), and the presence of a possible Kelvin (curvature) effect, which inhibits organic vapour condensation on the smallest particles (the nano-Kohler theory)(2,14), has so far remained ambiguous. Here we present experiments performed in a large chamber under atmospheric conditions that investigate the role of organic vapours in the initial growth of nucleated organic particles in the absence of inorganic acids and bases such as sulfuric acid or ammonia and amines, respectively. Using data from the same set of experiments, it has been shown(15) that organic vapours alone can drive nucleation. We focus on the growth of nucleated particles and find that the organic vapours that drive initial growth have extremely low volatilities (saturation concentration less than 10(-4.5) micrograms per cubic metre). As the particles increase in size and the Kelvin barrier falls, subsequent growth is primarily due to more abundant organic vapours of slightly higher volatility (saturation concentrations of 10(-4.5) to 10(-0.5) micrograms per cubic metre). We present a particle growth model that quantitatively reproduces our measurements. Furthermore, we implement a parameterization of the first steps of growth in a global aerosol model and find that concentrations of atmospheric cloud concentration nuclei can change substantially in response, that is, by up to 50 per cent in comparison with previously assumed growth rate parameterizations.	[Troestl, Jasmin; Molteni, Ugo; Frege, Carla; Bianchi, Federico; Lehtipalo, Katrianne; Franchin, Alessandro; Fuchs, Claudia; Gysel, Martin; Hoyle, Christopher R.; Krapf, Manuel; Weingartner, Ernest; Dommen, Josef; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Chuang, Wayne K.; Ye, Penglin; Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Gordon, Hamish; Almeida, Joao; Dias, Antonio; Ehrhart, Sebastian; Franchin, Alessandro; Guida, Roberto; Mathot, Serge; Onnela, Antti; Kirkby, Jasper] CERN, CH-1211 Geneva, Switzerland; [Heinritzi, Martin; Simon, Mario; Williamson, Christina; Brilke, Sophia; Kuerten, Andreas; Leiminger, Markus; Piel, Felix M.; Rondo, Linda; Wagner, Andrea C.; Wimmer, Daniela; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Yan, Chao; Bianchi, Federico; Wagner, Robert; Lehtipalo, Katrianne; Duplissy, Jonathan; Adamov, Alexey; Franchin, Alessandro; Jokinen, Tuija; Junninen, Heikki; Kangasluoma, Juha; Keskinen, Helmi; Nieminen, Tuomo; Petaejae, Tuukka; Rissanen, Matti P.; Sarnela, Nina; Schobesberger, Siegfried; Sipila, Mikko; Steiner, Gerhard; Wimmer, Daniela; Kulmala, Markku; Worsnop, Douglas R.; Donahue, Neil M.] Univ Helsinki, Dept Phys, POB 64, FI-00014 Helsinki, Finland; [Ahlm, Lars; Riipinen, Ilona] Univ Stockholm, Dept Appl Environm Sci, SE-10961 Stockholm, Sweden; [Bianchi, Federico] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Williamson, Christina] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO USA; [Craven, Jill S.; Flagan, Richard C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Duplissy, Jonathan; Nieminen, Tuomo; Worsnop, Douglas R.] Univ Helsinki, Helsinki Inst Phys, POB 64, FI-00014 Helsinki, Finland; [Bernhammer, Anne-Kathrin; Breitenlechner, Martin; Hansel, Armin; Steiner, Gerhard] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [Bernhammer, Anne-Kathrin; Breitenlechner, Martin; Hansel, Armin] Ionicon Analyt GmbH, A-6020 Innsbruck, Austria; [Hoyle, Christopher R.] SLF, WSL Inst Snow & Avalanche Res, CH-7260 Davos, Switzerland; [Keskinen, Helmi; Kim, Jaeseok; Laaksonen, Ari; Lawler, Michael; Miettinen, Pasi; Smith, James N.; Virtanen, Annele] Univ Eastern Finland, Kuopio 70211, Finland; [Laaksonen, Ari] Finnish Meteorol Inst, Helsinki 00101, Finland; [Lawler, Michael] Natl Ctr Atmospher Res, Atmospher Chem Observat & Modeling Lab, Boulder, CO 80301 USA; [Moehler, Ottmar] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, D-76021 Karlsruhe, Germany; [Sengupta, Kamalika; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Smith, James N.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Steiner, Gerhard; Winkler, Paul M.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Tome, Antonio] Univ Lisbon, SIM, P-1849016 Lisbon, Portugal; [Tome, Antonio] Univ Beira Interior, P-1849016 Lisbon, Portugal; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Williamson, Christina; Keskinen, Helmi; Kim, Jaeseok; Schobesberger, Siegfried; Weingartner, Ernest] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Williamson, Christina] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO USA; [Keskinen, Helmi] Univ Helsinki, SMEAR II, Hyytiala Forestry Field Stn, Hyytialantie 124, FI-35500 Korkeakoski, Finland; [Kim, Jaeseok] Korea Polar Res Inst, Arct Res Ctr, Inchon 21990, South Korea; [Schobesberger, Siegfried] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Weingartner, Ernest] Univ Appl Sci Northwestern Switzerland, Inst Aerosol & Sensor Technol, CH-5210 Windisch, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Carnegie Mellon University; European Organization for Nuclear Research (CERN); Goethe University Frankfurt; University of Helsinki; Stockholm University; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA; California Institute of Technology; Helsinki Institute of Physics; University of Helsinki; University of Innsbruck; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Eastern Finland; Finnish Meteorological Institute; National Center Atmospheric Research (NCAR) - USA; Helmholtz Association; Karlsruhe Institute of Technology; University of Leeds; University of California System; University of California Irvine; University of Vienna; Universidade de Lisboa; Universidade da Beira Interior; Aerodyne Research; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; University of Helsinki; Korea Polar Research Institute (KOPRI); University of Washington; University of Washington Seattle; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Baltensperger, U (corresponding author), Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland.	urs.baltensperger@psi.ch	Hoyle, Christopher R./B-7786-2008; Donahue, Neil M/A-2329-2008; Hansel, Armin/F-3915-2010; Gysel-Beer, Martin/C-3843-2008; kangasluoma, juha/W-7450-2019; Curtius, Joachim/A-2681-2011; Laaksonen, Ari/B-5094-2011; Adamov, Alexey/V-2477-2018; Lawler, Michael/AAI-9557-2021; Kürten, Andreas/O-3851-2019; Schobesberger, Siegfried/L-4454-2014; Breitenlechner, Martin/AAA-3402-2021; Franchin, Alessandro/GVR-8219-2022; Jokinen, Tuija/B-3365-2014; Williamson, Christina J/D-1484-2016; Sarnela, Nina/AAE-1372-2020; Nieminen, Tuomo J/D-1618-2011; Franchin, Alessandro/AAH-3069-2019; Petäjä, Tuukka/A-8009-2008; Riipinen, Ilona/ABD-5564-2021; Simon, Mario/AGI-2749-2022; Tome, Antonio R/A-5681-2013; Möhler, Ottmar/J-9426-2012; Weingartner, Ernest/B-6793-2009; Kirkby, Jasper/A-4973-2012; Wagner, Andrea Christine/AGH-3531-2022; Riipinen, Ilona/I-9379-2012; Sipilä, Mikko/G-3024-2010; Yan, Chao/ABA-5642-2020; Steiner, Gerhard/AAD-4219-2020; Smith, James/C-5614-2008; Kulmala, Markku T/I-7671-2016; Virtanen, Annele/E-7699-2010; Duplissy, Jonathan/A-1723-2010; Nieminen, Tuomo/AAB-8686-2020; Worsnop, Douglas R/D-2817-2009; Bianchi, Federico/G-8428-2012; Kangasluoma, Juha/AAY-7941-2021; Carslaw, Ken S/C-8514-2009; Junninen, Heikki/C-2157-2014	Hoyle, Christopher R./0000-0002-1369-9143; Donahue, Neil M/0000-0003-3054-2364; Hansel, Armin/0000-0002-1062-2394; Gysel-Beer, Martin/0000-0002-7453-1264; Curtius, Joachim/0000-0003-3153-4630; Laaksonen, Ari/0000-0002-1657-2383; Kürten, Andreas/0000-0002-8955-4450; Schobesberger, Siegfried/0000-0002-5777-4897; Jokinen, Tuija/0000-0002-1280-1396; Williamson, Christina J/0000-0002-5188-9378; Petäjä, Tuukka/0000-0002-1881-9044; Tome, Antonio R/0000-0001-9144-7120; Möhler, Ottmar/0000-0002-7551-9814; Weingartner, Ernest/0000-0002-2427-4634; Kirkby, Jasper/0000-0003-2341-9069; Wagner, Andrea Christine/0000-0003-3159-9434; Sipilä, Mikko/0000-0002-8594-7003; Yan, Chao/0000-0002-5735-9597; Steiner, Gerhard/0000-0003-3008-1414; Smith, James/0000-0003-4677-8224; Kulmala, Markku T/0000-0003-3464-7825; Virtanen, Annele/0000-0002-2917-5344; Duplissy, Jonathan/0000-0001-8819-0264; Nieminen, Tuomo/0000-0002-2713-715X; Worsnop, Douglas R/0000-0002-8928-8017; Bianchi, Federico/0000-0003-2996-3604; Kangasluoma, Juha/0000-0002-1639-1187; Carslaw, Ken S/0000-0002-6800-154X; Winkler, Paul/0000-0001-6861-6029; Leiminger, Markus/0000-0003-3343-5425; Brilke, Sophia/0000-0003-3133-249X; Kim, Jaeseok/0000-0002-7920-0288; Wagner, Robert/0000-0001-7365-8020; Breitenlechner, Martin/0000-0002-2382-6660; Ehrhart, Sebastian/0000-0002-6517-5341; Gordon, Hamish/0000-0002-1822-3224; Trostl, Jasmin/0000-0002-2807-0348; Rissanen, Matti/0000-0003-0463-8098; Molteni, Ugo/0000-0002-1623-1933; Dommen, Josef/0000-0002-0006-0009; Junninen, Heikki/0000-0001-7178-9430; Keskinen, Helmi/0000-0003-3614-0542; Bernhammer, Anne-Kathrin/0000-0002-0614-3649; Lehtipalo, Katrianne/0000-0002-1660-2706; Sarnela, Nina/0000-0003-1874-3235; Simon, Mario/0000-0002-4900-7460	CERN; EC (Marie Curie Initial Training Network 'CLOUD-ITN') [215072]; EC (MC-ITN 'CLOUD-TRAIN') [316662]; EC (ERC-StG-ATMOGAIN) [278277]; EC (ERC-Advanced 'ATMNUCLE') [227463]; German Federal Ministry of Education and Research [01LK0902A, 01LK1222A]; Swiss National Science Foundation [200020_135307, 200020_152907, 20FI20_149002, 200021_140663]; Academy of Finland Center of Excellence [1118615]; Academy of Finland (CoE) [1118615]; Academy of Finland (LASTU) [135054]; Nessling Foundation; Austrian Science Fund (FWF) [J3198-N21]; EU [656994]; Swedish Research Council, Vetenskapsradet [2011-5120]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research [08-02-91006-CERN, 12-02-91522-CERN]; Dreyfus Award [EP-11-117]; Davidow Foundation; US National Science Foundation [AGS1136479, AGS1447056, AGS1439551, CHE1012293]; US Department of Energy [DE-SC00014469]; FP7 project BACCHUS [603445]; Div Atmospheric & Geospace Sciences [1447056, 1439551] Funding Source: National Science Foundation	CERN; EC (Marie Curie Initial Training Network 'CLOUD-ITN'); EC (MC-ITN 'CLOUD-TRAIN'); EC (ERC-StG-ATMOGAIN); EC (ERC-Advanced 'ATMNUCLE'); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland Center of Excellence(Academy of Finland); Academy of Finland (CoE)(Academy of Finland); Academy of Finland (LASTU)(Academy of Finland); Nessling Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EU(European Commission); Swedish Research Council, Vetenskapsradet(Swedish Research Council); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Dreyfus Award; Davidow Foundation; US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); FP7 project BACCHUS; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank CERN for supporting CLOUD with technical and financial resources, and for providing a particle beam from the CERN Proton Synchrotron. This research has received funding from the EC Seventh Framework Programme (Marie Curie Initial Training Network 'CLOUD-ITN' no. 215072, MC-ITN 'CLOUD-TRAIN', no. 316662, and ERC-StG-ATMOGAIN (278277) and ERC-Advanced 'ATMNUCLE' grant no. 227463), the German Federal Ministry of Education and Research (project nos 01LK0902A and 01LK1222A), the Swiss National Science Foundation (project nos 200020_135307, 200020_152907, 20FI20_149002 and 200021_140663), the Academy of Finland Center of Excellence programme (project no. 1118615), the Academy of Finland (CoE project no. 1118615, LASTU project no. 135054), the Nessling Foundation, the Austrian Science Fund (FWF; project no. J3198-N21), the EU's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie (no. 656994), the Swedish Research Council, Vetenskapsradet (grant no. 2011-5120), the Portuguese Foundation for Science and Technology (project no. CERN/FP/116387/2010), the Presidium of the Russian Academy of Sciences and Russian Foundation for Basic Research (grants 08-02-91006-CERN and 12-02-91522-CERN), Dreyfus Award EP-11-117, the Davidow Foundation, the US National Science Foundation (grants AGS1136479, AGS1447056, AGS1439551 and CHE1012293), US Department of Energy (grant DE-SC00014469) and the FP7 project BACCHUS (grant agreement 603445).	Asmi E, 2009, ATMOS CHEM PHYS, V9, P141, DOI 10.5194/acp-9-141-2009; Berndt T, 2015, J PHYS CHEM A, V119, P10336, DOI 10.1021/acs.jpca.5b07295; Bianchi F, 2016, SCIENCE, V352, P1109, DOI 10.1126/science.aad5456; Bianchi F, 2012, ATMOS MEAS TECH, V5, P1719, DOI 10.5194/amt-5-1719-2012; Brunelli NA, 2009, AEROSOL SCI TECH, V43, P53, DOI 10.1080/02786820802464302; Cheng Y.S., 2001, AEROSOL MEASUREMENTS, P569; Chipperfield MP, 2006, Q J ROY METEOR SOC, V132, P1179, DOI 10.1256/qj.05.51; D'Andrea SD, 2013, ATMOS CHEM PHYS, V13, P11519, DOI 10.5194/acp-13-11519-2013; Donahue NM, 2012, ATMOS CHEM PHYS, V12, P615, DOI 10.5194/acp-12-615-2012; Donahue NM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048115; Donahue NM, 2013, FARADAY DISCUSS, V165, P91, DOI 10.1039/c3fd00046j; Duplissy J, 2016, J GEOPHYS RES-ATMOS, V121, P1752, DOI 10.1002/2015JD023539; Duplissy J, 2010, ATMOS CHEM PHYS, V10, P1635, DOI 10.5194/acp-10-1635-2010; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Fuchs N. A., 1970, COAGULATION RATE HIG; Gagne S, 2011, ATMOS MEAS TECH, V4, P805, DOI 10.5194/amt-4-805-2011; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hakkinen SAK, 2013, ATMOS CHEM PHYS, V13, P7665, DOI 10.5194/acp-13-7665-2013; Heinritzi M, 2016, ATMOS MEAS TECH, V9, P1449, DOI 10.5194/amt-9-1449-2016; Hinds W.C., 2011, AEROSOL MEASUREMENT, P31; Hyttinen N, 2015, J PHYS CHEM A, V119, P6339, DOI 10.1021/acs.jpca.5b01818; Iida K, 2009, AEROSOL SCI TECH, V43, P81, DOI 10.1080/02786820802488194; Jiang JK, 2011, AEROSOL SCI TECH, V45, P480, DOI 10.1080/02786826.2010.546819; Jokinen T, 2012, ATMOS CHEM PHYS, V12, P4117, DOI 10.5194/acp-12-4117-2012; Jokinen T, 2015, P NATL ACAD SCI USA, V112, P7123, DOI 10.1073/pnas.1423977112; Jokinen T, 2014, ANGEW CHEM INT EDIT, V53, P14596, DOI 10.1002/anie.201408566; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; KOROSI G, 1981, J CHEM ENG DATA, V26, P323, DOI 10.1021/je00025a032; Kuang C, 2012, ATMOS CHEM PHYS, V12, P3573, DOI 10.5194/acp-12-3573-2012; Kurten A, 2011, ATMOS MEAS TECH, V4, P437, DOI 10.5194/amt-4-437-2011; Kurten A, 2012, J PHYS CHEM A, V116, P6375, DOI 10.1021/jp212123n; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P2553, DOI 10.5194/acp-4-2553-2004; Kulmala M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003961; Kulmala M, 1998, J GEOPHYS RES-ATMOS, V103, P8301, DOI 10.1029/97JD03718; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kupc A, 2011, J AEROSOL SCI, V42, P532, DOI 10.1016/j.jaerosci.2011.05.001; Kurten T, 2015, J PHYS CHEM A, V119, P11366, DOI 10.1021/acs.jpca.5b08948; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Lehtinen KEJ, 2007, J AEROSOL SCI, V38, P988, DOI 10.1016/j.jaerosci.2007.06.009; Lehtipalo K, 2014, BOREAL ENVIRON RES, V19, P215; Lovejoy ER, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004460; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; McNaught A.D., 1997, COMPENDIUM CHEM TERM, V2nd; Mentel TF, 2015, ATMOS CHEM PHYS, V15, P6745, DOI 10.5194/acp-15-6745-2015; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Mirme S, 2013, ATMOS MEAS TECH, V6, P1061, DOI 10.5194/amt-6-1061-2013; MOHLER O, 1992, J CHEM PHYS, V97, P8233, DOI 10.1063/1.463394; Nieminen T, 2010, ATMOS CHEM PHYS, V10, P9773, DOI 10.5194/acp-10-9773-2010; Pandis S. N., 2006, ATMOSPHERIC CHEM PHY; Pankow JF, 2008, ATMOS CHEM PHYS, V8, P2773, DOI 10.5194/acp-8-2773-2008; PANKOW JF, 1994, ATMOS ENVIRON, V28, P185, DOI 10.1016/1352-2310(94)90093-0; Pierce JR, 2011, ATMOS CHEM PHYS, V11, P9019, DOI 10.5194/acp-11-9019-2011; Presto AA, 2006, ENVIRON SCI TECHNOL, V40, P3536, DOI 10.1021/es052203z; Riccobono F, 2012, ATMOS CHEM PHYS, V12, P9427, DOI 10.5194/acp-12-9427-2012; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; Riipinen I, 2011, ATMOS CHEM PHYS, V11, P3865, DOI 10.5194/acp-11-3865-2011; Riipinen I, 2012, NAT GEOSCI, V5, P453, DOI 10.1038/ngeo1499; Rissanen MP, 2014, J AM CHEM SOC, V136, P15596, DOI 10.1021/ja507146s; Schnitzhofer R, 2014, ATMOS MEAS TECH, V7, P2159, DOI 10.5194/amt-7-2159-2014; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Smith JN, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032523; Trump ER, 2014, ATMOS CHEM PHYS, V14, P3691, DOI 10.5194/acp-14-3691-2014; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Voigtlander J, 2012, ATMOS CHEM PHYS, V12, P2205, DOI 10.5194/acp-12-2205-2012; Wang J, 2002, AEROSOL SCI TECH, V36, P678, DOI 10.1080/02786820290038366; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; WANG SC, 1990, AEROSOL SCI TECH, V13, P230, DOI 10.1080/02786829008959441; Wimmer D, 2013, ATMOS MEAS TECH, V6, P1793, DOI 10.5194/amt-6-1793-2013; Yli-Juuti T, 2011, ATMOS CHEM PHYS, V11, P12865, DOI 10.5194/acp-11-12865-2011; Zhang D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862616; Zhao J, 2013, ATMOS CHEM PHYS, V13, P7631, DOI 10.5194/acp-13-7631-2013	74	401	408	27	516	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					527	+		10.1038/nature18271	http://dx.doi.org/10.1038/nature18271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225126	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000376443100039
J	Cipriani, A; Zhou, XY; Del Giovane, C; Hetrick, SE; Qin, B; Whittington, C; Coghill, D; Zhang, YQ; Hazell, P; Leucht, S; Cuijpers, P; Pu, JC; Cohen, D; Ravindran, AV; Liu, YY; Michael, KD; Yang, LN; Liu, LX; Xie, P				Cipriani, Andrea; Zhou, Xinyu; Del Giovane, Cinzia; Hetrick, Sarah E.; Qin, Bin; Whittington, Craig; Coghill, David; Zhang, Yuqing; Hazell, Philip; Leucht, Stefan; Cuijpers, Pim; Pu, Juncai; Cohen, David; Ravindran, Arun V.; Liu, Yiyun; Michael, Kurt D.; Yang, Lining; Liu, Lanxiang; Xie, Peng			Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis	LANCET			English	Article							MENTAL-HEALTH-CARE; ACCEPTABILITY; GUIDELINES; TRENDS	Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological interventions in this population and which drug should be preferred are still matters of controversy. Consequently, we aimed to compare and rank antidepressants and placebo for major depressive disorder in young people. Methods We did a network meta-analysis to identify both direct and indirect evidence from relevant trials. We searched PubMed, the Cochrane Library, Web of Science, Embase, CINAHL, PsycINFO, LiLACS, regulatory agencies' websites, and international registers for published and unpublished, double-blind randomised controlled trials up to May 31, 2015, for the acute treatment of major depressive disorder in children and adolescents. We included trials of amitriptyline, citalopram, clomipramine, desipramine, duloxetine, escitalopram, fluoxetine, imipramine, mirtazapine, nefazodone, nortriptyline, paroxetine, sertraline, and venlafaxine. Trials recruiting participants with treatment-resistant depression, treatment duration of less than 4 weeks, or an overall sample size of less than ten patients were excluded. We extracted the relevant information from the published reports with a predefined data extraction sheet, and assessed the risk of bias with the Cochrane risk of bias tool. The primary outcomes were efficacy (change in depressive symptoms) and tolerability (discontinuations due to adverse events). We did pair-wise meta-analyses using the random-effects model and then did a random-effects network meta-analysis within a Bayesian framework. We assessed the quality of evidence contributing to each network estimate using the GRADE framework. This study is registered with PROSPERO, number CRD42015016023. Findings We deemed 34 trials eligible, including 5260 participants and 14 antidepressant treatments. The quality of evidence was rated as very low in most comparisons. For efficacy, only fluoxetine was statistically significantly more effective than placebo (standardised mean difference -0.51, 95% credible interval [CrI] -0.99 to -0.03). In terms of tolerability, fluoxetine was also better than duloxetine (odds ratio [OR] 0.31, 95% CrI 0.13 to 0.95) and imipramine (0.23, 0.04 to 0.78). Patients given imipramine, venlafaxine, and duloxetine had more discontinuations due to adverse events than did those given placebo (5.49, 1.96 to 20.86; 3.19, 1.01 to 18.70; and 2.80, 1.20 to 9.42, respectively). In terms of heterogeneity, the global I-2 values were 33.21% for efficacy and 0% for tolerability. Interpretation When considering the risk-benefit profile of antidepressants in the acute treatment of major depressive disorder, these drugs do not seem to off er a clear advantage for children and adolescents. Fluoxetine is probably the best option to consider when a pharmacological treatment is indicated.	[Cipriani, Andrea] Univ Oxford, Dept Psychiat, Oxford, England; [Zhou, Xinyu; Qin, Bin; Zhang, Yuqing; Pu, Juncai; Liu, Yiyun; Yang, Lining; Liu, Lanxiang; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol & Psychiat, Chongqing, Peoples R China; [Zhou, Xinyu; Qin, Bin; Zhang, Yuqing; Pu, Juncai; Liu, Yiyun; Yang, Lining; Liu, Lanxiang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Zhou, Xinyu; Qin, Bin; Zhang, Yuqing; Pu, Juncai; Liu, Yiyun; Yang, Lining; Liu, Lanxiang; Xie, Peng] Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Hetrick, Sarah E.] Univ Melbourne, Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Whittington, Craig] Doctor Evidence, Santa Monica, CA USA; [Coghill, David] Univ Dundee, Sch Med, Div Neurosci, Dundee, Scotland; [Coghill, David] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Coghill, David] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Psychiat, Melbourne, Vic, Australia; [Hazell, Philip] Sydney Med Sch, Discipline Psychiat, Concord West, NSW, Australia; [Leucht, Stefan] Tech Univ Munich, Dept Psychiat & Psychol, Munich, Germany; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Cohen, David] Univ Paris 06, Inst Syst Intelligents & Robot, Hop Pitie Salpetriere, Dept Child & Adolescent Psychiat, Paris, France; [Ravindran, Arun V.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Ravindran, Arun V.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Michael, Kurt D.] Appalachian State Univ, Dept Psychol, Boone, NC 28608 USA; [Xie, Peng] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Oxford; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Universita di Modena e Reggio Emilia; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Dundee; University of Melbourne; University of Melbourne; University of Sydney; Technical University of Munich; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of North Carolina; Appalachian State University; South Australian Health & Medical Research Institute (SAHMRI)	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol & Psychiat, Chongqing, Peoples R China.; Cipriani, A (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	andrea.cipriani@psych.ox.ac.uk; xiepeng973@126.com	Cipriani, Andrea/P-6944-2015; Cuijpers, Pim/G-1703-2013; Coghill, David/ABF-5213-2020; Hetrick, Sarah Elisabeth/AAT-1277-2020; Leucht, Stefan/Y-2408-2019; Coghill, David R/X-6449-2018; Cipriani, Anna/A-2797-2012	Cipriani, Andrea/0000-0001-5179-8321; Coghill, David/0000-0003-3017-9737; Leucht, Stefan/0000-0002-4934-4352; Coghill, David R/0000-0003-3017-9737; Cipriani, Anna/0000-0001-8457-0147; Del Giovane, Cinzia/0000-0002-5028-932X	National Institute for Health Research Oxford Cognitive Health Clinical Research Facility; National Basic Research Program of China (973 Program) [2009CB918300]	National Institute for Health Research Oxford Cognitive Health Clinical Research Facility; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	We thank Graham J Emslie and Taryn Mayes from the University of Texas Southwestern Medical Center in Dallas for providing unpublished data in this review, and Salvatore Gentile from the Department of Mental Health, ASL Salerno Mental Health Center, Italy, for his valuable advice. AC is supported by the National Institute for Health Research Oxford Cognitive Health Clinical Research Facility. National Basic Research Program of China (973 Program) (grant number 2009CB918300).	Bachmann CJ, 2016, EUR NEUROPSYCHOPHARM, V26, P411, DOI 10.1016/j.euroneuro.2016.02.001; Biau DJ, 2008, CLIN ORTHOP RELAT R, V466, P2282, DOI 10.1007/s11999-008-0346-9; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brunoni AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009479; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Emslie GJ, 2004, J AM ACAD CHILD PSY, V43, P1397, DOI 10.1097/01.chi.0000140453.89323.57; Hammad TA, 2004, RELATIONSHIP PSYCHOT; Hetrick SE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub3; Hopkins K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h824; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Neupane B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115065; Olfson M, 2014, JAMA PSYCHIAT, V71, P81, DOI 10.1001/jamapsychiatry.2013.3074; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Samara MT, 2016, JAMA PSYCHIAT, V73, P199, DOI 10.1001/jamapsychiatry.2015.2955; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Tsapakis EM, 2008, BRIT J PSYCHIAT, V193, P10, DOI 10.1192/bjp.bp.106.031088; US Food and Drug Administration, 2004, SUIC CHILDR AD BEING; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Zhou X, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007768; Zhou XY, 2015, WORLD PSYCHIATRY, V14, P207, DOI 10.1002/wps.20217	30	345	358	7	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					881	890		10.1016/S0140-6736(16)30385-3	http://dx.doi.org/10.1016/S0140-6736(16)30385-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27289172	Green Submitted, Green Published			2022-12-28	WOS:000381911800026
J	Herbst, DA; Jakob, RP; Zahringer, F; Maier, T				Herbst, Dominik A.; Jakob, Roman P.; Zahringer, Franziska; Maier, Timm			Mycocerosic acid synthase exemplifies the architecture of reducing polyketide synthases (vol 531, pg 533, 2016)	NATURE			English	Correction																		Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Herbst DA, 2016, NATURE, V531, P533, DOI 10.1038/nature16993	2	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616								10.1038/nature18281	http://dx.doi.org/10.1038/nature18281			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27281192	Bronze			2022-12-28	WOS:000381804900044
J	Brunekreef, B; Hoffmann, B				Brunekreef, Bert; Hoffmann, Barbara			Air pollution and heart disease	LANCET			English	Editorial Material							EXPOSURE; ESCAPE; COHORT; SMOKE; ATHEROSCLEROSIS; MORTALITY; AREAS; PM2.5; PM10; NO2		[Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Hoffmann, Barbara] Univ Dusseldorf, Ctr Hlth & Soc, Fac Med, Inst Occupat & Social Med, Dusseldorf, Germany	Utrecht University; Utrecht University; Utrecht University Medical Center; Heinrich Heine University Dusseldorf	Brunekreef, B (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.; Brunekreef, B (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	b.brunekreef@uu.nl						Brunekreef B, 2015, EUR RESPIR J, V45, P861, DOI 10.1183/09031936.50186114; Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080; Dunbar A, 2013, CARDIOL REV, V21, P94, DOI 10.1097/CRD.0b013e31827362e4; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Hoek G, 2013, ENV HLTH, V12, P23; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Kaufman JD, 2016, LANCET; Kunzli N, 2011, PROG CARDIOVASC DIS, V53, P334, DOI 10.1016/j.pcad.2010.12.006; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Peinemann F, 2011, ENVIRON HEALTH PERSP, V119, P1556, DOI 10.1289/ehp.1003347; Perez L, 2015, ENVIRON HEALTH PERSP, V123, P597, DOI 10.1289/ehp.1307711; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Thurston GD, 2016, ENVIRON HEALTH PERSP, V124, P484, DOI 10.1289/ehp.1509676; WHO, 2016, WHO GLOB URB AMB AIR	14	14	14	3	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					640	642		10.1016/S0140-6736(16)30375-0	http://dx.doi.org/10.1016/S0140-6736(16)30375-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27233744				2022-12-28	WOS:000381268700007
J	Frieden, TR				Frieden, Thomas R.			Sodium Reduction-Saving Lives by Putting Choice Into Consumers' Hands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONSUMPTION		[Frieden, Thomas R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30329 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Adler AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009217.pub3; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campbell N, 2015, CAN MED ASSOC J, V187, P131, DOI 10.1503/cmaj.115-0005; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Institute of Medicine [IOM], 2010, STRATEGIES REDUCE SO; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127	9	19	19	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					579	580		10.1001/jama.2016.7992	http://dx.doi.org/10.1001/jama.2016.7992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27249371				2022-12-28	WOS:000380985600006
J	Joynt, KE; Orav, EJ; Zheng, J; Jha, AK				Joynt, Karen E.; Orav, E. John; Zheng, Jie; Jha, Ashish K.			Public Reporting of Mortality Rates for Hospitalized Medicare Patients and Trends in Mortality for Reported Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE; INTERVENTION; OUTCOMES	Background: Public reporting is seen as a powerful quality improvement tool, but data to support its efficacy are limited. The Centers for Medicare & Medicaid Services' Hospital Compare program initially reported process metrics only but started reporting mortality rates for acute myocardial infarction, heart failure, and pneumonia in 2008. Objective: To determine whether public reporting of mortality rates was associated with lower mortality rates for these conditions among Medicare beneficiaries. Design: For 2005 to 2007, process-only reporting was considered; for 2008 to 2012, process and mortality reporting was considered. Changes in mortality trends before and during reporting periods were estimated by using patient-level hierarchical modeling. Nonreported medical conditions were used as a secular control. Setting: U.S. acute care hospitals. Participants: 20 707 266 fee-for-service Medicare beneficiaries hospitalized from January 2005 through November 2012. Measurements: 30-day risk-adjusted mortality rates. Results: Mortality rates for the 3 publicly reported conditions were changing at an absolute rate of -0.23% per quarter during process-only reporting, but this change slowed to a rate of -0.09% per quarter during process and mortality reporting (change, 0.13% per quarter; 95% CI, 0.12% to 0.14%). Mortality for nonreported conditions was changing at -0.17% per quarter during process-only reporting and slowed slightly to -0.11% per quarter during process and mortality reporting (change, 0.06% per quarter; CI, 0.05% to 0.07%). Limitation: Administrative data may have limited ability to account for changes in patient complexity over time. Conclusion: Changes in mortality trends suggest that reporting in Hospital Compare was associated with a slowing, rather than an improvement, in the ongoing decline in mortality among Medicare patients.	Harvard Sch Publ Hlth, Boston, MA USA; Harvard Med Sch, Boston, MA USA; [Joynt, Karen E.; Orav, E. John] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Zheng, Jie; Jha, Ashish K.] Harvard Sch Publ Hlth, 43 Church St, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@hsph.harvard.edu			National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services, 2015, 2015 COND SPEC MEAS; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Ketelaar NABM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004538.pub2; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Ryan AM, 2012, HEALTH AFFAIR, V31, P585, DOI 10.1377/hlthaff.2011.0719; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2010, HEALTH AFFAIR, V29, P1319, DOI 10.1377/hlthaff.2008.0770; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09	21	21	21	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					153	+		10.7326/M15-1462	http://dx.doi.org/10.7326/M15-1462			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2HA	27239794	Green Accepted			2022-12-28	WOS:000380583300003
J	Tao, ZS; Chen, C; Szilvasi, T; Keller, M; Mavrikakis, M; Kapteyn, H; Murnane, M				Tao, Zhensheng; Chen, Cong; Szilvasi, Tibor; Keller, Mark; Mavrikakis, Manos; Kapteyn, Henry; Murnane, Margaret			Direct time-domain observation of attosecond final-state lifetimes in photoemission from solids	SCIENCE			English	Article							ANGLE-RESOLVED PHOTOEMISSION; HIGH-HARMONIC-GENERATION; CHARGE-DENSITY-WAVE; SPECTROSCOPY; BAND; ELECTRONS; SURFACES; PULSES; METAL; NI	Attosecond spectroscopic techniques have made it possible to measure differences in transport times for photoelectrons from localized core levels and delocalized valence bands in solids. We report the application of attosecond pulse trains to directly and unambiguously measure the difference in lifetimes between photoelectrons born into free electron-like states and those excited into unoccupied excited states in the band structure of nickel (111). An enormous increase in lifetime of 212 +/- 30 attoseconds occurs when the final state coincides with a short-lived excited state. Moreover, a strong dependence of this lifetime on emission angle is directly related to the final-state band dispersion as a function of electron transverse momentum. This finding underscores the importance of the material band structure in determining photoelectron lifetimes and corresponding electron escape depths.	[Tao, Zhensheng; Chen, Cong; Kapteyn, Henry; Murnane, Margaret] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Tao, Zhensheng; Chen, Cong; Kapteyn, Henry; Murnane, Margaret] Univ Colorado, JILA, Boulder, CO 80309 USA; [Tao, Zhensheng; Chen, Cong; Kapteyn, Henry; Murnane, Margaret] NIST, Boulder, CO 80309 USA; [Szilvasi, Tibor; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Keller, Mark] NIST, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Wisconsin System; University of Wisconsin Madison; National Institute of Standards & Technology (NIST) - USA	Tao, ZS; Chen, C (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.; Tao, ZS; Chen, C (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	zhensheng.tao@jila.colorado.edu; cong.chen@colorado.edu	Kapteyn, Henry C/H-6559-2011; Tao, Zhensheng/GQR-1453-2022; Mavrikakis, Manos/D-5702-2012; Tao, Zhensheng/J-5532-2016; Keller, Mark William/AAD-2883-2019; Chen, Cong/W-2841-2018	Kapteyn, Henry C/0000-0001-8386-6317; Mavrikakis, Manos/0000-0002-5293-5356; Tao, Zhensheng/0000-0003-1438-6074; Keller, Mark William/0000-0001-8573-2953; Chen, Cong/0000-0002-7091-9878	National Science Foundation through the JILA Physics Frontiers Centers Program; Gordon and Betty Moore Foundation EPiQS Award [GBMF4538]; Air Force Office of Scientific Research under a Basic Research Initiative grant [AFOSR FA9550-12-1-0481]; DOE-BES, the Division of Chemical Sciences [DE-FG02-05ER15731]	National Science Foundation through the JILA Physics Frontiers Centers Program(National Science Foundation (NSF)); Gordon and Betty Moore Foundation EPiQS Award; Air Force Office of Scientific Research under a Basic Research Initiative grant; DOE-BES, the Division of Chemical Sciences	We thank A. Carr, P. Matyba, G. D. Mahan, G. B. Arnold, G. F. Mancini, H. X. Li, Z. Zhu and Y. Cao for helpful discussions. This work was done at JILA. The JILA authors gratefully acknowledge support from the National Science Foundation through the JILA Physics Frontiers Centers Program and a Gordon and Betty Moore Foundation EPiQS Award through grant GBMF4538. T.S. and M.Ma. gratefully acknowledge support from Air Force Office of Scientific Research under a Basic Research Initiative grant (AFOSR FA9550-12-1-0481) and DOE-BES, the Division of Chemical Sciences (grant DE-FG02-05ER15731). The authors declare that they have no competing interests. H.K. and M.Mu. have a financial interest in a laser company, KMLabs.	Borisov AG, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.121110; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Chen C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501333; Dahlstrom JM, 2013, CHEM PHYS, V414, P53, DOI 10.1016/j.chemphys.2012.01.017; Dolado JS, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195128; EASTMAN DE, 1978, PHYS REV LETT, V41, P825, DOI 10.1103/PhysRevLett.41.825; Eich S, 2014, J ELECTRON SPECTROSC, V195, P231, DOI 10.1016/j.elspec.2014.04.013; FEUERBACHER B, 1976, J PHYS C SOLID STATE, V9, P169, DOI 10.1088/0022-3719/9/2/007; GUILLOT C, 1977, PHYS REV LETT, V39, P1632, DOI 10.1103/PhysRevLett.39.1632; Hellmann S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2078; HERMANSON J, 1977, SOLID STATE COMMUN, V22, P9, DOI 10.1016/0038-1098(77)90931-0; HIMPSEL FJ, 1979, PHYS REV B, V19, P2919, DOI 10.1103/PhysRevB.19.2919; Hufner S., 2003, SPECTROSCOPY PRINCIP, V3rd; Kazansky AK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177401; Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; KNAPP JA, 1979, PHYS REV B, V19, P4953, DOI 10.1103/PhysRevB.19.4952; Krasovskii EE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195106; Lemell C, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062901; Li W, 2010, P NATL ACAD SCI USA, V107, P20219, DOI 10.1073/pnas.1014723107; LIEBSCH A, 1979, PHYS REV LETT, V43, P1431, DOI 10.1103/PhysRevLett.43.1431; Locher R, 2015, OPTICA, V2, P405, DOI 10.1364/OPTICA.2.000405; Lucchini M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.137401; Lucchini M, 2015, OPT EXPRESS, V23, P8867, DOI 10.1364/OE.23.008867; Mathias S, 2012, P NATL ACAD SCI USA, V109, P4792, DOI 10.1073/pnas.1201371109; Miaja-Avila L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.046101; Miaja-Avila L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113604; Neppl S, 2015, NATURE, V517, P342, DOI 10.1038/nature14094; Neppl S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.087401; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Pazourek R, 2015, REV MOD PHYS, V87, DOI 10.1103/RevModPhys.87.765; Popmintchev D, 2015, SCIENCE, V350, P1225, DOI 10.1126/science.aac9755; POWELL CJ, 1974, SURF SCI, V44, P29, DOI 10.1016/0039-6028(74)90091-0; ROSSI G, 1983, PHYS REV B, V28, P3031, DOI 10.1103/PhysRevB.28.3031; Roth F, 2016, J ELECTRON SPECTROSC, V208, P2, DOI 10.1016/j.elspec.2015.09.006; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Turgut E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.197201; Zhang CH, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043405; Zhang CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.123601	40	147	149	9	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294					62	67		10.1126/science.aaf6793	http://dx.doi.org/10.1126/science.aaf6793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27256880	Green Submitted, Green Accepted			2022-12-28	WOS:000378816200035
J	Knapp, S; Zamir, D				Knapp, Sandra; Zamir, Dani			GENOMICS The language of flowers	NATURE			English	Editorial Material									[Knapp, Sandra] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel	Natural History Museum London; Hebrew University of Jerusalem	Knapp, S (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk; dani.zamir@mail.huji.ac.il						Bombarely A., 2016, NATURE PLANTS; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; Lyons E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016717; Puchta H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0922-3; Sheehan H, 2016, NAT GENET, V48, P159, DOI 10.1038/ng.3462; Stehmann Joao Renato, 2009, P1, DOI 10.1007/978-0-387-84796-2_1; Venail J, 2010, PHILOS T R SOC B, V365, P461, DOI 10.1098/rstb.2009.0242; White AC, 2016, J EXP BOT, V67, P31, DOI 10.1093/jxb/erv447	10	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					328	329						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281204				2022-12-28	WOS:000377856800021
J	Mayor, S				Mayor, Susan			Air pollution is a leading risk factor for stroke, global study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Hachinski V, 2016, LANCET NEUROL, V15, P892, DOI 10.1016/S1474-4422(16)30120-X	2	0	0	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2016	353								i3272	10.1136/bmj.i3272	http://dx.doi.org/10.1136/bmj.i3272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1FW	27298274				2022-12-28	WOS:000378236900005
J	Lunze, K; Idrisov, B; Golichenko, M; Kamarulzaman, A				Lunze, Karsten; Idrisov, Bulat; Golichenko, Mikhail; Kamarulzaman, Adeeba			Mandatory addiction treatment for people who use drugs: global health and human rights analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUASI-COMPULSORY TREATMENT; DETENTION CENTERS; INJECT DRUGS; HIV; RUSSIA; SERVICES; EAST		[Lunze, Karsten; Idrisov, Bulat] Boston Univ, Sch Med, Boston, MA 02118 USA; [Golichenko, Mikhail] Canadian HIV AIDS Legal Network, Toronto, ON, Canada; [Kamarulzaman, Adeeba] Univ Malaya, Kuala Lumpur, Malaysia	Boston University; Universiti Malaya	Lunze, K (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	karsten.lunze@post.harvard.edu	Lunze, Karsten/AAL-7240-2021; KAMARULZAMAN, ADEEBA/B-5216-2010; Idrisov, Bulat/A-8271-2018	Lunze, Karsten/0000-0001-8495-0350; Idrisov, Bulat/0000-0002-1971-2572	NATIONAL INSTITUTE ON DRUG ABUSE [K99DA041245] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Amon JJ, 2014, INT J DRUG POLICY, V25, P13, DOI 10.1016/j.drugpo.2013.05.019; Amon JJ, 2013, HEALTH HUM RIGHTS, V15, P124; Anokhina IP, 2005, COMPULSORY TREATMENT; Australian National Council on Drugs, 2014, MAND DRUG TREATM POS; Berezina A, 2016, NUMBER HIV INFECTED; Bobrova N, 2008, SUBST USE MISUSE, V43, P1770, DOI 10.1080/10826080802289291; Broadstock M, 2008, EFFECTIVENESS COMPUL; Bukten A, 2011, J SUBST ABUSE TREAT, V41, P407, DOI 10.1016/j.jsat.2011.06.006; Chen HT, 2013, AIDS EDUC PREV, V25, P336, DOI 10.1521/aeap.2013.25.4.336; Cohen J, 2010, SCIENCE, V329, P162; Cohen J, 2010, SCIENCE, V329, P160, DOI 10.1126/science.329.5988.160; Federal AIDS Center, 2016, HIV INF RUSS FED; Fu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044249; Golichenko M, 2013, HEALTH HUM RIGHTS, V15, P135; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Hall W, 2012, ADDICTION, V107, P1891, DOI 10.1111/j.1360-0443.2012.03888.x; Hoppener P E, 2013, Tijdschr Psychiatr, V55, P269; Human Rights Watch, 2010, SKIN CABL ILL ARR AR; Kamarulzaman A, 2015, INT J DRUG POLICY, V26, pS33, DOI 10.1016/j.drugpo.2014.11.011; Kaur S, 2013, M INT AIDS SOC; Kirzhanova V, 2016, MAIN INDICATORS NARC; Klag S, 2005, SUBST USE MISUSE, V40, P1777, DOI 10.1080/10826080500260891; Klimenko T, 2009, STATUS NARCOLOGY CAR; Koshkina E, 2013, MAIN INDICATORS NARC; LEUKEFELD CG, 1990, INT J ADDICT, V25, P621, DOI 10.3109/10826089009061324; Lucke J, 2010, CRIME JUSTICE B, V144, P12; Lunze K, 2015, ASAM ESSENTIALS ADDI; Lunze K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19043; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; McSweeney T, 2008, GUIDELINES QUASICOMP; Mee-Lee DE, 2013, ASAM CRITERIA TREATM; Mendelevich VD, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-15; NIDA, 2014, PRINC DRUG AB TREATM; Poznyak VB, 2002, EUR ADDICT RES, V8, P184, DOI 10.1159/000066138; Pritchard E, 2007, COMPULSORY TREATMENT; Rhodes T., 2004, International Journal of Drug Policy, V15, P1, DOI 10.1016/j.drugpo.2003.09.001; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rossman S.B., 2011, MULTISITE ADULT DRUG; Samet JH, 2011, ADDICTION, V106, P1883, DOI 10.1111/j.1360-0443.2011.03523.x; Schaub M, 2011, EUR ADDICT RES, V17, P97, DOI 10.1159/000322574; Stevens A, 2005, SUBST USE MISUSE, V40, P269, DOI 10.1081/JA-200049159; Stevens A, 2011, EU CHIN HUM RIGHTS D; UN Committee on Economic Social and Cultural Rights, 2000, GNE COMM 14 RIGHT HI; UNOCD, 2010, EV COMP CTR DRUG US; UNODC, JOINT STAT COMP DRUG; UNODC, 2009, COERC COH TREAT DRUG; UNODC, WORLD DRUG REP; UNODC, ANN PREV OP CONS; Walley Alexander Y, 2013, BMJ, V346, pf174, DOI 10.1136/bmj.f174; Werb D, 2016, INT J DRUG POLICY, V28, P1, DOI 10.1016/j.drugpo.2015.12.005; WHO, 2004, EVIDENCE FOR ACTION; Wodak A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000327439.20914.33; World Health Organization, 2009, GUID PSYCH ASS PHARM	54	10	11	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2016	353								i2943	10.1136/bmj.i2943	http://dx.doi.org/10.1136/bmj.i2943			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5YQ	27284009	Green Published			2022-12-28	WOS:000377859500002
J	Napier, BA; Monack, DM				Napier, Brooke A.; Monack, Denise M.			A lipid arsenal to control inflammation	SCIENCE			English	Editorial Material							CELL-DEATH; CASPASE-11; ACTIVATION		[Napier, Brooke A.; Monack, Denise M.] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94306 USA	Stanford University	Monack, DM (corresponding author), Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94306 USA.	dmonack@stanford.edu		Monack, Denise/0000-0003-3804-2209	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095396, F32AI115950] Funding Source: NIH RePORTER; NIAID NIH HHS [1F32AI115950-01, AI095396-05, R01 AI095396, F32 AI115950] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Huang WY, 2015, TOXICOL SCI, V145, P68, DOI 10.1093/toxsci/kfv014; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shirasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04736; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	12	2	2	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1173	1174		10.1126/science.aag0366	http://dx.doi.org/10.1126/science.aag0366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257241				2022-12-28	WOS:000377045700027
J	Oliver, D				Oliver, David			David Oliver: The pundits who do doctors down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, WHO CAR FUT GEN PRAC; Bowman S., 2016, INT BUSINESS TI 0311; Campbell D., 2016, OBSERVER; Hill H., 2016, CONSERVATIVE HO 0325; Imison C., 2016, RESHAPING WORKFORCE; Kirkup J., 2016, TELEGRAPH; New NHS Alliance, 2015, RED AV DEM GP APP AU; Page B, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1717; Smyth C, 2016, TIMES	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i3025	10.1136/bmj.i3025	http://dx.doi.org/10.1136/bmj.i3025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260255	Green Published, Bronze			2022-12-28	WOS:000377480200004
J	Cheerambathur, DK; Prevo, B; Desai, A				Cheerambathur, Dhanya K.; Prevo, Bram; Desai, Arshad			A TOGgle for Tension at Kinetochores	CELL			English	Editorial Material							BUDDING YEAST; MICROTUBULE	Differential stability of kinetochore-microtubule attachments at low versus high tension is critical for accurate chromosome segregation. Miller et al. find that a TOG domain microtubule-binding protein imparts intrinsic tension selectivity to kinetochore-microtubule attachments.	[Cheerambathur, Dhanya K.; Prevo, Bram; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cheerambathur, Dhanya K.; Prevo, Bram; Desai, Arshad] Ludwig Inst Canc Res, San Diego, CA 92093 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research	Desai, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Desai, A (corresponding author), Ludwig Inst Canc Res, San Diego, CA 92093 USA.	abdesai@ucsd.edu		Prevo, Bram/0000-0002-6526-5590; Cheerambathur, Dhanya/0000-0001-8525-8366	NIGMS NIH HHS [R01 GM074215] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Gandhi SR, 2011, DEV CELL, V21, P920, DOI 10.1016/j.devcel.2011.09.006; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Miller MP, 2016, CELL, V165, P1428, DOI 10.1016/j.cell.2016.04.030; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5	9	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1316	1318		10.1016/j.cell.2016.05.060	http://dx.doi.org/10.1016/j.cell.2016.05.060			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259144	Green Accepted, Bronze			2022-12-28	WOS:000377045400006
J	Halawani, H; Khalife, M				Halawani, Hamzeh; Khalife, Mohamed			Gastrointestinal Complication of Granulomatosis with Polyangiitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Halawani, Hamzeh; Khalife, Mohamed] Amer Univ Beirut, Beirut, Lebanon	American University of Beirut	Halawani, H (corresponding author), Amer Univ Beirut, Beirut, Lebanon.	halawani.md@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2159	2159		10.1056/NEJMicm1511069	http://dx.doi.org/10.1056/NEJMicm1511069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248621				2022-12-28	WOS:000387209900009
J	Mertins, P; Mani, DR; Ruggles, KV; Gillette, MA; Clauser, KR; Wang, P; Wang, XL; Qiao, JW; Cao, S; Petralia, F; Kawaler, E; Mundt, F; Krug, K; Tu, ZD; Lei, JT; Gatza, ML; Wilkerson, M; Perou, CM; Yellapantula, V; Huang, KL; Lin, CW; McLellan, MD; Yan, P; Davies, SR; Townsend, RR; Skates, SJ; Wang, J; Zhang, B; Kinsinger, CR; Mesri, M; Rodriguez, H; Ding, L; Paulovich, AG; Fenyo, D; Ellis, MJ; Carr, SA				Mertins, Philipp; Mani, D. R.; Ruggles, Kelly V.; Gillette, Michael A.; Clauser, Karl R.; Wang, Pei; Wang, Xianlong; Qiao, Jana W.; Cao, Song; Petralia, Francesca; Kawaler, Emily; Mundt, Filip; Krug, Karsten; Tu, Zhidong; Lei, Jonathan T.; Gatza, Michael L.; Wilkerson, Matthew; Perou, Charles M.; Yellapantula, Venkata; Huang, Kuan-lin; Lin, Chenwei; McLellan, Michael D.; Yan, Ping; Davies, Sherri R.; Townsend, R. Reid; Skates, Steven J.; Wang, Jing; Zhang, Bing; Kinsinger, Christopher R.; Mesri, Mehdi; Rodriguez, Henry; Ding, Li; Paulovich, Amanda G.; Fenyo, David; Ellis, Matthew J.; Carr, Steven A.		NCI CPTAC	Proteogenomics connects somatic mutations to signalling in breast cancer	NATURE			English	Article							PIK3CA MUTATIONS; EXPRESSION; RECEPTOR; PATHWAYS; GENES; PHOSPHORYLATION; HETEROGENEITY; SIGNATURE; REVEALS; BIOLOGY	Somatic mutations have been extensively characterized in breast cancer, but the effects of these genetic alterations on the proteomic landscape remain poorly understood. Here we describe quantitative mass-spectrometry-based proteomic and phosphoproteomic analyses of 105 genomically annotated breast cancers, of which 77 provided high-quality data. Integrated analyses provided insights into the somatic cancer genome including the consequences of chromosomal loss, such as the 5q deletion characteristic of basal-like breast cancer. Interrogation of the 5q trans-effects against the Library of Integrated Network-based Cellular Signatures, connected loss of CETN3 and SKP1 to elevated expression of epidermal growth factor receptor (EGFR), and SKP1 loss also to increased SRC tyrosine kinase. Global proteomic data confirmed a stromal-enriched group of proteins in addition to basal and luminal clusters, and pathway analysis of the phosphoproteome identified a G-protein-coupled receptor cluster that was not readily identified at the mRNA level. In addition to ERBB2, other amplicon-associated highly phosphorylated kinases were identified, including CDK12, PAK1, PTK2, RIPK2 and TLK2. We demonstrate that proteogenomic analysis of breast cancer elucidates the functional consequences of somatic mutations, narrows candidate nominations for driver genes within large deletions and amplified regions, and identifies therapeutic targets.	[Mertins, Philipp; Mani, D. R.; Gillette, Michael A.; Clauser, Karl R.; Qiao, Jana W.; Mundt, Filip; Krug, Karsten; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ruggles, Kelly V.; Kawaler, Emily; Fenyo, David] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Gillette, Michael A.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA; [Wang, Pei; Petralia, Francesca; Tu, Zhidong] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Wang, Xianlong; Lin, Chenwei; Yan, Ping; Paulovich, Amanda G.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Cao, Song; Yellapantula, Venkata; Huang, Kuan-lin; McLellan, Michael D.; Ding, Li] Washington Univ, Sch Med, Siteman Canc Ctr, Dept Med,McDonnell Genome Inst, St Louis, MO 63108 USA; [Mundt, Filip] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Lei, Jonathan T.; Ellis, Matthew J.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Lei, Jonathan T.; Ellis, Matthew J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lei, Jonathan T.; Ellis, Matthew J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gatza, Michael L.; Wilkerson, Matthew; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Davies, Sherri R.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Skates, Steven J.] Massachusetts Gen Hosp, Ctr Canc, Biostat Ctr, Boston, MA 02114 USA; [Wang, Jing; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Wang, Jing; Zhang, Bing] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Kinsinger, Christopher R.; Mesri, Mehdi; Rodriguez, Henry] NCI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; NYU Langone Medical Center; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center; Siteman Cancer Center; Washington University (WUSTL); Karolinska Institutet; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mertins, P; Carr, SA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Ellis, MJ (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.; Ellis, MJ (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Ellis, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	pmertins@broadinstitute.org; Matthew.Ellis@bcm.edu; scarr@broad.mit.edu	Carr, Steven A./AAH-8366-2019; Lin, Chen/GRR-2799-2022; Perou, Charles M/H-9934-2014; Kawaler, Emily/AAO-5923-2020; Yellapantula, Venkata/AAM-3996-2021	Perou, Charles M/0000-0001-9827-2247; Kawaler, Emily/0000-0002-7438-7282; Davies, Sherri/0000-0002-7141-8354; Oberti, Mauricio/0000-0001-7107-2616; Tabb, David/0000-0001-7223-578X; Gatza, Michael/0000-0001-6796-7791; Mani, D. R./0000-0003-3914-133X; Clauser, Karl/0000-0002-1052-9456; Ruggles, Kelly/0000-0002-0152-0863; Yellapantula, Venkata/0000-0001-9848-3263; MCLELLAN, MICHAEL/0000-0002-2703-8784; McGarvey, Peter/0000-0002-8312-6017; Lei, Jonathan/0000-0002-0209-8051; Wang, Pei/0000-0002-6890-6453; Levine, Douglas/0000-0003-1038-8232; Fenyo, David/0000-0001-5049-3825	National Cancer Institute (NCI) [U24CA160034, U24CA160036, U24CA160019, U24CA159988, U24CA160035]; CPRIT grant [RR140033]; Leidos contract [13XS068]; National Cancer Institute (NCI) CPTAC award [U24CA160035]; NCI Cancer Center Support Grant [P30 CA91842]; NIH/NCRR Washington University-ICTS [UL1 RR024992]; Susan G. Komen for the Cure [KG 090422]; Swedish Research Council [Dnr 2014-323];  [SUB-R01GM108711]; NATIONAL CANCER INSTITUTE [U24CA160035, U24CA160036, U24CA160019, R00CA166228, P30CA016087, P30CA091842, U24CA159988, U24CA160034] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108711, P41GM103422, T32GM088129] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT grant; Leidos contract; National Cancer Institute (NCI) CPTAC award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR Washington University-ICTS; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA160034 (Broad Institute; Fred Hutchinson Cancer Research Center), U24CA160036 (Johns Hopkins University), U24CA160019 (Pacific Northwest National Laboratory), U24CA159988 (Vanderbilt University), U24CA160035 (Washington University, St. Louis; University of North Carolina, Chapel Hill). P.W. and F.P. were also supported by SUB-R01GM108711 and MJE by CPRIT grant RR140033. M.J.E. is also a McNair Foundation Scholar. D.F. was supported by Leidos contract 13XS068. Primary genomics data for this study were generated by The Cancer Genome Atlas pilot project established by the NCI and the National Human Genome Research Institute. Resequencing of select samples conducted in this study was supported by National Cancer Institute (NCI) CPTAC award U24CA160035. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov/. We also acknowledge the expert assistance of J. Snider, P. Erdmann-Gilmore and R. Connors for the preparation of the tumour tissues for solubilization. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, for the use of the Tissue Procurement Core, which provided accessioning, histologic processing and review for the TCGA samples included in this study. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842 (see more at http://www.siteman.wustl.edu/ContentPage.aspx?id=243#sthash.mEU0QuXx.dpuf). We also thank the HAMLET Core at The Washington University in St. Louis for providing breast cancer xenograft tumors. The HAMLET Core was supported in part by grants from NIH/NCRR Washington University-ICTS (UL1 RR024992) and Susan G. Komen for the Cure (KG 090422). F.M. was also supported by The Swedish Research Council (Dnr 2014-323). We also thank A. Subramanian, C. Flynn and J. Asiedu at the Broad Institute for their guidance and assistance in accessing LINCS to run a large number of enrichment queries.	Agrawal PB, 2014, AM J HUM GENET, V95, P218, DOI 10.1016/j.ajhg.2014.07.004; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Borges S, 2015, MOL CANCER THER, V14, P1306, DOI 10.1158/1535-7163.MCT-14-0945; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476; Ellis MJ, 2013, CANCER DISCOV, V3, P1108, DOI 10.1158/2159-8290.CD-13-0219; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Jiang XL, 2012, STEM CELLS, V30, P1313, DOI 10.1002/stem.1120; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ong CC, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0564-5; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petralia F, 2016, J PROTEOME RES, V15, P743, DOI 10.1021/acs.jproteome.5b00925; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prudnikova TY, 2015, CLIN CANCER RES, V21, P24, DOI 10.1158/1078-0432.CCR-14-0827; Ruggles KV, 2016, MOL CELL PROTEOMICS, V15, P1060, DOI 10.1074/mcp.M115.056226; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Silva GO, 2015, BREAST CANCER RES TR, V152, P347, DOI 10.1007/s10549-015-3476-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SYMMANS WF, 1995, HUM PATHOL, V26, P210, DOI 10.1016/0046-8177(95)90039-X; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	41	927	942	12	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					55	+		10.1038/nature18003	http://dx.doi.org/10.1038/nature18003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251275	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000376962300032
J	Stafford, N				Stafford, Ned			Charles S Hirsch Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						HIRSCH CS, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3081	10.1136/bmj.i3081	http://dx.doi.org/10.1136/bmj.i3081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255495				2022-12-28	WOS:000377479000006
J	Yeh, JS; Bullen, C; Glantz, SA				Yeh, James S.; Bullen, Christopher; Glantz, Stanton A.			E-Cigarettes and Smoking Cessation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yeh, James S.; Bullen, Christopher] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Glantz, Stanton A.] Univ Calif San Francisco, UCSF Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Auckland; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yeh, JS (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand.		Bullen, Chris/E-4594-2017	Bullen, Chris/0000-0001-6807-2930; Yeh, James/0000-0003-3549-6096				Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kotz D, 2014, MAYO CLIN PROC, V89, P1360, DOI 10.1016/j.mayocp.2014.07.004; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; Pierce JP, 2002, JAMA-J AM MED ASSOC, V288, P1260, DOI 10.1001/jama.288.10.1260; Rutten LJF, 2015, NICOTINE TOB RES, V17, P1228, DOI 10.1093/ntr/ntv003; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023	9	17	18	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2172	2174						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248625				2022-12-28	WOS:000387209900015
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Asthma and the catwalk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bush A, 2016, ARCH DIS CHILD, V101, P688, DOI 10.1136/archdischild-2015-309053; Deaths Nro A, 2015, WHY ASTHMA STILL KIL; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; National Institute for Health and Care Excellence, 2014, MEAS FRACT EXH NITR	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i2975	10.1136/bmj.i2975	http://dx.doi.org/10.1136/bmj.i2975			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27245363	Bronze, Green Published			2022-12-28	WOS:000377477500007
J	Orkin, SH; Reilly, P				Orkin, Stuart H.; Reilly, Philip			MEDICINE Paying for future success in gene therapy	SCIENCE			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; DISEASE; VECTOR		[Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Reilly, Philip] Third Rock Ventures, Boston, MA 02116 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.; Orkin, SH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston Childrens Hosp, Boston, MA 02115 USA.; Reilly, P (corresponding author), Third Rock Ventures, Boston, MA 02116 USA.	stuart_orkin@dfci.harvard.edu; philip@thirdrockventures.com			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bonanas P., 2016, BIOCENTURY EXTRA; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Feldman BM, 2012, HAEMOPHILIA, V18, P680, DOI 10.1111/j.1365-2516.2012.02790.x; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Johnson C, 2016, WASHINGTON POST; Kaiser J, 2012, SCIENCE, V335, P645, DOI 10.1126/science.335.6069.645; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Orkin S. H., 1995, ORKIN MOTULSKY REPOR; Schoonveld E., 2016, REPRICING RULES JAPA; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; SLOAN FA, 2012, HLTH EC	18	33	36	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1059	1061		10.1126/science.aaf4770	http://dx.doi.org/10.1126/science.aaf4770			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230368				2022-12-28	WOS:000376480800023
J	Treutlein, B; Lee, QY; Camp, JG; Mall, M; Koh, W; Shariati, SAM; Sim, S; Neff, NF; Skotheim, JM; Wernig, M; Quake, SR				Treutlein, Barbara; Lee, Qian Yi; Camp, J. Gray; Mall, Moritz; Koh, Winston; Shariati, Seyed Ali Mohammad; Sim, Sopheak; Neff, Norma F.; Skotheim, Jan M.; Wernig, Marius; Quake, Stephen R.			Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq	NATURE			English	Article							FUNCTIONAL-NEURONS; DIRECT CONVERSION; HETEROGENEITY; EXPRESSION; MECHANISMS; GENERATION; REGULATORS; MOUSE	Direct lineage reprogramming represents a remarkable conversion of cellular and transcriptome states(1-3). However, the intermediate stages through which individual cells progress during reprogramming are largely undefined. Here we use single-cell RNA sequencing(4-7) at multiple time points to dissect direct reprogramming from mouse embryonic fibroblasts to induced neuronal cells. By deconstructing heterogeneity at each time point and ordering cells by transcriptome similarity, we find that the molecular reprogramming path is remarkably continuous. Overexpression of the proneural pioneer factor Ascl1 results in a well-defined initialization, causing cells to exit the cell cycle and re-focus gene expression through distinct neural transcription factors. The initial transcriptional response is relatively homogeneous among fibroblasts, suggesting that the early steps are not limiting for productive reprogramming. Instead, the later emergence of a competing myogenic program and variable transgene dynamics over time appear to be the major efficiency limits of direct reprogramming. Moreover, a transcriptional state, distinct from donor and target cell programs, is transiently induced in cells undergoing productive reprogramming. Our data provide a high-resolution approach for understanding transcriptome states during lineage differentiation.	[Treutlein, Barbara; Lee, Qian Yi; Koh, Winston; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Treutlein, Barbara] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Lee, Qian Yi; Mall, Moritz; Sim, Sopheak; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Lee, Qian Yi; Mall, Moritz; Wernig, Marius] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Camp, J. Gray] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Shariati, Seyed Ali Mohammad; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Max Planck Society; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Wernig, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Wernig, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	wernig@stanford.edu; quake@stanford.edu	Mall, Moritz/AAA-3558-2019; Koh, Lian Chye Winston/GYD-5873-2022; Skotheim, Jan/C-3238-2015	Mall, Moritz/0000-0002-1278-2594; Koh, Lian Chye Winston/0000-0003-4611-6490; Lee, Qian Yi/0000-0001-9200-0910; Skotheim, Jan/0000-0001-8420-6820; Treutlein, Barbara/0000-0002-3299-5597	NIH [RC4NS073015-01, GM092925]; Stinehart-Reed Foundation; Ellison Medical Foundation; New York Stem Cell Foundation; CIRM [RB5-07466]; National Science Scholarship from the Agency for Science, Technology and Research; German Research Foundation; PhRMA foundation Informatics fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092925, P50GM107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stinehart-Reed Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); New York Stem Cell Foundation; CIRM(California Institute for Regenerative Medicine); National Science Scholarship from the Agency for Science, Technology and Research; German Research Foundation(German Research Foundation (DFG)); PhRMA foundation Informatics fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to acknowledge B. Passarelli and B. Vernot for discussions regarding bioinformatic pipelines, P. Lovelace for support with FACS and other Quake and Wernig laboratory members for discussions and support. This work was supported by NIH grant RC4NS073015-01 (M.W., S.Q.R., B.T.), the Stinehart-Reed Foundation, the Ellison Medical Foundation, the New York Stem Cell Foundation, CIRM grant RB5-07466 (all to M.W.), a National Science Scholarship from the Agency for Science, Technology and Research (Q.Y.L.), NIH grant GM092925 (S.A.M.S., J.S.), the German Research Foundation (M. M.) and a PhRMA foundation Informatics fellowship (J.G.C.). S.R.Q. is an investigator of the Howard Hughes Medical Institute. M.W. is a New York Stem Cell Foundation (NYSCF) Robertson Investigator and a Tashia and John Morgridge Faculty Scholar at the Child Health Research Institute at Stanford.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; [Anonymous], BABR BIOINF; Arlotta P, 2014, CURR OPIN NEUROBIOL, V27, P208, DOI 10.1016/j.conb.2014.04.007; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lujan E, 2015, NATURE, V521, P352, DOI 10.1038/nature14274; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; R Core Team, R LANG ENV STAT COMP; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; RStudio, 2015, INT DEV R; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	45	255	258	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					391	+		10.1038/nature18323	http://dx.doi.org/10.1038/nature18323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281220	Green Accepted			2022-12-28	WOS:000377856800037
J	Ballantyne, JC				Ballantyne, Jane C.			Avoiding Opioid Analgesics for Treatment of Chronic Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; UNITED-STATES; DISEASE	IMPORTANCE Opioid analgesics are commonly used for low back pain; however, to our knowledge there has been no systematic evaluation of the effect of opioid dose and use of enrichment study design on estimates of treatment effect. OBJECTIVE To evaluate efficacy and tolerability of opioids in the management of back pain and investigate the effect of opioid dose and use of an enrichment study design on treatment effect. DATA SOURCES Medline, EMBASE, CENTRAL, CINAHL, and PsycINFO (inception to September 2015) with citation tracking from eligible randomized clinical trials (RCTs). STUDY SELECTION Placebo-controlled RCTs in any language. DATA EXTRACTION AND SYNTHESIS Two authors independently extracted data and assessed risk of bias. Data were pooled using a random effects model with strength of evidence assessed using the grading of recommendations assessment, development, and evaluation (GRADE). MAIN OUTCOMES AND MEASURES The primary outcome measure was pain. Pain and disability outcomes were converted to a common 0 to 100 scale, with effects greater than 20 points considered clinically important. RESULTS Of 20 included RCTs of opioid analgesics (with a total of 7925 participants), 13 trials (3419 participants) evaluated short-term effects on chronic low back pain, and no placebo-controlled trials enrolled patients with acute low back pain. In half of these 13 trials, at least 50% of participants withdrew owing to adverse events or lack of efficacy. There was moderate-quality evidence that opioid analgesics reduce pain in the short term: mean difference (MD), -10.1 (95% CI, -12.8 to -7.4). Meta-regression revealed a 12.0 point greater pain relief for every 1 log unit increase in morphine equivalent dose (P = .046). Clinically important pain relief was not observed within the dose range evaluated (40.0-240.0-mg morphine equivalents per day). There was no significant effect of enrichment study design. CONCLUSIONS AND RELEVANCE For people with chronic low back pain who tolerate the medicine, opioid analgesics provide modest short-term pain relief but the effect is not likely to be clinically important within guideline recommended doses. Evidence on long-term efficacy is lacking. The efficacy of opioid analgesics in acute low back pain is unknown.	[Ballantyne, Jane C.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, POB 356540, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ballantyne, JC (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, POB 356540, Seattle, WA 98195 USA.	jcb12@uw.edu						Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Olsen Y, 2006, J PAIN, V7, P225, DOI 10.1016/j.jpain.2005.11.006; Paulozzi L., CDC GRAND ROUNDS PRE; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	10	16	16	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2459	2460		10.1001/jama.2016.6753	http://dx.doi.org/10.1001/jama.2016.6753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299620				2022-12-28	WOS:000377656900023
J	Miyamoto, D; Hirai, D; Fung, CCA; Inutsuka, A; Odagawa, M; Suzuki, T; Boehringer, R; Adaikkan, C; Matsubara, C; Matsuki, N; Fukai, T; McHugh, TJ; Yamanaka, A; Murayama, M				Miyamoto, D.; Hirai, D.; Fung, C. C. A.; Inutsuka, A.; Odagawa, M.; Suzuki, T.; Boehringer, R.; Adaikkan, C.; Matsubara, C.; Matsuki, N.; Fukai, T.; McHugh, T. J.; Yamanaka, A.; Murayama, M.			Top-down cortical input during NREM sleep consolidates perceptual memory	SCIENCE			English	Article							OBJECT RECOGNITION; GRANGER CAUSALITY; RATS; PLASTICITY; NETWORK	During tactile perception, long-range intracortical top-down axonal projections are essential for processing sensory information. Whether these projections regulate sleep-dependent long-termmemory consolidation is unknown. We altered top-down inputs fromhigher-order cortex to sensory cortex during sleep and examined the consolidation of memories acquired earlier during awake texture perception. Mice learned novel textures and consolidated them during sleep. Within the first hour of non-rapid eye movement (NREM) sleep, optogenetic inhibition of top-down projecting axons fromsecondary motor cortex (M2) to primary somatosensory cortex (S1) impaired sleep-dependent reactivation of S1 neurons and memory consolidation. In NREM sleep and sleep-deprivation states, closed-loop asynchronous or synchronous M2-S1 coactivation, respectively, reduced or prolonged memory retention. Top-down cortical information flow in NREM sleep is thus required for perceptual memory consolidation.	[Miyamoto, D.; Hirai, D.; Odagawa, M.; Suzuki, T.; Matsubara, C.; Murayama, M.] RIKEN, Brain Sci Inst, Lab Behav Neurophysiol, Wako, Saitama, Japan; [Miyamoto, D.; Inutsuka, A.; Yamanaka, A.] Nagoya Univ, Environm Med Res Inst, Dept Neurosci 2, Nagoya, Aichi 464, Japan; [Miyamoto, D.; Matsuki, N.] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Chem Pharmacol, Bunkyo Ku, Tokyo, Japan; [Miyamoto, D.] Japan Soc Promot Sci, Chiyoda Ku, 5-3-1 Kojimachi, Tokyo 1020083, Japan; [Fung, C. C. A.; Fukai, T.] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Boehringer, R.; Adaikkan, C.; McHugh, T. J.] RIKEN, Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama, Japan	RIKEN; Nagoya University; University of Tokyo; Japan Society for the Promotion of Science; RIKEN; RIKEN	Murayama, M (corresponding author), RIKEN, Brain Sci Inst, Lab Behav Neurophysiol, Wako, Saitama, Japan.	masa_murayama@brain.riken.jp	Murayama, Masanori/G-5457-2015; Adaikkan, Chinnakkaruppan/Y-6415-2019; McHugh, Thomas J/A-6693-2010; Inutsuka, Ayumu/AAL-3494-2021; Yamanaka, Akihiro/AAD-8641-2021; Fung, Chi Chung Alan/P-8378-2018; Murayama, Masanori/AHA-9840-2022; McHugh, Thomas/M-6159-2019; Miyamoto, Daisuke/AAG-4537-2020; Miyamoto, Daisuke/I-2195-2016	Murayama, Masanori/0000-0001-7623-010X; Adaikkan, Chinnakkaruppan/0000-0002-1027-1096; McHugh, Thomas J/0000-0002-1243-5189; Yamanaka, Akihiro/0000-0001-6099-7306; Fung, Chi Chung Alan/0000-0002-7780-8230; McHugh, Thomas/0000-0002-1243-5189; Miyamoto, Daisuke/0000-0003-4735-9240; Inutsuka, Ayumu/0000-0001-6503-5501	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank C. Yokoyama for helpful comments and editing, H. Hirase, T. Toyoizumi, S. Fujisawa, J. P. Johansen and B. Mensh for comments and discussions, S. Itohara and K. Yasuda for behavioral analysis, T. Tsunematsu for sleep measurement, M. Kobayashi and H. Hioki for anatomical analysis, R. Endo and R. Kato for animal control, K. Tao for a part of firing data analysis, and A. Kamoshida for writing custom-made LabVIEW programs. The archaerhodopsin from the Halorubrum strain TP009 (AAV-CMV-ArchT-EGFP) was kindly given by E. Boyden (MIT, Cambridge, MA, USA). The authors acknowledge support from a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science to M. M.	Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Chen JD, 2015, SCIENCE, V350, P554, DOI 10.1126/science.aac6472; de Lima MNM, 2005, BEHAV BRAIN RES, V156, P139, DOI 10.1016/j.bbr.2004.05.016; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dudai Y, 2015, NEURON, V88, P20, DOI 10.1016/j.neuron.2015.09.004; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Inostroza M, 2013, BEHAV BRAIN RES, V237, P15, DOI 10.1016/j.bbr.2012.09.011; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Manita S, 2015, NEURON, V86, P1304, DOI 10.1016/j.neuron.2015.05.006; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; VALATX JL, 1974, BRAIN RES, V69, P315, DOI 10.1016/0006-8993(74)90009-2; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	23	75	77	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1315	1318		10.1126/science.aaf0902	http://dx.doi.org/10.1126/science.aaf0902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27229145				2022-12-28	WOS:000377972000040
J	Rewers, M; Ludvigsson, J				Rewers, Marian; Ludvigsson, Johnny			Environmental risk factors for type 1 diabetes	LANCET			English	Article							CALMETTE-GUERIN VACCINATION; BETA-CELL AUTOIMMUNITY; HLA-CONFERRED SUSCEPTIBILITY; ENDOPLASMIC-RETICULUM STRESS; CAPSID PROTEIN VP1; EARLY WEIGHT-GAIN; ISLET AUTOIMMUNITY; ENTEROVIRUS INFECTION; DRINKING-WATER; GUT MICROBIOTA	The incidence of type 1 diabetes has risen considerably in the past 30 years due to changes in the environment that have been only partially identified. In this Series paper, we critically discuss candidate triggers of islet autoimmunity and factors thought to promote progression from autoimmunity to overt type 1 diabetes. We revisit previously proposed hypotheses to explain the growth in the incidence of type 1 diabetes in light of current data. Finally, we suggest a unified model in which immune tolerance to beta cells can be broken by several environmental exposures that induce generation of hybrid peptides acting as neoautoantigens.	[Rewers, Marian] Univ Colorado, Sch Med, Barbara Davis Ctr Diabet, Aurora, CO USA; [Ludvigsson, Johnny] Linkoping Univ, Fac Med, Dept Clin & Expt Med, Div Pediat, SE-58185 Linkoping, Sweden; [Ludvigsson, Johnny] Linkoping Univ Hosp, SE-58185 Linkoping, Sweden	University of Colorado System; University of Colorado Anschutz Medical Campus; Linkoping University; Linkoping University	Ludvigsson, J (corresponding author), Linkoping Univ, Fac Med, Dept Clin & Expt Med, Div Pediat, SE-58185 Linkoping, Sweden.; Ludvigsson, J (corresponding author), Linkoping Univ Hosp, SE-58185 Linkoping, Sweden.	johnny.ludvigsson@liu.se	Ludvigsson, Johnny/AAI-2051-2020	Ludvigsson, Johnny/0000-0003-1695-5234	National Institutes of Health [DK32493]; Juvenile Diabetes Research Foundation [17-2013-535]; Swedish Child Diabetes Foundation (Barndiabetesfonden); JDF-Wallenberg [K98-99JD-12813-01A]; Swedish Medical Research Council (MFR) [K99-72X-11242-05A]; Research Council of Southeast Sweden; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032493, R01DK032493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Child Diabetes Foundation (Barndiabetesfonden); JDF-Wallenberg; Swedish Medical Research Council (MFR)(Swedish Medical Research Council (SMRC)); Research Council of Southeast Sweden; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This paper was supported by the National Institutes of Health grant DK32493 (MR), by the Juvenile Diabetes Research Foundation grant 17-2013-535 (MR), by Swedish Child Diabetes Foundation (Barndiabetesfonden; JL), by JDF-Wallenberg (K98-99JD-12813-01A; JL), the Swedish Medical Research Council (MFR) K99-72X-11242-05A (JL), and the Research Council of Southeast Sweden (JL)	Allen HF, 1999, DIABETES CARE, V22, P1703, DOI 10.2337/diacare.22.10.1703; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Benson VS, 2010, J AM COLL NUTR, V29, P612, DOI 10.1080/07315724.2010.10719900; Beyerlein A, 2014, DIABETES CARE, V37, pE194, DOI 10.2337/dc14-1208; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Brekke HK, 2010, PEDIATR DIABETES, V11, P244, DOI 10.1111/j.1399-5448.2009.00563.x; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Chapman NM, 2008, VIROLOGY, V375, P480, DOI 10.1016/j.virol.2008.02.030; Chmiel R, 2015, ACTA DIABETOL, V52, P621, DOI 10.1007/s00592-014-0628-5; Christen U, 2004, J CLIN INVEST, V114, P1290, DOI 10.1172/JCI200422557; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Coppieters KT, 2012, CLIN EXP IMMUNOL, V168, P5, DOI 10.1111/j.1365-2249.2011.04554.x; Couper JJ, 1999, DIABETES, V48, P2145, DOI 10.2337/diabetes.48.11.2145; Crevecoeur I, 2015, PROTEOM CLIN APPL, V9, P755, DOI 10.1002/prca.201400135; DAHLQUIST G, 1995, DIABETOLOGIA, V38, P873, DOI 10.1007/BF03035306; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; DAHLQUIST GG, 1990, BMJ-BRIT MED J, V300, P1302, DOI 10.1136/bmj.300.6735.1302; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dong JY, 2013, NUTRIENTS, V5, P3551, DOI 10.3390/nu5093551; Doyle HA, 2014, AUTOIMMUNITY, V47, P220, DOI 10.3109/08916934.2013.850495; Drescher KM, 2004, VIROLOGY, V329, P381, DOI 10.1016/j.virol.2004.06.049; Elliott JF, 1998, DIABETES CARE, V21, P1691, DOI 10.2337/diacare.21.10.1691; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Frederiksen B, 2013, JAMA PEDIATR, V167, P808, DOI 10.1001/jamapediatrics.2013.317; Frederiksen BN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/708289; Frederiksen BN, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/417657; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; GAMBLE DR, 1969, BRIT MED J, V3, P627, DOI 10.1136/bmj.3.5671.627; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gottlieb PA, 2014, J AUTOIMMUN, V50, P38, DOI 10.1016/j.jaut.2013.10.003; Graves PM, 1999, DIABETES CARE, V22, P1694, DOI 10.2337/diacare.22.10.1694; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Gundersen E, 1927, J INFECT DIS, V41, P197, DOI 10.1093/infdis/41.3.197; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Holmberg H, 2007, BRIT J NUTR, V97, P111, DOI 10.1017/S0007114507210189; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025792, 10.1371/journal.pone.0014764]; Horwitz MS, 2001, J AUTOIMMUN, V16, P211, DOI 10.1006/jaut.2000.0486; Hummel M, 2002, DIABETES CARE, V25, P1111, DOI 10.2337/diacare.25.7.1111; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Huppmann M, 2005, DIABETES CARE, V28, P1204, DOI 10.2337/diacare.28.5.1204; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Hypponen E, 1999, DIABETES CARE, V22, P1961, DOI 10.2337/diacare.22.12.1961; Ilonen J, 2013, DIABETES, V62, P3636, DOI 10.2337/db13-0300; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Jarosz-Chobot P, 2011, DIABETOLOGIA, V54, P508, DOI 10.1007/s00125-010-1993-4; Jefferson T, 1998, J EPIDEMIOL COMMUN H, V52, P674, DOI 10.1136/jech.52.10.674; Jin NY, 2015, P NATL ACAD SCI USA, V112, P13318, DOI 10.1073/pnas.1517862112; JOHANSSON C, 1994, DIABETOLOGIA, V37, P91; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; KOLB H, 1994, DIABETOLOGIA, V37, P729, DOI 10.1007/BF00417700; Kondrashova A, 2005, ANN MED, V37, P67, DOI 10.1080/07853890410018952; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Lamb MM, 2008, J CLIN ENDOCR METAB, V93, P3936, DOI 10.1210/jc.2008-0886; Lamb MM, 2015, PEDIATR DIABETES, V16, P31, DOI 10.1111/pedi.12115; Larsson HE, 2016, DIABETES; Larsson PG, 2013, DIABETOLOGIA, V56, P867, DOI 10.1007/s00125-013-2834-z; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Lindehammer SR, 2012, VIRAL IMMUNOL, V25, P254, DOI 10.1089/vim.2012.0022; Ludvigsson J, 2006, ANN NY ACAD SCI, V1079, P374, DOI 10.1196/annals.1375.058; Magnus MC, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.3759; Marre ML, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00067; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; Miettinen ME, 2012, DIABETOLOGIA, V55, P1291, DOI 10.1007/s00125-012-2458-8; Moltchanova E, 2004, DIABETIC MED, V21, P256, DOI 10.1111/j.1464-5491.2004.01125.x; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Morgan E, 2016, DIABETOLOGIA, V59, P237, DOI 10.1007/s00125-015-3800-8; Morgan NG, 2014, TRENDS ENDOCRIN MET, V25, P611, DOI 10.1016/j.tem.2014.08.002; Muntoni S, 2006, EUR J EPIDEMIOL, V21, P245, DOI 10.1007/s10654-006-0014-x; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Norris JM, 2007, JAMA-J AM MED ASSOC, V298, P1420, DOI 10.1001/jama.298.12.1420; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Nygren M, 2015, DIABETOLOGIA, V58, P1188, DOI 10.1007/s00125-015-3555-2; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; Oilinki T, 2012, PEDIATR DIABETES, V13, P176, DOI 10.1111/j.1399-5448.2011.00783.x; Parent ME, 1997, DIABETES CARE, V20, P767, DOI 10.2337/diacare.20.5.767; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Paulsson JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093053; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Rasmussen T, 2011, DIABETES-METAB RES, V27, P834, DOI 10.1002/dmrr.1258; Rewers M, 2012, PEDIATR DIABETES, V13, P333, DOI 10.1111/j.1399-5448.2011.00832.x; Richardson SJ, 2013, DIABETOLOGIA, V56, P185, DOI 10.1007/s00125-012-2745-4; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Rosenbauer J, 2008, DIABETES-METAB RES, V24, P211, DOI 10.1002/dmrr.791; Rousseau MC, 2016, PAEDIATR PERINAT EP, V30, P141, DOI 10.1111/ppe.12263; Samuelsson U, 2011, PEDIATR DIABETES, V12, P156, DOI 10.1111/j.1399-5448.2010.00678.x; Sane F, 2013, CELL MOL LIFE SCI, V70, P4169, DOI 10.1007/s00018-013-1383-4; Sepa A, 2005, DIABETES CARE, V28, P2394, DOI 10.2337/diacare.28.10.2394; Sepa A, 2005, DIABETES CARE, V28, P290, DOI 10.2337/diacare.28.2.290; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Simpson M, 2011, DIABETOLOGIA, V54, P2779, DOI 10.1007/s00125-011-2278-2; Smithee S, 2015, J VIROL, V89, P11761, DOI 10.1128/JVI.01308-15; Soderstrom U, 2012, ACTA PAEDIATR, V101, P73, DOI 10.1111/j.1651-2227.2011.02410.x; Sorensen IM, 2012, DIABETES-METAB RES, V28, P431, DOI 10.1002/dmrr.2293; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Stene LC, 2012, CLIN EXP IMMUNOL, V168, P12, DOI 10.1111/j.1365-2249.2011.04555.x; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Szabat M, 2016, CELL METAB, V23, P179, DOI 10.1016/j.cmet.2015.10.016; Tracy S, 2011, DIABETES-METAB RES, V27, P820, DOI 10.1002/dmrr.1255; van Lummel M, 2016, DIABETES, V65, P732, DOI 10.2337/db15-1031; VERGE CF, 1994, DIABETES CARE, V17, P1381, DOI 10.2337/diacare.17.12.1381; Virtanen SM, 2011, DIABETIC MED, V28, P965, DOI 10.1111/j.1464-5491.2011.03294.x; Virtanen SM, 2010, EUR J CLIN NUTR, V64, P792, DOI 10.1038/ejcn.2010.75; Virtanen SM, 2000, DIABETES, V49, P912, DOI 10.2337/diabetes.49.6.912; Virtanen SM, 2012, AM J CLIN NUTR, V95, P471, DOI 10.3945/ajcn.111.018879; Viskari H, 2005, DIABETOLOGIA, V48, P1280, DOI 10.1007/s00125-005-1780-9; Viskari H, 2012, DIABETES CARE, V35, P1328, DOI 10.2337/dc11-2389; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wahlberg J, 2006, BRIT J NUTR, V95, P603, DOI 10.1079/BJN20051676; Walter M, 2010, DIABETES CARE, V33, P1443, DOI 10.2337/dc09-2297; Weets I, 2004, DIABETOLOGIA, V47, P614, DOI 10.1007/s00125-004-1369-8; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Winkler C, 2008, HORM METAB RES, V40, P566, DOI 10.1055/s-2008-1073165; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102; Zhao HX, 2001, DIABETIC MED, V18, P709, DOI 10.1046/j.1464-5491.2001.00554.x; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	132	321	332	6	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2340	2348		10.1016/S0140-6736(16)30507-4	http://dx.doi.org/10.1016/S0140-6736(16)30507-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27302273	Green Accepted			2022-12-28	WOS:000376969100037
J	de Pater, I; Sault, RJ; Butler, B; DeBoer, D; Wong, MH				de Pater, Imke; Sault, R. J.; Butler, Bryan; DeBoer, David; Wong, Michael H.			Peering through Jupiter's clouds with radio spectral imaging	SCIENCE			English	Article							5-MICRON HOT-SPOTS; DYNAMICAL IMPLICATIONS; AMMONIA; ATMOSPHERE; WATER	Radio wavelengths can probe altitudes in Jupiter's atmosphere below its visible cloud layers. We used the Very Large Array to map this unexplored region down to similar to 8 bar, similar to 100 kilometers below the visible clouds. Our maps reveal a dynamically active planet at pressures less than 2 to 3 bar. A radio-hot belt exists, consisting of relatively transparent regions (a low ammonia concentration, NH3 being the dominant source of opacity) probing depths to over similar to 8 bar; these regions probably coincide with 5-micrometer hot spots. Just to the south we distinguish an equatorial wave, bringing up ammonia gas from Jupiter's deep atmosphere. This wave has been theorized to produce the 5-micrometer hot spots; we observed the predicted radio counterpart of such hot spots.	[de Pater, Imke; DeBoer, David; Wong, Michael H.] Univ Calif Berkeley, Dept Astron, 501 Campbell Hall, Berkeley, CA 94720 USA; [de Pater, Imke] Delft Univ Technol, Fac Aerosp Engn, NL-2629 HS Delft, Netherlands; [de Pater, Imke] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Sault, R. J.] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; [Butler, Bryan] Natl Radio Astron Observ, Socorro, NM 87801 USA	University of California System; University of California Berkeley; Delft University of Technology; University of Melbourne; National Radio Astronomy Observatory (NRAO)	de Pater, I (corresponding author), Univ Calif Berkeley, Dept Astron, 501 Campbell Hall, Berkeley, CA 94720 USA.; de Pater, I (corresponding author), Delft Univ Technol, Fac Aerosp Engn, NL-2629 HS Delft, Netherlands.; de Pater, I (corresponding author), SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands.	imke@berkeley.edu			NASA Planetary Astronomy (PAST) award [NNX14AJ43G]; NASA Outer Planets Research Program award [NNX11AM55G]	NASA Planetary Astronomy (PAST) award; NASA Outer Planets Research Program award	This research was supported by NASA Planetary Astronomy (PAST) award NNX14AJ43G and NASA Outer Planets Research Program award NNX11AM55G. The National Radio Astronomy Observatory (NRAO) is a facility of NSF operated under cooperative agreement by Associated Universities, Inc. VLA data used in this report, associated with project code 13B-064, are available from the NRAO Science Data Archive at https://archive.nrao.edu/archive/advquery.jsp. Ground-based optical Jupiter maps (8) are available from the Planetary Virtual Observatory & Laboratory (PVOL) website at http://www.pvol.ehu.es/pvol/index.jsp?action=iopw. We thank three anonymous reviewers for their thoughtful comments on this paper.	Asay-Davis XS, 2011, ICARUS, V211, P1215, DOI 10.1016/j.icarus.2010.11.018; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Baines KH, 2002, ICARUS, V159, P74, DOI 10.1006/icar.2002.6901; de Pater I, 2005, ICARUS, V173, P425, DOI 10.1016/j.icarus.2004.06.019; de Pater I, 2001, ICARUS, V149, P66, DOI 10.1006/icar.2000.6527; de Pater I, 2014, ICARUS, V237, P211, DOI 10.1016/j.icarus.2014.02.030; Friedson AJ, 2005, ICARUS, V177, P1, DOI 10.1016/j.icarus.2005.03.004; LINDAL GF, 1992, ASTRON J, V103, P967, DOI 10.1086/116119; Lissauer J.J., 2013, FUNDAMENTAL PLANETAR; Ortiz JL, 1998, J GEOPHYS RES-PLANET, V103, P23051, DOI 10.1029/98JE00696; Perley RA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L1; Sault RJ, 2004, ICARUS, V168, P336, DOI 10.1016/j.icarus.2003.11.014; Showman AP, 2000, SCIENCE, V289, P1737; Showman AP, 2005, ICARUS, V174, P192, DOI 10.1016/j.icarus.2004.10.004; Wong MH, 2015, ICARUS, V245, P273, DOI 10.1016/j.icarus.2014.09.042; Wong MH, 2011, ICARUS, V215, P211, DOI 10.1016/j.icarus.2011.06.032	17	55	55	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1198	1201		10.1126/science.aaf2210	http://dx.doi.org/10.1126/science.aaf2210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257253				2022-12-28	WOS:000377045700037
J	Lonnstedt, OM; Eklov, P				Lonnstedt, Oona M.; Eklov, Peter			RETRACTED: Environmentally relevant concentrations of microplastic particles influence larval fish ecology (Publication with Expression of Concern. See vol. 354, pg. 1242, 2016) (Retracted article. See vol. 358, pg. 1549, 2017)	SCIENCE			English	Article; Retracted Publication							MARINE; RECRUITMENT; BEHAVIOR; SEA; EGG	The widespread occurrence and accumulation of plastic waste in the environment have become a growing global concern over the past decade. Although some marine organisms have been shown to ingest plastic, few studies have investigated the ecological effects of plastic waste on animals. Here we show that exposure to environmentally relevant concentrations of microplastic polystyrene particles (90 micrometers) inhibits hatching, decreases growth rates, and alters feeding preferences and innate behaviors of European perch (Perca fluviatilis) larvae. Furthermore, individuals exposed to microplastics do not respond to olfactory threat cues, which greatly increases predator-induced mortality rates. Our results demonstrate that microplastic particles operate both chemically and physically on larval fish performance and development.	[Lonnstedt, Oona M.; Eklov, Peter] Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden	Uppsala University	Lonnstedt, OM (corresponding author), Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden.	oona.lonnstedt@ebc.uu.se			Uppsala University-Campus Gotland; Swedish Research Council Vetenskapsradet	Uppsala University-Campus Gotland; Swedish Research Council Vetenskapsradet(Swedish Research Council)	This study was financially supported by Uppsala University-Campus Gotland and the Swedish Research Council Vetenskapsradet. All work reported herein was conducted in accordance with the guidelines for the care and use of animals in research of the Swedish Board of Agriculture with approval by the Uppsala University Ethics Committee. We thank A. Nissling, J. Sundin, G. Rosenqvist, M. Cunha, I. Wallin, R. Gydemo, and L. Vallin for logistic support and A. Roswald, I. Lonnstedt, and M. McCormick for comments and statistical advice. The data reported in this paper are archived at the research database at Uppsala University and are also included in the online supplementary materials.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304; [Anonymous], 2013, PLASTICS FACTS 2013; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Browne MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2929; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Chae DH, 2015, ARCH ENVIRON CON TOX, V69, P269, DOI 10.1007/s00244-015-0173-4; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Lonnstedt OM, 2014, J ANIM ECOL, V83, P1178, DOI 10.1111/1365-2656.12209; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Mattsson K, 2015, ENVIRON SCI TECHNOL, V49, P553, DOI 10.1021/es5053655; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Noren F., 2007, KIMO SWEDEN; Noren F., 2014, LANS VASTRA GOTAKAND, V52; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sundblad G, 2014, ICES J MAR SCI, V71, P672, DOI 10.1093/icesjms/fst056; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; TREASURER JW, 1983, ENVIRON BIOL FISH, V8, P3, DOI 10.1007/BF00004941; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031	25	179	210	13	795	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1213	1216		10.1126/science.aad8828	http://dx.doi.org/10.1126/science.aad8828			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257256				2022-12-28	WOS:000377045700041
J	Gong, X; Qian, HW; Zhou, XH; Wu, JP; Wan, T; Cao, PP; Huang, WY; Zhao, X; Wang, XD; Wang, PY; Shi, Y; Gao, GF; Zhou, Q; Yan, N				Gong, Xin; Qian, Hongwu; Zhou, Xinhui; Wu, Jianping; Wan, Tao; Cao, Pingping; Huang, Weiyun; Zhao, Xin; Wang, Xudong; Wang, Peiyi; Shi, Yi; Gao, George F.; Zhou, Qiang; Yan, Nieng			Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection	CELL			English	Article							STEROL-SENSING DOMAIN; CLEAVAGE-ACTIVATING PROTEIN; EM STRUCTURE DETERMINATION; VIRUS ENTRY REQUIRES; COENZYME-A REDUCTASE; DISEASE TYPE-C; CRYO-EM; FILOVIRUS ENTRY; NPC1 PROTEIN; CRYSTAL-STRUCTURE	Niemann-Pick disease type C (NPC) is associated with mutations in NPC1 and NPC2, whose gene products are key players in the endosomal/lysosomal egress of low-density lipoprotein-derived cholesterol. NPC1 is also the intracellular receptor for Ebola virus (EBOV). Here, we present a 4.4 angstrom structure of full-length human NPC1 and a low-resolution reconstruction of NPC1 in complex with the cleaved glycoprotein (GPcl) of EBOV, both determined by single-particle electron cryomicroscopy. NPC1 contains 13 transmembrane segments (TMs) and three distinct lumenal domains A (also designated NTD), C, and I. TMs 2-13 exhibit a typical resistance-nodulation-cell division fold, among which TMs 3-7 constitute the sterol-sensing domain conserved in several proteins involved in cholesterol metabolism and signaling. A trimeric EBOV-GPcl binds to one NPC1 monomer through the domain C. Our structural and biochemical characterizations provide an important framework for mechanistic understanding of NPC1-mediated intracellular cholesterol trafficking and Ebola virus infection.	[Gong, Xin; Qian, Hongwu; Zhou, Xinhui; Wu, Jianping; Cao, Pingping; Huang, Weiyun; Zhao, Xin; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Gong, Xin; Qian, Hongwu; Zhou, Xinhui; Wu, Jianping; Cao, Pingping; Huang, Weiyun; Zhao, Xin; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Gong, Xin; Qian, Hongwu; Zhou, Xinhui; Wu, Jianping; Cao, Pingping; Huang, Weiyun; Zhao, Xin; Zhou, Qiang; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wan, Tao; Wang, Xudong; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing 100101, Peoples R China; [Wang, Peiyi] Univ Leeds, Sch Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Leeds; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Q; Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Zhou, Q; Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Zhou, Q; Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.	zhouqiang00@tsinghua.org.cn; nyan@tsinghua.edu.cn	Gong, Xin/W-6531-2018; Gao, George Fu/ABD-5229-2021; Wan, Tao/AAE-9290-2022; Qian, Hongwu/AAL-7468-2021	Wan, Tao/0000-0003-1833-2540; 	Ministry of Science and Technology of China [2015CB9101012014, ZX09507003006]; National Natural Science Foundation of China [31321062, 81590761]; special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020100]; International Early Career Scientist grant from the Howard Hughes Medical Institute; endowed professorship from Bayer Healthcare	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); endowed professorship from Bayer Healthcare	We thank Jianlin Lei, Yanji Xu, and Xiaomei Li for technical support. We thank Xueming Li and Mingxu Hu for critical discussions. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB9101012014, ZX09507003006), National Natural Science Foundation of China (project 31321062 and 81590761), the special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences, and Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020100). The research of Nieng Yan was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; DeLano W.L, PYMOL MOL GRAPHICS S; Delmar JA, 2014, ANNU REV BIOPHYS, V43, P93, DOI 10.1146/annurev-biophys-051013-022855; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Eicher T, 2014, ELIFE, V3, DOI 10.7554/eLife.03145; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hofmann-Winkler H, 2012, VIRUSES-BASEL, V4, P3336, DOI 10.3390/v4123336; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hunt CL, 2012, VIRUSES-BASEL, V4, P258, DOI 10.3390/v4020258; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Krishnan A, 2012, VIRUSES-BASEL, V4, P2471, DOI 10.3390/v4112471; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; LUSKEY KL, 1985, J BIOL CHEM, V260, P271; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Pak JE, 2013, P NATL ACAD SCI USA, V110, P18484, DOI 10.1073/pnas.1318705110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Venter H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00377; [王寒 Wang Han], 2015, [科学通报, Chinese Science Bulletin], V60, P3438; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; White JM, 2012, NAT REV MICROBIOL, V10, P317, DOI 10.1038/nrmicro2764; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yamaguchi A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00327; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao YG, 2016, FEBS LETT, V590, P605, DOI 10.1002/1873-3468.12089	70	198	205	5	107	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1467	1478		10.1016/j.cell.2016.05.022	http://dx.doi.org/10.1016/j.cell.2016.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27238017	Green Published, Bronze			2022-12-28	WOS:000377045400019
J	Gulland, A				Gulland, Anne			What would the NHS look like if the UK left the EU?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						[Anonymous], 2016, EU REF BREX COULD DA; General Medical Council, LIST REG MED PRACT S; Gulland A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3094; Institute for Fiscal Studies, 2016, BREX UKS PUBL FIN; McKee M, 2016, COUNTERING BREXIT MY; O'Dowd A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2904; ODOWD A, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I2015; Vote Leave, 2016, M GOV FACTS LIF SAY	8	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3027	10.1136/bmj.i3027	http://dx.doi.org/10.1136/bmj.i3027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27256368				2022-12-28	WOS:000377479000003
J	Koh, A; De Vadder, F; Kovatcheva-Datchary, P; Backhed, F				Koh, Ara; De Vadder, Filipe; Kovatcheva-Datchary, Petia; Backhed, Fredrik			From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites	CELL			English	Review							PROTEIN-COUPLED RECEPTOR; BUTYRATE-PRODUCING BACTERIA; GLUCAGON-LIKE PEPTIDE-1; GUT MICROBIOTA; SODIUM-BUTYRATE; NICOTINIC-ACID; FERMENTATION; PROPIONATE; COLON; ACETATE	A compelling set of links between the composition of the gut microbiota, the host diet, and host physiology has emerged. Do these links reflect cause-and-effect relationships, and what might be their mechanistic basis? A growing body of work implicates microbially produced metabolites as crucial executors of diet-based microbial influence on the host. Here, we will review data supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs). SCFAs can directly activate G-coupled-receptors, inhibit histone deacetylases, and serve as energy substrates. They thus affect various physiological processes and may contribute to health and disease.	[Koh, Ara; De Vadder, Filipe; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Koh, Ara; De Vadder, Filipe; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med, S-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Wallenberg Lab, S-41345 Gothenburg, Sweden.; Backhed, F (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med, S-41345 Gothenburg, Sweden.; Backhed, F (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark.	fredrik@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818; De Vadder, Filipe/0000-0001-9195-5344; Koh, Ara/0000-0001-7673-034X	Swedish Research Council; NovoNordisk foundation; Torsten Soderberg's foundation; Swedish Heart Lung Foundation; Goran Gustafsson's foundation; IngaBritt och Arne Lund-bergs Foundation; Knut and Alice Wallenberg Foundation; FP7 sponsored program METACARDIS; Region Vastra Gotaland; Sahlgrenska University Hospital; ERC Consolidator Grant (European Research Council) [615362-METABASE]; EMBO [ALTF 1305-2014, GA-2013-609409]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0008163] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk foundation(Novo Nordisk Foundation); Torsten Soderberg's foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Goran Gustafsson's foundation; IngaBritt och Arne Lund-bergs Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); FP7 sponsored program METACARDIS; Region Vastra Gotaland; Sahlgrenska University Hospital; ERC Consolidator Grant (European Research Council)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Eun Byul Koh for assistance with figures and artwork. Work in the authors' laboratory is supported by the Swedish Research Council, the NovoNordisk foundation, Torsten Soderberg's foundation, Swedish Heart Lung Foundation, Goran Gustafsson's foundation, IngaBritt och Arne Lund-bergs Foundation, Knut and Alice Wallenberg Foundation, the FP7 sponsored program METACARDIS, and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital. F.B. is a recipient of an ERC Consolidator Grant (European Research Council, consolidator grant 615362-METABASE). F.D.V. is a recipient of EMBO long-term fellowship ALTF 1305-2014 (Marie Curie Actions LTFCOFUND2013, GA-2013-609409). F.B. is founder and shareholder of Metabogen AB.	Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; De Vadder F, 2015, NEUROGASTROENT MOTIL, V27, P443, DOI 10.1111/nmo.12508; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garrote GL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00629; Haraguchi T, 2014, J AGR FOOD CHEM, V62, P5589, DOI 10.1021/jf501142k; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Hurst NR, 2014, NEUROGASTROENT MOTIL, V26, P1586, DOI 10.1111/nmo.12425; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MEIJERSEVERS GJ, 1987, SCAND J GASTROENTERO, V22, P672, DOI 10.3109/00365528709011141; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nohr MK, 2015, NEUROSCIENCE, V290, P126, DOI 10.1016/j.neuroscience.2015.01.040; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sanchez JI, 2009, MICROB BIOTECHNOL, V2, P101, DOI 10.1111/j.1751-7915.2008.00064.x; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Singh N, 2010, J BIOL CHEM, V285, P27601, DOI 10.1074/jbc.M110.102947; Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VENTER CS, 1990, AM J GASTROENTEROL, V85, P549; VIDELA S, 1994, GUT, V35, P1090, DOI 10.1136/gut.35.8.1090; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Yajima T, 2011, J PHYSIOL-LONDON, V589, P953, DOI 10.1113/jphysiol.2010.199976; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yoo DY, 2011, NEUROCHEM RES, V36, P1850, DOI 10.1007/s11064-011-0503-5; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012	100	2494	2642	115	853	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1332	1345		10.1016/j.cell.2016.05.041	http://dx.doi.org/10.1016/j.cell.2016.05.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259147	Bronze			2022-12-28	WOS:000377045400009
J	Lymer, S; Blau, J				Lymer, Seana; Blau, Justin			Do Flies Count Sheep or NMDA Receptors to Go to Sleep?	CELL			English	Editorial Material							DROSOPHILA; WAKEFULNESS; WAKING	The drive to sleep increases the longer that we stay awake, but this process is poorly understood at the cellular level. Now, Liu et al. show that the plasticity of a small group of neurons in the Drosophila central brain is a key component of the sleep homeostat.	[Lymer, Seana; Blau, Justin] NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA; [Blau, Justin] New York Univ, Ctr Genom & Syst Biol, Abu Dhabi Inst, Abu Dhabi, U Arab Emirates; [Blau, Justin] New York Univ Abu Dhabi, Program Biol, Abu Dhabi, U Arab Emirates	New York University	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.; Blau, J (corresponding author), New York Univ, Ctr Genom & Syst Biol, Abu Dhabi Inst, Abu Dhabi, U Arab Emirates.; Blau, J (corresponding author), New York Univ Abu Dhabi, Program Biol, Abu Dhabi, U Arab Emirates.	justin.blau@nyu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063911] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borbely A A, 1982, Hum Neurobiol, V1, P195; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Liu S, 2016, CELL, V165, P1347, DOI 10.1016/j.cell.2016.04.013; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834	9	0	0	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1310	1311		10.1016/j.cell.2016.05.059	http://dx.doi.org/10.1016/j.cell.2016.05.059			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259141	Bronze			2022-12-28	WOS:000377045400003
J	Mansoor, AM; Sullivan, PD				Mansoor, Andre M.; Sullivan, Peter D.			Intrafacial Synkinesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mansoor, Andre M.; Sullivan, Peter D.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Mansoor, AM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	mansooan@ohsu.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					E27	E27		10.1056/NEJMicm1507967	http://dx.doi.org/10.1056/NEJMicm1507967			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248646				2022-12-28	WOS:000387209900010
J	Sham, LJ				Sham, Lu J.			Walter Kohn (1923-2016) OBITUARY	NATURE			English	Biographical-Item									[Sham, Lu J.] Univ Calif San Diego, Phys, San Diego, CA 92103 USA	University of California System; University of California San Diego	Sham, LJ (corresponding author), Univ Calif San Diego, Phys, San Diego, CA 92103 USA.	lsham@ucsd.edu						KOHN W, PUBLICATION LIST	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					38	38		10.1038/534038a	http://dx.doi.org/10.1038/534038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251269	Bronze			2022-12-28	WOS:000376962300025
J	Shin, JY; Roughead, EE; Park, BJ; Pratt, NL				Shin, Ju-Young; Roughead, Elizabeth E.; Park, Byung-Joo; Pratt, Nicole L.			Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NERVOUS-SYSTEM STIMULANTS; AMBULATORY BLOOD-PRESSURE; RISK; EVENTS; ADOLESCENTS; MEDICATIONS; DESIGNS; DRUGS; DEATH	OBJECTIVE To determine whether treatment with methylphenidate in children and young people with attention-deficit/hyperactivity disorder (ADHD) was associated with cardiovascular events. DESIGN Self controlled case series analysis. SETTING Nationwide health insurance database, 1 January 2008 to 31 December 2011, in South Korea. PARTICIPANTS 1224 patients aged <= 17 who had experienced an incident cardiovascular event and had had at least one incident prescription for methylphenidate. MAIN OUTCOME MEASURES A recorded diagnosis (either a primary or secondary cause) of any of the following cardiovascular adverse events: arrhythmias (ICD-10 (international classification of diseases, 10th revision) codes I44, I45, I47, I48, I49), hypertension (codes I10-I15), myocardial infarction (code I21), ischemic stroke (code I63), or heart failure (code I50). Incidence rate ratios were calculated with conditional Poisson regression and adjusted for time varying comorbidity and comedication. RESULTS Increased risk of arrhythmia was observed in all exposed time periods-that is, periods of treatment with methylphenidate-(incidence rate ratio 1.61, 95% confidence interval 1.48 to 1.74), and the risk was highest in the children who had congenital heart disease. No significant risk of myocardial infarction was observed for all exposed time periods (1.33, 0.90 to 1.98), though risk was higher in the early risk periods between eight and 56 days after the start of treatment with methylphenidate. No significant increased risk was observed for hypertension, ischemic stroke, or heart failure. CONCLUSION The relative risk of myocardial infarction and arrhythmias is increased in the early period after the start of methylphenidate treatment for ADHD in children and young people. Though the absolute risk is likely to be low, the risk-benefit balance of methylphenidate should be carefully considered, particularly in children with mild ADHD.	[Shin, Ju-Young] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Shin, Ju-Young] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Shin, Ju-Young] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Shin, Ju-Young] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Roughead, Elizabeth E.; Pratt, Nicole L.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	McGill University; McGill University; McGill University; McGill University; University of South Australia; Seoul National University (SNU)	Pratt, NL (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	Nicole.Pratt@unisa.edu.au	Pratt, Nicole L/A-1348-2011; Roughead, Elizabeth E/G-4431-2010	Pratt, Nicole L/0000-0001-8730-8910; Roughead, Elizabeth E/0000-0002-6811-8991; Shin, Ju-Young/0000-0003-1010-7525	NHMRC [GNT1110139, GNT1035889]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. EER was supported by an NHMRC fellowship (GNT1110139). NP was supported by an NHMRC early career fellowship (GNT1035889).	Bange F, 2014, ARCH PEDIATRIE, V21, P108, DOI 10.1016/j.arcped.2013.11.001; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Douglas IJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1936; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Gould MS, 2009, AM J PSYCHIAT, V166, P992, DOI 10.1176/appi.ajp.2009.09040472; Hallas J, 2014, J INTERN MED, V275, P581, DOI 10.1111/joim.12186; Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10; Kraut AA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-11; Maclure M, 2007, PHARMACOEPIDEM DR S, V16, P850, DOI 10.1002/pds.1438; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; Martinez-Raga J, 2013, CNS DRUGS, V27, P15, DOI 10.1007/s40263-012-0019-9; Munk K, 2015, CASE REP PEDIAT, V2015, DOI 10.1155/2015/905097; Murray-Thomas Tarita, 2013, Cardiovasc Psychiatry Neurol, V2013, P247486, DOI 10.1155/2013/247486; Park B., 2003, REPORT EVALUATION VA, P19; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Pratt NL, 2014, DRUG SAFETY, V37, P1021, DOI 10.1007/s40264-014-0231-2; Ramsay EN, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-82; Samuels JA, 2006, PEDIATR NEPHROL, V21, P92, DOI 10.1007/s00467-005-2051-1; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Shin JY, 2015, REGUL TOXICOL PHARM, V72, P244, DOI 10.1016/j.yrtph.2015.04.022; Stowe CD, 2002, ANN PHARMACOTHER, V36, P1142, DOI 10.1345/aph.1A367; Swenson JR, 2006, CAN J PSYCHIAT, V51, P923, DOI 10.1177/070674370605101408; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; Westover AN, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-41; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Wikstrom Gerhard, 2012, Lakartidningen, V109, P2016; Winterstein AG, 2007, PEDIATRICS, V120, pE1494, DOI 10.1542/peds.2007-0675; Winterstein AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4627	30	70	72	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i2550	10.1136/bmj.i2550	http://dx.doi.org/10.1136/bmj.i2550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27245699	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000377477500001
J	Haines, IE; Ablin, RJ; Miklos, GLG				Haines, Ian E.; Ablin, Richard J.; Miklos, George L. Gabor			Screening for prostate cancer: time to put all the data on the table	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; ACCESS; NEED		[Haines, Ian E.] Cabrini Med Ctr, Melbourne Oncol Grp, Malvern 3144, Australia; [Haines, Ian E.] Monash Univ, AMREP Dept Med, Clayton, Vic 3800, Australia; [Ablin, Richard J.] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85721 USA; [Ablin, Richard J.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Ablin, Richard J.] BIO5 Inst, Tucson, AZ USA; [Miklos, George L. Gabor] Atom Oncol, Newport, NSW 2106, Australia	Cabrini Health; Monash University; University of Arizona; Arizona Center Cancer Care; University of Arizona	Haines, IE (corresponding author), Cabrini Med Ctr, Melbourne Oncol Grp, Malvern 3144, Australia.; Haines, IE (corresponding author), Monash Univ, AMREP Dept Med, Clayton, Vic 3800, Australia.	ian.haines@monash.edu						Ablin RJ, 2014, NY TIMES; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Australian Institute of Health and Welfare, 2013, PROSTRATE CANCER IN; Barbour V, 2015, THE CONVERSATION; Bonini S, 2014, NEW ENGL J MED, V371, P2452, DOI 10.1056/NEJMp1409464; Brawley OW, 2013, JNCI-J NATL CANCER I, V105, P1522, DOI 10.1093/jnci/djt266; Carlsson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2296; Centers for Disease Control and Prevention, 2011, DEATH IN THE UNITED; European Medicines Agency, 2014, POLICY ON PUBLICATIO; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Haines I, 2015, LANCET, V385, P1506, DOI 10.1016/S0140-6736(15)60747-4; Haines IE, 2013, JNCI-J NATL CANCER I, V105, P1534, DOI 10.1093/jnci/djt248; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V312, P1002, DOI 10.1001/jama.2014.9647; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Cancer Institute, SEER STAT FACT SHEET; National Cancer Institute, CANCER DATA ACCESS S; National Health and Medical Research Council, 2014, PSA TESTING FOR PROS; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder F, 2015, LANCET, V385, P1507, DOI 10.1016/S0140-6736(15)60749-8; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Urological Society of Australia and New Zealand, 2009, PSA TESTING POLICY; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; World Health Organization, WHO STATEMENT ON PUB	26	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2016	353								i2574	10.1136/bmj.i2574	http://dx.doi.org/10.1136/bmj.i2574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CG	27226459				2022-12-28	WOS:000376939400001
J	Wanner, C; Amann, K; Shoji, T				Wanner, Christoph; Amann, Kerstin; Shoji, Tetsuo			The heart and vascular system in dialysis	LANCET			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; CALCIFICATION PROPENSITY; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; HEMODIALYSIS-PATIENTS	The heart and the vascular tree undergo major structural and functional changes when kidney function declines and renal replacement therapy is required. The many cardiovascular risk factors and adaptive changes the heart undergoes include left ventricular hypertrophy and dilatation with concomitant systolic and diastolic dysfunction. Myocardial fibrosis is the consequence of impaired angio-adaptation, reduced capillary angiogenesis, myocyte-capillary mismatch, and myocardial micro-arteriopathy. The vascular tree can be affected by both atherosclerosis and arteriosclerosis with both lipid rich plaques and abundant media calcification. Development of cardiac and vascular disease is rapid, especially in young patients, and the phenotype resembles all aspects of an accelerated ageing process and latent cardiac failure. The major cause of left ventricular hypertrophy and failure and the most common problem directly affecting myocardial function is fluid overload and, usually, hypertension. In situations of stress, such as intradialytic hypotension and hypoxaemia, the hearts of these patients are more vulnerable to developing cardiac arrest, especially when such episodes occur frequently. As a result, cardiac and vascular mortality are several times higher in dialysis patients than in the general population. Trials investigating one pharmacological intervention (eg, statins) have shown limitations. Pragmatic designs for large trials on cardio-active interventions are mandatory for adequate cardioprotective renal replacement therapy.	[Wanner, Christoph] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Wanner, Christoph] Univ Hosp Wurzburg, Div Renal, Wurzburg, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Dept Pathol, Erlangen, Germany; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka, Japan	University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg; Osaka Metropolitan University	Wanner, C (corresponding author), Med Univ Klin, D-97080 Wurzburg, Germany.	wanner_c@ukw.de			German Research Foundation (Deutsche Forschungsgemeinschaft) [AM 93/12-1]; Bundesministerium fur Bildung und Forschung [BMFBF01 EO1004]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft; grant AM 93/12-1) and by the Bundesministerium fur Bildung und Forschung (BMFBF01 EO1004). We thank Nathan Levin for his advice.	Agarwal R, 2014, NEPHROL DIAL TRANSPL, V29, P672, DOI 10.1093/ndt/gft515; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amann K, 2011, AM J PHYSIOL-RENAL, V300, pF105, DOI 10.1152/ajprenal.00363.2010; Amann K, 2003, KIDNEY INT, V63, P1708, DOI 10.1046/j.1523-1755.2003.00927.x; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Amann K, 2006, J AM SOC NEPHROL, V17, P2112, DOI 10.1681/ASN.2006030204; Arismendi-Morillo G, 2010, ULTRASTRUCT PATHOL, V34, P214, DOI 10.3109/01913121003743690; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC; Chang AR, 2014, AM J KIDNEY DIS, V64, P567, DOI 10.1053/j.ajkd.2014.04.028; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; Cice G, 2001, J AM COLL CARDIOL, V37, P407, DOI 10.1016/S0735-1097(00)01158-X; Davison SN, 2015, KIDNEY INT, V88, P447, DOI 10.1038/ki.2015.110; de Bie MK, 2009, EUR HEART J, V30, P1559, DOI 10.1093/eurheartj/ehp185; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Di Marco GS, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0487-4; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Dikow R, 2004, J AM SOC NEPHROL, V15, P1530, DOI 10.1097/01.ASN.0000130154.42061.C6; Drechsler C, 2015, KIDNEY INT, V87, P1201, DOI 10.1038/ki.2014.429; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Flisinski M, 2012, KIDNEY BLOOD PRESS R, V35, P608, DOI 10.1159/000339706; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Hase H, 2006, KIDNEY INT, V70, P1142, DOI 10.1038/sj.ki.5001726; Hothi DK, 2009, CLIN J AM SOC NEPHRO, V4, P790, DOI 10.2215/CJN.05921108; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Iseki K, 2000, AM J KIDNEY DIS, V36, P820, DOI 10.1053/ajkd.2000.17676; Issa N, 2008, TRANSPLANTATION, V86, P1384, DOI 10.1097/TP.0b013e318188d640; Iwasaki M, 2014, J ATHEROSCLER THROMB, V21, P593; Ix JH, 2003, J AM SOC NEPHROL, V14, P3233, DOI 10.1097/01.ASN.0000095642.25603.7A; Jacobi J, 2006, KIDNEY INT, V69, P2013, DOI 10.1038/sj.ki.5000448; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Jefferies HJ, 2011, CLIN J AM SOC NEPHRO, V6, P1326, DOI 10.2215/CJN.05200610; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Keyzer CA, 2016, J AM SOC NEPHROL, V27, P239, DOI 10.1681/ASN.2014070670; Kooman JP, 2017, EXP GERONTOL, V87, P156, DOI 10.1016/j.exger.2016.02.003; Kopecky C, 2015, CLIN J AM SOC NEPHRO, V10, P224, DOI 10.2215/CJN.06560714; Kovesdy CP, 2008, KIDNEY INT, V73, P1355, DOI 10.1038/ki.2008.35; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Levin A, 2014, NEPHROL DIAL TRANSPL, V29, P1037, DOI 10.1093/ndt/gft479; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Levin NW, 2011, CURR OPIN NEPHROL HY, V20, P577, DOI 10.1097/MNH.0b013e32834bbae1; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Litwin M, 2005, J AM SOC NEPHROL, V16, P1494, DOI 10.1681/ASN.2004110932; London GM, 2016, J AM SOC NEPHROL, V27, P1837, DOI 10.1681/ASN.2015060617; Maggiore Q, 2002, AM J KIDNEY DIS, V40, P280, DOI 10.1053/ajkd.2002.34506; Matsui M, 2014, KIDNEY INT, V85, P393, DOI 10.1038/ki.2013.339; Meyring-Wosten A, 2016, CLIN J AM SOC NEPHRO, V11, P616, DOI 10.2215/CJN.08510815; Nishizawa Y, 2001, AM J KIDNEY DIS, V38, pS4, DOI 10.1053/ajkd.2001.27380; O'Hare AM, 2005, J AM SOC NEPHROL, V16, P514, DOI 10.1681/ASN.2004050409; Obi Y, 2016, AM J KIDNEY DIS, V68, P256, DOI 10.1053/j.ajkd.2016.01.008; Odudu A, 2015, CLIN J AM SOC NEPHRO, V10, P1408, DOI 10.2215/CJN.00200115; Ok E, 2016, LANCET, V388, P285, DOI 10.1016/S0140-6736(16)30389-0; Ortiz A, 2014, LANCET, V383, P1831, DOI 10.1016/S0140-6736(14)60384-6; Pabst S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035310; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Parfrey PS, 1996, NEPHROL DIAL TRANSPL, V11, P1277; Pinkau T, 2004, J AM SOC NEPHROL, V15, P517, DOI 10.1097/01.ASN.0000107565.17553.71; Raschenberger J, 2015, ATHEROSCLEROSIS, V242, P529, DOI 10.1016/j.atherosclerosis.2015.08.020; Rigatto C, 2009, CLIN J AM SOC NEPHRO, V4, P291, DOI 10.2215/CJN.01840408; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shoji T, 2013, AM J KIDNEY DIS, V62, P568, DOI 10.1053/j.ajkd.2013.02.362; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; Silbernagel G, 2015, J AM COLL CARDIOL, V65, P2291, DOI 10.1016/j.jacc.2015.03.551; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sise ME, 2013, KIDNEY INT, V84, P682, DOI 10.1038/ki.2013.186; Smith ER, 2014, J AM SOC NEPHROL, V25, P339, DOI 10.1681/ASN.2013060635; Smith GL, 2008, J AM SOC NEPHROL, V19, P141, DOI 10.1681/ASN.2007050554; Soriano S, 2014, AM J PHYSIOL-RENAL, V307, pF1302, DOI 10.1152/ajprenal.00114.2014; Speer T, 2013, NEPHROL DIAL TRANSPL, V28, P2456, DOI 10.1093/ndt/gft080; Stewart J, 2004, AM J PHYSIOL-HEART C, V287, pH2687, DOI 10.1152/ajpheart.00287.2004; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Svensson M, 2006, CLIN J AM SOC NEPHRO, V1, P780, DOI 10.2215/CJN.00630206; Tonelli M, 2013, J AM SOC NEPHROL, V24, P979, DOI 10.1681/ASN.2012080870; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wetmore JB, 2012, NEPHRON CLIN PRACT, V122, P9, DOI 10.1159/000347143; Wiley LA, 2006, INVEST OPHTH VIS SCI, V47, P439, DOI 10.1167/iovs.05-0656; Zewinger S, 2015, EUR HEART J, V36, P3007, DOI 10.1093/eurheartj/ehv352; Zoccali C, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133729; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60; Zoccali C, 2001, J HYPERTENS, V19, P287, DOI 10.1097/00004872-200102000-00016	89	160	168	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					276	284		10.1016/S0140-6736(16)30508-6	http://dx.doi.org/10.1016/S0140-6736(16)30508-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27226133				2022-12-28	WOS:000379736100032
J	Sannerud, R; Esselens, C; Ejsmont, P; Mattera, R; Rochin, L; Tharkeshwar, AK; De Baets, G; De Wever, V; Habets, R; Baert, V; Vermeire, W; Michiels, C; Groot, AJ; Wouters, R; Dillen, K; Vints, K; Baatsen, P; Munck, S; Derua, R; Waelkens, E; Basi, GS; Mercken, M; Vooijs, M; Bollen, M; Schymkowitz, J; Rousseau, F; Bonifacino, JS; Van Niel, G; De Strooper, B; Annaert, W				Sannerud, Ragna; Esselens, Cary; Ejsmont, Paulina; Mattera, Rafael; Rochin, Leila; Tharkeshwar, Arun Kumar; De Baets, Greet; De Wever, Veerle; Habets, Roger; Baert, Veerle; Vermeire, Wendy; Michiels, Christine; Groot, Arjan J.; Wouters, Rosanne; Dillen, Katleen; Vints, Katlijn; Baatsen, Pieter; Munck, Sebastian; Derua, Rita; Waelkens, Etienne; Basi, Guriqbal S.; Mercken, Mark; Vooijs, Marc; Bollen, Mathieu; Schymkowitz, Joost; Rousseau, Frederic; Bonifacino, Juan S.; Van Niel, Guillaume; De Strooper, Bart; Annaert, Wim			Restricted Location of PSEN2/gamma-Secretase Determines Substrate Specificity and Generates an Intracellular A beta Pool	CELL			English	Article							GAMMA-SECRETASE ACTIVITY; LYSOSOMAL MEMBRANE-PROTEINS; ALZHEIMERS-DISEASE; ENDOSOMAL DYSFUNCTION; AMYLOID ACCUMULATION; FORCE-FIELD; LOCALIZATION; PRESENILINS; MUTATIONS; MECHANISM	gamma-Secretases are a family of intramembrane-cleaving proteases involved in various signaling pathways and diseases, including Alzheimer's disease (AD). Cells co-express differing gamma-secretase complexes, including two homologous presenilins (PSENs). We examined the significance of this heterogeneity and identified a unique motif in PSEN2 that directs this gamma-secretase to late endosomes/lysosomes via a phosphorylation-dependent interaction with the AP-1 adaptor complex. Accordingly, PSEN2 selectively cleaves late endosomal/lysosomal localized substrates and generates the prominent pool of intracellular A beta that contains longer A beta; familial AD (FAD)-associated mutations in PSEN2 increased the levels of longer A beta further. Moreover, a subset of FAD mutants in PSEN1, normally more broadly distributed in the cell, phenocopies PSEN2 and shifts its localization to late endosomes/lysosomes. Thus, localization of gamma-secretases determines substrate specificity, while FAD-causing mutations strongly enhance accumulation of aggregation-prone A beta 42 in intracellular acidic compartments. The findings reveal potentially important roles for specific intracellular, localized reactions contributing to AD pathogenesis.	[Sannerud, Ragna; Esselens, Cary; Ejsmont, Paulina; Tharkeshwar, Arun Kumar; Baert, Veerle; Vermeire, Wendy; Michiels, Christine; Wouters, Rosanne; Dillen, Katleen; De Strooper, Bart; Annaert, Wim] Katholieke Univ Leuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Sannerud, Ragna; Esselens, Cary; Ejsmont, Paulina; Tharkeshwar, Arun Kumar; Baert, Veerle; Vermeire, Wendy; Michiels, Christine; Wouters, Rosanne; Dillen, Katleen; De Strooper, Bart; Annaert, Wim] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Mattera, Rafael; Bonifacino, Juan S.] NICHD, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA; [Rochin, Leila; Van Niel, Guillaume] PSL Res Univ, CNRS, Inst Curie, UMR 144, F-75005 Paris, France; [Rochin, Leila; Van Niel, Guillaume] CNRS, UMR 144, F-75005 Paris, France; [De Baets, Greet; Schymkowitz, Joost; Rousseau, Frederic] Katholieke Univ Leuven, VIB Switch Lab, B-3000 Louvain, Belgium; [De Baets, Greet; De Wever, Veerle; Derua, Rita; Waelkens, Etienne; Bollen, Mathieu; Schymkowitz, Joost; Rousseau, Frederic] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Groot, Arjan J.; Vooijs, Marc] Maastricht Univ, Dept Radiotherapy MAASTRO GROW, NL-6211 Maastricht, Netherlands; [Vints, Katlijn; Baatsen, Pieter; Munck, Sebastian] VIB BioImaging Core, B-3000 Louvain, Belgium; [Basi, Guriqbal S.] Avalanche Biotechnol, Menlo Pk, CA 94025 USA; [Mercken, Mark] Janssen Pharmaceut, B-2340 Beerse, Belgium; [De Strooper, Bart] UCL Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Maastricht University; Flanders Institute for Biotechnology (VIB); Johnson & Johnson; Janssen Pharmaceuticals; University of London; University College London	Annaert, W (corresponding author), Katholieke Univ Leuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium.; Annaert, W (corresponding author), Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium.	wim.annaert@cme.vib-kuleuven.be	Sannerud, Ragna/AAA-6497-2021; van Niel, Guillaume/HCI-8445-2022; Schymkowitz, Joost/AAV-3680-2021; Vooijs, Marc/K-3522-2019; Rousseau, Frederic/J-9044-2016; de+Strooper, Bart/Z-1638-2019; van Niel, Guillaume/A-6585-2011; Tharkeshwar Raghunath, Arunkumar/AGW-1110-2022; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; van Niel, Guillaume/0000-0002-8651-9705; Tharkeshwar Raghunath, Arunkumar/0000-0002-5529-9754; Schymkowitz, Joost/0000-0003-2020-0168; Sannerud, Ragna/0000-0002-6694-3154; Esselens, Cary/0000-0001-8876-634X; Bonifacino, Juan S./0000-0002-5673-6370; Wouters, Rosanne/0000-0001-7398-0351; Munck, Sebastian/0000-0002-5182-5358; Vints, Katlijn/0000-0002-2893-752X	VIB; KU Leuven [C16/15/073, IDO/12/020]; federal government [IAP P7/16]; Hercules [AKUL/09/037, 11/30, 13/39]; SAO [14017]; Alzheimer's Association [IIRG-08-91535]; NICHD Intramural Program [ZIA HD001607]; IWT; EU-ERC [208259]; "Fondation ARC" [DOC20130606986, PJA20131200286]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER	VIB; KU Leuven(KU Leuven); federal government; Hercules; SAO; Alzheimer's Association(Alzheimer's Association); NICHD Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EU-ERC(European Research Council (ERC)European Commission); "Fondation ARC"; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was from VIB (W.A., B.D.S., F.R., and J.S.), KU Leuven (C16/15/073 and IDO/12/020 to W.A.), the federal government (IAP P7/16: W.A., B.D.S., F.R., and J.S.), Hercules (AKUL/09/037, 11/30, 13/39 to W.A.), SAO (S#14017 to W.A.), the Alzheimer's Association (IIRG-08-91535 to W.A.), and the NICHD Intramural Program (ZIA HD001607 to J.S.B.). A.K.T. and G.D.B. held PhD fellowships from VIB and IWT. We thank K. Ivanova for initial FP-PSEN rescue. P.E. was a Marie-Curie postdoc, and R.W. is an FWO fellow. A.G., R.H., and M.V. are supported by EU-ERC (208259); L.R. and G.V.N. are supported by "Fondation ARC" (no. DOC20130606986 and # PJA20131200286). We thank PICT-IBiSA (Institut Curie) and France-Bio-Imaging (ANR-10-INSB-04).	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Bayer TA, 2011, BIOCHEM SOC T, V39, P857, DOI 10.1042/BST0390857; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Canevelli M, 2014, NEUROSCI BIOBEHAV R, V42, P170, DOI 10.1016/j.neubiorev.2014.02.010; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takitoh T, 2012, J NEUROSCI, V32, P11050, DOI 10.1523/JNEUROSCI.5664-11.2012; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	51	179	182	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					193	208		10.1016/j.cell.2016.05.020	http://dx.doi.org/10.1016/j.cell.2016.05.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27293189	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000380254400021
J	Schine, N; Ryou, A; Gromov, A; Sommer, A; Simon, J				Schine, Nathan; Ryou, Albert; Gromov, Andrey; Sommer, Ariel; Simon, Jonathan			Synthetic Landau levels for photons	NATURE			English	Article								Synthetic photonic materials are an emerging platform for exploring the interface between microscopic quantum dynamics and macroscopic material properties(1-5). Photons experiencing a Lorentz force develop handedness, providing opportunities to study quantum Hall physics and topological quantum science(6-8). Here we present an experimental realization of a magnetic field for continuum photons. We trap optical photons in a multimode ring resonator to make a two-dimensional gas of massive bosons, and then employ a non-planar geometry to induce an image rotation on each round-trip(9). This results in photonic Coriolis/Lorentz and centrifugal forces and so realizes the Fock-Darwin Hamiltonian for photons in a magnetic field and harmonic trap(10). Using spatial-and energy-resolved spectroscopy, we track the resulting photonic eigenstates as radial trapping is reduced, finally observing a photonic Landau level at degeneracy. To circumvent the challenge of trap instability at the centrifugal limit(10,11), we constrain the photons to move on a cone. Spectroscopic probes demonstrate flat space (zero curvature) away from the cone tip. At the cone tip, we observe that spatial curvature increases the local density of states, and we measure fractional state number excess consistent with the Wen-Zee theory, providing an experimental test of this theory of electrons in both a magnetic field and curved space(12-15). This work opens the door to exploration of the interplay of geometry and topology, and in conjunction with Rydberg electromagnetically induced transparency, enables studies of photonic fractional quantum Hall fluids(16,17) and direct detection of anyons(18,19).	[Schine, Nathan; Ryou, Albert; Sommer, Ariel; Simon, Jonathan] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Schine, Nathan; Ryou, Albert; Sommer, Ariel; Simon, Jonathan] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Gromov, Andrey] Univ Chicago, Kadanoff Ctr Theoret Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Simon, J (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.; Simon, J (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	simonjon@uchicago.edu		Sommer, Ariel/0000-0003-3390-4455; Simon, Jonathan/0000-0001-7854-4647; Schine, Nathan/0000-0001-5903-3200	DOE; DARPA; AFOSR; Kadanoff Center for Theoretical Physics; ARO through an NDSEG fellowship	DOE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Kadanoff Center for Theoretical Physics; ARO through an NDSEG fellowship	We acknowledge conversations with I. Carusotto, M. Levin and P Wiegmann. This work was supported by DOE, DARPA and AFOSR. A.G. acknowledges the support of the Kadanoff Center for Theoretical Physics. A.R. acknowledges support from ARO through an NDSEG fellowship.	Abanov AG, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014435; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Cooper NR, 2008, ADV PHYS, V57, P539, DOI 10.1080/00018730802564122; Cooper NR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185301; Gopalakrishnan S, 2009, NAT PHYS, V5, P845, DOI 10.1038/NPHYS1403; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hoyos C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.066805; Jia N., 2015, PHYS REV X, V5; Karzig T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031001; Klaers J, 2010, NATURE, V468, P545, DOI 10.1038/nature09567; Longhi S, 2015, OPT LETT, V40, P2941, DOI 10.1364/OL.40.002941; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Otterbach J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.033903; Paredes B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010402; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Read N, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045308; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Rechtsman MC, 2013, NAT PHOTONICS, V7, P153, DOI [10.1038/NPHOTON.2012.302, 10.1038/nphoton.2012.302]; Schweikhard V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040404; Sommer A., 2015, PREPRINT; Sommer A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/3/035008; Umucalilar RO, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023803; Umucalilar RO, 2013, PHYS LETT A, V377, P2074, DOI 10.1016/j.physleta.2013.06.011; WANG Z, 2008, PHYS REV LETT, V100; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; WEN XG, 1992, PHYS REV LETT, V69, P953, DOI 10.1103/PhysRevLett.69.953; Yuan J, 2007, APPL OPTICS, V46, P2980, DOI 10.1364/AO.46.002980	30	126	126	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					671	675		10.1038/nature17943	http://dx.doi.org/10.1038/nature17943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27281214	Green Submitted			2022-12-28	WOS:000378676000033
J	Parikh, RB; Prasad, V				Parikh, Ravi B.; Prasad, Vinay			Blood-Based Screening for Colon Cancer A Disruptive Innovation or Simply a Disruption?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; COLONOSCOPY		[Parikh, Ravi B.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	prasad@ohsu.edu		Prasad, Vinayak/0000-0002-6110-8221				Adler A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-183; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; FDA Center for Devices and Radiological Health Medical Devices Advisory Committee, 2014, MOL CLIN GEN PAN; Food and Drug Administration Molecular and Clinical Genetics Panel, 2014, FDA EX SUMM EP AG EP; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Lee JK, 2009, J GEN INTERN MED, V24, P1192, DOI 10.1007/s11606-009-1087-5; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; Prasad V, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6080; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133	9	22	23	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2519	2520		10.1001/jama.2016.7914	http://dx.doi.org/10.1001/jama.2016.7914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27305625	Bronze			2022-12-28	WOS:000378306700011
J	Evers, CHJ; Luiken, JA; Bolhuis, PG; Kegel, WK				Evers, Chris H. J.; Luiken, Jurriaan A.; Bolhuis, Peter G.; Kegel, Willem K.			Self-assembly of microcapsules via colloidal bond hybridization and anisotropy	NATURE			English	Article							SEEDED EMULSION POLYMERIZATION; PATCHY PARTICLES; GRAFTED NANOPARTICLES; PROTEIN	Particles with directional interactions are promising building blocks for new functional materials and may serve as models for biological structures(1-3). Mutually attractive nanoparticles that are deformable owing to flexible surface groups, for example, may spontaneously order themselves into strings, sheets and large vesicles(4-6). Furthermore, anisotropic colloids with attractive patches can self-assemble into open lattices and the colloidal equivalents of molecules and micelles(7-9). However, model systems that combine mutual attraction, anisotropy and deformability have not yet been realized. Here we synthesize colloidal particles that combine these three characteristics and obtain self-assembled microcapsules. We propose that mutual attraction and deformability induce directional interactions via colloidal bond hybridization. Our particles contain both mutually attractive and repulsive surface groups that are flexible. Analogously to the simplest chemical bond-in which two isotropic orbitals hybridize into the molecular orbital of H-2-these flexible groups redistribute on binding. Via colloidal bond hybridization, isotropic spheres self-assemble into planar monolayers, whereas anisotropic snowman-shaped particles self-assemble into hollow monolayer microcapsules. A modest change in the building blocks thus results in much greater complexity of the self-assembled structures. In other words, these relatively simple building blocks self-assemble into markedly more complex structures than do similar particles that are isotropic or non-deformable.	[Evers, Chris H. J.; Kegel, Willem K.] Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Debye Inst Nanomat Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Luiken, Jurriaan A.; Bolhuis, Peter G.] Univ Amsterdam, Vant Hoff Inst Mol Sci, POB 94157, NL-1090 GD Amsterdam, Netherlands	Utrecht University; University of Amsterdam	Evers, CHJ; Kegel, WK (corresponding author), Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Debye Inst Nanomat Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	c.h.j.evers@uu.nl; w.k.kegel@uu.nl	Kegel, Willem K/H-4084-2016; Bolhuis, Peter/K-6115-2015	Bolhuis, Peter/0000-0002-3698-9258	Netherlands Organization for Scientific Research [VICI 700.58.442, TOP-GO 700.10.355]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank B. G. P. van Ravensteijn for providing non-deformable, fluorescein functionalized snowman-shaped particles, S. I. R. Castillo for taking the SEM images, and J. D. Meeldijk and C. T. W. M. Schneijdenberg for help with freeze drying and TEM. This work is part of the research programmes VICI 700.58.442 and TOP-GO 700.10.355, which are financed by the Netherlands Organization for Scientific Research. We thank A. van Blaaderen and M. Dijkstra for discussions, and M. de Jong for reading the manuscript.	Akcora P, 2009, NAT MATER, V8, P354, DOI [10.1038/NMAT2404, 10.1038/nmat2404]; Asai M, 2015, SOFT MATTER, V11, P793, DOI 10.1039/c4sm02295e; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bhattacharyay A, 2008, CHEM PHYS LETT, V458, P210, DOI 10.1016/j.cplett.2008.04.052; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen T, 2007, LANGMUIR, V23, P6598, DOI 10.1021/la063755d; Crassous JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6516; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Freund SMV, 2008, J MOL BIOL, V384, P1301, DOI 10.1016/j.jmb.2008.10.020; Geerts N, 2010, SOFT MATTER, V6, P664, DOI 10.1039/b917846e; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Hu X, 2009, CHEM LETT, V38, P854, DOI 10.1246/cl.2009.854; Kraft DJ, 2012, P NATL ACAD SCI USA, V109, P10787, DOI 10.1073/pnas.1116820109; Kraft DJ, 2009, SOFT MATTER, V5, P3823, DOI 10.1039/b910593j; Larson-Smith K, 2011, SOFT MATTER, V7, P5339, DOI 10.1039/c0sm01497d; Luiken JA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012303; MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319; Mock EB, 2006, LANGMUIR, V22, P4037, DOI 10.1021/la060003a; Nikolic MS, 2009, ANGEW CHEM INT EDIT, V48, P2752, DOI 10.1002/anie.200805158; SHEU HR, 1990, J POLYM SCI POL CHEM, V28, P653, DOI 10.1002/pola.1990.080280315; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; van Ravensteijn BGP, 2013, CHEM MATER, V25, P4348, DOI 10.1021/cm4025606; Wang PH, 2002, COLLOID POLYM SCI, V280, P152, DOI 10.1007/s003960100588; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Yi GR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/19/193101; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500	30	62	64	4	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					364	+		10.1038/nature17956	http://dx.doi.org/10.1038/nature17956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281213	Green Submitted			2022-12-28	WOS:000377856800031
J	Hirabayashi, M; Scheeres, DJ; Chesley, SR; Marchi, S; McMahon, JW; Steckloff, J; Mottola, S; Naidu, SP; Bowling, T				Hirabayashi, Masatoshi; Scheeres, Daniel J.; Chesley, Steven R.; Marchi, Simone; McMahon, Jay W.; Steckloff, Jordan; Mottola, Stefano; Naidu, Shantanu P.; Bowling, Timothy			Fission and reconfiguration of bilobate comets as revealed by 67P/Churyumov-Gerasimenko	NATURE			English	Article							ASTEROIDS; PRESSURE; NUCLEUS; ORIGIN; PERIOD; SHAPE	The solid, central part of a comet-its nucleus-is subject to destructive processes(1,2), which cause nuclei to split at a rate of about 0.01 per year per comet(3). These destructive events are due to a range of possible thermophysical effects(4); however, the geophysical expressions of these effects are unknown. Separately, over two-thirds of comet nuclei that have been imaged at high resolution show bilobate shapes(5), including the nucleus of comet 67P/Churyumov-Gerasimenko (67P), visited by the Rosetta spacecraft. Analysis of the Rosetta observations suggests that 67P's components were brought together at low speed after their separate formation(6). Here, we study the structure and dynamics of 67P's nucleus. We find that sublimation torques have caused the nucleus to spin up in the past to form the large cracks observed on its neck. However, the chaotic evolution of its spin state has so far forestalled its splitting, although it should eventually reach a rapid enough spin rate to do so. Once this occurs, the separated components will be unable to escape each other; they will orbit each other for a time, ultimately undergoing a low-speed merger that will result in a new bilobate configuration. The components of four other imaged bilobate nuclei have volume ratios that are consistent with a similar reconfiguration cycle, pointing to such cycles as a fundamental process in the evolution of short-period comet nuclei. It has been shown(7,8) that comets were not strong contributors to the so-called late heavy bombardment about 4 billion years ago. The reconfiguration process suggested here would preferentially decimate comet nuclei during migration to the inner solar system, perhaps explaining this lack of a substantial cometary flux.	[Hirabayashi, Masatoshi; Scheeres, Daniel J.; McMahon, Jay W.] Univ Colorado, Dept Aerosp Engn Sci, 429 UCB, Boulder, CO 80309 USA; [Chesley, Steven R.; Naidu, Shantanu P.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Marchi, Simone] Southwest Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA; [Hirabayashi, Masatoshi; Steckloff, Jordan] Purdue Univ, Dept Earth Atmospher & Planetary Sci, 550 Stadium Mall Dr, W Lafayette, IN 47907 USA; [Mottola, Stefano] German Aerosp Ctr DLR, Inst Planetary Res, Rutherfordstr 2, D-12489 Berlin, Germany; [Bowling, Timothy] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA	University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Helmholtz Association; German Aerospace Centre (DLR); University of Chicago	Hirabayashi, M; Scheeres, DJ (corresponding author), Univ Colorado, Dept Aerosp Engn Sci, 429 UCB, Boulder, CO 80309 USA.; Hirabayashi, M (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, 550 Stadium Mall Dr, W Lafayette, IN 47907 USA.	thirabayashi@purdue.edu; scheeres@colorado.edu		Steckloff, Jordan/0000-0002-1717-2226; Naidu, Shantanu/0000-0003-4439-7014; SCHEERES, DANIEL/0000-0003-0558-3842	NASA [NNX14AL16G, NNX14AB08G, NNA14AB03A]; Jet Propulsion Laboratory	NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory	M.H. acknowledges the use of ANSYS Academic APDL, version 15.03. D.J.S. and M.H. were supported by NASA grants NNX14AL16G, NNX14AB08G and NNA14AB03A. S.R.C. carried out his work at the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. S.M. acknowledges support by the Jet Propulsion Laboratory.	ATKINSON BK, 1984, J GEOPHYS RES, V89, P4077, DOI 10.1029/JB089iB06p04077; Barnes T., 2015, SHAPE MODELS 67P CHU; Biele J, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9816; Boehnhardt H, 2004, SPACE SCI S, P301; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; CHEN J, 1994, ICARUS, V108, P265, DOI 10.1006/icar.1994.1061; Chen W. F., 1988, PLASTICITY STRUCTURA; Cook N. G. W., 2009, FUNDAMENTALS ROCK ME; El-Maarry MR, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525723; El-Maarry MR, 2015, GEOPHYS RES LETT, V42, P5170, DOI 10.1002/2015GL064500; Farnham T. L., 2013, PLATE SHAPE MODEL CO; Goodman D. J., 1980, PHYSICS MECH ICE, P129; Groussin O, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526379; Guilbert-Lepoutre A, 2015, SPACE SCI REV, V197, P271, DOI 10.1007/s11214-015-0148-9; Harmon JK, 2010, ICARUS, V207, P499, DOI 10.1016/j.icarus.2009.12.026; Hirabayashi M, 2015, MON NOT R ASTRON SOC, V454, P2249, DOI 10.1093/mnras/stv2017; Hirabayashi M, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/63; Hirabayashi M, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L8; Hirabayashi M, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/160; Jacobson SA, 2011, ICARUS, V214, P161, DOI 10.1016/j.icarus.2011.04.009; Jutzi M, 2015, SCIENCE, V348, P1355, DOI 10.1126/science.aaa4747; Keller HU, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525964; Keller HU, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526421; Keller HU, 2004, SPACE SCI S, P211; Kohnke P., 2009, THEORY REFERENCE MEC; Kring DA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001529; Lambe T. W., 1969, SOIL MECH, P12; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; MARSDEN BG, 1973, ASTRON J, V78, P211, DOI 10.1086/111402; Massironi M, 2015, NATURE, V526, P402, DOI 10.1038/nature15511; McMahon JW, 2015, J GUID CONTROL DYNAM, V38, P1366, DOI 10.2514/1.G000666; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Pollard D. D., 2005, FUNDAMENTALS STRUCTU; Pravec P, 2010, NATURE, V466, P1085, DOI 10.1038/nature09315; Preusker F, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526349; Rickman H, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526093; SAGDEEV RZ, 1986, NATURE, V321, P262, DOI 10.1038/321262a0; Scheeres DJ, 2007, ICARUS, V189, P370, DOI 10.1016/j.icarus.2007.02.015; Scheeres DJ, 2007, ICARUS, V188, P430, DOI 10.1016/j.icarus.2006.12.015; Scheeres DJ, 2002, CELEST MECH DYN ASTR, V83, P155, DOI 10.1023/A:1020143116091; Seelig T., 2011, FRACTURE MECH, P4; Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697; Sierks H., 2015, SCIENCE, V347, DOI [10.1126/science.aaa1044, DOI 10.1126/SCIENCE.AAA1044]; Steckloff JK, 2016, ICARUS, V264, P160, DOI 10.1016/j.icarus.2015.09.021; Steckloff JK, 2015, ICARUS, V258, P430, DOI 10.1016/j.icarus.2015.06.032; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Unger D. J., 1995, ANAL FRACTURE MECH, P25; WIEDERHORN SM, 1970, J AM CERAM SOC, V53, P543, DOI 10.1111/j.1151-2916.1970.tb15962.x; William KJ, 1974, P INT ASS BRIDG STRU, P1	51	56	57	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					352	+		10.1038/nature17670	http://dx.doi.org/10.1038/nature17670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281196				2022-12-28	WOS:000377856800028
J	Parmet, WE; Smith, JA; Miller, MJ				Parmet, Wendy E.; Smith, Jason A.; Miller, Matthew J.			Wollschlaeger v. Governor of Florida - The First Amendment, Physician Speech, and Firearm Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUICIDE; RISK		[Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Miller, Matthew J.] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA; [Smith, Jason A.] Calif State Univ Hayward, Dept Nursing & Hlth Sci, Hayward, CA USA	Northeastern University; Northeastern University; California State University System; California State University East Bay	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Roszko PJD, 2016, EPIDEMIOL REV, V38, P87, DOI 10.1093/epirev/mxv005	4	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2304	2307		10.1056/NEJMp1605740	http://dx.doi.org/10.1056/NEJMp1605740			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305190				2022-12-28	WOS:000377854600002
J	Liu, C; Colon, BC; Ziesack, M; Silver, PA; Nocera, DG				Liu, Chong; Colon, Brendan C.; Ziesack, Marika; Silver, Pamela A.; Nocera, Daniel G.			Water splitting-biosynthetic system with CO2 reduction efficiencies exceeding photosynthesis	SCIENCE			English	Article							OXYGEN-EVOLVING CATALYST; EARTH-ABUNDANT CATALYSTS; CARBON-DIOXIDE FIXATION; RALSTONIA-EUTROPHA; CONVERSION; EVOLUTION; BACTERIUM; ALCOHOLS; FUEL	Artificial photosynthetic systems can store solar energy and chemically reduce CO2. We developed a hybrid water splitting-biosynthetic system based on a biocompatible Earth-abundant inorganic catalyst system to split water into molecular hydrogen and oxygen (H-2 and O-2) at low driving voltages. When grown in contact with these catalysts, Ralstonia eutropha consumed the produced H-2 to synthesize biomass and fuels or chemical products from low CO2 concentration in the presence of O-2. This scalable system has a CO2 reduction energy efficiency of similar to 50% when producing bacterial biomass and liquid fusel alcohols, scrubbing 180 grams of CO2 per kilowatt-hour of electricity. Coupling this hybrid device to existing photovoltaic systems would yield a CO2 reduction energy efficiency of similar to 10%, exceeding that of natural photosynthetic systems.	[Liu, Chong; Nocera, Daniel G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Liu, Chong] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 637371, Singapore; [Colon, Brendan C.; Ziesack, Marika; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Harvard Medical School	Nocera, DG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu; dnocera@fas.harvard.edu	Liu, Chong/ABD-6782-2021; Liu, Chong/AAE-8518-2019	Liu, Chong/0000-0001-5546-3852	Lee Kuan Yew Postdoctoral Fellowship; NSF Graduate Research Fellowships Program; Office of Naval Research Multidisciplinary University Research Initiative award [N00014-11-1-0725]; Air Force Office of Scientific Research [FA9550-09-1-0689]; Wyss Institute for Biologically Inspired Engineering; Harvard University Climate Change Solutions Fund	Lee Kuan Yew Postdoctoral Fellowship; NSF Graduate Research Fellowships Program(National Science Foundation (NSF)); Office of Naval Research Multidisciplinary University Research Initiative award(MURI); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Wyss Institute for Biologically Inspired Engineering; Harvard University Climate Change Solutions Fund	We thank N. Li for ICP-MS measurement and reagents, and J. Torella, C. Myhrvold, C. Lemon, and M. Huynh for helpful discussions. C.L. acknowledges X. Ling at Nanyang Technological University. Supported by a Lee Kuan Yew Postdoctoral Fellowship (C.L.), a predoctoral fellowship from the NSF Graduate Research Fellowships Program (B.C.C.), Office of Naval Research Multidisciplinary University Research Initiative award N00014-11-1-0725 (P.A.S.), Air Force Office of Scientific Research grant FA9550-09-1-0689 (D.G.N.), the Wyss Institute for Biologically Inspired Engineering (P.A.S.), and the Harvard University Climate Change Solutions Fund. This work was performed under the First 100W Program at Harvard University. C.L., B.C.C., M.Z., P.A.S., and D.G.N. are inventors on patent applications (62/218,131) filed by Harvard University and Harvard Medical School related to the technology described in this paper. The genome sequences are accessible in the NCBI SRA database under accession number SRP073266.	Abdi FF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3195; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Bediako DK, 2016, TOP CURR CHEM, V371, P173, DOI 10.1007/128_2015_649; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Cheng SA, 2009, ENVIRON SCI TECHNOL, V43, P3953, DOI 10.1021/es803531g; Cook TR, 2010, CHEM REV, V110, P6474, DOI 10.1021/cr100246c; Cox CR, 2014, P NATL ACAD SCI USA, V111, P14057, DOI 10.1073/pnas.1414290111; Dinca M, 2010, P NATL ACAD SCI USA, V107, P10337, DOI 10.1073/pnas.1001859107; Grousseau E, 2014, APPL MICROBIOL BIOT, V98, P4277, DOI 10.1007/s00253-014-5591-0; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Lewis N. S., 2015, BRIDGE, V46, P41; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Licht S, 2001, INT J HYDROGEN ENERG, V26, P653, DOI 10.1016/S0360-3199(00)00133-6; Liu C, 2015, NANO LETT, V15, P3634, DOI 10.1021/acs.nanolett.5b01254; Lu JN, 2012, APPL MICROBIOL BIOT, V96, P283, DOI 10.1007/s00253-012-4320-9; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nichols EM, 2015, P NATL ACAD SCI USA, V112, P11461, DOI 10.1073/pnas.1508075112; Parkin A, 2007, J AM CHEM SOC, V129, P10328, DOI 10.1021/ja073643o; Paseka I, 1997, ELECTROCHIM ACTA, V42, P237, DOI 10.1016/0013-4686(96)00149-1; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Reda T, 2008, P NATL ACAD SCI USA, V105, P10654, DOI 10.1073/pnas.0801290105; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Rochelle GT, 2009, SCIENCE, V325, P1652, DOI 10.1126/science.1176731; Roede J. R., 1984, ENCY TOXICOLOGY, P756; Surendranath Y, 2012, J AM CHEM SOC, V134, P6326, DOI 10.1021/ja3000084; Torella JP, 2015, P NATL ACAD SCI USA, V112, P2337, DOI 10.1073/pnas.1424872112; Yu J, 2013, INT J HYDROGEN ENERG, V38, P8683, DOI 10.1016/j.ijhydene.2013.04.153; Zhang T, 2015, SCIENCE, V350, P738, DOI 10.1126/science.aad6452	32	545	570	68	1253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1210	1213		10.1126/science.aaf5039	http://dx.doi.org/10.1126/science.aaf5039			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257255	Green Submitted			2022-12-28	WOS:000377045700040
J	Dobson, D				Dobson, David			GEOPHYSICS Earth's core problem	NATURE			English	Editorial Material							ELECTRICAL-RESISTIVITY; THERMAL-CONDUCTIVITY; IRON		[Dobson, David] UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England	University of London; University College London	Dobson, D (corresponding author), UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England.	d.dobson@ucl.ac.uk		Dobson, David/0000-0002-0890-0121	NERC [NE/L006898/1, NE/K002902/1] Funding Source: UKRI; Natural Environment Research Council [NE/K002902/1, NE/L006898/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Buffett B, 2012, NATURE, V485, P319, DOI 10.1038/485319a; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Konopkova Z, 2016, NATURE, V534, P99, DOI 10.1038/nature18009; Labrosse S, 2015, PHYS EARTH PLANET IN, V247, P36, DOI 10.1016/j.pepi.2015.02.002; Ohta K, 2016, NATURE, V534, P95, DOI 10.1038/nature17957; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8	7	26	26	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					45	45		10.1038/534045a	http://dx.doi.org/10.1038/534045a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251274				2022-12-28	WOS:000376962300030
J	Jia, Y; Yun, CH; Park, E; Rcan, DE; Manuia, M; Juarez, J; Xu, CX; Rhee, K; Chen, T; Zhang, HK; Palakurthi, S; Jang, JB; Lelais, G; DiDonato, M; Bursulaya, B; Michellys, PY; Epple, R; Marsilje, TH; McNeill, M; Lu, WS; Harris, J; Bender, S; Wong, KK; Janne, PA; Eck, MJ				Jia, Yong; Yun, Cai-Hong; Park, Eunyoung; Rcan, Dalia E.; Manuia, Mari; Juarez, Jose; Xu, Chunxiao; Rhee, Kevin; Chen, Ting; Zhang, Haikuo; Palakurthi, Sangeetha; Jang, Jaebong; Lelais, Gerald; DiDonato, Michael; Bursulaya, Badry; Michellys, Pierre-Yves; Epple, Robert; Marsilje, Thomas H.; McNeill, Matthew; Lu, Wenshuo; Harris, Jennifer; Bender, Steven; Wong, Kwok-Kin; Janne, Pasi A.; Eck, Michael J.			Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; EGFR KINASE; TARGETED THERAPIES; MUTATIONS; GEFITINIB; AZD9291; ACTIVATION; MECHANISM	The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are approved treatments for non-small cell lung cancers harbouring activating mutations in the EGFR kinase(1,2), but resistance arises rapidly, most frequently owing to the secondary T790M mutation within the ATP site of the receptor(3,4). Recently developed mutant-selective irreversible inhibitors are highly active against the T790M mutant(5,6), but their efficacy can be compromised by acquired mutation of C797, the cysteine residue with which they form a key covalent bond(7). All current EGFR TKIs target the ATP-site of the kinase, highlighting the need for therapeutic agents with alternative mechanisms of action. Here we describe the rational discovery of EAI045, an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor. The crystal structure shows that the compound binds an allosteric site created by the displacement of the regulatory C-helix in an inactive conformation of the kinase. The compound inhibits L858R/T790M-mutant EGFR with low-nanomolar potency in biochemical assays. However, as a single agent it is not effective in blocking EGFR-driven proliferation in cells owing to differential potency on the two subunits of the dimeric receptor, which interact in an asymmetric manner in the active state(8). We observe marked synergy of EAI045 with cetuximab, an antibody therapeutic that blocks EGFR dimerization(9,10), rendering the kinase uniformly susceptible to the allosteric agent. EAI045 in combination with cetuximab is effective in mouse models of lung cancer driven by EGFR(L858R/T790M) and by EGFR(L858R/T790M/C797S), a mutant that is resistant to all currently available EGFR TKIs. More generally, our findings illustrate the utility of purposefully targeting allosteric sites to obtain mutant-selective inhibitors.	[Jia, Yong; Manuia, Mari; Juarez, Jose; Lelais, Gerald; DiDonato, Michael; Bursulaya, Badry; Michellys, Pierre-Yves; Epple, Robert; Marsilje, Thomas H.; McNeill, Matthew; Lu, Wenshuo; Harris, Jennifer; Bender, Steven] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Yun, Cai-Hong; Park, Eunyoung; Jang, Jaebong; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Yun, Cai-Hong; Park, Eunyoung; Jang, Jaebong; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rcan, Dalia E.; Xu, Chunxiao; Rhee, Kevin; Chen, Ting; Zhang, Haikuo; Wong, Kwok-Kin; Janne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02215 USA; [Palakurthi, Sangeetha; Wong, Kwok-Kin; Janne, Pasi A.] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02215 USA; [Yun, Cai-Hong] Peking Univ, Inst Syst Biomed, Beijing 100191, Peoples R China; [Yun, Cai-Hong] Peking Univ, Hlth Sci Ctr, Dept Biophys, Beijing 100191, Peoples R China	Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Peking University; Peking University	Eck, MJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@crystal.harvard.edu	云, 彩红/E-1437-2018	wong, kwok kin/0000-0001-6323-235X; DiDonato, Michael/0000-0002-9074-7284; Chen, Ting/0000-0003-1725-7956	NIH [CA116020, CA154303, CA120964, CA135257]; Gross-Loh Family Fund for Lung Cancer Research; NATIONAL CANCER INSTITUTE [R01CA135257, P01CA154303, P01CA120964, R01CA116020, R01CA166480, R01CA201049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gross-Loh Family Fund for Lung Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants CA116020 ( M. J. E.), CA154303 ( M. J. E., K.- K. W. and P. A. J.), CA120964 ( K.- K. W.) and CA135257 ( P. A. J.), and by the Gross-Loh Family Fund for Lung Cancer Research ( K.- K. W.). We thank N. Gray for helpful comments on the manuscript.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Cho J, 2013, CANCER RES, V73, P6770, DOI 10.1158/0008-5472.CAN-13-1145; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Finlay MRV, 2014, J MED CHEM, V57, P8249, DOI 10.1021/jm500973a; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Muller G. W., 1997, US patent, Patent No. 5698579; Oxnard GR, 2015, 16 WORLD C LUNG CANC; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tsou HR, 2005, J MED CHEM, V48, P1107, DOI 10.1021/jm040159c; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yu HA, 2013, NAT REV CLIN ONCOL, V10, P551, DOI 10.1038/nrclinonc.2013.154; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	32	460	518	23	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					129	+		10.1038/nature17960	http://dx.doi.org/10.1038/nature17960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251290	Green Accepted, Green Submitted			2022-12-28	WOS:000376962300048
J	Chan, M				Chan, Margaret			Yellow fever: the resurgence of a forgotten disease	LANCET			English	Editorial Material									[Chan, Margaret] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; IHR, 2005, INT HLTH REG 2005, V2; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; WHO, 2004, YELL FEV CURR THREAT; WHO, 2016, SIT REP ZIK VIR MICR; WHO, 2015, YELL FEV IN EL YELL; WHO, 2016, NIN HLTH GLOB OV; WHO, 2004, INCR RISK URB YELL F; WHO Unicef, 2010, YELL FEV IN PROV OPP; World Health Organization, 2009, DENGUE GUIDELINES DI	12	17	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2165	2166		10.1016/S0140-6736(16)30620-1	http://dx.doi.org/10.1016/S0140-6736(16)30620-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27229187				2022-12-28	WOS:000376820800005
J	Shanmugam, S; Boyer, C				Shanmugam, Sivaprakash; Boyer, Cyrille			POLYMER SYNTHESIS Organic photocatalysts for cleaner polymer synthesis	SCIENCE			English	Editorial Material							TRANSFER RADICAL POLYMERIZATION; VISIBLE-LIGHT; MONOMERS; DESIGN; ATRP		[Boyer, Cyrille] UNSW Australia, Sch Chem Engn, CAMD, Sydney, NSW 2052, Australia; UNSW Australia, Sch Chem Engn, ACN, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Boyer, C (corresponding author), UNSW Australia, Sch Chem Engn, CAMD, Sydney, NSW 2052, Australia.	cboyer@unsw.edu.au	Boyer, Cyrille A/A-5436-2009; Shanmugam, Sivaprakash/N-2391-2017	Boyer, Cyrille A/0000-0002-4564-4702; Shanmugam, Sivaprakash/0000-0001-5954-1336				Boyer C, 2016, CHEM REV, V116, P1803, DOI 10.1021/acs.chemrev.5b00396; Frazer L, 2007, ENVIRON HEALTH PERSP, V115, pA258, DOI 10.1289/ehp.115-a258; Magenau AJD, 2011, SCIENCE, V332, P81, DOI 10.1126/science.1202357; Miyake GM, 2014, MACROMOLECULES, V47, P8255, DOI 10.1021/ma502044f; Ribelli TG, 2014, J AM CHEM SOC, V136, P13303, DOI 10.1021/ja506379s; Shanmugam S, 2016, ANGEW CHEM INT EDIT, V55, P1036, DOI 10.1002/anie.201510037; Siegwart DJ, 2012, PROG POLYM SCI, V37, P18, DOI 10.1016/j.progpolymsci.2011.08.001; Teator AJ, 2016, CHEM REV, V116, P1969, DOI 10.1021/acs.chemrev.5b00426; Theriot JC, 2016, SCIENCE, V352, P1082, DOI 10.1126/science.aaf3935; Treat NJ, 2014, J AM CHEM SOC, V136, P16096, DOI 10.1021/ja510389m; Treat NJ, 2014, ACS MACRO LETT, V3, P580, DOI 10.1021/mz500242a; Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p; WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035; Xu JT, 2014, J AM CHEM SOC, V136, P5508, DOI 10.1021/ja501745g	14	67	67	5	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1053	1054		10.1126/science.aaf7465	http://dx.doi.org/10.1126/science.aaf7465			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230364				2022-12-28	WOS:000376480800019
J	Kirkby, J; Duplissy, J; Sengupta, K; Frege, C; Gordon, H; Williamson, C; Heinritzi, M; Simon, M; Yan, C; Almeida, J; Trostl, J; Nieminen, T; Ortega, IK; Wagner, R; Adamov, A; Amorim, A; Bernhammer, AK; Bianchi, F; Breitenlechner, M; Brilke, S; Chen, XM; Craven, J; Dias, A; Ehrhart, S; Flagan, RC; Franchin, A; Fuchs, C; Guida, R; Hakala, J; Hoyle, CR; Jokinen, T; Junninen, H; Kangasluoma, J; Kim, J; Krapf, M; Kurten, A; Laaksonen, A; Lehtipalo, K; Makhmutov, V; Mathot, S; Molteni, U; Onnela, A; Perakyla, O; Piel, F; Petaja, T; Praplan, AP; Pringle, K; Rap, A; Richards, NAD; Riipinen, I; Rissanen, MP; Rondo, L; Sarnela, N; Schobesberger, S; Scott, CE; Seinfeld, JH; Sipila, M; Steiner, G; Stozhkov, Y; Stratmann, F; Tome, A; Virtanen, A; Vogel, AL; Wagner, AC; Wagner, PE; Weingartner, E; Wimmer, D; Winkler, PM; Ye, PL; Zhang, X; Hansel, A; Dommen, J; Donahue, NM; Worsnop, DR; Baltensperger, U; Kulmala, M; Carslaw, KS; Curtius, J				Kirkby, Jasper; Duplissy, Jonathan; Sengupta, Kamalika; Frege, Carla; Gordon, Hamish; Williamson, Christina; Heinritzi, Martin; Simon, Mario; Yan, Chao; Almeida, Joao; Troestl, Jasmin; Nieminen, Tuomo; Ortega, Ismael K.; Wagner, Robert; Adamov, Alexey; Amorim, Antonio; Bernhammer, Anne-Kathrin; Bianchi, Federico; Breitenlechner, Martin; Brilke, Sophia; Chen, Xuemeng; Craven, Jill; Dias, Antonio; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Fuchs, Claudia; Guida, Roberto; Hakala, Jani; Hoyle, Christopher R.; Jokinen, Tuija; Junninen, Heikki; Kangasluoma, Juha; Kim, Jaeseok; Krapf, Manuel; Kuerten, Andreas; Laaksonen, Ari; Lehtipalo, Katrianne; Makhmutov, Vladimir; Mathot, Serge; Molteni, Ugo; Onnela, Antti; Peraekylae, Otso; Piel, Felix; Petaejae, Tuukka; Praplan, Arnaud P.; Pringle, Kirsty; Rap, Alexandru; Richards, Nigel A. D.; Riipinen, Ilona; Rissanen, Matti P.; Rondo, Linda; Sarnela, Nina; Schobesberger, Siegfried; Scott, Catherine E.; Seinfeld, John H.; Sipilae, Mikko; Steiner, Gerhard; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Virtanen, Annele; Vogel, Alexander L.; Wagner, Andrea C.; Wagner, Paul E.; Weingartner, Ernest; Wimmer, Daniela; Winkler, Paul M.; Ye, Penglin; Zhang, Xuan; Hansel, Armin; Dommen, Josef; Donahue, Neil M.; Worsnop, Douglas R.; Baltensperger, Urs; Kulmala, Markku; Carslaw, Kenneth S.; Curtius, Joachim			Ion-induced nucleation of pure biogenic particles	NATURE			English	Article							ATMOSPHERIC SULFURIC-ACID; AEROSOL FORMATION; MASS-SPECTROMETER; MOLECULAR-WEIGHT; COSMIC-RAYS; SIZE; OZONOLYSIS; PRODUCTS; GROWTH; COAGULATION	Atmospheric aerosols and their effect on clouds are thought to be important for anthropogenic radiative forcing of the climate, yet remain poorly understood(1). Globally, around half of cloud condensation nuclei originate from nucleation of atmospheric vapours(2). It is thought that sulfuric acid is essential to initiate most particle formation in the atmosphere(3,4), and that ions have a relatively minor role(5). Some laboratory studies, however, have reported organic particle formation without the intentional addition of sulfuric acid, although contamination could not be excluded(6,7). Here we present evidence for the formation of aerosol particles from highly oxidized biogenic vapours in the absence of sulfuric acid in a large chamber under atmospheric conditions. The highly oxygenated molecules (HOMs) are produced by ozonolysis of a-pinene. We find that ions from Galactic cosmic rays increase the nucleation rate by one to two orders of magnitude compared with neutral nucleation. Our experimental findings are supported by quantum chemical calculations of the cluster binding energies of representative HOMs. Ion-induced nucleation of pure organic particles constitutes a potentially widespread source of aerosol particles in terrestrial environments with low sulfuric acid pollution.	[Kirkby, Jasper; Williamson, Christina; Heinritzi, Martin; Simon, Mario; Almeida, Joao; Brilke, Sophia; Ehrhart, Sebastian; Franchin, Alessandro; Kuerten, Andreas; Piel, Felix; Rondo, Linda; Wagner, Andrea C.; Wimmer, Daniela; Curtius, Joachim] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Kirkby, Jasper; Gordon, Hamish; Almeida, Joao; Dias, Antonio; Ehrhart, Sebastian; Franchin, Alessandro; Guida, Roberto; Mathot, Serge; Onnela, Antti; Vogel, Alexander L.] CERN, CH-1211 Geneva, Switzerland; [Duplissy, Jonathan; Yan, Chao; Nieminen, Tuomo; Wagner, Robert; Adamov, Alexey; Chen, Xuemeng; Franchin, Alessandro; Hakala, Jani; Jokinen, Tuija; Junninen, Heikki; Kangasluoma, Juha; Kuerten, Andreas; Lehtipalo, Katrianne; Peraekylae, Otso; Petaejae, Tuukka; Praplan, Arnaud P.; Rap, Alexandru; Rissanen, Matti P.; Sarnela, Nina; Schobesberger, Siegfried; Sipilae, Mikko; Steiner, Gerhard; Vogel, Alexander L.; Wagner, Andrea C.; Wimmer, Daniela; Worsnop, Douglas R.; Kulmala, Markku] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Duplissy, Jonathan; Nieminen, Tuomo; Sipilae, Mikko; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Sengupta, Kamalika; Pringle, Kirsty; Rap, Alexandru; Richards, Nigel A. D.; Scott, Catherine E.; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Frege, Carla; Troestl, Jasmin; Bianchi, Federico; Franchin, Alessandro; Fuchs, Claudia; Hoyle, Christopher R.; Krapf, Manuel; Lehtipalo, Katrianne; Molteni, Ugo; Weingartner, Ernest; Dommen, Josef; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Heinritzi, Martin; Bernhammer, Anne-Kathrin; Breitenlechner, Martin; Steiner, Gerhard; Hansel, Armin] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [Ortega, Ismael K.] Onera French Aerosp Lab, F-91123 Palaiseau, France; [Amorim, Antonio] Univ Lisbon, SIM, P-1849016 Lisbon, Portugal; [Bernhammer, Anne-Kathrin; Breitenlechner, Martin; Hansel, Armin] Ionicon Analyt GmbH, A-6020 Innsbruck, Austria; [Bianchi, Federico] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Craven, Jill; Flagan, Richard C.; Seinfeld, John H.; Zhang, Xuan] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hoyle, Christopher R.] WSL Inst Snow & Avalanche Res SLF, CH-7260 Davos, Switzerland; [Kim, Jaeseok; Laaksonen, Ari; Virtanen, Annele; Worsnop, Douglas R.] Univ Eastern Finland, FI-70211 Kuopio, Finland; [Laaksonen, Ari] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [Makhmutov, Vladimir; Stozhkov, Yuri] Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 119991, Russia; [Richards, Nigel A. D.] Univ Leeds, Natl Ctr Earth Observat Leeds, Leeds LS2 9JT, W Yorkshire, England; [Riipinen, Ilona] Univ Stockholm, Dept Appl Environm Sci, SE-10961 Stockholm, Sweden; [Steiner, Gerhard; Wagner, Paul E.; Winkler, Paul M.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Stratmann, Frank] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Tome, Antonio] Univ Beira Interior, P-6201001 Covilha, Portugal; [Ye, Penglin; Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Williamson, Christina] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Kim, Jaeseok] Korea Polar Res Inst, Arct Res Ctr, Inchon 406840, South Korea; [Schobesberger, Siegfried] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	Goethe University Frankfurt; European Organization for Nuclear Research (CERN); University of Helsinki; Helsinki Institute of Physics; University of Helsinki; University of Leeds; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Innsbruck; National Office for Aerospace Studies & Research (ONERA); UDICE-French Research Universities; Universite Paris Saclay; Universidade de Lisboa; Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Eastern Finland; Finnish Meteorological Institute; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University of Leeds; Stockholm University; University of Vienna; Leibniz Institut fur Tropospharenforschung (TROPOS); Universidade da Beira Interior; Carnegie Mellon University; Aerodyne Research; University of Colorado System; University of Colorado Boulder; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); University of Washington; University of Washington Seattle	Kirkby, J (corresponding author), Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany.; Kirkby, J (corresponding author), CERN, CH-1211 Geneva, Switzerland.	jasper.kirkby@cern.ch	Duplissy, Jonathan/A-1723-2010; Sarnela, Nina/AAE-1372-2020; Weingartner, Ernest/B-6793-2009; Praplan, Arnaud P./F-8357-2011; Yuri, Stozhkov/ABG-7096-2021; Sipilä, Mikko/G-3024-2010; Makhmutov, Vladimir/N-2086-2015; Kangasluoma, Juha/AAY-7941-2021; Carslaw, Ken S/C-8514-2009; Wagner, Andrea Christine/AGH-3531-2022; Simon, Mario/AGI-2749-2022; Nieminen, Tuomo J/D-1618-2011; Jokinen, Tuija/B-3365-2014; Scott, Catherine E/K-8758-2013; Riipinen, Ilona/I-9379-2012; Tome, Antonio R/A-5681-2013; Bianchi, Federico/G-8428-2012; Kirkby, Jasper/A-4973-2012; Donahue, Neil M/A-2329-2008; Steiner, Gerhard/AAD-4219-2020; Amorim, Antonio/C-8460-2013; Worsnop, Douglas R/D-2817-2009; kangasluoma, juha/W-7450-2019; Stozhkov, Yuri/M-7433-2015; Virtanen, Annele/E-7699-2010; Laaksonen, Ari/B-5094-2011; Chen, Xuemeng/F-6072-2019; Schobesberger, Siegfried/L-4454-2014; Franchin, Alessandro/AAH-3069-2019; Riipinen, Ilona/ABD-5564-2021; Breitenlechner, Martin/AAA-3402-2021; Hoyle, Christopher R./B-7786-2008; Williamson, Christina J/D-1484-2016; Kürten, Andreas/O-3851-2019; Hansel, Armin/F-3915-2010; Nieminen, Tuomo/AAB-8686-2020; Adamov, Alexey/V-2477-2018; Rap, Alexandru/G-7532-2016; Franchin, Alessandro/GVR-8219-2022; Curtius, Joachim/A-2681-2011; Yan, Chao/ABA-5642-2020; Vogel, Alexander L./A-1772-2017; Kulmala, Markku T/I-7671-2016; Petäjä, Tuukka/A-8009-2008; Ortega Colomer, Ismael Kenneth/A-7930-2008; Junninen, Heikki/C-2157-2014	Duplissy, Jonathan/0000-0001-8819-0264; Weingartner, Ernest/0000-0002-2427-4634; Praplan, Arnaud P./0000-0002-9944-3084; Sipilä, Mikko/0000-0002-8594-7003; Makhmutov, Vladimir/0000-0002-2242-1055; Kangasluoma, Juha/0000-0002-1639-1187; Carslaw, Ken S/0000-0002-6800-154X; Wagner, Andrea Christine/0000-0003-3159-9434; Jokinen, Tuija/0000-0002-1280-1396; Scott, Catherine E/0000-0002-0187-969X; Tome, Antonio R/0000-0001-9144-7120; Bianchi, Federico/0000-0003-2996-3604; Kirkby, Jasper/0000-0003-2341-9069; Donahue, Neil M/0000-0003-3054-2364; Steiner, Gerhard/0000-0003-3008-1414; Amorim, Antonio/0000-0003-0638-2321; Worsnop, Douglas R/0000-0002-8928-8017; Stozhkov, Yuri/0000-0003-1917-0328; Virtanen, Annele/0000-0002-2917-5344; Laaksonen, Ari/0000-0002-1657-2383; Chen, Xuemeng/0000-0002-7731-6842; Schobesberger, Siegfried/0000-0002-5777-4897; Hoyle, Christopher R./0000-0002-1369-9143; Williamson, Christina J/0000-0002-5188-9378; Kürten, Andreas/0000-0002-8955-4450; Hansel, Armin/0000-0002-1062-2394; Nieminen, Tuomo/0000-0002-2713-715X; Rap, Alexandru/0000-0002-2319-6769; Curtius, Joachim/0000-0003-3153-4630; Yan, Chao/0000-0002-5735-9597; Vogel, Alexander L./0000-0002-1293-6370; Kulmala, Markku T/0000-0003-3464-7825; Petäjä, Tuukka/0000-0002-1881-9044; Trostl, Jasmin/0000-0002-2807-0348; Bernhammer, Anne-Kathrin/0000-0002-0614-3649; Gordon, Hamish/0000-0002-1822-3224; Lehtipalo, Katrianne/0000-0002-1660-2706; Simon, Mario/0000-0002-4900-7460; Rissanen, Matti/0000-0003-0463-8098; Perakyla, Otso/0000-0002-2089-0106; Kim, Jaeseok/0000-0002-7920-0288; Molteni, Ugo/0000-0002-1623-1933; Brilke, Sophia/0000-0003-3133-249X; Wagner, Robert/0000-0001-7365-8020; Winkler, Paul/0000-0001-6861-6029; Breitenlechner, Martin/0000-0002-2382-6660; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Junninen, Heikki/0000-0001-7178-9430; Ehrhart, Sebastian/0000-0002-6517-5341; Dommen, Josef/0000-0002-0006-0009; Sarnela, Nina/0000-0003-1874-3235	CERN; EC (Marie Curie Initial Training Network MC-ITN CLOUD-TRAIN) [316662]; EC (EU) [656994]; EC (ERC) [616075, 227463]; German Federal Ministry of Education and Research [01LK1222A]; Swiss National Science Foundation [200020_135307, 200021_140663, 206021_144947/1, 20FI20_149002/1]; Academy of Finland (Center of Excellence) [1118615]; Academy of Finland [135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451]; Finnish Funding Agency for Technology and Innovation; Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF) [L593]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Swedish Research Council, Vetenskapsradet [2011-5120]; Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research [12-02-91522-CERN]; UK Natural Environment Research Council [NE/K015966/1]; Royal Society; US National Science Foundation [AGS1136479, AGS1447056, CHE1012293]; Caltech ESE Grant (Davidow Foundation); Dreyfus Award [EP-11-117]; French National Research Agency (ANR); Nord-Pas de Calais; European Funds for Regional Economic Development (FEDER, Labex-Cappa) [ANR-11-LABX-0005-01]; Directorate For Geosciences [1447056] Funding Source: National Science Foundation; Natural Environment Research Council [NE/K015966/1] Funding Source: researchfish; NERC [NE/K015966/1] Funding Source: UKRI	CERN; EC (Marie Curie Initial Training Network MC-ITN CLOUD-TRAIN); EC (EU)(European CommissionEuropean Commission Joint Research Centre); EC (ERC); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland (Center of Excellence)(Academy of Finland); Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Swedish Research Council, Vetenskapsradet(Swedish Research Council); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); US National Science Foundation(National Science Foundation (NSF)); Caltech ESE Grant (Davidow Foundation); Dreyfus Award; French National Research Agency (ANR)(French National Research Agency (ANR)); Nord-Pas de Calais(Region Hauts-de-France); European Funds for Regional Economic Development (FEDER, Labex-Cappa); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank CERN for supporting CLOUD with important technical and financial resources, and for providing a particle beam from the CERN Proton Synchrotron. We also thank P. Carrie, L.-P. De Menezes, J. Dumollard, F. Josa, I. Krasin, R. Kristic, A. Laassiri, O. S. Maksumov, B. Marichy, H. Martinati, S. V. Mizin, R. Sitals, A. Wasem and M. Wilhelmsson for their contributions to the experiment. We thank the CSC Centre for Scientific Computing in Espoo, Finland for computer time. This research has received funding from the EC Seventh Framework Programme (Marie Curie Initial Training Network MC-ITN CLOUD-TRAIN no. 316662, EU Horizon 2020 Marie Curie grant no. 656994, ERC-Consolidator grant NANODYNAMITE no. 616075 and ERC-Advanced grant ATMNUCLE no. 227463), the German Federal Ministry of Education and Research (project no. 01LK1222A), the Swiss National Science Foundation (project nos 200020_135307, 200021_140663, 206021_144947/1 and 20FI20_149002/1), the Academy of Finland (Center of Excellence project no. 1118615), the Academy of Finland (135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451), the Finnish Funding Agency for Technology and Innovation, the Vaisala Foundation, the Nessling Foundation, the Austrian Science Fund (FWF; project no. L593), the Portuguese Foundation for Science and Technology (project no. CERN/FP/116387/2010), the Swedish Research Council, Vetenskapsradet (grant 2011-5120), the Presidium of the Russian Academy of Sciences and Russian Foundation for Basic Research (grant 12-02-91522-CERN), the UK Natural Environment Research Council (grant NE/K015966/1), the Royal Society (Wolfson Merit Award), the US National Science Foundation (grants AGS1136479, AGS1447056 and CHE1012293), Caltech ESE Grant (Davidow Foundation), Dreyfus Award EP-11-117, the French National Research Agency (ANR), the Nord-Pas de Calais, and the European Funds for Regional Economic Development (FEDER, Labex-Cappa, ANR-11-LABX-0005-01).	Almeida J, 2013, NATURE, V502, P359, DOI 10.1038/nature12663; Asmi E, 2009, ATMOS CHEM PHYS, V9, P141, DOI 10.5194/acp-9-141-2009; Atkinson R, 2006, ATMOS CHEM PHYS, V6, P3625, DOI 10.5194/acp-6-3625-2006; Bianchi F, 2016, SCIENCE, V352, P1109, DOI 10.1126/science.aad5456; Boucher O, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P571, DOI 10.1017/cbo9781107415324.016; Chan TW, 2001, J AEROSOL SCI, V32, P321, DOI 10.1016/S0021-8502(00)00081-1; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Ehrhart S, 2013, ATMOS CHEM PHYS, V13, P11465, DOI 10.5194/acp-13-11465-2013; EISELE FL, 1993, J GEOPHYS RES-ATMOS, V98, P9001, DOI 10.1029/93JD00031; Ekman AML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034970; Elm J, 2014, CHEM PHYS LETT, V615, P26, DOI 10.1016/j.cplett.2014.09.060; Enghoff MB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047036; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fuchs N. A., 1964, MECH AEROSOLS; Gagne S, 2011, ATMOS MEAS TECH, V4, P805, DOI 10.5194/amt-4-805-2011; Gao S, 2004, J PHYS CHEM A, V108, P10147, DOI 10.1021/jp047466e; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; Heland J, 2001, ENVIRON SCI TECHNOL, V35, P3207, DOI 10.1021/es000303t; Herschel W., 1801, PHILOS T R SOC LOND, V91, P265, DOI [10.1098/rstl.1801.0015, DOI 10.1098/RSTL.1801.0015]; Hirsikko A, 2011, ATMOS CHEM PHYS, V11, P767, DOI 10.5194/acp-11-767-2011; Iida K, 2009, AEROSOL SCI TECH, V43, P81, DOI 10.1080/02786820802488194; Jokinen T, 2012, ATMOS CHEM PHYS, V12, P4117, DOI 10.5194/acp-12-4117-2012; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kangasluoma J, 2014, ATMOS MEAS TECH, V7, P689, DOI 10.5194/amt-7-689-2014; Kathmann SM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116104; Kerminen VM, 2002, J AEROSOL SCI, V33, P609, DOI 10.1016/S0021-8502(01)00194-X; Kirkby J, 2007, SURV GEOPHYS, V28, P333, DOI 10.1007/s10712-008-9030-6; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kurten A, 2015, ATMOS CHEM PHYS, V15, P4063, DOI 10.5194/acp-15-4063-2015; Kurten A, 2011, ATMOS MEAS TECH, V4, P437, DOI 10.5194/amt-4-437-2011; Kurten A, 2014, P NATL ACAD SCI USA, V111, P15019, DOI 10.1073/pnas.1404853111; Kurten A, 2012, J PHYS CHEM A, V116, P6375, DOI 10.1021/jp212123n; Kulmala M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006963; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kulmala M, 2008, ATMOS RES, V90, P132, DOI 10.1016/j.atmosres.2008.01.005; Kurten T, 2015, J PHYS CHEM A, V119, P11366, DOI 10.1021/acs.jpca.5b08948; Laakso L, 2004, ATMOS CHEM PHYS, V4, P2353, DOI 10.5194/acp-4-2353-2004; Lee SH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009351; Lehtipalo K, 2014, BOREAL ENVIRON RES, V19, P215; Mann GW, 2012, ATMOS CHEM PHYS, V12, P4449, DOI 10.5194/acp-12-4449-2012; Martin ST, 2010, REV GEOPHYS, V48, DOI 10.1029/2008RG000280; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Mirme S, 2013, ATMOS MEAS TECH, V6, P1061, DOI 10.5194/amt-6-1061-2013; Mirme S, 2010, ATMOS CHEM PHYS, V10, P437, DOI 10.5194/acp-10-437-2010; MOHLER O, 1992, J CHEM PHYS, V97, P8233, DOI 10.1063/1.463394; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Ortega IK, 2012, ATMOS CHEM PHYS, V12, P225, DOI 10.5194/acp-12-225-2012; Ortega IK, 2016, J PHYS CHEM A, V120, P1452, DOI 10.1021/acs.jpca.5b07427; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Riccobono F, 2012, ATMOS CHEM PHYS, V12, P9427, DOI 10.5194/acp-12-9427-2012; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; Riipinen I, 2011, ATMOS CHEM PHYS, V11, P3865, DOI 10.5194/acp-11-3865-2011; Rissanen MP, 2015, J PHYS CHEM A, V119, P4633, DOI 10.1021/jp510966g; Rissanen MP, 2014, J AM CHEM SOC, V136, P15596, DOI 10.1021/ja507146s; SCEATS MG, 1989, J COLLOID INTERF SCI, V129, P105, DOI 10.1016/0021-9797(89)90419-0; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY, P600; Sihto SL, 2006, ATMOS CHEM PHYS, V6, P4079, DOI 10.5194/acp-6-4079-2006; Suni T, 2008, ATMOS CHEM PHYS, V8, P129, DOI 10.5194/acp-8-129-2008; TAIRA M, 1990, ANAL CHEM, V62, P630, DOI 10.1021/ac00205a018; Trostl J, 2016, NATURE, V533, P527, DOI 10.1038/nature18271; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Wimmer D, 2013, ATMOS MEAS TECH, V6, P1793, DOI 10.5194/amt-6-1793-2013; Zhang K, 2011, ATMOS CHEM PHYS, V11, P7817, DOI 10.5194/acp-11-7817-2011; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139; ZHANG SH, 1995, AEROSOL SCI TECH, V23, P357, DOI 10.1080/02786829508965320; Zhang X, 2015, P NATL ACAD SCI USA, V112, P14168, DOI 10.1073/pnas.1517742112; Zhao J, 2013, ATMOS CHEM PHYS, V13, P7631, DOI 10.5194/acp-13-7631-2013; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	74	327	330	19	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					521	+		10.1038/nature17953	http://dx.doi.org/10.1038/nature17953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225125	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000376443100038
J	Ko, AH				Ko, Andrew H.			Raising the bar for the adjuvant treatment of pancreatic cancer	LANCET			English	Editorial Material							CHEMOTHERAPY; GEMCITABINE; RESECTION; ADENOCARCINOMA; FLUOROURACIL; SUBTYPES; TRIAL		[Ko, Andrew H.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Div Hematol Oncol, Gastrointestinal Oncol Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Ko, AH (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Div Hematol Oncol, Gastrointestinal Oncol Program, San Francisco, CA 94143 USA.	Andrew.Ko@ucsf.edu						[Anonymous], 2016, NEWLINK GEN ANN RES; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cui YF, 2012, CLIN CANCER RES, V18, P6519, DOI 10.1158/1078-0432.CCR-12-0827; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					214	+		10.1016/S0140-6736(16)30680-8	http://dx.doi.org/10.1016/S0140-6736(16)30680-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27265348				2022-12-28	WOS:000379736100005
J	Veneziano, R; Ratanalert, S; Zhang, KM; Zhang, F; Yan, H; Chiu, W; Bathe, M				Veneziano, Remi; Ratanalert, Sakul; Zhang, Kaiming; Zhang, Fei; Yan, Hao; Chiu, Wah; Bathe, Mark			DNA NANOTECHNOLOGY Designer nanoscale DNA assemblies programmed from the top down	SCIENCE			English	Article							NUCLEIC-ACID NANOSTRUCTURES; SINGLE-STRANDED-DNA; INFORMATION-STORAGE; FOLDING DNA; ORIGAMI; SHAPES; COMPLEX; GENERATION; POLYHEDRA; JUNCTIONS	Scaffolded DNA origami is a versatile means of synthesizing complex molecular architectures. However, the approach is limited by the need to forward-design specific Watson-Crick base pairing manually for any given target structure. Here, we report a general, top-down strategy to design nearly arbitrary DNA architectures autonomously based only on target shape. Objects are represented as closed surfaces rendered as polyhedral networks of parallel DNA duplexes, which enables complete DNA scaffold routing with a spanning tree algorithm. The asymmetric polymerase chain reaction is applied to produce stable, monodisperse assemblies with custom scaffold length and sequence that are verified structurally in three dimensions to be high fidelity by single-particle cryo-electron microscopy. Their long-term stability in serum and low-salt buffer confirms their utility for biological as well as nonbiological applications.	[Veneziano, Remi; Ratanalert, Sakul; Bathe, Mark] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ratanalert, Sakul] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Zhang, Kaiming; Chiu, Wah] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Zhang, Fei; Yan, Hao] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Zhang, Fei; Yan, Hao] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Biodesign Inst, Tempe, AZ 85287 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Bathe, M (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mark.bathe@mit.edu	Zhang, Kaiming/O-1276-2017; Zhang, Kaiming/AAA-5788-2021	Zhang, Kaiming/0000-0003-0414-4776; Zhang, Kaiming/0000-0003-0414-4776; Veneziano, Remi/0000-0002-2726-3770; Ratanalert, Sakul/0000-0002-1766-807X	Office of Naval Research (ONR) [N000141410609]; Human Frontier Science Program (HFSP) [RGP0029/2015]; National Science Foundation (NSF-EAGER) [CCF-1547999]; National Science Foundation (NSF CMMI) [1334109]; National Institutes of Health [NIH P41GM103832, P50GM103297]; Direct For Computer & Info Scie & Enginr [1563799] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1547962, 1547999] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, P50GM103297] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); Human Frontier Science Program (HFSP)(Human Frontier Science Program); National Science Foundation (NSF-EAGER); National Science Foundation (NSF CMMI)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from the Office of Naval Research (ONR) N000141410609, the Human Frontier Science Program (HFSP) RGP0029/2015, and National Science Foundation (NSF-EAGER) CCF-1547999 to M.B.; the National Science Foundation (NSF CMMI) 1334109 to M.B. and H.Y.; and the National Institutes of Health (NIH P41GM103832 and P50GM103297) to W.C. is gratefully acknowledged. Patent applications have been filed by the MIT Technology and Licensing Office on behalf of M.B., R.V., and S.R. related to this work. M.B. is scientific founder of Structured DNA Technologies LLC. K. Pan is acknowledged for technical assistance with atomic-level rendering of origami models and with website construction; C. Hill for technical assistance with website construction; V. Kaushik, A. Leed, and M. Adendorff for technical assistance with QPCR; and S. Ludtke for advice on cryo-EM image processing.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Bellot G, 2011, NAT METHODS, V8, P192, DOI 10.1038/nmeth0311-192; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; BENT SW, 1987, DISCRETE APPL MATH, V18, P87, DOI 10.1016/0166-218X(87)90045-X; Bhatia D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1337; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dunn KE, 2015, NATURE, V525, P82, DOI 10.1038/nature14860; Dutta PK, 2011, J AM CHEM SOC, V133, P11985, DOI 10.1021/ja1115138; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2010, ANGEW CHEM INT EDIT, V49, P748, DOI 10.1002/anie.200904513; Helmi S, 2014, NANO LETT, V14, P6693, DOI 10.1021/nl503441v; Irobalieva RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9440; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Kato T, 2009, NANO LETT, V9, P2747, DOI 10.1021/nl901265n; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Krishnan Y, 2012, TRENDS CELL BIOL, V22, P624, DOI 10.1016/j.tcb.2012.10.001; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Liu WY, 2016, SCIENCE, V351, P582, DOI 10.1126/science.aad2080; Liu ZY, 2015, J AM CHEM SOC, V137, P1730, DOI 10.1021/ja5101307; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; Pan KY, 2014, NUCLEIC ACIDS RES, V42, P2159, DOI 10.1093/nar/gkt1269; Pandey S, 2011, P NATL ACAD SCI USA, V108, P19885, DOI 10.1073/pnas.1110857108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rothemund PWK, 2006, NAT COMP SER, P3, DOI 10.1007/3-540-30296-4_1; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Said H, 2013, NANOSCALE, V5, P284, DOI 10.1039/c2nr32393a; SEEMAN NC, 1983, BIOPHYS J, V44, P201, DOI 10.1016/S0006-3495(83)84292-1; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sun W, 2014, SCIENCE, V346, P717, DOI 10.1126/science.1258361; Surana S, 2015, NAT NANOTECHNOL, V10, P741, DOI [10.1038/NNANO.2015.180, 10.1038/nnano.2015.180]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tian Y, 2016, NAT MATER, V15, P654, DOI [10.1038/NMAT4571, 10.1038/nmat4571]; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Wooddell CI, 1996, GENOME RES, V6, P886, DOI 10.1101/gr.6.9.886; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang F, 2015, NAT NANOTECHNOL, V10, P779, DOI [10.1038/NNANO.2015.162, 10.1038/nnano.2015.162]; Zhirnov V, 2016, NAT MATER, V15, P366, DOI 10.1038/nmat4594	55	371	379	22	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293							aaf4388	10.1126/science.aaf4388	http://dx.doi.org/10.1126/science.aaf4388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27229143	Green Submitted, Green Accepted			2022-12-28	WOS:000378346500033
J	Blanco, S; Bandiera, R; Popis, M; Hussain, S; Lombard, P; Aleksic, J; Sajini, A; Tanna, H; Cortes-Garrido, R; Gkatza, N; Dietmann, S; Frye, M				Blanco, Sandra; Bandiera, Roberto; Popis, Martyna; Hussain, Shobbir; Lombard, Patrick; Aleksic, Jelena; Sajini, Abdulrahim; Tanna, Hinal; Cortes-Garrido, Rosana; Gkatza, Nikoletta; Dietmann, Sabine; Frye, Michaela			Stem cell function and stress response are controlled by protein synthesis	NATURE			English	Article							OPEN READING FRAMES; METHYLTRANSFERASE MISU NSUN2; RNA METHYLTRANSFERASE; GENE-EXPRESSION; MESSENGER-RNA; TRANSLATIONAL REGULATION; TGF-BETA; IN-VIVO; METHYLATION; IDENTIFICATION	Whether protein synthesis and cellular stress response pathways interact to control stem cell function is currently unknown. Here we show that mouse skin stem cells synthesize less protein than their immediate progenitors in vivo, even when forced to proliferate. Our analyses reveal that activation of stress response pathways drives both a global reduction of protein synthesis and altered translational programmes that together promote stem cell functions and tumorigenesis. Mechanistically, we show that inhibition of post-transcriptional cytosine-5 methylation locks tumour-initiating cells in this distinct translational inhibition programme. Paradoxically, this inhibition renders stem cells hypersensitive to cytotoxic stress, as tumour regeneration after treatment with 5-fluorouracil is blocked. Thus, stem cells must revoke translation inhibition pathways to regenerate a tissue or tumour.	[Blanco, Sandra; Bandiera, Roberto; Popis, Martyna; Lombard, Patrick; Aleksic, Jelena; Sajini, Abdulrahim; Cortes-Garrido, Rosana; Gkatza, Nikoletta; Dietmann, Sabine; Frye, Michaela] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Dept Genet, Cambridge CB2 1QR, England; [Hussain, Shobbir] Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England; [Tanna, Hinal] Univ Cambridge, CR UK, Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England	University of Cambridge; University of Bath; CRUK Cambridge Institute; University of Cambridge	Frye, M (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Dept Genet, Cambridge CB2 1QR, England.	mf364@cam.ac.uk	Sajini, Abdulrahim/AAU-9806-2020; Blanco, Sandra/B-2070-2017	Sajini, Abdulrahim/0000-0002-8600-3899; Blanco, Sandra/0000-0001-7352-9392; Garrido, Rosana/0000-0001-9420-1142; Dietmann, Sabine./0000-0001-6672-8457; Frye, Michaela/0000-0002-5636-6840	Cancer Research UK; Worldwide Cancer Research; Medical Research Council (MRC); European Research Council; EMBO; Wellcome Trust; MRC; MRC [MR/M01939X/1, G0801904] Funding Source: UKRI; Cancer Research UK [15181] Funding Source: researchfish; Medical Research Council [MC_PC_12009, G0801904, MR/M01939X/1] Funding Source: researchfish; British Skin Foundation [5010] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); British Skin Foundation	We thank J. Marioni and D. Odom for their advice on analysing the sequencing data. This work was funded by Cancer Research UK, Worldwide Cancer Research, the Medical Research Council (MRC), the European Research Council, and EMBO. Research in M.F.'s laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Cambridge Stem Cell Institute.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; Baranov PV, 2016, NAT METHODS, V13, P123, DOI 10.1038/nmeth.3738; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2015, J CELL BIOL, V209, P629, DOI 10.1083/jcb.201503129; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HIRAI Y, 1989, DEVELOPMENT, V105, P271; Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Joshi Rajiv S, 2011, Int J Trichology, V3, P57, DOI 10.4103/0974-7753.82119; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Lin HC, 2014, CLIN ORAL INVEST, V18, P1277, DOI 10.1007/s00784-013-1088-y; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schleich S, 2014, NATURE, V512, P208, DOI 10.1038/nature13401; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tang H, 2015, AGING-US, V7, P1143, DOI 10.18632/aging.100860; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Xing JY, 2015, MOL CELL BIOL, V35, P4043, DOI 10.1128/MCB.00742-15; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692	60	235	242	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					335	+		10.1038/nature18282	http://dx.doi.org/10.1038/nature18282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306184	Green Accepted			2022-12-28	WOS:000377856800025
J	Gao, Y; Cao, EH; Julius, D; Cheng, YF				Gao, Yuan; Cao, Erhu; Julius, David; Cheng, Yifan			TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action	NATURE			English	Article							CRYO-EM STRUCTURE; CAPSAICIN RECEPTOR; K+ CHANNEL; MEMBRANE; ACTIVATION; RESINIFERATOXIN; CRYSTALLIZATION; VISUALIZATION; DETERMINANTS; CAPSAZEPINE	When integral membrane proteins are visualized in detergents or other artificial systems, an important layer of information is lost regarding lipid interactions and their effects on protein structure. This is especially relevant to proteins for which lipids have both structural and regulatory roles. Here we demonstrate the power of combining electron cryo-microscopy with lipid nanodisc technology to ascertain the structure of the rat TRPV1 ion channel in a native bilayer environment. Using this approach, we determined the locations of annular and regulatory lipids and showed that specific phospholipid interactions enhance binding of a spider toxin to TRPV1 through formation of a tripartite complex. Furthermore, phosphatidylinositol lipids occupy the binding site for capsaicin and other vanilloid ligands, suggesting a mechanism whereby chemical or thermal stimuli elicit channel activation by promoting the release of bioactive lipids from a critical allosteric regulatory site.	[Gao, Yuan; Cao, Erhu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Gao, Yuan; Cheng, Yifan] Univ Calif San Francisco, Keck Adv Microscopy Lab, San Francisco, CA 94143 USA; [Gao, Yuan; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cao, Erhu] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Keck Adv Microscopy Lab, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	david.julius@ucsf.edu; ycheng@ucsf.edu		Gao, Yuan/0000-0003-1248-1828; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01NS047723, R37NS065071, R01NS055299, S10OD020054, R01GM098672, P01GM111126, P50GM082250]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM111126, T32GM008284, R01GM098672, P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R37NS065071, R01NS055299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank our laboratory colleagues, past and present, for many helpful discussions and manuscript critiques, C. Paulsen and E. Green for helping with initial screening for nanodisc reconstitution, and E. Palovcak for providing scripts for focused classification. This work was supported by grants from the National Institutes of Health (R01NS047723, R37NS065071 and R01NS055299 to D.J., S10OD020054, R01GM098672, P01GM111126 and P50GM082250 to Y.C.). Y.C. is an Investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hanson SM, 2015, BIOPHYS J, V108, P1425, DOI 10.1016/j.bpj.2015.02.013; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hilgemann DW, 2003, ANNU REV PHYSIOL, V65, P697, DOI 10.1146/annurev.physiol.65.092101.142453; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhlbrandt W, 2014, ELIFE, V3, DOI 10.7554/eLife.03678; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin F., 2007, V179, P509; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]	61	502	515	19	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					347	+		10.1038/nature17964	http://dx.doi.org/10.1038/nature17964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281200	Green Accepted, Green Submitted			2022-12-28	WOS:000377856800027
J	Czernik, Z; Lin, CT				Czernik, Zuzanna; Lin, C. T.			Time at the Bedside (Computing)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROOM		[Czernik, Zuzanna] Univ Colorado, Sch Med, Hosp Med Sect, Div Gen Internal Med, Aurora, CO USA; [Lin, C. T.] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Czernik, Z (corresponding author), Univ Colorado, Sch Med, Hosp Med Sect, Div Gen Internal Med, Aurora, CO USA.	zuzanna.czernik@ucdenver.edu	Lin, Chen-Tan/AAA-6856-2021					Block L, 2013, J GEN INTERN MED, V28, P1042, DOI 10.1007/s11606-013-2376-6; Frankel R, 2005, J GEN INTERN MED, V20, P677, DOI 10.1111/j.1525-1497.2005.0163.x; Frankel RM, 2016, JAMA INTERN MED, V176, P128, DOI 10.1001/jamainternmed.2015.6559; PARENTI C, 1993, AM J MED, V94, P654, DOI 10.1016/0002-9343(93)90220-J; PAYSON HE, 1961, NEW ENGL J MED, V264, P439, DOI 10.1056/NEJM196103022640906; Verghese A., 2011, NY TIMES; Wachter R, 2017, DIGITAL DOCTOR HOPE; ZDoggMD, 2015, EHR STATE OF MIND	8	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2399	2400		10.1001/jama.2016.1722	http://dx.doi.org/10.1001/jama.2016.1722			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299616				2022-12-28	WOS:000377656900014
J	Stappenbeck, TS; Virgin, HW				Stappenbeck, Thaddeus S.; Virgin, Herbert W.			Accounting for reciprocal host-microbiome interactions in experimental science	NATURE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL MICROBIOME; ENTERIC VIRUS; MOUSE MODEL; DISEASE; VIROME; INFECTION; IMMUNODEFICIENCY; METABOLITES	Mammals are defined by their metagenome, a combination of host and microbiome genes. This knowledge presents opportunities to further basic biology with translation to human diseases. However, the now-documented influence of the metagenome on experimental results and the reproducibility of in vivo mammalian models present new challenges. Here we provide the scientific basis for calling on all investigators, editors and funding agencies to embrace changes that will enhance reproducible and interpretable experiments by accounting for metagenomic effects. Implementation of new reporting and experimental design principles will improve experimental work, speed discovery and translation, and properly use substantial investments in biomedical research.	[Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 South Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Stappenbeck, TS; Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 South Euclid Ave, St Louis, MO 63110 USA.	stappenb@pathology.wustl.edu; virgin@wustl.edu		Virgin, Herbert/0000-0001-8580-7628				Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atkinson MA, 2012, DIABETOLOGIA, V55, P2868, DOI 10.1007/s00125-012-2672-4; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Beck JM, 2015, AM J RESP CRIT CARE, V192, P1335, DOI 10.1164/rccm.201501-0128OC; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dantas G, 2012, CURR OPIN MICROBIOL, V15, P577, DOI 10.1016/j.mib.2012.07.004; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Eberl G, 2015, MUCOSAL IMMUNOL, V8, P487, DOI 10.1038/mi.2015.26; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Farkas AM, 2015, J IMMUNOL METHODS, V421, P104, DOI 10.1016/j.jim.2015.03.020; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; HALL JE, 1980, LAB ANIM SCI, V30, P643; Handley SA, 2016, CELL HOST MICROBE, V19, P323, DOI 10.1016/j.chom.2016.02.010; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang EY, 2015, INFLAMM BOWEL DIS, V21, P963, DOI 10.1097/MIB.0000000000000332; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ijssennagger N, 2015, P NATL ACAD SCI USA, V112, P10038, DOI 10.1073/pnas.1507645112; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; Macpherson AJ, 2015, MUCOSAL IMMUNOL, V8, P476, DOI 10.1038/mi.2014.113; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McInnes EE, 2011, LAB ANIMAL, V40, P341, DOI 10.1038/laban1111-341; Metchnikoff Olga, 1921, LIFE ELIE METCHNIKOF; Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Moon C, 2012, CURR OPIN IMMUNOL, V24, P405, DOI 10.1016/j.coi.2012.05.002; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Mutlu EA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003829; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Ryu SH, 2015, IMMUNITY, V43, P216, DOI 10.1016/j.immuni.2015.08.003; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sefik E., 2015, SCIENCE; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Underhill DM, 2014, NAT REV IMMUNOL, V14, P405, DOI 10.1038/nri3684; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wheeler ML, 2014, NAT IMMUNOL, V15, P1000, DOI 10.1038/ni.3013; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wolf KJ, 2014, J HISTOCHEM CYTOCHEM, V62, P237, DOI 10.1369/0022155413519650; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	120	149	152	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					191	199		10.1038/nature18285	http://dx.doi.org/10.1038/nature18285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279212				2022-12-28	WOS:000377475100030
J	Manson, JE; Shufelt, CL; Robins, JM				Manson, Joann E.; Shufelt, Chrisandra L.; Robins, James M.			The Potential for Postrandomization Confounding in Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY		Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, 900 Commonwealth Ave Third Floor, Boston, MA 02215 USA; [Shufelt, Chrisandra L.] Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA USA; [Robins, James M.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, 900 Commonwealth Ave Third Floor, Boston, MA 02215 USA; [Robins, James M.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, 900 Commonwealth Ave Third Floor, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cedars Sinai Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Univ, Brigham andWomens Hosp, Sch Med, 900 Commonwealth Ave Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu		Shufelt, Chrisandra/0000-0001-6886-9210				Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Herrington DM, 2002, CIRCULATION, V105, P2962, DOI 10.1161/01.CIR.0000019406.74017.B2; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	5	30	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2273	2274		10.1001/jama.2016.3676	http://dx.doi.org/10.1001/jama.2016.3676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272576				2022-12-28	WOS:000377183100012
J	Wu, LS; Gannon, WJ; Zaliznyak, IA; Tsvelik, AM; Brockmann, M; Caux, JS; Kim, MS; Qiu, Y; Copley, JRD; Ehlers, G; Podlesnyak, A; Aronson, MC				Wu, L. S.; Gannon, W. J.; Zaliznyak, I. A.; Tsvelik, A. M.; Brockmann, M.; Caux, J. -S.; Kim, M. S.; Qiu, Y.; Copley, J. R. D.; Ehlers, G.; Podlesnyak, A.; Aronson, M. C.			Orbital-exchange and fractional quantum number excitations in an f-electron metal, Yb2Pt2Pb	SCIENCE			English	Article							SPIN; CHAIN; ANTIFERROMAGNET; MAGNETISM	Exotic quantum states and fractionalized magnetic excitations, such as spinons in one-dimensional chains, are generally expected to occur in 3d transition metal systems with spin 1/2. Our neutron-scattering experiments on the 4f-electron metal Yb2Pt2Pb overturn this conventional wisdom. We observe broad magnetic continuum dispersing in only one direction, which indicates that the underlying elementary excitations are spinons carrying fractional spin-1/2. These spinons are the emergent quantum dynamics of the anisotropic, orbital-dominated Yb moments. Owing to their unusual origin, only longitudinal spin fluctuations are measurable, whereas the transverse excitations such as spin waves are virtually invisible to magnetic neutron scattering. The proliferation of these orbital spinons strips the electrons of their orbital identity, resulting in charge-orbital separation.	[Wu, L. S.; Gannon, W. J.; Aronson, M. C.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Wu, L. S.; Gannon, W. J.; Zaliznyak, I. A.; Tsvelik, A. M.; Kim, M. S.; Aronson, M. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Div, Upton, NY 11973 USA; [Wu, L. S.; Ehlers, G.; Podlesnyak, A.] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Gannon, W. J.; Aronson, M. C.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Brockmann, M.] Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany; [Brockmann, M.; Caux, J. -S.] Univ Amsterdam, Inst Theoret Phys, NL-1098 XH Amsterdam, Netherlands; [Qiu, Y.; Copley, J. R. D.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Texas A&M University System; Texas A&M University College Station; Max Planck Society; University of Amsterdam; National Institute of Standards & Technology (NIST) - USA	Zaliznyak, IA (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Div, Upton, NY 11973 USA.	zaliznyak@bnl.gov	Ehlers, Georg/B-5412-2008; Wu, Liusuo/A-5611-2016; Zaliznyak, Igor/E-8532-2014; Zaliznyak, Igor/AAW-2535-2020; Podlesnyak, Andrey/A-5593-2013	Ehlers, Georg/0000-0003-3513-508X; Wu, Liusuo/0000-0003-0103-5267; Zaliznyak, Igor/0000-0002-8548-7924; Zaliznyak, Igor/0000-0002-8548-7924; Podlesnyak, Andrey/0000-0001-9366-6319; Gannon, William/0000-0001-5635-2185	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, U.S. Department of Energy (DOE) [DE-SC00112704]; NSF [DMR-131008, DMR-1508249]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. DOE; Netherlands Organization for Scientific Research (NWO); Foundation for Fundamental Research on Matter (FOM) of the Netherlands; Direct For Mathematical & Physical Scien [1310008] Funding Source: National Science Foundation	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, U.S. Department of Energy (DOE); NSF(National Science Foundation (NSF)); Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. DOE(United States Department of Energy (DOE)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM) of the Netherlands(FOM (The Netherlands)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Work at Brookhaven National Laboratory (I.A.Z., A.M.T., M.S.K.) was supported by the Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, U.S. Department of Energy (DOE), under contract DE-SC00112704. Work at Stony Brook (L.S.W., W.J.G., M.C.A.) was supported by NSF-DMR-131008. L.S.W. was also supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL). This research at ORNL's Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. DOE. Work at NIST Center for Neutron Research (NCNR) is supported in part by the NSF under Agreement no. DMR-1508249. J.-S.C. and M.B. acknowledge support from the Netherlands Organization for Scientific Research (NWO) and the Foundation for Fundamental Research on Matter (FOM) of the Netherlands.	Anderson PW, 1997, PHYS TODAY, V50, P42, DOI 10.1063/1.881959; Baxter R. J., 1973, J STAT PHYS, V9, P145, DOI 10.1007/bf01016845; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Bougourzi AH, 1998, PHYS REV B, V57, P11429, DOI 10.1103/PhysRevB.57.11429; Caux JS, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/12/P12013; Caux JS, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08006; COLEMAN P, 1983, PHYS REV B, V28, P5255, DOI 10.1103/PhysRevB.28.5255; COQBLIN B, 1969, PHYS REV, V185, P847, DOI 10.1103/PhysRev.185.847; Dirac PAM, 1929, P R SOC LOND A-CONTA, V123, P714, DOI 10.1098/rspa.1929.0094; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; Gorshkov AV, 2010, NAT PHYS, V6, P289, DOI 10.1038/NPHYS1535; Heisenberg W, 1928, Z PHYS, V49, P619, DOI 10.1007/BF01328601; Huberman T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014413; ISHIMURA N, 1980, PROG THEOR PHYS, V63, P743, DOI 10.1143/PTP.63.743; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim MS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017201; Kim MS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144425; KUGEL KI, 1973, ZH EKSP TEOR FIZ+, V64, P1429; Miiller W, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.104419; Mourigal M, 2013, NAT PHYS, V9, P435, DOI [10.1038/nphys2652, 10.1038/NPHYS2652]; Ochiai A, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.123705; Schlappa J, 2012, NATURE, V485, P82, DOI 10.1038/nature10974; SHASTRY BS, 1981, PHYSICA B & C, V108, P1069, DOI 10.1016/0378-4363(81)90838-X; Slater JC, 1930, PHYS REV, V36, P0057, DOI 10.1103/PhysRev.36.57; Squires G. L, 2012, INTRO THEORY THERMAL, DOI DOI 10.1017/; Tennant DA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.054414; Uimin G, 2000, EUR PHYS J B, V16, P241, DOI 10.1007/s100510070225; Walters AC, 2009, NAT PHYS, V5, P867, DOI 10.1038/NPHYS1405; Zaliznyak IA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.017202	29	57	57	5	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1206	1210		10.1126/science.aaf0981	http://dx.doi.org/10.1126/science.aaf0981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257254	Green Submitted, Green Published			2022-12-28	WOS:000377045700039
J	Hawkes, N				Hawkes, Nigel			The travesty of expensive insulin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Greene JA, 2015, NEW ENGL J MED, V372, P1171, DOI 10.1056/NEJMms1411398; HAWKES N, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H5337; Holden Sarah E, 2011, BMJ Open, V1, pe000258, DOI 10.1136/bmjopen-2011-000258; Hua XY, 2016, JAMA-J AM MED ASSOC, V315, P1400, DOI 10.1001/jama.2016.0126; Lipska K., 2016, NY TIMES	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i2933	10.1136/bmj.i2933	http://dx.doi.org/10.1136/bmj.i2933			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255667				2022-12-28	WOS:000377479000002
J	Kmietowicz, Z				Kmietowicz, Zosia			Statins could be new treatment option in women with oestrogen receptor positive breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Simigdala N, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0713-5	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3108	10.1136/bmj.i3108	http://dx.doi.org/10.1136/bmj.i3108			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27257183				2022-12-28	WOS:000377479000013
J	Lu, FL; Liu, YT; Inoue, A; Suzuki, T; Zhao, KJ; Zhang, Y				Lu, Falong; Liu, Yuting; Inoue, Azusa; Suzuki, Tsukasa; Zhao, Keji; Zhang, Yi			Establishing Chromatin Regulatory Landscape during Mouse Preimplantation Development	CELL			English	Article							MASTER TRANSCRIPTION FACTORS; TO-ZYGOTIC TRANSITION; GENE-EXPRESSION; HYPERSENSITIVE SITES; DNA LANDSCAPES; CELL FATE; GENOME; ACCESSIBILITY; EMBRYO; DYNAMICS	How the chromatin regulatory landscape in the inner cell mass cells is established from differentially packaged sperm and egg genomes during preimplantation development is unknown. Here, we develop a low-input DNase I sequencing (liDNase-seq) method that allows us to generate maps of DNase I-hypersensitive site (DHS) of mouse preimplantation embryos from 1-cell to morula stage. The DHS landscape is progressively established with a drastic increase at the 8-cell stage. Paternal chromatin accessibility is quickly reprogrammed after fertilization to the level similar to maternal chromatin, while imprinted genes exhibit allelic accessibility bias. We demonstrate that transcription factor Nfya contributes to zygotic genome activation and DHS formation at the 2-cell stage and that Oct4 contributes to the DHSs gained at the 8-cell stage. Our study reveals the dynamic chromatin regulatory landscape during early development and identifies key transcription factors important for DHS establishment in mammalian embryos.	[Lu, Falong; Liu, Yuting; Inoue, Azusa; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lu, Falong; Liu, Yuting; Inoue, Azusa; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lu, Falong; Liu, Yuting; Inoue, Azusa; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, WAB 149G,200 Longwood Ave, Boston, MA 02115 USA; [Zhao, Keji] NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Stem Cell Inst, WAB 149G,200 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Lu, Falong/Q-3013-2016	Lu, Falong/0000-0002-8321-4818	HHMI; Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL005801, ZICHL006058] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Shinpei Yamaguchi for helpful discussion and Dr. Luis Tuesta for critical reading of the manuscript. This project is supported by HHMI. F.L. is supported by a Charles A. King Trust Postdoctoral Research Fellowship. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Feil R, 1997, J BIOL CHEM, V272, P20893, DOI 10.1074/jbc.272.33.20893; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Jenkins Timothy G., 2012, Frontiers in Genetics, V3, P143, DOI 10.3389/fgene.2012.00143; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lu FL, 2015, NATL SCI REV, V2, P217, DOI 10.1093/nsr/nwv009; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Svoboda P, 2015, CURR TOP DEV BIOL, V113, P305, DOI 10.1016/bs.ctdb.2015.06.004; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Watanabe T, 2000, HUM MOL GENET, V9, P3029, DOI 10.1093/hmg/9.20.3029; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WIEKOWSKI M, 1991, DEV BIOL, V147, P403, DOI 10.1016/0012-1606(91)90298-H; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364	41	169	181	4	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1375	1388		10.1016/j.cell.2016.05.050	http://dx.doi.org/10.1016/j.cell.2016.05.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259149	Bronze, Green Accepted			2022-12-28	WOS:000377045400012
J	McKinnon, WB; Nimmo, F; Wong, T; Schenk, PM; White, OL; Roberts, JH; Moore, JM; Spencer, JR; Howard, AD; Umurhan, OM; Stern, SA; Weaver, HA; Olkin, CB; Young, LA; Smith, KE				McKinnon, William B.; Nimmo, Francis; Wong, Teresa; Schenk, Paul M.; White, Oliver L.; Roberts, J. H.; Moore, J. M.; Spencer, J. R.; Howard, A. D.; Umurhan, O. M.; Stern, S. A.; Weaver, H. A.; Olkin, C. B.; Young, L. A.; Smith, K. E.		New Horizons Geology Geophys	Convection in a volatile nitrogen-ice-rich layer drives Pluto's geological vigour	NATURE			English	Article							VISCOSITY; RHEOLOGY; IMPACT; RELAXATION; SURFACE; MANTLE; ONSET	The vast, deep, volatile-ice-filled basin informally named Sputnik Planum is central to Pluto's vigorous geological activity(1,2). Composed of molecular nitrogen, methane, and carbon monoxide ices(3), but dominated by nitrogen ice, this layer is organized into cells or polygons, typically about 10 to 40 kilometres across, that resemble the surface manifestation of solid-state convection(1,2). Here we report, on the basis of available rheological measurements(4), that solid layers of nitrogen ice with a thickness in excess of about one kilometre should undergo convection for estimated presentday heat-flow conditions on Pluto. More importantly, we show numerically that convective overturn in a several-kilometre-thick layer of solid nitrogen can explain the great lateral width of the cells. The temperature dependence of nitrogen-ice viscosity implies that the ice layer convects in the so-called sluggish lid regime(5), a unique convective mode not previously definitively observed in the Solar System. Average surface horizontal velocities of a few centimetres a year imply surface transport or renewal times of about 500,000 years, well under the ten-million-year upper-limit crater retention age for Sputnik Planum(2). Similar convective surface renewal may also occur on other dwarf planets in the Kuiper belt, which may help to explain the high albedos shown by some of these bodies.	[McKinnon, William B.; Wong, Teresa] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [McKinnon, William B.; Wong, Teresa] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Schenk, Paul M.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [White, Oliver L.; Moore, J. M.; Umurhan, O. M.; Smith, K. E.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Roberts, J. H.; Weaver, H. A.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Spencer, J. R.; Stern, S. A.; Olkin, C. B.; Young, L. A.] SW Res Inst, Boulder, CO 80302 USA; [Howard, A. D.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Virginia	McKinnon, WB (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.; McKinnon, WB (corresponding author), Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA.	mckinnon@wustl.edu	Roberts, James/AAI-3283-2020; Roberts, James H/I-9030-2012; Olkin, Catherine/AAF-5160-2019; Lisse, Carey M/B-7772-2016; Weaver, Harold A/D-9188-2016	Roberts, James/0000-0002-2671-3207; Roberts, James H/0000-0003-1766-6127; Olkin, Catherine/0000-0002-5846-716X; Lisse, Carey M/0000-0002-9548-1526; Weaver, Harold A/0000-0003-0951-7762; Lauer, Tod/0000-0003-3234-7247; Grundy, Will/0000-0002-8296-6540; Bray, Veronica/0000-0002-7277-3980; Stansberry, John/0000-0003-2434-5225; Parker, Joel/0000-0002-3672-0603	NASA's New Horizons project	NASA's New Horizons project	New Horizons was built and operated by the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, USA, for NASA. We thank the many engineers who have contributed to the success of the New Horizons mission, and NASA's Deep Space Network (DSN) for a decade of support of New Horizons. This work was supported by NASA's New Horizons project.	Barr AC, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002781; Barr AC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028799; Bland MT, 2015, ICARUS, V245, P247, DOI 10.1016/j.icarus.2014.09.008; Brown M.E., 2008, SOLAR SYSTEM NEPTUNE, P335; Cruikshank D.P., 1997, PLUTO CHARON, P221; Durham WB, 2010, SPACE SCI REV, V153, P273, DOI 10.1007/s11214-009-9619-1; Elbeshausen D, 2013, J GEOPHYS RES-PLANET, V118, P2295, DOI 10.1002/2013JE004477; ELUSZKIEWICZ J, 1990, GEOPHYS RES LETT, V17, P1753, DOI 10.1029/GL017i010p01753; ELUSZKIEWICZ J, 1991, J GEOPHYS RES-PLANET, V96, P19217, DOI 10.1029/91JA01858; ESTEVE D, 1981, SOLID STATE COMMUN, V39, P969, DOI 10.1016/0038-1098(81)90067-3; Frost H.J., 1982, DEFORMATION MECH MAP; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; Hammond NP, 2014, ICARUS, V227, P206, DOI 10.1016/j.icarus.2013.08.024; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; McKinnon W., 1997, PLUTO CHARON, P259; McKinnon W. B., 2016, LUNAR PLANET SCI C, V47; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Moore JM, 2015, ICARUS, V246, P65, DOI 10.1016/j.icarus.2014.04.028; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Protopapa S., 2016, P LUNAR PLANET SCI C, V47; Robuchon G, 2011, ICARUS, V216, P426, DOI 10.1016/j.icarus.2011.08.015; Robuchon G, 2011, ICARUS, V214, P82, DOI 10.1016/j.icarus.2011.05.011; Schenk P. M., 2015, AAS DIV PLAN SCI M, V47; Schenk PM, 2004, ICARUS, V169, P98, DOI 10.1016/j.icarus.2004.01.015; Schenk PM, 2002, NATURE, V417, P419, DOI 10.1038/417419a; Schubert G, 2001, MANTLE CONVECTION EA; Scott T. A., 1976, Physics Reports. Physics Letters Section C, V27c, P89, DOI 10.1016/0370-1573(76)90032-6; Singer KN, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/2/L50; Solomatov VS, 2007, PHYS EARTH PLANET IN, V165, P1, DOI 10.1016/j.pepi.2007.06.007; SOLOMATOV VS, 1995, PHYS FLUIDS, V7, P266, DOI 10.1063/1.868624; Solomatov VS, 1997, GEOPHYS RES LETT, V24, P1907, DOI 10.1029/97GL01682; Stansberry JA, 1999, ICARUS, V141, P299, DOI 10.1006/icar.1999.6169; STENGEL KC, 1982, J FLUID MECH, V120, P411, DOI 10.1017/S0022112082002821; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern SA, 2015, ICARUS, V250, P287, DOI 10.1016/j.icarus.2014.12.006; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032	40	74	74	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					82	+		10.1038/nature18289	http://dx.doi.org/10.1038/nature18289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251279	Green Submitted			2022-12-28	WOS:000376962300037
J	Charpentier, M; Sun, JH; Martins, TV; Radhakrishnan, GV; Findlay, K; Soumpourou, E; Thouin, J; Very, AA; Sanders, D; Morris, RJ; Oldroyd, GED				Charpentier, Myriam; Sun, Jongho; Martins, Teresa Vaz; Radhakrishnan, Guru V.; Findlay, Kim; Soumpourou, Eleni; Thouin, Julien; Very, Anne-Alienor; Sanders, Dale; Morris, Richard J.; Oldroyd, Giles E. D.			Nuclear-localized cyclic nucleotide-gated channels mediate symbiotic calcium oscillations	SCIENCE			English	Article							ARABIDOPSIS; RESPONSES; MEMBRANE; SPIKING; PLANTS	Nuclear-associated Ca2+ oscillationsmediate plant responses to beneficial microbial partners-namely, nitrogen-fixing rhizobial bacteria that colonize roots of legumes and arbuscular mycorrhizal fungi that colonize roots of the majority of plant species. A potassium-permeable channel is known to be required for symbiotic Ca2+ oscillations, but the calcium channels themselves have been unknown until now. We show that three cyclic nucleotide-gated channels in Medicago truncatula are required for nuclear Ca2+ oscillations and subsequent symbiotic responses. These cyclic nucleotide-gated channels are located at the nuclear envelope and are permeable to Ca2+. We demonstrate that the cyclic nucleotide-gated channels form a complex with the postassium-permeable channel, which modulates nuclear Ca2+ release. These channels, like their counterparts in animal cells, might regulate multiple nuclear Ca2+ responses to developmental and environmental conditions.	[Charpentier, Myriam; Sun, Jongho; Radhakrishnan, Guru V.; Findlay, Kim; Soumpourou, Eleni; Oldroyd, Giles E. D.] John Innes Ctr Plant Sci Res, Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Martins, Teresa Vaz; Morris, Richard J.] John Innes Ctr Plant Sci Res, Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Thouin, Julien; Very, Anne-Alienor] Univ Montpellier, Lab Biochim & Physiol Mol Plantes, UMR CNRS 386 5004, INRA French Natl Inst Agr Res,SupAgro M, Campus SupAgro INRA, F-34060 Montpellier, France; [Sanders, Dale] John Innes Ctr Plant Sci Res, Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Charpentier, M; Oldroyd, GED (corresponding author), John Innes Ctr Plant Sci Res, Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	myriam.charpentier@jic.ac.uk; giles.oldroyd@jic.ac.uk	Sun, Jongho/AAL-6673-2020; Oldroyd, Giles/ABA-7501-2020; Radhakrishnan, Guru/K-3881-2017; Oldroyd, Giles/ABD-8143-2021; Charpentier, Myriam/AAL-4624-2021; Sun, Jongho/G-5235-2016	Sun, Jongho/0000-0002-3705-3072; Radhakrishnan, Guru/0000-0003-0381-8804; Oldroyd, Giles/0000-0002-5245-6355; Sun, Jongho/0000-0002-3705-3072; Thouin, Julien/0000-0001-8229-6156; VERY, Anne-Alienor/0000-0003-1961-5243; Findlay, Kim/0000-0002-1556-0532; Morris, Richard/0000-0003-3080-2613	Biotechnology and Biological Sciences Research Council [BB/J004553/1, BB/J018627/1]; European Research Council; BBSRC [BB/J018627/1, BB/J008737/1, BBS/E/J/000CA491] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008737/1, BBS/E/J/00000603, BBS/E/J/00000611, BBS/E/J/000CA491] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J.-M. Ane for the construct 35S:DMI1:GFP, E. Peiter for the cch1/mid1 mutant, G. Calder for confocal help, E. Barclay for immunogold labeling, P. Bailey for bioinformatics, K. Mysore and J. Wen for Tnt1 mutant screening, and M. Hopkins for models of CNGC action. The work was supported by the Biotechnology and Biological Sciences Research Council (grants BB/J004553/1 and BB/J018627/1) and by the European Research Council (SYMBIOSIS project). M.C. and G.E.D.O. directed the research. M.C. performed the experiments with contributions by J.S. (calcium spiking), T.V.M. and R.J.M. (mathematical modeling), G.V.R. (phylogeny), K.F. (immunogold labeling and electron microscopy), E.S. (RNA extraction and quantitative reverse transcriptase polymerase chain reaction), and J.T. and A.-A.V. (electrophysiology). M.C., G.E.D.O., and D.S. wrote the manuscript. The supplementary materials contain additional data.	Borsics T, 2007, PLANTA, V225, P563, DOI 10.1007/s00425-006-0372-3; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Charpentier M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22894; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Iwano M, 2012, DEVELOPMENT, V139, P4202, DOI 10.1242/dev.081208; Laba JK, 2014, CURR OPIN CELL BIOL, V28, P36, DOI 10.1016/j.ceb.2014.01.006; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Oliveira AG, 2014, PHYSIOLOGY, V29, P361, DOI 10.1152/physiol.00056.2013; Pauly N, 2000, NATURE, V405, P754, DOI 10.1038/35015671; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yuen CCY, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt012	18	143	151	6	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1102	1105		10.1126/science.aae0109	http://dx.doi.org/10.1126/science.aae0109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230377				2022-12-28	WOS:000376480800039
J	Okbay, A; Beauchamp, JP; Fontana, MA; Lee, JJ; Pers, TH; Rietveld, CA; Turley, P; Chen, GB; Emilsson, V; Meddens, SFW; Oskarsson, S; Pickrell, JK; Thom, K; Timshel, P; de Vlaming, R; Abdellaoui, A; Ahluwalia, TS; Bacelis, J; Baumbach, C; Bjornsdottir, G; Brandsma, JH; Concas, MP; Derringer, J; Furlotte, NA; Galesloot, TE; Girotto, G; Gupta, R; Hall, LM; Harris, SE; Hofer, E; Horikoshi, M; Huffman, JE; Kaasik, K; Kalafati, IP; Karlsson, R; Kong, A; Lahti, J; van der Lee, SJ; de Leeuw, C; Lind, PA; Lindgren, KO; Liu, T; Mangino, M; Marten, J; Mihailov, E; Miller, MB; van der Most, PJ; Oldmeadow, C; Payton, A; Pervjakova, N; Peyrot, WJ; Qian, Y; Raitakari, O; Rueedi, R; Salvi, E; Schmidt, B; Schraut, KE; Shi, JX; Smith, AV; Poot, RA; St Pourcain, B; Teumer, A; Thorleifsson, G; Verweij, N; Vuckovic, D; Wellmann, J; Westra, HJ; Yang, JY; Zhao, W; Zhu, ZH; Alizadeh, BZ; Amin, N; Bakshi, A; Baumeister, SE; Biino, G; Bonnelykke, K; Boyle, PA; Campbell, H; Cappuccio, FP; Davies, G; De Neve, JE; Deloukas, P; Demuth, I; Ding, J; Eibich, P; Eisele, L; Eklund, N; Evans, DM; Faul, JD; Feitosa, MF; Forstner, AJ; Gandin, I; Gunnarsson, B; Halldorsson, BV; Harris, TB; Heath, AC; Hocking, LJ; Holliday, EG; Homuth, G; Horan, MA; Hottenga, JJ; de Jager, PL; Joshi, PK; Jugessur, A; Kaakinen, MA; Kahonen, M; Kanoni, S; Keltigangas-Jarvinen, L; Kiemeney, LALM; Kolcic, I; Koskinen, S; Kraja, AT; Kroh, M; Kutalik, Z; Latvala, A; Launer, LJ; Lebreton, MP; Levinson, DF; Lichtenstein, P; Lichtner, P; Liewald, DCM; Loukola, A; Madden, PA; Magi, R; Maki-Opas, T; Marioni, RE; Marques-Vidal, P; Meddens, GA; McMahon, G; Meisinger, C; Meitinger, T; Milaneschi, Y; Milani, L; Montgomery, GW; Myhre, R; Nelson, CP; Nyholt, DR; Ollier, WER; Palotie, A; Paternoster, L; Pedersen, NL; Petrovic, KE; Porteous, DJ; Raikkonen, K; Ring, SM; Robino, A; Rostapshova, O; Rudan, I; Rustichini, A; Salomaa, V; Sanders, AR; Sarin, AP; Schmidt, H; Scott, RJ; Smith, BH; Smith, JA; Staessen, JA; Steinhagen-Thiessen, E; Strauch, K; Terracciano, A; Tobin, MD; Ulivi, S; Vaccargiu, S; Quaye, L; van Rooij, FJA; Venturini, C; Vinkhuyzen, AAE; Volker, U; Volzke, H; Vonk, JM; Vozzi, D; Waage, J; Ware, EB; Willemsen, G; Attia, JR; Bennett, DA; Berger, K; Bertram, L; Bisgaard, H; Boomsma, DI; Borecki, IB; Bultmann, U; Chabris, CF; Cucca, F; Cusi, D; Deary, IJ; Dedoussis, GV; van Duijn, CM; Eriksson, JG; Franke, B; Franke, L; Gasparini, P; Gejman, PV; Gieger, C; Grabe, HJ; Gratten, J; Groenen, PJF; Gudnason, V; van der Harst, P; Hayward, C; Hinds, DA; Hoffmann, W; Hyppnen, E; Iacono, WG; Jacobsson, B; Jarvelin, MR; Jockel, KH; Kaprio, J; Kardia, SLR; Lehtimaki, T; Lehrer, SF; Magnusson, PKE; Martin, NG; McGue, M; Metspalu, A; Pendleton, N; Penninx, BWJH; Perola, M; Pirastu, N; Pirastu, M; Polasek, O; Posthuma, D; Power, C; Province, MA; Samani, NJ; Schlessinger, D; Schmidt, R; Sorensen, TIA; Spector, TD; Stefansson, K; Thorsteinsdottir, U; Thurik, AR; Timpson, NJ; Tiemeier, H; Tung, JY; Uitterlinden, AG; Vitart, V; Vollenweider, P; Weir, DR; Wilson, JF; Wright, AF; Conley, DC; Krueger, RF; Smith, GD; Hofman, A; Laibson, DI; Medland, SE; Meyer, MN; Yang, J; Johannesson, M; Visscher, PM; Esko, T; Koellinger, PD; Cesarini, D; Benjamin, DJ				Okbay, Aysu; Beauchamp, Jonathan P.; Fontana, Mark Alan; Lee, James J.; Pers, Tune H.; Rietveld, Cornelius A.; Turley, Patrick; Chen, Guo-Bo; Emilsson, Valur; Meddens, S. Fleur W.; Oskarsson, Sven; Pickrell, Joseph K.; Thom, Kevin; Timshel, Pascal; de Vlaming, Ronald; Abdellaoui, Abdel; Ahluwalia, Tarunveer S.; Bacelis, Jonas; Baumbach, Clemens; Bjornsdottir, Gyda; Brandsma, Johannes H.; Concas, Maria Pina; Derringer, Jaime; Furlotte, Nicholas A.; Galesloot, Tessel E.; Girotto, Giorgia; Gupta, Richa; Hall, Leanne M.; Harris, Sarah E.; Hofer, Edith; Horikoshi, Momoko; Huffman, Jennifer E.; Kaasik, Kadri; Kalafati, Ioanna P.; Karlsson, Robert; Kong, Augustine; Lahti, Jari; van der Lee, Sven J.; de Leeuw, Christiaan; Lind, Penelope A.; Lindgren, Karl-Oskar; Liu, Tian; Mangino, Massimo; Marten, Jonathan; Mihailov, Evelin; Miller, Michael B.; van der Most, Peter J.; Oldmeadow, Christopher; Payton, Antony; Pervjakova, Natalia; Peyrot, Wouter J.; Qian, Yong; Raitakari, Olli; Rueedi, Rico; Salvi, Erika; Schmidt, Brge; Schraut, Katharina E.; Shi, Jianxin; Smith, Albert V.; Poot, Raymond A.; St Pourcain, Beate; Teumer, Alexander; Thorleifsson, Gudmar; Verweij, Niek; Vuckovic, Dragana; Wellmann, Juergen; Westra, Harm-Jan; Yang, Jingyun; Zhao, Wei; Zhu, Zhihong; Alizadeh, Behrooz Z.; Amin, Najaf; Bakshi, Andrew; Baumeister, Sebastian E.; Biino, Ginevra; Bonnelykke, Klaus; Boyle, Patricia A.; Campbell, Harry; Cappuccio, Francesco P.; Davies, Gail; De Neve, Jan-Emmanuel; Deloukas, Panos; Demuth, Ilja; Ding, Jun; Eibich, Peter; Eisele, Lewin; Eklund, Niina; Evans, David M.; Faul, Jessica D.; Feitosa, Mary F.; Forstner, Andreas J.; Gandin, Ilaria; Gunnarsson, Bjarni; Halldorsson, Bjarni V.; Harris, Tamara B.; Heath, Andrew C.; Hocking, Lynne J.; Holliday, Elizabeth G.; Homuth, Georg; Horan, Michael A.; Hottenga, Jouke-Jan; de Jager, Philip L.; Joshi, Peter K.; Jugessur, Astanand; Kaakinen, Marika A.; Kahonen, Mika; Kanoni, Stavroula; Keltigangas-Jarvinen, Liisa; Kiemeney, Lambertus A. L. M.; Kolcic, Ivana; Koskinen, Seppo; Kraja, Aldi T.; Kroh, Martin; Kutalik, Zoltan; Latvala, Antti; Launer, Lenore J.; Lebreton, Mael P.; Levinson, Douglas F.; Lichtenstein, Paul; Lichtner, Peter; Liewald, David C. M.; Loukola, Anu; Madden, Pamela A.; Magi, Reedik; Maki-Opas, Tomi; Marioni, Riccardo E.; Marques-Vidal, Pedro; Meddens, Gerardus A.; McMahon, George; Meisinger, Christa; Meitinger, Thomas; Milaneschi, Yusplitri; Milani, Lili; Montgomery, Grant W.; Myhre, Ronny; Nelson, Christopher P.; Nyholt, Dale R.; Ollier, William E. R.; Palotie, Aarno; Paternoster, Lavinia; Pedersen, Nancy L.; Petrovic, Katja E.; Porteous, David J.; Raikkonen, Katri; Ring, Susan M.; Robino, Antonietta; Rostapshova, Olga; Rudan, Igor; Rustichini, Aldo; Salomaa, Veikko; Sanders, Alan R.; Sarin, Antti-Pekka; Schmidt, Helena; Scott, Rodney J.; Smith, Blair H.; Smith, Jennifer A.; Staessen, Jan A.; Steinhagen-Thiessen, Elisabeth; Strauch, Konstantin; Terracciano, Antonio; Tobin, Martin D.; Ulivi, Sheila; Vaccargiu, Simona; Quaye, Lydia; van Rooij, Frank J. A.; Venturini, Cristina; Vinkhuyzen, Anna A. E.; Volker, Uwe; Volzke, Henry; Vonk, Judith M.; Vozzi, Diego; Waage, Johannes; Ware, Erin B.; Willemsen, Gonneke; Attia, John R.; Bennett, David A.; Berger, Klaus; Bertram, Lars; Bisgaard, Hans; Boomsma, Dorret I.; Borecki, Ingrid B.; Bultmann, Ute; Chabris, Christopher F.; Cucca, Francesco; Cusi, Daniele; Deary, Ian J.; Dedoussis, George V.; van Duijn, Cornelia M.; Eriksson, Johan G.; Franke, Barbara; Franke, Lude; Gasparini, Paolo; Gejman, Pablo V.; Gieger, Christian; Grabe, Hans-Jorgen; Gratten, Jacob; Groenen, Patrick J. F.; Gudnason, Vilmundur; van der Harst, Pim; Hayward, Caroline; Hinds, David A.; Hoffmann, Wolfgang; Hyppnen, Elina; Iacono, William G.; Jacobsson, Bo; Jarvelin, Marjo-Riitta; Jockel, Karl-Heinz; Kaprio, Jaakko; Kardia, Sharon L. R.; Lehtimaki, Terho; Lehrer, Steven F.; Magnusson, Patrik K. E.; Martin, Nicholas G.; McGue, Matt; Metspalu, Andres; Pendleton, Neil; Penninx, Brenda W. J. H.; Perola, Markus; Pirastu, Nicola; Pirastu, Mario; Polasek, Ozren; Posthuma, Danielle; Power, Christine; Province, Michael A.; Samani, Nilesh J.; Schlessinger, David; Schmidt, Reinhold; Sorensen, Thorkild I. A.; Spector, Tim D.; Stefansson, Kari; Thorsteinsdottir, Unnur; Thurik, A. Roy; Timpson, Nicholas J.; Tiemeier, Henning; Tung, Joyce Y.; Uitterlinden, Andre G.; Vitart, Veronique; Vollenweider, Peter; Weir, David R.; Wilson, James F.; Wright, Alan F.; Conley, Dalton C.; Krueger, Robert F.; Smith, George Davey; Hofman, Albert; Laibson, David I.; Medland, Sarah E.; Meyer, Michelle N.; Yang, Jian; Johannesson, Magnus; Visscher, Peter M.; Esko, Tonu; Koellinger, Philipp D.; Cesarini, David; Benjamin, Daniel J.		LifeLines Cohort Study	Genome-wide association study identifies 74 loci associated with educational attainment	NATURE			English	Article							HERITABILITY; ACHIEVEMENT; IQ	Educational attainment is strongly influenced by social and other environmental factors, but genetic factors are estimated to account for at least 20% of the variation across individuals(1). Here we report the results of a genome-wide association study (GWAS) for educational attainment that extends our earlier discovery sample(1,2) of 101,069 individuals to 293,723 individuals, and a replication study in an independent sample of 111,349 individuals from the UK Biobank. We identify 74 genome-wide significant loci associated with the number of years of schooling completed. Single-nucleotide polymorphisms associated with educational attainment are disproportionately found in genomic regions regulating gene expression in the fetal brain. Candidate genes are preferentially expressed in neural tissue, especially during the prenatal period, and enriched for biological pathways involved in neural development. Our findings demonstrate that, even for a behavioural phenotype that is mostly environmentally determined, a well-powered GWAS identifies replicable associated genetic variants that suggest biologically relevant pathways. Because educational attainment is measured in large numbers of individuals, it will continue to be useful as a proxy phenotype in efforts to characterize the genetic influences of related phenotypes, including cognition and neuropsychiatric diseases.	[Okbay, Aysu; Rietveld, Cornelius A.; de Vlaming, Ronald; Thurik, A. Roy] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, NL-3062 PA Rotterdam, Netherlands; [Okbay, Aysu; Rietveld, Cornelius A.; de Vlaming, Ronald; van der Lee, Sven J.; Amin, Najaf; van Rooij, Frank J. A.; van Duijn, Cornelia M.; Tiemeier, Henning; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Okbay, Aysu; Rietveld, Cornelius A.; Meddens, S. Fleur W.; de Vlaming, Ronald; Palotie, Aarno; Thurik, A. Roy; Koellinger, Philipp D.] Erasmus Univ, Inst Behav & Biol, NL-3062 PA Rotterdam, Netherlands; [Beauchamp, Jonathan P.; Turley, Patrick; Rostapshova, Olga; Laibson, David I.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Fontana, Mark Alan; Benjamin, Daniel J.] Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA 90089 USA; [Lee, James J.; Miller, Michael B.; Iacono, William G.; McGue, Matt; Krueger, Robert F.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN 55455 USA; [Pers, Tune H.; Hofman, Albert; Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.; Hofman, Albert; Esko, Tonu] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Pers, Tune H.; Timshel, Pascal; Westra, Harm-Jan; de Jager, Philip L.; Esko, Tonu] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Pers, Tune H.; Ahluwalia, Tarunveer S.; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Chen, Guo-Bo; Zhu, Zhihong; Bakshi, Andrew; Marioni, Riccardo E.; Vinkhuyzen, Anna A. E.; Gratten, Jacob; Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Emilsson, Valur; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Emilsson, Valur] Univ Iceland, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland; [Meddens, S. Fleur W.; de Leeuw, Christiaan; Posthuma, Danielle; Koellinger, Philipp D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, NL-1081 HV Amsterdam, Netherlands; [Meddens, S. Fleur W.; Lebreton, Mael P.; Koellinger, Philipp D.] Univ Amsterdam, Amsterdam Business Sch, NL-1018 TV Amsterdam, Netherlands; [Oskarsson, Sven; Lindgren, Karl-Oskar] Uppsala Univ, Dept Govt, S-75120 Uppsala, Sweden; [Pickrell, Joseph K.] New York Genome Ctr, New York, NY 10013 USA; [Thom, Kevin; Cesarini, David] NYU, Dept Econ, New York, NY 10003 USA; [Timshel, Pascal] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Abdellaoui, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Ahluwalia, Tarunveer S.; Waage, Johannes; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, DK-2820 Copenhagen, Denmark; [Ahluwalia, Tarunveer S.; Waage, Johannes] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bacelis, Jonas; Jacobsson, Bo] Sahlgrens Acad, Inst Clin Sci, Dept Obstet & Gynecol, S-41685 Gothenburg, Sweden; [Baumbach, Clemens; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Baumbach, Clemens; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Brandsma, Johannes H.; Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 CN Rotterdam, Netherlands; [Concas, Maria Pina; Pirastu, Mario] Natl Res Council Italy, UOS Sassari, Ist Ric Genet & Biomed, I-07100 Sassari, Italy; [Derringer, Jaime] Univ Illinois, Psychol, Champaign, IL 61820 USA; [Furlotte, Nicholas A.; Hinds, David A.; Tung, Joyce Y.] 23andMe Inc, Mountain View, CA 94041 USA; [Galesloot, Tessel E.; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6500 HB Nijmegen, Netherlands; [Girotto, Giorgia; Vuckovic, Dragana; Gandin, Ilaria; Gasparini, Paolo; Pirastu, Nicola] Univ Trieste, Dept Med Surg & Hlth Sci, I-34100 Trieste, Italy; [Gupta, Richa; Latvala, Antti; Loukola, Anu; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Hall, Leanne M.; Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Leanne M.; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Gen Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Harris, Sarah E.; Davies, Gail; Liewald, David C. M.; Marioni, Riccardo E.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Harris, Sarah E.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hofer, Edith; Petrovic, Katja E.; Schmidt, Helena; Schmidt, Reinhold] Gen Hosp, Dept Neurol, A-8036 Graz, Austria; [Hofer, Edith; Petrovic, Katja E.; Schmidt, Helena; Schmidt, Reinhold] Med Univ Graz, A-8036 Graz, Austria; [Hofer, Edith] Gen Hosp, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria; [Horikoshi, Momoko] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England; [Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Huffman, Jennifer E.; Marten, Jonathan; Hayward, Caroline; Vitart, Veronique; Wilson, James F.; Wright, Alan F.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Kaasik, Kadri; Lahti, Jari; Keltigangas-Jarvinen, Liisa; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland; [Kalafati, Ioanna P.; Dedoussis, George V.] Harokopio Univ, Nutr & Dietet, Hlth Sci & Educ, Athens 17671, Greece; [Karlsson, Robert; Lichtenstein, Paul; Pedersen, Nancy L.; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Lahti, Jari; Raikkonen, Katri; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00014, Finland; [de Leeuw, Christiaan] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 EC Nijmegen, Netherlands; [Lind, Penelope A.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Quantitat Genet, Brisbane, Qld 4029, Australia; [Liu, Tian] Max Planck Inst Human Dev, Lifespan Psychol, D-14195 Berlin, Germany; [Mangino, Massimo; Quaye, Lydia; Venturini, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Mangino, Massimo; Venturini, Cristina] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London SE1 7EH, England; [Mihailov, Evelin; Pervjakova, Natalia; Magi, Reedik; Milani, Lili; Metspalu, Andres; Perola, Markus; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [van der Most, Peter J.; Alizadeh, Behrooz Z.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Attia, John R.] Hunter Med Res Inst, Publ Hlth Stream, New Lambton, NSW 2305, Australia; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney J.] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW 2300, Australia; [Payton, Antony; Ollier, William E. R.; Attia, John R.] Univ Manchester, Inst Populat Hlth, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Payton, Antony] Univ Manchester, Sch Psychol Sci, Human Commun & Deafness, Manchester M13 9PL, Lancs, England; [Pervjakova, Natalia; Eklund, Niina; Koskinen, Seppo; Maki-Opas, Tomi; Salomaa, Veikko; Kaprio, Jaakko; Perola, Markus] THL Natl Inst Hlth & Welf, Dept Hlth, Helsinki 00271, Finland; [Peyrot, Wouter J.; Milaneschi, Yusplitri; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Psychiat, NL-1081 HL Amsterdam, Netherlands; [Peyrot, Wouter J.; Milaneschi, Yusplitri; Penninx, Brenda W. J. H.] GGZ inGeest, NL-1081 HL Amsterdam, Netherlands; [Qian, Yong; Ding, Jun; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20521, Finland; [Rueedi, Rico; Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Rueedi, Rico; Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Salvi, Erika; Cusi, Daniele] Univ Milan, Dept Hlth Sci, I-20142 Milan, Italy; [Schmidt, Brge; Eisele, Lewin; Jockel, Karl-Heinz] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, D-45147 Essen, Germany; [Schraut, Katharina E.; Campbell, Harry; Joshi, Peter K.; Rudan, Igor; Polasek, Ozren; Wilson, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Smith, Albert V.] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur; Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [St Pourcain, Beate; Evans, David M.; McMahon, George; Paternoster, Lavinia; Ring, Susan M.; Sorensen, Thorkild I. A.; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [St Pourcain, Beate; Bonnelykke, Klaus] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England; [Teumer, Alexander; Baumeister, Sebastian E.; Volzke, Henry; Hoffmann, Wolfgang] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Verweij, Niek; Berger, Klaus; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Wellmann, Juergen] Univ Munster, Inst Epidemiol & Social Med, D-48149 Munster, Germany; [Westra, Harm-Jan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Westra, Harm-Jan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Westra, Harm-Jan] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Yang, Jingyun; Boyle, Patricia A.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Yang, Jingyun; Vaccargiu, Simona; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Zhao, Wei; Smith, Jennifer A.; Ware, Erin B.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 GZ Groningen, Netherlands; [Baumeister, Sebastian E.] Univ Regensburg, Inst Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, I-27100 Pavia, Italy; [Boyle, Patricia A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Davies, Gail; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [De Neve, Jan-Emmanuel] Univ Oxford, Said Business Sch, Oxford OX1 1HP, England; [Deloukas, Panos; Kanoni, Stavroula] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Charite, Res Grp Geriatr, Berlin Aging Study 2, D-13347 Berlin, Germany; [Demuth, Ilja] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Eibich, Peter; Kroh, Martin] DIW Berlin, German Socioecon Panel Study, D-10117 Berlin, Germany; [Eibich, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; [Evans, David M.; Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48109 USA; [Feitosa, Mary F.; Kraja, Aldi T.; Borecki, Ingrid B.; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63018 USA; [Forstner, Andreas J.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Forstner, Andreas J.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Halldorsson, Bjarni V.] Reykjavik Univ, Sch Sci & Engn, Inst Biomed & Neural Engn, IS-101 Reykjavik, Iceland; [Harris, Tamara B.] NIA, Lab Epidemiol, Demog, NIH, Bethesda, MD 20892 USA; [Heath, Andrew C.; Madden, Pamela A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hocking, Lynne J.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Homuth, Georg; Volker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Horan, Michael A.] Univ Manchester, Manchester Med Sch, Manchester M13 9PT, Lancs, England; [de Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA; [de Jager, Philip L.] Brigham & Womens Hosp, Dept Psychiat, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA; [de Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jugessur, Astanand; Myhre, Ronny; Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genes & Environm, N-0403 Oslo, Norway; [Kaakinen, Marika A.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London W12 0NN, England; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere 33014, Finland; [Kolcic, Ivana] Univ Split, Sch Med, Publ Hlth, Split 21000, Croatia; [Kutalik, Zoltan] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Launer, Lenore J.] NIA, Neuroepidemiol Sect, NIH, Bethesda, MD 20892 USA; [Lebreton, Mael P.] Univ Amsterdam, Amsterdam Brain & Cognit Ctr, NL-1018 XA Amsterdam, Netherlands; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Lichtner, Peter; Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Marioni, Riccardo E.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Marques-Vidal, Pedro; Vollenweider, Peter] Lausanne Univ Hosp CHUV, Dept Internal Med, Internal Med, CH-1011 Lausanne, Switzerland; [Meddens, Gerardus A.] Tema BV, NL-2131 HE Hoofddorp, Netherlands; [Montgomery, Grant W.; Nyholt, Dale R.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld 4029, Australia; [Nyholt, Dale R.] Queensland Inst Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Sarin, Antti-Pekka; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Robino, Antonietta; Ulivi, Sheila; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet, I-34100 Trieste, Italy; [Rostapshova, Olga; Vozzi, Diego] Social Impact, Arlington, VA 22201 USA; [Rustichini, Aldo] Univ Minnesota Twin Cities, Dept Econ, Minneapolis, MN 55455 USA; [Sanders, Alan R.; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; [Sanders, Alan R.; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Sarin, Antti-Pekka] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki 00300, Finland; [Schmidt, Helena] Gen Hosp, Ctr Mol Med, Inst Mol Biol & Biochem, Res Unit Genet Epidemiol, A-8010 Graz, Austria; [Schmidt, Helena] Med Univ, A-8010 Graz, Graz, Austria; [Scott, Rodney J.] Hunter Med Res Inst, Informat Based Med Stream, New Lambton, NSW 2305, Australia; [Smith, Blair H.] Univ Dundee, Res Inst, Dundee DD1 9SY, Scotland; [Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, B-3000 Leuven, Belgium; [Staessen, Jan A.] Maastricht Univ, R&D VitaK Grp, NL-6229 EV Maastricht, Netherlands; [Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, D-81377 Munich, Germany; [Terracciano, Antonio] Florida State Univ, Coll Med, Dept Geriatr, Tallahassee, FL 32306 USA; [Tobin, Martin D.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [van Rooij, Frank J. A.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Ware, Erin B.] Univ Michigan, Inst Social Res, Res Ctr Grp Dynam, Ann Arbor, MI 48104 USA; [Bertram, Lars] Univ Lubeck, Inst Neurogenet & Integrat & Expt Genom, Platform Genome Analyt, D-23562 Lubeck, Germany; [Bertram, Lars] Univ London Imperial Coll Sci Technol & Med, Neuroepidemiol & Ageing Res Unit, Sch Publ Hlth, Fac Med, London SW7 2AZ, England; [Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, NL-9713 AV Groningen, Netherlands; [Chabris, Christopher F.] Union Coll, Dept Psychol, Schenectady, NY 12308 USA; [Cucca, Francesco] Cittadella Univ Monserrato, CNR, IRGB, I-9042 Cagliari, Italy; [Cusi, Daniele] Italian Natl Res Council, Inst Biomed Technol, I-20090 Milan, Italy; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Franke, Barbara] Donders Ctr Neurosci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Donders Ctr Neurosci, Dept Psychiat, NL-6500 HB Nijmegen, Netherlands; [Franke, Lude; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Gasparini, Paolo] Sidra, Expt Genet Div, Doha 26999, Qatar; [Grabe, Hans-Jorgen] Univ Med Greifswald, Dept Psychiat & Psychotherapy, D-17475 Greifswald, Germany; [Grabe, Hans-Jorgen] HELIOS Hosp Stralsund, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany; [Groenen, Patrick J. F.] Erasmus Univ, Erasmus Sch Econ, Econometr Inst, NL-3062 PA Rotterdam, Netherlands; [van der Harst, Pim] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, NL-1105 AZ Utrecht, Netherlands; [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, Generat Scotland, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hyppnen, Elina] Univ S Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5000, Australia; [Hyppnen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5000, Australia; [Hyppnen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia; [Hyppnen, Elina; Power, Christine] UCL Inst Child Hlth, Populat Policy & Practice, London WC1N 1EH, England; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu 90029, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Lehtimaki, Terho] Fimlab Labs, Tampere 33520, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere 33014, Finland; [Lehrer, Steven F.] NYU Shanghai, Econ, Pudong 200122, Peoples R China; [Lehrer, Steven F.] Queens Univ, Policy Studies, Kingston, ON K7L 3N6, Canada; [Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld 4029, Australia; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Pendleton, Neil] Salford Royal Hosp, Inst Brain Behav & Mental Hlth, Ctr Clin & Cognit Neurosci, Manchester M6 8HD, Lancs, England; [Pendleton, Neil] Univ Manchester, Manchester Inst Collaborat Res Ageing, Manchester M13 9PL, Lancs, England; [Polasek, Ozren] Univ Split, Fac Med, Split 21000, Croatia; [Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2000 Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, DK-2000 Frederiksberg, Denmark; [Thurik, A. Roy] Montpellier Business Sch, F-34080 Montpellier, France; [Thurik, A. Roy] Panteia, NL-2715 CA Zoetermeer, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Psychiat, NL-3015 GE Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, NL-3015 GE Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Conley, Dalton C.] NYU, Dept Sociol, 550 1St Ave, New York, NY 10012 USA; [Conley, Dalton C.] NYU, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Meyer, Michelle N.] Icahn Sch Med Mt Sinai, Grad Coll, Bioeth Program, Schenectady, NY 12308 USA; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cesarini, David] Res Inst Ind Econ, S-10215 Stockholm, Sweden	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Harvard University; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novo Nordisk Foundation; University of Copenhagen; Statens Serum Institut; University of Queensland; Icelandic Heart Association; University of Iceland; Vrije Universiteit Amsterdam; University of Amsterdam; Uppsala University; New York University; Technical University of Denmark; Vrije Universiteit Amsterdam; University of Copenhagen; Steno Diabetes Center; University of Gothenburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Illinois System; University of Illinois Urbana-Champaign; Radboud University Nijmegen; University of Trieste; University of Helsinki; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Edinburgh; University of Edinburgh; Medical University of Graz; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Helsinki; Harokopio University Athens; Karolinska Institutet; Folkhalsan Research Center; Radboud University Nijmegen; QIMR Berghofer Medical Research Institute; Max Planck Society; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Tartu; University of Groningen; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Manchester; University of Manchester; Finland National Institute for Health & Welfare; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of Lausanne; Swiss Institute of Bioinformatics; University of Milan; University of Duisburg Essen; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icelandic Heart Association; University of Iceland; University of Bristol; University of Bristol; Greifswald Medical School; University of Groningen; University of Munster; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rush University; Rush University; University of Michigan System; University of Michigan; University of Groningen; University of Regensburg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Rush University; University of Warwick; University of Edinburgh; University of Oxford; University of London; Queen Mary University London; King Abdulaziz University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; University of Oxford; University of Queensland; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Bonn; University of Bonn; Reykjavik University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington University (WUSTL); University of Aberdeen; Greifswald Medical School; University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Norwegian Institute of Public Health (NIPH); Imperial College London; Tampere University; Tampere University Hospital; Tampere University; University of Split; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Amsterdam; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Edinburgh; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Helsinki; Harvard University; Massachusetts General Hospital; IRCCS Burlo Garofolo; University of Minnesota System; University of Minnesota Twin Cities; NorthShore University Health System; University of Chicago; Finland National Institute for Health & Welfare; Medical University of Graz; Hunter Medical Research Institute; University of Newcastle; University of Dundee; KU Leuven; Maastricht University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; State University System of Florida; Florida State University; University of Leicester; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Lubeck; Imperial College London; University of Groningen; Union College; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Helsinki; University of Groningen; Sidra Medical & Research Center; Greifswald Medical School; Erasmus University Rotterdam; University of Edinburgh; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of London; University College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; Tampere University; NYU Shanghai; Queens University - Canada; QIMR Berghofer Medical Research Institute; University of Tartu; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; University of Split; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Copenhagen; Bispebjerg Hospital; Montpellier Business School; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; New York University; New York University; Icahn School of Medicine at Mount Sinai; Stockholm School of Economics; Harvard University; Harvard Medical School; Research Institute of Industrial Economics (IFN)	Koellinger, PD (corresponding author), Erasmus Univ, Inst Behav & Biol, NL-3062 PA Rotterdam, Netherlands.; Benjamin, DJ (corresponding author), Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA 90089 USA.; Visscher, PM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.; Koellinger, PD (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, NL-1081 HV Amsterdam, Netherlands.; Koellinger, PD (corresponding author), Univ Amsterdam, Amsterdam Business Sch, NL-1018 TV Amsterdam, Netherlands.; Cesarini, D (corresponding author), NYU, Dept Econ, New York, NY 10003 USA.; Visscher, PM (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia.; Cesarini, D (corresponding author), Res Inst Ind Econ, S-10215 Stockholm, Sweden.	peter.visscher@uq.edu.au; p.d.koellinger@vu.nl; dac12@nyu.edu; daniel.benjamin@gmail.com	Lind, Penelope A/ABC-5341-2021; Wijmenga, Cisca/D-2173-2009; Stefansson, Kari/AAE-7187-2019; Visscher, Peter/ABB-6151-2020; Latvala, Antti/AFK-1462-2022; Teumer, Alexander/S-7438-2019; Lind, Penelope A/B-2553-2009; Polasek, Ozren/B-6002-2011; Porteous, David/AAA-3446-2021; Kiemeney, Lambertus A./D-3357-2009; Vonk, Judith M/ABA-3009-2020; Tiemeier, Henning/H-6534-2019; Boomsma, Dorret I/AAX-4470-2020; Fox, Laura J/C-6249-2016; Yang, Jian/A-5852-2010; Milani, Lili/N-1097-2019; Medland, Sarah E/C-7630-2013; Kalafati, Ioanna-Panagiota/AAJ-2287-2020; Yang, Jingyun/D-5361-2009; Franke, Lude/P-7036-2016; Feitosa, Mary F/K-8044-2012; Franke, Barbara/D-4836-2009; Gratten, Jacob/G-1485-2011; Jacobsson, Bo/O-8007-2014; Kaprio, Jaakko/A-1820-2008; Deary, Ian J/C-6297-2009; Gandin, Ilaria/B-2634-2017; Verweij, Niek/A-4499-2017; Kanoni, Stavroula/AAN-7161-2021; Timpson, Nicholas John/O-7548-2015; Salvi, Erika/AAA-1415-2019; Vonk, Judith/K-8477-2019; Staessen, Jan A/A-1065-2011; Ahluwalia, Tarunveer Singh/C-5549-2009; Montgomery, Grant W/B-7148-2008; Gupta, Richa/J-4774-2019; Biino, Ginevra/B-5334-2013; Smith, Blair H/G-2834-2012; Gudnason, Vilmundur/AAE-7126-2019; Kolcic, Ivana/E-2713-2017; Lebreton, Maël/J-3179-2019; Johannesson, Magnus/E-9680-2011; Zhu, Zhihong/F-8720-2015; Mangino, Massimo/F-5134-2011; Bisgaard, Hans/N-4761-2016; Mägi, Reedik/AAJ-9679-2021; Gasparini, Paolo/B-6173-2014; Thurik, Roy/A-9386-2012; Medland, Sarah/AAT-7595-2020; Baumeister, Sebastian-Edgar/P-7894-2019; Lahti, Jari/P-2283-2019; Attrill, Lauren/V-1688-2018; Hypponen, Elina/B-2596-2014; Wilson, James F/A-5704-2009; Kutalik, Zoltan/HHZ-5697-2022; Colaus, PsyColaus/K-6607-2013; Pirastu, Nicola/AHB-6226-2022; Ormel, Johan/C-6094-2013; Attia, John R/F-5376-2013; St Pourcain, Beate/K-8004-2017; Meitinger, Thomas/O-1318-2015; Verweij, Niek/ABC-6249-2021; Lahti, Jari/P-7987-2018; Dedoussis, George/AAN-7252-2021; Meisinger, Christine/B-5358-2014; Nyholt, Dale Robert/J-3174-2017; Evans, David M/H-6325-2013; Rudan, Igor/I-1467-2012; Lehtimäki, Terho/AAD-1094-2022; Concas, Maria Pina/K-2266-2018; Galesloot, Tessel/P-6667-2015; Terracciano, Antonio/H-7403-2019; Davey Smith, George/A-7407-2013; Penninx, Brenda WJH/S-7627-2017; Pendleton, Neil/F-2333-2015; Schmidt, Reinhold/E-1137-2014; Magnusson, Patrik KE/C-4458-2017; Deloukas, Panos/B-2922-2013; Marques-Vidal, Pedro M/C-9449-2009; Campbell, Harry/E-2959-2010; Demuth, Ilja/ABD-5352-2021; Horikoshi, Momoko/AAF-9034-2019; Laibson, David/AAA-7362-2022; Raitakari, Olli/AAQ-7389-2021; Bertram, Lars/K-3889-2015; Chen, Guo-Bo/C-2435-2009; Robino, Antonietta/K-9398-2016; Vinkhuyzen, Anna/N-8691-2013; Smith, Albert Vernon/K-5150-2015; Scott, Rodney/B-2827-2013; Girotto, Giorgia/I-9452-2018	Lind, Penelope A/0000-0002-3887-2598; Visscher, Peter/0000-0002-2143-8760; Teumer, Alexander/0000-0002-8309-094X; Lind, Penelope A/0000-0002-3887-2598; Polasek, Ozren/0000-0002-5765-1862; Porteous, David/0000-0003-1249-6106; Kiemeney, Lambertus A./0000-0002-2368-1326; Vonk, Judith M/0000-0001-7531-4547; Tiemeier, Henning/0000-0002-4395-1397; Yang, Jian/0000-0003-2001-2474; Milani, Lili/0000-0002-5323-3102; Medland, Sarah E/0000-0003-1382-380X; Yang, Jingyun/0000-0002-3495-3710; Franke, Lude/0000-0002-5159-8802; Feitosa, Mary F/0000-0002-0933-2410; Franke, Barbara/0000-0003-4375-6572; Gratten, Jacob/0000-0003-1293-409X; Jacobsson, Bo/0000-0001-5079-2374; Kaprio, Jaakko/0000-0002-3716-2455; Deary, Ian J/0000-0002-1733-263X; Gandin, Ilaria/0000-0003-3196-2491; Kanoni, Stavroula/0000-0002-1691-9615; Timpson, Nicholas John/0000-0002-7141-9189; Salvi, Erika/0000-0002-2724-2291; Vonk, Judith/0000-0001-7531-4547; Staessen, Jan A/0000-0002-3026-1637; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Montgomery, Grant W/0000-0002-4140-8139; Gupta, Richa/0000-0001-7700-5828; Biino, Ginevra/0000-0002-9936-946X; Smith, Blair H/0000-0002-5362-9430; Gudnason, Vilmundur/0000-0001-5696-0084; Kolcic, Ivana/0000-0001-7918-6052; Lebreton, Maël/0000-0002-2071-4890; Johannesson, Magnus/0000-0001-8759-6393; Zhu, Zhihong/0000-0002-6783-3037; Mangino, Massimo/0000-0002-2167-7470; Bisgaard, Hans/0000-0003-4131-7592; Thurik, Roy/0000-0002-0242-6908; Medland, Sarah/0000-0003-1382-380X; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Lahti, Jari/0000-0002-4310-5297; Hypponen, Elina/0000-0003-3670-9399; Wilson, James F/0000-0001-5751-9178; Kutalik, Zoltan/0000-0001-8285-7523; Attia, John R/0000-0001-9800-1308; St Pourcain, Beate/0000-0002-4680-3517; Verweij, Niek/0000-0002-4303-7685; Lahti, Jari/0000-0002-4310-5297; Dedoussis, George/0000-0002-7798-6221; Nyholt, Dale Robert/0000-0001-7159-3040; Evans, David M/0000-0003-0663-4621; Rudan, Igor/0000-0001-6993-6884; Lehtimäki, Terho/0000-0002-2555-4427; Concas, Maria Pina/0000-0003-3598-2537; Galesloot, Tessel/0000-0002-2717-3679; Terracciano, Antonio/0000-0001-5799-8885; Davey Smith, George/0000-0002-1407-8314; Penninx, Brenda WJH/0000-0001-7779-9672; Pendleton, Neil/0000-0003-0794-2386; Magnusson, Patrik KE/0000-0002-7315-7899; Deloukas, Panos/0000-0001-9251-070X; Marques-Vidal, Pedro M/0000-0002-4548-8500; Campbell, Harry/0000-0002-6169-6262; Demuth, Ilja/0000-0002-4340-2523; Bertram, Lars/0000-0002-0108-124X; Bacelis, Jonas/0000-0002-2450-732X; Emilsson, Valur/0000-0001-9982-0524; Oldmeadow, Christopher/0000-0001-6104-1322; Timshel, Pascal/0000-0002-0352-4323; Bonnelykke, Klaus/0000-0003-2003-1018; Derringer, Jaime/0000-0002-7352-9859; Joshi, Peter/0000-0002-6361-5059; s, hema/0000-0002-3440-9475; Chen, Guo-Bo/0000-0001-5475-8237; de Vlaming, Ronald/0000-0001-6416-6067; Palotie, Aarno/0000-0002-2527-5874; Okbay, Aysu/0000-0002-5170-7781; Koellinger, Philipp/0000-0001-7413-0412; CUCCA, Francesco/0000-0002-7414-1995; Robino, Antonietta/0000-0003-2152-2353; Payton, Antony/0000-0003-0335-152X; Ware, Erin/0000-0003-4731-8158; Meisinger, Christa/0000-0002-9026-6544; Loukola, Anu-Maria/0000-0003-0542-5967; Pedersen, Nancy/0000-0001-8057-3543; Bultmann, Ute/0000-0001-9589-9220; Gieger, Christian/0000-0001-6986-9554; Halldorsson, Bjarni/0000-0003-0756-0767; Magi, Reedik/0000-0002-2964-6011; Meitinger, Thomas/0000-0002-8838-8403; Gasparini, Paolo/0000-0002-0859-0856; Van Duijn, Cornelia/0000-0002-2374-9204; Vinkhuyzen, Anna/0000-0003-3352-0603; Pirastu, Nicola/0000-0002-5363-3886; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nelson, Christopher/0000-0001-8025-2897; Faul, Jessica/0000-0002-6969-6478; Amin, Najaf/0000-0002-8944-1771; Marten, Jonathan/0000-0001-6916-2014; Cesarini, David/0000-0002-0043-009X; Smith, Albert Vernon/0000-0003-1942-5845; Smith, Jennifer Ann/0000-0002-3575-5468; Scott, Rodney/0000-0001-7724-3404; Kahonen, Mika/0000-0002-4510-7341; Maki-Opas, Tomi/0000-0002-0472-719X; Volker, Uwe/0000-0002-5689-3448; Venturini, Cristina/0000-0002-4769-7912; Kong, Augustine/0000-0001-8193-5438; Tobin, Martin/0000-0002-3596-7874; Eriksson, Johan/0000-0002-2516-2060; Kroh, Martin/0000-0002-4889-8425; Groenen, Patrick/0000-0001-6683-8971; Marioni, Riccardo/0000-0003-4430-4260; vozzi, diego/0000-0002-2902-8184; Peyrot, Wouter/0000-0001-7954-8383; Pers, Tune/0000-0003-0207-4831; Girotto, Giorgia/0000-0003-4507-6589; Karlsson, Robert/0000-0002-8949-2587; Willemsen, Gonneke/0000-0003-3755-0236; Bjornsdottir, Gyda/0000-0002-8100-0306; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Latvala, Antti/0000-0001-5695-117X; van der Lee, Sven/0000-0003-1606-8643; Hinds, David/0000-0002-4911-803X; Bakshi, Andrew/0000-0001-5650-7036; Vuckovic, Dragana/0000-0001-9343-6142	Social Science Genetic Association Consortium (SSGAC); Ragnar Soderberg Foundation [E9/11]; Swedish Research Council [421-2013-1061]; Jan Wallander and Tom Hedelius Foundation; ERC [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; NIA/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23, R01-AG042568]; BBSRC [BB/F022441/1] Funding Source: UKRI; ESRC [ES/M010341/1] Funding Source: UKRI; MRC [G1001799, MC_UU_12013/3, MC_UU_12013/4, MC_UU_12013/1, MR/N01104X/1, MC_PC_U127561128, MR/J012165/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022441/1] Funding Source: researchfish; Economic and Social Research Council [ES/M010341/1] Funding Source: researchfish; Lundbeck Foundation [R190-2014-3904, R163-2013-16235] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MC_PC_U127561128, 1201677, MC_qA137853, MC_UU_12013/4, MR/J012165/1, G1001799, MR/N01104X/1, MC_UU_12013/3, MC_UU_12013/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, RF1AG015819, P01AG005842, P30AG012810, P30AG010161, R01AG042568, T32AG000186, R01AG017917, ZIAAG000675, ZIAAG000693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036216, R37DA005147] Funding Source: NIH RePORTER	Social Science Genetic Association Consortium (SSGAC); Ragnar Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Jan Wallander and Tom Hedelius Foundation; ERC(European Research Council (ERC)European Commission); Pershing Square Fund of the Foundations of Human Behavior(Pershing Square Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Chief Scientist Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out under the auspices of the Social Science Genetic Association Consortium (SSGAC). This research has also been conducted using the UK Biobank Resource. This study was supported by funding from the Ragnar Soderberg Foundation (E9/11), the Swedish Research Council (421-2013-1061), The Jan Wallander and Tom Hedelius Foundation, an ERC Consolidator Grant (647648 EdGe), the Pershing Square Fund of the Foundations of Human Behavior, and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810, and T32-AG000186-23 to NBER, and R01-AG042568 to USC. We thank S. Cunningham, N. Galla and J. Rashtian for research assistance. A full list of acknowledgments is provided in the Supplementary Information.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fowler T, 2012, ARCH GEN PSYCHIAT, V69, P460, DOI 10.1001/archgenpsychiatry.2011.1370; HEATH AC, 1985, NATURE, V314, P734, DOI 10.1038/314734a0; Krapohl E, 2014, P NATL ACAD SCI USA, V111, P15273, DOI 10.1073/pnas.1408777111; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rietveld CA, 2014, PSYCHOL SCI, V25, P1975, DOI 10.1177/0956797614545132; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; TAMBS K, 1989, BEHAV GENET, V19, P209, DOI 10.1007/BF01065905; THOMPSON LA, 1991, PSYCHOL SCI, V2, P158, DOI 10.1111/j.1467-9280.1991.tb00124.x; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	16	671	674	1	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					539	+		10.1038/nature17671	http://dx.doi.org/10.1038/nature17671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225129	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000376443100042
J	Page, L				Page, Leigh			What Donald Trump would do with the US healthcare system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												leighpage@comcast.net						[Anonymous], 2016, HEALTHCARE REFORM MA; Santucci D, 2015, ABC NEWS	2	4	4	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2016	353								i2996	10.1136/bmj.i2996	http://dx.doi.org/10.1136/bmj.i2996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CL	27230259				2022-12-28	WOS:000376939900008
J	Krogeloh-Mann, I; Groeschel, S				Krogeloh-Mann, Ingeborg; Groeschel, Samuel			Therapies of lysosomal storage disorders targeting the brain	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION; METACHROMATIC LEUKODYSTROPHY; MICROGLIA; OUTCOMES		[Krogeloh-Mann, Ingeborg; Groeschel, Samuel] Univ Childrens Hosp Tubingen, Dept Pediat Neurol, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Krogeloh-Mann, I (corresponding author), Univ Childrens Hosp Tubingen, Dept Pediat Neurol, Tubingen, Germany.	Ingeborg.Kraegeloh-Mann@med.uni-tuebingen.de						Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Gieselmann V., 2014, ONLINE METABOLIC MOL; Ginocchio VM, 2016, HUM MOL GENET, V25, pR27, DOI 10.1093/hmg/ddv418; Kehrer C, 2013, EUR J PAEDIATR NEURO, V17, pS132; Kehrer C, 2011, DEV MED CHILD NEUROL, V53, P850, DOI 10.1111/j.1469-8749.2011.04028.x; Martin HR, 2013, BIOL BLOOD MARROW TR, V19, P616, DOI 10.1016/j.bbmt.2013.01.010; Sessa M, 2016, LANCET; Zerah M, 2015, HUM GENE THER CL DEV, V26, P113, DOI 10.1089/humc.2014.139	11	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					440	442		10.1016/S0140-6736(16)30450-0	http://dx.doi.org/10.1016/S0140-6736(16)30450-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27289176				2022-12-28	WOS:000380559400005
J	Bach, SP; Fearnhead, NS				Bach, Simon P.; Fearnhead, Nicola S.			Does HubBLe spell trouble for HAL?	LANCET			English	Editorial Material							HEMORRHOIDAL ARTERY LIGATION; CLINICAL-OUTCOMES; METAANALYSIS		[Bach, Simon P.] Queen Elizabeth Hosp, Inst Translat Med, Diagnost Drugs Devices & Biomarkers Early Phase T, Birmingham, W Midlands, England; [Fearnhead, Nicola S.] Addenbrookes Hosp, Cambridge, England	University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bach, SP (corresponding author), Queen Elizabeth Hosp, Inst Translat Med, Diagnost Drugs Devices & Biomarkers Early Phase T, Birmingham, W Midlands, England.	s.p.bach@bham.ac.uk	Bach, Simon P/X-5328-2018	Bach, Simon P/0000-0001-8412-7241				Brown SR, 2016, LANCET; Hospital Episode Statistics, 2013, ADM PAT CAR ENGL 201; Liu H, 2015, INT J CLIN EXP MED, V8, P4932; National Institute for Health and Care Excellence (NICE), 2014, GUID PROC TECHN APPR; Pucher PH, 2013, COLORECTAL DIS, V15, pE284, DOI 10.1111/codi.12205; Sajid MS, 2012, TECH COLOPROCTOL, V16, P1, DOI 10.1007/s10151-011-0796-z; Shanmugam V, 2005, COCHRANE DB SYST REV, V3; Simillis C, 2015, BRIT J SURG, V102, P1603, DOI 10.1002/bjs.9913; Speight J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2921	9	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					311	312		10.1016/S0140-6736(16)30657-2	http://dx.doi.org/10.1016/S0140-6736(16)30657-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27238945	hybrid			2022-12-28	WOS:000380016900005
J	Kamal, AH; LeBlanc, TW; Meier, DE				Kamal, Arif H.; LeBlanc, Thomas W.; Meier, Diane E.			Better Palliative Care for All Improving the Lived Experience With Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kamal, Arif H.; LeBlanc, Thomas W.] Duke Univ, Med Ctr, Duke Canc Inst, POB 2715, Durham, NC 27705 USA; [Meier, Diane E.] Ctr Adv Palliat Care, New York, NY USA	Duke University	Kamal, AH (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, POB 2715, Durham, NC 27705 USA.	arif.kamal@duke.edu	LeBlanc, Thomas W/AAT-3650-2020	LeBlanc, Thomas W/0000-0002-0546-7895				Davis MP, 2015, ANN PALLIAT MED, V4, P99, DOI 10.3978/j.issn.2224-5820.2015.04.04; Gelfman LP, 2013, J PALLIAT MED, V16, P125, DOI 10.1089/jpm.2012.0427; Horwitz RI, 2016, JAMA-J AM MED ASSOC, V315, P1231, DOI 10.1001/jama.2016.2242; Kamal AH, 2015, ANN INTERN MED, V163, P637, DOI 10.7326/M15-0071; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Thomas RA, 2015, J PALLIAT MED, V18, P747, DOI 10.1089/jpm.2015.0035; von Gunten CF, 2002, JAMA-J AM MED ASSOC, V287, P875, DOI 10.1001/jama.287.7.875	7	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					29	30		10.1001/jama.2016.6491	http://dx.doi.org/10.1001/jama.2016.6491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ2MY	27244674				2022-12-28	WOS:000379037600012
J	Hofhuis, H; Moulton, D; Lessinnes, T; Routier-Kierzkowska, AL; Bomphrey, RJ; Mosca, G; Reinhardt, H; Sarchet, P; Gan, XC; Tsiantis, M; Ventikos, Y; Walker, S; Goriely, A; Smith, R; Hay, A				Hofhuis, Hugo; Moulton, Derek; Lessinnes, Thomas; Routier-Kierzkowska, Anne-Lise; Bomphrey, Richard J.; Mosca, Gabriella; Reinhardt, Hagen; Sarchet, Penny; Gan, Xiangchao; Tsiantis, Miltos; Ventikos, Yiannis; Walker, Simon; Goriely, Alain; Smith, Richard; Hay, Angela			Morphomechanical Innovation Drives Explosive Seed Dispersal	CELL			English	Article							RELATIVE CARDAMINE-HIRSUTA; TOPOISOMERASE-VI COMPLEX; ARABIDOPSIS-THALIANA; MECHANICAL-PROPERTIES; CATAPULT; CELLS; FRUIT; ENDOREDUPLICATION; VISUALIZATION; MICROTUBULES	How mechanical and biological processes are coordinated across cells, tissues, and organs to produce complex traits is a key question in biology. Cardamine hirsuta, a relative of Arabidopsis thaliana, uses an explosive mechanism to disperse its seeds. We show that this trait evolved through morphomechanical innovations at different spatial scales. At the organ scale, tension within the fruit wall generates the elastic energy required for explosion. This tension is produced by differential contraction of fruit wall tissues through an active mechanism involving turgor pressure, cell geometry, and wall properties of the epidermis. Explosive release of this tension is controlled at the cellular scale by asymmetric lignin deposition within endocarp b cells-a striking pattern that is strictly associated with explosive pod shatter across the Brassicaceae plant family. By bridging these different scales, we present an integrated mechanism for explosive seed dispersal that links evolutionary novelty with complex trait innovation.	[Hofhuis, Hugo; Routier-Kierzkowska, Anne-Lise; Mosca, Gabriella; Reinhardt, Hagen; Gan, Xiangchao; Tsiantis, Miltos; Smith, Richard; Hay, Angela] Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany; [Moulton, Derek; Lessinnes, Thomas; Goriely, Alain] Univ Oxford, Inst Math, Radcliffe Observ Quarter, Radcliffe Observ Quarter,Woodstock Rd, Oxford OX2 6GG, England; [Bomphrey, Richard J.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Mosca, Gabriella] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [Sarchet, Penny] Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England; [Ventikos, Yiannis] UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England; [Walker, Simon] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England; [Lessinnes, Thomas] Ecole Polytech Fed Lausanne, Dept Math, LCVMM, CH-1015 Lausanne, Switzerland	Max Planck Society; University of Oxford; University of London; University of London Royal Veterinary College; University of Bern; University of Oxford; University of London; University College London; University of Oxford; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hay, A (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	hay@mpipz.mpg.de	Routier-Kierzkowska, Anne-Lise/AAO-9760-2020; Mosca, Gabriella/AAC-6638-2019; Bomphrey, Richard/I-6272-2013	Routier-Kierzkowska, Anne-Lise/0000-0003-0383-0811; Mosca, Gabriella/0000-0003-4509-498X; Bomphrey, Richard/0000-0002-4748-0510; hofhuis, hugo/0000-0001-7882-7380; Ventikos, Yiannis/0000-0002-8589-8117	European Research Council (ERC) [204513]; Biotechnology and Biological Sciences Research Council [BB/H01313X/1]; Human Frontiers Science Program (HFSP) young investigator's grant [RGY0087/2011]; HFSP [RGP0008/2013]; SystemsX.ch iPhD project; Reintegration Grant under EC Framework VII; Swiss National Science Foundation [200020-143613, 200020-163324]; Max Planck Society; Max Planck Society W2 Minerva programme; Royal Society University Research Fellowship; Royal Society Wolfson Merit Award; EPSRC Career Acceleration Fellowship [EP/H004025/1]; Engineering and Physical Sciences Research Council [EP/H004025/1, EP/H004025/2] Funding Source: researchfish; BBSRC [BB/H01313X/1] Funding Source: UKRI; EPSRC [EP/H004025/2, EP/H004025/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontiers Science Program (HFSP) young investigator's grant; HFSP(Human Frontier Science Program); SystemsX.ch iPhD project; Reintegration Grant under EC Framework VII; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Society W2 Minerva programme; Royal Society University Research Fellowship(Royal Society of London); Royal Society Wolfson Merit Award(Royal Society of London); EPSRC Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank G. Coupland and P. Prusinkiewicz for comments; E. Coen for helpful discussions; E. Gaffney, A. St. Leger-Honeybone, H. Dickinson, U. Neumann, R. Berndtgen, L. Nikolov, K. Schneeberger, C. Kiefer, M. Lysak, B. Scheres, B. Pieper, A. Galstyan, C. Rookyard, T. Nakata, and P. Huijser for materials and assistance; and G. Taylor for use of cameras purchased on European Research Council (ERC) grant 204513. This work was supported by Biotechnology and Biological Sciences Research Council grant BB/H01313X/1 and Human Frontiers Science Program (HFSP) young investigator's grant RGY0087/2011 to A. H., HFSP grant RGP0008/2013 and SystemsX.ch iPhD project to R.S., a Reintegration Grant under EC Framework VII to A. G, Swiss National Science Foundation grants 200020-143613 and 200020-163324 to T. L., and a Max Planck Society core grant to M. T. A. H. was supported by the Max Planck Society W2 Minerva programme and a Royal Society University Research Fellowship; A. G. by a Royal Society Wolfson Merit Award; and R.J.B. by an EPSRC Career Acceleration Fellowship (EP/H004025/1).	Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Bassel GW, 2014, P NATL ACAD SCI USA, V111, P8685, DOI 10.1073/pnas.1404616111; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Clements DR, 2008, CAN J PLANT SCI, V88, P403, DOI 10.4141/CJPS06040; Cosgrove DJ, 2016, J EXP BOT, V67, P463, DOI 10.1093/jxb/erv511; Darwin C., 1875, INSECTIVOROUS PLANTS; de Reuille PB, 2015, ELIFE, V4, DOI 10.7554/eLife.05864; Deegan RD, 2012, P NATL ACAD SCI USA, V109, P5166, DOI 10.1073/pnas.1119737109; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Dunlop J. W. C., 2011, MECH INTEGRATION PLA; Edwards J, 2005, NATURE, V435, P164, DOI 10.1038/435164a; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Garrison WJ, 2000, AM J BOT, V87, P1257, DOI 10.2307/2656718; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Hay AS, 2014, PLANT J, V78, P1, DOI 10.1111/tpj.12447; Hayashi M, 2010, AM J BOT, V97, P1595, DOI 10.3732/ajb.1000173; Hayashi M, 2009, J EXP BOT, V60, P2045, DOI 10.1093/jxb/erp070; HOSHIZAKI T, 1964, SCIENCE, V144, P1240, DOI 10.1126/science.144.3623.1240; Kim K, 2015, AM J BOT, V102, P12, DOI 10.3732/ajb.1400273; Kirik V, 2007, PLANT CELL, V19, P3100, DOI 10.1105/tpc.107.054361; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Landrein B, 2013, CURR BIOL, V23, P895, DOI 10.1016/j.cub.2013.04.013; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Noblin X, 2012, SCIENCE, V335, P1322, DOI 10.1126/science.1215985; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; PRITCHARD J, 1989, J EXP BOT, V40, P567, DOI 10.1093/jxb/40.5.567; Randall RP, 2002, GLOBAL COMPENDIUM WE; Rich TCG., 1991, BSBI HDB, V6, P334; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; Routier-Kierzkowska AL, 2012, PLANT PHYSIOL, V158, P1514, DOI 10.1104/pp.111.191460; Schneider S., 1935, JAHRBUECHER FUER WIS; SCHROEDER JI, 1984, NATURE, V312, P361, DOI 10.1038/312361a0; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; Tondu B, 2012, J INTEL MAT SYST STR, V23, P225, DOI 10.1177/1045389X11435435; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vaughn KC, 2011, AM J BOT, V98, P1276, DOI 10.3732/ajb.1000374; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384; Vogel S, 2005, J BIOSCIENCES, V30, P167, DOI 10.1007/BF02703696; Walker SM, 2009, J R SOC INTERFACE, V6, P351, DOI 10.1098/rsif.2008.0245; Wang CX, 2004, ANN BOT-LONDON, V93, P443, DOI 10.1093/aob/mch062; Weber A, 2015, J EXP BOT, V66, P3229, DOI 10.1093/jxb/erv135; Yatsu Yoshinori, 2003, Plant Species Biology, V18, P35, DOI 10.1046/j.1442-1984.2003.00086.x	45	86	87	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					222	233		10.1016/j.cell.2016.05.002	http://dx.doi.org/10.1016/j.cell.2016.05.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27264605	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000380254400023
J	Sidibe, M; Singh, PK				Sidibe, Michel; Singh, Poonam Khetrapal			Thailand eliminates mother-to-child transmission of HIV and syphilis	LANCET			English	Editorial Material									[Sidibe, Michel] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland; [Singh, Poonam Khetrapal] WHO Reg Off South East Asia, New Delhi, India	UNAIDS	Singh, PK (corresponding author), WHO Reg Off South East Asia, New Delhi, India.	serdo@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2016, WHO VAL COUNTR EL MO; Brown T, 2003, UNDERSTANDING HIV PR; HIV and AIDS Data Hub for Asia-Pacific, 2012, THAIL COUNTR REV; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Regional Validation Committee, 2016, EL MOTH TO CHILD TRA; [Royal Government of Thailand Ministry of Public Health], 2016, VAL EL MOTH TO CHILD; Simonds R, 2002, AIDS, V16, P953; UNAIDS, 2016, UNAIDS ANN LOW PRIC; World Health Organization, 2016, THAIL IS 1 COUNTR AS	9	6	11	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2488	2489		10.1016/S0140-6736(16)30787-5	http://dx.doi.org/10.1016/S0140-6736(16)30787-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27291996				2022-12-28	WOS:000377947200008
J	O'Herron, P; Chhatbar, PY; Levy, M; Shen, ZM; Schramm, AE; Lu, ZY; Kara, P				O'Herron, Philip; Chhatbar, Pratik Y.; Levy, Manuel; Shen, Zhiming; Schramm, Adrien E.; Lu, Zhongyang; Kara, Prakash			Neural correlates of single-vessel haemodynamic responses in vivo	NATURE			English	Article							PRIMARY VISUAL-CORTEX; BLOOD-FLOW; NEURONAL-ACTIVITY; CAPILLARY PERICYTES; FMRI; STIMULATION; SIGNALS; BRAIN; MICROARCHITECTURE; OXYGENATION	Neural activation increases blood flow locally. This vascular signal is used by functional imaging techniques to infer the location and strength of neural activity(1,2). However, the precise spatial scale over which neural and vascular signals are correlated is unknown. Furthermore, the relative role of synaptic and spiking activity in driving haemodynamic signals is controversial(3-9). Previous studies recorded local field potentials as a measure of synaptic activity together with spiking activity and low-resolution haemodynamic imaging. Here we used two-photon microscopy to measure sensory-evoked responses of individual blood vessels (dilation, blood velocity) while imaging synaptic and spiking activity in the surrounding tissue using fluorescent glutamate and calcium sensors. In cat primary visual cortex, where neurons are clustered by their preference for stimulus orientation, we discovered new maps for excitatory synaptic activity, which were organized similarly to those for spiking activity but were less selective for stimulus orientation and direction. We generated tuning curves for individual vessel responses for the first time and found that parenchymal vessels in cortical layer 2/3 were orientation selective. Neighbouring penetrating arterioles had different orientation preferences. Pial surface arteries in cats, as well as surface arteries and penetrating arterioles in rat visual cortex (where orientation maps do not exist(10)), responded to visual stimuli but had no orientation selectivity. We integrated synaptic or spiking responses around individual parenchymal vessels in cats and established that the vascular and neural responses had the same orientation preference. However, synaptic and spiking responses were more selective than vascular responses-vessels frequently responded robustly to stimuli that evoked little to no neural activity in the surrounding tissue. Thus, local neural and haemodynamic signals were partly decoupled. Together, these results indicate that intrinsic cortical properties, such as propagation of vascular dilation between neighbouring columns, need to be accounted for when decoding haemodynamic signals.	[O'Herron, Philip; Chhatbar, Pratik Y.; Levy, Manuel; Shen, Zhiming; Schramm, Adrien E.; Lu, Zhongyang; Kara, Prakash] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kara, P (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kara@musc.edu		Lu, Zhongyang/0000-0002-2182-7854; levy, manuel/0000-0003-1117-5028	National Institutes of Health [NS088827]; National Science Foundation [1539034]; Whitehall and Dana Foundations; NATIONAL EYE INSTITUTE [R01EY017925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088827] Funding Source: NIH RePORTER; Office of Integrative Activities [1539034] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Whitehall and Dana Foundations; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank A. Shih for comments on the manuscript. This work was supported by grants from the National Institutes of Health (NS088827), National Science Foundation (1539034), and Whitehall and Dana Foundations to P.K.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Berwick J, 2008, J NEUROPHYSIOL, V99, P787, DOI 10.1152/jn.00658.2007; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Chen BR, 2011, NEUROIMAGE, V54, P1021, DOI 10.1016/j.neuroimage.2010.09.036; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chhatbar PY, 2016, BRAIN STIMUL, V9, P16, DOI 10.1016/j.brs.2015.09.002; Chhatbar PY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00106; Drew PJ, 2011, P NATL ACAD SCI USA, V108, P8473, DOI 10.1073/pnas.1100428108; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Fukuda M, 2005, CEREB CORTEX, V15, P823, DOI 10.1093/cercor/bhh183; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hedges LV, 2014, STAT METHOD METAANAL; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; O'Herron P, 2012, JOVE-J VIS EXP, V70, DOI DOI 10.3791/50025; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rao SC, 1997, J COMP NEUROL, V387, P358; Ringach DL, 2002, J NEUROSCI, V22, P5639; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Vanzetta I, 2004, NEURON, V42, P843, DOI 10.1016/j.neuron.2004.04.004; Wang Z, 2012, J CEREBR BLOOD F MET, V32, P6, DOI 10.1038/jcbfm.2011.152	37	123	124	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					378	+		10.1038/nature17965	http://dx.doi.org/10.1038/nature17965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281215	Green Accepted			2022-12-28	WOS:000377856800034
J	Huang, ES				Huang, Elbert S.			Management of diabetes mellitus in older people with comorbidities	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE GLUCOSE CONTROL; CLINICAL-PRACTICE GUIDELINES; MULTIPLE CHRONIC CONDITIONS; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; FOLLOW-UP; HEALTH OUTCOMES; DECISION AID; ADULTS	Diabetes mellitus is a chronic disease of aging that affects more than 20% of people over 65. In older patients with diabetes, comorbidities are highly prevalent and their presence may alter the relative importance, effectiveness, and safety of treatments for diabetes. Randomized controlled trials have shown that intensive glucose control produces microvascular and cardiovascular benefits but typically after extended treatment periods (five to nine years) and with exposure to short term risks such as mortality (in one trial) and hypoglycemia. Decision analysis, health economics, and observational studies have helped to illustrate the importance of acknowledging life expectancy, hypoglycemia, and treatment burden when setting goals in diabetes. Guidelines recommend that physicians individualize the intensity of glucose control and treatments on the basis of the prognosis (for example, three tiers based on comorbidities and functional impairments) and preferences of individual patients. Very few studies have attempted to formally implement and study these concepts in clinical practice. To better meet the treatment needs of older patients with diabetes and comorbidities, more research is needed to determine the risks and benefits of intensifying, maintaining, or de-intensifying treatments in this population. This research effort should extend to the development and study of decision support tools as well as targeted care management.	[Huang, Elbert S.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Huang, ES (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ehuang@medicine.bsd.uchicago.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK105340, R01DK081796, P30DK092949] Funding Source: NIH RePORTER; AHRQ [5R01HS018542-02, 5R01HS018542-03] Funding Source: Federal RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adams K, 2012, J AM GERIATR SOC, V60, P2333, DOI 10.1111/j.1532-5415.2012.04240.x; Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 1999, DEATH FORETOLD PROPH; Araki A, 2012, GERIATR GERONTOL INT, V12, P7, DOI 10.1111/j.1447-0594.2011.00808.x; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Blaum CS, 2010, MED CARE, V48, P327, DOI 10.1097/MLR.0b013e3181ca4035; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cegelka A, 2013, J AM GERIATR SOC, V61, P2020, DOI 10.1111/jgs.12514; Centers for Disease Control and Prevention, 2015, RATE PER 100 OF CIVI; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cigolle Christine T, 2012, J Gerontol A Biol Sci Med Sci, V67, P1313, DOI 10.1093/gerona/gls095; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; Corser W, 2007, DIABETES EDUCATOR, V33, P700, DOI 10.1177/0145721707304086; Denig P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5651; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Huang ES, 2013, DIABETES, V62, pA336; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; International Diabetes Federation (IDF), 2015, IDF DIABETES ATLAS, V7th, DOI DOI 10.1214/AOMS/1177699147; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Laiteerapong N, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110287; Laiteerapong N, 2011, DIABETES CARE, V34, P1749, DOI 10.2337/dc10-2424; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; Moritz T, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc096250; Morley JE, 1998, DIABETIC MED, V15, pS41, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S41::AID-DIA747>3.3.CO;2-5; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Munshi MN, 2013, DIABETES CARE, V36, P543, DOI 10.2337/dc12-1303; Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Saunders C, 2013, DIABETIC MED, V30, P300, DOI 10.1111/dme.12047; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Silveira MJ, 2014, J AM GERIATR SOC, V62, P706, DOI 10.1111/jgs.12736; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Thorpe CT, 2015, DIABETES CARE, V38, P588, DOI 10.2337/dc14-0599; Tierney EF, 2004, DIABETES CARE, V27, P2723, DOI 10.2337/diacare.27.11.2723; Tseng CL, 2014, JAMA INTERN MED, V174, P259, DOI 10.1001/jamainternmed.2013.12963; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Department of Veterans Affairs, 2010, VA DOD CLINICAL PRAC; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Vincent GK, 2010, THE NEXT FOUR DECADE; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; Wilkinson MJ, 2013, CURR DIABETES REP, V13, P205, DOI 10.1007/s11892-012-0348-6; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zhou H, 2005, DIABETES CARE, V28, P2856, DOI 10.2337/diacare.28.12.2856; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	80	34	34	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i2200	10.1136/bmj.i2200	http://dx.doi.org/10.1136/bmj.i2200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27307175	Green Published			2022-12-28	WOS:000378240400001
J	Yudkin, JS; Kavanagh, J; McCormack, JP				Yudkin, John S.; Kavanagh, Jayne; McCormack, James P.			Guidelines for treating risk factors should include tools for shared decision making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN-DIABETES-ASSOCIATION; CENTERED APPROACH. UPDATE; EUROPEAN ASSOCIATION; POSITION STATEMENT; LIFE-EXPECTANCY; TYPE-2; BENEFITS; HYPERGLYCEMIA; MANAGEMENT; MEDICATION		[Yudkin, John S.] UCL, Div Med, London, England; [Kavanagh, Jayne] UCL Med Sch, Acad Ctr Med Educ, Royal Free Campus, London, England; [McCormack, James P.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada	University of London; University College London; University of London; University College London; University of British Columbia	Yudkin, JS (corresponding author), UCL, Div Med, London, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	McCormack, James/0000-0002-7801-5515				Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS81, DOI 10.2337/dc16-S013; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; General Medical Council, 2008, CONS PAT DOCT MAK DE; Hayes AJ, 2013, DIABETOLOGIA, V56, P1925, DOI 10.1007/s00125-013-2940-y; Hayward RA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6549; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0; Leal J, 2009, EUR HEART J, V30, P834, DOI 10.1093/eurheartj/ehn567; McCormack JP, 2015, DIABETES CARE, V38, pE141, DOI 10.2337/dc15-0074; National Institute for Health and Care Excellence (NICE), 2015, TYP 2 DIAB AD MAN NG; National Institute for Health and Care Excellence (NICE), 2015, BLOOD GLUC CONTR AD; Nolan T, 2015, BRIT J GEN PRACT, V65, pE152, DOI 10.3399/bjgp15X683953; Price HC, 2009, DIABETIC MED, V26, P454, DOI 10.1111/j.1464-5491.2009.02702.x; Rodriguez-Gutierrez R, 2016, LANCET DIABETES ENDO, V4, P706, DOI 10.1016/S2213-8587(15)00468-4; Sapre N, 2009, INTERN MED J, V39, P277, DOI 10.1111/j.1445-5994.2008.01729.x; Sarosi George A, 2015, Ann Intern Med, V163, P562, DOI 10.7326/M15-1202; Sokol DK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6432; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995	22	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3147	10.1136/bmj.i3147	http://dx.doi.org/10.1136/bmj.i3147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27302041	Green Submitted			2022-12-28	WOS:000378239800005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Uncertain science in soundbites	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONS; DIET					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, 2016, ALC GUID REV REP GUI; Department of Health, 2016, NEW GUID SHOW INCR R; Owen C., 1989, Thatcheria, V24, P1; Johns DJ, 2014, J ACAD NUTR DIET, V114, P1557, DOI 10.1016/j.jand.2014.07.005; Meier P., 2016, MORTALITY MORBIDITY; [Public Health Collaboration National Obesity Forum], 2016, EAT FAT CUT CARBS AV; Tobias DK, 2015, LANCET DIABETES ENDO, V3, P968, DOI 10.1016/S2213-8587(15)00367-8	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2016	353								i3218	10.1136/bmj.i3218	http://dx.doi.org/10.1136/bmj.i3218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1FW	27298315	Green Published, Bronze			2022-12-28	WOS:000378236900003
J	Wise, J				Wise, Jacqui			Diagnosing cancer early is vital, new figures show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Office for National Statistics Public Health England, 2016, CANC SURV STAG DIAGN	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2016	353								i3277	10.1136/bmj.i3277	http://dx.doi.org/10.1136/bmj.i3277			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1FW	27298300				2022-12-28	WOS:000378236900007
J	Grimes, DT; Boswell, CW; Morante, NFC; Henkelman, RM; Burdine, RD; Ciruna, B				Grimes, D. T.; Boswell, C. W.; Morante, N. F. C.; Henkelman, R. M.; Burdine, R. D.; Ciruna, B.			Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature	SCIENCE			English	Article							PRIMARY CILIARY DYSKINESIA; PRIMARY CILIUM; SUSCEPTIBILITY; DOCKING	Idiopathic scoliosis (IS) affects 3% of children worldwide, yet the mechanisms underlying this spinal deformity remain unknown. Here we show that ptk7 mutant zebrafish, a faithful developmental model of IS, exhibit defects in ependymal cell cilia development and cerebrospinal fluid (CSF) flow. Transgenic reintroduction of Ptk7 in motile ciliated lineages prevents scoliosis in ptk7 mutants, and mutation of multiple independent cilia motility genes yields IS phenotypes. We define a finite developmental window for motile cilia in zebrafish spine morphogenesis. Notably, restoration of cilia motility after the onset of scoliosis blocks spinal curve progression. Together, our results indicate a critical role for cilia -driven CSF flow in spine development, implicate irregularities in CSF flow as an underlying biological cause of IS, and suggest that noninvasive therapeutic intervention may prevent severe scoliosis.	[Grimes, D. T.; Morante, N. F. C.; Burdine, R. D.] Princeton Univ, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA; [Boswell, C. W.; Ciruna, B.] Hosp Sick Children, Program Dev & Stem Cell Biol, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Boswell, C. W.; Ciruna, B.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Henkelman, R. M.] Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3H7, Canada; [Henkelman, R. M.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Princeton University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Ciruna, B (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.	ciruna@sickkids.ca		Grimes, Daniel/0000-0003-0173-1887; Burdine, Rebecca/0000-0001-6620-5015; Boswell, Curtis/0000-0002-9521-8779	Canada Research Chairs program; National Institute of Child Health and Development [2R01HD048584]; Canadian Institutes of Health Research [MOP-111075]; March of Dimes Foundation [1-FY13-398]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048584] Funding Source: NIH RePORTER	Canada Research Chairs program(Canada Research Chairs); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully acknowledge E. Lee, D. Holmyard, P. Paroutis, and L. Yu for technical assistance; A. Morley, A. Ng, C. Hasty D. Bosco, and P. Johnson for zebra fish care; and J. Schottenfeld-Roames and T. Ku for initial observations of spine curvatures a c21orf59<SUP>TS</SUP> mutant fish. This work was supported in part by funding from the Canada Research Chairs program to R.M.H. and B.C.; National Institute of Child Health and Development grant 2R01HD048584 to R.D.B.; and Canadian Institutes of Health Research (MOP-111075) and March of Dimes Foundation, (#1-FY13-398) grants to B.C. D.T.G., C.W.B.; and N.F.C.M. performed all experiments characterizing scoliosis phenotypes. C.W.B. cloned and characterized foxjla transgenic lines. N.F.C.M. generated the dyx1c1<SUP>pr13</SUP> allele C.W.B. and R.M.H. performed mu CT. B.C. and C.W.B. performed SEM and CSF flow analyses. D.T.G.; C.W.B.; N.F.C.M., R.D.B., and B.C. analyzed the data. D.T.G., C.W.B. and B.C. wrote the manuscript, and all authors edited the manuscript.	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Buchan JG, 2014, DEV DYNAM, V243, P1646, DOI 10.1002/dvdy.24208; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Cheng JC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.30; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Chuma A, 1997, SPINE, V22, P589, DOI 10.1097/00007632-199703150-00002; ENGESAETH VG, 1993, PEDIATR PULM, V16, P9, DOI 10.1002/ppul.1950160103; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gorman KF, 2009, MED HYPOTHESES, V72, P348, DOI 10.1016/j.mehy.2008.09.052; Hayes M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5777; Hayes M, 2013, DEVELOPMENT, V140, P1807, DOI 10.1242/dev.090183; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; Janssen MMA, 2011, SPINE J, V11, P347, DOI 10.1016/j.spinee.2011.03.010; Karner CM, 2015, HUM MOL GENET, V24, P4365, DOI 10.1093/hmg/ddv170; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Ozerdemoglu RA, 2003, SPINE, V28, P1410, DOI 10.1097/00007632-200307010-00011; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Patten SA, 2015, J CLIN INVEST, V125, P1124, DOI 10.1172/JCI77262; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7452; Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Turgut M, 2005, NEUROSURG REV, V28, P289, DOI 10.1007/s10143-005-0391-8; Verhoef M, 2004, DEV MED CHILD NEUROL, V46, P420, DOI 10.1017/S0012162204000684; Wang WJ, 2011, J PEDIATR ORTHOPED, V31, pS14, DOI 10.1097/BPO.0b013e3181f73c12	30	136	140	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1341	1344		10.1126/science.aaf6419	http://dx.doi.org/10.1126/science.aaf6419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284198	Green Accepted			2022-12-28	WOS:000377972000047
J	Mendell, JT				Mendell, Joshua T.			Targeting a Long Noncoding RNA in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTASIS; MALAT1		[Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003	5	123	128	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2287	2289		10.1056/NEJMcibr1603785	http://dx.doi.org/10.1056/NEJMcibr1603785			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276568				2022-12-28	WOS:000377920500015
J	Ohta, K; Kuwayama, Y; Hirose, K; Shimizu, K; Ohishi, Y				Ohta, Kenji; Kuwayama, Yasuhiro; Hirose, Kei; Shimizu, Katsuya; Ohishi, Yasuo			Experimental determination of the electrical resistivity of iron at Earth's core conditions	NATURE			English	Article							THERMAL-CONDUCTIVITY; HIGH-PRESSURE; LIQUID FE; ALLOY; CONVECTION; EVOLUTION; STATE	Earth continuously generates a dipole magnetic field in its convecting liquid outer core by a self-sustained dynamo action. Metallic iron is a dominant component of the outer core, so its electrical and thermal conductivity controls the dynamics and thermal evolution of Earth's core(1). However, in spite of extensive research, the transport properties of iron under core conditions are still controversial(2-9). Since free electrons are a primary carrier of both electric current and heat, the electron scattering mechanism in iron under high pressure and temperature holds the key to understanding the transport properties of planetary cores. Here we measure the electrical resistivity (the reciprocal of electrical conductivity) of iron at the high temperatures (up to 4,500 kelvin) and pressures (megabars) of Earth's core in a laser-heated diamond-anvil cell. The value measured for the resistivity of iron is even lower than the value extrapolated from high-pressure, low-temperature data using the Bloch-Gruneisen law, which considers only the electron-phonon scattering. This shows that the iron resistivity is strongly suppressed by the resistivity saturation effect at high temperatures. The low electrical resistivity of iron indicates the high thermal conductivity of Earth's core, suggesting rapid core cooling and a young inner core less than 0.7 billion years old(10). Therefore, an abrupt increase in palaeomagnetic field intensity around 1.3 billion years ago(11) may not be related to the birth of the inner core.	[Ohta, Kenji] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan; [Kuwayama, Yasuhiro] Ehime Univ, Geodynam Res Ctr, 2-5 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan; [Hirose, Kei] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan; [Hirose, Kei] Japan Agcy Marine Earth Sci & Technol, Lab Ocean Earth Life Evolut Res, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Shimizu, Katsuya] Osaka Univ, Ctr Sci & Technol Extreme Condit, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan; [Ohishi, Yasuo] Japan Synchrotron Radiat Res Inst, 1-1-1 Koto, Sayo, Hyogo 6795198, Japan	Tokyo Institute of Technology; Ehime University; Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Osaka University; Japan Synchrotron Radiation Research Institute	Ohta, K (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	k-ohta@geo.titech.ac.jp	Hirose, Kei/C-2165-2009; Ohta, Kenji/C-2825-2009	Hirose, Kei/0000-0003-4366-7721; Ohta, Kenji/0000-0002-6107-8720; Shimizu, Katsuya/0000-0003-0560-8325; Kuwayama, Yasuhiro/0000-0002-0077-3877	Grants-in-Aid for Scientific Research [16H06285] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akahama Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335683; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Bi Y, 2002, J PHYS-CONDENS MAT, V14, P10849, DOI 10.1088/0953-8984/14/44/389; Biggin AJ, 2015, NATURE, V526, P245, DOI 10.1038/nature15523; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Bohnenkamp U, 2002, J APPL PHYS, V92, P4402, DOI 10.1063/1.1502182; Braginsky L, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134201; Bridgman P.W., 1952, P AM ACAD ARTS SCI, V81, P165, DOI DOI 10.2307/20023677; Davies C, 2015, NAT GEOSCI, V8, P678, DOI 10.1038/NGEO2492; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Deng LW, 2013, GEOPHYS RES LETT, V40, P33, DOI 10.1029/2012GL054347; Dewaele A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215504; Gomi H, 2015, PHYS EARTH PLANET IN, V247, P2, DOI 10.1016/j.pepi.2015.04.003; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; Imada S, 2014, GEOPHYS RES LETT, V41, P4542, DOI 10.1002/2014GL060423; Jaccard D, 2002, PHYS LETT A, V299, P282, DOI 10.1016/S0375-9601(02)00725-9; Kiarasi S, 2015, PHYS STATUS SOLIDI B, V252, P2034, DOI 10.1002/pssb.201552029; Labrosse S, 2015, PHYS EARTH PLANET IN, V247, P36, DOI 10.1016/j.pepi.2015.02.002; Le Bars M, 2015, ANNU REV FLUID MECH, V47, P163, DOI 10.1146/annurev-fluid-010814-014556; Matassov G, 1977, THESIS; MURR LE, 1976, APPL PHYS LETT, V28, P432, DOI 10.1063/1.88810; O'Rourke JG, 2016, NATURE, V529, P387, DOI 10.1038/nature16495; Ohishi Y, 2008, HIGH PRESSURE RES, V28, P163, DOI 10.1080/08957950802208910; OHNO H, 1971, J PHYS SOC JPN, V31, P92, DOI 10.1143/JPSJ.31.92; Ohta K, 2012, EARTH PLANET SC LETT, V349, P109, DOI 10.1016/j.epsl.2012.06.043; Olson P, 2013, PHYS EARTH PLANET IN, V214, P87, DOI 10.1016/j.pepi.2012.10.003; POWELL RW, 1953, PHILOS MAG, V44, P772; Pozzo M, 2014, EARTH PLANET SC LETT, V393, P159, DOI 10.1016/j.epsl.2014.02.047; Pozzo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.014110; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Sata N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006975; Seagle CT, 2013, GEOPHYS RES LETT, V40, P5377, DOI 10.1002/2013GL057930; SECCO RA, 1989, J GEOPHYS RES-SOLID, V94, P5887, DOI 10.1029/JB094iB05p05887; Sha XW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/7/075401; SIMPSON A, 1971, J PHYS PART C SOLID, V4, P1710, DOI 10.1088/0022-3719/4/13/021; Stacey FD, 2007, PHYS EARTH PLANET IN, V161, P13, DOI 10.1016/j.pepi.2006.12.001; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8; Tarduno JA, 2015, SCIENCE, V349, P521, DOI 10.1126/science.aaa9114; Touloukian Y. S., 1970, THERMOPHYSICAL PROPE; Tsujino N, 2013, EARTH PLANET SC LETT, V375, P244, DOI 10.1016/j.epsl.2013.05.040; WIESMANN H, 1977, PHYS REV LETT, V38, P782, DOI 10.1103/PhysRevLett.38.782; Zytveld JBV, 1980, J PHYS COLLOQUES, DOI [10.1051/jphyscol:19808126, DOI 10.1051/JPHYSCOL:19808126]	44	165	168	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					95	+		10.1038/nature17957	http://dx.doi.org/10.1038/nature17957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251282				2022-12-28	WOS:000376962300040
J	Rash, A				Rash, Amar			Ramakant Maganlal Rash OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2970	10.1136/bmj.i2970	http://dx.doi.org/10.1136/bmj.i2970			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27234055				2022-12-28	WOS:000376940700007
J	Torjesen, I				Torjesen, Ingrid			Three new treatments for diabetes recommended by NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NICE, 2016, CAN ZIN DAP EMP MON	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2016	353								i2980	10.1136/bmj.i2980	http://dx.doi.org/10.1136/bmj.i2980			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CG	27226458				2022-12-28	WOS:000376939400006
J	McGill, F; Heyderman, RS; Panagiotou, S; Tunkel, AR; Solomon, T				McGill, Fiona; Heyderman, Robert S.; Panagiotou, Stavros; Tunkel, Allan R.; Solomon, Tom			Acute bacterial meningitis in adults	LANCET			English	Review							INVASIVE MENINGOCOCCAL DISEASE; PNEUMOCOCCAL CONJUGATE VACCINE; MEDIATED ISOTHERMAL AMPLIFICATION; HAEMOPHILUS-INFLUENZAE DISEASE; POST-NEUROSURGICAL MENINGITIS; REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; SEROGROUP-B; NEISSERIA-MENINGITIDIS; COMBINATION THERAPY	Over the past several decades, the incidence of bacterial meningitis in children has decreased but there remains a significant burden of disease in adults, with a mortality of up to 30%. Although the pathogenesis of bacterial meningitis is not completely understood, knowledge of bacterial invasion and entry into the CNS is improving. Clinical features alone cannot determine whether meningitis is present and analysis of cerebrospinal fluid is essential for diagnosis. Newer technologies, such as multiplex PCR, and novel diagnostic platforms that incorporate proteomics and genetic sequencing, might help provide a quicker and more accurate diagnosis. Even with appropriate antimicrobial therapy, mortality is high and so attention has focused on adjunctive therapies; adjunctive corticosteroids are beneficial in certain circumstances. Any further improvements in outcome are likely to come from either modulation of the host response or novel approaches to therapy, rather than new antibiotics. Ultimately, the best hope to reduce the disease burden is with broadly protective vaccines.	[McGill, Fiona; Panagiotou, Stavros; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England; [Heyderman, Robert S.] Univ Malawi, Coll Med, Clin Res Programme, Malawi Liverpool Wellcome Trust, Blantyre, Malawi; [Tunkel, Allan R.] Brown Univ, Warren Alpert Med Sch, Providence, RI USA; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [McGill, Fiona; Solomon, Tom] NIHR, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [McGill, Fiona] Leeds Univ Hosp NHS Trust, Leeds, W Yorkshire, England; [McGill, Fiona; Solomon, Tom] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Heyderman, Robert S.] UCL, Div Infect & Immun, London, England	University of Liverpool; University of Malawi; Brown University; Walton Centre; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of London; University College London	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England.	tsolomon@liv.ac.uk	Bartusek, Karel/D-3389-2012	Bartusek, Karel/0000-0002-6598-5424; Heyderman, Robert/0000-0003-4573-449X; Solomon, Tom/0000-0001-7266-6547; Panagiotou, Stavros/0000-0001-9972-5068	NIHR; National Institute for Health Research [RP-PG-0108-10048, IS-HPU-1112-10117, NF-SI-0514-10177] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	FM is a National Institute for Health Research (NIHR) doctoral research fellow and TS is an NIHR senior investigator. Both receive support from the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. This work was conducted independently of influence from the NIHR.	Abdeldaim GMK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-310; Adriani KS, 2013, J INFECTION, V66, P255, DOI 10.1016/j.jinf.2012.10.008; Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Antignac A, 2003, CLIN INFECT DIS, V37, P912, DOI 10.1086/377739; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Aubert L, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.3.21016; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Balganesh M, 2000, MOL CELL PROBE, V14, P61, DOI 10.1006/mcpr.2000.0287; Barichello T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/371465; Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Bijlsma MW, 2014, LANCET INFECT DIS, V14, P805, DOI 10.1016/S1473-3099(14)70806-0; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Boden K, 2011, TOCCMJ, V4, P44, DOI [10.2174/1874828701104010044, DOI 10.2174/1874828701104010044]; Bodilsen J, 2014, SCAND J INFECT DIS, V46, P418, DOI 10.3109/00365548.2014.887223; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Bourke TW, 2015, LANCET INFECT DIS, V15, P552, DOI 10.1016/S1473-3099(15)70038-1; Bronska E, 2006, CLIN MICROBIOL INFEC, V12, P137, DOI 10.1111/j.1469-0691.2005.01327.x; Brouwer MC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub4; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brown EM, 2010, ANTIMICROB AGENTS CH, V54, P1016, DOI 10.1128/AAC.01077-09; Bryant PA, 2004, J CLIN MICROBIOL, V42, P2919, DOI 10.1128/JCM.42.7.2919-2925.2004; Canica M, 2004, J MED MICROBIOL, V53, P921, DOI 10.1099/jmm.0.45556-0; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; Centers for Disease Control, 2014, ACT BACT COR SURV; Chaudhuri A, 2008, EUR J NEUROL, V15, P649, DOI 10.1111/j.1468-1331.2008.02193.x; Cheong JWS, 2015, EPIDEMIOL INFECT, V143, P2993, DOI 10.1017/S0950268815000345; Chiba N, 2013, MICROB DRUG RESIST, V19, P308, DOI 10.1089/mdr.2012.0180; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046688, 10.1371/journal.pone.0039927]; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Collard JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-576; Coureuil M, 2014, TRENDS MOL MED, V20, P571, DOI 10.1016/j.molmed.2014.08.002; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Darrieux M, 2015, CRIT REV MICROBIOL, V41, P190, DOI 10.3109/1040841X.2013.813902; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Demar M, 2013, EMERG INFECT DIS, V19, P1545, DOI 10.3201/eid1909.121872; Djukic M, 2005, NEUROCRIT CARE, V2, P325, DOI 10.1385/NCC:2:3:325; Domingo P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-108; Domingo P, 2013, J INFECTION, V66, P147, DOI 10.1016/j.jinf.2012.10.030; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Elliott I, 2013, CLIN MICROBIOL INFEC, V19, pE466, DOI 10.1111/1469-0691.12260; Ellis-Pegler R, 2003, CLIN INFECT DIS, V37, P658, DOI 10.1086/377203; Erdem H, 2014, INT J INFECT DIS, V19, P13, DOI 10.1016/j.ijid.2013.09.012; European Centre for Disease Prevention and Control, 2013, PROP PEN RES STREPT; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Fernandez-Ruiz M, 2010, INTERNAL MED, V49, P1971, DOI 10.2169/internalmedicine.49.3942; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Fletcher MA, 2015, EXPERT REV VACCINES, V14, P975, DOI 10.1586/14760584.2015.1037743; Fowler HN, 2013, EMERG INFECT DIS, V19, P330, DOI 10.3201/eid1902.120918; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Gerner-Smidt P, 2005, CLIN MICROBIOL INFEC, V11, P618, DOI 10.1111/j.1469-0691.2005.01171.x; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Gillespie IA, 2009, J CLIN MICROBIOL, V47, P3301, DOI 10.1128/JCM.00969-09; Glimaker M, 2015, CLIN INFECT DIS, V60, P1162, DOI 10.1093/cid/civ011; Gomez-Zorrilla S, 2014, EMERG INFECT DIS, V20, P1067, DOI 10.3201/eid2006.131167; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Grandgirard D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/312476; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Ho PL, 2011, VACCINE, V29, P3270, DOI 10.1016/j.vaccine.2011.02.025; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; Karageorgopoulos DE, 2009, ARCH DIS CHILD, V94, P607, DOI 10.1136/adc.2008.151563; Kelesidis T, 2011, DIAGN MICR INFEC DIS, V71, P286, DOI 10.1016/j.diagmicrobio.2011.07.001; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Knoll BM, 2013, SCAND J INFECT DIS, V45, P131, DOI 10.3109/00365548.2012.717711; Koopmans MM, 2013, CLIN INFECT DIS, V57, P247, DOI 10.1093/cid/cit250; Kutlesa M, 2014, CLIN NEUROL NEUROSUR, V123, P181, DOI 10.1016/j.clineuro.2014.05.018; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Lavezzo E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-554; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122922; Lepur D, 2011, J INFECTION, V62, P172, DOI 10.1016/j.jinf.2010.10.001; Leroux-Roels G, 2014, VACCINE, V32, P6838, DOI 10.1016/j.vaccine.2014.02.052; Leroux-Roels I, 2015, VACCINE, V33, P577, DOI 10.1016/j.vaccine.2013.10.052; Liechti FD, 2015, FUTURE MICROBIOL, V10, P1195, DOI 10.2217/fmb.15.43; Link-Gelles R, 2013, VACCINE, V31, P2572, DOI 10.1016/j.vaccine.2013.03.049; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Mai N, 2004, NEW ENGL J MED, V357, P2431; Marcus U, 2013, Euro Surveill, V18; Marra A, 2001, INFECT IMMUN, V69, P7318, DOI 10.1128/IAI.69.12.7318-7325.2001; Martin NG, 2014, LANCET INFECT DIS, V14, P397, DOI 10.1016/S1473-3099(14)70027-1; McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007; Michael B, 2010, EMERG MED J, V27, P433, DOI 10.1136/emj.2009.075598; Molyneux E, 2011, LANCET, V377, P1837, DOI 10.1016/S0140-6736(11)60580-1; Morelli P, 2014, J ANTIMICROB CHEMOTH, V69, P857, DOI 10.1093/jac/dkt437; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Nagdev KJ, 2011, J CLIN MICROBIOL, V49, P1861, DOI 10.1128/JCM.00824-10; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nathan N, 2005, LANCET, V366, P308, DOI 10.1016/S0140-6736(05)66792-X; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; Nemescu RE, 2014, MED-SURG J, V118, P497; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Pordardottir A, 2014, SCAND J INFECT DIS, V46, P354, DOI 10.3109/00365548.2014.880184; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Public Health England, OPPORTUNISTIC CHLAMY; Ramachandran P, 2013, INDIAN J MED RES, V137, P712; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Richardson DC, 2003, J CLIN MICROBIOL, V41, P3851, DOI 10.1128/JCM.41.8.3851-3853.2003; Roed C, 2012, J INFECTION, V64, P34, DOI 10.1016/j.jinf.2011.10.003; Rubach MP, 2011, EMERG INFECT DIS, V17, P1645, DOI 10.3201/eid1709.101991; Sadarangani M, 2015, CLIN INFECT DIS, V60, pE27, DOI 10.1093/cid/civ028; Sadarangani M, 2014, CLIN INFECT DIS, V59, P1208, DOI 10.1093/cid/ciu597; Sakoulas G, 2015, ANTIMICROB AGENTS CH, V59, P2428, DOI 10.1128/AAC.04965-14; Sakushima K, 2011, J INFECTION, V62, P255, DOI 10.1016/j.jinf.2011.02.010; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Segawa S, 2014, CLIN CHIM ACTA, V435, P59, DOI 10.1016/j.cca.2014.04.024; Shibl AM, 2012, VACCINE, V30, pG32, DOI 10.1016/j.vaccine.2012.07.030; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Singhi SC, 2002, ANN TROP PAEDIATR, V22, P347, DOI 10.1179/027249302125002010; Sipahi OR, 2011, SCAND J INFECT DIS, V43, P757, DOI 10.3109/00365548.2011.585177; Skoczynska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071943; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Solomon Tom, 2007, Pract Neurol, V7, P288, DOI 10.1136/jnnp.2007.129098; Srinivasan L, 2012, ANN EMERG MED, V60, P609, DOI 10.1016/j.annemergmed.2012.05.040; STEPHENS DS, 1991, REV INFECT DIS, V13, P22; Trivedi K, 2011, TRENDS MICROBIOL, V19, P456, DOI 10.1016/j.tim.2011.06.006; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Vena A, 2013, DIAGN MICR INFEC DIS, V76, P99, DOI 10.1016/j.diagmicrobio.2013.01.021; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Vyse A, 2011, EPIDEMIOL INFECT, V139, P967, DOI 10.1017/S0950268811000574; Wache C, 2015, J INFECT DIS, V212, P247, DOI 10.1093/infdis/jiv028; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; WHO, 2015, RAP GROW OUTBR MEN D	141	114	121	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3036	3047		10.1016/S0140-6736(16)30654-7	http://dx.doi.org/10.1016/S0140-6736(16)30654-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27265346	Green Submitted			2022-12-28	WOS:000390112300036
J	Klompas, M; Rhee, C				Klompas, Michael; Rhee, Chanu			The CMS Sepsis Mandate: Right Disease, Wrong Measure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; MEDICARE; TIME		Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Klompas, Michael; Rhee, Chanu] Dept Populat Med, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Klompas, M (corresponding author), Dept Populat Med, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA.	mklompas@partners.org	Rhee, Chanu/AAO-8368-2020; Klompas, Michael/Z-2415-2019					Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Klouwenberg PMCK, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1035-1; Nicks BA, 2009, ACAD EMERG MED, V16, P184, DOI 10.1111/j.1553-2712.2008.00320.x; Quattromani E, 2011, ACAD EMERG MED, V18, P495, DOI 10.1111/j.1553-2712.2011.01053.x; Rhee C, 2016, INFECT CONT HOSP EP, V37, P163, DOI [10.1017/ice.2015.264, DOI 10.1017/ICE.2015.264]; Rhee C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1266-9; Seymour CW, 2016, CRIT CARE MED, V44, pE122, DOI 10.1097/CCM.0000000000001724; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84	10	35	35	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					517	+		10.7326/M16-0588	http://dx.doi.org/10.7326/M16-0588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27294338				2022-12-28	WOS:000384771300010
J	Anglemyer, A; Miller, ML; Buttrey, S; Whitaker, L				Anglemyer, Andrew; Miller, Matthew L.; Buttrey, Samuel; Whitaker, Lyn			Suicide Rates and Methods in Active Duty Military Personnel, 2005 to 2011 A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							US MILITARY; RISK-FACTORS; SERVICE MEMBERS; YOUNG MEN; VETERANS; SOLDIERS; ARMY; RESILIENCE; PREDICTORS; OCCUPATION	Background: Suicide prevention programs have become ubiquitous among military units; identifying temporal trends and nonclinical factors associated with the chosen suicide methods may help improve suicide prevention strategies. Objective: To calculate suicide rates of active duty military personnel and identify those who are at risk for firearm-specific suicide. Design: Retrospective cohort study. Setting: Military units in the United States. Patients: All active duty enlisted U.S. military personnel from 2005 to 2011. Measurements: Suicide rates per 100 000 were calculated for each branch. Adjusted odds ratios for firearm-specific suicide were calculated with 95% CIs. Results: 1455 military personnel committed suicide from 2005 to 2011. From 2006 to 2011, the rates were highest among army personnel (19.13 to 29.44 cases per 100 000). Among suicides with a known cause of death, 62% were attributed to firearms. The results of this study also suggest that among army personnel or marines who committed suicide, those with infantry or special operations job classifications were more likely than those in non-infantry positions to use a firearm. Limitations: Results are generalizable only to enlisted personnel and reflect only stateside suicides. Data regarding previous psychiatric illness, deployment history, and firearms ownership were lacking. Conclusion: These results may help inform policymakers and advisors about differences in risks of suicide and violent suicide among the armed services and may help guide efforts to prevent self-harm within the military.	[Anglemyer, Andrew; Miller, Matthew L.; Buttrey, Samuel; Whitaker, Lyn] Naval Postgrad Sch, Monterey, CA USA; [Anglemyer, Andrew; Miller, Matthew L.; Buttrey, Samuel; Whitaker, Lyn] US Naval Postgrad Sch, Operat Res Dept, 1411 Cunningham Rd,G-239, Monterey, CA 93943 USA	United States Department of Defense; United States Navy; Naval Postgraduate School; United States Department of Defense; United States Navy; Naval Postgraduate School	Anglemyer, A (corresponding author), US Naval Postgrad Sch, Operat Res Dept, 1411 Cunningham Rd,G-239, Monterey, CA 93943 USA.	atanglem@nps.edu		Anglemyer, Andrew/0000-0002-9091-496X				American Academy of Family Physicians, 2015, JOIN FORC; Anglemyer A., 2014, SUICIDE VIOLENCE OTH; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2011, WAR PREVENTING SUICI; Bush NE, 2013, SUICIDE LIFE-THREAT, V43, P262, DOI 10.1111/sltb.12012; Centers for Disease Control and Prevention, 2021, 10 LEAD CAUS DEATH U; Defense Suicide Prevention Office, 2013, DEF SUIC PREV OFF FY; Freeman TW, 2003, SOUTH MED J, V96, P240, DOI 10.1097/01.SMJ.0000054421.36880.6E; Gilman SE, 2014, PSYCHOL MED, V44, P2579, DOI 10.1017/S003329171400018X; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haley RW, 1998, AM J EPIDEMIOL, V148, P315, DOI 10.1093/oxfordjournals.aje.a009645; HELMKAMP JC, 1995, MIL MED, V160, P45, DOI 10.1093/milmed/160.2.45; Helmkamp JC, 1996, ANN EPIDEMIOL, V6, P83, DOI 10.1016/1047-2797(95)00121-2; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Hyman J, 2012, AM J PUBLIC HEALTH, V102, pS138, DOI 10.2105/AJPH.2011.300484; HYTTEN K, 1989, ACTA PSYCHIAT SCAND, V79, P224, DOI 10.1111/j.1600-0447.1989.tb10248.x; Isung J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.113; Jollant F, 2007, J AFFECT DISORDERS, V99, P59, DOI 10.1016/j.jad.2006.07.022; Kaplan MS, 2009, J TRAUMA, V67, P503, DOI 10.1097/TA.0b013e3181b36521; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Lamothe Dan, 2015, WASHINGTON POST; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Mahon MJ, 2005, AM J PSYCHIAT, V162, P1688, DOI 10.1176/appi.ajp.162.9.1688; Mancinelli I, 2003, MIL MED, V168, P146, DOI 10.1093/milmed/168.2.146; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Pompili M, 2012, SUICIDE GLOBAL PERSP; Ponteva M., 1983, PSYCHIAT FENNICA S, V2, P97; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Preti A, 1998, PSYCHIAT RES, V81, P219, DOI 10.1016/S0165-1781(98)00099-7; R Development Core Team, 2009, R LANG ENV STAT COMP; Rasanen P, 2002, J AFFECT DISORDERS, V71, P51, DOI 10.1016/S0165-0327(01)00411-6; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Rubin D.B., 2002, STAT ANAL MISSING DA; Rubin DB., 1978, P SURV RES METH SECT, P20, DOI DOI 10.1631/JZUS.C10B0359; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Sentell JW, 1997, MIL MED, V162, P168, DOI 10.1093/milmed/162.3.168; Skipper LD, 2014, MIL MED, V179, P301, DOI 10.7205/MILMED-D-13-00400; Stenbacka M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0570-2; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wong A, 2001, SUICIDE LIFE-THREAT, V31, P103, DOI 10.1521/suli.31.1.103.21305; Wright J., 2014, STANDARDIZED DEP DEF	45	20	20	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					167	+		10.7326/M15-2785	http://dx.doi.org/10.7326/M15-2785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2HA	27272476				2022-12-28	WOS:000380583300005
J	Arribere, JA; Cenik, ES; Jain, N; Hess, GT; Lee, CH; Bassik, MC; Fire, AZ				Arribere, Joshua A.; Cenik, Elif S.; Jain, Nimit; Hess, Gaelen T.; Lee, Cameron H.; Bassik, Michael C.; Fire, Andrew Z.			Translation readthrough mitigation	NATURE			English	Article							STOP CODON READTHROUGH; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; GENE-TRANSFER; READ-THROUGH; IN-VIVO; SUPPRESSOR; MUTATIONS; TRANSFORMATION; DEGRADATION	A fraction of ribosomes engaged in translation will fail to terminate when reaching a stop codon, yielding nascent proteins inappropriately extended on their C termini. Although such extended proteins can interfere with normal cellular processes, known mechanisms of translational surveillance(1) are insufficient to protect cells from potential dominant consequences. Here, through a combination of transgenics and CRISPR-Cas9 gene editing in Caenorhabditis elegans, we demonstrate a consistent ability of cells to block accumulation of C-terminal-extended proteins that result from failure to terminate at stop codons. Sequences encoded by the 3' untranslated region (UTR) were sufficient to lower protein levels. Measurements of mRNA levels and translation suggested a co-or post-translational mechanism of action for these sequences in C. elegans. Similar mechanisms evidently operate in human cells, in which we observed a comparable tendency for translated human 3' UTR sequences to reduce mature protein expression in tissue culture assays, including 3' UTR sequences from the hypomorphic 'Constant Spring' haemoglobin stop codon variant. We suggest that 3' UTRs may encode peptide sequences that destabilize the attached protein, providing mitigation of unwelcome and varied translation errors.	[Arribere, Joshua A.; Cenik, Elif S.; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Jain, Nimit] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Hess, Gaelen T.; Lee, Cameron H.; Bassik, Michael C.; Fire, Andrew Z.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Fire, AZ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu	Lee, Cameron/U-6605-2019; Jain, Nimit/HIK-2809-2022	Fire, Andrew/0000-0001-6217-8312; , Nimit/0000-0001-8759-2456; Hess, Gaelen/0000-0002-3836-0277; sarinay cenik;sarinay;cenik, elif/0000-0001-8514-5505	NIH [R01GM37706, T32HG000044, 1DP2HD084069-01, 5F32GM112474-02]; Walter and Idun Berry Foundation; NSF [DGE-114747]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706, F32GM112474, T32GM007790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter and Idun Berry Foundation; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Fire Laboratory for critical reading of the manuscript, C. Frokjaer-Jensen and K. Artiles for technical expertise, and T. Schedl, T. Inada, C. Joazeiro, L. Ling, A. Nager, and N. Spies for discussions. A. Sapiro and B. Li were instrumental in developing the RNA-seq2 protocol. This work was supported by grants from NIH R01GM37706, T32HG000044 (G.T.H.), 1DP2HD084069-01 (M.C.B.), 5F32GM112474-02 (J.A.A.), Walter and Idun Berry Foundation (E.S.C.), and NSF DGE-114747 (C.H.L.).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahier A, 2014, GENETICS, V196, P605, DOI 10.1534/genetics.113.160846; ANDERSON P, 1984, P NATL ACAD SCI-BIOL, V81, P4470, DOI 10.1073/pnas.81.14.4470; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; BRENNER S, 1974, GENETICS, V77, P71; CAPONE JP, 1985, EMBO J, V4, P213, DOI 10.1002/j.1460-2075.1985.tb02338.x; CLEGG JB, 1971, NATURE, V234, P337, DOI 10.1038/234337a0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; EIDE D, 1985, GENETICS, V109, P67; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hamby Stephen E., 2011, Human Genomics, V5, P241; HODGKIN J, 1989, GENETICS, V123, P301; HODGKIN JA, 1977, GENETICS, V86, P275; Hollingsworth TJ, 2013, J BIOL CHEM, V288, P29047, DOI 10.1074/jbc.M113.495184; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HUDZIAK RM, 1982, CELL, V31, P137, DOI 10.1016/0092-8674(82)90413-5; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Klauer AA, 2012, WIRES RNA, V3, P649, DOI 10.1002/wrna.1124; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKI FA, 1989, P NATL ACAD SCI USA, V86, P6696, DOI 10.1073/pnas.86.17.6696; LIEBHABER SA, 1981, J CLIN INVEST, V68, P439, DOI 10.1172/JCI110273; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Mapes J, 2010, P NATL ACAD SCI USA, V107, P18022, DOI 10.1073/pnas.1004513107; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; OKKEMA PG, 1993, GENETICS, V135, P385; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Shibata N, 2015, J BIOL CHEM, V290, P28428, DOI 10.1074/jbc.M115.670901; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Torabi N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002546; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; VENOLIA L, 1990, GENETICS, V126, P345; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; WATERSTON RH, 1981, GENETICS, V97, P307; Williams I, 2004, NUCLEIC ACIDS RES, V32, P6605, DOI 10.1093/nar/gkh1004; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	54	50	50	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2016	534	7609					719	+		10.1038/nature18308	http://dx.doi.org/10.1038/nature18308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP7JV	27281202	Green Accepted			2022-12-28	WOS:000378676000044
J	Hanzen, S; Vielfort, K; Yang, JS; Roger, F; Andersson, V; Zamarbide-Fores, S; Andersson, R; Malm, L; Palais, G; Biteau, B; Liu, BD; Toledano, MB; Molin, M; Nystrom, T				Hanzen, Sarah; Vielfort, Katarina; Yang, Junsheng; Roger, Friederike; Andersson, Veronica; Zamarbide-Fores, Sara; Andersson, Rebecca; Malm, Lisa; Palais, Gael; Biteau, Benoit; Liu, Beidong; Toledano, Michel B.; Molin, Mikael; Nystrom, Thomas			Lifespan Control by Redox-Dependent Recruitment of Chaperones to Misfolded Proteins	CELL			English	Article							HUMAN LUNG-CANCER; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; ASYMMETRIC INHERITANCE; PEROXIREDOXIN TSA1; GENOME INSTABILITY; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; THIOREDOXIN; EXTENSION	Caloric restriction (CR) extends the lifespan of flies, worms, and yeast by counteracting age-related oxidation of H2O2-scavenging peroxiredoxins (Prxs). Here, we show that increased dosage of the major cytosolic Prx in yeast, Tsa1, extends lifespan in an Hsp70 chaperone-dependent and CR-independent manner without increasing H2O2 scavenging or genome stability. We found that Tsa1 and Hsp70 physically interact and that hyperoxidation of Tsa1 by H2O2 is required for the recruitment of the Hsp70 chaperones and the Hsp104 disaggregase to misfolded and aggregated proteins during aging, but not heat stress. Tsa1 counteracted the accumulation of ubiquitinated aggregates during aging and the reduction of hyperoxidized Tsa1 by sulfiredoxin facilitated clearance of H2O2-generated aggregates. The data reveal a conceptually new role for H2O2 signaling in proteostasis and lifespan control and shed new light on the selective benefits endowed to eukaryotic peroxiredoxins by their reversible hyperoxidation.	[Hanzen, Sarah; Vielfort, Katarina; Yang, Junsheng; Roger, Friederike; Andersson, Veronica; Zamarbide-Fores, Sara; Andersson, Rebecca; Malm, Lisa; Liu, Beidong; Molin, Mikael] Univ Gothenburg, Dept Chem & Mol Biol CMB, Medicinaregatan 9C, S-41390 Gothenburg, Sweden; [Palais, Gael; Biteau, Benoit; Toledano, Michel B.] CEA Saclay, SBIGEM, IBITECS, Oxidat Stress & Canc, F-91191 Gif Sur Yvette, France; [Biteau, Benoit] Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,Box 633, Rochester, NY 14642 USA; [Hanzen, Sarah; Vielfort, Katarina; Andersson, Rebecca; Nystrom, Thomas] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Medicinaregatan 7A, S-41390 Gothenburg, Sweden	University of Gothenburg; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Rochester; University of Gothenburg	Molin, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol CMB, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.; Nystrom, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Medicinaregatan 7A, S-41390 Gothenburg, Sweden.	mikael.molin@cmb.gu.se; thomas.nystrom@cmb.gu.se	Liu, Beidong/L-2485-2015	Liu, Beidong/0000-0001-6052-8411; Molin, Mikael/0000-0002-3903-8503; Hanzen, Sarah/0000-0003-2409-5350; Vielfort, Katarina/0000-0002-9988-6336; Roger, Friederike/0000-0003-3829-0245; Andersson, Rebecca/0000-0003-3765-5038; Yang, Junsheng/0000-0002-6425-8495	Swedish Research Council (VR); Swedish Cancer Society; Knut and Alice Wallenberg Foundation; ERC (QualiAge, Advanced Grant); foundation of Olle Engkvist; foundation of Carl Trygger; foundation of Magnus Bergvall; ANR ERRed; PLBIO [INCA_5869]; Fondation pour la Recherche Medicale [DCM20111223065]	Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ERC (QualiAge, Advanced Grant); foundation of Olle Engkvist; foundation of Carl Trygger; foundation of Magnus Bergvall; ANR ERRed(French National Research Agency (ANR)); PLBIO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors thank G. Lagniel and J. Labarre for 2D-PAGE analysis, D. Oling for strains, and the Centre for Cellular Imaging at the Sahlgrenska Academy, University of Gothenburg for the use of imaging equipment and, in particular, Maria Smedh for support. This work was supported by grants from the Swedish Research Council (VR), the Swedish Cancer Society, Knut and Alice Wallenberg Foundation (Wallenberg Scholar), and ERC (QualiAge, Advanced Grant) (to T.N.), the Swedish Research Council (VR) and the foundations of Olle Engkvist, Carl Trygger, and Magnus Bergvall (to M.M.), and grants from ANR ERRed, PLBIO INCA_5869, and Fondation pour la Recherche Medicale (DCM20111223065) (to M.B.T.).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Amberg DC., 2005, METHODS YEAST GENETI; Andersson V, 2013, AGING-US, V5, P802, DOI 10.18632/aging.100613; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chen MF, 2006, INT J RADIAT ONCOL, V66, P1461, DOI 10.1016/j.ijrobp.2006.07.1372; Choi HI, 2006, FREE RADICAL BIO MED, V40, P651, DOI 10.1016/j.freeradbiomed.2005.09.018; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Hill SM, 2014, SCIENCE, V344, P1389, DOI 10.1126/science.1252634; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kaya A, 2015, AGING CELL, V14, P366, DOI 10.1111/acel.12290; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mogk A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00022; Molin Mikael, 2014, Int J Cell Biol, V2014, P913071, DOI 10.1155/2014/913071; Molin M, 2011, MOL CELL, V43, P823, DOI 10.1016/j.molcel.2011.07.027; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Nystrom T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Saarikangas J, 2015, ELIFE, V4, DOI 10.7554/eLife.06197; Saccoccia F, 2012, STRUCTURE, V20, P429, DOI 10.1016/j.str.2012.01.004; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Stolz A, 2012, METHODS MOL BIOL, V832, P489, DOI 10.1007/978-1-61779-474-2_35; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wei QO, 2013, CARCINOGENESIS, V34, P1403, DOI 10.1093/carcin/bgt059; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Weids AJ, 2014, J CELL SCI, V127, P1327, DOI 10.1242/jcs.144022; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yao YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004968	55	82	84	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					140	151		10.1016/j.cell.2016.05.006	http://dx.doi.org/10.1016/j.cell.2016.05.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27264606	Bronze			2022-12-28	WOS:000380254400017
J	Wise, J				Wise, Jacqui			Long acting opioids are linked to increased risk of death	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789	1	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i3313	10.1136/bmj.i3313	http://dx.doi.org/10.1136/bmj.i3313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27307304				2022-12-28	WOS:000378240400006
J	Brown, TI; Carr, VA; LaRocque, KF; Favila, SE; Gordon, AM; Bowles, B; Bailenson, JN; Wagner, AD				Brown, Thackery I.; Carr, Valerie A.; LaRocque, Karen F.; Favila, Serra E.; Gordon, Alan M.; Bowles, Ben; Bailenson, Jeremy N.; Wagner, Anthony D.			Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; SPATIAL NAVIGATION; HIPPOCAMPAL-NEURONS; MEMORY; CONTEXT; RETRIEVAL; CORTEX; EVENTS; FUTURE; ENCODE	Oligodendrocytes have been considered as a functionally homogeneous population in the central nervous system (CNS). We performed single-cell RNA sequencing on 5072 cells of the oligodendrocyte lineage from 10 regions of the mouse juvenile and adult CNS. Thirteen distinct populations were identified, 12 of which represent a continuum from Pdgfra' oligodendrocyte precursor cells (OPCs) to distinct mature oligodendrocytes. Initial stages of differentiation were similar across the juvenile CNS, whereas subsets of mature oligodendrocytes were enriched in specific regions in the adult brain. Newly formed oligodendrocytes were detected in the adult CNS and were responsive to complex motor learning. A second Pdgfra' population, distinct from OPCs, was found along vessels. Our study reveals the dynamics of oligodendrocyte differentiation and maturation, uncoupling them at a transcriptional level and highlighting oligodendrocyte heterogeneity in the CNS.	[Brown, Thackery I.; Carr, Valerie A.; LaRocque, Karen F.; Gordon, Alan M.; Wagner, Anthony D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Carr, Valerie A.] San Jose State Univ, Dept Psychol, San Jose, CA 95192 USA; [Favila, Serra E.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Bowles, Ben] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Bailenson, Jeremy N.] Stanford Univ, Dept Commun, Stanford, CA 94305 USA; [Wagner, Anthony D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; California State University System; San Jose State University; New York University; University of California System; University of California Berkeley; Stanford University; Stanford University	Brown, TI; Wagner, AD (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.; Wagner, AD (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	thackery@stanford.edu; awagner@stanford.edu		Carr, Valerie/0000-0002-2969-2181; Brown, Thackery/0000-0001-8586-3099; Favila, Serra/0000-0003-1528-2875; Wagner, Anthony/0000-0003-0624-4543	National Institute of Mental Health [R01-MH016932]; Wallenberg Network Initiative on Culture, Brain, and Learning; John Templeton, Foundation; NSF Graduate Research Fellowship Program; NSF Integrative Graduate Education and Research Traineeship program; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076932] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wallenberg Network Initiative on Culture, Brain, and Learning; John Templeton, Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship program(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (grant R01-MH016932) and the Wallenberg Network Initiative on Culture, Brain, and Learning. It was also made possible through the support of a grant from the John Templeton, Foundation, "Prospective Psychology Stage 2: A Research Competition," to M. Seligman. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. This work was additionally supported by fellowships from the NSF Graduate Research Fellowship Program, the NSF Integrative Graduate Education and Research Traineeship program, and the Natural Sciences and Engineering Research Council of Canada. Raw data are archived on the Stanford Neuroscience Institute server and will be mace available upon request.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Brown TI, 2014, HIPPOCAMPUS, V24, P819, DOI 10.1002/hipo.22273; Brown TI, 2014, CEREB CORTEX, V24, P1906, DOI 10.1093/cercor/bht041; Brown TI, 2014, J NEUROSCI, V34, P2314, DOI 10.1523/JNEUROSCI.2202-13.2014; Brown TI, 2012, NEUROIMAGE, V60, P1316, DOI 10.1016/j.neuroimage.2012.01.046; Brown TI, 2010, J NEUROSCI, V30, P7414, DOI 10.1523/JNEUROSCI.6021-09.2010; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chadwick MJ, 2015, CURR BIOL, V25, P87, DOI 10.1016/j.cub.2014.11.001; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Hasselmo ME, 2014, NEUROIMAGE, V85, P656, DOI 10.1016/j.neuroimage.2013.06.022; Hasselmo ME, 2009, NEUROBIOL LEARN MEM, V92, P559, DOI 10.1016/j.nlm.2009.07.005; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Ito HT, 2015, NATURE, V522, P50, DOI 10.1038/nature14396; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Liang JC, 2013, CEREB CORTEX, V23, P80, DOI 10.1093/cercor/bhr379; Marchette SA, 2015, J NEUROSCI, V35, P14896, DOI 10.1523/JNEUROSCI.2270-15.2015; Marchette SA, 2014, NAT NEUROSCI, V17, P1598, DOI 10.1038/nn.3834; McKenzie S, 2013, J NEUROSCI, V33, P10243, DOI 10.1523/JNEUROSCI.0879-13.2013; Miller JF, 2013, SCIENCE, V342, P1111, DOI 10.1126/science.1244056; Navawongse R, 2013, J NEUROSCI, V33, P1002, DOI 10.1523/JNEUROSCI.3891-12.2013; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Smith DM, 2006, J NEUROSCI, V26, P3154, DOI 10.1523/JNEUROSCI.3234-05.2006; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Spiers HJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00125; Sulpizio V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00716; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; Wikenheiser AM, 2015, NAT NEUROSCI, V18, P289, DOI 10.1038/nn.3909; Wolbers T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00571; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	40	123	123	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1323	1326		10.1126/science.aaf0784	http://dx.doi.org/10.1126/science.aaf0784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284194				2022-12-28	WOS:000377972000042
J	Rose, T; Jaepel, J; Hubener, M; Bonhoffer, T				Rose, Tobias; Jaepel, Juliane; Huebener, Mark; Bonhoeffer, Tobias			Cell-specific restoration of stimulus preference after monocular deprivation in the visual cortex	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; INHIBITORY SYNAPSES; DENDRITIC SPINES; FUNCTIONAL-ORGANIZATION; FLUORESCENT PROTEINS; STRIATE CORTEX; IN-VIVO; RESPONSES; RECOVERY; MOUSE	Monocular deprivation evokes a prominent shift of neuronal responses in the visual cortex toward the open eye, accompanied by functional and structural synaptic rearrangements. This shift is reversible, but it is unknown whether the recovery happens at the level of individual neurons or whether it reflects a population effect. We used ratiometric Ca2+ imaging to follow the activity of the same excitatory layer 2/3 neurons in the mouse visual cortex over months during repeated episodes of ocular dominance (OD) plasticity. We observed robust shifts toward the open eye in most neurons. Nevertheless, these cells faithfully returned to their pre-deprivation OD during binocular recovery. Moreover, the initial network correlation structure was largely recovered, suggesting that functional connectivity may be regained despite prominent experience-dependent plasticity.	[Rose, Tobias; Jaepel, Juliane; Huebener, Mark; Bonhoeffer, Tobias] Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society	Rose, T; Bonhoffer, T (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	trose@neuro.mpg.de; tobias.bonhoeffer@neuro.mpg.de	Rose, Tobias/H-5388-2019; Bonhoeffer, Tobias/B-9481-2009	Rose, Tobias/0000-0002-7156-4714; Jaepel, Juliane/0000-0002-6648-5640; Bonhoeffer, Tobias/0000-0001-7897-6634	Max Planck Society; Marie Curie Intra-European Fellowship; Boehringer Ingelheim Ph.D. fellowship; Deutsche Forschungsgerneinschatt [SFB870]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Marie Curie Intra-European Fellowship(European Commission); Boehringer Ingelheim Ph.D. fellowship(Boehringer Ingelheim); Deutsche Forschungsgerneinschatt	We thank T. Mrsic-Flogel for discussions, P. Goltstein for discussions and programming help, and C. Huber and V. Staiger tor help with molecular cloning and imrnunohistochemistry. This work was supported by the Max Planck Society, a Marie Curie Intra-European Fellowship to T.R., a Boehringer Ingelheim Ph.D. fellowship to J.J., and the Deutsche Forschungsgerneinschatt (grant SFB870 to T.R. and T.B.). Data and analysis codes are stored and curated at the Max Planck Computing and Data Facility Garching, Munich. Plasmic have been deposited at Addgene.org (accession no. 68717).	Antonini A, 1999, J NEUROSCI, V19, P4388; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Doiron B, 2016, NAT NEUROSCI, V19, P383, DOI 10.1038/nn.4242; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gordon JA, 1996, J NEUROSCI, V16, P3274; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matthies U, 2013, J NEUROSCI, V33, P11774, DOI 10.1523/JNEUROSCI.4262-12.2013; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shadlen MN, 1998, J NEUROSCI, V18, P3870; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Villa KL, 2016, NEURON, V89, P756, DOI 10.1016/j.neuron.2016.01.010; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060	31	91	92	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1319	1322		10.1126/science.aad3358	http://dx.doi.org/10.1126/science.aad3358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284193				2022-12-28	WOS:000377972000041
J	Trajkovski, M; Wollheim, CB				Trajkovski, Mirko; Wollheim, Claes B.			PHYSIOLOGY Microbial signals to the brain control weight	NATURE			English	Editorial Material							GUT MICROBIOTA; OBESITY		[Trajkovski, Mirko; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, Fac Med, CH-1211 Geneva, Switzerland	University of Geneva	Trajkovski, M (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, Fac Med, CH-1211 Geneva, Switzerland.	mirko.trajkovski@unige.ch; claes.wollheim@unige.ch		Wollheim, Claes/0000-0002-4570-9879; Trajkovski, Mirko/0000-0002-3152-9551				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BEREITER DA, 1981, AM J PHYSIOL, V241, pE22, DOI 10.1152/ajpendo.1981.241.1.E22; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; de Lartigue G., 2016, J PHYSL LOND; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Petrof EO, 2014, GASTROENTEROLOGY, V146, P1573, DOI 10.1053/j.gastro.2014.01.004; Priyadarshini M., 2016, TRENDS ENDOCRINOL ME; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	13	17	18	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					185	187		10.1038/534185a	http://dx.doi.org/10.1038/534185a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279209	Green Published			2022-12-28	WOS:000377475100027
J	Litchinitser, NM				Litchinitser, Natalia M.			Photonic multitasking enabled with geometric phase	SCIENCE			English	Editorial Material							METASURFACES; REFLECTION; LIGHT		[Litchinitser, Natalia M.] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Litchinitser, NM (corresponding author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	natashal@buffalo.edu						BERRY M, 1988, SCI AM, V259, P46, DOI 10.1038/scientificamerican1288-46; BERRY MV, 1987, J MOD OPTIC, V34, P1401, DOI 10.1080/09500348714551321; Bomzon Z, 2001, OPT LETT, V26, P1424, DOI 10.1364/OL.26.001424; Haupt RL, 2005, IEEE T ANTENN PROPAG, V53, P2858, DOI 10.1109/TAP.2005.854522; Herbert N., 1987, NEW SCI, V1564, P37; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Maguid E, 2016, SCIENCE, V352, P1202, DOI 10.1126/science.aaf3417; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; Pors A, 2013, OPT LETT, V38, P513, DOI 10.1364/OL.38.000513; Shalaev MI, 2015, NANO LETT, V15, P6261, DOI 10.1021/acs.nanolett.5b02926; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yu NF, 2015, J LIGHTWAVE TECHNOL, V33, P2344, DOI 10.1109/JLT.2015.2404860; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	13	10	10	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1177	1178		10.1126/science.aaf8391	http://dx.doi.org/10.1126/science.aaf8391			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257244				2022-12-28	WOS:000377045700030
J	Lin, FR; Hazzard, WR; Blazer, DG				Lin, Frank R.; Hazzard, William R.; Blazer, Dan G.			Priorities for Improving Hearing Health Care for Adults A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lin, Frank R.] Johns Hopkins Univ, Dept Otolaryngol, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Univ, Dept Geriatr Med, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Hazzard, William R.] Wake Forest Univ, Bowman Gray Sch Med, Dept Gerontol & Geriatr Med, Sticht Ctr Aging, Winston Salem, NC USA; [Blazer, Dan G.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center; Duke University	Lin, FR (corresponding author), Johns Hopkins Ctr Aging & Hlth, 2024 E Monument St,Ste 2-700, Baltimore, MD 21205 USA.	flin1@jhmi.edu						Blazer D.G., 2016, HEARING HLTH CARE AD, DOI [10.17226/23446, DOI 10.17226/23446]; Cassel C, 2016, JAMA-J AM MED ASSOC, V315, P553, DOI 10.1001/jama.2016.0044; Lustig TA, 2014, HEAR LOSS HLTH AG WO; President's Council of Advisors on Science and Technology, 2015, AG AM HEAR LOSS IMP	4	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					819	820		10.1001/jama.2016.7916	http://dx.doi.org/10.1001/jama.2016.7916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27254725				2022-12-28	WOS:000381736200009
J	Koldewey, P; Stull, F; Horowitz, S; Martin, R; Bardwell, JCA				Koldewey, Philipp; Stull, Frederick; Horowitz, Scott; Martin, Raoul; Bardwell, James C. A.			Forces Driving Chaperone Action	CELL			English	Article							PROTEIN-PROTEIN ASSOCIATION; ESCHERICHIA-COLI; ELECTROSTATIC INTERACTIONS; CONFORMATIONAL PROPERTIES; FOLDING INTERMEDIATE; TRIGGER FACTOR; HEAT-CAPACITY; BINDING; IM7; RECOGNITION	It is still unclear what molecular forces drive chaperone-mediated protein folding. Here, we obtain a detailed mechanistic understanding of the forces that dictate the four key steps of chaperone-client interaction: initial binding, complex stabilization, folding, and release. Contrary to the common belief that chaperones recognize unfolding intermediates by their hydrophobic nature, we discover that the model chaperone Spy uses long-range electrostatic interactions to rapidly bind to its unfolded client protein Im7. Short-range hydrophobic interactions follow, which serve to stabilize the complex. Hydrophobic collapse of the client protein then drives its folding. By burying hydrophobic residues in its core, the client's affinity to Spy decreases, which causes client release. By allowing the client to fold itself, Spy circumvents the need for client-specific folding instructions. This mechanism might help explain how chaperones can facilitate the folding of various unrelated proteins.	[Koldewey, Philipp; Stull, Frederick; Horowitz, Scott; Martin, Raoul; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Koldewey, Philipp; Stull, Frederick; Horowitz, Scott; Martin, Raoul; Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Bardwell, JCA (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Bardwell, JCA (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	jbardwel@umich.edu		Stull, Frederick/0000-0002-2969-4224; Horowitz, Scott/0000-0002-1148-0105	NIH [GM102829]; Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102829] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.C.A.B. acknowledges support from NIH grant GM102829. J.C.A.B. is a Howard Hughes Medical Investigator. P.K. was funded by Boehringer Ingelheim Fonds. We would like to thank Sheena Radford and Ursula Jakob for helpful discussions. We thank Shu Quan for experiments that led to the identification of casein<INF>133-193</INF> as a Spy substrate.	BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; De Los Rios P, 2014, ELIFE, V3, DOI 10.7554/eLife.02218; Docter B.E., 2016, NUCLEIC ACIDS RES; FEKKES P, 1995, BIOCHEMISTRY-US, V34, P10078, DOI 10.1021/bi00031a032; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Gsponer J, 2006, P NATL ACAD SCI USA, V103, P99, DOI 10.1073/pnas.0508667102; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hall Z, 2012, J AM SOC MASS SPECTR, V23, P1161, DOI 10.1007/s13361-012-0393-z; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Heidary S, 2014, BIOTECHNOL LETT, V36, P1479, DOI 10.1007/s10529-014-1504-7; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Horowitz S, 2016, NAT STRUCT MOL BIOL, V23, P691, DOI 10.1038/nsmb.3237; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kabiri M, 2014, BIOMACROMOLECULES, V15, P3463, DOI 10.1021/bm5004515; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kasper P, 2000, PROTEINS, V40, P185, DOI 10.1002/(SICI)1097-0134(20000801)40:2<185::AID-PROT20>3.0.CO;2-X; Katsumata K, 1996, J MOL BIOL, V264, P643, DOI 10.1006/jmbi.1996.0666; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Liu L, 2000, BIOPHYS CHEM, V84, P239, DOI 10.1016/S0301-4622(00)00130-7; Liu W, 2003, J PHYS CHEM B, V107, P11563, DOI 10.1021/jp035872c; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041; Perrett S, 1997, J MOL BIOL, V269, P892, DOI 10.1006/jmbi.1997.1081; PONTIUS BW, 1993, TRENDS BIOCHEM SCI, V18, P181, DOI 10.1016/0968-0004(93)90111-Y; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Quan S, 2014, ELIFE, V3, DOI 10.7554/eLife.01584; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Whittaker SBM, 2007, J MOL BIOL, V366, P1001, DOI 10.1016/j.jmb.2006.11.012; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhou HX, 2003, PROTEIN SCI, V12, P2379, DOI 10.1110/ps.03216203; Zhou HX, 2001, BIOPOLYMERS, V59, P427, DOI 10.1002/1097-0282(200111)59:6<427::AID-BIP1047>3.0.CO;2-7	63	61	63	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					369	379		10.1016/j.cell.2016.05.054	http://dx.doi.org/10.1016/j.cell.2016.05.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27293188	Bronze, Green Accepted			2022-12-28	WOS:000380255400015
J	Sujino, T; London, M; van Konijnenburg, DPH; Rendon, T; Buch, T; Silva, HM; Lafaille, JJ; Reis, BS; Mucida, D				Sujino, Tomohisa; London, Mariya; van Konijnenburg, David P. Hoytema; Rendon, Tomiko; Buch, Thorsten; Silva, Hernandez M.; Lafaille, Juan J.; Reis, Bernardo S.; Mucida, Daniel			Tissue adaptation of regulatory and intraepithelial CD4(+) T cells controls gut inflammation	SCIENCE			English	Article							RETINOIC-ACID; EXPRESSION; TOLERANCE; DIFFERENTIATION; METABOLITES; POPULATION; INDUCTION; IMMUNITY; LINEAGE	The human brain has enormously complex cellular diversity and connectivities fundamental to our neural functions, yet difficulties in interrogating individual neurons has impeded understanding of the underlying transcriptional landscape. We developed a scalable approach to sequence and quantify RNA molecules in isolated neuronal nuclei from a postmortem brain, generating 3227 sets of single-neuron data from six distinct regions of the cerebral cortex. Using an iterative clustering and classification approach, we identified 16 neuronal subtypes that were further annotated on the basis of known markers and cortical cytoarchitecture. These data demonstrate a robust and scalable method for identifying and categorizing single nuclear transcriptomes, revealing shared genes sufficient to distinguish previously unknown and orthologous neuronal subtypes as well as regional identity and transcriptomic heterogeneity within the human brain.	[Sujino, Tomohisa; London, Mariya; van Konijnenburg, David P. Hoytema; Rendon, Tomiko; Reis, Bernardo S.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [van Konijnenburg, David P. Hoytema] Univ Med Ctr, Lab Translat Immunol, Utrecht, Netherlands; [Buch, Thorsten] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Silva, Hernandez M.; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Rockefeller University; Utrecht University; Utrecht University Medical Center; University of Zurich; New York University	Reis, BS; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA.	breis@rockefeller.edu; mucida@rockefeller.edu	Buch, Thorsten/P-1659-2019	Buch, Thorsten/0000-0002-2236-9074; Sujino, Tomohisa/0000-0003-0699-6577; Hoytema van Konijnenburg, David/0000-0001-5198-9718	Leona and Harry B. Helmsley Charitable Trust; Japan Foundation for Applied Enzymology; Uehara Memorial Foundation; Alexandre Suerman Stipend; Royal Netherlands Academy of Sciences; Prince Bernhard Cultural Foundation; Deutsche Forschungsgemeinschaft [1410/1]; Swiss National Science Foundation [0310030-11620]; National Multiple Sclerosis Society; Crohn's & Colitis Foundation of America; Irma T. Hirschl Award; National Institutes of Health [NIH R01 DK093674]; Empire State Stem Cell Fund through New York State Department of Health [C023046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093674] Funding Source: NIH RePORTER	Leona and Harry B. Helmsley Charitable Trust; Japan Foundation for Applied Enzymology; Uehara Memorial Foundation(Uehara Memorial Foundation); Alexandre Suerman Stipend; Royal Netherlands Academy of Sciences; Prince Bernhard Cultural Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Crohn's & Colitis Foundation of America; Irma T. Hirschl Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to K. Velinzon and N. Thomas for sorting cells and to members of the Nussenzweig lab and The Rockefeller University employees for continuous assistance. We thank S. Hemmers (Memorial Sloan Kettering Cancer Center) for generating Cd4<SUP>CreER</SUP> mice. We especially thank A. Rogoz for outstanding technical support. We thank members of our laboratory, particularly V. Pedicord, and D. Esterhazy, for discussions and critical reading and editing of the manuscript. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by Leona and Harry B. Helmsley Charitable Trust (T.S., D.P.H.v.K., B.S.R., D.M.), Japan Foundation for Applied Enzymology and Uehara Memorial Foundation (T.S.), Alexandre Suerman Stipend, Royal Netherlands Academy of Sciences, and the Prince Bernhard Cultural Foundation (D.P.H.v.K.), Deutsche Forschungsgemeinschaft 1410/1 grant and Swiss National Science Foundation 0310030-11620 grant (T.B.), National Multiple Sclerosis Society (J.J.L.), the Crohn's & Colitis Foundation of America (B.S.R., D.M.), the Irma T. Hirschl Award (D.M.), and National Institutes of Health grant NIH R01 DK093674 (D.M.). The Rockefeller University Bio-Imaging Resource Center is supported by the Empire State Stem Cell Fund through New York State Department of Health C023046. D.M. conceived of and D.M. and B.S.R. supervised this study; T.S., J.J.L., B.S.R., and D.M. designed experiments; T.S., M.L., D.P.H.v.K., T.R., H.M.S.,	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bollrath J, 2013, SEMIN IMMUNOL, V25, P352, DOI 10.1016/j.smim.2013.09.002; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Edelblum KL, 2012, P NATL ACAD SCI USA, V109, P7097, DOI 10.1073/pnas.1112519109; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shale M, 2013, IMMUNOL REV, V252, P164, DOI 10.1111/imr.12039; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960	33	130	133	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2016	352	6293					1581	1586		10.1126/science.aaf3892	http://dx.doi.org/10.1126/science.aaf3892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2TT	27256884	Green Accepted			2022-12-28	WOS:000378346500045
J	Shabahang, S; Tao, GM; Kaufman, JJ; Qiao, YY; Wei, L; Bouchenot, T; Gordon, AP; Fink, Y; Bai, YL; Hoy, RS; Abouraddy, AF				Shabahang, Soroush; Tao, Guangming; Kaufman, Joshua J.; Qiao, Yangyang; Wei, Lei; Bouchenot, Thomas; Gordon, Ali P.; Fink, Yoel; Bai, Yuanli; Hoy, Robert S.; Abouraddy, Ayman F.			Controlled fragmentation of multimaterial fibres and films via polymer cold-drawing	NATURE			English	Article							MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; PHOSPHATE-GLASSES; NECK PROPAGATION; STRESS TRANSFER; SILKWORM SILK; COMPOSITES; BEHAVIOR; BLENDS; MATRIX	Polymer cold-drawing(1-4) is a process in which tensile stress reduces the diameter of a drawn fibre (or thickness of a drawn film) and orients the polymeric chains. Cold-drawing has long been used in industrial applications(5-7), including the production of flexible fibres with high tensile strength such as polyester and nylon(8,9). However, cold-drawing of a composite structure has been less studied. Here we show that in a multimaterial fibre(10,11) composed of a brittle core embedded in a ductile polymer cladding, cold-drawing results in a surprising phenomenon: controllable and sequential fragmentation of the core to produce uniformly sized rods along metres of fibre, rather than the expected random or chaotic fragmentation. These embedded structures arise from mechanical-geometric instabilities associated with 'neck' propagation(2,3). Embedded, structured multimaterial threads with complex transverse geometry are thus fragmented into a periodic train of rods held stationary in the polymer cladding. These rods can then be easily extracted via selective dissolution of the cladding, or can self-heal by thermal restoration to re-form the brittle thread. Our method is also applicable to composites with flat rather than cylindrical geometries, in which case cold-drawing leads to the break-up of an embedded or coated brittle film into narrow parallel strips that are aligned normally to the drawing axis. A range of materials was explored to establish the universality of this effect, including silicon, germanium, gold, glasses, silk, polystyrene, biodegradable polymers and ice. We observe, and verify through nonlinear finite-element simulations, a linear relationship between the smallest transverse scale and the longitudinal break-up period. These results may lead to the development of dynamical and thermoreversible camouflaging via a nanoscale Venetian-blind effect, and the fabrication of large-area structured surfaces that facilitate high-sensitivity bio-detection.	[Shabahang, Soroush; Tao, Guangming; Kaufman, Joshua J.; Abouraddy, Ayman F.] Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA; [Qiao, Yangyang; Bouchenot, Thomas; Gordon, Ali P.; Bai, Yuanli] Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL 32816 USA; [Wei, Lei] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Fink, Yoel] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Hoy, Robert S.] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Abouraddy, Ayman F.] Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT); State University System of Florida; University of South Florida; State University System of Florida; University of Central Florida	Abouraddy, AF (corresponding author), Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA.; Abouraddy, AF (corresponding author), Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA.	raddy@creol.ucf.edu	Hoy, Robert S/B-1169-2009; Tao, Guangming/AAH-2617-2021; Wei, Lei/F-1596-2010	Tao, Guangming/0000-0002-1371-7735; Wei, Lei/0000-0003-0819-8325	US Air Force Office of Scientific Research (AFOSR) [FA-9550-12-1-0148]; AFOSR MURI [FA9550-14-1-0037]; US National Science Foundation [CMMI-1300773]; MIT MRSEC through the MRSEC Program of the National Science Foundation [DMR-1419807]	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); US National Science Foundation(National Science Foundation (NSF)); MIT MRSEC through the MRSEC Program of the National Science Foundation	We thank E.-H. Banaei, L. N. Pye, F. Tan, A. Schulzgen, C. Jollivet, C. Cariker, A. Schulte, M. Lodge, M. Ishigami, E. Duenas, C. Burchett, M. Finke, Y. Xu, S. Dai, H. Ren and X. Wang for technical assistance. We also thank M. Rein, F. Sorin, M. Kolle, A. Dogariu, D. N. Christodoulides and B. E. A. Saleh for discussions. The authors acknowledge the University of Central Florida Stokes Advanced Research Computing Center for providing computational resources and support that have contributed to results reported here. We also thank Simulia, Inc. for providing the license of the ABAQUS software package. This work was supported by the US Air Force Office of Scientific Research (AFOSR) under contract FA-9550-12-1-0148 and AFOSR MURI contract FA9550-14-1-0037, and the US National Science Foundation (CMMI-1300773). This work was supported in part by the MIT MRSEC through the MRSEC Program of the National Science Foundation under award number DMR-1419807.	Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889; Anand L, 2003, INT J SOLIDS STRUCT, V40, P1465, DOI 10.1016/S0020-7683(02)00651-0; [Anonymous], 2011, ABAQUS US MAN VERS 6; Argon A. S., 2013, PHYS DEFORMATION FRA; ASLOUN EM, 1989, J MATER SCI, V24, P1835, DOI 10.1007/BF01105713; Bai YL, 2008, INT J MECH SCI, V50, P1012, DOI 10.1016/j.ijmecsci.2008.02.010; Ballato J, 2008, OPT EXPRESS, V16, P18675, DOI 10.1364/OE.16.018675; Bellan LM, 2005, NANOTECHNOLOGY, V16, P1095, DOI 10.1088/0957-4484/16/8/017; BOYCE MC, 1992, POLYM ENG SCI, V32, P1073, DOI 10.1002/pen.760321605; Carothers W.H., 1938, U.S. Patent, Patent No. [2,130,948A, 2130948, 2,130,948]; Carothers W. H., 1932, J AM CHEM SOC, V54, P1579, DOI DOI 10.1021/JA01343A051; Carraher CE, 2012, INTRO POLYM CHEM; Chang KH, 2003, CHINESE J PHYS, V41, P414; Cheung HY, 2009, J COMPOS MATER, V43, P2521, DOI 10.1177/0021998309345347; COLEMAN BD, 1985, COMPUT MATH APPL, V11, P35, DOI 10.1016/0898-1221(85)90137-3; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; El-Mallawany R.A.H., 2011, TELLURITE GLASSES HD; Fakirov S, 2007, J MACROMOL SCI B, V46, P183, DOI 10.1080/00222340601044375; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; FIGUEROA JC, 1991, COMPOS SCI TECHNOL, V42, P77, DOI 10.1016/0266-3538(91)90013-F; Friedrich K, 2005, COMPOS SCI TECHNOL, V65, P107, DOI 10.1016/j.compscitech.2004.06.008; Galiotis C, 1998, J MATER SCI, V33, P1137, DOI 10.1023/A:1004357121802; Hartouni E., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V683, P92, DOI 10.1117/12.936421; Hermes M.E., 1996, ENOUGH ONE LIFETIME; Hillerborg A., 1976, CEMENT CONCRETE RES, V6, P773, DOI [10.1016/0008-8846(76)90007-7, DOI 10.1016/0008-8846(76)90007-7]; Hu ZX, 2010, PROC SPIE, V7522, DOI 10.1117/12.851415; HUTCHINSON JW, 1983, J MECH PHYS SOLIDS, V31, P405, DOI 10.1016/0022-5096(83)90007-8; Kaplan PD, 2011, INT J COSMETIC SCI, V33, P171, DOI 10.1111/j.1468-2494.2010.00614.x; Kaufman JJ, 2011, NANO LETT, V11, P4768, DOI 10.1021/nl202583g; Kim BW, 2002, J COMPOS MATER, V36, P1825, DOI 10.1106/002199802026243; Kurkjian CR, 2000, J NON-CRYST SOLIDS, V263, P207, DOI 10.1016/S0022-3093(99)00637-7; Li T, 1985, OPTICAL FIBER COMMUN, V1; Littler ICM, 2006, OPT EXPRESS, V14, P8088, DOI 10.1364/OE.14.008088; Loos J, 2001, POLYMER, V42, P3827, DOI 10.1016/S0032-3861(00)00660-1; Lu NS, 2010, ACTA MATER, V58, P1679, DOI 10.1016/j.actamat.2009.11.010; MARSHALL I, 1953, NATURE, V171, P38, DOI 10.1038/171038a0; MITAL SK, 1993, J COMPOS MATER, V27, P1678, DOI 10.1177/002199839302701703; Nairn JA, 1997, MECH MATER, V26, P63, DOI 10.1016/S0167-6636(97)00023-9; NEALE KW, 1985, J MECH PHYS SOLIDS, V33, P323, DOI 10.1016/0022-5096(85)90032-8; NIE HY, 1995, J VAC SCI TECHNOL B, V13, P1163, DOI 10.1116/1.588229; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Rouxel T, 2007, J AM CERAM SOC, V90, P3019, DOI 10.1111/j.1551-2916.2007.01945.x; Saleh, 2007, FUNDAMENTALS PHOTONI, V2; Schulson EM, 1999, JOM-J MIN MET MAT S, V51, P21, DOI 10.1007/s11837-999-0206-4; STOREN S, 1975, J MECH PHYS SOLIDS, V23, P421, DOI 10.1016/0022-5096(75)90004-6; Tanaka K, 2011, AMORPHOUS CHALCOGENIDE SEMICONDUCTORS AND RELATED MATERIALS, P1, DOI 10.1007/978-1-4419-9510-0; Tao GM, 2015, ADV OPT PHOTONICS, V7, P379, DOI 10.1364/AOP.7.000379; Tao GM, 2012, INT J APPL GLASS SCI, V3, P349, DOI 10.1111/ijag.12007; Thostenson ET, 2002, J APPL PHYS, V91, P6034, DOI 10.1063/1.1466880; Ung B, 2010, OPT EXPRESS, V18, P8647, DOI 10.1364/OE.18.008647; VINCENT PI, 1960, POLYMER, V1, P7, DOI 10.1016/0032-3861(60)90003-3; Wang XH, 2010, MATER DESIGN, V31, P2464, DOI 10.1016/j.matdes.2009.11.050; Weeks W., 1967, MECH PROPERTIES SEA; Zartman GD, 2012, MACROMOLECULES, V45, P6719, DOI 10.1021/ma300955h; Zhang K, 2010, ACTA BIOMATER, V6, P2165, DOI 10.1016/j.actbio.2009.12.030; Ziabicki A., 1976, PROCESSES FIBER FORM	56	53	54	21	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					529	+		10.1038/nature17980	http://dx.doi.org/10.1038/nature17980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27281223				2022-12-28	WOS:000378270300049
J	Renier, N; Adams, EL; Kirst, C; Wu, ZH; Azevedo, R; Kohl, J; Autry, AE; Kadiri, L; Venkataraju, KU; Zhou, Y; Wang, VX; Tang, CY; Olsen, O; Dulac, C; Osten, P; Tessier-Lavigne, M				Renier, Nicolas; Adams, Eliza L.; Kirst, Christoph; Wu, Zhuhao; Azevedo, Ricardo; Kohl, Johannes; Autry, Anita E.; Kadiri, Lolahon; Venkataraju, Kannan Umadevi; Zhou, Yu; Wang, Victoria X.; Tang, Cheuk Y.; Olsen, Olav; Dulac, Catherine; Osten, Pavel; Tessier-Lavigne, Marc			Mapping of Brain Activity by Automated Volume Analysis of Immediate Early Genes	CELL			English	Article							WHOLE-BRAIN; CELLULAR RESOLUTION; INSULAR CORTEX; CIRCUITS; NEURONS	Understanding how neural information is processed in physiological and pathological states would benefit from precise detection, localization, and quantification of the activity of all neurons across the entire brain, which has not, to date, been achieved in the mammalian brain. We introduce a pipeline for high-speed acquisition of brain activity at cellular resolution through profiling immediate early gene expression using immunostaining and light-sheet fluorescence imaging, followed by automated mapping and analysis of activity by an open-source software program we term ClearMap. We validate the pipeline first by analysis of brain regions activated in response to haloperidol. Next, we report new cortical regions downstream of whisker-evoked sensory processing during active exploration. Last, we combine activity mapping with axon tracing to un-cover new brain regions differentially activated during parenting behavior. This pipeline is widely applicable to different experimental paradigms, including animal species for which transgenic activity reporters are not readily available.	[Renier, Nicolas; Adams, Eliza L.; Wu, Zhuhao; Azevedo, Ricardo; Olsen, Olav; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA; [Kirst, Christoph] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA; [Kohl, Johannes; Autry, Anita E.; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Venkataraju, Kannan Umadevi; Osten, Pavel] Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA; [Kadiri, Lolahon; Venkataraju, Kannan Umadevi] Certerra, Cold Spring Harbor, NY 11724 USA; [Zhou, Yu; Wang, Victoria X.; Tang, Cheuk Y.] Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA	Rockefeller University; Rockefeller University; Harvard University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Icahn School of Medicine at Mount Sinai	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA.	marctl@rockefeller.edu	Renier, Nicolas/E-1855-2018; Wu, Zhuhao/I-5852-2018; Autry, Anita/ABF-9006-2021	Renier, Nicolas/0000-0003-2642-4402; Dulac, Catherine/0000-0001-5024-5418; Kohl, Johannes/0000-0001-8222-0282; Wu, Zhuhao/0000-0002-2471-0555	Shelby White and Leon Levy fellowship; Rockefeller University Women & Science Initiative; Human Frontier Long-Term Fellowship; EMBO Long-Term Fellowship; Sir Henry Wellcome Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Development of the NIH [F32HD078040]; NARSAD Young Investigator award; NIH [1R01HD082131-01A1]; Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078040, R01HD082131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105971, R01MH096946] Funding Source: NIH RePORTER	Shelby White and Leon Levy fellowship; Rockefeller University Women & Science Initiative; Human Frontier Long-Term Fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Development of the NIH; NARSAD Young Investigator award(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Nils Brose for helpful discussions. We are also grateful to Yingxi Lin for sharing reagents and insights. We would also like to thank members of the M.T.-L. lab for helpful discussions. Our gratitude goes to the Rockefeller University Bio-Imaging Resource Center, and, in particular, Pablo Ariel, Kaye Thomas, Tao Tong, and Alison North. N.R. is supported by a Shelby White and Leon Levy fellowship. E.L.A. is supported by a fellowship from the Rockefeller University Women & Science Initiative. J.K. is supported by a Human Frontier Long-Term Fellowship, an EMBO Long-Term Fellowship and a Sir Henry Wellcome Fellowship. A.E.A. is supported by the Eunice Kennedy Shriver National Institute of Child Health and Development of the NIH under award F32HD078040 and by a NARSAD Young Investigator award. This work was supported by NIH grant 1R01HD082131-01A1 (to C.D.) and by the Rockefeller University (to M.T.-L.). C.D. is an investigator of the Howard Hughes Medical Institute.	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Barnes SJ, 2015, NEURON, V86, P1290, DOI 10.1016/j.neuron.2015.05.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bepari AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052783; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Cui GH, 2014, NAT PROTOC, V9, P1213, DOI 10.1038/nprot.2014.080; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Gogolla N, 2014, NEURON, V83, P894, DOI 10.1016/j.neuron.2014.06.033; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Keller PJ, 2015, NEURON, V85, P462, DOI 10.1016/j.neuron.2014.12.039; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Mongeau R, 2003, J NEUROSCI, V23, P3855; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; ROTH BL, 1992, J PHARMACOL EXP THER, V260, P1361; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Schwarz MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124650; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Sumner BEH, 2004, PSYCHOPHARMACOLOGY, V171, P306, DOI 10.1007/s00213-003-1579-7; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	40	361	368	5	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1789	1802		10.1016/j.cell.2016.05.007	http://dx.doi.org/10.1016/j.cell.2016.05.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27238021	Green Accepted, Bronze			2022-12-28	WOS:000378062000027
J	Wise, J				Wise, Jacqui			Breast feeding premature babies improves their heart function as adults, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lewandowski AJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0050	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2016	353								i3307	10.1136/bmj.i3307	http://dx.doi.org/10.1136/bmj.i3307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1GZ	27301984				2022-12-28	WOS:000378239800014
J	Magnan, AK; Ribera, T				Magnan, Alexandre K.; Ribera, Teresa			Global adaptation after Paris	SCIENCE			English	Editorial Material									[Magnan, Alexandre K.; Ribera, Teresa] Inst Sustainable Dev & Int Relat, Paris, France		Magnan, AK (corresponding author), Inst Sustainable Dev & Int Relat, Paris, France.	alexandre.magnan@iddri.org	Magnan, Alexandre K/I-3377-2017	Magnan, Alexandre K/0000-0001-7421-5184				[Anonymous], 2015, LITICAL EC; [Anonymous], 2015, MEX GOB REP; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Ford JD, 2015, NAT CLIM CHANGE, V5, P967, DOI 10.1038/nclimate2744; Helgeson J., 2015, 20151 OECD CLIM CHAN; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Juhola S, 2016, ENVIRON SCI POLICY, V55, P135, DOI 10.1016/j.envsci.2015.09.014; Kienk NL, 2015, SCIENCE, V350, P743, DOI 10.1126/science.aab1495; Lesnikowski A, 2016, NAT CLIM CHANGE, V6, P261, DOI [10.1038/nclimate2863, 10.1038/NCLIMATE2863]; Magnan A., 2015, 0415 IDDRI I SUST DE; Magnan AK, 2016, NATURE, V530, P160, DOI 10.1038/530160d; Murray V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P487; UNFCCC, 2014, REP AD COMM SUBS BOD	13	54	54	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1280	1282		10.1126/science.aaf5002	http://dx.doi.org/10.1126/science.aaf5002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7ON	27284184				2022-12-28	WOS:000377972000023
J	DuBois, JM; Chibnall, JT; Tait, R; Wal, JV				DuBois, James M.; Chibnall, John T.; Tait, Raymond; Wal, Jillon Vander			Lessons from researcher rehab	NATURE			English	Editorial Material									[DuBois, James M.] Washington Univ, Sch Med, Ctr Clin & Res Eth, St Louis, MO 63130 USA; [Chibnall, John T.; Tait, Raymond] St Louis Univ, Psychiat, St Louis, MO 63103 USA; [Tait, Raymond] St Louis Univ, Res, St Louis, MO 63103 USA; [Wal, Jillon Vander] St Louis Univ, Psychol, St Louis, MO 63103 USA	Washington University (WUSTL); Saint Louis University; Saint Louis University; Saint Louis University	DuBois, JM (corresponding author), Washington Univ, Sch Med, Ctr Clin & Res Eth, St Louis, MO 63130 USA.	duboisjm@wustl.edu						Antes AL, 2010, ACAD MED, V85, P519, DOI 10.1097/ACM.0b013e3181cd1cc5; Asplund J., 2009, CLIFTON STRENGTHSFIN; DuBois J. M., 2015, SCI ENG ETHICS; DuBois JM, 2016, SCI ENG ETHICS, V22, P391, DOI 10.1007/s11948-015-9667-8; Feist G J, 1998, Pers Soc Psychol Rev, V2, P290, DOI 10.1207/s15327957pspr0204_5; Kornfeld DS, 2012, ACAD MED, V87, P877, DOI 10.1097/ACM.0b013e318257ee6a; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Michalek AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000318	8	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					173	175		10.1038/534173a	http://dx.doi.org/10.1038/534173a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO0NH	27279195	Bronze			2022-12-28	WOS:000377475100014
J	Esvelt, K				Esvelt, Kevin			Gene editing can drive science to openness	NATURE			English	Editorial Material									[Esvelt, Kevin] MIT, Media Lab, Sculpting Evolut Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Esvelt, K (corresponding author), MIT, Media Lab, Sculpting Evolut Grp, Cambridge, MA 02139 USA.	esvelt@mit.edu							0	22	22	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					153	153		10.1038/534153a	http://dx.doi.org/10.1038/534153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279174	Bronze			2022-12-28	WOS:000377475100004
J	Li, ZM; Pradeep, KG; Deng, Y; Raabe, D; Tasan, CC				Li, Zhiming; Pradeep, Konda Gokuldoss; Deng, Yun; Raabe, Dierk; Tasan, Cemal Cem			Metastable high-entropy dual-phase alloys overcome the strength-ductility trade-off	NATURE			English	Article							STACKING-FAULT; STEEL; MARTENSITE; PLASTICITY; BOUNDARIES; AUSTENITE; DESIGN; TRANSFORMATION; STABILITY	Metals have been mankind's most essential materials for thousands of years; however, their use is affected by ecological and economical concerns. Alloys with higher strength and ductility could alleviate some of these concerns by reducing weight and improving energy efficiency. However, most metallurgical mechanisms for increasing strength lead to ductility loss, an effect referred to as the strength-ductility trade-off(1,2). Here we present a metastability-engineering strategy in which we design nanostructured, bulk high-entropy alloys with multiple compositionally equivalent high-entropy phases. High-entropy alloys were originally proposed to benefit from phase stabilization through entropy maximization(3-6). Yet here, motivated by recent work that relaxes the strict restrictions on high-entropy alloy compositions by demonstrating the weakness of this connection(7-11), the concept is overturned. We decrease phase stability to achieve two key benefits: interface hardening due to a dual-phase microstructure (resulting from reduced thermal stability of the high-temperature phase(12)); and transformation-induced hardening (resulting from the reduced mechanical stability of the room-temperature phase(13)). This combines the best of two worlds: extensive hardening due to the decreased phase stability known from advanced steels(14,15) and massive solid-solution strengthening of high-entropy alloys(3). In our transformation-induced plasticity-assisted, dual-phase high-entropy alloy (TRIP-DP-HEA), these two contributions lead respectively to enhanced trans-grain and inter-grain slip resistance, and hence, increased strength. Moreover, the increased strain hardening capacity that is enabled by dislocation hardening of the stable phase and transformation-induced hardening of the metastable phase produces increased ductility. This combined increase in strength and ductility distinguishes the TRIP-DP-HEA alloy from other recently developed structural materials(16,17). This metastability-engineering strategy should thus usefully guide design in the near-infinite compositional space of high-entropy alloys.	[Li, Zhiming; Pradeep, Konda Gokuldoss; Deng, Yun; Raabe, Dierk; Tasan, Cemal Cem] Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany; [Tasan, Cemal Cem] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Max Planck Society; Massachusetts Institute of Technology (MIT)	Li, ZM; Raabe, D; Tasan, CC (corresponding author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.; Tasan, CC (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	zhiming.li@mpie.de; d.raabe@mpie.de; tasan@mit.edu	Raabe, Dierk/A-6470-2009; LI, ZHIMING/F-5049-2012	Raabe, Dierk/0000-0003-0194-6124; LI, ZHIMING/0000-0002-8170-5621; Deng, Yun/0000-0002-7420-6648	European Research Council under the EU [290998]	European Research Council under the EU(European Research Council (ERC))	This work is financially supported by the European Research Council under the EU's 7th Framework Programme (FP7/2007-2013)/ERC grant agreement 290998. The contributions of H. Springer, S. Zaefferer, M. Nellessen, M. Adamek and F. Schluter are also gratefully acknowledged.	BROOKS JW, 1979, ACTA METALL MATER, V27, P1839, DOI 10.1016/0001-6160(79)90074-9; Deng Y, 2015, ACTA MATER, V94, P124, DOI 10.1016/j.actamat.2015.04.014; Dmitrieva O, 2011, ACTA MATER, V59, P364, DOI 10.1016/j.actamat.2010.09.042; Gludovatz B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10602; Gludovatz B, 2014, SCIENCE, V345, P1153, DOI 10.1126/science.1254581; Grassel O, 2000, INT J PLASTICITY, V16, P1391, DOI 10.1016/S0749-6419(00)00015-2; Hadfield R. A., 1888, SCIENCE, V12, P284; Hays CC, 2000, PHYS REV LETT, V84, P2901, DOI 10.1103/PhysRevLett.84.2901; Herrera C, 2011, ACTA MATER, V59, P4653, DOI 10.1016/j.actamat.2011.04.011; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Kim CP, 2011, SCRIPTA MATER, V65, P304, DOI 10.1016/j.scriptamat.2011.04.037; Kim SH, 2015, NATURE, V518, P77, DOI 10.1038/nature14144; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Mandal S, 2014, SCRIPTA MATER, V81, P16, DOI 10.1016/j.scriptamat.2014.02.016; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Pierce DT, 2014, ACTA MATER, V68, P238, DOI 10.1016/j.actamat.2014.01.001; Pradeep KG, 2015, MAT SCI ENG A-STRUCT, V648, P183, DOI 10.1016/j.msea.2015.09.010; Raabe D, 2013, ACTA MATER, V61, P6132, DOI 10.1016/j.actamat.2013.06.055; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Tasan CC, 2015, ANNU REV MATER RES, V45, P391, DOI 10.1146/annurev-matsci-070214-021103; Tasan CC, 2014, JOM-US, V66, P1993, DOI 10.1007/s11837-014-1133-6; Wang MM, 2015, ACTA MATER, V85, P216, DOI 10.1016/j.actamat.2014.11.010; Wang YP, 2009, ADV ENG MATER, V11, P641, DOI 10.1002/adem.200900057; Wei YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4580; Wu XL, 2015, P NATL ACAD SCI USA, V112, P14501, DOI 10.1073/pnas.1517193112; Yakubtsov IA, 1999, ACTA MATER, V47, P1271, DOI 10.1016/S1359-6454(98)00419-4; Yao MJ, 2014, SCRIPTA MATER, V72-73, P5, DOI 10.1016/j.scriptamat.2013.09.030; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Zaefferer S, 2014, ACTA MATER, V75, P20, DOI 10.1016/j.actamat.2014.04.018; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001	30	1855	1878	235	2254	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					227	+		10.1038/nature17981	http://dx.doi.org/10.1038/nature17981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279217				2022-12-28	WOS:000377475100036
J	Flegal, KM; Kruszon-Moran, D; Carroll, MD; Fryar, CD; Ogden, CL				Flegal, Katherine M.; Kruszon-Moran, Deanna; Carroll, Margaret D.; Fryar, Cheryl D.; Ogden, Cynthia L.			Trends in Obesity Among Adults in the United States, 2005 to 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; US ADULTS; PREVALENCE; OVERWEIGHT; CHILDHOOD; HEALTH; BURDEN	IMPORTANCE Between 1980 and 2000, the prevalence of obesity increased significantly among adult men and women in the United States; further significant increases were observed through 2003-2004 for men but not women. Subsequent comparisons of data from 2003-2004 with data through 2011-2012 showed no significant increases for men or women. OBJECTIVE To examine obesity prevalence for 2013-2014 and trends over the decade from 2005 through 2014 adjusting for sex, age, race/Hispanic origin, smoking status, and education. DESIGN, SETTING, AND PARTICIPANTS Analysis of data obtained from the National Health and Nutrition Examination Survey (NHANES), a cross-sectional, nationally representative health examination survey of the US civilian noninstitutionalized population that includes measured weight and height. EXPOSURES Survey period. MAIN OUTCOMES AND MEASURES Prevalence of obesity (body mass index >= 30) and class 3 obesity (body mass index >= 40). RESULTS This report is based on data from 2638 adult men (mean age, 46.8 years) and 2817 women (mean age, 48.4 years) from the most recent 2 years (2013-2014) of NHANES and data from 21 013 participants in previous NHANES surveys from 2005 through 2012. For the years 2013-2014, the overall age-adjusted prevalence of obesity was 37.7%(95% CI, 35.8%-39.7%); among men, it was 35.0% (95% CI, 32.8%-37.3%); and among women, it was 40.4%(95% CI, 37.6%-43.3%). The corresponding prevalence of class 3 obesity overall was 7.7%(95% CI, 6.2%-9.3%); among men, it was 5.5%(95% CI, 4.0%-7.2%); and among women, it was 9.9%(95% CI, 7.5%-12.3%). Analyses of changes over the decade from 2005 through 2014, adjusted for age, race/Hispanic origin, smoking status, and education, showed significant increasing linear trends among women for overall obesity (P =.004) and for class 3 obesity (P =.01) but not among men (P =.30 for overall obesity; P =.14 for class 3 obesity). CONCLUSIONS AND RELEVANCE In this nationally representative survey of adults in the United States, the age-adjusted prevalence of obesity in 2013-2014 was 35.0% among men and 40.4% among women. The corresponding values for class 3 obesity were 5.5% for men and 9.9% for women. For women, the prevalence of overall obesity and of class 3 obesity showed significant linear trends for increase between 2005 and 2014; there were no significant trends for men. Other studies are needed to determine the reasons for these trends.	[Flegal, Katherine M.; Kruszon-Moran, Deanna; Carroll, Margaret D.; Fryar, Cheryl D.; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	kflegal@cdc.gov	Flegal, Katherine M/A-4608-2013					Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Centers for Disease Control and Prevention, 2015, NHANES RESPONSE RATE; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; Costa DL, 1997, NAT BUR EC, P47; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Flegal KM, 2007, AM J PUBLIC HEALTH, V97, P1510, DOI 10.2105/AJPH.2005.084343; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Haby MM, 2012, HEALTH PROMOT INT, V27, P250, DOI 10.1093/heapro/dar036; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Johnson CL., 2013, ANAL GUIDELINES 1999; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Korn E, 1998, SURV METHODOL, V24, P193; Korn EL., 1999, ANAL HLTH SURVEYS; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Lo E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-996; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ogden Cynthia L, 2015, NCHS Data Brief, P1; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Sperrin M, 2014, INT J OBESITY, V38, P818, DOI 10.1038/ijo.2013.161; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Twells Laurie K, 2014, CMAJ Open, V2, pE18, DOI 10.9778/cmajo.20130016; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wabitsch M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-17; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zipf G, 2013, VITAL HLTH STAT, V56, P1	39	1918	1952	13	171	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2284	2291		10.1001/jama.2016.6458	http://dx.doi.org/10.1001/jama.2016.6458			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272580	Bronze			2022-12-28	WOS:000377183100017
J	Lim, SY; Lu, N; Oza, A; Fisher, M; Rai, SK; Menendez, ME; Choi, HK				Lim, Sian Yik; Lu, Na; Oza, Amar; Fisher, Mark; Rai, Sharan K.; Menendez, Mariano E.; Choi, Hyon K.			Trends in Gout and Rheumatoid Arthritis Hospitalizations in the United States, 1993-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH		[Lim, Sian Yik; Lu, Na; Oza, Amar; Fisher, Mark; Choi, Hyon K.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, 55 Fruit St,Bulfinch 165, Boston, MA 02114 USA; [Rai, Sharan K.] Arthrit Res Canada, Vancouver, BC, Canada; [Menendez, Mariano E.] Massachusetts Gen Hosp, Dept Orthopaed Surg, 55 Fruit St,Bulfinch 165, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Arthritis Research Canada; Harvard University; Massachusetts General Hospital	Choi, HK (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, 55 Fruit St,Bulfinch 165, Boston, MA 02114 USA.	hchoi@partners.org			NIAMS NIH HHS [T32 AR007258, R01AR065944, R01 AR065944] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007258, R01AR065944] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agency for Healthcare Research and Quality, OV NAT NAT INP SAMPL; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Patel NJ, 2014, CIRCULATION, V129, P2371, DOI 10.1161/CIRCULATIONAHA.114.008201; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	6	66	67	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2345	2347		10.1001/jama.2016.3517	http://dx.doi.org/10.1001/jama.2016.3517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272587	Bronze, Green Accepted			2022-12-28	WOS:000377183100025
J	Appleby, J				Appleby, John			DATA BRIEFING Is the UK spending more than we thought on healthcare (and much less on social care)?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2016, 19 KINGS FUND; Barker K, 2014, COMMISSION FUTURE HL; NHS Improvement, 2016, PERF NHS PROV SECT Y; OECD, 2015, HLTH STAT; Office for National Statistics, 2016, UK HLTH ACC 2014	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3094	10.1136/bmj.i3094	http://dx.doi.org/10.1136/bmj.i3094			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27269594				2022-12-28	WOS:000377857800005
J	Coates, AJ				Coates, Andrew J.			Connecting the dots in magnetic reconnection	SCIENCE			English	Editorial Material									[Coates, Andrew J.] UCL, Dept Space & Climate Phys, Mullard Space Sci Lab, Mortimer St, London WC1E 6BT, England	University of London; University College London	Coates, AJ (corresponding author), UCL, Dept Space & Climate Phys, Mullard Space Sci Lab, Mortimer St, London WC1E 6BT, England.	a.coates@ucl.ac.uk	Coates, Andrew/C-2396-2008	Coates, Andrew/0000-0002-6185-3125	STFC [ST/K000977/1, ST/N000722/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/N000722/1, ST/K000977/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		ALFVEN HOG, 1990, IEEE T PLASMA SCI, V18, P5, DOI 10.1109/27.45495; Arridge CS, 2016, NAT PHYS, V12, P268, DOI 10.1038/NPHYS3565; Burch JL, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2939; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Fuselier SA, 2011, SPACE SCI REV, V160, P95, DOI 10.1007/s11214-011-9820-x; Ness W.N., 1964, NASA SPECIAL PUBLICA, P425; PARKER EN, 1957, J GEOPHYS RES, V62, P509, DOI 10.1029/JZ062i004p00509; Paschmann G, 2013, SPACE SCI REV, V178, P385, DOI 10.1007/s11214-012-9957-2; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Sweet P. A., 1958, IAU S, V6, P123, DOI [DOI 10.1017/S0074180900237704, 10.1017/S0074180900237704]	10	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1176	1177		10.1126/science.aaf7269	http://dx.doi.org/10.1126/science.aaf7269			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257243	Green Submitted			2022-12-28	WOS:000377045700029
J	Frantz, LAF; Mullin, VE; Pionnier-Capitan, M; Lebrasseur, O; Ollivier, M; Perri, A; Linderholm, A; Mattiangeli, V; Teasdale, MD; Dimopoulos, EA; Tresset, A; Duffraisse, M; McCormick, F; Bartosiewicz, L; Gal, E; Nyerges, EA; Sablin, MV; Brehard, S; Mashkour, M; Balasescu, A; Gillet, B; Hughes, S; Chassaing, O; Hitte, C; Vigne, JD; Dobney, K; Hanni, C; Bradley, DG; Larson, G				Frantz, Laurent A. F.; Mullin, Victoria E.; Pionnier-Capitan, Maud; Lebrasseur, Ophelie; Ollivier, Morgane; Perri, Angela; Linderholm, Anna; Mattiangeli, Valeria; Teasdale, Matthew D.; Dimopoulos, Evangelos A.; Tresset, Anne; Duffraisse, Marilyne; McCormick, Finbar; Bartosiewicz, Laszlo; Gal, Erika; Nyerges, Eva A.; Sablin, Mikhail V.; Brehard, Stephanie; Mashkour, Marjan; Balasescu, Adrian; Gillet, Benjamin; Hughes, Sandrine; Chassaing, Olivier; Hitte, Christophe; Vigne, Jean-Denis; Dobney, Keith; Hanni, Catherine; Bradley, Daniel G.; Larson, Greger			Genomic and archaeological evidence suggests a dual origin of domestic dogs	SCIENCE			English	Article							HISTORY; MIGRATION; SELECTION; GENETICS; REVEALS	The geographic and temporal origins of dogs remain controversial. We generated genetic sequences from 59 ancient dogs and a complete (28x) genome of a late Neolithic dog (dated to similar to 4800 calendar years before the present) from Ireland. Our analyses revealed a deep split separating modern East Asian and Western Eurasian dogs. Surprisingly, the date of this divergence (similar to 14,000 to 6400 years ago) occurs commensurate with, or several millennia after, the first appearance of dogs in Europe and East Asia. Additional analyses of ancient and modern mitochondrial DNA revealed a sharp discontinuity in haplotype frequencies in Europe. Combined, these results suggest that dogs may have been domesticated independently in Eastern and Western Eurasia from distinct wolf populations. East Eurasian dogs were then possibly transported to Europe with people, where they partially replaced European Paleolithic dogs.	[Frantz, Laurent A. F.; Lebrasseur, Ophelie; Linderholm, Anna; Dimopoulos, Evangelos A.; Larson, Greger] Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, Oxford, England; [Mullin, Victoria E.; Mattiangeli, Valeria; Teasdale, Matthew D.; Bradley, Daniel G.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Pionnier-Capitan, Maud; Ollivier, Morgane; Duffraisse, Marilyne; Gillet, Benjamin; Hughes, Sandrine; Chassaing, Olivier; Hanni, Catherine] ENS Lyon, CNRS, UMR 5242, IGFL, 46 Allee Italie, F-69364 Lyon 07, France; [Pionnier-Capitan, Maud; Ollivier, Morgane; Duffraisse, Marilyne; Gillet, Benjamin; Hughes, Sandrine; Chassaing, Olivier; Hanni, Catherine] Ecole Normale Super Lyon, PALGENE, French Natl Platform Paleogenet, 46 Allee Italie, F-69364 Lyon 07, France; [Pionnier-Capitan, Maud; Ollivier, Morgane; Duffraisse, Marilyne; Gillet, Benjamin; Hughes, Sandrine; Chassaing, Olivier; Hanni, Catherine] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Pionnier-Capitan, Maud; Tresset, Anne; Brehard, Stephanie; Mashkour, Marjan; Vigne, Jean-Denis] Univ Paris 04, CNRS, UMR 7209, Museum Natl Hist Nat,Archeozool Archeobot Soc Pra, CP56,55 Rue Buffon, F-75005 Paris, France; [Perri, Angela] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Linderholm, Anna] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Dimopoulos, Evangelos A.] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece; [McCormick, Finbar] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Univ Rd, Belfast, Antrim, North Ireland; [Bartosiewicz, Laszlo] Univ Stockholm, Osteoarchaeol Res Lab, Stockholm, Sweden; [Gal, Erika; Nyerges, Eva A.] Hungarian Acad Sci, Res Ctr Humanities, Archaeol Inst, Budapest, Hungary; [Sablin, Mikhail V.] Russian Acad Sci, Inst Zool, Univ Skaya Nab 1, St Petersburg 199034, Russia; [Balasescu, Adrian] Natl Museum Romanian Hist, 12 Calea Victoriei, Bucharest 030026, Romania; [Hitte, Christophe] Univ Rennes 1, CNRS, UMR6290, Inst Genet & Dev Rennes, Rennes, France; [Dobney, Keith] Univ Aberdeen, Sch Geosci, Dept Archaeol, Elphinstone Rd, St Marys AB24 3UF, Aberdeen, Scotland; [Dobney, Keith] Univ Liverpool, Dept Archaeol Class & Egyptol, 12-14 Abercromby Sq, Liverpool L69 7WZ, Merseyside, England	University of Oxford; Trinity College Dublin; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Texas A&M University System; Texas A&M University College Station; Aristotle University of Thessaloniki; Queens University Belfast; Stockholm University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Aberdeen; University of Liverpool	Frantz, LAF; Larson, G (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, Oxford, England.; Bradley, DG (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	laurent.frantz@arch.ox.ac.uk; dbradley@tcd.ie; greger.larson@arch.ox.ac.uk	Linderholm, Anna/R-7516-2019; Ollivier, Morgane/AAA-6059-2019; Gillet, Benjamin/ABD-6704-2020; Mikhail, Sablin/K-7835-2013; Balasescu, Adrian/L-6149-2013; Gal, Erika/AAI-5915-2020; Mashkour, Marjan/B-5724-2018	Ollivier, Morgane/0000-0002-8361-4221; Mikhail, Sablin/0000-0002-2773-7454; Balasescu, Adrian/0000-0001-7834-5111; Mashkour, Marjan/0000-0003-3630-9459; Dobney, Keith/0000-0001-9036-4681; Linderholm, Anna/0000-0002-1613-9926; Teasdale, Matthew David/0000-0002-7376-9975; Frantz, Laurent/0000-0001-8030-3885; Hitte, Christophe/0000-0003-1714-437X; Bradley, Daniel G/0000-0001-7335-7092	European Nucleotide Archive (ENA) [PRJEB13070]; European Research Council [ERC-2013-StG-337574-UNDEAD]; Natural Environmental Research Council [NE/K005243/1, NE/K003259/1]; Junior Research Fellowship (Wolfson College, University of Oxford); BDI CNRS grant; ERC [295729-CodeX]; Science Foundation Ireland Award [12/ERC/B2227]; Romanian National Authority for Scientific Research [PN-II-ID-PCE-2011-3-1015]; Nestle Purina; Natural Environment Research Council [NRCF010002, NE/K005243/2, NE/K003259/1, NE/K005243/1, NE/K003259/2] Funding Source: researchfish; NERC [NE/K005243/2, NRCF010002, NE/K003259/1, NE/K005243/1, NE/K003259/2] Funding Source: UKRI	European Nucleotide Archive (ENA); European Research Council(European Research Council (ERC)European Commission); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Junior Research Fellowship (Wolfson College, University of Oxford); BDI CNRS grant; ERC(European Research Council (ERC)European Commission); Science Foundation Ireland Award(Science Foundation Ireland); Romanian National Authority for Scientific Research; Nestle Purina(Nestle SA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Raw reads of the Newgrange dog have been deposited at the European Nucleotide Archive (ENA) with project number PRJEB13070. Mitochondrial sequences as well as genotype files (in plink format) were deposited on Dryad (doi:10.5061/dryad. 8gp06). We thank G. Wang, J. Schraiber, L. Orlando, L. Dalen, R. E. Green, P. Savolainen, and E. Loftus for their valuable input; and A. Osztas, I. Zalai-Gaal, R.-M. Arbogast, A. Beeching, A. Boroneant, O. Lecomte, S. Madeleine, C. and D. Mordant, M. Patou-Mathis, P. Petrequin, L. Salanova, J. Schibler, A. Tsuneki, and F. Valla for providing archaeological material. L. A. F. F., O. L., A. L., and G. L. were supported by a European Research Council grant (ERC-2013-StG-337574-UNDEAD) and Natural Environmental Research Council grants (NE/K005243/1 and NE/K003259/1). L. A. F. F. was supported by a Junior Research Fellowship (Wolfson College, University of Oxford). M. P.-C. was supported by a BDI CNRS grant. V.E.M, V. M, M.D.T., and the sequencing of the Newgrange dog genome were funded by ERC Investigator grant 295729-CodeX awarded to D.G.B. We also acknowledge the National Museum of Ireland for providing the petrous bone of the Newgrange dog and the Science Foundation Ireland Award 12/ERC/B2227 and Trinseq. A.B. was supported by a Romanian National Authority for Scientific Research (PN-II-ID-PCE-2011-3-1015). The work at ENS Lyon and at Museum National d'Histoire Naturelle Paris was also supported by Nestle Purina. The authors declare no conflict of interest.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Frantz LAF, 2015, NAT GENET, V47, P1141, DOI 10.1038/ng.3394; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Morris D., 2008, DOGS ULTIMATE DICT 1; Ollivier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075110; Pilot M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2189; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147	21	240	248	10	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1228	1231		10.1126/science.aaf3161	http://dx.doi.org/10.1126/science.aaf3161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257259	Green Accepted, Green Submitted			2022-12-28	WOS:000377045700045
J	Courtney, R				Courtney, Rosemary			David Stanley Hinchcliff Cannon Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		CANNON DSH, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3107	10.1136/bmj.i3107	http://dx.doi.org/10.1136/bmj.i3107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255335				2022-12-28	WOS:000377479000012
J	Iijima, N; Iwasaki, A				Iijima, Norifumi; Iwasaki, Akiko			Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; BLOOD-BRAIN-BARRIER; SENSORY GANGLIA; VIRAL-INFECTION; NERVE BARRIER; B-CELLS; RECEPTOR; TYPE-2; MICE; RECRUITMENT	Circulating antibodies can access most tissues to mediate surveillance and elimination of invading pathogens. Immunoprivileged tissues such as the brain and the peripheral nervous system are shielded from plasma proteins by the blood-brain barrier(1) and blood-nerve barrier(2), respectively. Yet, circulating antibodies must somehow gain access to these tissues to mediate their antimicrobial functions. Here we examine the mechanism by which antibodies gain access to neuronal tissues to control infection. Using a mouse model of genital herpes infection, we demonstrate that both antibodies and CD4 T cells are required to protect the host after immunization at a distal site. We show that memory CD4 T cells migrate to the dorsal root ganglia and spinal cord in response to infection with herpes simplex virus type 2. Once inside these neuronal tissues, CD4 T cells secrete interferon-gamma and mediate local increase in vascular permeability, enabling antibody access for viral control. A similar requirement for CD4 T cells for antibody access to the brain is observed after intranasal challenge with vesicular stomatitis virus. Our results reveal a previously unappreciated role of CD4 T cells in mobilizing antibodies to the peripheral sites of infection where they help to limit viral spread.	[Iijima, Norifumi; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	National Institutes of Health [AI054359, AI062428, AI064705]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062428, R56AI062428, R01AI064705, R01AI054359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Dong, S. L. Fink and K. Hashimoto-Torii for animal care support and technical help. We thank R. Medzhitov for discussions. This study was supported by awards from National Institutes of Health grants AI054359, AI062428, AI064705 (to A.I.). A.I. is an investigator of the Howard Hughes Medical Institute.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Capaldo CT, 2014, MOL BIOL CELL, V25, P2710, DOI 10.1091/mbc.E14-02-0773; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; MCDERMOTT MR, 1990, J GEN VIROL, V71, P1497, DOI 10.1099/0022-1317-71-7-1497; Milligan GN, 1998, J IMMUNOL, V160, P6093; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Ohashi M, 2011, J VIROL, V85, P3030, DOI 10.1128/JVI.02426-10; Parr MB, 2000, IMMUNOLOGY, V101, P126, DOI 10.1046/j.1365-2567.2000.00080.x; PARR MB, 1994, LAB INVEST, V70, P369; POLLARD JD, 1995, ANN NEUROL, V37, P467, DOI 10.1002/ana.410370409; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sato A, 2014, J VIROL, V88, P13699, DOI 10.1128/JVI.02279-14; Stock AT, 2014, J EXP MED, V211, P751, DOI 10.1084/jem.20132183; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6; Westland KW, 1999, BRAIN, V122, P1283, DOI 10.1093/brain/122.7.1283	30	51	52	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					552	+		10.1038/nature17979	http://dx.doi.org/10.1038/nature17979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225131	Green Accepted			2022-12-28	WOS:000376443100045
J	Barnett, R				Barnett, Richard			Case histories Autism	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	3	3	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2082	2082		10.1016/S0140-6736(16)30530-X	http://dx.doi.org/10.1016/S0140-6736(16)30530-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27308673				2022-12-28	WOS:000376450800016
J	Deak, D; Outterson, K; Powers, JH; Kesselheim, AS				Deak, Dalia; Outterson, Kevin; Powers, John H.; Kesselheim, Aaron S.			Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of US Food and Drug Administration-Approved Antibiotics, 2010-2015	ANNALS OF INTERNAL MEDICINE			English	Article							SKIN-STRUCTURE INFECTIONS; ANTIMICROBIAL DRUGS; UNITED-STATES; NO ESKAPE; TRENDS; NONINFERIORITY; TUBERCULOSIS; BEDAQUILINE; INNOVATION; DISCOVERY	A weak antibiotic pipeline and the increase in drug-resistant pathogens have led to calls for more new antibiotics. Eight new antibiotics were approved by the U.S. Food and Drug Administration (FDA) between January 2010 and December 2015: ceftaroline, fidaxomicin, bedaquiline, dalbavancin, tedizolid, oritavancin, ceftolozane-tazobactam, and ceftazidime-avibactam. This study evaluates the development course and pivotal trials of these antibiotics for their innovativeness, development process, documented patient outcomes, and cost. Data sources were FDA approval packages and databases (January 2010 to December 2015); the Red Book (Truven Health Analytics); Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (FDA); and supplementary information from company filings, press releases, and media reports. Four antibiotics were approved for acute bacterial skin and skin-structure infection. Seven had similar mechanisms of action to those of previously approved drugs. Six were initially developed by small to midsized companies, and 7 are currently marketed by 1 of 3 large companies. The drugs spent a median of 6.2 years in clinical trials (interquartile range [IQR], 5.4 to 8.8 years) and 8 months in FDA review (IQR, 7.5 to 8 months). The median number of patients enrolled in the pivotal trials was 666 (IQR, 553 to 739 patients; full range, 44 to 1005 patients), and median trial duration was 18 months (IQR, 15 to 22 months). Seven drugs were approved on the basis of pivotal trials evaluating noninferiority. One drug demonstrated superiority on an exploratory secondary end point, 2 showed decreased efficacy in patients with renal insufficiency, and 1 showed increased mortality compared with older drugs. Seven of the drugs are substantially more expensive than their trial comparators. Limitations are that future research may show benefit to patients, new drugs from older classes may show superior effectiveness in specific patient populations, and initial U.S. prices for each new antibiotic were obtained from public sources. Recently marketed antibiotics are more expensive but have been approved without evidence of clinical superiority.	Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, Boston, MA USA; [Outterson, Kevin] Boston Univ, Sch Law, 765 Commonwealth Ave, Boston, MA 02215 USA; [Powers, John H.] George Washington Univ, Sch Med, 2300 Eye St,NW, Washington, DC 20037 USA; [Deak, Dalia; Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Deak, Dalia; Kesselheim, Aaron S.] Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; George Washington University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Powers III, John H/0000-0002-5150-5119; Outterson, Kevin/0000-0003-2513-3216	Greenwall Faculty Scholars in Bioethics Program; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; European Union's Innovative Medicines Initiative	Greenwall Faculty Scholars in Bioethics Program; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; European Union's Innovative Medicines Initiative	By the Greenwall Faculty Scholars in Bioethics Program, the Laura and John Arnold Foundation, and the Harvard Program in Therapeutic Science (Dr. Kesselheim). Prof. Outterson is a partner in DRIVE-AB, which is funded by the European Union's Innovative Medicines Initiative.	Alemayehu D, 2012, CLIN INFECT DIS, V55, P562, DOI 10.1093/cid/cis503; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Boucher HW, 2014, NEW ENGL J MED, V370, P2169, DOI 10.1056/NEJMoa1310480; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351; CDC, 2014, NAT STRAT COMB ANT R; CDC, 2013, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention, 2015, ANT RES SOL IN 2015; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621; Clift C, 2015, NEW GLOBAL BUSINESS; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Corey GR, 2015, CLIN INFECT DIS, V60, P254, DOI 10.1093/cid/ciu778; Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Doshi P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1453; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Kotz J., 2005, NAT CHEM BIOL; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Outterson K, 2015, HEALTH AFFAIR, V34, P277, DOI 10.1377/hlthaff.2014.1003; Outterson K, 2013, J LAW MED ETHICS, V41, P688, DOI 10.1111/jlme.12079; Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Prokocimer P, 2013, JAMA-J AM MED ASSOC, V309, P559, DOI 10.1001/jama.2013.241; Reichert JM, 2003, NAT REV DRUG DISCOV, V2, P695, DOI 10.1038/nrd1178; Rex JH, 2014, ANN NY ACAD SCI, V1323, P11, DOI 10.1111/nyas.12441; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sertkaya A, 2014, ANAL FRAMEWORK EXAMI; So AD, 2011, DRUG RESIST UPDATE, V14, P88, DOI 10.1016/j.drup.2011.01.006; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Truven Health Analytics, RED BOOK ONL; U.S. Department of Commerce and Labor, 1906, MORT STAT 1900 1904; U.S. Food and Drug Administration, 2013, POSTM REQ COMM; U.S. Food and Drug Administration, 2015, NEW MOL ENT NEW THER; U.S. Food and Drug Administration, 2012, NOV NEW DRUGS 2011; U.S. Food and Drug Administration, 2014, DOR DOR DRUG SAF COM; U.S. Food and Drug Administration, 2014, STAT REV CEFT TAZ ZE; U.S. Food and Drug Administration, 1998, GUID PROV CLIN EV EF, P4; U.S. Food and Drug Administration, 2010, CDER NEW MOL ENT NMR; U.S. Food and Drug Administration, 2015, NOV NEW DRUGS 2014 S; U.S. Food and Drug Administration, 2014, NOV NEW DRUGS 2013 S; U.S. Food and Drug Administration, 2013, NOV NEW DRUGS SUMM 2; U.S. Food and Drug Administration, 2011, MED REV DIF FID; United States Government Accountability Office, 2015, DRUG SAF FDA EXP MAN; US Food and Drug Administration, 2014, GUID IND EXP PROGR S; US Food and Drug Administration, 2013, OR BOOK APPR DRUG PR; WHO, 2001, WHO GLOB STRAT CONT; Wilcox MH, 2010, J ANTIMICROB CHEMOTH, V65, piv53, DOI 10.1093/jac/dkq255; Woodcock J, 2014, FDA VOICE BLOG  0923; World Health Organization, 2016, ANTIMICROBIAL RESIST	55	68	70	1	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					363	+		10.7326/M16-0291	http://dx.doi.org/10.7326/M16-0291			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27239977				2022-12-28	WOS:000382795000006
J	Tap, WD; Jones, RL; Van Tine, BA; Chmielowski, B; Elias, AD; Adkins, D; Agulnik, M; Cooney, MM; Livingston, MB; Pennock, G; Hameed, MR; Shah, GD; Qin, A; Shahir, A; Cronier, DM; Ilaria, R; Conti, O; Cosaert, J; Schwartz, GK				Tap, William D.; Jones, Robin L.; Van Tine, Brian A.; Chmielowski, Bartosz; Elias, Anthony D.; Adkins, Douglas; Agulnik, Mark; Cooney, Matthew M.; Livingston, Michael B.; Pennock, Gregory; Hameed, Meera R.; Shah, Gaurav D.; Qin, Amy; Shahir, Ashwin; Cronier, Damien M.; Ilaria, Robert, Jr.; Conti, Ilaria; Cosaert, Jan; Schwartz, Gary K.			Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial	LANCET			English	Article							INTENSIFIED DOXORUBICIN; EUROPEAN-ORGANIZATION; 1ST-LINE TREATMENT; DOSE DOXORUBICIN; PLUS IFOSFAMIDE; GROWTH-FACTOR; III TRIAL; PDGF; STANDARD	Background Treatment with doxorubicin is a present standard of care for patients with metastatic soft-tissue sarcoma and median overall survival for those treated is 12-16 months, but few, if any, novel treatments or chemotherapy combinations have been able to improve these poor outcomes. Olaratumab is a human antiplatelet-derived growth factor receptor a monoclonal antibody that has antitumour activity in human sarcoma xenografts. We aimed to assess the efficacy of olaratumab plus doxorubicin in patients with advanced or metastatic soft-tissue sarcoma. Methods We did an open-label phase 1b and randomised phase 2 study of doxorubicin plus olaratumab treatment in patients with unresectable or metastatic soft-tissue sarcoma at 16 clinical sites in the USA. For both the phase 1b and phase 2 parts of the study, eligible patients were aged 18 years or older and had a histologically confirmed diagnosis of locally advanced or metastatic soft-tissue sarcoma not previously treated with an anthracycline, an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2, and available tumour tissue to determine PDGFR alpha expression by immunohistochemistry. In the phase 2 part of the study, patients were randomly assigned in a 1:1 ratio to receive either olaratumab (15 mg/kg) intravenously on day 1 and day 8 plus doxorubicin (75 mg/m(2)) or doxorubicin alone (75 mg/m(2)) on day 1 of each 21-day cycle for up to eight cycles. Randomisation was dynamic and used the minimisation randomisation technique. The phase 1b primary endpoint was safety and the phase 2 primary endpoint was progression-free survival using a two-sided a level of 0.2 and statistical power of 0.8. This study was registered with ClinicalTrials.gov, number NCT01185964. Findings 15 patients were enrolled and treated with olaratumab plus doxorubicin in the phase 1b study, and 133 patients were randomised (66 to olaratumab plus doxorubicin; 67 to doxorubicin alone) in the phase 2 trial, 129 (97%) of whom received at least one dose of study treatment (64 received olaratumab plus doxorubicin, 65 received doxorubicin). Median progression-free survival in phase 2 was 6.6 months (95% CI 4.1-8.3) with olaratumab plus doxorubicin and 4.1 months (2.8-5.4) with doxorubicin (stratified hazard ratio [HR] 0.67; 0.44-1.02, p = 0.0615). Median overall survival was 26.5 months (20.9-31.7) with olaratumab plus doxorubicin and 14.7 months (9.2-17.1) with doxorubicin (stratified HR 0.46, 0.30-0.71, p = 0.0003). The objective response rate was 18.2% (9.8-29.6) with olaratumab plus doxorubicin and 11.9% (5.3-22.2) with doxorubicin (p = 0.3421). Steady state olaratumab serum concentrations were reached during cycle 3 with mean maximum and trough concentrations ranging from 419 mu g/mL (geometric coefficient of variation in percentage [CV%] 26.2) to 487 mu g/mL (CV% 33.0) and from 123 mu g/mL (CV% 31.2) to 156 mu g/mL (CV% 38.0), respectively. Adverse events that were more frequent with olaratumab plus doxorubicin versus doxorubicin alone included neutropenia (37 [58%] vs 23 [35%]), mucositis (34 [53%] vs 23 [35%]), nausea (47 [73%] vs 34 [52%]), vomiting (29 [45%] vs 12 [18%]), and diarrhoea (22 [34%] vs 15 [23%]). Febrile neutropenia of grade 3 or higher was similar in both groups (olaratumab plus doxorubicin: eight [13%] of 64 patients vs doxorubicin: nine [14%] of 65 patients). Interpretation This study of olaratumab with doxorubicin in patients with advanced soft-tissue sarcoma met its predefined primary endpoint for progression-free survival and achieved a highly significant improvement of 11.8 months in median overall survival, suggesting a potential shift in the treatment of soft-tissue sarcoma.	[Tap, William D.; Hameed, Meera R.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Tap, William D.] Weill Cornell Med Coll, New York, NY USA; [Jones, Robin L.] Univ Washington, Seattle, WA 98195 USA; [Jones, Robin L.] Royal Marsden Hosp, London, England; [Van Tine, Brian A.; Adkins, Douglas] Washington Univ, St Louis, MO USA; [Chmielowski, Bartosz] Univ Calif Los Angeles, Med Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Elias, Anthony D.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Agulnik, Mark] Northwestern Univ, Chicago, IL 60611 USA; [Cooney, Matthew M.] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Div Hematol & Oncol, Cleveland, OH USA; [Livingston, Michael B.] Charlotte Mecklenburg Hosp Author, Carolinas Healthcare Syst, Charlotte, NC USA; [Pennock, Gregory] Baptist MD Anderson Canc Ctr, Jacksonville, FL USA; [Shah, Gaurav D.] Novartis Pharmaceut, E Hanover, NJ USA; [Qin, Amy; Cosaert, Jan] Eli Lilly & Co, Bridgewater, NJ USA; [Shahir, Ashwin; Cronier, Damien M.] Eli Lilly & Co, Windlesham, Surrey, England; [Ilaria, Robert, Jr.; Conti, Ilaria] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Schwartz, Gary K.] Columbia Univ, Sch Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of Washington; University of Washington Seattle; Royal Marsden NHS Foundation Trust; Washington University (WUSTL); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Northwestern University; Case Western Reserve University; Case Western Reserve University Hospital; Carolinas HealthCare System; University of Texas System; UTMD Anderson Cancer Center; Novartis; Eli Lilly; Eli Lilly; Eli Lilly; Columbia University	Tap, WD (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	tapw@mskcc.org; tapw@mskcc.org	van+Tine, Brain/AAI-1919-2019; Jones, Robin L/AAO-3738-2020	Jones, Robin L/0000-0003-4173-3844	Eli Lilly and Company; NATIONAL CANCER INSTITUTE [P50CA140146, P30CA008748] Funding Source: NIH RePORTER	Eli Lilly and Company(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Eli Lilly and Company.	Bramwell V H, 2000, Sarcoma, V4, P103, DOI 10.1080/13577140020008066; Bui-Nguyen B, 2012, ANN ONCOL, V23, P777, DOI 10.1093/annonc/mdr282; Chawla SP, 2015, JAMA ONCOL, V9, P1; Chen CY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131250; D'Angelo S. P., 2014, Sarcoma, V2014, P391967, DOI 10.1155/2014/391967; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fayette J, 2009, INVEST NEW DRUG, V27, P482, DOI 10.1007/s10637-008-9217-1; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Le Cesne A, 2000, J CLIN ONCOL, V18, P2676, DOI 10.1200/JCO.2000.18.14.2676; Loizos N, 2005, MOL CANCER THER, V4, P369; Lorigan P, 2007, J CLIN ONCOL, V25, P3144, DOI 10.1200/JCO.2006.09.7717; Movva S, 2015, ONCOTARGET, V6, P12234, DOI 10.18632/oncotarget.3498; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; O'Sullivan Brian, 2003, Surg Oncol Clin N Am, V12, P333, DOI 10.1016/S1055-3207(03)00011-5; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Riedel RF, 2012, CANCER-AM CANCER SOC, V118, P1474, DOI 10.1002/cncr.26415; Ryan CW, 2013, EUR J CANCER, V49, pS876; Sharma S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-385; Singer S, 2000, Lancet Oncol, V1, P75, DOI 10.1016/S1470-2045(00)00016-4; Tonra J, 2005, AACR NCI EORTC MOL T, pA67	22	401	421	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					488	497		10.1016/S0140-6736(16)30587-6	http://dx.doi.org/10.1016/S0140-6736(16)30587-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27291997	Green Accepted			2022-12-28	WOS:000380559400028
J	Dzau, VJ; Sands, P				Dzau, Victor J.; Sands, Peter			Beyond the Ebola Battle - Winning the War against Future Epidemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA; [Sands, Peter] Harvard Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA USA	National Academies of Sciences, Engineering & Medicine; Harvard University	Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.							Fan Victoria, 2016, 22137 NBER; Medecins Sans Frontieres, 2015, PUSH LIM YEAR LARG E; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236; World Health Organisation, 2015, FACT CONTR UND SPREA	5	18	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					203	204		10.1056/NEJMp1605847	http://dx.doi.org/10.1056/NEJMp1605847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27276419	Bronze			2022-12-28	WOS:000380325400002
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			Preventing Mitochondrial DNA Diseases One Step Forward, Two Steps Back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MUTATIONS		[Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Brennan Z., 2016, EXPERT COMMITTEE FDA; FDA U.S. Food and Drug Administration, 2014, CELL TISS GEN THER A; Kmietowicz Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1103; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051	6	10	10	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2016	316	3					273	274		10.1001/jama.2016.4930	http://dx.doi.org/10.1001/jama.2016.4930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR3LN	27280528				2022-12-28	WOS:000379804800012
J	Ding, JJ; Wang, K; Liu, W; She, Y; Sun, Q; Shi, JJ; Sun, HZ; Wang, DC; Shao, F				Ding, Jingjin; Wang, Kun; Liu, Wang; She, Yang; Sun, Qi; Shi, Jianjin; Sun, Hanzi; Wang, Da-Cheng; Shao, Feng			Pore-forming activity and structural autoinhibition of the gasdermin family	NATURE			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; CELL-DEATH; CASPASES; MUTATION; PROTEIN; GENE; LPS; CONSERVATION; MECHANISMS; RECEPTORS	Inflammatory caspases cleave the gasdermin D (GSDMD) protein to trigger pyroptosis, a lytic form of cell death that is crucial for immune defences and diseases. GSDMD contains a functionally important gasdermin-N domain that is shared in the gasdermin family. The functional mechanism of action of gasdermin proteins is unknown. Here we show that the gasdermin-N domains of the gasdermin proteins GSDMD, GSDMA3 and GSDMA can bind membrane lipids, phosphoinositides and cardiolipin, and exhibit membrane-disrupting cytotoxicity in mammalian cells and artificially transformed bacteria. Gasdermin-N moved to the plasma membrane during pyroptosis. Purified gasdermin-N efficiently lysed phosphoinositide/cardiolipin-containing liposomes and formed pores on membranes made of artificial or natural phospholipid mixtures. Most gasdermin pores had an inner diameter of 10-14 nm and contained 16 symmetric protomers. The crystal structure of GSDMA3 showed an autoinhibited two-domain architecture that is conserved in the gasdermin family. Structure-guided mutagenesis demonstrated that the liposome-leakage and pore-forming activities of the gasdermin-N domain are required for pyroptosis. These findings reveal the mechanism for pyroptosis and provide insights into the roles of the gasdermin family in necrosis, immunity and diseases.	[Ding, Jingjin; She, Yang; Wang, Da-Cheng; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ding, Jingjin; Wang, Kun; Liu, Wang; She, Yang; Sun, Qi; Shi, Jianjin; Sun, Hanzi; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wang, Da-Cheng] Foshan Univ, Foshan 528000, Guangdong, Peoples R China; [Shao, Feng] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Foshan University; National Institute of Biological Sciences, Beijing	Wang, DC; Shao, F (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.; Wang, DC (corresponding author), Foshan Univ, Foshan 528000, Guangdong, Peoples R China.; Shao, F (corresponding author), Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China.	dcwang@sun5.ibp.ac.cn; shaofeng@nibs.ac.cn		Ding, Jingjin/0000-0001-9941-7997; Shi, Jianjin/0000-0001-8048-5180	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]; Program for International Collaborations [31461143006]; National Basic Research Program of China 973 Program [2012CB518700, 2014CB849602]; International Early Career Scientist grant from Howard Hughes Medical Institute; Beijing Scholar Program	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)); Program for International Collaborations; National Basic Research Program of China 973 Program(National Basic Research Program of China); International Early Career Scientist grant from Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beijing Scholar Program	We thank W. Wei for reagents, H. Wang for suggestions on electron microscopy data analysis, and the staff of beamlines BL18U1 and BL19U1 at National Center for Protein Sciences, Shanghai, and Shanghai Synchrotron Radiation Facility for X-ray data collection. This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202), the China National Science Foundation Program for Distinguished Young Scholars (31225002) and Program for International Collaborations (31461143006), and the National Basic Research Program of China 973 Program (2012CB518700 and 2014CB849602) to F.S. The research was also supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and the Beijing Scholar Program to F.S.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Delmaghani S, 2015, CELL, V163, P894, DOI 10.1016/j.cell.2015.10.023; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porter RM, 2002, J INVEST DERMATOL, V119, P32, DOI 10.1046/j.1523-1747.2002.01806.x; Reboul CF, 2016, BBA-BIOMEMBRANES, V1858, P475, DOI 10.1016/j.bbamem.2015.11.017; Runkel F, 2004, GENOMICS, V84, P824, DOI 10.1016/j.ygeno.2004.07.003; Saeki N., 2011, ENDOTHELIUM EPITHELI, P193; Sato H, 1998, MAMM GENOME, V9, P20, DOI 10.1007/s003359900673; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tanaka S, 2013, G3-GENES GENOM GENET, V3, P1843, DOI 10.1534/g3.113.007393; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Van Laer L, 1998, NAT GENET, V20, P194; Van Rossom S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00231; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WILSCHUT J, 1979, NATURE, V281, P690, DOI 10.1038/281690a0; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	42	1153	1229	42	507	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2016	535	7610					111	+		10.1038/nature18590	http://dx.doi.org/10.1038/nature18590			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ2EU	27281216				2022-12-28	WOS:000379015600034
J	Bagley, N				Bagley, Nicholas			A Legal Setback for the Affordable Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Buettgens M, 2016, IMPLICATIONS FINDING	1	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2307	2309		10.1056/NEJMp1606670	http://dx.doi.org/10.1056/NEJMp1606670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27248445				2022-12-28	WOS:000377854600003
J	de Vries, J; Figdor, C				de Vries, Jolanda; Figdor, Carl			IMMUNOTHERAPY Cancer vaccine triggers antiviral-type defences	NATURE			English	Editorial Material							HUMAN DENDRITIC CELLS; IN-VIVO; ANTIGEN; RESPONSES; DEC-205		[de Vries, Jolanda; Figdor, Carl] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen	de Vries, J (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands.	jolanda.devries@radboudumc.nl; carl.figdor@radboudumc.nl	de Vries, I. Jolanda M./F-5563-2010	de Vries, I. Jolanda M./0000-0002-8653-4040				Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Tel J, 2013, CANCER RES, V73, P1063, DOI 10.1158/0008-5472.CAN-12-2583	10	18	18	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					329	331						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281206				2022-12-28	WOS:000377856800022
J	Khera, R; Murad, MH; Chandar, AK; Dulai, PS; Wang, Z; Prokop, LJ; Loomba, R; Camilleri, M; Singh, S				Khera, Rohan; Murad, Mohammad Hassan; Chandar, Apoorva K.; Dulai, Parambir S.; Wang, Zhen; Prokop, Larry J.; Loomba, Rohit; Camilleri, Michael; Singh, Siddharth			Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARDIOVASCULAR-DISEASE RISK; PLACEBO-CONTROLLED TRIAL; BODY-WEIGHT; RANDOMIZED-TRIAL; CONTROLLED-RELEASE; DOUBLE-BLIND; TASK-FORCE; ORLISTAT; OVERWEIGHT; ADULTS	IMPORTANCE Five medications have been approved for the management of obesity, but data on comparative effectiveness are limited. OBJECTIVE To compare weight loss and adverse events among drug treatments for obesity using a systematic review and network meta-analysis. DATA SOURCES MEDLINE, EMBASE, Web of Science, Scopus, and Cochrane Central from inception to March 23, 2016; clinical trial registries. STUDY SELECTION Randomized clinical trials conducted among overweight and obese adults treated with US Food and Drug Administration-approved long-term weight loss agents (orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, or liraglutide) for at least 1 year compared with another active agent or placebo. DATA EXTRACTION AND SYNTHESIS Two investigators identified studies and independently abstracted data using a predefined protocol. A Bayesian network meta-analysis was performed and relative ranking of agents was assessed using surface under the cumulative ranking (SUCRA) probabilities. Quality of evidence was assessed using GRADE criteria. MAIN OUTCOMES AND MEASURES Proportions of patients with at least 5% weight loss and at least 10% weight loss, magnitude of decrease in weight, and discontinuation of therapy because of adverse events at 1 year. RESULTS Twenty-eight randomized clinical trials with 29018 patients (median age, 46 years; 74% women; median baseline body weight, 100.5 kg; median baseline body mass index, 36.1) were included. A median 23% of placebo participants had at least 5% weight loss vs 75% of participants taking phentermine-topiramate (odds ratio [OR], 9.22; 95% credible interval [CrI], 6.63-12.85; SUCRA, 0.95), 63% of participants taking liraglutide (OR, 5.54; 95% CrI, 4.16-7.78; SUCRA, 0.83), 55% taking naltrexone-bupropion (OR, 3.96; 95% CrI, 3.03-5.11; SUCRA, 0.60), 49% taking lorcaserin (OR, 3.10; 95% CrI, 2.38-4.05; SUCRA, 0.39), and 44% taking orlistat (OR, 2.70; 95% CrI, 2.34-3.09; SUCRA, 0.22). All active agents were associated with significant excess weight loss compared with placebo at 1 year-phentermine-topiramate, 8.8 kg (95% CrI, -10.20 to -7.42 kg); liraglutide, 5.3 kg (95% CrI, -6.06 to -4.52 kg); naltrexone-bupropion, 5.0 kg (95% CrI, -5.94 to -3.96 kg); lorcaserin, 3.2 kg (95% CrI, -3.97 to -2.46 kg); and orlistat, 2.6 kg (95% CrI, -3.04 to -2.16 kg). Compared with placebo, liraglutide (OR, 2.95; 95% CrI, 2.11-4.23) and naltrexone-bupropion (OR, 2.64; 95% CrI, 2.10-3.35) were associated with the highest odds of adverse event-related treatment discontinuation. High attrition rates (30%-45% in all trials) were associated with lower confidence in estimates. CONCLUSIONS AND RELEVANCE Among overweight or obese adults, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide, compared with placebo, were each associated with achieving at least 5% weight loss at 52 weeks. Phentermine-topiramate and liraglutide were associated with the highest odds of achieving at least 5% weight loss.	[Dulai, Parambir S.; Loomba, Rohit; Singh, Siddharth] Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Khera, Rohan] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Murad, Mohammad Hassan; Wang, Zhen] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Murad, Mohammad Hassan] Mayo Clin, Div Prevent Med, Rochester, MN USA; [Chandar, Apoorva K.] Case Western Reserve Univ, Div Gastroenterol & Liver Dis, Cleveland, OH 44106 USA; [Prokop, Larry J.] Mayo Clin, Dept Lib Serv, Rochester, MN USA; [Camilleri, Michael] Mayo Clin, Clin Enter Neurosci Translat & Epidemiol Res CENT, Rochester, MN USA; [Singh, Siddharth] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Iowa; Mayo Clinic; Mayo Clinic; Case Western Reserve University; Mayo Clinic; Mayo Clinic; University of California System; University of California San Diego	Singh, S (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sis040@ucsd.edu	Dulai, Parambir/AAE-2983-2021; Murad, M. Hassan/AAW-4367-2020; Khera, Rohan/AAQ-6838-2021; Khera, Rohan/P-2378-2019; Dulai, Parambir/AAF-4408-2020	Khera, Rohan/0000-0001-9467-6199; Murad, Mohammad Hassan/0000-0001-5502-5975	National Library of Medicine [T15LM011271]; National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007202]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202, R56DK067071] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM011271] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr Singh is supported by National Library of Medicine training grant T15LM011271. Dr Dulai is supported by National Institute of Diabetes and Digestive and Kidney Diseases training grant 5T32DK007202.	Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Bakris G, 2002, J HYPERTENS, V20, P2257, DOI 10.1097/00004872-200211000-00026; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Berne C, 2005, DIABETIC MED, V22, P612, DOI 10.1111/j.1464-5491.2004.01474.x; Broom I, 2002, INT J CLIN PRACT, V56, P494; Camilleri M, 2016, GASTROINTEST ENDOSC, V83, P48, DOI 10.1016/j.gie.2015.08.007; Center for Drug Evaluation and Research, 2007, GUID IND DEV PROD WE; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Daubresse M, 2015, INT J OBESITY, V39, P377, DOI 10.1038/ijo.2014.169; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Finer N, 2000, INT J OBESITY, V24, P306, DOI 10.1038/sj.ijo.0801128; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Hanefeld M, 2002, DIABETES OBES METAB, V4, P415, DOI 10.1046/j.1463-1326.2002.00237.x; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kelley DE, 2002, DIABETES CARE, V25, P1033, DOI 10.2337/diacare.25.6.1033; Khera R, 2015, COMP EFFECTIVENESS W; Krempf M, 2003, INT J OBESITY, V27, P591, DOI 10.1038/sj.ijo.0802281; Lindgarde F, 2000, J INTERN MED, V248, P245, DOI 10.1046/j.1365-2796.2000.00720.x; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Miles JM, 2002, DIABETES CARE, V25, P1123, DOI 10.2337/diacare.25.7.1123; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rossner S, 2000, OBES RES, V8, P49, DOI 10.1038/oby.2000.8; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Swinburn BA, 2005, DIABETES OBES METAB, V7, P254, DOI 10.1111/j.1463-1326.2004.00467.x; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; US Food and Drug Administration, 2014, FDA APPR DRUG PROD C; US Food and Drug Administration, 2015, FDA APPR DRUG PROD S; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	55	373	385	6	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2424	2434		10.1001/jama.2016.7602	http://dx.doi.org/10.1001/jama.2016.7602			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299618	Green Accepted, Bronze			2022-12-28	WOS:000377656900020
J	Bohnet, JG; Sawyer, BC; Britton, JW; Wall, ML; Rey, AM; Foss-Feig, M; Bollinger, JJ				Bohnet, Justin G.; Sawyer, Brian C.; Britton, Joseph W.; Wall, Michael L.; Rey, Ana Maria; Foss-Feig, Michael; Bollinger, John J.			Quantum spin dynamics and entanglement generation with hundreds of trapped ions	SCIENCE			English	Article							RANGE INTERACTIONS; OPTICAL LATTICE; STATES; ATOMS; PROPAGATION; SIMULATION; NOISE	Quantum simulation of spin models can provide insight into problems that are difficult or impossible to study with classical computers. Trapped ions are an established platform for quantum simulation, but only systems with fewer than 20 ions have demonstrated quantum correlations. We studied quantum spin dynamics arising from an engineered, homogeneous Ising interaction in a two-dimensional array of Be-9(+) ions in a Penning trap. We verified entanglement in spin-squeezed states of up to 219 ions, directly observing 4.0 +/- 0.9 decibels of spectroscopic enhancement, and observed states with non-Gaussian statistics consistent with oversqueezed states. The good agreement with ab initio theory that includes interactions and decoherence lays the groundwork for simulations of the transverse-field Ising model with variable-range interactions, which are generally intractable with classical methods.	[Bohnet, Justin G.; Sawyer, Brian C.; Britton, Joseph W.; Bollinger, John J.] NIST, Boulder, CO 80305 USA; [Sawyer, Brian C.] Georgia Tech Res Inst, Atlanta, GA 30332 USA; [Britton, Joseph W.; Foss-Feig, Michael] Army Res Lab, Adelphi, MD 20783 USA; [Wall, Michael L.; Rey, Ana Maria] Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Wall, Michael L.] Univ Colorado, Boulder, CO 80309 USA; [Rey, Ana Maria] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Foss-Feig, Michael] Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Foss-Feig, Michael] NIST, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University System of Georgia; Georgia Institute of Technology; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Bohnet, JG; Bollinger, JJ (corresponding author), NIST, Boulder, CO 80305 USA.	justin.bohnet@nist.gov; jjb@nist.gov		Wall, Michael/0000-0002-6223-0800	NSF [PHY 1521080]; JILA-NSF [PFC-1125844]; Army Research Office; Air Force Office of Scientific Research; Multidisciplinary University Research Initiative; National Research Council Research Associateship Award at NIST; NIST; Direct For Mathematical & Physical Scien [1521080] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); JILA-NSF(National Science Foundation (NSF)); Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Multidisciplinary University Research Initiative(MURI); National Research Council Research Associateship Award at NIST; NIST(National Institute of Standards & Technology (NIST) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Hume, J. Thompson, A. Keith, J. Schachenmayer, A. Safavi-Naini, M. Gaerttner, and M. Kastner for helpful discussions. Supported by NSF grant PHY 1521080, JILA-NSF grant PFC-1125844, the Army Research Office, and the Air Force Office of Scientific Research and its Multidisciplinary University Research Initiative (A.M.R.) and by a National Research Council Research Associateship Award at NIST (J.G.B., M.F.-F., and M.L.W.). All authors acknowledge financial support from NIST. This manuscript is the contribution of NIST and is not subject to U.S. copyright.	Arnold K, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.032108; Baltrusch JD, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.042319; Behbood N, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.093601; Belitz D, 2005, REV MOD PHYS, V77, P579, DOI 10.1103/RevModPhys.77.579; Biercuk MJ, 2009, QUANTUM INF COMPUT, V9, P920; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Brown RC, 2015, SCIENCE, V348, P540, DOI 10.1126/science.aaa1385; Cox KC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.093602; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; ELLIOTT RJ, 1970, PHYS REV LETT, V25, P443, DOI 10.1103/PhysRevLett.25.443; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Foss-Feig M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042101; Fukuhara T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035302; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; Hauke P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/8/082401; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lucas A, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00005; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Ockeloen CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.143001; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Sachdev S., 2007, QUANTUM PHASE TRANSI, DOI 10.1002/9780470022184; Sawyer BC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213003; Schmied R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.233002; Shalm LK, 2009, NATURE, V457, P67, DOI 10.1038/nature07624; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Wang CCJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013422; Wasilewski W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133601; Worm M, 2013, NEW J PHYS, V15; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	47	297	300	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1297	1301		10.1126/science.aad9958	http://dx.doi.org/10.1126/science.aad9958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284189	Green Submitted			2022-12-28	WOS:000377972000035
J	Feng, Y; Zhang, Y; Ebright, RH				Feng, Yu; Zhang, Yu; Ebright, Richard H.			Structural basis of transcription activation	SCIENCE			English	Article							RNA-POLYMERASE; REGION 4; DEPENDENT PROMOTERS; CRYSTAL-STRUCTURE; DNA-BINDING; PROTEIN; MECHANISM; CONTACT; CAP	Class II transcription activators function by binding to a DNA site overlapping a core promoter and stimulating isomerization of an initial RNA polymerase (RNAP)promoter closed complex into a catalytically competent RNAP-promoter open complex. Here, we report a 4.4 angstrom crystal structure of an intact bacterial class II transcription activation complex. The structure comprises Thermus thermophilus transcription activator protein TTHB099 (TAP) [homolog of Escherichia coil catabolite activator protein (CAP)], T. thermophilus RNAP (TA holoenzyme, a class II TAP-dependent promoter, and a ribotetranucleotide primer. The structure reveals the interactions between RNAP holoenzyme and DNA responsible for transcription initiation and reveals the interactions between TAP and RNAP holoenzyme responsible for transcription activation. The structure indicates that TAP stimulates isomerization through simple, adhesive, stabilizing protein -protein interactions with RNAP holoenzyme.	[Ebright, Richard H.] Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	Zhang, Yu/AAV-5722-2021; Ebright, Richard/O-3321-2019	Zhang, Yu/0000-0002-1778-8389; Ebright, Richard/0000-0001-8915-7140; Feng, Yu/0000-0003-4239-8320	NIH [GM041376]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Synchrotron Light Source for beamline access and E. Arnold for discussion. This work was funded by NIH grant GM041376 to R.H.E. The Protein Data Bank accession code is 5I2D.	Agari Y, 2012, PROTEINS, V80, P1490, DOI 10.1002/prot.24049; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chan CL, 1996, STRUCTURE, V4, P1235, DOI 10.1016/S0969-2126(96)00131-1; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Patrick M, 2015, BIOCHIMIE, V119, P80, DOI 10.1016/j.biochi.2015.10.015; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Rhodius VA, 1997, NUCLEIC ACIDS RES, V25, P326, DOI 10.1093/nar/25.2.326; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Zafar MA, 2010, J MOL BIOL, V401, P13, DOI 10.1016/j.jmb.2010.05.052; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	19	58	59	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1330	1333		10.1126/science.aaf4417	http://dx.doi.org/10.1126/science.aaf4417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284196	Green Accepted			2022-12-28	WOS:000377972000044
J	Koshkelashvili, N; Lai, JYK				Koshkelashvili, Nikoloz; Lai, Julie Y. K.			Hyperkalemia after Missed Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koshkelashvili, Nikoloz; Lai, Julie Y. K.] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA	Yeshiva University	Koshkelashvili, N (corresponding author), Albert Einstein Med Ctr, Philadelphia, PA 19141 USA.	nika.koshkelashvili@gmail.com							0	6	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2268	2268		10.1056/NEJMicm1512236	http://dx.doi.org/10.1056/NEJMicm1512236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276564				2022-12-28	WOS:000377920500010
J	Montesi, SB; Nance, JW; Harris, RS; Mark, EJ				Montesi, Sydney B.; Nance, John W.; Harris, R. Scott; Mark, Eugene J.			Case 17-2016: A 60-Year-Old Woman with Increasing Dyspnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTERED INTERSTITIAL FIBROSIS; SURGICAL LUNG BIOPSIES; BRONCHIOLITIS OBLITERANS; FOLLICULAR BRONCHIOLITIS; RHEUMATOID-ARTHRITIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; CONSTRICTIVE BRONCHIOLITIS; DISEASE; INVOLVEMENT; AIRWAYS		[Montesi, Sydney B.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Nance, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Montesi, Sydney B.; Harris, R. Scott] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Nance, John W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Montesi, SB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Montesi, SB (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.							Aerni MR, 2008, RESP MED, V102, P307, DOI 10.1016/j.rmed.2007.07.032; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664; Sorroche PB, 2015, ARCH BRONCONEUMOL, V51, P539, DOI 10.1016/j.arbres.2015.01.008; Churg A, 2004, AM J SURG PATHOL, V28, P62, DOI 10.1097/00000478-200401000-00006; Cohen M, 1999, CHEST, V116, P1063, DOI 10.1378/chest.116.4.1063; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Epler Gary R, 2007, Expert Rev Respir Med, V1, P139, DOI 10.1586/17476348.1.1.139; Epler GR, 2010, F1000 MED REP, V2; GARG K, 1994, AM J ROENTGENOL, V162, P803, DOI 10.2214/ajr.162.4.8140994; Ghanei M, 2008, RESP MED, V102, P825, DOI 10.1016/j.rmed.2008.01.016; HOMMA H, 1983, CHEST, V83, P63, DOI 10.1378/chest.83.1.63; Howling SJ, 1999, RADIOLOGY, V212, P637, DOI 10.1148/radiology.212.3.r99se04637; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Kuranishi LT, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0213-7; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; LOWRY T, 1956, JAMA-J AM MED ASSOC, V162, P153, DOI 10.1001/jama.1956.02970200001001; MURPHY KC, 1981, ARTHRITIS RHEUM, V24, P557, DOI 10.1002/art.1780240318; Murphy RLH, 1996, NEW ENGL J MED, V334, P521, DOI 10.1056/NEJM199602223340808; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; ODUFFY JD, 1986, ARTHRITIS RHEUM, V29, P556, DOI 10.1002/art.1780290415; Papiris SA, 1999, ANN RHEUM DIS, V58, P61, DOI 10.1136/ard.58.1.61; Perez T, 1998, AM J RESP CRIT CARE, V157, P1658, DOI 10.1164/ajrccm.157.5.9710018; Rahaghi FF, 2012, COPD, V9, P352, DOI 10.3109/15412555.2012.669433; Shipe R, 2013, AM J RESP CRIT CARE, V188, P510, DOI 10.1164/rccm.201206-1096IM; Sugino K, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-134; Sugino K, 2011, PATHOL INT, V61, P192, DOI 10.1111/j.1440-1827.2010.02637.x; ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026; Vandenplas O, 1998, AM J RESP CRIT CARE, V158, P1676, DOI 10.1164/ajrccm.158.5.9801070; Wenzel S E, 2005, Exp Lung Res, V31 Suppl 1, P22; Williams KM, 2009, JAMA-J AM MED ASSOC, V302, P306, DOI 10.1001/jama.2009.1018	32	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2269	2279		10.1056/NEJMcpc1516452	http://dx.doi.org/10.1056/NEJMcpc1516452			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276565				2022-12-28	WOS:000377920500011
J	Elbers, RG; Berendse, HW; Kwakkel, G				Elbers, Roy G.; Berendse, Henk W.; Kwakkel, Gert			Treatment of Fatigue in Parkinson Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONMOTOR SYMPTOMS; DOUBLE-BLIND; RASAGILINE; MODAFINIL; ADAGIO; SCORES		[Elbers, Roy G.] Univ Appl Sci, Dept Physiotherapy, Leiden, Netherlands; [Elbers, Roy G.; Kwakkel, Gert] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands; [Berendse, Henk W.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kwakkel, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, NL-1007 MB Amsterdam, Netherlands.	g.kwakkel@vumc.nl	Elbers, Roy G./B-4790-2013	Berendse, Henk/0000-0002-9189-3662; Kwakkel, Gert/0000-0002-4041-4043				Elbers RG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010925.pub2; Elbers RG, 2014, CLIN REHABIL, V28, P300, DOI 10.1177/0269215513503355; Franssen M, 2014, MOVEMENT DISORD, V29, P1675, DOI 10.1002/mds.26030; Lou JS, 2009, CLIN NEUROPHARMACOL, V32, P305, DOI 10.1097/WNF.0b013e3181aa916a; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Pahwa R, 2015, MOVEMENT DISORD, V30, P788, DOI 10.1002/mds.26159; Rascol O, 2011, LANCET NEUROL, V10, P415, DOI 10.1016/S1474-4422(11)70073-4; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Smith KM, 2015, JAMA NEUROL, V72, P88, DOI 10.1001/jamaneurol.2014.2472; Tyne HL, 2010, J NEUROL, V257, P452, DOI 10.1007/s00415-009-5351-8	10	17	17	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2340	2341		10.1001/jama.2016.5260	http://dx.doi.org/10.1001/jama.2016.5260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272586				2022-12-28	WOS:000377183100024
J	Gulland, A				Gulland, Anne			Sixty seconds on ... Government research	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, MISS EV INQ DEL PUBL; Brennan A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5452; Kmietowicz Z, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5469	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2016	353								i3159	10.1136/bmj.i3159	http://dx.doi.org/10.1136/bmj.i3159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YH	27267925				2022-12-28	WOS:000377858600008
J	Mohamed, M; Mahmud, A				Mohamed, Muhajir; Mahmud, Arsalan			A pregnant woman with anaemia and thrombocytopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELEVATED LIVER-ENZYMES; HELLP-SYNDROME; DIAGNOSIS; MORBIDITY; HEMOLYSIS		[Mohamed, Muhajir; Mahmud, Arsalan] Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia; [Mohamed, Muhajir] Univ Tasmania, Launceston Clin Sch, Launceston, Tas 7250, Australia	University of Tasmania	Mohamed, M (corresponding author), Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia.; Mohamed, M (corresponding author), Univ Tasmania, Launceston Clin Sch, Launceston, Tas 7250, Australia.	muhajirbm@yahoo.com						American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Erez O, 2015, AM J OBSTET GYNECOL, V213, P452, DOI 10.1016/j.ajog.2015.03.054; George JN, 2015, HEMATOL-AM SOC HEMAT, P644, DOI 10.1182/asheducation-2015.1.644; Gernsheimer T, 2013, BLOOD, V121, P38, DOI 10.1182/blood-2012-08-448944; Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; MARTIN JN, 1991, AM J OBSTET GYNECOL, V164, P1500, DOI 10.1016/0002-9378(91)91429-Z; Peyvandi F, 2004, BRIT J HAEMATOL, V127, P433, DOI 10.1111/j.1365-2141.2004.05217.x; Provan D, 2003, J PEDIAT HEMATOL ONC, V25, pS34, DOI 10.1097/00043426-200312001-00008; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Vesely SK, 2004, TRANSFUSION, V44, P1149, DOI 10.1111/j.1537-2995.2004.03422.x; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i3035	10.1136/bmj.i3035	http://dx.doi.org/10.1136/bmj.i3035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260492				2022-12-28	WOS:000377480200005
J	Munoz-Darias, T; Casares, J; Sanchez, DM; Fender, RP; Padilla, MA; Linares, M; Ponti, G; Charles, PA; Mooley, KP; Rodriguez, J				Munoz-Darias, T.; Casares, J.; Mata Sanchez, D.; Fender, R. P.; Armas Padilla, M.; Linares, M.; Ponti, G.; Charles, P. A.; Mooley, K. P.; Rodriguez, J.			Regulation of black-hole accretion by a disk wind during a violent outburst of V404 Cygni	NATURE			English	Article							X-RAY; LIGHT CURVES; STELLAR; SPECTROSCOPY; MECHANISM; FEEDBACK	Accretion of matter onto black holes is universally associated with strong radiative feedback(1) and powerful outflows(2). In particular, black-hole transients(3) have outflows whose properties(4) are strongly coupled to those of the accretion flow. This includes X-ray winds of ionized material, expelled from the accretion disk encircling the black hole, and collimated radio jets(5,6). Very recently, a distinct optical variability pattern has been reported in the transient stellar-mass black hole V404 Cygni, and interpreted as disrupted mass flow into the inner regions of its large accretion disk(7). Here we report observations of a sustained outer accretion disk wind in V404 Cyg, which is unlike any seen hitherto. We find that the outflowing wind is neutral, has a large covering factor, expands at one per cent of the speed of light and triggers a nebular phase once accretion drops sharply and the ejecta become optically thin. The large expelled mass (> 10(-8) solar masses) indicates that the outburst was prematurely ended when a sizeable fraction of the outer disk was depleted by the wind, detaching the inner regions from the rest of the disk. The luminous, but brief, accretion phases shown by transients with large accretion disks(2) imply that this outflow is probably a fundamental ingredient in regulating mass accretion onto black holes.	[Munoz-Darias, T.; Casares, J.; Mata Sanchez, D.; Armas Padilla, M.; Linares, M.] Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, Santa Cruz De T, Spain; [Munoz-Darias, T.; Casares, J.; Mata Sanchez, D.; Armas Padilla, M.; Linares, M.] Univ La Laguna, Dept Astrofis, E-38206 San Cristobal la Laguna, Santa Cruz De T, Spain; [Casares, J.; Fender, R. P.; Charles, P. A.; Mooley, K. P.] Univ Oxford, Dept Phys, Astrophys, Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England; [Armas Padilla, M.] Kyoto Univ, Dept Astron, Kyoto 6068502, Japan; [Linares, M.] NTNU, Inst Fys, Trondheim, Norway; [Ponti, G.] Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85748 Garching, Germany; [Charles, P. A.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Rodriguez, J.] Univ Paris Diderot, CEA CNRS,CEA DRF IRFU SAp, UMR 7158, Lab Astrophys Instrumentat Modelisat AIM, F-91191 Gif Sur Yvette, France	Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Oxford; Kyoto University; Norwegian University of Science & Technology (NTNU); Max Planck Society; University of Southampton; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA	Munoz-Darias, T (corresponding author), Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, Santa Cruz De T, Spain.; Munoz-Darias, T (corresponding author), Univ La Laguna, Dept Astrofis, E-38206 San Cristobal la Laguna, Santa Cruz De T, Spain.	teo.munoz-darias@iac.es	Casares, Jorge/GVT-2693-2022; Linares, Manuel/ABG-6233-2020; Mata-Sanchez, Daniel/AAA-9259-2020; Muñoz-Darias, Teo/AAE-1950-2019; Casares, Jorge/N-4012-2014; Padilla, Montserrat Armas/N-5958-2014; Rodriguez, Jerome/GMX-5000-2022	Linares, Manuel/0000-0002-0237-1636; Mata-Sanchez, Daniel/0000-0003-0245-9424; Muñoz-Darias, Teo/0000-0002-3348-4035; Padilla, Montserrat Armas/0000-0002-4344-7334; Casares, Jorge/0000-0001-5031-0128; Ponti, Gabriele/0000-0003-0293-3608	Spanish Ministerio de Economia y competitividad [AYA2013-42627, PSR2015-00397]; Leverhulme Trust [VP2-2015-046]; International Research Fellowship program of the Japan Society for the Promotion of Science [PE15024]; Bundesministerium fur Wirtschaft und Technologie (BMWI/DLR) [FKZ 50 OR 1408]; French Research National Agency's CHAOS project [ANR-12-BS05-0009]; STFC [ST/N000919/1] Funding Source: UKRI	Spanish Ministerio de Economia y competitividad(Spanish Government); Leverhulme Trust(Leverhulme Trust); International Research Fellowship program of the Japan Society for the Promotion of Science; Bundesministerium fur Wirtschaft und Technologie (BMWI/DLR); French Research National Agency's CHAOS project; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Nine of the spectra of 27 June were taken during the visit of King Felipe VI of Spain to the 10.4-m Gran Telescopio Canarias (GTC); we appreciate the support this visit provides to astrophysical research in Spain. This work is based on observations made with the GTC telescope, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, during both Time Allocation Committee and Director's Discretionary observing time. We are thankful to the GTC team for the fast response and efficient work throughout the observing campaign. We acknowledge support by the Spanish Ministerio de Economia y competitividad under grants AYA2013-42627 and PSR2015-00397, the Leverhulme Trust Visiting Professorship Grant VP2-2015-046, the International Research Fellowship program of the Japan Society for the Promotion of Science (PE15024), the Bundesministerium fur Wirtschaft und Technologie (BMWI/DLR, FKZ 50 OR 1408) and the French Research National Agency's CHAOS project ANR-12-BS05-0009. The use of the MOLLY software developed by T. R. Marsh is gratefully acknowledged.	Barthelmy S. D., 2015, 17929 GRB COORD NETW, V17929; Beardmore A. P., 2015, ASTRON TELEGRAM, P8455; BEGELMAN MC, 1983, ASTROPHYS J, V271, P70, DOI 10.1086/161178; Belloni TM, 2011, B ASTRON SOC INDIA, V39, P409; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; CANNIZZO JK, 1988, ASTROPHYS J, V333, P227, DOI 10.1086/166739; CASA Consortium, 2011, CASA COMM ASTR SOFTW; Casares J, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/80; Casares J, 2014, SPACE SCI REV, V183, P223, DOI 10.1007/s11214-013-0030-6; CASARES J, 1991, MON NOT R ASTRON SOC, V250, P712, DOI 10.1093/mnras/250.4.712; CASARES J, 1992, NATURE, V355, P614, DOI 10.1038/355614a0; CASTOR JI, 1979, ASTROPHYS J SUPPL S, V39, P481, DOI 10.1086/190583; Chen W, 1997, ASTROPHYS J, V491, P312, DOI 10.1086/304921; Corral-Santana JM, 2016, ASTRON ASTROPHYS, V587, DOI 10.1051/0004-6361/201527130; Davies ML, 2009, MON NOT R ASTRON SOC, V400, P984, DOI 10.1111/j.1365-2966.2009.15518.x; DRAKE SA, 1980, ASTROPHYS J SUPPL S, V42, P351, DOI 10.1086/190654; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Fender R, 2016, LECT NOTES PHYS, V905, P65, DOI 10.1007/978-3-319-19416-5_3; Feruglio C, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201015164; Groot PJ, 2001, ASTRON ASTROPHYS, V368, P183, DOI 10.1051/0004-6361:20000483; Iijima T, 2003, ASTRON ASTROPHYS, V404, P997, DOI 10.1051/0004-6361:20030528; Kimura M, 2016, NATURE, V529, P54, DOI 10.1038/nature16452; King AR, 1998, MON NOT R ASTRON SOC, V293, pL42, DOI 10.1046/j.1365-8711.1998.01295.x; King AR, 1996, ASTROPHYS J, V464, pL127, DOI 10.1086/310105; King AL, 2015, ASTROPHYS J LETT, V813, DOI 10.1088/2041-8205/813/2/L37; KRAUTTER J, 1981, ASTRON ASTROPHYS, V102, P337; Kuulkers E., 2015, ATEL, P7758; Lebrun F, 2003, ASTRON ASTROPHYS, V411, pL141, DOI 10.1051/0004-6361:20031367; Lindstrom C, 2005, MON NOT R ASTRON SOC, V363, P882, DOI 10.1111/j.1365-2966.2005.09483.x; Marti J, 2016, ASTRON ASTROPHYS, V586, DOI 10.1051/0004-6361/201527239; MAUCHE CW, 1987, ASTROPHYS J, V323, P690, DOI 10.1086/165865; McMullin JP, 2007, ASTR SOC P, V376, P127; Miller-Jones JCA, 2009, ASTROPHYS J LETT, V706, pL230, DOI 10.1088/0004-637X/706/2/L230; Mooley K., 2015, ATEL, P7658; Munoz-Darias T., 2015, ASTRON TELEGR, P7659; Neilsen J, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/69; Neilsen J, 2009, NATURE, V458, P481, DOI 10.1038/nature07680; Padilla MA, 2014, MON NOT R ASTRON SOC, V444, P902, DOI 10.1093/mnras/stu1487; Ponti G, 2012, MON NOT R ASTRON SOC, V422, pL11, DOI 10.1111/j.1745-3933.2012.01224.x; Proga D, 2002, ASTROPHYS J, V565, P455, DOI 10.1086/324534; Rodriguez J, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201527043; Rodriguez J, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/17; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Smith N, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/82; Smith N, 2014, MON NOT R ASTRON SOC, V438, P1191, DOI 10.1093/mnras/stt2269; Staley TD, 2015, ASTRON COMPUT, V13, P38, DOI 10.1016/j.ascom.2015.08.003; THACKERAY AD, 1977, MON NOT R ASTRON SOC, V180, P95, DOI 10.1093/mnras/180.2.95; Walton D., 2015, ATEL, P7752; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Zycki PT, 1999, MON NOT R ASTRON SOC, V309, P561, DOI 10.1046/j.1365-8711.1999.02885.x; [No title captured]	52	76	76	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					75	+		10.1038/nature17446	http://dx.doi.org/10.1038/nature17446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251277	Green Submitted			2022-12-28	WOS:000376962300035
J	Vatanen, T; Kostic, AD; d'Hennezel, E; Siljander, H; Franzosa, EA; Yassour, M; Kolde, R; Vlamakis, H; Arthur, TD; Hamalainen, AM; Peet, A; Tillmann, V; Uibo, R; Mokurov, S; Dorshakova, N; Ilonen, J; Virtanen, SM; Szabo, SJ; Porter, JA; Lahdesmaki, H; Huttenhower, C; Gevers, D; Cullen, TW; Knip, M; Xavier, RJ				Vatanen, Tommi; Kostic, Aleksandar D.; d'Hennezel, Eva; Siljander, Heli; Franzosa, Eric A.; Yassour, Moran; Kolde, Raivo; Vlamakis, Hera; Arthur, Timothy D.; Hamalainen, Anu-Maaria; Peet, Aleksandr; Tillmann, Vallo; Uibo, Raivo; Mokurov, Sergei; Dorshakova, Natalya; Ilonen, Jorma; Virtanen, Suvi M.; Szabo, Susanne J.; Porter, Jeffrey A.; Lahdesmaki, Harri; Huttenhower, Curtis; Gevers, Dirk; Cullen, Thomas W.; Knip, Mikael; Xavier, Ramnik J.		DIABIMMUNE Study Grp	Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans (vol 165, pg 842, 2016)	CELL			English	Correction												xavier@molbio.mgh.harvard.edu	Virtanen, Suvi/AAP-1922-2021; Kolde, Raivo/AAB-8149-2022; Yassour, Moran/ABE-7415-2020; Knip, Mikael/AAL-3773-2020; Tillmann, Vallo/G-8118-2012; Gevers, Dirk/C-1451-2009; Vatanen, Tommi/J-5458-2018	Kolde, Raivo/0000-0003-2886-6298; Yassour, Moran/0000-0002-7344-5188; Tillmann, Vallo/0000-0002-5279-4493; Vatanen, Tommi/0000-0003-0949-1291; Virtanen, Suvi/0000-0001-8928-0878; Knip, Mikael/0000-0003-0474-0033; Uibo, Raivo/0000-0002-2298-1300				Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007	1	126	134	12	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1551	1551		10.1016/j.cell.2016.05.056	http://dx.doi.org/10.1016/j.cell.2016.05.056			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259157	Bronze			2022-12-28	WOS:000377045400027
J	Howard, J; Chang, CC; Schill, AL; Chosewood, LC				Howard, John; Chang, Chia-Chia; Schill, Anita L.; Chosewood, L. Casey			NIOSH Response to the NIH Pathways to Prevention Workshop Recommendations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Howard, John; Chang, Chia-Chia; Schill, Anita L.] NIOSH, Patriots Plaza 1,395 E St Southwest,Suite 9200, Washington, DC 20201 USA; [Chosewood, L. Casey] NIOSH, 1600 Clifton Rd, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Howard, J (corresponding author), NIOSH, Patriots Plaza 1,395 E St Southwest,Suite 9200, Washington, DC 20201 USA.	jhoward1@cdc.gov						Bradley CJ, 2016, ANN INTERN MED, V165, P279, DOI 10.7326/M16-0740; Feltner C, 2016, ANN INTERN MED, V165, P262, DOI 10.7326/M16-0626; National Institute for Occupational Safety and Health, 2015, TOT WORK HLTH NIOSH; National Institute for Occupational Safety and Health, 2015, NIOSH TOT WORK HLTH; National Institute for Occupational Safety and Health, 2015, TOT WORK HLTH; National Institutes of Health, 2015, WORKSH PLANN; National Institutes of Health Office of Extramural Research, 2015, FUND OPP ANN NIOSH C; NIOSH, 2016, NIOSH PUBL	8	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					296	+		10.7326/M16-0904	http://dx.doi.org/10.7326/M16-0904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27240415				2022-12-28	WOS:000381267200024
J	van der Graaf, WT				van der Graaf, Winette Ta			Olaratumab in soft-tissue sarcomas	LANCET			English	Editorial Material							PAZOPANIB; PDGFR		[van der Graaf, Winette Ta] Inst Canc Res, Div Clin Studies, Sutton SM2 5NG, Surrey, England; [van der Graaf, Winette Ta] Royal Marsden NHS Fdn Trust, Sarcoma Unit, London, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	van der Graaf, WT (corresponding author), Inst Canc Res, Div Clin Studies, Sutton SM2 5NG, Surrey, England.; van der Graaf, WT (corresponding author), Royal Marsden NHS Fdn Trust, Sarcoma Unit, London, England.	winette.vandergraaf@icr.ac.uk						BENJAMIN R S, 1975, Medical and Pediatric Oncology, V1, P63, DOI 10.1002/mpo.2950010109; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Ehnman M, 2013, CANCER RES, V73, P2139, DOI 10.1158/0008-5472.CAN-12-1646; Fletcher CDM, 2013, TUMOURS SOFT TISSUE; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Hoven-Gondrie ML, 2016, ANN SURG ONCOL, V23, P2577, DOI 10.1245/s10434-016-5158-7; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Schoffski P, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.18_suppl.lba10502; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Tap WD, 2016, LANCET, V388, P488; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Yousaf N, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-015-0026-y	12	9	9	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					442	444		10.1016/S0140-6736(16)30788-7	http://dx.doi.org/10.1016/S0140-6736(16)30788-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27291995				2022-12-28	WOS:000380559400006
J	McKenna, A; Findlay, GM; Gagnon, JA; Horwitz, MS; Schier, AF; Shendure, J				McKenna, Aaron; Findlay, Gregory M.; Gagnon, James A.; Horwitz, Marshall S.; Schier, Alexander F.; Shendure, Jay			Whole-organism lineage tracing by combinatorial and cumulative genome editing	SCIENCE			English	Article							CELL LINEAGE; TISSUE HOMEOSTASIS; SYSTEMS BIOLOGY; NERVOUS-SYSTEM; STEM-CELLS; IN-VIVO; ZEBRAFISH; EXPRESSION; NUCLEASES; FATE	Multicellular systems develop from single cells through distinct lineages. However, current lineage-tracing approaches scale poorly to whole, complex organisms. Here, we use genome editing to progressively introduce and accumulate diverse mutations in a DNA barcode over multiple rounds of cell division. The barcode, an array of clustered regularly interspaced short palindromic repeats ( CRISPR)/Cas9 target sites, marks cells and enables the elucidation of lineage relationships via the patterns of mutations shared between cells. In cell culture and zebrafish, we show that rates and patterns of editing are tunable and that thousands of lineage-informative barcode alleles can be generated. By sampling hundreds of thousands of cells from individual zebrafish, we find that most cells in adult organs derive from relatively few embryonic progenitors. In future analyses, genome editing of synthetic target arrays for lineage tracing ( GESTALT) can be used to generate large-scale maps of cell lineage in multicellular systems for normal development and disease.	[McKenna, Aaron; Findlay, Gregory M.; Horwitz, Marshall S.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gagnon, James A.; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Horwitz, Marshall S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; University of Washington; University of Washington Seattle; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Howard Hughes Medical Institute	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Schier, AF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Schier, AF (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Schier, AF (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Schier, AF (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	schier@fas.harvard.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Findlay, Gregory/AAX-9029-2020; Horwitz, Marshall/AAE-8376-2021	Findlay, Gregory/0000-0002-7767-8608; Schier, Alexander Franz/0000-0001-7645-5325; Gagnon, James/0000-0003-3978-6058; Horwitz, Marshall/0000-0002-1683-1680	Paul G. Allen Family Foundation; NIH Director's Pioneer Award [DP1HG007811]; NIH/NIGMS [GM056211]; NIH/NICHD [HD085905]; NIH/NIMH [MH105960]; American Cancer Society; NIH/NHLBI [T32HL007312]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085905] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056211, T32GM007266, R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105960] Funding Source: NIH RePORTER	Paul G. Allen Family Foundation; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Cancer Society(American Cancer Society); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	For discussion and advice, we thank J. Felsenstein, M. Kuhner, M. Rossmann, E. Fast, C. Burns, R. Ben-Yair, S. Salipante; members of the Shendure laboratory, particularly M. Snyder; members of the Schier laboratory, particularly J. Farrell, B. Raj, M. Norris, and N. Lord; and members of the Horwitz laboratory, particularly D. Anderson. We thank G. Church for work on predecessors of this concept with J.S. in 2000. We thank M. Desai, R. Losick, A. Murray, and L. Zon for comments on the manuscript. We also thank the Bauer Core FACS Facility, the staff of the zebrafish facility, and L. Pieper for technical support. Data associated with this paper are archived at Dryad and can be downloaded from doi: 10.5061/dryad.478t9. This work was supported by grants from the Paul G. Allen Family Foundation (J.S. and M.S.H.), an NIH Director's Pioneer Award (J.S.; DP1HG007811), NIH/NIGMS (A.F.S.; GM056211), NIH/NICHD (A.F.S.; HD085905), and NIH/NIMH (A.F.S.; MH105960). J.A.G. was supported by a fellowship from the American Cancer Society. A.M. was supported by a fellowship from the NIH/NHLBI (T32HL007312). J.S. is an investigator of the Howard Hughes Medical Institute. J.S., A.M., G.M.F., J.A.G., and A.F.S. have filed a provisional patent application (62/332,896) that relates to genome editing of synthetic target arrays for lineage tracing.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/nmeth.1781, 10.1038/NMETH.1781]; Church GM, 2003, US Patent, Patent No. 20030228611; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KIMMEL CB, 1985, DEV BIOL, V108, P94, DOI 10.1016/0012-1606(85)90012-0; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; LEDOUARI.NM, 1974, DEV BIOL, V41, P162, DOI 10.1016/0012-1606(74)90291-7; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Liu Z, 2016, DEV CELL, V36, P597, DOI 10.1016/j.devcel.2016.02.016; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Miner BE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh132; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Porter SN, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r75; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stent GS, 1998, INT J DEV BIOL, V42, P237; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WEISBLAT DA, 1978, SCIENCE, V202, P1295, DOI 10.1126/science.725606; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	46	369	382	8	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298							aaf7907	10.1126/science.aaf7907	http://dx.doi.org/10.1126/science.aaf7907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27229144	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000380583600032
J	Key, HM; Dydio, P; Clark, DS; Hartwig, JF				Key, Hanna M.; Dydio, Pawel; Clark, Douglas S.; Hartwig, John F.			Abiological catalysis by artificial haem proteins containing noble metals in place of iron	NATURE			English	Article							ENANTIOSELECTIVE CATALYSIS; OLEFIN CYCLOPROPANATION; DIRECTED EVOLUTION; METALLOENZYMES; COMPLEXES; HYDROXYLATION; MYOGLOBIN; CYTOCHROME-P450; INSERTION	Enzymes that contain metal ions-that is, metalloenzymes-possess the reactivity of a transition metal centre and the potential of molecular evolution to modulate the reactivity and substrate-selectivity of the system(1). By exploiting substrate promiscuity and protein engineering, the scope of reactions catalysed by native metalloenzymes has been expanded recently to include abiological transformations(2,3). However, this strategy is limited by the inherent reactivity of metal centres in native metalloenzymes. To overcome this limitation, artificial metalloproteins have been created by incorporating complete, noble-metal complexes within proteins lacking native metal sites(1,4,5). The interactions of the substrate with the protein in these systems are, however, distinct from those with the native protein because the metal complex occupies the substrate binding site. At the intersection of these approaches lies a third strategy, in which the native metal of a metalloenzyme is replaced with an abiological metal with reactivity different from that of the metal in a native protein(6-8). This strategy could create artificial enzymes for abiological catalysis within the natural substrate binding site of an enzyme that can be subjected to directed evolution. Here we report the formal replacement of iron in Fe-porphyrin IX (Fe-PIX) proteins with abiological, noble metals to create enzymes that catalyse reactions not catalysed by native Fe-enzymes or other metalloenzymes(9,10). In particular, we prepared modified myoglobins containing an Ir(Me) site that catalyse the functionalization of C-H bonds to form C-C bonds by carbene insertion and add carbenes to both beta-substituted vinylarenes and unactivated aliphatic alpha-olefins. We conducted directed evolution of the Ir(Me)-myoglobin and generated mutants that form either enantiomer of the products of C-H insertion and catalyse the enantio-and diastereoselective cyclopropanation of unactivated olefins. The presented method of preparing artificial haem proteins containing abiological metal porphyrins sets the stage for the generation of artificial enzymes from innumerable combinations of PIX-protein scaffolds and unnatural metal cofactors to catalyse a wide range of abiological transformations.	[Key, Hanna M.; Dydio, Pawel; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Key, Hanna M.; Dydio, Pawel; Hartwig, John F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Clark, Douglas S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Hartwig, JF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu		Dydio, Pawel/0000-0001-5095-4943	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NSF; NWO Netherlands Organization for Scientific Research [680-50-1306]; NIH [1S10RR022393-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022393] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NWO Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Director, Office of Science, of the US Department of Energy under contract no. DE-AC02-05CH11231, by the NSF (graduate research fellowship to H.M.K.), and the NWO Netherlands Organization for Scientific Research (Rubicon postdoctoral fellowship no. 680-50-1306 to P.D.). We thank the QB3 MacroLab facility (sub-cloning), the UC Berkeley DNA Sequencing Facility (plasmid sequencing), T. Iavarone and the QB3 Mass Spectrometry Facility (supported by NIH grant 1S10RR022393-01) for native NS-ESI-MS data and analysis, and H. Zhao (University of Illinois-Champaign Urbana) for the P411-CIS gene.	Abe S, 2009, J AM CHEM SOC, V131, P6958, DOI 10.1021/ja901234j; Anding BJ, 2012, ORGANOMETALLICS, V31, P3628, DOI 10.1021/om300135f; Bordeaux M, 2015, ANGEW CHEM INT EDIT, V54, P1744, DOI 10.1002/anie.201409928; Bordeaux M, 2014, BIOORGAN MED CHEM, V22, P5697, DOI 10.1016/j.bmc.2014.05.015; Carey JR, 2004, J AM CHEM SOC, V126, P10812, DOI 10.1021/ja046908x; Chan KH, 2014, ANGEW CHEM INT EDIT, V53, P2982, DOI 10.1002/anie.201309888; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Farwell CC, 2015, ACS CENTRAL SCI, V1, P89, DOI 10.1021/acscentsci.5b00056; Hyster TK, 2015, ISR J CHEM, V55, P14, DOI 10.1002/ijch.201400080; Ilie A, 2015, ISR J CHEM, V55, P51, DOI 10.1002/ijch.201400087; Jing Q, 2010, CHEMCATCHEM, V2, P953, DOI 10.1002/cctc.201000159; Kawakami N, 2012, CHEMBIOCHEM, V13, P2045, DOI 10.1002/cbic.201200446; Key HM, 2015, J AM CHEM SOC, V137, P8261, DOI 10.1021/jacs.5b04431; Lelyveld VS, 2011, J AM CHEM SOC, V133, P649, DOI 10.1021/ja107936d; Lewis JC, 2013, ACS CATAL, V3, P2954, DOI 10.1021/cs400806a; MAXWELL JL, 1992, ORGANOMETALLICS, V11, P645, DOI 10.1021/om00038a023; Ohashi M, 2003, ANGEW CHEM INT EDIT, V42, P1005, DOI 10.1002/anie.200390256; Oohora K, 2013, J AM CHEM SOC, V135, P17282, DOI 10.1021/ja409404k; PAULSON DR, 1979, J BIOL CHEM, V254, P7002; Peters MW, 2003, J AM CHEM SOC, V125, P13442, DOI 10.1021/ja0303790; Ringenberg MR, 2011, CHEM COMMUN, V47, P8470, DOI 10.1039/c1cc11592h; Roiban GD, 2015, CHEM COMMUN, V51, P2208, DOI 10.1039/c4cc09218j; Suematsu H, 2008, J AM CHEM SOC, V130, P10327, DOI 10.1021/ja802561t; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tyagi V, 2015, CHEM SCI, V6, P2488, DOI 10.1039/c5sc00080g; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; Watson H.C., 1969, PROGR STEREOCHEM, V4, P229; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984	30	256	259	13	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					534	537		10.1038/nature17968	http://dx.doi.org/10.1038/nature17968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27296224	Green Published			2022-12-28	WOS:000378270300050
J	Ly, DP; Seabury, SA; Jena, AB				Ly, Dan P.; Seabury, Seth A.; Jena, Anupam B.			Differences in incomes of physicians in the United States by race and sex: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE PROFESSIONALS; GENDER-DIFFERENCES; EARNINGS; TRENDS	OBJECTIVES To estimate differences in annual income of physicians in the United States by race and sex adjusted for characteristics of physicians and practices. DESIGN Cross sectional survey study. SETTING Nationally representative samples of US physicians. PARTICIPANTS The 2000-13 American Community Survey (ACS) included 43 213 white male, 1698 black male, 15 164 white female, and 1252 black female physicians. The 2000-08 Center for Studying Health System Change (HSC) physician surveys included 12 843 white male, 518 black male, 3880 white female, and 342 black female physicians. MAIN OUTCOME MEASURES Annual income adjusted for age, hours worked, time period, and state of residence (from ACS data). Income was adjusted for age, specialty, hours worked, time period, years in practice, practice type, and percentage of revenue from Medicare/Medicaid (from HSC physician surveys). RESULTS White male physicians had a higher median annual income than black male physicians, whereas race was not consistently associated with median income among female physicians. For example, in 2010-13 in the ACS, white male physicians had an adjusted median annual income of $253 042 (95% confidence interval $248 670 to $257 413) compared with $188 230 ($170 844 to $205 616) for black male physicians (difference $64 812; P<0.001). White female physicians had an adjusted median annual income of $163 234 ($159 912 to 166 557) compared with $152 784 ($137 927 to $167 641) for black female physicians (difference $10 450; P=0.17). $100 000 is currently equivalent to about 69 pound 000 ((sic)89 000). Patterns were unaffected by adjustment for specialty and characteristics of practice in the HSC physician surveys. CONCLUSIONS White male physicians earn substantially more than black male physicians, after adjustment for characteristics of physicians and practices, while white and black female physicians earn similar incomes to each other, but significantly less than their male counterparts. Whether these differences reflect disparities in job opportunities is important to determine.	[Ly, Dan P.; Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Seabury, Seth A.] Univ So Calif, Dept Emergency Med, 635 Downey Way,VPD Suite 210, Los Angeles, CA 90089 USA; [Seabury, Seth A.] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, 635 Downey Way,VPD Suite 210, Los Angeles, CA 90089 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of Southern California; University of Southern California; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.; Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Jena, AB (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health (NIH) [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ABJ had support from the Office of the Director, National Institutes of Health (NIH Early Independence Award, Grant 1DP5OD017897-01) for the submitted work. The research conducted was independent of any involvement from the sponsors of the study. Study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	Ambati B, 2014, JAMA INTERN MED, V174, P822, DOI 10.1001/jamainternmed.2014.48; Association of American Medical Colleges, 2014, DIV PHYS WORKF FACTS; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; Black DA, 2010, FED RESERVE BANK ST, V92, P353; British Medical Association, 2009, PAY GAP WOM MED AC M; Canon M, 2013, CHANGES RACIAL EARNI; Center for Studying Health System Change, 2016, CTS PHYS SURV HSC 20; Center for Studying Health System Change, 2010, 2008 HLTH TRACK PHYS; IPUMS-USA, 2016, WAG SAL INC; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Lasser KE, 2008, J GEN INTERN MED, V23, P1477, DOI 10.1007/s11606-008-0660-7; Leigh JP, 2010, ARCH INTERN MED, V170, P1728, DOI 10.1001/archinternmed.2010.350; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; Muench U, 2015, JAMA-J AM MED ASSOC, V313, P1265, DOI 10.1001/jama.2015.1487; Neal D, 2004, J POLIT ECON, V112, pS1, DOI 10.1086/379940; Office of National Statistics, 2013, ANN SURV HOURS EARN; Seabury SA, 2013, JAMA INTERN MED, V173, P1748; Seabury SA, 2012, JAMA-J AM MED ASSOC, V308, P2083, DOI 10.1001/jama.2012.14552; Staiger DO, 2010, JAMA-J AM MED ASSOC, V303, P747, DOI 10.1001/jama.2010.168; U. S. Census Bureau, 2011, POV HLTH INS COV US; Weeks WB, 2006, J AM BOARD FAM MED, V19, P548, DOI 10.3122/jabfm.19.6.548; Weeks WB, 2006, J AM COLL SURGEONS, V203, P558, DOI 10.1016/j.jamcollsurg.2006.06.025; Weeks WB, 2006, J GEN INTERN MED, V21, P1167, DOI 10.1111/j.1525-1497.2006.00592.x; Weeks WB, 2009, HEALTH AFFAIR, V28, P557, DOI 10.1377/hlthaff.28.2.557	24	79	79	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2016	353								i2923	10.1136/bmj.i2923	http://dx.doi.org/10.1136/bmj.i2923			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5YH	27268490	Green Published, hybrid			2022-12-28	WOS:000377858600002
J	Rimmer, A				Rimmer, Abi			Five minutes with ... Scarlett McNally, RCS council member	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2016	353								i3197	10.1136/bmj.i3197	http://dx.doi.org/10.1136/bmj.i3197			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YH	27267966				2022-12-28	WOS:000377858600017
J	Sun, LS; Li, GH; Miller, TLK; Salorio, C; Byrne, MW; Bellinger, DC; Ing, C; Park, R; Radcliffe, J; Hays, SR; DiMaggio, CJ; Cooper, TJ; Rauh, V; Maxwell, LG; Youn, A; McGowan, FX				Sun, Lena S.; Li, Guohua; Miller, Tonya L. K.; Salorio, Cynthia; Byrne, Mary W.; Bellinger, David C.; Ing, Caleb; Park, Raymond; Radcliffe, Jerilynn; Hays, Stephen R.; DiMaggio, Charles J.; Cooper, Timothy J.; Rauh, Virginia; Maxwell, Lynne G.; Youn, Ahrim; McGowan, Francis X.			Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACADEMIC-PERFORMANCE; CHILDREN; BRAIN; SURGERY; INFANCY; RISK; NEURODEVELOPMENT; NEUROTOXICITY; EPIDEMIOLOGY; DISORDERS	IMPORTANCE Exposure of young animals to commonly used anesthetics causes neurotoxicity including impaired neurocognitive function and abnormal behavior. The potential neurocognitive and behavioral effects of anesthesia exposure in young children are thus important to understand. OBJECTIVE To examine if a single anesthesia exposure in otherwise healthy young children was associated with impaired neurocognitive development and abnormal behavior in later childhood. DESIGN, SETTING, AND PARTICIPANTS Sibling-matched cohort study conducted between May 2009 and April 2015 at 4 university-based US pediatric tertiary care hospitals. The study cohort included sibling pairs within 36 months in age and currently 8 to 15 years old. The exposed siblings were healthy at surgery/anesthesia. Neurocognitive and behavior outcomes were prospectively assessed with retrospectively documented anesthesia exposure data. EXPOSURES A single exposure to general anesthesia during inguinal hernia surgery in the exposed sibling and no anesthesia exposure in the unexposed sibling, before age 36 months. MAIN OUTCOMES AND MEASURES The primary outcome was global cognitive function (IQ). Secondary outcomes included domain-specific neurocognitive functions and behavior. A detailed neuropsychological battery assessed IQ and domain-specific neurocognitive functions. Parents completed validated, standardized reports of behavior. RESULTS Among the 105 sibling pairs, the exposed siblings (mean age, 17.3 months at surgery/anesthesia; 9.5% female) and the unexposed siblings (44% female) had IQ testing at mean ages of 10.6 and 10.9 years, respectively. All exposed children received inhaled anesthetic agents, and anesthesia duration ranged from 20 to 240 minutes, with a median duration of 80 minutes. Mean IQ scores between exposed siblings (scores: full scale = 111; performance = 108; verbal = 111) and unexposed siblings (scores: full scale = 111; performance = 107; verbal = 111) were not statistically significantly different. Differences in mean IQ scores between sibling pairs were: full scale = -0.2 (95% CI, -2.6 to 2.9); performance = 0.5 (95% CI, -2.7 to 3.7); and verbal = -0.5 (95% CI, -3.2 to 2.2). No statistically significant differences in mean scores were found between sibling pairs in memory/learning, motor/processing speed, visuospatial function, attention, executive function, language, or behavior. CONCLUSIONS AND RELEVANCE Among healthy children with a single anesthesia exposure before age 36 months, compared with healthy siblings with no anesthesia exposure, there were no statistically significant differences in IQ scores in later childhood. Further study of repeated exposure, prolonged exposure, and vulnerable subgroups is needed.	[Sun, Lena S.; Ing, Caleb] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp New York Presbyteri, 622 W 168th St,CH 4-440 N, New York, NY 10032 USA; [Li, Guohua; Rauh, Virginia; Youn, Ahrim] Columbia Univ, Mailman Sch Publ Hlth, 622 W 168th St,CH 4-440 N, New York, NY 10032 USA; [Li, Guohua; Byrne, Mary W.] Columbia Univ, Coll Phys & Surg, 622 W 168th St,CH 4-440 N, New York, NY 10032 USA; [Miller, Tonya L. K.; Bellinger, David C.; Park, Raymond] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Salorio, Cynthia] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Byrne, Mary W.] Columbia Univ, Sch Nursing, 622 W 168th St,CH 4-440 N, New York, NY 10032 USA; [Radcliffe, Jerilynn; Maxwell, Lynne G.; McGowan, Francis X.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hays, Stephen R.; Cooper, Timothy J.] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [DiMaggio, Charles J.] NYU, Sch Med, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; Columbia University; Harvard University; Boston Children's Hospital; Harvard Medical School; Johns Hopkins University; Kennedy Krieger Institute; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Vanderbilt University; New York University	Sun, LS (corresponding author), Columbia Univ, Med Ctr, 622 W 168th St,CH 4-440 N, New York, NY 10032 USA.	lss4@cumc.columbia.edu	zhou, hua/A-6862-2017	Hays, Stephen/0000-0003-2166-8811; DiMaggio, Charles/0000-0003-2356-6659	US Food and Drug Administration [HHSF223200810036C]; SmartTots grant; Columbia University; Vanderbilt University; Boston Children's Hospital; Children's Hospital of Philadelphia; National Center for Advancing Translational Sciences, NIH [UL1 TR000040];  [R34 HD060741]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255, R01HD084566] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R34HD060741] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002096] Funding Source: NIH RePORTER	US Food and Drug Administration; SmartTots grant; Columbia University; Vanderbilt University; Boston Children's Hospital; Children's Hospital of Philadelphia; National Center for Advancing Translational Sciences, NIH; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was supported by grant R34 HD060741 (to Dr Sun), US Food and Drug Administration contract HHSF223200810036C (to Dr Sun), a SmartTots grant (to Dr Sun), and intramural departmental funding from Columbia University (to Dr Sun), Vanderbilt University (to Dr Hays), Boston Children's Hospital (to Drs Miller and McGowan), and Children's Hospital of Philadelphia (to Drs Maxwell and McGowan). This study was also supported by the National Center for Advancing Translational Sciences, NIH, through grant UL1 TR000040.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Backeljauw B, 2015, PEDIATRICS, V136, pE1, DOI 10.1542/peds.2014-3526; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Bellinger DC, 2012, ENVIRON HEALTH PERSP, V120, P501, DOI 10.1289/ehp.1104170; Bellinger DC, 2011, CIRCULATION, V124, P1361, DOI 10.1161/CIRCULATIONAHA.111.026963; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Block RI, 2012, ANESTHESIOLOGY, V117, P494, DOI 10.1097/ALN.0b013e3182644684; Bong CL, 2013, ANESTH ANALG, V117, P1419, DOI 10.1213/ANE.0b013e318299a7c2; Brooks BL, 2010, CHILD NEUROPSYCHOL, V16, P80, DOI 10.1080/09297040903146966; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; DeFrances Carol J, 2007, Vital Health Stat 13, P1; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Harrison PL, 2003, TECHNICAL REPORT ADA; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Mellon RD, 2007, ANESTH ANALG, V104, P509, DOI 10.1213/01.ane.0000255729.96438.b0; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Psaty BM, 2015, JAMA-J AM MED ASSOC, V313, P1515, DOI 10.1001/jama.2015.1149; R Foundation, R PROJECT STAT COMPU; Rabbitts JA, 2010, ANESTH ANALG, V111, P1011, DOI 10.1213/ANE.0b013e3181ee8479; Rappaport BA, 2015, NEW ENGL J MED, V372, P796, DOI 10.1056/NEJMp1414786; Ronfani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127052; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; SmartTots, 2015, CONS STAT US AN SED; Stratmann G, 2014, NEUROPSYCHOPHARMACOL, V39, P2275, DOI 10.1038/npp.2014.134; Sun LS, 2012, J NEUROSURG ANESTH, V24, P382, DOI 10.1097/ANA.0b013e31826a0371; Susser E, 2010, AM J EPIDEMIOL, V172, P537, DOI 10.1093/aje/kwq196; Tzong KYS, 2012, J NEUROSURG ANESTH, V24, P391, DOI 10.1097/ANA.0b013e31826a0345; Wechsler D., 2007, WASI 2 WECHSLER ABBR; WEISS B, 1988, TRENDS PHARMACOL SCI, V9, P59, DOI 10.1016/0165-6147(88)90118-6; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	37	452	473	7	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2312	2320		10.1001/jama.2016.6967	http://dx.doi.org/10.1001/jama.2016.6967			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272582	Bronze, Green Accepted			2022-12-28	WOS:000377183100020
J	Fiore, LD; Lavori, PW				Fiore, Louis D.; Lavori, Philip W.			Integrating Randomized Comparative Effectiveness Research with Patient Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CLINICAL-TRIAL; INFORMED-CONSENT; POINT; ATTITUDES		[Fiore, Louis D.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Dept Vet Affairs, VA Cooperat Studies Program, Boston, MA USA; [Lavori, Philip W.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Stanford University	Lavori, PW (corresponding author), Stanford Univ, Dept Hlth Res & Policy, HRP Redwood Bldg,259 Campus Dr, Stanford, CA 94305 USA.	lavori@stanford.edu						[Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18430; [Anonymous], 2015, ID REC PART HLTH RES; Cho MK, 2015, ANN INTERN MED, V162, P690, DOI 10.7326/M15-0166; D'Avolio L, 2012, J AM MED INFORM ASSN, V19, pE170, DOI 10.1136/amiajnl-2011-000623; Faden R, 2013, MED CARE, V51, pS53, DOI 10.1097/MLR.0b013e31829b1e4b; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Geogio M, 2006, J CLIN EPIDEMIOL, V59, P497, DOI 10.1016/j.jclinepi.2005.11.007; Noto MJ, 2015, JAMA-J AM MED ASSOC, V313, P369, DOI 10.1001/jama.2014.18400; Weir CR, 2014, CLIN TRIALS, V11, P292, DOI 10.1177/1740774514523848; Winhusen T, 2014, CONTEMP CLIN TRIALS, V39, P158, DOI 10.1016/j.cct.2014.08.009	10	74	74	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2152	2158		10.1056/NEJMra1510057	http://dx.doi.org/10.1056/NEJMra1510057			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2RP	27248620	Bronze			2022-12-28	WOS:000387209900008
J	Rigg, ND; Rigg, AW				Rigg, Nancy D.; Rigg, Alastair W.			Jean Forbes Trainer Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		FORBES J, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3105	10.1136/bmj.i3105	http://dx.doi.org/10.1136/bmj.i3105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27255284				2022-12-28	WOS:000377479000010
J	Schrag, D				Schrag, Deborah			Reimbursing Wisely? CMS's Trial of Medicare Part B Drug Payment Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schrag, Deborah] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Schrag, D (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Brady U, 2016, COMMUNICATION; Food and Drug Administration, 2016, FED REG; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Marchetti-Bowick E, 2016, MEDICARE B	5	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2101	2105		10.1056/NEJMp1603735	http://dx.doi.org/10.1056/NEJMp1603735			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248616				2022-12-28	WOS:000387209900001
J	Tewhey, R; Kotliar, D; Park, DS; Liu, B; Winnicki, S; Reilly, SK; Andersen, KG; Mikkelsen, TS; Lander, ES; Schaffner, SF; Sabeti, PC				Tewhey, Ryan; Kotliar, Dylan; Park, Daniel S.; Liu, Brandon; Winnicki, Sarah; Reilly, Steven K.; Andersen, Kristian G.; Mikkelsen, Tarjei S.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.			Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay	CELL			English	Article							SYSTEMATIC DISSECTION; FUNCTIONAL DISSECTION; GENETIC-VARIATION; ENHANCERS; REPRESSION; PROTEIN; REVEAL; DORSAL; STATES; CELLS	Although studies have identified hundreds of loci associated with human traits and diseases, pinpointing causal alleles remains difficult, particularly for non-coding variants. To address this challenge, we adapted the massively parallel reporter assay (MPRA) to identify variants that directly modulate gene expression. We applied it to 32,373 variants from 3,642 cis-expression quantitative trait loci and control regions. Detection by MPRA was strongly correlated with measures of regulatory function. We demonstrate MPRA's capabilities for pinpointing causal alleles, using it to identify 842 variants showing differential expression between alleles, including 53 well-annotated variants associated with diseases and traits. We investigated one in detail, a risk allele for ankylosing spondylitis, and provide direct evidence of a non-coding variant that alters expression of the prostaglandin EP4 receptor. These results create a resource of concrete leads and illustrate the promise of this approach for comprehensively interrogating how non-coding polymorphism shapes human biology.	[Tewhey, Ryan; Kotliar, Dylan; Reilly, Steven K.; Andersen, Kristian G.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Tewhey, Ryan; Kotliar, Dylan; Park, Daniel S.; Liu, Brandon; Winnicki, Sarah; Reilly, Steven K.; Andersen, Kristian G.; Mikkelsen, Tarjei S.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tewhey, R; Sabeti, PC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.; Tewhey, R; Sabeti, PC (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	rtewhey@broadinstitute.org; pardis@broadinstitute.org	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022; Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Park, Daniel/0000-0001-5191-1371; Schaffner, Stephen/0000-0001-6699-3568; Reilly, Steven/0000-0003-3140-1483	NIH grant [DP2OD006514, K99HG008179, R01HG006785]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG009226, R01HG006785, K99HG008179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R01AI114855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank A. Melnikov, members of the Sabeti lab, the Broad walk-up sequencing platform, and C. Daly and K. Groglio of Harvard's Bauer Core Facility for their expertise and advice. This work was supported by NIH grants DP2OD006514 to P.C.S. and K99HG008179 to R.T. T.S.M. is supported by NIH grant R01HG006785. Broad Institute and Harvard have filed patent applications directed to the work described in this paper.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; IP YT, 1991, CELL, V64, P439; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mogno I, 2013, GENOME RES, V23, P1908, DOI 10.1101/gr.157891.113; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115	35	193	194	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1519	1529		10.1016/j.cell.2016.04.027	http://dx.doi.org/10.1016/j.cell.2016.04.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259153	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000377045400023
J	Tschaharganeh, DF; Xue, W; Calvisi, DF; Evert, M; Michurina, TV; Dow, LE; Banito, A; Katz, SF; Kastenhuber, ER; Weissmueller, S; Huang, CH; Lechel, A; Andersen, JB; Capper, D; Zender, L; Longerich, T; Enikolopov, G; Lowe, SW				Tschaharganeh, Darjus F.; Xue, Wen; Calvisi, Diego F.; Evert, Matthias; Michurina, Tatyana V.; Dow, Lukas E.; Banito, Ana; Katz, Sarah F.; Kastenhuber, Edward R.; Weissmueller, Susann; Huang, Chun-Hao; Lechel, Andre; Andersen, Jesper B.; Capper, David; Zender, Lars; Longerich, Thomas; Enikolopov, Grigori; Lowe, Scott W.			p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer (vol 158, pg 579, 2014)	CELL			English	Correction												lowes@mskcc.org	Lechel, André/AAQ-2041-2021; Banito, Ana/P-6168-2017; Enikolopov, Grigori/B-7771-2009; Capper, David/I-8500-2014	Lechel, André/0000-0003-0221-6959; Andersen, Jesper B/0000-0003-1760-5244; Enikolopov, Grigori/0000-0001-8178-8917; Capper, David/0000-0003-1945-497X	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051	1	13	15	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1546	1547		10.1016/j.cell.2016.05.058	http://dx.doi.org/10.1016/j.cell.2016.05.058			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259155	Green Accepted, Bronze			2022-12-28	WOS:000377045400025
J	Ulirsch, JC; Nandakumar, SK; Wang, L; Giani, FC; Zhang, XL; Rogov, P; Melnikov, A; McDonel, P; Do, R; Mikkelsen, TS; Sankaran, VG				Ulirsch, Jacob C.; Nandakumar, Satish K.; Wang, Li; Giani, Felix C.; Zhang, Xiaolan; Rogov, Peter; Melnikov, Alexandre; McDonel, Patrick; Do, Ron; Mikkelsen, Tarjei S.; Sankaran, Vijay G.			Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits	CELL			English	Article							DIAMOND-BLACKFAN ANEMIA; GENOME-WIDE ASSOCIATION; IN-VIVO; TERMINAL ERYTHROPOIESIS; SIDEROBLASTIC ANEMIA; MAMMALIAN ENHANCERS; HUMAN HEMATOPOIESIS; NONCODING VARIANTS; DNA-SEQUENCE; EXPRESSION	Genome-wide association studies (GWAS) have successfully identified thousands of associations between common genetic variants and human disease phenotypes, but the majority of these variants are non-coding, often requiring genetic fine-mapping, epigenomic profiling, and individual reporter assays to delineate potential causal variants. We employ a massively parallel reporter assay (MPRA) to simultaneously screen 2,756 variants in strong linkage disequilibrium with 75 sentinel variants associated with red blood cell traits. We show that this assay identifies elements with endogenous erythroid regulatory activity. Across 23 sentinel variants, we conservatively identified 32 MPRA functional variants (MFVs). We used targeted genome editing to demonstrate endogenous enhancer activity across 3 MFVs that predominantly affect the transcription of SMIM1, RBM38, and CD164. Functional follow-up of RBM38 delineates a key role for this gene in the alternative splicing program occurring during terminal erythropoiesis. Finally, we provide evidence for how common GWAS-nominated variants can disrupt cell-type-specific transcriptional regulatory pathways.	[Ulirsch, Jacob C.; Nandakumar, Satish K.; Giani, Felix C.; Sankaran, Vijay G.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA; [Ulirsch, Jacob C.; Nandakumar, Satish K.; Giani, Felix C.; Sankaran, Vijay G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA; [Ulirsch, Jacob C.; Nandakumar, Satish K.; Wang, Li; Giani, Felix C.; Zhang, Xiaolan; Rogov, Peter; Melnikov, Alexandre; McDonel, Patrick; Mikkelsen, Tarjei S.; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Giani, Felix C.] Charite, D-10117 Berlin, Germany; [Do, Ron] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Mikkelsen, Tarjei S.; Sankaran, Vijay G.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University	Sankaran, VG (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Sankaran, VG (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	sankaran@broadinstitute.org	Nandakumar, Satish/S-5309-2019; Mikkelsen, Tarjei S/A-1306-2007	Nandakumar, Satish/0000-0002-7853-426X; Mikkelsen, Tarjei S/0000-0002-8133-3135; Ulirsch, Jacob/0000-0002-7947-0827	Broad Institute/Boston Children's Hospital collaborative grant; National Institutes of Health [R01 DK103794, R21 HL120791, R01 HG006785]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL120791, R33HL120791] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794] Funding Source: NIH RePORTER	Broad Institute/Boston Children's Hospital collaborative grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the Sankaran Lab and numerous colleagues for valuable comments and discussions. This work was supported by a Broad Institute/Boston Children's Hospital collaborative grant and by the National Institutes of Health grants R01 DK103794, R21 HL120791 (to V.G.S.), and R01 HG006785 (to T.S.M.).	Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Campagna DR, 2014, AM J HEMATOL, V89, P315, DOI 10.1002/ajh.23616; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; CONBOY JG, 1993, J CLIN INVEST, V91, P77, DOI 10.1172/JCI116203; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Erickson-Miller CL, 2000, STEM CELLS, V18, P366, DOI 10.1634/stemcells.18-5-366; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Haer-Wigman L, 2015, TRANSFUSION, V55, P1457, DOI 10.1111/trf.13014; Heinicke LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078031; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hughes JR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0361; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kaneko K, 2014, HAEMATOLOGICA, V99, P252, DOI 10.3324/haematol.2013.085449; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Levo M, 2015, GENOME RES, V25, P1410, DOI 10.1101/gr.196725.115; Ludwig LS, 2015, AM J HEMATOL, V90, P386, DOI 10.1002/ajh.23952; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Manco L, 2000, BRIT J HAEMATOL, V110, P993, DOI 10.1046/j.1365-2141.2000.02283.x; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pimentel H, 2014, NUCLEIC ACIDS RES, V42, P4031, DOI 10.1093/nar/gkt1388; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; Sankaran VG, 2013, CURR OPIN GENET DEV, V23, P339, DOI 10.1016/j.gde.2013.02.006; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Ulirsch JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004890; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Wakabayashi A, 2016, P NATL ACAD SCI USA, V113, P4434, DOI 10.1073/pnas.1521754113; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Zhang J, 2014, P NATL ACAD SCI USA, V111, P18637, DOI 10.1073/pnas.1415607112; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	56	173	174	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1530	1545		10.1016/j.cell.2016.04.048	http://dx.doi.org/10.1016/j.cell.2016.04.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259154	Bronze, Green Accepted			2022-12-28	WOS:000377045400024
J	Martinez, AT				Martinez, Angel T.			CHEMISTRY How to break down crystalline cellulose	SCIENCE			English	Editorial Material							POLYSACCHARIDE MONOOXYGENASE; CELLOBIOSE DEHYDROGENASE; DEGRADATION; METALLOENZYME; OXIDATION; INSIGHTS		[Martinez, Angel T.] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, AT (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.		Martínez, Angel T/G-7284-2017	Martínez, Angel T/0000-0002-1584-2863				Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Cannella D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11134; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Ju XH, 2014, APPL MICROBIOL BIOT, V98, P4409, DOI 10.1007/s00253-013-5450-4; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Tan TC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8542; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561	13	25	26	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1050	1051		10.1126/science.aaf8920	http://dx.doi.org/10.1126/science.aaf8920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230362				2022-12-28	WOS:000376480800017
J	Smith, IB; Putzig, NE; Holt, JW; Phillips, RJ				Smith, Isaac B.; Putzig, Nathaniel E.; Holt, John W.; Phillips, Roger J.			An ice age recorded in the polar deposits of Mars	SCIENCE			English	Article							LAYERED DEPOSITS; GROUND ICE; STRATIGRAPHY; RADAR	Layered ice deposits at the poles of Mars record a detailed history of accumulation and erosion related to climate processes. Radar investigations measure these layers and provide evidence for climate changes such as ice advance and retreat. We present a detailed analysis of observational data showing that similar to 87,000 cubic kilometers of ice have accumulated at the poles since the end of the last ice age similar to 370,000 years ago; this volume is equivalent to a global layer of similar to 60 centimeters. The majority of the material accumulated at the north pole. These results provide both a means to understand the accumulation history of the polar deposits as related to orbital Milankovitch cycles and constraints for better determination of Mars' past and future climates.	[Smith, Isaac B.; Putzig, Nathaniel E.] Southwest Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Holt, John W.] Univ Texas Austin, Jackson Sch Geosci, Univ Texas Inst Geophys, JJ Pickle Res Campus, Austin, TX 78758 USA; [Phillips, Roger J.] Southwest Res Inst, Planetary Sci Div, Boulder, CO 80302 USA; [Phillips, Roger J.] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; [Phillips, Roger J.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Southwest Research Institute; University of Texas System; University of Texas Austin; Southwest Research Institute; Washington University (WUSTL); Washington University (WUSTL)	Smith, IB (corresponding author), Southwest Res Inst, Dept Space Studies, Boulder, CO 80302 USA.	isaac@boulder.swri.edu		Smith, Isaac/0000-0002-4331-913X; Putzig, Nathaniel/0000-0003-4485-6321	NASA [NNX10AQ32G, NNX11AL10G]; Institute for Geophysics, Jackson School of Geoscience, University of Texas at Austin	NASA(National Aeronautics & Space Administration (NASA)); Institute for Geophysics, Jackson School of Geoscience, University of Texas at Austin	Supported by the SHARAD instrument, NASA grants NNX10AQ32G (N.E.P.) and NNX11AL10G (J.W.H.), and the Institute for Geophysics, Jackson School of Geoscience, University of Texas at Austin (J.W.H.). Data used in this investigation are available at NASA's planetary data system (PDS), http://pds-geosciences.wustl.edu/mro/mro-m-sharad-5-radargram-v1/mrosh_2001/. We thank the SHARAD team and Mars polar group for supportive comments and suggestions, F. Foss and B. Campbell for their roles in generating the 3D radar volume, and Seisware International for use of its seismic mapping tools.	Bramson AM, 2015, GEOPHYS RES LETT, V42, P6566, DOI 10.1002/2015GL064844; Brothers TC, 2015, J GEOPHYS RES-PLANET, V120, P1357, DOI 10.1002/2015JE004830; Brothers T. C., 2013, MARS GEOPHYS RES LET, V40, P1334, DOI [10.1002/grl.50293, DOI 10.1002/GRL.50293]; Byrne S, 2009, SCIENCE, V325, P1674, DOI 10.1126/science.1175307; Christian S, 2013, ICARUS, V226, P1241, DOI 10.1016/j.icarus.2013.07.003; Dundas CM, 2010, ICARUS, V206, P716, DOI 10.1016/j.icarus.2009.09.007; Fishbaugh KE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002571; Greve R, 2010, PLANET SPACE SCI, V58, P931, DOI 10.1016/j.pss.2010.03.002; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Herny C, 2014, EARTH PLANET SC LETT, V403, P56, DOI 10.1016/j.epsl.2014.06.033; Holt JW, 2010, NATURE, V465, P446, DOI 10.1038/nature09050; Holt JW, 2008, SCIENCE, V322, P1235, DOI 10.1126/science.1164246; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; Kostama VP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025946; Koutnik M, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001805; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Madeleine JB, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053564; McEwen A. S., 1994, 25 LUN PLAN SCI C, P871; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI [10.1029/2006JE002772, 10.1029/2007JE002944]; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Plaut JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036379; Putzig N. E., 2014, LPI CONTRIB, V1791, P1336; Putzig NE, 2009, ICARUS, V204, P443, DOI 10.1016/j.icarus.2009.07.034; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Smith IB, 2015, GEOMORPHOLOGY, V240, P54, DOI 10.1016/j.geomorph.2014.08.026; Smith IB, 2015, J GEOPHYS RES-PLANET, V120, P362, DOI 10.1002/2014JE004720; Smith IB, 2013, J GEOPHYS RES-PLANET, V118, P1835, DOI 10.1002/jgre.20142; Smith IB, 2010, NATURE, V465, P450, DOI 10.1038/nature09049; Tanaka KL, 2008, ICARUS, V196, P318, DOI 10.1016/j.icarus.2008.01.021; Tanaka KL, 2005, NATURE, V437, P991, DOI 10.1038/nature04065	31	50	52	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1075	1078		10.1126/science.aad6968	http://dx.doi.org/10.1126/science.aad6968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230372	Green Submitted			2022-12-28	WOS:000376480800032
J	O'Dowd, A				O'Dowd, Adrian			Home run for integrated primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						NHS England, 2014, 5 YEAR FORW VIEW	1	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2016	353								i2922	10.1136/bmj.i2922	http://dx.doi.org/10.1136/bmj.i2922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CL	27229741				2022-12-28	WOS:000376939900002
J	Kronick, R; Arnold, S; Brady, J				Kronick, Richar; Arnold, Sharon; Brady, Jeffrey			Improving Safety for Hospitalized Patients Much Progress but Many Challenges Remain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kronick, Richar] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Kronick, Richar; Arnold, Sharon; Brady, Jeffrey] Agcy Healthcare Res & Qual, Rockville, MD USA	University of California System; University of California San Diego; Agency for Healthcare Research & Quality	Kronick, R (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkronick@ucsd.edu						Hunt DR., 2005, ADV PATIENT SAFETY R, V2; Jha A, 2016, JAMA-J AM MED ASSOC, V315, P1831, DOI 10.1001/jama.2016.3448; McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991	6	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					489	490		10.1001/jama.2016.7887	http://dx.doi.org/10.1001/jama.2016.7887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27295371				2022-12-28	WOS:000381075000010
J	Uesaka, K; Boku, N; Fukutomi, A; Okamura, Y; Konishi, M; Matsumoto, I; Kaneoka, Y; Shimizu, Y; Nakamori, S; Sakamoto, H; Morinaga, S; Kainuma, O; Imai, K; Sata, N; Hishinuma, S; Ojima, H; Yamaguchi, R; Hirano, S; Sudo, T; Ohashi, Y				Uesaka, Katsuhiko; Boku, Narikazu; Fukutomi, Akira; Okamura, Yukiyasu; Konishi, Masaru; Matsumoto, Ippei; Kaneoka, Yuji; Shimizu, Yasuhiro; Nakamori, Shoji; Sakamoto, Hirohiko; Morinaga, Soichiro; Kainuma, Osamu; Imai, Koji; Sata, Naohiro; Hishinuma, Shoichi; Ojima, Hitoshi; Yamaguchi, Ryuzo; Hirano, Satoshi; Sudo, Takeshi; Ohashi, Yasuo		JASPAC 01 Study Grp	Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)	LANCET			English	Article							III TRIAL; JAPAN	Background Although adjuvant chemotherapy with gemcitabine is standard care for resected pancreatic cancer, S-1 has shown non-inferiority to gemcitabine for advanced disease. We aimed to investigate the non-inferiority of S-1 to gemcitabine as adjuvant chemotherapy for pancreatic cancer in terms of overall survival. Methods We did a randomised, open-label, multicentre, non-inferiority phase 3 trial undertaken at 33 hospitals in Japan. Patients who had histologically proven invasive ductal carcinoma of the pancreas, pathologically documented stage I-III, and no local residual or microscopic residual tumour, and were aged 20 years or older were eligible. Patients with resected pancreatic cancer were randomly assigned (in a 1: 1 ratio) to receive gemcitabine (1000 mg/m(2), intravenously administered on days 1, 8, and 15, every 4 weeks [one cycle], for up to six cycles) or S-1 (40 mg, 50 mg, or 60 mg according to body-surface area, orally administered twice a day for 28 days followed by a 14 day rest, every 6 weeks [one cycle], for up to four cycles) at the data centre by a modified minimisation method, balancing residual tumour status, nodal status, and institutions. The primary outcome was overall survival in the two treatment groups, assessed in the per-protocol population, excluding ineligible patients and those not receiving the allocated treatment. The protocol prespecified that the superiority of S-1 with respect to overall survival was also to be assessed in the perprotocol population by a log-rank test, if the non-inferiority of S-1 was verified. We estimated overall and relapse-free survival using the Kaplan-Meier methods, and assessed non-inferiority of S-1 to gemcitabine using the Cox proportional hazard model. The expected hazard ratio (HR) for mortality was 0.87 with a non-inferiority margin of 1.25 (power 80%; one-sided type I error 2.5%). This trial is registered at UMIN CTR (UMIN000000655). Findings 385 patients were randomly assigned to treatment between April 11, 2007, and June 29, 2010 (193 to the gemcitabine group and 192 to the S-1 group). Of these, three were exlcuded because of ineligibility and five did not receive chemotherapy. The per-protocol population therefore consisted of 190 patients in the gemcitabine group and 187 patients in the S-1 group. On Sept 15, 2012, following the recommendation from the independent data and safety monitoring committee, this study was discontinued because the prespecified criteria for early discontinuation were met at the interim analysis for efficacy, when all the protocol treatments had been finished. Analysis with the follow-up data on Jan 15, 2016, showed HR of mortality was 0.57 (95% CI 0.44-0.72, p(non-inferiority)<0.0001, p<0.0001 for superiority), associated with 5-year overall survival of 24.4% (18.6-30.8) in the gemcitabine group and 44.1% (36.9-51.1) in the S-1 group. Grade 3 or 4 leucopenia, neutropenia, aspartate aminotransferase, and alanine aminotransferase were observed more frequently in the gemcitabine group, whereas stomatitis and diarrhoea were more frequently experienced in the S-1 group. Interpretation Adjuvant chemotherapy with S-1 can be a new standard care for resected pancreatic cancer in Japanese patients. These results should be assessed in non-Asian patients.	[Uesaka, Katsuhiko; Fukutomi, Akira; Okamura, Yukiyasu] Shizuoka Canc Ctr Hosp, Shizuoka, Japan; [Boku, Narikazu] Natl Canc Ctr, Tokyo, Japan; [Konishi, Masaru] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Matsumoto, Ippei] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan; [Kaneoka, Yuji] Ogaki Municipal Hosp, Ogaki, Japan; [Shimizu, Yasuhiro] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Nakamori, Shoji] Osaka Natl Hosp, Osaka, Japan; [Sakamoto, Hirohiko] Saitama Canc Ctr, Saitama, Japan; [Morinaga, Soichiro] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan; [Kainuma, Osamu] Chiba Canc Ctr, Chiba, Japan; [Imai, Koji] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Sata, Naohiro] Jichi Med Univ, Shimotsuke, Japan; [Hishinuma, Shoichi] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan; [Ojima, Hitoshi] Gunma Prefectural Canc Ctr, Ota, Japan; [Yamaguchi, Ryuzo] Kasugai Municipal Hosp, Kasugai, Aichi, Japan; [Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Sudo, Takeshi] Natl Hosp Org, Kure Med Ctr, Kure, Japan; [Ohashi, Yasuo] Chuo Univ, Tokyo, Japan	Shizuoka Cancer Center; National Cancer Center - Japan; National Cancer Center - Japan; Kobe University; Ogaki Municipal Hospital; Aichi Cancer Center; Osaka National Hospital; Kanagawa Prefectural Cancer Center; Chiba Cancer Center; Asahikawa Medical College; Jichi Medical University; Tochigi Prefectural Cancer Center; Hokkaido University; Chuo University	Boku, N (corresponding author), Natl Canc Ctr, Div Gastrointesitnal Med Oncol, Chuo Ku, Tokyo 1040045, Japan.	nboku@ncc.go.jp	MATSUMOTO, IPPEI/AFK-9075-2022		Pharma Valley Center; Shizuoka Industrial Foundation; Taiho Pharmaceutical	Pharma Valley Center; Shizuoka Industrial Foundation; Taiho Pharmaceutical	Pharma Valley Center, Shizuoka Industrial Foundation, Taiho Pharmaceutical.	Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Hoff PM, 2003, CLIN CANCER RES, V9, P134; *JAP PANCR SOC, 2002, GEN RUL STUD PANCR C; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Maeda A, 2008, JPN J CLIN ONCOL, V38, P227, DOI 10.1093/jjco/hym178; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Okusaka T, 2008, CANCER CHEMOTH PHARM, V61, P615, DOI 10.1007/s00280-007-0514-8; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Schultheis B, 2012, INVEST NEW DRUG, V30, P1184, DOI 10.1007/s10637-011-9665-x; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Ueno H, 2005, ONCOLOGY-BASEL, V68, P171, DOI 10.1159/000086771; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; ( UICC) IUAC, 2002, TNM CLASSIFICATION M; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	23	565	586	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					248	257		10.1016/S0140-6736(16)30583-9	http://dx.doi.org/10.1016/S0140-6736(16)30583-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27265347				2022-12-28	WOS:000379736100028
J	Boeke, JD; Church, G; Hessel, A; Kelley, NK; Arkin, A; Cai, Y; Carlson, R; Chakravarti, A; Cornish, VW; Holt, L; Isaacs, FJ; Kuiken, T; Lajoie, M; Lessor, T; Lunshof, J; Maurano, MT; Mitchell, LA; Rine, J; Rosser, S; Sanjana, NE; Silver, PA; Valle, D; Wang, H; Way, JC; Yang, LH				Boeke, Jef D.; Church, George; Hessel, Andrew; Kelley, Nancy J.; Arkin, Adam; Cai, Yizhi; Carlson, Rob; Chakravarti, Aravinda; Cornish, Virginia W.; Holt, Liam; Isaacs, Farren J.; Kuiken, Todd; Lajoi, Marc; Lessor, Tracy; Lunshof, Jeantine; Maurano, Matthew T.; Mitchell, Leslie A.; Rine, Jasper; Rosser, Susan; Sanjana, Neville E.; Silver, Pamela A.; Valle, David; Wang, Harris; Way, Jeffrey C.; Yang, Luhan			The Genome Project-Write	SCIENCE			English	Editorial Material							CHROMOSOME; DESIGN					jef.boeke@nyumc.org	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019; Kuiken, Todd/U-3476-2019; Cai, Yizhi/A-3550-2010	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Kuiken, Todd/0000-0001-7851-6232; Holt, Liam/0000-0002-4002-0861; Cai, Yizhi/0000-0003-1663-2865; church, george/0000-0001-6232-9969; Rosser, Susan/0000-0002-2560-6485; Mitchell, Leslie/0000-0001-7869-9817; Lunshof, Jeantine E/0000-0002-5630-7947	Direct For Biological Sciences [1616111, 1441866] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1443299] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031105] Funding Source: NIH RePORTER; BBSRC [BB/M005690/1, BB/M018040/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005690/1] Funding Source: Medline	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; [Anonymous], 2010, PRESIDENTIAL COMMISS; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Haimovich AD, 2015, NAT REV GENET, V16, P501, DOI 10.1038/nrg3956; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kimmelman J, 2016, NATURE, V533, P311, DOI 10.1038/533311a; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	16	129	142	8	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2016	353	6295					126	127		10.1126/science.aaf6850	http://dx.doi.org/10.1126/science.aaf6850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ4XP	27256881				2022-12-28	WOS:000379208400044
J	McGuire, BA; Carroll, PB; Loomis, RA; Finneran, IA; Jewell, PR; Remijan, AJ; Blake, GA				McGuire, Brett A.; Carroll, P. Brandon; Loomis, Ryan A.; Finneran, Ian A.; Jewell, Philip R.; Remijan, Anthony J.; Blake, Geoffrey A.			Discovery of the interstellar chiral molecule propylene oxide (CH3CHCH2O)	SCIENCE			English	Article							GBT PRIMOS SURVEY; ORGANIC-MOLECULES; AMINO-ACIDS; TELESCOPE; CHEMISTRY; METEORITE; REGIONS; C-C2H4O; ICE	Life on Earth relies on chiral molecules that is, species not superimposable on their mirror images.This manifests itself in the selection of a single molecular handedness, or homochirality, across the biosphere. We present the astronomical detection of a chiral molecule, propylene oxide (CH3CHCH2O), in absorption toward the Galactic center. Propylene oxide is detected in the gas phase in a cold, extended molecular shell around the embedded, massive protostellar clusters in the Sagittarius B2 star-forming region. This material is representative of the earliest stage of solar system evolution in which a chiral molecule has been found.	[McGuire, Brett A.; Jewell, Philip R.; Remijan, Anthony J.] Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA; [McGuire, Brett A.; Carroll, P. Brandon; Finneran, Ian A.; Blake, Geoffrey A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Loomis, Ryan A.] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	National Radio Astronomy Observatory (NRAO); California Institute of Technology; Harvard University; California Institute of Technology	McGuire, BA (corresponding author), Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA.; McGuire, BA; Carroll, PB (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	bmcguire@nrao.edu; pcarroll@caltech.edu		Finneran, Ian/0000-0003-2506-4652; Carroll, Paul/0000-0002-3191-5401; Loomis, Ryan/0000-0002-8932-1219	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowship; National Science Foundation; NASA Astrobiology Institute through the Goddard Team [NNX09AH63A, NNX15AT33A (NNX09AH63A)]; NSF Astronomy and Astrophysics [AST-1109857]; Australian government;  [AGBT06B-006]	NASA Astrobiology Institute Early Career Collaboration Award; National Radio Astronomy Observatory Jansky Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); NASA Astrobiology Institute through the Goddard Team; NSF Astronomy and Astrophysics; Australian government(Australian GovernmentCGIAR); 	We thank the PRIMOS team, GBT, and Parkes staff for their ongoing support in acquiring the GBT and Parkes data and S. Breen, S. Mader, and J. Reynolds for assistance with Parkes data reduction. We acknowledge the support of L. Snyder, J. M. Hollis, and F. Lovas. B.A.M. thanks J. Mangum and J. Corby for helpful discussions. P.B.C. and B.A.M. acknowledge the support of a NASA Astrobiology Institute Early Career Collaboration Award. B.A.M. is funded by a National Radio Astronomy Observatory Jansky Postdoctoral Fellowship. R.A.L. and I.A.F. am funded by a National Science Foundation Graduate Research Fellowship. P.B.C., I.A.F., and G.A.B. acknowledge support from the NASA Astrobiology Institute through the Goddard Team (M. J. Mumma, PI) under Cooperative Research Agreements NNX09AH63A and NNX15AT33A (NNX09AH63A), and the NSF Astronomy and Astrophysics (AST-1109857) grant program. Access to the entire PRIMOS data set, specifics on the observing strategy, and overall frequency coverage information is available at www.cv.nrao.edu/PRIMOS/. The spectra obtained with Parkes are available through this website as well. Data from project AGBT06B-006 are available in the NRAO Archive at https://science.nrao.edu/observing/data-archive. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The Australia Telescope Compact Array (Parkes Radio Telescope/Mopra Radio Telescope/Long Baseline Array) is part of the Australia Telescope National Facility, which a funded by the Australian government for operation as a National Facility managed by the Commonwealth Scientific and Industrial Research Organisation (CSIRO).	Bailey J, 1998, SCIENCE, V281, P672, DOI 10.1126/science.281.5377.672; Belloche A, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321096; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; Cunningham MR, 2007, MON NOT R ASTRON SOC, V376, P1201, DOI 10.1111/j.1365-2966.2007.11504.x; Dickens JE, 1997, ASTROPHYS J, V489, P753, DOI 10.1086/304821; Dreiling JM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.118103; Engel MH, 1997, NATURE, V389, P265, DOI 10.1038/38460; Glavin DP, 2009, P NATL ACAD SCI USA, V106, P5487, DOI 10.1073/pnas.0811618106; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hollis JM, 2004, ASTROPHYS J, V613, pL45, DOI 10.1086/424927; Hollis JM, 2004, ASTROPHYS J, V610, pL21, DOI 10.1086/423200; Ikeda M, 2001, ASTROPHYS J, V560, P792, DOI 10.1086/322957; Jones PA, 2008, MON NOT R ASTRON SOC, V386, P117, DOI 10.1111/j.1365-2966.2008.13009.X; LIFSHITZ A, 1994, J PHYS CHEM-US, V98, P1161, DOI 10.1021/j100055a020; Loomis RA, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/34; Loomis RA, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L9; Lunine JI, 2005, ASTROBIOLOGY MULTIDI, P619; McGuire BA, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/2/L33; Modica P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/79; Neill JL, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/153; Pizzarello S, 2011, GEOCHIM COSMOCHIM AC, V75, P645, DOI 10.1016/j.gca.2010.10.025; Requena-Torres MA, 2006, ASTRON ASTROPHYS, V455, P971, DOI 10.1051/0004-6361:20065190; Snyder LE, 2002, ASTROPHYS J, V578, P245, DOI 10.1086/342273	25	186	189	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1449	1452		10.1126/science.aae0328	http://dx.doi.org/10.1126/science.aae0328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27303055	Green Submitted			2022-12-28	WOS:000377975400046
J	Eisenstein, M				Eisenstein, Michael			A SIMPLER TWIST OF FATE	NATURE			English	Editorial Material							FIBROBLASTS											Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cao N., 2016, SCIENCE; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang ML, 2016, CELL STEM CELL, V18, P653, DOI 10.1016/j.stem.2016.03.020	8	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					421	423		10.1038/534421a	http://dx.doi.org/10.1038/534421a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306187	Bronze			2022-12-28	WOS:000377856800043
J	Richardson, TT; Harran, O; Murray, H				Richardson, Tomas T.; Harran, Omar; Murray, Heath			The bacterial DnaA-trio replication origin element specifies single-stranded DNA initiator binding	NATURE			English	Article							BACILLUS-SUBTILIS CHROMOSOME; ESCHERICHIA-COLI; STRUCTURAL BASIS; OPEN COMPLEX; PROTEIN; RECOGNITION; REGION; MECHANISM	DNA replication is tightly controlled to ensure accurate inheritance of genetic information. In all organisms, initiator proteins possessing AAA+ (ATPases associated with various cellular activities) domains bind replication origins to license new rounds of DNA synthesis(1). In bacteria the master initiator protein, DnaA, is highly conserved and has two crucial DNA binding activities(2). DnaA monomers recognize the replication origin (oriC) by binding double-stranded DNA sequences (DnaA-boxes); subsequently, DnaA filaments assemble and promote duplex unwinding by engaging and stretching a single DNA strand(3-5). While the specificity for duplex DnaA-boxes by DnaA has been appreciated for over 30 years, the sequence specificity for single-strand DNA binding has remained unknown. Here we identify a new indispensable bacterial replication origin element composed of a repeating trinucleotide motif that we term the DnaA-trio. We show that the function of the DnaA-trio is to stabilize DnaA filaments on a single DNA strand, thus providing essential precision to this binding mechanism. Bioinformatic analysis detects Dna-Atrios in replication origins throughout the bacterial kingdom, indicating that this element is part of the core oriC structure. The discovery and characterization of the novel DnaA-trio extends our fundamental understanding of bacterial DNA replication initiation, and because of the conserved structure of AAA+ initiator proteins these findings raise the possibility of specific recognition motifs within replication origins of higher organisms.	[Richardson, Tomas T.; Harran, Omar; Murray, Heath] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Murray, H (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	heath.murray@newcastle.ac.uk		Murray, Heath/0000-0002-6467-3656	Royal Society University Research Fellowship; Biotechnology and Biological Sciences Research Council Research Grant [BB/K017527/1]; Iraqi Ministry of Higher Education and Scientific Research Studentship; BBSRC [BB/K017527/1] Funding Source: UKRI; MRC [MC_PC_13071] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017527/1] Funding Source: researchfish	Royal Society University Research Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council Research Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Iraqi Ministry of Higher Education and Scientific Research Studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Errington and W. Vollmer for reviewing the manuscript. We thank G. Scholefield for preliminary data, A. Koh for research assistance and I. Selmes for technical assistance. Research support was provided to H.M. by a Royal Society University Research Fellowship and a Biotechnology and Biological Sciences Research Council Research Grant (BB/K017527/1), and to O.H. by an Iraqi Ministry of Higher Education and Scientific Research Studentship.	Berkmen MB, 2007, MOL MICROBIOL, V63, P150, DOI 10.1111/j.1365-2958.2006.05505.x; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; CALCUTT MJ, 1992, J BACTERIOL, V174, P3220, DOI 10.1128/jb.174.10.3220-3226.1992; Cheng HM, 2015, NUCLEIC ACIDS RES, V43, P396, DOI 10.1093/nar/gku1284; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donczew R, 2012, NUCLEIC ACIDS RES, V40, P9647, DOI 10.1093/nar/gks742; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; HANSEN EB, 1986, P NATL ACAD SCI USA, V83, P4423, DOI 10.1073/pnas.83.12.4423; Hassan AKM, 1997, J BACTERIOL, V179, P2494, DOI 10.1128/jb.179.8.2494-2502.1997; Kaur G, 2014, MOL MICROBIOL, V91, P1148, DOI 10.1111/mmi.12525; Krause M, 1999, GENE, V228, P123, DOI 10.1016/S0378-1119(99)00009-8; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; MORIYA S, 1992, MOL MICROBIOL, V6, P309, DOI 10.1111/j.1365-2958.1992.tb01473.x; Noguchi Y, 2015, J BIOL CHEM, V290, P20295, DOI 10.1074/jbc.M115.662601; OKA A, 1980, MOL GEN GENET, V178, P9, DOI 10.1007/BF00267207; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Pei HD, 2007, NUCLEIC ACIDS RES, V35, P3087, DOI 10.1093/nar/gkm137; Scholefield G, 2012, EMBO J, V31, P1542, DOI 10.1038/emboj.2012.6; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Watanabe S, 2012, MOL MICROBIOL, V83, P856, DOI 10.1111/j.1365-2958.2012.07971.x; Wolanski M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00735	37	44	44	5	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					412	+		10.1038/nature17962	http://dx.doi.org/10.1038/nature17962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281207	Green Accepted			2022-12-28	WOS:000377856800041
J	Sauaia, A; Gonzalez, E; Moore, HB; Bol, K; Moore, EE				Sauaia, Angela; Gonzalez, Eduardo; Moore, Hunter B.; Bol, Kirk; Moore, Ernest E.			Fatality and Severity of Firearm Injuries in a Denver Trauma Center, 2000-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SCORE		[Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Aurora, CO USA; [Gonzalez, Eduardo; Moore, Hunter B.] Univ Colorado, Sch Med, Aurora, CO USA; [Bol, Kirk] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Denver, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado Department of Public Health & Environment; Denver Health Medical Center	Sauaia, A (corresponding author), Univ Colorado Denver, 13011 E 17th Pl,Room E-3360-C, Aurora, CO 80045 USA.	angela.sauaia@ucdenver.edu		Bol, Kirk/0000-0002-9208-6424				ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Gun Violence Archive, 2022, SUMM LEDG; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P1689, DOI 10.1001/jama.2016.1707; Schluter PJ, 2010, J TRAUMA, V68, P761, DOI 10.1097/TA.0b013e3181d3223b	6	26	27	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2465	2467		10.1001/jama.2016.5978	http://dx.doi.org/10.1001/jama.2016.5978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299622	Bronze			2022-12-28	WOS:000377656900025
J	Fang, D; Gan, HY; Lee, JH; Han, J; Wang, ZQ; Riester, SM; Jin, L; Chen, JJ; Zhou, H; Wang, JL; Zhang, HL; Yang, N; Bradley, EW; Ho, TH; Rubin, BP; Bridge, JA; Thibodeau, SN; Ordog, T; Chen, Y; van Wijnen, AJ; Oliveira, AM; Xu, RM; Westendorf, JJ; Zhang, ZG				Fang, Dong; Gan, Haiyun; Lee, Jeong-Heon; Han, Jing; Wang, Zhiquan; Riester, Scott M.; Jin, Long; Chen, Jianji; Zhou, Hui; Wang, Jinglong; Zhang, Honglian; Yang, Na; Bradley, Elizabeth W.; Ho, Thai H.; Rubin, Brian P.; Bridge, Julia A.; Thibodeau, Stephen N.; Ordog, Tamas; Chen, Yue; van Wijnen, Andre J.; Oliveira, Andre M.; Xu, Rui-Ming; Westendorf, Jennifer J.; Zhang, Zhiguo			The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas	SCIENCE			English	Article							H3K36 METHYLATION; VARIANT H3.3; REPAIR; ACTIVATION; EXPRESSION; REGIONS; BONE	More than 90% of chondroblastomas contain a heterozygous mutation replacing lysine-36 with methionine-36 (K36M) in the histone H3 variant H3.3. Here we show that H3K36 methylation is reduced globally in human chondroblastomas and in chondrocytes harboring the same genetic mutation, due to inhibition of at least two H3K36 methyltransferases, MMSET and SETD2, by the H3.3K36M mutant proteins. Genes with altered expression as well as H3K36 di- and trimethylation in H3.3K36M cells are enriched in cancer pathways. In addition, H3.3K36M chondrocytes exhibit several hallmarks of cancer cells, including increased ability to form colonies, resistance to apoptosis, and defects in differentiation. Thus, H3.3K36M proteins reprogram the H3K36 methylation landscape and contribute to tumorigenesis, in part through altering the expression of cancer-associated genes.	[Fang, Dong; Gan, Haiyun; Lee, Jeong-Heon; Han, Jing; Wang, Zhiquan; Zhou, Hui; Zhang, Honglian; van Wijnen, Andre J.; Westendorf, Jennifer J.; Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Lee, Jeong-Heon; Ordog, Tamas; Zhang, Zhiguo] Mayo Clin, Coll Med, Ctr Individualized Med, Epigen Program, 200 First St SW, Rochester, MN 55905 USA; [Riester, Scott M.; Jin, Long; Bradley, Elizabeth W.; van Wijnen, Andre J.; Oliveira, Andre M.; Westendorf, Jennifer J.] Mayo Clin, Coll Med, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Chen, Jianji; Chen, Yue] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Wang, Jinglong; Yang, Na; Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 5 Datun Rd, Beijing 100101, Peoples R China; [Wang, Jinglong; Xu, Rui-Ming] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Ho, Thai H.] Mayo Clin Arizona, Div Hematol Oncol, 13400 East Shea B, Scottsdale, AZ 85259 USA; [Rubin, Brian P.] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, L2 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rubin, Brian P.] Cleveland Clin, Dept Canc Biol, L2 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, L2 9500 Euclid Ave, Cleveland, OH 44195 USA; [Bridge, Julia A.] Mayo Clin, Coll Med, Dept Pathol & Microbiol, 200 First St SW, Rochester, MN 55905 USA; [Bridge, Julia A.] Mayo Clin, Coll Med, Dept Pediat, 200 First St SW, Rochester, MN 55905 USA; [Bridge, Julia A.] Mayo Clin, Coll Med, Dept Orthopaed Surg & Rehabil, 200 First St SW, Rochester, MN 55905 USA; [Thibodeau, Stephen N.; Oliveira, Andre M.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA; [Ordog, Tamas] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Dept Physiol & Biomed Engn, 200 First St SW, Rochester, MN 55905 USA; [Ordog, Tamas] Univ Illinois, Interdisciplinary Hlth Sci Initiat, Micro & Nanotechnol Lab 1110, M-C 249, Urbana, IL 61801 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Mayo Clinic; Mayo Clinic Phoenix; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.; Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Ctr Individualized Med, Epigen Program, 200 First St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; Chen, Jianji/GPX-4751-2022; xu, rui/GRX-5734-2022; Wang, Zhiquan/X-9242-2018	van Wijnen, Andre J./0000-0002-4458-0946; Chen, Jianji/0000-0003-4098-1811; Wang, Zhiquan/0000-0002-8243-7251; Ho, Thai/0000-0003-0023-2939; Bradley, Elizabeth/0000-0002-8814-5524; Wang, Jinglong/0000-0002-0125-8201; Harrington, Jon/0000-0003-1293-5201	NIH [GM81838, CA157489, AR68103, AR65397, AR049069, DK58185]; Natural Science Foundation of China [31210103914]; Epigenomics Program (Center tor Individualized Medicine) of the Mayo Clinic; NATIONAL CANCER INSTITUTE [R01CA157489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068103, K01AR065397, R56AR068103, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Epigenomics Program (Center tor Individualized Medicine) of the Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Goldring for T/C28a2 cells and Z. Lou for plasmids B. Ecklott and I. Wood for sequencing and B. Madden for mass spectrometry analysis. These studies were supported by the NIH [grants GM81838 and CA157489 (Z.Z.), AR68103 (J.J.W.), AR65397 (E.W.B.) AR049069 (A.J.v.W.), and DK58185 (T.O.)], the Natural Science Foundation of China [grant 31210103914 (R.-M.X.)], and the Epigenomics Program (Center tor Individualized Medicine) of the Mayo Clinic. ChIP-seq and RNA-seq data sets have been deposited into the Gene Expression Omnibus under accession number GSE7523.	Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Chan KM, 2013, CELL CYCLE, V12, P2546, DOI 10.4161/cc.25625; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Qasem SA, 2014, SEMIN DIAGN PATHOL, V31, P10, DOI 10.1053/j.semdp.2014.01.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	21	148	154	6	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1344	1348		10.1126/science.aae0065	http://dx.doi.org/10.1126/science.aae0065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27229140	Green Accepted			2022-12-28	WOS:000377972000048
J	Rosemann, NW; Eussner, JP; Beyer, A; Koch, SW; Volz, K; Dehnen, S; Chatterjee, S				Rosemann, Nils W. i; Eussner, Jens P.; Beyer, Andreas; Koch, Stephan W.; Volz, Kerstin; Dehnen, Stefanie; Chatterjee, Sangam			A highly efficient directional molecular white-light emitter driven by a continuous-wave laser diode	SCIENCE			English	Article							PHOTONIC CRYSTAL FIBER; SUPERCONTINUUM GENERATION; THRESHOLD IONIZATION; PHOSPHORS; EMISSION	Tailored light sources have greatly advanced technological and scientific progress by optimizing the emission spectrum or color and the emission characteristics. We demonstrate an efficient spectrally broadband and highly directional warm-white-light emitter based on a nonlinear process driven by a cheap, low-power continuous-wave infrared laser diode. The nonlinear medium is a specially designed amorphous material composed of symmetry-free, diamondoid-like cluster molecules that are readily obtained from ubiquitous resources. The visible part of the spectrum resembles the color of a tungsten-halogen lamp at 2900 kelvin while retaining the superior beam divergence of the driving laser. This approach of functionalizing energy-efficient state-of-the-art semiconductor lasers enables a technology complementary to light-emitting diodes for replacing incandescent white-light emitters in high-brilliance applications.	[Rosemann, Nils W. i; Beyer, Andreas; Koch, Stephan W.; Volz, Kerstin; Chatterjee, Sangam] Univ Marburg, Fachbereich Phys, DE-35032 Marburg, Germany; [Rosemann, Nils W. i; Eussner, Jens P.; Beyer, Andreas; Koch, Stephan W.; Volz, Kerstin; Dehnen, Stefanie; Chatterjee, Sangam] Univ Marburg, Wissensch Zentrum Mat Wissensch, DE-35032 Marburg, Germany; [Eussner, Jens P.; Dehnen, Stefanie] Univ Marburg, Fachbereich Chem, DE-35032 Marburg, Germany; [Chatterjee, Sangam] Univ Giessen, Inst Expt Phys 1, DE-35392 Giessen, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen	Chatterjee, S (corresponding author), Univ Marburg, Fachbereich Phys, DE-35032 Marburg, Germany.; Dehnen, S; Chatterjee, S (corresponding author), Univ Marburg, Wissensch Zentrum Mat Wissensch, DE-35032 Marburg, Germany.; Dehnen, S (corresponding author), Univ Marburg, Fachbereich Chem, DE-35032 Marburg, Germany.; Chatterjee, S (corresponding author), Univ Giessen, Inst Expt Phys 1, DE-35392 Giessen, Germany.	stefanie.dehnen@uni-marburg.de; sangam.chatterjee@physik.uni-giessen.de	Rosemann, Nils/AGK-7098-2022; Chatterjee, Sangam/E-3124-2012	Rosemann, Nils/0000-0002-7663-0397; Chatterjee, Sangam/0000-0002-0237-5880; Beyer, Andreas/0000-0001-6533-0631; Volz, Kerstin/0000-0002-4456-5439	Deutsche Forschungsgemeinschaft [GRK1782]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of the research training group GRK1782. N.W.R., S.W.K., and S.C. thank U. Huttner and M. Kira for stimulating discussions on the model.	Alfano R. R., 2016, SUPERCONTINUUM LASER; Atkins P. W., 2004, MOL QUANTUM MECH; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BERWE H, 1987, CHEM BER-RECL, V120, P1175, DOI 10.1002/cber.19871200712; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Coen S, 2001, OPT LETT, V26, P1356, DOI 10.1364/OL.26.001356; *COMM OPT SCI ENG, 1998, HARN LIGHT OPT SCI E; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dudley JM, 2006, REV MOD PHYS, V78, P1135, DOI 10.1103/RevModPhys.78.1135; Eussner JP, 2014, CHEM COMMUN, V50, P11385, DOI 10.1039/c4cc05666c; George NC, 2013, ANNU REV MATER RES, V43, P481, DOI 10.1146/annurev-matsci-073012-125702; HassanzadehFard Z., 2010, J AM CHEM SOC, V132, P2848; Kano H, 2004, APPL PHYS LETT, V85, P4298, DOI 10.1063/1.1818741; Kim JS, 2000, J APPL PHYS, V88, P1073, DOI 10.1063/1.373779; Lin CC, 2011, J PHYS CHEM LETT, V2, P1268, DOI 10.1021/jz2002452; Muthu S, 2002, IEEE J SEL TOP QUANT, V8, P333, DOI 10.1109/2944.999188; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Nakamura S, 2015, REV MOD PHYS, V87, P1139, DOI 10.1103/RevModPhys.87.1139; Palmer J.M., 2009, ART RADIOMETRY; PAULUS GG, 1994, PHYS REV LETT, V72, P2851, DOI 10.1103/PhysRevLett.72.2851; Pimputkar S, 2009, NAT PHOTONICS, V3, P179, DOI 10.1038/nphoton.2009.32; Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Shang MM, 2014, CHEM SOC REV, V43, P1372, DOI 10.1039/c3cs60314h; Thejokalyani N, 2014, RENEW SUST ENERG REV, V32, P448, DOI 10.1016/j.rser.2014.01.013; TSUJIMURA T, 2012, OLED DISPLAY FUNDAME; Yang CC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2714326; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052	29	85	88	8	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1301	1304		10.1126/science.aaf6138	http://dx.doi.org/10.1126/science.aaf6138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284190				2022-12-28	WOS:000377972000036
J	Brumm, A; van den Bergh, GD; Storey, M; Kurniawan, I; Alloway, BV; Setiawan, R; Setiyabudi, E; Grun, R; Moore, MW; Yurnaldi, D; Puspaningrum, MR; Wibowo, UP; Insani, H; Sutisna, I; Westgate, JA; Pearce, NJG; Duval, M; Meijer, HJM; Aziz, F; Sutikna, T; van der Kaars, S; Flude, S; Morwood, MJ				Brumm, Adam; van den Bergh, Gerrit D.; Storey, Michael; Kurniawan, Iwan; Alloway, Brent V.; Setiawan, Ruly; Setiyabudi, Erick; Gruen, Rainer; Moore, Mark W.; Yurnaldi, Dida; Puspaningrum, Mika R.; Wibowo, Unggul P.; Insani, Halmi; Sutisna, Indra; Westgate, John A.; Pearce, Nick J. G.; Duval, Mathieu; Meijer, Hanneke J. M.; Aziz, Fachroel; Sutikna, Thomas; van der Kaars, Sander; Flude, Stephanie; Morwood, Michael J.			Age and context of the oldest known hominin fossils from Flores	NATURE			English	Article							FISSION-TRACK AGES; STONE TECHNOLOGY; LATE PLEISTOCENE; SOUTHEAST-ASIA; TOOTH ENAMEL; GLASS SHARDS; SOA BASIN; LIANG-BUA; INDONESIA; CHRONOLOGY	Recent excavations at the early Middle Pleistocene site of Mata Menge in the So'a Basin of central Flores, Indonesia, have yielded hominin fossils(1) attributed to a population ancestral to Late Pleistocene Homo floresiensis(2). Here we describe the age and context of the Mata Menge hominin specimens and associated archaeological findings. The fluvial sandstone layer from which the in situ fossils were excavated in 2014 was deposited in a small valley stream around 700 thousand years ago, as indicated by Ar-40/Ar-39 and fission track dates on stratigraphically bracketing volcanic ash and pyroclastic density current deposits, in combination with coupled uranium-series and electron spin resonance dating of fossil teeth. Palaeoenvironmental data indicate a relatively dry climate in the So'a Basin during the early Middle Pleistocene, while various lines of evidence suggest the hominins inhabited a savannah-like open grassland habitat with a wetland component. The hominin fossils occur alongside the remains of an insular fauna and a simple stone technology that is markedly similar to that associated with Late Pleistocene H. floresiensis.	[Brumm, Adam; Gruen, Rainer] Griffith Univ, Res Ctr Human Evolut Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Brumm, Adam] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [van den Bergh, Gerrit D.; Alloway, Brent V.; Setiawan, Ruly; Yurnaldi, Dida; Puspaningrum, Mika R.; Wibowo, Unggul P.; Sutikna, Thomas; Morwood, Michael J.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Storey, Michael] Univ Copenhagen, Quadlab, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Kurniawan, Iwan; Setiyabudi, Erick; Wibowo, Unggul P.; Insani, Halmi; Sutisna, Indra; Aziz, Fachroel] Geol Museum, Bandung 40122, Indonesia; [Alloway, Brent V.] Victoria Univ, Sch Geog Environm & Earth Sci, Wellington 6012, New Zealand; [Setiawan, Ruly; Yurnaldi, Dida] Geol Agcy, Ctr Geol Survey, Bandung 40122, Indonesia; [Gruen, Rainer] Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 2601, Australia; [Moore, Mark W.] Univ New England, Stone Tools & Cognit Hub, Armidale, NSW 2351, Australia; [Westgate, John A.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Pearce, Nick J. G.] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Duval, Mathieu] Ctr Nacl Invest Evoluc Humana CENIEH, Geochronol, Paseo Atapuerca 3, Burgos 09002, Spain; [Meijer, Hanneke J. M.] Univ Bergen, Univ Museum Bergen, N-5007 Bergen, Norway; [Sutikna, Thomas] Pusat Penelitian Arkeol Nas ARKENAS, Jakarta 12510, Indonesia; [van der Kaars, Sander] Vrije Univ Amsterdam, Fac Earth & Life Sci, Cluster Earth & Climate, NL-1081 HV Amsterdam, Netherlands; [van der Kaars, Sander] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic 3800, Australia; [Flude, Stephanie] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9AD, Midlothian, Scotland	Griffith University; University of Wollongong; University of Wollongong; University of Copenhagen; Victoria University Wellington; Australian National University; University of New England; University of Toronto; Aberystwyth University; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Bergen; Vrije Universiteit Amsterdam; Monash University; University of Edinburgh	Brumm, A (corresponding author), Griffith Univ, Res Ctr Human Evolut Environm Futures Res Inst, Nathan, Qld 4111, Australia.; Brumm, A (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia.; van den Bergh, GD (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	a.brumm@griffith.edu.au; gert@uow.edu.au	Grun, Rainer/A-1437-2012; Moore, Mark W/B-4729-2015; van den Bergh, Gerrit D/I-7670-2016; Duval, Mathieu/U-9446-2018; Flude, Stephanie/A-5768-2014; Meijer, Hanneke J.M./A-1912-2013; Pearce, Nicholas JG/B-5295-2009; Sutikna, Thomas/C-4709-2018; van der Kaars, Sander/G-2268-2016	Grun, Rainer/0000-0003-1366-3674; Moore, Mark W/0000-0003-4768-5329; Duval, Mathieu/0000-0003-3181-7753; Flude, Stephanie/0000-0002-0511-0116; Meijer, Hanneke J.M./0000-0001-7066-6869; Pearce, Nicholas JG/0000-0003-3157-9564; Sutikna, Thomas/0000-0002-9742-4226; Storey, Michael/0000-0002-3126-4637; Puspaningrum, Mika Rizki/0000-0002-5486-4213; van der Kaars, Sander/0000-0002-2511-0439; Setiabudi, Erick/0000-0002-8417-4133; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; wibowo, unggul/0000-0002-5475-1673	Australian Research Council (ARC) [DP1093342]; Geological Survey Institute (GSI) of Bandung, Indonesia; ARC Future Fellowship [FT100100384]; ARC [DP1096558]; Villum Foundation; EU [PIOF-GA-2013-626474]; Victoria University of Wellington Science Faculty Research Grant [201255]; Villum Fonden [00007408] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); Geological Survey Institute (GSI) of Bandung, Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); ARC Future Fellowship(Australian Research Council); ARC(Australian Research Council); Villum Foundation(Villum Fonden); EU(European Commission); Victoria University of Wellington Science Faculty Research Grant; Villum Fonden(Villum Fonden)	The So'a Basin project was funded by an Australian Research Council (ARC) Discovery grant (DP1093342) awarded to M.J.M. and A.B., and directed by M.J.M. (2010-2013) and G.v.d.B. (2013-2015). The Geological Survey Institute (GSI) of Bandung, Indonesia, provided additional financial and technical support. G.v.d.B.'s research was also supported by ARC Future Fellowship FT100100384. M.W.M. was funded by ARC grant DP1096558. Quadlab is funded by a grant to M.S. from the Villum Foundation. M.D. received funding from a Marie Curie International Outgoing Fellowship of the EU's Seventh Framework Programme (FP7/2007-2013), awarded under REA Grant Agreement No. PIOF-GA-2013-626474. B.V.A. received funding from a Victoria University of Wellington Science Faculty Research Grant (201255). For permission to undertake this research, we thank the Indonesian State Ministry of Research and Technology (RISTEK), the former Heads of the Geological Agency (R. Sukyiar and Surono), the successive directors of the GSI (S. Permanandewi, Y. Kusumahbrata (formerly) and A. Pribadi) and Bandung's Geology Museum (S. Baskoro and O. Abdurahman). Local research permissions were issued by the provincial government of East Nusa Tenggara at Kupang, and the Ngada and Nage Keo administrations. We also thank the Ngada Tourism and Culture and Education Departments for their ongoing support. In addition, we acknowledge support and advice provided by I. Setiadi, D. Pribadi, and Suyono (GSI), the Pusat Penelitian Arkeologi Nasional (ARKENAS) in Jakarta, and J. T. Solo of the provincial Culture and Tourism office in Kupang. Scientific and technical personnel involved in the fieldwork included: T. Suryana, S. Sonjaya, H. Oktariana, I. Sutisna, A. Rahman, S. Bronto, E. Sukandar, A. Gunawan, Widji, A. T. Hascaryo, Jatmiko, S. Wasisto, R. A. Due, S. Hayes, Y. Perston, B. Pillans, K. Grant, M. Marsh, D. McGahan, A. M. Saiful, B. Burhan, L. Siagian, D. Susanti, P. D. Moi, M. Tocheri, A. R. Chivas, and A. Cahyana. F. Wesselingh identified gastropod remains. Sidarto (GSI) provided digital elevation model data used in Fig. 1b. Geodetic surveys and measurements were conducted by E. E. Laksmana, A. Rahmadi, Y. Sofyan, and G. Hazell. J. Noblett constructed the Mata Menge 3D model, based on drone aerial photographs taken by K. Riza, T. P. Ertanto, and M. Faizal. The research team was supported by similar to 100 excavators and support personnel from the Ngada and Nage Keo districts. We thank L. Kinsley, Research School of Earth Sciences, The Australian National University, for assistance with mass spectrometric measurements.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Aziz F., 2009, SPECIAL PUBLICATION, V36, P1; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brumm A, 2006, NATURE, V441, P624, DOI 10.1038/nature04618; Brumm A, 2012, AUST ARCHAEOL, P32; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Brumm A, 2010, J ARCHAEOL SCI, V37, P451, DOI 10.1016/j.jas.2009.09.012; Deino A., 1992, QUATERN INT, V13, P47, DOI DOI 10.1016/1040-6182(92)90009-Q; Duval M, 2016, QUAT GEOCHRONOL, V31, P19, DOI 10.1016/j.quageo.2015.09.007; Duval M, 2011, J QUATERNARY SCI, V26, P603, DOI 10.1002/jqs.1476; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Gansecki CA, 1998, GEOLOGY, V26, P343, DOI 10.1130/0091-7613(1998)026<0343:NAFTCE>2.3.CO;2; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; GRUN R, 1994, RADIAT MEAS, V23, P307, DOI 10.1016/1350-4487(94)90057-4; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Grun R, 2000, RADIAT MEAS, V32, P767, DOI 10.1016/S1350-4487(99)00281-4; Grun R., 1994, ANCIENT TL, V12, P35; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; Jochum KP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001060; Laurenzi MA, 2003, METEORIT PLANET SCI, V38, P887, DOI 10.1111/j.1945-5100.2003.tb00285.x; Laurenzi MA, 2007, GEOSTAND GEOANAL RES, V31, P105, DOI 10.1111/j.1751-908X.2007.00844.x; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; MARINGER J, 1970, ANTHROPOS, V65, P530; MARINGER J, 1970, ANTHROPOS, V65, P229; Marsh R. E., 1999, THESIS MCMASTER U; Meijer HJM, 2015, PALAEOGEOGR PALAEOCL, V440, P161, DOI 10.1016/j.palaeo.2015.08.042; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Moore MW, 2011, WORLD ARCHAEOL, V43, P702, DOI 10.1080/00438243.2011.624778; Moore MW, 2009, VERTEBR PALEOBIOL PA, P61, DOI 10.1007/978-1-4020-9060-8_6; Morwood M.J., 1997, AUST ARCHAEOL, V44, P26; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Morwood MJ, 1999, ANTIQUITY, V73, P273, DOI 10.1017/S0003598X00088244; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; MUSSER G G, 1981, Bulletin of the American Museum of Natural History, V169, P67; Nomade S, 2005, CHEM GEOL, V218, P315, DOI 10.1016/j.chemgeo.2005.01.005; O'Sullivan PB, 2001, GEOLOGY, V29, P607, DOI 10.1130/0091-7613(2001)029<0607:AIOTGA>2.0.CO;2; Pearce NJG, 2014, J QUATERNARY SCI, V29, P729, DOI 10.1002/jqs.2741; Pearce NJG, 2011, QUATERN INT, V246, P57, DOI 10.1016/j.quaint.2011.07.012; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Powell R, 2002, CHEM GEOL, V185, P191, DOI 10.1016/S0009-2541(01)00403-X; Rivera TA, 2013, CHEM GEOL, V345, P87, DOI 10.1016/j.chemgeo.2013.02.021; SANDHU AS, 1995, EARTH PLANET SC LETT, V131, P289, DOI 10.1016/0012-821X(95)00022-5; Shea JJ., 1999, GEOARCHAEOLOGY, V14, P191, DOI [10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:23.0.CO;2-K, DOI 10.1002/(SICI)1520-6548(199902)14:2]; SONDAAR PY, 1994, CR ACAD SCI II, V319, P1255; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Van den Bergh GD, 2008, QUATERN INT, V182, P16, DOI 10.1016/j.quaint.2007.02.001; van den Bergh G. D., 1996, BIPPA, V14, P27; van den Bergh G. D., 2016, NATURE; van den Bergh G. D., 1997, SCRIPTA GEOLOGICA, V117; van den Bergh G. D., 2014, SASG, V102, P207; Westgate J. A., 2013, ENCY QUATERNARY SCI, P643, DOI DOI 10.1016/B978-0-444-53643-3.00039-X; Westgate J. A., ISSUES INDI IN PRESS; WESTGATE JA, 1989, EARTH PLANET SC LETT, V95, P226, DOI 10.1016/0012-821X(89)90099-X; Westra J. R., 2014, PROC IEEE CUSTOM INT, P1; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079	59	48	50	1	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					249	+		10.1038/nature17663	http://dx.doi.org/10.1038/nature17663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DO0NH	27279222	Green Submitted			2022-12-28	WOS:000377475100041
J	Friedman, EM				Friedman, Ellen M.			You've Got Mail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Friedman, Ellen M.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Friedman, Ellen M.] Baylor Coll Med, Ctr Professionalism Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Friedman, EM (corresponding author), Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA.; Friedman, EM (corresponding author), Baylor Coll Med, Ctr Professionalism Med, Houston, TX 77030 USA.	ellenf@bcm.edu						[Anonymous], 2008, PHYS PAT GUID EM COM; [Anonymous], 2012, WALL STREET J; Choudhry A, 2015, JAMA DERMATOL, V151, P513, DOI 10.1001/jamadermatol.2014.5634; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001	4	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2275	2276		10.1001/jama.2016.1757	http://dx.doi.org/10.1001/jama.2016.1757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272577				2022-12-28	WOS:000377183100013
J	Cowper, A				Cowper, Andy			JUNIOR DOCTORS' STRIKE Snatching defeat from the jaws of Pyrrhic victory	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, Timisoara, Romania		Cowper, A (corresponding author), Hlth Policy Insight, Timisoara, Romania.	andycowper@hotmail.com						[Anonymous], 2016, MAJORITY SUPPORT JUN; [Anonymous], 2015, HUNT PLEDGES; Cowper A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2237; Cowper A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i961; McKee M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2750; Renaud-Komiya N., 2016, MATTER IS CLOSED HUN; Rimmer A., 2016, DOCTORS CRITICISE AP; Rimmer A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3026; Rimmer A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2853	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3053	10.1136/bmj.i3053	http://dx.doi.org/10.1136/bmj.i3053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27266707				2022-12-28	WOS:000377857800003
J	Gulland, A				Gulland, Anne			Pregnant women are too cautious about risk of medicines	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Twigg MJ, 2016, INT J CLIN PHARM-NET, V38, P968, DOI 10.1007/s11096-016-0322-5	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i3135	10.1136/bmj.i3135	http://dx.doi.org/10.1136/bmj.i3135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0PG	27260137				2022-12-28	WOS:000377480200007
J	Kuscu, C; Dutta, A				Kuscu, Canan; Dutta, Anindya			A Pro-metastatic tRNA Pathway	CELL			English	Editorial Material							FRAGMENTS; REVEALS	tRNAs are best known as basic modules for global regulation of protein synthesis. Goodarzi et al. now show that two tRNAs upregulated in metastatic breast cancer cells enhance stability and translation of transcripts enriched with these codons, leading to specific increase in production of prometastatic proteins.	[Kuscu, Canan; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Kuscu, Canan/0000-0002-8043-7960				Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kumar P., 2016, TRENDS BIOCH SCI; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	7	2	3	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1314	1315		10.1016/j.cell.2016.05.066	http://dx.doi.org/10.1016/j.cell.2016.05.066			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259143	Bronze			2022-12-28	WOS:000377045400005
J	Sommer, A; Bothschafter, EM; Sato, SA; Jakubeit, C; Latka, T; Razskazovskaya, O; Fattahi, H; Jobst, M; Schweinberger, W; Shirvanyan, V; Yakovlev, VS; Kienberger, R; Yabana, K; Karpowicz, N; Schultze, M; Krausz, F				Sommer, A.; Bothschafter, E. M.; Sato, S. A.; Jakubeit, C.; Latka, T.; Razskazovskaya, O.; Fattahi, H.; Jobst, M.; Schweinberger, W.; Shirvanyan, V.; Yakovlev, V. S.; Kienberger, R.; Yabana, K.; Karpowicz, N.; Schultze, M.; Krausz, F.			Attosecond nonlinear polarization and light-matter energy transfer in solids	NATURE			English	Article							REFRACTIVE-INDEX; FIELD; GENERATION	Electric-field-induced charge separation (polarization) is the most fundamental manifestation of the interaction of light with matter and a phenomenon of great technological relevance. Nonlinear optical polarization(1,2) produces coherent radiation in spectral ranges inaccessible by lasers and constitutes the key to ultimate-speed signal manipulation. Terahertz techniques(3-8) have provided experimental access to this important observable up to frequencies of several terahertz(9-13). Here we demonstrate that attosecond metrology(14) extends the resolution to petahertz frequencies of visible light. Attosecond polarization spectroscopy allows measurement of the response of the electronic system of silica to strong (more than one volt per angstrom) few-cycle optical (about 750 nanometres) fields. Our proof-of-concept study provides time-resolved insight into the attosecond nonlinear polarization and the light-matter energy transfer dynamics behind the optical Kerr effect and multi-photon absorption. Timing the nonlinear polarization relative to the driving laser electric field with sub-30-attosecond accuracy yields direct quantitative access to both the reversible and irreversible energy exchange between visible-infrared light and electrons. Quantitative determination of dissipation within a signal manipulation cycle of only a few femtoseconds duration (by measurement and ab initio calculation) reveals the feasibility of dielectric optical switching at clock rates above 100 terahertz. The observed sub-femtosecond rise of energy transfer from the field to the material (for a peak electric field strength exceeding 2.5 volts per angstrom) in turn indicates the viability of petahertz-bandwidth metrology with a solid-state device.	[Sommer, A.; Bothschafter, E. M.; Jakubeit, C.; Latka, T.; Razskazovskaya, O.; Fattahi, H.; Jobst, M.; Schweinberger, W.; Shirvanyan, V.; Yakovlev, V. S.; Karpowicz, N.; Schultze, M.; Krausz, F.] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Bothschafter, E. M.; Schweinberger, W.; Schultze, M.; Krausz, F.] Univ Munich, Fak Phys, Coulombwall 1, D-85748 Garching, Germany; [Sato, S. A.; Yabana, K.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Yakovlev, V. S.] Georgia State Univ, Ctr Nanoopt, Atlanta, GA 30303 USA; [Yakovlev, V. S.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Kienberger, R.] Tech Univ Munich, Dept Phys, James Franck Str 1, D-85748 Garching, Germany; [Yabana, K.] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Bothschafter, E. M.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Max Planck Society; University of Munich; University of Tsukuba; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Technical University of Munich; University of Tsukuba; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Schultze, M; Krausz, F (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.; Schultze, M; Krausz, F (corresponding author), Univ Munich, Fak Phys, Coulombwall 1, D-85748 Garching, Germany.	martin.schultze@mpq.mpg.de; ferenc.krausz@mpq.mpg.de	Fattahi, Hanieh/AAZ-9013-2021; Yakovlev, Vladislav S/C-4091-2015; Sato, Shunsuke/I-3294-2015; Yabana, Kazuhiro/Q-7396-2019	Yakovlev, Vladislav S/0000-0002-0648-9375; Sato, Shunsuke/0000-0001-9543-2620; Kienberger, Reinhard/0000-0001-8781-3685; Fattahi, Hanieh/0000-0002-6485-529X; , Vahe/0000-0002-5709-9334; Schultze, Martin/0000-0003-0438-9255	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics; Marie Curie International Outgoing Fellowship [FP7-PEOPLE-2011-IOF]; European Community's Seventh Framework Programme [290605]; Swiss National Science Foundation through NCCR MUST; US Air Force Office of Scientific Research [FA9550-16-1-0073]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140103]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Marie Curie International Outgoing Fellowship(European Commission); European Community's Seventh Framework Programme(European Commission); Swiss National Science Foundation through NCCR MUST; US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); RIKEN Advanced Institute for Computational Science through the HPCI System Research project	We acknowledge discussions with M. Stockman and V. Apalkov. This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (http://www.munich-photonics.de). M.S. was supported by a Marie Curie International Outgoing Fellowship (FP7-PEOPLE-2011-IOF). E.M.B. acknowledges funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 290605 (PSI-FELLOW/COFUND) and from the Swiss National Science Foundation through NCCR MUST. This research is based upon work supported by the US Air Force Office of Scientific Research under award number FA9550-16-1-0073 and used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140103).	Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Bree C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.183902; Cavalieri AL, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/242; Geissler M, 1999, PHYS REV LETT, V83, P2930, DOI 10.1103/PhysRevLett.83.2930; Hebling J, 2008, IEEE J SEL TOP QUANT, V14, P345, DOI 10.1109/JSTQE.2007.914602; Huber R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3578341; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; Junginger F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.147403; Kampfrath T, 2013, NAT PHOTONICS, V7, P680, DOI [10.1038/nphoton.2013.184, 10.1038/NPHOTON.2013.184]; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kuehn W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075204; Leitenstorfer A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/045016; Loriot V, 2010, OPT EXPRESS, V18, P3011, DOI 10.1364/OE.18.003011; Loriot V, 2009, OPT EXPRESS, V17, P13429, DOI 10.1364/OE.17.013429; Markov IL, 2014, NATURE, V512, P147, DOI 10.1038/nature13570; Milam D, 1998, APPL OPTICS, V37, P546, DOI 10.1364/AO.37.000546; Pati AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8746; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Somma C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.146602; Taur Y., 2009, FUNDAMENTALS MODERN; Ulbricht R, 2011, REV MOD PHYS, V83, P543, DOI 10.1103/RevModPhys.83.543; VALDMANIS JA, 1982, APPL PHYS LETT, V41, P211, DOI 10.1063/1.93485; Wegener M., 2005, ADV TEXTS PHYS; WU Q, 1995, APPL PHYS LETT, V67, P3523, DOI 10.1063/1.114909; Yabana K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045134; YABLONOVITCH E, 1989, PHYS REV LETT, V63, P976, DOI 10.1103/PhysRevLett.63.976	30	142	144	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					86	90		10.1038/nature17650	http://dx.doi.org/10.1038/nature17650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251280				2022-12-28	WOS:000376962300038
J	Wise, J				Wise, Jacqui			GPs achieve dramatic cut in antibiotic prescriptions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Owen J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2863	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2016	353								i3002	10.1136/bmj.i3002	http://dx.doi.org/10.1136/bmj.i3002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CL	27229522				2022-12-28	WOS:000376939900009
J	Shibuya, K; Nomura, S; Okayasu, H; Ezoe, S; Hara, S; Hara, Y; Izutsu, T; Kato, T; Mabuchi, S; Maeda, Y; Murakami, Y; Nishimoto, H; Ono, T; Shioda, K; Sorita, A; Sugimoto, A; Tase, K; Watabe, A; Smith, A; Abe, SK; Gilmour, S; Gostin, LO; Yamey, G; Schaferhoff, M; Suzuki, EM; Kraus, J; Oshio, T; Hayashi, R; Kondo, N; Shiba, K; Yasunaga, H; Sasabuchi, Y; Takasaki, Y; Akahane, N; Kasahara, S; Machida, M; Maruyama, S; Okada, S; Tanimura, T; Sugishita, T; Takizawa, I; Ozawa, M; Yoneyama, Y; Akashi, H; Miyoshi, C; Murakami, H; Kumakawa, T; Horii, S; Taneda, K; Shiroyama, H; Katsuma, Y; Matsuo, M; Kanamori, S; Sato, C; Yasuda, K; Kemp, J; Slingsby, BT; Katsuno, K; Tamamura, B; Takemi, K; Hashimoto, H; Reich, MR				Shibuya, Kenji; Nomura, Shuhei; Okayasu, Hiromasa; Ezoe, Satoshi; Hara, Seigo; Hara, Yuriko; Izutsu, Takashi; Kato, Takuma; Mabuchi, Shunsuke; Maeda, Yujiro; Murakami, Yuki; Nishimoto, Hiroko; Ono, Tomoko; Shioda, Kayoko; Sorita, Atsushi; Sugimoto, Amina; Tase, Kazuo; Watabe, Akihito; Smith, Anne; Abe, Sarah K.; Gilmour, Stuart; Gostin, Lawrence O.; Yamey, Gavin; Schaeferhoff, Marco; Suzuki, Elina M.; Kraus, Jessica; Oshio, Takashi; Hayashi, Reiko; Kondo, Naoki; Shiba, Koichiro; Yasunaga, Hideo; Sasabuchi, Yusuke; Takasaki, Yohsuke; Akahane, Naoki; Kasahara, Shingo; Machida, Munehito; Maruyama, Satoshi; Okada, Shuushou; Tanimura, Tadayuki; Sugishita, Tomohiko; Takizawa, Ikuo; Ozawa, Maki; Yoneyama, Yoshiharu; Akashi, Hidechika; Miyoshi, Chiaki; Murakami, Hitoshi; Kumakawa, Toshiro; Horii, Satoko; Taneda, Kenichiro; Shiroyama, Hideaki; Katsuma, Yasushi; Matsuo, Makiko; Kanamori, Sayako; Sato, Chiaki; Yasuda, Kayo; Kemp, Jonas; Slingsby, B. T.; Katsuno, Kei; Tamamura, Bumpei; Takemi, Keizo; Hashimoto, Hideki; Reich, Michael R.		Japan Global Hlth Working Grp	Protecting human security: proposals for the G7 Ise-Shima Summit in Japan	LANCET			English	Article							SUSTAINABLE DEVELOPMENT GOALS; UNIVERSAL HEALTH COVERAGE; EBOLA; LESSONS; SOCIETY; VISION; AID	In today's highly globalised world, protecting human security is a core challenge for political leaders who are simultaneously dealing with terrorism, refugee and migration crises, disease epidemics, and climate change. Promoting universal health coverage (UHC) will help prevent another disease outbreak similar to the recent Ebola outbreak in west Africa, and create robust health systems, capable of withstanding future shocks. Robust health systems, in turn, are the prerequisites for achieving UHC. We propose three areas for global health action by the G7 countries at their meeting in Japan in May, 2016, to protect human security around the world: restructuring of the global health architecture so that it enables preparedness and responses to health emergencies; development of platforms to share best practices and harness shared learning about the resilience and sustainability of health systems; and strengthening of coordination and financing for research and development and system innovations for global health security. Rather than creating new funding or organisations, global leaders should reorganise current financing structures and institutions so that they work more effectively and efficiently. By making smart investments, countries will improve their capacity to monitor, track, review, and assess health system performance and accountability, and thereby be better prepared for future global health shocks.	[Shibuya, Kenji; Okayasu, Hiromasa; Ezoe, Satoshi; Abe, Sarah K.; Gilmour, Stuart; Kasahara, Shingo; Maruyama, Satoshi] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Hara, Seigo] Hlth & Global Policy Inst, Tokyo, Japan; [Hara, Yuriko] Japan Comm, Vaccines Worlds Children, Tokyo, Japan; [Izutsu, Takashi] Univ Tokyo, Coll Arts & Sci, Div Int Cooperat, Tokyo 153, Japan; [Kato, Takuma] Saku Cent Hosp, Dept Global Hlth, Nagano, Japan; [Mabuchi, Shunsuke] World Bank, Hlth Nutr & Populat, 1818 H St NW, Washington, DC 20433 USA; [Maeda, Yujiro] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan; [Murakami, Yuki] Org Econ Cooperat & Dev, Directorate Employment Labour & Social Affairs, Paris, France; [Nishimoto, Hiroko] Japan Pharmaceut Manufacturers Assoc, Int Affairs, Tokyo, Japan; [Ono, Tomoko] Japan Int Cooperat Agcy, Dept Human Dev, Tokyo, Japan; [Shioda, Kayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Tokyo, Japan; [Sorita, Atsushi] Mayo Clin, Hosp Internal Med, Rochester, MN USA; [Sugimoto, Amina] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Tase, Kazuo] Deloitte Tohmatsu Consulting LLC, Global Management Inst, Tokyo, Japan; [Watabe, Akihito] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Smith, Anne] Hlth & Global Policy Inst, Tokyo, Japan; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Yamey, Gavin] Duke Global Hlth Inst, Durham, NC USA; [Schaeferhoff, Marco; Suzuki, Elina M.; Kraus, Jessica] SEEK Dev, Berlin, Germany; [Oshio, Takashi] Hitotsubashi Univ, Inst Econ Res, Tokyo, Japan; [Hayashi, Reiko] Natl Inst Populat & Social Secur Res, Tokyo, Japan; [Kondo, Naoki; Shiba, Koichiro; Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan; [Yasunaga, Hideo; Sasabuchi, Yusuke] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Takasaki, Yohsuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008530, Japan; [Akahane, Naoki] Yokohama City Univ, Grad Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan; [Machida, Munehito] Jichi Med Univ, Sch Med, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Okada, Shuushou] Tokyo Med & Dent Univ, Dept Gen Med, Univ Hosp, Dept Med Educ Res & Dev, Tokyo, Japan; [Tanimura, Tadayuki] Osaka Univ, Grad Sch Med, Dept Publ Hlth, Osaka, Japan; [Sugishita, Tomohiko; Takizawa, Ikuo; Ozawa, Maki; Yoneyama, Yoshiharu] Japan Int Cooperat Agcy, Tokyo, Japan; [Akashi, Hidechika; Miyoshi, Chiaki; Murakami, Hitoshi] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Kumakawa, Toshiro; Horii, Satoko; Taneda, Kenichiro] Natl Inst Publ Hlth, Saitama, Japan; [Shiroyama, Hideaki] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Shiroyama, Hideaki] Univ Tokyo, Grad Sch Law, Tokyo, Japan; [Shiroyama, Hideaki] Univ Tokyo, Grad Sch Polit, Tokyo, Japan; [Katsuma, Yasushi] Waseda Univ, Grad Sch Asia Pacific Studies, Int Studies Program, Tokyo, Japan; [Matsuo, Makiko] Univ Tokyo, Policy Alternat Res Inst, Tokyo, Japan; [Kanamori, Sayako] Japan Inst Global Hlth, Tokyo, Japan; [Sato, Chiaki] Aoyama Gakuin Univ, Fac Law, Tokyo, Japan; [Yasuda, Kayo] Tokyo Metropolitan Univ, Fac Urban Liberal Arts, Dept Law & Polit, Tokyo 158, Japan; [Kemp, Jonas] Stanford Univ, Program Human Biol, Pao Alto, CA USA; [Slingsby, B. T.; Katsuno, Kei; Tamamura, Bumpei] Global Hlth Innovat Technol Fund, Tokyo, Japan; [Reich, Michael R.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of Tokyo; Imperial College London; University of Tokyo; The World Bank; University of Tokyo; Organisation for Economic Co-operation & Development (OECD); University of Tokyo; Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine; Deloitte Touche Tohmatsu Limited; Juntendo University; Georgetown University; Duke University; Hitotsubashi University; University of Tokyo; University of Tokyo; Okayama University; Yokohama City University; Jichi Medical University; Tokyo Medical & Dental University (TMDU); Osaka University; National Center for Global Health & Medicine - Japan; National Institute of Public Health - Japan; University of Tokyo; University of Tokyo; University of Tokyo; Waseda University; University of Tokyo; Aoyama Gakuin University; Tokyo Metropolitan University; Harvard University; Harvard T.H. Chan School of Public Health	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp	Abe, Sarah/ABF-2941-2020; Nomura, Shuhei/HCH-5356-2022; Kondo, Naoki/K-3898-2012; Machida, Munehito/AAQ-6879-2021; Kondo, Naoki/ABC-5865-2020; HORII, Satoko/AAE-5649-2022; Katsuma, Yasushi/AAR-6775-2020	Abe, Sarah/0000-0003-3991-2739; Kondo, Naoki/0000-0002-6425-6844; Machida, Munehito/0000-0002-7566-9011; Kondo, Naoki/0000-0002-6425-6844; HORII, Satoko/0000-0002-8459-1498; Katsuma, Yasushi/0000-0002-2957-9867; Nomura, Shuhei/0000-0002-2963-7297; Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare [H27-Chikyukibo-Tokutei-004]; Bill & Melinda Gates Foundation; WHO Kobe Center for Health Development	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO Kobe Center for Health Development	The Japan Global Health Working Group was chaired by Keizo Takemi and organised by the Japan Center for International Exchange (JCIE) and The University of Tokyo with the support of the Bill & Melinda Gates Foundation and the WHO Kobe Center for Health Development. This work is partly funded by a research grant from the Ministry of Health, Labour and Welfare (H27-Chikyukibo-Tokutei-004). We thank Shigeru Omi, Naoki Ikegami, Hiroki Nakatani, and Kiyoko Ikegami for their comments, and Satoko Itoh, Tomoko Suzuki, Kazumi Inden, Susan Hubbard, Maya Wedemeyer, and Shiho Kato for their support. The views expressed in this report are solely those of the authors.	Abe S, 2015, LANCET, V386, P2367, DOI 10.1016/S0140-6736(15)01172-1; Abe S, 2013, LANCET, V382, P915, DOI 10.1016/S0140-6736(13)61639-6; Anand S, 2012, LANCET, V379, P9, DOI 10.1016/S0140-6736(11)61148-3; [Anonymous], 2012, LANCET, V379, P193, DOI 10.1016/S0140-6736(12)60081-6; [Anonymous], 2015, FIN GLOB HLTH 2014 S; [Anonymous], 1999, DEV FREEDOM; [Anonymous], PAND RISK ON HLTH; [Anonymous], 2013, ECONOMIST; Cabinet Secretariat of Japan, 2011, DEF PLAN COMPR REF S; Commission on Human Security, 2003, HUMAN SECURITY NOW P; Consultative Expert Working Group on Research and Development Financing and Coordination, 2012, RES DEV MEET HLTH NE; Coutinho A, 2012, JAIDS-J ACQ IMM DEF, V60, pS152, DOI 10.1097/QAI.0b013e31825d0383; Farlow AWK, 2016, OXFORD REV ECON POL, V32, P1, DOI 10.1093/oxrep/grw002; G7 Germany, 2015, G7 GERM DECL G7 HLTH; Germany's Federal Ministry for Economic Cooperation and Development, 2015, ROADM HLTH SYST HLTH; Gostin LO, 2015, JAMA-J AM MED ASSOC, V314, P2621, DOI 10.1001/jama.2015.16281; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; International Federation of Pharmaceutical Manufacturers and Associations, 2015, RETH WAY WE FIGHT BA; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Japan International Cooperation Agency, 2014, OUTL PROJ; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1283, DOI 10.1016/j.drudis.2014.07.005; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ministry of Health Labour and Welfare of Japan, 2011, COMPR REF SOC SEC TA; Ministry of Health Labour and Welfare of Japan, 2015, INT COMM HEALTHC SYS; Miyata H, 2015, LANCET, V385, P2549, DOI 10.1016/S0140-6736(15)61135-7; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Moran M, 2015, NEGLECTED DIS RES DE; Oshio T, 2014, UNIVERSAL HLTH COVER; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; Reich MR, 2015, NEW ENGL J MED, V373, P1793, DOI 10.1056/NEJMp1410676; Reich MR, 2011, LANCET, V378, P1051, DOI 10.1016/S0140-6736(11)60274-2; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Schaferhoff M, 2015, LANCET, V386, P2436, DOI 10.1016/S0140-6736(15)61161-8; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Sen A., 1995, MORTALITY INDICATOR; Shiroyama H, 2016, ROUNDT DISC JAP GLOB; Slingsby BT, 2016, ROUNDT DISC JAP GLOB; Sridhar D, 2014, OVERSEEING GLOBAL HL; Sugishita T, 2016, ROUNDT DISC JAP GLOB; Tanihara S, 2013, DISASTER MED PUBLIC, V7, P403, DOI 10.1017/dmp.2013.41; The World Bank, 2014, WORLD BANK GROUP PRE; Tsutsui T, 2014, INT J INTEGR CARE, V14; United Nations, 2015, GOAL 17 REV GLOB PAR; WHO (World Health Organization), 2015, REP EB INT ASS PAN J; World Bank, 2015, GLOB FIN FAC SUPP EV; World Health Organization, CONT FUND EM; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization, 2014, ANT RES; Yamey G, 2016, OXFORD REV ECON POL, V32, P122, DOI 10.1093/oxrep/grv024	52	7	7	5	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2155	2162		10.1016/S0140-6736(16)30177-5	http://dx.doi.org/10.1016/S0140-6736(16)30177-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27301827				2022-12-28	WOS:000376450800039
J	Withington, P				Withington, Phil			The art of medicine Utopia, health, and happiness	LANCET			English	Editorial Material									[Withington, Phil] Univ Sheffield, Dept Hist, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Withington, P (corresponding author), Univ Sheffield, Dept Hist, Sheffield S10 2TN, S Yorkshire, England.	p.withington@sheffield.ac.uk			ESRC [ES/K00493X/1] Funding Source: UKRI; Economic and Social Research Council [ES/K00493X/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2011, HAPPINESS LESSONS NE; Davies William., 2015, HAPPINESS IND GOVT B; Dolan P., 2014, HAPPINESS DESIGN FIN; Withington Phil., 2017, SUFFERING HAPPINESS	4	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2084	2085		10.1016/S0140-6736(16)30532-3	http://dx.doi.org/10.1016/S0140-6736(16)30532-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM6HC	27308674	Green Accepted			2022-12-28	WOS:000376450800018
J	Qureshi, AI; Palesch, YY; Barsan, WG; Hanley, DF; Hsu, CY; Martin, RL; Moy, CS; Silbergleit, R; Steiner, T; Suarez, JI; Toyoda, K; Wang, YJ; Yamamoto, H; Yoon, BW				Qureshi, Adnan I.; Palesch, Yuko Y.; Barsan, William G.; Hanley, Daniel F.; Hsu, Chung Y.; Martin, Renee L.; Moy, Claudia S.; Silbergleit, Robert; Steiner, Thorsten; Suarez, Jose I.; Toyoda, Kazunori; Wang, Yongjun; Yamamoto, Haruko; Yoon, Byung-Woo		ATACH-2 Trial Investigators; Neurological Emergency Treatment T	Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE INTRACEREBRAL HEMORRHAGE; PERIHEMATOMAL EDEMA; REDUCTION; HEMATOMA; GROWTH; MANAGEMENT; STATES; TRIAL; CARE	BACKGROUND Limited data are available to guide the choice of a target for the systolic blood-pressure level when treating acute hypertensive response in patients with intracerebral hemorrhage. METHODS We randomly assigned eligible participants with intracerebral hemorrhage (volume, <60 cm(3)) and a Glasgow Coma Scale (GCS) score of 5 or more (on a scale from 3 to 15, with lower scores indicating worse condition) to a systolic blood-pressure target of 110 to 139 mm Hg (intensive treatment) or a target of 140 to 179 mm Hg (standard treatment) in order to test the superiority of intensive reduction of systolic blood pressure to standard reduction; intravenous nicardipine to lower blood pressure was administered within 4.5 hours after symptom onset. The primary outcome was death or disability (modified Rankin scale score of 4 to 6, on a scale ranging from 0 [no symptoms] to 6 [death]) at 3 months after randomization, as ascertained by an investigator who was unaware of the treatment assignments. RESULTS Among 1000 participants with a mean (+/- SD) systolic blood pressure of 200.6 +/- 27.0 mm Hg at baseline, 500 were assigned to intensive treatment and 500 to standard treatment. The mean age of the patients was 61.9 years, and 56.2% were Asian. Enrollment was stopped because of futility after a prespecified interim analysis. The primary outcome of death or disability was observed in 38.7% of the participants (186 of 481) in the intensive-treatment group and in 37.7% (181 of 480) in the standard-treatment group (relative risk, 1.04; 95% confidence interval, 0.85 to 1.27; analysis was adjusted for age, initial GCS score, and presence or absence of intraventricular hemorrhage). Serious adverse events occurring within 72 hours after randomization that were considered by the site investigator to be related to treatment were reported in 1.6% of the patients in the intensive-treatment group and in 1.2% of those in the standard-treatment group. The rate of renal adverse events within 7 days after randomization was significantly higher in the intensive-treatment group than in the standard-treatment group (9.0% vs. 4.0%, P = 0.002). CONCLUSIONS The treatment of participants with intracerebral hemorrhage to achieve a target systolic blood pressure of 110 to 139 mm Hg did not result in a lower rate of death or disability than standard reduction to a target of 140 to 179 mm Hg. (Funded by the National Institute of Neurological Disorders and Stroke and the National Cerebral and Cardiovascular Center; ATACH-2 ClinicalTrials. gov number, NCT01176565.)	[Qureshi, Adnan I.] Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, 925 Delaware St SE, Minneapolis, MN 55455 USA; [Palesch, Yuko Y.; Martin, Renee L.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Barsan, William G.; Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Hanley, Daniel F.] Johns Hopkins Univ, Div Brain Injury Outcomes, Baltimore, MD USA; [Moy, Claudia S.] NINDS, Neurol Inst, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Hsu, Chung Y.] China Med Univ, Taichung, Taiwan; [Steiner, Thorsten] Klinikum Frankfurt Hochst, Dept Neurol, Frankfurt, Germany; [Steiner, Thorsten] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Suarez, Jose I.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Yamamoto, Haruko] Natl Cerebral & Cardiovasc Ctr, Dept Data Sci, Suita, Osaka, Japan; [Wang, Yongjun] Beijing Tiantan Hosp, Beijing, Peoples R China; [Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea	University of Minnesota System; University of Minnesota Twin Cities; Medical University of South Carolina; University of Michigan System; University of Michigan; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); China Medical University Taiwan; Ruprecht Karls University Heidelberg; Baylor College of Medicine; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Capital Medical University; Seoul National University (SNU); Seoul National University Hospital	Qureshi, AI (corresponding author), Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, 925 Delaware St SE, Minneapolis, MN 55455 USA.	qureshai@gmail.com	Carhuapoma, Juan/AAC-5279-2019; Güresir, Erdem/AAV-7224-2021; Yamamoto, Haruko/HII-5306-2022; Steiner, Thorsten/L-2868-2018; Takahashi, Shinichi/L-3454-2013; IWUCHUKWU, IFEANYI/G-2559-2013; Rose, David Z./AAE-7437-2022; Carhuapoma, Juan/X-9195-2018; Poli, Sven/ACY-0995-2022	Carhuapoma, Juan/0000-0002-5868-7701; Güresir, Erdem/0000-0001-8319-0847; Steiner, Thorsten/0000-0002-5080-8222; Takahashi, Shinichi/0000-0002-0903-3891; IWUCHUKWU, IFEANYI/0000-0001-7790-7725; Rose, David Z./0000-0002-9449-6494; Jickling, Glen/0000-0003-3543-0820; Kulstad, Erik/0000-0002-9331-8266; Malkoff, Marc/0000-0002-6665-3114; Poli, Sven/0000-0002-0286-8781; Quinn, James/0000-0002-3694-2118; Hsu, Chung Y./0000-0002-5632-2733; , Dorothea/0000-0001-9893-989X; Sergot, Paulina/0000-0003-0796-8009; Qureshi, Adnan/0000-0003-4962-540X; Fukuda-Doi, Mayumi/0000-0003-0922-4417; Seder, David/0000-0002-9717-1038; Hanley, Daniel/0000-0002-9536-4258	National Institute of Neurological Disorders and Stroke; National Cerebral and Cardiovascular Center [ATACH-2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS062091, U01NS056975, U10NS086484, U01NS061861, U10NS058927, U01NS059041] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cerebral and Cardiovascular Center(National Cerebral & Cardiovascular Center - Japan); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and the National Cerebral and Cardiovascular Center; ATACH-2 ClinicalTrials.gov number, NCT01176565.	About EQ- 5D, ABOUT EQ 5D; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Anderson CS, 2010, STROKE, V41, P307, DOI 10.1161/STROKEAHA.109.561795; Arima H, 2010, HYPERTENSION, V56, P852, DOI 10.1161/HYPERTENSIONAHA.110.154328; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; DANDAPANI BK, 1995, STROKE, V26, P21, DOI 10.1161/01.STR.26.1.21; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Lattanzi S, 2015, J STROKE CEREBROVASC, V24, P1493, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.014; Lyden PD, 2007, STROKE, V38, P2262, DOI 10.1161/STROKEAHA.106.472746; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; McBee Na, 2012, J Vasc Interv Neurol, V5, P10; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P34; Qureshi AI, 2013, STROKE, V44, pS67, DOI 10.1161/STROKEAHA.111.000758; Qureshi AI, 2011, NEUROCRIT CARE, V14, P291, DOI 10.1007/s12028-010-9453-z; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Qureshi Ai, 2012, J Vasc Interv Neurol, V5, P6; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Steiner T., 2006, CEREBROVASC DIS, V22, P294; Sykora M, 2009, J NEUROL SCI, V284, P108, DOI 10.1016/j.jns.2009.04.028; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	23	509	537	4	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2016	375	11					1033	1043		10.1056/NEJMoa1603460	http://dx.doi.org/10.1056/NEJMoa1603460			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV6ZG	27276234	Green Accepted, Bronze			2022-12-28	WOS:000383085000006
J	Dong, XQ				Dong, XinQi			Elder Abuse in Nursing Homes: How Do We Advance the Field of Elder Justice?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MISTREATMENT; PINE		[Dong, XinQi] Rush Inst Hlth Aging, Chicago, IL USA	Rush University	Dong, XQ (corresponding author), Rush Univ, Med Ctr, Rush Inst Hlth Aging, 1645 West Jackson,Suite 675, Chicago, IL 60612 USA.	xinqi_dong@rush.edu			NATIONAL CANCER INSTITUTE [P20CA165588, R01CA163830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH100393, R34MH100443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042318, RC4AG039085] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD001650, R01MD006173] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Beach SR, 2010, GERONTOLOGIST, V50, P744, DOI 10.1093/geront/gnq053; Daly JM, 2011, J ELDER ABUSE NEGL, V23, P348, DOI 10.1080/08946566.2011.608048; Dong XQ, 2015, J AM GERIATR SOC, V63, P1214, DOI 10.1111/jgs.13454; Dong XQ, 2014, J GERONTOL A-BIOL, V69, pS68, DOI 10.1093/gerona/glu141; Dong XQ, 2014, J AGING HEALTH, V26, P1085, DOI 10.1177/0898264314526620; Dong XQ, 2011, JAMA-J AM MED ASSOC, V305, P2460, DOI 10.1001/jama.2011.835; Garcia M, 2015, CHICAGO TRIBUNE; Harris-Kojetin L, 2016, LONG TERM CAR PROV S; Lachs MS, 2016, ANN INTERN MED, V165, P229, DOI 10.7326/M15-1209; Sedensky Matt, 2016, CHICAGO TRIBUNE	10	1	1	2	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					288	289		10.7326/M16-1161	http://dx.doi.org/10.7326/M16-1161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27294410				2022-12-28	WOS:000381267200020
J	McLellan, RK				McLellan, Robert K.			Total Worker Health: A Promising Approach to a Safer and Healthier Workforce	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION WORKSHOP; INTERVENTIONS; PATHWAYS		[McLellan, Robert K.] Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA	Dartmouth College	McLellan, RK (corresponding author), Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA.	robert.k.mclellan@hitchcock.org	McLellan, Robert/AAF-5304-2020	McLellan, Robert/0000-0002-7163-3302				Anger WK, 2015, J OCCUP HEALTH PSYCH, V20, P226, DOI 10.1037/a0038340; Bradley CJ, 2016, ANN INTERN MED, V165, P279, DOI 10.7326/M16-0740; Feltner C, 2016, ANN INTERN MED, V165, P262, DOI 10.7326/M16-0626; Goetzel RZ, 2014, J OCCUP ENVIRON MED, V56, P927, DOI 10.1097/JOM.0000000000000276; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; NIOSH, 2016, NIOSH PUBL; Politi BJ, 2004, J OCCUP ENVIRON MED, V46, P550, DOI 10.1097/01.jom.0000128153.79025.e4; Schulte PA, 2012, AM J PUBLIC HEALTH, V102, P434, DOI 10.2105/AJPH.2011.300249; Sorensen G, 2011, AM J PUBLIC HEALTH, V101, pS196, DOI 10.2105/AJPH.2010.300075; Tomek IM, 2012, HEALTH AFFAIR, V31, P1329, DOI 10.1377/hlthaff.2011.0935	10	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					294	295		10.7326/M16-0965	http://dx.doi.org/10.7326/M16-0965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27239810				2022-12-28	WOS:000381267200023
J	Proudfoot, NJ				Proudfoot, Nick J.			Transcriptional termination in mammals: Stopping the RNA polymerase II juggernaut	SCIENCE			English	Review							PRE-MESSENGER-RNA; BUDDING YEAST; R-LOOPS; ALTERNATIVE POLYADENYLATION; EXORIBONUCLEASE RAT1; GENOME INSTABILITY; CONVERGENT GENES; POLY(A) SIGNALS; PIRNA CLUSTERS; END FORMATION	Terminating transcription is a highly intricate process for mammalian protein-coding genes. First, the chromatin template slows down transcription at the gene end. Then, the transcript is cleaved at the poly(A) signal to release themessenger RNA. The remaining transcript is selectively unraveled and degraded. This induces critical conformational changes in the heart of the enzyme that trigger termination. Termination can also occur at variable positions along the gene and so prevent aberrant transcript formation or intentionallymake different transcripts. Thesemay form multiplemessenger RNAs with altered regulatory properties or encode different proteins. Finally, termination can be perturbed to achieve particular cellular needs or blocked in cancer or virally infected cells. In such cases, failure to terminate transcription can spell disaster for the cell.	[Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk			Wellcome Trust [107928/Z/15/Z]; European Research Council [339270]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	I thank my lab colleagues, especially M. Dye and H. Mischo, for advice on the text. I am indebted to H. Mischo for the illustrations. The expanding field of Pol II termination has generated a large literature. I apologize that space restricts its wider citation. My laboratory is supported by a Wellcome Trust Investigator Award (107928/Z/15/Z) and European Research Council Advanced Grant (339270).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ASHE MP, 1995, GENE DEV, V9, P3008, DOI 10.1101/gad.9.23.3008; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Colin J, 2014, MOL CELL, V56, P667, DOI 10.1016/j.molcel.2014.10.026; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; de Almeida SF, 2014, SEMIN CELL DEV BIOL, V32, P2, DOI 10.1016/j.semcdb.2014.03.010; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Fong N, 2015, MOL CELL, V60, P256, DOI 10.1016/j.molcel.2015.09.026; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Genest PA, 2015, NUCLEIC ACIDS RES, V43, P2102, DOI 10.1093/nar/gkv095; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Gloss B. S., 2015, BIOCHIM BIOPHYS ACTA, V1859, P16, DOI DOI 10.1016/J.BBAGRM.2015.08.005; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; GROSSO AR, 2015, WIFE, V4, DOI DOI 10.7554/ELIFE.09214; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Li WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005166; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Masuda A, 2015, GENE DEV, V29, P1045, DOI 10.1101/gad.255737.114; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neve J, 2016, GENOME RES, V26, P24, DOI 10.1101/gr.193995.115; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Park J, 2015, NUCLEIC ACIDS RES, V43, P2625, DOI 10.1093/nar/gkv133; Pinto PAB, 2011, EMBO J, V30, P2431, DOI 10.1038/emboj.2011.156; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sanso M, 2016, GENE DEV, V30, P117, DOI 10.1101/gad.269589.115; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Varley KE, 2014, BREAST CANCER RES TR, V146, P287, DOI 10.1007/s10549-014-3019-2; Vilborg A, 2015, MOL CELL, V59, P449, DOI 10.1016/j.molcel.2015.06.016; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027; Zhang HM, 2015, MOL CELL, V59, P437, DOI 10.1016/j.molcel.2015.06.008; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030; Zhao DY, 2016, NATURE, V529, P48, DOI 10.1038/nature16469	97	214	215	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291							aad9926	10.1126/science.aad9926	http://dx.doi.org/10.1126/science.aad9926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284201	Green Accepted, Green Submitted			2022-12-28	WOS:000377972000032
J	Torjesen, I				Torjesen, Ingrid			Extra five years of aromatase inhibitors increases disease-free survival in breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chlebowski RT, 2016, NEW ENGL J MED, V375, P274, DOI 10.1056/NEJMe1606031; Goss PE, 2016, NEW ENGL J MED, V375, P209, DOI 10.1056/NEJMoa1604700	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3153	10.1136/bmj.i3153	http://dx.doi.org/10.1136/bmj.i3153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27268511				2022-12-28	WOS:000377857800010
J	Schwalb, B; Michel, M; Zacher, B; Fruhauf, K; Demel, C; Tresch, A; Gagneur, J; Cramer, P				Schwalb, Bjorn; Michel, Margaux; Zacher, Benedikt; Fruehauf, Katja; Demel, Carina; Tresch, Achim; Gagneur, Julien; Cramer, Patrick			TT-seq maps the human transient transcriptome	SCIENCE			English	Article							RNA-POLYMERASE-II; U1 SNRNP; HUMAN GENOME; INITIATION; TERMINATION; PROMOTERS; ENHANCERS; POLYADENYLATION; EXPRESSION; RESOLUTION	Pervasive transcription of the genome produces both stable and transient RNAs. We developed transient transcriptome sequencing (TT-seq), a protocol that uniformly maps the entire range of RNA-producing units and estimates rates of RNA synthesis and degradation. Application of TT-seq to human K562 cells recovers stable messenger RNAs and long intergenic noncoding RNAs and additionally maps transient enhancer, antisense, and promoter-associated RNAs. TT-seq analysis shows that enhancer RNAs are short-lived and lack U1 motifs and secondary structure. TT-seq also maps transient RNA downstream of polyadenylation sites and uncovers sites of transcription termination; we found, on average, four transcription termination sites, distributed in a window with a median width of similar to 3300 base pairs. Termination sites coincide with a DNA motif associated with pausing of RNA polymerase before its release from the genome.	[Schwalb, Bjorn; Michel, Margaux; Demel, Carina; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany; [Zacher, Benedikt; Gagneur, Julien] Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany; [Fruehauf, Katja] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, Halsovagen 7, S-14183 Huddinge, Sweden; [Fruehauf, Katja] Karolinska Inst, Sci Life Lab, Novum, Halsovagen 7, S-14183 Huddinge, Sweden; [Tresch, Achim] Univ Cologne, Dept Biol, Zulpicher Str 47, D-50647 Cologne, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany; [Gagneur, Julien] Tech Univ Munich, Dept Informat, Boltzmannstr 3, D-85748 Garching, Germany	Max Planck Society; University of Munich; Karolinska Institutet; Karolinska Institutet; University of Cologne; Max Planck Society; Technical University of Munich	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.; Gagneur, J (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.; Gagneur, J (corresponding author), Tech Univ Munich, Dept Informat, Boltzmannstr 3, D-85748 Garching, Germany.	gagneur@in.tum.de; patrick.cramer@mpibpc.mpg.de		Lidschreiber, Katja/0000-0001-6319-1076; Schwalb, Bjorn/0000-0003-2987-2622; Gagneur, Julien/0000-0002-8924-8365	Center for Innovative Medicine (CIMED) at Karolinska Institutet; Science for Life Laboratory (SciLifeLab) in Stockholm; Deutsche Forschungsgemeinschaft (DFG) fellowship at the Graduate School of Quantitative Biosciences Munich; German Federal Ministry of Education and Research (BMBF); DFG [SFB 680]; Bavarian Research Center for Molecular Biosystems; Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405A]; Advanced Grant TRANSIT of the European Research Council; DFG; Volkswagen Foundation; CIMED; SciLifeLab	Center for Innovative Medicine (CIMED) at Karolinska Institutet; Science for Life Laboratory (SciLifeLab) in Stockholm; Deutsche Forschungsgemeinschaft (DFG) fellowship at the Graduate School of Quantitative Biosciences Munich(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Bavarian Research Center for Molecular Biosystems; Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); Advanced Grant TRANSIT of the European Research Council; DFG(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); CIMED; SciLifeLab	The sequencing data and the annotation file have been deposited in the Gene Expression Omnibus database under accession code GSE75792. We thank H. Blum, S. Krebs, and A. Graf (Laboratory for Functional Genome Analysis, Gene Center, Ludwig-Maximilians-Universitat Munchen) for help with sequencing and J. A. Feuillet, J. Soeding, A. Sawicka, and C. Bernecky for help and discussions. K.F. was supported by the Center for Innovative Medicine (CIMED) at Karolinska Institutet and by the Science for Life Laboratory (SciLifeLab) in Stockholm. C.D. was supported by a Deutsche Forschungsgemeinschaft (DFG) fellowship at the Graduate School of Quantitative Biosciences Munich. A.T. was supported by a German Federal Ministry of Education and Research (BMBF) e:Bio grant and by DFG grant SFB 680. J.G. was supported by the Bavarian Research Center for Molecular Biosystems and the Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics" (grant FKZ 01ZX1405A). P.C. was funded by the Advanced Grant TRANSIT of the European Research Council, the DFG, the Volkswagen Foundation, CIMED, and SciLifeLab.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035	23	222	228	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1225	1228		10.1126/science.aad9841	http://dx.doi.org/10.1126/science.aad9841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257258				2022-12-28	WOS:000377045700044
J	Wolverton, M				Wolverton, Mark			DIGITAL FORENSICS IN THE LIBRARY	NATURE			English	Editorial Material																			0	0	0	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					139	140		10.1038/534139a	http://dx.doi.org/10.1038/534139a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN3LB	27257653	Bronze			2022-12-28	WOS:000376962300053
J	Luce, BR; Connor, JT; Broglio, KR; Mullins, CD; Ishak, KJ; Saunders, E; Davis, BR				Luce, Bryan R.; Connor, Jason T.; Broglio, Kristine R.; Mullins, C. Daniel; Ishak, K. Jack; Saunders, Elijah; Davis, Barry R.		RE-ADAPT REs Adaptive Methods Pra	Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution	ANNALS OF INTERNAL MEDICINE			English	Article							OFFER ADVANTAGES	Background: Bayesian and adaptive clinical trial designs offer the potential for more efficient processes that result in lower sample sizes and shorter trial durations than traditional designs. Objective: To explore the use and potential benefits of Bayesian adaptive clinical trial designs in comparative effectiveness research. Design: Virtual execution of ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) as if it had been done according to a Bayesian adaptive trial design. Setting: Comparative effectiveness trial of antihypertensive medications. Patients: Patient data sampled from the more than 42 000 patients enrolled in ALLHAT with publicly available data. Measurements: Number of patients randomly assigned between groups, trial duration, observed numbers of events, and overall trial results and conclusions. Results: The Bayesian adaptive approach and original design yielded similar overall trial conclusions. The Bayesian adaptive trial randomly assigned more patients to the better-performing group and would probably have ended slightly earlier. Limitations: This virtual trial execution required limited resampling of ALLHAT patients for inclusion in RE-ADAPT (REsearch in ADAptive methods for Pragmatic Trials). Involvement of a data monitoring committee and other trial logistics were not considered. Conclusion: In a comparative effectiveness research trial, Bayesian adaptive trial designs are a feasible approach and potentially generate earlier results and allocate more patients to better-performing groups.	[Luce, Bryan R.] Univ Washington, Dept Pharm, H172 Hlth Sci Bldg,1959 Northeast Pacific St, Seattle, WA 98195 USA; [Connor, Jason T.] Berry Consultants, 8290 Southwest 180th St, Miami, FL 33157 USA; [Broglio, Kristine R.] Berry Consultants, 4301 Westbank Dr,Bldg B,Suite 140, Austin, TX 78746 USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, 20 North Pine St, Baltimore, MD 21201 USA; [Ishak, K. Jack] Evidera, Dept Biostat, 7575 Trans Canada Highway,Suite 500, St Laurent, PQ H4T 1V6, Canada; [Davis, Barry R.] Univ Texas Houston, Sch Publ Hlth, Dept Biostat, 1200 Pressler St,Room W916, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Luce, BR (corresponding author), Univ Washington, Dept Pharm, H172 Hlth Sci Bldg,1959 Northeast Pacific St, Seattle, WA 98195 USA.	bluce@luceresearch.com		Mullins, C. Daniel/0000-0003-4322-2490	National Heart, Lung, and Blood Institute; NHLBI [1RC4HL106363-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC4HL106363] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Heart, Lung, and Blood Institute.; The RE-ADAPT (REsearch in ADAptive methods for Pragmatic Trials) project was supported by the NHLBI (award 1RC4HL106363-01).	BERGER JO, 1988, J AM STAT ASSOC, V83, P364, DOI 10.2307/2288851; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Brown CH, 2009, ANNU REV PUBL HEALTH, V30, P1, DOI 10.1146/annurev.publhealth.031308.100223; Connor JT, 2013, CLIN TRIALS, V10, P807, DOI 10.1177/1740774513497293; Connor JT, 2013, J CLIN EPIDEMIOL, V66, pS130, DOI 10.1016/j.jclinepi.2013.02.015; Davis BR, 2006, DATA MONITORING IN CLINICAL TRIALS, P248, DOI 10.1007/0-387-30107-0_23; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Karrison TG, 2003, CONTROL CLIN TRIALS, V24, P506, DOI 10.1016/S0197-2456(03)00092-8	9	12	12	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					431	+		10.7326/M15-0823	http://dx.doi.org/10.7326/M15-0823			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27273013				2022-12-28	WOS:000383962000018
J	Baragana, B; Hallyburton, I; Lee, MCS; Norcross, NR; Grimaldi, R; Otto, TD; Proto, WR; Blagborough, AM; Meister, S; Wirjanata, G; Ruecker, A; Upton, LM; Abraham, TS; Almeida, MJ; Pradhan, A; Porzelle, A; Martinez, MS; Bolscher, JM; Woodland, A; Lukschl, T; Norval, S; Zuccotto, F; Thomas, J; Simeons, F; Stojanovski, L; Osuna-Cabello, M; Brock, PM; Churcher, TS; Sala, KA; Zakutansky, SE; Jimenez-Diaz, MB; Sanz, LM; Riley, J; Basak, R; Campbell, M; Avery, VM; Sauerwein, RW; Dechering, KJ; Noviyanti, R; Campo, B; Frearson, JA; Angulo-Barturen, I; Ferrer-Bazaga, S; Gamo, FJ; Wyatt, PG; Leroy, D; Siegl, P; Delves, MJ; Kyle, DE; Wittlin, S; Marfurt, J; Price, RN; Sinden, RE; Winzeler, EA; Charman, SA; Bebrevska, L; Gray, DW; Campbell, S; Fairlamb, AH; Willis, PA; Rayner, JC; Fidock, DA; Read, KD; Gilbert, IH				Baragana, Beatriz; Hallyburton, Irene; Lee, Marcus C. S.; Norcross, Neil R.; Grimaldi, Raffaella; Otto, Thomas D.; Proto, William R.; Blagborough, Andrew M.; Meister, Stephan; Wirjanata, Grennady; Ruecker, Andrea; Upton, Leanna M.; Abraham, Tara S.; Almeida, Mariana J.; Pradhan, Anupam; Porzelle, Achim; Martinez, Maria Santos; Bolscher, Judith M.; Woodland, Andrew; Lukschl, Torsten; Norval, Suzanne; Zuccotto, Fabio; Thomas, John; Simeons, Frederick; Stojanovski, Laste; Osuna-Cabello, Maria; Brock, Paddy M.; Churcher, Tom S.; Sala, Katarzyna A.; Zakutansky, Sara E.; Jimenez-Diaz, Maria Belen; Sanz, Laura Maria; Riley, Jennifer; Basak, Rajshekhar; Campbell, Michael; Avery, Vicky M.; Sauerwein, Robert W.; Dechering, Koen J.; Noviyanti, Rintis; Campo, Brice; Frearson, Julie A.; Angulo-Barturen, Inigo; Ferrer-Bazaga, Santiago; Gamo, Francisco Javier; Wyatt, Paul G.; Leroy, Didier; Siegl, Peter; Delves, Michael J.; Kyle, Dennis E.; Wittlin, Sergio; Marfurt, Jutta; Price, Ric N.; Sinden, Robert E.; Winzeler, Elizabeth A.; Charman, Susan A.; Bebrevska, Lidiya; Gray, David W.; Campbell, Simon; Fairlamb, Alan H.; Willis, Paul A.; Rayner, Julian C.; Fidock, David A.; Read, Kevin D.; Gilbert, Ian H.			A novel multiple-stage antimalarial agent that inhibits protein synthesis (vol 522, pg 315, 2015)	NATURE			English	Correction													Fairlamb, Alan/A-5272-2009; Gray, David W/F-6674-2011; Avery, Vicky M/A-5449-2010; Ferrer-Bazaga, Santiago/AAA-7749-2021; Winzeler, Elizabeth/AAP-6752-2020; Zuccotto, Fabio/E-7144-2017; Otto, Thomas/ABE-7632-2020; Meister, Stephan/M-6608-2014	Fairlamb, Alan/0000-0001-5134-0329; Gray, David W/0000-0001-9512-3828; Avery, Vicky M/0000-0003-4914-2299; Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Winzeler, Elizabeth/0000-0002-4049-2113; Zuccotto, Fabio/0000-0002-3888-7423; Ruecker, Andrea/0000-0003-3804-9670; Delves, Michael/0000-0001-8526-4782; Otto, Thomas/0000-0002-1246-7404; Gilbert, Ian/0000-0002-5238-1314; Kyle, Dennis/0000-0002-0238-965X; Baragana, Beatriz/0000-0002-0959-1113; Meister, Stephan/0000-0003-2436-7037	MRC [MR/N00227X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103058] Funding Source: NIH RePORTER; Medical Research Council [MR/N00227X/1] Funding Source: Medline; NIAID NIH HHS [R01 AI103058] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451	1	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					122	122		10.1038/nature18280	http://dx.doi.org/10.1038/nature18280			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27281209	Bronze, Green Published			2022-12-28	WOS:000382426900051
J	Kaufman, JD; Adar, SD; Barr, RG; Budoff, M; Burke, GL; Curl, CL; Daviglus, ML; Roux, AVD; Gassett, AJ; Jacobs, DR; Kronmal, R; Larson, TV; Navas-Acien, A; Olives, C; Sampson, PD; Sheppard, L; Siscovick, DS; Stein, JH; Szpiro, AA; Watson, KE				Kaufman, Joel D.; Adar, Sara D.; Barr, R. Graham; Budoff, Matthew; Burke, Gregory L.; Curl, Cynthia L.; Daviglus, Martha L.; Roux, Ana V. Diez; Gassett, Amanda J.; Jacobs, David R., Jr.; Kronmal, Richard; Larson, Timothy V.; Navas-Acien, Ana; Olives, Casey; Sampson, Paul D.; Sheppard, Lianne; Siscovick, David S.; Stein, James H.; Szpiro, Adam A.; Watson, Karol E.			Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study	LANCET			English	Article							CARDIOVASCULAR-DISEASE; MESA AIR; YOUNG-ADULTS; PROGRESSION; EXPOSURE; PLAQUE; RISK; THICKNESS; CALCIUM; BURDEN	Background Long-term exposure to fine particulate matter less than 2.5 mu m in diameter (PM2.5) and traffic-related air pollutant concentrations are associated with cardiovascular risk. The disease process underlying these associations remains uncertain. We aim to assess association between long-term exposure to ambient air pollution and progression of coronary artery calcium and common carotid artery intima-media thickness. Methods In this prospective 10-year cohort study, we repeatedly measured coronary artery calcium by CT in 6795 participants aged 45-84 years enrolled in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) in six metropolitan areas in the USA. Repeated scans were done for nearly all participants between 2002 and 2005, for a subset of participants between 2005 and 2007, and for half of all participants between 2010 and 2012. Common carotid artery intima-media thickness was measured by ultrasound in all participants at baseline and in 2010-12 for 3459 participants. Residence-specific spatio-temporal pollution concentration models, incorporating community-specific measurements, agency monitoring data, and geographical predictors, estimated concentrations of PM2.5 and nitrogen oxides (NOX) between 1999 and 2012. The primary aim was to examine the association between both progression of coronary artery calcium and mean carotid artery intima-media thickness and long-term exposure to ambient air pollutant concentrations (PM2.5, NOX, and black carbon) between examinations and within the six metropolitan areas, adjusting for baseline age, sex, ethnicity, socioeconomic characteristics, cardiovascular risk factors, site, and CT scanner technology. Findings In this population, coronary calcium increased on average by 24 Agatston units per year (SD 58), and intimamedia thickness by 12 mu m per year (10), before adjusting for risk factors or air pollutant exposures. Participant-specific pollutant concentrations averaged over the years 2000-10 ranged from 9.2-22.6 mu g PM2.5/m(3) and 7.2-139.2 parts per billion (ppb) NOX. For each 5 mu g PM2.5/m(3) increase, coronary calcium progressed by 4.1 Agatston units per year (95% CI 1.4-6.8) and for each 40 ppb NOX coronary calcium progressed by 4.8 Agatston units per year (0.9-8.7). Pollutant exposures were not associated with intima-media thickness change. The estimate for the effect of a 5 mu g/m(3) higher long-term exposure to PM2.5 in intima-media thickness was -0.9 mu m per year (95% CI -3.0 to 1.3). For 40 ppb higher NOX, the estimate was 0.2 mu m per year (-1.9 to 2.4). Interpretation Increased concentrations of PM 2.5 and traffic-related air pollution within metropolitan areas, in ranges commonly encountered worldwide, are associated with progression in coronary calcification, consistent with acceleration of atherosclerosis. This study supports the case for global efforts of pollution reduction in prevention of cardiovascular diseases.	[Kaufman, Joel D.; Gassett, Amanda J.; Olives, Casey; Sheppard, Lianne] Univ Washington, Dept Environm & Occupat Hlth, Seattle, WA 98195 USA; [Kaufman, Joel D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kaufman, Joel D.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Kronmal, Richard; Sheppard, Lianne; Szpiro, Adam A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Larson, Timothy V.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Sampson, Paul D.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Adar, Sara D.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Barr, R. Graham] Columbia Univ, Dept Med, New York, NY USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, New York, NY USA; [Budoff, Matthew] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Burke, Gregory L.] Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Curl, Cynthia L.] Boise State Univ, Dept Community & Environm Hlth, Boise, ID 83725 USA; [Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Roux, Ana V. Diez] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Navas-Acien, Ana] Johns Hopkins Univ, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Stein, James H.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Watson, Karol E.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Columbia University; Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Wake Forest University; Idaho; Boise State University; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Drexel University; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; New York Academy of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles	Kaufman, JD (corresponding author), Univ Washington, Seattle, WA 98105 USA.	joelk@u.washington.edu	Watson, Karol/ABD-7425-2021; Budoff, Matthew/ABD-5175-2021; Kaufman, Joel D/B-5761-2008; Sheppard, Lianne/AAF-6304-2021	Budoff, Matthew/0000-0002-9616-1946; Kaufman, Joel D/0000-0003-4174-9037; Sheppard, Lianne/0000-0003-1622-508X; Jacobs, David/0000-0002-7232-0543; Stein, James/0000-0002-2770-8223; Curl, Cynthia/0000-0002-2478-2292	US Environmental Protection Agency and US National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095162, N01HC095164, N01HC095165, N01HC095166, N01HC095168, N01HC095160, N01HC095163, N01HC095161, N01HC095169, N01HC095167] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR001420, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095163, R21HL095165, R43HL095167, R44HL095169, R43HL095161, R43HL095169, R13HL095166, R43HL095160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, K24ES013195, P50ES015915, P30ES007033] Funding Source: NIH RePORTER	US Environmental Protection Agency and US National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	US Environmental Protection Agency and US National Institutes of Health.	Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430; Allen RW, 2012, ENVIRON HEALTH PERSP, V120, P824, DOI 10.1289/ehp.1104447; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Budoff MJ, 2009, AM J ROENTGENOL, V192, P613, DOI 10.2214/AJR.08.1242; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cohen MA, 2009, ENVIRON SCI TECHNOL, V43, P4687, DOI 10.1021/es8030837; Cosselman KE, 2015, NAT REV CARDIOL, V12, P627, DOI 10.1038/nrcardio.2015.152; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Gan WQ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004743; Gassett AJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001726; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Kaufman JD, 2012, AM J EPIDEMIOL, V176, P825, DOI 10.1093/aje/kws169; Keller JP, 2015, ENVIRON HEALTH PERSP, V123, P301, DOI 10.1289/ehp.1408145; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038; Murphy DM, 2011, ATMOS CHEM PHYS, V11, P4679, DOI 10.5194/acp-11-4679-2011; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shaw LJ, 2015, J AM COLL CARDIOL, V65, P1283, DOI 10.1016/j.jacc.2015.02.024; Spalt EW, 2016, J EXPO SCI ENV EPID, V26, P349, DOI 10.1038/jes.2015.29; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; U.S. EPA (U.S. Environmental Protection Agency), 2013, FED REG, V78, P3086	29	272	282	7	136	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					696	704		10.1016/S0140-6736(16)00378-0	http://dx.doi.org/10.1016/S0140-6736(16)00378-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	27233746	Green Accepted			2022-12-28	WOS:000381268700029
J	Cogswell, ME; Mugavero, K; Bowman, BA; Frieden, TR				Cogswell, Mary E.; Mugavero, Kristy; Bowman, Barbara A.; Frieden, Thomas R.			Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							URINARY SODIUM; POTASSIUM EXCRETION; BLOOD-PRESSURE; SALT; MORTALITY; REDUCTION; HEALTH; HYPERTENSION; SCIENCE; CONSUMPTION		[Cogswell, Mary E.; Mugavero, Kristy; Bowman, Barbara A.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA; [Frieden, Thomas R.] Ctr Dis Control & Prevent, Off Director, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cogswell, ME (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Adler AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009217.pub3; ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; [Anonymous], 2016, JAMA-J AM MED ASSOC; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Centers for Disease Control and Prevention, UND CAUS DEATH 1999; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cogswell ME, 2015, ANNU REV NUTR, V35, P349, DOI 10.1146/annurev-nutr-071714-034322; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; Department of Health and Human Services Department of Agriculture (Eds.), 2015, DIET GUID AM 2015 20, V8th; Dickinson BD, 2007, ARCH INTERN MED, V167, P1460, DOI 10.1001/archinte.167.14.1460; Drewnowski A, 2012, AM J CLIN NUTR, V96, P439, DOI 10.3945/ajcn.111.025353; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Hall J. E., 2011, GUYTON HALL TXB MED; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Institute of Medicine, 2013, SOD INT POP ASS EV; Institute of Medicine [IOM], 2010, STRATEGIES REDUCE SO; Institute of Medicine-IOM, 2008, DIETARY REFERENCE IN; International Food Information Council Foundation, WHATS YOUR HLTH WORT; Jackson SL, 2016, MMWR-MORBID MORTAL W, V64, P1393, DOI 10.15585/mmwr.mm6452a1; Jackson SL, 2016, AM J PREV MED, V50, P30, DOI 10.1016/j.amepre.2015.04.034; Johnson C, 2015, J CLIN HYPERTENS, V17, P401, DOI 10.1111/jch.12529; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Legetic B, 2011, J HEALTH COMMUN, V16, P37, DOI 10.1080/10810730.2011.601227; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; McMahon EJ, 2015, COCHRANE DB SYST REV, V2; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; Oparil S, 2014, NEW ENGL J MED, V371, P677, DOI 10.1056/NEJMe1407695; Patel SM, 2015, J NUTR, V145, P505, DOI 10.3945/jn.114.195982; Pfister R, 2014, EUR J HEART FAIL, V16, P394, DOI 10.1002/ejhf.56; Poggio R, 2015, PUBLIC HEALTH NUTR, V18, P695, DOI 10.1017/S1368980014000949; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Singer P, 2015, AM J HYPERTENS, V28, P335, DOI 10.1093/ajh/hpu141; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Strom BL, 2013, JAMA-J AM MED ASSOC, V310, P31, DOI 10.1001/jama.2013.7687; Suckling RJ, 2010, COCHRANE DB SYST REV, V12; Trinquart L, 2016, INT J EPIDEMIOL, V45, P251, DOI 10.1093/ije/dyv184; Udagawa K, 2008, ASIA PAC J CLIN NUTR, V17, P445; Van Vliet BN, 2008, INT J OBESITY, V32, pS35, DOI 10.1038/ijo.2008.205; Weaver CM, 2016, J HYPERTENS, V34, P1290, DOI 10.1097/HJH.0000000000000960; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; World Health Organization, 2012, DAIL IR FOL AC SUPPL; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1	64	117	120	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					580	586		10.1056/NEJMsb1607161	http://dx.doi.org/10.1056/NEJMsb1607161			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27248297	Green Accepted			2022-12-28	WOS:000382193100014
J	Cohen, AT; Harrington, RA; Goldhaber, SZ; Hull, RD; Wiens, BL; Gold, A; Hernandez, AF; Gibson, CM; Cohen, A; Harrington, R; Gibson, CM; Hull, R; Goldhaber, S; Hernandez, A; Ceresetto, JM; Colquhoun, D; Pilger, E; Polonetsky, L; Motte, S; Saraiva, JF; Raev, D; Mincheva, V; Kahn, S; Canon, CO; Malojcic, B; Mayer, O; Husted, S; Marandi, T; Lassila, R; Mottier, D; Shaburishvili, T; Bauersachs, R; Zeymer, U; Hajko, E; Zeltser, D; Ageno, W; Krievins, D; Bagdonas, A; Osores, JL; Tomkowski, W; Mot, S; Panchenko, E; Tan, RS; Gaspar, L; Jacobson, B; Monreal, M; Ongen, G; Parkhomenko, A; Uprichard, J; Yusen, R; Merli, G; Peacock, F; Schellong, S; Januzzi, J; Piovella, F; Cochet, M; Michalak, N; Stepanchak, M; Spielman, K; Neal, B; Florea, A; Chi, G; Szlosek, D; Jain, P; Popma, C; Korjian, S; Daaboul, Y; Halaby, R; Lemor, A; Zacarkim, M; Romero, G; Elenes, JRH; Alvarado, A; Susheela, A; Leitao, M; Gold, A; Bandman, O; Strumph, P; Vinh, N; Vance, A; Wiens, B; Smoak, C; Castelino, R; Goodman, S; Leeds, J; Al-Khalidi, H; Leimberger, J; Phillips, T; Francis, C; Buller, H; Roberts, R; Prins, M; Spyropoulos, A; Carrier, M; Lopes, RD; Devor, A; Kolls, B; Dedrick, J; Todd, J; Jones, WS; Eapen, Z; Ahmad, T; Brenna, JM; Brito, F; Gulack, B; Meza, J; Parikh, K; Cooper, L; Pagidipati, N; Guimaraes, P; Perkins, LM; Wilson, M; Collier, J; Hayden, N; Leizorovicz, A; Becker, F; Jennings, L; Bello, F; Ferrari, AE; Jure, H; Macin, S; Oliva, M; Parody, M; Poy, C; Baker, R; Coughlin, P; Finfer, S; Rubinfeld, A; Huber, K; Konig, J; Mathies, R; Schoenerr, H; Adzerikho, I; Koryk, V; Mikhailova, E; Mitkovskaya, N; Pimanov, S; Polonetsy, L; Soroka, N; Blockmans, D; Delforge, M; Dive, A; Lienart, F; Bizzacchi, JA; Fiss, E; Freire, A; Manenti, E; Ramacciotti, E; Raymuno, S; Rocha, A; Dimov, B; Grigorov, M; Kalpachki, R; Kamenova, Z; Kostadinova, M; Milanova, M; Pencheva, G; Runev, N; Stoeva, N; Stoyanov, M; Syulemzova, S; Todorov, G; Tokmakova, M; Dhar, A; Douketis, J; Le Gal, G; Pearce, M; Provencher, S; Verreault, S; Alarcon, MA; Lazcano, MO; Cardenas, SP; Butkovic-Soldo, S; Car, S; Ciglenecki, N; Francetic, I; Jakopovic, M; Kalinic-Grgorinic, H; Knezevic, A; Marusic, S; Vagic, JS; Skerk, V; Cermak, O; Chlumsky, J; Chochola, J; Cizek, V; Dunaj, M; Dusek, J; Francek, L; Havelka, J; Herold, M; Holaj, R; Horny, I; Hubac, J; Jajtner, P; Kolman, P; Lang, P; Mikulova, J; Podpera, I; Reiterer, P; Spacek, R; Vejvoda, J; Vyhnanek, M; Christensen, H; Lassen, M; Storgaard, M; Tuxen, C; Urhammer, S; Lember, M; Uuetoa, T; Airaksinen, J; Honkaniemi, J; Kaaja, R; Saarinen, J; Tatlisumak, T; Vikman, S; Agraou, B; Aquilanti, S; Belhassane, A; Brisot, D; De Geeter, G; Debourdeau, P; Decoulx, E; El Kouri, D; Falvo, N; Grange, C; Lacroix, P; Messas, E; Mismetti, P; Montaclair, K; Paleiron, N; Payot, L; Pernod, G; Pottier, P; Proust, A; Quere, I; Roy, PM; Schmidt, J; Simoneau, G; Datikashvili-David, I; Khabeishvili, G; Khintibidze, I; Kobulia, B; Megreladze, I; Pagava, Z; Paposhvili, K; Amann, B; Berrouschot, J; Beyer-Westendorf, J; Blessing, E; Bott, M; Dengler, T; Dziewas, R; Genth-Zotz, S; Hamann, F; Horacek, T; Klimpe, S; Kroning, R; Lapp, H; Lawall, H; Licka, M; Rizos, T; Tiefenbacher, C; Weimar, C; Alkonyi, B; Falukozy, J; Futo, L; Katona, A; Kirschner, R; Kristof, P; Lakatos, F; Laszlo, Z; Lupkovics, G; Merkely, B; Andras, CN; Nemeth, L; Papp, A; Soltesz, P; Sudar, Z; Szabo, G; Szegedi, N; Timar, G; Valco, J; Vertes, A; Efrati, S; Elias, M; Gafter, A; Hayek, T; Hussein, O; Lishner, M; Lugassy, G; Cerveri, I; D'Angelo, A; De Pellegrin, A; Imberti, D; Landolfi, R; Lembo, G; Lodigiani, C; Moia, M; Molteni, M; Mumoli, N; Novo, S; Orlandini, F; Parisi, R; Pizzini, A; Pomero, F; Salvi, A; Schenone, A; Visona, A; Martinova, V; Pontaga, N; Rozitis, V; Stukena, I; Alekniene, B; Basijokiene, V; Butkiene, Z; Griskeviciene, V; Naudziunas, A; Norvaisiene, R; Norviliene, R; Petrauskiene, R; Poskiene, R; Susinskiene, D; Valavicius, A; Leon, RC; Pereyra, RC; Karlo, LF; Horna, M; Salas, M; Yanez, LT; Fryze, W; Gaciong, Z; Gniot, J; Gorecka, D; Gruenpeter, P; Grzelakowski, P; Jastrzebski, D; Kucharski, L; Mirek-Bryniarska, E; Pulkowski, G; Sobkowicz, B; Sulik, P; Walasek, L; Waldemar, K; Wrzesinski, K; Balogh, ZE; Bojinca, M; Marin, I; Musetescu, R; Podoleanu, C; Popescu, M; Stamate, S; Stanciulescu, G; Vida-Simiti, L; Abashev, A; Andreev, D; Apartsin, K; Arkhipov, M; Averkov, O; Barbarash, O; Belskaya, G; Bogdanov, E; Boldueva, S; Chefranova, Z; Dovgalevskiy, Y; Ershova, O; Goloshchekin, B; Khachatryan, N; Klein, G; Kobalava, Z; Kosmacheva, E; Kostenko, V; Malygin, A; Martynenko, T; Martynenko, V; Maslova, N; Mordovin, V; Nikolaev, K; Nilk, R; Popov, D; Privalova, E; Reshetko, O; Sergeeva, E; Shapovalova, Y; Shpagina, L; Shvarts, Y; Simanenkov, V; Solovyov, O; Vishneva, E; Vishnevskiy, A; Apostolovic, S; Celic, V; Ilic, S; Kovacevic-Kuzmanovic, A; Miloradovic, V; Bodikova, S; Cervenakova, A; Dvorak, M; Herman, O; Hrubon, A; Kokles, M; Krastev, G; Payer, J; Prokop, D; Spisakova, M; Adler, D; Basson, M; Breedt, J; Engelbrecht, J; Mitha, I; Van Dyk, C; Sala, LAA; Lopez, CB; Bisbe, J; Guardiola, AC; Cepeda, JM; Cereto, F; Santos, ED; Ferrer, R; Cerezo, JG; Gonzales-Porras, JR; Grandes, J; Jimenez, D; Mellibovsky, L; Richart, C; Riera, A; Trujillo, J; Nunez, JAV; Villalta, J; Akgul, O; Guneri, S; Kilichesmez, K; Kirma, C; Kutluk, H; Nazliel, B; Okumus, G; Tigen, K; Topcuoglu, M; Tuncay, E; Abrahamovych, O; Batushkin, V; Brozhyk, J; Burmak, I; Godlevska, O; Goloborodko, A; Goloborodko, B; Goncharova, Y; Gryb, V; Karpenko, O; Kopytsya, M; Koshlia, V; Krakhmalova, O; Kyrychenko, I; Legkonogov, O; Malynovsky, Y; Maslovaskyi, V; Nikonov, V; Parkhomenko, O; Perepeliuk, M; Reshotko, D; Rudenko, L; Ryabichenko, T; Svyridova, I; Svyshchenko, Y; Tseluyko, V; Ursol, G; Vakaliuk, I; Vishnivestsky, I; Voronkov, L; Yagensky, A; Body, R; Davis, M; MacCallum, P; McCollum, C; Natarajan, I; Almasri, E; Amin, M; Anderson, C; Baker, S; Barney, J; Bastani, A; Bercz, P; Bidair, M; Carman, T; Chang, H; Clark, C; Concha, M; Cornell, J; Dhingra, R; Doshi, A; Farley, B; Fermann, G; Fraiz, J; Fulmer, J; Gaggin, H; Goytia-Leos, D; Hahn, B; Haidar, A; Hamad, A; Hazelrigg, M; Ioachimescu, O; Kabler, H; Kao, CK; Kazimir, M; Kouras, F; Kung, M; Lerner, R; Lopez, J; Macchiavelli, A; Mahal, S; Margolis, B; McLaren, G; Milling, T; Mittal, M; Nadar, V; Ohaju, V; Ortel, T; Overcash, J; Parthiban, K; Pearl, R; Pineda, L; Pratt, R; Pullman, J; Quintana, O; Rajan, R; Rastogi, P; Rees, C; Rodriguez, W; Saba, F; Shammas, N; Sharma, S; Sokol, S; Stoltz, S; Tuck, M; Updegrove, J; Warner, A; Welch, M; Welker, J; Whitman, B; Wichman, T; Yousef, K; Zakai, N				Cohen, Alexander T.; Harrington, Robert A.; Goldhaber, Samuel Z.; Hull, Russell D.; Wiens, Brian L.; Gold, Alex; Hernandez, Adrian F.; Gibson, C. Michael; Cohen, Alexander; Harrington, Robert; Gibson, C. Michael; Hull, Russell; Goldhaber, Samuel; Hernandez, Adrian; Ceresetto, Jose Manuel; Colquhoun, David; Pilger, Ernst; Polonetsky, Leonid; Motte, Serge; Saraiva, Jose Francisco; Raev, Dimitar; Mincheva, Valentina; Kahn, Susan; Canon, Claudia Olivares; Malojcic, Branko; Mayer, Otto; Husted, Steen; Marandi, Toomas; Lassila, Riitta; Mottier, Dominique; Shaburishvili, Tamaz; Bauersachs, Rupert; Zeymer, Uwe; Hajko, Erik; Zeltser, David; Ageno, Walter; Krievins, Dainis; Bagdonas, Alfredas; Osores, Juan Lema; Tomkowski, Witold; Mot, Stefan; Panchenko, Elizaveta; Tan, Ru San; Gaspar, Ludovit; Jacobson, Barry; Monreal, Manuel; Ongen, Gul; Parkhomenko, Alexander; Uprichard, James; Yusen, Roger; Merli, Geno; Peacock, Frank; Schellong, Sebastian; Januzzi, James; Piovella, Franco; Cochet, Madeleine; Michalak, Nathan; Stepanchak, Maria; Spielman, Kathryn; Neal, Brandon; Florea, Ana; Chi, Gerald; Szlosek, Donald; Jain, Purva; Popma, Christopher; Korjian, Serge; Daaboul, Yazan; Halaby, Rim; Lemor, Alejandro; Zacarkim, Marcelo; Romero, Gonzalo; Hernandez Elenes, Jesus Rosario; Alvarado, Alonso; Susheela, Ammu; Leitao, Meghan; Gold, Alex; Bandman, Olga; Strumph, Peter; Vinh, Nancy; Vance, Annemarie; Wiens, Brian; Smoak, Carey; Castelino, Rennie; Goodman, Shelly; Leeds, Janet; al-Khalidi, Hussein; Leimberger, Jeffrey; Phillips, Thomas; Francis, Charles; Buller, Harry; Roberts, Robin; Prins, Martin; Spyropoulos, Alex; Carrier, Marc; Lopes, Renato D.; Devor, Adam; Kolls, Bradley; Dedrick, Joseph; Todd, Jamie; Jones, William Schuyler; Eapen, Zubin; Ahmad, Tariq; Brenna, J. Matthew; Brito, Flavio; Gulack, Brian; Meza, James; Parikh, Kishan; Cooper, Lauren; Pagidipati, Neha; Guimaraes, Patricia; Perkins, Lynn M.; Wilson, Matthew; Collier, Jeannie; Hayden, Nikieia; Leizorovicz, Alain; Becker, Francois; Jennings, Lisa; Bello, F.; Ferrari, A. E.; Jure, H.; Macin, S.; Oliva, M.; Parody, M.; Poy, C.; Baker, R.; Coughlin, P.; Finfer, S.; Rubinfeld, A.; Huber, K.; Konig, J.; Mathies, R.; Schoenerr, H.; Adzerikho, I.; Koryk, V.; Mikhailova, E.; Mitkovskaya, N.; Pimanov, S.; Polonetsy, L.; Soroka, N.; Blockmans, D.; Delforge, M.; Dive, A.; Lienart, F.; Bizzacchi, J. Annichino; Fiss, E.; Freire, A.; Manenti, E.; Ramacciotti, E.; Raymuno, S.; Rocha, A.; Dimov, B.; Grigorov, M.; Kalpachki, R.; Kamenova, Z.; Kostadinova, M.; Milanova, M.; Pencheva, G.; Runev, N.; Stoeva, N.; Stoyanov, M.; Syulemzova, S.; Todorov, G.; Tokmakova, M.; Dhar, A.; Douketis, J.; Le Gal, G.; Pearce, M.; Provencher, S.; Verreault, S.; Alarcon, M. Arias; Lazcano, M. Opazo; Cardenas, S. Potthoff; Butkovic-Soldo, S.; Car, S.; Ciglenecki, N.; Francetic, I.; Jakopovic, M.; Kalinic-Grgorinic, H.; Knezevic, A.; Marusic, S.; Vagic, J. Sikic; Skerk, V.; Cermak, O.; Chlumsky, J.; Chochola, J.; Cizek, V.; Dunaj, M.; Dusek, J.; Francek, L.; Havelka, J.; Herold, M.; Holaj, R.; Horny, I.; Hubac, J.; Jajtner, P.; Kolman, P.; Lang, P.; Mikulova, J.; Podpera, I.; Reiterer, P.; Spacek, R.; Vejvoda, J.; Vyhnanek, M.; Christensen, H.; Lassen, M.; Storgaard, M.; Tuxen, C.; Urhammer, S.; Lember, M.; Uuetoa, T.; Airaksinen, J.; Honkaniemi, J.; Kaaja, R.; Saarinen, J.; Tatlisumak, T.; Vikman, S.; Agraou, B.; Aquilanti, S.; Belhassane, A.; Brisot, D.; De Geeter, G.; Debourdeau, P.; Decoulx, E.; El Kouri, D.; Falvo, N.; Grange, C.; Lacroix, P.; Messas, E.; Mismetti, P.; Montaclair, K.; Paleiron, N.; Payot, L.; Pernod, G.; Pottier, P.; Proust, A.; Quere, I.; Roy, P-M.; Schmidt, J.; Simoneau, G.; Datikashvili-David, I.; Khabeishvili, G.; Khintibidze, I.; Kobulia, B.; Megreladze, I.; Pagava, Z.; Paposhvili, K.; Amann, B.; Berrouschot, J.; Beyer-Westendorf, J.; Blessing, E.; Bott, M.; Dengler, T.; Dziewas, R.; Genth-Zotz, S.; Hamann, F.; Horacek, T.; Klimpe, S.; Kroning, R.; Lapp, H.; Lawall, H.; Licka, M.; Rizos, T.; Tiefenbacher, C.; Weimar, C.; Alkonyi, B.; Falukozy, J.; Futo, L.; Katona, A.; Kirschner, R.; Kristof, P.; Lakatos, F.; Laszlo, Z.; Lupkovics, G.; Merkely, B.; Andras, C. Nagy; Nemeth, L.; Papp, A.; Soltesz, P.; Sudar, Z.; Szabo, G.; Szegedi, N.; Timar, G.; Valco, J.; Vertes, A.; Efrati, S.; Elias, M.; Gafter, A.; Hayek, T.; Hussein, O.; Lishner, M.; Lugassy, G.; Cerveri, I.; D'Angelo, A.; De Pellegrin, A.; Imberti, D.; Landolfi, R.; Lembo, G.; Lodigiani, C.; Moia, M.; Molteni, M.; Mumoli, N.; Novo, S.; Orlandini, F.; Parisi, R.; Pizzini, A.; Pomero, F.; Salvi, A.; Schenone, A.; Visona, A.; Martinova, V.; Pontaga, N.; Rozitis, V.; Stukena, I.; Alekniene, B.; Basijokiene, V.; Butkiene, Z.; Griskeviciene, V.; Naudziunas, A.; Norvaisiene, R.; Norviliene, R.; Petrauskiene, R.; Poskiene, R.; Susinskiene, D.; Valavicius, A.; Castillo Leon, R.; Pereyra, R. Cotrina; Karlo, L. Farjardo; Horna, M.; Salas, M.; Yanez, L. Toche; Fryze, W.; Gaciong, Z.; Gniot, J.; Gorecka, D.; Gruenpeter, P.; Grzelakowski, P.; Jastrzebski, D.; Kucharski, L.; Mirek-Bryniarska, E.; Pulkowski, G.; Sobkowicz, B.; Sulik, P.; Walasek, L.; Waldemar, K.; Wrzesinski, K.; Balogh, Z. E.; Bojinca, M.; Marin, I.; Musetescu, R.; Podoleanu, C.; Popescu, M.; Stamate, S.; Stanciulescu, G.; Vida-Simiti, L.; Abashev, A.; Andreev, D.; Apartsin, K.; Arkhipov, M.; Averkov, O.; Barbarash, O.; Belskaya, G.; Bogdanov, E.; Boldueva, S.; Chefranova, Z.; Dovgalevskiy, Y.; Ershova, O.; Goloshchekin, B.; Khachatryan, N.; Klein, G.; Kobalava, Z.; Kosmacheva, E.; Kostenko, V.; Malygin, A.; Martynenko, T.; Martynenko, V.; Maslova, N.; Mordovin, V.; Nikolaev, K.; Nilk, R.; Popov, D.; Privalova, E.; Reshetko, O.; Sergeeva, E.; Shapovalova, Y.; Shpagina, L.; Shvarts, Y.; Simanenkov, V.; Solovyov, O.; Vishneva, E.; Vishnevskiy, A.; Apostolovic, S.; Celic, V.; Ilic, S.; Kovacevic-Kuzmanovic, A.; Miloradovic, V.; Bodikova, S.; Cervenakova, A.; Dvorak, M.; Herman, O.; Hrubon, A.; Kokles, M.; Krastev, G.; Payer, J.; Prokop, D.; Spisakova, M.; Adler, D.; Basson, M.; Breedt, J.; Engelbrecht, J.; Mitha, I.; Van Dyk, C.; Alvarez Sala, L. A.; Barbagelata Lopez, C.; Bisbe, J.; Castro Guardiola, A.; Cepeda, J. M.; Cereto, F.; Diaz Santos, E.; Ferrer, R.; Gomez Cerezo, J.; Gonzales-Porras, J. R.; Grandes, J.; Jimenez, D.; Mellibovsky, L.; Richart, C.; Riera, A.; Trujillo, J.; Vargas Nunez, J. A.; Villalta, J.; Akgul, O.; Guneri, S.; Kilichesmez, K.; Kirma, C.; Kutluk, H.; Nazliel, B.; Okumus, G.; Tigen, K.; Topcuoglu, M.; Tuncay, E.; Abrahamovych, O.; Batushkin, V.; Brozhyk, J.; Burmak, I.; Godlevska, O.; Goloborodko, A.; Goloborodko, B.; Goncharova, Y.; Gryb, V.; Karpenko, O.; Kopytsya, M.; Koshlia, V.; Krakhmalova, O.; Kyrychenko, I.; Legkonogov, O.; Malynovsky, Y.; Maslovaskyi, V.; Nikonov, V.; Parkhomenko, O.; Perepeliuk, M.; Reshotko, D.; Rudenko, L.; Ryabichenko, T.; Svyridova, I.; Svyshchenko, Y.; Tseluyko, V.; Ursol, G.; Vakaliuk, I.; Vishnivestsky, I.; Voronkov, L.; Yagensky, A.; Body, R.; Davis, M.; MacCallum, P.; McCollum, C.; Natarajan, I.; Almasri, E.; Amin, M.; Anderson, C.; Baker, S.; Barney, J.; Bastani, A.; Bercz, P.; Bidair, M.; Carman, T.; Chang, H.; Clark, C.; Concha, M.; Cornell, J.; Dhingra, R.; Doshi, A.; Farley, B.; Fermann, G.; Fraiz, J.; Fulmer, J.; Gaggin, H.; Goytia-Leos, D.; Hahn, B.; Haidar, A.; Hamad, A.; Hazelrigg, M.; Ioachimescu, O.; Kabler, H.; Kao, C-K.; Kazimir, M.; Kouras, F.; Kung, M.; Lerner, R.; Lopez, J.; Macchiavelli, A.; Mahal, S.; Margolis, B.; McLaren, G.; Milling, T., Jr.; Mittal, M.; Nadar, V.; Ohaju, V.; Ortel, T.; Overcash, J.; Parthiban, K.; Pearl, R.; Pineda, L.; Pratt, R.; Pullman, J.; Quintana, O.; Rajan, R.; Rastogi, P.; Rees, C.; Rodriguez, W.; Saba, F.; Shammas, N.; Sharma, S.; Sokol, S.; Stoltz, S.; Tuck, M.; Updegrove, J.; Warner, A.; Welch, M.; Welker, J.; Whitman, B.; Wichman, T.; Yousef, K.; Zakai, N.		APEX Investigators	Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM RISK; HOSPITALIZED-PATIENTS; PREVENTION; DURATION; PLACEBO; PROPHYLAXIS; ENOXAPARIN	BACKGROUND Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. METHODS Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) for 10 +/- 4 days plus oral betrixaban placebo for 35 to 42 days or subcutaneous enoxaparin placebo for 10 +/- 4 days plus oral betrixaban (at a dose of 80 mg once daily) for 35 to 42 days. We performed sequential analyses in three prespecified, progressively inclusive cohorts: patients with an elevated d-dimer level (cohort 1), patients with an elevated d-dimer level or an age of at least 75 years (cohort 2), and all the enrolled patients (overall population cohort). The statistical analysis plan specified that if the between-group difference in any analysis in this sequence was not significant, the other analyses would be considered exploratory. The primary efficacy outcome was a composite of asymptomatic proximal deep-vein thrombosis and symptomatic venous thromboembolism. The principal safety outcome was major bleeding. RESULTS A total of 7513 patients underwent randomization. In cohort 1, the primary efficacy outcome occurred in 6.9% of patients receiving betrixaban and 8.5% receiving enoxaparin (relative risk in the betrixaban group, 0.81; 95% confidence interval [CI], 0.65 to 1.00; P = 0.054). The rates were 5.6% and 7.1%, respectively (relative risk, 0.80; 95% CI, 0.66 to 0.98; P = 0.03) in cohort 2 and 5.3% and 7.0% (relative risk, 0.76; 95% CI, 0.63 to 0.92; P = 0.006) in the overall population. (The last two analyses were considered to be exploratory owing to the result in cohort 1.) In the overall population, major bleeding occurred in 0.7% of the betrixaban group and 0.6% of the enoxaparin group (relative risk, 1.19; 95% CI, 0.67 to 2.12; P = 0.55). CONCLUSIONS Among acutely ill medical patients with an elevated d-dimer level, there was no significant difference between extended-duration betrixaban and a standard regimen of enoxaparin in the prespecified primary efficacy outcome. However, prespecified exploratory analyses provided evidence suggesting a benefit for betrixaban in the two larger cohorts. (Funded by Portola Pharmaceuticals; APEX ClinicalTrials.gov number, NCT01583218.)	[Cohen, Alexander T.] Guys & St Thomas Hosp, London, England; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Wiens, Brian L.; Gold, Alex] Portola Pharmaceut, San Francisco, CA USA; [Goldhaber, Samuel Z.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hull, Russell D.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Hernandez, Adrian F.] Duke Univ, Div Cardiol, Durham, NC USA; [Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA	Guy's & St Thomas' NHS Foundation Trust; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Calgary; Duke University; Duke University	Cohen, AT (corresponding author), Kings Coll London, Guys & St Thomas Hosp, Dept Haematol Med, London SE1 7EH, England.	alexander.cohen@kcl.ac.uk	Quere, Isabelle/AAB-8519-2020; Okumus, Gulfer/AAE-4618-2020; Mordovin, Victor/F-8913-2017; Nikolaev, Konstantin/P-4750-2017; Mikhailova, Elena/AAC-5722-2021; Dziewas, Rainer/AAX-9505-2020; Lemor, Alejandro/AAN-3346-2020; Body, Richard/C-2736-2010; Imberti, Davide/AGB-5049-2022; Januzzi, James/Y-2436-2019; Panchenko, Elizaveta/AAN-1884-2020; Baker, Ross/AAG-5798-2021; Gibson, C. Michael/AAE-8212-2019; Payer, Juraj/AAG-1606-2019; Maslovskyi, Valentyn/V-3896-2019; Landolfi, Raffaele/AAL-4496-2020; Nunez, Juan/GVT-1608-2022; Lodigiani, Corrado/AAW-1964-2020; Podoleanu, Cristian/E-2850-2010; Daaboul, Yazan/AAP-7792-2020; Apartsin, Konstantin A/B-9179-2017; Nazliel, Bijen/ABI-2924-2020; Ioachimescu, Octavian Cosmin/AAG-5963-2019; Reshetko, Olga/I-7011-2013; Mumoli, Nicola/J-4652-2019; Topcuoglu, Mehmet A./ABE-2655-2021; Milling, Truman J/N-6601-2017; Lember, Margus/H-2306-2015; Kosmacheva, Elena/AAY-4841-2020; RICHART, CRISTOBAL C/S-9158-2017; Maslovskyi, Valentyn/GQO-9125-2022; Holaj, Robert/D-4241-2017; Beyer-Westendorf, Jan/K-7569-2019; Malynovsky, Yaroslav/T-1898-2017; falvo, nicolas/AAT-1864-2021; Douketis, James/AAO-5659-2021; Roy, Pierre-Marie/AAA-7737-2022; Apartsin, Konstantin/ABC-5678-2020; Hernandez, Adrian F/A-7818-2016; Airaksinen, Juhani/AAC-7857-2021; Holaj, Robert/GLR-5862-2022; Chi, Gerald/M-7855-2017; Mitkovskaya, Natalya/AAV-6369-2021; Shvarts, Yury Григорьевич/AAB-4929-2022; Shpagina, Lyubov/Y-7864-2018; Boldueva, Svetlana/AAH-3862-2019; Bojinca, Mihai/ABE-4724-2021; Averkov, Oleg V/P-9566-2017; Piovella, Franco/AAM-8305-2020; Apartsin, Konstantin/ACA-8088-2022; Barbarash, Olga/A-4834-2017; Aleksandr, Legkonogov/P-8914-2015	Quere, Isabelle/0000-0002-1492-9764; Mordovin, Victor/0000-0002-2238-4573; Nikolaev, Konstantin/0000-0003-4601-6203; Mikhailova, Elena/0000-0001-9716-4009; Dziewas, Rainer/0000-0003-1592-8461; Body, Richard/0000-0001-9089-8130; Imberti, Davide/0000-0002-9284-6227; Baker, Ross/0000-0002-2728-6788; Maslovskyi, Valentyn/0000-0001-5184-1799; Landolfi, Raffaele/0000-0002-7913-8576; Lodigiani, Corrado/0000-0002-9152-9385; Podoleanu, Cristian/0000-0001-9987-2519; Apartsin, Konstantin A/0000-0003-0577-9001; Ioachimescu, Octavian Cosmin/0000-0001-9047-6894; Reshetko, Olga/0000-0003-3107-7636; Mumoli, Nicola/0000-0001-7166-5630; Milling, Truman J/0000-0002-5588-0426; RICHART, CRISTOBAL C/0000-0003-0852-6739; Maslovskyi, Valentyn/0000-0001-5184-1799; Holaj, Robert/0000-0002-9488-9706; Beyer-Westendorf, Jan/0000-0002-6983-9993; Malynovsky, Yaroslav/0000-0002-9118-1104; Apartsin, Konstantin/0000-0003-0577-9001; Hernandez, Adrian F/0000-0003-3387-9616; Airaksinen, Juhani/0000-0002-0193-568X; Chi, Gerald/0000-0002-8371-1689; Mitkovskaya, Natalya/0000-0002-9088-721X; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Shpagina, Lyubov/0000-0003-0871-7551; Boldueva, Svetlana/0000-0002-1898-084X; Apartsin, Konstantin/0000-0003-0577-9001; Averkov, Oleg/0000-0002-3010-755X; salvi, aldo/0000-0002-5601-8790; hamad, abdullah/0000-0003-4677-7686; Khachatryan, Nvard/0000-0003-1109-6864; Krastev, Georgi/0000-0002-2904-3317; Apostolovic, Svetlana/0000-0001-9015-297X; Barbarash, Olga/0000-0002-4642-3610; Nazliel, Bijen/0000-0002-6148-3814; Adzeriho, Igor'/0000-0001-6572-8842; Aleksandr, Legkonogov/0000-0002-5551-4872; Viktoriia, Gryb/0000-0001-6111-7921; Kosmacheva, Elena/0000-0001-8600-0199; Nikonov, Vadim/0000-0002-0078-9991; Szabo, Gabor/0000-0001-6038-9968; Godlevska, Olga/0000-0001-7473-9711; Storgaard, Merete/0000-0001-6110-5963; Ramacciotti, Eduardo/0000-0002-5735-1333; Tuck, Matthew/0000-0002-5991-0709	Portola Pharmaceuticals; National Institute for Health Research [PDF-2012-05-193] Funding Source: researchfish	Portola Pharmaceuticals; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Portola Pharmaceuticals; APEX ClinicalTrials.gov number, NCT01583218.	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Amin AN, 2012, J HOSP MED, V7, P231, DOI 10.1002/jhm.1002; Anderson FA, 2007, AM J HEMATOL, V82, P777, DOI 10.1002/ajh.20983; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Cohen AT, 2014, J THROMB HAEMOST, V12, P479, DOI 10.1111/jth.12515; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Cohen AT, 2015, AM HEART J, V169, P186, DOI 10.1016/j.ahj.2014.09.004; Cohen AT, 2014, AM HEART J, V167, P335, DOI 10.1016/j.ahj.2013.11.006; Cohen AT, 2013, NEW ENGL J MED, V368, P513, DOI 10.1056/NEJMoa1111096; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Fraisse F, 2000, AM J RESP CRIT CARE, V161, P1109, DOI 10.1164/ajrccm.161.4.9807025; Goldhaber SZ, 2011, NEW ENGL J MED, V365, P2167, DOI 10.1056/NEJMoa1110899; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Quan H, 2007, STAT MED, V26, P4703, DOI 10.1002/sim.2893; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Vaitkus PT, 2005, THROMB HAEMOSTASIS, V93, P76, DOI 10.1160/TH04-05-0323; Westfall PH, 1998, STAT MED, V17, P2107, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2107::AID-SIM910>3.0.CO;2-W	25	304	316	3	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					534	544		10.1056/NEJMoa1601747	http://dx.doi.org/10.1056/NEJMoa1601747			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27232649	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000382193100006
J	Sisirak, V; Sally, B; D'Agati, V; Martinez-Ortiz, W; Ozcakar, ZB; David, J; Rashidfarrokhi, A; Yeste, A; Panea, C; Chida, AS; Bogunovic, M; Ivanov, II; Quintana, FJ; Sanz, I; Elkon, KB; Tekin, M; Yalcinkaya, F; Cardozo, TJ; Clancy, RM; Buyon, JP; Reizis, B				Sisirak, Vanja; Sally, Benjamin; D'Agati, Vivette; Martinez-Ortiz, Wilnelly; Ozcakar, Z. Birsin; David, Joseph; Rashidfarrokhi, Ali; Yeste, Ada; Panea, Casandra; Chida, Asiya Seema; Bogunovic, Milena; Ivanov, Ivaylo I.; Quintana, Francisco J.; Sanz, Inaki; Elkon, Keith B.; Tekin, Mustafa; Yalcinkaya, Fatos; Cardozo, Timothy J.; Clancy, Robert M.; Buyon, Jill P.; Reizis, Boris			Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY LOCI; FREE DNA; DNASE1L3; DISEASE; AUTOANTIBODIES; PLASMA; NEUTROPHILS; ACTIVATION; ANTIBODIES	Antibodies to DNA and chromatin drive autoimmunity in systemic lupus erythematosus (SLE). Null mutations and hypomorphic variants of the secreted deoxyribonuclease DNASE1L3 are linked to familial and sporadic SLE, respectively. We report that DNASE1L3-deficient mice rapidly develop autoantibodies to DNA and chromatin, followed by an SLE-like disease. Circulating DNASE1L3 is produced by dendritic cells and macrophages, and its levels inversely correlate with anti-DNA antibody response. DNASE1L3 is uniquely capable of digesting chromatin in microparticles released from apoptotic cells. Accordingly, DNASE1L3-deficient mice and human patients have elevated DNA levels in plasma, particularly in circulating microparticles. Murine and human autoantibody clones and serum antibodies from human SLE patients bind to DNASE1L3-sensitive chromatin on the surface of microparticles. Thus, extracellular microparticle-associated chromatin is a potential self-antigen normally digested by circulating DNASE1L3. The loss of this tolerance mechanism can contribute to SLE, and its restoration may represent a therapeutic opportunity in the disease.	[Sisirak, Vanja; Sally, Benjamin; David, Joseph; Rashidfarrokhi, Ali; Reizis, Boris] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Sally, Benjamin; Panea, Casandra; Ivanov, Ivaylo I.; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [D'Agati, Vivette] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Martinez-Ortiz, Wilnelly; Cardozo, Timothy J.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Ozcakar, Z. Birsin; Yalcinkaya, Fatos] Ankara Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, TR-06100 Ankara, Turkey; [Yeste, Ada; Quintana, Francisco J.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Chida, Asiya Seema; Sanz, Inaki] Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Bogunovic, Milena] Penn State Univ, Milton S Hershey Med Ctr, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Elkon, Keith B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Tekin, Mustafa] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Clancy, Robert M.; Buyon, Jill P.; Reizis, Boris] NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University; Columbia University; Columbia University; New York University; Ankara University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Washington; University of Washington Seattle; University of Miami; New York University	Reizis, B (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.; Reizis, B (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	boris.reizis@nyumc.org	Tekin, Mustafa/ABG-7627-2020; Quintana, Francisco Javier/AAB-6915-2020; Sisirak, Vanja/GRJ-7805-2022; Ozcakar, Zeynep/AAG-1760-2020; Yalcinkaya, Fatma Fatos/AAI-7277-2020; Sisirak, Vanja/O-9393-2016; Sisirak, Vanja/L-7304-2019	Ozcakar, Zeynep/0000-0002-6376-9189; Sisirak, Vanja/0000-0003-3070-6533; Sisirak, Vanja/0000-0003-3070-6533; Tekin, Mustafa/0000-0002-3525-7960; Buyon, Jill/0000-0002-3852-7129; Reizis, Boris/0000-0003-1140-7853	NIH [AR064460, AI072571, DK098378]; Lupus Research Institute; Judith and Stewart Colton Center for Autoimmunity; Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL124898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571, R37AI049660, U19AI110483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Judith and Stewart Colton Center for Autoimmunity; Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Silverman for help and discussions, M. Shlomchik and A. Davidson for reagents, and S. Rasmussen for technical assistance. This work was supported by NIH grants (AR064460 and AI072571 to B.R.; DK098378 to I. I. I.), the Lupus Research Institute (to B.R.), the Judith and Stewart Colton Center for Autoimmunity (to B.R. and J.P.B.), and the Irvington Institute Fellowship of the Cancer Research Institute (to V.S.). K.B.E. is a co-founder and consultant of Resolve Therapeutics, which develops soluble nucleases for therapeutic purposes.	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Baron WF, 1998, GENE, V215, P291, DOI 10.1016/S0378-1119(98)00281-9; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Dieker J, 2016, ARTHRITIS RHEUMATOL, V68, P462, DOI 10.1002/art.39417; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Ghodke-Puranik Y, 2015, J AUTOIMMUN, V64, P125, DOI 10.1016/j.jaut.2015.08.004; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Jenks SA, 2013, ARTHRITIS RHEUM-US, V65, P3165, DOI 10.1002/art.38138; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Martin JE, 2013, HUM MOL GENET, V22, P4021, DOI 10.1093/hmg/ddt248; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Mizuta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080223; Nagata S, 2011, ADV IMMUNOL, V110, P139, DOI 10.1016/B978-0-12-387663-8.00004-1; Napirei M, 2005, BIOCHEM J, V389, P355, DOI 10.1042/BJ20042124; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; Nielsen CT, 2012, ARTHRITIS RHEUM-US, V64, P1227, DOI 10.1002/art.34381; Nielsen CT, 2011, ARTHRITIS RHEUM-US, V63, P3067, DOI 10.1002/art.30499; Ozcakar ZB, 2013, ARTHRITIS RHEUM-US, V65, P2183, DOI 10.1002/art.38010; Picard C, 2015, AUTOIMMUN REV, V14, P1147, DOI 10.1016/j.autrev.2015.08.002; Pisetsky DS, 2016, NAT REV RHEUMATOL, V12, P102, DOI 10.1038/nrrheum.2015.151; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Rekvig OP, 2014, ARTHRITIS RHEUMATOL, V66, P1061, DOI 10.1002/art.38365; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Sharma S, 2015, P NATL ACAD SCI USA, V112, pE710, DOI 10.1073/pnas.1420217112; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Ullal AJ, 2014, CLIN IMMUNOL, V154, P178, DOI 10.1016/j.clim.2014.05.007; Ullal AJ, 2011, J AUTOIMMUN, V36, P173, DOI 10.1016/j.jaut.2011.02.001; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Wilber A, 2002, MOL THER, V6, P35, DOI 10.1006/mthe.2002.0625; Zochling J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0438-8	43	225	237	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					88	101		10.1016/j.cell.2016.05.034	http://dx.doi.org/10.1016/j.cell.2016.05.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27293190	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000380254400013
J	Wang, X; Feng, J; Xue, Y; Guan, ZY; Zhang, DL; Liu, Z; Gong, Z; Wang, Q; Huang, JB; Tang, C; Zou, TT; Yin, P				Wang, Xiang; Feng, Jing; Xue, Yuan; Guan, Zeyuan; Zhang, Delin; Liu, Zhu; Gong, Zhou; Wang, Qiang; Huang, Jinbo; Tang, Chun; Zou, Tingting; Yin, Ping			Structural basis of N-6-adenosine methylation by the METTL3-METTL14 complex	NATURE			English	Article							MESSENGER-RNA METHYLATION; NUCLEAR-RNA; M(6)A; N-6-METHYLADENOSINE; REVEALS; DNA; N6-METHYLADENOSINE; METHYLTRANSFERASE; EPITRANSCRIPTOME; WIDESPREAD	Chemical modifications of RNA have essential roles in a vast range of cellular processes(1-3). N-6-methyladenosine (m(6)A) is an abundant internal modification in messenger RNA and long non-coding RNA that can be dynamically added and removed by RNA methyltransferases (MTases) and demethylases, respectively(2-5). An MTase complex comprising methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14) efficiently catalyses methyl group transfer(6,7). In contrast to the well-studied DNA MTase(8), the exact roles of these two RNA MTases in the complex remain to be elucidated. Here we report the crystal structures of the METTL3-METTL14 heterodimer with MTase domains in the ligand-free, S-adenosyl methionine (AdoMet)-bound and S-adenosyl homocysteine (AdoHcy)-bound states, with resolutions of 1.9, 1.71 and 1.61 angstrom, respectively. Both METTL3 and METTL14 adopt a class I MTase fold and they interact with each other via an extensive hydrogen bonding network, generating a positively charged groove. Notably, AdoMet was observed in only the METTL3 pocket and not in METTL14. Combined with biochemical analysis, these results suggest that in the m(6)A MTase complex, METTL3 primarily functions as the catalytic core, while METTL14 serves as an RNA-binding platform, reminiscent of the target recognition domain of DNA N-6-adenine MTase(9,10). This structural information provides an important framework for the functional investigation of m(6)A.	[Wang, Xiang; Feng, Jing; Xue, Yuan; Guan, Zeyuan; Zhang, Delin; Wang, Qiang; Huang, Jinbo; Zou, Tingting; Yin, Ping] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Wang, Xiang; Feng, Jing; Xue, Yuan; Guan, Zeyuan; Zhang, Delin; Wang, Qiang; Huang, Jinbo; Zou, Tingting; Yin, Ping] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Liu, Zhu; Tang, Chun] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310028, Zhejiang, Peoples R China; [Gong, Zhou; Tang, Chun] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Ctr Magnet Resonance Wuhan,Wuhan Inst Phys &, Wuhan 430071, Peoples R China; [Zou, Tingting] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Zhejiang University; Chinese Academy of Sciences; Huazhong Agricultural University	Yin, P (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.; Yin, P (corresponding author), Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China.	yinping@mail.hzau.edu.cn		Tang, Chun/0000-0001-6477-6500; Xiang, Wang/0000-0001-9348-7441; Zou, Tingting/0000-0002-7240-1378; jinbo, huang/0000-0003-0902-6357; liu, zhu/0000-0003-4073-7237	Ministry of Science and Technology [2015CB910900, 2013CB900200]; Fok Ying-Tong Education Foundation [151021]; Fundamental Research Funds for the Central Universities [2014PY026, 2015PY219, 2014JQ001]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2013RC013]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Huazhong Agricultural University Scientific & Technological Self-innovation Foundation	We thank B. Sun (SSRF beamline BL17U), R. Zhang (BL19U1), and N. Li (BL19U2) for on-site assistance; S. Fan for data collection support; and research associates at the Center for Protein Research, Huazhong Agricultural University, for technical support. This work was supported by funds from the Ministry of Science and Technology (grants 2015CB910900 and 2013CB900200), Fok Ying-Tong Education Foundation (grant 151021), the Fundamental Research Funds for the Central Universities (Program No. 2014PY026, No. 2015PY219, and No. 2014JQ001), and Huazhong Agricultural University Scientific & Technological Self-innovation Foundation (Program No. 2013RC013).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; Choi J, 2016, NAT STRUCT MOL BIOL, V23, P110, DOI 10.1038/nsmb.3148; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L, PYMOL MOL GRAPHICS S; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Gupta YK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8363; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2016, NAT STRUCT MOL BIOL, V23, P98, DOI 10.1038/nsmb.3162; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwartz S, 2016, RNA, V22, P169, DOI 10.1261/rna.054502.115; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	37	522	557	14	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					575	+		10.1038/nature18298	http://dx.doi.org/10.1038/nature18298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27281194				2022-12-28	WOS:000378270300059
J	Rompolas, P; Mesa, KR; Kawaguchi, K; Park, S; Gonzalez, D; Brown, S; Boucher, J; Klein, AM; Greco, V				Rompolas, Panteleimon; Mesa, Kailin R.; Kawaguchi, Kyogo; Park, Sangbum; Gonzalez, David; Brown, Samara; Boucher, Jonathan; Klein, Allon M.; Greco, Valentina			Spatiotemporal coordination of stem cell commitment during epidermal homeostasis	SCIENCE			English	Article							HAIR-FOLLICLE REGENERATION; INTERFOLLICULAR EPIDERMIS; PROGENITOR CELLS; LINEAGE ANALYSIS; ORGANIZATION; EPITHELIUM; MOUSE; NICHE; FATE; SKIN	Adult tissues replace lost cells via pools of stem cells. However, the mechanisms of cell self-renewal, commitment, and functional integration into the tissue remain unsolved. Using imaging techniques in live mice, we captured the lifetime of individual cells in the ear and paw epidermis. Our data suggest that epidermal stem cells have equal potential to either divide or directly differentiate. Tracking stem cells over multiple generations reveals that cell behavior is not coordinated between generations. However, sibling cell fate and lifetimes are coupled. We did not observe regulated asymmetric cell divisions. Lastly, we demonstrated that differentiating stem cells integrate into preexisting ordered spatial units of the epidermis. This study elucidates how a tissue is maintained by both temporal and spatial coordination of stem cell behaviors.	[Rompolas, Panteleimon; Mesa, Kailin R.; Park, Sangbum; Gonzalez, David; Brown, Samara; Boucher, Jonathan; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Kawaguchi, Kyogo; Klein, Allon M.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, Dept Dermatol,Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, Dept Cell Biol,Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Rompolas, Panteleimon] Univ Penn, Dept Dermatol, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Yale University; Harvard University; Harvard Medical School; Yale University; Yale University; University of Pennsylvania; Pennsylvania Medicine	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Klein, AM (corresponding author), Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA.; Greco, V (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, Dept Dermatol,Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Greco, V (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, Dept Cell Biol,Yale Stem Cell Ctr, New Haven, CT 06510 USA.	allon_klein@hms.harvard.edu; valentina.greco@yale.edu	Kawaguchi, Kyogo/AAF-5133-2021	Rompolas, Panteleimon/0000-0001-9135-7651; Mesa, Kailin/0000-0003-4452-9048; Kawaguchi, Kyogo/0000-0001-9395-9875; Boucher, Jonathan/0000-0001-6938-4813	New York Stem Cell Foundation; Edward Mallinckrodt Jr. Foundation; National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) [NIH-5R01AR063663-04, NIH-1R01AR067755-01A1]; NIH [T32GM007223]; CT Stem Cell grant [14-SCA-YALE-05, 13-SCA-YALE-20]; American Skin Association Research Scholar Award; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, P30AR053495, R01AR067755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Edward Mallinckrodt Jr. Foundation; National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Stem Cell grant; American Skin Association Research Scholar Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Fuchs for K14-actinGFP mice; V. Verkhusha for the PAmCherry construct; and M. Theo, S. Ghazizadeh, and P. Jones for critical manuscript feedback. This work was supported by The New York Stem Cell Foundation; the Edward Mallinckrodt Jr. Foundation; the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS), grants NIH-5R01AR063663-04 and NIH-1R01AR067755-01A1; and the NIH Predoctoral Program in Cellular and Molecular Biology (K.R.M. and S.B., grant T32GM007223). K.R.M is an NSF Graduate Research Fellow. S.P. is supported by CT Stem Cell grant 14-SCA-YALE-05. P.R. is supported by an American Skin Association Research Scholar Award, was a New York Stem Cell Foundation-Druckenmiller Fellow, and was supported by CT Stem Cell grant 13-SCA-YALE-20. V.G. is a New York Stem Cell Foundation Robertson Investigator. A.M.K. is supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and an Edward Mallinckrodt Jr. Foundation grant. The K14-H2BPAmCherry mouse is available from the Greco lab under a materials transfer agreement with Yale.	Christophers E, 1976, Curr Probl Dermatol, V6, P87; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Fullgrabe A, 2015, STEM CELL REP, V5, P843, DOI 10.1016/j.stemcr.2015.09.013; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Honda H, 1996, J INVEST DERMATOL, V106, P312, DOI 10.1111/1523-1747.ep12342964; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; MENTON DN, 1976, J INVEST DERMATOL, V66, P283, DOI 10.1111/1523-1747.ep12482234; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Pineda CM, 2015, NAT PROTOC, V10, P1116, DOI 10.1038/nprot.2015.070; POTTEN CS, 1988, J CELL SCI, P45; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Roshan A, 2016, NAT CELL BIOL, V18, P145, DOI 10.1038/ncb3282; Sada A, 2016, NAT CELL BIOL, V18, P619, DOI 10.1038/ncb3359; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436	30	137	137	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1471	1474		10.1126/science.aaf7012	http://dx.doi.org/10.1126/science.aaf7012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27229141	Green Accepted			2022-12-28	WOS:000377975400052
J	Abraham, SA; Hopcroft, LEM; Carrick, E; Drotar, ME; Dunn, K; Williamson, AJK; Korfi, K; Baquero, P; Park, LE; Scott, MT; Pellicano, F; Pierce, A; Copland, M; Nourse, C; Grimmond, SM; Vetrie, D; Whetton, AD; Holyoake, TL				Abraham, Sheela A.; Hopcroft, Lisa E. M.; Carrick, Emma; Drotar, Mark E.; Dunn, Karen; Williamson, Andrew J. K.; Korfi, Koorosh; Baquero, Pablo; Park, Laura E.; Scott, Mary T.; Pellicano, Francesca; Pierce, Andrew; Copland, Mhairi; Nourse, Craig; Grimmond, Sean M.; Vetrie, David; Whetton, Anthony D.; Holyoake, Tessa L.			Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; CD34(+) CELLS; CANCER; INHIBITION; EXPRESSION; IMATINIB; TUMOR; COMBINATION; MICROARRAY	Chronic myeloid leukaemia (CML) arises after transformation of a haemopoietic stem cell (HSC) by the protein-tyrosine kinase BCR-ABL. Direct inhibition of BCR-ABL kinase has revolutionized disease management, but fails to eradicate leukaemic stem cells (LSCs), which maintain CML. LSCs are independent of BCR-ABL for survival, providing a rationale for identifying and targeting kinase-independent pathways. Here we show-using proteomics, transcriptomics and network analyses-that in human LSCs, aberrantly expressed proteins, in both imatinib-responder and non-responder patients, are modulated in concert with p53 (also known as TP53) and c-MYC regulation. Perturbation of both p53 and c-MYC, and not BCR-ABL itself, leads to synergistic cell kill, differentiation, and near elimination of transplantable human LSCs in mice, while sparing normal HSCs. This unbiased systems approach targeting connected nodes exemplifies a novel precision medicine strategy providing evidence that LSCs can be eradicated.	[Abraham, Sheela A.; Hopcroft, Lisa E. M.; Drotar, Mark E.; Dunn, Karen; Korfi, Koorosh; Park, Laura E.; Scott, Mary T.; Pellicano, Francesca; Copland, Mhairi; Holyoake, Tessa L.] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Inst Canc Sci, Gartnavel Gen Hosp, 1053 Great Western Rd, Glasgow G12 0YN, Lanark, Scotland; [Carrick, Emma; Williamson, Andrew J. K.; Pierce, Andrew; Whetton, Anthony D.] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester M20 3LJ, Lancs, England; [Carrick, Emma; Williamson, Andrew J. K.; Pierce, Andrew; Whetton, Anthony D.] Univ Manchester, Manchester Precis Med Inst, Manchester M20 3LJ, Lancs, England; [Korfi, Koorosh; Baquero, Pablo; Nourse, Craig; Vetrie, David] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland; [Grimmond, Sean M.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic 3010, Australia; [Whetton, Anthony D.] Univ Manchester, Stoller Biomarker Discovery Ctr, Manchester M20 3LJ, Lancs, England	University of Glasgow; University of Manchester; University of Manchester; University of Glasgow; University of Melbourne; University of Manchester	Holyoake, TL (corresponding author), Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Inst Canc Sci, Gartnavel Gen Hosp, 1053 Great Western Rd, Glasgow G12 0YN, Lanark, Scotland.	Tessa.Holyoake@glasgow.ac.uk	Baquero, Pablo/Q-4469-2018; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Holyoake, Tessa/M-3668-2015	Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Holyoake, Tessa/0000-0002-0608-6066; Vetrie, David/0000-0003-2075-4662; Abraham, Sheela/0000-0003-4114-138X; Carrick, Emma/0000-0002-8678-6192; Scott, Mary/0000-0002-7177-6960; Pierce, Andrew/0000-0001-5995-2469; Korfi, Koorosh/0000-0001-5009-4509; WHETTON, ANTHONY D/0000-0002-1098-3878; Pablo, Baquero Valls/0000-0002-5292-071X; Hopcroft, Lisa/0000-0002-7022-1322	Constellation Pharmaceuticals; Roche; Glasgow and Manchester Experimental Cancer Medicine Centres (ECMC) - CR-UK; Chief Scientist's Office (Scotland); MRC; CR-UK [C11074/A11008, LLR08071, LLR11017, SCD/04, LLR13035, LLR14005, KKL690, KKL698, LLR08004]; MRC CiC; Howat Foundation; Friends of Paul O'Gorman [ELF 67954]; British Society for Haematology [MR/K014854/1]; Cancer Research UK [11008] Funding Source: researchfish; Medical Research Council [MR/M008959/1, MR/K014854/1, MR/N00583X/1, G0600782, MC_PC_13063, 1515962] Funding Source: researchfish; Chief Scientist Office [CZB/4/690] Funding Source: researchfish; MRC [MR/M008959/1, MR/N00583X/1, MR/K014854/1, G0600782, MC_PC_13063] Funding Source: UKRI	Constellation Pharmaceuticals; Roche(Roche Holding); Glasgow and Manchester Experimental Cancer Medicine Centres (ECMC) - CR-UK; Chief Scientist's Office (Scotland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); MRC CiC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howat Foundation; Friends of Paul O'Gorman; British Society for Haematology; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all CML patients and UK haematology departments who contributed samples; A. Hair for sample processing; J. Cassels for cell sorting; A. Michie and V. Helgason for assisting with the in vivo research and providing cord blood samples; C. Wells, P. Bailey and J. Cole for discussions regarding the RNA-seq analysis. We acknowledge the Cancer Research UK (CR-UK) Glasgow Centre (C596/A18076) and the CR-UK Beatson Institute (C596/A17196) for providing animal care and housing facilities. We acknowledge Constellation Pharmaceuticals for providing CPI-203, CPI-0610 and part funding M.E.D., Roche for providing RG7112, RG7388 and part funding M.E.D. and the SPIRIT Trials Management Group for access to CML samples. This study was supported by the Glasgow and Manchester Experimental Cancer Medicine Centres (ECMC), which are funded by CR-UK and the Chief Scientist's Office (Scotland). We acknowledge the funders who have contributed to this work: MRC stratified medicine infrastructure award (A.D.W.), CR-UK C11074/A11008 (F.P., L.E.M.H., T.L.H., A.D.W.); LLR08071 (S.A.A., E.C.); LLR11017 (M.C.); SCD/04 (M.C.); LLR13035 (S.A.A., K.D., A.D.W. and A. P.); LLR14005; (M.T.S., D.V.); KKL690 (L.E.P.); KKL698 (P.B.); LLR08004 (A.D.W., A.P. and A.J.W.); MRC CiC (M.E.D.); The Howat Foundation (fluorescence-activated cell sorting (FACS) support); Friends of Paul O'Gorman (K.D. and FACS support); ELF 67954 (S.A.A.); British Society for Haematology start-up fund (S.A.A.); MR/K014854/1 (K.D.).	Affer M, 2011, J ONCOL, V2011, DOI 10.1155/2011/798592; Albrecht BK, 2016, J MED CHEM, V59, P1330, DOI 10.1021/acs.jmedchem.5b01882; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boichenko AP, 2014, J PROTEOME RES, V13, P4995, DOI 10.1021/pr500601w; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; LANZA F, 1995, STEM CELLS, V13, P445, DOI 10.1002/stem.5530130416; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Neviani P, 2013, J CLIN INVEST, V123, P4144, DOI 10.1172/JCI68951; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Pizzatti L, 2006, BBA-PROTEINS PROTEOM, V1764, P929, DOI 10.1016/j.bbapap.2006.02.004; Prost S, 2015, NATURE, V525, P380, DOI 10.1038/nature15248; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sutton CW, 2010, J PROTEOME RES, V9, P3891, DOI 10.1021/pr100113a; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Van Dang Chi, 2010, Genes Cancer, V1, P560; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Winter GE, 2012, NAT CHEM BIOL, V8, P905, DOI [10.1038/NCHEMBIO.1085, 10.1038/nchembio.1085]; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wong C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.396; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011; Zhang HJ, 2012, MOL CELL BIOL, V32, P1776, DOI 10.1128/MCB.05672-11	57	148	158	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					341	+		10.1038/nature18288	http://dx.doi.org/10.1038/nature18288			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281222	Green Accepted, Green Submitted			2022-12-28	WOS:000377856800026
J	Pan, CQ; Duan, ZP; Dai, EH; Zhang, SQ; Han, GR; Wang, YM; Zhang, HH; Zou, HB; Zhu, BS; Zhao, WJ; Jiang, HX				Pan, Calvin Q.; Duan, Zhongping; Dai, Erhei; Zhang, Shuqin; Han, Guorong; Wang, Yuming; Zhang, Huaihong; Zou, Huaibin; Zhu, Baoshen; Zhao, Wenjing; Jiang, Hongxiu		China Study Grp Mother-to-Childu	Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCES PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; DISOPROXIL FUMARATE; VIRUS INFECTION; CARRIER MOTHERS; POSITIVE WOMEN; LATE PREGNANCY; ANTIGEN; TELBIVUDINE; EFFICACY	BACKGROUND Few data are available regarding the use of tenofovir disoproxil fumarate (TDF) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV). METHODS In this trial, we included 200 mothers who were positive for hepatitis B e antigen (HBeAg) and who had an HBV DNA level higher than 200,000 IU per milliliter. Participants were randomly assigned, in a 1:1 ratio, to receive usual care without antiviral therapy or to receive TDF (at an oral dose of 300 mg per day) from 30 to 32 weeks of gestation until postpartum week 4; the participants were followed until postpartum week 28. All the infants received immunoprophylaxis. The primary outcomes were the rates of mother-to-child transmission and birth defects. The secondary outcomes were the safety of TDF, the percentage of mothers with an HBV DNA level of less than 200,000 IU per milliliter at delivery, and loss or seroconversion of HBeAg or hepatitis B surface antigen at postpartum week 28. RESULTS At delivery, 68 % of the mothers in the TDF group (66 of 97 women), as compared with 2% in the control group (2 of 100), had an HBV DNA level of less than 200,000 IU per milliliter (P<0.001). At postpartum week 28, the rate of mother-to-child transmission was significantly lower in the TDF group than in the control group, both in the intention-to-treat analysis (with transmission of virus to 5% of the infants [5 of 97] vs. 18 % [18 of 100], P=0.007) and the per-protocol analysis (with transmission of virus to 0 vs. 7% [6 of 88], P=0.01). The maternal and infant safety profiles were similar in the TDF group and the control group, including birth-defect rates (2% [2 of 95 infants] and 10% [1 of 88], respectively; P=1.00), although more mothers in the TDF group had an increase in the creatine kinase level. After the discontinuation of TDF, alanine aminotransferase elevations above the normal range occurred more frequently in mothers in the TDF group than in those in the control group (45% [44 of 97 women] vs. 30% [30 of 100], P=0.03). The maternal HBV serologic outcomes did not differ significantly between the groups. CONCLUSIONS In a cohort of HBeAg-positive mothers with an HBV DNA level of more than 200,000 IU per milliliter during the third trimester, the rate of mother-to-child transmission was lower among those who received TDF therapy than among those who received usual care without antiviral therapy.	[Pan, Calvin Q.] NYU, Sch Med, Div Gastroenterol & Hepatol, Langone Med Ctr,Dept Med, New York, NY USA; [Pan, Calvin Q.] Capital Med Univ, Beijing Youan Hosp, Ctr Major Infect Dis, Beijing, Peoples R China; [Duan, Zhongping; Zou, Huaibin] Capital Med Univ, Beijing Youan Hosp, Artificial Liver Ctr, Beijing, Peoples R China; [Dai, Erhei] Hebei Med Univ, Hosp Shijiazhuang 5, Div Liver Dis, Shijiazhuang, Peoples R China; [Zhu, Baoshen] Hebei Med Univ, Hosp Shijiazhuang 5, Dept Gynecol & Obstet, Shijiazhuang, Peoples R China; [Zhang, Shuqin] Hepatobiliary Dis Hosp Ji Lin Prov, Dept Artificial Liver, Changchun, Peoples R China; [Zhao, Wenjing] Hepatobiliary Dis Hosp Ji Lin Prov, Cent Lab, Changchun, Peoples R China; [Han, Guorong; Jiang, Hongxiu] Southeast Univ, Affiliated Hosp 2, Dept Gynecol & Obstet, Nanjing, Jiangsu, Peoples R China; [Wang, Yuming] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing, Peoples R China; [Zhang, Huaihong] Nanyang Ctr Hosp, Dept Med, Nanyang, Henan, Peoples R China	New York University; NYU Langone Medical Center; Capital Medical University; Capital Medical University; Hebei Medical University; Hebei Medical University; Southeast University - China; Army Medical University	Pan, CQ (corresponding author), NYU, Sch Med, Langone Med Ctr, Div Gastroenterol & Hepatol,Depat Med, 132-21 41st Ave, Flushing, NY 11355 USA.	panc01@nyu.edu	Jin, Zhi/O-3281-2015		Gilead Sciences	Gilead Sciences(Gilead Sciences)	Funded by Gilead Sciences; ClinicalTrials.gov number, NCT01488526.	[Anonymous], 1989, INT REP; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; Benaboud S, 2011, ANTIMICROB AGENTS CH, V55, P1315, DOI 10.1128/AAC.00514-10; Centers for Disease Control and Prevention, 2005, HEP B VACC REC INF C; Chen HL, 2015, HEPATOLOGY, V62, P375, DOI 10.1002/hep.27837; DELCANHO R, 1994, J HEPATOL, V20, P483, DOI 10.1016/S0168-8278(05)80494-5; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; Greenup AJ, 2014, J HEPATOL, V61, P502, DOI 10.1016/j.jhep.2014.04.038; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Keeffe EB, 2008, CLIN GASTROENTEROL H, V6, P1315, DOI 10.1016/j.cgh.2008.08.021; Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Pan Calvin Q, 2005, Int J Med Sci, V2, P36; Pan CQ, 2015, WORLD J GASTROENTERO, V21, P5524, DOI 10.3748/wjg.v21.i18.5524; Pan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089789; Pan CQ, 2013, ANTIVIR THER, V18, P841, DOI 10.3851/IMP2481; Pan CQ, 2013, CLIN GASTROENTEROL H, V11, P1349, DOI 10.1016/j.cgh.2013.04.026; Pan CQ, 2013, SEMIN LIVER DIS, V33, P138, DOI 10.1055/s-0033-1345718; Pan CQ, 2012, DIGEST DIS SCI, V57, P2423, DOI 10.1007/s10620-012-2187-3; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P520, DOI 10.1016/j.cgh.2012.01.019; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park JS, 2014, FRONT MED-PRC, V8, P158, DOI 10.1007/s11684-014-0340-4; Perumalswami PV, 2013, J HEPATOL, V58, P890, DOI 10.1016/j.jhep.2013.01.004; Rapicetta M, 2009, VACCINE, V27, P3271, DOI 10.1016/j.vaccine.2009.01.063; Rysgaard CD, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-15; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; WHO, 2015, WHO GUID PREV CAR TR; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; WONG VCW, 1980, BRIT J OBSTET GYNAEC, V87, P958, DOI 10.1111/j.1471-0528.1980.tb04458.x; Wu QX, 2015, CLIN GASTROENTEROL H, V13, P1170, DOI 10.1016/j.cgh.2014.08.043; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Zhang H, 2014, HEPATOLOGY, V60, P468, DOI 10.1002/hep.27034; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	36	349	412	8	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2324	2334		10.1056/NEJMoa1508660	http://dx.doi.org/10.1056/NEJMoa1508660			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305192	Bronze			2022-12-28	WOS:000377854600006
J	Gao, Y; Yang, W				Gao, Yang; Yang, Wei			Capture of a third Mg2+ is essential for catalyzing DNA synthesis	SCIENCE			English	Article							POLYMERASE-ETA; COMPUTATIONAL DESIGN; ENZYME CATALYSIS; INDUCED-FIT; MECHANISM; NUCLEOTIDE; FIDELITY; POLYMERIZATION; REPLICATION; SPECIFICITY	It is generally assumed that an enzyme-substrate (ES) complex contains all components necessary for catalysis and that conversion to products occurs by rearrangement of atoms, protons, and electrons. However, we find that DNA synthesis does not occur in a fully assembled DNA polymerase-DNA-deoxynucleoside triphosphate complex with two canonical metal ions bound. Using time -resolved x-ray crystallography, we show that the phosphoryltransfer reaction takes place only after the ES complex captures a third divalent cation that is not coordinated by the enzyme. Binding of the third cation is incompatible with the basal ES complex and requires thermal activation of the ES for entry. It is likely that the third cation provides the ultimate boost over the energy barrier to catalysis of DNA synthesis.	[Gao, Yang; Yang, Wei] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Gao, Yang/O-3445-2016	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; 	NIH [DK036146-08]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Y.G. carried out all experiments; W.Y. conceived and designed the project, and both authors interpreted data and prepared the manuscript. We thank D. J. Leahy and M. Gellert for critical reading and editing the manuscript. This work is funded by NIH intramural program (DK036146-08, W.Y.).	Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BURGERS PMJ, 1978, P NATL ACAD SCI USA, V75, P4798, DOI 10.1073/pnas.75.10.4798; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Tsai MD, 2014, BIOCHEMISTRY-US, V53, P2749, DOI 10.1021/bi500417m; Vyas R, 2015, J AM CHEM SOC, V137, P5225, DOI 10.1021/jacs.5b02109; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	32	109	109	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1334	1337		10.1126/science.aad9633	http://dx.doi.org/10.1126/science.aad9633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284197	Green Accepted, Green Submitted			2022-12-28	WOS:000377972000045
J	Rademakers, LM; Van Nunen, LX				Rademakers, Leonard M.; Van Nunen, Lokien X.			Ventricular Septal Defect after Acute Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rademakers, Leonard M.; Van Nunen, Lokien X.] Catharina Hosp, Eindhoven, Netherlands	Catharina Hospital	Rademakers, LM (corresponding author), Catharina Hosp, Eindhoven, Netherlands.	nard.rademakers@catharinaziekenhuis.nl	van nunen, Lokien/GLU-5691-2022	van nunen, Lokien/0000-0003-4650-5381					0	1	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					E28	E28		10.1056/NEJMicm1512579	http://dx.doi.org/10.1056/NEJMicm1512579			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276580				2022-12-28	WOS:000377920500001
J	Goodman, SN				Goodman, Steven N.			Aligning statistical and scientific reasoning	SCIENCE			English	Editorial Material							BAYES FACTORS; TESTS		[Goodman, Steven N.] Stanford Univ, Dept Med, Sch Med, Div Epidemiol,Meta Res Innovat Ctr Stanford METRI, Stanford, CA 94305 USA; [Goodman, Steven N.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Div Epidemiol,Meta Res Innovat Ctr Stanford METRI, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, SN (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Epidemiol,Meta Res Innovat Ctr Stanford METRI, Stanford, CA 94305 USA.; Goodman, SN (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Sch Med, Div Epidemiol,Meta Res Innovat Ctr Stanford METRI, Stanford, CA 94305 USA.	steve.goodman@stanford.edu		Goodman, Steven/0000-0002-3872-5723				[Anonymous], J MINISTRY AGR; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; COX DR, 1982, BRIT J CLIN PHARMACO, V14, P325, DOI 10.1111/j.1365-2125.1982.tb01987.x; EFRON B, 1986, AM STAT, V40, P11, DOI 10.2307/2683111; Fisher R.A., 1956, STAT METHODS SCI INF; Gigerenzer G., 1989, THE EMPIRE OF CHANCE; Gigerenzer G, 2015, J MANAGE, V41, P421, DOI 10.1177/0149206314547522; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Greenland S, 2013, EPIDEMIOLOGY, V24, P62, DOI 10.1097/EDE.0b013e3182785741; Hoijtink H, 2016, MULTIVAR BEHAV RES, V51, P2, DOI 10.1080/00273171.2014.969364; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Morey RD, 2016, MULTIVAR BEHAV RES, V51, P11, DOI 10.1080/00273171.2015.1052710; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108	16	61	62	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1180	1181		10.1126/science.aaf5406	http://dx.doi.org/10.1126/science.aaf5406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257246				2022-12-28	WOS:000377045700032
J	Tao, G; Kahr, PC; Morikawa, Y; Zhang, M; Rahmani, M; Heallen, TR; Li, LL; Sun, Z; Olson, EN; Amendt, BA; Martin, JF				Tao, Ge; Kahr, Peter C.; Morikawa, Yuka; Zhang, Min; Rahmani, Mahdis; Heallen, Todd R.; Li, Lele; Sun, Zhao; Olson, Eric N.; Amendt, Brad A.; Martin, James F.			Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury	NATURE			English	Article							CARDIOMYOCYTE PROLIFERATION; OXIDATIVE STRESS; RIEGER-SYNDROME; REGENERATION; GENOME; GROWTH; ENHANCERS; ELEMENTS; FAMILY; GENE	Myocardial infarction results in compromised myocardial function and heart failure owing to insufficient cardiomyocyte self-renewal(1). Unlike many vertebrates, mammalian hearts have only a transient neonatal renewal capacity(2). Reactivating primitive reparative ability in the mature mammalian heart requires knowledge of the mechanisms that promote early heart repair. By testing an established Hippo-deficient heart regeneration mouse model for factors that promote renewal, here we show that the expression of Pitx2 is induced in injured, Hippo-deficient ventricles. Pitx2-deficient neonatal mouse hearts failed to repair after apex resection, whereas adult mouse cardiomyocytes with Pitx2 gain-of-function efficiently regenerated after myocardial infarction. Genomic analyses indicated that Pitx2 activated genes encoding electron transport chain components and reactive oxygen species scavengers. A subset of Pitx2 target genes was cooperatively regulated with the Hippo pathway effector Yap. Furthermore, Nrf2, a regulator of the antioxidant response(3), directly regulated the expression and subcellular localization of Pitx2. Pitx2 mutant myocardium had increased levels of reactive oxygen species, while antioxidant supplementation suppressed the Pitx2 loss-of-function phenotype. These findings reveal a genetic pathway activated by tissue damage that is essential for cardiac repair.	[Tao, Ge; Kahr, Peter C.; Zhang, Min; Li, Lele; Martin, James F.] Baylor Coll Med, Dept Mol Physiol & Biophys, One Baylor Plaza, Houston, TX 77030 USA; [Morikawa, Yuka; Rahmani, Mahdis; Heallen, Todd R.; Martin, James F.] Texas Heart Inst, Houston, TX 77030 USA; [Sun, Zhao; Amendt, Brad A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Sun, Zhao; Amendt, Brad A.] Univ Iowa, Craniofacial Anomalies Res Ctr, Iowa City, IA 52242 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Martin, James F.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Martin, James F.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Texas Heart Institute; University of Iowa; University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Baylor College of Medicine	Martin, JF (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, One Baylor Plaza, Houston, TX 77030 USA.; Martin, JF (corresponding author), Texas Heart Inst, Houston, TX 77030 USA.; Martin, JF (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Martin, JF (corresponding author), Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.	jfmartin@bcm.edu	Morikawa, Yuka/AAP-8917-2021; Morikawa, Yuka/E-3092-2010; sun, zhao/B-3291-2018; Morikawa, Yuka/ABH-6969-2020; Tao, Ge/L-1276-2016	Morikawa, Yuka/0000-0002-4571-8409; Morikawa, Yuka/0000-0002-4571-8409; Amendt, Brad A./0000-0001-6524-1006; Heallen, Todd/0000-0002-6003-8743; Li, Lele/0000-0002-3607-3821; Zhang, Min/0000-0001-7055-6790	IDDRC from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [1U54 HD083092]; Mouse Phenotyping Core at Baylor College of Medicine; National Institutes of Health (NIH) [U54 HG006348]; NIH [DE 023177, HL 118761, DE 13941, HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Vivian L. Smith Foundation; Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research [14CVD01]; Fondation Leducq Networks of Excellence; Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation [1-0025]; American Heart Association (AHA) [13POST17040027]; German Research Foundation (DFG) [KA4018/1-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, R01HL127717, R01HL130804, R01HL077439, U01HL100401, R01HL118761, R01HL093039] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE023177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	IDDRC from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Mouse Phenotyping Core at Baylor College of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vivian L. Smith Foundation; Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research; Fondation Leducq Networks of Excellence; Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); American Heart Association (AHA)(American Heart Association); German Research Foundation (DFG)(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported in part by IDDRC grant number 1U54 HD083092 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. This project was supported by the Mouse Phenotyping Core at Baylor College of Medicine with funding from the National Institutes of Health (NIH) (U54 HG006348). The project was also supported by grants from the NIH (DE 023177 and HL 118761 to J. F. M.; DE 13941 to B. A. A.; HL-077439, HL-111665, HL-093039, DK-099653 and U01-HL-100401 to E. N. O.), and the Vivian L. Smith Foundation (J. F. M.). J. F. M. was supported by Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research 14CVD01: "Defining the genomic topology of atrial fibrillation". E. N. O. was supported by Fondation Leducq Networks of Excellence, Cancer Prevention and Research Institute of Texas and the Robert A. Welch Foundation (grant 1-0025). G. T. was supported by American Heart Association (AHA) (13POST17040027). P. C. K was supported by German Research Foundation (DFG) (KA4018/1-1).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Galli GG, 2015, MOL CELL, V60, P328, DOI 10.1016/j.molcel.2015.09.001; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; L'honore A, 2014, DEV CELL, V29, P392, DOI 10.1016/j.devcel.2014.04.006; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Nascimento DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025045; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216	32	165	172	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					119	+		10.1038/nature17959	http://dx.doi.org/10.1038/nature17959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251288	Green Accepted			2022-12-28	WOS:000376962300046
J	Colditz, GA; Emmons, KM				Colditz, Graham A.; Emmons, Karen M.			The role of universal health coverage in reducing cancer deaths and disparities	LANCET			English	Editorial Material							COLON-CANCER; SYSTEMS; CARE		[Colditz, Graham A.] Washington Univ, Div Publ Hlth Sci, Sch Med, St Louis, MO 63110 USA; [Emmons, Karen M.] Kaiser Fdn, Res Inst, Oakland, CA USA	Washington University (WUSTL)	Colditz, GA (corresponding author), Washington Univ, Div Publ Hlth Sci, Sch Med, St Louis, MO 63110 USA.	colditzg@wudosis.wustl.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291				Beckmann KR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1263-3; Eloranta S, 2010, EUR J CANCER, V46, P2965, DOI 10.1016/j.ejca.2010.05.028; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; IOM, 2013, DELIVERING HIGH QUAL; Maruthappu M., 2016, LANCET; Ramsey S, 2013, HEALTH AFFAIR, V32, P1143, DOI 10.1377/hlthaff.2012.1263; Rhoads KF, 2015, J CLIN ONCOL, V33, P854, DOI 10.1200/JCO.2014.56.8642; Shortell SM, 2010, STUD HEALTH TECHNOL, V153, P369, DOI 10.3233/978-1-60750-533-4-369; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tehranifar P, 2009, CANCER EPIDEM BIOMAR, V18, P2701, DOI 10.1158/1055-9965.EPI-09-0305	12	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					638	640		10.1016/S0140-6736(16)30376-2	http://dx.doi.org/10.1016/S0140-6736(16)30376-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27236343				2022-12-28	WOS:000381268700006
J	Barrett, ADT				Barrett, Alan D. T.			Yellow Fever in Angola and Beyond - The Problem of Vaccine Supply and Demand	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Dept Pathol, Galveston, TX 77555 USA; [Barrett, Alan D. T.] Univ Texas Med Branch, World Hlth Org, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; World Health Organization	Barrett, ADT (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Dept Pathol, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, World Hlth Org, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA.							Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391; Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; World Health Organization, 2005, M EM COMM INT HLTH R	5	63	63	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					301	303		10.1056/NEJMp1606997	http://dx.doi.org/10.1056/NEJMp1606997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS0UV	27276108	Bronze			2022-12-28	WOS:000380313200002
J	Brown, SR; Tiernan, JP; Watson, AJM; Biggs, K; Shephard, N; Wailoo, AJ; Bradburn, M; Alshreef, A; Hind, D				Brown, Steven R.; Tiernan, James P.; Watson, Angus J. M.; Biggs, Katie; Shephard, Neil; Wailoo, Allan J.; Bradburn, Mike; Alshreef, Abualbishr; Hind, Daniel		HubBLe Study Team	Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial	LANCET			English	Article							STAPLED HAEMORRHOIDOPEXY; GRADE II; CONVENTIONAL HEMORRHOIDECTOMY; ECONOMIC-EVALUATION; CLINICAL-TRIAL; DEARTERIALIZATION; DISEASE; MUCOPEXY; PROLAPSE; EXCISION	Background Optimum surgical intervention for low-grade haemorrhoids is unknown. Haemorrhoidal artery ligation (HAL) has been proposed as an efficacious, safe therapy while rubber band ligation (RBL) is a commonly used outpatient treatment. We compared recurrence after HAL versus RBL in patients with grade II-III haemorrhoids. Methods This multicentre, open-label, parallel group, randomised controlled trial included patients from 17 acute UK NHS trusts. We screened patients aged 18 years or older presenting with grade II-III haemorrhoids. We excluded patients who had previously received any haemorrhoid surgery, more than one injection treatment for haemorrhoids, or more than one RBL procedure within 3 years before recruitment. Eligible patients were randomly assigned (in a 1: 1 ratio) to either RBL or HAL with Doppler. Randomisation was computer-generated and stratified by centre with blocks of random sizes. Allocation concealment was achieved using a web-based system. The study was open-label with no masking of participants, clinicians, or research staff. The primary outcome was recurrence at 1 year, derived from the patient's self-reported assessment in combination with resource use from their general practitioner and hospital records. Recurrence was analysed in patients who had undergone one of the interventions and been followed up for at least 1 year. This study is registered with the ISRCTN registry, ISRCTN41394716. Findings From Sept 9, 2012, to May 6, 2014, of 969 patients screened, 185 were randomly assigned to the HAL group and 187 to the RBL group. Of these participants, 337 had primary outcome data (176 in the RBL group and 161 in the HAL group). At 1 year post-procedure, 87 (49%) of 176 patients in the RBL group and 48 (30%) of 161 patients in the HAL group had haemorrhoid recurrence (adjusted odds ratio [aOR] 2.23, 95% CI 1.42-3.51; p= 0.0005). The main reason for this difference was the number of extra procedures required to achieve improvement (57 [32%] participants in the RBL group and 23 [14%] participants in the HAL group had a subsequent procedure for haemorrhoids). The mean pain 1 day after procedure was 3.4 (SD 2.8) in the RBL group and 4.6 (2.8) in the HAL group (diff erence -1.2, 95% CI -1.8 to -0.5; p= 0.0002); at day 7 the scores were 1.6 (2.3) in the RBL group and 3.1 (2.4) in the HAL group (diff erence -1.5, -2.0 to -1.0; p<0.0001). Pain scores did not diff er between groups at 21 days and 6 weeks. 15 individuals reported serious adverse events requiring hospital admission. One patient in the RBL group had a pre-existing rectal tumour. Of the remaining 14 serious adverse events, 12 (7%) were among participants treated with HAL and two (1%) were in those treated with RBL. Six patients had pain (one treated with RBL, five treated with HAL), three had bleeding not requiring transfusion (one treated with RBL, two treated with HAL), two in the HAL group had urinary retention, two in the HAL group had vasovagal upset, and one in the HAL group had possible sepsis (treated with antibiotics). Interpretation Although recurrence after HAL was lower than a single RBL, HAL was more painful than RBL. The diff erence in recurrence was due to the need for repeat bandings in the RBL group. Patients (and health commissioners) might prefer such a course of RBL to the more invasive HAL. Copyright (C) Brown et al. Open Access article distributed under the terms of CC BY.	[Brown, Steven R.] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England; [Tiernan, James P.] St James Univ Hosp, Leeds, W Yorkshire, England; [Watson, Angus J. M.] Raigmore Hosp, Inverness, Scotland; [Biggs, Katie; Shephard, Neil; Bradburn, Mike; Hind, Daniel] Univ Sheffield, Sch Hlth & Related Res, Clin Trials Res Unit, Sheffield, S Yorkshire, England; [Wailoo, Allan J.; Alshreef, Abualbishr] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England	University of Sheffield; Saint James's University Hospital; University of Sheffield; University of Sheffield	Brown, SR (corresponding author), Northern Gen Hosp, Sheffield Teaching Hosp, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	steven.brown@sth.nhs.uk	brown, steve/AAG-2066-2019; Biggs, Catherine/AAT-5555-2021; Hind, Daniel/A-2180-2010; Lund, Jonathan/K-6631-2019; Hind, Daniel/AAE-1769-2020; Alshreef, Abualbishr/AAW-9791-2021	Biggs, Catherine/0000-0003-4468-7417; Hind, Daniel/0000-0002-6409-4793; Lund, Jonathan/0000-0001-5195-2181; Hind, Daniel/0000-0002-6409-4793; Alshreef, Abualbishr/0000-0003-2737-1365; Wailoo, Allan/0000-0002-9324-1617; Conaghan, Philip/0000-0002-3478-5665; Shephard, Neil/0000-0001-8301-6857; Brown, Steven/0000-0002-0980-2793	NIHR Health Technology Assessment programme; National Institute for Health Research [10/57/46] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	NIHR Health Technology Assessment programme.	Burch J, 2008, HEALTH TECHNOL ASSES, V12, P1; Bursics A, 2004, INT J COLORECTAL DIS, V19, P176, DOI 10.1007/s00384-003-0517-9; De Nardi P, 2014, DIS COLON RECTUM, V57, P348, DOI 10.1097/DCR.0000000000000085; Denoya PI, 2013, COLORECTAL DIS, V15, P1281, DOI 10.1111/codi.12303; Elmer SE, 2013, DIS COLON RECTUM, V56, P484, DOI 10.1097/DCR.0b013e31827a8567; Gerjy R, 2008, COLORECTAL DIS, V10, P694, DOI 10.1111/j.1463-1318.2008.01498.x; Giordano P, 2009, DIS COLON RECTUM, V52, P1665, DOI 10.1007/DCR.0b013e3181af50f4; Goligher JC, 1980, SURG ANUS RECTUM COL, V4th, P96; Infantino A, 2012, COLORECTAL DIS, V14, P205, DOI 10.1111/j.1463-1318.2011.02628.x; Iyer VS, 2004, DIS COLON RECTUM, V47, P1364, DOI 10.1007/s10350-004-0591-2; Johannsson HO, 2005, AM J GASTROENTEROL, V100, P401, DOI 10.1111/j.1572-0241.2005.40195.x; Liu H, 2015, INT J CLIN EXP MED, V8, P4932; LODER PB, 1994, BRIT J SURG, V81, P946, DOI 10.1002/bjs.1800810707; Lunniss P J, 2004, Colorectal Dis, V6, P226, DOI 10.1111/j.1463-1318.2004.00590.x; McKenzie L, 2010, COLORECTAL DIS, V12, P587, DOI 10.1111/j.1463-1318.2009.01889.x; National Institute for Health and Care Excellence, NICE PMG9 GUID METH; National Institute for Health and Clinical Excellence, 2010, HAEM ART LIG IPG342, P2; Nisar PJ, 2004, DIS COLON RECTUM, V47, P1837, DOI 10.1007/s10350-004-0679-8; Nystrom PO, 2010, BRIT J SURG, V97, P167, DOI 10.1002/bjs.6804; Pucher PH, 2015, COLORECTAL DIS, V17, P612, DOI 10.1111/codi.12903; Pucher PH, 2013, COLORECTAL DIS, V15, pE284, DOI 10.1111/codi.12205; Sajid MS, 2012, TECH COLOPROCTOL, V16, P1, DOI 10.1007/s10151-011-0796-z; Schuurman JP, 2012, ANN SURG, V255, P840, DOI 10.1097/SLA.0b013e31824e2bb5; Shanmugam V, 2005, Cochrane Database Syst Rev, pCD005034, DOI 10.1002/14651858.CD005034.pub2; Shanmugam V, 2010, COLORECTAL DIS, V12, P579, DOI 10.1111/j.1463-1318.2009.01841.x; Szmulowicz UM, 2011, J GASTROINTEST SURG, V15, P803, DOI 10.1007/s11605-011-1460-7; Tiernan J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-153; Ukoumunne O C, 1999, Health Technol Assess, V3, piii; Walega P, 2012, SCI WORLD J, V2012, P1; Wilkerson PM, 2009, COLORECTAL DIS, V11, P394, DOI 10.1111/j.1463-1318.2008.01602.x	30	99	109	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					356	364		10.1016/S0140-6736(16)30584-0	http://dx.doi.org/10.1016/S0140-6736(16)30584-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27236344	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000380016900039
J	Goss, PE; Ingle, JN; Pritchard, KI; Robert, NJ; Muss, H; Gralow, J; Gelmon, K; Whelan, T; Strasser-Weippl, K; Rubin, S; Sturtz, K; Wolff, AC; Winer, E; Hudis, C; Stopeck, A; Beck, JT; Kaur, JS; Whelan, K; Tu, D; Parulekar, WR				Goss, P. E.; Ingle, J. N.; Pritchard, K. I.; Robert, N. J.; Muss, H.; Gralow, J.; Gelmon, K.; Whelan, T.; Strasser-Weippl, K.; Rubin, S.; Sturtz, K.; Wolff, A. C.; Winer, E.; Hudis, C.; Stopeck, A.; Beck, J. T.; Kaur, J. S.; Whelan, K.; Tu, D.; Parulekar, W. R.			Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE BREAST-CANCER; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; ENDOCRINE THERAPY; RANDOMIZED-TRIAL; ADHERENCE; LETROZOLE	BACKGROUND Treatment with an aromatase inhibitor for 5 years as up-front monotherapy or after tamoxifen therapy is the treatment of choice for hormone-receptor-positive early breast cancer in postmenopausal women. Extending treatment with an aromatase inhibitor to 10 years may further reduce the risk of breast-cancer recurrence. METHODS We conducted a double-blind, placebo-controlled trial to assess the effect of the extended use of letrozole for an additional 5 years. Our primary end point was disease-free survival. RESULTS We enrolled 1918 women. After a median follow-up of 6.3 years, there were 165 events involving disease recurrence or the occurrence of contralateral breast cancer (67 with letrozole and 98 with placebo) and 200 deaths (100 in each group). The 5-year disease-free survival rate was 95% (95% confidence interval [CI], 93 to 96) with letrozole and 91% (95% CI; 89 to 93) with placebo (hazard ratio for disease recurrence or the occurrence of contralateral breast cancer, 0.66; P = 0.01 by a two-sided log-rank test stratified according to nodal status, prior adjuvant chemotherapy, the interval from the last dose of aromatase-inhibitor therapy, and the duration of treatment with tamoxifen). The rate of 5-year overall survival was 93% (95% CI, 92 to 95) with letrozole and 94% (95% CI, 92 to 95) with placebo (hazard ratio, 0.97; P = 0.83). The annual incidence rate of contralateral breast cancer in the letrozole group was 0.21% (95% CI, 0.10 to 0.32), and the rate in the placebo group was 0.49% (95% CI, 0.32 to 0.67) (hazard ratio, 0.42; P = 0.007). Bone-related toxic effects occurred more frequently among patients receiving letrozole than among those receiving placebo, including a higher incidence of bone pain, bone fractures, and new-onset osteoporosis. No significant differences between letrozole and placebo were observed in scores on most subscales measuring quality of life. CONCLUSIONS The extension of treatment with an adjuvant aromatase inhibitor to 10 years resulted in significantly higher rates of disease-free survival and a lower incidence of contralateral breast cancer than those with placebo, but the rate of overall survival was not higher with the aromatase inhibitor than with placebo. ( Funded by the Canadian Cancer Society and others;)	[Goss, P. E.] Massachusetts Gen Hosp, Ctr Canc, Avon Int Breast Canc Res Program, 55 Fruit St,LRH 302, Boston, MA 02114 USA; [Goss, P. E.; Winer, E.] Harvard Med Sch, Boston, MA USA; [Winer, E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ingle, J. N.; Kaur, J. S.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Pritchard, K. I.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Gelmon, K.] British Columbia Canc Agcy, Vancouver, BC, Canada; [Whelan, K.; Tu, D.; Parulekar, W. R.] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada; [Whelan, T.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Rubin, S.] Dalhousie Univ, Fac Med, Moncton Hosp, Moncton, NB, Canada; [Robert, N. J.] Virginia Canc Specialists US Oncol Network, Fairfax, VA USA; [Muss, H.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Gralow, J.] Univ Washington, Sch Med, Seattle, WA USA; [Strasser-Weippl, K.] Wilheminen Hosp, Ctr Oncol & Hematol, Vienna, Austria; [Sturtz, K.] Colorado Canc Res Program, Denver, CO USA; [Wolff, A. C.] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA; [Hudis, C.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Stopeck, A.] Univ Arizona, Tucson, AZ USA; [Beck, J. T.] Highlands Oncol Grp, Fayetteville, AR USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; British Columbia Cancer Agency; Queens University - Canada; McMaster University; Dalhousie University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Wilhelminenspital; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; University of Arizona	Goss, PE (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Avon Int Breast Canc Res Program, 55 Fruit St,LRH 302, Boston, MA 02114 USA.	pgoss@mgh.harvard.edu	Hudis, Clifford/AAW-9482-2021; Whelan, Timothy/D-3185-2017; Evans, Diane/F-9258-2017; Wolff, Antonio C./T-8796-2019	Hudis, Clifford/0000-0001-7144-8791; Whelan, Timothy/0000-0001-9844-2023; Wolff, Antonio C./0000-0003-3734-1063	Canadian Cancer Society Research Institute [021039, 015469]; National Cancer Institute [CA180888, CA189953, CA180828, CA13612, CA37981, CA077202, CA180863, CA67753, CA189805, CA16116, CA180802]; Canadian Cancer Trials Group [CA077202, CA180863]; ECOG-ACRIN Cancer Research Group [CA180820, CA21115]; Novartis Pharmaceuticals; Avon Foundation; AstraZeneca; Pfizer; Roche; Amgen; Novartis; Glaxo-SmithKline; Eisai; Genomic Health; NanoString; Genentech; BioMarin; NATIONAL CANCER INSTITUTE [U10CA180791, U10CA016116, U10CA180802, U10CA077202, UG1CA189805, UG1CA189953, U10CA180820, U10CA180863, P30CA008748, U10CA180838, U10CA067753, U10CA013612, U10CA037981, U10CA180888, U10CA021115, U10CA180828] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Trials Group; ECOG-ACRIN Cancer Research Group; Novartis Pharmaceuticals(Novartis); Avon Foundation; AstraZeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); Amgen(Amgen); Novartis(Novartis); Glaxo-SmithKline(GlaxoSmithKline); Eisai(Eisai Co Ltd); Genomic Health; NanoString; Genentech(Roche HoldingGenentech); BioMarin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Canadian Cancer Society Research Institute (021039 and 015469), the National Cancer Institute (CA180888, CA189953, CA180828, CA13612, CA37981, CA077202, CA180863, CA67753, CA189805 [to Dr. Sturtz], CA16116, CA180802 [to Dr. Wolff], CA16116, and CA180802 [to Dr. Robert]), the Canadian Cancer Trials Group (CA077202 and CA180863), the ECOG-ACRIN Cancer Research Group (CA180820 and CA21115), and Novartis Pharmaceuticals. Dr. Goss was funded in part by the Avon Foundation.; Dr. Pritchard reports receiving fees for serving on advisory boards from AstraZeneca, Pfizer, Roche, Amgen, Novartis, Glaxo-SmithKline and Eisai, consulting fees from Pfizer and Novartis, and lecture fees from Novartis; Dr. Muss, serving as an uncompensated consultant and advisor to Pfizer and HarborPath and serving on the board of directors of HarborPath; Dr. Gralow, serving on data safety and monitoring committees for Novartis and Roche-Genentech and on a steering committee for Roche-Genentech; Dr. Whelan, receiving fees for serving on an advisory board from Genomic Health and fees for testing reagents from NanoString; Dr. Winer, receiving grant support through his institution from Novartis; Dr. Hudis, receiving consulting fees and fees for serving on advisory boards from Novartis, Pfizer, and AstraZeneca; and Dr. Stopeck, receiving consulting fees from Amgen, Genentech, and BioMarin and honoraria from Amgen and serving on a data safety and monitoring committee for Pfizer and a steering committee for Sandoz. No other potential conflict of interest relevant to this article was reported.	Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Early Breast Cancer Trialists' Collaborative Group, 2001, COCHRANE DB SYST REV, V1; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Gray RG, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.513; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Jakesz R, 2005, P AM SOC CLIN ONCOS, V23, P527; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Partridge AH, 2003, J CLIN ONCOL, V21, P602, DOI 10.1200/JCO.2003.07.071; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Perez EA, 2006, J CLIN ONCOL, V24, P3629, DOI 10.1200/JCO.2005.05.4882; Strasser-Weippl K, 2013, BREAST, V22, pS171, DOI 10.1016/j.breast.2013.07.033; Tu D., 2003, ENCY BIOPHARMACEUTIC, P614; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	15	362	376	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					209	219		10.1056/NEJMoa1604700	http://dx.doi.org/10.1056/NEJMoa1604700			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27264120	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000380325400004
J	Orefice, LL; Zimmerman, AL; Chirila, AM; Sleboda, SJ; Head, JP; Ginty, DD				Orefice, Lauren L.; Zimmerman, Amanda L.; Chirila, Anda M.; Sleboda, Steven J.; Head, Joshua P.; Ginty, David D.			Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs	CELL			English	Article							RAT SPINAL-CORD; RETT-SYNDROME; NEURODEVELOPMENTAL DISORDERS; GABA(A) RECEPTOR; AUTISM; MECP2; MICE; GENE; INHIBITION; ANXIETY	Patients with autism spectrum disorders (ASDs) commonly experience aberrant tactile sensitivity, yet the neural alterations underlying somatosensory dysfunction and the extent to which tactile deficits contribute to ASD characteristics are unknown. We report that mice harboring mutations in Mecp2, Gabrb3, Shank3, and Fmr1 genes associated with ASDs in humans exhibit altered tactile discrimination and hypersensitivity to gentle touch. Deletion of Mecp2 or Gabrb3 in peripheral somatosensory neurons causes mechanosensory dysfunction through loss of GABA(A) receptor-mediated presynaptic inhibition of inputs to the CNS. Remarkably, tactile defects resulting from Mecp2 or Gabrb3 deletion in somatosensory neurons during development, but not in adulthood, cause social interaction deficits and anxiety-like behavior. Restoring Mecp2 expression exclusively in the somatosensory neurons of Mecp2-null mice rescues tactile sensitivity, anxiety like behavior, and social interaction deficits, but not lethality, memory, or motor deficits. Thus, mechanosensory processing defects contribute to anxiety like behavior and social interaction deficits in ASD mouse models.	[Orefice, Lauren L.; Zimmerman, Amanda L.; Chirila, Anda M.; Sleboda, Steven J.; Head, Joshua P.; Ginty, David D.] Harvard Med Sch, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Ginty, DD (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	david_ginty@hms.harvard.edu			Hearst Post-doctoral Fellowship; Simons Foundation; NIH [T32 NS007484-14, DE022750, NS34814]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097344, R01NS034814, R37NS034814, T32NS007484] Funding Source: NIH RePORTER	Hearst Post-doctoral Fellowship; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chinfei Chen, Patrick Forcelli, Michael Greenberg, Christopher Harvey, Alex Kolodkin, Laura Mamounas, David Paul, and members of the D.D.G. laboratory for discussions and comments on the manuscript. We thank Michael Greenberg, John Wood, and Fan Wang for mouse lines, Ofer Mazor and Pavel Gorelik in the Harvard Research Instrumentation Core, Patrick Forcelli and the Harvard NeuroBehavior Laboratory Core for advice about behavioral analyses, and Ryan Dosumu-Johnson and Susan Dymecki for assistance with plethysmography. This work was supported by a Hearst Post-doctoral Fellowship (to L.L.O.), a SFARI Pilot Award from the Simons Foundation (to D.D.G.), and NIH grants (T32 NS007484-14 to L.L.O.; DE022750 and NS34814 to D.D.G). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnett MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109116; BADR GG, 1987, BRAIN DEV-JPN, V9, P517, DOI 10.1016/S0387-7604(87)80076-1; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; BARKER JL, 1972, SCIENCE, V176, P1043, DOI 10.1126/science.176.4038.1043; Blakemore SJ, 2006, BRAIN COGNITION, V61, P5, DOI 10.1016/j.bandc.2005.12.013; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Campbell ML, 2014, COGNITION EMOTION, V28, P46, DOI 10.1080/02699931.2013.799062; Cascio C, 2008, J AUTISM DEV DISORD, V38, P127, DOI 10.1007/s10803-007-0370-8; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Chen JTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6331; Chirila AM, 2014, P NATL ACAD SCI USA, V111, P8263, DOI 10.1073/pnas.1401013111; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; DeLorey TM, 2011, BEHAV BRAIN RES, V216, P36, DOI 10.1016/j.bbr.2010.06.032; Frank DA, 1996, PEDIATRICS, V97, P569; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; GLOWA JR, 1992, NEUROENDOCRINOLOGY, V56, P719, DOI 10.1159/000126298; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hertenstein MJ, 2006, GENET SOC GEN PSYCH, V132, P5, DOI 10.3200/MONO.132.1.5-94; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; LEVY RA, 1971, BRAIN RES, V32, P261, DOI 10.1016/0006-8993(71)90178-8; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Russo RE, 2000, J PHYSIOL-LONDON, V528, P115, DOI 10.1111/j.1469-7793.2000.00115.x; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Voos AC, 2013, SOC COGN AFFECT NEUR, V8, P378, DOI 10.1093/scan/nss009; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010	45	168	173	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					299	313		10.1016/j.cell.2016.05.033	http://dx.doi.org/10.1016/j.cell.2016.05.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27293187	Bronze, Green Accepted			2022-12-28	WOS:000380255400010
J	Yang, HH; St-Pierre, F; Sun, XL; Ding, XZ; Lin, MZ; Clandinin, TR				Yang, Helen H.; St-Pierre, Francois; Sun, Xulu; Ding, Xiaozhe; Lin, Michael Z.; Clandinin, Thomas R.			Subcellular Imaging of Voltage and Calcium Signals Reveals Neural Processing In Vivo	CELL			English	Article							CONTRAST ADAPTATION; GRADED POTENTIALS; MOTION DETECTION; DROSOPHILA; FLIES; SYNAPSES; PATHWAYS; BEHAVIOR; CURRENTS; CIRCUIT	A mechanistic understanding of neural computation requires determining how information is processed as it passes through neurons and across synapses. However, it has been challenging to measure membrane potential changes in axons and dendrites in vivo. We use in vivo, two-photon imaging of novel genetically encoded voltage indicators, as well as calcium imaging, to measure sensory stimulus-evoked signals in the Drosophila visual system with subcellular resolution. Across synapses, we find major transformations in the kinetics, amplitude, and sign of voltage responses to light. We also describe distinct relationships between voltage and calcium signals in different neuronal compartments, a substrate for local computation. Finally, we demonstrate that ON and OFF selectivity, a key feature of visual processing across species, emerges through the transformation of membrane potential into intracellular calcium concentration. By imaging voltage and calcium signals to map information flow with subcellular resolution, we illuminate where and how critical computations arise.	[Yang, Helen H.; Sun, Xulu; Lin, Michael Z.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [St-Pierre, Francois; Ding, Xiaozhe; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [St-Pierre, Francois] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [St-Pierre, Francois] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA	Stanford University; Stanford University; Baylor College of Medicine; Rice University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu	Ding, Xiaozhe/M-6923-2013	Ding, Xiaozhe/0000-0002-0267-0791; Yang, Helen/0000-0001-5140-9664; Lin, Michael/0000-0002-0492-1961; St-Pierre, Francois/0000-0001-8618-4135; Sun, Xulu/0000-0003-3076-0994	NIH [S10RR027431-01, NS069375, R01 EY022638, R21 NS081507]; Stanford Neurosciences Institute; National Science Foundation [1134416]; Defense Advanced Research Projects Agency (DARPA) [W911NF-14-1-0013]; NIH Brain Initiative grant [1U01NS090600-01]; Stanford Graduate Fellowship; Stanford Interdisciplinary Graduate Fellowship; Rita Allen Foundation; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, U01NS090600, R21NS081507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Neurosciences Institute; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH Brain Initiative grant; Stanford Graduate Fellowship(Stanford University); Stanford Interdisciplinary Graduate Fellowship; Rita Allen Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Luo, S. Baccus, and members of the T.R.C. lab for comments on the manuscript. We thank Y. Geng, M. Hintze, and S. Ganesan for providing dissociated neurons. We thank C. Desplan for the otd-Gal4 driver line and M. Wernet for building the GMR-Gal80; otd-Gal4 driver line. Cytometry data were collected on an instrument in the Stanford Shared FACS Facility supported by NIH shared instrument grant S10RR027431-01. Two-photon photo-bleaching data were collected using equipment from the Stanford Neuroscience Microscopy Service, supported by NIH NS069375; training and use of this equipment was supported by a two-photon pilot grant from the Stanford Neurosciences Institute. This work was supported by National Science Foundation grant 1134416 (to F.S.-P. and M.Z.L.), Defense Advanced Research Projects Agency (DARPA) grant W911NF-14-1-0013 (to M.Z.L.), NIH Brain Initiative grant 1U01NS090600-01 (to M.Z.L.), and NIH grants R01 EY022638 (to T.R.C.) and R21 NS081507 (to T.R.C.). H.H.Y. is supported by a Stanford Graduate Fellowship and a Stanford Interdisciplinary Graduate Fellowship. M.Z.L. receives funding from the Rita Allen Foundation and the Burroughs Wellcome Fund. F.S.-P. and M.Z.L. have filed a patent application for a voltage sensor design that includes the sensors reported in this paper.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Carnevale NT, 2006, NEURON BOOK; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark DA, 2014, NAT NEUROSCI, V17, P296, DOI 10.1038/nn.3600; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Cuntz H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071540; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; Gjorgjieva J, 2014, J NEUROSCI, V34, P12127, DOI 10.1523/JNEUROSCI.1032-14.2014; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Gu H, 2009, J NEUROPHYSIOL, V101, P42, DOI 10.1152/jn.91103.2008; Iniguez J, 2013, J NEUROPHYSIOL, V110, P1490, DOI 10.1152/jn.00368.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Leonhardt A, 2016, NAT NEUROSCI, V19, P706, DOI 10.1038/nn.4262; Liu WW, 2015, NATURE, V519, P353, DOI 10.1038/nature14170; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MIALL RC, 1978, PHYSIOL ENTOMOL, V3, P99, DOI 10.1111/j.1365-3032.1978.tb00139.x; Nikolaev A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004306; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Ryglewski S, 2012, J PHYSIOL-LONDON, V590, P809, DOI 10.1113/jphysiol.2011.222836; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Silies M, 2014, ANNU REV NEUROSCI, V37, P307, DOI 10.1146/annurev-neuro-071013-013931; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Smith SW, 1997, SCI ENG GUIDE DIGITA; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Westheimer G, 2007, PROG RETIN EYE RES, V26, P636, DOI 10.1016/j.preteyeres.2007.07.003; ZETTLER F, 1971, Z VERGL PHYSIOL, V75, P402, DOI 10.1007/BF00630560	47	156	158	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2016	166	1					245	257		10.1016/j.cell.2016.05.031	http://dx.doi.org/10.1016/j.cell.2016.05.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZH	27264607	Green Accepted, Bronze			2022-12-28	WOS:000380254400025
J	Costello, M; Enzler, MJ				Costello, Maria; Enzler, Mark J.			Chronic Splenic Brucellosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Costello, Maria] Natl Univ Ireland, Galway, Ireland; [Enzler, Mark J.] Mayo Clin, Rochester, MN USA	Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Enzler, MJ (corresponding author), Mayo Clin, Rochester, MN USA.	enzler.mark@mayo.edu							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2377	2377		10.1056/NEJMicm1511012	http://dx.doi.org/10.1056/NEJMicm1511012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305195				2022-12-28	WOS:000377854600011
J	Laine, L				Laine, Loren			Upper Gastrointestinal Bleeding Due to a Peptic Ulcer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; PROTON-PUMP INHIBITOR; UPPER-GI HEMORRHAGE; HIGH-RISK; UNITED-STATES; ENDOSCOPY; THERAPY; PREVENTION; MANAGEMENT; MORTALITY	A 55-year-old woman presents to the emergency department at 11:30 p.m. with hematemesis. She is otherwise healthy and has no risk factors for liver disease. Her only medication is aspirin (at a dose of 81 mg daily), which she started to take 6 months ago after reading that it reduces the risk of heart disease. The blood pressure is 94160 mm Hg, and the heart rate is 108 beats per minute; the physical examination is otherwise normal. The hemoglobin level is 11.0 g per deciliter, platelet count 220,000 per cubic millimeter, international normalized ratio 1.0, and blood urea nitrogen level 20 mg per deciliter (7.1 mmol per liter). How should this case be further evaluated and managed?	[Laine, Loren] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Laine, Loren] VA Connecticut Healthcare Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Laine, L (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, POB 208019, New Haven, CT 06520 USA.	loren.laine@yale.edu			Bayer and Pharmaceutical Product Development	Bayer and Pharmaceutical Product Development	Dr. Laine reports receiving fees for serving on data and safety monitoring boards from Bayer and Pharmaceutical Product Development (a contract research organization that oversaw trials sponsored by Eisai), and providing a review for a law firm representing Mylan in a patent-litigation case regarding formulation of a pill combining an NSAID and a proton-pump inhibitor. No other potential conflict of interest relevant to this article was reported.	Abougergi MS, 2015, GASTROINTEST ENDOSC, V81, P882, DOI 10.1016/j.gie.2014.09.027; Abraham NS, 2012, CURR OPIN GASTROEN, V28, P615, DOI 10.1097/MOG.0b013e328358d5b9; Bai Y, 2011, ALIMENT PHARM THER, V34, P166, DOI 10.1111/j.1365-2036.2011.04708.x; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Berger JS, 2011, AM HEART J, V162; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bjorkman DJ, 2004, GASTROINTEST ENDOSC, V60, P1, DOI 10.1016/S0016-5107(04)01287-8; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Cheng HC, 2014, GUT, V63, P1864, DOI 10.1136/gutjnl-2013-306531; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cooper GS, 1998, MED CARE, V36, P462, DOI 10.1097/00005650-199804000-00003; El Ouali S, 2014, CAN J GASTROENTEROL, V28, P543; Enestvedt BK, 2008, GASTROINTEST ENDOSC, V67, P422, DOI 10.1016/j.gie.2007.09.024; Fallone CA, 2016, GASTROENTEROLOGY; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Gralnek IM, 2015, ENDOSCOPY, V47, pA1, DOI 10.1055/s-0034-1393172; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Hwang JH, 2012, GASTROINTEST ENDOSC, V75, P1132, DOI 10.1016/j.gie.2012.02.033; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; LAINE L, 1992, GASTROENTEROLOGY, V102, P314, DOI 10.1016/0016-5085(92)91816-M; LAINE L, 1994, NEW ENGL J MED, V331, P717, DOI 10.1056/NEJM199409153311107; Laine L, 2012, AM J GASTROENTEROL, V107, P1190, DOI 10.1038/ajg.2012.168; Laine L, 2012, AM J GASTROENTEROL, V107, P345, DOI 10.1038/ajg.2011.480; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lau JYW, 1999, NEW ENGL J MED, V340, P751, DOI 10.1056/NEJM199903113401002; Laursen SB, 2015, CLIN GASTROENTEROL H, V13, P115, DOI 10.1016/j.cgh.2014.07.023; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Lee JG, 1999, GASTROINTEST ENDOSC, V50, P755, DOI 10.1016/S0016-5107(99)70154-9; Lim LG, 2011, ENDOSCOPY, V43, P300, DOI 10.1055/s-0030-1256110; Lin HJ, 1996, J CLIN GASTROENTEROL, V22, P267, DOI 10.1097/00004836-199606000-00005; Nahon S, 2012, ENDOSCOPY, V44, P998, DOI 10.1055/s-0032-1310006; National Institute for Health and Clinical Excellence, 2012, AC GASTR BLEED MAN; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Sachar H, 2014, JAMA INTERN MED, V174, P1755, DOI 10.1001/jamainternmed.2014.4056; Sreedharan A, 2010, COCHRANE DB SYST REV, V7; Stanley AJ, 2009, LANCET, V373, P42, DOI 10.1016/S0140-6736(08)61769-9; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wong GLH, 2009, GASTROENTEROLOGY, V137, P525, DOI 10.1053/j.gastro.2009.05.006; Wysocki JD, 2012, ALIMENT PHARM THER, V36, P30, DOI 10.1111/j.1365-2036.2012.05129.x	50	52	60	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2367	2376		10.1056/NEJMcp1514257	http://dx.doi.org/10.1056/NEJMcp1514257			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305194				2022-12-28	WOS:000377854600010
J	Tu, S; Narendra, V; Yamaji, M; Vidal, SE; Rojas, LA; Wang, XS; Kim, SY; Garcia, BA; Tuschl, T; Stadtfeld, M; Reinberg, D				Tu, Shengjiang; Narendra, Varun; Yamaji, Masashi; Vidal, Simon E.; Rojas, Luis Alejandro; Wang, Xiaoshi; Kim, Sang Yong; Garcia, Benjamin A.; Tuschl, Thomas; Stadtfeld, Matthias; Reinberg, Danny			Co-repressor CBFA2T2 regulates pluripotency and germline development	NATURE			English	Article							EMBRYONIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MICE; PRDM14; SPECIFICATION; LINEAGE; GENES; RNA; METHYLATION; COMPLEXES	Developmental specification of germ cells lies at the heart of inheritance, as germ cells contain all of the genetic and epigenetic information transmitted between generations. The critical developmental event distinguishing germline from somatic lineages is the differentiation of primordial germ cells (PGCs)(1,2), precursors of sex-specific gametes that produce an entire organism upon fertilization. Germ cells toggle between uni- and pluripotent states as they exhibit their own 'latent' form of pluripotency. For example, PGCs express a number of transcription factors in common with embryonic stem (ES) cells, including OCT4 (encoded by Pou5f1), SOX2, NANOG and PRDM14 (refs 2-4). A biochemical mechanism by which these transcription factors converge on chromatin to produce the dramatic rearrangements underlying ES-cell-and PGC-specific transcriptional programs remains poorly understood. Here we identify a novel co-repressor protein, CBFA2T2, that regulates pluripotency and germline specification in mice. Cbfa2t2(-/-) mice display severe defects in PGC maturation and epigenetic reprogramming. CBFA2T2 forms a biochemical complex with PRDM14, a germline-specific transcription factor. Mechanistically, CBFA2T2 oligomerizes to form a scaffold upon which PRDM14 and OCT4 are stabilized on chromatin. Thus, in contrast to the traditional 'passenger' role of a co-repressor, CBFA2T2 functions synergistically with transcription factors at the crossroads of the fundamental developmental plasticity between uni- and pluripotency.	[Tu, Shengjiang; Narendra, Varun; Rojas, Luis Alejandro; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Tu, Shengjiang; Narendra, Varun; Rojas, Luis Alejandro; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Yamaji, Masashi; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Vidal, Simon E.; Stadtfeld, Matthias] NYU, Sch Med, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA; [Vidal, Simon E.; Stadtfeld, Matthias] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Wang, Xiaoshi; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, Sang Yong] NYU, Sch Med, Rodent Genet Engn Core, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; New York University	Reinberg, D (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.; Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Yamaji, Masashi/ABA-5267-2020	Yamaji, Masashi/0000-0002-8215-2184; Kim, Sang Yong/0000-0001-7326-7505; Stadtfeld, Matthias/0000-0002-5852-9906; Rojas, Luis Alejandro/0000-0001-6445-1562; Reinberg, Danny/0000-0003-4288-2016	Howard Hughes Medical Institute (HHMI); National Institutes of Health (NIH) [RO1GM064844-12, R01GM110174]; Starr Foundation; Tri-Institutional Stem Cell Initiative; Japan Society for the Promotion of Science (JSPS); NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111852, R01GM110174, R01GM064844] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016400] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Tri-Institutional Stem Cell Initiative; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Andrews and X.-J. Sun for providing plasmids. We are grateful to L. Vales, M. E. Torres-Padilla and L. Bu for critical comments, H. Zheng for MS analysis, and D. Hernandez, C. Leek, M. Yamaji, A. Paradkar and M. Alu for excellent technical assistance. The work was supported by the Howard Hughes Medical Institute (HHMI) and National Institutes of Health (NIH; RO1GM064844-12) (D.R.). B.A.G. acknowledges funding from NIH grant R01GM110174. T.T. was supported by the HHMI, NIH, Starr Foundation, and Tri-Institutional Stem Cell Initiative. M.Y. was a recipient of a Japan Society for the Promotion of Science (JSPS) Research Fellowship.	Amann JM, 2005, MOL CELL BIOL, V25, P9576, DOI 10.1128/MCB.25.21.9576-9585.2005; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Calabi F, 1998, GENOMICS, V52, P332, DOI 10.1006/geno.1998.5429; Chan YS, 2013, STEM CELLS, V31, P682, DOI 10.1002/stem.1307; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; De Braekeleer E, 2011, FUTURE ONCOL, V7, P77, DOI [10.2217/fon.10.158, 10.2217/FON.10.158]; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Guastadisegni MC, 2010, LEUKEMIA, V24, P1516, DOI 10.1038/leu.2010.106; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nady N, 2015, ELIFE, V4, DOI 10.7554/eLife.10150; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Payer B, 2013, MOL CELL, V52, P805, DOI 10.1016/j.molcel.2013.10.023; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi Y, 2000, GENE DEV, V14, P804; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011	41	46	50	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					387	+		10.1038/nature18004	http://dx.doi.org/10.1038/nature18004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281218	Green Accepted			2022-12-28	WOS:000377856800036
J	Wise, J				Wise, Jacqui			Weight loss drugs are compared for effectiveness	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i3330	10.1136/bmj.i3330	http://dx.doi.org/10.1136/bmj.i3330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27307315				2022-12-28	WOS:000378240400008
J	Cronin, L; Walker, SI				Cronin, Leroy; Walker, Sara Imari			Beyond prebiotic chemistry	SCIENCE			English	Editorial Material							LIFE; EVOLUTION; CELLS; EARTH; RNA		[Cronin, Leroy] Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland; [Walker, Sara Imari] Arizona State Univ, Sch Earth & Space Explorat, Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA; [Walker, Sara Imari] Blue Marble Space Inst Sci, Seattle, WA 98154 USA	University of Glasgow; Arizona State University; Arizona State University-Tempe	Cronin, L (corresponding author), Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland.; Walker, SI (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA.; Walker, SI (corresponding author), Blue Marble Space Inst Sci, Seattle, WA 98154 USA.	lee.cronin@glasgow.ac.uk; sara.i.walker@asu.edu	Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008	Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757				Adami C., 2015, ENTROPY INFORM BIASE; Bapteste E, 2013, TRENDS GENET, V29, P439, DOI 10.1016/j.tig.2013.05.007; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036; Davies PCW, 2011, PHILOS T R SOC A, V369, P624, DOI 10.1098/rsta.2010.0235; DeDeo S., 2015, MAJOR TRANSITIONS PO; Erwin DH, 2015, CURR BIOL, V25, pR930, DOI 10.1016/j.cub.2015.08.019; Grosch EG, 2015, ASTROBIOLOGY, V15, P922, DOI 10.1089/ast.2015.1302; Jafarpour F, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.158101; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Morowitz H, 2007, COMPLEXITY, V13, P51, DOI 10.1002/cplx.20191; Rodriguez-Garcia M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9385; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Walker SI, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0057	15	49	51	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1174	1175		10.1126/science.aaf6310	http://dx.doi.org/10.1126/science.aaf6310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257242	Green Accepted			2022-12-28	WOS:000377045700028
J	Rochman, CM				Rochman, Chelsea M.			Ecologically relevant data are policy-relevant data	SCIENCE			English	Editorial Material							MICROPLASTIC POLLUTION; HUMAN CONSUMPTION; FIBERS		[Rochman, Chelsea M.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Rochman, Chelsea M.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of Toronto; University of California System; University of California Davis	Rochman, CM (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada.; Rochman, CM (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	cmrochman@ucdavis.edu						Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Johnston EL, 2015, J APPL ECOL, V52, P140, DOI 10.1111/1365-2664.12355; Lonnstedt OM, 2016, SCIENCE, V352, P1213, DOI 10.1126/science.aad8828; Rochman CM, 2016, ECOLOGY, V97, P302, DOI 10.1890/14-2070.1; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Yang DQ, 2015, ENVIRON SCI TECHNOL, V49, P13622, DOI 10.1021/acs.est.5b03163	12	19	21	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1172	1172		10.1126/science.aaf8697	http://dx.doi.org/10.1126/science.aaf8697			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN4NY	27257240				2022-12-28	WOS:000377045700026
J	Lee, AI; Chaar, CIO				Lee, Alfred I.; Chaar, Cassius I. Ochoa			The Hidden Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MAY-THURNER-SYNDROME; ILIAC VEIN COMPRESSION; THROMBOSIS; MANAGEMENT		[Lee, Alfred I.] Yale Univ, Sch Med, Dept Med, Sect Hematol, 333 Cedar St, New Haven, CT 06510 USA; [Chaar, Cassius I. Ochoa] Yale Univ, Sch Med, Dept Surg, Vasc Surg Sect, New Haven, CT 06510 USA	Yale University; Yale University	Lee, AI (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Hematol, 333 Cedar St, New Haven, CT 06510 USA.	alfred.lee@yale.edu						Burke RM, 2006, VASCULAR, V14, P47, DOI 10.2310/6670.2006.00012; Casey ET, 2012, J VASC SURG, V55, P1463, DOI 10.1016/j.jvs.2011.12.082; COCKETT FB, 1967, BRIT MED J, V2, P14, DOI 10.1136/bmj.2.5543.14; De Stefano V, 2013, THROMB HAEMOSTASIS, V110, P697, DOI 10.1160/TH13-01-0011; DeRubertis BG, 2013, ANN VASC SURG, V27, P577, DOI 10.1016/j.avsg.2012.05.024; DeRubertis BG, 2012, J VASC SURG, V56, P1252, DOI 10.1016/j.jvs.2012.04.070; Hager ES, 2013, J VASC SURG-VENOUS L, V1, P270, DOI 10.1016/j.jvsv.2012.11.002; Hicks LK, 2013, BLOOD, V122, P3879, DOI 10.1182/blood-2013-07-518423; Kibbe MR, 2004, J VASC SURG, V39, P937, DOI 10.1016/j.jvs.2003.12.032; Middeldorp S, 2011, HEMATOL-AM SOC HEMAT, P150, DOI 10.1182/asheducation-2011.1.150; Mousa AY, 2013, ANN VASC SURG, V27, P984, DOI 10.1016/j.avsg.2013.05.001; Steinberg J B, 1993, Ann Vasc Surg, V7, P577, DOI 10.1007/BF02000154	12	5	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2160	2165		10.1056/NEJMcps1406615	http://dx.doi.org/10.1056/NEJMcps1406615			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2RP	27248622				2022-12-28	WOS:000387209900011
J	Nurse, P				Nurse, Paul			Learning from the Uncontrollable	CELL			English	Editorial Material														Nurse, Paul/0000-0002-9244-7787	The Francis Crick Institute [10121] Funding Source: researchfish	The Francis Crick Institute			0	2	2	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1301	1306		10.1016/j.cell.2016.05.068	http://dx.doi.org/10.1016/j.cell.2016.05.068			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259139	Bronze			2022-12-28	WOS:000377045400001
J	Watson, R				Watson, Rory			Ecstasy is making a comeback, European drugs report warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		European Monitoring Centre for Drugs and Drug Addiction, 2016, EUR DRUG REP 2016	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i3078	10.1136/bmj.i3078	http://dx.doi.org/10.1136/bmj.i3078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27245254				2022-12-28	WOS:000377477500014
J	Fessenden, M				Fessenden, Marissa			ILLUMINATING LIFE'S BUILDING BLOCKS	NATURE			English	Editorial Material																		Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bottanelli F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10778; Cutler PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064320; Hensel Z, 2013, JOVE-J VIS EXP, DOI 10.3791/50042; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Juette MF, 2010, NANO LETT, V10, P4657, DOI 10.1021/nl1028792; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Ma L, 2016, J AM CHEM SOC, V138, P3382, DOI 10.1021/jacs.5b12378; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2015, P NATL ACAD SCI USA, V112, pE6752, DOI 10.1073/pnas.1520957112; Spille JH, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1194	11	7	7	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					565	U336		10.1038/533565a	http://dx.doi.org/10.1038/533565a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225132	Bronze			2022-12-28	WOS:000376443100048
J	Gargiulo, G; Sannino, A; Capodanno, D; Barbanti, M; Buccheri, S; Perrino, C; Capranzano, P; Indolfi, C; Trimarco, B; Tamburino, C; Esposito, G				Gargiulo, Giuseppe; Sannino, Anna; Capodanno, Davide; Barbanti, Marco; Buccheri, Sergio; Perrino, Cinzia; Capranzano, Piera; Indolfi, Ciro; Trimarco, Bruno; Tamburino, Corrado; Esposito, Giovanni			Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL-OUTCOMES; TRANSFEMORAL TRANSCATHETER; CONVENTIONAL SURGERY; 1-YEAR MORTALITY; 2-YEAR OUTCOMES; STENOSIS; RISK; SUTURELESS; COSTS; IMPACT	Background: The comparative benefits and harms of transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) for patients with aortic stenosis are unclear. Purpose: To compare clinical outcomes, including early (<= 30day) and midterm (<= 1-year) mortality, in adults with severe aortic stenosis undergoing either TAVI or SAVR. Data Sources: MEDLINE, Cochrane, and Scopus databases (without language restrictions) from April 2002 to 5 April 2016; multiple registries and Web sites; scientific meeting presentations. Study Selection: Five randomized trials and 31 observational matched studies comparing mortality outcomes after TAVI or SAVR. Data Extraction: Two investigators independently extracted study data and rated risk of bias. Data Synthesis: 16 638 patients were analyzed. Overall, there was no statistically significant difference between TAVI and SAVR in early (odds ratio [OR], 1.01 [95% CI, 0.81 to 1.26]) or midterm (OR, 0.96 [CI, 0.81 to 1.14]) all-cause mortality. Analyses restricted to trials (early: OR, 0.80 [CI, 0.51 to 1.25]; midterm: OR, 0.90 [CI, 0.64 to 1.26]) were inconclusive, with wide CIs, whereas analyses of matched studies were similar to the overall results. Transfemoral TAVI provided mortality benefits over SAVR in trials. Analyses restricted to studies of patients at low to intermediate risk showed statistically nonsignificant reductions in early (OR, 0.67 [CI, 0.42 to 1.07]) and midterm (OR, 0.91 [CI, 0.67 to 1.23]) mortality with TAVI. Incidence of periprocedural myocardial infarction, major bleeding, acute kidney injury, and new-onset atrial fibrillation was lower with TAVI, but risk for pacemaker implantation, vascular complications, and paravalvular leak increased. Overall, there was a statistically nonsignificant increased risk in long-term (2- to 5-year) all-cause mortality with TAVI (OR, 1.28 [CI, 0.97 to 1.69]), whereas long-term mortality outcomes in patients at low to intermediate risk were inconclusive, with wide CIs (OR, 1.06 [CI, 0.59 to 1.91]). Limitation: The number of trials was limited, and study designs and patient characteristics were heterogeneous. Conclusion: Compared with SAVR, TAVI may have similar or better early and midterm outcomes for adults with aortic stenosis, including those at low to intermediate risk.	[Gargiulo, Giuseppe; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni] Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Via Pansini 5, I-80131 Naples, Italy; [Sannino, Anna] Baylor Heart & Vasc Hosp, Baylor Res Inst, 621 North Hall St, Dallas, TX 75226 USA; [Barbanti, Marco; Buccheri, Sergio; Capranzano, Piera; Tamburino, Corrado] Univ Catania, Ferrarotto Hosp, Dept Gen Surg & Med Surg Specialties, Via Salvatore Citelli 31, I-95124 Catania, Italy; [Indolfi, Ciro] Magna Graecia Univ Catanzaro, URT Consiglio Nazl Ric, Viale Europa, I-88100 Catanzaro, Italy; [Indolfi, Ciro] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, I-88100 Catanzaro, Italy	University of Naples Federico II; Baylor Scott & White Health; Baylor University Medical Center; University of Catania; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Esposito, G (corresponding author), Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Via Pansini 5, I-80131 Naples, Italy.	espogiov@unina.it	Capranzano, Piera/AAG-2696-2019; Capodanno, Davide/AAP-4949-2020; Trimarco, Bruno BT/K-7851-2016; Buccheri, Sergio/AAA-3013-2022; Perrino, Cinzia/K-3183-2016; Gargiulo, Giuseppe/AAC-2356-2022; GARGIULO, Giuseppe/AAC-2336-2022; Esposito, Giovanni/F-2880-2010; Barbanti, Marco/AAP-4373-2020; Sannino, Anna/AAA-2412-2019	Capranzano, Piera/0000-0001-8434-7367; Trimarco, Bruno BT/0000-0002-0701-6449; Perrino, Cinzia/0000-0002-2274-0048; GARGIULO, Giuseppe/0000-0003-4395-6742; Esposito, Giovanni/0000-0003-0565-7127; Barbanti, Marco/0000-0002-4903-5437; SANNINO, ANNA/0000-0003-4275-8066; Buccheri, Sergio/0000-0002-7767-3073	CardioPath PhD Program; Federico II University of Naples; European Association of Percutaneous Coronary Interventions	CardioPath PhD Program; Federico II University of Naples; European Association of Percutaneous Coronary Interventions	Dr. Gargiulo reports grants from the CardioPath PhD Program, Federico II University of Naples, and from the European Association of Percutaneous Coronary Interventions, outside the submitted work. Dr. Barbanti is a consultant for Edwards Lifesciences. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-0060.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Ailawadi G, 2016, ANN THORAC SURG, V101, P154, DOI 10.1016/j.athoracsur.2015.05.120; Amat-Santos IJ, 2014, AM J CARDIOL, V114, P1075, DOI 10.1016/j.amjcard.2014.07.019; Appel CF, 2012, SCAND CARDIOVASC J, V46, P301, DOI 10.3109/14017431.2012.699636; Biancari F, 2016, HEART VESSELS, V31, P427, DOI 10.1007/s00380-014-0623-3; Blackstone EH, 2015, CIRCULATION, V131, P1989, DOI 10.1161/CIRCULATIONAHA.114.012525; Cao C, 2013, ANN CARDIOTHORAC SUR, V2, P10, DOI 10.3978/j.issn.2225-319X.2012.11.09; Capodanno D, 2016, EUR HEART J-ACUTE CA, V5, P253, DOI 10.1177/2048872615572599; Conradi L, 2012, J THORAC CARDIOV SUR, V143, P64, DOI 10.1016/j.jtcvs.2011.08.047; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; D'Onofrio A, 2012, J THORAC CARDIOV SUR, V144, P1010, DOI 10.1016/j.jtcvs.2012.07.040; Deeb GM, 2016, J AM COLL CARDIOL, V67, P2565, DOI 10.1016/j.jacc.2016.03.506; Ewe SH, 2010, AM HEART J, V160, P1113, DOI 10.1016/j.ahj.2010.09.003; Fusari M, 2012, J CARDIOVASC MED, V13, P229, DOI 10.2459/JCM.0b013e3283515c0f; Gargiulo G, 2015, CATHETER CARDIO INTE, V86, P518, DOI 10.1002/ccd.25867; Gargiulo G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002220; Giacoppo D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5392; Guarracino F, 2010, J CARDIOTHOR VASC AN, V24, P25, DOI 10.1053/j.jvca.2009.09.009; Hannan EL, 2016, JACC-CARDIOVASC INTE, V9, P578, DOI 10.1016/j.jcin.2015.12.022; Higgins J, 2011, J THORAC CARDIOV SUR, V142, pE47, DOI 10.1016/j.jtcvs.2011.02.045; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Holzhey DM, 2012, HEART SURG FORUM, V15, pE4, DOI 10.1532/HSF98.20111084; Johansson M, 2011, ANN THORAC SURG, V91, P57, DOI 10.1016/j.athoracsur.2010.07.072; Jones SG, 2013, J HEART VALVE DIS, V22, P204; Kobrin DM, 2015, ANN THORAC SURG, V100, P1230, DOI 10.1016/j.athoracsur.2015.05.039; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kondur A, 2016, AM J CARDIOL, V117, P252, DOI 10.1016/j.amjcard.2015.10.034; Latib A, 2012, AM HEART J, V164, P910, DOI 10.1016/j.ahj.2012.09.005; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Liao WC, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7371; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; Minutello RM, 2015, AM J CARDIOL, V115, P1443, DOI 10.1016/j.amjcard.2015.02.026; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Muneretto C, 2015, J THORAC CARDIOV SUR, V150, P1570, DOI 10.1016/j.jtcvs.2015.08.052; Nagaraja V, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000013; Nielsen HHM, 2012, EUROINTERVENTION, V8, P383, DOI 10.4244/EIJV8I3A58; Onorati F, 2016, INTERACT CARDIOV TH, V22, P806, DOI 10.1093/icvts/ivw049; Osnabrugge RLJ, 2012, ANN THORAC SURG, V94, P1954, DOI 10.1016/j.athoracsur.2012.07.002; Panchal HB, 2013, AM J CARDIOL, V112, P850, DOI 10.1016/j.amjcard.2013.05.015; Papadopoulos N, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-99; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Santarpino G, 2015, AM J CARDIOL, V116, P1737, DOI 10.1016/j.amjcard.2015.08.043; Schymik G, 2015, CATHETER CARDIO INTE, V86, P738, DOI 10.1002/ccd.25866; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sondergaard L., 2015, EUROPCR PAR FRANC 19; Stohr R, 2011, CORONARY ARTERY DIS, V22, P595, DOI 10.1097/MCA.0b013e32834d335e; Takagi H, 2013, ANN THORAC SURG, V96, P513, DOI 10.1016/j.athoracsur.2013.04.049; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013; Thakkar B, 2016, CATHETER CARDIO INTE, V87, P955, DOI 10.1002/ccd.26345; Thongprayoon C, 2016, J AM SOC NEPHROL, V27, P1854, DOI 10.1681/ASN.2015050577; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Walther T, 2010, EUR HEART J, V31, P1398, DOI 10.1093/eurheartj/ehq060; Wendt D, 2015, J CARDIOL, V66, P292, DOI 10.1016/j.jjcc.2015.04.003; Zweng I, 2016, HEART LUNG CIRC, V25, P661, DOI 10.1016/j.hlc.2016.01.005	59	90	91	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					334	+		10.7326/M16-0060	http://dx.doi.org/10.7326/M16-0060			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV3BC	27272666				2022-12-28	WOS:000382795000003
J	Abudayyeh, OO; Gootenberg, JS; Konermann, S; Joung, J; Slaymaker, IM; Cox, DBT; Shmakov, S; Makarova, KS; Semenova, E; Minakhin, L; Severinov, K; Regev, A; Lander, ES; Koonin, EV; Zhang, F				Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Konermann, Silvana; Joung, Julia; Slaymaker, Ian M.; Cox, David B. T.; Shmakov, Sergey; Makarova, Kira S.; Semenova, Ekaterina; Minakhin, Leonid; Severinov, Konstantin; Regev, Aviv; Lander, Eric S.; Koonin, Eugene V.; Zhang, Feng			C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector	SCIENCE			English	Article							ADAPTIVE BACTERIAL IMMUNITY; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; CRYSTAL-STRUCTURE; CAS IMMUNITY; THERMUS-THERMOPHILUS; SURVEILLANCE COMPLEX; PYROCOCCUS-FURIOSUS; SPACER ACQUISITION; BINDING PROTEINS	The clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated genes (Cas) adaptive immune system defends microbes against foreign genetic elements via DNA or RNA-DNA interference. We characterize the class 2 type VI CRISPR-Cas effector C2c2 and demonstrate its RNA-guided ribonuclease function. C2c2 from the bacterium Leptotrichia shahii provides interference against RNA phage. In vitro biochemical analysis shows that C2c2 is guided by a single CRISPR RNA and can be programmed to cleave single-stranded RNA targets carrying complementary protospacers. In bacteria, C2c2 can be programmed to knock down specific mRNAs. Cleavage is mediated by catalytic residues in the two conserved Higher Eukaryotes and Prokaryotes Nucleotide-binding (HEPN) domains, mutations of which generate catalytically inactive RNA-binding proteins. These results broaden our understanding of CRISPR-Cas systems and suggest that C2c2 can be used to develop new RNA-targeting tools.	[Abudayyeh, Omar O.; Cox, David B. T.; Zhang, Feng] MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Konermann, Silvana; Joung, Julia; Slaymaker, Ian M.; Cox, David B. T.; Regev, Aviv; Lander, Eric S.; Zhang, Feng] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Konermann, Silvana; Joung, Julia; Slaymaker, Ian M.; Cox, David B. T.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Konermann, Silvana; Joung, Julia; Slaymaker, Ian M.; Cox, David B. T.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Konermann, Silvana; Joung, Julia; Slaymaker, Ian M.; Cox, David B. T.; Zhang, Feng] MIT, Dept Biomol Engn, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Cox, David B. T.; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shmakov, Sergey] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia; [Shmakov, Sergey; Makarova, Kira S.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Semenova, Ekaterina; Minakhin, Leonid; Severinov, Konstantin] State Univ New Jersey, Rutgers, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Skolkovo Institute of Science & Technology; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Rutgers State University New Brunswick; Russian Academy of Sciences	Zhang, F (corresponding author), MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), Broad Inst & Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biomol Engn, Cambridge, MA 02139 USA.; Koonin, EV (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov; zhang@broadinstitute.org	Joung, Julia/HCH-8944-2022; Severinov, Konstantin/C-8545-2016; Abudayyeh, Omar/ABF-1746-2020; Gootenberg, Jonathan/AAY-8174-2021; Macrae, Rhiannon/AAX-1536-2020	Abudayyeh, Omar/0000-0002-7979-3220; Gootenberg, Jonathan/0000-0003-2757-2175; 	Paul and Daisy Soros Fellowship; Friends of the McGovern Institute Fellowship; Poitras Center for Affective Disorders; U.S. Department of Energy (DOE); graduate program of Skoltech Data-Intensive Biomedicine and Biotechnology Center for Research, Education, and Innovation; Simons Center for the Social Brain; National Institute of General Medical Sciences [T32GM007753]; U.S. Department of Health and Human Services; NIH [GM10407]; Russian Science Foundation [14-14-00988]; Skoltech; NIH through the National Institute of Mental Health [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell Foundation; Simons, Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL CANCER INSTITUTE [P30CA014051, F30CA210382] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	Paul and Daisy Soros Fellowship; Friends of the McGovern Institute Fellowship; Poitras Center for Affective Disorders; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); graduate program of Skoltech Data-Intensive Biomedicine and Biotechnology Center for Research, Education, and Innovation; Simons Center for the Social Brain; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Skoltech; NIH through the National Institute of Mental Health; NSF(National Science Foundation (NSF)); New York Stem Cell Foundation; Simons, Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank P. Boutz, J. Doench, P. Sharp, and B. Zetsche for helpful discussions and insights; R. Belliveau for overall research support; J. Francis and D. O'Connell for generous MiSeq instrument access; D. Daniels and C. Garvie for providing bacterial incubation space for protein purification; R. Macrae for critical reading of the manuscript; and the entire Zhang laboratory for support and advice. We thank N. Ranu for generously providing plasmid pRFP and D. Daniels for providing 6-His-MBP-TEV. O.O.A. is supported by a Paul and Daisy Soros Fellowship, a Friends of the McGovern Institute Fellowship, and the Poitras Center for Affective Disorders. J.S.G. is supported by a U.S. Department of Energy (DOE) Computational Science Graduate Fellowship. S.S. is supported by the graduate program of Skoltech Data-Intensive Biomedicine and Biotechnology Center for Research, Education, and Innovation. I.M.S. is supported by the Simons Center for the Social Brain. D.B.T.C. is supported by award T32GM007753 from the National Institute of General Medical Sciences. K.S.M., E.V.K., and, in part, S.S. are supported by the intramural program of the U.S. Department of Health and Human Services (to the National Library of Medicine). K.S. is supported by NIH grant GM10407, Russian Science Foundation grant 14-14-00988, and Skoltech. F.Z. is a New York Stem Cell Foundation Robertson Investigator. F.Z. is supported by the NIH through the National Institute of Mental Health (5DP1-MH100706 and 1R01-MH110049), NSF, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and J. Poitras, P. Poitras, R. Metcalfe, and D. Cheng. A. R. is a member of the scientific advisory board for Syros Pharmaceuticals and Thermo Fisher. O.O.A., J.S.G., J.J., E.V.K., S.K., E.S.L., K.S.M., L.M., E.S., K.S., S.S., and F.Z. are inventors on provisional patent application 62/181,675 applied for by the Broad Institute, MIT, Harvard, NIH, Skoltech, and Rutgers that covers the C2c2 proteins described in this paper. Deep sequencing data are available at Sequence Read Archive under BioProject accession no. PRJNA318890. The authors plan to make the reagents widely available to the academic community through Addgene subject to a materials transfer agreement and to provide software tools via the Zhang laboratory website (www.genome-engineering.org) and GitHub (https://github.com/fengzhanglab).	Abil Z, 2015, MOL BIOSYST, V11, P2658, DOI 10.1039/c5mb00289c; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim YK, 2013, PROTEINS, V81, P261, DOI 10.1002/prot.24183; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-40; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	50	1086	1285	80	524	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299							aaf5573	10.1126/science.aaf5573	http://dx.doi.org/10.1126/science.aaf5573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27256883	Green Submitted, Green Accepted			2022-12-28	WOS:000381560900032
J	Fukaya, T; Lim, B; Levine, M				Fukaya, Takashi; Lim, Bomyi; Levine, Michael			Enhancer Control of Transcriptional Bursting	CELL			English	Article							CIS-REGULATORY MODULES; DROSOPHILA EMBRYO; SNAIL EXPRESSION; TRANSGENIC DROSOPHILA; CHROMATIN INSULATOR; GYPSY INSULATOR; IN-VIVO; PROMOTER; GENE; NEUROECTODERM	Transcription is episodic, consisting of a series of discontinuous bursts. Using live-imaging methods and quantitative analysis, we examine transcriptional bursting in living Drosophila embryos. Different developmental enhancers positioned downstream of synthetic reporter genes produce transcriptional bursts with similar amplitudes and duration but generate very different bursting frequencies, with strong enhancers producing more bursts than weak enhancers. Insertion of an insulator reduces the number of bursts and the corresponding level of gene expression, suggesting that enhancer regulation of bursting frequency is a key parameter of gene control in development. We also show that linked reporter genes exhibit coordinated bursting profiles when regulated by a shared enhancer, challenging conventional models of enhancer-promoter looping.	[Fukaya, Takashi; Lim, Bomyi; Levine, Michael] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Levine, Michael] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Levine, M (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Levine, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	msl2@princeton.edu		Levine, Michael/0000-0001-7629-0081; Fukaya, Takashi/0000-0003-1478-6860	Human Frontier Science Program Long-Term Fellowship; National Institutes of Health [U01EB021239, GM46638]; JSPS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431, R01GM046638, R37GM046638] Funding Source: NIH RePORTER	Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Thomas Gregor for sharing the His2Av-mRFP; MCP-GFP fly strain. We also thank Samuel Pak Ng for assistance with fly injections, Evangelos Gatzogiannis for instruction and help with confocal imaging, and the Bloomington Drosophila Stock Center for fly strains. We are also grateful to members of the M.L. laboratory for discussions. T.F. was the recipient of a JSPS Postdoctoral Fellowship for Research Abroad and is currently supported by a Human Frontier Science Program Long-Term Fellowship. This study was funded by grants from the National Institutes of Health (U01EB021239 and GM46638).	Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; BUSTURIA A, 1993, EMBO J, V12, P1415, DOI 10.1002/j.1460-2075.1993.tb05785.x; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Cai HN, 1997, EMBO J, V16, P1732, DOI 10.1093/emboj/16.7.1732; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Dunipace L, 2013, DEV CELL, V26, P536, DOI 10.1016/j.devcel.2013.08.010; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; FOE VE, 1983, J CELL SCI, V61, P31; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lenstra TL, 2015, MOL CELL, V60, P597, DOI 10.1016/j.molcel.2015.09.028; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; MCKNIGHT SL, 1979, CELL, V17, P551; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Otsu N., 1975, IEEE T SYST MAN CYB, V11, P23; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Schoborg T, 2013, J CELL BIOL, V202, P261, DOI 10.1083/jcb.201304181; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	45	350	351	3	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2016	166	2					358	368		10.1016/j.cell.2016.05.025	http://dx.doi.org/10.1016/j.cell.2016.05.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR9ZR	27293191	Green Accepted, Bronze			2022-12-28	WOS:000380255400014
J	Chi, YL; Krishnakumar, J; Maurer, J; Loncar, D; Flahault, A				Chi, Y-Ling; Krishnakumar, Jaya; Maurer, Juergen; Loncar, Dejan; Flahault, Antoine			Who should finance WHO's work on emergencies?	LANCET			English	Editorial Material									[Chi, Y-Ling; Loncar, Dejan; Flahault, Antoine] Univ Geneva, Fac Med, Inst Global Hlth, CH-1202 Geneva, Switzerland; [Krishnakumar, Jaya] Univ Geneva, Inst Econ & Econometr, GSEM, CH-1202 Geneva, Switzerland; [Maurer, Juergen] Univ Lausanne, HEC, Lausanne, Switzerland; [Flahault, Antoine] Univ Paris 05, Ctr Virchow Villerme, Paris, France	University of Geneva; University of Geneva; University of Lausanne; UDICE-French Research Universities; Universite Paris Cite	Flahault, A (corresponding author), Univ Geneva, Fac Med, Inst Global Hlth, CH-1202 Geneva, Switzerland.; Flahault, A (corresponding author), Univ Paris 05, Ctr Virchow Villerme, Paris, France.	antoine.flahault@unige.ch		/0000-0002-3923-677X				Chan M., 2015, COMMUNICATION   0518; Gates B., 2011, B GAT G 20 LEAD CANN; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2014 S; Taskforce on Innovative International Financing for Health Systems, MOR MON HLTH MOR HLT; WHO, 2015, REFL ADV GROUP CHAIR; WHO, 2014, A6826 WHO; WHO, 2000, EB10720 WHO; WHO, 2015, GRAD 3 GRAD 2 EM ERM; WHO, 2015, WORK DRAFT SUMM SEL; World Health Organization, 2014, FIN REP AUD FIN STAT	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2584	2585		10.1016/S0140-6736(16)30586-4	http://dx.doi.org/10.1016/S0140-6736(16)30586-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP3JX	27233745				2022-12-28	WOS:000378390500009
J	Zubko, P; Wojdel, JC; Hadjimichael, M; Fernandez-Pena, S; Sene, A; Luk'yanchuk, I; Triscone, JM; Iniguez, J				Zubko, Pavlo; Wojdel, Jacek C.; Hadjimichael, Marios; Fernandez-Pena, Stephanie; Sene, Anais; Luk'yanchuk, Igor; Triscone, Jean-Marc; Iniguez, Jorge			Negative capacitance in multidomain ferroelectric superlattices	NATURE			English	Article							THIN-FILMS; ROOM-TEMPERATURE; DOMAINS; OXIDE; INTERFACES; BATIO3	The stability of spontaneous electrical polarization in ferroelectrics is fundamental to many of their current applications, which range from the simple electric cigarette lighter to non-volatile random access memories(1). Research on nanoscale ferroelectrics reveals that their behaviour is profoundly different from that in bulk ferroelectrics, which could lead to new phenomena with potential for future devices(2-4). As ferroelectrics become thinner, maintaining a stable polarization becomes increasingly challenging. On the other hand, intentionally destabilizing this polarization can cause the effective electric permittivity of a ferroelectric to become negative(5), enabling it to behave as a negative capacitance when integrated in a heterostructure. Negative capacitance has been proposed as a way of overcoming fundamental limitations on the power consumption of field-effect transistors(6). However, experimental demonstrations of this phenomenon remain contentious(7). The prevalent interpretations based on homogeneous polarization models are difficult to reconcile with the expected strong tendency for domain formation(8,9), but the effect of domains on negative capacitance has received little attention(5,10-12). Here we report negative capacitance in a model system of multidomain ferroelectric-dielectric superlattices across a wide range of temperatures, in both the ferroelectric and paraelectric phases. Using a phenomenological model, we show that domain-wall motion not only gives rise to negative permittivity, but can also enhance, rather than limit, its temperature range. Our first-principles-based atomistic simulations provide detailed microscopic insight into the origin of this phenomenon, identifying the dominant contribution of near-interface layers and paving the way for its future exploitation.	[Zubko, Pavlo; Hadjimichael, Marios] UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0HA, England; [Zubko, Pavlo; Hadjimichael, Marios] UCL, Dept Phys & Astron, 17-19 Gordon St, London WC1H 0HA, England; [Wojdel, Jacek C.; Iniguez, Jorge] Inst Ciencia Mat Barcelona ICMAB CSIC, Campus UAB, Bellaterra 08193, Spain; [Fernandez-Pena, Stephanie; Triscone, Jean-Marc] Univ Geneva, Dept Quantum Matter Phys, CH-1211 Geneva, Switzerland; [Sene, Anais; Luk'yanchuk, Igor] Univ Picardie, Lab Condensed Matter Phys, F-80000 Amiens, France; [Luk'yanchuk, Igor] LD Landau Theoret Phys Inst, Moscow, Russia; [Iniguez, Jorge] LIST, Mat Res & Technol Dept, 5 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg	University of London; University College London; University of London; University College London; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); University of Geneva; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Russian Academy of Sciences; Landau Institute for Theoretical Physics; Luxembourg Institute of Science & Technology	Zubko, P (corresponding author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0HA, England.; Zubko, P (corresponding author), UCL, Dept Phys & Astron, 17-19 Gordon St, London WC1H 0HA, England.; Iniguez, J (corresponding author), Inst Ciencia Mat Barcelona ICMAB CSIC, Campus UAB, Bellaterra 08193, Spain.; Iniguez, J (corresponding author), LIST, Mat Res & Technol Dept, 5 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg.	p.zubko@ucl.ac.uk; jorge.iniguez@list.lu	Zubko, Pavlo/B-5496-2009; Íñiguez, Jorge/B-6856-2009; Igor, Lukyanchuk A./C-4206-2008; Íñiguez, Jorge/K-3828-2019	Zubko, Pavlo/0000-0002-7330-3163; Íñiguez, Jorge/0000-0001-6435-3604; Igor, Lukyanchuk A./0000-0001-8622-3552; Íñiguez, Jorge/0000-0001-6435-3604; Hadjimichael, Marios/0000-0001-6618-8075	EPSRC [EP/M007073/1]; A. G. Leventis Foundation; FNR Luxembourg [FNR/P12/4853155/Kreisel]; MINECO-Spain [MAT2013-40581-P]; Swiss National Science Foundation Division II; European Research Council under the European Union [319286]; EU; Engineering and Physical Sciences Research Council [EP/M007073/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); A. G. Leventis Foundation; FNR Luxembourg(Luxembourg National Research Fund); MINECO-Spain; Swiss National Science Foundation Division II(Swiss National Science Foundation (SNSF)); European Research Council under the European Union(European Research Council (ERC)); EU(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the EPSRC (Grant No. EP/M007073/1; P.Z. and M.H.), the A. G. Leventis Foundation (M.H.); FNR Luxembourg (Grant No. FNR/P12/4853155/Kreisel; J.I.), MINECO-Spain (Grant No. MAT2013-40581-P; J.I. and J.C.W.), the Swiss National Science Foundation Division II (J.-M.T. and S.F.-P.), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC (Grant No. 319286 (Q-MAC); J.-M.T. and S.F.-P.), and the EU-FP7-ITN project NOTEDEV (Grant No. 607521; I.L.).	Aguado-Puente P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184105; Aguado-Puente P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177601; Appleby DJR, 2014, NANO LETT, V14, P3864, DOI 10.1021/nl5017255; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Bratkovsky AM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2408650; Bratkovsky AM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.132103; Cano A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3494533; Catalan G, 2000, APPL PHYS LETT, V77, P3078, DOI 10.1063/1.1324729; Catalan G, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/13/132201; Catalan G, 2015, NAT MATER, V14, P137, DOI 10.1038/nmat4195; Dawber M, 2007, ADV MATER, V19, P4153, DOI 10.1002/adma.200700965; De Guerville F, 2005, MAT SCI ENG B-SOLID, V120, P16, DOI 10.1016/j.mseb.2005.02.039; Gao WW, 2014, NANO LETT, V14, P5814, DOI 10.1021/nl502691u; Garcia A, 1998, APPL PHYS LETT, V72, P2981, DOI 10.1063/1.121514; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Ghosez P, 1999, PHYS REV B, V60, P836, DOI 10.1103/PhysRevB.60.836; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Khan AI, 2015, NAT MATER, V14, P182, DOI [10.1038/NMAT4148, 10.1038/nmat4148]; Khan AI, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634072; Kim DJ, 2012, NANO LETT, V12, P5697, DOI 10.1021/nl302912t; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; Kopal A, 1999, FERROELECTRICS, V223, P127, DOI 10.1080/00150199908260562; Krowne CM, 2011, NANO LETT, V11, P988, DOI 10.1021/nl1037215; Landau LD., 1935, PHYS SOVIETUNION, V8, P153, DOI DOI 10.1016/B978-0-08-036364-6.50008-9; Lichtensteiger C, 2014, NANO LETT, V14, P4205, DOI 10.1021/nl404734z; Lisenkov S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020102; Luk'yanchuk IA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147601; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Pakhomov A., 2014, TERAHERTZ ELECTRODYN; Plonka R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931063; Ponomareva I, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235403; Ponomareva I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.227601; Salahuddin S, 2008, NANO LETT, V8, P405, DOI 10.1021/nl071804g; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Sene A, 2010, THESIS; Stengel M, 2006, NATURE, V443, P679, DOI 10.1038/nature05148; Stengel M, 2009, NAT MATER, V8, P392, DOI [10.1038/NMAT2429, 10.1038/nmat2429]; Stephanovich VA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047601; Warusawithana MP, 2009, SCIENCE, V324, P367, DOI 10.1126/science.1169678; Wojdel JC, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014105; Wojdel JC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.247603; Wojdel JC, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/30/305401; Zubko P, 2012, FERROELECTRICS, V433, P127, DOI 10.1080/00150193.2012.678159; Zubko P, 2012, NANO LETT, V12, P2846, DOI 10.1021/nl3003717	47	222	224	19	411	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					524	+		10.1038/nature17659	http://dx.doi.org/10.1038/nature17659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27296225	Green Submitted, Green Accepted			2022-12-28	WOS:000378270300048
J	Paruch, P; Ghosez, P				Paruch, Patrycja; Ghosez, Philippe			COMPUTATIONAL MATERIALS SCIENCE Predictions of pinning	NATURE			English	Editorial Material									[Paruch, Patrycja] Univ Geneva, Dept Quantum Matter Phys, CH-1211 Geneva 4, Switzerland; [Ghosez, Philippe] Univ Liege, Grp Theoret Mat Phys, CESAM Res Unit, B-4000 Liege, Belgium	University of Geneva; University of Liege	Ghosez, P (corresponding author), Univ Liege, Grp Theoret Mat Phys, CESAM Res Unit, B-4000 Liege, Belgium.	patrycja.paruch@unige.ch; philippe.ghosez@ulg.ac.be	Ghosez, Philippe/F-1954-2014	Paruch, Patrycja/0000-0001-7799-6721				Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Giamarchi T, 2006, LECT NOTES PHYS, V688, P91; Jo JY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.267602; Liu S, 2016, NATURE, V534, P360, DOI 10.1038/nature18286; Marzari N, 2016, NAT MATER, V15, P381, DOI 10.1038/nmat4613; NATTERMANN T, 1983, J PHYS C SOLID STATE, V16, P4125, DOI 10.1088/0022-3719/16/21/014; NATTERMANN T, 1990, PHYS REV B, V42, P8577, DOI 10.1103/PhysRevB.42.8577; Paruch P, 2013, CR PHYS, V14, P667, DOI 10.1016/j.crhy.2013.08.004	10	3	3	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					331	332		10.1038/534331a	http://dx.doi.org/10.1038/534331a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306183				2022-12-28	WOS:000377856800023
J	Mistry, J; Berardi, A				Mistry, Jayalaxshmi; Berardi, Andrea			Bridging indigenous and scientific knowledge	SCIENCE			English	Editorial Material							INUIT		[Mistry, Jayalaxshmi] Royal Holloway Univ London, Dept Geog, Egham TW20 0EX, Surrey, England; [Berardi, Andrea] Open Univ, Milton Keynes MK7 6AA, Bucks, England	University of London; Royal Holloway University London; Open University - UK	Mistry, J (corresponding author), Royal Holloway Univ London, Dept Geog, Egham TW20 0EX, Surrey, England.	j.mistry@rhul.ac.uk	Berardi, Andrea/F-3443-2016	Berardi, Andrea/0000-0003-3546-4916; Mistry, Jayalaxshmi/0000-0001-7582-3739				Bates P, 2007, ARCTIC ANTHROPOL, V44, P87, DOI 10.1353/arc.2011.0065; Berkes F, 2009, FUTURES, V41, P6, DOI 10.1016/j.futures.2008.07.003; Brondizio ES, 2016, SCIENCE, V352, P1272, DOI 10.1126/science.aaf5122; Ford JD, 2016, NAT CLIM CHANGE, V6, P349, DOI 10.1038/NCLIMATE2954; Ford JD, 2015, NAT CLIM CHANGE, V5, P1046, DOI [10.1038/nclimate2723, 10.1038/NCLIMATE2723]; Gomez-Baggethun E, 2013, ECOL SOC, V18, DOI 10.5751/ES-06288-180472; Idrobo CJ, 2012, HUM ECOL, V40, P405, DOI 10.1007/s10745-012-9490-7; Klein J. A., 2015, GLOBAL ENVIRON CHANG, V28, P141; Klenk N, 2015, ENVIRON SCI POLICY, V54, P160, DOI 10.1016/j.envsci.2015.05.017; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Mistry J., 2015, UP SCALING SUPPORT C; Mistry J., 2009, INTERNATIONALENCYCLO, P371; Mistry J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0174; Walker W, 2015, CARBON MANAG, V5, P479; Weiss K, 2013, SOC NATUR RESOUR, V26, P285, DOI 10.1080/08941920.2012.690065	15	178	179	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1274	1275		10.1126/science.aaf1160	http://dx.doi.org/10.1126/science.aaf1160			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7ON	27284180	Green Accepted			2022-12-28	WOS:000377972000019
J	Brown, A; Fernandez, IS; Gordiyenko, Y; Ramakrishnan, V				Brown, Alan; Fernandez, Israel S.; Gordiyenko, Yuliya; Ramakrishnan, V.			Ribosome-dependent activation of stringent control	NATURE			English	Article							ESCHERICHIA-COLI; RIBONUCLEIC-ACID; GUANOSINE TETRAPHOSPHATE; STRUCTURAL BASIS; EF-TU; PROTEIN; RELA; RNA; RESOLUTION; PPGPP	In order to survive, bacteria continually sense, and respond to, environmental fluctuations. Stringent control represents a key bacterial stress response to nutrient starvation(1,2) that leads to rapid and comprehensive reprogramming of metabolic and transcriptional patterns(3). In general, transcription of genes for growth and proliferation is downregulated, while those important for survival and virulence are upregulated(4). Amino acid starvation is sensed by depletion of the aminoacylated tRNA pools(5), and this results in accumulation of ribosomes stalled with non-aminoacylated (uncharged) tRNA in the ribosomal A site(6,7). RelA is recruited to stalled ribosomes and activated to synthesize a hyperphosphorylated guanosine analogue, (p)ppGpp(8), which acts as a pleiotropic secondary messenger. However, structural information about how RelA recognizes stalled ribosomes and discriminates against aminoacylated tRNAs is missing. Here we present the cryo-electron microscopy structure of RelA bound to the bacterial ribosome stalled with uncharged tRNA. The structure reveals that RelA utilizes a distinct binding site compared to the translational factors, with a multi-domain architecture that wraps around a highly distorted A-site tRNA. The TGS (ThrRS, GTPase and SpoT) domain of RelA binds the CCA tail to orient the free 3'hydroxyl group of the terminal adenosine towards a beta-strand, such that an aminoacylated tRNA at this position would be sterically precluded. The structure supports a model in which association of RelA with the ribosome suppresses auto-inhibition to activate synthesis of (p) ppGpp and initiate the stringent response. Since stringent control is responsible for the survival of pathogenic bacteria under stress conditions, and contributes to chronic infections and antibiotic tolerance, RelA represents a good target for the development of novel antibacterial therapeutics.	[Brown, Alan; Fernandez, Israel S.; Gordiyenko, Yuliya; Ramakrishnan, V.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Fernandez, Israel S.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA	MRC Laboratory Molecular Biology; Columbia University	Ramakrishnan, V (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Brown, Alan/I-1473-2019	Brown, Alan/0000-0002-0021-0476; Ramakrishnan, V/0000-0002-4699-2194; Fernandez, Israel/0000-0001-7218-1603	UK Medical Research Council [MC_U105184332]; Wellcome Trust [WT096570]; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Kelley for providing tRNAs, A. Xu and J. Murray for their contributions to the early stages of this project, C. G. Savva for help with data collection, J. Grimmett and T. Darling for computing support, and X. Bai, G. Murshudov, S. H. W. Scheres, and S. Tan for discussions. This work was supported by grants to V.R. from the UK Medical Research Council (MC_U105184332), the Wellcome Trust (WT096570), the Agouron Institute, and the Louis-Jeantet Foundation.	Agirrezabala X, 2013, EMBO REP, V14, P811, DOI 10.1038/embor.2013.106; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; CASHEL M, 1970, J BIOL CHEM, V245, P2309; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; FANGMAN WL, 1964, J BIOL CHEM, V239, P1844; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; FRIESEN JD, 1974, P NATL ACAD SCI USA, V71, P3465, DOI 10.1073/pnas.71.9.3465; Gropp M, 2001, J BACTERIOL, V183, P570, DOI 10.1128/JB.183.2.570-579.2001; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li WT, 2016, MOL MICROBIOL, V99, P571, DOI 10.1111/mmi.13252; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; PEDERSEN FS, 1973, NATURE-NEW BIOL, V243, P13; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SANDS MK, 1952, J BACTERIOL, V63, P505, DOI 10.1128/JB.63.4.505-511.1952; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4693; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SPRINZL M, 1976, EUR J BIOCHEM, V71, P171, DOI 10.1111/j.1432-1033.1976.tb11103.x; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Yang XM, 2001, BIOCHEM CELL BIOL, V79, P729, DOI 10.1139/bcb-79-6-729; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	51	127	131	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					277	+		10.1038/nature17675	http://dx.doi.org/10.1038/nature17675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279228	Green Accepted			2022-12-28	WOS:000377475100047
J	Cole, WTS; Farrell, JD; Wales, DJ; Saykally, RJ				Cole, William T. S.; Farrell, James D.; Wales, David J.; Saykally, Richard J.			Structure and torsional dynamics of the water octamer from THz laser spectroscopy near 215 mu m	SCIENCE			English	Article							HYDROGEN-BOND COOPERATIVITY; POTENTIAL-ENERGY SURFACE; VIRIAL-COEFFICIENT; BINDING-ENERGIES; (H2O)20 CLUSTERS; MODEL (H2O)8; MONTE-CARLO; HEXAMER; LIQUID; PRISM	Clusters of eight water molecules play an important role in theoretical analysis of aqueous structure and dynamics but have proven to be challenging experimental targets. Here we report the high-resolution spectroscopic characterization of the water octamer. Terahertz (THz) vibration-rotation-tunneling (VRT) spectroscopy resolved 99 transitions with 1 part per million precision in a narrow range near 46.5 wave numbers, which were assigned to the h(16) octamer via detailed isotope dilution experiments. Fitting to a semi-rigid symmetric top model supports predictions of two coexisting cuboidal structures and provides precise values for the changes in their rotational constants. Comparison with theory and previous spectroscopic data provides a characterization of the two structures and the observed torsional vibration and supports the prediction that the D-2d symmetry structure is lower in energy than the S-4 isomer.	[Cole, William T. S.; Saykally, Richard J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94705 USA; [Farrell, James D.; Wales, David J.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	University of California System; University of California Berkeley; University of Cambridge	Saykally, RJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94705 USA.; Wales, DJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	dw34@cam.ac.uk; saykally@berkeley.edu		Farrell, James/0000-0002-1893-1773; SAYKALLY, RICHARD/0000-0001-8942-3656	Chemical Structure, Dynamics, and Mechanisms-A Division of the National Science Foundation [1300723]	Chemical Structure, Dynamics, and Mechanisms-A Division of the National Science Foundation	The Berkeley Terahertz project is supported by Chemical Structure, Dynamics, and Mechanisms-A Division of the National Science Foundation under grant no. 1300723. J.D.F. gratefully acknowledges A. Thom and D. Chakraborty for stimulating discussions. We thank the referees for thoughtful discussion during review. For details of the pattern recognition methodology, contact the authors or visit www.cchem.berkeley.edu/rjsgrp/.	Asare E, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3259047; Babin V, 2014, J CHEM THEORY COMPUT, V10, P1599, DOI 10.1021/ct500079y; Babin V, 2013, J CHEM THEORY COMPUT, V9, P5395, DOI 10.1021/ct400863t; Blanton WB, 1999, J AM CHEM SOC, V121, P3551, DOI 10.1021/ja982100z; BRINK G, 1984, J PHYS CHEM-US, V88, P3412, DOI 10.1021/j150660a009; Buck U, 1998, PHYS REV LETT, V80, P2578, DOI 10.1103/PhysRevLett.80.2578; Cruzan JD, 1996, SCIENCE, V271, P59, DOI 10.1126/science.271.5245.59; Day MB, 2005, INT J QUANTUM CHEM, V102, P565, DOI 10.1002/qua.20371; Fellers RS, 1999, SCIENCE, V284, P945, DOI 10.1126/science.284.5416.945; Gelman-Constantin J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3455716; Gruenloh CJ, 1998, J CHEM PHYS, V109, P6601, DOI 10.1063/1.477346; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hao HJ, 2011, CRYST GROWTH DES, V11, P5475, DOI 10.1021/cg201067q; Hernandez-Rojas J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400853; James T, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2429659; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; Maeda S, 2007, J PHYS CHEM A, V111, P4527, DOI 10.1021/jp070606a; Medders GR, 2014, J CHEM THEORY COMPUT, V10, P2906, DOI 10.1021/ct5004115; Miliordos E, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4922262; Miyake T, 2006, CHEM PHYS LETT, V427, P215, DOI 10.1016/j.cplett.2006.06.077; Mukhopadhyay A, 2015, CHEM PHYS LETT, V633, P13, DOI 10.1016/j.cplett.2015.04.016; Nigra P, 2001, J CHEM PHYS, V115, P2621, DOI 10.1063/1.1385795; Perez C, 2014, ANGEW CHEM INT EDIT, V53, P14368, DOI 10.1002/anie.201407447; Perez C, 2013, CHEM PHYS LETT, V571, P1, DOI 10.1016/j.cplett.2013.04.014; Perez C, 2012, SCIENCE, V336, P897, DOI 10.1126/science.1220574; Prasad TK, 2006, CRYST GROWTH DES, V6, P488, DOI 10.1021/cg050417m; Richardson JO, 2016, SCIENCE, V351, P1310, DOI 10.1126/science.aae0012; Richardson JO, 2013, J PHYS CHEM A, V117, P6960, DOI 10.1021/jp311306a; Shields RM, 2010, J PHYS CHEM A, V114, P11725, DOI 10.1021/jp104865w; STILLINGER FH, 1980, J CHEM PHYS, V73, P3384, DOI 10.1063/1.440534; Suitte BP, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.043204; Sun YG, 2007, INORG CHEM COMMUN, V10, P467, DOI 10.1016/j.inoche.2006.12.021; Temelso B, 2011, J PHYS CHEM A, V115, P12034, DOI 10.1021/jp2069489; Temelso B, 2011, J CHEM THEORY COMPUT, V7, P2804, DOI 10.1021/ct2003308; Tharrington AN, 2003, J PHYS CHEM A, V107, P7380, DOI 10.1021/jp030355f; TSAI CJ, 1991, J CHEM PHYS, V95, P3850, DOI 10.1063/1.460788; WALES DJ, 1993, J CHEM PHYS, V98, P7257, DOI 10.1063/1.464717; WALES DJ, 1993, J CHEM PHYS, V98, P7245, DOI 10.1063/1.464716; Wang YM, 2012, J AM CHEM SOC, V134, P11116, DOI 10.1021/ja304528m; Xantheas SS, 2004, J CHEM PHYS, V120, P823, DOI 10.1063/1.1626624	41	55	58	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1194	1197		10.1126/science.aad8625	http://dx.doi.org/10.1126/science.aad8625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257252	Green Published, Green Submitted			2022-12-28	WOS:000377045700036
J	Piunti, A; Shilatifard, A				Piunti, Andrea; Shilatifard, Ali			Epigenetic balance of gene expression by Polycomb and COMPASS families	SCIENCE			English	Review							EMBRYONIC STEM-CELLS; REPRESSIVE COMPLEX 2; HISTONE METHYLTRANSFERASE ACTIVITY; ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTIPLE ENDOCRINE NEOPLASIA; CHROMATIN REMODELING GENES; EARLY MOUSE DEVELOPMENT; NON-HODGKIN-LYMPHOMA; NERVE SHEATH TUMORS; BREAST-CANCER CELLS	Epigenetic regulation of gene expression in metazoans is central for establishing cellular diversity, and its deregulation can result in pathological conditions. Although transcription factors are essential for implementing gene expression programs, they do not function in isolation and require the recruitment of various chromatin-modifying and -remodeling machineries. A classic example of developmental chromatin regulation is the balanced activities of the Polycomb group (PcG) proteins within the PRC1 and PRC2 complexes, and the Trithorax group (TrxG) proteins within the COMPASS family, which are highly mutated in a large number of human diseases. In this review, we will discuss the latest findings regarding the properties of the PcG and COMPASS families and the insight they provide into the epigenetic control of transcription under physiological and pathological settings.	[Piunti, Andrea; Shilatifard, Ali] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, 320 East Super St, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shilatifard, A (corresponding author), Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, 320 East Super St, Chicago, IL 60611 USA.	ash@northwestern.edu			National Cancer Institute [R35CA197569]; NATIONAL CANCER INSTITUTE [R35CA197569] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all of the members of the Shilatifard laboratory for helpful discussions and in particular E. Smith and M. Morgan for critical suggestions and help with the manuscript, and L. Shilatifard for editorial assistance. We are also grateful to M. Miller for assistance during the preparation of figures for this review. A. P. is an EMBO postdoctoral fellow (ALTF 372-2015), AIRC and Marie Curie Actions - People - COFUND. A.S. is on the scientific advisory boards of Genentech and Cell Signaling Technology. The studies in the Shilatifard laboratory in regard to the Polycomb and COMPASS family are supported by the National Cancer Institute grant R35CA197569.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Andricovich J, 2016, J CLIN INVEST, V126, P905, DOI 10.1172/JCI84014; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bauer M., 2015, CHROMOSOMA, DOI [10.1007/s00412-015-0539-4, DOI 10.1007/S00412-015-0539-4;PMID:26453572]; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Borkin D, 2015, CANCER CELL, V27, P589, DOI 10.1016/j.ccell.2015.02.016; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Cai L, 2013, MOL CELL, V49, P571, DOI 10.1016/j.molcel.2012.11.026; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Cavalli G, 2015, NAT GENET, V47, P1105, DOI 10.1038/ng.3411; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; CIMINO G, 1991, CANCER RES, V51, P6712; Core N, 1997, DEVELOPMENT, V124, P721; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dumesic PA, 2015, CELL, V160, P204, DOI 10.1016/j.cell.2014.11.039; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Forzati F, 2014, BIOL OPEN, V3, P871, DOI 10.1242/bio.20147872; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; HAUPT Y, 1993, ONCOGENE, V8, P3161; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Herz HM, 2012, MOL CELL BIOL, V32, P1683, DOI 10.1128/MCB.06503-11; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; INGHAM PW, 1983, NATURE, V306, P591, DOI 10.1038/306591a0; Ingham PW, 1998, INT J DEV BIOL, V42, P423; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jamieson K, 2013, P NATL ACAD SCI USA, V110, P6027, DOI 10.1073/pnas.1303750110; Jermann P, 2014, P NATL ACAD SCI USA, V111, pE3415, DOI 10.1073/pnas.1400672111; Jiang H, 2013, NAT STRUCT MOL BIOL, V20, P1156, DOI 10.1038/nsmb.2656; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lewis P. H., 1947, DROS INFORM SERV, V21, P69; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li JZ, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P195, DOI 10.1016/B978-0-12-404568-2.00018-2; Li TM, 2016, MOL THER, V24, P261, DOI 10.1038/mt.2015.208; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Mahajan Muktar A, 2008, Nucl Recept Signal, V6, pe002, DOI 10.1621/nrs.06002; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Minocha S, 2016, DEV BIOL, V412, P1, DOI 10.1016/j.ydbio.2016.02.019; Mochizuki-Kashio M, 2015, BLOOD, V126, P1172, DOI 10.1182/blood-2015-03-634428; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1266, DOI 10.1038/nsmb.2435; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Piunti A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4649; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Prasad R, 1995, P NATL ACAD SCI USA, V92, P12160, DOI 10.1073/pnas.92.26.12160; PURO J, 1975, HEREDITAS, V81, P237; Qi J, 2014, J BIOL CHEM, V289, P31373, DOI 10.1074/jbc.M114.579839; Rai K, 2015, CANCER DISCOV, V5, P1314, DOI 10.1158/2159-8290.CD-15-0493; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; RUBNITZ JE, 1994, BLOOD, V84, P1747; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Scelfo A, 2015, FEBS J, V282, P1703, DOI 10.1111/febs.13112; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Serresi M, 2016, CANCER CELL, V29, P17, DOI 10.1016/j.ccell.2015.12.006; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Skulte KA, 2014, EPIGENOMICS-UK, V6, P397, DOI 10.2217/epi.14.37; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Son J, 2013, GENE DEV, V27, P2663, DOI 10.1101/gad.225888.113; Soshnikova N, 2011, BIRTH DEFECTS RES A, V91, P781, DOI 10.1002/bdra.20774; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; Takihara Y, 1997, DEVELOPMENT, V124, P3673; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yeh HH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1155-7; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	243	266	272	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290							aad9780	10.1126/science.aad9780	http://dx.doi.org/10.1126/science.aad9780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257261				2022-12-28	WOS:000377045700033
J	Harris, LK; Theriot, JA				Harris, Leigh K.; Theriot, Julie A.			Relative Rates of Surface and Volume Synthesis Set Bacterial Cell Size	CELL			English	Article							ESCHERICHIA-COLI; PEPTIDOGLYCAN SYNTHESIS; SALMONELLA-TYPHIMURIUM; GENE-EXPRESSION; DIVISION CYCLE; GROWTH; CAULOBACTER; HOMEOSTASIS; TOPOGRAPHY; MREB	Many studies have focused on the mechanisms underlying length and width determination in rod-shaped bacteria. Here, we focus instead on cell surface area to volume ratio (SA/V) and demonstrate that SA/V homeostasis underlies size determination. We propose a model whereby the instantaneous rates of surface and volume synthesis both scale with volume. This model predicts that these relative rates dictate SA/V and that cells approach a new steady-state SA/V exponentially, with a decay constant equal to the volume growth rate. To test this, we exposed diverse bacterial species to sublethal concentrations of a cell wall biosynthesis inhibitor and observed dose-dependent decreases in SA/V. Furthermore, this decrease was exponential and had the expected decay constant. The model also quantitatively describes SA/V alterations induced by other chemical, nutritional, and genetic perturbations. We additionally present evidence for a surface material accumulation threshold underlying division, sensitizing cell length to changes in SA/V requirements.	[Harris, Leigh K.; Theriot, Julie A.] Stanford Univ, Dept Biochem, Biophys Program, Stanford, CA 94305 USA; [Harris, Leigh K.; Theriot, Julie A.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Theriot, JA (corresponding author), Stanford Univ, Dept Biochem, Biophys Program, Stanford, CA 94305 USA.; Theriot, JA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	theriot@stanford.edu	Theriot, Julie/HHN-2034-2022	Theriot, Julie/0000-0002-2334-2535	NSF Graduate Research Fellowship; NIH [R01 AI067712, R01 AI036929]; Stanford Center for Systems Biology [P50-GM107615]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067712, R01AI036929, R37AI036929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, P50GM107615] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Center for Systems Biology; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Theriot lab as well as K.C. Huang and L. Shapiro and their labs for helpful suggestions, particularly E. Rojas, X. Zhou, and M. Footer. We thank S. Crosson, L. Shapiro, D. Portnoy, J. Dawson, and S. Austin for strains and C. Gross and J. Peters for sharing unpublished data. Helpful comments on the manuscript were provided by A. Colavin, N. Dye, A. Kennard, and E. Rojas. This work was supported by an NSF Graduate Research Fellowship to L.K.H., NIH R01 AI067712, NIH R01 AI036929, the Stanford Center for Systems Biology (P50-GM107615), and HHMI.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; COOPER S, 1988, J BACTERIOL, V170, P422, DOI 10.1128/jb.170.1.422-430.1988; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Deforet M, 2015, BIOPHYS J, V109, P521, DOI 10.1016/j.bpj.2015.07.002; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Dye NA, 2011, MOL MICROBIOL, V81, P368, DOI 10.1111/j.1365-2958.2011.07698.x; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; GANTI T, 1975, BIOSYSTEMS, V7, P15, DOI 10.1016/0303-2647(75)90038-6; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/NMETH.1452, 10.1038/nmeth.1452]; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Harris LK, 2014, MOL MICROBIOL, V94, P988, DOI 10.1111/mmi.12811; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Iyer-Biswas S, 2014, P NATL ACAD SCI USA, V111, P15912, DOI 10.1073/pnas.1403232111; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Jun S, 2015, TRENDS MICROBIOL, V23, P4, DOI 10.1016/j.tim.2014.12.001; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Monds RD, 2014, CELL REP, V9, P1528, DOI 10.1016/j.celrep.2014.10.040; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Morgan JJ, 2004, J THEOR BIOL, V231, P581, DOI 10.1016/j.jtbi.2004.07.014; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; PREVIC EP, 1970, J THEOR BIOL, V27, P471, DOI 10.1016/S0022-5193(70)80010-8; PRITCHARD RH, 1974, PHILOS T R SOC B, V267, P303, DOI 10.1098/rstb.1974.0003; Real G, 2006, J BACTERIOL, V188, P1721, DOI 10.1128/JB.188.5.1721-1732.2006; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHAECHTER M, 1962, J GEN MICROBIOL, V29, P421, DOI 10.1099/00221287-29-3-421; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; SUD IJ, 1964, J BACTERIOL, V88, P1612, DOI 10.1128/JB.88.6.1612-1617.1964; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Tanouchi Y, 2015, NATURE, V523, P357, DOI 10.1038/nature14562; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989; WOLDRINGH CL, 1987, J GEN MICROBIOL, V133, P575; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	49	109	111	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1479	1492		10.1016/j.cell.2016.05.045	http://dx.doi.org/10.1016/j.cell.2016.05.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259152	Green Accepted, Bronze			2022-12-28	WOS:000377045400020
J	Wu, S; Tutuncuoglu, B; Yan, KG; Brown, H; Zhang, YX; Tan, D; Gamalinda, M; Yuan, Y; Li, ZF; Jakovljevic, J; Ma, CY; Lei, JL; Dong, MQ; Woolford, JL; Gao, N				Wu, Shan; Tutuncuoglu, Beril; Yan, Kaige; Brown, Hailey; Zhang, Yixiao; Tan, Dan; Gamalinda, Michael; Yuan, Yi; Li, Zhifei; Jakovljevic, Jelena; Ma, Chengying; Lei, Jianlin; Dong, Meng-Qiu; Woolford, John L., Jr.; Gao, Ning			Diverse roles of assembly factors revealed by structures of late nuclear pre-60S ribosomes	NATURE			English	Article							RNA; BIOGENESIS; MATURATION; ASSOCIATION; SUBUNIT; COMPLEX; IDENTIFICATION; INITIATION; RESOLUTION; REFINEMENT	Ribosome biogenesis is a highly complex process in eukaryotes, involving temporally and spatially regulated ribosomal protein (r-protein) binding and ribosomal RNA remodelling events in the nucleolus, nucleoplasm and cytoplasm(1,2). Hundreds of assembly factors, organized into sequential functional groups(3,4), facilitate and guide the maturation process into productive assembly branches in and across different cellular compartments. However, the precise mechanisms by which these assembly factors function are largely unknown. Here we use cryo-electron microscopy to characterize the structures of yeast nucleoplasmic pre-60S particles affinity-purified using the epitope-tagged assembly factor Nog2. Our data pinpoint the locations and determine the structures of over 20 assembly factors, which are enriched in two areas: an arc region extending from the central protuberance to the polypeptide tunnel exit, and the domain including the internal transcribed spacer 2 (ITS2) that separates 5.8S and 25S ribosomal RNAs. In particular, two regulatory GTPases, Nog2 and Nog1, act as hub proteins to interact with multiple, distant assembly factors and functional ribosomal RNA elements, manifesting their critical roles in structural remodelling checkpoints and nuclear export. Moreover, our snapshots of compositionally and structurally different pre-60S intermediates provide essential mechanistic details for three major remodelling events before nuclear export: rotation of the 5S ribonucleoprotein, construction of the active centre and ITS2 removal. The rich structural information in our structures provides a framework to dissect molecular roles of diverse assembly factors in eukaryotic ribosome assembly.	[Wu, Shan; Yan, Kaige; Zhang, Yixiao; Yuan, Yi; Li, Zhifei; Ma, Chengying; Lei, Jianlin; Gao, Ning] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Tutuncuoglu, Beril; Brown, Hailey; Gamalinda, Michael; Jakovljevic, Jelena; Woolford, John L., Jr.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Tan, Dan; Dong, Meng-Qiu] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Tan, Dan; Dong, Meng-Qiu] Peking Union Med Coll, Beijing 100730, Peoples R China; [Tan, Dan; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tsinghua University; Carnegie Mellon University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Biological Sciences, Beijing	Gao, N (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China.; Woolford, JL (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	jw17@andrew.cmu.edu; ninggao@tsinghua.edu.cn	Gao, Ning/J-9623-2012; Gao, Ning/AAK-2214-2020	Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Brown, Hailey/0000-0003-0872-7119; Yan, Kaige/0000-0003-4176-5109	Ministry of Science and Technology of China [2013CB910404, 2014CB849800]; National Natural Science Foundation of China [31422016, 31470722, 21375010]; National Institutes of Health [R01GM028301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028301] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Center for Protein Sciences ( Beijing, China) for providing resource for cryo-EM data collection and computation. We also thank members of Woolford laboratory for reading the manuscript. This work was supported by the Ministry of Science and Technology of China ( 2013CB910404 to N. G. and 2014CB849800 to M.-Q.D.), the National Natural Science Foundation of China ( 31422016 and 31470722 to N. G., and 21375010 to M.-Q.D.) and National Institutes of Health grant R01GM028301 ( to J.L.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Asano N, 2015, NUCLEIC ACIDS RES, V43, P4746, DOI 10.1093/nar/gkv305; Barrio-Garcia C, 2016, NAT STRUCT MOL BIOL, V23, P37, DOI 10.1038/nsmb.3132; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; Greber BJ, 2016, CELL, V164, P91, DOI 10.1016/j.cell.2015.11.027; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Kharde S, 2015, NUCLEIC ACIDS RES, V43, P7083, DOI 10.1093/nar/gkv640; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Madru C, 2015, GENE DEV, V29, P1432, DOI 10.1101/gad.260349.115; Matsuo Y, 2014, NATURE, V505, P112, DOI 10.1038/nature12731; McCann KL, 2015, GENE DEV, V29, P862, DOI 10.1101/gad.256370.114; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Talkish J, 2012, NUCLEIC ACIDS RES, V40, P8646, DOI 10.1093/nar/gks609; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	60	126	131	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					133	+		10.1038/nature17942	http://dx.doi.org/10.1038/nature17942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251291	Green Accepted			2022-12-28	WOS:000376962300049
J	Azevedo, EM; Weyl, EG				Azevedo, Eduardo M.; Weyl, E. Glen			ECONOMICS Matching markets in the digital age	SCIENCE			English	Editorial Material									[Azevedo, Eduardo M.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Weyl, E. Glen] Microsoft Res New England, Cambridge, MA 02142 USA; [Weyl, E. Glen] Univ Chicago, Chicago, IL 60637 USA	University of Pennsylvania; Microsoft; University of Chicago	Azevedo, EM (corresponding author), Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA.; Weyl, EG (corresponding author), Microsoft Res New England, Cambridge, MA 02142 USA.; Weyl, EG (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	eazevedo@wharton.upenn.edu; glenweyl@microsoft.com		Azevedo, Eduardo/0000-0001-6048-6506				Buchholz N, 2020, WORKING PAPER, V31, P1301; Cachon GP, 2015, ROLE SURGE PRICING S; Chen K., 2015, WORKING PAPER; Chen L, 2015, IMC'15: PROCEEDINGS OF THE 2015 ACM CONFERENCE ON INTERNET MEASUREMENT CONFERENCE, P495, DOI 10.1145/2815675.2815681; CHICAGO U, 1994, J POLIT ECON, V102, P468, DOI 10.1086/261942; Cramer J., 2015, 22083 NBER; Einav L, 2016, ANNU REV ECON, V8, P615, DOI 10.1146/annurev-economics-080315-015334; Gentzkow M., 2014, AM ECON REV, V104, P5; Hall J., 2015, EFFECTS UBERS SURGE; Kaldor N, 1933, REV ECON STUD, V1, P122; Rochet JC, 2008, INT J IND ORGAN, V26, P1333, DOI 10.1016/j.ijindorg.2008.01.002; Roth A. E., 2012, NOBEL LECT; Tirole J., 2014, NOBEL LECT; Weyl E. G., 2014, COMP POLICY INT, V10, P28	14	30	32	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1056	1057		10.1126/science.aaf7781	http://dx.doi.org/10.1126/science.aaf7781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM6RT	27230366				2022-12-28	WOS:000376480800021
J	Buckels, J; Simms, M				Buckels, John; Simms, Malcolm			Anthony David Barnes OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2959	10.1136/bmj.i2959	http://dx.doi.org/10.1136/bmj.i2959			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27234511				2022-12-28	WOS:000376940700002
J	Munro, AJ				Munro, Alastair J.			Alan Wilfrid Gough Goolden OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		GOOLDEN AWG, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2965	10.1136/bmj.i2965	http://dx.doi.org/10.1136/bmj.i2965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27234266				2022-12-28	WOS:000376940700005
J	[Anonymous]				[Anonymous]			Effect on falls of providing single lens distance vision glasses to multifocal glasses wearers: VISIBLE randomised controlled trial (vol 340, c2265, 2010)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Haran Mark J, 2010, BMJ, V340, pc2265, DOI 10.1136/bmj.c2265	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i3041	10.1136/bmj.i3041	http://dx.doi.org/10.1136/bmj.i3041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27235404	Bronze, Green Published			2022-12-28	WOS:000376940700014
J	Sliwa, K; Anthony, J				Sliwa, Karen; Anthony, John			Late maternal deaths: a neglected responsibility	LANCET			English	Editorial Material							COUNTRIES; INJURIES		[Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, SA MRC Cape Heart Ctr, ZA-7925 Cape Town, South Africa; [Anthony, John] Univ Cape Town, Groote Schuur Hosp, Div Obstet & Gynaecol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Sliwa, K (corresponding author), Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, SA MRC Cape Heart Ctr, ZA-7925 Cape Town, South Africa.	karen.sliwa-hahnle@uct.ac.za		Sliwa, Karen/0000-0002-8272-0911				Duxbury F., 2014, ABC DOMESTIC SEXUAL, P9; Fuhr DC, 2014, LANCET PSYCHIAT, V1, P213, DOI 10.1016/S2215-0366(14)70282-2; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; Hoyert Donna L, 2007, Vital Health Stat 3, P1; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Knight M, 2015, SAVING LIVES IMPROVI, P22; Kurinczuk Jennifer J., 2015, SAVING LIVES IMPROVI; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Sliwa K, 2016, CIRCULATION, V133, P1199, DOI 10.1161/CIRCULATIONAHA.114.008730; Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P1; WHO, INT CLASS DIS 2013; World Health Organization, 2012, WHO APPL ICD 10 DEAT; Yamin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071674	14	32	32	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2072	2073		10.1016/S0140-6736(16)30391-9	http://dx.doi.org/10.1016/S0140-6736(16)30391-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27301808				2022-12-28	WOS:000376450800009
J	Chouchani, ET; Kazak, L; Jedrychowski, MP; Lu, GZ; Erickson, BK; Zpyt, JS; Pierce, KA; Laznik-Bogoslavski, D; Vetrivelan, R; Clish, CB; Robinson, AJ; Gygi, SP; Spiegelman, BM				Chouchani, Edward T.; Kazak, Lawrence; Jedrychowski, Mark P.; Lu, Gina Z.; Erickson, Brian K.; Zpyt, John S.; Pierce, Kerry A.; Laznik-Bogoslavski, Dina; Vetrivelan, Ramalingam; Clish, Clary B.; Robinson, Alan J.; Gygi, Steve P.; Spiegelman, Bruce M.			Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1 (vol 532, pg 112, 2016)	NATURE			English	Correction													Clish, Clary/AAB-7124-2019; Chouchani, Edward T./HCH-3775-2022; Clish, Clary B/ABB-9374-2021	Clish, Clary B/0000-0001-8259-9245	Medical Research Council [MC_U105674181] Funding Source: Medline; MRC [MC_U105674181] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399	1	3	3	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616								10.1038/nature18279	http://dx.doi.org/10.1038/nature18279			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27281219	Bronze			2022-12-28	WOS:000381804900043
J	Pimenta-Marques, A; Bento, I; Lopes, CAM; Duarte, P; Jana, SC; Bettencourt-Dias, M				Pimenta-Marques, A.; Bento, I.; Lopes, C. A. M.; Duarte, P.; Jana, S. C.; Bettencourt-Dias, M.			A mechanism for the elimination of the female gamete centrosome in Drosophila melanogaster	SCIENCE			English	Article							MICROTUBULE-ORGANIZING CENTERS; POLO-LIKE KINASES; CENTRIOLE DUPLICATION; IN-VITRO; MITOTIC CENTROSOMES; GAMMA-TUBULIN; CELL; ORGANIZATION; SCAFFOLD; OOCYTES	An important feature of fertilization is the asymmetric inheritance of centrioles. In most species it is the sperm that contributes the initial centriole, which builds the first centrosome that is essential for early development. However, given that centrioles are thought to be exceptionally stable structures, the mechanism behind centriole disappearance in the female germ line remains elusive and paradoxical. We elucidated a program for centriole maintenance in fruit flies, led by Polo kinase and the pericentriolar matrix (PCM): The PCM is down-regulated in the female germ line during oogenesis, which results in centriole loss. Perturbing this program prevents centriole loss, leading to abnormal meiotic and mitotic divisions, and thus to female sterility. This mechanism challenges the view that centrioles are intrinsically stable structures and reveals general functions for Polo kinase and the PCM in centriole maintenance. We propose that regulation of this maintenance program is essential for successful sexual reproduction and defines centriole life span in different tissues in homeostasis and disease, thereby shaping the cytoskeleton.	[Pimenta-Marques, A.; Bento, I.; Lopes, C. A. M.; Duarte, P.; Jana, S. C.; Bettencourt-Dias, M.] Inst Gulbenkian Ciencias, Rua Quinta Grande, P-2780156 Oeiras, Portugal; [Bento, I.] Inst Mol Med, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa	Pimenta-Marques, A; Bento, I; Bettencourt-Dias, M (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande, P-2780156 Oeiras, Portugal.	armarques@igc.gulbenkian.pt; inesbento@hotmail.com; mdias@igc.gulbenkian.pt	Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Duarte, Paulo/0000-0003-1833-5629; Jana, Swadhin/0000-0002-8311-3849; Lopes, Carla A. M./0000-0003-3182-8305; Bento, Ines/0000-0002-1049-1443; Marques da Costa, Ana/0000-0001-6318-3922	Fundacao Para a Ciencia e Tecnologia [SFRH/BD/33565/2008, SFRH/BPD/79680/2011, SFRH/BPD/87479/2012, PTDC/SAU-BD/105616/2008]; Fundacao Para a Ciencia e Tecnologia (Ciencia programme); Fundacao Para a Ciencia e Tecnologia (FCT Investigator programme); EMBO Installation grant; ERC grant [ERC-2010-StG-261344]	Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Para a Ciencia e Tecnologia (Ciencia programme); Fundacao Para a Ciencia e Tecnologia (FCT Investigator programme); EMBO Installation grant; ERC grant	We thank M.-F. B. Tsou, R. Martinho, R. Oliveira, A. Dammermann, T. Schupbach, P. Lenart, J. Pinto, J. Januschke, V. Archambault, P. Prudencio, M. Francia, M. Lince-Faria, J. Pereira-Leal, and E. Sucena for critical reading of the manuscript; all members of the M.B.-D. laboratory for discussions; H. Ohkura for sharing protocols; A. Carpenter and J. Dobbelaere for discussions and sharing unpublished data; T. Avidor-Reiss, J. Raff, D. St. Johnston, and V. Archambault for sharing tools; and G. Martins, S. Mendonca, and M. Pinho for help with experiments. Supported by Fundacao Para a Ciencia e Tecnologia (SFRH/BD/33565/2008; SFRH/BPD/79680/2011; SFRH/BPD/87479/2012; PTDC/SAU-BD/105616/2008; Ciencia2007 and FCT Investigator programmes), an EMBO Installation grant, and an ERC grant (ERC-2010-StG-261344).	Archambault V, 2015, ONCOGENE, V34, P4799, DOI 10.1038/onc.2014.451; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Borrego-Pinto J, 2016, J CELL BIOL, V212, P815, DOI 10.1083/jcb.201510083; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Brodu V, 2010, DEV CELL, V18, P790, DOI [10.1016/j.devcel.2010.03.015, 10.1016/j.devce1.2010.03.015]; Conduit PT, 2014, DEV CELL, V28, P659, DOI 10.1016/j.devcel.2014.02.013; Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055; CONNOLLY JA, 1986, EUR J CELL BIOL, V39, P341; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Egana AL, 2007, MOL REPROD DEV, V74, P76, DOI 10.1002/mrd.20511; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; GARD DL, 1995, DEV BIOL, V168, P189, DOI 10.1006/dbio.1995.1071; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Gillingham AK, 2000, EMBO REP, V1, P524; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Huettner AF, 1933, SCIENCE, V78, P367, DOI 10.1126/science.78.2025.367-a; Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Jambor H, 2015, ELIFE, V4, DOI 10.7554/eLife.05003; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; Karaiskou A, 2004, DEVELOPMENT, V131, P1543, DOI 10.1242/dev.01050; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Mikeladze-Dvali T, 2012, DEVELOPMENT, V139, P1670, DOI 10.1242/dev.075440; Mirouse V, 2006, DEVELOPMENT, V133, P4005, DOI 10.1242/dev.02565; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; PRUDENCIO P, 2015, BIOL PROTOC, V5, pE1459; PRZYBYLS.RJ, 1971, J CELL BIOL, V49, P214, DOI 10.1083/jcb.49.1.214; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sato M, 2013, TRAFFIC, V14, P479, DOI 10.1111/tra.12050; Shang YH, 2002, J CELL BIOL, V158, P1195, DOI 10.1083/jcb.200205101; Sitaram P, 2012, DEVELOPMENT, V139, P2945, DOI 10.1242/dev.077511; SUNKEL CE, 1988, J CELL SCI, V89, P25; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; TOURNIER F, 1989, DEV BIOL, V136, P321, DOI 10.1016/0012-1606(89)90259-5; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; WARREN RH, 1974, J CELL BIOL, V63, P550, DOI 10.1083/jcb.63.2.550; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	66	60	60	4	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2016	353	6294							aaf4866	10.1126/science.aaf4866	http://dx.doi.org/10.1126/science.aaf4866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9KX	27229142	Green Submitted			2022-12-28	WOS:000378816200030
J	Merk, A; Bartesaghi, A; Banerjee, S; Falconieri, V; Rao, P; Davis, MI; Pragani, R; Boxer, MB; Earl, LA; Milne, JLS; Subramaniam, S				Merk, Alan; Bartesaghi, Alberto; Banerjee, Soojay; Falconieri, Veronica; Rao, Prashant; Davis, Mindy I.; Pragani, Rajan; Boxer, Matthew B.; Earl, Lesley A.; Milne, Jacqueline L. S.; Subramaniam, Sriram			Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery	CELL			English	Article							LACTATE-DEHYDROGENASE; ANGSTROM RESOLUTION; CRYOELECTRON MICROSCOPY; SELECTIVE-INHIBITION; BETA-GALACTOSIDASE; MECHANISM; RIBOSOME; IDH1; RECEPTOR; SUBUNIT	Recent advances in single-particle cryoelecton microscopy (cryo-EM) are enabling generation of numerous near- atomic resolution structures for well-ordered protein complexes with sizes >= similar to 200 kDa. Whether cryo-EM methods are equally useful for high-resolution structural analysis of smaller, dynamic protein complexes such as those involved in cellular metabolism remains an important question. Here, we present 3.8 angstrom resolution cryo-EM structures of the cancer target isocitrate dehydrogenase (93 kDa) and identify the nature of conformational changes induced by binding of the allosteric small-molecule inhibitor ML309. We also report 2.8-angstrom- and 1.8-angstrom-resolution structures of lactate dehydrogenase (145 kDa) and glutamate dehydrogenase (334 kDa), respectively. With these results, two perceived barriers in single-particle cryo-EM are overcome: (1) crossing 2 angstrom resolution and (2) obtaining structures of proteins with sizes < 100 kDa, demonstrating that cryo-EM can be used to investigate a broad spectrum of drug-target interactions and dynamic conformational states.	[Merk, Alan; Bartesaghi, Alberto; Banerjee, Soojay; Falconieri, Veronica; Rao, Prashant; Earl, Lesley A.; Milne, Jacqueline L. S.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Davis, Mindy I.; Pragani, Rajan; Boxer, Matthew B.] Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	ss1@nih.gov		Subramaniam, Sriram/0000-0003-4231-4115	Center for Cancer Research, National Cancer Institute, NIH in Bethesda; NATIONAL CANCER INSTITUTE [ZIABC010826, ZIABC010278, ZIABC010412] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH in Bethesda; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by funds from the Center for Cancer Research, National Cancer Institute, NIH in Bethesda. We thank Kieran Moynihan, Robert Mueller, and Joe Cometa for technical assistance with electron microscopy; Fred Ulmer, Paul Mooney, and Chris Booth for advice and assistance with optimizing K2 detector performance; and Rishub Jain, Jierui Fang, and Amy Jin for assistance with data analysis. This work utilized the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Belnap D. M., 2015, CURR PROTOC PROTEIN, V82; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Borgnia MJ, 2016, MOL PHARMACOL, V89, P645, DOI 10.1124/mol.116.103382; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Danev R, 2016, ELIFE, V5, DOI 10.7554/eLife.13046; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Deng GJ, 2015, J BIOL CHEM, V290, P762, DOI 10.1074/jbc.M114.608497; Dragovich PS, 2014, BIOORG MED CHEM LETT, V24, P3764, DOI 10.1016/j.bmcl.2014.06.076; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Fiume L, 2014, FUTURE MED CHEM, V6, P429, DOI [10.4155/FMC.13.206, 10.4155/fmc.13.206]; Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108; Glaeser RM, 2011, BIOPHYS J, V100, P2331, DOI 10.1016/j.bpj.2011.04.018; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Jomaa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10471; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; Matthies D, 2016, CELL, V164, P747, DOI 10.1016/j.cell.2015.12.055; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002; Okoye-Okafor UC, 2015, NAT CHEM BIOL, V11, P878, DOI 10.1038/nchembio.1930; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Rodriguez S, 2003, ONCOGENE, V22, P1880, DOI 10.1038/sj.onc.1206302; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Skiniotis G, 2016, MICROSCOPY-JPN, V65, P9, DOI 10.1093/jmicro/dfv366; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Thompson RF, 2016, METHODS, V100, P3, DOI 10.1016/j.ymeth.2016.02.017; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Wu FR, 2015, J MED CHEM, V58, P6899, DOI 10.1021/acs.jmedchem.5b00684; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	49	321	334	18	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1698	1707		10.1016/j.cell.2016.05.040	http://dx.doi.org/10.1016/j.cell.2016.05.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27238019	Green Accepted, Bronze			2022-12-28	WOS:000378062000020
J	Nilsson, M; Griggs, D; Visbeck, M				Nilsson, Mans; Griggs, Dave; Visbeck, Martin			Map the interactions between Sustainable Development Goals	NATURE			English	Editorial Material									[Nilsson, Mans] Stockholm Environm Inst, Stockholm, Sweden; [Nilsson, Mans] KTH Royal Inst Technol, Practice Policy Anal, Stockholm, Sweden; [Griggs, Dave] Monash Univ, Monash Sustainabil Inst, Sustainable Dev, Melbourne, Vic 3004, Australia; [Visbeck, Martin] GEOMAR Helmholtz Ctr Ocean Res Kiel, Phys Oceanog, Kiel, Germany; [Visbeck, Martin] Univ Kiel, Kiel, Germany	Stockholm Environment Institute; Royal Institute of Technology; Monash University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Nilsson, M (corresponding author), Stockholm Environm Inst, Stockholm, Sweden.; Nilsson, M (corresponding author), KTH Royal Inst Technol, Practice Policy Anal, Stockholm, Sweden.	mans.nilsson@sei-international.org	Visbeck, Martin H/B-6541-2016; Nilsson, Mans/HGU-9139-2022	Visbeck, Martin H/0000-0002-0844-834X; Nilsson, Mans/0000-0003-2157-1083; Griggs, David/0000-0002-9461-9933				Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the United Nations, 2015, AGR FOR OTH LAND US; Hakkila P, 2006, BIOMASS BIOENERG, V30, P281, DOI 10.1016/j.biombioe.2005.07.003; International Council for Science, 2016, DRAFT FRAM UND SDG I; Organisation for Economic Co-operation and Development, 2015, OECD EC OUTLOOK, V2015	5	777	792	49	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					320	322		10.1038/534320a	http://dx.doi.org/10.1038/534320a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306173	Bronze			2022-12-28	WOS:000377856800012
J	Todorovic, A				Todorovic, Ana			WHAT YOUR PATIENT IS THINKING Palliative care is not just for those who are dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com	Todorovic, Ana/ABG-2264-2020						0	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i2846	10.1136/bmj.i2846	http://dx.doi.org/10.1136/bmj.i2846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27306758	Bronze, Green Published			2022-12-28	WOS:000378240400003
J	Malem, A				Malem, Andrew			CASE REVIEW Photophobia and a painful rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE HERPES-ZOSTER; POSTHERPETIC NEURALGIA; ANTIVIRALS		[Malem, Andrew] Queen Alexandra Hosp, Eye Dept, Ophthalmol, Portsmouth PO6 3LY, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Malem, A (corresponding author), Queen Alexandra Hosp, Eye Dept, Ophthalmol, Portsmouth PO6 3LY, Hants, England.	andrew.malem@cantab.net						Leung J, 2010, CLIN INFECT DIS, V51, P23, DOI 10.1086/653113; McDonald EM, 2012, ANTIVIR THER, V17, P255, DOI 10.3851/IMP2011; Moore R Andrew, 2014, Cochrane Database Syst Rev, pCD007938, DOI 10.1002/14651858.CD007938.pub3; Pavan-Langston D, 2008, OPHTHALMOLOGY, V115, pS13, DOI 10.1016/j.ophtha.2007.10.012; Roth T, 2010, CURR MED RES OPIN, V26, P2411, DOI 10.1185/03007995.2010.516142; Saarto T, 2010, J NEUROL NEUROSUR PS, V81, P1372, DOI 10.1136/jnnp.2008.144964; Schmader K, 2001, CLIN INFECT DIS, V32, P1481, DOI 10.1086/320169; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; WOMACK LW, 1983, ARCH OPHTHALMOL-CHIC, V101, P42; Zaal MJW, 2003, GRAEF ARCH CLIN EXP, V241, P187, DOI 10.1007/s00417-002-0609-1	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2016	353								i3221	10.1136/bmj.i3221	http://dx.doi.org/10.1136/bmj.i3221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1FW	27295959				2022-12-28	WOS:000378236900004
J	Marques, S; Zeisel, A; Codeluppi, S; van Bruggen, D; Falcao, AM; Xiao, L; Li, HL; Haring, M; Hochgerner, H; Romanov, RA; Gyllborg, D; Munoz-Manchado, AB; La Manno, G; Lonnerberg, P; Floriddia, EM; Rezayee, F; Ernfors, P; Arenas, E; Hjerling-Leffler, J; Harkany, T; Richardson, WD; Linnarsson, S; Castelo-Branco, G				Marques, Sueli; Zeisel, Amit; Codeluppi, Simone; van Bruggen, David; Falcao, Ana Mendanha; Xiao, Lin; Li, Huiliang; Haring, Martin; Hochgerner, Hannah; Romanov, Roman A.; Gyllborg, Daniel; Munoz-Manchado, Ana B.; La Manno, Gioele; Lonnerberg, Peter; Floriddia, Elisa M.; Rezayee, Fatemah; Ernfors, Patrik; Arenas, Ernest; Hjerling-Leffler, Jens; Harkany, Tibor; Richardson, William D.; Linnarsson, Sten; Castelo-Branco, Goncalo			Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system	SCIENCE			English	Article							HUMAN INFANCY; MYELIN; TRANSCRIPTOME; NEURONS; CELLS; CNS; DIFFERENTIATION; SEQUENCE; DATABASE; HEALTHY	Oligodendrocytes have been considered as a functionally homogeneous population in the central nervous system (CNS). We performed single -cell RNA sequencing on 5072 cells of the oligodendrocyte lineage from 10 regions of the mouse juvenile and adult CNS. Thirteen distinct populations were identified, 12 of which represent a continuum from Pdgfra' oligodendrocyte precursor cells (OPCs) to distinct mature oligodendrocytes. Initial stages of differentiation were similar across the juvenile CNS, whereas subsets of mature oligodendrocytes were enriched in specific regions in the adult brain. Newly formed oligodendrocytes were detected in the adult CNS and were responsive to complex motor learning. A second Pdgfra' population, distinct from OPCs, was found along vessels. Our study reveals the dynamics of oligodendrocyte differentiation and maturation, uncoupling them at a transcriptional level and highlighting oligodendrocyte heterogeneity in the CNS.	[Marques, Sueli; Zeisel, Amit; Codeluppi, Simone; van Bruggen, David; Falcao, Ana Mendanha; Haring, Martin; Hochgerner, Hannah; Romanov, Roman A.; Gyllborg, Daniel; Munoz-Manchado, Ana B.; La Manno, Gioele; Lonnerberg, Peter; Floriddia, Elisa M.; Rezayee, Fatemah; Ernfors, Patrik; Arenas, Ernest; Hjerling-Leffler, Jens; Harkany, Tibor; Linnarsson, Sten; Castelo-Branco, Goncalo] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, SE-17177 Stockholm, Sweden; [Codeluppi, Simone] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Xiao, Lin; Li, Huiliang; Richardson, William D.] UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England; [Xiao, Lin] Second Mil Med Univ, Inst Neurosci, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Romanov, Roman A.; Harkany, Tibor] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Vienna, Austria	Karolinska Institutet; Karolinska Institutet; University of London; University College London; Naval Medical University; Medical University of Vienna	Linnarsson, S; Castelo-Branco, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, SE-17177 Stockholm, Sweden.	sten.linnarsson@ki.se; goncalo.castelo-branco@ki.se	La Manno, Gioele/AAC-7968-2022; Falcao, Ana Luisa/AAF-8371-2021; Romanov, Roman/J-2349-2015; Arenas, Ernest/AAO-5231-2020; Linnarsson, Sten/HCH-3909-2022; Castelo-Branco, Goncalo/A-8357-2015; Manchado, Ana Munoz/AAB-6399-2019; Castelo-Branco, Gonçalo/O-9162-2019; Hjerling Leffler, Jens/E-3775-2012; Richardson FMedSci FRS, William D/C-1762-2008	La Manno, Gioele/0000-0003-1428-8757; Falcao, Ana Luisa/0000-0003-4356-5936; Romanov, Roman/0000-0002-3937-518X; Arenas, Ernest/0000-0003-0197-6577; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Munoz Manchado, Ana/0000-0002-1121-6072; Harkany, Tibor/0000-0002-6637-5900; Marques, Sueli/0000-0003-3368-4392; Floriddia, Elisa/0000-0003-2304-8114; van Bruggen, David/0000-0001-6794-7731; Gyllborg, Daniel/0000-0002-1429-6426; Hjerling Leffler, Jens/0000-0002-4539-1776; Hochgerner, Hannah/0000-0002-7739-666X; Richardson FMedSci FRS, William D/0000-0001-7261-2485	Swedish Research Council (VR) (Medicine and Health); Swedish Cancer Society; Wallenberg Scholar and Soderberg Foundation; VR (Linnaeus Center in Developmental Biology for Regenerative Medicine) [2011-3116, 2011-3318]; Swedish Foundation for Strategic Research (Successful Research Leaders program); European Union (EU) (NeuroStemCellRepair); European Union (EU) (DDPDGENES); Karolinska Institutet (KI) (SFO Stem Cells and Regenerative Medicine); VR; StratNeuro; Hjarnfonden; EU FP7/Marie Curie Actions; European Molecular Biology Organization (ALTF) [596-2014]; EU FP7 (Marie Curie Actions, EMBOCOFUND) [GA-2012-600394]; Petrus and Augusta Hedlunds Foundation; Novo Nordisk Foundation; European Research Council (ERC) (SECRET-CELLS); EU (PAINCAGE); ERC [293544]; Wellcome Trust [100269/Z/12/Z, 108/26/Z/15/2, 108/26/2/15/Z]; National Natural Science Foundation of China [31411013]; UK Biotechnology and Biological Sciences Research Council [BB/L003236/1]; Human Frontier Science Program; ERC (BRAINCELL) [261063]; VR (STARGET); EU (FP7/DDPDGENES); European Committee for Treatment and Research of Multiple Sclerosis; VR [2015-03558]; EU (EP7/Marie Curie Integration Grant, EPIOPC); Swedish Society of Medicine; Ake Wiberg Foundation; Clas Groschinsky Foundation; Petrus och Augusta Hedlunds Foundation; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/L003236/1] Funding Source: researchfish; Medical Research Council [G0800575] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0015964, NNF14OC0010695] Funding Source: researchfish; BBSRC [BB/L003236/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI	Swedish Research Council (VR) (Medicine and Health)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Scholar and Soderberg Foundation; VR (Linnaeus Center in Developmental Biology for Regenerative Medicine); Swedish Foundation for Strategic Research (Successful Research Leaders program); European Union (EU) (NeuroStemCellRepair); European Union (EU) (DDPDGENES); Karolinska Institutet (KI) (SFO Stem Cells and Regenerative Medicine); VR(Swedish Research Council); StratNeuro; Hjarnfonden; EU FP7/Marie Curie Actions; European Molecular Biology Organization (ALTF); EU FP7 (Marie Curie Actions, EMBOCOFUND); Petrus and Augusta Hedlunds Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC) (SECRET-CELLS)(European Research Council (ERC)); EU (PAINCAGE); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Program(Human Frontier Science Program); ERC (BRAINCELL); VR (STARGET); EU (FP7/DDPDGENES); European Committee for Treatment and Research of Multiple Sclerosis; VR(Swedish Research Council); EU (EP7/Marie Curie Integration Grant, EPIOPC); Swedish Society of Medicine; Ake Wiberg Foundation; Clas Groschinsky Foundation; Petrus och Augusta Hedlunds Foundation; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Soriano (Mount Sinai, New York) for the Pdgfra-H2B-GFP mouse; C. Goritz for discussions; and Samudyata, G. Chen, A. Nanni, and J. Sederlund for additional support. P.E. was supported by the Swedish Research Council (VR) (Medicine and Health), the Swedish Cancer Society, and the Wallenberg Scholar and Soderberg Foundation. E.A. was supported by VR (Linnaeus Center in Developmental Biology for Regenerative Medicine, grants 2011-3116 and 2011-3318), the Swedish Foundation for Strategic Research (Successful Research Leaders program), the European Union (EU) (NeuroStemCellRepair and DDPDGENES), and the Karolinska Institutet (KI) (SFO Stem Cells and Regenerative Medicine). J.H.-L. was supported by VR, StratNeuro, Hjarnfonden, and EU FP7/Marie Curie Actions. R.A.R. was supported by the European Molecular Biology Organization (ALTF reference 596-2014) and EU FP7 (Marie Curie Actions, EMBOCOFUND2012 grant GA-2012-600394). T.H. was supported by VR, Hjarnfonden, the Petrus and Augusta Hedlunds Foundation, the Novo Nordisk Foundation, the European Research Council (ERC) (SECRET-CELLS), and the EU (PAINCAGE). W.D.R. was supported by the ERC (grant 293544) and the Wellcome Trust (grants 100269/Z/12/Z and 108/26/Z/15/2). L.X. was supported by the National Natural Science Foundation of China (grant 31411013). H.L. was supported by a New Investigator Award from the UK Biotechnology and Biological Sciences Research Council (BB/L003236/1). A.Z. was supported by the Human Frontier Science Program. S.L. was supported by the ERC (BRAINCELL grant 261063), VR (STARGET), the Wellcome Trust (grant 108/26/2/15/Z), and the EU (FP7/DDPDGENES). A.M.F. was supported by the European Committee for Treatment and Research of Multiple Sclerosis. G.C.-B. was supported by VR (grant 2015-03558), the EU (EP7/Marie Curie Integration Grant, EPIOPC), Hjarnfonden, the Swedish Society of Medicine, Ake Wiberg, Clas Groschinsky, the Petrus och Augusta Hedlunds Foundations and KI. Data sets were deposited in the Gene Expression Omnibus (accession no. GSE75330) and in a web interface at http://linnarssonlab.org/oligodendrocytes./. The supplementary materials contain additional data. S.M., A.Z., H.L., W.D.R., S.L., and G.C.-B. designed the experiments. RE., E.A., J.H.-L., T.H., W.D.R., S.L. and G.C.-B. (senior authors) obtained funding. S.M., A.Z., S.C., N.H., R.A.R., D.G., M.H., A.B.M.-M., G.L.M., F.R., H.L., L.X., and E.M.F. performed experiments. L.X., H.L., and W.D.R. have priority of observation of the rapid differentiation of oligodendrocytes in the complex motor wheel paradigm. S.M., A.Z., D.v.B., A.M.F., and P.L. analyzed the data. S.M., A.Z., S.L., and G.C.-B. wrote the paper, with the assistance of and proofreading by all authors.	Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Coffey JC, 1997, J NEUROCYTOL, V26, P149, DOI 10.1023/A:1018579912831; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Hamano K, 1998, DEV BRAIN RES, V108, P287, DOI 10.1016/S0165-3806(98)00063-7; Hamilton NB, 2016, NATURE, V529, P523, DOI 10.1038/nature16519; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Micu I, 2016, EXP NEUROL, V276, P41, DOI 10.1016/j.expneurol.2015.10.006; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Ruio-Hortega, 1928, MEM REL SOC ESPAN HI, V14, P5; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	26	497	499	17	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1326	1329		10.1126/science.aaf6463	http://dx.doi.org/10.1126/science.aaf6463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284195	Green Accepted, Green Submitted			2022-12-28	WOS:000377972000043
J	Faust, K; Raes, J				Faust, Karoline; Raes, Jeroen			HOST-MICROBE INTERACTION Rules of the game for microbiota	NATURE			English	Editorial Material							GUT MICROBIOME; DIVERSITY		[Faust, Karoline; Raes, Jeroen] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, B-3000 Leuven, Belgium; [Faust, Karoline; Raes, Jeroen] VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Faust, Karoline] Vrije Univ Brussel, Microbiol Unit, Fac Sci & Bioengn Sci, Brussels, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Raes, J (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, B-3000 Leuven, Belgium.; Raes, J (corresponding author), VIB, Ctr Biol Dis, B-3000 Leuven, Belgium.	jeroen.raes@kuleuven.be	raes, jeroen/D-7835-2018; Faust, Karoline/P-7578-2017	raes, jeroen/0000-0002-1337-041X; Faust, Karoline/0000-0001-7129-2803				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	10	8	8	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					182	183		10.1038/534182a	http://dx.doi.org/10.1038/534182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279206				2022-12-28	WOS:000377475100024
J	Limb, M				Limb, Matthew			John Corbett McDonald	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												limb@btinternet.com						MCDONALD JC, PUBLICATION LIST, P1617	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2016	353								i3161	10.1136/bmj.i3161	http://dx.doi.org/10.1136/bmj.i3161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YM	27279253				2022-12-28	WOS:000377859100004
J	't Hoen, EFM				't Hoen, Ellen F. M.			Indian hepatitis C drug patent decision shakes public health community	LANCET			English	Editorial Material									['t Hoen, Ellen F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, NL-9713 AV Groningen, Netherlands	University of Groningen	't Hoen, EFM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, NL-9713 AV Groningen, Netherlands.	e.f.m.t.hoen@umcg.nl						[Anonymous], 2016, Dr Rajesh Dixit in the matter of Patent Application, Patent No. [6087/DELNP/2005, 6087]; Barooah S, 2015, SPICYIP         0115; Gilead, 2016, CHRON HEP C TREATM E; Gilead, 2014, LIC AGR; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hordijk L, 2014, CORRESPONDENT   1211; Kapczynski A, 2016, HEALTH AFFAIR, V35, P791, DOI 10.1377/hlthaff.2015.1120; Raghavan P, 2016, EC TIMES INDIA  0514; Silverman E, 2016, STATNEWS        0511; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; United Nations Secretary-Generals High-Level Panel on Access to Medicines, 2016, CHELSEA WESTMINSTER; WHO, 2016, DRAFT GLOB HLTH SECT; World Trade Organization, 1994, WORLD TRAD ORG AGR T	14	7	8	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2272	+		10.1016/S0140-6736(16)30656-0	http://dx.doi.org/10.1016/S0140-6736(16)30656-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN3NN	27238944				2022-12-28	WOS:000376969100008
J	Kubben, N; Zhang, WQ; Wang, LX; Voss, TC; Yang, JP; Qu, J; Liu, GH; Misteli, T				Kubben, Nard; Zhang, Weiqi; Wang, Lixia; Voss, Ty C.; Yang, Jiping; Qu, Jing; Liu, Guang-Hui; Misteli, Tom			Repression of the Antioxidant NRF2 Pathway in Premature Aging	CELL			English	Article							GILFORD PROGERIA SYNDROME; MESENCHYMAL STEM-CELLS; DNA-DAMAGE RESPONSES; OXIDATIVE STRESS; DEFECTIVE MATURATION; TRANSCRIPTION FACTOR; LAMIN; ACTIVATION; PROTEIN; ACCUMULATION	Hutchinson-Gilford progeria syndrome (HGPS) is a rare, invariably fatal premature aging disorder. The disease is caused by constitutive production of progerin, a mutant form of the nuclear architectural protein lamin A, leading, through unknown mechanisms, to diverse morphological, epigenetic, and genomic damage and to mesenchymal stem cell (MSC) attrition in vivo. Using a high-throughput siRNA screen, we identify the NRF2 antioxidant pathway as a driver mechanism in HGPS. Progerin sequesters NRF2 and thereby causes its subnuclear mislocalization, resulting in impaired NRF2 transcriptional activity and consequently increased chronic oxidative stress. Suppressed NRF2 activity or increased oxidative stress is sufficient to recapitulate HGPS aging defects, whereas reactivation of NRF2 activity in HGPS patient cells reverses progerin-associated nuclear aging defects and restores in vivo viability of MSCs in an animal model. These findings identify repression of the NRF2-mediated antioxidative response as a key contributor to the premature aging phenotype.	[Kubben, Nard; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Zhang, Weiqi; Wang, Lixia; Yang, Jiping; Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Weiqi; Liu, Guang-Hui] Foshan Univ, FSU CAS Innovat Inst, Foshan 528000, Guangdong, Peoples R China; [Wang, Lixia; Qu, Jing] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Voss, Ty C.] NCI, High Throughput Imaging Facil, NIH, Bethesda, MD 20892 USA; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Wang, Lixia; Yang, Jiping; Qu, Jing; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Institute of Biophysics, CAS; Foshan University; Chinese Academy of Sciences; Institute of Zoology, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.; Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Liu, GH (corresponding author), Foshan Univ, FSU CAS Innovat Inst, Foshan 528000, Guangdong, Peoples R China.; Liu, GH (corresponding author), Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.; Liu, GH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	ghliu@ibp.ac.cn; mistelit@mail.nih.gov	Qu, Jing/ABB-9088-2020	qu, jing/0000-0002-3988-5067; Zhang, Weiqi/0000-0002-8885-5104	National Basic Research Program of China (973 Program) [2015CB964800, 2014CB910503]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National High Technology Research and Development Program of China [2015AA020307]; National Natural Science Foundation of China [81330008, 31222039, 31201111, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, 81401159]; Program of Beijing Municipal Science and Technology Commission [Z151100003915072]; Beijing Natural Science Foundation [7141005, 5142016]; Key Research Program of the Chinese Academy of Sciences [KJZDEW-TZ-L05]; Thousand Young Talents program of China; Intramural Research Program of the NIH/NCI/CCR; Progeria Research Foundation grant; NATIONAL CANCER INSTITUTE [ZICBC011567, ZIABC010309] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Beijing Municipal Science and Technology Commission; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Thousand Young Talents program of China(Chinese Academy of Sciences); Intramural Research Program of the NIH/NCI/CCR; Progeria Research Foundation grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the T.M. lab members, P. Scaffidi, Y. Xiong, and J.C. Izpisua Belmonte for sharing feedback, data, and reagents. The G.-H.L. and J.Q. labs were supported by the National Basic Research Program of China (973 Program, 2015CB964800 and 2014CB910503), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), the National High Technology Research and Development Program of China (2015AA020307), the National Natural Science Foundation of China (81330008, 31222039, 31201111, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, and 81401159), the Program of Beijing Municipal Science and Technology Commission (Z151100003915072), the Beijing Natural Science Foundation (7141005 and 5142016), the Key Research Program of the Chinese Academy of Sciences (KJZDEW-TZ-L05), and the Thousand Young Talents program of China. The T.M. lab was supported by the Intramural Research Program of the NIH/NCI/CCR and a Progeria Research Foundation grant.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chua YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016071; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Dialynas G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005231; Duan SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10068; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Gabriel D, 2015, AGING CELL, V14, P78, DOI 10.1111/acel.12300; Gordon LB, 2005, J PEDIATR-US, V146, P336, DOI 10.1016/j.jpeds.2004.10.064; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; Ibanez L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/726590; Kubben N, 2016, METHODS, V96, P46, DOI 10.1016/j.ymeth.2015.08.024; Kubben N, 2010, NUCLEUS-PHILA, V1, P513, DOI 10.4161/nucl.1.6.13512; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Mateos J, 2013, STEM CELL RES, V11, P1137, DOI 10.1016/j.scr.2013.07.004; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Murakami S, 2014, GENES CELLS, V19, P239, DOI 10.1111/gtc.12126; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Pacheco LM, 2014, AGING-US, V6, P1049, DOI 10.18632/aging.100709; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pekovic V, 2011, AGING CELL, V10, P1067, DOI 10.1111/j.1474-9726.2011.00750.x; Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Pickering AM, 2013, J EXP BIOL, V216, P543, DOI 10.1242/jeb.074757; Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x; Richards SA, 2011, HUM MOL GENET, V20, P3997, DOI 10.1093/hmg/ddr327; Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Steel R, 2012, ACS MED CHEM LETT, V3, P407, DOI 10.1021/ml300041g; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Viteri G, 2010, MECH AGEING DEV, V131, P2, DOI 10.1016/j.mad.2009.11.006; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	62	289	306	6	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2016	165	6					1361	1374		10.1016/j.cell.2016.05.017	http://dx.doi.org/10.1016/j.cell.2016.05.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN4NV	27259148	Green Accepted, Bronze			2022-12-28	WOS:000377045400011
J	Morley, C; Cursiter, J				Morley, Colin; Cursiter, Jane			Gillian Gandy Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		GANDY G, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2016	353								i3106	10.1136/bmj.i3106	http://dx.doi.org/10.1136/bmj.i3106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OU	27256283				2022-12-28	WOS:000377479000011
J	Saint, S; Greene, T; Krein, SL; Rogers, MAM; Ratz, D; Fowler, KE; Edson, BS; Watson, SR; Meyer-Lucas, B; Masuga, M; Faulkner, K; Gould, CV; Battles, J; Fakih, MG				Saint, Sanjay; Greene, Todd; Krein, Sarah L.; Rogers, Mary A. M.; Ratz, David; Fowler, Karen E.; Edson, Barbara S.; Watson, Sam R.; Meyer-Lucas, Barbara; Masuga, Marie; Faulkner, Kelly; Gould, Carolyn V.; Battles, James; Fakih, Mohamad G.			A Program to Prevent Catheter-Associated Urinary Tract Infection in Acute Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLLABORATION; INTERVENTION; SAFETY	BACKGROUND Catheter-associated urinary tract infection (UTI) is a common device-associated infection in hospitals. Both technical factors - appropriate catheter use, aseptic insertion, and proper maintenance - and socioadaptive factors, such as cultural and behavioral changes in hospital units, are important in preventing catheter-associated UTI. METHODS The national Comprehensive Unit-based Safety Program, funded by the Agency for Healthcare Research and Quality, aimed to reduce catheter-associated UTI in intensive care units (ICUs) and non-ICUs. The main program features were dissemination of information to sponsor organizations and hospitals, data collection, and guidance on key technical and socioadaptive factors in the prevention of catheter-associated UTI. Data on catheter use and catheter-associated UTI rates were collected during three phases: baseline (3 months), implementation (2 months), and sustainability (12 months). Multilevel negative binomial models were used to assess changes in catheter use and catheter-associated UTI rates. RESULTS Data were obtained from 926 units (59.7% were non-ICUs, and 40.3% were ICUs) in 603 hospitals in 32 states, the District of Columbia, and Puerto Rico. The unadjusted catheter-associated UTI rate decreased overall from 2.82 to 2.19 infections per 1000 catheterdays. In an adjusted analysis, catheter-associated UTI rates decreased from 2.40 to 2.05 infections per 1000 catheter-days (incidence rate ratio, 0.86; 95% confidence interval [CI], 0.76 to 0.96; P = 0.009). Among non-ICUs, catheter use decreased from 20.1% to 18.8% (incidence rate ratio, 0.93; 95% CI, 0.90 to 0.96; P<0.001) and catheter-associated UTI rates decreased from 2.28 to 1.54 infections per 1000 catheter-days (incidence rate ratio, 0.68; 95% CI, 0.56 to 0.82; P<0.001). Catheter use and catheter-associated UTI rates were largely unchanged in ICUs. Tests for heterogeneity (ICU vs. non-ICU) were significant for catheter use (P = 0.004) and catheter-associated UTI rates (P = 0.001). CONCLUSIONS A national prevention program appears to reduce catheter use and catheter-associated UTI rates in non-ICUs. (Funded by the Agency for Healthcare Research and Quality.)	[Saint, Sanjay; Greene, Todd; Krein, Sarah L.; Ratz, David; Fowler, Karen E.] Vet Affairs VA Ann Arbor Healthcare Syst, Hosp Outcomes Program Excellence, Ann Arbor, MI USA; [Saint, Sanjay; Greene, Todd; Krein, Sarah L.; Rogers, Mary A. M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay; Greene, Todd; Krein, Sarah L.; Rogers, Mary A. M.; Ratz, David; Fowler, Karen E.] VA UM Patient Safety Enhancement Program, Ann Arbor, MI USA; [Watson, Sam R.; Meyer-Lucas, Barbara; Masuga, Marie] Michigan Hlth & Hosp Assoc, Okemos, MI USA; [Fakih, Mohamad G.] St John Hosp & Med Ctr, Detroit, MI USA; [Edson, Barbara S.; Faulkner, Kelly] Hlth Res & Educ Trust, Chicago, IL USA; [Gould, Carolyn V.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Battles, James] Agcy Healthcare Res & Qual, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; St. John Hospital & Medical Center; Centers for Disease Control & Prevention - USA; Agency for Healthcare Research & Quality	Saint, S (corresponding author), Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Rm 430W, Ann Arbor, MI 48109 USA.	saint@med.umich.edu	Fowler, Karen/B-5383-2015; Saint, Sanjay/AAF-5126-2019; Krein, Sarah L/E-2742-2014	Fowler, Karen/0000-0001-8274-8407; Krein, Sarah L/0000-0003-2111-8131; Rogers, Mary/0000-0001-5519-3223	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Agency for Healthcare Research and Quality.	[Anonymous], 2009, ACT PLAN PREV HEALTH; [Anonymous], 2014, UR TRACT INF CATH AS; [Anonymous], 2014, CRIT ACC HOSP CAH RU; [Anonymous], COMPR UN BAS SAF PRO; [Anonymous], 2009, NAT ACT PLAN PREV HL; Berenholtz SM, 2014, INFECT CONT HOSP EP, V35, P56, DOI 10.1086/674384; Centers for Disease Control and Prevention, 2014, NAT STAT HEALTHC ASS; Centers for disease control and prevention (CDC), 2015, NAT STAT HEALTHC ASS; Fakih MG, 2008, INFECT CONT HOSP EP, V29, P815, DOI 10.1086/589584; Fakih MG, 2013, INFECT CONT HOSP EP, V34, P1048, DOI 10.1086/673149; Fakih MG, 2012, ARCH INTERN MED, V172, P255, DOI 10.1001/archinternmed.2011.627; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hanna FAQ, 2013, AM J INFECT CONTROL, V41, P1173, DOI 10.1016/j.ajic.2013.05.024; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Krein SL, 2013, JAMA INTERN MED, V173, P881, DOI 10.1001/jamainternmed.2013.105; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mody L, 2015, CLIN INFECT DIS, V61, P86, DOI 10.1093/cid/civ236; Mody L, 2015, JAMA INTERN MED, V175, P714, DOI 10.1001/jamainternmed.2015.132; Pearson SD, 2001, AM J MED, V110, P175, DOI 10.1016/S0002-9343(00)00705-1; Saint S, 2008, INFECT CONT HOSP EP, V29, P333, DOI 10.1086/529589; Saint S, 2005, JT COMM J QUAL PATIE, V31, P455, DOI 10.1016/S1553-7250(05)31059-2; Saint S, 2013, JAMA INTERN MED, V173, P874, DOI 10.1001/jamainternmed.2013.101; Saint S, 2009, JT COMM J QUAL PATIE, V35, P449, DOI 10.1016/S1553-7250(09)35062-X; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Sawyer M, 2010, CRIT CARE MED, V38, pS292, DOI 10.1097/CCM.0b013e3181e6a165; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; WHO, 2011, WHO LIB CAT PUBL DAT; [No title captured]	28	174	187	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2111	2119		10.1056/NEJMoa1504906	http://dx.doi.org/10.1056/NEJMoa1504906			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2RP	27248619	Green Accepted, Bronze			2022-12-28	WOS:000387209900004
J	Trowbridge, AJ; Melosh, HJ; Steckloff, JK; Freed, AM				Trowbridge, A. J.; Melosh, H. J.; Steckloff, J. K.; Freed, A. M.			Vigorous convection as the explanation for Pluto's polygonal terrain	NATURE			English	Article							PHASE-TRANSITIONS; ORIGIN; VISCOSITY	Pluto's surface is surprisingly young and geologically active(1). One of its youngest terrains is the near-equatorial region informally named Sputnik Planum, which is a topographic basin filled by nitrogen (N-2) ice mixed with minor amounts of CH4 and CO ices(1). Nearly the entire surface of the region is divided into irregular polygons about 20-30 kilometres in diameter, whose centres rise tens of metres above their sides. The edges of this region exhibit bulk flow features without polygons(1). Both thermal contraction and convection have been proposed to explain this terrain(1), but polygons formed from thermal contraction (analogous to ice-wedges or mud-crack networks)(2,3) of N-2 are inconsistent with the observations on Pluto of non-brittle deformation within the N-2-ice sheet. Here we report a parameterized convection model to compute the Rayleigh number of the N-2 ice and show that it is vigorously convecting, making Rayleigh-Benard convection the most likely explanation for these polygons. The diameter of Sputnik Planum's polygons and the dimensions of the 'floating mountains' (the hills of of water ice along the edges of the polygons) suggest that its N-2 ice is about ten kilometres thick. The estimated convection velocity of 1.5 centimetres a year indicates a surface age of only around a million years.	[Trowbridge, A. J.; Melosh, H. J.; Freed, A. M.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Melosh, H. J.; Steckloff, J. K.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Trowbridge, AJ (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA.	atrowbr@purdue.edu		Trowbridge, Alexander/0000-0002-7832-1387; Steckloff, Jordan/0000-0002-1717-2226	Fredrick N. Andrews Fellowship	Fredrick N. Andrews Fellowship	We thank all of the New Horizons team members, without whom none of this work would have been possible. We also thank T. Bowling, D. Minton, B. Hogan, J. Kendall, B. Link and C. Milbury for discussions. A.J.T. thanks the Fredrick N. Andrews Fellowship for funding.	ANGWIN MJ, 1966, J CHEM PHYS, V44, P417, DOI 10.1063/1.1726486; Barr AC, 2015, PHYS EARTH PLANET IN, V249, P18, DOI 10.1016/j.pepi.2015.09.009; Blair DM, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2012JE004198; CHRISTENSEN UR, 1984, J GEOPHYS RES, V89, P4389, DOI 10.1029/JB089iB06p04389; EISENBERG D, 1969, STRUCTURE PROPERTIES, P296; Freed AM, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004119; Hansen CJ, 1996, ICARUS, V120, P247, DOI 10.1006/icar.1996.0049; Harry D.G., 1988, J QUATERNARY SCI, V3, P39, DOI [DOI 10.1002/JQS.3390030107, 10.1002/jqs.3390030107]; Hobbs P., 2010, ICE PHYS, P346; Kameyama M, 2000, EARTH PLANET SC LETT, V180, P355, DOI 10.1016/S0012-821X(00)00171-0; Karato S., 2012, DEFORMATION EARTH MA, P338; Kindle EM, 1917, J GEOL, V25, P135, DOI 10.1086/622446; Lachenbruch A. H., 1962, GEOL SOC AM SPEC PAP, V70, P1, DOI DOI 10.1130/SPE70-P1; MCGILL GE, 1992, J GEOPHYS RES-PLANET, V97, P2633, DOI 10.1029/91JE02863; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Niemela JJ, 2000, NATURE, V404, P837, DOI 10.1038/35009036; PECHMANN JC, 1980, ICARUS, V42, P185, DOI 10.1016/0019-1035(80)90071-8; SCHUBERT G, 1975, GEOPHYS J ROY ASTR S, V42, P705, DOI 10.1111/j.1365-246X.1975.tb05888.x; SCHUBERT G, 1992, ANNU REV FLUID MECH, V24, P359, DOI 10.1146/annurev.fluid.24.1.359; Schubert G, 2001, MANTLE CONVECTION EA; Scott T. A., 1976, Physics Reports. Physics Letters Section C, V27c, P89, DOI 10.1016/0370-1573(76)90032-6; STACHOWIAK P, 1994, PHYS REV B, V50, P543, DOI 10.1103/PhysRevB.50.543; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern SA, 2015, ICARUS, V250, P287, DOI 10.1016/j.icarus.2014.12.006; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032; ZHAO WL, 1992, PHYS EARTH PLANET IN, V72, P185, DOI 10.1016/0031-9201(92)90201-6	26	47	47	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					79	+		10.1038/nature18016	http://dx.doi.org/10.1038/nature18016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27251278				2022-12-28	WOS:000376962300036
J	Kurth, T; Winter, AC; Eliassen, AH; Dushkes, R; Mukamal, KJ; Rimm, EB; Willett, WC; Manson, JE; Rexrode, KM				Kurth, Tobias; Winter, Anke C.; Eliassen, A. Heather; Dushkes, Rimma; Mukamal, Kenneth J.; Rimm, Eric B.; Willett, Walter C.; Manson, JoAnn E.; Rexrode, Kathryn M.			Migraine and risk of cardiovascular disease in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-STROKE; SEVERE HEADACHE; UNITED-STATES; PREVALENCE; BURDEN; AURA; DEPOLARIZATION; ASSOCIATION; DYSFUNCTION	OBJECTIVE To evaluate the association between migraine and incident cardiovascular disease and cardiovascular mortality in women. DESIGN Prospective cohort study among Nurses' Health Study II participants, with follow-up from 1989 and through June 2011. SETTING Cohort of female nurses in United States. PARTICIPANTS 115 541 women aged 25-42 years at baseline and free of angina and cardiovascular disease. Cumulative follow-up rates were more than 90%. Main outcome measures The primary outcome of the study was major cardiovascular disease, a combined endpoint of myocardial infarction, stroke, or fatal cardiovascular disease. Secondary outcome measures included individual endpoints of myocardial infarction, stroke, angina/coronary revascularization procedures, and cardiovascular mortality. RESULTS 17 531 (15.2%) women reported a physician's diagnosis of migraine. Over 20 years of follow-up, 1329 major cardiovascular disease events occurred and 223 women died from cardiovascular disease. After adjustment for potential confounding factors, migraine was associated with an increased risk for major cardiovascular disease (hazard ratio 1.50, 95% confidence interval 1.33 to 1.69), myocardial infarction (1.39, 1.18 to 1.64), stroke (1.62, 1.37 to 1.92), and angina/coronary revascularization procedures (1.73, 1.29 to 2.32), compared with women without migraine. Furthermore, migraine was associated with a significantly increased risk for cardiovascular disease mortality (hazard ratio 1.37, 1.02 to 1.83). Associations were similar across subgroups of women, including by age (<50/>= 50), smoking status (current/past/never), hypertension (yes/no), postmenopausal hormone therapy (current/not current), and oral contraceptive use (current/not current). CONCLUSIONS Results of this large, prospective cohort study in women with more than 20 years of follow-up indicate a consistent link between migraine and cardiovascular disease events, including cardiovascular mortality. Women with migraine should be evaluated for their vascular risk. Future targeted research is warranted to identify preventive strategies to reduce the risk of future cardiovascular disease among patients with migraine.	[Kurth, Tobias; Dushkes, Rimma; Manson, JoAnn E.; Rexrode, Kathryn M.] Charite, Inst Publ Hlth, D-10117 Berlin, Germany; [Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Eliassen, A. Heather; Rimm, Eric B.; Willett, Walter C.; Manson, JoAnn E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Winter, Anke C.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Eliassen, A. Heather; Rimm, Eric B.; Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Mukamal, Kenneth J.; Rimm, Eric B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kurth, T (corresponding author), Charite, Inst Publ Hlth, D-10117 Berlin, Germany.; Kurth, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA.; Kurth, T (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	tobias.kurth@charite.de	Kurth, Tobias/A-9243-2012; Rexrode, Kathryn M/I-1177-2018; Mukamal, Kenneth/GVR-7978-2022	Kurth, Tobias/0000-0001-7169-2620; Eliassen, A Heather/0000-0002-3961-6609; Rexrode, Kathryn/0000-0003-3387-8429	National Institutes of Health [HL-088521, HL-34594, CA-050385, CA-176276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study had no specific funding. The Nurses' Health Study II is supported by grants from the National Institutes of Health (HL-088521, HL-34594, CA-050385, CA-176276). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buettner C, 2015, ANN NEUROL, V78, P970, DOI 10.1002/ana.24534; Buettner C, 2015, CEPHALALGIA, V35, P757, DOI 10.1177/0333102414559733; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Eikermann-Haerter K, 2014, HEADACHE, V54, P1146, DOI 10.1111/head.12386; Gonzalez-Quintanilla V, 2016, CEPHALALGIA, V36, P552, DOI 10.1177/0333102415607857; Gudmundsson Larus S, 2010, BMJ, V341, pc3966, DOI 10.1136/bmj.c3966; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Kurth T, 2012, LANCET NEUROL, V11, P92, DOI 10.1016/S1474-4422(11)70266-6; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Liman TG, 2012, CEPHALALGIA, V32, P459, DOI 10.1177/0333102412444014; Liman TG, 2015, CEPHALALGIA, V35, P88, DOI 10.1177/0333102414529671; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Longoni M, 2006, NEUROL SCI, V27, pS107, DOI 10.1007/s10072-006-0582-2; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Malik R, 2015, NEUROLOGY, V84, P2132, DOI 10.1212/WNL.0000000000001606; Mawet J, 2015, CEPHALALGIA, V35, P165, DOI 10.1177/0333102414550106; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Napoli R, 2009, NEUROLOGY, V72, P2111, DOI 10.1212/WNL.0b013e3181aa53ce; ROSE G. A., 1982, Monograph Series. World Health Organisation, V56; Rose KM, 2007, NEUROLOGY, V68, P1694, DOI 10.1212/01.wnl.0000261916.42871.05; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Sacco S, 2013, STROKE, V44, P3032, DOI 10.1161/STROKEAHA.113.002465; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schurks M, 2009, CEPHALALGIA, V29, P1086, DOI 10.1111/j.1468-2982.2008.01835.x; Schurks M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022106; Schurks Markus, 2009, BMJ, V339, pb3914, DOI 10.1136/bmj.b3914; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tietjen GE, 2007, THROMB RES, V119, P217, DOI 10.1016/j.thromres.2005.12.020; Totaro R, 1997, CEPHALALGIA, V17, P191, DOI 10.1046/j.1468-2982.1997.1703191.x; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Wang YC, 2014, INT J CARDIOL, V172, P213, DOI 10.1016/j.ijcard.2014.01.005; Weinfeld, 1981, STROKE S1, V12, pI13	43	157	162	2	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2016	353								i2610	10.1136/bmj.i2610	http://dx.doi.org/10.1136/bmj.i2610			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO0OF	27247281	Green Published, hybrid			2022-12-28	WOS:000377477500002
J	Webb, P				Webb, Peter			John Cockrill OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2016	353								i2961	10.1136/bmj.i2961	http://dx.doi.org/10.1136/bmj.i2961			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CT	27233941				2022-12-28	WOS:000376940700003
J	Lupold, S; Manier, MK; Puniamoorthy, N; Schoff, C; Starmer, WT; Luepold, SHB; Belote, JM; Pitnick, S				Lupold, Stefan; Manier, Mollie K.; Puniamoorthy, Nalini; Schoff, Christopher; Starmer, William T.; Luepold, Shannon H. Buckley; Belote, John M.; Pitnick, Scott			How sexual selection can drive the evolution of costly sperm ornamentation	NATURE			English	Article							COMPETITIVE FERTILIZATION SUCCESS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC ANALYSIS; TRADE-OFF; ALLOMETRY; EJACULATE; SIZE; DIMORPHISM; MECHANISMS; INTENSITY	Post-copulatory sexual selection (PSS), fuelled by female promiscuity, is credited with the rapid evolution of sperm quality traits across diverse taxa(1). Yet, our understanding of the adaptive significance of sperm ornaments and the cryptic female preferences driving their evolution is extremely limited(1,2). Here we review the evolutionary allometry of exaggerated sexual traits (for example, antlers, horns, tail feathers, mandibles and dewlaps), show that the giant sperm of some Drosophila species are possibly the most extreme ornaments(3,4) in all of nature and demonstrate how their existence challenges theories explaining the intensity of sexual selection, mating-system evolution and the fundamental nature of sex differences(5-9). We also combine quantitative genetic analyses of interacting sex-specific traits in D. melanogaster with comparative analyses of the condition dependence of male and female reproductive potential across species with varying ornament size to reveal complex dynamics that may underlie sperm-length evolution. Our results suggest that producing few gigantic sperm evolved by (1) Fisherian runaway selection mediated by genetic correlations between sperm length, the female preference for long sperm and female mating frequency, and (2) longer sperm increasing the indirect benefits to females. Our results also suggest that the developmental integration of sperm quality and quantity renders post-copulatory sexual selection on ejaculates unlikely to treat male-male competition and female choice as discrete processes.	[Lupold, Stefan; Manier, Mollie K.; Puniamoorthy, Nalini; Schoff, Christopher; Starmer, William T.; Luepold, Shannon H. Buckley; Belote, John M.; Pitnick, Scott] Syracuse Univ, Dept Biol, Ctr Reprod Evolut, 107 Coll Pl, Syracuse, NY 13244 USA; [Lupold, Stefan] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Manier, Mollie K.] George Washington Univ, Dept Biol Sci, 800 22nd St NW,Suite 6000, Washington, DC 20052 USA; [Puniamoorthy, Nalini] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr, SG-117543 Singapore, Singapore	Syracuse University; University of Zurich; George Washington University; National University of Singapore	Pitnick, S (corresponding author), Syracuse Univ, Dept Biol, Ctr Reprod Evolut, 107 Coll Pl, Syracuse, NY 13244 USA.	sspitnic@syr.edu	Lüpold, Stefan/C-2091-2012; Manier, Mollie K./I-2069-2019	Lüpold, Stefan/0000-0002-5069-1992; Manier, Mollie K./0000-0001-9114-8649	National Science Foundation [DEB-9806649, DEB-1145965]; Swiss National Science Foundation [PA00P3_134191, PZ00P3_154767]; National University of Singapore	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National University of Singapore(National University of Singapore)	The authors thank B. Reil for technical assistance and S. Dorus for helpful comments on the manuscript. Financial support for this research was provided by the National Science Foundation (grants DEB-9806649 to S.P. and DEB-1145965 to S.P., S.L., M.K.M. and J.M.B.), the Swiss National Science Foundation (Fellowships PA00P3_134191 and PZ00P3_154767 to S.L.), the National University of Singapore (Overseas Postdoctoral Fellowship to N.P.) and a generous gift from Mike and Jane Weeden to Syracuse University.	Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Andersson Malte, 1994; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Baker RH, 2001, EVOLUTION, V55, P1373; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bergmann PJ, 2012, EVOL BIOL, V39, P311, DOI 10.1007/s11692-011-9147-2; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; Bonduriansky R, 2013, J EVOLUTION BIOL, V26, P76, DOI 10.1111/jeb.12028; Bonduriansky R, 2015, ECOL LETT, V18, P317, DOI 10.1111/ele.12412; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; COCKERHAM CC, 1977, BIOMETRICS, V33, P187, DOI 10.2307/2529312; CRUSIO WE, 1993, BEHAV GENET, V23, P59, DOI 10.1007/BF01067554; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; ECHELLE AF, 1978, COPEIA, P245; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; Falconer D. S., 1989, Introduction to quantitative genetics.; Falconer DS, 1996, INTRO QUANTITATIVE G; FORSTER R. R., 1955, AUSTRALIAN JOUR ZOOL, V3, P354, DOI 10.1071/ZO9550354; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fry JD, 2004, GENETIC ANAL COMPLEX, P11; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Juenger T, 2000, EVOLUTION, V54, P764, DOI 10.1111/j.0014-3820.2000.tb00078.x; Karr TL, 1996, NATURE, V379, P405, DOI 10.1038/379405a0; Kawano K, 2006, ANN ENTOMOL SOC AM, V99, P327, DOI 10.1603/0013-8746(2006)099[0327:SDATMO]2.0.CO;2; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, P523, DOI 10.1098/rspb.2003.2641; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Lemaitre JF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0869; Lupold S, 2015, J EVOLUTION BIOL, V28, P2187, DOI 10.1111/jeb.12742; Lupold S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4184; Lupold S, 2013, P NATL ACAD SCI USA, V110, P10693, DOI 10.1073/pnas.1300954110; Lupold S, 2012, CURR BIOL, V22, P1667, DOI 10.1016/j.cub.2012.06.059; Lynch M., 1998, GENETICS ANAL QUANTI; Madge S., 2002, PHEASANTS PARTRIDGES; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Miller GT, 2003, J EVOLUTION BIOL, V16, P114, DOI 10.1046/j.1420-9101.2003.00476.x; Moen RA, 1999, EVOL ECOL RES, V1, P235; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; PARSONS PA, 1968, GENETICA, V38, P328; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Pitnick S, 1997, EVOLUTION, V51, P833, DOI [10.2307/2411158, 10.1111/j.1558-5646.1997.tb03665.x]; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; PITNICK S, 1994, P NATL ACAD SCI USA, V91, P9277, DOI 10.1073/pnas.91.20.9277; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Plard F, 2011, OIKOS, V120, P601, DOI 10.1111/j.1600-0706.2010.18934.x; ROEWER C. F., 1927, ABH NAT VER BREMEN, V26, P261; Roewer C.F, 1923, WEBERKNECHTE ERDE SI; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rowland J. M., 2012, Insecta Mundi, P1; Seetharam AS, 2013, PEERJ, V1, DOI 10.7717/peerj.226; Sharma PP, 2012, ZOOTAXA, P29, DOI 10.11646/zootaxa.3280.1.2; Sharma PP, 2012, ZOOTAXA, P1; Sharma PP, 2012, P ROY SOC B-BIOL SCI, V279, P3501, DOI 10.1098/rspb.2012.0675; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 1996, EVOL ECOL, V10, P97, DOI 10.1007/BF01239350; Starmer W. T., 2003, EVOL BIOL, P139; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520	71	86	86	3	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					535	+		10.1038/nature18005	http://dx.doi.org/10.1038/nature18005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225128	Green Published			2022-12-28	WOS:000376443100041
J	Walensky, RP; Borre, ED; Bekker, LG; Resch, SC; Hyle, EP; Wood, R; Weinstein, MC; Ciaranello, AL; Freedberg, KA; Paltiel, AD				Walensky, Rochelle P.; Borre, Ethan D.; Bekker, Linda-Gail; Resch, Stephen C.; Hyle, Emily P.; Wood, Robin; Weinstein, Milton C.; Ciaranello, Andrea L.; Freedberg, Kenneth A.; Paltiel, A. David			The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa	ANNALS OF INTERNAL MEDICINE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT PROGRAMS; RESOURCE-LIMITED SETTINGS; VIRAL LOAD; HIV-1 INFECTION; CD4 COUNT; FOLLOW-UP; THERAPY; COST; METAANALYSIS	Background: The Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 global treatment target aims to achieve 73% virologic suppression among HIV-infected persons worldwide by 2020. Objective: To estimate the clinical and economic value of reaching this ambitious goal in South Africa, by using a microsimulation model of HIV detection, disease, and treatment. Design: Modeling of the "current pace" strategy, which simulates existing scale-up efforts and gradual increases in overall virologic suppression from 24% to 36% in 5 years, and the UNAIDS target strategy, which simulates 73% virologic suppression in 5 years. Data Sources: Published estimates and South African survey data on HIV transmission rates (0.16 to 9.03 per 100 person-years), HIV-specific age-stratified fertility rates (1.0 to 9.1 per 100 person-years), and costs of care ($11 to $31 per month for antiretroviral therapy and $20 to $157 per month for routine care). Target Population: South African HIV-infected population, including incident infections over the next 10 years. Perspective: Modified societal perspective, excluding time and productivity costs. Time Horizon: 5 and 10 years. Intervention: Aggressive HIV case detection, efficient linkage to care, rapid treatment scale-up, and adherence and retention interventions toward the UNAIDS target strategy. Outcome Measures: HIV transmissions, deaths, years of life saved, maternal orphans, costs (2014 U.S. dollars), and cost-effectiveness. Results of Base-Case Analysis: Compared with the current pace strategy, over 5 years the UNAIDS target strategy would avert 873 000 HIV transmissions, 1 174 000 deaths, and 726 000 maternal orphans while saving 3 002 000 life-years; over 10 years, it would avert 2 051 000 HIV transmissions, 2 478 000 deaths, and 1 689 000 maternal orphans while saving 13 340 000 life-years. The additional budget required for the UNAIDS target strategy would be $7.965 billion over 5 years and $15.979 billion over 10 years, yielding an incremental cost-effectiveness ratio of $2720 and $1260 per year of life saved, respectively. Results of Sensitivity Analysis: Outcomes generally varied less than 20% from base-case outcomes when key input parameters were varied within plausible ranges. Limitation: Several pathways may lead to 73% overall virologic suppression; these were examined in sensitivity analyses. Conclusion: Reaching the 90-90-90 HIV suppression target would be costly but very effective and cost-effective in South Africa. Global health policymakers should mobilize the political and economic support to realize this target.	[Walensky, Rochelle P.; Borre, Ethan D.; Hyle, Emily P.; Ciaranello, Andrea L.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA; [Bekker, Linda-Gail; Wood, Robin] Desmond Tutu HIV Fdn, POB 13801, ZA-7705 Cape Town, South Africa; [Resch, Stephen C.; Weinstein, Milton C.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Paltiel, A. David] Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	rwalensky@partners.org	Bekker, Linda-Gail/AAZ-8929-2020; , Andrea/ABB-3330-2021	, Andrea/0000-0002-4268-3263; Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290; Borre, Ethan/0000-0002-8666-5382; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institutes of Health; Steve and Deborah Gorlin MGH Research Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079214] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL123349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI093269, R01AI058736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steve and Deborah Gorlin MGH Research Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health and the Steve and Deborah Gorlin MGH Research Scholars Award.	aids2031 Costs and Financing Working Group, 2010, LONG RUN COSTS FIN H; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Braithwaite RS, 2006, PLOS MED, V3, P14, DOI 10.1371/journal.pmed.0030060; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; CLEARY S, 2004, COST EFFECTIVENESS A; Clinton Health Access Initiative (CHAI), 2015, ARV CEIL PRIC LIST 2; Cohen S., 2014, FINANCING S AFRICAN; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Hall K, 2015, STAT CHILDREN S AFRI; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Kranzer K, 2013, JAIDS-J ACQ IMM DEF, V63, P498, DOI 10.1097/QAI.0b013e318293ae48; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Meyer-Rath G, 2012, JAIDS-J ACQ IMM DEF, V61, pE25, DOI 10.1097/QAI.0b013e31826cc575; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Novitsky V, 2012, CURR OPIN HIV AIDS, V7, P117, DOI 10.1097/COH.0b013e32834fe8ff; Ochalek J, 2015, COST PER DALY AVERTE; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Shisana O, 2014, S AFRICAN NATL HIV P; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Smith JA, 2015, LANCET HIV, V2, pE159, DOI 10.1016/S2352-3018(15)00016-8; South Africa National AIDS Council, 2010, S AFR ANT TREATM GUI; Statistics South Africa, 2015, MORT CAUS DEATH S AF; Statistics South Africa, 2015, CENS 2011 FERT S AFR; UNAIDS, 2014, 90 90 90 AMB TREATM; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT DAT 2012; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	37	29	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2016	165	5					325	+		10.7326/M16-0799	http://dx.doi.org/10.7326/M16-0799			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0XW	27240120	Green Accepted			2022-12-28	WOS:000385564000003
J	Leston, J; Finkbonner, J				Leston, Jessica; Finkbonner, Joe			The Need to Expand Access to Hepatitis C Virus Drugs in the Indian Health Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE		[Leston, Jessica] Northwest Portland Area Indian Hlth Board, HIV HCV Clin Program, Portland, OR USA; [Finkbonner, Joe] Northwest Portland Area Indian Hlth Board, Portland, OR USA		Leston, J (corresponding author), 2121 SW Broadway,Ste 300, Portland, OR 97201 USA.	jleston@npaihb.org						Backus LI, 2013, JAMA INTERN MED, V173, P1549, DOI 10.1001/jamainternmed.2013.8133; Bruno S, 2016, J HEPATOL, V64, P1217, DOI 10.1016/j.jhep.2016.01.034; Centers for Disease Control and Prevention, 2013, VIR HEP SURV; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978	4	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2016	316	8					817	818		10.1001/jama.2016.7186	http://dx.doi.org/10.1001/jama.2016.7186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8JL	27228394				2022-12-28	WOS:000381736200008
J	Feltner, C; Peterson, K; Weber, RP; Cluff, L; Coker-Schwimmer, E; Viswanathan, M; Lohr, KN				Feltner, Cynthia; Peterson, Kristina; Weber, Rachel Palmieri; Cluff, Laurie; Coker-Schwimmer, Emmanuel; Viswanathan, Meera; Lohr, Kathleen N.			The Effectiveness of Total Worker Health Interventions: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; WORKSITE CANCER PREVENTION; DIRECTIONS-SMALL-BUSINESS; BEHAVIOR-CHANGE; UNITED-STATES; WELLWORKS PROJECT; PROTECTION; PROMOTION; PROGRAM; INTEGRATION	Background: The Total Worker Health (TWH) program of the National Institute for Occupational Safety and Health aims to advance worker well-being by integrating injury and illness prevention efforts with work-related safety and health hazard efforts. Purpose: To evaluate evidence on the benefits and harms of integrated TWH interventions. Data Sources: MEDLINE, Cochrane Library, and PsycINFO (January 1990 through September 2015); clinical trial registries; and reference lists. Study Selection: English-language studies that enrolled employed adults and compared integrated interventions with usual work practice, no intervention, or another intervention. Data Extraction: Dual abstraction and risk-of-bias (ROB) assessment. Data Synthesis: Ten of the 15 included studies had high ROB, primarily because of selection and attrition bias. Findings graded as having low strength of evidence (SOE) supported the effectiveness of TWH interventions for improving smoking cessation, as measured by self-reported 7-day abstinence over 22 to 26 weeks (2 randomized, controlled trials [RCTs]; n = 737), and increasing consumption of fruits and vegetables over 26 to 104 weeks (3 RCTs; n = 6056); results apply to populations of blue-collar manufacturing and construction workers. Findings graded as having low SOE supported the effectiveness of TWH interventions for reducing sedentary work behavior in office workers over 16 to 52 weeks (2 RCTs; n = 262). Evidence was insufficient or lacking for other outcomes of interest, such as rates of work injuries, quality of life, and harms. Limitation: Small, diverse body of evidence with many methodological limitations; possible publication bias. Conclusion: Integrated TWH interventions might improve health behaviors (for example, reduce tobacco use and sedentary behavior and improve diet) of workers, but effects of these interventions on injuries and overall quality of life are not known.	[Weber, Rachel Palmieri; Coker-Schwimmer, Emmanuel] Univ North Carolina Chapel Hill, RTI UNC Evidence Based Practice Ctr, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd,CB 7590, Chapel Hill, NC 27599 USA; [Peterson, Kristina; Cluff, Laurie; Viswanathan, Meera; Lohr, Kathleen N.] RTI Int, Workplace Hlth & Safety, 3040 Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA; [Feltner, Cynthia] Univ North Carolina Chapel Hill, Dept Med, 5034 Old Clin Bldg,CB 7110,POB 12194, Chapel Hill, NC 27599 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Feltner, C (corresponding author), Univ North Carolina Chapel Hill, Dept Med, 5034 Old Clin Bldg,CB 7110,POB 12194, Chapel Hill, NC 27599 USA.	cindy_feltner@med.unc.edu		Lohr, Kathleen/0000-0002-3825-0713; Weber, Rachel/0000-0001-7119-7734	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Allen HM, 2003, J OCCUP ENVIRON MED, V45, P956, DOI 10.1097/01.jom.0000090742.76380.8c; Anger WK, 2015, J OCCUP HEALTH PSYCH, V20, P226, DOI 10.1037/a0038340; [Anonymous], 2014, METH GUID EFF COMP E; Barbeau E, 2004, AM J IND MED, V45, P371, DOI 10.1002/ajim.10336; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Boggild H, 2001, SCAND J WORK ENV HEA, V27, P87, DOI 10.5271/sjweh.594; Carr LJ, 2016, AM J PREV MED, V50, P9, DOI 10.1016/j.amepre.2015.06.022; Centers for Disease Control and Prevention, 2013, GUID IMPL TOT WORK H; Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH), 2013, TOT WORK HLTH; Coffeng JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114860; Coffeng JK, 2013, J OCCUP ENVIRON MED, V55, P1409, DOI 10.1097/JOM.0b013e3182a50053; Coffeng JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-592; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Eriksen HR, 2002, OCCUP MED-OXFORD, V52, P383, DOI 10.1093/occmed/52.7.383; Feltner C, 2015, COMP EFFECTIVENESS R; Hammer LB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/836967; Hunt MK, 2007, HEALTH EDUC BEHAV, V34, P90, DOI 10.1177/1090198105277971; Hunt MK, 2005, HEALTH EDUC BEHAV, V32, P10, DOI 10.1177/1090198104264216; Hymel PA, 2011, J OCCUP ENVIRON MED, V53, P695, DOI 10.1097/JOM.0b013e31822005d0; LaMontagne AD, 2005, AM J IND MED, V48, P282, DOI 10.1002/ajim.20218; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; Maes S, 1998, AM J PUBLIC HEALTH, V88, P1037, DOI 10.2105/AJPH.88.7.1037; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Institute for Occupational Safety and Health, 2012, USITC PUBL; Okechukwu CA, 2009, CANCER CAUSE CONTROL, V20, P887, DOI 10.1007/s10552-009-9324-0; Palumbo MV, 2012, APPL NURS RES, V25, P54, DOI 10.1016/j.apnr.2010.01.002; Pronk NP, 2013, J OCCUP ENVIRON MED, V55, pS30, DOI 10.1097/JOM.0000000000000031; Schwarz UV, 2015, J OCCUP ENVIRON MED, V57, P217, DOI 10.1097/JOM.0000000000000344; Sorensen G, 1998, AM J PUBLIC HEALTH, V88, P1685, DOI 10.2105/AJPH.88.11.1685; Sorensen G, 1996, HEALTH EDUC QUART, V23, P191, DOI 10.1177/109019819602300205; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1389, DOI 10.2105/AJPH.2004.038745; Sorensen G, 2003, J PUBLIC HEALTH POL, V24, P5, DOI 10.2307/3343174; SORENSEN G, 1995, AM J HEALTH PROMOT, V10, P55, DOI 10.4278/0890-1171-10.1.55; Sorensen G, 2007, CANCER CAUSE CONTROL, V18, P51, DOI 10.1007/s10552-006-0076-9; Sorensen G, 2013, J OCCUP ENVIRON MED, V55, pS12, DOI 10.1097/JOM.0000000000000032; Tveito TH, 2009, J ADV NURS, V65, P110, DOI 10.1111/j.1365-2648.2008.04846.x; United Nations Development Programme, 2014, HUM DEV REP 2014 SUS; Viswanathan M., 2013, AHRQ METHODS EFFECTI; Williams JAR, 2015, J OCCUP ENVIRON MED, V57, P1017, DOI 10.1097/JOM.0000000000000521; World Health Organization, 1997, JAK STAT HLTH WORKPL	40	59	60	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					262	+		10.7326/M16-0626	http://dx.doi.org/10.7326/M16-0626			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27240022	Green Submitted			2022-12-28	WOS:000381267200015
J	Saotome, K; Singh, AK; Yelshanskaya, MV; Sobolevsky, AI				Saotome, Kei; Singh, Appu K.; Yelshanskaya, Maria V.; Sobolevsky, Alexander I.			Crystal structure of the epithelial calcium channel TRPV6	NATURE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; MEMBRANE; CALMODULIN; IDENTIFICATION; ACTIVATION; PROTEINS	Precise regulation of calcium homeostasis is essential for many physiological functions. The Ca2+-selective transient receptor potential (TRP) channels TRPV5 and TRPV6 play vital roles in calcium homeostasis as Ca2+ uptake channels in epithelial tissues. Detailed structural bases for their assembly and Ca2+ permeation remain obscure. Here we report the crystal structure of rat TRPV6 at 3.25 angstrom resolution. The overall architecture of TRPV6 reveals shared and unique features compared with other TRP channels. Intracellular domains engage in extensive interactions to form an intracellular 'skirt' involved in allosteric modulation. In the K+ channel-like transmembrane domain, Ca2+ selectivity is determined by direct coordination of Ca2+ by a ring of aspartate side chains in the selectivity filter. On the basis of crystallographically identified cation-binding sites at the pore axis and extracellular vestibule, we propose a Ca2+ permeation mechanism. Our results provide a structural foundation for understanding the regulation of epithelial Ca2+ uptake and its role in pathophysiology.	[Saotome, Kei; Singh, Appu K.; Yelshanskaya, Maria V.; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, 680 West 168th St, New York, NY 10032 USA	Columbia University	Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 680 West 168th St, New York, NY 10032 USA.	as4005@cumc.columbia.edu		Saotome, Kei/0000-0002-4135-5356	National Institutes of Health [R01 NS083660, T32 GM008281]; Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences; Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award in Biomedical Sciences; Schaefer Research Scholar Award; Klingenstein Fellowship Award in the Neurosciences(Klingenstein Philanthropies); Irma T. Hirschl Career Scientist Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. C. Twomey and J. M. Sampson for comments on the manuscript, members of the E. C. Greene laboratory for assistance with their fluorimeter, and the Columbia Protein Core facility for assistance with isothermal titration calorimetry (ITC) measurements. We also thank the personnel at beamlines 24-ID-C/E of APS, X25/X29 of NSLS and 5.0.1/5.0.2 of ALS. This work was supported by National Institutes of Health grants R01 NS083660 (A.I.S.) and T32 GM008281 (K.S.), by a Pew Scholar Award in Biomedical Sciences, a Schaefer Research Scholar Award, a Klingenstein Fellowship Award in the Neurosciences and an Irma T. Hirschl Career Scientist Award (A.I.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barton WA, 2006, PROTEIN SCI, V15, P2008, DOI 10.1110/ps.062244206; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Bolanz KA, 2009, MOL CANCER RES, V7, P2000, DOI 10.1158/1541-7786.MCR-09-0188; Bowen CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058866; Cao CK, 2013, J BIOL CHEM, V288, P5278, DOI 10.1074/jbc.M112.409482; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; DeLano W.L, PYMOL MOL GRAPHICS S; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fecher-Trost C, 2014, HANDB EXP PHARMACOL, V222, P359, DOI 10.1007/978-3-642-54215-2_14; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kovacs G, 2011, CELL CALCIUM, V49, P43, DOI 10.1016/j.ceca.2010.11.007; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Lehen'kyi V, 2012, J PHYSIOL-LONDON, V590, P1369, DOI 10.1113/jphysiol.2011.225862; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miura S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9871; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Raphael M, 2014, P NATL ACAD SCI USA, V111, pE3870, DOI 10.1073/pnas.1413409111; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Woudenberg-Vrenken TE, 2012, AM J PHYSIOL-GASTR L, V303, pG879, DOI 10.1152/ajpgi.00089.2012; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	48	151	154	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2016	534	7608					506	+		10.1038/nature17975	http://dx.doi.org/10.1038/nature17975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP1SS	27296226	Green Accepted, Green Submitted			2022-12-28	WOS:000378270300044
J	Hyslop, LA; Blakeley, P; Craven, L; Richardson, J; Fogarty, NME; Fragouli, E; Lamb, M; Wamaitha, SE; Prathalingam, N; Zhang, Q; O'Keefe, H; Takeda, Y; Arizzi, L; Alfarawati, S; Tuppen, HA; Irving, L; Kalleas, D; Choudhary, M; Wells, D; Murdoch, AP; Turnbull, DM; Niakan, KK; Herbert, M				Hyslop, Louise A.; Blakeley, Paul; Craven, Lyndsey; Richardson, Jessica; Fogarty, Norah M. E.; Fragouli, Elpida; Lamb, Mahdi; Wamaitha, Sissy E.; Prathalingam, Nilendran; Zhang, Qi; O'Keefe, Hannah; Takeda, Yuko; Arizzi, Lucia; Alfarawati, Samer; Tuppen, Helen A.; Irving, Laura; Kalleas, Dimitrios; Choudhary, Meenakshi; Wells, Dagan; Murdoch, Alison P.; Turnbull, Douglass M.; Niakan, Kathy K.; Herbert, Mary			Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease	NATURE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; POINT MUTATIONS; HUMAN EMBRYOS; TRANSMISSION; TRANSCRIPTOMES; PLURIPOTENT; SEGREGATION; BLASTOCYST; ANEUPLOIDY; DISORDERS	Mitochondrial DNA (mtDNA) mutations are maternally inherited and are associated with a broad range of debilitating and fatal diseases(1). Reproductive technologies designed to uncouple the inheritance of mtDNA from nuclear DNA may enable affected women to have a genetically related child with a greatly reduced risk of mtDNA disease. Here we report the first preclinical studies on pronuclear transplantation (PNT). Surprisingly, techniques used in proof-of-concept studies involving abnormally fertilized human zygotes(2) were not well tolerated by normally fertilized zygotes. We have therefore developed an alternative approach based on transplanting pronuclei shortly after completion of meiosis rather than shortly before the first mitotic division. This promotes efficient development to the blastocyst stage with no detectable effect on aneuploidy or gene expression. After optimization, mtDNA carryover was reduced to <2% in the majority (79%) of PNT blastocysts. The importance of reducing carryover to the lowest possible levels is highlighted by a progressive increase in heteroplasmy in a stem cell line derived from a PNT blastocyst with 4% mtDNA carryover. We conclude that PNT has the potential to reduce the risk of mtDNA disease, but it may not guarantee prevention.	[Hyslop, Louise A.; Richardson, Jessica; Lamb, Mahdi; Prathalingam, Nilendran; Zhang, Qi; O'Keefe, Hannah; Takeda, Yuko; Arizzi, Lucia; Irving, Laura; Kalleas, Dimitrios; Herbert, Mary] Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Hyslop, Louise A.; Prathalingam, Nilendran; Arizzi, Lucia; Choudhary, Meenakshi; Murdoch, Alison P.; Herbert, Mary] Newcastle Fertil Ctr, Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Blakeley, Paul; Fogarty, Norah M. E.; Wamaitha, Sissy E.; Niakan, Kathy K.] Francis Crick Inst, Human Embryo & Stem Cell Lab, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Craven, Lyndsey; Tuppen, Helen A.; Turnbull, Douglass M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Fragouli, Elpida; Alfarawati, Samer] Reprogenet UK, Inst Reprod Sci, Oxford Business Pk North, Oxford OX4 2HW, England; [Wells, Dagan] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Zhang, Qi] Acad Mil Med Sci, Dept Cell Biol, 27th Taiping Rd, Beijing 100850, Peoples R China; [Irving, Laura] Gateshead Hlth NHS Trust, Queen Elizabeth Hosp, Gateshead Fertil Unit, Sheriff Hill, Gateshead NE9 6SX, England; [Kalleas, Dimitrios] Old St Marys Hosp, St Marys Hosp, Dept Reprod Med, Oxford Rd, Manchester M13 9WL, Lancs, England	Newcastle University - UK; Newcastle University - UK; University of Oxford; Academy of Military Medical Sciences - China; University of Manchester	Herbert, M (corresponding author), Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.; Herbert, M (corresponding author), Newcastle Fertil Ctr, Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.	mary.herbert@ncl.ac.uk	Fragouli, Elpida/B-4067-2019; Hyslop, Louise/AAJ-2583-2021	Fragouli, Elpida/0000-0002-4538-6715; Lamb, Mahdi/0000-0002-3897-4519; Wamaitha, Sissy/0000-0001-6245-6255; O'Keefe, Hannah/0000-0002-0107-711X; Herbert, Mary/0000-0002-8488-2770; Choudhary, Meenakshi/0000-0003-0483-3627; Lamb, Mahdi/0000-0001-5634-8768; Tuppen, Helen/0000-0001-8762-0824; Kalleas, Dimitrios/0000-0002-3920-433X; Niakan, Kathy/0000-0003-1646-4734; Turnbull, Doug/0000-0002-8878-9901; Fogarty, Norah/0000-0003-1085-8185	Wellcome Trust [096919]; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre; Barbour Foundation; Francis Crick Institute - Cancer Research UK; UK Medical Research Council [MC_UP_1202/9]; Wellcome Trust; March of Dimes Foundation [FY11-436]; NIHR Oxford Biomedical Research Centre; MRC [MR/L016354/1, MC_UP_1202/9, MR/J003603/1] Funding Source: UKRI; Medical Research Council [MR/L016354/1, MC_UP_1202/9] Funding Source: researchfish; The Francis Crick Institute [10120] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre(National Institute for Health Research (NIHR)); Barbour Foundation; Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); March of Dimes Foundation(March of Dimes); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We are very grateful to those who donated gametes for this research and we thank M. Nesbitt and K. Lennox for obtaining their consent. We also thank P. Chinnery and V. Floros for helpful discussion. The work was funded by the Wellcome Trust (096919) and by grants from the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre and the Barbour Foundation. K.K.N. and co-workers are supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council (MC_UP_1202/9) and the Wellcome Trust, and by the March of Dimes Foundation (FY11-436). D.W. and co-workers are funded by the NIHR Oxford Biomedical Research Centre.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2009, HFEA COD PRACT; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090; Choudhary M, 2012, CELL STEM CELL, V10, P239, DOI 10.1016/j.stem.2012.02.001; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008; Herbert M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017970; Hyslop L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Richardson J, 2015, STEM CELLS, V33, P639, DOI 10.1002/stem.1887; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172; Samuels DC, 2013, HUM REPROD, V28, P554, DOI 10.1093/humrep/des439; Schatten H, 2009, MOL HUM REPROD, V15, P531, DOI 10.1093/molehr/gap049; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Steffann J, 2014, CELL REP, V7, P933, DOI 10.1016/j.celrep.2014.05.005; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wamaitha SE, 2015, GENE DEV, V29, P1239, DOI 10.1101/gad.257071.114; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190	42	179	190	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					383	+		10.1038/nature183030	http://dx.doi.org/10.1038/nature183030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281217				2022-12-28	WOS:000377856800035
J	Bagenal, J; Bodhinayake, J; Williams, KE				Bagenal, Jessamy; Bodhinayake, Janani; Williams, Kathryn E.			10-MINUTE CONSULTATION Acute painful breast in a non-lactating woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING		[Bagenal, Jessamy] BMJ Editorial, BMA House, London WC1H9JR, England; [Bodhinayake, Janani] UCL, London, England; [Williams, Kathryn E.] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England	University of London; University College London; Wythenshawe Hospital NHS Foundation Trust	Bagenal, J (corresponding author), BMJ Editorial, BMA House, London WC1H9JR, England.	jbagenal@bmj.com						BUNDRED NJ, 1993, BRIT MED J, V307, P772, DOI 10.1136/bmj.307.6907.772; Cariati M, 2005, SURG ONCOL, V14, P133, DOI 10.1016/j.suronc.2005.07.004; Dixon J Michael, 2013, BMJ, V347, pf3291, DOI 10.1136/bmj.f3291; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2015, 37 NIH CAR EX; National Institute for Health and Care Excellence, 2015, CLIN KNOWL SUMM MAST; SCHAFER P, 1988, INT J EPIDEMIOL, V17, P810, DOI 10.1093/ije/17.4.810; Singletary SE, 2008, SEMIN ONCOL, V35, P7, DOI 10.1053/j.seminoncol.2007.11.010; World Health Organization, 2000, MAST CAUS MAN	9	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2016	353								i2646	10.1136/bmj.i2646	http://dx.doi.org/10.1136/bmj.i2646			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1HF	27306992				2022-12-28	WOS:000378240400002
J	Hirano, Y; Takeda, K; Miki, K				Hirano, Yu; Takeda, Kazuki; Miki, Kunio			Charge-density analysis of an iron-sulfur protein at an ultra-high resolution of 0.48 angstrom	NATURE			English	Article							HUMAN ALDOSE REDUCTASE; RAY-DIFFRACTION DATA; X-RAY; THERMOCHROMATIUM-TEPIDUM; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURES; SMALL-MOLECULE; ACTIVE-SITES; CLUSTERS; CRYSTALLOGRAPHY	The fine structures of proteins, such as the positions of hydrogen atoms, distributions of valence electrons and orientations of bound waters, are critical factors for determining the dynamic and chemical properties of proteins. Such information cannot be obtained by conventional protein X-ray analyses at 3.0-1.5 angstrom resolution, in which amino acids are fitted into atomically unresolved electron-density maps and refinement calculations are performed under strong restraints(1,2). Therefore, we usually supplement the information on hydrogen atoms and valence electrons in proteins with preexisting common knowledge obtained by chemistry in small molecules. However, even now, computational calculation of such information with quantum chemistry also tends to be difficult, especially for polynuclear metalloproteins(3). Here we report a charge-density analysis of the high-potential iron-sulfur protein from the thermophilic purple bacterium Thermochromatium tepidum using X-ray data at an ultra-high resolution of 0.48 angstrom. Residual electron densities in the conventional refinement are assigned as valence electrons in the multipolar refinement. Iron 3d and sulfur 3p electron densities of the Fe4S4 cluster are visualized around the atoms. Such information provides the most detailed view of the valence electrons of the metal complex in the protein. The asymmetry of the iron-sulfur cluster and the protein environment suggests the structural basis of charge storing on electron transfer. Our charge-density analysis reveals many fine features around the metal complex for the first time, and will enable further theoretical and experimental studies of metalloproteins.	[Hirano, Yu; Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Hirano, Yu] Natl Inst Quantum & Radiol Sci & Technol, Quantum Beam Sci Res Directorate, Tokai, Ibaraki 3191195, Japan	Kyoto University; National Institutes for Quantum Science & Technology	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [23657073]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We thank K. Kusumoto and H. Ohno for their contributions in the initial steps of the work, and T. Tsujinaka and S. Niwa for their contributions in the preparation of the manuscript. We also thank the BL41XU beamline staff of SPring-8 for their help in data collection. This work was supported by a Grant-in-Aid for Scientific Research (number 23657073 to K.T.) and the Photon and Quantum Basic Research Coordinated Development Program (to K.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALLEN FH, 1986, ACTA CRYSTALLOGR B, V42, P515, DOI 10.1107/S0108768186097823; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Berkholz DS, 2012, P NATL ACAD SCI USA, V109, P449, DOI 10.1073/pnas.1107115108; Bertini I, 1997, INORG CHEM, V36, P4798, DOI 10.1021/ic970057v; DeLano W.L, PYMOL MOL GRAPHICS S; Dey A, 2005, INORG CHEM, V44, P8349, DOI 10.1021/ic050981m; Dey A, 2007, SCIENCE, V318, P1464, DOI 10.1126/science.1147753; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Fournier B, 2009, J AM CHEM SOC, V131, P10929, DOI 10.1021/ja8095015; Gibbs GV, 2007, J PHYS CHEM B, V111, P1923, DOI 10.1021/jp065086i; Glaser T, 2001, J AM CHEM SOC, V123, P4859, DOI 10.1021/ja0155940; Guillot B, 2001, J APPL CRYSTALLOGR, V34, P214, DOI 10.1107/S0021889801001753; Guillot B, 2008, ACTA CRYSTALLOGR D, V64, P567, DOI 10.1107/S0907444908006082; HANSEN NK, 1978, ACTA CRYSTALLOGR A, V34, P909, DOI 10.1107/S0567739478001886; Harris TV, 2014, J COMPUT CHEM, V35, P540, DOI 10.1002/jcc.23518; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HOLLADAY A, 1983, ACTA CRYSTALLOGR A, V39, P377, DOI 10.1107/S0108767383000823; Improta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024533; Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171; Koritsanszky TS, 2001, CHEM REV, V101, P1583, DOI 10.1021/cr990112c; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; MOUESCA JM, 1995, INORG CHEM, V34, P4347, DOI 10.1021/ic00121a013; MURRAYRUST P, 1984, J AM CHEM SOC, V106, P1018, DOI 10.1021/ja00316a034; Niu SQ, 2009, J AM CHEM SOC, V131, P5724, DOI 10.1021/ja900406j; Niwa S, 2014, NATURE, V508, P228, DOI 10.1038/nature13197; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Rokob TA, 2012, DALTON T, V41, P5754, DOI 10.1039/c2dt12423h; Sabino JR, 2003, ACTA CRYSTALLOGR A, V59, P127, DOI 10.1107/S0108767302023127; Schmidt A, 2003, J BIOL CHEM, V278, P43357, DOI 10.1074/jbc.M306944200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith GT, 1997, J AM CHEM SOC, V119, P5028, DOI 10.1021/ja964264q; Takeda K, 2010, J STRUCT BIOL, V169, P135, DOI 10.1016/j.jsb.2009.09.012; Wang YF, 2009, J PHYS CHEM A, V113, P10521, DOI 10.1021/jp9020036; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Wu G, 2002, J APPL CRYSTALLOGR, V35, P356, DOI 10.1107/S0021889802005770; Yu M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3553716; Zarychta B, 2007, ACTA CRYSTALLOGR A, V63, P108, DOI 10.1107/S0108767306053748; Zarychta B, 2015, ACTA CRYSTALLOGR D, V71, P954, DOI 10.1107/S1399004715002382	41	56	56	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					281	+		10.1038/nature18001	http://dx.doi.org/10.1038/nature18001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279229				2022-12-28	WOS:000377475100048
J	Kypridemos, C; Allen, K; Hickey, GL; Guzman-Castillo, M; Bandosz, P; Buchan, I; Capewell, S; O'Flaherty, M				Kypridemos, Chris; Allen, Kirk; Hickey, Graeme L.; Guzman-Castillo, Maria; Bandosz, Piotr; Buchan, Iain; Capewell, Simon; O'Flaherty, Martin			Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NHS HEALTH CHECK; SOCIOECONOMIC INEQUALITIES; TOBACCO CONTROL; HEART-DISEASE; ENGLAND; MORTALITY; STRATEGY; SMOKING; ADULTS; TAXES	OBJECTIVES To estimate the potential impact of universal screening for primary prevention of cardiovascular disease (National Health Service Health Checks) on disease burden and socioeconomic inequalities in health in England, and to compare universal screening with alternative feasible strategies. DESIGN Microsimulation study of a close-to-reality synthetic population. Five scenarios were considered: baseline scenario, assuming that current trends in risk factors will continue in the future; universal screening; screening concentrated only in the most deprived areas; structural population-wide intervention; and combination of population-wide intervention and concentrated screening. SETTING Synthetic population with similar characteristics to the community dwelling population of England. PARTICIPANTS Synthetic people with traits informed by the health survey for England. MAIN OUTCOME MEASURE Cardiovascular disease cases and deaths prevented or postponed by 2030, stratified by fifths of socioeconomic status using the index of multiple deprivation. RESULTS Compared with the baseline scenario, universal screening may prevent or postpone approximately 19 000 cases (interquartile range 11000-28000) and 3000 deaths (-1000-6000); concentrated screening 17000 cases (9000-26000) and 2000 deaths (-1000-5000); population-wide intervention 67000 cases (57000-77000) and 8000 deaths (4000-11000); and the combination of the population-wide intervention and concentrated screening 82 000 cases (73000-93000) and 9000 deaths (6000-13000). The most equitable strategy would be the combination of the population-wide intervention and concentrated screening, followed by concentrated screening alone and the population-wide intervention. Universal screening had the least apparent impact on socioeconomic inequalities in health. CONCLUSIONS When primary prevention strategies for reducing cardiovascular disease burden and inequalities are compared, universal screening seems less effective than alternative strategies, which incorporate population-wide approaches. Further research is needed to identify the best mix of population-wide and risk targeted CVD strategies to maximise cost effectiveness and minimise inequalities.	[Kypridemos, Chris; Allen, Kirk; Guzman-Castillo, Maria; Bandosz, Piotr; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Allen, Kirk] Univ Lancaster, Lancaster Med Sch, Lancaster, England; [Hickey, Graeme L.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Bandosz, Piotr] Med Univ Gdansk, Dept Prevent & Med Educ, Gdansk, Poland; [Buchan, Iain] Univ Manchester, Farr Inst HeRC, Manchester, Lancs, England	University of Liverpool; Lancaster University; University of Liverpool; Fahrenheit Universities; Medical University Gdansk	Kypridemos, C (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England.	c.kypridemos@liverpool.ac.uk	Bandosz, Piotr/E-4964-2017; Buchan, Iain E/H-5767-2013; Kypridemos, Chris/I-4172-2019	Buchan, Iain E/0000-0003-3392-1650; Kypridemos, Chris/0000-0002-0746-9229; O'Flaherty, Martin/0000-0001-8944-4131	Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre [MR/K006665/1]; National Institute for Health Research through grant SPHR-LIL-PH1-MCD; Medical Research Council [MC_PC_13042, MR/K006665/1, G0900847] Funding Source: researchfish; MRC [G0900847, MR/K006665/1] Funding Source: UKRI	Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research through grant SPHR-LIL-PH1-MCD; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The health survey for England was funded by the Department of Health until 2004 and the Health and Social Care Information Centre from 2005. IB and CK were supported by Medical Research Council Health eResearch Centre grant MR/K006665/1. SC, MOF, MGC, KA, and PB were supported by the National Institute for Health Research through a grant (SPHR-LIL-PH1-MCD) to the LiLaC collaboration between the University of Liverpool and Lancaster University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth JD, 2011, METHOD INFORM MED, V50, P454, DOI 10.3414/ME11-02-0006; Alfons A, 2011, STAT METHOD APPL-GER, V20, P383, DOI 10.1007/s10260-011-0163-2; Attwood S, 2016, J PUBLIC HEALTH-UK, V38, P560, DOI 10.1093/pubmed/fdv070; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Baker C, 2015, J PUBLIC HEALTH-UK, V37, P202, DOI 10.1093/pubmed/fdv053; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bartlett S., 2014, EVALUATION HLTH INCE; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Bauld L, 2010, J PUBLIC HEALTH-UK, V32, P71, DOI 10.1093/pubmed/fdp074; Bender AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129819; Bodker M, 2015, HEALTH POLICY, V119, P737, DOI 10.1016/j.healthpol.2015.03.003; Braillon A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1006; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Capewell S, 2015, J PUBLIC HEALTH-UK, V37, P187, DOI 10.1093/pubmed/fdv063; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chang KCM, 2015, PREV MED, V78, P1, DOI 10.1016/j.ypmed.2015.05.022; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2015, GOV RESP HOUS COMM S; Department of Health, 2013, CARD DIS OUTC STRAT; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Farr Institute, INV SUP ACC PAC HLTH; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Forster AS, 2015, J PUBLIC HEALTH-UK, V37, P234, DOI 10.1093/pubmed/fdu079; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Gidlow C, 2015, J PUBLIC HEALTH-UK, V37, P195, DOI 10.1093/pubmed/fdu092; Gillespie DOS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127927; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Hutfless S, 2013, AM J PREV MED, V45, pE41, DOI 10.1016/j.amepre.2013.07.013; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Krogsboll Lasse T, 2012, BMJ, V345, pe7191, DOI 10.1136/bmj.e7191; Leifert RM, 2015, APPL ECON PERSPECT P, V37, P634, DOI 10.1093/aepp/ppu062; Levy DT, 2014, HEALTH POLICY PLANN, V29, P1031, DOI 10.1093/heapol/czt085; Levy DT, 2013, EUR J PUBLIC HEALTH, V23, P201, DOI 10.1093/eurpub/cks090; Lloyd-Williams F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1195; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Madden D, 2015, HEALTH ECON, V24, P104, DOI 10.1002/hec.3006; Maguire ER, 2015, BRIT J NUTR, V113, P181, DOI 10.1017/S0007114514002621; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Molarius A, 2001, AM J PUBLIC HEALTH, V91, P206, DOI 10.2105/AJPH.91.2.206; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Dowd A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6498; Office for National Statistics, 2011, RES ICD 10 V2010 BRI; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Schmid VJ, 2007, J STAT SOFTW, V21, P1; Scholes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069935; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Schuetz CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066454; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; The Marmot Review, 2010, FAIR SOC HLTH LIV ST; Townsend N, 2012, CORONARY HEART DIS S; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vos T, 2010, ASSESSING COST EFFEC; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; Wallach-Kildemoes H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-610; Waterall J, 2015, J PUBLIC HEALTH-UK, V37, P177, DOI 10.1093/pubmed/fdv062; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; West R, 2012, ESTIMATES 52 WEEK CO; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; World Health Organization, 2004, COMP QUANTIFICATION	66	38	40	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2016	353								i2793	10.1136/bmj.i2793	http://dx.doi.org/10.1136/bmj.i2793			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5YM	27279346	hybrid, Green Published			2022-12-28	WOS:000377859100001
J	Jackson, SP; Helleday, T				Jackson, Stephen P.; Helleday, Thomas			Drugging DNA repair	SCIENCE			English	Editorial Material							INHIBITION; DEFECTS; MTH1		[Jackson, Stephen P.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Karolinska Institutet	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.; Jackson, SP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England.; Jackson, SP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.; Helleday, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden.	s.jackson@gurdon.cam.ac.uk; thomas.helleday@scilifelab.se	Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937	Cancer Research UK [18796] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Zauri M, 2015, NATURE, V524, P114, DOI 10.1038/nature14948	14	48	49	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1178	1179		10.1126/science.aab0958	http://dx.doi.org/10.1126/science.aab0958			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257245				2022-12-28	WOS:000377045700031
J	Ghssein, G; Brutesco, C; Ouerdane, L; Fojcik, C; Izaute, A; Wang, SL; Hajjar, C; Lobinski, R; Lemaire, D; Richaud, P; Voulhoux, R; Espaillat, A; Cava, F; Pignol, D; Borezee-Durant, E; Arnoux, P				Ghssein, Ghassan; Brutesco, Catherine; Ouerdane, Laurent; Fojcik, Clementine; Izaute, Amelie; Wang, Shuanglong; Hajjar, Christine; Lobinski, Ryszard; Lemaire, David; Richaud, Pierre; Voulhoux, Rome; Espaillat, Akbar; Cava, Felipe; Pignol, David; Borezee-Durant, Elise; Arnoux, Pascal			Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus	SCIENCE			English	Article							D-AMINO ACIDS; ESCHERICHIA-COLI; IRON UPTAKE; CELL-WALL; NICKEL; HOMEOSTASIS; SUBSTRATE; SYNTHASE; CLONING; PLANTS	Metal acquisition is a vital microbial process in metal-scarce environments, such as inside a host. Using metabolomic exploration, targeted mutagenesis, and biochemical analysis, we discovered an operon in Staphylococcus aureus that encodes the different functions required for the biosynthesis and trafficking of a broad-spectrum metallophore related to plant nicotianamine (here called staphylopine). The biosynthesis of staphylopine reveals the association of three enzyme activities: a histidine racemase, an enzyme distantly related to nicotianamine synthase, and a staphylopine dehydrogenase belonging to the DUF2338 family. Staphylopine is involved in nickel, cobalt, zinc, copper, and iron acquisition, depending on the growth conditions. This biosynthetic pathway is conserved across other pathogens, thus underscoring the importance of this metal acquisition strategy in infection.	[Ghssein, Ghassan; Brutesco, Catherine; Izaute, Amelie; Hajjar, Christine; Pignol, David; Arnoux, Pascal] Commissariat Energie Atom & Energies Alternat CEA, Inst Biosci & Biotechnol Aix Marseille BIAM, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France; [Ghssein, Ghassan; Brutesco, Catherine; Izaute, Amelie; Hajjar, Christine; Lemaire, David; Richaud, Pierre; Pignol, David; Arnoux, Pascal] CNRS, UMR 7265, St Paul Les Durance, France; [Ghssein, Ghassan; Brutesco, Catherine; Izaute, Amelie; Hajjar, Christine; Lemaire, David; Richaud, Pierre; Pignol, David; Arnoux, Pascal] Aix Marseille Univ, Marseille, France; [Ouerdane, Laurent; Wang, Shuanglong; Lobinski, Ryszard] Univ Pau & Pays Adour, CNRS, Lab Chim Analyt Bioinorgan & Environm, IPREM UMR5254, Helioparc 2,Ave Angot, F-64053 Pau, France; [Fojcik, Clementine; Borezee-Durant, Elise] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Lemaire, David] CEA, BIAM, Lab Interact Prot Met, F-13108 St Paul Les Durance, France; [Richaud, Pierre] CEA, BIAM, Lab Bioenerget Biotechnol Bacteries & Microalgues, F-13108 St Paul Les Durance, France; [Voulhoux, Rome] CNRS, Marseille, France; [Voulhoux, Rome] Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, Inst Microbiol Mediterranee, Marseille, France; [Espaillat, Akbar; Cava, Felipe] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden	CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Umea University	Arnoux, P (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, Inst Biosci & Biotechnol Aix Marseille BIAM, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France.; Arnoux, P (corresponding author), CNRS, UMR 7265, St Paul Les Durance, France.; Arnoux, P (corresponding author), Aix Marseille Univ, Marseille, France.	pascal.arnoux@cea.fr	Ghssein, Ghassan/GRJ-7050-2022; Cava, Felipe/L-2082-2017; Voulhoux, Rome/AAT-5333-2021; Ouerdane, Laurent/A-8353-2015	Cava, Felipe/0000-0001-5995-718X; Ouerdane, Laurent/0000-0002-2752-3579; Lemaire, David/0000-0001-6874-3685; PIGNOL, David/0000-0002-8070-0319; ARNOUX, Pascal/0000-0003-4609-4893; Lobinski, Ryszard/0000-0003-1908-2029; Ghssein, Ghassan/0000-0002-9313-1418	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); Agence Nationale de la Recherche (ANR) [ANR-14-CE09-0007]; CEA program ToxNuc-E; HelioBiotec platform - European Regional Development Fund; HelioBiotec platform - Region Provence Alpes Cote d'Azur; HelioBiotec platform - French Ministry of Research; HelioBiotec platform - "Commissariat a l'Energie Atomique et aux Energies Alternatives"; Region PACA; Laboratory for Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation; Swedish Research Council; Kempe foundation; Chinese Scholarship Council	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CEA program ToxNuc-E; HelioBiotec platform - European Regional Development Fund; HelioBiotec platform - Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); HelioBiotec platform - French Ministry of Research; HelioBiotec platform - "Commissariat a l'Energie Atomique et aux Energies Alternatives"; Region PACA(Region Provence-Alpes-Cote d'Azur); Laboratory for Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe foundation; Chinese Scholarship Council(China Scholarship Council)	We thank the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), the Agence Nationale de la Recherche (ANR, program ANR-14-CE09-0007), and the CEA program ToxNuc-E for financial support. Support was also provided by the HelioBiotec platform (funded by the European Regional Development Fund, the Region Provence Alpes Cote d'Azur, the French Ministry of Research, and the "Commissariat a l'Energie Atomique et aux Energies Alternatives"). G.G. was supported by the Region PACA. Work at the F.C. lab was supported by the Laboratory for Molecular Infection Medicine Sweden, the Knut and Alice Wallenberg Foundation, the Swedish Research Council, and a Kempe foundation scholarship to A.E. S.W. was supported by a fellowship from the Chinese Scholarship Council. We thank J. Lavergne for careful reading of the manuscript and A. Vermeglio, C. Cavazza, and H. Lebrette for fruitful discussions. All data are presented in the supplementary materials.	Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; BEVAN MW, 1982, ANNU REV GENET, V16, P357, DOI 10.1146/annurev.ge.16.120182.002041; Bobrov AG, 2014, MOL MICROBIOL, V93, P759, DOI 10.1111/mmi.12693; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Ding YP, 2012, J BACTERIOL, V194, P6586, DOI 10.1128/JB.01414-12; Dreyfus C, 2009, P NATL ACAD SCI USA, V106, P16180, DOI 10.1073/pnas.0904439106; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Harcet M, 2013, BIOCHEM GENET, V51, P666, DOI 10.1007/s10528-013-9596-7; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lebrette H, 2015, METALLOMICS, V7, P613, DOI 10.1039/c4mt00295d; Lebrette H, 2013, J INORG BIOCHEM, V121, P16, DOI 10.1016/j.jinorgbio.2012.12.010; Ling HQ, 1999, P NATL ACAD SCI USA, V96, P7098, DOI 10.1073/pnas.96.12.7098; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; OConnor KA, 1997, MOL MICROBIOL, V24, P839, DOI 10.1046/j.1365-2958.1997.3931757.x; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Reniere ML, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P247; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Shaik MM, 2014, MOL MICROBIOL, V91, P724, DOI 10.1111/mmi.12487; Smitst SHJ, 2008, J MOL BIOL, V381, P200, DOI 10.1016/j.jmb.2008.06.003; THOMPSON J, 1992, ANNU REV BIOCHEM, V61, P517; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Walker EL, 2011, CURR OPIN PLANT BIOL, V14, P318, DOI 10.1016/j.pbi.2011.03.025	32	123	135	6	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1105	1109		10.1126/science.aaf1018	http://dx.doi.org/10.1126/science.aaf1018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230378	Green Submitted			2022-12-28	WOS:000376480800040
J	Huchard, E; English, S; Bell, MBV; Thavarajah, N; Clutton-Brock, T				Huchard, Elise; English, Sinead; Bell, Matt B. V.; Thavarajah, Nathan; Clutton-Brock, Tim			Competitive growth in a cooperative mammal	NATURE			English	Article							MEERKATS SURICATA-SURICATTA; REPRODUCTIVE SUCCESS; FEMALE MEERKATS; WILD MEERKATS; SIZE; SUPPRESSION; VERTEBRATE; DISPERSAL; SOCIETIES; DOMINANCE	In many animal societies where hierarchies govern access to reproduction, the social rank of individuals is related to their age and weight(1-5) and slow-growing animals may lose their place in breeding queues to younger 'challengers' that grow faster(5,6). The threat of being displaced might be expected to favour the evolution of competitive growth strategies, where individuals increase their own rate of growth in response to increases in the growth of potential rivals. Although growth rates have been shown to vary in relation to changes in the social environment in several vertebrates including fish(2,3,7) and mammals(8), it is not yet known whether individuals increase their growth rates in response to increases in the growth of particular reproductive rivals. Here we show that, in wild Kalahari meerkats (Suricata suricatta), subordinates of both sexes respond to experimentally induced increases in the growth of same-sex rivals by raising their own growth rate and food intake. In addition, when individuals acquire dominant status, they show a secondary period of accelerated growth whose magnitude increases if the difference between their own weight and that of the heaviest subordinate of the same sex in their group is small. Our results show that individuals adjust their growth to the size of their closest competitor and raise the possibility that similar plastic responses to the risk of competition may occur in other social mammals, including domestic animals and primates.	[Huchard, Elise; English, Sinead; Bell, Matt B. V.; Clutton-Brock, Tim] Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England; [Huchard, Elise] Univ Montpellier, CNRS, CEFE UMR 5175, 1919 Route Mende, F-34293 Montpellier 5, France; [Thavarajah, Nathan; Clutton-Brock, Tim] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, Gauteng, South Africa; [English, Sinead] Univ Cambridge, Dept Zool, Behav Ecol Grp, Downing St, Cambridge CB2 3EJ, England; [Bell, Matt B. V.] Univ Edinburgh, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; University of Pretoria; University of Cambridge; University of Edinburgh	Huchard, E (corresponding author), Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England.; Huchard, E (corresponding author), Univ Montpellier, CNRS, CEFE UMR 5175, 1919 Route Mende, F-34293 Montpellier 5, France.	ehuchard@gmail.com	English, Sinead/N-6348-2014; Huchard, Elise/G-9072-2011	English, Sinead/0000-0003-2898-2301; Huchard, Elise/0000-0002-6944-449X	Animal Ethics Committee of the University of Pretoria [EC010-13]; University of Cambridge; University of Zurich; Natural Environment Research Council [NE/G006822/1]; European Research Council [294494]; NERC [NE/G006822/1] Funding Source: UKRI	Animal Ethics Committee of the University of Pretoria; University of Cambridge(University of Cambridge); University of Zurich; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to the many volunteers, field managers, PhD students and post-doctoral researchers who have contributed to data collection over the past 15 years, and to D. Gaynor, I. Stevenson, P. Roth, J. Samson, R. Millar, E. Cameron, J. du Toit and M. Haupt for support. We are grateful to M. Manser for her contribution to the organization of the Kalahari Meerkat Project and to C. Drea for additional help and advice. We also thank D. Cram for comments on previous drafts, and A. Bateman, A. Courtiol and M. Crawley for statistical advice. Northern Cape Conservation and the Kotze family provided permission to work in the Kalahari. Our work was approved by the Animal Ethics Committee of the University of Pretoria (project number EC010-13). The Kalahari Meerkat Project is supported and organized by the Universities of Cambridge and Zurich. This research was supported by the Natural Environment Research Council (grant NE/G006822/1) and the European Research Council (grant 294494).	Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Auguie B, 2017, GRIDEXTRA MISCELLANE; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Dantzer B, 2012, BIOL REV, V87, P414, DOI 10.1111/j.1469-185X.2011.00204.x; Dengler-Crish CM, 2007, J EXP BIOL, V210, P4351, DOI 10.1242/jeb.009399; Doolan SP, 1996, J ZOOL, V240, P59, DOI 10.1111/j.1469-7998.1996.tb05486.x; English S, 2012, OECOLOGIA, V169, P143, DOI 10.1007/s00442-011-2192-9; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, pS505, DOI 10.1098/rsbl.2004.0232; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; O'Riain MJ, 2000, P NATL ACAD SCI USA, V97, P13194, DOI 10.1073/pnas.97.24.13194; Reeve HK, 1998, P NATL ACAD SCI USA, V95, P13737, DOI 10.1073/pnas.95.23.13737; Russell AF, 2004, EVOLUTION, V58, P1600; Sharp SP, 2013, EVOL ECOL, V27, P1033, DOI 10.1007/s10682-012-9615-x; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; Thavarajah NK, 2014, BEHAVIOUR, V151, P89, DOI 10.1163/1568539X-00003124; Wong MYL, 2008, CURR BIOL, V18, pR372, DOI 10.1016/j.cub.2008.02.063; Young AJ, 2008, HORM BEHAV, V53, P131, DOI 10.1016/j.yhbeh.2007.09.005; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316; Young AJ, 2010, EVOLUTION, V64, P3190, DOI 10.1111/j.1558-5646.2010.01066.x	28	73	74	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					532	+		10.1038/nature17986	http://dx.doi.org/10.1038/nature17986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27225127	Green Submitted, Green Accepted			2022-12-28	WOS:000376443100040
J	Kantarjian, HM; DeAngelo, DJ; Stelljes, M; Martinelli, G; Liedtke, M; Stock, W; Gokbuget, N; O'Brien, S; Wang, KM; Wang, T; Paccagnella, ML; Sleight, B; Vandendries, E; Advani, AS				Kantarjian, Hagop M.; DeAngelo, Daniel J.; Stelljes, Matthias; Martinelli, Giovanni; Liedtke, Michaela; Stock, Wendy; Gokbuget, Nicola; O'Brien, Susan; Wang, Kongming; Wang, Tao; Paccagnella, M. Luisa; Sleight, Barbara; Vandendries, Erik; Advani, Anjali S.			Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; INTENSIVE CONSOLIDATION; MONOCLONAL-ANTIBODY; INDUCTION THERAPY; ADULTS; CHEMOTHERAPY; ANTIGEN; TRIAL; IMMUNOCONJUGATE; BLINATUMOMAB	BACKGROUND The prognosis for adults with relapsed acute lymphoblastic leukemia is poor. We sought to determine whether inotuzumab ozogamicin, an anti-CD22 antibody conjugated to calicheamicin, results in better outcomes in patients with relapsed or refractory acute lymphoblastic leukemia than does standard therapy. METHODS In this phase 3 trial, we randomly assigned adults with relapsed or refractory acute lymphoblastic leukemia to receive either inotuzumab ozogamicin (inotuzumab ozogamicin group) or standard intensive chemotherapy (standard-therapy group). The primary end points were complete remission (including complete remission with incomplete hematologic recovery) and overall survival. RESULTS Of the 326 patients who underwent randomization, the first 218 (109 in each group) were included in the primary intention-to-treat analysis of complete remission. The rate of complete remission was significantly higher in the inotuzumab ozogamicin group than in the standard-therapy group (80.7% [95% confidence interval {CI}, 72.1 to 87.7] vs. 29.4% [95% CI, 21.0 to 38.8], P < 0.001). Among the patients who had complete remission, a higher percentage in the inotuzumab ozogamicin group had results below the threshold for minimal residual disease (0.01% marrow blasts) (78.4% vs. 28.1%, P < 0.001); the duration of remission was longer in the inotuzumab ozogamicin group (median, 4.6 months [95% CI, 3.9 to 5.4] vs. 3.1 months [95% CI, 1.4 to 4.9]; hazard ratio, 0.55 [95% CI, 0.31 to 0.96]; P = 0.03). In the survival analysis, which included all 326 patients, progression-free survival was significantly longer in the inotuzumab ozogamicin group (median, 5.0 months [95% CI, 3.7 to 5.6] vs. 1.8 months [95% CI, 1.5 to 2.2]; hazard ratio, 0.45 [97.5% CI, 0.34 to 0.61]; P < 0.001); the median overall survival was 7.7 months (95% CI, 6.0 to 9.2) versus 6.7 months (95% CI, 4.9 to 8.3), and the hazard ratio was 0.77 (97.5% CI, 0.58 to 1.03) (P = 0.04). In the safety population, the most frequent grade 3 or higher nonhematologic adverse events with inotuzumab ozogamicin were liver-related. Veno-occlusive liver disease of any grade occurred in 15 patients (11%) who received inotuzumab ozogamicin and in 1 patient (1%) who received standard therapy. CONCLUSIONS The rate of complete remission was higher with inotuzumab ozogamicin than with standard therapy, and a higher percentage of patients in the inotuzumab ozogamicin group had results below the threshold for minimal residual disease. Both progression-free and overall survival were longer with inotuzumab ozogamicin. Veno-occlusive liver disease was a major adverse event associated with inotuzumab ozogamicin. (Funded by Pfizer; INO-VATE ALL ClinicalTrials.gov number, NCT01564784.)	[Kantarjian, Hagop M.] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [DeAngelo, Daniel J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Vandendries, Erik] Pfizer, Cambridge, MA USA; [Stelljes, Matthias] Univ Klinikum Munster, Munster, Germany; [Gokbuget, Nicola] Goethe Univ Frankfurt, Frankfurt, Germany; [Martinelli, Giovanni] Univ Bologna, DIMES Dept Expt Diagnost & Specialty Med, Inst Seragnoli, Bologna, Italy; [Liedtke, Michaela] Stanford Canc Inst, Stanford, CA USA; [O'Brien, Susan] Univ Calif Irvine, Med Ctr, Orange, CA 92668 USA; [Stock, Wendy] Univ Chicago, Chicago, IL 60637 USA; [Wang, Kongming] Pfizer, Pearl River, NY USA; [Wang, Tao; Paccagnella, M. Luisa; Sleight, Barbara] Pfizer, Groton, CT USA; [Advani, Anjali S.] Cleveland Clin, Cleveland, OH 44106 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Pfizer; University of Munster; Goethe University Frankfurt; University of Bologna; Stanford Cancer Institute; University of California System; University of California Irvine; University of Chicago; Pfizer; Pfizer; Cleveland Clinic Foundation	Kantarjian, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hkantarjian@mdanderson.org	Martinelli, Giovanni/AAK-9211-2020	Martinelli, Giovanni/0000-0002-1025-4210	Pfizer; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer.	Advani A, 2010, J CLIN ONCOL, V28, P2085, DOI 10.1200/JCO.2009.25.1900; Annino L, 2002, BLOOD, V99, P863, DOI 10.1182/blood.V99.3.863; Bouchard H, 2014, BIOORG MED CHEM LETT, V24, P5357, DOI 10.1016/j.bmcl.2014.10.021; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Daver N, 2013, CURR HEMATOL MALIG R, V8, P123, DOI 10.1007/s11899-013-0160-7; DiJoseph JF, 2004, BLOOD, V103, P1807, DOI 10.1182/blood-2003-07-2466; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Gokbuget N, 2000, HEMATOL ONCOL CLIN N, V14, P1307, DOI 10.1016/S0889-8588(05)70188-X; Goldstone AH, 2008, BLOOD, V111, P1827, DOI 10.1182/blood-2007-10-116582; Hanna R, 1996, CANCER RES, V56, P3062; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; HINMAN LM, 1993, CANCER RES, V53, P3336; Jabbour E, 2015, BLOOD, V125, P4010, DOI 10.1182/blood-2014-08-596403; Jain Nitin, 2014, Front Biosci (Elite Ed), V6, P40; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; Kantarjian H, 2013, CANCER-AM CANCER SOC, V119, P2728, DOI 10.1002/cncr.28136; LARSON RA, 1995, BLOOD, V85, P2025, DOI 10.1182/blood.V85.8.2025.bloodjournal8582025; Le Jeune C, 2015, EUR J HAEMATOL, V94, P99, DOI 10.1111/ejh.12408; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; O'Brien S, 2008, CANCER-AM CANCER SOC, V113, P3186, DOI 10.1002/cncr.23919; Piccaluga PP, 2011, LEUKEMIA LYMPHOMA, V52, P325, DOI 10.3109/10428194.2010.529206; Rowe JM, 2005, BLOOD, V106, P3760, DOI 10.1182/blood-2005-04-1623; SCHWARTZALBIEZ R, 1991, INT IMMUNOL, V3, P623, DOI 10.1093/intimm/3.7.623; Shah NN, 2015, PEDIATR BLOOD CANCER, V62, P964, DOI 10.1002/pbc.25410; Shor B, 2015, MOL IMMUNOL, V67, P107, DOI 10.1016/j.molimm.2014.09.014; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Takeuchi J, 2002, LEUKEMIA, V16, P1259, DOI 10.1038/sj.leu.2402526; Tavernier E, 2007, LEUKEMIA, V21, P1907, DOI 10.1038/sj.leu.2404824; Thomas DA, 1999, CANCER-AM CANCER SOC, V86, P1216, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O; Thomas X, 2004, J CLIN ONCOL, V22, P4075, DOI 10.1200/JCO.2004.10.050; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; VAICKUS L, 1991, CRIT REV ONCOL HEMAT, V11, P267, DOI 10.1016/1040-8428(91)90029-C; ZEIN N, 1988, SCIENCE, V240, P1198, DOI 10.1126/science.3240341; Zhao LH, 2016, BIOMETRICS, V72, P215, DOI 10.1111/biom.12384	38	720	736	7	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2016	375	8					740	753		10.1056/NEJMoa1509277	http://dx.doi.org/10.1056/NEJMoa1509277			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9ET	27292104	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000381799300012
J	Wellings, K; Palmer, MJ; Geary, RS; Gibson, LJ; Copas, A; Datta, J; Glasier, A; Scott, RH; Mercer, CH; Erens, B; Macdowall, W; French, RS; Jones, K; Johnson, AM; Tanton, C; Wilkinson, P				Wellings, Kaye; Palmer, Melissa J.; Geary, Rebecca S.; Gibson, Lorna J.; Copas, Andrew; Datta, Jessica; Glasier, Anna; Scott, Rachel H.; Mercer, Catherine H.; Erens, Bob; Macdowall, Wendy; French, Rebecca S.; Jones, Kyle; Johnson, Anne M.; Tanton, Clare; Wilkinson, Paul			Changes in conceptions in women younger than 18 years and the circumstances of young mothers in England in 2000-12: an observational study	LANCET			English	Article							TEENAGE PREGNANCY; ADOLESCENT PREGNANCY; ABORTION RATES; CHILDBEARING; BIRTH; BRITAIN	Background In 2000, a 10-year Teenage Pregnancy Strategy was launched in England to reduce conceptions in women younger than 18 years and social exclusion in young parents. We used routinely collected data and data from Britain's National Surveys of Sexual Attitudes and Lifestyles (Natsal) to examine progress towards these goals. Methods In this observational study, we used random-effects meta-regression to analyse the change in conception rates from 1994-98 to 2009-13 by top-tier local authorities in England, in relation to Teenage Pregnancy Strategy-related expenditure per head, socioeconomic deprivation, and region. Data from similar probability sample surveys: Natsal-1 (1990-91), Natsal-2 (1999-2001), and Natsal-3 (2010-12) were used to assess the prevalence of risk factors and their association with conception in women younger than 18 years in women aged 18-24 years; and the prevalence of participation in education, work, and training in young mothers. Findings Conception rates in women younger than 18 years declined steadily from their peak in 1996-98 and more rapidly from 2007 onwards. More deprived areas and those receiving greater Teenage Pregnancy Strategy-related investment had higher rates of conception in 1994-98 and had greater declines to 2009-13. Regression analyses assessing the association between Teenage Pregnancy Strategy funding and decline in conception rates in women younger than 18 years showed an estimated reduction in the conception rate of 11.4 conceptions (95% CI 9.6-13.2; p<0.0001) per 1000 women aged 15-17 years for every 100 Teenage Pregnancy Strategy spend per head and a reduction of 8.2 conceptions (5.8-10.5; p<0.0001) after adjustment for socioeconomic deprivation and region. The association between conception in women younger than 18 years and lower socioeconomic status weakened slightly between Natsal-2 and Natsal-3. The prevalence of participation in education, work, or training among young women with a child conceived before age 18 years was low, but the odds of them doing so doubled between Natsal-2 and Natsal-3 (odds ratio 1.99, 95% CI 0.99-4.00). Interpretation A sustained, multifaceted policy intervention involving health and education agencies, alongside other social and educational changes, has probably contributed to a substantial and accelerating decline in conceptions in women younger than 18 years in England since the late 1990s.	[Wellings, Kaye; Palmer, Melissa J.; Gibson, Lorna J.; Datta, Jessica; Scott, Rachel H.; Macdowall, Wendy; French, Rebecca S.; Wilkinson, Paul] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England; [Erens, Bob] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Hlth Serv Res & Policy, London, England; [Glasier, Anna] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Geary, Rebecca S.; Copas, Andrew; Mercer, Catherine H.; Jones, Kyle; Johnson, Anne M.; Tanton, Clare] UCL, Res Dept Infect & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England.	kaye.wellings@lshtm.ac.uk	Weatherburn, Peter/AAC-2701-2019	Tanton, Clare/0000-0002-4612-1858; Mercer, Catherine/0000-0002-4220-5034; Copas, Andrew/0000-0001-8968-5963; Macdowall, Wendy/0000-0001-5868-8336; Johnson, Anne/0000-0003-1330-7100; Wilkinson, Paul/0000-0001-7456-259X; Geary, Rebecca/0000-0003-1417-1057	Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244, NF-SI-0513-10078] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council, Wellcome Trust, Economic and Social Research Council, and Department of Health.	[Anonymous], 2010, DAILY MAIL; [Anonymous], 2010, TELEGRAPH; Connolly A, 2014, INT J WOMENS HEALTH, V6, P961, DOI 10.2147/IJWH.S64431; Conrad D, 2012, J PUBLIC HEALTH-UK, V34, P609, DOI 10.1093/pubmed/fds031; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Gigante DP, 2004, REV PANAM SALUD PUBL, V16, P1, DOI 10.1590/S1020-49892004000700001; Girma S, 2015, SOC SCI MED, V131, P1, DOI 10.1016/j.socscimed.2015.02.040; Hadley A, 2016, J ADOLESC H IN PRESS; Hobcraft J, 2001, BRIT J SOCIOL, V52, P495; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Nanchahal K, 2005, J EPIDEMIOL COMMUN H, V59, P828, DOI 10.1136/jech.2004.026021; Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752; Oringanje C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005215.PUB3; Payne R, 2012, HLTH STAT Q, V53, P22; Penman-Aguilar A, 2013, PUBLIC HEALTH REP, V128, P5, DOI 10.1177/00333549131282S102; Pietri G, 2014, INT J WOMENS HLTH, V6, P961; Santelli JS, 2007, AM J PUBLIC HEALTH, V97, P150, DOI 10.2105/AJPH.2006.089169; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; *SOC EXCL UN, 1999, TEEN PREGN; UNICEF, UNICEF REP REV GEN U; Uren Zoe, 2007, Health Stat Q, P34; Wellings K, 1999, REV REPROD, V4, P184, DOI 10.1530/revreprod/4.3.184; Wellings K, 2015, CONTRACEPTION, V91, P57, DOI 10.1016/j.contraception.2014.09.008; Wilkinson P, 2006, LANCET, V368, P1879, DOI 10.1016/S0140-6736(06)69777-8; World Health Organization Regional Office for Europe, WHO EUR HLTH ALL DAT; Yang Z, 2010, J ADOLESCENT HEALTH, V46, P517, DOI 10.1016/j.jadohealth.2010.03.021	29	37	40	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					586	595		10.1016/s0140-6736(16)30449-4	http://dx.doi.org/10.1016/s0140-6736(16)30449-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27229190	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000380756600031
J	Guerin, T; Levernier, N; Benichou, O; Voituriez, R				Guerin, T.; Levernier, N.; Benichou, O.; Voituriez, R.			Mean first-passage times of non-Markovian random walkers in confinement	NATURE			English	Article							GEOMETRY-CONTROLLED KINETICS; BROWNIAN-MOTION; DIFFUSION; PERSISTENCE; POLYMERS; COLLOIDS	The first-passage time, defined as the time a random walker takes to reach a target point in a confining domain, is a key quantity in the theory of stochastic processes(1). Its importance comes from its crucial role in quantifying the efficiency of processes as varied as diffusion-limited reactions(2,3), target search processes(4) or the spread of diseases(5). Most methods of determining the properties of first-passage time in confined domains have been limited to Markovian (memoryless) processes(3,6,7). However, as soon as the random walker interacts with its environment, memory effects cannot be neglected: that is, the future motion of the random walker does not depend only on its current position, but also on its past trajectory. Examples of non-Markovian dynamics include single-file diffusion in narrow channels(8), or the motion of a tracer particle either attached to a polymeric chain(9) or diffusing in simple(10) or complex fluids such as nematics(11), dense soft colloids(12) or viscoelastic solutions(13,14). Here we introduce an analytical approach to calculate, in the limit of a large confining volume, the mean first-passage time of a Gaussian non-Markovian random walker to a target. The non-Markovian features of the dynamics are encompassed by determining the statistical properties of the fictitious trajectory that the random walker would follow after the first-passage event takes place, which are shown to govern the first-passage time kinetics. This analysis is applicable to a broad range of stochastic processes, which may be correlated at long times. Our theoretical predictions are confirmed by numerical simulations for several examples of non-Markovian processes, including the case of fractional Brownian motion in one and higher dimensions. These results reveal, on the basis of Gaussian processes, the importance of memory effects in first-passage statistics of non-Markovian random walkers in confinement.	[Guerin, T.] Univ Bordeaux, Lab Ondes & Mat Aquitaine, Unite Mixte Rech 5798, CNRS, F-33400 Talence, France; [Levernier, N.; Benichou, O.; Voituriez, R.] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, 4 Pl Jussieu, F-75005 Paris, France; [Voituriez, R.] Univ Paris 06, CNRS, Lab Jean Perrin, 4 Pl Jussieu, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Benichou, O; Voituriez, R (corresponding author), Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, 4 Pl Jussieu, F-75005 Paris, France.; Voituriez, R (corresponding author), Univ Paris 06, CNRS, Lab Jean Perrin, 4 Pl Jussieu, F-75005 Paris, France.	benichou@lptmc.jussieu.fr; voiturie@lptmc.jussieu.fr	voituriez, raphael/V-3418-2017; GUERIN, THOMAS/Q-4509-2017	GUERIN, THOMAS/0000-0002-6979-7770; voituriez, raphael/0000-0001-8746-5713	ERC [FPTOpt-277998]	ERC(European Research Council (ERC)European Commission)	This work was supported by ERC grant FPTOpt-277998.	ben Avraham D., 2000, DIFFUSION REACTIONS; Benichou O, 2015, J PHYS A-MATH THEOR, V48, DOI 10.1088/1751-8113/48/16/163001; Benichou O, 2014, PHYS REP, V539, P225, DOI 10.1016/j.physrep.2014.02.003; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; Benichou O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130601; Bray AJ, 2013, ADV PHYS, V62, P225, DOI 10.1080/00018732.2013.803819; Burnecki K, 2012, BIOPHYS J, V103, P1839, DOI 10.1016/j.bpj.2012.09.040; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Cutland NJ, 1995, PROG PROBAB, V36, P327; Demery V, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053032; Ernst D, 2012, SOFT MATTER, V8, P4886, DOI 10.1039/c2sm25220a; Franosch T, 2011, NATURE, V478, P85, DOI 10.1038/nature10498; Guerin T, 2012, NAT CHEM, V4, P568, DOI [10.1038/NCHEM.1378, 10.1038/nchem.1378]; HANGGI P, 1985, PHYS REV A, V32, P1934, DOI 10.1103/PhysRevA.32.1934; Holcman D, 2014, SIAM REV, V56, P213, DOI 10.1137/120898395; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; Krug J, 1997, PHYS REV E, V56, P2702, DOI 10.1103/PhysRevE.56.2702; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; MANDELBROT BB, 1968, WATER RESOUR RES, V4, P909, DOI 10.1029/WR004i005p00909; MASOLIVER J, 1986, PHYS REV A, V34, P2351, DOI 10.1103/PhysRevA.34.2351; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Molchan GM, 1999, COMMUN MATH PHYS, V205, P97, DOI 10.1007/s002200050669; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Ochab-Marcinek A, 2011, SOFT MATTER, V7, P7366, DOI 10.1039/c1sm05217a; Panja D, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/06/P06011; Redner S, 2001, GUIDE 1 PASSAGE PROC; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Turiv T, 2013, SCIENCE, V342, P1351, DOI 10.1126/science.1240591; Wei QH, 2000, SCIENCE, V287, P625, DOI 10.1126/science.287.5453.625; WILEMSKI G, 1974, J CHEM PHYS, V60, P866, DOI 10.1063/1.1681162	30	82	83	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					356	359		10.1038/nature18272	http://dx.doi.org/10.1038/nature18272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27306185	Green Submitted			2022-12-28	WOS:000377856800029
J	Kataoka, K; Shiraishi, Y; Takeda, Y; Sakata, S; Matsumoto, M; Nagano, S; Maeda, T; Nagata, Y; Kitanaka, A; Mizuno, S; Tanaka, H; Chiba, K; Ito, S; Watatani, Y; Kakiuchi, N; Suzuki, H; Yoshizato, T; Yoshida, K; Sanada, M; Itonaga, H; Imaizumi, Y; Totoki, Y; Munakata, W; Nakamura, H; Hama, N; Shide, K; Kubuki, Y; Hidaka, T; Kameda, T; Masuda, K; Minato, N; Kashiwase, K; Izutsu, K; Takaori-Kondo, A; Miyazaki, Y; Takahashi, S; Shibata, T; Kawamoto, H; Akatsuka, Y; Shimoda, K; Takeuchi, K; Seya, T; Miyano, S; Ogawa, S				Kataoka, Keisuke; Shiraishi, Yuichi; Takeda, Yohei; Sakata, Seiji; Matsumoto, Misako; Nagano, Seiji; Maeda, Takuya; Nagata, Yasunobu; Kitanaka, Akira; Mizuno, Seiya; Tanaka, Hiroko; Chiba, Kenichi; Ito, Satoshi; Watatani, Yosaku; Kakiuchi, Nobuyuki; Suzuki, Hiromichi; Yoshizato, Tetsuichi; Yoshida, Kenichi; Sanada, Masashi; Itonaga, Hidehiro; Imaizumi, Yoshitaka; Totoki, Yasushi; Munakata, Wataru; Nakamura, Hiromi; Hama, Natsuko; Shide, Kotaro; Kubuki, Yoko; Hidaka, Tomonori; Kameda, Takuro; Masuda, Kyoko; Minato, Nagahiro; Kashiwase, Koichi; Izutsu, Koji; Takaori-Kondo, Akifumi; Miyazaki, Yasushi; Takahashi, Satoru; Shibata, Tatsuhiro; Kawamoto, Hiroshi; Akatsuka, Yoshiki; Shimoda, Kazuya; Takeuchi, Kengo; Seya, Tsukasa; Miyano, Satoru; Ogawa, Seishi			Aberrant PD-L1 expression through 3 '-UTR disruption in multiple cancers	NATURE			English	Article							GENOMIC REARRANGEMENTS; POLYMORPHISM; GENE; ACTIVATION; ONCOGENES; BLOCKADE; ANTIBODY; SAFETY; CELLS; RISK	Successful treatment of many patients with advanced cancer using antibodies against programmed cell death 1 (PD-1; also known as PDCD1) and its ligand (PD-L1; also known as CD274) has highlighted the critical importance of PD-1/PD-L1-mediated immune escape in cancer development(1-6). However, the genetic basis for the immune escape has not been fully elucidated, with the exception of elevated PD-L1 expression by gene amplification and utilization of an ectopic promoter by translocation, as reported in Hodgkin and other B-cell lymphomas, as well as stomach adenocarcinoma(6-10). Here we show a unique genetic mechanism of immune escape caused by structural variations (SVs) commonly disrupting the 3' region of the PD-L1 gene. Widely affecting multiple common human cancer types, including adult T-cell leukaemia/lymphoma (27%), diffuse large B-cell lymphoma (8%), and stomach adenocarcinoma (2%), these SVs invariably lead to a marked elevation of aberrant PD-L1 transcripts that are stabilized by truncation of the 3'-untranslated region (UTR). Disruption of the Pd-l1 3'-UTR in mice enables immune evasion of EG7-OVA tumour cells with elevated Pd-l1 expression in vivo, which is effectively inhibited by Pd-1/Pd-l1 blockade, supporting the role of relevant SVs in clonal selection through immune evasion. Our findings not only unmask a novel regulatory mechanism of PD-L1 expression, but also suggest that PD-L1 3'-UTR disruption could serve as a genetic marker to identify cancers that actively evade anti-tumour immunity through PD-L1 overexpression.	[Kataoka, Keisuke; Nagata, Yasunobu; Watatani, Yosaku; Kakiuchi, Nobuyuki; Suzuki, Hiromichi; Yoshizato, Tetsuichi; Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Shiraishi, Yuichi; Tanaka, Hiroko; Chiba, Kenichi; Ito, Satoshi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Takeda, Yohei; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 0608638, Japan; [Sakata, Seiji; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 1358550, Japan; [Nagano, Seiji; Maeda, Takuya; Masuda, Kyoko; Kawamoto, Hiroshi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunol, Kyoto 6068507, Japan; [Kitanaka, Akira; Shide, Kotaro; Kubuki, Yoko; Hidaka, Tomonori; Kameda, Takuro; Shimoda, Kazuya] Miyazaki Univ, Dept Gastroenterol & Hematol, Fac Med, Miyazaki 8891692, Japan; [Mizuno, Seiya; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; [Mizuno, Seiya; Takahashi, Satoru] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Sanada, Masashi] Nagoya Med Ctr, Dept Adv Diag, Clin Res Ctr, Nagoya, Aichi 4600001, Japan; [Itonaga, Hidehiro] Sasebo City Gen Hosp, Dept Hematol, Sasebo 8578511, Japan; [Imaizumi, Yoshitaka; Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusya Med Unit, Dept Hematol, Nagasaki 8528523, Japan; [Totoki, Yasushi; Nakamura, Hiromi; Hama, Natsuko; Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo 1040045, Japan; [Munakata, Wataru] Natl Canc Ctr, Dept Hematol, Tokyo 1040045, Japan; [Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto 6068501, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Dept HLA Lab, Tokyo 1358639, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Tokyo 1058470, Japan; [Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068501, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo 1088639, Japan; [Akatsuka, Yoshiki] Fujita Hlth Univ, Sch Med, Sch Med, Toyoake, Aichi 4701192, Japan; [Akatsuka, Yoshiki] Aichi Canc Ctr, Div Immunol, Res Inst, Nagoya, Aichi 4648681, Japan	Kyoto University; University of Tokyo; Hokkaido University; Japanese Foundation for Cancer Research; Kyoto University; University of Miyazaki; University of Tsukuba; University of Tsukuba; Nagoya Medical Center; Nagasaki University; National Cancer Center - Japan; National Cancer Center - Japan; Kyoto University; Toranomon Hospital; Kyoto University; University of Tokyo; Fujita Health University; Aichi Cancer Center	Ogawa, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	sogawa-tky@umin.ac.jp	Suzuki, Hiromichi/AAO-4664-2021; Yoshizato, Tetsuichi/AAD-7308-2019; Kataoka, Keisuke/AAS-2546-2020; Seya, Tsukasa/A-4336-2012; Shibata, Tatsuhiro/ABA-8234-2020; Ogawa, Seishi/AAE-7088-2019; Shibata, Tatsuhiro/AAO-1278-2021; Izutsu, Koji/AAI-1125-2019; Shide, Kotaro/AAG-7133-2020; Takeuchi, Kengo/C-3614-2008	Suzuki, Hiromichi/0000-0002-8858-0294; Yoshizato, Tetsuichi/0000-0003-4283-2983; Kataoka, Keisuke/0000-0002-8263-9902; Shide, Kotaro/0000-0002-0046-3254; Takeda, Yohei/0000-0003-1319-2198; Yoshida, Kenichi/0000-0003-4612-2778; Miyano, Satoru/0000-0002-1753-6616; Izutsu, Koji/0000-0001-9129-8057; Takeuchi, Kengo/0000-0002-1599-5800; akatsuka, yoshiki/0000-0003-3623-2826	Japan Agency for Medical Research and Development [15Ack0106014h0002, 15im0210102h0001]; KAKENHI [22134006, 15H05909, 25250020]; National Cancer Center Research and Development Funds [26-A-6]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230, hp160219, hp150232]; Grants-in-Aid for Scientific Research [24111008] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Funds; RIKEN Advanced Institute for Computational Science through the HPCI System Research project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid from the Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control (15Ack0106014h0002) and Medical Research and Development Programs Focused on Technology Transfer (15im0210102h0001)), Grant-in-Aid for Scientific Research (KAKENHI 22134006, 15H05909, 25250020), and National Cancer Center Research and Development Funds (26-A-6). We thank M. Sago, M. Nakamura and S. Baba for technical assistance, and R. Velaga for English editing. The supercomputing resources were provided by the Human Genome Center, the Institute of Medical Science, the University of Tokyo. This research also used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (hp140230, hp160219, and hp150232). The results shown here are partly based on data generated by the TCGA Research Network (http://cancergenome.nih.gov/).	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Horn PA, 2002, BLOOD, V100, P3960, DOI 10.1182/blood-2002-05-1359; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Matsumoto M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7280; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Swerdllow S., 2008, WHO CLASSIFICATION T, V2; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Twa DDW, 2014, BLOOD, V123, P2062, DOI 10.1182/blood-2013-10-535443; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang WP, 2013, HUM GENET, V132, P641, DOI 10.1007/s00439-013-1275-6; Wang X, 2015, CELL SIGNAL, V27, P443, DOI 10.1016/j.cellsig.2014.12.003; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	40	402	413	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2016	534	7607					402	+		10.1038/nature18294	http://dx.doi.org/10.1038/nature18294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5XQ	27281199				2022-12-28	WOS:000377856800039
J	Butt, CA				Butt, Carrie A.			Still-Life With Orange	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2380	2381		10.1001/jama.2015.14307	http://dx.doi.org/10.1001/jama.2015.14307			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27299606				2022-12-28	WOS:000377656900001
J	Wasylczyk, P				Wasylczyk, Piotr			Three lessons rarely taught	SCIENCE			English	Editorial Material									[Wasylczyk, Piotr] Univ Warsaw, Fac Phys, PL-00325 Warsaw, Poland	University of Warsaw	Wasylczyk, P (corresponding author), Univ Warsaw, Fac Phys, PL-00325 Warsaw, Poland.	SciCareerEditor@aaas.org		Wasylczyk, Piotr/0000-0003-0851-9838					0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1358	1358		10.1126/science.352.6291.1358	http://dx.doi.org/10.1126/science.352.6291.1358			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO7ON	27284199				2022-12-28	WOS:000377972000050
J	Bashan, A; Gibson, TE; Friedman, J; Carey, VJ; Weiss, ST; Hohmann, EL; Liu, YY				Bashan, Amir; Gibson, Travis E.; Friedman, Jonathan; Carey, Vincent J.; Weiss, Scott T.; Hohmann, Elizabeth L.; Liu, Yang-Yu			Universality of human microbial dynamics	NATURE			English	Article							GUT MICROBIOTA; TRANSPLANTATION; DIVERSITY; HEALTH	Human-associated microbial communities have a crucial role in determining our health and well-being(1,2), and this has led to the continuing development of microbiome-based therapies(3) such as faecal microbiota transplantation(4,5). These microbial communities are very complex, dynamic(6) and highly personalized ecosystems(3,7), exhibiting a high degree of inter-individual variability in both species assemblages(8) and abundance profiles(9). It is not known whether the underlying ecological dynamics of these communities, which can be parameterized by growth rates, and intra-and inter-species interactions in population dynamics models(10), are largely host-independent (that is, universal) or host-specific. If the inter-individual variability reflects host-specific dynamics due to differences in host lifestyle(11), physiology(12) or genetics(13), then generic microbiome manipulations may have unintended consequences, rendering them ineffective or even detrimental. Alternatively, microbial ecosystems of different subjects may exhibit universal dynamics, with the inter-individual variability mainly originating from differences in the sets of colonizing species(7,14). Here we develop a new computational method to characterize human microbial dynamics. By applying this method to cross-sectional data from two large-scale metagenomic studiesthe Human Microbiome Project(9,15) and the Student Microbiome Project(16)-we show that gut and mouth microbiomes display pronounced universal dynamics, whereas communities associated with certain skin sites are probably shaped by differences in the host environment. Notably, the universality of gut microbial dynamics is not observed in subjects with recurrent Clostridium difficile infection(17) but is observed in the same set of subjects after faecal microbiota transplantation. These results fundamentally improve our understanding of the processes that shape human microbial ecosystems, and pave the way to designing general microbiomebased therapies(18).	[Bashan, Amir; Gibson, Travis E.; Carey, Vincent J.; Weiss, Scott T.; Liu, Yang-Yu] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Bashan, Amir; Gibson, Travis E.; Carey, Vincent J.; Weiss, Scott T.; Hohmann, Elizabeth L.; Liu, Yang-Yu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Friedman, Jonathan] MIT, Dept Phys, Phys Living Syst, Cambridge, MA 02139 USA; [Hohmann, Elizabeth L.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA; [Liu, Yang-Yu] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Liu, YY (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Liu, YY (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Liu, YY (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA.	yyl@channing.harvard.edu	Friedman, Jonathan/I-6930-2019; Bashan, Amir/ABE-3163-2020	Friedman, Jonathan/0000-0001-8476-8030; Bashan, Amir/0000-0002-4502-3850	John Templeton Foundation [51977]; National Institutes of Health [R01 HL091528]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091528] Funding Source: NIH RePORTER	John Templeton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. K. Silverman, G. Weinstock, C. Huttenhower, R. Knight, G. Ackermann, D. Del Vecchio, D. Lauffenburger, G. Abu-Ali, J. Sordillo, M. McGeachie, and J. Gore for discussions. Special thanks to A.-L. Barabasi and J. Loscalzo for careful reading of the manuscript. This work was partially supported by the John Templeton Foundation (award number 51977) and National Institutes of Health (R01 HL091528).	Aroniadis OC, 2013, CURR OPIN GASTROEN, V29, P79, DOI 10.1097/MOG.0b013e32835a4b3e; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel SL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00243; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Bucci V, 2014, J MOL BIOL, V426, P3907, DOI 10.1016/j.jmb.2014.03.017; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gerber GK, 2014, FEBS LETT, V588, P4131, DOI 10.1016/j.febslet.2014.02.037; Gibson TE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004688; Gilbert JA, 2016, GUT, V65, P1, DOI 10.1136/gutjnl-2015-310043; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135	38	131	136	3	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					259	+		10.1038/nature18301	http://dx.doi.org/10.1038/nature18301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279224	Green Accepted, Green Submitted			2022-12-28	WOS:000377475100043
J	Rodrik-Outmezguine, VS; Okaniwa, M; Yao, Z; Novotny, CJ; McWhirter, C; Banaji, A; Won, H; Wong, W; Berger, M; de Stanchina, E; Barratt, DG; Cosulich, S; Klinowska, T; Rosen, N; Shokat, KM				Rodrik-Outmezguine, Vanessa S.; Okaniwa, Masanori; Yao, Zhan; Novotny, Chris J.; McWhirter, Claire; Banaji, Arpitha; Won, Helen; Wong, Wai; Berger, Mike; de Stanchina, Elisa; Barratt, Derek G.; Cosulich, Sabina; Klinowska, Teresa; Rosen, Neal; Shokat, Kevan M.			Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor	NATURE			English	Article							PROTEIN; KINASE; EVEROLIMUS; PHOSPHORYLATION; FEEDBACK	Precision medicines exert selective pressure on tumour cells that leads to the preferential growth of resistant subpopulations, necessitating the development of next-generation therapies to treat the evolving cancer. The PIK3CA-AKT-mTOR pathway is one of the most commonly activated pathways in human cancers(1), which has led to the development of small-molecule inhibitors that target various nodes in the pathway. Among these agents, first-generation mTOR inhibitors (rapalogs) have caused responses in 'N-of-1' cases, and second-generation mTOR kinase inhibitors (TORKi) are currently in clinical trials(2-4). Here we sought to delineate the likely resistance mechanisms to existing mTOR inhibitors in human cell lines, as a guide for next-generation therapies. The mechanism of resistance to the TORKi was unusual in that intrinsic kinase activity of mTOR was increased, rather than a direct active-site mutation interfering with drug binding. Indeed, identical drug-resistant mutations have been also identified in drug-naive patients, suggesting that tumours with activating MTOR mutations will be intrinsically resistant to second-generation mTOR inhibitors. We report the development of a new class of mTOR inhibitors that overcomes resistance to existing first-and second-generation inhibitors. The third-generation mTOR inhibitor exploits the unique juxtaposition of two drug-binding pockets to create a bivalent interaction that allows inhibition of these resistant mutants.	[Rodrik-Outmezguine, Vanessa S.; Yao, Zhan; Banaji, Arpitha; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA; [Okaniwa, Masanori; Novotny, Chris J.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Okaniwa, Masanori; Novotny, Chris J.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [McWhirter, Claire; Barratt, Derek G.; Cosulich, Sabina; Klinowska, Teresa] AstraZeneca, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Won, Helen; Berger, Mike] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Wong, Wai; de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Shokat, Kevan M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; AstraZeneca; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Berkeley	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA.; Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Shokat, KM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rosenn@mskcc.org; kevan.shokat@ucsf.edu	Yao, Zhan/AAK-6756-2020; Rosen, Neal/ABF-2677-2020	YAO, ZHAN/0000-0001-5391-5691; Okaniwa, Masanori/0000-0002-6982-9947; McWhirter, Claire/0000-0003-3316-205X	National Institutes of Health (NIH) [P01 CA094060]; Breast Cancer Research Foundation; National Cancer Institute Cancer Center [P30 CA008748]; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; NIH [P50 AA017072]; Stand Up 2 Cancer Lung Cancer Dream Team; Samuel Waxman Cancer Research Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA094060, P01CA129243, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up 2 Cancer Lung Cancer Dream Team; Samuel Waxman Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	N.R. would like to thank the National Institutes of Health (NIH) (P01 CA094060) for funding, as well as the Breast Cancer Research Foundation grant and the National Cancer Institute Cancer Center Support grant P30 CA008748, W. H. Goodwin and A. Goodwin, the Commonwealth Foundation for Cancer Research, The Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center, and the team up for a Cure Fund. K.M.S. would like to thank the NIH P50 AA017072, the Stand Up 2 Cancer Lung Cancer Dream Team, The Samuel Waxman Cancer Research Foundation and the Howard Hughes Medical Institute for funding. We would like to thank R. Mukherjee, S. Schwartz, J. Taunton and B. Roth for helpful comments.	[Anonymous], 2016, MOL OP ENV; Basu B, 2015, CLIN CANCER RES, V21, P3412, DOI 10.1158/1078-0432.CCR-14-2422; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Cheng AC, 2010, J MED CHEM, V53, P4502, DOI 10.1021/jm100301x; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marinec PS, 2009, P NATL ACAD SCI USA, V106, P1336, DOI 10.1073/pnas.0805375106; Patel M. R., 2015, P AACR 106 ANN M AAC; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Szczepankiewicz BG, 2003, J AM CHEM SOC, V125, P4087, DOI 10.1021/ja0296733; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wei LY, 2010, BIOORG MED CHEM LETT, V20, P3897, DOI 10.1016/j.bmcl.2010.05.019; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001	29	252	264	8	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					272	+		10.1038/nature17963	http://dx.doi.org/10.1038/nature17963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279227	Green Accepted, Green Submitted			2022-12-28	WOS:000377475100046
J	Pavlou, M				Pavlou, Menelaos			How to develop a more accurate risk prediction model when there are few events (vol 351, pg h3868, 2015)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868	1	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2016	353									10.1136/bmj.i3235	http://dx.doi.org/10.1136/bmj.i3235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YM	27278096	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000377859100013
J	Cole, TB				Cole, Thomas B.			Woman at the Window	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2258	2259		10.1001/jama.2015.14294	http://dx.doi.org/10.1001/jama.2015.14294			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272568				2022-12-28	WOS:000377183100001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Bring high street pharmacists into the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, Drug Ther Bull, V50, P45, DOI 10.1136/dtb.2012.04.0099; Chakrabortty A., 2016, GUARDIAN; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub5	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2016	353								i3132	10.1136/bmj.i3132	http://dx.doi.org/10.1136/bmj.i3132			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YA	27270329	Bronze, Green Published			2022-12-28	WOS:000377857800007
J	Jansen, J; Naganathan, V; Carter, SM; McLachlan, AJ; Nickel, B; Irwig, L; Bonner, C; Doust, J; Colvin, J; Heaney, A; Turner, R; McCaffery, K				Jansen, Jesse; Naganathan, Vasi; Carter, Stacy M.; McLachlan, Andrew J.; Nickel, Brooke; Irwig, Les; Bonner, Carissa; Doust, Jenny; Colvin, Jim; Heaney, Aine; Turner, Robin; McCaffery, Kirsten			Too much medicine in older people? Deprescribing through shared decision making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULTS; POLYPHARMACY; MEDICATION; HEALTH; INFORMATION; PERCEPTIONS; COMMUNICATION; ILLNESS; TIME; PARTICIPATION		[Jansen, Jesse; Nickel, Brooke; Irwig, Les; Bonner, Carissa; McCaffery, Kirsten] Univ Sydney, Sydney Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Jansen, Jesse; Nickel, Brooke; Bonner, Carissa; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW 2006, Australia; [Naganathan, Vasi; McLachlan, Andrew J.] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; [Carter, Stacy M.] Univ Sydney, Eth & Law Med, Ctr Values, Sydney, NSW 2006, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Colvin, Jim] Hlth Consumers New South Wales, Sydney, NSW, Australia; [Heaney, Aine] NPS MedicineWise, Surry Hills, NSW, Australia; [Turner, Robin] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; University of Sydney; University of Sydney; Bond University; University of New South Wales Sydney	Jansen, J (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.; Jansen, J (corresponding author), Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW 2006, Australia.	jesse.jansen@sydney.edu.au	Doust, Jenny/AGI-8773-2022; Nickel, Brooke/I-1667-2019; Carter, Stacy/A-6544-2011; McCaffery, Kirsten/K-7945-2019	Doust, Jenny/0000-0002-4024-9308; Nickel, Brooke/0000-0002-8100-4278; Carter, Stacy/0000-0003-2617-8694; McCaffery, Kirsten/0000-0003-2696-5006; Naganathan, Vasikaran/0000-0001-7243-0796; McLachlan, Andrew/0000-0003-4674-0242; Bonner, Carissa/0000-0002-4797-6460				Anderson K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006544; Anthierens S, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-65; Belcher VN, 2006, J GEN INTERN MED, V21, P298, DOI 10.1111/j.1525-1497.2006.00329.x; Bynum JPW, 2014, MED DECIS MAKING, V34, P216, DOI 10.1177/0272989X13508008; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Declercq T, 2013, COCHRANE DB SYST REV, V3; Duerden M, 2013, POLYPHARMACY AND MED; Dumbreck S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h949; Fagerlin A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S8; Fawzi W, 2012, INT PSYCHOGERIATR, V24, P159, DOI 10.1017/S1041610211001049; Flynn KE, 2007, J GERONTOL B-PSYCHOL, V62, pP261, DOI 10.1093/geronb/62.5.P261; Fried TR, 2007, J AM GERIATR SOC, V55, P1007, DOI 10.1111/j.1532-5415.2007.01232.x; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Fuller R, 2001, AGE AGEING, V30, P473, DOI 10.1093/ageing/30.6.473; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Hanoch Y, 2007, HUM DEV, V50, P333, DOI 10.1159/000109835; Hibbard JH, 2002, HEALTH SERV RES, V37, P291, DOI 10.1111/1475-6773.024; Hibbard JH, 2003, ANNU REV PUBL HEALTH, V24, P413, DOI 10.1146/annurev.publhealth.24.100901.141005; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Hilmer SN, 2007, FUND CLIN PHARMACOL, V21, P217, DOI 10.1111/j.1472-8206.2007.00473.x; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Iyer S, 2008, DRUG AGING, V25, P1021, DOI 10.2165/0002512-200825120-00004; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Kutner JS, 2015, JAMA INTERN MED, V175, P691, DOI 10.1001/jamainternmed.2015.0289; Laidsaar-Powell RC, 2013, PATIENT EDUC COUNS, V91, P3, DOI 10.1016/j.pec.2012.11.007; Lau DT, 2008, DRUG AGING, V25, P1061, DOI 10.2165/0002512-200825120-00007; Le Couteur D, 2011, AUST PRESCR, V34, P182; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Linsky A, 2015, PATIENT EDUC COUNS, V98, P220, DOI 10.1016/j.pec.2014.11.010; Lockenhoff CE, 2004, J PERS, V72, P1395, DOI 10.1111/j.1467-6494.2004.00301.x; Mata R, 2007, PSYCHOL AGING, V22, P796, DOI 10.1037/0882-7974.22.4.796; Moen J, 2010, J EVAL CLIN PRACT, V16, P69, DOI 10.1111/j.1365-2753.2008.01116.x; Moen J, 2009, PATIENT EDUC COUNS, V74, P135, DOI 10.1016/j.pec.2008.08.019; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Moynihan R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5184; National Stakeholders' Meeting, 2015, QUALITY USE OF MEDIC; Peters E, 2007, PERSPECT PSYCHOL SCI, V2, P1, DOI 10.1111/j.1745-6916.2007.00025.x; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; Reed AE, 2008, PSYCHOL AGING, V23, P671, DOI 10.1037/a0012772; Reeve E, 2014, BRIT J CLIN PHARMACO, V78, P738, DOI 10.1111/bcp.12386; Reeve E, 2013, J AM GERIATR SOC, V61, P1508, DOI 10.1111/jgs.12418; RIGBY D, 2010, AUST J PHARM, V91, P38; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Schuling J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-56; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Shah BM, 2012, CLIN GERIATR MED, V28, P173, DOI 10.1016/j.cger.2012.01.002; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Stacey D, 2010, PATIENT EDUC COUNS, V80, P164, DOI 10.1016/j.pec.2009.10.015; Straand J, 2001, FAM PRACT, V18, P597, DOI 10.1093/fampra/18.6.597; Tannenbaum C, 2014, JAMA INTERN MED; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766; van der Cammen TJM, 2014, AGE AGEING, V43, P20, DOI 10.1093/ageing/aft166; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	57	160	162	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2016	353								i2893	10.1136/bmj.i2893	http://dx.doi.org/10.1136/bmj.i2893			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO0PG	27260319	Green Published			2022-12-28	WOS:000377480200003
J	Chu, HT; Khosravi, A; Kusumawardhani, IP; Kwon, AHK; Vasconcelos, AC; Cunha, LD; Mayer, AE; Shen, Y; Wu, WL; Kambal, A; Targan, SR; Xavier, RJ; Ernst, PB; Green, DR; McGovern, DPB; Virgin, H; Mazmanian, SK				Chu, Hiutung; Khosravi, Arya; Kusumawardhani, Indah P.; Kwon, Alice H. K.; Vasconcelos, Anilton C.; Cunha, Larissa D.; Mayer, Anne E.; Shen, Yue; Wu, Wei-Li; Kambal, Amal; Targan, Stephan R.; Xavier, Ramnik J.; Ernst, Peter B.; Green, Douglas R.; McGovern, Dermot P. B.; Virgin, HerbertW.; Mazmanian, Sarkis K.			Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; DENDRITIC CELLS; IMMUNE-SYSTEM; AUTOPHAGY; SUSCEPTIBILITY; ATG16L1; COMMENSAL; VARIANT; HERITABILITY	Inflammatory bowel disease (IBD) is associated with risk variants in the human genome and dysbiosis of the gut microbiome, though unifying principles for these findings remain largely undescribed. The human commensal Bacteroides fragilis delivers immunomodulatory molecules to immune cells via secretion of outer membrane vesicles (OMVs). We reveal that OMVs require IBD-associated genes, ATG16L1 and NOD2, to activate a noncanonical autophagy pathway during protection from colitis. ATG16L1-deficient dendritic cells do not induce regulatory T cells (T-regs) to suppress mucosal inflammation. Immune cells from human subjects with a major risk variant in ATG16L1 are defective in T-reg responses to OMVs. We propose that polymorphisms in susceptibility genes promote disease through defects in "sensing" protective signals from the microbiome, defining a potentially critical gene-environment etiology for IBD.	[Chu, Hiutung; Khosravi, Arya; Kusumawardhani, Indah P.; Kwon, Alice H. K.; Shen, Yue; Wu, Wei-Li; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Vasconcelos, Anilton C.; Ernst, Peter B.] Univ Calif San Diego, Ctr Vet Sci & Comparat Med, La Jolla, CA 92093 USA; [Cunha, Larissa D.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mayer, Anne E.; Kambal, Amal; Virgin, HerbertW.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Targan, Stephan R.; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA	California Institute of Technology; University of California System; University of California San Diego; St Jude Children's Research Hospital; Washington University (WUSTL); Cedars Sinai Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chu, HT; Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	hiuchu@caltech.edu; sarkis@caltech.edu	Cunha, Larissa D/I-4204-2012; Wu, Wei-Li/ADY-3311-2022; Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417; Dias da Cunha, Larissa/0000-0002-1290-0263; Chu, Hiutung/0000-0001-7489-0446; Virgin, Herbert/0000-0001-8580-7628; Ernst, Peter/0000-0001-7777-1813	National Institutes of Health (NIH) under a Ruth L. Kirschtein National Research Service Award [DK100109]; NIH [DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535]; Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds; Feintech Family Chair in IBD; Wayne and Gladys Valley Foundation; Lupus Research Institute; Lisa Z. Greer Endowed Chair in IBD Genetics; European Union [305479]; Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; Heritage Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079145, U01AI067068, R56AI079145, R01AI040646, U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062413, F32DK100109, P01DK046763, R56DK078938, R42DK103361, P30DK043351, R01DK097485, R01DK078938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099535] Funding Source: NIH RePORTER	National Institutes of Health (NIH) under a Ruth L. Kirschtein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds; Feintech Family Chair in IBD; Wayne and Gladys Valley Foundation; Lupus Research Institute; Lisa Z. Greer Endowed Chair in IBD Genetics; European Union(European Commission); Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; Heritage Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Hwang, E. Park, and M. Salas for clinical research coordination (Cedars-Sinai); A. Maskell, L. Sandoval, and C. Rumaldo for animal husbandry (Caltech); and members of the Mazmanian laboratory for discussions and critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the National Institutes of Health (NIH) under a Ruth L. Kirschtein National Research Service Award (DK100109) to H. C.; NIH DK097485 to R.J.X.; NIH PO1DK046763, the Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds, and The Feintech Family Chair in IBD to S.R.T.; Wayne and Gladys Valley Foundation and NIH AI079145 to P.B.E.; The Lupus Research Institute and NIH AI40646 to D.R.G; NIH U19 AI109725 to H.W.V.; The Lisa Z. Greer Endowed Chair in IBD Genetics, NIH DK062413, NIH DE023789-01, grant 305479 from the European Union, The Crohn's and Colitis Foundation of America, and The Leona M. and Harry B. Helmsley Charitable Trust to D.P.B.M.; NIH AI109725 to H.W.V.; and NIH DK078938, NIH GM099535, The Crohn's and Colitis Foundation of America, and the Heritage Medical Research Institute to S.K.M. Rubicon and ULK1 knockout mice were obtained from D. R. Green and M. Kundu, respectively, under a materials transfer agreement with St. Jude Children's Research Hospital. A provisional patent application entitled "Beneficial Activation of Autophagy Components by the Microbiome" has been filed by H. C., H.W.V., and S.K.M.	Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brant SR, 2011, INFLAMM BOWEL DIS, V17, P1, DOI 10.1002/ibd.21385; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Gardet A, 2012, CURR OPIN IMMUNOL, V24, P522, DOI 10.1016/j.coi.2012.08.001; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hubbard-Lucey VM, 2014, IMMUNITY, V41, P579, DOI 10.1016/j.immuni.2014.09.011; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lu Q, 2016, CELL HOST MICROBE, V19, P102, DOI 10.1016/j.chom.2015.12.011; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Park S, 2016, CELL HOST MICROBE, V19, P91, DOI 10.1016/j.chom.2015.12.010; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008	41	350	381	22	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1116	1120		10.1126/science.aad9948	http://dx.doi.org/10.1126/science.aad9948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230380	Green Accepted			2022-12-28	WOS:000376480800043
J	Mayor, S				Mayor, Susan			Bariatric surgery should be an option for treating type 2 diabetes, societies say	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2016	353								i2955	10.1136/bmj.i2955	http://dx.doi.org/10.1136/bmj.i2955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CG	27226456				2022-12-28	WOS:000376939400004
J	Jureidini, J				Jureidini, Jon			Antidepressants fail, but no cause for therapeutic gloom	LANCET			English	Editorial Material							DEPRESSION		[Jureidini, Jon] Univ Adelaide, Robinson Res Inst, Crit & Eth Mental Hlth Res Grp, Adelaide, SA 5006, Australia	Robinson Research Institute; University of Adelaide	Jureidini, J (corresponding author), Univ Adelaide, Robinson Res Inst, Crit & Eth Mental Hlth Res Grp, Adelaide, SA 5006, Australia.	jon.jureidini@adelaide.edu.au	Jureidini, Jon/AFS-5457-2022	Jureidini, Jon/0000-0001-7585-2660				Batstra L, 2012, J NERV MENT DIS, V200, P474, DOI 10.1097/NMD.0b013e318257c4a2; Cipriani A., 2016, LANCET; Jureidini Jon N, 2016, Int J Risk Saf Med, V28, P33, DOI 10.3233/JRS-160671; Jureidini JN, 2014, MED J AUSTRALIA, V201, P612, DOI 10.5694/mja14.00060; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320	5	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					844	845		10.1016/S0140-6736(16)30585-2	http://dx.doi.org/10.1016/S0140-6736(16)30585-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27289173				2022-12-28	WOS:000381911800005
J	Atkins, HL; Bowman, M; Allan, D; Anstee, G; Arnold, DL; Bar-Or, A; Bence-Bruckler, I; Birch, P; Bredeson, C; Chen, J; Fergusson, D; Halpenny, M; Hamelin, L; Huebsch, L; Hutton, B; Laneuville, P; Lapierre, Y; Lee, H; Martin, L; McDiarmid, S; O'Connor, P; Ramsay, T; Sabloff, M; Walker, L; Freedman, MS				Atkins, Harold L.; Bowman, Marjorie; Allan, David; Anstee, Grizel; Arnold, Douglas L.; Bar-Or, Amit; Bence-Bruckler, Isabelle; Birch, Paul; Bredeson, Christopher; Chen, Jacqueline; Fergusson, Dean; Halpenny, Mike; Hamelin, Linda; Huebsch, Lothar; Hutton, Brian; Laneuville, Pierre; Lapierre, Yves; Lee, Hyunwoo; Martin, Lisa; McDiarmid, Sheryl; O'Connor, Paul; Ramsay, Timothy; Sabloff, Mitchell; Walker, Lisa; Freedman, Mark S.			Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial	LANCET			English	Article							DOSE IMMUNOSUPPRESSIVE THERAPY; CONDITIONING REGIMEN; INTERNATIONAL BLOOD; AUTOIMMUNE-DISEASES; EUROPEAN GROUP; BRAIN ATROPHY; DISABILITY; OUTCOMES; 3-YEAR; MS	Background Strong immunosuppression, including chemotherapy and immune-depleting antibodies followed by autologous haemopoietic stem-cell transplantation (aHSCT), has been used to treat patients with multiple sclerosis, improving control of relapsing disease. We addressed whether near-complete immunoablation followed by immune cell depleted aHSCT would result in long-term control of multiple sclerosis. Methods We did this phase 2 single-arm trial at three hospitals in Canada. We enrolled patients with multiple sclerosis, aged 18-50 years with poor prognosis, ongoing disease activity, and an Expanded Disability Status Scale of 3.0-6.0. Autologous CD34 selected haemopoietic stem-cell grafts were collected after mobilisation with cyclophosphamide and filgrastim. Immunoablation with busulfan, cyclophosphamide, and rabbit anti-thymocyte globulin was followed by aHSCT. The primary outcome was multiple sclerosis activity-free survival (events were clinical relapse, appearance of a new or Gd-enhancing lesion on MRI, and sustained progression of Expanded Disability Status Scale score). This study was registered at ClinicalTrials.gov, NCT01099930. Findings Between diagnosis and aHSCT, 24 patients had 167 clinical relapses over 140 patient-years with 188 Gd-enhancing lesions on 48 pre-aHSCT MRI scans. Median follow-up was 6.7 years (range 3.9-12.7). The primary outcome, multiple sclerosis activity-free survival at 3 years after transplantation was 69.6% (95% CI 46.6-84.2). With up to 13 years of follow-up after aHSCT, no relapses occurred and no Gd enhancing lesions or new T2 lesions were seen on 314 MRI sequential scans. The rate of brain atrophy decreased to that expected for healthy controls. One of 24 patients died of transplantation-related complications. 35% of patients had a sustained improvement in their Expanded Disability Status Scale score. Interpretation We describe the first treatment to fully halt all detectable CNS inflammatory activity in patients with multiple sclerosis for a prolonged period in the absence of any ongoing disease-modifying drugs. Furthermore, many of the patients had substantial recovery of neurological function despite their disease's aggressive nature.	[Atkins, Harold L.; Bowman, Marjorie; Allan, David; Bredeson, Christopher; Fergusson, Dean; Hutton, Brian; Ramsay, Timothy; Freedman, Mark S.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Atkins, Harold L.; Allan, David; Anstee, Grizel; Bence-Bruckler, Isabelle; Bredeson, Christopher; Hamelin, Linda; Huebsch, Lothar; McDiarmid, Sheryl; Sabloff, Mitchell] Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada; [Atkins, Harold L.; Allan, David; Bence-Bruckler, Isabelle; Bredeson, Christopher; Fergusson, Dean; Huebsch, Lothar; Ramsay, Timothy; Sabloff, Mitchell; Freedman, Mark S.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Walker, Lisa] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Bowman, Marjorie; Walker, Lisa; Freedman, Mark S.] Ottawa Hosp, MS Clin, Ottawa, ON, Canada; [Arnold, Douglas L.; Bar-Or, Amit; Chen, Jacqueline; Lapierre, Yves; Lee, Hyunwoo] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada; [Arnold, Douglas L.] NeuroRx Res, Montreal, PQ, Canada; [Birch, Paul; Halpenny, Mike; Martin, Lisa] Canadian Blood Serv, Ottawa Stem Cell Program, Ottawa, ON, Canada; [Chen, Jacqueline] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Laneuville, Pierre] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Laneuville, Pierre] McGill Univ, Div Oncol, Dept Med, Montreal, PQ, Canada; [O'Connor, Paul] Univ Toronto, St Michaels Hosp, Div Neurol, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University; Canadian Blood Services; Cleveland Clinic Foundation; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Atkins, HL (corresponding author), Ottawa Hosp, 501 Smyth Rd,Box 926, Ottawa, ON K1H 8L6, Canada.	hatkins@ohri.ca	Bar-Or, Amit/AIC-1416-2022; Walker, Lisa/AAH-7842-2019; Sabloff, Mitchell/ABI-6594-2020; Laneuville, Pierre/AAH-2293-2021	Walker, Lisa/0000-0001-5865-7257; Sabloff, Mitchell/0000-0002-0122-6138; Ramsay, Tim/0000-0001-8478-8170; Laneuville, Pierre/0000-0002-7031-4297; Arnold, Douglas/0000-0003-4266-0106; Allan, David/0000-0003-3261-8289; Hutton, Brian/0000-0001-5662-8647; Fergusson, Dean/0000-0002-3389-2485	Multiple Sclerosis Scientific Research Foundation; Ottawa Hospital Department of Medicine; Multiple Sclerosis Scientific Research Foundation of Canada	Multiple Sclerosis Scientific Research Foundation; Ottawa Hospital Department of Medicine; Multiple Sclerosis Scientific Research Foundation of Canada	Multiple Sclerosis Scientific Research Foundation.; We acknowledge the contribution of the Data Safety Monitoring Committee (Dr Michael Barnett, Dr Luanne Metz, Dr George Rice, Dr Anthony Traboulsee, Dr Anne Smith, and the late Dr Donald Paty), the scientific advice provided by Dr Jack Antel and Dr Roland Martin, and the care provided to our patients by the Ottawa Hospital Blood and Marrow Transplant Multidisciplinary team and the Ottawa Hospital MS Clinical Research Team. We acknowledge the editorial suggestions of Dr Keith Sullivan. We thank Amgen for the in kind support they provided. Dr Mark Freedman and Dr Harold Atkins receive salary support from the Ottawa Hospital Department of Medicine. This research was funded through a research grant provided by the Multiple Sclerosis Scientific Research Foundation of Canada.	Alajlan A, 2002, J AM ACAD DERMATOL, V46, P606, DOI 10.1067/mjd.2002.117215; Alix JJP, 2013, J NEUROL, V260, P914, DOI 10.1007/s00415-012-6796-8; Atkins H, 2010, BONE MARROW TRANSPL, V45, P1671, DOI 10.1038/bmt.2010.168; Atkins Harold, 2009, V549, P231, DOI 10.1007/978-1-60327-931-4_16; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Bowen JD, 2012, BONE MARROW TRANSPL, V47, P946, DOI 10.1038/bmt.2011.208; Burman J, 2014, J NEUROL NEUROSUR PS, V85, P1116, DOI 10.1136/jnnp-2013-307207; Burt RK, 2015, JAMA-J AM MED ASSOC, V313, P275, DOI 10.1001/jama.2014.17986; Burt RK, 2003, BLOOD, V102, P2373, DOI 10.1182/blood-2003-03-0877; Chen JT, 2005, NEUROIMAGE, V25, P1272, DOI 10.1016/j.neuroimage.2004.12.046; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Darlington PJ, 2013, ANN NEUROL, V73, P341, DOI 10.1002/ana.23784; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; De Stefano N, 2016, J NEUROL NEUROSUR PS, V87, P93, DOI 10.1136/jnnp-2014-309903; Edan G, 2011, J NEUROL NEUROSUR PS, V82, P1344, DOI 10.1136/jnnp.2010.229724; Fagnoni FF, 2003, BONE MARROW TRANSPL, V31, P31, DOI 10.1038/sj.bmt.1703782; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Fassas A, 2011, NEUROLOGY, V76, P1066, DOI 10.1212/WNL.0b013e318211c537; FAZEKAS F, 1988, NEUROLOGY, V38, P1822, DOI 10.1212/WNL.38.12.1822; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; KAPPOS L, 2000, NEUROSTATUS TRAINING; Krasulova E, 2010, MULT SCLER J, V16, P685, DOI 10.1177/1352458510364538; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Le Page E, 2008, J NEUROL NEUROSUR PS, V79, P52, DOI 10.1136/jnnp.2007.124958; Mancardi GL, 2012, MULT SCLER J, V18, P835, DOI 10.1177/1352458511429320; Mancardi GL, 2015, NEUROLOGY, V84, P981, DOI 10.1212/WNL.0000000000001329; Menon S, 2013, J NEUROL NEUROSUR PS, V84, P1192, DOI 10.1136/jnnp-2013-304951; Muraro P, 2013, BONE MARROW TRANSPL, V48, pS1; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Pasquini MC, 2012, BIOL BLOOD MARROW TR, V18, P1471, DOI 10.1016/j.bbmt.2012.06.003; Pasquini MC, 2012, J CLIN ONCOL, V30, P3194, DOI 10.1200/JCO.2012.41.7071; PATY DW, 1998, MULTIPLE SCLEROSIS; Rocca MA, 2007, AM J NEURORADIOL, V28, P1659, DOI 10.3174/ajnr.A0644; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Shevchenko JL, 2012, EXP HEMATOL, V40, P892, DOI 10.1016/j.exphem.2012.07.003; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002	38	197	201	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					576	585		10.1016/S0140-6736(16)30169-6	http://dx.doi.org/10.1016/S0140-6736(16)30169-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27291994				2022-12-28	WOS:000380756600030
J	Ok, E; Asci, G; Chazot, C; Ozkahya, M; Mees, EJD				Ok, Ercan; Asci, Gulay; Chazot, Charles; Ozkahya, Mehmet; Mees, Evert J. Dorhout			Controversies and problems of volume control and hypertension in haemodialysis	LANCET			English	Article							BLOOD-PRESSURE CONTROL; DIALYSATE SODIUM PRESCRIPTION; LEFT-VENTRICULAR HYPERTROPHY; STAGE RENAL-DISEASE; INFERIOR VENA-CAVA; CARDIOVASCULAR EVENTS; MORTALITY RISK; DRY-WEIGHT; FREQUENT HEMODIALYSIS; RECEPTOR BLOCKADE	Extracellular volume overload and hypertension are important contributors to the high risk of cardiovascular mortality in patients undergoing haemodialysis. Hypertension is present in more than 90% of patients at the initiation of haemodialysis and persists in more than two-thirds, despite use of several antihypertensive medications. High blood pressure is a risk factor for the development of left ventricular hypertrophy, heart failure, and mortality, although there are controversies with some study findings showing poor survival with low-but not high-blood pressure. The most frequent cause of hypertension in patients undergoing haemodialysis is volume overload, which is associated with poor cardiovascular outcomes itself independent of blood pressure. Although antihypertensive medications might not be successful to control blood pressure, extracellular volume reduction by persistent ultrafiltration and dietary salt restriction can produce favourable results with good blood pressure control. More frequent or longer haemodialysis can facilitate volume and blood pressure control. However, successful volume and blood pressure control is also possible in patients undergoing conventional haemodialysis.	[Ok, Ercan; Asci, Gulay; Ozkahya, Mehmet] Ege Univ, Sch Med, Div Nephrol, Izmir, Turkey; [Chazot, Charles] NephroCare Tassin Charcot, Sainte Foy Les Lyon, France; [Mees, Evert J. Dorhout] Univ Utrecht, NL-3508 TC Utrecht, Netherlands	Ege University; Utrecht University	Ok, E (corresponding author), Ege Univ, Sch Med, Internal Med, Div Nephrol, TR-35100 Bornova, Turkey.	ercan.ok@ege.edu.tr	asci, gulay/B-9067-2018					Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; Agarwal R, 2010, NEPHROL DIAL TRANSPL, V25, P3355, DOI 10.1093/ndt/gfq210; Agarwal R, 2010, HYPERTENSION, V56, P512, DOI 10.1161/HYPERTENSIONAHA.110.154815; Agarwal R, 2010, HYPERTENSION, V55, P762, DOI 10.1161/HYPERTENSIONAHA.109.144899; Agarwal R, 2009, HYPERTENSION, V53, P500, DOI 10.1161/HYPERTENSIONAHA.108.125674; Arneson TJ, 2010, CLIN J AM SOC NEPHRO, V5, P1054, DOI 10.2215/CJN.00340110; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Braam B, 2011, HYPERTENSION CARDIOV; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Charra B, 1996, NEPHROL DIAL TRANSPL, V11, P16; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; Charra B, 1998, AM J KIDNEY DIS, V32, P720, DOI 10.1016/S0272-6386(98)70147-7; Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x; CHAZOT C, 1995, NEPHROL DIAL TRANSPL, V10, P831; CHERIEX EC, 1989, NEPHROL DIAL TRANSPL, V4, P563; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Chou KJ, 2006, KIDNEY INT, V69, P1833, DOI 10.1038/sj.ki.5000266; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; CIRIT M, 1995, NEPHROL DIAL TRANSPL, V10, P1417; Cirit M, 1998, NEPHROL DIAL TRANSPL, V13, P389, DOI 10.1093/oxfordjournals.ndt.a027835; Conlon PJ, 1996, J AM SOC NEPHROL, V7, P2658; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Curatola G, 2011, J NEPHROL, V24, P465, DOI 10.5301/JN.2011.7735; CURTIS JR, 1969, Q J MED, V38, P49; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; De Lima JJG, 2001, NEPHROL DIAL TRANSPL, V16, P793, DOI 10.1093/ndt/16.4.793; de Paula FM, 2004, KIDNEY INT, V66, P1232, DOI 10.1111/j.1523-1755.2004.00876.x; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Erdem Y, 2010, BLOOD PRESSURE, V19, P313, DOI 10.3109/08037051003802541; Flythe JE, 2011, KIDNEY INT, V79, P250, DOI 10.1038/ki.2010.383; Foley RN, 2002, KIDNEY INT, V62, P1784, DOI 10.1046/j.1523-1755.2002.00636.x; Foley RN, 1996, KIDNEY INT, V49, P1379, DOI 10.1038/ki.1996.194; Gunal AI, 2002, J NEPHROL, V15, P42; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; Guyton AC, 1980, ARTERIAL PRESSURE HY; HARNETT JD, 1995, KIDNEY INT, V47, P884, DOI 10.1038/ki.1995.132; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Inrig JK, 2009, AM J KIDNEY DIS, V54, P881, DOI 10.1053/j.ajkd.2009.05.012; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Katzarski KS, 1999, NEPHROL DIAL TRANSPL, V14, P369, DOI 10.1093/ndt/14.2.369; Katzarski KS, 1997, AM J KIDNEY DIS, V30, P459, DOI 10.1016/S0272-6386(97)90302-4; Kayikcioglu M, 2009, NEPHROL DIAL TRANSPL, V24, P956, DOI 10.1093/ndt/gfn599; Kaysen GA, 2012, KIDNEY INT, V82, P90, DOI 10.1038/ki.2012.75; KOOMANS HA, 1982, HYPERTENSION, V4, P190, DOI 10.1161/01.HYP.4.2.190; KOOMANS HA, 1984, KIDNEY INT, V26, P848, DOI 10.1038/ki.1984.227; Laurent G, 1998, NEPHROL DIAL TRANSPL, V13, P125, DOI 10.1093/ndt/13.suppl_6.125; Laurent G, 1997, NEPHROL DIAL TRANSPL, V12, P1104, DOI 10.1093/ndt/12.6.1104; Levin NW, 2010, KIDNEY INT, V77, P273, DOI 10.1038/ki.2009.469; Lopes AA, 2009, NEPHROL DIAL TRANSPL, V24, P2809, DOI 10.1093/ndt/gfp212; Lynn KL, 2002, KIDNEY INT, V62, P2281, DOI 10.1046/j.1523-1755.2002.00685.x; Mazzuchi N, 2000, KIDNEY INT, V58, P2147; Mc Causland FR, 2012, KIDNEY INT, V82, P204, DOI 10.1038/ki.2012.42; Merchant A, 2015, J AM SOC HYPERTENS, V9, P275, DOI 10.1016/j.jash.2015.01.011; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Ozdogan O, 2010, AM HEART J, V159, P1089, DOI 10.1016/j.ahj.2010.03.020; Ozkahya M, 1999, AM J KIDNEY DIS, V34, P218, DOI 10.1016/S0272-6386(99)70346-X; Ozkahya M, 2002, J NEPHROL, V15, P655; Ozkahya M, 1998, NEPHROL DIAL TRANSPL, V13, P1489, DOI 10.1093/ndt/13.6.1489; Ozkahya M, 2006, NEPHROL DIAL TRANSPL, V21, P3506, DOI 10.1093/ndt/gfl487; Paoletti E, 2004, NEPHROL DIAL TRANSPL, V19, P1829, DOI 10.1093/ndt/gfh288; Penne EL, 2011, BLOOD PURIFICAT, V31, P86, DOI 10.1159/000321851; Peters CD, 2014, KIDNEY INT, V86, P625, DOI 10.1038/ki.2014.69; Raimann JG, 2015, NEPHROL DIAL TRAN S3, V30, pii276; Robinson BM, 2012, KIDNEY INT, V82, P570, DOI 10.1038/ki.2012.136; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Salem MM, 1999, NEPHROL DIAL TRANSPL, V14, P125, DOI 10.1093/ndt/14.1.125; Salem MM, 1996, AM J KIDNEY DIS, V28, P737, DOI 10.1016/S0272-6386(96)90257-7; Santos SFF, 2008, CLIN J AM SOC NEPHRO, V3, P522, DOI 10.2215/CJN.03360807; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; SCRIBNER BH, 1960, T AM SOC ART INT ORG, V6, P114; SELLARS L, 1979, BMJ-BRIT MED J, V1, P520, DOI 10.1136/bmj.1.6162.520; Sinha AD, 2010, HYPERTENSION, V55, P305, DOI 10.1161/HYPERTENSIONAHA.109.143974; Stidley CA, 2006, J AM SOC NEPHROL, V17, P513, DOI 10.1681/ASN.2004110921; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P689, DOI 10.1053/j.ajkd.2011.12.020; Tai DJ, 2010, CLIN J AM SOC NEPHRO, V5, P623, DOI 10.2215/CJN.07831109; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Tomson CRV, 2001, NEPHROL DIAL TRANSPL, V16, P1538, DOI 10.1093/ndt/16.8.1538; Toz Huseyin, 2007, Hemodial Int, V11, P46; Tozawa M, 2002, KIDNEY INT, V61, P717, DOI 10.1046/j.1523-1755.2002.00173.x; Tripepi G, 2009, HYPERTENSION, V54, P818, DOI 10.1161/HYPERTENSIONAHA.109.136804; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Twardowski ZJ, 2008, HEMODIAL INT, V12, P412, DOI 10.1111/j.1542-4758.2008.00304.x; VERTES V, 1969, NEW ENGL J MED, V280, P978, DOI 10.1056/NEJM196905012801802; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657; Zoccali C, 2013, J AM SOC NEPHROL, V24, P639, DOI 10.1681/ASN.2012100990	91	41	46	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					285	293		10.1016/S0140-6736(16)30389-0	http://dx.doi.org/10.1016/S0140-6736(16)30389-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27226131				2022-12-28	WOS:000379736100033
J	Casarett, D; Teno, J				Casarett, David; Teno, Joan			Why Population Health and Palliative Care Need Each Other	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Casarett, David] Univ Penn, Perelman Sch Med, Dept Med, 3615 Chestnut St, Philadelphia, PA 19119 USA; [Teno, Joan] Univ Washington, Cambia Palliat Care Ctr Excellence, Div Gerontol & Geriatr, Seattle, WA 98195 USA	University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle	Casarett, D (corresponding author), Univ Penn, Perelman Sch Med, 3615 Chestnut St, Philadelphia, PA 19119 USA.	casarett@mail.med.upenn.edu						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Kindig D., 2015, HLTH AFFAIRS BL 0406; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Washington AE, 2016, JAMA-J AM MED ASSOC, V315, P459, DOI 10.1001/jama.2015.18550	7	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2016	316	1					27	28		10.1001/jama.2016.5961	http://dx.doi.org/10.1001/jama.2016.5961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ2MY	27257779				2022-12-28	WOS:000379037600011
J	Williams, EG; Wu, YB; Jha, P; Dubuis, S; Blattmann, P; Argmann, CA; Houten, SM; Amariuta, T; Wolski, W; Zamboni, N; Aebersold, R; Auwerx, J				Williams, Evan G.; Wu, Yibo; Jha, Pooja; Dubuis, Sebastien; Blattmann, Peter; Argmann, Carmen A.; Houten, Sander M.; Amariuta, Tiffany; Wolski, Witold; Zamboni, Nicola; Aebersold, Ruedi; Auwerx, Johan			Systems proteomics of liver mitochondria function	SCIENCE			English	Article							HIGH-THROUGHPUT; WIDE ASSOCIATION; PPAR-GAMMA; IDENTIFICATION; CHOLESTEROL; METABOLISM; OMICS; GENE; METABOLOMICS; VALIDATION	Recent improvements in quantitative proteomics approaches, including Sequential Window Acquisition of all Theoretical Mass Spectra (SWATH-MS), permit reproducible large-scale protein measurements across diverse cohorts. Together with genomics, transcriptomics, and other technologies, transomic data sets can be generated that permit detailed analyses across broad molecular interaction networks. Here, we examine mitochondrial links to livermetabolism through the genome, transcriptome, proteome, and metabolome of 386 individuals in the BXD mouse reference population. Several links were validated between genetic variants toward transcripts, proteins, metabolites, and phenotypes. Among these, sequence variants in Cox7a2l alter its protein's activity, which in turn leads to downstream differences in mitochondrial supercomplex formation. This data set demonstrates that the proteome can now be quantified comprehensively, serving as a key complement to transcriptomics, genomics, andmetabolomics -a combination moving us forward in complex trait analysis.	[Williams, Evan G.; Jha, Pooja; Amariuta, Tiffany; Auwerx, Johan] Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Wu, Yibo; Dubuis, Sebastien; Blattmann, Peter; Wolski, Witold; Zamboni, Nicola; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA; [Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, 1425 Madison Ave,Box 1498, New York, NY 10029 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Zurich	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.; Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.; Aebersold, R (corresponding author), Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch; admin.auwerx@epfl.ch	Wu, Yibo/AAK-8294-2020; Blattmann, Peter/D-2880-2012; Wu, Yibo/AAW-7121-2020; Williams, Evan/M-7539-2017; Auwerx, Johan/ABE-9307-2021; Zamboni, Nicola/K-3042-2012; Houten, Sander/Y-3599-2019	Wu, Yibo/0000-0002-8256-3901; Blattmann, Peter/0000-0001-9105-6381; Wu, Yibo/0000-0002-8256-3901; Williams, Evan/0000-0002-9746-376X; Zamboni, Nicola/0000-0003-1271-1021; Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393; Jha, Pooja/0000-0002-0293-9287	EPFL; ETHZ; ERC [AdG-670821, AdG-233226]; AgingX program of the Swiss Initiative for Systems Biology [51RTP0-151019, 2013/134, 2013/153]; SNSF [31003A-140780, 31003A-143914, CSRII3-136201]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	EPFL; ETHZ(ETH Zurich); ERC(European Research Council (ERC)European Commission); AgingX program of the Swiss Initiative for Systems Biology; SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Lamy, C. Cartoni, and the Center of Phenogenomics (CPG, EPFL) for their help on the phenotyping and L. Rose at the Molecular Resource Center of Excellence at the University of Tennessee Health Science Center for processing the microarrays. J.A. is the Nestle Chair in Energy Metabolism. Research was further supported by the EPFL, ETHZ, ERC (AdG-670821 and Proteomics v3.0; AdG-233226), the AgingX program of the Swiss Initiative for Systems Biology (51RTP0-151019, 2013/134, and 2013/153), SNSF (31003A-140780, 31003A-143914, and CSRII3-136201), and the NIH (R01AG043930). Raw transcriptome data are published on GEO: GSE60149. Raw MS data for SWATH proteomics are available on PRIDE (41): PXD003266. Raw MS data for metabolomics are available on MassIVE: MSV000079411. Genotype information is available at www.GeneNetwork.org/genotypes/BXD.geno. Full sequence data on the parental lines were published separately (18). All data from this study can also be found and queried on the www.GeneNetwork.org resource. On the main search page, set Species to "Mouse" and Group to "BXD." Change "Type" to "Phenotype" and search for LISP3 to find phenotype data. Transcriptome data can be downloaded on GeneNetwork by changing Type to "Liver mRNA" and Data Set to any of the four EPFL/LISP entries. Pressing the INFO button to the right will lead to a page with links to download the raw data sets in the upper right. The same process can be performed to download the metabolome (change Type to "Liver Metabolome") or proteome data (change Type to "Liver Proteome"). The semiprocessed data files used for each omics layer can also be found in the supplementary materials online.	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Aylor D. L., 2008, NOT JUST ANOTHER TRA; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Emmett MR, 2014, NEUROPSYCHOPHARMACOL, V39, P5, DOI 10.1038/npp.2013.156; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hasenfuss SC, 2014, CELL METAB, V19, P84, DOI 10.1016/j.cmet.2013.11.018; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izem L, 1998, BIOCHEM J, V329, P81, DOI 10.1042/bj3290081; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kingsmore SF, 2007, BIOMARK INSIGHTS, V2, P283; Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Mayr M, 2007, TRENDS CARDIOVAS MED, V17, P43, DOI 10.1016/j.tcm.2006.11.004; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Scharnagl H, 2001, BIOCHEM PHARMACOL, V62, P1545, DOI 10.1016/S0006-2952(01)00790-0; Schon EA, 2009, CELL METAB, V9, P1, DOI 10.1016/j.cmet.2008.12.011; Selevsek N, 2015, MOL CELL PROTEOMICS, V14, P739, DOI 10.1074/mcp.M113.035550; Sevin DC, 2015, CURR OPIN BIOTECH, V34, P1, DOI 10.1016/j.copbio.2014.10.001; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Strauss K. A., 2013, GENEREVIEWS; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Knaap MS, 1999, ANN NEUROL, V45, P111, DOI 10.1002/1531-8249(199901)45:1<111::AID-ART17>3.0.CO;2-N; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Weisser H, 2013, J PROTEOME RES, V12, P1628, DOI 10.1021/pr300992u; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams EG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004673; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wong N, 2013, DIABETOLOGIA, V56, P1569, DOI 10.1007/s00125-013-2908-y; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039	58	186	188	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291							aad0189	10.1126/science.aad0189	http://dx.doi.org/10.1126/science.aad0189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27284200	Green Published			2022-12-28	WOS:000377972000033
J	Papaemmanuil, E; Gerstung, M; Bullinger, L; Gaidzik, VI; Paschka, P; Roberts, ND; Potter, NE; Heuser, M; Thol, F; Bolli, N; Gundem, G; Van Loo, P; Martincorena, I; Ganly, P; Mudie, L; McLaren, S; O'Meara, S; Raine, K; Jones, DR; Teague, JW; Butler, AP; Greaves, MF; Ganser, A; Dohner, K; Schlenk, RF; Dohner, H; Campbell, PJ				Papaemmanuil, Elli; Gerstung, Moritz; Bullinger, Lars; Gaidzik, Verena I.; Paschka, Peter; Roberts, Nicola D.; Potter, Nicola E.; Heuser, Michael; Thol, Felicitas; Bolli, Niccolo; Gundem, Gunes; Van Loo, Peter; Martincorena, Inigo; Ganly, Peter; Mudie, Laura; McLaren, Stuart; O'Meara, Sarah; Raine, Keiran; Jones, David R.; Teague, Jon W.; Butler, Adam P.; Greaves, Mel F.; Ganser, Arnold; Doehner, Konstanze; Schlenk, Richard F.; Doehner, Hartmut; Campbell, Peter J.			Genomic Classification and Prognosis in Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLONAL HEMATOPOIESIS; MONOSOMAL KARYOTYPE; MUTATIONS; CANCER; AML; ADULTS; DRIVE	BACKGROUND Recent studies have provided a detailed census of genes that are mutated in acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity defines the pathophysiology of AML and informs clinical practice. METHODS We enrolled a total of 1540 patients in three prospective trials of intensive therapy. Combining driver mutations in 111 cancer genes with cytogenetic and clinical data, we defined AML genomic subgroups and their relevance to clinical outcomes. RESULTS We identified 5234 driver mutations across 76 genes or genomic regions, with 2 or more drivers identified in 86% of the patients. Patterns of co-mutation compartmentalized the cohort into 11 classes, each with distinct diagnostic features and clinical outcomes. In addition to currently defined AML subgroups, three heterogeneous genomic categories emerged: AML with mutations in genes encoding chromatin, RNA-splicing regulators, or both (in 18% of patients); AML with TP53 mutations, chromosomal aneuploidies, or both (in 13%); and, provisionally, AML with IDH2(R172) mutations (in 1%). Patients with chromatin-spliceosome and TP53-aneuploidy AML had poor outcomes, with the various class-defining mutations contributing independently and additively to the outcome. In addition to class-defining lesions, other co-occurring driver mutations also had a substantial effect on overall survival. The prognostic effects of individual mutations were often significantly altered by the presence or absence of other driver mutations. Such gene-gene interactions were especially pronounced for NPM1-mutated AML, in which patterns of co-mutation identified groups with a favorable or adverse prognosis. These predictions require validation in prospective clinical trials. CONCLUSIONS The driver landscape in AML reveals distinct molecular subgroups that reflect discrete paths in the evolution of AML, informing disease classification and prognostic stratification. (Funded by the Wellcome Trust and others; ClinicalTrials.gov number, NCT00146120.)	[Papaemmanuil, Elli; Gerstung, Moritz; Roberts, Nicola D.; Bolli, Niccolo; Gundem, Gunes; Van Loo, Peter; Martincorena, Inigo; Mudie, Laura; McLaren, Stuart; O'Meara, Sarah; Raine, Keiran; Jones, David R.; Teague, Jon W.; Butler, Adam P.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Gerstung, Moritz] European Mol Biol Lab, European Bioinformat Inst, Hinxton, England; [Potter, Nicola E.; Greaves, Mel F.] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England; [Bolli, Niccolo] Univ Cambridge, Dept Haematol, Cambridge, England; [Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Canc Biol, 1275 York Ave, New York, NY 10021 USA; [Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Bullinger, Lars; Gaidzik, Verena I.; Paschka, Peter; Doehner, Konstanze; Schlenk, Richard F.; Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Heuser, Michael; Thol, Felicitas; Ganser, Arnold] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Bolli, Niccolo] Fdn IRCCS, Ist Nazl Tumori, Div Hematol, Milan, Italy; [Bolli, Niccolo] Univ Milan, Dept Oncol & Oncohematol, Milan, Italy; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Ganly, Peter; Campbell, Peter J.] Univ Otago, Dept Pathol, Christchurch, New Zealand	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Ulm University; Hannover Medical School; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; KU Leuven; University of Otago	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England.	pc8@sanger.ac.uk	Heuser, Michael/S-2363-2017; Bullinger, Lars/AAL-7965-2020; Schlenk, Richard/AAG-3218-2019; Bolli, Niccolo/D-4057-2011; Döhner, Hartmut/C-8933-2016; Ganly, Peter/B-8355-2008	Heuser, Michael/0000-0001-5318-9044; Bolli, Niccolo/0000-0002-1018-5139; Döhner, Hartmut/0000-0003-2116-5536; Bullinger, Lars/0000-0002-5890-5510; Ganly, Peter/0000-0003-0335-2063; Gerstung, Moritz/0000-0001-6709-963X; Raine, Keiran/0000-0002-5634-1539; Roberts, Nicola/0000-0002-0469-1043; Van Loo, Peter/0000-0003-0292-1949; Martincorena, Inigo/0000-0003-1122-4416	Wellcome Trust; The Francis Crick Institute [10202] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	Funded by the Wellcome Trust and others; ClinicalTrials.gov number, NCT00146120.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dunson DB, 2010, BAYESIAN NONPARAMETR, P35; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Groschel S, 2015, BLOOD, V125, P133, DOI 10.1182/blood-2014-07-591461; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Paschka P, 2013, BLOOD, V121, P170, DOI 10.1182/blood-2012-05-431486; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Schlenk RF, 2004, LEUKEMIA, V18, P1798, DOI 10.1038/sj.leu.2403528; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Taskesen E, 2014, BLOOD, V123, P3327, DOI 10.1182/blood-2013-07-512855; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhao Z, 2015, NAT GENET, V47, P539, DOI 10.1038/ng.3251	39	2123	2198	13	192	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2209	2221		10.1056/NEJMoa1516192	http://dx.doi.org/10.1056/NEJMoa1516192			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27276561	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000377920500005
J	Perry, RJ; Peng, L; Barry, NA; Cline, GW; Zhang, DY; Cardone, RL; Petersen, KF; Kibbey, RG; Goodman, AL; Shulman, GI				Perry, Rachel J.; Peng, Liang; Barry, Natasha A.; Cline, Gary W.; Zhang, Dongyan; Cardone, Rebecca L.; Petersen, Kitt Falk; Kibbey, Richard G.; Goodman, Andrew L.; Shulman, Gerald I.			Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome	NATURE			English	Article							CHAIN FATTY-ACIDS; HEPATIC VAGUS NERVE; INSULIN-SECRETION; GUT MICROBIOTA; ELECTRICAL-STIMULATION; VAGAL-STIMULATION; OVERWEIGHT; GLUCOSE; ACTIVATION; CAPACITY	Obesity, insulin resistance and the metabolic syndrome are associated with changes to the gut microbiota; however, the mechanism by which modifications to the gut microbiota might lead to these conditions is unknown. Here we show that increased production of acetate by an altered gut microbiota in rodents leads to activation of the parasympathetic nervous system, which, in turn, promotes increased glucose-stimulated insulin secretion, increased ghrelin secretion, hyperphagia, obesity and related sequelae. Together, these findings identify increased acetate production resulting from a nutrient-gut microbiota interaction and subsequent parasympathetic activation as possible therapeutic targets for obesity.	[Perry, Rachel J.; Peng, Liang; Cline, Gary W.; Cardone, Rebecca L.; Petersen, Kitt Falk; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Barry, Natasha A.; Goodman, Andrew L.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06510 USA; [Barry, Natasha A.; Goodman, Andrew L.] Yale Univ, Sch Med, Microbial Sci Inst, New Haven, CT 06516 USA; [Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Novo Nordisk Foundation; University of Copenhagen; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA.; Shulman, GI (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064	National Institutes of Health [R01 DK-40936, R01 AG-23686, P30 DK-45735, U24 DK-59635, T32 DK-101019, R01 DK-92606, R01 GM-103574, DP2 GM-105456]; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R01DK092606, K01DK089121, P30DK034989, T32DK101019, P30DK045735, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105456, R01GM103574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Dong, Y. Nozaki, W. Zhu, X. Zhao, J. Stack, M. Kahn, B. Lim, and Y. Kosover for technical assistance. This study was funded by grants from the National Institutes of Health (R01 DK-40936, R01 AG-23686, P30 DK-45735, U24 DK-59635, T32 DK-101019, R01 DK-92606, R01 GM-103574 and DP2 GM-105456) and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen.	Aguirre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113864; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; BERGMAN RN, 1973, AM J PHYSIOL, V225, P481, DOI 10.1152/ajplegacy.1973.225.2.481; D'Alessio DA, 2001, J CLIN ENDOCR METAB, V86, P1253, DOI 10.1210/jc.86.3.1253; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Drucker DJ, 2001, ENDOCRINOLOGY, V142, P521, DOI 10.1210/en.142.2.521; Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23; FROHMAN LA, 1967, DIABETES, V16, P443, DOI 10.2337/diab.16.7.443; IONESCU E, 1983, ENDOCRINOLOGY, V112, P904, DOI 10.1210/endo-112-3-904; La-ongkham O, 2015, ARCH MICROBIOL, V197, P561, DOI 10.1007/s00203-015-1089-0; LEE KC, 1985, ENDOCRINOLOGY, V117, P307, DOI 10.1210/endo-117-1-307; Li M, 2014, BENEF MICROBES, V5, P335, DOI 10.3920/BM2013.0071; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murugesan S, 2015, EUR J CLIN MICROBIOL, V34, P1337, DOI 10.1007/s10096-015-2355-4; Rahat-Rozenbloom S, 2014, INT J OBESITY, V38, P1525, DOI 10.1038/ijo.2014.46; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; SAKAGUCHI T, 1979, BRAIN RES, V164, P314, DOI 10.1016/0006-8993(79)90028-3; Shen W, 2008, J CELL BIOCHEM, V104, P1232, DOI 10.1002/jcb.21701; Shepherd ML, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Yamazaki H, 2006, AM J PHYSIOL-ENDOC M, V290, pE26, DOI 10.1152/ajpendo.00149.2005	24	687	772	20	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					213	+		10.1038/nature18309	http://dx.doi.org/10.1038/nature18309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279214	Green Accepted			2022-12-28	WOS:000377475100033
J	Tremblay, GR; Oonk, JBR; Combes, F; Salome, P; O'Dea, CP; Baum, SA; Voit, GM; Donahue, M; McNamara, BR; Davis, TA; McDonald, MA; Edge, AC; Clarke, TE; Galvan-Madrid, R; Bremer, MN; Edwards, LOV; Fabian, AC; Hamer, S; Li, Y; Maury, A; Russell, HR; Quillen, AC; Urry, CM; Sanders, JS; Wise, MW				Tremblay, Grant R.; Oonk, J. B. Raymond; Combes, Franoise; Salome, Philippe; O'Dea, Christopher P.; Baum, Stefi A.; Voit, G. Mark; Donahue, Megan; McNamara, Brian R.; Davis, Timothy A.; McDonald, Michael A.; Edge, Alastair C.; Clarke, Tracy E.; Galvan-Madrid, Roberto; Bremer, Malcolm N.; Edwards, Louise O. V.; Fabian, Andrew C.; Hamer, Stephen; Li, Yuan; Maury, Anaelle; Russell, Helen R.; Quillen, Alice C.; Urry, C. Megan; Sanders, Jeremy S.; Wise, Michael W.			Cold, clumpy accretion onto an active supermassive black hole	NATURE			English	Article							GALACTIC NUCLEUS FEEDBACK; H I ABSORPTION; STAR-FORMATION; MOLECULAR GAS; CORE CLUSTERS; FLOW; PRECIPITATION; FILAMENTS; EMISSION; A2597	Supermassive black holes in galaxy centres can grow by the accretion of gas, liberating energy that might regulate star formation on galaxy-wide scales(1-3). The nature of the gaseous fuel reservoirs that power black hole growth is nevertheless largely unconstrained by observations, and is instead routinely simplified as a smooth, spherical inflow of very hot gas(4). Recent theory(5-7) and simulations(8-10) instead predict that accretion can be dominated by a stochastic, clumpy distribution of very cold molecular clouds-a departure from the 'hot mode' accretion model-although unambiguous observational support for this prediction remains elusive. Here we report observations that reveal a cold, clumpy accretion flow towards a supermassive black hole fuel reservoir in the nucleus of the Abell 2597 Brightest Cluster Galaxy (BCG), a nearby (redshift z = 0.0821) giant elliptical galaxy surrounded by a dense halo of hot plasma(11-13). Under the right conditions, thermal instabilities produce a rain of cold clouds that fall towards the galaxy's centre(14), sustaining star formation amid a kiloparsec-scale molecular nebula that is found at its core(15). The observations show that these cold clouds also fuel black hole accretion, revealing 'shadows' cast by the molecular clouds as they move inward at about 300 kilometres per second towards the active supermassive black hole, which serves as a bright backlight. Corroborating evidence from prior observations(16) of warmer atomic gas at extremely high spatial resolution(17), along with simple arguments based on geometry and probability, indicate that these clouds are within the innermost hundred parsecs of the black hole, and falling closer towards it.	[Tremblay, Grant R.; Edwards, Louise O. V.; Urry, C. Megan] Yale Univ, Yale Ctr Astron & Astrophys, 52 Hillhouse Ave, New Haven, CT 06511 USA; [Tremblay, Grant R.; Davis, Timothy A.; Galvan-Madrid, Roberto] European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Oonk, J. B. Raymond; Wise, Michael W.] Netherlands Inst Radio Astron, ASTRON, POB 2, NL-7990 AA Dwingeloo, Netherlands; [Oonk, J. B. Raymond] Leiden Univ, Leiden Observ, Niels Borhweg 2, NL-2333 CA Leiden, Netherlands; [Combes, Franoise; Salome, Philippe; Hamer, Stephen] Univ Paris 04, CNRS, Lab Studies Radiat & Matter Astrophys & Atmospher, PSL Res Univ,Observ Paris,Coll France, Paris, France; [O'Dea, Christopher P.; Baum, Stefi A.] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; [O'Dea, Christopher P.] Rochester Inst Technol, Sch Phys & Astron, 84 Lomb Mem Dr, Rochester, NY 14623 USA; [Baum, Stefi A.] Rochester Inst Technol, Chester F Carlson Ctr Imaging Sci, 84 Lomb Mem Dr, Rochester, NY 14623 USA; [Voit, G. Mark; Donahue, Megan] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [McNamara, Brian R.] Univ Waterloo, Dept Phys & Astron, 200 Univ Ave West, Waterloo, ON N2L 2GL, Canada; [Davis, Timothy A.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales; [McDonald, Michael A.] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Edge, Alastair C.] Univ Durham, Dept Phys, Durham DHL 3LE, England; [Clarke, Tracy E.] Naval Res Lab, Remote Sensing Div, Code 7213,4555 Overlook Ave Southwest, Washington, DC 20375 USA; [Galvan-Madrid, Roberto] UNAM, Inst Radioastron & Astrofis, Apartado Postal 3-72 Xangari, Morelia 58089, Michoacan, Mexico; [Bremer, Malcolm N.] Univ Bristol, HW Wills Phys Lab, Tyndall Ave, Bristol BS8 1TL, Avon, England; [Fabian, Andrew C.; Russell, Helen R.] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Li, Yuan] Univ Michigan, Dept Astron, 1085 South Univ Ave, Ann Arbor, MI 48109 USA; [Maury, Anaelle] Univ Paris Diderot, CE Saclay, CNRS, CEA DSM Irfu,Lab AIM Paris Saclay, F-91191 Gif Sur Yvette, France; [Quillen, Alice C.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Sanders, Jeremy S.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Yale University; European Southern Observatory; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Observatoire de Paris; Sorbonne Universite; University of Manitoba; Rochester Institute of Technology; Rochester Institute of Technology; Michigan State University; University of Waterloo; Cardiff University; Massachusetts Institute of Technology (MIT); Durham University; United States Department of Defense; United States Navy; Naval Research Laboratory; Universidad Nacional Autonoma de Mexico; University of Bristol; University of Cambridge; University of Michigan System; University of Michigan; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Rochester; Max Planck Society	Tremblay, GR (corresponding author), Yale Univ, Yale Ctr Astron & Astrophys, 52 Hillhouse Ave, New Haven, CT 06511 USA.; Tremblay, GR (corresponding author), European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany.	grant.tremblay@yale.edu	Combes, Francoise/F-6046-2011; Tremblay, Grant/ABB-7070-2020; Urry, Meg/G-7381-2011	Combes, Francoise/0000-0003-2658-7893; Tremblay, Grant/0000-0002-5445-5401; Maury, Anaelle/0000-0002-3801-8754; Urry, Meg/0000-0002-0745-9792; Wise, Michael/0000-0002-6470-2285; Edwards, Louise/0000-0002-9135-997X; Edge, Alastair/0000-0002-3398-6916; Donahue, Megan/0000-0002-2808-0853; Hamer, Stephen/0000-0003-1932-0162; Li, Yuan/0000-0001-5262-6150; Galvan-Madrid, Roberto/0000-0003-1480-4643; Quillen, Alice/0000-0003-1280-2054; Russell, Helen/0000-0001-5208-649X; Sanders, Jeremy/0000-0003-2189-4501	National Aeronautics and Space Administration (NASA) [PF-150128]; NASA [NAS8-03060]; European Research Council (ERC) [267399-Momentum]; Natural Sciences and Engineering Research Council of Canada; Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship; STFC [ST/L00075X/1]; ERC [340442-Feedback]; 6.1 Base funding; Science and Technology Facilities Council [ST/L004496/1, ST/L00075X/1, ST/L005042/1, ST/L004496/2] Funding Source: researchfish; STFC [ST/L005042/1, ST/L004496/1, ST/M000907/1, ST/L004496/2] Funding Source: UKRI	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); European Research Council (ERC)(European Research Council (ERC)European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ERC(European Research Council (ERC)European Commission); 6.1 Base funding(Princeton University); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. We are grateful to the European ALMA Regional Centres, particularly those in Garching and Manchester, for their dedicated end-to-end support of data associated with this paper. We thank R. Larson for discussions. G.R.T. acknowledges support from National Aeronautics and Space Administration (NASA) through Einstein Postdoctoral Fellowship Award Number PF-150128, issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA under contract NAS8-03060. F.C. acknowledges the European Research Council (ERC) for the Advanced Grant Program no. 267399-Momentum. B.R.M. is supported by a grant from the Natural Sciences and Engineering Research Council of Canada. T.A.D. acknowledges support from a Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship. A.C.E. acknowledges support from STFC grant ST/L00075X/1. A.C.F. and H.R.R. acknowledge support from ERC Advanced Grant Program no. 340442-Feedback. M.N.B. acknowledges funding from the STFC. Basic research in radio astronomy at the Naval Research Laboratory is supported by 6.1 Base funding.	Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195, DOI 10.1093/mnras/112.2.195; Clarke TE, 2005, ASTROPHYS J, V625, P748, DOI 10.1086/429717; David LP, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/94; Espada D, 2010, ASTROPHYS J, V720, P666, DOI 10.1088/0004-637X/720/1/666; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Gaspari M, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526151; Gaspari M, 2013, MON NOT R ASTRON SOC, V432, P3401, DOI 10.1093/mnras/stt692; Jaffe W, 2005, MON NOT R ASTRON SOC, V360, P748, DOI 10.1111/j.1365-2966.2005.09073.x; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809, DOI 10.1093/mnras/194.4.809; Li Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/153; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; McNamara BR, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/44; McNamara BR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055023; McNamara BR, 2001, ASTROPHYS J, V562, pL149, DOI 10.1086/338326; O'Dea CP, 2004, ASTROPHYS J, V612, P131, DOI 10.1086/422402; ODEA CP, 1994, ASTROPHYS J, V436, P669, DOI 10.1086/174941; Oonk JBR, 2011, MON NOT R ASTRON SOC, V414, P2309, DOI 10.1111/j.1365-2966.2011.18551.x; Pizzolato F, 2005, ASTROPHYS J, V632, P821, DOI 10.1086/444344; Russell HR, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/78; Salome P, 2006, ASTRON ASTROPHYS, V454, P437, DOI 10.1051/0004-6361:20054745; Salome P, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/200811333; Sharma P, 2012, MON NOT R ASTRON SOC, V420, P3174, DOI 10.1111/j.1365-2966.2011.20246.x; SMITH EP, 1990, ASTROPHYS J, V356, P399, DOI 10.1086/168848; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Taylor GB, 1999, ASTROPHYS J, V512, pL27, DOI 10.1086/311873; Tremblay GR, 2015, MON NOT R ASTRON SOC, V451, P3768, DOI 10.1093/mnras/stv1151; Tremblay GR, 2012, MON NOT R ASTRON SOC, V424, P1042, DOI 10.1111/j.1365-2966.2012.21278.x; Tremblay GR, 2012, MON NOT R ASTRON SOC, V424, P1026, DOI 10.1111/j.1365-2966.2012.21281.x; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Voit GM, 2015, NATURE, V519, P203, DOI 10.1038/nature14167; Voit GM, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/1/L30; Voit GM, 1997, ASTROPHYS J, V486, P242, DOI 10.1086/304509; Wiklind T, 1997, ASTRON ASTROPHYS, V324, P51	34	113	114	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					218	+		10.1038/nature17969	http://dx.doi.org/10.1038/nature17969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO0NH	27279215	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000377475100034
J	Wagner, S; Jain, S				Wagner, Siegfried; Jain, Saurabh			CASE REVIEW Sequential vision loss in a patient with headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GIANT-CELL ARTERITIS; COLOR-DUPLEX ULTRASONOGRAPHY; LARGE-VESSEL VASCULITIS; TEMPORAL ARTERITIS; FOLLOW-UP; DIAGNOSIS; THERAPY		[Wagner, Siegfried; Jain, Saurabh] Royal Free Hosp NHS Fdn Trust, Dept Ophthalmol, London NW3 2QG, England		Wagner, S (corresponding author), Royal Free Hosp NHS Fdn Trust, Dept Ophthalmol, London NW3 2QG, England.	siegfried.wagner@ndcn.ox.ac.uk		Wagner, Siegfried/0000-0003-4915-4353				Biousse V, 2015, NEW ENGL J MED, V372, P2428, DOI 10.1056/NEJMra1413352; Blockmans D, 2009, CURR OPIN RHEUMATOL, V21, P19, DOI 10.1097/BOR.0b013e32831cec7b; Hall JK, 2003, OPHTHALMOLOGY, V110, P543, DOI 10.1016/S0161-6420(02)01758-X; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; LIU GT, 1994, OPHTHALMOLOGY, V101, P1779; MACHADO EBV, 1988, ARTHRITIS RHEUM, V31, P745, DOI 10.1002/art.1780310607; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; National Institute for Health and Care Excellence, 2014, GIANT CELL ART MAN C; Lopez JP, 2009, CLIN EXP RHEUMATOL, V27, pS77; Pfadenhauer K, 2003, J RHEUMATOL, V30, P2177; Pipitone N, 2008, RHEUMATOLOGY, V47, P403, DOI 10.1093/rheumatology/kem379; Ponte C, 2015, WORLD J CLIN CASES, V3, P484, DOI 10.12998/wjcc.v3.i6.484; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; Tsianakas A, 2009, J AM ACAD DERMATOL, V61, P701, DOI 10.1016/j.jaad.2008.11.913; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750	17	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2016	353								i3055	10.1136/bmj.i3055	http://dx.doi.org/10.1136/bmj.i3055			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YM	27278518				2022-12-28	WOS:000377859100002
J	Hill, KP; Weiss, RD				Hill, Kevin P.; Weiss, Roger D.			Minimal Physical Health Risk Associated With Long-term Cannabis Use-But Buyer Beware	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MARIJUANA USE; MEDICAL MARIJUANA		[Hill, Kevin P.; Weiss, Roger D.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Hill, Kevin P.; Weiss, Roger D.] McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Hill, KP (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	khill@mclean.harvard.edu	Hill, Kevin/GLQ-8874-2022		NATIONAL INSTITUTE ON DRUG ABUSE [K99DA029115, K24DA022288] Funding Source: NIH RePORTER; NIDA NIH HHS [K99/R00 DA029115, K24 DA022288] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2004 SURG GEN REP HL; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Center for Behavioral Health Statistics and Quality (CBHSQ), 2015, HHS PUBL SMA, VSMA 15-4927; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Meier MH, 2016, JAMA PSYCHIAT, V73, P731, DOI 10.1001/jamapsychiatry.2016.0637; Ngueta G, 2015, OBESITY, V23, P290, DOI 10.1002/oby.20973; Vidot DC, 2014, J ADDICT DIS, V33, P1, DOI 10.1080/10550887.2014.882718; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	10	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2338	+		10.1001/jama.2016.5181	http://dx.doi.org/10.1001/jama.2016.5181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27272585				2022-12-28	WOS:000377183100023
J	Tavares, J; Eugenio, G; Calretas, S; Silva, R; Santos, R; Carvalho, A				Tavares, Joao; Eugenio, Gisela; Calretas, Suzana; Silva, Rui; Santos, Rui; Carvalho, Armando			CASE REVIEW A link between asthenia, pallor, and jaundice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERNICIOUS-ANEMIA; VITAMIN-B-12; DEFICIENCY; COBALAMIN; DIAGNOSIS; HOLOTRANSCOBALAMIN; FOLATE		[Tavares, Joao] Hosp Univ Coimbra, P-3000075 Coimbra, Portugal; [Eugenio, Gisela] Hosp Univ Coimbra, Dept Rheumatol, P-3000075 Coimbra, Portugal; [Calretas, Suzana; Santos, Rui; Carvalho, Armando] Hosp Univ Coimbra, Dept Internal Med, P-3000075 Coimbra, Portugal; [Silva, Rui] Hosp Univ Coimbra, Dept Pathol, P-3000075 Coimbra, Portugal	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Tavares, J (corresponding author), Hosp Univ Coimbra, P-3000075 Coimbra, Portugal.	joaoptavares@sapo.pt	Santos, Rui M/B-4190-2009; Carvalho, Armando/H-4510-2016; Silva, Rui Miguel/GYK-4626-2022; Carvalho, Armando/P-6134-2018	Carvalho, Armando/0000-0003-2455-8781; Silva, Rui Miguel/0000-0003-3380-864X; Carvalho, Armando/0000-0003-2455-8781				Annibale Bruno, 2011, Curr Gastroenterol Rep, V13, P518, DOI 10.1007/s11894-011-0225-5; Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Bayraktar UD, 2010, WORLD J GASTROENTERO, V16, P2720, DOI 10.3748/wjg.v16.i22.2720; Carmel R, 2008, BLOOD, V112, P2214, DOI 10.1182/blood-2008-03-040253; Cattan D, 2011, WORLD J GASTROENTERO, V17, P543, DOI 10.3748/wjg.v17.i4.543; Dali-Youcef N, 2009, QJM-INT J MED, V102, P17, DOI 10.1093/qjmed/hcn138; Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959; Garcia-Carrasco M, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P513, DOI 10.1007/978-1-60327-285-8_94; Herrmann W, 2005, CURR DRUG METAB, V6, P47, DOI 10.2174/1389200052997384; Hershko C, 2014, BLOOD, V123, P326, DOI 10.1182/blood-2013-10-512624; Kaferle J, 2009, AM FAM PHYSICIAN, V79, P203; Lahner E, 2009, WORLD J GASTROENTERO, V15, P5121, DOI 10.3748/wjg.15.5121; Miller JW, 2006, CLIN CHEM, V52, P278, DOI 10.1373/clinchem.2005.061382; Murphy G, 2015, CLIN GASTROENTEROL H, V13, P2282, DOI 10.1016/j.cgh.2015.05.040; Neumann WL, 2013, NAT REV GASTRO HEPAT, V10, P529, DOI 10.1038/nrgastro.2013.101; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Okam MM, 2014, BRIGHAM INTENSIVE RE, P185; Puig A, 2012, NEW ENGL J MED, V366, P1626, DOI 10.1056/NEJMcpc1111575; Sanz-Cuesta T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-394; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Vannella L, 2013, ALIMENT PHARM THER, V37, P375, DOI 10.1111/apt.12177; Vidal-Alaball J, 2005, COCHRANE DB SYST REV, V3; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x; Wickramasinghe SN, 2006, BLOOD REV, V20, P299, DOI 10.1016/j.blre.2006.02.002	25	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2016	353								i2937	10.1136/bmj.i2937	http://dx.doi.org/10.1136/bmj.i2937			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5YH	27268002	Green Published			2022-12-28	WOS:000377858600003
J	Margalida, A				Margalida, Antoni			Flying free before building my nest	SCIENCE			English	Editorial Material									[Margalida, Antoni] Univ Lleida, Dept Anim Sci, Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, CH-3012 Bern, Switzerland	Universitat de Lleida; University of Bern	Margalida, A (corresponding author), Univ Lleida, Dept Anim Sci, Lleida, Spain.; Margalida, A (corresponding author), Univ Bern, Div Conservat Biol, CH-3012 Bern, Switzerland.	SciCareerEditor@aaas.org	Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Margalida, Antoni/0000-0002-3904-6212; Margalida, Antoni/0000-0002-7383-671X					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1246	1246		10.1126/science.352.6290.1246	http://dx.doi.org/10.1126/science.352.6290.1246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27257260	Green Submitted			2022-12-28	WOS:000377045700047
J	Flaschner, N; Rem, BS; Tarnowski, M; Vogel, D; Luhmann, DS; Sengstock, K; Weitenberg, C				Flaeschner, N.; Rem, B. S.; Tarnowski, M.; Vogel, D.; Luehmann, D. -S.; Sengstock, K.; Weitenberg, C.			Experimental reconstruction of the Berry curvature in a Floquet Bloch band	SCIENCE			English	Article							EDGE STATES; TOPOLOGICAL INSULATORS; FERMIONS; LATTICE; ATOMS	Topological properties lie at the heart of many fascinating phenomena in solid-state systems such as quantum Hall systems or Chern insulators. The topology of the bands can be captured by the distribution of Berry curvature, which describes the geometry of the eigenstates across the Brillouin zone. Using fermionic ultracold atoms in a hexagonal optical lattice, we engineered the Berry curvature of the Bloch bands using resonant driving and show a full momentum-resolved measurement of the ensuing Berry curvature. Our results pave the way to explore intriguing phases of matter with interactions in topological band structures.	[Flaeschner, N.; Rem, B. S.; Tarnowski, M.; Vogel, D.; Luehmann, D. -S.; Sengstock, K.; Weitenberg, C.] Univ Hamburg, Insti Laserphys ILP, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Flaeschner, N.; Rem, B. S.; Sengstock, K.; Weitenberg, C.] Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Sengstock, K.] Univ Hamburg, ZOQ, Luruper Chaussee 149, D-22761 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg	Sengstock, K (corresponding author), Univ Hamburg, Insti Laserphys ILP, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Sengstock, K (corresponding author), Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Sengstock, K (corresponding author), Univ Hamburg, ZOQ, Luruper Chaussee 149, D-22761 Hamburg, Germany.	klaus.sengstock@physnet.uni-hamburg.de		Flaschner, Nick/0000-0002-6882-1337	excellence cluster "The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale"; Deutsche Forschungsgemeinschaft [GrK 1355]	excellence cluster "The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge stimulating discussions with A. Eckardt, M. Lewenstein, L. Mathey, and C. Strater. This work has been supported by the excellence cluster "The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale" and the GrK 1355 of the Deutsche Forschungsgemeinschaft.	Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Alba E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.235301; Bukov M, 2015, ADV PHYS, V64, P139, DOI 10.1080/00018732.2015.1055918; Cooper NR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185301; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Goldman N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031027; Grushin AG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.156801; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hauke P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045303; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kennedy CJ, 2015, NAT PHYS, V11, P859, DOI [10.1038/NPHYS3421, 10.1038/nphys3421]; Kitagawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.235114; Krauser JS, 2014, SCIENCE, V343, P157, DOI 10.1126/science.1244059; Li T, 2015, ARXIV150902185; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Neupert T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236804; Ningyuan J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021031; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Sie EJ, 2015, NAT MATER, V14, P290, DOI 10.1038/nmat4156; Soltan-Panahi P, 2011, NAT PHYS, V7, P434, DOI [10.1038/nphys1916, 10.1038/NPHYS1916]; Struck J, 2013, NAT PHYS, V9, P738, DOI [10.1038/nphys2750, 10.1038/NPHYS2750]; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959	31	316	317	10	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1091	1094		10.1126/science.aad4568	http://dx.doi.org/10.1126/science.aad4568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230375	Green Submitted			2022-12-28	WOS:000376480800036
J	Orsini, MJ				Orsini, Michael J.			Three strikes and research is out	SCIENCE			English	Editorial Material									[Orsini, Michael J.] Bristol Myers Squibb Co, R&D Strategy & Planning, Lawrenceville, NJ USA	Bristol-Myers Squibb	Orsini, MJ (corresponding author), Bristol Myers Squibb Co, R&D Strategy & Planning, Lawrenceville, NJ USA.	SciCareerEditor@aaas.org							0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1138	1138		10.1126/science.352.6289.1138	http://dx.doi.org/10.1126/science.352.6289.1138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27230382				2022-12-28	WOS:000376480800046
J	Oliver, D				Oliver, David			More older patients are stuck in hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Healthwatch England, 2015, SPEC INQ SAF HOM WHA; House of Commons Committee of Public Accounts, 2016, SUST FIN PERF AC HOS; Humphries R, 2015, HLTH SERV J; Kings Fund, 2015, SOC CAR BUDG CUTS DA; National Audit Office, 2016, HC18 SESS 2016 17; *NHS BENCHM, 2015, OLD PEOPL AC CAR SET; NHS Benchmarking, 2015, NAT AUD INT CAR SUMM; NHS Confederation, 2010, DEAL DOWNT US EV; Thompson J, 2015, KINGS FUND BLOG 1109	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2016	353								i2948	10.1136/bmj.i2948	http://dx.doi.org/10.1136/bmj.i2948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3CL	27230037	Bronze, Green Published			2022-12-28	WOS:000376939900004
J	Lane, R				Lane, Richard			Yasuhisa Shiozaki: Japan's progressive Minister of Health	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2081	2081		10.1016/S0140-6736(16)30528-1	http://dx.doi.org/10.1016/S0140-6736(16)30528-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	27301814				2022-12-28	WOS:000376450800015
J	Garcia, HH; Gonzalez, AE; Tsang, VCW; O'Neal, SE; Llanos-Zavalaga, F; Gonzalvez, G; Romero, J; Rodriguez, S; Moyano, LM; Ayvar, V; Diaz, A; Hightower, A; Craig, PS; Lightowlers, MW; Gauci, CG; Leontsini, E; Gilman, RH				Garcia, Hector H.; Gonzalez, Armando E.; Tsang, Victor C. W.; O'Neal, Seth E.; Llanos-Zavalaga, Fernando; Gonzalvez, Guillermo; Romero, Jaime; Rodriguez, Silvia; Moyano, Luz M.; Ayvar, Viterbo; Diaz, Andre; Hightower, Allen; Craig, Philip S.; Lightowlers, Marshall W.; Gauci, Charles G.; Leontsini, Elli; Gilman, Robert H.		Cysticercosis Working Grp Peru	Elimination of Taenia solium Transmission in Northern Peru	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORCINE CYSTICERCOSIS; MASS CHEMOTHERAPY; FIELD TRIAL; PIGS; VACCINATION; NEUROCYSTICERCOSIS; PRAZIQUANTEL; INFECTIONS; ANTIBODIES	BACKGROUND Taeniasis and cysticercosis are major causes of seizures and epilepsy. Infection by the causative parasite Taenia solium requires transmission between humans and pigs. The disease is considered to be eradicable, but data on attempts at regional elimination are lacking. We conducted a three-phase control program in Tumbes, Peru, to determine whether regional elimination would be feasible. METHODS We systematically tested and compared elimination strategies to show the feasibility of interrupting the transmission of T solium infection in a region of highly endemic disease in Peru. In phase 1, we assessed the effectiveness and feasibility of six intervention strategies that involved screening of humans and pigs, antiparasitic treatment, prevention education, and pig replacement in 42 villages. In phase 2, we compared mass treatment with mass screening (each either with or without vaccination of pigs) in 17 villages. In phase 3, we implemented the final strategy of mass treatment of humans along with the mass treatment and vaccination of pigs in the entire rural region of Tumbes (107 villages comprising 81,170 people and 55,638 pigs). The effect of the intervention was measured after phases 2 and 3 with the use of detailed necropsy to detect pigs with live, nondegenerated cysts capable of causing new infection. The necropsy sampling was weighted in that we preferentially included more samples from seropositive pigs than from seronegative pigs. RESULTS Only two of the strategies implemented in phase 1 resulted in limited control over the transmission of T solium infection, which highlighted the need to intensify the subsequent strategies. After the strategies in phase 2 were implemented, no cyst that was capable of further transmission of T. solium infection was found among 658 sampled pigs. One year later, without further intervention, 7 of 310 sampled pigs had live, nondegenerated cysts, but no infected pig was found in 11 of 17 villages, including all the villages in which mass antiparasitic treatment plus vaccination was implemented. After the final strategy was implemented in phase 3, a total of 3 of 342 pigs had live, nondegenerated cysts, but no infected pig was found in 105 of 107 villages. CONCLUSIONS We showed that the transmission of T solium infection was interrupted on a regional scale in a highly endemic region in Peru.	[Garcia, Hector H.; O'Neal, Seth E.; Moyano, Luz M.; Ayvar, Viterbo; Diaz, Andre] Univ Peruana Cayetano Heredia, Ctr Global Health Tumbes, Lima, Peru; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Llanos-Zavalaga, Fernando] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Garcia, Hector H.; Rodriguez, Silvia] Inst Nacl Ciencias Neurol, Cysticercosis Unit, Lima 14, Peru; [Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru; [Romero, Jaime] Interamer Inst Cooperat Agr, Lima, Peru; [Tsang, Victor C. W.] Ctr Dis Control & Prevent, Immunol Branch, Div Parasit Dis & Malaria, Natl Ctr Infect Dis, Atlanta, GA USA; [Hightower, Allen] Ctr Dis Control & Prevent, Data Management Act, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Tsang, Victor C. W.] Georgia State Univ, Atlanta, GA 30303 USA; [O'Neal, Seth E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [O'Neal, Seth E.] Portland State Univ, Portland, OR 97207 USA; [Gonzalvez, Guillermo] Pan Amer Hlth Org, Managua, Nicaragua; [Craig, Philip S.] Univ Salford, Sch Environm & Life Sci, Manchester, England; [Lightowlers, Marshall W.; Gauci, Charles G.] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [Leontsini, Elli; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; Oregon Health & Science University; Portland State University; Pan American Health Organization; University of Manchester; University of Salford; University of Melbourne; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Garcia, HH (corresponding author), Univ Peruana Cayetano Heredia, SMP, H Delgado 430, Lima 31, Peru.	hgarcia@jhsph.edu	vidal, luz maria moyano/AAF-2054-2020	vidal, luz maria moyano/0000-0002-5878-5782; Gonzalez, Armando/0000-0003-1909-1873; O'Neal, Seth/0000-0002-4782-3368; Gauci, Charles/0000-0001-5097-2164; Llanos-Zavalaga, Luis/0000-0001-6050-6001; Leontsini, Elli/0000-0001-7895-8065	Bill and Melinda Gates Foundation; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW007393, D43TW001140] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funded by the Bill and Melinda Gates Foundation and others.	Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; ANDERSON RM, 1982, NATURE, V297, P557, DOI 10.1038/297557a0; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Bustos JA, 2012, CLIN VACCINE IMMUNOL, V19, P570, DOI 10.1128/CVI.05428-11; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; CAMPBELL WC, 1986, J PARASITOL, V72, P45, DOI 10.2307/3281795; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; de Aluja AS, 1998, VET PARASITOL, V76, P71, DOI 10.1016/S0304-4017(97)00059-9; Flisser A, 2004, J PARASITOL, V90, P914, DOI 10.1645/GE-3354CC; Flisser A, 2004, INFECT IMMUN, V72, P5292, DOI 10.1128/IAI.72.9.5292-5297.2004; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Garcia HH, 2007, J NEUROL SCI, V262, P153, DOI 10.1016/j.jns.2007.06.039; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Gavidia CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002192; Gonzales AE, 1996, AM J TROP MED HYG, V54, P391, DOI 10.4269/ajtmh.1996.54.391; Gonzalez AE, 2005, AM J TROP MED HYG, V72, P837, DOI 10.4269/ajtmh.2005.72.837; Gonzalez AE, 1999, VET PARASITOL, V86, P113, DOI 10.1016/S0304-4017(99)00106-5; KEILBACH N M, 1989, Acta Leidensia, V57, P181; Lipscomb FM, 1961, CYSTICERCOSIS ANAL F; Medina MT, 2011, EPILEPSIA, V52, P1177, DOI 10.1111/j.1528-1167.2010.02945.x; Molinari JL, 1997, VET PARASITOL, V69, P55, DOI 10.1016/S0304-4017(96)01102-8; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; Sarti E, 1999, TAENIA SOLIUM TAENIS, P327; Schantz P M, 1993, Bull Pan Am Health Organ, V27, P397; Schantz Peter M., 2002, P63, DOI 10.1079/9780851996288.0063; Schantz PM, 1998, EMERG INFECT DIS, V2, P213, DOI [10.1128/9781555816957.ch12, DOI 10.1128/9781555816957.CH12]; TORRES JR, 1988, REV I MED TROP, V30, P433, DOI 10.1590/S0036-46651988000600008	30	83	86	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2335	2344		10.1056/NEJMoa1515520	http://dx.doi.org/10.1056/NEJMoa1515520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO5WW	27305193	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000377854600007
J	Powell, K				Powell, Kendall			THE WAITING GAME	NATURE			English	News Item											No Org, Lafayette, CO USA.							Cheeseman LP, 2013, J CELL SCI, V126, P2102, DOI 10.1242/jcs.124834; Fraser D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106499; Himmelstein DS, 2016, ZENODO REPOSITORY; Vale RD, 2015, P NATL ACAD SCI USA, V112, P13439, DOI 10.1073/pnas.1511912112; Vosshall LB, 2012, FASEB J, V26, P3589, DOI 10.1096/fj.12-0901ufm	5	121	124	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					148	151		10.1038/530148a	http://dx.doi.org/10.1038/530148a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863966	hybrid			2022-12-28	WOS:000369916700013
J	Wanner, C; Inzucchi, SE; Zinman, B				Wanner, Christoph; Inzucchi, Silvio E.; Zinman, Bernard			Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Reply	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INHIBITION		[Wanner, Christoph] Wurzburg Univ Clin, Wurzburg, Germany; [Inzucchi, Silvio E.] Yale Univ, Sch Med, New Haven, CT USA; [Zinman, Bernard] Univ Toronto, Toronto, ON, Canada	University of Wurzburg; Yale University; University of Toronto	Wanner, C (corresponding author), Wurzburg Univ Clin, Wurzburg, Germany.	wanner_c@ukw.de	Krarup, Thure/AHD-5424-2022; Scott, Russell/ABC-8328-2020; Trescolí, Carlos/GLQ-7462-2022; Chumakova, Galina A/L-5677-2015; Woerle, Hans/ABE-1013-2021; mathieu, chantal/ABD-5505-2021; Halimi, jean-michel/AAO-5268-2020; Zateyshchikov, Dmitry/AGN-8590-2022; TENTOLOURIS, NIKOLAOS/AAH-6231-2019; Cruz, Ana Fernández/L-2429-2019; Toplak, Hermann/ABG-3269-2020; Khokhlov, Alexander L./E-2765-2017; Chee, Kok Han/I-2138-2013; Inzucchi, Silvio/ABF-4121-2021; catrinoiu, doina/AAC-9317-2021; Zinman, Bernard/E-7266-2013; Rigla, Mercedes/AAM-2183-2020; Arutyunov, Gregory/M-7368-2019; Nikolaev, Konstantin/P-4750-2017; Geloneze, Bruno/F-4231-2010; Babkowski, Miguel Camafort/AAE-3657-2021; Camafort-Babkowski, Miguel/H-6310-2014; fioretto, paola/AHD-4415-2022; Urina-Triana, Miguel A/H-2605-2016; Marchionni, Niccolò/ABE-3977-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; pinto, leonor/HGC-4320-2022; De Jong, Audrey/AAA-8553-2020; Schaper, Nicolaas C/E-7112-2014; Heerspink, Hiddo J Lambers/K-3358-2014; de Zeeuw, Dick/E-9080-2014; Libov, Igor/GRN-8152-2022; Onishi, Yukiko/AAU-9057-2021; Rha, Seung-Woon/AGE-5810-2022; Uwaifo, Gabriel I/M-2361-2016; Calabro, Paolo/AAC-2704-2022; Zateyshchikov, Dmitry A/D-6575-2012; Semplicini, Andrea/B-5959-2013; Mirosevic, Gorana/AAK-9294-2021; Barbarash, Olga/A-4834-2017; Couffinhal, Thierry/M-6857-2014	Krarup, Thure/0000-0002-9152-0583; Scott, Russell/0000-0002-2107-6480; Chumakova, Galina A/0000-0002-2810-6531; mathieu, chantal/0000-0002-4055-5233; Zateyshchikov, Dmitry/0000-0001-7065-2045; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Cruz, Ana Fernández/0000-0003-1189-1120; Toplak, Hermann/0000-0002-7513-5167; Khokhlov, Alexander L./0000-0002-0032-0341; Chee, Kok Han/0000-0002-4485-0504; Rigla, Mercedes/0000-0002-6691-4871; Arutyunov, Gregory/0000-0002-6645-2515; Nikolaev, Konstantin/0000-0003-4601-6203; Geloneze, Bruno/0000-0002-0557-4578; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Urina-Triana, Miguel A/0000-0001-6003-4622; Marchionni, Niccolò/0000-0002-8101-4695; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; de Zeeuw, Dick/0000-0003-3434-7777; Onishi, Yukiko/0000-0003-1180-5982; Rha, Seung-Woon/0000-0001-9456-9852; Uwaifo, Gabriel I/0000-0002-6962-9304; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Semplicini, Andrea/0000-0003-0652-0739; Tabak, Adam/0000-0002-6234-3936; Mulder, Hindrik/0000-0002-6593-8417; Lochnan, Heather/0000-0002-3820-7897; schaper, nicolaas/0000-0002-2128-8029; Sairanen, Tiina/0000-0002-2923-7445; Marchesini, Giulio/0000-0003-2407-9860; Andrade, Lucia/0000-0002-3078-8957; Barbarash, Olga/0000-0002-4642-3610; Turan, Tanya/0000-0001-5399-8845; Segura, Julian/0000-0003-4677-9526; Gardner, Thomas/0000-0002-5112-5810; Godlevska, Olga/0000-0001-7473-9711; Deerochanawong, Chaicharn/0000-0001-9666-7050; S, Paramesh/0000-0002-0693-4483; Zanella, Maria Teresa/0000-0002-8451-8522; Colivicchi, Furio/0000-0001-7187-2234; Lachin, John/0000-0001-9838-2841; Vidal, Josep/0000-0002-4564-4518; Wakisaka, Masanori/0000-0002-1373-4287; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Couffinhal, Thierry/0000-0002-9217-2533; Sgarbi, Jose/0000-0001-7187-984X; BUCCI, MARCO/0000-0002-5213-7768				Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013	5	1781	1880	4	220	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1801	1802						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806236				2022-12-28	WOS:000387007300023
J	Wanner, C; Inzucchi, SE; Lachin, JM; Fitchett, D; von Eynatten, M; Mattheus, M; Johansen, OE; Woerle, HJ; Broedl, UC; Zinman, B; Aizenberg, D; Ulla, M; Waitman, J; De Loredo, L; Farias, J; Fideleff, H; Lagrutta, M; Maldonado, N; Colombo, H; Pacora, FF; Wasserman, A; Maffei, L; Lehman, R; Selvanayagam, J; d'Emden, M; Fasching, P; Paulweber, B; Toplak, H; Luger, A; Drexel, H; Prager, R; Schnack, C; Schernthaner, G; Fliesser-Gorzer, E; Kaser, S; Scheen, A; Van Gaal, L; Hollanders, G; Kockaerts, Y; Capiau, L; Chachati, A; Persu, A; Hermans, M; Vantroyen, D; Vercammen, C; Van de Borne, P; Mathieu, C; Benhalima, K; Lienart, F; Mortelmans, J; Strivay, M; Vereecken, G; Keymeulen, B; Lamkanfi, F; Chacra, A; Eliaschewitz, F; Zanella, M; Faludi, A; Bertolami, M; Hayashida, C; Salles, JN; Monte, O; Dinato, M; Manenti, E; Rassi, N; Halpern, A; Lima, M; Ayoub, J; Felicio, J; Borges, J; Gross, J; Sgarbi, J; Betti, R; Tiburcio, A; Purisch, S; Schmid, H; Takahashi, M; Castro, M; Rea, R; Hissa, M; Neto, BG; Saraiva, J; Henein, S; Lochnan, H; Imran, SA; Clayton, D; Bayly, K; Berlingieri, J; Boucher, P; Chan, Y; Gupta, M; Chehayeb, R; Ouellett, A; Ur, E; Woo, V; Zinman, B; St Amour, E; Lozano, MT; Lozno, HY; Urina, M; Jaramillo, PL; Jaramillo, N; Sanchez, G; Perez, G; Tusek, S; Mirosevic, G; Goldoni, V; Jurisic-Erzen, D; Balasko, A; Balic, S; Drvodelic-Sunic, E; Varzic, SC; Machkova, M; Weiner, P; Lastuvka, J; Olsovsky, J; Krarup, T; Ridderstrale, M; Tarnow, L; Boesgaard, TW; Lihn, AS; Christensen, P; Juhl, H; Urhammer, S; Lund, P; Adojaan, B; Jakovlev, U; Lanno, R; Lubi, M; Marandi, T; Gouet, D; Courreges, J; Zaoui, P; Choukroun, G; Petit, C; Formagne, L; Estour, B; Mabire, P; Daugenet, C; Lemarie, B; Clavel, S; Aure, P; Remaud, P; Halimi, J; Hadjadj, S; Couffinhal, T; Glonti, S; Metreveli, D; Lominadze, Z; Giorgadze, E; Burtchuladze, T; Javashvili, L; Kurashvili, G; Kurashvili, R; Virsaladze, D; Nadareishvili, L; Khomasuridze, A; Cahill, T; Green, F; MacRury, S; Waldron, M; Middleton, A; McKnight, J; Pearson, E; Butler, M; Choksi, M; Caldwell, I; Farmer, I; Wyatt, N; Patrick, J; O'Brien, I; Devers, M; Bousboulas, S; Pappas, S; Piaditis, G; Vryonidou, A; Tentolouris, N; Karamitsos, K; Manes, C; Benroubi, M; Avramidis, I; Ozaki, R; Tan, K; Siu, S; Tsang, C; Dudas, M; Nagy, K; Salamon, C; Ip, T; Geroo, L; Patkay, J; Tabak, A; Juhasz, F; Szentpeteri, I; Tamas, G; Ghaisas, N; Bantwal, G; Mohan, V; Gupta, J; Sadhu, N; Kulkarni, A; Garg, N; Reddy, S; Deshpande, N; Gutlapalli, K; Pillai, M; Premchand, R; Badgandi, M; Jain, S; Aravind, S; Shamanna, P; Pandey, A; Gupta, S; Pramono, B; Saksono, HD; Agung, P; Wahono, SD; Suastika, K; Tanggo, Y; Juwana, Y; Siswanto, B; Adawi, F; Efrati, S; Mazen, E; Bashkin, A; Herskovits, T; Jaffe, A; Schiff, E; Wainstein, J; Taddei, S; Aiello, A; Arca, M; Calabro, P; Cignarelli, M; Fioretto, P; Reggiani, GM; Gnasso, A; Marchionni, N; Marsilii, A; Bucci, M; Mezzetti, A; Pozzilli, P; Colivicchi, F; Santini, M; Moro, E; Toscano, V; Fucili, A; Semplicini, A; Monno, S; Furui, K; Higashiue, S; Hiramatsu, N; Kawamitsu, K; Takenaka, T; Takahashi, H; Hojo, F; Onishi, Y; Izumino, K; Okubo, M; Wakida, Y; Kondo, Y; Hieshima, K; Jinnouchi, H; Suzuki, A; Ito, M; Park, S; Kim, Y; Hong, T; Park, H; Gwon, H; Kim, H; Kang, K; Jeong, M; Seung, K; Lim, D; Rha, S; Tahk, S; Yang, J; Yoon, J; Shin, M; Kim, D; Jeong, J; Ahmad, NN; Mustafa, N; Mohamed, WW; Fung, Y; Ghani, RA; Chandramouli, A; Chee, K; Kadir, KA; Ling, K; Abu Hassan, M; Foo, S; Lee, S; Hernandez, PG; Aguilar-Salinas, C; Velazquez, MV; Flores, F; Salazar, MA; Escalante, DM; Soria, MG; Munoz, EC; Storms, G; Schaper, N; Kooy, A; Krekels, M; van Bemmel, T; Verhoeven, R; Mulder, H; Oldenburg-Ligtenberg, P; Gonkel, F; de Jong, A; van Soest, J; Viergever, P; Mevissen, H; Lochorn, G; Zwiers, G; Hoogslag, P; Ronner, E; Nierop, P; Al-Windy, N; Kragten, J; Dekelver, P; Benatar, J; Krebs, J; Scott, R; Heggen, E; Berz, A; Fossum, C; Hurtig, U; Langslet, G; Baranowski, M; Sparby, J; Karlsson, T; Karlsson, T; Torres, CD; Escudero, AR; Lisson, R; Maldonado, AA; Rojas, WG; Bravo, LG; Osores, JL; Farfan, J; Zapata, L; Junchaya, JG; Concha, YR; Calderon, JU; Sy, R; Tan, G; Aquitania, G; De Los Santos, G; Panelo, A; Roderos, O; Rosales, R; Toledo, R; Liwag, A; Ramoncito, H; Skokowska, E; Krzyzagorska, E; Ogorek, M; Wojnowski, L; Spyra, J; Konieczny, M; Piesiewicz, W; Kus, W; Ocicka-Kozakiewicz, A; Orlowska-Kunikowska, E; Zmuda, W; Duarte, S; Leitao, A; Monteiro, P; Rita, H; Salgado, V; Pinto, L; Queiros, J; Teixeira, J; Rogado, C; Duarte, R; do Rosario, FS; Silva, A; Andrade, L; Velez, M; Brazao, M; Istratoaie, O; Lichiardopol, R; Catrinoiu, D; Militaru, C; Zetu, C; Barbonta, D; Cosma, D; Crisan, C; Pop, L; Esip, V; Khetagurova, F; Petrov, A; Arutyunov, G; Boyarkin, M; Agafyina, A; Vorokhobina, N; Petunina, N; Libov, I; Zalevskaya, A; Nikolaev, K; Barbarash, O; Potemkin, V; Bystrova, A; Krasilnikova, E; Barbarich, V; Chumakova, G; Tarasov, N; Meleshkevich, T; Zateyshchikov, D; Lantseva, O; Belenkiy, D; Obrezan, A; Rossolko, L; Fillipova, E; Yakhontova, P; Khokhlov, A; Tan, R; Sum, C; Chang, H; Distiller, L; Pretorius, M; Nortje, H; Mitha, E; Burgess, L; Blignaut, S; Venter, T; Moodley, R; Lombaard, J; Govind, U; Naidoo, V; Mookadam, M; Engelbrecht, J; Omar, M; Jurgens, J; Podgorski, G; Vawda, H; Naidoo, D; Emanuel, S; Roodt, A; Amod, A; Van Zyl, L; Segura, J; Brito, M; Fernandez-Cruz, A; Artola, S; Iglesias, R; Toural, E; Garcia-Ortiz, L; Saban, J; Mesa, J; Vidal, J; Linares, J; del Canizo, F; Rigla, M; Suarez, C; Llorente, I; Moreno, B; Antoli, A; Peralta, FG; Iglesias, M; Pereg, V; de Teresa, L; Camafort, M; Trescoli, C; Satarasinghe, R; Somasundaram, N; Siyambalapitiya, S; Antonypillai, C; Bulugahapitiya, D; Medagama, U; Huang, C; Lu, Y; Hwang, J; Chiang, C; Wen, M; Chen, J; Lai, W; Chang, K; Wang, J; Yeh, H; Kriangsak, P; Deerochanawong, C; Suwanwalaikorn, S; Mangklabruks, A; Kaewsuwanna, P; Piyayotai, D; Iabluchanskyi, M; Samoylov, O; Godlevska, O; Kovalyova, O; Voloshyna, O; Tseluyko, V; Zotov, S; Vykhovanyuk, I; Dulgeroff, A; Mayfield, R; Zaniewski-Singh, M; Ullal, J; Aloi, J; De La Rosa, R; Mosely, J; Wittmer, B; Aronoff, S; Rosenfeld, J; Seidner, M; Warren, M; Fishman, N; Weiss, R; Arif, A; Sandberg, M; Lewis, D; Ball, E; Graf, R; Breton, C; Tamayo, R; Richards, R; Cefalu, W; Uwaifo, G; Zayour, D; Hoffman, J; Fitz-Patrick, D; Khan, B; Blaze, K; Bressler, P; Halpern, S; Chappell, D; Bergenstal, R; Cuddihy, R; Matfin, G; Freedman, Z; Gonzalez-Campoy, J; Lerman, S; Rendell, M; Sitar, S; Reeves, M; Howard, T; Soufer, J; Miranda-Palma, B; Laliotis, A; Shomali, M; Teltser, M; Hurley, D; Morawski, E; Cherlin, R; Houchin, V; Welch, M; Goytia-Leos, D; Syed, M; Kowaloff, E; Weinrauch, L; Peniston, J; Brockmyre, A; First, B; Feld, L; Huffman, D; Nassim, O; Gottschlich, G; Patel, A; Knopke, C; Hernandez, M; Diaz, J; Giugliano, G; Nicasio, J; Eagerton, D; Huntley, R; Reed, J; Magee, M; Hippert, R; Sofley, C; Alzohaili, O; Levins, P; Anspach, R; Shah, S; Brusco, O; Naidu, J; Lindenbaum, J; Jacks, R; Hammond, G; Arena, C; Saxman, K; Mach, M; Kerstein, H; Kereiakes, D; Wahlen, J; Wehmeier, K; Chaykin, L; Rothman, J; Fogelfeld, L; Stroger, JH; Bittar, N; Rosenstock, J; Kayne, D; Navarro, J; Colfer, H; Mokshagundam, S; Shandilya, L; Connery, L; Wysham, C; Dela Llana, A; Jardula, M; MacAdams, M; Flippo, G; Heurich, E; Curtis, C; Sanders, D; Rawls, R; Velazquez, F; Osea, E; Mahood, K; Feldman, G; Eder, F; Riley, E; Fowler, W; Jain, M; Shepard, M; Schear, M; Barker, B; Strout, C; Obiekwe, O; Shanik, M; Green, C; Blakney, E; Roberson, K; Bretton, E; Pish, R; Kaveh, K; Maynard, B; Barager, W; Soldyshev, R; Austin, B; Parmar, P; Simpson, R; Chauhan, A; Kasper, J; Burr, R; Patel, N; Mariano, H; Pluto, T; Bratcher, C; Juarez, M; Levinson, L; Awad, A; Longshaw, K; Hoffman, K; Richwine, R; Molter, D; Boscia, J; Kowalyk, S; Lemis, P; Liss, J; Orr, R; Riser, J; Wood, J; Ubani, A; Paine, W; Hassani, F; Miranda, F; Hansen, V; Hansen, VR; Farris, N; Bowden, R; Ajani, D; Maw, K; Andersen, J; Bergman, B; Dunmyer, S; Brandon, D; Anderson, M; Bononi, P; Prawer, J; Seidman, B; Cruz, H; Wilks, K; DiSanto, L; Buynak, R; Christensen, T; Denker, P; Koppel, W; Stedman, M; Lewy-Alterbaum, L; Karim, S; Shapiro, J; Gardner, T; Oskin, T; Gabra, N; Malano, J				Wanner, Christoph; Inzucchi, Silvio E.; Lachin, John M.; Fitchett, David; von Eynatten, Maximilian; Mattheus, Michaela; Johansen, Odd Erik; Woerle, Hans J.; Broedl, Uli C.; Zinman, Bernard; Aizenberg, D.; Ulla, M.; Waitman, J.; De Loredo, L.; Farias, J.; Fideleff, H.; Lagrutta, M.; Maldonado, N.; Colombo, H.; Ferre Pacora, F.; Wasserman, A.; Maffei, L.; Lehman, R.; Selvanayagam, J.; d'Emden, M.; Fasching, P.; Paulweber, B.; Toplak, H.; Luger, A.; Drexel, H.; Prager, R.; Schnack, C.; Schernthaner, G.; Fliesser-Goerzer, E.; Kaser, S.; Scheen, A.; Van Gaal, L.; Hollanders, G.; Kockaerts, Y.; Capiau, L.; Chachati, A.; Persu, A.; Hermans, M.; Vantroyen, D.; Vercammen, C.; Van de Borne, P.; Mathieu, C.; Benhalima, K.; Lienart, F.; Mortelmans, J.; Strivay, M.; Vereecken, G.; Keymeulen, B.; Lamkanfi, F.; Chacra, A.; Eliaschewitz, F.; Zanella, M.; Faludi, A.; Bertolami, M.; Hayashida, C.; Nunes Salles, J.; Monte, O.; Dinato, M.; Manenti, E.; Rassi, N.; Halpern, A.; Lima Filho, M.; Ayoub, J.; Felicio, J.; Borges, J.; Gross, J.; Sgarbi, J.; Betti, R.; Tiburcio, A.; Purisch, S.; Schmid, H.; Takahashi, M.; Castro, M.; Rea, R.; Hissa, M.; Geloneze Neto, B.; Saraiva, J.; Henein, S.; Lochnan, H.; Imran, S. A.; Clayton, D.; Bayly, K.; Berlingieri, J.; Boucher, P.; Chan, Y.; Gupta, M.; Chehayeb, R.; Ouellett, A.; Ur, E.; Woo, V.; Zinman, B.; St Amour, E.; Terront Lozano, M.; Yupanqui Lozno, H.; Urina, M.; Lopez Jaramillo, P.; Jaramillo, N.; Sanchez, G.; Perez, G.; Tusek, S.; Mirosevic, G.; Goldoni, V.; Jurisic-Erzen, D.; Balasko, A.; Balic, S.; Drvodelic-Sunic, E.; Varzic, S. Canecki; Machkova, M.; Weiner, P.; Lastuvka, J.; Olsovsky, J.; Krarup, T.; Ridderstrale, M.; Tarnow, L.; Boesgaard, T. Wellov; Lihn, A. Saetre; Christensen, P.; Juhl, H.; Urhammer, S.; Lund, P.; Adojaan, B.; Jakovlev, U.; Lanno, R.; Lubi, M.; Marandi, T.; Gouet, D.; Courreges, J.; Zaoui, P.; Choukroun, G.; Petit, C.; Formagne, L.; Estour, B.; Mabire, P.; Daugenet, C.; Lemarie, B.; Clavel, S.; Aure, P.; Remaud, P.; Halimi, J.; Hadjadj, S.; Couffinhal, T.; Glonti, S.; Metreveli, D.; Lominadze, Z.; Giorgadze, E.; Burtchuladze, T.; Javashvili, L.; Kurashvili, G.; Kurashvili, R.; Virsaladze, D.; Nadareishvili, L.; Khomasuridze, A.; Cahill, T.; Green, F.; MacRury, S.; Waldron, M.; Middleton, A.; McKnight, J.; Pearson, E.; Butler, M.; Choksi, M.; Caldwell, I.; Farmer, I.; Wyatt, N.; Patrick, J.; O'Brien, I.; Devers, M.; Bousboulas, S.; Pappas, S.; Piaditis, G.; Vryonidou, A.; Tentolouris, N.; Karamitsos, K.; Manes, C.; Benroubi, M.; Avramidis, I.; Ozaki, R.; Tan, K.; Siu, S.; Tsang, C.; Dudas, M.; Nagy, K.; Salamon, C.; Ip, T.; Geroo, L.; Patkay, J.; Tabak, A.; Juhasz, F.; Szentpeteri, I.; Tamas, G.; Ghaisas, N.; Bantwal, G.; Mohan, V.; Gupta, J.; Sadhu, N.; Kulkarni, A.; Garg, N.; Reddy, S.; Deshpande, N.; Gutlapalli, K.; Pillai, M.; Premchand, R.; Badgandi, M.; Jain, S.; Aravind, S.; Shamanna, P.; Pandey, A.; Gupta, S.; Pramono, B.; Saksono, H. Dante; Agung, P.; Wahono, S. Djoko; Suastika, K.; Tanggo, Y.; Juwana, Y.; Siswanto, B.; Adawi, F.; Efrati, S.; Mazen, E.; Bashkin, A.; Herskovits, T.; Jaffe, A.; Schiff, E.; Wainstein, J.; Taddei, S.; Aiello, A.; Arca, M.; Calabro, P.; Cignarelli, M.; Fioretto, P.; Reggiani, G. Marchesini; Gnasso, A.; Marchionni, N.; Marsilii, A.; Bucci, M.; Mezzetti, A.; Pozzilli, P.; Colivicchi, F.; Santini, M.; Moro, E.; Toscano, V.; Fucili, A.; Semplicini, A.; Monno, S.; Furui, K.; Higashiue, S.; Hiramatsu, N.; Kawamitsu, K.; Takenaka, T.; Takahashi, H.; Hojo, F.; Onishi, Y.; Izumino, K.; Okubo, M.; Wakida, Y.; Kondo, Y.; Hieshima, K.; Jinnouchi, H.; Suzuki, A.; Ito, M.; Park, S.; Kim, Y.; Hong, T.; Park, H.; Gwon, H.; Kim, H.; Kang, K.; Jeong, M.; Seung, K.; Lim, D.; Rha, S.; Tahk, S.; Yang, J.; Yoon, J.; Shin, M.; Kim, D.; Jeong, J.; Ahmad, N. Nik; Mustafa, N.; Mohamed, W. Wan; Fung, Y.; Ghani, R. Abdul; Chandramouli, A.; Chee, K.; Kadir, K. Abdul; Ling, K.; Abu Hassan, M.; Foo, S.; Lee, S.; Garcia Hernandez, P.; Aguilar-Salinas, C.; Vidrio Velazquez, M.; Flores, F.; Alpizar Salazar, M.; Micher Escalante, D.; Garcia Soria, M.; Cardona Munoz, E.; Storms, G.; Schaper, N.; Kooy, A.; Krekels, M.; van Bemmel, T.; Verhoeven, R.; Mulder, H.; Oldenburg-Ligtenberg, P.; Gonkel, F.; de Jong, A.; van Soest, J.; Viergever, P.; Mevissen, H.; Lochorn, G.; Zwiers, G.; Hoogslag, P.; Ronner, E.; Nierop, P.; Al-Windy, N.; Kragten, J.; Dekelver, P.; Benatar, J.; Krebs, J.; Scott, R.; Heggen, E.; Berz, A.; Fossum, C.; Hurtig, U.; Langslet, G.; Baranowski, M.; Sparby, J.; Karlsson, T.; Karlsson, Thomas; Delgado Torres, C.; Rodriguez Escudero, A.; Lisson, R.; Allemant Maldonado, A.; Gallardo Rojas, W.; Gonzales Bravo, L.; Lema Osores, J.; Farfan, J.; Zapata, L.; Godoy Junchaya, J.; Roldan Concha, Y.; Urquiaga Calderon, J.; Sy, R.; Tan, G.; Aquitania, G.; De Los Santos, G.; Panelo, A.; Roderos, O.; Rosales, R.; Toledo, R.; Liwag, A.; Ramoncito, H.; Skokowska, E.; Krzyzagorska, E.; Ogorek, M.; Wojnowski, L.; Spyra, J.; Konieczny, M.; Piesiewicz, W.; Kus, W.; Ocicka-Kozakiewicz, A.; Orlowska-Kunikowska, E.; Zmuda, W.; Duarte, S.; Leitao, A.; Monteiro, P.; Rita, H.; Salgado, V.; Pinto, L.; Queiros, J.; Teixeira, J.; Rogado, C.; Duarte, R.; Sobral do Rosario, F.; Silva, A.; Andrade, L.; Velez, M.; Brazao, M.; Istratoaie, O.; Lichiardopol, R.; Catrinoiu, D.; Militaru, C.; Zetu, C.; Barbonta, D.; Cosma, D.; Crisan, C.; Pop, L.; Esip, V.; Khetagurova, F.; Petrov, A.; Arutyunov, G.; Boyarkin, M.; Agafyina, A.; Vorokhobina, N.; Petunina, N.; Libov, I.; Zalevskaya, A.; Nikolaev, K.; Barbarash, O.; Potemkin, V.; Bystrova, A.; Krasilnikova, E.; Barbarich, V.; Chumakova, G.; Tarasov, N.; Meleshkevich, T.; Zateyshchikov, D.; Lantseva, O.; Belenkiy, D.; Obrezan, A.; Rossolko, L.; Fillipova, E.; Yakhontova, P.; Khokhlov, A.; Tan, R.; Sum, C.; Chang, H.; Distiller, L.; Pretorius, M.; Nortje, H.; Mitha, E.; Burgess, L.; Blignaut, S.; Venter, T.; Moodley, R.; Lombaard, J.; Govind, U.; Naidoo, V.; Mookadam, M.; Engelbrecht, J.; Omar, M.; Jurgens, J.; Podgorski, G.; Vawda, H.; Naidoo, D.; Emanuel, S.; Roodt, A.; Amod, A.; Van Zyl, L.; Segura, J.; Brito, M.; Fernandez-Cruz, A.; Artola, S.; Iglesias, R.; Toural, E.; Garcia-Ortiz, L.; Saban, J.; Mesa, J.; Vidal, J.; Linares, J.; del Canizo, F.; Rigla, M.; Suarez, C.; Llorente, I.; Moreno, B.; Antoli, A.; Gomez Peralta, F.; Iglesias, M.; Pereg, V.; de Teresa, L.; Camafort, M.; Trescoli, C.; Satarasinghe, R.; Somasundaram, N.; Siyambalapitiya, S.; Antonypillai, C.; Bulugahapitiya, D.; Medagama, U.; Huang, C.; Lu, Y.; Hwang, J.; Chiang, C.; Wen, M.; Chen, J.; Lai, W.; Chang, K.; Wang, J.; Yeh, H.; Kriangsak, P.; Deerochanawong, C.; Suwanwalaikorn, S.; Mangklabruks, A.; Kaewsuwanna, P.; Piyayotai, D.; Iabluchanskyi, M.; Samoylov, O.; Godlevska, O.; Kovalyova, O.; Voloshyna, O.; Tseluyko, V.; Zotov, S.; Vykhovanyuk, I.; Dulgeroff, A.; Mayfield, R.; Zaniewski-Singh, M.; Ullal, J.; Aloi, J.; De La Rosa, R.; Mosely, J.; Wittmer, B.; Aronoff, S.; Rosenfeld, J.; Seidner, M.; Warren, M.; Fishman, N.; Weiss, R.; Arif, A.; Sandberg, M.; Lewis, D.; Ball, E.; Graf, R.; Breton, C.; Tamayo, R.; Richards, R.; Cefalu, W.; Uwaifo, G.; Zayour, D.; Hoffman, J.; Fitz-Patrick, D.; Khan, B.; Blaze, K.; Bressler, P.; Halpern, S.; Chappell, D.; Bergenstal, R.; Cuddihy, R.; Matfin, G.; Freedman, Z.; Gonzalez-Campoy, J.; Lerman, S.; Rendell, M.; Sitar, S.; Reeves, M.; Howard, T.; Soufer, J.; Miranda-Palma, B.; Laliotis, A.; Shomali, M.; Teltser, M.; Hurley, D.; Morawski, E.; Cherlin, R.; Houchin, V.; Welch, M.; Goytia-Leos, D.; Syed, M.; Kowaloff, E.; Weinrauch, L.; Peniston, J.; Brockmyre, A.; First, B.; Feld, L.; Huffman, D.; Nassim, O.; Gottschlich, G.; Patel, A.; Knopke, C.; Hernandez, M.; Diaz, J.; Giugliano, G.; Nicasio, J.; Eagerton, D.; Huntley, R.; Reed, J., III; Magee, M.; Hippert, R.; Sofley, C., Jr.; Alzohaili, O.; Levins, P.; Anspach, R.; Shah, S.; Brusco, O.; Naidu, J.; Lindenbaum, J.; Jacks, R.; Hammond, G.; Arena, C.; Saxman, K.; Mach, M.; Kerstein, H.; Kereiakes, D.; Wahlen, J.; Wehmeier, K.; Chaykin, L.; Rothman, J.; Fogelfeld, L.; Stroger, John H., Jr.; Bittar, N.; Rosenstock, J.; Kayne, D.; Navarro, J.; Colfer, H.; Mokshagundam, S.; Shandilya, L.; Connery, L.; Wysham, C.; Dela Llana, A.; Jardula, M.; MacAdams, M.; Flippo, G.; Heurich, E.; Curtis, C.; Sanders, D.; Rawls, R.; Velazquez, F.; Osea, E.; Mahood, K.; Feldman, G.; Eder, F.; Riley, E.; Fowler, W.; Jain, M.; Shepard, M.; Schear, M.; Barker, B.; Strout, C.; Obiekwe, O.; Shanik, M.; Green, C.; Blakney, E.; Roberson, K.; Bretton, E.; Pish, R.; Kaveh, K.; Maynard, B.; Barager, W.; Soldyshev, R.; Austin, B.; Parmar, P.; Simpson, R.; Chauhan, A.; Kasper, J.; Burr, R.; Patel, N.; Mariano, H.; Pluto, T.; Bratcher, C.; Juarez, M.; Levinson, L.; Awad, A.; Longshaw, K.; Hoffman, K.; Richwine, R.; Molter, D.; Boscia, J., III; Kowalyk, S.; Lemis, P.; Liss, J.; Orr, R.; Riser, J.; Wood, J.; Ubani, A.; Paine, W.; Hassani, F.; Miranda, F.; Hansen, V.; Hansen, Val R.; Farris, N.; Bowden, R.; Ajani, D.; Maw, K.; Andersen, J.; Bergman, B.; Dunmyer, S.; Brandon, D.; Anderson, M.; Bononi, P.; Prawer, J.; Seidman, B.; Cruz, H.; Wilks, K.; DiSanto, L.; Buynak, R.; Christensen, T.; Denker, P.; Koppel, W.; Stedman, M.; Lewy-Alterbaum, L.; Karim, S.; Shapiro, J.; Gardner, T.; Oskin, T.; Gabra, N.; Malano, J.		EMPA-REG OUTCOME Investigators	Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; INTENSIVE GLUCOSE CONTROL; DOUBLE-BLIND; BLOOD-PRESSURE; ADD-ON; CARDIOVASCULAR OUTCOMES; ARTERIAL STIFFNESS; END-POINTS; INHIBITION; METFORMIN	BACKGROUND Diabetes confers an increased risk of adverse cardiovascular and renal events. In the EMPA-REG OUTCOME trial, empagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of major adverse cardiovascular events in patients with type 2 diabetes at high risk for cardiovascular events. We wanted to determine the long-term renal effects of empagliflozin, an analysis that was a prespecified component of the secondary microvascular outcome of that trial. METHODS We randomly assigned patients with type 2 diabetes and an estimated glomerular filtration rate of at least 30 ml per minute per 1.73 m(2) of body-surface area to receive either empagliflozin (at a dose of 10 mg or 25 mg) or placebo once daily. Prespecified renal outcomes included incident or worsening nephropathy (progression to macroalbuminuria, doubling of the serum creatinine level, initiation of renal-replacement therapy, or death from renal disease) and incident albuminuria. RESULTS Incident or worsening nephropathy occurred in 525 of 4124 patients (12.7%) in the empagliflozin group and in 388 of 2061 (18.8%) in the placebo group (hazard ratio in the empagliflozin group, 0.61; 95% confidence interval, 0.53 to 0.70; P<0.001). Doubling of the serum creatinine level occurred in 70 of 4645 patients (1.5%) in the empagliflozin group and in 60 of 2323 (2.6%) in the placebo group, a significant relative risk reduction of 44%. Renal-replacement therapy was initiated in 13 of 4687 patients (0.3%) in the empagliflozin group and in 14 of 2333 patients (0.6%) in the placebo group, representing a 55% lower relative risk in the empagliflozin group. There was no significant between-group difference in the rate of incident albuminuria. The adverse-event profile of empagliflozin in patients with impaired kidney function at baseline was similar to that reported in the overall trial population. CONCLUSIONS In patients with type 2 diabetes at high cardiovascular risk, empagliflozin was associated with slower progression of kidney disease and lower rates of clinically relevant renal events than was placebo when added to standard care. (Funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance; EMPA-REG OUTCOME ClinicalTrials.gov number, NCT01131676.)	[Wanner, Christoph] Univ Wurzburg, Dept Med, Div Nephrol, Wurzburg, Germany; [von Eynatten, Maximilian; Mattheus, Michaela; Woerle, Hans J.; Broedl, Uli C.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Inzucchi, Silvio E.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA; [Lachin, John M.] George Washington Univ, Biostat Ctr, Rockville, MD USA; [Fitchett, David] Univ Toronto, Div Cardiol, Toronto, ON, Canada; [Zinman, Bernard] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Zinman, Bernard] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Johansen, Odd Erik] Boehringer Ingelheim Norway, Asker, Norway; [Aizenberg, D.] Ctr Med Viamonte, Buenos Aires, DF, Argentina; [Ulla, M.] ILAIMCEOM, Cordoba, Cba, Argentina; [Waitman, J.] Ctr Diabetol Dr Waitman, Cordoba, Cba, Argentina; [De Loredo, L.] Hosp Privado Ctr Med Cordoba SA, Cordoba, Cba, Argentina; [De Loredo, L.] Parque Velez Sarfield, Cordoba, Cba, Argentina; [Farias, J.; Fideleff, H.] Sanatorio Guemes Hosp Privado, Buenos Aires, DF, Argentina; [Lagrutta, M.] Inst Invest Clin, Rosario, Santa Fe, Argentina; [Maldonado, N.] Ctr Med Alta Complejidad, Rosario, Santa Fe, Argentina; [Colombo, H.] Clin Privada Colombo, Cordoba, Co, Argentina; [Ferre Pacora, F.] Ctr Med Colon, Cordoba, Co, Argentina; [Wasserman, A.] Fepreva, Buenos Aires, DF, Argentina; [Maffei, L.] Consultorios Asociados Endocrinol & Invest Clin, Buenos Aires, DF, Argentina; [Lehman, R.] Adelaide Med Res, Ashford, SA, Australia; [Selvanayagam, J.] Heart & Vasc Inst, Fullarton, SA, Australia; [d'Emden, M.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Fasching, P.] Wilhelminenspital Wien, Vienna, Austria; [Paulweber, B.] LKH Salzburg, St Johanns Spital, Salzburg, Austria; [Toplak, H.] Med Univ Graz, Graz, Austria; [Luger, A.] Univ Klin Innere Med III, Vienna, Austria; [Drexel, H.] Landeskrankenhaus Feldkirch, Feldkirch, Austria; [Prager, R.] Krankenhaus Hietzing NZR, Vienna, Austria; [Schnack, C.; Schernthaner, G.] Krankenanstalt Rudolfstiftung Wien, Semmelweis Frauenklin, Vienna, Austria; [Schernthaner, G.] Univ Klin Innere Med II, Vienna, Austria; [Kaser, S.] Univ Klin Innsbruck, Innsbruck, Austria; [Scheen, A.] Ctr Hosp Univ Liege, Liege, Belgium; [Van Gaal, L.] UZA, Edegem, Belgium; [Kockaerts, Y.] Ziekenhuis Oost Limburg, Genk, Belgium; [Chachati, A.] CHR Huy, Huy, Belgium; [Persu, A.; Hermans, M.] Clin Univ St Luc, Brussels, Belgium; [Vantroyen, D.] Huisartsenpraktijk Hygeia, Hasselt, Belgium; [Vercammen, C.] Imelda ZH Bonheiden, Bonheiden, Belgium; [Van de Borne, P.] Hop Univ Erasme, Brussels, Belgium; [Mathieu, C.; Benhalima, K.] Univ Hosp Gasthuisberg, Leuven, Belgium; [Lienart, F.] CHU Tivoli, La Louviere, Belgium; [Strivay, M.] CHR Citadelle, Site Citadelle, Liege, Belgium; [Keymeulen, B.; Lamkanfi, F.] UZ Brussels, Brussels, Belgium; [Chacra, A.] Hosp Sao Paulo UNIFESP, Villa Clementino, SP, Brazil; [Eliaschewitz, F.] Ctr Pesquisas Clin Ltda, Higienopolis, SP, Brazil; [Zanella, M.] Hosp Rim Hipertensao, Vila Clementino, SP, Brazil; [Faludi, A.; Bertolami, M.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hayashida, C.] Blumenau Serv Med SC Ltda, Vila Leopoldina, SP, Brazil; [Monte, O.] Irmandade Santa Casa Misericordia Sao Paulo, Vila Albuquerque, SP, Brazil; [Dinato, M.] Hosp Guilherme Alvaro, Ctr Pesquisas Clin, Boqueirao, ST, Brazil; [Manenti, E.] Hosp Mae Deus, Porto Alegre, RS, Brazil; [Rassi, N.] Hosp Geral Goiania, Goiania, Go, Brazil; [Halpern, A.] FMUSP, Hosp Clin Sao Paulo, Sao Paulo, Brazil; [Lima Filho, M.] Univ Ribeirao Preto, Hosp Elect Bonini, Ribeirao Preto, Brazil; [Ayoub, J.] IMC, Sao Jose Do Rio Preto, Brazil; [Felicio, J.] Hosp Univ Joao Barros Barreto, Belem, Para, Brazil; [Borges, J.] Ctr Pesquisa Clin Brasil, Brasilia, DF, Brazil; [Gross, J.] Ctr Pesquisas Diabet, Porto Alegre, RS, Brazil; [Sgarbi, J.] Hosp Clin, Fac Med Marilia, Marilia, Brazil; [Betti, R.] Inst Coracao, Sao Paulo, Brazil; [Tiburcio, A.; Purisch, S.] Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil; [Schmid, H.] Irmandade Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Takahashi, M.] Univ Estadual Maringa, Maringa, Parana, Brazil; [Castro, M.] Inst Pesquisa Clin Med Avancada, Sao Paulo, Brazil; [Rea, R.] Univ Fed Parana, Curitiba, Parana, Brazil; [Hissa, M.] Ctr Pesquisas Diabet Doencas, Fortaleza, Ceara, Brazil; [Geloneze Neto, B.] Ced Ctr Endocrinol Diabet, Campinas, Brazil; [Saraiva, J.] PUCCAMP, Hosp Maternidade Celso Peirro, Campinas, Brazil; [Henein, S.] SKDS Res Inc, Newmarket, ON, Canada; [Imran, S. A.; Clayton, D.] QEII Hlth Sci Ctr, Clin Res Ctr, Halifax, NS, Canada; [Bayly, K.] Mt Royal Family Physicians, Saskatoon, SK, Canada; [Chehayeb, R.; Ouellett, A.] ViaCar Rech Clinique Inc, Longueuil, PQ, Canada; [St Amour, E.] Q&T Res Outaouais, Gatineau, PQ, Canada; [Terront Lozano, M.] UNIENDO Unidad Integral Endocrinol, Bogota, Colombia; [Yupanqui Lozno, H.] Dexa Diab IPS, Bogota, Colombia; [Urina, M.] Fdn Caribe Investigac Biomed, Barranquilla, Colombia; [Lopez Jaramillo, P.] Fdn Oftalmolog Santander, Floridablanca, ON, Canada; [Jaramillo, N.] CEMDE, Medellin, Colombia; [Sanchez, G.] CEQUIN, Armenia, Colombia; Cardiolab Ltda, Bogota, Colombia; [Tusek, S.] Specialized Hosp Med Rehabil, Krapinske Toplice, Croatia; [Mirosevic, G.; Goldoni, V.] Univ Hosp Ctr Sestre Milosrdnice, Zagreb, Croatia; [Jurisic-Erzen, D.] Univ Hosp Ctr Rijeka, Rijeka, Croatia; [Balasko, A.; Balic, S.] Gen Hosp Sveti Duh, Zagreb, Croatia; [Drvodelic-Sunic, E.] Gen Hosp Karlovac, Karlovac, Croatia; [Varzic, S. Canecki] Clin Hosp Ctr Osijek, Osijek, Croatia; [Machkova, M.] CCBR Czech Prague Sro, Prague 3, Czech Republic; [Weiner, P.] Hosp Jindrichuv Hradec, Diabetol Out Patient Clin, Jindrichuv Hrade, Czech Republic; Masaryk Hosp, Usti Nad Labem, Czech Republic; [Olsovsky, J.] St Anna Hosp, Brno, Czech Republic; [Krarup, T.] Bispebjerg Hosp, Kobenhavn NV, Denmark; [Ridderstrale, M.; Tarnow, L.; Boesgaard, T. Wellov] Steno Diabet Ctr, Gentofte, Denmark; [Lihn, A. Saetre] Reg Hosp Randers, Randers NO, Denmark; [Christensen, P.; Juhl, H.] Slagelse Sygehus, Slagelse, Denmark; [Urhammer, S.] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Lund, P.] Forskningsctr Nordsjaellands Hosp, Helsingor, Denmark; [Adojaan, B.] Tartu Endocrinol Ctr, Tartu, Estonia; [Jakovlev, U.] East Tallinn Cent Hosp, Tallinn, Estonia; [Lanno, R.] Merelahe Family Doctors Ctr, Tallinn, Estonia; [Lubi, M.; Marandi, T.] Tartu Univ Hosp, Tartu, Estonia; [Marandi, T.] North Estonia Med Ctr Fdn, Tallinn, Estonia; [Gouet, D.] Hop St Louis, La Rochelle 1, France; [Courreges, J.] CH Narbonne, Narbonne, France; [Zaoui, P.] CHU Grenoble, Grenoble, France; [Choukroun, G.] Chu Sud, Amiens, France; [Petit, C.] Ctr Hosp Gen Sud Francilien, Corbeil Essonnes, France; [Formagne, L.] Cabinet Med, Derval, France; Hop Nord, St Priez Jarez, France; [Mabire, P.] Cabinet Med, Fleury Orne, France; [Daugenet, C.] Cabinet Med, Equeurdreville Hainevill, France; [Lemarie, B.] Cabinet Med, Bourg Des Cptes, France; [Clavel, S.] Hop Hotel Dieu, Le Creusot, France; [Aure, P.; Remaud, P.] Cabinet Med, Angers, France; [Halimi, J.] CHU Tours, Tours, France; [Hadjadj, S.] Hop Poitiers, Poitiers, France; [Couffinhal, T.] Hop Cardiol Haut Leveque, Pessac, France; [Glonti, S.] Unimed Ajara LLC, Batumi, Georgia; [Metreveli, D.] David Metreveli Med Ctr Ltd, Tbilisi, Georgia; [Lominadze, Z.] L&J Clin, Kutaisi, Georgia; [Giorgadze, E.] Natl Inst Endocrinol Ltd, Tbilisi, Georgia; [Burtchuladze, T.; Javashvili, L.] Chemotherapy & Immunotherapy Clin Medulla, Tbilisi, Georgia; [Kurashvili, G.; Kurashvili, R.] Natl Ctr Diabet Res Ltd, Tbilisi, Georgia; [Virsaladze, D.] Med Ctr Medelite Ltd, Tbilisi, Georgia; [Nadareishvili, L.; Khomasuridze, A.] Zhordania Inst Human Reprod, Tbilisi, Georgia; [Cahill, T.] Res Unit, Somerset, England; [Green, F.] NHS Dumfries Galloway, Dumfries, Scotland; [MacRury, S.] Highland Diabet Inst, Inverness, Scotland; [Waldron, M.; Middleton, A.] Fowey River Practice, Fowey, England; [McKnight, J.] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Pearson, E.] NHS Tayside, Dundee, Scotland; [Butler, M.] Waterloo Med Ctr, Blackpool, England; [Choksi, M.; Caldwell, I.] Swan Lane Med Ctr, Bolton, England; [Farmer, I.] Stanwell Rd Surg, Ashford, Kent, England; [Wyatt, N.; Patrick, J.] Ctr Hlth, Bradford, W Yorkshire, England; [O'Brien, I.] NHS Lanarkshire, Wishaw, England; [Devers, M.] NHS Lanarkshire, Airdrie, Scotland; [Bousboulas, S.; Pappas, S.] Gen Hosp Nikaia, Nikaia, Greece; [Piaditis, G.] Gen Hosp Athens G Gennimatas, Athens, Greece; [Vryonidou, A.] Korgialenio Benakio Hellen Red Cross Hosp, Athens, Greece; [Tentolouris, N.] Gen Hosp Athens Laiko, Athens, Greece; [Karamitsos, K.] Gen Hosp Larissa, Larisa, Greece; [Manes, C.] Gen Hosp Papageorgiou, Thessaloniki, Greece; [Benroubi, M.] Gen Hosp Athens Polikliniki, Athens, Greece; [Avramidis, I.] Gen Hosp Thessaloniki G Papanikolaou, Thessaloniki, Greece; [Ozaki, R.] Prince Wales Hosp, Hong Kong, Peoples R China; [Tan, K.] Queen Mary Hosp, Hong Kong, Peoples R China; [Siu, S.; Ip, T.] Tung Wah Eastern Hosp, Hong Kong, Peoples R China; [Tsang, C.] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Peoples R China; [Dudas, M.] Bekes Cty Pandy Kalman Hosp, Gyula, Hungary; [Nagy, K.] Synexus Hungary Ltd, Budapest, Hungary; [Salamon, C.] Clinfan SMO Ltd, Szekszard, Hungary; [Geroo, L.; Tabak, A.; Tamas, G.] Semmelweis Univ, Budapest, Hungary; [Patkay, J.] Szent Pantaleon Hosp, Dunaujvaros, Hungary; [Juhasz, F.] CEE Res Kft, Kisvarda, Hungary; [Szentpeteri, I.] CRU Hungary Kft, Szikszo, Hungary; [Ghaisas, N.] Shatabdi Super Special Hosp, Nasik, Maharashtra, India; [Bantwal, G.] St Johns Med Coll & Hosp, Bangalore, Karnataka, India; [Mohan, V.] Dr Mohans Diabet Special, Chennai, Tamil Nadu, India; [Gupta, J.] S R Kalla Gastroentorol & Gen Hosp, Jaipur, Rajasthan, India; [Sadhu, N.] Shree Krishna Hosp & Heart Care Ctr, Ahmadabad, Gujarat, India; [Kulkarni, A.] Deendayal Mem Hosp, Pune, Maharashtra, India; [Garg, N.] Tagore Hosp & Heart Care Ctr, Jalandhar, Punjab, India; [Reddy, S.] Sumana Hosp, Hyderabad, Telangana, India; [Deshpande, N.] Spandan Heart Inst & Res Ctr, Nagpur, Maharashtra, India; [Gutlapalli, K.] Dr Ramesh Cardiac & Multispecial Hosp Ltd, Vijaywada, Andhra Pradesh, India; [Pillai, M.] Lakshmi Hosp, Cochin, Kerala, India; [Premchand, R.] Krishna Inst Med Sci, Secunderabad, Telangana, India; [Badgandi, M.] Manipal Hosp, Bangalore, Karnataka, India; [Jain, S.] TOTAL Diabet Hormone Inst, Indore, Madhya Pradesh, India; [Aravind, S.] DIACON Hosp & Res Ctr, Bangalore, Karnataka, India; [Shamanna, P.] Bangalore Clinisearch, Bangalore, Karnataka, India; [Pandey, A.] Heritage Hosp Ltd, Varanasi, Uttar Pradesh, India; [Gupta, S.] Diabet Care N Res Ctr, Nagpur, Maharashtra, India; [Pramono, B.] Sardjito Hosp, Yogyakarta, Indonesia; [Saksono, H. Dante] Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Agung, P.] Soetomo Hosp, Surabaya, Indonesia; [Wahono, S. Djoko] Saiful Anwar Hosp, Malang, Indonesia; [Suastika, K.] Sanglah Hosp, Denpasar, Bali, Indonesia; [Tanggo, Y.] Rumah Sakit FK UKI, Jakarta, Indonesia; [Juwana, Y.] Cinere Hosp, Depok, Indonesia; [Siswanto, B.] Harapan Kita Natl Cardiovasc Ctr, Jakarta, Indonesia; [Adawi, F.] ZIV Med Ctr, Safed, Israel; [Efrati, S.] Assaf Harofeh Med Ctr, Zerifin, Israel; [Mazen, E.] Haemek Med Ctr, Afula, Israel; [Bashkin, A.; Herskovits, T.] Western Galilee Hosp, Nahariyya, Israel; [Jaffe, A.] Hillel Yaffe Med Ctr, Hadera, Israel; [Schiff, E.] Bnai Zion Med Ctr, Haifa, Israel; [Wainstein, J.] E Wolfson Med Ctr, Holon, Israel; [Taddei, S.] Dipartimento Med Interna, Pisa, Italy; [Aiello, A.] UOC Endocrinol Diabetol & Malattie Metabol, Campobasso, Italy; [Arca, M.] Dipartimento Clin & Terapia Med, Rome, Italy; [Calabro, P.] UOC Cardiol, Naples, Italy; [Cignarelli, M.] Dipartimento Sci Med, Foggia, Italy; [Fioretto, P.] Azienda Osped Padova, Padua, Italy; [Reggiani, G. Marchesini] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Gnasso, A.] A O Mater Domini, Catanzaro, Italy; [Marchionni, N.; Marsilii, A.] A O Careggi, Florence, Italy; [Bucci, M.; Mezzetti, A.] Fdn Univ G DAnnunzio, Chieti, Italy; [Pozzilli, P.] Area Endocrinol, Rome, Italy; [Colivicchi, F.; Santini, M.] Div Cardiol, Rome, Italy; [Moro, E.; Semplicini, A.] UO Med Interna, Venice, Italy; [Toscano, V.] UOC Endocrinol, Rome, Italy; [Fucili, A.] Ctr Scompenso Cardiaco, Ferrara, Italy; [Monno, S.] Chibanishi Gen Hosp, Matsudo, Chiba, Japan; [Furui, K.] Hanyu Gen Hosp, Hanyu, Saitama, Japan; [Higashiue, S.; Hiramatsu, N.] Kishiwada Tokushukai Hosp, Kishiwada, Osaka, Japan; [Kawamitsu, K.] Okinawa Tokushukai Med Corp, Yaesecho, Okinawa, Japan; [Takenaka, T.] Natl Hosp Org Hokkaido Med Ctr, Nishi Ku, Sapporo, Hokkaido, Japan; [Takahashi, H.] Iryouhouijneiwakai Minamiakatsuka Clin, Mito, Ibaraki, Japan; [Hojo, F.] Kobari Gen Hosp, Noda, Chiba, Japan; [Onishi, Y.] Inst Adult Dis, Chuo Ku, Tokyo, Japan; [Izumino, K.] Fujikoshi Hosp, Toyama, Toyama, Japan; [Okubo, M.] Gifu Heart Ctr, Gifu, Gifu, Japan; [Wakida, Y.] Daishinkai Med Corp Ookuma Hosp, Kita Ku, Nagoya, Aichi, Japan; [Kondo, Y.] Clin Horikawa, Kamigyo Ku, Kyoto, Kyoto, Japan; [Hieshima, K.; Jinnouchi, H.] Jinnouchi Diabet Ctr, Kumamoto, Kumamoto, Japan; [Suzuki, A.; Ito, M.] Fujita Hlth Univ Hosp, Toyoake, Aichi, Japan; [Park, S.] Severance Hosp, Seoul, South Korea; [Kim, Y.] Asan Med Ctr, Seoul, South Korea; [Hong, T.] Pusan Natl Univ Hosp, Pusan, South Korea; [Park, H.] Kyungpook Natl Univ Hosp, Daegu, South Korea; [Gwon, H.] Samsung Med Ctr, Seoul, South Korea; [Kim, H.] Seoul Natl Univ Hosp, Seoul, South Korea; [Kang, K.; Lee, S.] Eulji Univ Hosp, Daejeon, South Korea; [Jeong, M.] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Seung, K.] Catholic Univ Korea, Seoul, South Korea; [Lim, D.] Korea Univ Anam Hosp, Seoul, South Korea; [Rha, S.] Korea Univ Guro Hosp, Seoul, South Korea; [Tahk, S.] Ajou Univ Hosp, Suwon, South Korea; [Yang, J.] Natl Hlth Insurance Serv Ilsan Hosp, Goyang, South Korea; [Yoon, J.] Wonju Severance Christian Hosp, Wonju, South Korea; [Shin, M.] Gachon Univ Gil Med Ctr, Incheon, South Korea; [Kim, D.] Inje Univ Haeundae Paik Hosp, Busan, South Korea; [Jeong, J.] Chungnam Natl Univ Hosp, Daejoen, South Korea; [Ahmad, N. Nik] Hosp Tengku Ampuan Afzan, Pahang, Malaysia; [Mustafa, N.] Pusat Perubatan Univ, Kuala Lumpur, Malaysia; [Mohamed, W. Wan] Hosp Univ Sains Malaysia, Kelantan, Malaysia; [Fung, Y.] Queen Elizabeth Hosp, Kota Kinabalu, Malaysia; [Ghani, R. Abdul; Chandramouli, A.] Univ Teknol Mara, Selangor, Malaysia; [Chee, K.] Univ Malaya Med Ctr, Kuala Lumpur, Malaysia; [Kadir, K. Abdul] Monash Univ Sunway Campus, Selangor Darul Ehsan, Malaysia; [Ling, K.] Hosp Sultanah Aminah, Johor Baharu, Malaysia; [Abu Hassan, M.] Hosp Sultanah Bahiyah, Kedah, Malaysia; [Foo, S.] Hosp Selayang, Selangor, Malaysia; [Garcia Hernandez, P.] Hosp Univ Nuevo Leon, Monterrey, Nl, Mexico; [Aguilar-Salinas, C.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Vidrio Velazquez, M.] Unidad Invest Clin Cardiometab, Colonia Americana, Gua, Mexico; [Flores, F.] Hosp Dr Angel Leano, Los Robles, Mexico; [Alpizar Salazar, M.] Ctr Especializado Diabet, Reforma Social, Mexico; [Micher Escalante, D.; Garcia Soria, M.] Clin Res Inst, San Lucas Tepetlcalco, Mexico; [Cardona Munoz, E.] ICLE SC, Ladron De Guevara, Mexico; [Storms, G.] St Antonius Hosp, Utrecht, Netherlands; [Schaper, N.] Maastricht UMC, Maastricht, Netherlands; [Kooy, A.] Bethesda Ziekenhuis, Hoogeveen, Netherlands; [Krekels, M.] Orbis Med Ctr, Geleen, Netherlands; [van Bemmel, T.; Verhoeven, R.] Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Netherlands; [Mulder, H.] Rotterdam Res Inst, Rotterdam, Netherlands; [Oldenburg-Ligtenberg, P.] Meander Med Ctr, Amersfoort, Netherlands; [Gonkel, F.] Ropcke Zweers Ziekenhuis, Hardenberg, Netherlands; [de Jong, A.] Huisartsenpraktijk Hooge Boom, Hoogwoud, Netherlands; [van Soest, J.] Huisartsenmaatschap LSV, Nijverdal, Netherlands; [Viergever, P.] Gemini Ziekenhuis, Den Helder, Netherlands; [Mevissen, H.] Huisartsenpraktijk Wildervank, Wildervank, Netherlands; [Lochorn, G.] Med Ctr Gorecht, Hoogezand, Netherlands; [Zwiers, G.] Vlietland Ziekenhuis, Schiedam, Netherlands; [Hoogslag, P.] Diaconessenhuis Meppel, Meppel, Netherlands; [Ronner, E.] Reinier de Graaf Gasthuis, Delft, Netherlands; [Nierop, P.] St Franciscus Gasthuis, Rotterdam, Netherlands; [Al-Windy, N.] Gelre Ziekenhuizen Locatie Zutphen, Zutphen, Netherlands; [Kragten, J.] Atrium Med Ctr, Heerlen, Netherlands; [Dekelver, P.] Huisartsenpraktijk Dekelver, Baarle Nassau, Netherlands; [Benatar, J.] Auckland City Hosp, Auckland, New Zealand; [Krebs, J.] Wellington Hosp, Wellington, New Zealand; [Scott, R.] Christchurch Hosp Campus, Christchurch, New Zealand; [Heggen, E.; Langslet, G.] Oslo Univ Sykehus HF, Oslo, Norway; [Berz, A.] Med Senter Fornebu, Fornebu, Norway; [Fossum, C.] Sykehuset Innlandet HF, Gjovik, Norway; [Hurtig, U.] Sykehuset Innlandet HF, Avd Tynset, Tynset, Norway; [Baranowski, M.] Intern Med, Trondheim, Norway; [Sparby, J.] Sykehuset Innlandet HF, Kongsvinger, Kongvinger, Norway; [Delgado Torres, C.] Inst Delgado Invest Med, Arequipa, Peru; [Rodriguez Escudero, A.] Hosp Alberto Sabogal Sologuren, Bellavista, Peru; [Lisson, R.] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Allemant Maldonado, A.] Hosp Nacl Hipolito Unanue, El Agustino, Peru; [Gallardo Rojas, W.] Inst Med Miraflores, Miraflores, Peru; [Gonzales Bravo, L.] Clin Med San Martin, Ica, Peru; [Lema Osores, J.] Hosp Nacl Arzobispo Loayza, Lima, Peru; [Farfan, J.] Inst Endocrinol Farfan, Arequipa, Peru; [Zapata, L.] Casa Diabet & Nutr, Lima, Peru; [Godoy Junchaya, J.] Hosp Nacl Daniel Alcides Carrion, Lima, Peru; [Urquiaga Calderon, J.] Ctr Invest Heart Help, Lima, LI, Peru; [Sy, R.] Cardinal Santos Med Ctr, Manila, Philippines; [Tan, G.] Cebu Doctors Univ Hosp, Cebu, Philippines; [Aquitania, G.] Philippine Nikkei Jin Kai Polyclin & Diagnost Ctr, Davao, Philippines; [De Los Santos, G.; Rosales, R.] Metropolitan Med Ctr, Manila, Philippines; [Panelo, A.] UERM Inst Studies Diabet Fdn Inc, Marikina City, Philippines; [Roderos, O.] De La Salle Univ Med Ctr, Cavite City, Philippines; [Toledo, R.] Senor Santo Nino Hosp, Tarlac, Philippines; [Liwag, A.] West Visayas State Univ Med Ctr, Jaro Iloilo City, Philippines; [Ramoncito, H.] Amang Rodriguez Med Ctr, Marikina City, Philippines; [Skokowska, E.] NZOZ Przychodnia Specjalistyczna Med, Lublin, Poland; [Ogorek, M.] NZOZ All Med Med Ctr, Lodz, Poland; [Wojnowski, L.] Citomed Sp Zoo, Torun, Poland; [Konieczny, M.] Specialized Phys Off Ko Med, Pulawy, Poland; [Piesiewicz, W.] Med Ctr Hosp Swietej Rodziny, Lodz, Poland; [Ocicka-Kozakiewicz, A.] NonPubl HealthCare Ctr Nasz Lekarz, Torun, Poland; [Orlowska-Kunikowska, E.] Univ Clin Ctr, Gdansk, Poland; [Zmuda, W.] Oswiecimskie Ctr Badan Klinicznych Medicome Sp Zo, Oswiecim, Poland; [Duarte, S.] Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Leitao, A.] Ctr Hosp Lisboa Cent, Lisbon, Portugal; [Monteiro, P.] Hosp Univ Coimbra, Coimbra, Portugal; [Rita, H.] EPE, Unidade Saude Litoral Alentejano, Santiago Do Cacem, Portugal; [Salgado, V.] Hosp Fernando Fonseca, Amadora, Portugal; [Pinto, L.] EPE, Ctr Hosp Leiria Pombal, Leiria, Portugal; [Queiros, J.] Hosp Sao Joao, Porto, Portugal; [Teixeira, J.] Unidade Local Saude Alto Minho, Viana Do Castelo, Portugal; [Rogado, C.; Duarte, R.] APDP, Lisbon, Portugal; [Sobral do Rosario, F.] Hosp Luz, Lisbon, Portugal; [Silva, A.] EPE, Ctr Hosp Algarve, Faro, Portugal; [Andrade, L.] Ctr Hosp Vila Nova De Gaia Espinho, Vila Nova De Gaia, Portugal; [Velez, M.] EPE, Ctr Hosp Medio Tejo, Torres Novas, Portugal; [Brazao, M.] EPE, Serv Regiao Autonoma Madeira, Funchal, Madeira, Portugal; [Istratoaie, O.] SC Cardioctr Dr Istratoaie SRL, Craiova, Romania; [Lichiardopol, R.; Zetu, C.] Inst Diabet Nutr & Metab Dis, Bucharest, Romania; [Catrinoiu, D.] Cty Clin Hosp, Constanta, Romania; [Militaru, C.] SC Cardiomed SRL, Craiova, Romania; [Barbonta, D.] SC Diana Barbonta SRL, Alba Iulia, Romania; [Cosma, D.] Pelican Impex SRL, Cabinet 15, Oradea, Romania; [Crisan, C.] Mediab SRL, RAI Med SRL, Targu Mures, Romania; [Esip, V.; Lantseva, O.] St Petersburg State Healthcare Inst, St Petersburg, Russia; [Khetagurova, F.; Petrov, A.] Vsevolozhsk Cent Reg Hosp, Vsevolozhsk, Russia; [Arutyunov, G.] City Clin Hosp 4, Moscow, Russia; [Boyarkin, M.] City Alexander Hosp St Petersburg, St Petersburg, Russia; [Agafyina, A.] St Petersburg GUZ City Clin Hosp 40, St Petersburg, Russia; [Vorokhobina, N.] St Petersburg GUZ City Clin Hosp St Petersburg, St Petersburg, Russia; [Petunina, N.] City Clin Hosp 67, Moscow, Russia; [Libov, I.] Moscow GUZ City Clin Hosp, Moscow, Russia; [Zalevskaya, A.] Autonomous Nonprofit Org, St Petersburg, Russia; [Nikolaev, K.] City Clin Hosp 19, Novosibirsk, Russia; [Barbarash, O.] Heart & Vessels Dis Complex Problems, Kemerovo, Russia; [Potemkin, V.] Moscow GUZ City Clin Hosp 68, Moscow, Russia; [Krasilnikova, E.] St Petersburg State Med Univ, St Petersburg, Russia; [Barbarich, V.] City Clin Hosp 1, Novosibirsk, Russia; [Chumakova, G.] Altai State Med Univ, Barnaul, Russia; [Tarasov, N.] Main Dept Internal Affairs, Medicosanit Unit, Kemerovo, Russia; [Meleshkevich, T.] Cent Clin Hosp 2, Moscow, Russia; [Zateyshchikov, D.] City Hosp 17, Moscow, Russia; [Belenkiy, D.] MUZ Novosibirsk Municipal Clin Hosp Emergency 2, Novosibirsk, Russia; [Obrezan, A.] LLC Int Med Ctr SOGAZ, St Petersburg, Russia; [Rossolko, L.] City Polyclin 120, St Petersburg, Russia; [Fillipova, E.] LLC Medinet, St Petersburg, Russia; [Yakhontova, P.] Novosibirsk Reg Clin, Novosibirsk, Russia; [Khokhlov, A.] MUZ Clin Hosp 2, Yaroslavl, Russia; [Tan, R.] Natl Heart Ctr, Singapore, Singapore; [Sum, C.] Khoo Teck Puat Hosp, Singapore, Singapore; [Chang, H.] Singapore Gen Hosp, Singapore, Singapore; [Distiller, L.] Ctr Diabet & Endocrinol, Houghton, South Africa; [Pretorius, M.] Tiervlei Trial Ctr, Bellville, South Africa; [Mitha, E.] Newtown Clin Res Ctr, Newtown, South Africa; [Burgess, L.] Tread Res, Parow, South Africa; [Blignaut, S.] Paarl Res Ctr, Paarl, South Africa; [Venter, T.] Cardiol Clin Res, Alberton, South Africa; [Moodley, R.] Dr Moodley & Dr Sarvan, Tongaa, South Africa; [Lombaard, J.] Josha Res Ctr, Bloemfontein, South Africa; [Govind, U.] Dr U Govind, Sydenham, South Africa; [Mookadam, M.] Langeberg Clin Trials, Cape Town, WC, South Africa; [Engelbrecht, J.] Vergelegen Mediclin, Somerset West, South Africa; [Omar, M.] Ctr Diabet & Endocrinol, Durban, South Africa; [Jurgens, J.] DJW Navorsing, Krugersdorp, South Africa; [Podgorski, G.] Greenacres Hosp, Port Elizabeth, South Africa; [Vawda, H.; Naidoo, D.] Cardiol Res Clin, Durban, Kzn, South Africa; [Emanuel, S.] Synopsis Res, Cape Town, Wc, South Africa; [Roodt, A.] Clinresco Ctr Pty Ltd, Kempton Pk, Gau, South Africa; [Amod, A.] Chatsworth Unit 10, Med Ctr, Kzn, South Africa; [Van Zyl, L.] Clin Projects Res, Worcester, Wc, South Africa; [Segura, J.] Hosp 12 Octubre, Madrid, Spain; [Brito, M.] Hosp Univ Puerta de Hierro, Mahadahonda, Madrid, Spain; [Fernandez-Cruz, A.] Hosp Clin Univ San Carlos, Madrid, Spain; [Artola, S.] Ctr Salud Maria Jesus Hereza, Leganest, Madrid, Spain; [Iglesias, R.] Ctr Salud Pedro Lain Entralgo, Alcorcon, Madrid, Spain; [Toural, E.] Ctr Salud Lavapies, Madrid, Spain; [Garcia-Ortiz, L.] Ctr Salud La Alamedilla, Salamanca, Spain; [Saban, J.] Hosp Univ Ramon y Cajal, Madrid, Spain; [Mesa, J.] Hosp Valle De Hebron, Barcelona, Spain; [Vidal, J.; Camafort, M.] Hosp Clin Barcelona, Barcelona, Spain; [Linares, J.] Clin Inmaculada Concepc, Granada, Spain; [del Canizo, F.] Hosp Infanta Leonor, Madrid, Spain; [Rigla, M.] Corp Sanitaria Parc Tauli, Sabadell, Barcelona, Spain; [Suarez, C.] Hosp Univ La Princesa, Madrid, Spain; [Llorente, I.] Hosp Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain; [Moreno, B.] Hosp Gen Univ, Madrid, Spain; [Antoli, A.; Gomez Peralta, F.] Hosp Nuestra Senora de Sonsoles, Avila, Spain; [Iglesias, M.] AP Badia del Valles, Badia Valles Barcelona, Spain; [Gomez Peralta, F.] Hosp Gen Segovia, Segovia, Spain; [Pereg, V.] Hosp Son Espases, Palma De Mallorca, Spain; [de Teresa, L.] Inst Ciencias Med, Alicante, Spain; [Trescoli, C.] Hosp Ribera, Valencia, Spain; [Satarasinghe, R.] Sri Jayewardenepura Gen Hosp & PGMI, Nugegoda, Sri Lanka; [Somasundaram, N.] Natl Hosp, Colombo, Sri Lanka; [Siyambalapitiya, S.] Colombo North Teaching Hosp, Ragama, Sri Lanka; [Antonypillai, C.] Diabet & Endocrine Unit, Kandy, Sri Lanka; [Bulugahapitiya, D.] Diabet Clin, Kalubowila, Sri Lanka; [Medagama, U.] Teaching Hosp Peradeniya, Kandy, Sri Lanka; [Huang, C.] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Lu, Y.] E Da Hosp, Kaohsiung, Taiwan; [Hwang, J.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chiang, C.] Taipei Vet Gen Hosp, Taipei, Taiwan; [Wen, M.] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chen, J.] Natl Cheng Kung Univ Hosp, Tainan, Taiwan; [Lai, W.] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chang, K.] China Med Univ Hosp, Taichung, Taiwan; [Wang, J.] Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Yeh, H.] Mackay Mem Hosp, Tamsui, Taipei County, Taiwan; [Kriangsak, P.] Udonthani Hosp, Udon Thani, Muang District, Thailand; [Deerochanawong, C.] Rajavithi Hosp, Bangkok, Thailand; [Suwanwalaikorn, S.] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Mangklabruks, A.] Maharaj Nakorn Chiangmai Hosp, Chiang Mai, Thailand; [Kaewsuwanna, P.] Maharat Nakhon Ratchasima Hosp, Nakhon Ratchasima, Thailand; [Piyayotai, D.] Thammasat Univ Hosp, Pathum Tani, Thailand; [Iabluchanskyi, M.] Clin Hosp 5, Kharkov, Ukraine; [Samoylov, O.] Sci Ctr Radiat, Kiev, Ukraine; [Godlevska, O.] City Clin Hosp Emergency Care, Kharkov, Ukraine; [Kovalyova, O.] Kharkiv City Hosp 3, Kharkov, Ukraine; [Voloshyna, O.] Odessa State Med Univ, Odessa, Ukraine; [Tseluyko, V.] City Clin Hosp 8, Kharkov, Ukraine; [Zotov, S.; Vykhovanyuk, I.] Clin Cardiol Sertse i Sudyny LTD, Kiev, Ukraine; [Dulgeroff, A.] High Desert Med Grp, Lancaster, CA USA; [Mayfield, R.] Mt View Clin Res, Greer, SC USA; [Zaniewski-Singh, M.] Michelle Zaniewski MD PA, Houston, TX USA; [Ullal, J.; Aloi, J.] Strelitz Diabet Ctr, Norfolk, VA USA; [De La Rosa, R.] Four Rivers Clin Res, Paducah, KY USA; [Mosely, J.; Wittmer, B.] Commonwealth Biomed Res LLC, Madisonville, KY USA; [Aronoff, S.] Res Inst Dallas, Dallas, TX USA; [Rosenfeld, J.; Seidner, M.] Green & Seidner Family Practice, Lansdale, PA USA; [Warren, M.] Phys East PA, Greenville, NC USA; [Fishman, N.] Diabet & Endocrine Specialists Inc, Chesterfield, MO USA; [Weiss, R.] Maine Res Associates, Auburn, ME USA; [Arif, A.] Apex Med Res, Flint, MI USA; [Sandberg, M.] Westcott Med Ctr, Flemington, NJ USA; [Lewis, D.] Arkansas Primary Care Clin, Little Rock, AK USA; [Ball, E.] Walla Walla Clin, Walla Walla, WA USA; [Graf, R.] MultiCare Specialties Res, Tacoma, WA USA; [Breton, C.] Int Res Associates LLC, Miami, FL USA; [Tamayo, R.] Genesis Res Int, Longwood, FL USA; [Richards, R.; Cefalu, W.; Uwaifo, G.] Louisiana State Univ, New Orleans, LA USA; [Zayour, D.; Hoffman, J.] Via Christi Clin PA, Wichita, KS USA; [Fitz-Patrick, D.] East West Med Res, Honolulu, HI USA; [Khan, B.] Atlanta Clin Res Ctr, Atlanta, GA USA; [Blaze, K.] South Broward Res, Pembroke Pines, FL USA; [Bressler, P.] North Texas Endocrine Ctr, Dallas, TX USA; [Halpern, S.; Chappell, D.] Radiant Res Inc, Santa Rosa, CA USA; [Bergenstal, R.; Cuddihy, R.; Matfin, G.] Int Diabet Ctr, Minneapolis, MN USA; [Freedman, Z.] Endocrine Diabet Care & Resource Ctr, Rochester, NY USA; [Gonzalez-Campoy, J.] Minnesota Ctr Obes Metab & Edocrinol PA, Eagan, MN USA; [Lerman, S.] Ctr Diabet & Endocrine Care, Ft Lauderdale, FL USA; [Rendell, M.] Creighton Univ, Sch Med, Diabet Ctr, Omaha, NE USA; [Sitar, S.] Orange Cty Res Inst, Anaheim, CA USA; [Reeves, M.] Michael L Reeves MD, Chattanooga, MD USA; [Howard, T.] Med Affiliated Res Ctr Inc, Huntsville, AL USA; [Soufer, J.] Chase Med Res LLC, Waterbury, CT USA; [Miranda-Palma, B.] Univ Miami, Diabet Res Inst, Miami, FL USA; [Laliotis, A.] Integrated Res Ctr, San Diego, CA USA; [Shomali, M.] Union Mem Hosp, Diabet & Endocrine Ctr, Baltimore, MD USA; [Teltser, M.] A&R Res Grp LLC, Pembroke Pines, FL USA; [Hurley, D.] Med Res South LLC, Charleston, SC USA; [Morawski, E.] Holston Med Grp, Kingsport, TN USA; [Cherlin, R.] Richard Cherlin MD, Los Gatos, CA USA; [Houchin, V.] Harrisburg Family Med Ctr, Harrisburg, AR USA; [Welch, M.; Goytia-Leos, D.] Consano Clin Res, San Antonio, TX USA; [Syed, M.] Ilumina Clin Associates, Indiana, PA USA; [Kowaloff, E.; Weinrauch, L.] Atlantic Clin Trials LLC, Watertown, MA USA; [Peniston, J.] Avington Mem Hosp, Feasterville Trevose, PA USA; [Brockmyre, A.] Holston Med Grp, Bristol, TN USA; [First, B.] Ritchken & First MDs, San Diegeo, CA USA; [Feld, L.] Horizon Clin Res Associates, Gilbert, AZ USA; [Huffman, D.] Univ Diabet & Endocrine Consultants Inc, Chattanooga, TN USA; [Nassim, O.] Clin Res Inc, Huntington Pk, CA USA; [Gottschlich, G.] New Horizons Clin Res, Cincinnati, OH USA; [Patel, A.; Knopke, C.] Integrated Res Grp Inc, Riverside, CA USA; [Hernandez, M.] Berma Res Grp, Hialeah, FL USA; [Diaz, J.] Community Res South Florida, Hialeah, FL USA; [Giugliano, G.; Nicasio, J.] Baystate Med Ctr, Springfield, MA USA; [Eagerton, D.] Carolina Hlth Specialists, Myrtle Beach, SC USA; [Huntley, R.] Norwalk Med, Norwalk, CT USA; [Reed, J., III] Endocrine Res Solut Inc, Roswell, GA USA; [Magee, M.] MedStar Hlth Res Inst, Washington, DC USA; [Hippert, R.] Integrated Med Grp PC, Fleetwood, PA USA; [Sofley, C., Jr.] Internal Med Associates Anderson PA, Anderson, SC USA; [Alzohaili, O.] Alzohaili Med Consultants, Dearborn, MI USA; [Levins, P.; Anspach, R.] Clin Res Adv Inc, Phoenix, AZ USA; [Shah, S.] St Josephs Med Associates, Stockton, CA USA; [Brusco, O.] Osvaldo Brusco MD, Corpus Christi, TX USA; [Naidu, J.] Naidu Clin, Odessa, TX USA; [Lindenbaum, J.] Jeffry Lindenbaum DO PC, Yardley, PA USA; [Jacks, R.] Hill Cty Med Associates, New Braunfels, TX USA; [Hammond, G.] Dormir Clin Trials Inc, Midvale, UT USA; [Arena, C.] Utah Clin Trials LLC, Salt Lake City, UT USA; [Saxman, K.] Oregon Med Grp, Adult Med Clin, Eugene, OR USA; [Mach, M.] Valley Endocrine & Diabet Consultants Inc, Valencia, CA USA; [Kerstein, H.] Howard Kerstein MD, Denver, CO USA; [Kereiakes, D.] Carl & Edyth Linder Ctr Res & Educ, Cincinnati, OH USA; [Wahlen, J.] Adv Res Inst, South Ogden, UT USA; [Wehmeier, K.] UF Endocrinol & Diabet, Jacksonville, FL USA; [Chaykin, L.] Meriden Res, Bradenton, FL USA; [Rothman, J.] Univ Phys Grp, Staten Isl, NY USA; [Fogelfeld, L.; Stroger, John H., Jr.] Cook Cty Hosp, Chicago, IL 60612 USA; [Bittar, N.] Gemini Sci LLC, Madison, WI USA; [Rosenstock, J.] Dallas Diabet & Endocrine Ctr, Dallas, TX USA; [Kayne, D.] Med Grp Encino, Encino, CA USA; [Navarro, J.] Genesis Clin Res, Tampa, FL USA; [Colfer, H.] Nisus Res, Petoskey, MI USA; [Mokshagundam, S.] Robley Rex VA Med Ctr, Louisville, KY USA; [Shandilya, L.] Ettrick Hlth Ctr PA, South Chesterfield, PA USA; [Connery, L.] Lion Res, Norman, OK USA; [Wysham, C.] Rockwood Diabet & Metab Hlth Ctr, Spokane, WA USA; [Dela Llana, A.] MediSphere Med Res Ctr LLC, Evansville, IN USA; [Jardula, M.] Desert Oasis Healthcare, Palm Springs, CA USA; [MacAdams, M.] Lubbock Diagnost Clin, Lubbock, TX USA; [Flippo, G.] Alabama Clin Therapeut LLC, Birmingham, AL USA; [Heurich, E.; Curtis, C.] Compass Res, Orlando, FL USA; [Sanders, D.; Rawls, R.] Horizan Res Grp Inc, Mobile, AL USA; [Velazquez, F.] Pioneer Res Solut Inc, Houston, TX USA; [Osea, E.] Innovat Clin Res Inc, Harbor City, CA USA; [Mahood, K.] Family Med Sayebrook, Myrtle Beach, SC USA; [Feldman, G.] South Carolina Pharmaceut Res, Spartanburg, SC USA; [Eder, F.] United Med Associates, Binghamton, NY USA; [Riley, E.; Fowler, W.] Tower Pointe Res Ctr, Hodges, SC USA; [Jain, M.] Southwest Clin Res Ctr LLC, Pearland, TX USA; [Shepard, M.] Medstar Res Inst, Hyattsville, MD USA; [Schear, M.] Dayton Clin Res, Dayton, OH USA; [Barker, B.] Delaware Res, Delaware, OH USA; [Strout, C.] Coastal Carolina Res Ctr, Mt Pleasant, SC USA; [Obiekwe, O.] Ropheka Med Ctr, Riverdale, GA USA; [Shanik, M.] Endocrine Associates Long Isl PC, Smithtown, NY USA; [Green, C.; Blakney, E.] Green Clin PC, Memphis, TN USA; [Roberson, K.] Delta Waves Inc, Colorado Springs, CO USA; [Bretton, E.] Albuquerque Clin Trials, Albuquerque, NM USA; [Pish, R.] Pish Med Associates, Uniontown, PA USA; [Kaveh, K.] Coastal Nephrol Associates Res Ctr LLC, Port Charlotte, FL USA; [Maynard, B.; Barager, W.; Soldyshev, R.] Great Falls Clin LLP, Great Falls, MT USA; [Austin, B.] Preferred Primary Care Phys Inc, Pittsburgh, PA USA; [Parmar, P.; Simpson, R.] Lynn Inst, Denver, CO USA; [Chauhan, A.] Prime Med Grp, Clairton, PA USA; [Kasper, J.; Burr, R.] Focus Clin Res, Draper, UT USA; [Patel, N.] Wells Inst Hlth Awareness, Kettering, OH USA; [Mariano, H.] Fresno Inc, Res Ctr, Fresno, CA USA; [Pluto, T.] Fay West Family Practice, Scottdale, PA USA; [Bratcher, C.] Diabet Amer, Plano, TX USA; [Juarez, M.] Panacea Clin Res, San Antonio, TX USA; [Levinson, L.] Tipton Med Diagnost Ctr, Tipton, PA USA; [Awad, A.] Clin Res Consultants LLC, Kansas City, MO USA; [Longshaw, K.] Leading Edge Res PA, Dallas, TX USA; [Hoffman, K.] TRY Res, Maitland, FL USA; [Richwine, R.] Texas Hlth Physicians Grp, Ft Worth, TX USA; [Molter, D.] North Myrtle Beach Family Practice, North Myrtle Beach, SC USA; [Boscia, J., III] CU Pharmaceut Res, Union, SC USA; [Kowalyk, S.] Endocrinol Associates, Greensburg, PA USA; [Lemis, P.] Jefferson Cardiol Assoc, Clairton, PA USA; [Liss, J.] Med Res & Hlth Educ Fdn Inc, Columbus, GA USA; [Orr, R.] Phoenix Med Grp PC, Peoria, AZ USA; [Riser, J.] Riser Med Res, Picayune, MS USA; [Wood, J.] Leading Edge Res PA INOVA, Richardson, TX USA; [Ubani, A.] Windsor Med Clin, Tampa, FL USA; [Paine, W.; Hassani, F.] Mileground Family Practice, Morgantown, WV USA; [Farris, N.] Lexington LLC, Res Grp, Lexington, KY USA; [Bowden, R.] Charleston Internal Med Res Inst, Charleston, WV USA; [Ajani, D.] Southwest Clin Trial, Houston, TX USA; [Maw, K.; Andersen, J.] Meridien Res, Brooksville, FL USA; [Bergman, B.] Benefis Hlth Grp, Great Falls, MT USA; [Dunmyer, S.] Pharmacotherapy Res Associates Inc, Zanesville, OH USA; [Brandon, D.] Calif Res Fdn, San Diego, CA USA; [Anderson, M.] Kernodle Clin, Burlington, NC USA; [Bononi, P.] Partners Nephrol Endocrinol, Pittsburgh, PA USA; [Seidman, B.] Seidman Clin Trials, Delray Beach, FL USA; [Cruz, H.] Florida Inst Clin Res, Orlando, FL USA; [Buynak, R.] Buynak Clin Res, Valparaiso, IN USA; [Christensen, T.] Calabash Med Ctr, Calabash, NC USA; [Denker, P.] Gulfcoast Endocrine & Diabet Ctr, Clearwater, FL USA; [Stedman, M.] Stedman Clin Trials, Tampa, FL USA; [Lewy-Alterbaum, L.] All Med Res LLC, Cooper City, FL USA; [Karim, S.; Shapiro, J.] Philadelphia Hlth Associates, Philadelphia, PA USA; [Gardner, T.; Oskin, T.] Northside Internal Med, Spokane, WA USA; [Gabra, N.; Malano, J.] Burke Internal Med & Res, Burke, VA USA	University of Wurzburg; Boehringer Ingelheim; Yale University; George Washington University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Boehringer Ingelheim; Hospital Privado - Universitario de Cordoba; Royal Brisbane & Women's Hospital; Wilhelminenspital; Medical University of Graz; Rudolfstiftung Hospital; Medical University of Innsbruck; University of Liege; East Limburg Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven; Universidade Federal de Sao Paulo (UNIFESP); Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Ribeirao Preto; Faculdade de Medicina de Marilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Maringa; Universidade Federal do Parana; Pontificia Universidade Catolica de Campinas; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Rijeka; Masaryk Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); University of Copenhagen; Bispebjerg Hospital; Steno Diabetes Center; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Tours; CHU Poitiers; Universite de Poitiers; CHU Bordeaux; University of Edinburgh; Laiko General Hospital; Papageorgiou Hospital; George Papanikolaou General Hospital of Thessaloniki; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Alice Ho Miu Ling Nethersole Hospital; Semmelweis University; St. John's National Academy of Health Sciences; St. John's Medical College; Central General Hospital Dr. Sardjito; University of Indonesia; Sanglah General Hospital; Ziv Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Emek Medical Center; Western Galilee Hospital; Bnai Zion Medical Center; University of Padua; Azienda Ospedaliera - Universita di Padova; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; G d'Annunzio University of Chieti-Pescara; Fujita Health University; Yonsei University; Yonsei University Health System; Pusan National University; Pusan National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Eulji University; Chonnam National University; Chonnam National University Hospital; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Ajou University; Ajou University Hospital; National Health Insurance Service; Gachon University; Inje University; Chungnam National University; Chungnam National University Hospital; Universiti Malaya; Universiti Sains Malaysia; Universiti Teknologi MARA; Universiti Malaya; Monash University; Monash University Sunway; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; St. Antonius Hospital Utrecht; Maastricht University; Maastricht University Medical Centre (MUMC); Orbis Medical Center; Gelre Hospitals; Meander Medisch Centrum; Reinier de Graaf Hospital; Franciscus Gasthuis; Atrium Medical Center; Auckland City Hospital; Christchurch Hospital New Zealand; Innlandet Hospital Trust; Innlandet Hospital Trust; Innlandet Hospital Trust; Seguro Social de Salud del Peru; Cebu Doctors University; UERM Memorial Medical Center; De La Salle University; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Hospital Professor Doutor Fernando Fonseca, EPE; Sao Joao Hospital; Pavlov First Saint Petersburg State Medical University; Altai State Medical University; National Heart Centre Singapore; Singapore General Hospital; Hospital Universitario 12 de Octubre; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Ramon y Cajal; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Infanta Leonor; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital de La Princesa; Hospital Universitari Son Espases; University of Colombo; Colombo North Teaching Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; E-Da Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Mackay Memorial Hospital; Rajavithi Hospital; Chulalongkorn University; Chiang Mai University; Thammasat University; National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; Odessa National Medical University; Louisiana State University System; International Diabetes Center; Creighton University; University of Miami; Union Memorial Hospital; Baystate Medical Center; MedStar Health Research Institute; John H Stroger Junior Hospital Cook County; Diabetes & Endocrine Center	Wanner, C (corresponding author), Univ Clin, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.	wanner_c@ukw.de	Krarup, Thure/AHD-5424-2022; Scott, Russell/ABC-8328-2020; Trescolí, Carlos/GLQ-7462-2022; Chumakova, Galina A/L-5677-2015; Woerle, Hans/ABE-1013-2021; mathieu, chantal/ABD-5505-2021; Halimi, jean-michel/AAO-5268-2020; Zateyshchikov, Dmitry/AGN-8590-2022; TENTOLOURIS, NIKOLAOS/AAH-6231-2019; Cruz, Ana Fernández/L-2429-2019; Toplak, Hermann/ABG-3269-2020; Khokhlov, Alexander L./E-2765-2017; Chee, Kok Han/I-2138-2013; Inzucchi, Silvio/ABF-4121-2021; catrinoiu, doina/AAC-9317-2021; Zinman, Bernard/E-7266-2013; Rigla, Mercedes/AAM-2183-2020; Arutyunov, Gregory/M-7368-2019; Nikolaev, Konstantin/P-4750-2017; Geloneze, Bruno/F-4231-2010; Babkowski, Miguel Camafort/AAE-3657-2021; Camafort-Babkowski, Miguel/H-6310-2014; fioretto, paola/AHD-4415-2022; Urina-Triana, Miguel A/H-2605-2016; Marchionni, Niccolò/ABE-3977-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; pinto, leonor/HGC-4320-2022; De Jong, Audrey/AAA-8553-2020; Schaper, Nicolaas C/E-7112-2014; Heerspink, Hiddo J Lambers/K-3358-2014; de Zeeuw, Dick/E-9080-2014; Libov, Igor/GRN-8152-2022; Onishi, Yukiko/AAU-9057-2021; Rha, Seung-Woon/AGE-5810-2022; Uwaifo, Gabriel I/M-2361-2016; Calabro, Paolo/AAC-2704-2022; Zateyshchikov, Dmitry A/D-6575-2012; Semplicini, Andrea/B-5959-2013; Mirosevic, Gorana/AAK-9294-2021; Barbarash, Olga/A-4834-2017; Couffinhal, Thierry/M-6857-2014	Krarup, Thure/0000-0002-9152-0583; Scott, Russell/0000-0002-2107-6480; Chumakova, Galina A/0000-0002-2810-6531; mathieu, chantal/0000-0002-4055-5233; Zateyshchikov, Dmitry/0000-0001-7065-2045; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Cruz, Ana Fernández/0000-0003-1189-1120; Toplak, Hermann/0000-0002-7513-5167; Khokhlov, Alexander L./0000-0002-0032-0341; Chee, Kok Han/0000-0002-4485-0504; Rigla, Mercedes/0000-0002-6691-4871; Arutyunov, Gregory/0000-0002-6645-2515; Nikolaev, Konstantin/0000-0003-4601-6203; Geloneze, Bruno/0000-0002-0557-4578; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Urina-Triana, Miguel A/0000-0001-6003-4622; Marchionni, Niccolò/0000-0002-8101-4695; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; de Zeeuw, Dick/0000-0003-3434-7777; Onishi, Yukiko/0000-0003-1180-5982; Rha, Seung-Woon/0000-0001-9456-9852; Uwaifo, Gabriel I/0000-0002-6962-9304; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Semplicini, Andrea/0000-0003-0652-0739; Tabak, Adam/0000-0002-6234-3936; Mulder, Hindrik/0000-0002-6593-8417; Lochnan, Heather/0000-0002-3820-7897; schaper, nicolaas/0000-0002-2128-8029; Sairanen, Tiina/0000-0002-2923-7445; Marchesini, Giulio/0000-0003-2407-9860; Andrade, Lucia/0000-0002-3078-8957; Barbarash, Olga/0000-0002-4642-3610; Turan, Tanya/0000-0001-5399-8845; Segura, Julian/0000-0003-4677-9526; Gardner, Thomas/0000-0002-5112-5810; Godlevska, Olga/0000-0001-7473-9711; Deerochanawong, Chaicharn/0000-0001-9666-7050; S, Paramesh/0000-0002-0693-4483; Zanella, Maria Teresa/0000-0002-8451-8522; Colivicchi, Furio/0000-0001-7187-2234; Lachin, John/0000-0001-9838-2841; Vidal, Josep/0000-0002-4564-4518; Wakisaka, Masanori/0000-0002-1373-4287; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Couffinhal, Thierry/0000-0002-9217-2533; Sgarbi, Jose/0000-0001-7187-984X; BUCCI, MARCO/0000-0002-5213-7768	Boehringer Ingelheim; Eli Lilly and Company Diabetes Alliance	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly and Company Diabetes Alliance(Eli Lilly)	Funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance; EMPA-REG OUTCOME ClinicalTrials.gov number, NCT01131676.)	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Barnett AH, 2014, LANCET DIABETES ENDO, V2, P369, DOI 10.1016/S2213-8587(13)70208-0; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Cherney DZI, 2014, KIDNEY INT, V86, P1057, DOI 10.1038/ki.2014.246; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Chilton R, 2015, DIABETES OBES METAB, V17, P1180, DOI 10.1111/dom.12572; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073; Holtkamp FA, 2011, KIDNEY INT, V80, P282, DOI 10.1038/ki.2011.79; Jordan J, 2014, DIABETES, V63, pA265; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Molitch ME, 2015, KIDNEY INT, V87, P20, DOI 10.1038/ki.2014.128; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Roscioni SS, 2014, NAT REV NEPHROL, V10, P77, DOI 10.1038/nrneph.2013.251; Rosenstock J, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12503; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schoolwerth AC, 2001, CIRCULATION, V104, P1985, DOI 10.1161/hc4101.096153; Skrtic M, 2015, CURR OPIN NEPHROL HY, V24, P96, DOI 10.1097/MNH.0000000000000084; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Tikkanen I, 2015, DIABETES CARE, V38, P420, DOI 10.2337/dc14-1096; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zinman B, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-102; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	38	1781	1880	4	220	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					323	334		10.1056/NEJMoa1515920	http://dx.doi.org/10.1056/NEJMoa1515920			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0UV	27806236	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000380313200006
